PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dermer, J; Fuchs, G				Dermer, Juri; Fuchs, Georg			Molybdoenzyme That Catalyzes the Anaerobic Hydroxylation of a Tertiary Carbon Atom in the Side Chain of Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLBENZENE DEHYDROGENASE; INITIAL STEPS; DEGRADATION; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; MECHANISM; MEMBRANE; PROTEINS	Cholesterol is a ubiquitous hydrocarbon compound that can serve as substrate for microbial growth. This steroid and related cyclic compounds are recalcitrant due to their low solubility in water, complex ring structure, the presence of quaternary carbon atoms, and the low number of functional groups. Aerobic metabolism therefore makes use of reactive molecular oxygen as co-substrate of oxygenases to hydroxylate and cleave the sterane ring system. Consequently, anaerobic metabolism must substitute oxygenase-catalyzed steps by O-2-independent hydroxylases. Here we show that one of the initial reactions of anaerobic cholesterol metabolism in the beta-proteobacterium Sterolibacterium denitrificans is catalyzed by an unprecedented enzyme that hydroxylates the tertiary C25 atom of the side chain without molecular oxygen forming a tertiary alcohol. This steroid C25 dehydrogenase belongs to the dimethyl sulfoxide dehydrogenase molybdoenzyme family, the closest relative being ethylbenzene dehydrogenase. It is a heterotrimer, which is probably located at the periplasmic side of the membrane and contains one molybdenum cofactor, five [Fe-S] clusters, and one heme b. The draft genome of the organism contains several genes coding for related enzymes that probably replace oxygenases in steroid metabolism.	[Dermer, Juri; Fuchs, Georg] Univ Freiburg, Lehrstuhl Mikrobiol, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Lehrstuhl Mikrobiol, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Behrman EJ, 2005, J CHEM EDUC, V82, P1791, DOI 10.1021/ed082p1791; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bode HB, 2003, MOL MICROBIOL, V47, P471, DOI 10.1046/j.1365-2958.2003.03309.x; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2008, APPL ENVIRON MICROB, V74, P107, DOI 10.1128/AEM.01968-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Chiang YR, 2010, MICROBIOL-SGM, V156, P2253, DOI 10.1099/mic.0.037788-0; Drummond A. J., 2011, GENEIOUS VERSION 5 4; Ferrato F, 1997, METHOD ENZYMOL, V286, P327; Gallien S, 2009, GENOME RES, V19, P128, DOI 10.1101/gr.081901.108; GENNIS RB, 1977, ANNU REV BIOPHYS BIO, V6, P195, DOI 10.1146/annurev.bb.06.060177.001211; Hanlon SP, 1996, EUR J BIOCHEM, V239, P391, DOI 10.1111/j.1432-1033.1996.0391u.x; Harder J, 1997, ARCH MICROBIOL, V167, P269, DOI 10.1007/s002030050442; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; KIESLICH K, 1985, J BASIC MICROB, V25, P461, DOI 10.1002/jobm.3620250713; KIESLICH K, 1980, BIOTECHNOL LETT, V2, P211, DOI 10.1007/BF01209435; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; Krafft T, 2000, DNA Seq, V10, P365, DOI 10.3109/10425170009015604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MACKENZIE AS, 1982, SCIENCE, V217, P491, DOI 10.1126/science.217.4559.491; McDevitt CA, 2002, MOL MICROBIOL, V44, P1575, DOI 10.1046/j.1365-2958.2002.02978.x; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; PRUTZ WA, 1993, FREE RADICAL RES COM, V18, P159, DOI 10.3109/10715769309147489; Rabus R, 2002, ARCH MICROBIOL, V178, P506, DOI 10.1007/s00203-002-0487-2; Ramos-Vera WH, 2010, J BACTERIOL, V192, P5329, DOI 10.1128/JB.00729-10; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; ROTHMAN JE, 1972, NATURE-NEW BIOL, V237, P42, DOI 10.1038/newbio237042a0; Sachelaru P, 2006, APPL ENVIRON MICROB, V72, P5126, DOI 10.1128/AEM.00437-06; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SEYBERT DW, 1979, J BIOL CHEM, V254, P2088; Szaleniec M, 2007, BIOCHEMISTRY-US, V46, P7637, DOI 10.1021/bi700633c; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; WITTENBERG C, 1985, J BIOL CHEM, V260, P2535	42	39	40	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36905	36916		10.1074/jbc.M112.407304	http://dx.doi.org/10.1074/jbc.M112.407304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942275	Green Published, hybrid			2022-12-28	WOS:000310588500027
J	Koutsoupakis, C; Soulimane, T; Varotsis, C				Koutsoupakis, Constantinos; Soulimane, Tewfik; Varotsis, Constantinos			Spectroscopic and Kinetic Investigation of the Fully Reduced and Mixed Valence States of ba(3)-Cytochrome c Oxidase from Thermus thermophilus A FOURIER TRANSFORM INFRARED (FTIR) AND TIME-RESOLVED STEP-SCAN FTIR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; ELECTRON-TRANSFER REACTIONS; CYTOCHROME BA(3) OXIDASE; LOW-SPIN HEME; PARACOCCUS-DENITRIFICANS; SINGLE-TURNOVER; DOCKING SITE; DYNAMICS; BINDING; PHOTODISSOCIATION	The complete understanding of a molecular mechanism of action requires the thermodynamic and kinetic characterization of different states and intermediates. Cytochrome c oxidase reduces O-2 to H2O, a reaction coupled to proton translocation across the membrane. Therefore, it is necessary to undertake a thorough characterization of the reduced form of the enzyme and the determination of the electron transfer processes and pathways between the redox-active centers. In this study Fourier transform infrared (FTIR) and time-resolved step-scan FTIR spectroscopy have been applied to study the fully reduced and mixed valence states of cytochrome ba(3) from Thermus thermophilus. We used as probe carbon monoxide (CO) to characterize both thermodynamically and kinetically the cytochrome ba(3)-CO complex in the 5.25-10.10 pH/pD range and to study the reverse intramolecular electron transfer initiated by the photolysis of CO in the two-electron reduced form. The time-resolved step-scan FTIR data revealed no pH/pD dependence in both the decay of the transient Cu-B 1(+)-CO complex and rebinding to heme a(3) rates, suggesting that no structural change takes place in the vicinity of the binuclear center. Surprisingly, photodissociation of CO from the mixed valence form of the enzyme does not lead to reverse electron transfer from the reduced heme a3 to the oxidized low-spin heme b, as observed in all the other aa(3) and bo(3) oxidases previously examined. The heme b-heme a(3) electron transfer is guaranteed, and therefore, there is no need for structural rearrangements and complex synchronized cooperativities. Comparison among the available structures of ba(3) and aa(3)-cytochrome c oxidases identifies possible active pathways involved in the electron transfer processes and key structural elements that contribute to the different behavior observed in cytochrome ba(3).	[Koutsoupakis, Constantinos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	Cyprus University of Technology; University of Limerick; University of Limerick	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, POB 50329, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy		Varotsis, Constantinos/0000-0003-2771-8891	Cyprus University of Technology research funds; Science Foundation Ireland Grant [BICF865]	Cyprus University of Technology research funds; Science Foundation Ireland Grant(Science Foundation Ireland)	This work was supported by Cyprus University of Technology research funds (to C. V.) and Science Foundation Ireland Grant BICF865 (to T. S.).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; [Anonymous], 2001, PYMOL MOL GRAPH SYST; Belevich I, 2006, BIOCHEMISTRY-US, V45, P4000, DOI 10.1021/bi052458p; Brzezinski P, 1996, BIOCHEMISTRY-US, V35, P5611, DOI 10.1021/bi960260m; BRZEZINSKI P, 1985, FEBS LETT, V187, P111, DOI 10.1016/0014-5793(85)81224-2; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Daskalakis V, 2011, J PHYS CHEM B, V115, P3648, DOI 10.1021/jp1115993; EINARSDOTTIR O, 1989, J BIOL CHEM, V264, P2405; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; Farver O, 2006, FEBS LETT, V580, P3417, DOI 10.1016/j.febslet.2006.05.013; Fee JA, 2008, J AM CHEM SOC, V130, P15002, DOI 10.1021/ja803112w; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOLDBECK RA, 1992, BIOCHEMISTRY-US, V31, P9376, DOI 10.1021/bi00154a008; Gomes CM, 2001, FEBS LETT, V497, P159, DOI 10.1016/S0014-5793(01)02431-0; Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Hayashi T, 2007, J AM CHEM SOC, V129, P14952, DOI 10.1021/ja074600a; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P9648, DOI 10.1021/bi9903401; HILL BC, 1994, J BIOL CHEM, V269, P2419; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Iwaki M, 2007, J AM CHEM SOC, V129, P2923, DOI 10.1021/ja067779i; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 2005, P NATL ACAD SCI USA, V102, P10882, DOI 10.1073/pnas.0503001102; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kannt A, 1998, FEBS LETT, V434, P17, DOI 10.1016/S0014-5793(98)00942-9; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; Koutsoupakis C, 2004, BIOPHYS J, V86, P2438, DOI 10.1016/S0006-3495(04)74300-3; Koutsoupakis C, 2003, J AM CHEM SOC, V125, P14728, DOI 10.1021/ja036107e; Koutsoupakis C, 2003, J BIOL CHEM, V278, P36806, DOI 10.1074/jbc.M307117200; Koutsoupakis K, 2003, J BIOL CHEM, V278, P14893, DOI 10.1074/jbc.M210293200; Koutsoupakis K, 2002, J BIOL CHEM, V277, P32860, DOI 10.1074/jbc.M204943200; Liu B, 2009, BIOCHEMISTRY-US, V48, P820, DOI 10.1021/bi801759a; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Maneg O, 2003, J BIOL CHEM, V278, P46734, DOI 10.1074/jbc.M307594200; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Medvedev DM, 2000, J AM CHEM SOC, V122, P6571, DOI 10.1021/ja0000706; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; Nicholls P, 2004, BBA-BIOENERGETICS, V1655, P381, DOI 10.1016/j.bbabio.2003.06.007; Noor MR, 2012, BBA-BIOENERGETICS, V1817, P638, DOI 10.1016/j.bbabio.2011.08.004; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; Pilet E, 2004, BIOCHEMISTRY-US, V43, P14118, DOI 10.1021/bi0488808; Pinakoulaki E, 2005, J AM CHEM SOC, V127, P15161, DOI 10.1021/ja0539490; Pinakoulaki E, 2004, J BIOL CHEM, V279, P22791, DOI 10.1074/jbc.C400124200; Prutsch A, 2002, BBA-BIOENERGETICS, V1554, P22, DOI 10.1016/S0005-2728(02)00207-4; Regan JJ, 1998, J BIOENERG BIOMEMBR, V30, P35, DOI 10.1023/A:1020551326307; Rost B, 1999, BIOCHEMISTRY-US, V38, P7565, DOI 10.1021/bi990225q; Siletsky SA, 2007, BBA-BIOENERGETICS, V1767, P1383, DOI 10.1016/j.bbabio.2007.09.010; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Sousa FL, 2008, BIOPHYS J, V94, P2434, DOI 10.1529/biophysj.107.122614; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Szundi I, 2007, BIOCHEMISTRY-US, V46, P12568, DOI 10.1021/bi700728g; Szundi I, 2010, P NATL ACAD SCI USA, V107, P21010, DOI 10.1073/pnas.1008603107; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Than M. E., 2001, BA3 CYTOCHROME OXIDA, P363; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 2001, BBA-BIOENERGETICS, V1506, P143, DOI 10.1016/S0005-2728(01)00220-1; WOODRUFF WH, 1993, J BIOENERG BIOMEMBR, V25, P177, DOI 10.1007/BF00762859; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	71	7	7	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37495	37507		10.1074/jbc.M112.403600	http://dx.doi.org/10.1074/jbc.M112.403600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22927441	Green Published, hybrid			2022-12-28	WOS:000310588500078
J	Wong, AHM; Zhou, DX; Rini, JM				Wong, Alan H. M.; Zhou, Dongxia; Rini, James M.			The X-ray Crystal Structure of Human Aminopeptidase N Reveals a Novel Dimer and the Basis for Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE A(4) HYDROLASE; RENIN-ANGIOTENSIN SYSTEM; TUMOR-NECROSIS-FACTOR; ACTIVE-SITE; CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; CD13; INHIBITORS; BINDING; RECEPTOR	Human aminopeptidase N (hAPN/hCD13) is a dimeric membrane protein and a member of the M1 family of zinc metallopeptidases. Within the rennin-angiotensin system, its enzymatic activity is responsible for processing peptide hormones angiotensin III and IV. In addition, hAPN is also involved in cell adhesion, endocytosis, and signal transduction and it is an important target for cancer therapy. Reported here are the high resolution x-ray crystal structures of the dimeric ectodomain of hAPN and its complexes with angiotensin IV and the peptidomimetic inhibitors, amastatin and bestatin. Each monomer of the dimer is found in what has been termed the closed form in other M1 enzymes and each monomer is characterized by an internal cavity surrounding the catalytic site as well as a unique substrate/inhibitor-dependent loop ordering, which in the case of the bestatin complex suggests a new route to inhibitor design. The hAPN structure provides the first example of a dimeric M1 family member and the observed structural features, in conjunction with a model for the open form, provide novel insights into the mechanism of peptide processing and signal transduction.	[Zhou, Dongxia; Rini, James M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wong, Alan H. M.; Rini, James M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Rini, JM (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	james.rini@utoronto.ca		Wong, Alan H.M./0000-0001-9763-6555	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; ASHMUN RA, 1990, BLOOD, V75, P462; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bhagwat SV, 2003, BLOOD, V101, P1818, DOI 10.1182/blood-2002-05-1422; Birtley J. R., 2011, BIOCHEMISTRY; Chai SY, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S14; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAVALORO E, 1993, EXP HEMATOL, V21, P1695; FERACCI H, 1981, BIOCHIM BIOPHYS ACTA, V658, P148, DOI 10.1016/0005-2744(81)90258-8; Fujita K, 2000, BIOCHEM BIOPH RES CO, V267, P134, DOI 10.1006/bbrc.1999.1963; Gandhi A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00186; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Ghosh M, 2012, J IMMUNOL, V188, P5489, DOI 10.4049/jimmunol.1103490; GORVEL JP, 1989, J CELL BIOL, V108, P2193, DOI 10.1083/jcb.108.6.2193; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; Helgstrand C, 2011, J MOL BIOL, V406, P120, DOI 10.1016/j.jmb.2010.11.059; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; HUSSAIN MM, 1981, BIOCHEM J, V199, P179, DOI 10.1042/bj1990179; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Jacobsen FE, 2007, CHEMMEDCHEM, V2, P152, DOI 10.1002/cmdc.200600204; Jones PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028589; KANIA RK, 1977, J BIOL CHEM, V252, P4929; Kehlen A, 2003, CANCER RES, V63, P8500; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Nocek B, 2008, PROTEINS, V70, P273, DOI 10.1002/prot.21276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak JE, 2006, METHOD ENZYMOL, V416, P30, DOI 10.1016/S0076-6879(06)16003-6; Pasqualini R, 2000, CANCER RES, V60, P722; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; RICH DH, 1984, J MED CHEM, V27, P417, DOI 10.1021/jm00370a001; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Ruiz-Ortega M, 2007, TRENDS CARDIOVAS MED, V17, P19, DOI 10.1016/j.tcm.2006.10.003; Santos AN, 2000, CELL IMMUNOL, V201, P22, DOI 10.1006/cimm.2000.1629; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; XU Y, 1995, BIOCHEM BIOPH RES CO, V208, P664, DOI 10.1006/bbrc.1995.1390; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	62	103	107	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36804	36813		10.1074/jbc.M112.398842	http://dx.doi.org/10.1074/jbc.M112.398842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932899	hybrid, Green Published			2022-12-28	WOS:000310588500017
J	Hsu, SHC; Zhang, XY; Cheng, S; Wunder, JS; Hui, CC; Alman, BA				Hsu, Shu-Hsuan C.; Zhang, Xiaoyun; Cheng, Steven; Wunder, Jay S.; Hui, Chi-Chung; Alman, Benjamin A.			Suppressor of Fused (Sufu) Mediates the Effect of Parathyroid Hormone-like Hormone (Pthlh) on Chondrocyte Differentiation in the Growth Plate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTH/PTHRP RECEPTOR; HEDGEHOG; PTHRP; GLI2; PROLIFERATION; EXPRESSION; REGULATOR; REVEALS; MOUSE; KIF7	Growth plate chondrocytes undergo a coordinated process of differentiation, regulating long bone growth. Parathyroid hormone-like hormone (Pthlh) inhibits hypertrophic differentiation in the growth plate chondrocytes and reduces Hedgehog (Hh) signaling. In mice lacking the Hh mediator Suppressor of fused (Sufu), Pthlh treatment resulted in the up-regulation of Hh activity and an increased number of hypertrophic chondrocytes. Furthermore, Pthlh increased Sufu protein levels, and in chondrocytes lacking Sufu, it was unable to process Hh-regulated Gli transcription factors. Pthlh regulates chondrocyte differentiation and Gli activity in a Sufu-dependent manner, with Sufu acting as a molecular switch in its regulation of differentiation.	[Hsu, Shu-Hsuan C.; Zhang, Xiaoyun; Hui, Chi-Chung; Alman, Benjamin A.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Hsu, Shu-Hsuan C.; Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cheng, Steven] Nanjing Med Univ, Dept Dev Genet, Nanjing 210029, Jiangsu, Peoples R China; [Cheng, Steven] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Wunder, Jay S.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wunder, Jay S.] Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Dept Surg, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Nanjing Medical University; Nanjing Medical University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	benjamin.alman@sickkids.ca			Canadian Institutes of Health Research [37913, 106587]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants 37913 and 106587.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Han LZ, 2012, J BIOL CHEM, V287, P20483, DOI 10.1074/jbc.M112.359299; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LINSENMAYER TF, 1988, PATHOL IMMUNOPATH R, V7, P14, DOI 10.1159/000157085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2001, DEVELOPMENT, V128, P5099; Mak IWY, 2012, J BONE MINER RES, V27, P1976, DOI 10.1002/jbmr.1638; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Minina E, 2001, DEVELOPMENT, V128, P4523; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P2577, DOI 10.1167/iovs.04-0001; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9	33	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36222	36228		10.1074/jbc.M112.382275	http://dx.doi.org/10.1074/jbc.M112.382275			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930757	hybrid, Green Published			2022-12-28	WOS:000310364000043
J	Quade, N; Mendonca, C; Herbst, K; Heroven, AK; Ritter, C; Heinz, DW; Dersch, P				Quade, Nick; Mendonca, Chriselle; Herbst, Katharina; Heroven, Ann Kathrin; Ritter, Christiane; Heinz, Dirk W.; Dersch, Petra			Structural Basis for Intrinsic Thermosensing by the Master Virulence Regulator RovA of Yersinia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULE GENE-CLUSTER; H-NS; TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; SALMONELLA; EXPRESSION; SLYA; ENTEROCOLITICA; RESISTANCE; PROTEIN	Pathogens often rely on thermosensing to adjust virulence gene expression. In yersiniae, important virulence-associated traits are under the control of the master regulator RovA, which uses a built-in thermosensor to control its activity. Thermal upshifts encountered upon host entry induce conformational changes in the RovA dimer that attenuate DNA binding and render the protein more susceptible to proteolysis. Here, we report the crystal structure of RovA in the free and DNA-bound forms and provide evidence that thermo-induced loss of RovA activity is promoted mainly by a thermosensing loop in the dimerization domain and residues in the adjacent C-terminal helix. These determinants allow partial unfolding of the regulator upon an upshift to 37 degrees C. This structural distortion is transmitted to the flexible DNA-binding domain of RovA. RovA contacts mainly the DNA backbone in a low-affinity binding mode, which allows the immediate release of RovA from its operator sites. We also show that SlyA, a close homolog of RovA from Salmonella with a very similar structure, is not a thermosensor and remains active and stable at 37 degrees C. Strikingly, changes in only three amino acids, reflecting evolutionary replacements in SlyA, result in a complete loss of the thermosensing properties of RovA and prevent degradation. In conclusion, only minor alterations can transform a thermotolerant regulator into a thermosensor that allows adjustment of virulence and fitness determinants to their thermal environment.	[Quade, Nick; Ritter, Christiane; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Mendonca, Chriselle; Herbst, Katharina; Heroven, Ann Kathrin; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Heinz, DW (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de; petra.dersch@helmholtz-hzi.de			German Research Foundation [IRTG1273]; Fonds der Chemischen Industrie	German Research Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Grant IRTG1273 from the German Research Foundation (to C. M.) and the Fonds der Chemischen Industrie (to P. D. and D. W. H.).	BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Servant P, 2000, P NATL ACAD SCI USA, V97, P3538, DOI 10.1073/pnas.070426197; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Xue P, 2009, J BACTERIOL, V191, P1838, DOI 10.1128/JB.01388-08; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	30	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35796	35803		10.1074/jbc.M112.379156	http://dx.doi.org/10.1074/jbc.M112.379156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936808	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000310364000003
J	Chang, FM; Reyna, SM; Granados, JC; Wei, SJ; Innis-Whitehouse, W; Maffi, SK; Rodriguez, E; Slaga, TJ; Short, JD				Chang, Fang-Mei; Reyna, Sara M.; Granados, Jose C.; Wei, Sung-Jen; Innis-Whitehouse, Wendy; Maffi, Shivani K.; Rodriguez, Edward; Slaga, Thomas J.; Short, John D.			Inhibition of Neddylation Represses Lipopolysaccharide-induced Proinflammatory Cytokine Production in Macrophage Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NEDD8-ACTIVATING ENZYME; HUMAN MONOCYTES; LEUKEMIA-CELLS; TNF-ALPHA; ACTIVATION; MLN4924; NEDD8; TRANSCRIPTION; EXPRESSION	Cullin-RING E3 ligases (CRLs) are a class of ubiquitin ligases that control the proteasomal degradation of numerous target proteins, including I kappa B, and the activity of these CRLs are positively regulated by conjugation of a Nedd8 polypeptide onto Cullin proteins in a process called neddylation. CRL-mediated degradation of I kappa B, which normally interacts with and retains NF-kappa B in the cytoplasm, permits nuclear translocation and transactivation of the NF-kappa B transcription factor. Neddylation occurs through a multistep enzymatic process involving Nedd8 activating enzymes, and recent studies have shown that the pharmacological agent, MLN4924, can potently inhibit Nedd8 activating enzymes, thereby preventing neddylation of Cullin proteins and preventing the degradation of CRL target proteins. In macrophages, regulation of NF-kappa B signaling functions as a primary pathway by which infectious agents such as lipopolysaccharides (LPSs) cause the up-regulation of proinflammatory cytokines. Here we have analyzed the effects of MLN4924, and compared the effects of MLN4924 with a known anti-inflammatory agent (dexamethasone), on certain proinflammatory cytokines (TNF-alpha and IL-6) and the NF-kappa B signaling pathway in LPS-stimulated macrophages. We also used siRNA to block neddylation to assess the role of this molecular process during LPS-induced cytokine responsiveness. Our results demonstrate that blocking neddylation, either pharmacologically or using siRNA, abrogates the increase in certain proinflammatory cytokines secreted from macrophages in response to LPS. In addition, we have shown that MLN4924 and dexamethasone inhibit LPS-induced cytokine up-regulation at the transcriptional level, albeit through different molecular mechanisms. Thus, neddylation represents a novel molecular process in macrophages that can be targeted to prevent and/or treat the LPS-induced up-regulation of proinflammatory cytokines and the disease processes associated with their up-regulation.	[Chang, Fang-Mei; Reyna, Sara M.; Granados, Jose C.; Wei, Sung-Jen; Innis-Whitehouse, Wendy; Maffi, Shivani K.; Rodriguez, Edward; Short, John D.] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78541 USA; [Reyna, Sara M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Wei, Sung-Jen; Slaga, Thomas J.; Short, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Maffi, Shivani K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Short, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Div Med Res, Edinburg, TX 78541 USA.	shortj@uthscsa.edu		Reyna, Sara/0000-0002-4913-0186; Wei, Sung Jen/0000-0002-9810-9041				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Anas AA, 2010, NETH J MED, V68, P147; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; Bellezzo JM, 1996, AM J PHYSIOL-GASTR L, V270, pG956, DOI 10.1152/ajpgi.1996.270.6.G956; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Crinelli R, 2000, BLOOD CELL MOL DIS, V26, P211, DOI 10.1006/bcmd.2000.0298; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Fainboim L, 2007, CYTOKINE GROWTH F R, V18, P143, DOI 10.1016/j.cytogfr.2007.01.017; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Haas M, 1998, J LEUKOCYTE BIOL, V63, P395, DOI 10.1002/jlb.63.3.395; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Lukkarila JL, 2011, ACS MED CHEM LETT, V2, P577, DOI 10.1021/ml2000615; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Meisel SR, 2002, ATHEROSCLEROSIS, V161, P35, DOI 10.1016/S0021-9150(01)00616-5; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Nazinitsky A, 2010, INFECT DIS CLIN PRAC, V18, P188, DOI DOI 10.1097/IPC.0B013E3181D2EE41; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TRANTHI TA, 1995, HEPATOLOGY, V22, P613, DOI 10.1016/0270-9139(95)90587-1; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866; Weiss T, 2004, ANTIMICROB AGENTS CH, V48, P1974, DOI 10.1128/AAC.48.6.1974-1982.2004; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yuk Jae-Min, 2011, Journal of Bacteriology and Virology, V41, P225	57	63	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35756	35767		10.1074/jbc.M112.397703	http://dx.doi.org/10.1074/jbc.M112.397703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927439	hybrid, Green Published			2022-12-28	WOS:000309968000086
J	Greenfield, LK; Richards, MR; Li, JJ; Wakarchuk, WW; Lowary, TL; Whitfield, C				Greenfield, Laura K.; Richards, Michele R.; Li, Jianjun; Wakarchuk, Warren W.; Lowary, Todd L.; Whitfield, Chris			Biosynthesis of the Polymannose Lipopolysaccharide O-antigens from Escherichia coli Serotypes O8 and O9a Requires a Unique Combination of Single- and Multiple-active Site Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; BINDING CASSETTE TRANSPORTER; ACID-SEQUENCE SIMILARITIES; S-LAYER GLYCOPROTEIN; GENE-CLUSTER; GEOBACILLUS-STEAROTHERMOPHILUS; ABC TRANSPORTER; BIOCHEMICAL-CHARACTERIZATION; BAND LIPOPOLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA	The Escherichia coli O9a and O8 O-antigen serotypes represent model systems for the ABC transporter-dependent synthesis of bacterial polysaccharides. The O9a and O8 antigens are linear mannose homopolymers containing conserved reducing termini (the primer-adaptor), a serotype-specific repeat unit domain, and a terminator. Synthesis of these glycans occurs on the polyisoprenoid lipid-linked primer, undecaprenol pyrophosphoryl-GlcpNAc, by two conserved mannosyltransferases, WbdC and WbdB, and a serotype-specific mannosyltransferase, WbdA. The glycan structure and pattern of conservation in the O9a and O8 mannosyltransferases are not consistent with the existing model of O9a biosynthesis. Here we establish a revised pathway using a combination of in vivo (mutant complementation) experiments and in vitro strategies with purified enzymes and synthetic acceptors. WbdC and WbdB synthesize the adaptor region, where they transfer one and two alpha-(1 -> 3)-linked mannose residues, respectively. The WbdA enzymes are solely responsible for forming the repeat unit domains of these O-antigens. WbdA(O9a) has two predicted active sites and polymerizes a tetrasaccharide repeat unit containing two alpha-(1 -> 3)-and two alpha-(1 -> 2)-linked mannopyranose residues. In contrast, WbdA(O8) polymerizes trisaccharide repeat units containing single alpha-(1 -> 3)-, alpha-(1 -> 2)-, and beta-(1 -> 2)-mannopyranoses. These studies illustrate assembly systems exploiting several mannosyltransferases with flexible active sites, arranged in single-and multiple-domain formats.	[Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Li, Jianjun; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Alberta; University of Alberta; National Research Council Canada	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019; Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Li, Jianjun/0000-0002-6531-3687	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alberta Innovates Health Solutions	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alberta Innovates Health Solutions	This work was supported by grants from the Natural Sciences and Engineering Research Council (awarded to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.).; Recipient of an Alberta Innovates Health Solutions Ph.D. studentship.	Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; ARSENAULT TL, 1991, CAN J CHEM, V69, P1273, DOI 10.1139/v91-190; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Blixt O, 2005, CARBOHYD RES, V340, P1963, DOI 10.1016/j.carres.2005.06.008; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; FITZGERA.DK, 1971, EUR J BIOCHEM, V24, P222, DOI 10.1111/j.1432-1033.1971.tb19674.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hodson N, 2000, J BIOL CHEM, V275, P27311; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; KANEGASAKI S, 1979, EUR J BIOCHEM, V95, P287, DOI 10.1111/j.1432-1033.1979.tb12964.x; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; Kido N, 1997, MICROBIOL IMMUNOL, V41, P519, DOI 10.1111/j.1348-0421.1997.tb01887.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CJ, 2007, CARBOHYD RES, V342, P2818, DOI 10.1016/j.carres.2007.08.020; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Miller J. H., 1972, EXPT MOL GENETICS, P432; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Perepelov AV, 2009, FEMS IMMUNOL MED MIC, V57, P80, DOI 10.1111/j.1574-695X.2009.00584.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rocchetta HL, 1998, MOL MICROBIOL, V28, P1103, DOI 10.1046/j.1365-2958.1998.00871.x; SAEKI A, 1993, MICROBIOL IMMUNOL, V37, P601, DOI 10.1111/j.1348-0421.1993.tb01682.x; Sambrook J., 1989, MOL CLONING LAB MANU; Schaffer C, 2002, J BIOL CHEM, V277, P6230, DOI 10.1074/jbc.M108873200; Shatzman A. R., 2001, CURRENT PROTOCOLS MO, V11; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Sugiyama T, 1997, GENE, V198, P111, DOI 10.1016/S0378-1119(97)00300-4; Sugiyama T, 1998, J BACTERIOL, V180, P2775, DOI 10.1128/JB.180.10.2775-2778.1998; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wakarchuk Warren W, 2003, Methods Mol Biol, V213, P263	70	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35078	35091		10.1074/jbc.M112.401000	http://dx.doi.org/10.1074/jbc.M112.401000			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22875852	Green Published, hybrid			2022-12-28	WOS:000309968000019
J	Kwon, SE; Chapman, ER				Kwon, Sung E.; Chapman, Edwin R.			Glycosylation Is Dispensable for Sorting of Synaptotagmin 1 but Is Critical for Targeting of SV2 and Synaptophysin to Recycling Synaptic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; N-GLYCOSYLATION; TRAFFICKING; ENDOCYTOSIS; CELLS; LOCALIZATION; TRANSMISSION	Glycosylation is a major form of post-translational modification of synaptic vesicle membrane proteins. For example, the three major synaptic vesicle glycoproteins, synaptotagmin 1, synaptophysin, and SV2, represent similar to 30% of the total copy number of vesicle proteins. Previous studies suggested that glycosylation is required for the vesicular targeting of synaptotagmin 1, but the role of glycosylation of synaptophysin and SV2 has not been explored in detail. In this study, we analyzed all glycosylation sites on synaptotagmin 1, synaptophysin, and SV2A via mutagenesis and optical imaging of pHluorin-tagged proteins in cultured neurons from knock-out mice lacking each protein. Surprisingly, these experiments revealed that glycosylation is completely dispensable for the sorting of synaptotagmin 1 to SVs whereas the N-glycans on SV2A are only partially dispensable. In contrast, N-glycan addition is essential for the synaptic localization and function of synaptophysin. Thus, glycosylation plays distinct roles in the trafficking of each of the three major synaptic vesicle glycoproteins.	[Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), 1300 Univ Ave,SMI 203, Madison, WI 53706 USA.	chapman@wisc.edu		Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health Grant [MH 61876]; Epilepsy Foundation predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation predoctoral fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported, in whole or in part, by National Institutes of Health Grant MH 61876.; Supported by an Epilepsy Foundation predoctoral fellowship.	Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Duffield A, 2008, INT REV CEL MOL BIO, V270, P145, DOI 10.1016/S1937-6448(08)01404-4; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haas KF, 2008, BBA-GENE REGUL MECH, V1779, P495, DOI 10.1016/j.bbagrm.2007.12.010; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kanno E., 2007, J NEUROSCI RES; Kanno E, 2008, J NEUROSCI RES, V86, P1036, DOI 10.1002/jnr.21568; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013	32	29	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35658	35668		10.1074/jbc.M112.398883	http://dx.doi.org/10.1074/jbc.M112.398883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908222	Green Published, hybrid			2022-12-28	WOS:000309968000077
J	Moon, SM; Kim, SA; Yoon, JH; Ahn, SG				Moon, Sung-Min; Kim, Soo-A; Yoon, Jung-Hoon; Ahn, Sang-Gun			HOXC6 Is Deregulated in Human Head and Neck Squamous Cell Carcinoma and Modulates Bcl-2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENES; CANCER; APOPTOSIS; PROSTATE; FAMILY; GROWTH; DEATH; MORPHOGENESIS; EPIDEMIOLOGY; METHYLATION	Homeobox C6 (HOXC6) genes belong to the homeoprotein family of transcription factors, which play an important role in morphogenesis and cellular differentiation during embryonic development. The aim of this study was to explore the role of HOXC6 in the regulation of Bcl-2 in human head and neck squamous cell carcinoma (HNSCC). The HOXC6 and Bcl-2 gene were identified as being overexpressed in HNSCC tissue and cell lines. Transfection assays demonstrated that HOXC6 increased the levels of Bcl-2 mRNA and protein. A luciferase reporter assay suggested that HOXC6 induced activity of the Bcl-2 promoter. A series of Bcl-2 promoter deletion mutants were examined and the minimal HOXC6-responsive region was identified to be in the TAAT motif (-420 bp) of the Bcl-2 promoter. Interestingly, the inhibition of HOXC6 using siRNA led to the repression of Bcl-2 expression and induced caspase-3-dependent apoptosis; overexpression of HOXC6 in HNSCC cells increased the resistance to paclitaxel-induced apoptosis. Together, our findings suggest that HOXC6 is an important mechanism of the anti-apoptotic pathway via regulation of Bcl-2 expression.	[Ahn, Sang-Gun] Chosun Univ, Sch Dent, Dept Pathol, Coll Dent, Kwangju 501759, South Korea; [Kim, Soo-A] Dongguk Univ, Dept Biochem, Gyeongju 780714, South Korea; [Yoon, Jung-Hoon] Wonkwang Univ, Daejeon Dent Hosp, Dept Oral Pathol, Taejon 302120, South Korea	Chosun University; Dongguk University; Wonkwang University	Ahn, SG (corresponding author), Chosun Univ, Sch Dent, Dept Pathol, Coll Dent, 375 Seosuk Dong, Kwangju 501759, South Korea.	ahnsg@chosun.ac.kr		Kim, Soo-A/0000-0001-6777-739X	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [R13-2008-010-00000-0, 2012-0002140]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (No. R13-2008-010-00000-0; No. 2012-0002140).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Argiris A, 2003, CANC TREAT, V114, P15; Babidge WJ, 2001, ANTICANCER RES, V21, P2809; Bijl J, 1996, BLOOD, V87, P1737, DOI 10.1182/blood.V87.5.1737.bloodjournal8751737; Bodey B, 2000, ANTICANCER RES, V20, P3281; Bodey B, 2000, ANTICANCER RES, V20, P2717; CASTRONOVO V, 1994, BIOCHEM PHARMACOL, V47, P137, DOI 10.1016/0006-2952(94)90447-2; Cazal C, 2006, ORAL DIS, V12, P424, DOI 10.1111/j.1601-0825.2005.01218.x; Chen KN, 2005, CLIN CANCER RES, V11, P1044; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Drenning SD, 1998, CLIN CANCER RES, V4, P2913; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Fujiki K, 2008, GASTROENTEROLOGY, V135, P907, DOI 10.1053/j.gastro.2008.06.034; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Hassan NMM, 2006, ONCOL RES, V16, P217, DOI 10.3727/000000006783981080; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JONES FS, 1993, P NATL ACAD SCI USA, V90, P6557, DOI 10.1073/pnas.90.14.6557; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Li RX, 2007, NEOPLASIA, V9, P801, DOI 10.1593/neo.07394; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; McCabe CD, 2008, CANCER RES, V68, P1988, DOI 10.1158/0008-5472.CAN-07-5843; Miller GJ, 2003, CANCER RES, V63, P5879; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Park S, 2007, BIOCHEM BIOPH RES CO, V357, P1011, DOI 10.1016/j.bbrc.2007.04.051; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ricort JM, 2002, J BIOL CHEM, V277, P19448, DOI 10.1074/jbc.M200439200; Sharma H, 2005, CANCER BIOL THER, V4, P720, DOI 10.4161/cbt.4.7.1783; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Trask DK, 2002, LARYNGOSCOPE, V112, P638, DOI 10.1097/00005537-200204000-00009; Tucci R, 2011, J APPL ORAL SCI, V19, P125, DOI 10.1590/S1678-77572011000200008; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Warnakulasuriya Saman, 2009, Evid Based Dent, V10, P4, DOI 10.1038/sj.ebd.6400623; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Zhu QH, 2011, SCAND J GASTROENTERO, V46, P436, DOI 10.3109/00365521.2010.537682; Zhu X, 2007, AM J PATHOL, V170, P1618, DOI 10.2353/ajpath.2007.061111	45	35	36	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35678	35688		10.1074/jbc.M112.361675	http://dx.doi.org/10.1074/jbc.M112.361675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896703	Green Published, hybrid			2022-12-28	WOS:000309968000079
J	Wejda, M; Impens, F; Takahashi, N; Van Damme, P; Gevaert, K; Vandenabeele, P				Wejda, Magdalena; Impens, Francis; Takahashi, Nozomi; Van Damme, Petra; Gevaert, Kris; Vandenabeele, Peter			Degradomics Reveals That Cleavage Specificity Profiles of Caspase-2 and Effector Caspases Are Alike	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PEPTIDES; FRACTIONAL DIAGONAL CHROMATOGRAPHY; CYTOSOLIC PHOSPHOLIPASE A(2); FAS-INDUCED APOPTOSIS; CELL-DEATH; QUANTITATIVE PROTEOMICS; INFLAMMATORY CASPASES; GENOTOXIC STRESS; STRUCTURAL BASIS; DNA-DAMAGE	Caspase-2 is considered an initiator caspase because its long prodomain contains a CARD domain that allows its recruitment and activation in several complexes by homotypic death domain-fold interactions. Because little is known about the function and specificity of caspase-2 and its physiological substrates, we compared the cleavage specificity profile of recombinant human caspase-2 with those of caspase-3 and -7 by analyzing cell lysates using N-terminal COmbined FRActional DIagonal Chromatography (COFRADIC). Substrate analysis of the 68 cleavage sites identified in 61 proteins revealed that the protease specificities of human caspases-2, -3, and -7 largely overlap, revealing the DEVD down arrow G consensus cleavage sequence. We confirmed that Asp(563) in eukaryotic translation initiation factor 4B (eIF4B) is a cleavage site preferred by caspase-2 not only in COFRADIC setup but also upon co-expression in HEK 293T cells. These results demonstrate that activated human caspase-2 shares remarkably overlapping protease specificity with the prototype apoptotic executioner caspases-3 and -7, suggesting that caspase-2 could function as a proapoptotic caspase once released from the activating complex.	[Wejda, Magdalena; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Zwijnaarde, Belgium; [Wejda, Magdalena; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Zwijnaarde, Belgium; [Impens, Francis; Van Damme, Petra; Gevaert, Kris] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Impens, Francis; Van Damme, Petra; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vandenabeele, P (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Zwijnaarde, Belgium.	peter.vandenabeele@dmbr.UGent.be	Van Damme, Petra/C-7269-2008; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/D-6489-2017; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Van Damme, Petra/0000-0001-9090-027X; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Vandenabeele, Peter/0000-0002-6669-8822; Takahashi, Nozomi/0000-0002-3751-4203; Impens, Francis/0000-0003-2886-9616	European grants [MRTN-CT-035624, FP7-200767]; Belgian grants (Interuniversity Attraction Poles) [IAP 6/18]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11]; Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Fund for Scientific Research-Flanders (Belgium) [G.0048.08]; Flemish Government [BOF09/01M00709]	European grants; Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Fund for Scientific Research-Flanders (Belgium)(FWO); Flemish Government(European Commission)	This work was supported by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (MRP, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB).; Recipient of a research grant from the Fund for Scientific Research-Flanders (Belgium) (project number G.0048.08).; Holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. To whom correspondence should be addressed: Dept. for Molecular Biomedical Research, VIB and Ghent University, Technologiepark 927, Ghent 9052, Belgium. Tel.: 32-93313760; Fax: 32-92217673; E-mail: peter.vandenabeele@dmbr.UGent.be.	Adam-Klages S, 1998, J IMMUNOL, V161, P5687; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Fang B, 2006, J MOL BIOL, V360, P654, DOI 10.1016/j.jmb.2006.05.041; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Ghesquiere B, 2006, J PROTEOME RES, V5, P2438, DOI 10.1021/pr060186m; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Impens F, 2010, MOL CELL PROTEOMICS, V9, P2327, DOI 10.1074/mcp.M110.001271; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Karki P, 2008, PROTEIN PEPTIDE LETT, V15, P1044, DOI 10.2174/092986608786071193; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Oliver TG, 2011, MOL CELL, V43, P57, DOI 10.1016/j.molcel.2011.06.012; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Saelens X, 2005, J CELL BIOL, V168, P545, DOI 10.1083/jcb.200407162; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Staes A, 2008, PROTEOMICS, V8, P1362, DOI 10.1002/pmic.200700950; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	76	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33983	33995		10.1074/jbc.M112.384552	http://dx.doi.org/10.1074/jbc.M112.384552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22825847	Green Published, hybrid			2022-12-28	WOS:000309654200006
J	Kadurin, I; Alvarez-Laviada, A; Ng, SFJ; Walker-Gray, R; D'Arco, M; Fadel, MG; Pratt, WS; Dolphin, AC				Kadurin, Ivan; Alvarez-Laviada, Anita; Ng, Shu Fun Josephine; Walker-Gray, Ryan; D'Arco, Marianna; Fadel, Michael G.; Pratt, Wendy S.; Dolphin, Annette C.			Calcium Currents Are Enhanced by alpha(2)delta-1 Lacking Its Membrane Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNEL ALPHA(2)DELTA; LIPID RAFTS; ENDOPLASMIC-RETICULUM; SUBUNIT INTERACTION; BETA-SUBUNITS; ALPHA 1A; EXPRESSION; PROTEIN; SITE; FORM	The accessory alpha(2)delta subunits of voltage-gated calcium channels are membrane-anchored proteins, which are highly glycosylated, possess multiple disulfide bonds, and are post-translationally cleaved into alpha(2) and delta. All alpha(2)delta subunits have a C-terminal hydrophobic, potentially trans-membrane domain and were described as type I transmembrane proteins, but we found evidence that they can be glycosylphosphatidylinositol-anchored. To probe further the function of membrane anchoring in alpha(2)delta subunits, we have now examined the properties of alpha(2)delta-1 constructs truncated at their putative glycosylphosphatidylinositol anchor site, located before the C-terminal hydrophobic domain (alpha(2)delta-1 Delta C-term). We find that the majority of alpha(2)delta-1 Delta C-term is soluble and secreted into the medium, but unexpectedly, some of the protein remains associated with detergent-resistant membranes, also termed lipid rafts, and is extrinsically bound to the plasma membrane. Furthermore, heterologous co-expression of alpha(2)delta-1 Delta C-term with Ca(V)2.1/beta 1b results in a substantial enhancement of the calcium channel currents, albeit less than that produced by wild-type alpha(2)delta-1. These results call into question the role of membrane anchoring of alpha(2)delta subunits for calcium current enhancement.	[Kadurin, Ivan; Alvarez-Laviada, Anita; Ng, Shu Fun Josephine; Walker-Gray, Ryan; D'Arco, Marianna; Fadel, Michael G.; Pratt, Wendy S.; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Kadurin, I (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	i.kadurin@ucl.ac.uk; a.dolphin@ucl.ac.uk	Ng, Shu Fun Josephine/AAH-4384-2021; Kadurin, Ivan/F-7759-2012; Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856; Ng, Shu Fun Josephine/0000-0003-4567-1409; Kadurin, Ivan/0000-0002-7720-367X	Medical Research Council [G0700368, G0801756]; Medical Research Council [G0901758] Funding Source: researchfish; MRC [G0901758, G0801756, G0700368] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Grants G0700368 and G0801756.	Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown JP, 1998, J BIOL CHEM, V273, P25458, DOI 10.1074/jbc.273.39.25458; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; CAMPBELL V, 1995, J PHYSIOL-LONDON, V485, P365, DOI 10.1113/jphysiol.1995.sp020735; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti Carles, 2003, Current Neuropharmacology, V1, P209, DOI 10.2174/1570159033477116; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DELAHUNTY MD, 1993, J BIOL CHEM, V268, P12017; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Douglas L, 2006, BIOCHEM SOC T, V34, P894, DOI 10.1042/BST0340894; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Felix R, 1997, J NEUROSCI, V17, P6884; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hobom M, 2000, EUR J NEUROSCI, V12, P1217, DOI 10.1046/j.1460-9568.2000.01009.x; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; JAY SD, 1991, J BIOL CHEM, V266, P3287; Klugbauer N, 1999, J NEUROSCI, V19, P684; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Robinson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019802; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9	41	24	24	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33554	33566		10.1074/jbc.M112.378554	http://dx.doi.org/10.1074/jbc.M112.378554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869375	Green Published, hybrid			2022-12-28	WOS:000309602100041
J	Narayanan, A; Kehn-Hall, K; Senina, S; Lundberg, L; Van Duyne, R; Guendel, I; Das, R; Baer, A; Bethel, L; Turell, M; Hartman, AL; Das, B; Bailey, C; Kashanchi, F				Narayanan, Aarthi; Kehn-Hall, Kylene; Senina, Svetlana; Lundberg, Lindsay; Van Duyne, Rachel; Guendel, Irene; Das, Ravi; Baer, Alan; Bethel, Laura; Turell, Michael; Hartman, Amy Lynn; Das, Bhaskar; Bailey, Charles; Kashanchi, Fatah			Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NSS PROTEIN; PROTEASOME EXPRESSION; P65 PHOSPHORYLATION; MEDIATED ACTIVATION; DOWN-REGULATION; IKK-BETA; KINASE; TRANSCRIPTION; INDUCTION	Rift Valley fever virus (RVFV) is an arbovirus that is classified as a select agent, an emerging infectious virus, and an agricultural pathogen. Understanding RVFV-host interactions is imperative to the design of novel therapeutics. Here, we report that an infection by the MP-12 strain of RVFV induces phosphorylation of the p65 component of the NF kappa B cascade. We demonstrate that phosphorylation of p65 (serine 536) involves phosphorylation of I kappa B alpha and occurs through the classical NF kappa B cascade. A unique, low molecular weight complex of the IKK-beta subunit can be observed in MP-12-infected cells, which we have labeled IKK-beta 2. The IKK-beta 2 complex retains kinase activity and phosphorylates an I kappa B alpha substrate. Inhibition of the IKK complex using inhibitors impairs viral replication, thus alluding to the requirement of an active IKK complex to the viral life cycle. Curcumin strongly down-regulates levels of extracellular infectious virus. Our data demonstrated that curcumin binds to and inhibits kinase activity of the IKK-beta 2 complex in infected cells. Curcumin partially exerts its inhibitory influence on RVFV replication by interfering with IKK-beta 2-mediated phosphorylation of the viral protein NSs and by altering the cell cycle of treated cells. Curcumin also demonstrated efficacy against ZH501, the fully virulent version of RVFV. Curcumin treatment down-regulated viral replication in the liver of infected animals. Our data point to the possibility that RVFV infection may result in the generation of novel versions of host components (such as IKK-beta 2) that, by virtue of altered protein interaction and function, qualify as unique therapeutic targets.	[Narayanan, Aarthi; Kehn-Hall, Kylene; Senina, Svetlana; Lundberg, Lindsay; Van Duyne, Rachel; Guendel, Irene; Das, Ravi; Baer, Alan; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Van Duyne, Rachel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Turell, Michael] USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Das, Bhaskar] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10461 USA; [Bethel, Laura; Hartman, Amy Lynn] Univ Pittsburgh, Reg Biocontainment Lab, Ctr Vaccine Res, Pittsburgh, PA 15261 USA	George Mason University; George Washington University; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Discovery Hall,Rm 182,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Turell, Michael/ABE-1826-2020; Van Duyne, Rachel/ABI-2429-2020; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/I-7365-2019	Turell, Michael/0000-0003-1902-7740; Van Duyne, Rachel/0000-0003-2914-6874; Hartman, Amy/0000-0002-0857-2973	United States Department of Energy [DE-FC52-04NA25455]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FC52-04NA25455 (to C.B. and F.K.).	Agbottah Emmanuel, 2008, AIDS Res Ther, V5, P12, DOI 10.1186/1742-6405-5-12; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ahmed KM, 2007, CURR CANCER DRUG TAR, V7, P335; Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; Caselli E, 2007, BLOOD, V109, P2718, DOI 10.1182/blood-2006-03-012500; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Dattani JJ, 2010, ENVIRON TOXICOL PHAR, V30, P103, DOI 10.1016/j.etap.2010.04.001; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Dong XN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002336; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haddad JJ, 2002, CELL SIGNAL, V14, P211, DOI 10.1016/S0898-6568(01)00233-9; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Jin HL, 2011, J VIROL, V85, P3397, DOI 10.1128/JVI.02373-10; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Pise-Masison CA, 2000, AIDS RES HUM RETROV, V16, P1669, DOI 10.1089/08892220050193128; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Smith HJ, 2003, BRIT J CANCER, V89, P1783, DOI 10.1038/sj.bjc.6601328; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Tu CT, 2011, MOL CELL BIOCHEM, V358, P53, DOI [10.1007/s11010-011-0920-4, 10.1007/s11010-011-0978-z]; Tu CT, 2012, INT IMMUNOPHARMACOL, V12, P151, DOI 10.1016/j.intimp.2011.11.005; Valentine R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-1; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wan SB, 2010, INT J MOL MED, V26, P447, DOI 10.3892/ijmm_00000484; Wang J, 2010, VIROLOGY, V400, P215, DOI 10.1016/j.virol.2010.01.035; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Yu Wen-Guang, 2011, Indian J Med Res, V134, P717, DOI 10.4103/0971-5916.91009; Zheng ZH, 2011, J IMMUNOL, V187, P2202, DOI 10.4049/jimmunol.1100285; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	63	53	55	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33198	33214		10.1074/jbc.M112.356535	http://dx.doi.org/10.1074/jbc.M112.356535			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22847000	Green Published, hybrid			2022-12-28	WOS:000309602100011
J	Ray, R; de Ridder, GG; Eu, JP; Paton, AW; Paton, JC; Pizzo, SV				Ray, Rupa; de Ridder, Gustaaf G.; Eu, Jerry P.; Paton, Adrienne W.; Paton, James C.; Pizzo, Salvatore V.			The Escherichia coli Subtilase Cytotoxin A Subunit Specifically Cleaves Cell-surface GRP78 Protein and Abolishes COOH-terminal-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; NF-KAPPA-B; CANCER-CELLS; BIASED AGONISM; RECEPTOR; ACTIVATION; BINDING; EXPRESSION; APOPTOSIS; LIGATION	GRP78, a molecular chaperone with critical endoplasmic reticulum functions, is aberrantly expressed on the surface of cancer cells, including prostate and melanoma. Here it functions as a pro-proliferative and anti-apoptotic signaling receptor via NH2-terminal domain ligation. Auto-antibodies to this domain may appear in cancer patient serum where they are a poor prognostic indicator. Conversely, GRP78 COOH-terminal domain ligation is pro-apoptotic and anti-proliferative. There is no method to disrupt cell-surface GRP78 without compromising the total GRP78 pool, making it difficult to study cell-surface GRP78 function. We studied six cell lines representing three cancer types. One cell line per group expresses high levels of cell-surface GRP78, and the other expresses low levels (human hepatoma: Hep3B and HepG2; human prostate cancer: PC3 and 1-LN; murine melanoma: B16F0 and B16F1). We investigated the effect of Escherichia coli subtilase cytoxin catalytic subunit (SubA) on GRP78. We report that SubA specifically cleaves cell-surface GRP78 on HepG2, 1-LN, and B16F1 cells without affecting intracellular GRP78. B16F0 cells (GRP78(low)) have lower amounts of cleaved cell-surface GRP78. SubA has no effect on Hep3B and PC3 cells. The predicted 28-kDa GRP78 COOH-terminal fragment is released into the culture medium by SubA treatment, and COOH-terminal domain signal transduction is abrogated, whereas pro-proliferative signaling mediated through NH2-terminal domain ligation is unaffected. These experiments clarify cell-surface GRP78 topology and demonstrate that the COOH-terminal domain is necessary for pro-apoptotic signal transduction occurring upon COOH-terminal antibody ligation. SubA is a powerful tool to specifically probe the functions of cell-surface GRP78.	[Ray, Rupa; de Ridder, Gustaaf G.; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Eu, Jerry P.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Duke University; Duke University; University of Adelaide	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	salvatore.pizzo@dm.duke.edu	Paton, James C/A-9920-2008					Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Berger CL, 1997, INT J CANCER, V71, P1077; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; Cohen M, 2011, CANCER LETT, V309, P104, DOI 10.1016/j.canlet.2011.05.022; de Ridder GG, 2011, MELANOMA RES, V21, P35, DOI 10.1097/CMR.0b013e3283426805; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dugourd C, 2003, HYPERTENSION, V41, P882, DOI 10.1161/01.HYP.0000060821.62417.35; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kim S, 2011, BEHAV NEUROSCI, V125, P404, DOI 10.1037/a0023185; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee SH, 2009, J IMMUNOL, V183, P7497, DOI 10.4049/jimmunol.0900503; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; May KL, 2010, INFECT IMMUN, V78, P4691, DOI 10.1128/IAI.00801-10; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhao Y, 2011, TOXICOL SCI, V120, P79, DOI 10.1093/toxsci/kfq368	44	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32755	32769		10.1074/jbc.M112.399808	http://dx.doi.org/10.1074/jbc.M112.399808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851173	Green Published, hybrid			2022-12-28	WOS:000309168300043
J	Zamocky, M; Garcia-Fernandez, Q; Gasselhuber, B; Jakopitsch, C; Furtmuller, PG; Loewen, PC; Fita, I; Obinger, C; Carpena, X				Zamocky, Marcel; Garcia-Fernandez, Queralt; Gasselhuber, Bernhard; Jakopitsch, Christa; Furtmueller, Paul G.; Loewen, Peter C.; Fita, Ignacio; Obinger, Christian; Carpena, Xavi			High Conformational Stability of Secreted Eukaryotic Catalase-peroxidases ANSWERS FROM FIRST CRYSTAL STRUCTURE AND UNFOLDING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE BLAST FUNGUS; MAGNAPORTHE-GRISEA; BURKHOLDERIA-PSEUDOMALLEI; CRYSTAL-STRUCTURE; KATG; EVOLUTION; CATALASE/PEROXIDASE; SEQUENCE; CELLS	Catalase-peroxidases (KatGs) are bifunctional heme enzymes widely spread in archaea, bacteria, and lower eukaryotes. Here we present the first crystal structure (1.55 angstrom resolution) of an eukaryotic KatG, the extracellular or secreted enzyme from the phytopathogenic fungus Magnaporthe grisea. The heme cavity of the homodimeric enzyme is similar to prokaryotic KatGs including the unique distal (+)Met-Tyr-Trp adduct (where the Trp is further modified by peroxidation) and its associated mobile arginine. The structure also revealed several conspicuous peculiarities that are fully conserved in all secreted eukaryotic KatGs. Peculiarities include the wrapping at the dimer interface of the N-terminal elongations from the two subunits and cysteine residues that cross-link the two subunits. Differential scanning calorimetry and temperature- and urea-mediated unfolding followed by UV-visible, circular dichroism, and fluorescence spectroscopy combined with site-directed mutagenesis demonstrated that secreted eukaryotic KatGs have a significantly higher conformational stability as well as a different unfolding pattern when compared with intracellular eukaryotic and prokaryotic catalase-peroxidases. We discuss these properties with respect to the structure as well as the postulated roles of this metalloenzyme in host-pathogen interactions.	[Garcia-Fernandez, Queralt; Fita, Ignacio; Carpena, Xavi] CSIC, Inst Res Biomed IRB Barcelona, E-08028 Barcelona, Spain; [Garcia-Fernandez, Queralt; Fita, Ignacio; Carpena, Xavi] CSIC, IBMB, E-08028 Barcelona, Spain; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Mol Microbiol Lab, SK-84551 Bratislava, Slovakia; [Obinger, Christian] Univ Nat Resources & Life Sci, BOKU, Div Biochem, Dept Chem, A-1190 Vienna, Austria; [Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Slovak Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Manitoba	Carpena, X (corresponding author), CSIC, Inst Res Biomed IRB Barcelona, Parc Cient Barcelona,Baldiri Reixac 10, E-08028 Barcelona, Spain.	xcvcri@ibmb.csic.es	Furtmüller, Paul G./Y-5819-2018; Carpena, Xavi/J-5877-2017; Zamocky, Marcel/AAC-2882-2019; Fita, Ignasi/R-4515-2019; Obinger, Christian/AAV-3173-2021	Furtmüller, Paul G./0000-0002-1199-2469; Carpena, Xavi/0000-0002-8646-0440; Zamocky, Marcel/0000-0002-2443-2823; Fita, Ignasi/0000-0002-7521-2679; Obinger, Christian/0000-0002-7133-3430; Jakopitsch, Christa/0000-0002-5855-2057	Ministerio de Ciencia y Tecnologia [BFU2009-09268]; Natural Sciences and Engineering Research Council of Canada [DG 9600]; Canada Research Chair Program; Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [W1224, P20996, P23855]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	This work was supported by Grants BFU2009-09268 from Ministerio de Ciencia y Tecnologia (to I. F.), by Grant DG 9600 from the Natural Sciences and Engineering Research Council of Canada (to P. C. L.), and by the Canada Research Chair Program (to P. C. L.). The work was also supported by the Austrian Science Foundation - Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) with doctoral program BioToP, Biomolecular Technology of Proteins, W1224 and the projects P20996 and P23855.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2010, BBA-PROTEINS PROTEOM, V1804, P2136, DOI 10.1016/j.bbapap.2010.07.013; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; Peraza L, 2002, BIOL CHEM, V383, P569, DOI 10.1515/BC.2002.058; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe S, 2008, BIOSCI BIOTECH BIOCH, V72, P889, DOI 10.1271/bbb.70684; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Tanabe S, 2009, PHYSIOL PLANTARUM, V137, P148, DOI 10.1111/j.1399-3054.2009.01272.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Wiseman B, 2010, J BIOL CHEM, V285, P26662, DOI 10.1074/jbc.M110.139428; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Zamocky M, 2009, BIOCHEM J, V418, P443, DOI 10.1042/BJ20081478; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zamocky M, 2009, BIOCHEM SOC T, V37, P772, DOI 10.1042/BST0370772; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e	34	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32254	32262		10.1074/jbc.M112.384271	http://dx.doi.org/10.1074/jbc.M112.384271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822072	Green Published, hybrid			2022-12-28	WOS:000309059400062
J	Geiss-Liebisch, S; Rooijakkers, SHM; Beczala, A; Sanchez-Carballo, P; Kruszynska, K; Repp, C; Sakinc, T; Vinogradov, E; Holst, O; Huebner, J; Theilacker, C				Geiss-Liebisch, Stefan; Rooijakkers, Suzan H. M.; Beczala, Agnieszka; Sanchez-Carballo, Patricia; Kruszynska, Karolina; Repp, Christian; Sakinc, Tuerkan; Vinogradov, Evgeny; Holst, Otto; Huebner, Johannes; Theilacker, Christian			Secondary Cell Wall Polymers of Enterococcus faecalis Are Critical for Resistance to Complement Activation via Mannose-binding Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-D STREPTOCOCCI; PATTERN-RECOGNITION MOLECULE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; LIPOTEICHOIC ACID; TEICHOIC-ACIDS; GENE-CLUSTER; RISK-FACTORS; L-FICOLIN; INFECTION	The complement system is part of our first line of defense against invading pathogens. The strategies used by Enterococcus faecalis to evade recognition by human complement are incompletely understood. In this study, we identified an insertional mutant of the wall teichoic acid (WTA) synthesis gene tagB in E. faecalis V583 that exhibited an increased susceptibility to complement-mediated killing by neutrophils. Further analysis revealed that increased killing of the mutant was due to a higher rate of phagocytosis by neutrophils, which correlated with higher C3b deposition on the bacterial surface. Our studies indicated that complement activation via the lectin pathway was much stronger on the tagB mutant compared with wild type. In concordance, we found an increased binding of the key lectin pathway components mannose-binding lectin and mannose-binding lectin-associated serine protease-2 (MASP-2) on the mutant. To understand the mechanism of lectin pathway inhibition by E. faecalis, we purified and characterized cell wall carbohydrates of E. faecalis wild type and V583 Delta tagB. NMR analysis revealed that the mutant strain lacked two WTAs with a repeating unit of -> 6)[alpha-L-Rhap-(1 -> 3)]beta-D-GalpNAc-(1 -> 5)-Rbo-1-P and -> 6) beta-D-Glcp-(1 -> 3) [alpha-D-Glcp-(1 -> 4)]-beta-D-Gal-pNAc-(1 -> 5)-Rbo-1-P ->, respectively (Rbo, ribitol). In addition, compositional changes in the enterococcal rhamnopolysaccharide were noticed. Our study indicates that in E. faecalis, modification of peptidoglycan by secondary cell wall polymers is critical to evade recognition by the complement system.	[Geiss-Liebisch, Stefan; Theilacker, Christian] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht G04 614, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Beczala, Agnieszka; Sanchez-Carballo, Patricia; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Kruszynska, Karolina; Repp, Christian; Sakinc, Tuerkan; Huebner, Johannes; Theilacker, Christian] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, D-79106 Freiburg, Germany; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, D-80337 Munich, Germany	University of Freiburg; Forschungszentrum Borstel; University of Freiburg; National Research Council Canada; University of Munich	Huebner, J (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Lindwurmstr 4, D-80337 Munich, Germany.	johannes.huebner@med.uni-muenchen.de		Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646; Sanchez Carballo, Patricia M./0000-0003-1061-7023; Vinogradov, Evgeny/0000-0002-5364-1376	German Federal Ministry of Education and Research [BMBF 01 EO 0803]; ERA-Net PathoGenoMics; Netherlands Organization of Scientific Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); ERA-Net PathoGenoMics; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803). This work was also supported by the German grant (0313933) from the 1st call of the ERA-Net PathoGenoMics, a European program for cooperation and coordination of genome sequencing and functional genomics of human-pathogenic microorganisms.; Supported by a Vidi grant from the Netherlands Organization of Scientific Research.	ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; BLEIWEIS AS, 1967, J BACTERIOL, V94, P1381, DOI 10.1128/JB.94.5.1381-1387.1967; Bychowska A, 2011, CARBOHYD RES, V346, P2816, DOI 10.1016/j.carres.2011.09.026; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; ELLIOTT SD, 1959, NATURE, V184, P1342, DOI 10.1038/1841342a0; ELLIOTT SD, 1960, J EXP MED, V111, P621, DOI 10.1084/jem.111.5.621; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Ghanem G, 2007, INFECT CONT HOSP EP, V28, P1054, DOI 10.1086/519932; Gjelstrup LC, 2012, J IMMUNOL, V188, P1292, DOI 10.4049/jimmunol.1103012; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Haseley SR, 1997, EUR J BIOCHEM, V244, P761, DOI 10.1111/j.1432-1033.1997.00761.x; Hummelshoj T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038196; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mullighan CG, 2008, BLOOD, V112, P2120, DOI 10.1182/blood-2007-07-100222; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peel T, 2012, CLIN MICROBIOL INFEC, V18, P388, DOI 10.1111/j.1469-0691.2011.03591.x; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Schlapbach LJ, 2010, CLIN INFECT DIS, V51, P153, DOI 10.1086/653531; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Theilacker C, 2009, INFECTION, V37, P540, DOI 10.1007/s15010-009-9023-5; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Vekemans M, 2007, CLIN INFECT DIS, V44, P1593, DOI 10.1086/518171; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Worthley DL, 2009, CLIN INFECT DIS, V48, P410, DOI 10.1086/596313; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Zeng J, 2004, J CLIN MICROBIOL, V42, P1149, DOI 10.1128/JCM.42.3.1149-1154.2004	49	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.358283	http://dx.doi.org/10.1074/jbc.M112.358283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22908219	Green Published, hybrid			2022-12-28	WOS:000310642200016
J	Chaurasia, P; Sen, R; Pandita, TK; Bhaumik, SR				Chaurasia, Priyasri; Sen, Rwik; Pandita, Tej K.; Bhaumik, Sukesh R.			Preferential Repair of DNA Double-strand Break at the Active Gene in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; BASE EXCISION-REPAIR; HUMAN CSB GENE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; PYRIMIDINE DIMERS; INO80 COMPLEX; PHO5 PROMOTER; YEAST RAD26	Previous studies have demonstrated transcription-coupled nucleotide/base excision repair. We report here for the first time that DNA double-strand break (DSB) repair is also coupled to transcription. We generated a yeast strain by introducing a homing (Ho) endonuclease cut site followed by a nucleotide sequence for multiple Myc epitopes at the 3' end of the coding sequence of a highly active gene, ADH1. This yeast strain also contains the Ho cut site at the nearly silent or poorly active mating type alpha (MAT alpha) locus and expresses Ho endonuclease under the galactose-inducible GAL1 promoter. Using this strain, DSBs were generated at the ADH1 and MAT alpha loci in galactose-containing growth medium that induced HO expression. Subsequently, yeast cells were transferred to dextrose-containing growth medium to stop HO expression, and the DSB repair was monitored at the ADH1 and MAT alpha loci by PCR, using the primer pairs flanking the Ho cut sites. Our results revealed a faster DSB repair at the highly active ADH1 than that at the nearly silent MAT alpha locus, hence implicating a transcription-coupled DSB repair at the active gene in vivo. Subsequently, we extended this study to another gene, PHO5 (carrying the Ho cut site at its coding sequence), under transcriptionally active and inactive growth conditions. We found a fast DSB repair at the active PHO5 gene in comparison to its inactive state. Collectively, our results demonstrate a preferential DSB repair at the active gene, thus supporting transcription-coupled DSB repair in living cells.	[Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu	Pandita, Tej K/AAM-9188-2020	Sen, Rwik/0000-0003-2853-2378	National Institutes of Health Grant [1R15GM088798-01]; American Heart Association [10GRNT4300059]; Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) the Southern Illinois University School of Medicine;  [R01 CA123232];  [R01 CA129537];  [R01 CA154320]; NATIONAL CANCER INSTITUTE [R01CA154320, R01CA129537, R01CA123232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) the Southern Illinois University School of Medicine; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01 (to S. R. B.), American Heart Association Grant-in-Aid 10GRNT4300059 (Greater Midwest Affiliate), a Mallinckrodt Foundation grant, and Excellence in Academic Medicine (EAM) grants of the Southern Illinois University School of Medicine. This work was also supported by Grants R01 CA123232, R01 CA129537, and R01 CA154320 (to T. K. P.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bucheli M, 2004, MOL MICROBIOL, V52, P1653, DOI 10.1111/j.1365-2958.2004.04081.x; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1992, CANCER-AM CANCER SOC, V69, P2615, DOI 10.1002/1097-0142(19920515)69:10<2615::AID-CNCR2820691036>3.0.CO;2-1; He Y, 2012, MOL MICROBIOL, V83, P395, DOI 10.1111/j.1365-2958.2011.07941.x; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Larsen E, 2004, DNA REPAIR, V3, P1457, DOI 10.1016/j.dnarep.2004.06.008; Lau WTW, 1998, GENETICS, V150, P1349; Leadon SA, 2000, COLD SPRING HARB SYM, V65, P561, DOI 10.1101/sqb.2000.65.561; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Ljungman M, 1996, ONCOGENE, V13, P823; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S., 2012, BIOCHEMISTR IN PRESS; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; Malik S, 2012, NUCLEIC ACIDS RES, V40, P3348, DOI 10.1093/nar/gkr1244; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; PANDITA TK, 1992, RADIAT RES, V131, P214, DOI 10.2307/3578443; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Richardson C, 2004, DNA REPAIR, V3, P1149, DOI 10.1016/j.dnarep.2004.05.007; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott SP, 2006, J CELL BIOCHEM, V99, P1463, DOI 10.1002/jcb.21067; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SWEDER KS, 1993, SCIENCE, V262, P439, DOI 10.1126/science.8211165; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tsutakawa SE, 2000, COLD SPRING HARB SYM, V65, P201, DOI 10.1101/sqb.2000.65.201; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775	65	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36414	36422		10.1074/jbc.M112.364661	http://dx.doi.org/10.1074/jbc.M112.364661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910905	Green Published, hybrid			2022-12-28	WOS:000310364000061
J	Coincon, M; Wang, WJ; Sygusch, J; Seah, SYK				Coincon, Mathieu; Wang, Weijun; Sygusch, Jurgen; Seah, Stephen Y. K.			Crystal Structure of Reaction Intermediates in Pyruvate Class II Aldolase SUBSTRATE CLEAVAGE, ENOLATE STABILIZATION, AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; MICROBIAL ALDOLASES; MOLECULAR-BASIS; MECHANISM; RIBONUCLEASE-T1; CONVERGENT; CATALYSIS; RESIDUES; COMPLEX; VALUES	Crystal structures of divalent metal-dependent pyruvate aldolase, HpaI, in complex with substrate and cleavage products were determined to 1.8-2.0 angstrom resolution. The enzyme substrate complex with 4-hydroxy-2-ketoheptane-1,7-dioate indicates that water molecule W2 bound to the divalent metal ion initiates C3-C4 bond cleavage. The binding mode of the aldehyde donor delineated a solvent-filled capacious binding locus lined with predominantly hydrophobic residues. The absence of direct interactions with the aldehyde aliphatic carbons accounts for the broad specificity and lack of stereospecific control by the enzyme. Enzymatic complex structures formed with keto acceptors, pyruvate, and 2-ketobutyrate revealed bidentate interaction with the divalent metal ion by C1-carboxyl and C2-carbonyl oxygens and water molecule W4 that is within close contact of the C3 carbon. Arg(70) assumes a multivalent role through its guanidinium moiety interacting with all active site enzymatic species: C2 oxygen in substrate, pyruvate, and ketobutyrate; substrate C4 hydroxyl; aldehyde C1 oxygen; and W4. The multiple interactions made by Arg(70) stabilize the negatively charged C4 oxygen following proton abstraction, the aldehyde alignment in aldol condensation, and the pyruvate enolate upon aldol cleavage as well as support proton exchange at C3. This role is corroborated by loss of aldol cleavage ability and pyruvate C3 proton exchange activity and by a 730-fold increase in the dissociation constant toward the pyruvate enolate analog oxalate in the R70A mutant. Based on the crystal structures, a mechanism is proposed involving the two enzyme-bound water molecules, W2 and W4, in acid/base catalysis that facilitates reversible aldol cleavage. The same reaction mechanism promotes decarboxylation of oxaloacetate.	[Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochem, Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Wang, Weijun; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Universite de Montreal; University of Guelph	Sygusch, J (corresponding author), Univ Montreal, Dept Biochem, Stn Ctr Ville, CP6128, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca; sseah@uoguelph.ca		wang, weijun/0000-0001-9283-5619; Sygusch, Jurgen/0000-0002-6629-2128	National Science and Engineering Research Council of Canada; Canadian Institutes for Health Research; United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences [DE-AC02-98CH10886]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences(United States Department of Energy (DOE))	This work was supported by discovery grants from the National Science and Engineering Research Council of Canada (to S.S. and J.S.) and by a grant from the Canadian Institutes for Health Research (to J.S.).; Work was carried out in part at the National Synchrotron Light Source, Brookhaven National Laboratory, which is supported by the United States Department of Energy, Division of Materials Sciences, and Division of Chemical Sciences under Contract DE-AC02-98CH10886.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2011, BIOCHEMISTRY-US, V50, P3559, DOI 10.1021/bi101947g; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fish D. C., 1966, METHOD ENZYMOL, V9, P529; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; Hernaez MJ, 2002, APPL ENVIRON MICROB, V68, P4841, DOI 10.1128/AEM.68.10.4841-4846.2002; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Herzberg O, 2002, BIOCHEMISTRY-US, V41, P780, DOI 10.1021/bi011799+; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Joerger AC, 2000, BIOCHEMISTRY-US, V39, P6033, DOI 10.1021/bi9927686; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Liu T, 1997, PROTEIN SCI, V6, P1937, DOI 10.1002/pro.5560060914; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luchinat C., 1994, BIOINORGANIC BIOCH, P41; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; MCNUTT M, 1990, BIOCHEMISTRY-US, V29, P7572, DOI 10.1021/bi00485a005; MOCK WL, 1988, J BIOL CHEM, V263, P8635; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; O'Leary M. H., 1992, MECH CATALYSIS, P239; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Rea D, 2008, BIOCHEMISTRY-US, V47, P9955, DOI 10.1021/bi800943g; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wang WJ, 2008, FEBS LETT, V582, P3385, DOI 10.1016/j.febslet.2008.08.032; Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509; Wang WJ, 2010, BIOCHEMISTRY-US, V49, P3774, DOI 10.1021/bi100251u; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Zheng YQ, 2002, J COORD CHEM, V55, P1249, DOI 10.1080/0095897021000036262	46	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36208	36221		10.1074/jbc.M112.400705	http://dx.doi.org/10.1074/jbc.M112.400705			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22908224	Green Published, hybrid			2022-12-28	WOS:000310364000042
J	Khurana, S; Chakraborty, S; Zhao, X; Liu, Y; Guan, DY; Lam, M; Huang, W; Yang, SC; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Zhao, Xuan; Liu, Yu; Guan, Dongyin; Lam, Minh; Huang, Wei; Yang, Sichun; Kao, Hung-Ying			Identification of a Novel LXXLL Motif in alpha-Actinin 4-spliced Isoform That Is Critical for Its Interaction with Estrogen Receptor alpha and Co-activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; ACETYLATION; BINDING; PROTEINS; SUPERFAMILY; SPECIFICITY; COMPLEX; SRC-1; GENE	alpha-Actinins (ACTNs) are a family of proteins cross-linking actin filaments that maintain cytoskeletal organization and cell motility. Recently, it has also become clear that ACTN4 can function in the nucleus. In this report, we found that ACTN4 (full length) and its spliced isoform ACTN4 (Iso) possess an unusual LXXLL nuclear receptor interacting motif. Both ACTN4 (full length) and ACTN4 (Iso) potentiate basal transcription activity and directly interact with estrogen receptor alpha, although ACTN4 (Iso) binds ER alpha more strongly. We have also found that both ACTN4 (full length) and ACTN4 (Iso) interact with the ligand-independent and the ligand-dependent activation domains of estrogen receptor alpha. Although ACTN4 (Iso) interacts efficiently with transcriptional co-activators such as p300/CBP-associated factor (PCAF) and steroid receptor co-activator 1 (SRC-1), the full length ACTN4 protein either does not or does so weakly. More importantly, the flanking sequences of the LXXLL motif are important not only for interacting with nuclear receptors but also for the association with co-activators. Taken together, we have identified a novel extended LXXLL motif that is critical for interactions with both receptors and co-activators. This motif functions more efficiently in a spliced isoform of ACTN4 than it does in the full-length protein.	[Khurana, Simran; Chakraborty, Sharmistha; Zhao, Xuan; Liu, Yu; Guan, Dongyin; Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Huang, Wei; Yang, Sichun] Case Western Reserve Univ, Sch Med, Ctr Prote, Cleveland, OH 44106 USA; [Huang, Wei; Yang, Sichun] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lam, Minh] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Lam, Minh] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Yang, Sichun/B-1608-2008; Huang, Wei/O-2035-2016	Yang, Sichun/0000-0002-1726-0576; Huang, Wei/0000-0003-2097-8148	National Institutes of Health [RO1 DK078965, HL093269, P30 CA43703-12]; American Cancer Society-Institutional Research Grant [ACS IRG-91-022-15]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK078965 and HL093269 (to H.-Y.K.) and P30 CA43703-12. This work was also supported by American Cancer Society-Institutional Research Grant ACS IRG-91-022-15 (to S.Y.).	Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Glass CK, 2000, GENE DEV, V14, P121; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jeong KW, 2009, J BIOL CHEM, V284, P29298, DOI 10.1074/jbc.M109.037010; Kao HY, 2000, GENE DEV, V14, P55; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104	38	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35418	35429		10.1074/jbc.M112.401364	http://dx.doi.org/10.1074/jbc.M112.401364			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908231	Green Published, hybrid			2022-12-28	WOS:000309968000049
J	Notomi, T; Ezura, Y; Noda, M				Notomi, Takuya; Ezura, Yoichi; Noda, Masaki			Identification of Two-pore Channel 2 as a Novel Regulator of Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; MOBILIZES CALCIUM; BONE-RESORPTION; ACTIVATION; NAADP; CELLS; CD38; INDUCTION; MUSCLE	Osteoclast differentiation is one of the critical steps that control bone mass levels in osteoporosis, but the molecules involved in osteoclastogenesis are still incompletely understood. Here, we show that two-pore channel 2 (TPC2) is expressed in osteoclast precursor cells, and its knockdown (TPC2-KD) in these cells suppressed RANKL-induced key events including multi-nucleation, enhancement of tartrate-resistant acid phosphatase (TRAP) activities, and TRAP mRNA expression levels. With respect to intracellular signaling, TPC2-KD reduced the levels of the RANKL-induced dynamic waving of Ca2+ in RAW cells. The search for the target of TPC2 identified that nuclear localization of NFATc1 is retarded in TPC2-KD cells. Finally, TPC2-KD suppressed osteoclastic pit formation in cultures. We conclude that TPC2 is a novel critical molecule for osteoclastogenesis.	[Notomi, Takuya; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program Mol Sci Tooth & Bon, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Notomi, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tnotomi.gcoe@tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Ezura, Yoichi/L-9485-2016		Ministry of Education, Science, and Culture; Uehara Memorial Foundation; Nakatomi Foundation; Mochida Memorial Foundation	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Mochida Memorial Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture, Uehara Memorial Foundation, Nakatomi Foundation, and Mochida Memorial Foundation.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Henriksen K, 2008, CALCIFIED TISSUE INT, V83, P230, DOI 10.1007/s00223-008-9168-8; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; KUKITA A, 1993, BIOCHEM BIOPH RES CO, V196, P1383, DOI 10.1006/bbrc.1993.2406; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; McClung MR, 2012, J BONE MINER RES, V27, P211, DOI 10.1002/jbmr.536; Mori H, 2003, J BONE MINER RES, V18, P2069, DOI 10.1359/jbmr.2003.18.11.2069; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Razzouk S, 1999, EUR J CELL BIOL, V78, P249, DOI 10.1016/S0171-9335(99)80058-2; Schmid F, 2011, FEBS LETT, V585, P3544, DOI 10.1016/j.febslet.2011.10.017; Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196; SILVERTON S, 1994, J CELL BIOCHEM, V56, P367, DOI 10.1002/jcb.240560313; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Youn MY, 2010, GENES CELLS, V15, P1025, DOI 10.1111/j.1365-2443.2010.01441.x; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028	36	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35057	35064		10.1074/jbc.M111.328930	http://dx.doi.org/10.1074/jbc.M111.328930			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22833668	hybrid, Green Published			2022-12-28	WOS:000309968000017
J	Zhou, JD; Zhang, SY; Xue, J; Avery, J; Wu, JC; Lind, SE; Ding, WQ				Zhou, Jundong; Zhang, Shuyu; Xue, Jing; Avery, Jori; Wu, Jinchang; Lind, Stuart E.; Ding, Wei-Qun			Activation of Peroxisome Proliferator-activated Receptor alpha (PPAR alpha) Suppresses Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OVARIAN-CANCER; DOCOSAHEXAENOIC ACID; IN-VITRO; PROTEASOME INHIBITORS; GENE-EXPRESSION; CLOFIBRIC ACID; DNA-BINDING; HIF-ALPHA; GROWTH; ANGIOGENESIS	Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) has been demonstrated to inhibit tumor growth and angiogenesis, yet the mechanisms behind these actions remain to be characterized. In this study, we examined the effects of PPAR alpha activation on the hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling pathway in human breast (MCF-7) and ovarian (A2780) cancer cells under hypoxia. Incubation of cancer cells under 1% oxygen for 16 h significantly induced HIF-1 alpha expression and activity as assayed by Western blotting and reporter gene analysis. Treatment of the cells with PPAR alpha agonists, but not a PPAR gamma agonist, prior to hypoxia diminished hypoxia-induced HIF-1 alpha expression and activity, and addition of a PPAR alpha antagonist attenuated the suppression of HIF-1 alpha signaling. Activation of PPAR alpha attenuated hypoxia-induced HA-tagged HIF-1 alpha protein expression without affecting the HA-tagged HIF-1 alpha mutant protein level, indicating that PPAR alpha activation promotes HIF-1 alpha degradation in these cells. This was further confirmed using proteasome inhibitors, which reversed PPAR alpha-mediated suppression of HIF-1 alpha expression under hypoxia. Using the co-immunoprecipitation technique, we found that activation of PPAR alpha enhances the binding of HIF-1 alpha to von Hippel-Lindau tumor suppressor (pVHL), a protein known to mediate HIF-1 alpha degradation through the ubiquitin-proteasome pathway. Following PPAR alpha mediated suppression of HIF-1 alpha signaling, VEGF secretion from the cancer cells was significantly reduced, and tube formation by endothelial cells was dramatically impaired. Taken together, these findings demonstrate for the first time that activation of PPAR alpha suppresses hypoxia-induced HIF-1 alpha signaling in cancer cells, providing novel insight into the anticancer properties of PPAR alpha agonists.	[Zhou, Jundong; Zhang, Shuyu; Xue, Jing; Avery, Jori; Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zhou, Jundong; Xue, Jing; Wu, Jinchang] Nanjing Med Univ, Suzhou Hosp, Dept Radiooncol, Suzhou 205123, Peoples R China; [Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou 205123, Peoples R China; [Lind, Stuart E.] Univ Colorado Denver, Dept Pathol, Denver, CO 80217 USA; [Lind, Stuart E.] Univ Colorado Denver, Dept Med, Denver, CO 80217 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Nanjing Medical University; Soochow University - China; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, 975 NE 10th St,BRC 411A, Oklahoma City, OK 73104 USA.	weiqun-ding@ouhsc.edu			National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program [3P20RR016478-09S2]; American Cancer Society [CNE-117557]; Susan G. Komen for the Cure Foundation [KG081083]; Oklahoma Center for the Advancement of Science and Technology [HR09-025]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program; American Cancer Society(American Cancer Society); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) Program Grant 3P20RR016478-09S2. This work was also supported by American Cancer Society Grant CNE-117557, Susan G. Komen for the Cure Foundation Grant KG081083, and Oklahoma Center for the Advancement of Science and Technology Grant HR09-025.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Birle DC, 2007, CANCER RES, V67, P1735, DOI 10.1158/0008-5472.CAN-06-2722; Brahimi-Horn Christiane, 2006, Bull Cancer, V93, pE73; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chang TT, 2011, MOL PHARMACEUT, V8, P117, DOI 10.1021/mp100137q; Cui Y, 2012, J CELL PHYSIOL, V227, P772, DOI 10.1002/jcp.22789; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Drukala J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-159; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Grabacka M, 2004, ARCH DERMATOL RES, V296, P54, DOI 10.1007/s00403-004-0479-y; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Grau R, 2006, BIOCHEM J, V395, P81, DOI 10.1042/BJ20050964; Grau R, 2008, PPAR RES, V2008, DOI 10.1155/2008/352437; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shigeto T, 2007, ONCOL REP, V18, P833; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Tuller ER, 2009, MOL PHARMACOL, V76, P588, DOI 10.1124/mol.109.057430; Tuller ER, 2009, BIOCHEM PHARMACOL, V77, P1480, DOI 10.1016/j.bcp.2009.02.002; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Yokoyama Y, 2007, MOL CANCER THER, V6, P1379, DOI 10.1158/1535-7163.MCT-06-0722; Zak Z, 2010, LEUKEMIA, V24, P1476, DOI 10.1038/leu.2010.117; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530	46	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35161	35169		10.1074/jbc.M112.367367	http://dx.doi.org/10.1074/jbc.M112.367367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932900	Green Published, hybrid			2022-12-28	WOS:000309968000026
J	Alam, MR; Groschner, LN; Parichatikanond, W; Kuo, L; Bondarenko, AI; Rost, R; Waldeck-Weiermair, M; Malli, R; Graier, WF				Alam, Muhammad Rizwan; Groschner, Lukas N.; Parichatikanond, Warisara; Kuo, Liang; Bondarenko, Alexander I.; Rost, Rene; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.			Mitochondrial Ca2+ Uptake 1 (MICU1) and Mitochondrial Ca2+ Uniporter (MCU) Contribute to Metabolism-Secretion Coupling in Clonal Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; ESSENTIAL COMPONENT; RYANODINE RECEPTOR; GLUCOSE; CALCIUM; MEMBRANE; PROTEINS; SIGNALS; ENTRY; LETM1	In pancreatic beta-cells, uptake of Ca2+ into mitochondria facilitates metabolism-secretion coupling by activation of various matrix enzymes, thus facilitating ATP generation by oxidative phosphorylation and, in turn, augmenting insulin release. We employed an siRNA-based approach to evaluate the individual contribution of four proteins that were recently described to be engaged in mitochondrial Ca2+ sequestration in clonal INS-1 832/13 pancreatic beta-cells: the mitochondrial Ca2+ uptake 1 (MICU1), mitochondrial Ca2+ uniporter (MCU), uncoupling protein 2 (UCP2), and leucine zipper EF-hand-containing transmembrane protein 1 (LETM1). Using a FRET-based genetically encoded Ca2+ sensor targeted to mitochondria, we show that a transient knockdown of MICU1 or MCU diminished mitochondrial Ca2+ uptake upon both intracellular Ca2+ release and Ca2+ entry via L-type channels. In contrast, knockdown of UCP2 and LETM1 exclusively reduced mitochondrial Ca2+ uptake in response to either intracellular Ca2+ release or Ca2+ entry, respectively. Therefore, we further investigated the role of MICU1 and MCU in metabolism-secretion coupling. Diminution of MICU1 or MCU reduced mitochondrial Ca2+ uptake in response to D-glucose, whereas D-glucose-triggered cytosolic Ca2+ oscillations remained unaffected. Moreover, D-glucose-evoked increases in cytosolic ATP and D-glucose-stimulated insulin secretion were diminished in MICU1- or MCU-silenced cells. Our data highlight the crucial role of MICU1 and MCU in mitochondrial Ca2+ uptake in pancreatic beta-cells and their involvement in the positive feedback required for sustained insulin secretion.	[Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Mol & Cellular Physiol Res Unit, A-8010 Graz, Austria; [Kuo, Liang] Capital Med Univ, Xuan Wu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China	Medical University of Graz; Capital Medical University	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Mol & Cellular Physiol Res Unit, Harrachgasse 21-3, A-8010 Graz, Austria.	wolfgang.graier@medunigraz.at	Waldeck-Weiermair, Markus/AAV-5193-2020; Alam, Muhammad Rizwan/AAE-2266-2019; Graier, Wolfgang F./B-7052-2008; Groschner, Lukas/AHD-6319-2022; Groschner, Lukas/J-9398-2012; Bondarenko, Alexander I/B-3080-2013	Waldeck-Weiermair, Markus/0000-0002-5792-6766; Alam, Muhammad Rizwan/0000-0002-1578-5723; Graier, Wolfgang F./0000-0003-1871-3298; Groschner, Lukas/0000-0002-4325-0232; Groschner, Lukas/0000-0002-4325-0232; Parichatikanond, Warisara/0000-0001-7851-2477; Malli, Roland/0000-0001-6327-8729; Rost, Rene/0000-0002-5393-0370; Bondarenko, Oleksandr/0000-0003-2629-5962	Austrian Science Funds (FWF) [P21857-B18, P22553-B18]; FWF within the Doctoral College "Molecular Medicine" at the Medical University of Graz [P21857-B18]; Austrian Academic Exchange Service (AD); Austrian Science Fund (FWF) [P 21857, P 22553] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); FWF within the Doctoral College "Molecular Medicine" at the Medical University of Graz; Austrian Academic Exchange Service (AD); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF) (Grants P21857-B18 and P22553-B18).; Funded by the FWF (Grant P21857-B18) within the Doctoral College "Molecular Medicine" at the Medical University of Graz.; Supported by the Austrian Academic Exchange Service (AD).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Malli R, 2007, CELL CALCIUM, V41, P63, DOI 10.1016/j.ceca.2006.05.001; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Medvedev AV, 2002, J BIOL CHEM, V277, P42639, DOI 10.1074/jbc.M208645200; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Ravier MA, 2010, DIABETOLOGIA, V53, P1947, DOI 10.1007/s00125-010-1775-z; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; RUTTER GA, 1989, ANN NY ACAD SCI, V573, P206, DOI 10.1111/j.1749-6632.1989.tb14998.x; Ryu SY, 2011, J BIOL CHEM, V286, P21324, DOI 10.1074/jbc.C111.245597; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	39	93	97	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34445	34454		10.1074/jbc.M112.392084	http://dx.doi.org/10.1074/jbc.M112.392084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904319	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000309654200046
J	Darmellah, A; Rayah, A; Auger, R; Cuif, MH; Prigent, M; Arpin, M; Alcover, A; Delarasse, C; Kanellopoulos, JM				Darmellah, Amaria; Rayah, Amel; Auger, Rodolphe; Cuif, Marie-Helene; Prigent, Magali; Arpin, Monique; Alcover, Andres; Delarasse, Cecile; Kanellopoulos, Jean M.			Ezrin/Radixin/Moesin Are Required for the Purinergic P2X7 Receptor (P2X7R)-dependent Processing of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERM PROTEINS; P2X(7) RECEPTOR; EXTRACELLULAR ATP; STRUCTURAL BASIS; NEUTRAL ENDOPEPTIDASE-24.11; MEMBRANE-PROTEINS; ADAPTER PROTEINS; CELL CORTEX; ACTIVATION; PHOSPHORYLATION	The amyloid precursor protein (APP) can be cleaved by alpha-secretases in neural cells to produce the soluble APP ectodomain (sAPP alpha), which is neuroprotective. We have shown previously that activation of the purinergic P2X7 receptor(P2X7R) triggers sAPP alpha shedding from neural cells. Here, we demonstrate that the activation of ezrin, radixin, and moesin(ERM) proteins is required for the P2X7R-dependent proteolytic processing of APP leading to sAPP alpha release. Indeed, the down-regulation of ERM by siRNA blocked the P2X7R-dependent shedding of sAPP alpha. We also show that P2X7R stimulation triggered the phosphorylation of ERM. Thus, ezrin translocates to the plasma membrane to interact with P2X7R. Using specific pharmacological inhibitors, we established the order in which several enzymes trigger the P2X7R-dependent release of sAPP alpha. Thus, a Rho kinase and the MAPK modules ERK1/2 and JNK act upstream of ERM, whereas a PI3K activity is triggered downstream. For the first time, this work identifies ERM as major partners in the regulated non-amyloidogenic processing of APP.	[Delarasse, Cecile] Univ Paris 06, INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,UMRS 975,UMR 7225,CRICM, F-75013 Paris, France; [Darmellah, Amaria; Rayah, Amel; Auger, Rodolphe; Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Cuif, Marie-Helene; Prigent, Magali] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Arpin, Monique] CNRS, Inst Curie, Ctr Rech, UMR 144, F-75248 Paris, France; [Alcover, Andres] CNRS, Dept Immunol, Lymphocyte Cell Biol Unit, Inst Pasteur,URA 1961, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Delarasse, C (corresponding author), Univ Paris 06, INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,UMRS 975,UMR 7225,CRICM, F-75013 Paris, France.	cecile.delarasse@upmc.fr; jean.kanellopoulos@u-psud.fr	Delarasse, Cecile/K-8234-2017	Delarasse, Cecile/0000-0001-9739-4306; Alcover, Andres/0000-0002-9507-3450	CNRS; Agence Nationale pour la Recherche [ANR-07-BLAN-0089-02]; Neuropple de Recherche Francilien; French government; Association France Alzheimer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Neuropple de Recherche Francilien; French government; Association France Alzheimer	This work was supported in part by the CNRS and Agence Nationale pour la Recherche Grant ANR-07-BLAN-0089-02.; Supported by a postdoctoral fellowship from Neuropple de Recherche Francilien.; Supported by a Ph.D. fellowship from the French government.; Supported by Association France Alzheimer. To whom correspondence may be addressed: CRICM, INSERM UMRS_975, Universite Pierre et Marie Curie (Paris 6), CNRS UMR 7225, 75013 Paris, France. E-mail: cecile.delarasse@upmc.fr.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Darmellah A, 2009, CARDIOVASC RES, V81, P294, DOI 10.1093/cvr/cvn320; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Feyt C, 2007, BIOCHEM BIOPH RES CO, V357, P1004, DOI 10.1016/j.bbrc.2007.04.036; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; PASTOR R, 1994, ONCOGENE, V9, P1081; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Roubinet C, 2011, J CELL BIOL, V195, P99, DOI 10.1083/jcb.201106048; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takenouchi T, 2008, J IMMUNOL, V180, P7827, DOI 10.4049/jimmunol.180.12.7827; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	75	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34583	34595		10.1074/jbc.M112.400010	http://dx.doi.org/10.1074/jbc.M112.400010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891241	Green Published, hybrid			2022-12-28	WOS:000309654200061
J	Peterson, S; Liu, J				Peterson, Sherket; Liu, Jian			Deciphering Mode of Action of Heparanase Using Structurally Defined Oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SPECIFICITY; PROGRESSION; METASTASIS; MECHANISM; SEQUENCE; RELEASE; ROLES	Heparan sulfate (HS) is a highly sulfated polysaccharide that serves many biological functions, including regulating cell growth and inflammatory responses as well as the blood coagulation process. Heparanase is an enzyme that cleaves HS and is known to display a variety of pathophysiological effects in cancer, diabetes, and Alzheimer disease. The link between heparanase and diseases is a result of its selective cleavage of HS, which releases smaller HS fragments to enhance cell proliferation, migration, and invasion. Despite its importance in pathological diseases, the structural cues in HS that direct heparanase cleavage and the steps of HS depolymerization remain unknown. Here, we sought to probe the substrate specificity of heparanase using a series of structurally defined oligosaccharide substrates. The sites of heparanase cleavage on the oligosaccharide substrates were determined by mass spectrometry and gel permeation chromatography. We discovered that heparanase cleaves the linkage of glucuronic acid linked to glucosamine carrying 6-O-sulfo groups. Furthermore, our findings suggest that heparanase displays different cleavage modes by recognizing the structures of the nonreducing ends of the substrates. Our results deepen the understanding of the action mode of heparanase.	[Peterson, Sherket; Liu, Jian] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Beard Hall,Rm 303, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [HL094463]; Ruth L. Kirschstein National Research Service Award from the National Institutes of Health [F31GM090647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM090647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant HL094463.; Recipient of Ruth L. Kirschstein National Research Service Award F31GM090647 from the National Institutes of Health.	Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; BASHKIN P, 1992, J CELL PHYSIOL, V151, P126, DOI 10.1002/jcp.1041510117; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Steinkuhler C., 2007, U.S. Patent, Patent No. [2007/0009989, 20070009989]; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	24	45	45	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34836	34843		10.1074/jbc.M112.390161	http://dx.doi.org/10.1074/jbc.M112.390161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893710	Green Published, hybrid			2022-12-28	WOS:000309654200082
J	Sexton, AN; Youmans, DT; Collins, K				Sexton, Alec N.; Youmans, Daniel T.; Collins, Kathleen			Specificity Requirements for Human Telomere Protein Interaction with Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL BODIES; CATALYTIC SUBUNIT; LENGTH REGULATION; YEAST TELOMERASE; END-PROTECTION; EST3 PROTEIN; HUMAN CANCER; 10 DOMAIN; OB-FOLD; RECRUITMENT	Human telomeres are maintained by the enzyme telomerase, which uses a template within its integral RNA subunit (hTR) and telomerase reverse transcriptase protein (TERT) to accomplish the synthesis of single-stranded DNA repeats. Many questions remain unresolved about the cellular regulation of telomerase subunits and the fully assembled telomerase holoenzyme, including the basis for the specificity of binding and acting on telomeres. Previous studies have revealed that the telomere protein TPP1 is necessary for stable TERT and hTR association with telomeres in vivo. Here, we expand the biochemical characterization and understanding of TPP1 interaction with TERT and the catalytically active telomerase holoenzyme. Using extracts from human cells, we show that TPP1 interacts sequence-specifically with TERT when TERT is assembled into holoenzyme context. In holoenzyme context, the TERT N-terminal domain mediates a TPP1 interaction. Assays of stable subunit complexes purified after their cellular assembly suggest that other telomere proteins do not necessarily influence TPP1 association with telomerase holoenzyme or alter its impact on elongation processivity. We show that a domain of recombinant TPP1 comprised of an oligonucleotide/oligosaccharide binding fold recapitulates the full-length protein interaction specificity for the TERT N-terminal domain assembled into telomerase holoenzyme. By global analysis of TPP1 side chain requirements for holoenzyme association, we demonstrate a selective requirement for the amino acids in one surface-exposed protein loop. Our results reveal the biochemical determinants of a sequence-specific TPP1-TERT interaction in human cells, with implications for the mechanisms of TPP1 function in recruiting telomerase subunits to telomeres and in promoting telomere elongation.	[Sexton, Alec N.; Youmans, Daniel T.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu		Youmans, Daniel/0000-0003-2648-0797	National Institutes of Health [RO1 HL079585]; University of California Cancer Research Coordinating Committee predoctoral fellowship award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee predoctoral fellowship award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant RO1 HL079585 and a University of California Cancer Research Coordinating Committee predoctoral fellowship award.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Egan E. D., 2012, RNA IN PRESS, V18; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Lee SR, 2003, J BIOL CHEM, V278, P52531, DOI 10.1074/jbc.M311359200; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	35	80	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34455	34464		10.1074/jbc.M112.394767	http://dx.doi.org/10.1074/jbc.M112.394767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893708	hybrid, Green Published			2022-12-28	WOS:000309654200047
J	Aikawa, Y				Aikawa, Yoshikatsu			Rabex-5 Protein Regulates the Endocytic Trafficking Pathway of Ubiquitinated Neural Cell Adhesion Molecule L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR RABEX-5; BINDING DOMAINS; GROWTH CONES; RECEPTOR ENDOCYTOSIS; NUCLEOTIDE EXCHANGE; NEURONAL MIGRATION; MEMBRANE-PROTEINS; STRUCTURAL BASIS; EARLY ENDOSOMES; INTERNALIZATION	Ubiquitination of integral membrane proteins is a common posttranslational modification used to mediate endocytosis and endocytic sorting of cell surface proteins in eukaryotic cells. Ubiquitin (Ub)-binding proteins (UBPs) regulate the stability, function, and localization of ubiquitinated cell surface proteins in the endocytic pathway. Here, I report that the immunoglobulin superfamily cell adhesion molecule L1 undergoes ubiquitination and dephosphorylation on the plasma membrane upon L1 antibody-induced clustering, which mimics L1-L1 homophilic binding, and that these modifications are critical for obtaining the maximal rate of internalization and trafficking to the lysosome, but not to the proteasome. Notably, L1 antibody-induced clustering leads to the association of ubiquitinated L1 with Rabex-5, a UBP and guanine nucleotide exchange factor for Rab5, via interaction with the motif interacting with Ub (MIU) domain, but not the A20-type zinc finger domain. This interaction specifically depends on the presence of an Ub moiety on lysine residues in L1. Rabex-5 expression accelerates the internalization rates of L1(WT) and L1(Y1176A), a tyrosine-based motif mutant, but not L1(K11R), an ubiquitination-deficient mutant, leading to the accumulation of ubiquitinated L1 on endosomes. In contrast, RNA interference-mediated knockdown of Rabex-5 impairs the internalizations of L1(WT) and L1(Y1176A), but not L1(K11R) from the plasma membrane. Overall, these results provide a novel mechanistic insight into how Rabex-5 regulates internalization and postendocytic trafficking of ubiquitinated L1 destined for lysosomal degradation.	Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, Kyoto 6100394, Japan	Doshisha University	Aikawa, Y (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, 1-3 Miyakodani, Kyoto 6100394, Japan.	yaikawa@mail.doshisha.ac.jp			Japan Society for the Promotion of Science [20790085]; Uehara Memorial Foundation; Doshisha University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Doshisha University	This work was supported by Grant-in-aid for Young Scientists (B) (20790085) from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and individual research allowances from Doshisha University (to Y. A.). Measurement and data analyses were done at Kagawa School, Tokushima Bunri University.	Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sakurai T, 2008, J NEUROSCI RES, V86, P2602, DOI 10.1002/jnr.21705; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schafer MKE, 2010, FEBS LETT, V584, P4475, DOI 10.1016/j.febslet.2010.10.011; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Thelen K, 2008, J BIOL CHEM, V283, P32792, DOI 10.1074/jbc.M805896200; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Volpicelli LA, 2001, J BIOL CHEM, V276, P47590, DOI 10.1074/jbc.M106535200; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143	47	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32312	32323		10.1074/jbc.M112.374322	http://dx.doi.org/10.1074/jbc.M112.374322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846990	hybrid, Green Published			2022-12-28	WOS:000309168300003
J	Hodder, AN; Czabotar, PE; Uboldi, AD; Clarke, OB; Lin, CS; Healer, J; Smith, BJ; Cowman, AF				Hodder, Anthony N.; Czabotar, Peter E.; Uboldi, Alessandro D.; Clarke, Oliver B.; Lin, Clara S.; Healer, Julie; Smith, Brian J.; Cowman, Alan F.			Insights into Duffy Binding-like Domains through the Crystal Structure and Function of the Merozoite Surface Protein MSPDBL2 from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; GLYCOPHORIN-C; MALARIA; RECEPTOR; ANTIGEN; FAMILY; IDENTIFICATION; RECOGNITION; DISRUPTION; SELECTION	Invasion of human red blood cells by Plasmodium falciparum involves interaction of the merozoite form through proteins on the surface coat. The erythrocyte binding-like protein family functions after initial merozoite interaction by binding via the Duffy binding-like (DBL) domain to receptors on the host red blood cell. The merozoite surface proteins DBL1 and -2 (PfMSPDBL1 and PfMSPDBL2) (PF10_0348 and PF10_0355) are extrinsically associated with the merozoite, and both have a DBL domain in each protein. We expressed and refolded recombinant DBL domains for PfMSPDBL1 and -2 and show they are functional. The red cell binding characteristics of these domains were shown to be similar to full-length forms of these proteins isolated from parasite cultures. Futhermore, metal cofactors were found to enhance the binding of both the DBL domains and the parasite-derived full-length proteins to erythrocytes, which has implications for receptor binding of other DBL-containing proteins in Plasmodium spp. We solved the structure of the erythrocyte-binding DBL domain of PfMSPDBL2 to 2.09 angstrom resolution and modeled that of PfMSPDBL1, revealing a canonical DBL fold consisting of a boomerang shaped alpha-helical core formed from three subdomains. PfMSPDBL2 is highly polymorphic, and mapping of these mutations shows they are on the surface, predominantly in the first two domains. For both PfMSPDBL proteins, polymorphic variation spares the cleft separating domains 1 and 2 from domain 3, and the groove between the two major helices of domain 3 extends beyond the cleft, indicating these regions are functionally important and are likely to be associated with the binding of a receptor on the red blood cell.	[Hodder, Anthony N.; Czabotar, Peter E.; Uboldi, Alessandro D.; Clarke, Oliver B.; Lin, Clara S.; Healer, Julie; Smith, Brian J.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Hodder, Anthony N.; Czabotar, Peter E.; Clarke, Oliver B.; Lin, Clara S.; Smith, Brian J.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University	Hodder, AN (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	hodder@wehi.edu.au; cowman@wehi.edu.au	Cowman, Alan F/C-7642-2013; Smith, Brian J/F-8282-2011	Cowman, Alan F/0000-0001-5145-9004; Smith, Brian J/0000-0003-0498-1910; Czabotar, Peter/0000-0002-2594-496X	Victorian State Government; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme	Victorian State Government; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld DS, 2009, BIOMETALS, V22, P141, DOI 10.1007/s10534-008-9184-1; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashford D., 1997, Scientific Computing in Object-Oriented Parallel Environments. First International Conference, ISCOPE 97. Proceedings, P233; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	51	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32922	32939		10.1074/jbc.M112.350504	http://dx.doi.org/10.1074/jbc.M112.350504			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843685	Green Published, hybrid			2022-12-28	WOS:000309168300057
J	Jennemann, R; Kaden, S; Sandhoff, R; Nordstrom, V; Wang, SJ; Volz, M; Robine, S; Amen, N; Rothermel, U; Wiegandt, H; Grone, HJ				Jennemann, Richard; Kaden, Sylvia; Sandhoff, Roger; Nordstroem, Viola; Wang, Shijun; Volz, Martina; Robine, Sylvie; Amen, Nicole; Rothermel, Ulrike; Wiegandt, Herbert; Groene, Hermann-Josef			Glycosphingolipids Are Essential for Intestinal Endocytic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TO-MESENCHYMAL TRANSITION; CEREBELLAR GRANULE CELLS; LIPID ABSORPTION; GANGLIOSIDE GM3; BRUSH-BORDER; MEMBRANE; CERAMIDE; COMPLEX; EXPRESSION	Glycosphingolipids (GSLs) constitute major components of enterocytes and were hypothesized to be potentially important for intestinal epithelial polarization. The enzyme UDP-glucose ceramide glucosyltransferase (Ugcg) catalyzes the initial step of GSL biosynthesis. Newborn and adult mice with enterocyte-specific genetic deletion of the gene Ugcg were generated. In newborn mutants lacking GSLs at day P0, intestinal epithelia were indistinguishable from those in control littermates displaying an intact polarization with regular brush border. However, those mice were not consistently able to absorb nutritional lipids from milk. Between postnatal days 5 and 7, severe defects in intestinal epithelial differentiation occurred accompanied by impaired intestinal uptake of nutrients. Villi of mutant mice became stunted, and enterocytes lacked brush border. The defects observed in mutant mice caused diarrhea, malabsorption, and early death. In this study, we show that GSLs are essential for enterocyte resorptive function but are primarily not for polarization; GSLs are required for intracellular vesicular transport in resorption-active intestine.	[Jennemann, Richard; Kaden, Sylvia; Sandhoff, Roger; Nordstroem, Viola; Wang, Shijun; Volz, Martina; Amen, Nicole; Rothermel, Ulrike; Wiegandt, Herbert; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Sandhoff, Roger] Inst Curie, CNRS, F-75248 Paris, France; [Robine, Sylvie] German Canc Res Ctr, Lipid Pathobiochem Grp, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Helmholtz Association; German Cancer Research Center (DKFZ)	Jennemann, R (corresponding author), German Canc Res Ctr, Dept Cellular & Mol Pathol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.jennemann@dkfz.de; h.-j.groene@dkfz.de		Nordstrom, Viola/0000-0002-8830-2964	Deutsche Forschungsgemeinschaft [SFB 938, GK 880]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants-in-aid SFB 938 and GK 880 (to H.-J. G.).	Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Chester MA, 1999, J MOL BIOL, V286, P963, DOI 10.1006/jmbi.1998.2485; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANSEN K, 1981, BIOCHIM BIOPHYS ACTA, V647, P188, DOI 10.1016/0005-2736(81)90245-5; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; DICKSON JJ, 1978, BIOCHEM J, V170, P407, DOI 10.1042/bj1700407; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elkjaer ML, 2001, AM J PHYSIOL-RENAL, V281, pF1047, DOI 10.1152/ajprenal.0158.2001; GHIDONI R, 1986, BIOCHEM J, V237, P147, DOI 10.1042/bj2370147; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hansen GH, 2007, AM J PHYSIOL-GASTR L, V293, pG1325, DOI 10.1152/ajpgi.00379.2007; Hansen GH, 2003, BIOCHEM J, V373, P125, DOI 10.1042/BJ20030235; Hoekstra D, 2003, J LIPID RES, V44, P869, DOI 10.1194/jlr.R300003-JLR200; Hou Q, 2011, J LIPID RES, V52, P278, DOI 10.1194/jlr.M012161; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jennemann R, 2010, HEPATOLOGY, V51, P1799, DOI 10.1002/hep.23545; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mansbach CM, 2007, AM J PHYSIOL-GASTR L, V293, pG645, DOI 10.1152/ajpgi.00299.2007; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Pescio LG, 2012, BBA-MOL CELL BIOL L, V1821, P884, DOI 10.1016/j.bbalip.2012.02.009; RIBONI L, 1992, FEBS LETT, V300, P188, DOI 10.1016/0014-5793(92)80193-K; RIBONI L, 1990, NEUROCHEM RES, V15, P1175, DOI 10.1007/BF01208577; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Tokuyasu KT, 1997, CELLS LAB MANUAL, V131.1-27; Tso P, 2004, BIOCHEM SOC T, V32, P75, DOI 10.1042/BST0320075; Willenborg C, 2011, J CELL BIOL, V195, P71, DOI 10.1083/jcb.201011112; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoneshige A, 2010, J NUTR BIOCHEM, V21, P214, DOI 10.1016/j.jnutbio.2008.12.009; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328	47	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32598	32616		10.1074/jbc.M112.371005	http://dx.doi.org/10.1074/jbc.M112.371005			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851168	Green Published, hybrid			2022-12-28	WOS:000309168300029
J	Mondragon-Rodriguez, S; Trillaud-Doppia, E; Dudilot, A; Bourgeois, C; Lauzon, M; Leclerc, N; Boehm, J				Mondragon-Rodriguez, Siddhartha; Trillaud-Doppia, Emilie; Dudilot, Anthony; Bourgeois, Catherine; Lauzon, Michel; Leclerc, Nicole; Boehm, Jannic			Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-D-aspartate Receptor-dependent Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; A-BETA; TRAFFICKING; TRANSMISSION; DEPRESSION; EXPRESSION; PLASTICITY	Amyloid-beta and tau protein are the two most prominent factors in the pathology of Alzheimer disease. Recent studies indicate that phosphorylated tau might affect synaptic function. We now show that endogenous tau is found at postsynaptic sites where it interacts with the PSD95-NMDA receptor complex. NMDA receptor activation leads to a selective phosphorylation of specific sites in tau, regulating the interaction of tau with Fyn and the PSD95-NMDA receptor complex. Based on our results, we propose that the physiologically occurring phosphorylation of tau could serve as a regulatory mechanism to prevent NMDA receptor overexcitation.	[Mondragon-Rodriguez, Siddhartha; Trillaud-Doppia, Emilie; Dudilot, Anthony; Bourgeois, Catherine; Boehm, Jannic] Univ Montreal, Dept Physiol, Montreal, PQ H3T 1J4, Canada; [Lauzon, Michel; Leclerc, Nicole] Univ Montreal, Dept Pathol & Biol Cellulaire, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Physiol, 2960 Chemin Tour, Montreal, PQ H3T 1J4, Canada.	jannic.boehm@umontreal.ca	Mondragon-Rodriguez, Siddhartha/AAA-2452-2019; Boehm, Jannic/AAK-8882-2020		Canadian Institutes of Health Research; Alzheimer Society of Canada; Groupe de Recherche sur le Systeme Nerveux Central; Department of Physiology, Universite de Montreal; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Groupe de Recherche sur le Systeme Nerveux Central; Department of Physiology, Universite de Montreal; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research and the Alzheimer Society of Canada.; Supported by a fellowship from the Groupe de Recherche sur le Systeme Nerveux Central.; Supported by stipends from the Department of Physiology, Universite de Montreal.; Supported by a salary award from the Fonds de la Recherche en Sante du Quebec.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; Chittajallu R, 1998, CELL CALCIUM, V24, P377, DOI 10.1016/S0143-4160(98)90061-6; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grey KB, 2010, J NEUROPHYSIOL, V103, P2737, DOI 10.1152/jn.01112.2009; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lee G, 1998, J CELL SCI, V111, P3167; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Yu JZ, 2006, FASEB J, V20, P1452, DOI 10.1096/fj.05-5206com; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	68	164	166	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32040	32053		10.1074/jbc.M112.401240	http://dx.doi.org/10.1074/jbc.M112.401240			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833681	Green Published, hybrid			2022-12-28	WOS:000309059400042
J	Hu, ZX; Perumal, SK; Yue, HJ; Benkovic, SJ				Hu, Zhenxin; Perumal, Senthil K.; Yue, Hongjun; Benkovic, Stephen J.			The Human Lagging Strand DNA Polymerase delta Holoenzyme Is Distributive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; ATP BINDING; EPSILON; MECHANISM; FORK; COMPLEX; PROCESSIVITY; ELONGATION; MOVEMENT	Polymerase delta is widely accepted as the lagging strand replicative DNA polymerase in eukaryotic cells. It forms a replication complex in the presence of replication factor C and proliferating cell nuclear antigen to perform efficient DNA synthesis in vivo. In this study, the human lagging strand holoenzyme was reconstituted in vitro. The rate of DNA synthesis of this holoenzyme, measured with a singly primed ssM13 DNA substrate, is 4.0 +/- 0.4 nucleotides. Results from adenosine 5'-(3-thiotriphosphate) tetralithium salt (ATP gamma S) inhibition experiments revealed the nonprocessive characteristic of the human DNA polymerase (Pol delta) holoenzyme (150 bp for one binding event), consistent with data from chase experiments with catalytically inactive mutant Pol delta(AA.) The ATPase activity of replication factor C was characterized and found to be stimulated similar to 10-fold in the presence of both proliferating cell nuclear antigen and DNA, but the activity was not shut down by Pol delta in accord with rapid association/dissociation of the holoenzyme to/from DNA. It is noted that high concentrations of ATP inhibit the holoenzyme DNA synthesis activity, most likely due to its inhibition of the clamp loading process.	[Benkovic, Stephen J.] Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Lab 414, University Pk, PA 16802 USA.	sjb1@psu.edu		Hu, Zhenxin/0000-0003-4410-4189	National Institutes of Health [RO1 GM13307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM13307 (to S. J. B.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Berdis AJ, 1997, BIOCHEMISTRY-US, V36, P2733, DOI 10.1021/bi962139l; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6739, DOI 10.1073/pnas.77.11.6739; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Langston LD, 2008, J BIOL CHEM, V283, P29522, DOI 10.1074/jbc.M804488200; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; MAGA G, 1995, BIOCHEMISTRY-US, V34, P891, DOI 10.1021/bi00003a023; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; PODUST VN, 1992, NUCLEIC ACIDS RES, V20, P4159, DOI 10.1093/nar/20.16.4159; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38442	38448		10.1074/jbc.M112.404319	http://dx.doi.org/10.1074/jbc.M112.404319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22942285	hybrid, Green Published			2022-12-28	WOS:000310982800004
J	Azevedo, EPC; Guimaraes-Costa, AB; Torezani, GS; Braga, CA; Palhano, FL; Kelly, JW; Saraiva, EM; Foguel, D				Azevedo, Estefania P. C.; Guimaraes-Costa, Anderson B.; Torezani, Guilherme S.; Braga, Carolina A.; Palhano, Fernando L.; Kelly, Jeffery W.; Saraiva, Elvira M.; Foguel, Debora			Amyloid Fibrils Trigger the Release of Neutrophil Extracellular Traps (NETs), Causing Fibril Fragmentation by NET-associated Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PATHOGENESIS; MECHANISMS; EXPRESSION; VARIANT; ESCAPE; DNA	The accumulation of amyloid fibrils is a feature of amyloid diseases, where cell toxicity is due to soluble oligomeric species that precede fibril formation or are formed by fibril fragmentation, but the mechanism(s) of fragmentation is still unclear. Neutrophil-derived elastase and histones were found in amyloid deposits from patients with different systemic amyloidoses. Neutrophil extracellular traps (NETs) are key players in a death mechanism in which neutrophils release DNA traps decorated with proteins such as elastase and histones to entangle pathogens. Here, we asked whether NETs are triggered by amyloid fibrils, reasoning that because proteases are present in NETs, protease digestion of amyloid may generate soluble, cytotoxic species. We show that amyloid fibrils from three different sources (alpha-synuclein, Sup35, and transthyretin) induced NADPH oxidase-dependent NETs in vitro from human neutrophils. Surprisingly, NET-associated elastase digested amyloid fibrils into short species that were cytotoxic for BHK-21 and HepG2 cells. In tissue sections from patients with primary amyloidosis, we also observed the co-localization of NETs with amyloid deposits as well as with oligomers, which are probably derived from elastase-induced fibril degradation (amyloidolysis). These data reveal that release of NETs, so far described to be elicited by pathogens, can also be triggered by amyloid fibrils. Moreover, the involvement of NETs in amyloidoses might be crucial for the production of toxic species derived from fibril fragmentation.	[Guimaraes-Costa, Anderson B.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Imunol, BR-21941902 Rio De Janeiro, Brazil; [Azevedo, Estefania P. C.; Torezani, Guilherme S.; Braga, Carolina A.; Palhano, Fernando L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Braga, Carolina A.] Univ Fed Rio de Janeiro, BR-25245390 Duque De Caxias, Brazil; [Palhano, Fernando L.; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Scripps Research Institute	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Imunol, Bloco D, BR-21941902 Rio De Janeiro, Brazil.	esaraiva@micro.ufrj.br; foguel@bioqmed.ufrj.br	Costa, Anderson G. B./K-1059-2012; Azevedo, Estefania/I-3807-2012; Palhano, Fernando/AAB-3144-2021; Saraiva, Elvira M/L-2864-2017; Palhano, Fernando/C-2586-2008; Braga, Carolina/E-3471-2013	Costa, Anderson G. B./0000-0003-4582-1980; Palhano, Fernando/0000-0001-5336-632X; Saraiva, Elvira M/0000-0002-6388-5286; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Instituto Nacional de Ciencia e Tecnologia emBiologia Estrutural e Bioimagem, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro.	Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BRUUN CF, 1994, SCAND J IMMUNOL, V40, P337, DOI 10.1111/j.1365-3083.1994.tb03470.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gertz MA, 2011, AM J HEMATOL, V86, P181, DOI 10.1002/ajh.21934; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Komissarov AA, 2011, J BIOL CHEM, V286, P41949, DOI 10.1074/jbc.M111.301218; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Lee WL, 2004, SCIENCE, V303, P1477, DOI 10.1126/science.1095484; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Mumford AD, 2000, BRIT J HAEMATOL, V110, P454, DOI 10.1046/j.1365-2141.2000.02183.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; NORDSTOGA K, 1994, J VET MED A, V41, P741, DOI 10.1111/j.1439-0442.1994.tb00144.x; Palhano FL, 2009, BIOCHEMISTRY-US, V48, P6811, DOI 10.1021/bi9000276; Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRELLI F, 1991, SCAND J IMMUNOL, V33, P783, DOI 10.1111/j.1365-3083.1991.tb02553.x; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Serio TR, 2002, ADV PROTEIN CHEM, V59, P391; STONE PJ, 1993, BIOCHEM BIOPH RES CO, V197, P130, DOI 10.1006/bbrc.1993.2451; SUMEGI I, 1973, ACTA DERM-VENEREOL, V53, P99; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Weldon DT, 1998, J NEUROSCI, V18, P2161; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	50	49	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37206	37218		10.1074/jbc.M112.369942	http://dx.doi.org/10.1074/jbc.M112.369942			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22918834	Green Published, hybrid			2022-12-28	WOS:000310588500054
J	Willis, CM; Kluppel, M				Willis, Catherine M.; Klueppel, Michael			Inhibition by Chondroitin Sulfate E Can Specify Functional Wnt/beta-Catenin Signaling Thresholds in NIH3T3 Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT PROTEINS; DISEASE; CHONDROITIN-4-SULFOTRANSFERASE-1; PROLIFERATION; HEMATOPOIESIS; TRANSCRIPTION; MAINTENANCE; EXPRESSION; APOPTOSIS; PATHWAY	Aberrant activation of the Wnt/beta-catenin signaling pathway is frequently associated with human disease, including cancer, and thus represents a key therapeutic target. However, Wnt/beta catenin signaling also plays critical roles in many aspects of normal adult tissue homeostasis. The identification of mechanisms and strategies to selectively inhibit the disease-related functions of Wnt signaling, while preserving normal physiological functions, is in its infancy. Here, we report the identification of exogenous chondroitin sulfate-E (CS-E) as an inhibitor of specific molecular and biological outcomes of Wnt3a signaling in NIH3T3 fibroblasts. We demonstrate that CS-E can decrease Wnt3a signaling through the negative regulation of LRP6 receptor activation. However, this inhibitory effect of CS-E only affected Wnt3a-mediated induction, but not repression, of target gene expression. We went on to identify a critical Wnt3a signaling threshold that differentially affects target gene induction versus repression. This signaling threshold also controlled the effects of Wnt3a on proliferation and serum starvation-induced apoptosis. Limiting Wnt3a signaling to this critical threshold, either by CS-E treatment or by ligand dilution, interfered with Wnt3a-mediated stimulation of proliferation but did not impair Wnt3a-mediated reduction of serum starvation-induced apoptosis. Treatment with pharmacological inhibitors demonstrated that both induction and repression of Wnt3a target genes in NIH3T3 cells require the canonical Wnt/beta-catenin signaling cascade. Our data establish the feasibility of selective inhibition of Wnt/beta-catenin transcriptional programs and biological outcomes through the exploitation of intrinsic signaling thresholds.	[Willis, Catherine M.; Klueppel, Michael] Childrens Hosp Chicago Res Ctr, Human Mol Genet Program, Chicago, IL 60614 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Dept Pediat, Chicago, IL 60614 USA; [Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60614 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Childrens Hosp Chicago Res Ctr, Human Mol Genet Program, 2430 N Halsted St, Chicago, IL 60614 USA.	m-kluppel@northwestern.edu			Children's Hospital of Chicago Research Center	Children's Hospital of Chicago Research Center	This work was supported by the Children's Hospital of Chicago Research Center.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Blankesteijn WM, 2008, TRENDS PHARMACOL SCI, V29, P175, DOI 10.1016/j.tips.2008.01.003; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chakraborty PK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-102; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Chien AJ, 2007, FRONT BIOSCI-LANDMRK, V12, P448, DOI 10.2741/2074; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Huelsken J, 2009, EUR J IMMUNOL, V39, P3582, DOI 10.1002/eji.200838982; Jia LW, 2008, CELL BIOL INT, V32, P807, DOI 10.1016/j.cellbi.2008.03.011; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Li Q, 2005, CANCER RES, V65, P8622, DOI 10.1158/0008-5472.CAN-05-2145; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Maeda Nobuaki, 2010, Front Biosci (Landmark Ed), V15, P626; Mirkovic I, 2002, MECH DEVELOP, V119, P9, DOI 10.1016/S0925-4773(02)00289-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Shih YL, 2007, INT J CANCER, V121, P1028, DOI 10.1002/ijc.22750; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Uebelhart D, 2008, OSTEOARTHR CARTILAGE, V16, pS19, DOI 10.1016/j.joca.2008.06.006; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vangsness CT, 2009, ARTHROSCOPY, V25, P86, DOI 10.1016/j.arthro.2008.07.020; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	53	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37042	37056		10.1074/jbc.M112.391490	http://dx.doi.org/10.1074/jbc.M112.391490			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22915582	hybrid, Green Published			2022-12-28	WOS:000310588500039
J	Maki, BA; Aman, TK; Amico-Ruvio, SA; Kussius, CL; Popescu, GK				Maki, Bruce A.; Aman, Teresa K.; Amico-Ruvio, Stacy A.; Kussius, Cassandra L.; Popescu, Gabriela K.			C-terminal Domains of N-Methyl-D-aspartic Acid Receptor Modulate Unitary Channel Conductance and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMERIC NMDA RECEPTORS; PROTEIN-KINASE-A; SYNAPTIC-TRANSMISSION; ALPHA-ACTININ; TIME COURSE; RAT-BRAIN; SUBUNIT; ZINC; CALMODULIN; GLUTAMATE	NMDA receptors (NRs) are glutamate-gated calcium-permeable channels that are essential for normal synaptic transmssion and contribute to neurodegeneration. Tetrameric proteins consist of two obligatory GluN1 (N1) and two GluN2 (N2) subunits, of which GluN2A (2A) and GluN2B (2B) are prevalent in adult brain. The intracellularly located C-terminal domains (CTDs) make a significant portion of mass of the receptors and are essential for plasticity and excitotoxicity, but their functions are incompletely defined. Recent evidence shows that truncation of the N2 CTD alters channel kinetics; however, the mechanism by which this occurs is unclear. Here we recorded activity from individual NRs lacking the CTDs of N1, 2A, or 2B and determined the gating mechanisms of these receptors. Receptors lacking the N1 CTDs had larger unitary conductance and faster deactivation kinetics, receptors lacking the 2A or 2B CTDs had longer openings and longer desensitized intervals, and the first 100 amino acids of the N2 CTD were essential for these changes. In addition, receptors lacking the CTDs of either 2A or 2B maintained isoform-specific kinetic differences and swapping CTDs between 2A and 2B had no effect on single-channel properties. Based on these results, we suggest that perturbations in the CTD can modify the NR-mediated signal in a subunit-dependent manner, in 2A these effects are most likely mediated by membrane-proximal residues, and the isoform-specific biophysical properties conferred by 2A and 2B are CTD-independent. The kinetic mechanisms we developed afford a quantitative approach to understanding how the intracellular domains of NR subunits can modulate the responses of the receptor.	[Aman, Teresa K.; Amico-Ruvio, Stacy A.; Kussius, Cassandra L.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Maki, Bruce A.; Popescu, Gabriela K.] SUNY Buffalo, Neurosci Program, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 636 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002; Maki, Bruce/0000-0002-6760-375X	National Institutes of Health through the NINDS [052669]; SUNY REACH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SUNY REACH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 052669 through the NINDS. This work was also supported by SUNY REACH.	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Banke TG, 2005, J NEUROSCI, V25, P42, DOI 10.1523/JNEUROSCI.3154-04.2005; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Groschner K, 1996, BIOCHEM J, V318, P513, DOI 10.1042/bj3180513; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kohr G, 2003, J NEUROSCI, V23, P10791; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Laube B, 1998, J NEUROSCI, V18, P2954; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mohrmann R, 2002, J NEUROSCI RES, V68, P265, DOI 10.1002/jnr.10219; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mullner C, 2003, BIOPHYS J, V84, P1399, DOI 10.1016/S0006-3495(03)74954-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Popescu GK, 2012, J PHYSIOL-LONDON, V590, P73, DOI 10.1113/jphysiol.2011.223750; Punnakkal P, 2012, NEUROPHARMACOLOGY, V62, P1985, DOI 10.1016/j.neuropharm.2011.12.018; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Rossi P, 2002, J NEUROSCI, V22, P9687; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Rycroft BK, 2004, J PHYSIOL-LONDON, V557, P795, DOI 10.1113/jphysiol.2003.059212; Rycroft BK, 2002, J NEUROSCI, V22, P8860; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Singer-Lahat D, 1999, PFLUG ARCH EUR J PHY, V439, P18, DOI 10.1007/s004240051123; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X	65	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36071	36080		10.1074/jbc.M112.390013	http://dx.doi.org/10.1074/jbc.M112.390013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948148	Green Published, hybrid			2022-12-28	WOS:000310364000029
J	An, YF; Li, TL; Geng, XR; Yang, G; Zhao, CQ; Yang, PC				An, Yun-Fang; Li, Tong-Li; Geng, Xiao-Rui; Yang, Gui; Zhao, Chang-Qing; Yang, Ping-Chang			Ubiquitin E3 Ligase A20 Facilitates Processing Microbial Product in Nasal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSEPITHELIAL ANTIGEN TRANSPORT; STAPHYLOCOCCUS-AUREUS COLONIZATION; ENTEROTOXIN-B; SENSITIZATION; IGE	Microbial products play a role in the pathogenesis of allergic diseases; ubiquitin E3 ligase A20 (A20) is an important molecule in regulating inflammation in the body. The present study aims to elucidate the role of A20 in processing the absorbed microbial products in nasal epithelial cells. Human nasal mucosal specimens were collected from patients with or without chronic rhinitis and analyzed by immunohistochemistry. Human nasal epithelial cell line, RPMI2650 cell, was employed to assess the role of A20 in processing the absorbed staphylococcal enterotoxin B (SEB). The RPMI2650 cells absorbed SEB in the culture. The increase in A20 was observed in RPMI2650 cells in parallel to the absorption of SEB. A20 is a critical molecule in the degradation of SEB in the nasal epithelial cells by promoting the tethering of endosomes and lysosomes. A20 plays a critical role in processing of the absorbed SEB in nasal epithelial cells.	[An, Yun-Fang; Zhao, Chang-Qing] Shanxi Med Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Taiyuan 030001, Peoples R China; [Li, Tong-Li] Shanxi Prov Peoples Hosp, Dept Otolaryngol, Taiyuan 030012, Peoples R China; [Li, Tong-Li; Geng, Xiao-Rui; Yang, Gui; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 4A6, Canada	Shanxi Medical University; Shanxi People's Hospital; McMaster University	Zhao, CQ (corresponding author), Shanxi Med Univ, Hosp 2, Dept Otolaryngol, Taiyuan 030001, Peoples R China.	fahyj@126.com; yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019; zhao, chang qing/AGQ-0505-2022		Canadian Institutes of Health Research (CIHR) [191063, 220058]; Natural Sciences and Engineering Research Council of Canada [371268]; National Natural Science Foundation of China [81070767, 81271059]; New Investigator Award (CIHR Grant) [177843]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Investigator Award (CIHR Grant)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research (CIHR); Grants 191063 and 220058), the Natural Sciences and Engineering Research Council of Canada (Grant 371268), and the National Natural Science Foundation of China (Grants 81070767 and 81271059).; Recipient of a New Investigator Award (CIHR Grant 177843). To whom correspondence may be addressed: Rm.T3303, 50 Charlton Ave. E., Hamilton, Ontario L8N 4A6, Canada. Tel.: 905-522-1155, (ext. 32934); Fax: 905-540-6593; E-mail: yangp@mcmaster.ca.	Berin MC, 1997, GASTROENTEROLOGY, V113, P856, DOI 10.1016/S0016-5085(97)70180-X; Chen X, 2010, N AM J MED SCI, V2, P241, DOI 10.4297/najms.2010.2241; Forbes-Blom E, 2012, CLIN EXP ALLERGY, V42, P305, DOI 10.1111/j.1365-2222.2011.03861.x; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huvenne W, 2010, CLIN EXP ALLERGY, V40, P1079, DOI 10.1111/j.1365-2222.2010.03464.x; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Lu J, 1998, J PHARMACOL EXP THER, V287, P128; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Moon IJ, 2012, ACTA OTO-LARYNGOL, V132, pS6, DOI 10.3109/00016489.2012.661074; Niebuhr M, 2011, INT ARCH ALLERGY IMM, V156, P412, DOI 10.1159/000323905; Niebuhr M, 2010, J ALLERGY CLIN IMMUN, V126, P1176, DOI 10.1016/j.jaci.2010.07.041; Thienhaus ML, 2011, RHINOLOGY, V49, P554, DOI [10.4193/Rhino11.072, 10.4193/Rhino10.072]; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008; Yang PC, 1999, J IMMUNOL, V163, P2769; Yang PC, 2001, OTOLARYNG HEAD NECK, V125, P54, DOI 10.1067/mhn.2001.116185; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	24	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35318	35323		10.1074/jbc.M112.392639	http://dx.doi.org/10.1074/jbc.M112.392639			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22936803	hybrid, Green Published			2022-12-28	WOS:000309968000040
J	Tanaka, T; Yamaguchi, J; Shoji, K; Nangaku, M				Tanaka, Tetsuhiro; Yamaguchi, Junna; Shoji, Kumi; Nangaku, Masaomi			Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; CANCER; EXPRESSION; CARCINOMA; BINDING; MODEL; HIF; HIF-2-ALPHA; HIF-1-ALPHA; METASTASIS	Anthracycline chemotherapeutic agents of the topoisomerase inhibitor family are widely used for the treatment of various tumors. Although targeted tumor tissues are generally situated in a hypoxic environment, the connection between efficacy of anthracycline agents and cellular hypoxia response has not been investigated in depth. Here, we report that doxorubicin (DXR) impairs the transcriptional response of the hypoxia-inducible factor (HIF) by inhibiting the binding of the HIF heterodimer to the consensus - RCGTG-enhancer element. This pleiotropic effect retarded migration of von Hippel-Lindau (VHL)-defective renal cell carcinoma and that of VHL-competent renal cell carcinoma in hypoxia. This effect was accompanied by a coordinated down-regulation of HIF target lysyl oxidase (LOX) family members LOX, LOX-like2 (LOXL2), and LOXL4. Furthermore, DXR suppressed HIF target genes in tumor xenografts, inhibited cardiac induction of HIF targets in rats with acute anemia, and impaired the angiogenic response in the isoproterenol-induced heart failure model, which may account for the clinical fragility of doxorubicin cardiomyopathy. Collectively, these findings highlight the impaired hypoxia response by anthracycline agents affecting both tumors and organs of the cancer host and offer a promising opportunity to develop HIF inhibitors using DXR as a chemical template.	[Tanaka, Tetsuhiro] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan; [Tanaka, Tetsuhiro; Yamaguchi, Junna; Shoji, Kumi; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Tanaka, T (corresponding author), Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan.	tetsu-tky@umin.ac.jp; mnangaku-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390213, 22790781]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research 24390213 (to M. N.) and 22790781 (to T. T.) from the Japan Society for the Promotion of Science and a research grant from the Takeda Science Foundation (to T. T.).	Aebersold DM, 2001, CANCER RES, V61, P2911; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; HOCKEL M, 1993, RADIOTHER ONCOL, V26, P45, DOI 10.1016/0167-8140(93)90025-4; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Oh MK, 2011, J BIOL CHEM, V286, P8857, DOI 10.1074/jbc.M110.150557; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Spagnuolo RD, 2011, BRIT J PHARMACOL, V163, P299, DOI 10.1111/j.1476-5381.2011.01208.x; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Turner KJ, 2002, CANCER RES, V62, P2957; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108	33	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34866	34882		10.1074/jbc.M112.374587	http://dx.doi.org/10.1074/jbc.M112.374587			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908232	hybrid, Green Published			2022-12-28	WOS:000309968000001
J	Meisel, E; Dvir, M; Haitin, Y; Giladi, M; Peretz, A; Attali, B				Meisel, Eshcar; Dvir, Meidan; Haitin, Yoni; Giladi, Moshe; Peretz, Asher; Attali, Bernard			KCNQ1 Channels Do Not Undergo Concerted but Sequential Gating Transitions in Both the Absence and the Presence of KCNE1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; VOLTAGE SENSOR; WILD-TYPE; KVLQT1; MUTATIONS; SUBUNITS; FORM; COOPERATIVITY; INACTIVATION; ACTIVATION	The co-assembly of KCNQ1 with KCNE1 produces I-KS, a K+ current, crucial for the repolarization of the cardiac action potential. Mutations in these channel subunits lead to life-threatening cardiac arrhythmias. However, very little is known about the gating mechanisms underlying KCNQ1 channel activation. Shaker channels have provided a powerful tool to establish the basic gating mechanisms of voltage-dependent K+ channels, implying prior independent movement of all four voltage sensor domains (VSDs) followed by channel opening via a last concerted cooperative transition. To determine the nature of KCNQ1 channel gating, we performed a thermodynamic mutant cycle analysis by constructing a concatenated tetrameric KCNQ1 channel and by introducing separately a gain and a loss of function mutation, R231W and R243W, respectively, into the S4 helix of the VSD of one, two, three, and four subunits. The R231W mutation destabilizes channel closure and produces constitutively open channels, whereas the R243W mutation disrupts channel opening solely in the presence of KCNE1 by right-shifting the voltage dependence of activation. The linearity of the relationship between the shift in the voltage dependence of activation and the number of mutated subunits points to an independence of VSD movements, with each subunit incrementally contributing to channel gating. Contrary to Shaker channels, our work indicates that KCNQ1 channels do not experience a late cooperative concerted opening transition. Our data suggest that KCNQ1 channels in both the absence and the presence of KCNE1 undergo sequential gating transitions leading to channel opening even before all VSDs have moved.	[Meisel, Eshcar; Dvir, Meidan; Haitin, Yoni; Giladi, Moshe; Peretz, Asher; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il	Haitin, Yoni/AAQ-4571-2021	Haitin, Yoni/0000-0002-1648-6792; Giladi, Moshe/0000-0002-8589-6920	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft); Israel Science Foundation (ISF) [488/09]	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft) and the Israel Science Foundation (ISF Grant 488/09).	Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bartos DC, 2011, HEART RHYTHM, V8, P48, DOI 10.1016/j.hrthm.2010.09.010; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Gagnon DG, 2009, J GEN PHYSIOL, V133, P467, DOI 10.1085/jgp.200810082; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Haitin Y, 2009, EMBO J, V28, P1994, DOI 10.1038/emboj.2009.157; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma LJ, 2011, BIOPHYS J, V100, P885, DOI 10.1016/j.bpj.2010.12.3726; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Miceli F, 2008, BIOPHYS J, V95, P2254, DOI 10.1529/biophysj.107.128371; Miceli F, 2009, CHANNELS, V3, P274; Mohammad-Panah R, 1999, AM J HUM GENET, V64, P1015, DOI 10.1086/302346; Morin TJ, 2008, J BIOL CHEM, V283, P25105, DOI 10.1074/jbc.R800033200; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Osteen JD, 2012, P NATL ACAD SCI USA, V109, P7103, DOI 10.1073/pnas.1201582109; Osteen JD, 2010, P NATL ACAD SCI USA, V107, P22710, DOI 10.1073/pnas.1016300108; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pusch M, 1998, BIOPHYS J, V75, P785, DOI 10.1016/S0006-3495(98)77568-X; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shamgar L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001943; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wu D, 2010, BIOPHYS J, V99, P3599, DOI 10.1016/j.bpj.2010.10.018; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yifrach O, 2009, METHOD ENZYMOL, V466, P179, DOI 10.1016/S0076-6879(09)66008-0; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105	52	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34212	34224		10.1074/jbc.M112.364901	http://dx.doi.org/10.1074/jbc.M112.364901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908235	Green Published, hybrid			2022-12-28	WOS:000309654200026
J	Nikitovic, D; Aggelidakis, J; Young, MF; Iozzo, RV; Karamanos, NK; Tzanakakis, GN				Nikitovic, Dragana; Aggelidakis, John; Young, Marian F.; Iozzo, Renato V.; Karamanos, Nikos K.; Tzanakakis, George N.			The Biology of Small Leucine-rich Proteoglycans in Bone Pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; BIGLYCAN DEFICIENCY; GENE-EXPRESSION; TOLL-LIKE; OSTEOBLAST DIFFERENTIATION; ECTOPIC OSSIFICATION; HISTOLOGICAL SUBTYPE; PREDICTIVE FACTORS; COLLAGEN FIBRILS	The class of small leucine-rich proteoglycans (SLRPs) is a family of homologous proteoglycans harboring relatively small (36-42 kDa) protein cores compared with the larger cartilage and mesenchymal proteoglycans. SLRPs have been localized to most skeletal regions, with specific roles designated during all phases of bone formation, including periods relating to cell proliferation, organic matrix deposition, remodeling, and mineral deposition. This is mediated by key signaling pathways regulating the osteogenic program, including the activities of TGF-beta, bone morphogenetic protein, Wnt, and NF-kappa B, which influence both the number of available osteogenic precursors and their subsequent development, differentiation, and function. On the other hand, SLRP depletion is correlated with degenerative diseases such as osteoporosis and ectopic bone formation. This minireview will focus on the SLRP roles in bone physiology and pathology.	[Nikitovic, Dragana; Tzanakakis, George N.] Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece; [Aggelidakis, John] Univ Hosp Herakl, Dept Orthoped, Iraklion 71003, Greece; [Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Karamanos, Nikos K.] Univ Patras, Dept Chem, Biochem Lab, GR-26110 Patras, Greece	University of Crete; University Hospital of Heraklion; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Jefferson University; University of Patras	Tzanakakis, GN (corresponding author), Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece.	tzanakak@med.uoc.gr	Nikitovic, Dragana/AAS-6215-2020; Iozzo, Renato/AAS-1980-2020; Karamanos, Nikos/A-3616-2008; Tzanakakis, George/ABH-7725-2020; Tzanakakis, George N/F-6955-2010	Nikitovic, Dragana/0000-0003-3882-7399; Karamanos, Nikos/0000-0003-3618-0288; Tzanakakis, George/0000-0001-5276-4764; Tzanakakis, George N/0000-0001-5276-4764; Iozzo, Renato/0000-0002-5908-5112; Young, Marian F/0000-0003-0929-8854	National Institutes of Health [R01 CA39481, R01 CA47282]; NIDCR Division of Intramural Research; ELKE (Research Committee, University of Crete) [KA 3082]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ELKE (Research Committee, University of Crete); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA39481 and R01 CA47282 (to R. V. I.) and the NIDCR Division of Intramural Research (to M. F. Y.). This work was also supported by ELKE (Research Committee, University of Crete) Grant KA 3082 (to G. N. T.).	Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bacci G, 1998, J CLIN ONCOL, V16, P658, DOI 10.1200/JCO.1998.16.2.658; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Bi YM, 2006, BONE, V38, P778, DOI 10.1016/j.bone.2005.11.005; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Chansky H, 1998, J ORTHOPAED RES, V16, P521, DOI 10.1002/jor.1100160502; Chen XD, 2005, BONE, V37, P192, DOI 10.1016/j.bone.2005.04.006; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Chen XD, 2003, CALCIFIED TISSUE INT, V72, P577, DOI 10.1007/s00223-002-1101-y; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Datsis GA, 2011, FEBS J, V278, P3782, DOI 10.1111/j.1742-4658.2011.08300.x; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Desnoyers L, 2001, J BIOL CHEM, V276, P47599, DOI 10.1074/jbc.M108339200; EGGLI PS, 1985, ANAT REC, V211, P246, DOI 10.1002/ar.1092110304; Ferrari S, 2001, ANN ONCOL, V12, P1145, DOI 10.1023/A:1011636912674; GEERKENS C, 1995, HUM GENET, V96, P44, DOI 10.1007/BF00214185; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gori F, 2001, J CELL BIOCHEM, V82, P46, DOI 10.1002/jcb.1115; Gruber HE, 2002, BIOTECH HISTOCHEM, V77, P81, DOI 10.1080/714028181; Guidetti GF, 2004, FEBS LETT, V574, P95, DOI 10.1016/j.febslet.2004.08.011; Hauben EI, 2006, EUR J CANCER, V42, P460, DOI 10.1016/j.ejca.2005.09.032; Hauben EI, 2002, EUR J CANCER, V38, P1218, DOI 10.1016/S0959-8049(02)00037-0; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huvos A, 1991, BONE TUMORS DIAGNOSI; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Iozzo R. V., 2011, BIOL EXTRACELLULAR M; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Kilts T, 2009, SCAND J MED SCI SPOR, V19, P536, DOI 10.1111/j.1600-0838.2009.00909.x; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Kubista B, 2011, INT ORTHOP, V35, P401, DOI 10.1007/s00264-010-0996-6; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Mochida Y, 2006, ADV EXP MED BIOL, V585, P101; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Nielsen KL, 2003, J BONE MINER RES, V18, P2152, DOI 10.1359/jbmr.2003.18.12.2152; Nikitovic D, 2008, CONNECT TISSUE RES, V49, P235, DOI 10.1080/03008200802147589; Nikitovic D, 2008, FEBS J, V275, P350, DOI 10.1111/j.1742-4658.2007.06205.x; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Nuka S, 2010, OSTEOARTHR CARTILAGE, V18, P88, DOI 10.1016/j.joca.2009.11.006; Ohta K, 2006, DEVELOPMENT, V133, P3777, DOI 10.1242/dev.02579; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Papatheodorou LK, 2009, ULTRASOUND MED BIOL, V35, P576, DOI 10.1016/j.ultrasmedbio.2008.07.003; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Parkinson T, 2008, CURR OPIN MOL THER, V10, P21; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Raouf A, 2002, MATRIX BIOL, V21, P361, DOI 10.1016/S0945-053X(02)00027-6; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Sanders EJ, 2003, INVEST OPHTH VIS SCI, V44, P5404, DOI 10.1167/iovs.03-0500; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L., 2010, CELL TISSUE RES, V339, P37; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Schulz A., 1998, VERH DTSCH GES PATHO, V82, P44; Shimizu-Hirota R, 2004, FEBS LETT, V563, P69, DOI 10.1016/S0014-5793(04)00250-9; Shintani K, 2008, ONCOL REP, V19, P1533; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Soderstrom M, 2002, INT J CANCER, V100, P144, DOI 10.1002/ijc.10457; Strauss LG, 2004, J NUCL MED, V45, P1528; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Vanderploeg EJ, 2012, J ANAT, V221, P174, DOI 10.1111/j.1469-7580.2012.01523.x; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Waddington R. J., 2003, European Cells & Materials, V6, P12; Wang XY, 2010, BIOL PHARM BULL, V33, P1891, DOI 10.1248/bpb.33.1891; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000; Young AA, 2005, ARTHRITIS RES THER, V7, pR852, DOI 10.1186/ar1756; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	95	107	107	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33926	33933		10.1074/jbc.R112.379602	http://dx.doi.org/10.1074/jbc.R112.379602			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879588	Green Published, hybrid			2022-12-28	WOS:000309654200001
J	Zhong, WX; Wang, YB; Peng, L; Ge, XZ; Zhang, J; Liu, SS; Zhang, XN; Xu, ZH; Chen, Z; Luo, JH				Zhong, Wei-xia; Wang, Yu-bin; Peng, Lin; Ge, Xue-zhen; Zhang, Jie; Liu, Shuang-shuang; Zhang, Xiang-nan; Xu, Zheng-hao; Chen, Zhong; Luo, Jian-hong			Lanthionine Synthetase C-like Protein 1 Interacts with and Inhibits Cystathionine beta-Synthase A TARGET FOR NEURONAL ANTIOXIDANT DEFENSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; S-ADENOSYL-METHIONINE; TRANSSULFURATION PATHWAY; REDOX REGULATION; GLUTATHIONE; BRAIN; DISEASE; IDENTIFICATION; HOMEOSTASIS; METABOLISM	The finding that eukaryotic lanthionine synthetase C-like protein 1 (LanCL1) is a glutathione-binding protein prompted us to investigate the potential relationship between LanCL1 and cystathionine beta-synthase (CBS). CBS is a trans-sulfuration enzyme critical for the reduced glutathione (GSH) synthesis and GSH-dependent defense against oxidative stress. In this study we found that LanCL1 bound to CBS in mouse cortex and HEK293 cells. Mapping studies revealed that the binding region in LanCL1 spans amino acids 158-169, and that in CBS contains N-terminal and C-terminal regulatory domains. Recombinant His-LanCL1 directly bound endogenous CBS from mouse cortical lysates and inhibited its activity. Overexpression of LanCL1 inhibited CBS activity in HEK293 cells. CBS activity is reported to be regulated by oxidative stress. Here we found that oxidative stress induced by H2O2 or glutamate lowered the GSH/GSSG ratio, dissociated LanCL1 from CBS, and elevated CBS activity in primary rat cortical neurons. Decreasing the GSH/GSSG ratio by adding GSSG to cellular extracts also dissociated LanCL1 from CBS. Either lentiviral knockdown of LanCL1 or specific disruption of the LanCL1-CBS interaction using the peptide Tat-LanCL1(153-173) released CBS activity in neurons but occluded CBS activation in response to oxidative stress, indicating the major contribution of the LanCL1-CBS interaction to the regulation of CBS activity. Furthermore, LanCL1 knockdown or Tat-LanCL1(153-173) treatment reduced H2O2 or glutamate-induced neuronal damage. This study implies potential therapeutic value in targeting the LanCL1-CBS interaction for neuronal oxidative stress-related diseases.	[Luo, Jian-hong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xiang-nan; Xu, Zheng-hao; Chen, Zhong] Zhejiang Univ, Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol, Dept Pharmacol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhong, Wei-xia] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Wang, Yu-bin] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA	Zhejiang University; Zhejiang University; Western University of Health Sciences; Western University of Health Sciences	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Zhang, xiangnan/C-9649-2010; Luo, jian/HGE-7331-2022; ZHANG, Jie/S-6936-2019	Zhang, xiangnan/0000-0002-7603-7403; ZHANG, Jie/0000-0002-5492-8088	National Basic Research Program of China [2010CB912002]; Natural Science Foundation of China [81221003]; Natural Science Foundation of Zhejiang, China [Y2100494]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Basic Research Program of China (2010CB912002), the Natural Science Foundation of China (81221003), and the Natural Science Foundation of Zhejiang, China (Y2100494).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adams James D. Jr., 2001, Current Topics in Medicinal Chemistry, V1, P473, DOI 10.2174/1568026013394778; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Hensley K, 2010, MOLECULES, V15, P5581, DOI 10.3390/molecules15085581; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Hnizda A, 2010, BIOCHEMISTRY-US, V49, P10526, DOI 10.1021/bi101384m; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P3483, DOI 10.1073/pnas.95.7.3483; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kim EA, 2010, CELL MOL NEUROBIOL, V30, P807, DOI 10.1007/s10571-010-9508-x; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Lee ES, 2008, LIFE SCI, V83, P821, DOI 10.1016/j.lfs.2008.09.020; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Mayer H, 2001, GENE, V269, P73, DOI 10.1016/S0378-1119(01)00463-2; McBean GJ, 2012, AMINO ACIDS, V42, P199, DOI 10.1007/s00726-011-0864-8; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Regnier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029056; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shea TB, 2008, J ALZHEIMERS DIS, V13, P67; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Suchy J, 2010, NEUROMOL MED, V12, P86, DOI 10.1007/s12017-009-8089-7; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209; Zhao WQ, 2002, J NEUROSCI RES, V69, P519, DOI 10.1002/jnr.10314	39	37	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34189	34201		10.1074/jbc.M112.383646	http://dx.doi.org/10.1074/jbc.M112.383646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891245	hybrid, Green Published			2022-12-28	WOS:000309654200024
J	Henriques, ST; Huang, YH; Castanho, MARB; Bagatolli, LA; Sonza, S; Tachedjian, G; Daly, NL; Craik, DJ				Henriques, Sonia Troeira; Huang, Yen-Hua; Castanho, Miguel A. R. B.; Bagatolli, Luis A.; Sonza, Secondo; Tachedjian, Gilda; Daly, Norelle L.; Craik, David J.			Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING-PEPTIDES; CYCLIC CYSTINE KNOT; KALATA B1; MACROCYCLIC PEPTIDES; OLDENLANDIA-AFFINIS; PLANT CYCLOTIDES; CYCLOVIOLACIN O2; CIRCULAR PROTEIN; ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-VESICLES	Cyclotides are bioactive cyclic peptides isolated from plants that are characterized by a topologically complex structure and exceptional resistance to enzymatic or thermal degradation. With their sequence diversity, ultra-stable core structural motif, and range of bioactivities, cyclotides are regarded as a combinatorial peptide template with potential applications in drug design. The mode of action of cyclotides remains elusive, but all reported biological activities are consistent with a mechanism involving membrane interactions. In this study, a diverse set of cyclotides from the two major subfamilies, Mobius and bracelet, and an all-D mirror image form, were examined to determine their mode of action. Their lipid selectivity and membrane affinity were determined, as were their toxicities against a range of targets (red blood cells, bacteria, and HIV particles). Although they had different membrane-binding affinities, all of the tested cyclotides targeted membranes through binding to phospholipids containing phosphatidylethanolamine headgroups. Furthermore, the biological potency of the tested cyclotides broadly correlated with their ability to target and disrupt cell membranes. The finding that a broad range of cyclotides target a specific lipid suggests their categorization as a new lipid-binding protein family. Knowledge of their membrane specificity has the potential to assist in the design of novel drugs based on the cyclotide framework, perhaps allowing the targeting of peptide drugs to specific cell types.	[Henriques, Sonia Troeira; Huang, Yen-Hua; Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Henriques, Sonia Troeira; Castanho, Miguel A. R. B.] Univ Lisbon, Sch Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Sonza, Secondo; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic 3004, Australia; [Bagatolli, Luis A.] Univ So Denmark, Membrane Biophys & Biophoton Grp, Ctr Biomembrane Phys, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	University of Queensland; Universidade de Lisboa; Burnet Institute; University of Southern Denmark; Monash University; Monash University	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Daly, Norelle L/D-4302-2013; Tachedjian, Gilda/AAF-1327-2020; Huang, Yen-Hua/J-9056-2014; Craik, David/B-1695-2010; Henriques, Sonia Troeira/J-3500-2016; Bagatolli, Luis/L-5159-2016	Daly, Norelle L/0000-0002-4697-6602; Tachedjian, Gilda/0000-0002-7733-7037; Huang, Yen-Hua/0000-0001-6937-2660; Craik, David/0000-0003-0007-6796; Henriques, Sonia Troeira/0000-0001-9564-9651; Bagatolli, Luis/0000-0002-4727-8611; FCCN, Bogus/0000-0003-1034-3552; FCCN, Bogus/0000-0001-6282-8004; Castanho, Miguel/0000-0001-7891-7562	Australian Research Council Grant [DP0880105]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program [PIOF-GA-2008-220318]	Australian Research Council Grant(Australian Research Council); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program	This work was supported in part by Australian Research Council Grant DP0880105 and by Marie Curie International Outgoing Fellowship PIOF-GA-2008-220318 (to S. T. H.) within the 7th European Community Framework Program.	ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Ambroggio EE, 2005, BIOPHYS J, V89, P1874, DOI 10.1529/biophysj.105.066589; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Cho KH, 2010, J PEPT SCI, V16, P85, DOI 10.1002/psc.1199; Coccia C, 2011, EUR BIOPHYS J BIOPHY, V40, P577, DOI 10.1007/s00249-011-0681-8; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Contreras J, 2011, J CONTROL RELEASE, V155, P134, DOI 10.1016/j.jconrel.2011.08.030; Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; DALEKE DL, 1989, J CELL BIOL, V108, P1375, DOI 10.1083/jcb.108.4.1375; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Domenech O, 2007, J MOL RECOGNIT, V20, P546, DOI 10.1002/jmr.849; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2007, MOL MEMBR BIOL, V24, P282, DOI 10.1080/09687860601142936; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; JAWORSKY M, 1985, BIOCHEMISTRY-US, V24, P3422, DOI 10.1021/bi00335a005; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Lindholm P, 2002, MOL CANCER THER, V1, P365; Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Pokorny A, 2006, BIOPHYS J, V91, P2184, DOI 10.1529/biophysj.106.085027; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Sando L, 2011, CHEMBIOCHEM, V12, P2456, DOI 10.1002/cbic.201100450; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Stafford JH, 2011, NEOPLASIA, V13, P299, DOI 10.1593/neo.101366; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wang CKL, 2011, BIOCHEMISTRY-US, V50, P4077, DOI 10.1021/bi2004153; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Zhao M, 2011, AMINO ACIDS, V41, P1071, DOI 10.1007/s00726-009-0386-9	74	99	101	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33629	33643		10.1074/jbc.M112.372011	http://dx.doi.org/10.1074/jbc.M112.372011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22854971	hybrid, Green Published			2022-12-28	WOS:000309602100047
J	Salter, MD; Blouin, GC; Soman, J; Singleton, EW; Dewilde, S; Moens, L; Pesce, A; Nardini, M; Bolognesi, M; Olson, JS				Salter, Mallory D.; Blouin, George C.; Soman, Jayashree; Singleton, Eileen W.; Dewilde, Sylvia; Moens, Luc; Pesce, Alessandra; Nardini, Marco; Bolognesi, Martino; Olson, John S.			Determination of Ligand Pathways in Globins APOLAR TUNNELS VERSUS POLAR GATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; SPERM-WHALE MYOGLOBIN; CEREBRATULUS-LACTEUS; CARBON-MONOXIDE; X-RAY; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-DYNAMICS; HEME POCKET; DISTAL HISTIDINE; TRUNCATED HEMOGLOBINS	Although molecular dynamics simulations suggest multiple interior pathways for O-2 entry into and exit from globins, most experiments indicate well defined single pathways. In 2001, we highlighted the effects of large-to-small amino acid replacements on rates for ligand entry and exit onto the three-dimensional structure of sperm whale myoglobin. The resultant map argued strongly for ligand movement through a short channel from the heme iron to solvent that is gated by the distal histidine (His-64(E7)) near the solvent edge of the porphyrin ring. In this work, we have applied the same mutagenesis mapping strategy to the neuronal mini-hemoglobin from Cerebratulus lacteus (CerHb), which has a large internal tunnel from the heme iron to the C-terminal ends of the E and H helices, a direction that is 180 opposite to the E7 channel. Detailed comparisons of the new CerHb map with expanded results for Mb show unambiguously that the dominant (> 90%) ligand pathway in CerHb is through the internal tunnel, and the major (> 75%) ligand pathway in Mb is through the E7 gate. These results demonstrate that: 1) mutagenesis mapping can identify internal pathways when they exist; 2) molecular dynamics simulations need to be refined to address discrepancies with experimental observations; and 3) alternative pathways have evolved in globins to meet specific physiological demands.	[Salter, Mallory D.; Blouin, George C.; Soman, Jayashree; Singleton, Eileen W.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Pesce, Alessandra] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy	Rice University; University of Antwerp; University of Genoa; University of Milan	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main, Houston, TX 77005 USA.	olson@rice.edu	Bolognesi, Martino/B-7924-2017; Pesce, Alessandra/A-3660-2015; Nardini, Marco/B-7842-2017	Bolognesi, Martino/0000-0002-9253-5170; Nardini, Marco/0000-0002-3718-2165; Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Robert A. Welch Foundation Grant [C-0612]; Italian Ministry of University and Scientific Research Grant FIRB Project "Biologia Strutturale," [RBLA03B3KC]; University of Milano; Fund for Scientific Research Flanders Project "Hypoxia and Nerve Globins" Grant [G.0331.04N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation Grant(The Welch Foundation); Italian Ministry of University and Scientific Research Grant FIRB Project "Biologia Strutturale,"; University of Milano; Fund for Scientific Research Flanders Project "Hypoxia and Nerve Globins" Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020. This work was also supported by Robert A. Welch Foundation Grant C-0612 (to J. S. O.), Italian Ministry of University and Scientific Research Grant FIRB Project "Biologia Strutturale," RBLA03B3KC, the University of Milano (to M. B.), and Fund for Scientific Research Flanders Project "Hypoxia and Nerve Globins" Grant G.0331.04N (to L. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; Bossa C, 2005, BIOPHYS J, V89, P465, DOI 10.1529/biophysj.104.055020; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Daigle R, 2009, BIOPHYS J, V97, P2967, DOI 10.1016/j.bpj.2009.09.006; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Elber R, 2008, J PHYS CHEM B, V112, P6147, DOI 10.1021/jp0769779; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Germani F, 2012, INT J MOL SCI, V13, P8025, DOI 10.3390/ijms13078025; Golden SD, 2008, METHOD ENZYMOL, V437, P459, DOI 10.1016/S0076-6879(07)37023-7; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LIM M, 1995, SCIENCE, V269, P962, DOI 10.1126/science.7638619; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mouawad L, 2005, BBA-GEN SUBJECTS, V1724, P385, DOI 10.1016/j.bbagen.2005.05.014; Nutt DR, 2004, P NATL ACAD SCI USA, V101, P5998, DOI 10.1073/pnas.0306712101; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson JS, 2003, METH MOLEC MED, V82, P65; Orlowski S, 2007, J MOL MODEL, V13, P715, DOI 10.1007/s00894-007-0203-x; Orlowski S, 2007, THEOR CHEM ACC, V117, P253, DOI 10.1007/s00214-006-0139-8; Orlowski S, 2008, BIOSYSTEMS, V94, P263, DOI 10.1016/j.biosystems.2008.04.016; Ouellet YH, 2008, J BIOL CHEM, V283, P27270, DOI 10.1074/jbc.M804215200; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3; Pesce A, 2011, J BIOL CHEM, V286, P5347, DOI 10.1074/jbc.M110.169045; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Savard PY, 2011, BIOCHEMISTRY-US, V50, P11121, DOI 10.1021/bi201059a; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; SCHOENBORN BP, 1966, MOL PHARMACOL, V2, P495; SCHOENBORN BP, 1969, J MOL BIOL, V45, P297, DOI 10.1016/0022-2836(69)90106-5; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; SCHOENBORN BP, 1965, NATURE, V208, P760, DOI 10.1038/208760a0; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Teng TY, 1997, BIOCHEMISTRY-US, V36, P12087, DOI 10.1021/bi971140x; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; TILTON RF, 1982, BIOCHEMISTRY-US, V21, P6850, DOI 10.1021/bi00269a035; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998	65	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33163	33178		10.1074/jbc.M112.392258	http://dx.doi.org/10.1074/jbc.M112.392258			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859299	Green Published, hybrid			2022-12-28	WOS:000309602100008
J	Bansal, H; Seifert, T; Bachier, C; Rao, M; Tomlinson, G; Iyer, SP; Bansal, S				Bansal, Hima; Seifert, Theresea; Bachier, Carlos; Rao, Manjeet; Tomlinson, Gail; Iyer, Swaminathan Padmanabhan; Bansal, Sanjay			The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor alpha-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WT1 EXPRESSION; CYTOCHROME-C; CANCER-CELLS; MECHANISMS; GENE; ACTIVATION; DEATH; DIFFERENTIATION; MITOCHONDRIA; CHEMOTHERAPY	Tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL) is considered a promising cancer therapeutic agent due to its ability to induce apoptosis in a variety of cancer cells, while sparing normal cells. However, many human tumors including acute myeloid leukemia (AML) are partially or completely resistant to monotherapy with TRAIL, limiting its therapeutic utility. Therefore, identification of factors that contribute to TRAIL resistance may facilitate future development of more effective TRAIL-based cancer therapies. Here, we report a previously unknown role for WT1 in mediating TRAIL resistance in leukemia. Knockdown of WT1 with shRNA rendered TRAIL-resistant myeloid leukemia cells sensitive to TRAIL-induced cell death, and re-expression of shRNA-resistant WT1 restored TRAIL resistance. Notably, TRAIL-mediated apoptosis in WT1-silenced cells was largely due to down-regulation of the antiapoptotic protein Bcl-xL. Moreover, WT1 expression strongly correlated with overexpression of Bcl-xL in AML cell lines and blasts from AML patients. Furthermore, we found that WT1 transactivates Bcl-xL by directly binding to its promoter. We previously showed that WT1 is a novel client protein of heat shock protein 90 (Hsp90). Consistent with this, pharmacological inhibition of Hsp90 resulted in reduced WT1 and Bcl-xL expression leading to increased sensitivity of leukemia cells to TRAIL-mediated apoptosis. Collectively, our results suggest that WT1-dependent Bcl-xL overexpression contributes to TRAIL resistance in myeloid leukemias.	[Bansal, Sanjay] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Bachier, Carlos] Texas Transplant Inst, San Antonio, TX 78229 USA; [Iyer, Swaminathan Padmanabhan] Methodist Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; The Methodist Hospital System; The Methodist Hospital - Houston	Bansal, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	bansals@uthscsa.edu	Iyer, Swaminathan Padmanabhan/AAB-6709-2020; Iyer, Swaminathan/GRS-9668-2022; Bansal, Sanjay/F-5944-2012; Tomlinson, Gail/AAR-9776-2020	Iyer, Swaminathan Padmanabhan/0000-0002-1646-813X; 	National Institutes of Health [HD057118]; Castella Foundation; American Cancer Society through the Roswell Park Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Castella Foundation; American Cancer Society through the Roswell Park Cancer Institute(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057118 (to M. R.). This work was also supported by the Castella Foundation, institutional start-up funds (to S. B.), and an institutional grant from the American Cancer Society (to S. P. I.) through the Roswell Park Cancer Institute.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Ariyaratana Suzie, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000336; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bansal H, 2010, BLOOD, V116, P4591, DOI 10.1182/blood-2009-10-247239; Boublikova L, 2006, LEUKEMIA, V20, P254, DOI 10.1038/sj.leu.2404047; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Cheng JR, 2006, MOL CANCER THER, V5, P1844, DOI 10.1158/1535-7163.MCT-06-0050; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Elmaagacli AH, 2005, HAEMATOLOGICA, V90, P326; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Hasegawa H, 2006, BLOOD, V107, P679, DOI 10.1182/blood-2005-05-1982; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim KI, 2003, BRIT J CANCER, V88, P910, DOI 10.1038/sj.bjc.6600795; Lapillonne H, 2006, J CLIN ONCOL, V24, P1507, DOI 10.1200/JCO.2005.03.5303; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Medema JP, 1998, J BIOL CHEM, V273, P3388, DOI 10.1074/jbc.273.6.3388; Morrison DJ, 2005, CANCER RES, V65, P8174, DOI 10.1158/0008-5472.CAN-04-3657; Ogawa H, 2003, BLOOD, V101, P1698, DOI 10.1182/blood-2002-06-1831; Oka Y, 2006, CURR MED CHEM, V13, P2345, DOI 10.2174/092986706777935104; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Rosenfeld C, 2003, LEUKEMIA, V17, P1301, DOI 10.1038/sj.leu.2402988; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Simpson LA, 2006, BLOOD, V107, P4695, DOI 10.1182/blood-2005-10-4025; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Sugiyama Haruo, 2002, Methods Mol Med, V68, P223; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Tschan MP, 2008, LEUKEMIA, V22, P1087, DOI 10.1038/sj.leu.2405018; Wang XD, 2001, GENE DEV, V15, P2922; Weisser M, 2005, LEUKEMIA, V19, P1416, DOI 10.1038/sj.leu.2403809; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	42	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32875	32880		10.1074/jbc.C112.366559	http://dx.doi.org/10.1074/jbc.C112.366559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22898820	hybrid, Green Published			2022-12-28	WOS:000309168300053
J	Lieder, F; Reisen, F; Geppert, T; Sollberger, G; Beer, HD; Keller, UAD; Schafer, M; Detmar, M; Schneider, G; Werner, S				Lieder, Franziska; Reisen, Felix; Geppert, Tim; Sollberger, Gabriel; Beer, Hans-Dietmar; Keller, Ulrich Auf Dem; Schaefer, Matthias; Detmar, Michael; Schneider, Gisbert; Werner, Sabine			Identification of UV-protective Activators of Nuclear Factor Erythroid-derived 2-Related Factor 2 (Nrf2) by Combining a Chemical Library Screen with Computer-based Virtual Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; FACTOR E2-RELATED FACTOR-2; TRANSCRIPTION FACTORS; OXIDATIVE STRESS; NITRIC-OXIDE; CANCER CHEMOPREVENTION; GENE-EXPRESSION; RECEPTOR-GAMMA; SKIN; SULFORAPHANE	Nuclear factor erythroid-derived 2-related factor 2 (Nrf2) is a master regulator of cellular antioxidant defense systems, and activation of this transcription factor is a promising strategy for protection of skin and other organs from environmental insults. To identify efficient Nrf2 activators in keratinocytes, we combined a chemical library screen with computer-based virtual screening. Among 14 novel Nrf2 activators, the most potent compound, a nitrophenyl derivative of 2-chloro-5-nitro-N-phenyl-benzamide, was characterized with regard to its molecular mechanism of action. This compound induced the expression of cytoprotective genes in keratinocytes isolated from wild-type but not from Nrf2-deficient mice. Most importantly, it showed low toxicity and protected primary human keratinocytes from UVB-induced cell death. Therefore, it represents a potential lead compound for the development of drugs for skin protection under stress conditions. Our study demonstrates that chemical library screening combined with advanced computational similarity searching is a powerful strategy for identification of bioactive compounds, and it points toward an innovative therapeutic approach against UVB-induced skin damage.	[Lieder, Franziska; Keller, Ulrich Auf Dem; Schaefer, Matthias; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Reisen, Felix; Geppert, Tim; Detmar, Michael; Schneider, Gisbert] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Sollberger, Gabriel; Beer, Hans-Dietmar] Univ Zurich Hosp, Dept Dermatol, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	sabine.werner@cell.biol.ethz.ch	Keller, Ulrich auf dem/G-6004-2012; Schäfer, Matthias/K-1911-2012; Keller, Ulrich auf dem/X-2710-2019	Keller, Ulrich auf dem/0000-0002-3431-7415; Schäfer, Matthias/0000-0001-6754-0448; Keller, Ulrich auf dem/0000-0002-3431-7415; Werner, Sabine/0000-0001-7397-8710; Schneider, Gisbert/0000-0001-6706-1084; Beer, Hans-Dietmar/0000-0002-8085-713X	Swiss National Science Foundation [310030_132884/1, CRSI33_130576/1]; Promedica Foundation, Chur, Switzerland; C.E.R.I.E.S. award; Studienstiftung des Deutschen Volkes; EMBO	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Promedica Foundation, Chur, Switzerland; C.E.R.I.E.S. award; Studienstiftung des Deutschen Volkes; EMBO(European Molecular Biology Organization (EMBO))	This work was supported in part by Swiss National Science Foundation Grants 310030_132884/1 and CRSI33_130576/1 (to S. W.), the Promedica Foundation, Chur, Switzerland (to S. W.), and the C.E.R.I.E.S. award (to S. W.).; Supported by a Ph.D. fellowship from the "Studienstiftung des Deutschen Volkes."; Supported by an EMBO postdoctoral fellowship.	Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dinkova-Kostova AT, 1998, J MED CHEM, V41, P5287, DOI 10.1021/jm980424s; Durchdewald M, 2007, J INVEST DERMATOL, V127, P646, DOI 10.1038/sj.jid.5700585; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Geppert T, 2012, J COMPUT CHEM, V33, P573, DOI 10.1002/jcc.22894; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hur W, 2010, CHEM BIOL, V17, P537, DOI 10.1016/j.chembiol.2010.03.013; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Kerns M, 2010, MOL BIOL CELL, V21, P4068, DOI 10.1091/mbc.E10-02-0153; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; MEDANA C, 1994, J MED CHEM, V37, P4412, DOI 10.1021/jm00051a020; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; ODwyer PJ, 1996, J CLIN INVEST, V98, P1210, DOI 10.1172/JCI118904; Reisen F, 2010, J PROTEOME RES, V9, P6498, DOI 10.1021/pr100719n; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Schneider G, 1999, ANGEW CHEM INT EDIT, V38, P2894, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.3.CO;2-6; Schneider G, 2010, NAT REV DRUG DISCOV, V9, P273, DOI 10.1038/nrd3139; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Smirnova NA, 2011, CHEM BIOL, V18, P752, DOI 10.1016/j.chembiol.2011.03.013; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Tanrikulu Y, 2007, CHEMBIOCHEM, V8, P1932, DOI 10.1002/cbic.200700195; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zhu M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/420194	53	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33001	33013		10.1074/jbc.M112.383430	http://dx.doi.org/10.1074/jbc.M112.383430			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851183	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000309168300063
J	Banerjee, P; Basu, A; Wegiel, B; Otterbein, LE; Mizumura, K; Gasser, M; Waaga-Gasser, AM; Choi, AM; Pal, S				Banerjee, Pallavi; Basu, Aninda; Wegiel, Barbara; Otterbein, Leo E.; Mizumura, Kenji; Gasser, Martin; Waaga-Gasser, Ana Maria; Choi, Augustine M.; Pal, Soumitro			Heme Oxygenase-1 Promotes Survival of Renal Cancer Cells through Modulation of Apoptosis- and Autophagy-regulating Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; CARBON-MONOXIDE; TUMOR-GROWTH; INHIBITION; INDUCTION; EXPRESSION; TUMORIGENESIS; ACTIVATION; CROSSTALK; PATHWAYS	The cytoprotective enzyme heme oxygenase-1 (HO-1) is often overexpressed in different types of cancers and promotes cancer progression. We have recently shown that the Ras-Raf-ERK pathway induces HO-1 to promote survival of renal cancer cells. Here, we examined the possible mechanisms underlying HO-1-mediated cell survival. Considering the growing evidence about the significance of apoptosis and autophagy in cancer, we tried to investigate how HO-1 controls these events to regulate survival of cancer cells. Rapamycin (RAPA) and sorafenib, two commonly used drugs for renal cancer treatment, were found to induce HO-1 expression in renal cancer cells Caki-1 and 786-O; and the apoptotic effect of these drugs was markedly enhanced upon HO-1 knockdown. Overexpression of HO-1 protected the cells from RAPA- and sorafenib-induced apoptosis and also averted drug-mediated inhibition of cell proliferation. HO-1 induced the expression of anti-apoptotic Bcl-xL and decreased the expression of autophagic proteins Beclin-1 and LC3B-II; while knockdown of HO-1 down-regulated Bcl-xL and markedly increased LC3B-II. Moreover, HO-1 promoted the association of Beclin-1 with Bcl-xL and Rubicon, a novel negative regulator of autophagy. Drug-induced dissociation of Beclin-1 from Rubicon and the induction of autophagy were also inhibited by HO-1. Together, our data signify that HO-1 is up-regulated in renal cancer cells as a survival strategy against chemotherapeutic drugs and promotes growth of tumor cells by inhibiting both apoptosis and autophagy. Thus, application of chemotherapeutic drugs along with HO-1 inhibitor may elevate therapeutic efficiency by reducing the cytoprotective effects of HO-1 and by simultaneous induction of both apoptosis and autophagy.	[Banerjee, Pallavi; Basu, Aninda; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Banerjee, Pallavi; Basu, Aninda; Wegiel, Barbara; Otterbein, Leo E.; Mizumura, Kenji; Choi, Augustine M.; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wegiel, Barbara; Otterbein, Leo E.] Beth Israel Deaconess Med Ctr, Dept Surg, Transplant Inst, Boston, MA 02215 USA; [Mizumura, Kenji] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu		Mizumura, Kenji/0000-0001-8532-9670	National Institutes of Health [R01 CA131145]; American Society of Transplantation; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Transplantation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.) and a Fellowship Grant from American Society of Transplantation (to P. B.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Al-Owais MMA, 2012, J BIOL CHEM, V287, P24754, DOI 10.1074/jbc.M112.357012; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Amundson SA, 2000, CANCER RES, V60, P6101; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Hill M, 2005, FASEB J, V19, P1957, DOI 10.1096/fj.05-3875com; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kongpetch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034994; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Long J. S., 2012, ONCOGENE IN PRESS; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Schorr K, 2000, CANCER RES, V60, P5950; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	49	63	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32113	32123		10.1074/jbc.M112.393140	http://dx.doi.org/10.1074/jbc.M112.393140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843690	hybrid, Green Published			2022-12-28	WOS:000309059400049
J	Hoshino, S; Hayashi, I				Hoshino, Shota; Hayashi, Ikuko			Filament Formation of the FtsZ/Tubulin-like Protein TubZ from the Bacillus cereus pXO1 Plasmid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULIN HOMOLOG TUBZ; PROKARYOTIC ACTIN HOMOLOG; BACTERIAL CYTOSKELETON; THURINGIENSIS SUBSP; ATOMIC STRUCTURES; FTSZ; ANTHRACIS; REPLICATION; SOFTWARE; POLYMERIZATION	Stable maintenance of low-copy-number plasmids requires partition (par) systems that consist of a nucleotide hydrolase, a DNA-binding protein, and a cis-acting DNA-binding site. The FtsZ/tubulin-like GTPase TubZ was identified as a partitioning factor of the virulence plasmids pBtoxis and pXO1 in Bacillus thuringiensis and Bacillus anthracis, respectively. TubZ exhibits high GTPase activity and assembles into polymers both in vivo and in vitro, and its "treadmilling" movement is required for plasmid stability in the cell. To investigate the molecular mechanism of pXO1 plasmid segregation by TubZ filaments, we determined the crystal structures of Bacillus cereus TubZ in apo-, GDP-, and guanosine 5'-3-O-(thio)triphosphate (GTP gamma S)-bound forms at resolutions of 2.1, 1.9, and 3.3 angstrom, respectively. Interestingly, the slowly hydrolyzable GTP analog GTP gamma S was hydrolyzed to GDP in the crystal. In the post-GTP hydrolysis state, GDP-bound B. cereus TubZ forms a dimer by the head-to-tail association of individual subunits in the asymmetric unit, which is similar to the protofilament formation of FtsZ and B. thuringiensis TubZ. However, the M loop interacts with the nucleotide-binding site of the adjacent subunit and stabilizes the filament structure in a different manner, which indicates that the molecular assembly of the TubZ-related par systems is not stringently conserved. Furthermore, we show that the C-terminal tail of TubZ is required for association with the DNA-binding protein TubR. Using a combination of crystallography, site-directed mutagenesis, and biochemical analysis, our results provide the structural basis of the TubZ polymer that may drive DNA segregation.	[Hoshino, Shota; Hayashi, Ikuko] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan	Yokohama City University	Hayashi, I (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	ihay@tsurumi.yokohama-cu.ac.jp			Hayashi Memorial Foundation for Female Natural Scientists	Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by the Hayashi Memorial Foundation for Female Natural Scientists (to I. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhtar P, 2009, J BACTERIOL, V191, P2493, DOI 10.1128/JB.00027-09; Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Delano W.L, 2002, PYMOL USERS MANUAL; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Makarova KS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-33; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2012, P NATL ACAD SCI USA, V109, P7711, DOI 10.1073/pnas.1121546109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Tang M, 2007, J BACTERIOL, V189, P8053, DOI 10.1128/JB.00908-07; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018	37	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32103	32112		10.1074/jbc.M112.373803	http://dx.doi.org/10.1074/jbc.M112.373803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22847006	Green Published, hybrid			2022-12-28	WOS:000309059400048
J	Eckford, PDW; Li, CH; Ramjeesingh, M; Bear, CE				Eckford, Paul D. W.; Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.			Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; SMALL-MOLECULE MODULATOR; CL-CHANNEL; CHLORIDE CHANNEL; FUNCTIONAL RECONSTITUTION; IN-VITRO; RESCUE; G551D; PURIFICATION; DIMERIZATION	The cystic fibrosis transmembrane conductance regulator (CFTR) acts as a channel on the apical membrane of epithelia. Disease-causing mutations in the cystic fibrosis gene can lead to CFTR protein misfolding as in the case of the F508del mutation and/or channel dysfunction. Recently, a small molecule, VX-770 (ivacaftor), has shown efficacy in restoring lung function in patients bearing the G551D mutation, and this has been linked to repair of its channel gating defect. However, these studies did not reveal the mechanism of action of VX-770 in detail. Normally, CFTR channel activity is regulated by phosphorylation, ATP binding, and hydrolysis. Hence, it has been hypothesized that VX-770 modifies one or more of these metabolic events. In this study, we examined VX-770 activity using a reconstitution system for purified CFTR protein, a system that enables control of known regulatory factors. We studied the consequences of VX-770 interaction with CFTR incorporated in planar lipid bilayers and in proteoliposomes, using a novel flux-based assay. We found that purified and phosphorylated CFTR was potentiated in the presence of Mg-ATP, suggesting that VX-770 bound directly to the CFTR protein, rather than associated kinases or phosphatases. Interestingly, we also found that VX-770 enhanced the channel activity of purified and mutant CFTR in the nominal absence of Mg-ATP. These findings suggest that VX-770 can cause CFTR channel opening through a nonconventional ATP-independent mechanism. This work sets the stage for future studies of the structural properties that mediate CFTR gating using VX-770 as a probe.	[Eckford, Paul D. W.; Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.] Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Eckford, Paul D. W.; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Bear, Christine E.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bear@sickkids.ca	Eckford, Paul/ABE-9189-2021		Cystic Fibrosis Canada; Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR) [F508del-CFTR, G551D-CFTR]; Vertex Pharmaceuticals; Canadian Institutes of Health Research and Cystic Fibrosis Canada	Cystic Fibrosis Canada; Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR)(Canadian Institutes of Health Research (CIHR)); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Canadian Institutes of Health Research and Cystic Fibrosis Canada(Canadian Institutes of Health Research (CIHR))	This work was supported in part by operating grants (to C. E. B.) by Cystic Fibrosis Canada and the Canadian Institutes of Health Research (supporting studies of channel function of purified and reconstituted WT-CFTR, F508del-CFTR, and G551D-CFTR). Vertex Pharmaceuticals supported the ATPase studies in Fig. 6D with a sponsored research agreement.; Supported by postdoctoral fellowships from Canadian Institutes of Health Research and Cystic Fibrosis Canada.; Studies of the effect of VX-770 on the ATPase activity of G551D-CFTR were supported by a sponsored research agreement from Vertex Pharmaceuticals (Fig. 6D). Vertex Pharmaceuticals provided VX-770 and its inactive analog for this study. We also thank Ling Jun Huan, Steven Molinski, and Stan Pasyk for their assistance with ATPase studies and discussions regarding interpretation. Stan Pasyk also assisted in the single channel analyses. We acknowledge the Cystic Fibrosis Foundation Therapeutics (CFFT) and Dr. Robert Bridges, Rosalind Franklin University, for providing CFTR<INF>inh</INF>-172 and other CFTR modulator compounds.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Alkhouri B, 2011, J MED CHEM, V54, P8693, DOI 10.1021/jm201335c; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Artigas P, 2006, MOL PHARMACOL, V70, P2015, DOI 10.1124/mol.106.026070; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Bear CE, 1997, J BIOENERG BIOMEMBR, V29, P465, DOI 10.1023/A:1022435007193; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Gadsby DC, 1999, ADV SEC MESS PHOSPH, V33, P79; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kogan Ilana, 2002, Methods Mol Med, V70, P143; Kogan Ilana, 2004, J Cyst Fibros, V3 Suppl 2, P133, DOI 10.1016/j.jcf.2004.05.028; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Proesmans M, 2008, EUR J PEDIATR, V167, P839, DOI 10.1007/s00431-008-0693-2; Ramjeesingh M, 1997, BIOCHEM J, V327, P17, DOI 10.1042/bj3270017; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Ramjeesingh M, 1999, Methods Enzymol, V294, P227; Ramjeesingh M., 2010, RELIABLE LAB SOLUTIO, P337; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608	49	190	203	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36639	36649		10.1074/jbc.M112.393637	http://dx.doi.org/10.1074/jbc.M112.393637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942289	hybrid, Green Published			2022-12-28	WOS:000310588500002
J	Gupta, V; Bhinge, KN; Hosain, SB; Xiong, K; Gu, X; Shi, RH; Ho, MY; Khoo, KH; Li, SC; Li, YT; Ambudkar, SV; Jazwinski, SM; Liu, YY				Gupta, Vineet; Bhinge, Kaustubh N.; Hosain, Salman B.; Xiong, Katherine; Gu, Xin; Shi, Runhua; Ho, Ming-Yi; Khoo, Kay-Hooi; Li, Su-Chen; Li, Yu-Teh; Ambudkar, Suresh V.; Jazwinski, S. Michal; Liu, Yong-Yu			Ceramide Glycosylation by Glucosylceramide Synthase Selectively Maintains the Properties of Breast Cancer Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; SELF-RENEWAL; BONE-MARROW; IN-VITRO; EXPRESSION; GLYCOSPHINGOLIPIDS; CARCINOMA; INHIBITOR; PATHWAY; DIFFERENTIATION	Cancer stem cells are distinguished from normal adult stem cells by their stemness without tissue homeostasis control. Glycosphingolipids (GSLs), particularly globo-series GSLs, are important markers of undifferentiated embryonic stem cells, but little is known about whether or not ceramide glycosylation, which controls glycosphingolipid synthesis, plays a role in modulating stem cells. Here, we report that ceramide glycosylation catalyzed by glucosylceramide synthase, which is enhanced in breast cancer stem cells (BCSCs) but not in normal mammary epithelial stem cells, maintains tumorous pluripotency of BCSCs. Enhanced ceramide glycosylation and globotriosylceramide (Gb3) correlate well with the numbers of BCSCs in breast cancer cell lines. In BCSCs sorted with CD44(+)/ESA(+)/CD24(-) markers, Gb3 activates c-Src/beta-catenin signaling and up-regulates the expression of FGF-2, CD44, and Oct-4 enriching tumorigenesis. Conversely, silencing glucosylceramide synthase expression disrupts Gb3 synthesis and selectively kills BCSCs through deactivation of c-Src/beta-catenin signaling. These findings highlight the unexploited role of ceramide glycosylation in selectively maintaining the tumorous pluripotency of cancer stem cells. It speculates that disruption of ceramide glycosylation or globo-series GSL is a useful approach to specifically target BCSCs specifically.	[Gupta, Vineet; Bhinge, Kaustubh N.; Hosain, Salman B.; Xiong, Katherine; Liu, Yong-Yu] Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA; [Gu, Xin] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71130 USA; [Shi, Runhua; Khoo, Kay-Hooi] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA; [Ho, Ming-Yi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Li, Su-Chen; Li, Yu-Teh] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Jazwinski, S. Michal] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Jazwinski, S. Michal] Tulane Univ, Sch Med, Tulane Ctr Aging, New Orleans, LA 70112 USA; [Ambudkar, Suresh V.] NCI, Cell Biol Lab, Bethesda, MD 20892 USA	University of Louisiana System; University of Louisiana Monroe; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Academia Sinica - Taiwan; Tulane University; Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, YY (corresponding author), Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, 700 Univ Ave, Monroe, LA 71209 USA.	yliu@ulm.edu	Ambudkar, Suresh V/L-1317-2016; Liu, Yong-Yu/H-8593-2014; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Liu, Yong-Yu/0000-0002-7968-0162; Xiong, Katherine/0000-0002-1603-2037	National Institutes of Health, National Center for Research Resources [5P20RR016456-11]; National Institute of General Medical Sciences [8 P20 GM103424-11]; Mizutani Foundation for Glycoscience, Japan; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010030, R15CA167476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mizutani Foundation for Glycoscience, Japan; Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR016456-11 from the National Center for Research Resources and 8 P20 GM103424-11 from the National Institute of General Medical Sciences (to Y.-Y. L.). This work was also supported by funds from the Mizutani Foundation for Glycoscience, Japan (to Y.-Y. L.).; Supported by the Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; BASU S, 1968, J BIOL CHEM, V243, P5802; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Booker-Dwyer T, 2008, DEV NEUROBIOL, V68, P859, DOI 10.1002/dneu.20606; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Carney D N, 1982, Stem Cells, V1, P149; Chang WW, 2008, P NATL ACAD SCI USA, V105, P11667, DOI 10.1073/pnas.0804979105; DELL A, 1994, METHOD ENZYMOL, V230, P108; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Gupta V, 2011, METHODS MOL BIOL, V716, P179, DOI 10.1007/978-1-61779-012-6_11; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; INOKUCHI J, 1990, CANCER RES, V50, P6731; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Maupas-Schwalm F, 2005, CANCER RES, V65, P526; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Patwardhan GA, 2011, PROG LIPID RES, V50, P104, DOI 10.1016/j.plipres.2010.10.003; Patwardhan GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006938; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; RADIN NS, 1994, MOL CHEM NEUROPATHOL, V21, P111, DOI 10.1007/BF02815346; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Steelant WF, 2002, FEBS LETT, V531, P93, DOI 10.1016/S0014-5793(02)03484-1; Suila H, 2011, J MOL CELL BIOL, V3, P99, DOI 10.1093/jmcb/mjq041; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xu JX, 2007, EXP CELL RES, V313, P1877, DOI 10.1016/j.yexcr.2007.03.006; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHOU B, 1989, J BIOL CHEM, V264, P12272	71	52	54	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37195	37205		10.1074/jbc.M112.396390	http://dx.doi.org/10.1074/jbc.M112.396390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936806	hybrid, Green Published			2022-12-28	WOS:000310588500053
J	Saouros, S; Dou, ZC; Henry, M; Marchant, J; Carruthers, VB; Matthews, S				Saouros, Savvas; Dou, Zhicheng; Henry, Maud; Marchant, Jan; Carruthers, Vern B.; Matthews, Stephen			Microneme Protein 5 Regulates the Activity of Toxoplasma Subtilisin 1 by Mimicking a Subtilisin Prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; SWISS-MODEL; GONDII; SPECIFICITY; PROTEOLYSIS; PROPEPTIDE; ADHESION; TGSUB1; RECOGNITION; ASSIGNMENT	Toxoplasma gondii is the model parasite of the phylum Apicomplexa, which contains obligate intracellular parasites of medical and veterinary importance. Apicomplexans invade host cells by a multistep process involving the secretion of adhesive microneme protein (MIC) complexes. The subtilisin protease TgSUB1 trims several MICs on the parasite surface to activate gliding motility and host invasion. Although a previous study showed that expression of the secretory protein TgMIC5 suppresses TgSUB1 activity, the mechanism was unknown. Here, we solve the three-dimensional structure of TgMIC5 by nuclear magnetic resonance (NMR), revealing that it mimics a subtilisin prodomain including a flexible C-terminal peptide that may insert into the subtilisin active site. We show that TgMIC5 is an almost 50-fold more potent inhibitor of TgSUB1 activity than the small molecule inhibitorN-[N-(N-acetyl-L-leucyl)-L-leucyl]-L-norleucine (ALLN). Moreover, we demonstrate that TgMIC5 is retained on the parasite plasma membrane via its physical interaction with the membrane-anchored TgSUB1.	[Dou, Zhicheng; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Saouros, Savvas; Henry, Maud; Marchant, Jan; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu; s.j.matthews@imperial.ac.uk		Carruthers, Vern/0000-0001-6859-8895; Matthews, Steve/0000-0003-0676-0927	National Institutes of Health [AI063263]; Medical Research Council [G0800038]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI063263] Funding Source: NIH RePORTER; MRC [G0800038] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by Medical Research Council Grants G0800038 (to S. M.) and an American Heart Association postdoctoral fellowship (to Z. D.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Brydges SD, 2006, EUKARYOT CELL, V5, P2174, DOI 10.1128/EC.00163-06; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Friedrich N, 2010, INT J PARASITOL, V40, P1145, DOI 10.1016/j.ijpara.2010.04.007; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Garcia-Castellanos R, 2005, CELL MOL LIFE SCI, V62, P1996, DOI 10.1007/s00018-005-5174-4; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Helland R, 2006, FEBS J, V273, P61, DOI 10.1111/j.1742-4658.2005.05040.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Lai L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002296; Marchant J, 2012, J BIOL CHEM, V287, P16720, DOI 10.1074/jbc.M111.325928; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; RICHARDS FO, 1995, CLIN INFECT DIS, V21, pS49, DOI 10.1093/clinids/21.Supplement_1.S49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Ruan B, 2008, BIOCHEMISTRY-US, V47, P6628, DOI 10.1021/bi800089f; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sell M, 2005, CLIN NEUROPATHOL, V24, P106; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	45	19	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36029	36040		10.1074/jbc.M112.389825	http://dx.doi.org/10.1074/jbc.M112.389825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896704	Green Published, hybrid			2022-12-28	WOS:000310364000025
J	Anderson, DM; George, R; Noyes, MB; Rowton, M; Liu, WJ; Jiang, RL; Wolfe, SA; Wilson-Rawls, J; Rawls, A				Anderson, Douglas M.; George, Rajani; Noyes, Marcus B.; Rowton, Megan; Liu, Wenjin; Jiang, Rulang; Wolfe, Scot A.; Wilson-Rawls, Jeanne; Rawls, Alan			Characterization of the DNA-binding Properties of the Mohawk Homeobox Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NEGATIVE AUTOREGULATION; MOUSE DEVELOPMENT; SKELETAL-MUSCLE; FIBER-TYPE; SOX6; FAMILY; DIFFERENTIATION; IDENTIFICATION; SPECIFICITIES	The homeobox transcription factor Mohawk (Mkx) is a potent transcriptional repressor expressed in the embryonic precursors of skeletal muscle, cartilage, and bone. MKX has recently been shown to be a critical regulator of musculoskeletal tissue differentiation and gene expression; however, the genetic pathways through which MKX functions and its DNA-binding properties are currently unknown. Using a modified bacterial one-hybrid site selection assay, we determined the core DNA-recognition motif of the mouse monomeric Mkx homeodomain to be A-C-A. Using cell-based assays, we have identified a minimal Mkx-responsive element (MRE) located within the Mkx promoter, which is composed of a highly conserved inverted repeat of the core Mkx recognition motif. Using the minimal MRE sequence, we have further identified conserved MREs within the locus of Sox6, a transcription factor that represses slow fiber gene expression during skeletal muscle differentiation. Real-time PCR and immunostaining of in vitro differentiated muscle satellite cells isolated from Mkx-null mice revealed an increase in the expression of Sox6 and down-regulation of slow fiber structural genes. Together, these data identify the unique DNA-recognition properties of MKX and reveal a novel role for Mkx in promoting slow fiber type specification during skeletal muscle differentiation.	[Anderson, Douglas M.; George, Rajani; Rowton, Megan; Wilson-Rawls, Jeanne; Rawls, Alan] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Anderson, Douglas M.; George, Rajani; Rowton, Megan] Arizona State Univ, Mol & Cellular Biol Grad Program, Tempe, AZ 85287 USA; [Rawls, Alan] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ 85287 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Med Ctr, Program Gene Funct & Express, Worcester, MA 01605 USA; [Noyes, Marcus B.; Wolfe, Scot A.] Univ Massachusetts, Med Ctr, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Liu, Wenjin; Jiang, Rulang] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, Rochester, NY 14642 USA; [Liu, Wenjin; Jiang, Rulang] Univ Rochester, Sch Med & Dent, Ctr Oral Biol, Rochester, NY 14642 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Rochester; University of Rochester	Rawls, A (corresponding author), Arizona State Univ, Sch Life Sci, Box 874501,Life Sci C Bldg,Rm 544, Tempe, AZ 85287 USA.	alan.rawls@asu.edu	George, Rajani Mary/AAM-7256-2020	George, Rajani Mary/0000-0002-9153-5523; Jiang, Rulang/0000-0001-7842-4696; Wilson-Rawls, Jeanne/0000-0002-3704-6956	National Institutes of Health [1R01HG004744]; National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HG004744 (to S. A. W.) and National Science Foundation (to J.A.R. and J.W.R.).	ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Fu DC, 2003, MOL CELL BIOL, V23, P4439, DOI 10.1128/MCB.23.13.4439-4448.2003; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Hagiwara N, 2005, DEV DYNAM, V234, P301, DOI 10.1002/dvdy.20535; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; IRVINE KD, 1993, DEVELOPMENT, V117, P387; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Liu H, 2006, GENE EXPR PATTERNS, V6, P632, DOI 10.1016/j.modgep.2005.11.012; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; NEUTEBOOM STC, 1995, P NATL ACAD SCI USA, V92, P9166, DOI 10.1073/pnas.92.20.9166; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Takeuchi JK, 2007, GENE EXPR PATTERNS, V7, P51, DOI 10.1016/j.modgep.2006.05.007; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wilson-Rawls J, 2004, J BIOL CHEM, V279, P37685, DOI 10.1074/jbc.M401319200; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Zabet NR, 2011, J THEOR BIOL, V284, P82, DOI 10.1016/j.jtbi.2011.06.021	45	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35351	35359		10.1074/jbc.M112.399386	http://dx.doi.org/10.1074/jbc.M112.399386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923612	Green Published, hybrid			2022-12-28	WOS:000309968000044
J	Mariante, RM; Nobrega, A; Martins, RAP; Areal, RB; Bellio, M; Linden, R				Mariante, Rafael M.; Nobrega, Alberto; Martins, Rodrigo A. P.; Areal, Romulo B.; Bellio, Maria; Linden, Rafael			Neuroimmunoendocrine Regulation of the Prion Protein in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; EXPRESSION; RECEPTOR; CELLS; ACTIVATION; NEURODEGENERATION; PROLIFERATION; PHAGOCYTOSIS; APOPTOSIS; TOXICITY	The prion protein (PrPC) is a cell surface protein expressed mainly in the nervous system. In addition to the role of its abnormal conformer in transmissible spongiform encephalopathies, normal PrPC may be implicated in other degenerative conditions often associated with inflammation. PrPC is also present in cells of hematopoietic origin, including T cells, dendritic cells, and macrophages, and it has been shown to modulate their functions. Here, we investigated the impact of inflammation and stress on the expression and function of PrPC in neutrophils, a cell type critically involved in both acute and chronic inflammation. We found that systemic injection of LPS induced transcription and translation of PrPC in mouse neutrophils. Up-regulation of PrPC was dependent on the serum content of TGF-beta and glucocorticoids (GC), which, in turn, are contingent on the activation of the hypothalamic-pituitary-adrenal axis in response to systemic inflammation. GC and TGF-beta, either alone or in combination, directly up-regulated PrPC in neutrophils, and accordingly, the blockade of GC receptors in vivo curtailed the LPS-induced increase in the content of PrPC. Moreover, GC also mediated up-regulation of PrPC in neutrophils following noninflammatory restraint stress. Finally, neutrophils with up-regulated PrPC presented enhanced peroxide-dependent cytotoxicity to endothelial cells. The data demonstrate a novel interplay of the nervous, endocrine, and immune systems upon both the expression and function of PrPC in neutrophils, which may have a broad impact upon the physiology and pathology of various organs and systems.	[Linden, Rafael] John Simon Guggenheim Fdn, New York, NY USA; [Mariante, Rafael M.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biophys, BR-21941902 Rio De Janeiro, Brazil; [Nobrega, Alberto; Areal, Romulo B.; Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil; [Martins, Rodrigo A. P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mariante, RM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis, Ctr Ciencias Saude, Bloco G,Cidade Univ, BR-21941902 Rio de Janeiro, Brazil.	rafaelmariante@gmail.com; rlinden@biof.ufrj.br	Nobrega, Alberto/U-1161-2019; Mariante, Rafael/A-2971-2015; Linden, Rafael/F-2275-2011; Martins, Rodrigo/W-7604-2019; Mariante, Rafael/AAM-6010-2021; Bellio, Maria/N-8525-2018; Martins, Rodrigo A. P./A-4701-2010	Mariante, Rafael/0000-0001-8024-9612; Linden, Rafael/0000-0003-3287-336X; Martins, Rodrigo/0000-0002-8420-6991; Mariante, Rafael/0000-0001-8024-9612; Bellio, Maria/0000-0002-3360-2740; Martins, Rodrigo A. P./0000-0002-8420-6991; Nobrega, Alberto/0000-0002-9840-0103; Braga Areal, Romulo/0000-0001-9531-0092	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Financiadora de Estudos e Projetos; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; International Brain Research Organization; International Retinal Research Foundation; Programa de Apoio a Nucleos de Excelencia; Rio de Janeiro Postdoctoral Support Program	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Brain Research Organization; International Retinal Research Foundation; Programa de Apoio a Nucleos de Excelencia; Rio de Janeiro Postdoctoral Support Program	This work was supported in part by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Financiadora de Estudos e Projetos, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, International Brain Research Organization, International Retinal Research Foundation, and Programa de Apoio a Nucleos de Excelencia.; Recipient of a postdoctoral fellowship from Rio de Janeiro Postdoctoral Support Program. To whom correspondence may be addressed: Instituto de Biofisica da UFRJ, Centro de Ciencias da Saude, Bloco G, Cidade Universitaria, 21941-902, Rio de Janeiro, Brasil. Tel.: 55-21-25626553; Fax: 55-21-22808193; E-mail: rafaelmariante@gmail.com.	Albus C, 2010, ANN MED, V42, P487, DOI 10.3109/07853890.2010.515605; Ballerini C, 2006, J IMMUNOL, V176, P7254, DOI 10.4049/jimmunol.176.12.7254; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Butcher SK, 2004, AGING CELL, V3, P151, DOI 10.1111/j.1474-9728.2004.00103.x; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Cohen S, 2003, BRAIN BEHAV IMMUN, V17, P407, DOI 10.1016/S0889-1591(03)00110-7; COX G, 1995, J IMMUNOL, V154, P4719; de Almeida CJG, 2005, J LEUKOCYTE BIOL, V77, P238, DOI 10.1189/jlb.1103531; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Durig J, 2000, BRIT J HAEMATOL, V108, P488, DOI 10.1046/j.1365-2141.2000.01881.x; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Jensen K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-224; Kagi D, 1999, J IMMUNOL, V162, P4598; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khanfer Riyad, 2010, Psychosom Med, V72, P636, DOI 10.1097/PSY.0b013e3181e7fae8; Kuczius T, 2011, J CELL BIOCHEM, V112, P954, DOI 10.1002/jcb.23012; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; LICURSI PC, 1972, INFECT IMMUN, V6, P370, DOI 10.1128/IAI.6.3.370-376.1972; LILES WC, 1995, BLOOD, V86, P3181; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; MIRAGLIOTTA G, 1990, ACTA VIROL, V34, P517; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; NALBANDIAN RM, 1983, CLIN IMMUNOL IMMUNOP, V28, P155, DOI 10.1016/0090-1229(83)90150-2; Paar C, 2007, EUR J CELL BIOL, V86, P253, DOI 10.1016/j.ejcb.2007.03.001; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Satoh J, 1998, J NEUROPATH EXP NEUR, V57, P131, DOI 10.1097/00005072-199802000-00004; Sauer H, 2003, FREE RADICAL BIO MED, V35, P586, DOI 10.1016/S0891-5849(03)00360-5; Scali C, 2002, NEUROBIOL AGING, V23, P523, DOI 10.1016/S0197-4580(01)00346-3; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Simard M, 2009, CURR PSYCHIAT REP, V11, P41, DOI 10.1007/s11920-009-0007-z; Smith ELP, 2002, BRAIN BEHAV IMMUN, V16, P140, DOI 10.1006/brbi.2001.0629; Splettstoesser WD, 2002, MICROSC RES TECHNIQ, V57, P441, DOI 10.1002/jemt.10098; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Vitte J, 2004, J CLIN IMMUNOL, V24, P683, DOI 10.1007/s10875-004-6243-4; WEISSMANN C, 1993, BRIT MED BULL, V49, P995, DOI 10.1093/oxfordjournals.bmb.a072658; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	65	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35506	35515		10.1074/jbc.M112.394924	http://dx.doi.org/10.1074/jbc.M112.394924			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910907	hybrid, Green Published			2022-12-28	WOS:000309968000059
J	Vollmer, TR; Stockhausen, A; Zhang, JZ				Vollmer, Thomas R.; Stockhausen, Anthony; Zhang, Jin-Zhong			Anti-inflammatory Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, Is Partially Mediated by MAP Kinase Phosphatase-1 (MKP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; DUAL-SPECIFICITY PHOSPHATASES; INNATE IMMUNE-RESPONSES; INITIATION-FACTOR 4E; MESSENGER-RNA; LIPOPOLYSACCHARIDE STIMULATION; CONDITIONAL EXPRESSION; P38 MAPK; TNF	Mapracorat is a novel selective glucocorticoid receptor agonist (SEGRA), structurally distinct from corticosteroids. In preclinical studies, mapracorat potently inhibits the production of a variety of inflammatory mediators including cytokines and prostaglandin E2 (PGE(2)), with limited side effects associated with traditional corticosteroids. The objective of this study was to delineate the mechanisms underlying the anti-inflammatory properties of mapracorat. We found that mapracorat potently inhibited the production of GM-CSF and TNF-alpha in LPS-stimulated Raw 264.7 macrophages. Mapracorat also substantially attenuated the expression of COX-2 and the production of PGE(2). The inhibition of mapracorat on the inflammatory response was dose-dependent, and substantially inhibitory effects were observed at concentrations in the 10-100 nM range. Examination of the activation kinetics of p38 and its downstream target MAPK-activated protein kinase-2 (MK-2) revealed a shortened activation course after LPS stimulation in cells pretreated with mapracorat. Supporting the notion that mapracorat augments a feedback control mechanism restraining the p38 pathway, we found that mapracorat enhanced the expression of MAPK phosphatase-1 (MKP-1), a critical negative regulator of MAPKs that drive the production of cytokines and other inflammatory mediators. While mapracorat alone did not stimulate MKP-1 expression, it markedly enhanced the expression of MKP-1 in cells stimulated by LPS, in a similar manner and potency to the augmenting effect of dexamethasone. Blocking MKP-1 expression by triptolide also abolished the accelerating effects of mapracorat on p38 and MK-2 deactivation, further supporting a role of MKP-1 in the anti-inflammatory mechanism of mapracorat. Taken together, these results indicate that mapracorat exerts its anti-inflammatory effects, at least in part, by augmenting MKP-1 expression.	[Vollmer, Thomas R.; Stockhausen, Anthony; Zhang, Jin-Zhong] Bausch Lomb Inc, Global Pharmaceut R&D, Rochester, NY 14609 USA	Bausch Health; Bausch + Lomb	Zhang, JZ (corresponding author), Reata Pharmaceut Inc, 2801 Gateway Dr,Suite 150, Irving, TX 75063 USA.	jz168_us@hotmail.com						Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aeberli D, 2006, FEBS LETT, V580, P974, DOI 10.1016/j.febslet.2006.01.027; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Baiula M, 2011, MOL VIS, V17, P3208; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BEUTLER B, 1995, J INVEST MED, V43, P227; Beutler B, 1998, BLOOD CELL MOL DIS, V24, P216, DOI 10.1006/bcmd.1998.0187; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; Cavet ME, 2010, MOL VIS, V16, P1791; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joyce DA, 2001, INFLAMM RES, V50, P337, DOI 10.1007/PL00012387; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Morris DL, 2010, TOXICOL PATHOL, V38, P606, DOI 10.1177/0192623310367807; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pfeffer BA, 2010, INVEST OPHTH VIS SCI, V51, P437, DOI 10.1167/iovs.09-4202; Pratt PF, 2003, J BIOL CHEM, V278, P51928, DOI 10.1074/jbc.M309256200; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schacke H, 2009, BRIT J PHARMACOL, V158, P1088, DOI 10.1111/j.1476-5381.2009.00238.x; Shafiee A, 2011, INVEST OPHTH VIS SCI, V52, P1422, DOI 10.1167/iovs.10-5598; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Sweeney SE, 2006, ANN RHEUM DIS, V65, P83, DOI 10.1136/ard.2006.058388; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Zhang JZ, 2009, MOL VIS, V15, P2606; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	71	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35212	35221		10.1074/jbc.M112.400671	http://dx.doi.org/10.1074/jbc.M112.400671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22898817	Green Published, hybrid			2022-12-28	WOS:000309968000031
J	Kroth, H; Ansaloni, A; Varisco, Y; Jan, A; Sreenivasachary, N; Rezaei-Ghaleh, N; Giriens, V; Lohmann, S; Lopez-Deber, MP; Adolfsson, O; Pihlgren, M; Paganetti, P; Froestl, W; Nagel-Steger, L; Willbold, D; Schrader, T; Zweckstetter, M; Pfeifer, A; Lashuel, HA; Muhs, A				Kroth, Heiko; Ansaloni, Annalisa; Varisco, Yvan; Jan, Asad; Sreenivasachary, Nampally; Rezaei-Ghaleh, Nasrollah; Giriens, Valerie; Lohmann, Sophie; Lopez-Deber, Maria Pilar; Adolfsson, Oskar; Pihlgren, Maria; Paganetti, Paolo; Froestl, Wolfgang; Nagel-Steger, Luitgard; Willbold, Dieter; Schrader, Thomas; Zweckstetter, Markus; Pfeifer, Andrea; Lashuel, Hilal A.; Muhs, Andreas			Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic beta-Amyloid-42 Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-AGGREGATION; A-BETA; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; SHEET; FIBRILLOGENESIS; PATHOLOGY; PEPTIDES; TAU	Increasing evidence implicates A beta peptides self-assembly and fibril formation as crucial events in the pathogenesis of Alzheimer disease. Thus, inhibiting A beta aggregation, among others, has emerged as a potential therapeutic intervention for this disorder. Herein, we employed 3-aminopyrazole as a key fragment in our design of non-dye compounds capable of interacting with A beta 42 via a donor-acceptor-donor hydrogen bond pattern complementary to that of the beta-sheet conformation of A beta 42. The initial design of the compounds was based on connecting two 3-aminopyrazole moieties via a linker to identify suitable scaffold molecules. Additional aryl substitutions on the two 3-aminopyrazole moieties were also explored to enhance pi-pi stacking/hydrophobic interactions with amino acids of A beta 42. The efficacy of these compounds on inhibiting A beta fibril formation and toxicity in vitro was assessed using a combination of biophysical techniques and viability assays. Using structure activity relationship data from the in vitro assays, we identified compounds capable of preventing pathological self-assembly of A beta 42 leading to decreased cell toxicity.	[Kroth, Heiko; Varisco, Yvan; Sreenivasachary, Nampally; Giriens, Valerie; Lohmann, Sophie; Lopez-Deber, Maria Pilar; Adolfsson, Oskar; Pihlgren, Maria; Paganetti, Paolo; Froestl, Wolfgang; Pfeifer, Andrea; Muhs, Andreas] Swiss Fed Inst Technol Lausanne EPFL, AC Immune SA, CH-1015 Lausanne, Switzerland; [Ansaloni, Annalisa; Jan, Asad; Lashuel, Hilal A.] Swiss Fed Inst Technol Lausanne EPFL, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, Struct Biochem, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Schrader, Thomas] Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis, DZNE, D-37077 Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Duisburg Essen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Muhs, A (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, AC Immune SA, PSE Bldg B, CH-1015 Lausanne, Switzerland.	andreas.muhs@acimmune.com	Paganetti, Paolo/AAF-8039-2020; Nagel-Steger, Luitgard/H-6415-2013; Jan, Asad/AAZ-2920-2021; Jan, Asad/D-4389-2009; Willbold, Dieter/A-6280-2013; Rezaei-Ghaleh, Nasrollah/B-9443-2008; Lashuel, Hilal/M-3500-2017	Nagel-Steger, Luitgard/0000-0001-5232-2149; Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; Willbold, Dieter/0000-0002-0065-7366; Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Kroth, Heiko/0000-0002-6936-3921; Paganetti, Paolo/0000-0003-1896-6324; Zweckstetter, Markus/0000-0002-2536-6581	Heisenberg scholarship [ZW71/2-2, 3-2]	Heisenberg scholarship(German Research Foundation (DFG))	This work was supported by a Heisenberg scholarship (ZW71/2-2 and 3-2; to M. Z.). Heiko Kroth, Yvan Varisco, Nampally Sreenivasachary, Valerie Giriens, Sophie Lohmann, Mar a Pilar Lopez-Deber, Oskar Adolfsson, Maria Pihlgren, Paolo Paganetti, Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs are all full-time employees of AC Immune SA.	Adlard PA, 2009, DRUG TODAY, V45, P293, DOI [10.1358/dot.2009.045.004.1353853, 10.1358/dot.2009.45.4.1353853]; Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0; Bandiera T, 1997, CURR MED CHEM, V4, P159; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Clark CM, 2003, ANN INTERN MED, V138, P400, DOI 10.7326/0003-4819-138-5-200303040-00010; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Di Giovanni S, 2010, J BIOL CHEM, V285, P14941, DOI 10.1074/jbc.M109.080390; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Grundman M, 2000, NEUROL CLIN, V18, P807, DOI 10.1016/S0733-8619(05)70227-9; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JORGENSEN WL, 1990, J AM CHEM SOC, V112, P2008, DOI 10.1021/ja00161a061; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Klunk WE, 1998, LIFE SCI, V63, P1807, DOI 10.1016/S0024-3205(98)00454-8; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Nakagami Y, 2002, BRIT J PHARMACOL, V137, P676, DOI 10.1038/sj.bjp.0704911; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Poduslo JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008813; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Rzepecki P, 2004, J BIOL CHEM, V279, P47497, DOI 10.1074/jbc.M405914200; Rzepecki P, 2003, SYNTHESIS-STUTTGART, P1815, DOI 10.1055/s-2003-41031; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smith MA, 1998, INT REV NEUROBIOL, V42, P1, DOI 10.1016/S0074-7742(08)60607-8; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Thapa A, 2011, BIOCHEMISTRY-US, V50, P2445, DOI 10.1021/bi101731d; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	70	47	47	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34786	34800		10.1074/jbc.M112.357665	http://dx.doi.org/10.1074/jbc.M112.357665			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891248	Green Published, hybrid			2022-12-28	WOS:000309654200078
J	Safavi-Hemami, H; Gorasia, DG; Steiner, AM; Williamson, NA; Karas, JA; Gajewiak, J; Olivera, BM; Bulaj, G; Purcell, AW				Safavi-Hemami, Helena; Gorasia, Dhana G.; Steiner, Andrew M.; Williamson, Nicholas A.; Karas, John A.; Gajewiak, Joanna; Olivera, Baldomero M.; Bulaj, Grzegorz; Purcell, Anthony W.			Modulation of Conotoxin Structure and Function Is Achieved through a Multienzyme Complex in the Venom Glands of Cone Snails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; IN-VITRO; ENDOPLASMIC-RETICULUM; BIOLOGICAL-ACTIVITY; ALPHA-CONOTOXINS; QUALITY-CONTROL; ISOMERIZATION; IDENTIFICATION; EXPRESSION; CHAPERONE	The oxidative folding of large polypeptides has been investigated in detail; however, comparatively little is known about the enzyme-assisted folding of small, disulfide-containing peptide substrates. To investigate the concerted effect of multiple enzymes on the folding of small disulfide-rich peptides, we sequenced and expressed protein-disulfide isomerase (PDI), peptidyl-prolyl cis-trans isomerase, and immunoglobulin-binding protein (BiP) from Conus venom glands. Conus PDI was shown to catalyze the oxidation and reduction of disulfide bonds in two conotoxins, alpha-GI and alpha-ImI. Oxidative folding rates were further increased in the presence of Conus PPI with the maximum effect observed in the presence of both enzymes. In contrast, Conus BiP was only observed to assist folding in the presence of microsomes, suggesting that additional co-factors were involved. The identification of a complex between BiP, PDI, and nascent conotoxins further suggests that the folding and assembly of conotoxins is a highly regulated multienzyme-assisted process. Unexpectedly, all three enzymes contributed to the folding of the ribbon isomer of alpha-ImI. Here, we identify this alternative disulfide-linked species in the venom of Conus imperialis, providing the first evidence for the existence of a "non-native" peptide isomer in the venom of cone snails. Thus, ER-resident enzymes act in concert to accelerate the oxidative folding of conotoxins and modulate their conformation and function by reconfiguring disulfide connectivities. This study has evaluated the role of a number of ER-resident enzymes in the folding of conotoxins, providing novel insights into the enzyme-guided assembly of these small, disulfide-rich peptides.	[Safavi-Hemami, Helena; Gorasia, Dhana G.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Safavi-Hemami, Helena; Gorasia, Dhana G.; Williamson, Nicholas A.; Karas, John A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Steiner, Andrew M.; Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Gajewiak, Joanna; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia	University of Melbourne; University of Melbourne; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Monash University	Purcell, AW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	anthony.purcell@monash.edu	Safavi-Hemami, Helena/E-7624-2015; Purcell, Anthony/AAH-1942-2019; Williamson, Nicholas A/O-9812-2016; Karas, John/AAE-9729-2019	Safavi-Hemami, Helena/0000-0002-1984-2721; Purcell, Anthony/0000-0003-0532-8331; Williamson, Nicholas A/0000-0002-2173-3452; Karas, John/0000-0002-3800-5152	National Institutes of Health, NIGMS [GM48677]; Australian Research Council [DP110101331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Program Project GM48677. This work was also supported by Australian Research Council Grant DP110101331.	Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FORTE LR, 1995, FASEB J, V9, P643, DOI 10.1096/fasebj.9.8.7768356; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kang TS, 2007, BIOCHEMISTRY-US, V46, P3338, DOI 10.1021/bi061969o; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Marcinkiewicz C, 2003, CANCER RES, V63, P2020; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MURRAY I, 1971, Journal of the History of Medicine and Allied Sciences, V26, P150; Nicke A, 2003, FEBS LETT, V554, P219, DOI 10.1016/S0014-5793(03)01161-X; Okudo H, 2005, J BIOCHEM, V138, P773, DOI 10.1093/jb/mvi166; Ostermeier M, 1996, J BIOL CHEM, V271, P10616, DOI 10.1074/jbc.271.18.10616; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rioux V, 1998, ELECTROPHORESIS, V19, P788, DOI 10.1002/elps.1150190531; Safavi-Hemami H, 2011, J PROTEOME RES, V10, P3904, DOI 10.1021/pr1012976; Safavi-Hemami H, 2011, J BIOL CHEM, V286, P22546, DOI 10.1074/jbc.M110.217703; Safavi-Hemami H, 2010, J BIOL CHEM, V285, P12735, DOI 10.1074/jbc.M109.078691; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x; Wang ZQ, 2007, FEBS J, V274, P4778, DOI 10.1111/j.1742-4658.2007.06003.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	62	33	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34288	34303		10.1074/jbc.M112.366781	http://dx.doi.org/10.1074/jbc.M112.366781			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891240	Green Published, hybrid			2022-12-28	WOS:000309654200033
J	Zhang, WC; Wang, J; Shu, YW; Tang, TT; Zhu, ZF; Xia, N; Nie, SF; Liu, J; Zhou, SF; Li, JJ; Xiao, H; Yuan, J; Liao, MY; Cheng, LX; Liao, YH; Cheng, X				Zhang, Wen-cai; Wang, Jun; Shu, Yan-wen; Tang, Ting-ting; Zhu, Zheng-feng; Xia, Ni; Nie, Shao-fang; Liu, Juan; Zhou, Su-feng; Li, Jing-jing; Xiao, Hong; Yuan, Jing; Liao, Meng-yang; Cheng, Long-xian; Liao, Yu-hua; Cheng, Xiang			Impaired Thymic Export and Increased Apoptosis Account for Regulatory T Cell Defects in Patients with Non-ST Segment Elevation Acute Coronary Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SUPPRESSIVE FUNCTION; NERVOUS-SYSTEM; TNF-ALPHA; ATHEROSCLEROSIS; INTERLEUKIN-10; INFLAMMATION; IMMUNITY; MECHANISMS; EXPRESSION	Regulatory T (Treg) cells play a protective role against the development of atherosclerosis. Previous studies have revealed Treg cell defects in patients with non-ST elevation acute coronary syndrome (NSTACS), but the mechanisms underlying these defects remain unclear. In this study, we found that the numbers of peripheral blood CD4(+)CD25(+)CD127(low) Treg cells and CD4(+)CD25(+)CD127(low)CD45RA(+)CD45RO(-) naive Treg cells were lower in the NSTACS patients than in the chronic stable angina (CSA) and the chest pain syndrome (CPS) patients. However, the number of CD4(+)CD25(+)CD127(low)CD45RA(-) CD45RO(+) memory Treg cells was comparable in all of the groups. The frequency of CD4(+)CD25(+)CD127(low)CD45RO(-) CD45RA(+)CD31(+) recent thymic emigrant Treg cells and the T cell receptor excision circle content of purified Treg cells were lower in the NSTACS patients than in the CSA patients and the CPS controls. The spontaneous apoptosis of Treg cells (defined as CD4(+)CD25(+)CD127(low)annexinV(+)7-AAD(-)) was increased in the NSTACS patients compared with the CSA and CPS groups. Furthermore, oxidized LDL could induce Treg cell apoptosis, and the oxidized LDL levels were significantly higher in the NSTACS patients than in the CSA and CPS groups. In accordance with the altered Treg cell levels, the concentration of TNF-alpha was increased in the NSTACS patients, resulting in a decreased IL-10/TNF-alpha ratio. These findings indicate that the impaired thymic output of Treg cells and their enhanced susceptibility to apoptosis in the periphery were responsible for Treg cell defects observed in the NSTACS patients.	[Zhang, Wen-cai; Wang, Jun; Shu, Yan-wen; Tang, Ting-ting; Zhu, Zheng-feng; Xia, Ni; Nie, Shao-fang; Liu, Juan; Zhou, Su-feng; Li, Jing-jing; Yuan, Jing; Liao, Meng-yang; Cheng, Long-xian; Liao, Yu-hua; Cheng, Xiang] Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol, Inst Cardiol,Union Hosp,Tongji Med Coll,Minist Ed, Wuhan 430022, Peoples R China; [Wang, Jun] NO1 Peoples Hosp Yangzhou, Dept Cardiol, Yangzhou 225000, Peoples R China; [Xiao, Hong] NO1 Hosp Wuhan, Wuhan 430000, Peoples R China	Huazhong University of Science & Technology	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol, Inst Cardiol,Union Hosp,Tongji Med Coll,Minist Ed, Wuhan 430022, Peoples R China.	nathancx@mail.hust.edu.cn	Cheng, Xiang/K-2190-2012; Wu, yanxia/HGA-0318-2022	yan, wei/0000-0001-5575-7017	National Basic Research Program of China 973 Program [2012CB517805]; National Natural Science Foundation of China [81170303, 81222002, 81200177]; Program for New Century Excellent Talents in University of China [NCET-09-0380]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB517805 (to X. C.), National Natural Science Foundation of China Grants 81170303 and 81222002 (to X. C.) and 81200177 (to T.-T. T.), and Program for New Century Excellent Talents in University of China Grant NCET-09-0380 (to X. C.).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ehara S, 2002, J DIABETES COMPLICAT, V16, P60, DOI 10.1016/S1056-8727(01)00210-0; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Fritzsching B, 2006, J NEUROL SCI, V251, P91, DOI 10.1016/j.jns.2006.09.006; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gossl M, 2010, JACC-CARDIOVASC IMAG, V3, P32, DOI 10.1016/j.jcmg.2009.10.009; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Holven KB, 2002, ARTERIOSCL THROM VAS, V22, P699, DOI 10.1161/01.ATV.0000013288.35930.90; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Kinscherf R, 1998, FASEB J, V12, P461, DOI 10.1096/fasebj.12.6.461; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Livak F, 1996, MOL CELL BIOL, V16, P609; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Meier P, 2007, J AM SOC NEPHROL, V18, P331, DOI 10.1681/ASN.2006050514; Meilhac O, 1999, FASEB J, V13, P485, DOI 10.1096/fasebj.13.3.485; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Nakano A, 2007, THYROID, V17, P25, DOI 10.1089/thy.2006.0231; Naruko T, 2006, ARTERIOSCL THROM VAS, V26, P877, DOI 10.1161/01.ATV.0000209886.31510.7f; Patel KD, 2009, CLIN IMMUNOL, V133, P251, DOI 10.1016/j.clim.2009.07.007; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Stanzer S, 2008, J CLIN IMMUNOL, V28, P107, DOI 10.1007/s10875-007-9139-2; Steffens S, 2006, CIRCULATION, V114, P1977, DOI 10.1161/CIRCULATIONAHA.106.627430; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Tziakas DN, 2006, J AM COLL CARDIOL, V48, P2471, DOI 10.1016/j.jacc.2006.08.032; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Es T, 2010, ATHEROSCLEROSIS, V209, P74, DOI 10.1016/j.atherosclerosis.2009.08.041; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955	65	46	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34157	34166		10.1074/jbc.M112.382978	http://dx.doi.org/10.1074/jbc.M112.382978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872639	hybrid, Green Published			2022-12-28	WOS:000309654200021
J	Faingold, O; Cohen, T; Shai, Y				Faingold, Omri; Cohen, Tomer; Shai, Yechiel			A GxxxG-like Motif within HIV-1 Fusion Peptide Is Critical to Its Immunosuppressant Activity, Structure, and Interaction with the Transmembrane Domain of the T-cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-SPANNING DOMAIN; PROTEIN-KINASE-C; SYNTHETIC PEPTIDE; ENVELOPE GLYCOPROTEIN; SEQUENCE IDENTITY; DENDRITIC CELLS; IN-VIVO; GP41; INHIBITION	To thrive in the human body, HIV fuses to its target cell and evades the immune response via several mechanisms. The fusion cascade is initiated by the fusion peptide (FP), which is located at the N-terminal of gp41, the transmembrane protein of HIV. Recently, it has been shown that the HIV-1 FP, particularly its 5-13 amino acid region (FP5-13), suppresses T-cell activation and interacts with the transmembrane domain (TMD) of the T-cell receptor (TCR) complex. Specific amino acid motifs often contribute to such interactions in TMDs of membrane proteins. Using bioinformatics and experimental studies, we report on a GxxxG-like motif (AxxxG), which is conserved in the FP throughout different clades and strains of HIV-1. Biological activity studies and FTIR spectroscopy revealed that HIV FP5-13-derived peptides, in which the motif was altered either by randomization or by a single amino acid shift, lost their immunosuppressive activity concomitant with a loss of the beta-sheet structure in a membranous environment. Furthermore, fluorescence studies revealed that the inactive mutants lost their ability to interact with their target site, namely, the TMD of TCR alpha, designated CP. Importantly, lipotechoic acid activated macrophages (lacking TCR) were not affected by FP, further demonstrating the specificity of the immunosuppressant activity of CP. Finally, although the AxxxG WT and the GxxxG analog both associated with the CP and immunosuppressed T-cells, the AxxxG WT but not the GxxxG analog induced lipid mixing. Overall, the data support an important role for the AxxxG motif in the function of FP and might explain the natural selection of the AxxxG motif rather than the classical GxxxG motif in FP.	[Faingold, Omri; Cohen, Tomer; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.jac.il	Cohen, Tomer/HIR-6215-2022		Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bloch I, 2007, FASEB J, V21, P393, DOI 10.1096/fj.06-7061com; BLUMENTHAL R, 1991, ANN NY ACAD SCI, V635, P285, DOI 10.1111/j.1749-6632.1991.tb36499.x; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; CHIRMULE N, 1995, J IMMUNOL, V155, P917; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cohen T, 2008, BIOCHEMISTRY-US, V47, P4826, DOI 10.1021/bi800100p; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; Donaghy H, 2004, CURR OPIN INFECT DIS, V17, P1, DOI 10.1097/00001432-200402000-00002; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fernando K, 2007, BLOOD, V109, P2538, DOI 10.1182/blood-2006-08-038661; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; GABUZDA D, 1991, J ACQ IMMUN DEF SYND, V4, P34; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Grasnick D, 2011, EUR BIOPHYS J BIOPHY, V40, P529, DOI 10.1007/s00249-011-0676-5; HAYNES BF, 1993, J EXP MED, V177, P717, DOI 10.1084/jem.177.3.717; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Manolios N, 2008, ADV EXP MED BIOL, V640, P208, DOI 10.1007/978-0-387-09789-3_16; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Masci AM, 2003, J LEUKOCYTE BIOL, V74, P1117, DOI 10.1189/jlb.0503239; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; Oren Z, 1999, EUR J BIOCHEM, V259, P360, DOI 10.1046/j.1432-1327.1999.00047.x; Peisajovich SG, 2003, BBA-BIOMEMBRANES, V1614, P122, DOI 10.1016/S0005-2736(03)00170-6; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sigalov AB, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000404; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang XM, 2002, CELL IMMUNOL, V215, P12, DOI 10.1016/S0008-8749(02)00002-3; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731	64	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33503	33511		10.1074/jbc.M112.370817	http://dx.doi.org/10.1074/jbc.M112.370817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872636	hybrid, Green Published			2022-12-28	WOS:000309602100036
J	Hu, P; Nebreda, AR; Liu, Y; Carlesso, N; Kaplan, M; Kapur, R				Hu, Ping; Nebreda, Angel R.; Liu, Yan; Carlesso, Nadia; Kaplan, Mark; Kapur, Reuben			p38 alpha Protein Negatively Regulates T Helper Type 2 Responses by Orchestrating Multiple T Cell Receptor-associated Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; PKC-THETA; T(H)2 DIFFERENTIATION; MEDIATED ACTIVATION; IL-4 EXPRESSION; TRANSCRIPTION; PATHWAY; INTERLEUKIN-4; NFAT; PROLIFERATION	Mitogen-activated protein kinase p38 alpha is a critical regulator of certain inflammatory diseases. However, its role in T helper type 2 (Th2) responses and allergic inflammation remains unknown. Here we show an increase in the production of inter-leukin-4 (IL-4) in p38 alpha(-/-) CD4(+) T cells in response to antigen stimulation. p38 alpha-deficient naive CD4(+) T cells preferentially differentiate into Th2 cells through increased endogenous production of IL-4. Consistent with those results, we also observed decreased expression of p38 alpha during T helper cell differentiation. Furthermore, deficiency of p38 alpha alters the balance in the expression of NFATc1 and NFATc2 under steady-state conditions and enhances the expression and nuclear translocation of NFATc1 in CD4(+) T cells upon antigen stimulation. Knockdown of NFATc1 significantly inhibits Th2 differentiation in p38 alpha(-/-) T cells but not in p38 alpha(-/-) T cells. p38 alpha deficiency also inhibits the activation of Akt but enhances the activation of ERK in response to T cell receptor engagement without impacting IL-2/Stat5 signaling. In a model of ovalbumin-induced acute allergic airway inflammation, mice with induced deletion of p38 alpha show elevated serum ovalbumin-specific IgE level, increased infiltration of eosinophils, and higher concentrations of Th2 cytokines including IL-4 and IL-5 in the bronchoalveolar lavage fluid relative to control mice. Taken together, p38 alpha regulates multipleT cell receptor-associated signals and negatively influences Th2 differentiation and allergic inflammation.	[Hu, Ping; Liu, Yan; Carlesso, Nadia; Kaplan, Mark; Kapur, Reuben] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avanc, Barcelona 08028, Spain	Indiana University System; Indiana University Bloomington; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Kapur, R (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, 1044 W Walnut St,Rm W168, Indianapolis, IN 46202 USA.	rkapur@iupui.edu	Nebreda, Angel Rodriguez/R-9594-2019		National Institutes of Health [R01 HL077177, R01 HL08111]; ICREA Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICREA(ICREA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077177 and R01 HL08111 (to R. K.).	Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Bourgeois C, 2008, P NATL ACAD SCI USA, V105, P8691, DOI 10.1073/pnas.0803732105; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Cook R, 2007, CELL MOL IMMUNOL, V4, P253; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Hu P, 2012, J BIOL CHEM, V287, P20258, DOI 10.1074/jbc.M112.358119; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Zhang J, 1999, J IMMUNOL, V162, P3819; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33215	33226		10.1074/jbc.M112.355594	http://dx.doi.org/10.1074/jbc.M112.355594			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859305	Green Published, hybrid			2022-12-28	WOS:000309602100012
J	Kim, SO; Ives, KL; Wang, XF; Davey, RA; Chao, C; Hellmich, MR				Kim, Sung Ok; Ives, Kirk L.; Wang, Xiaofu; Davey, Robert A.; Chao, Celia; Hellmich, Mark R.			Raf-1 Kinase Inhibitory Protein (RKIP) Mediates Ethanol-induced Sensitization of Secretagogue Signaling in Pancreatic Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; INDUCED ZYMOGEN ACTIVATION; C-ALPHA PHOSPHORYLATION; ACID ETHYL-ESTERS; CHOLECYSTOKININ RECEPTOR; BASOLATERAL EXOCYTOSIS; ENDOPLASMIC-RETICULUM; CALCIUM HOMEOSTASIS; CA2+; MECHANISM	Excessive alcohol consumption is associated with most cases of chronic pancreatitis, a progressive necrotizing inflammatory disease that can result in pancreatic insufficiency due to acinar atrophy and fibrosis and an increased risk of pancreatic cancer. At a cellular level acute alcohol exposure can sensitize pancreatic acinar cells to secretagogue stimulation, resulting in dys-regulation of intracellular Ca2+ homeostasis and premature digestive enzyme activation; however, the molecular mechanisms by which ethanol exerts these toxic effects have remained undefined. In this study we identify Raf-1 kinase inhibitory protein as an essential mediator of ethanol-induced sensitization of cholecystokinin-and carbachol-regulated Ca2+ signaling in pancreatic acinar cells. We show that exposure of rodent acinar cells to ethanol induces protein kinase C-dependent Raf-1 kinase inhibitory protein phosphorylation, sensitization of cholecystokinin- stimulated Ca2+ signaling, and potentiation of both basal and cholecystokinin-stimulated extracellular signal-regulated kinase activation. Furthermore, we show that either suppression of Raf-1 kinase inhibitory protein expression using short hairpin RNA or gene ablation prevented the sensitizing effects of ethanol on cholecystokinin-and carbachol-stimulated Ca2+ signaling and intracellular chymotrypsin activation in pancreatic acinar cells, suggesting that the modulation of Raf-1 inhibitory protein expression may have future therapeutic utility in the prevention or treatment of alcohol-associated pancreatitis.	[Kim, Sung Ok; Ives, Kirk L.; Wang, Xiaofu; Chao, Celia; Hellmich, Mark R.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Davey, Robert A.] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA; [Hellmich, Mark R.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hellmich, MR (corresponding author), Univ Texas Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	mhellmic@utmb.edu		Davey, Robert/0000-0001-9168-2892	National Institutes of Health [P01-DK035608, 1K08CA125209-01A2]; NATIONAL CANCER INSTITUTE [K08CA125209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-DK035608 and 1K08CA125209-01A2.	Altomare E, 1996, GUT, V38, P742, DOI 10.1136/gut.38.5.742; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen LA, 2009, J BIOL CHEM, V284, P2459, DOI 10.1074/jbc.M801697200; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; Criddle DN, 2006, J GASTROEN HEPATOL, V21, pS14, DOI 10.1111/j.1440-1746.2006.04577.x; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Del Castillo-Vaquero A, 2010, INT J EXP PATHOL, V91, P114, DOI 10.1111/j.1365-2613.2009.00691.x; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Fagenholz PJ, 2007, PANCREAS, V35, P302, DOI 10.1097/MPA.0b013e3180cac24b; Fernandez-Sanchez M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-77; GATES LK, 1993, AM J PHYSIOL, V264, pG840, DOI 10.1152/ajpgi.1993.264.5.G840; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Goel R, 2004, TRENDS ENDOCRIN MET, V15, P91, DOI 10.1016/j.tem.2004.02.004; Gonzalez A, 2008, ALCOHOL, V42, P565, DOI 10.1016/j.alcohol.2008.06.005; Gorelick F, 2008, J GASTROEN HEPATOL, V23, pS37, DOI 10.1111/j.1440-1746.2007.05282.x; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; Gukovskaya AS, 2004, AM J PHYSIOL-GASTR L, V286, pG204, DOI 10.1152/ajpgi.00088.2003; Halangk W, 2004, GASTROENTEROL CLIN N, V33, P717, DOI 10.1016/j.gtc.2004.07.009; Han B, 1999, AM J PHYSIOL-CELL PH, V277, pC74, DOI 10.1152/ajpcell.1999.277.1.C74; Huang JA, 2007, AM J PHYSIOL-GASTR L, V292, pG867, DOI 10.1152/ajpgi.00326.2006; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Katz M, 1996, AM J PHYSIOL-GASTR L, V270, pG171, DOI 10.1152/ajpgi.1996.270.1.G171; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; KLOPPEL G, 1993, PANCREAS, V8, P659; KLUEPPELBERG UG, 1991, J BIOL CHEM, V266, P2403; Krause E, 1996, J BIOL CHEM, V271, P32523, DOI 10.1074/jbc.271.51.32523; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; LANGE LG, 1983, J CLIN INVEST, V72, P724, DOI 10.1172/JCI111022; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lu Z, 2003, AM J PHYSIOL-GASTR L, V285, pG822, DOI 10.1152/ajpgi.00213.2003; Lu Z, 2002, AM J PHYSIOL-GASTR L, V282, pG501, DOI 10.1152/ajpgi.00388.2001; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Lur G, 2009, CURR BIOL, V19, P1648, DOI 10.1016/j.cub.2009.07.072; Niederau C, 1999, HEPATO-GASTROENTEROL, V46, P2723; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OKONSKI MS, 1990, J CLIN INVEST, V86, P1649, DOI 10.1172/JCI114887; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Papachristou GI, 2006, AM J GASTROENTEROL, V101, P2605, DOI 10.1111/j.1572-0241.2006.00795.x; Petersen OH, 2011, CELL CALCIUM, V50, P193, DOI 10.1016/j.ceca.2011.02.010; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Petersen OH, 2008, J GASTROEN HEPATOL, V23, pS31, DOI 10.1111/j.1440-1746.2007.05281.x; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; ROSEWICZ S, 1989, GASTROENTEROLOGY, V97, P1005, DOI 10.1016/0016-5085(89)91510-2; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; Talukdar R, 2009, CLIN GASTROENTEROL H, V7, pS3, DOI 10.1016/j.cgh.2009.07.037; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Tonsi AF, 2009, WORLD J GASTROENTERO, V15, P2945, DOI 10.3748/wjg.15.2945; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Williams JA, 2010, CURR OPIN GASTROEN, V26, P478, DOI 10.1097/MOG.0b013e32833d11c6; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhou WG, 1996, J SURG RES, V60, P147, DOI 10.1006/jsre.1996.0024	66	5	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33377	33388		10.1074/jbc.M112.367656	http://dx.doi.org/10.1074/jbc.M112.367656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859298	Green Published, hybrid			2022-12-28	WOS:000309602100025
J	Permanyer, M; Ballana, E; Badia, R; Pauls, E; Clotet, B; Este, JA				Permanyer, Marc; Ballana, Ester; Badia, Roger; Pauls, Eduardo; Clotet, Bonaventura; Este, Jose A.			Trans-infection but Not Infection from within Endosomal Compartments after Cell-to-cell HIV-1 Transfer to CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSES; MEDIATED ENDOCYTOSIS; ENTRY INHIBITORS; MEMBRANE-FUSION; PLASMA-MEMBRANE; SPREAD; REPLICATION; TYPE-1; DEGRADATION	Cellular contacts between HIV-1-infected donor cells and uninfected primary CD4(+) T lymphocytes lead to virus transfer into endosomes. Recent evidence suggests that HIV particles may fuse with endosomal membranes to initiate a productive infection. To explore the role of endocytosis in the entry and replication of HIV, we evaluated the infectivity of transferred HIV particles in a cell-to-cell culture model of virus transmission. Endocytosed virus led to productive infection of cells, except when cells were cultured in the presence of the anti-gp120 mAb IgGb12, an agent that blocks virus attachment to CD4, suggesting that endocytosed virus was recycled to the outer cell surface. Confocal microscopy confirmed the colocalization of internalized virus antigen and the endosomal marker dynamin. Additionally, virus transfer, fusion, or productive infection was not blocked by dynasore, dynamin-dependent endosome-scission inhibitor, at subtoxic concentrations, suggesting that the early capture of virus into intracellular compartments did not depend on endosomal maturation. Our results suggest that endocytosis is not a mechanism of infection of primary CD4 T cells, but may serve as a reservoir capable of inducing trans-infection of cells after the release of HIV particles to the extracellular environment.	[Permanyer, Marc; Ballana, Ester; Badia, Roger; Pauls, Eduardo; Clotet, Bonaventura; Este, Jose A.] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa, Badalona 08916, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Este, JA (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa, Canyet S-N, Badalona 08916, Spain.	jaeste@irsicaixa.es	Este, Jose/B-5509-2008; Guix, Ester Ballana/R-4117-2018; Badia, Roger/T-6929-2017	Este, Jose/0000-0002-1436-5823; Badia, Roger/0000-0003-3982-7577; Pauls, Eduardo/0000-0002-2511-0711; Ballana, Ester/0000-0002-5215-7363	Spanish Ministerio de Economia y Competitividad [BFU2009-06958, SAF2010-21617-C02]; FIPSE [360783-09]; Gala contra la SIDA	Spanish Ministerio de Economia y Competitividad(Spanish Government); FIPSE; Gala contra la SIDA	This work was supported in part by the Spanish Ministerio de Economia y Competitividad Projects BFU2009-06958 and SAF2010-21617-C02, FIPSE 360783-09, and Gala contra la SIDA 2011.	Adamson CS, 2010, ANTIVIR RES, V85, P119, DOI 10.1016/j.antiviral.2009.09.009; Ballana E, 2011, J IMMUNOL, V186, P464, DOI 10.4049/jimmunol.1002693; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bosch B, 2005, ANTIMICROB AGENTS CH, V49, P4296, DOI 10.1128/AAC.49.10.4296-4304.2005; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Izquierdo-Useros N, 2011, TRAFFIC, V12, P1702, DOI 10.1111/j.1600-0854.2011.01281.x; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; KIELIAN M, 1990, MOL BIOL MED, V7, P17; Luo TC, 1996, J VIROL, V70, P1527, DOI 10.1128/JVI.70.3.1527-1534.1996; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; PAUZA CD, 1988, J CELL BIOL, V107, P959, DOI 10.1083/jcb.107.3.959; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Permanyer M, 2012, J VIROL, V86, P8773, DOI 10.1128/JVI.01044-12; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu D., 2009, PLOS PATHOG, V5	42	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32017	32026		10.1074/jbc.M112.343293	http://dx.doi.org/10.1074/jbc.M112.343293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22846998	Green Published, hybrid			2022-12-28	WOS:000309059400040
J	Watanabe, Y; Kobayashi, T; Yamamoto, H; Hoshida, H; Akada, R; Inagaki, F; Ohsumi, Y; Noda, NN				Watanabe, Yasunori; Kobayashi, Takafumi; Yamamoto, Hayashi; Hoshida, Hisashi; Akada, Rinji; Inagaki, Fuyuhiko; Ohsumi, Yoshinori; Noda, Nobuo N.			Structure-based Analyses Reveal Distinct Binding Sites for Atg2 and Phosphoinositides in Atg18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PREAUTOPHAGOSOMAL STRUCTURE; PROTEIN FAMILY; CVT PATHWAY; COMPLEX; YEAST; 3,5-BISPHOSPHATE; LOCALIZATION	Autophagy is an intracellular degradation system by which cytoplasmic materials are enclosed by an autophagosome and delivered to a lysosome/vacuole. Atg18 plays a critical role in autophagosome formation as a complex with Atg2 and phosphatidylinositol 3-phosphate (PtdIns(3) P). However, little is known about the structure of Atg18 and its recognition mode of Atg2 or PtdIns(3) P. Here, we report the crystal structure of Kluyveromyces marxianus Hsv2, an Atg18 paralog, at 2.6 angstrom resolution. The structure reveals a seven-bladed beta-propeller without circular permutation. Mutational analyses of Atg18 based on the K. marxianus Hsv2 structure suggested that Atg18 has two phosphoinositide-binding sites at blades 5 and 6, whereas the Atg2-binding region is located at blade 2. Point mutations in the loops of blade 2 specifically abrogated autophagy without affecting another Atg18 function, the regulation of vacuolar morphology at the vacuolar membrane. This architecture enables Atg18 to form a complex with Atg2 and PtdIns(3) P in parallel, thereby functioning in the formation of autophagosomes at autophagic membranes.	[Noda, Nobuo N.] Inst Microbial Chem, Shinagawa Ku, Tokyo 1410021, Japan; [Watanabe, Yasunori] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600812, Japan; [Kobayashi, Takafumi; Yamamoto, Hayashi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan; [Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Tokyo Institute of Technology; Yamaguchi University; Hokkaido University	Noda, NN (corresponding author), Inst Microbial Chem, Shinagawa Ku, Kamiosaki 3-14-23, Tokyo 1410021, Japan.	nn@bikaken.or.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Watanabe, Yasunori/0000-0002-7846-680X; Noda, Nobuo/0000-0002-6940-8069	Japan Society for the Promotion of Science (JSPS) [23687012, 10J01988, 23000015]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24113725]; Targeted Proteins Research Program; Leave a Nest Grant BioGARAGE award	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leave a Nest Grant BioGARAGE award	This work was supported in part by Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research (KAKENHI) 23687012 (to N. N. N.), 10J01988 (to Y. W.), and 23000015 (to Y. O.); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grant-in-aid for Scientific Research 24113725 (to N. N. N.) and Targeted Proteins Research Program (to F. I. and Y. O.); and a Leave a Nest Grant BioGARAGE award (to T. K.).	Amberg DC., 2005, METHODS YEAST GENETI; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kobayashi T, 2012, FEBS LETT, V586, P2473, DOI 10.1016/j.febslet.2012.06.008; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Meiling-Wesse K, 2004, J BIOL CHEM, V279, P37741, DOI 10.1074/jbc.M401066200; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2012, J BIOL CHEM, V287, P16256, DOI 10.1074/jbc.M112.348250; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, AUTOPHAGY, V4, P952, DOI 10.4161/auto.6790; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Romanyuk D, 2011, ACTA BIOCHIM POL, V58, P365; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018	40	87	90	9	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31681	31690		10.1074/jbc.M112.397570	http://dx.doi.org/10.1074/jbc.M112.397570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22851171	hybrid, Green Published			2022-12-28	WOS:000309059400010
J	Giguere, PM; Laroche, G; Oestreich, EA; Duncan, JA; Siderovski, DP				Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Duncan, Joseph A.; Siderovski, David P.			Regulation of the Subcellular Localization of the G-protein Subunit Regulator GPSM3 through Direct Association with 14-3-3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLOCO MOTIF; STRUCTURAL BASIS; PEPTIDE; ALPHA; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; ACTIVATION; PARTNERS; BETA	G-protein signaling modulator-3 (GPSM3), also known as G18 or AGS4, is a member of the G alpha(i/o)-Loco (GoLoco) motif containing proteins. GPSM3 acts through its two GoLoco motifs to exert GDP dissociation inhibitor activity over G alpha(i) subunits; recently revealed is the existence of an additional regulatory site within GPSM3 directed toward monomeric G beta subunits during their biosynthesis. Here, using in silico and proteomic approaches, we have found that GPSM3 also interacts directly with numerous members of the 14-3-3 protein family. This interaction is dependent on GPSM3 phosphorylation, creating a mode II consensus 14-3-3 binding site. 14-3-3 binding to the N-terminal disordered region of GPSM3 confers stabilization from protein degradation. The complex of GPSM3 and 14-3-3 is exclusively cytoplasmic, and both moieties mutually control their exclusion from the nucleus. Phosphorylation of GPSM3 by a proline-directed serine/threonine kinase and the resultant association of 14-3-3 is the first description of post-translational regulation of GPSM3 subcellular localization, a process that likely regulates important spatio-temporal aspects of G-protein-coupled receptor signaling modulation by GPSM3.	[Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Duncan, Joseph A.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; West Virginia University	Siderovski, DP (corresponding author), Robert C Byrd Hlth Sci Ctr, Hlth Sci Ctr 3051, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210	National Institutes of Health [R01 GM082892, R01 AI088255]; Burroughs Wellcome Fund Career Award for Medical Scientists; NIAMS Postdoctoral Fellowship from the National Institutes of Health [F32 AR057644]; Heart and Stroke Foundation of Canada; Fond de la recherche en sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIAMS Postdoctoral Fellowship from the National Institutes of Health; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fond de la recherche en sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM082892 (to D. P. S.) and R01 AI088255 (to J. A. D.). This work was also supported by a Burroughs Wellcome Fund Career Award for Medical Scientists (to J. A. D.), NIAMS Postdoctoral Fellowship F32 AR057644 (to E. A. O.) from the National Institutes of Health, and postdoctoral fellowships from the Heart and Stroke Foundation of Canada and Fond de la recherche en sante Quebec (to P. M. G. and G. L.).	Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Diez R., 2010, NEUROPROTEOMICS, P51; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Giguere PM, 2012, J BIOL CHEM, V287, P4863, DOI 10.1074/jbc.M111.311712; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sun SY, 2009, J ENDOCRINOL, V202, P327, DOI 10.1677/JOE-09-0041; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeidner Leigh C, 2011, Int J Biochem Mol Biol, V2, P318	44	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31270	31279		10.1074/jbc.M112.394379	http://dx.doi.org/10.1074/jbc.M112.394379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22843681	Green Published, hybrid			2022-12-28	WOS:000308791300039
J	Burns, KE; McAllister, FE; Schwerdtfeger, C; Mintseris, J; Cerda-Maira, F; Noens, EE; Wilmanns, M; Hubbard, SR; Melandri, F; Ovaa, H; Gygi, SP; Darwin, KH				Burns, Kristin E.; McAllister, Fiona E.; Schwerdtfeger, Carsten; Mintseris, Julian; Cerda-Maira, Francisca; Noens, Elke E.; Wilmanns, Matthias; Hubbard, Stevan R.; Melandri, Francesco; Ovaa, Huib; Gygi, Steven P.; Darwin, K. Heran			Mycobacterium tuberculosis Prokaryotic Ubiquitin-like Protein-deconjugating Enzyme Is an Unusual Aspartate Amidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOMAL ATPASE MPA; ANHYDRIDE INTERMEDIATE; CATALYZED-HYDROLYSIS; CARBOXYPEPTIDASE-A; PUPYLATION; PUP; MECHANISMS; PATHWAY; DOP; HYDROXYLAMINE	Deamidase of Pup (Dop), the prokaryotic ubiquitin-like protein (Pup)-deconjugating enzyme, is critical for the full virulence of Mycobacterium tuberculosis and is unique to bacteria, providing an ideal target for the development of selective chemotherapies. We used a combination of genetics and chemical biology to characterize the mechanism of depupylation. We identified an aspartate as a potential nucleophile in the active site of Dop, suggesting a novel protease activity to target for inhibitor development.	[Burns, Kristin E.; Cerda-Maira, Francisca; Darwin, K. Heran] NYU, Dept Microbiol, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Skirball Inst, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Dept Pharmacol, New York, NY 10016 USA; [McAllister, Fiona E.; Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Schwerdtfeger, Carsten; Melandri, Francesco] Boston Biochem, Cambridge, MA 02139 USA; [Noens, Elke E.; Wilmanns, Matthias] European Mol Biol Lab, D-22603 Hamburg, Germany; [Ovaa, Huib] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	New York University; New York University; New York University; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Netherlands Cancer Institute	Darwin, KH (corresponding author), NYU, Dept Microbiol, 550 1st Ave,MSB 236, New York, NY 10016 USA.	heran.darwin@med.nyu.edu	Noens, Elke/A-6742-2015; ovaa, huib/M-2334-2016	Hubbard, Stevan/0000-0002-2707-9383; ovaa, huib/0000-0002-0068-054X; Darwin, K Heran/0000-0002-5043-7548; Wilmanns, Matthias/0000-0002-4643-5435	National Institutes of Health [1R01AI088075, GM67945]; Irma T. Hirschl Trust; Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust; Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI088075 (to K. H. D) and GM67945 (to S. P. G.).; Supported by the Irma T. Hirschl Trust and an Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Microbiology, New York University, 550 First Ave., MSB 236, New York, NY 10016. Tel.: 212-263-2624; E-mail: heran.darwin@med.nyu.edu.	Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; BRESLOW R, 1983, P NATL ACAD SCI USA, V80, P4585, DOI 10.1073/pnas.80.14.4585; BRESLOW R, 1977, P NATL ACAD SCI USA, V74, P1303, DOI 10.1073/pnas.74.4.1303; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, CELL MICROBIOL, V12, P424, DOI 10.1111/j.1462-5822.2010.01447.x; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; CROOKS GP, 1995, J AM CHEM SOC, V117, P10791, DOI 10.1021/ja00149a001; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; Delley CL, 2012, J BIOL CHEM, V287, P7907, DOI 10.1074/jbc.M111.331124; DION HW, 1956, J AM CHEM SOC, V78, P3075, DOI 10.1021/ja01594a036; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; JENCKS WP, 1958, J AM CHEM SOC, V80, P4581, DOI 10.1021/ja01550a040; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; KAISER BL, 1969, P NATL ACAD SCI USA, V64, P36, DOI 10.1073/pnas.64.1.36; KUO LC, 1983, J MOL BIOL, V163, P63, DOI 10.1016/0022-2836(83)90030-X; Lee HC, 1998, BIOORG MED CHEM LETT, V8, P3379, DOI 10.1016/S0960-894X(98)00624-6; Lehmann C, 2004, PROTEINS, V56, P376, DOI 10.1002/prot.20103; Li J, 2000, J MOL BIOL, V299, P641, DOI 10.1006/jmbi.2000.3800; LIPMANN F, 1945, J BIOL CHEM, V161, P415; Liu JQ, 1997, J BIOL CHEM, V272, P3363, DOI 10.1074/jbc.272.6.3363; Merkx R, 2012, CHEMBIOCHEM, V13, P2056, DOI 10.1002/cbic.201200460; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Ortlund E, 2000, BIOCHEMISTRY-US, V39, P1199, DOI 10.1021/bi991797d; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; SANDER ME, 1985, BIOCHEM BIOPH RES CO, V132, P681, DOI 10.1016/0006-291X(85)91186-6; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; STELTE B, 1986, EUR J BIOCHEM, V155, P121, DOI 10.1111/j.1432-1033.1986.tb09466.x; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375	41	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37522	37529		10.1074/jbc.M112.384784	http://dx.doi.org/10.1074/jbc.M112.384784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942282	hybrid, Green Published			2022-12-28	WOS:000310588500080
J	Das, D; Samanta, D; Hasan, S; Das, A; Bhattacharya, A; Dasgupta, S; Chakrabarti, A; Ghorai, P; Das Gupta, C				Das, Debasis; Samanta, Dibyendu; Hasan, Salman; Das, Anindita; Bhattacharya, Arpita; Dasgupta, Santanu; Chakrabarti, Abhijit; Ghorai, Pradip; Das Gupta, Chanchal			Identical RNA-Protein Interactions in Vivo and in Vitro and a Scheme of Folding the Newly Synthesized Proteins by Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOME; CARBONIC-ANHYDRASE-I; EXIT TUNNEL; MOLECULAR-DYNAMICS; DOMAIN-V; CHAIN; SUBUNIT; SITE; REACTIVATION	A distinct three-dimensional shape of rRNA inside the ribosome is required for the peptidyl transfer activity of its peptidyltransferase center (PTC). In contrast, even the in vitro transcribed PTC RNA interacts with unfolded protein(s) at about five sites to let them attain their native states. We found that the same set of conserved nucleotides in the PTC interact identically with nascent and chemically unfolded proteins in vivo and in vitro, respectively. The time course of this interaction, difficult to follow in vivo, was observed in vitro. It suggested nucleation of folding of cytosolic globular proteins vectorially from hydrophilic N to hydrophobic C termini, consistent with our discovery of a regular arrangement of cumulative hydrophobic indices of the peptide segments of cytosolic proteins from N to C termini. Based on this observation, we propose a model here for the nucleation of folding of the nascent protein chain by the PTC.	[Ghorai, Pradip] Indian Inst Sci Educ & Research Kolkata, Dept Chem Sci, Nadia 741252, W Bengal, India; [Hasan, Salman; Das Gupta, Chanchal] Indian Inst Sci Educ & Research Kolkata, Dept Biol Sci, Nadia 741252, W Bengal, India; [Das, Debasis; Samanta, Dibyendu; Das, Anindita; Bhattacharya, Arpita; Das Gupta, Chanchal] Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, W Bengal, India; [Chakrabarti, Abhijit] Saha Inst Nucl Phys, Struct Genom Div, Kolkata 700064, W Bengal, India; [Dasgupta, Santanu] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Kolkata; University of Calcutta; Saha Institute of Nuclear Physics; Uppsala University	Ghorai, P (corresponding author), Indian Inst Sci Educ & Research Kolkata, Dept Chem Sci, Nadia 741252, W Bengal, India.	pradip.ghorai@gmail.com; chanchaldg2000@yahoo.com	Matyushov, Dmitry V./B-1343-2008	Matyushov, Dmitry V./0000-0002-9352-764X; Bhattacharya, Arpita/0000-0002-0252-1550	Department of Science and Technology Grant [SR/SO/BB-26/2004]; Council of Scientific and Industrial Research Grant CSIR from the Government of India [37(1213)/04/EMR-II]	Department of Science and Technology Grant; Council of Scientific and Industrial Research Grant CSIR from the Government of India	This work was supported in part by Department of Science and Technology Grant SR/SO/BB-26/2004 and Council of Scientific and Industrial Research Grant CSIR 37(1213)/04/EMR-II from the Government of India.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Amit M, 2005, FEBS LETT, V579, P3207, DOI 10.1016/j.febslet.2005.03.023; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Baldwin TO, 1999, NAT CELL BIOL, V1, pE154, DOI 10.1038/14107; Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, BIOCHEM MOL BIOL INT, V32, P315; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; Choi KM, 1998, NUCLEIC ACIDS RES, V26, P887, DOI 10.1093/nar/26.4.887; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Ellis RJ, 1997, BIOCHEM BIOPH RES CO, V238, P687, DOI 10.1006/bbrc.1997.7339; ENGSTRAND C, 1995, EUR J BIOCHEM, V229, P696, DOI 10.1111/j.1432-1033.1995.tb20516.x; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Ghosh J, 2003, MOL MICROBIOL, V48, P1679, DOI 10.1046/j.1365-2958.2003.03538.x; Gilbert RJC, 2004, MOL CELL, V14, P57, DOI 10.1016/S1097-2765(04)00163-7; Gregory ST, 1999, J MOL BIOL, V285, P1475, DOI 10.1006/jmbi.1998.2410; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jermutus L, 1998, CURR OPIN BIOTECH, V9, P534, DOI 10.1016/S0958-1669(98)80042-6; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Liu ZR, 2005, J MOL BIOL, V349, P872, DOI 10.1016/j.jmb.2005.03.084; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Mohanty AK, 1998, J BIOSCIENCES, V23, P235, DOI 10.1007/BF02720025; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Petrone PM, 2008, P NATL ACAD SCI USA, V105, P16549, DOI 10.1073/pnas.0801795105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Rodriguez-Larrea D, 2006, BIOPHYS J, V91, pL48, DOI 10.1529/biophysj.106.087932; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Sessions RB, 2004, J MOL BIOL, V343, P1125, DOI 10.1016/j.jmb.2004.08.105; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P5931, DOI 10.1073/pnas.1103011108; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YONATH A, 1992, ANNU REV BIOPH BIOM, V21, P77, DOI 10.1146/annurev.biophys.21.1.77	49	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37508	37521		10.1074/jbc.M112.396127	http://dx.doi.org/10.1074/jbc.M112.396127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932895	Green Published, hybrid			2022-12-28	WOS:000310588500079
J	Douse, CH; Green, JL; Salgado, PS; Simpson, PJ; Thomas, JC; Langsley, G; Holder, AA; Tate, EW; Cota, E				Douse, Christopher H.; Green, Judith L.; Salgado, Paula S.; Simpson, Peter J.; Thomas, Jemima C.; Langsley, Gordon; Holder, Anthony A.; Tate, Edward W.; Cota, Ernesto			Regulation of the Plasmodium Motor Complex PHOSPHORYLATION OF MYOSIN A TAIL-INTERACTING PROTEIN (MTIP) LOOSENS ITS GRIP ON MyoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ERYTHROCYTE INVASION; TOXOPLASMA-GONDII; GLIDING MOTILITY; NMR-SPECTROSCOPY; FALCIPARUM; PARASITE; EXPRESSION; ASSIGNMENT; SYSTEM	The interaction between the C-terminal tail of myosin A (MyoA) and its light chain, myosin A tail domain interacting protein (MTIP), is an essential feature of the conserved molecular machinery required for gliding motility and cell invasion by apicomplexan parasites. Recent data indicate that MTIP Ser-107 and/or Ser-108 are targeted for intracellular phosphorylation. Using an optimized MyoA tail peptide to reconstitute the complex, we show that this region of MTIP is an interaction hotspot using x-ray crystallography and NMR, and S107E and S108E mutants were generated to mimic the effect of phosphorylation. NMR relaxation experiments and other biophysical measurements indicate that the S108E mutation serves to break the tight clamp around the MyoA tail, whereas S107E has a smaller but measurable impact. These data are consistent with physical interactions observed between recombinant MTIP and native MyoA from Plasmodium falciparum lysates. Taken together these data support the notion that the conserved interactions between MTIP and MyoA may be specifically modulated by this post-translational modification.	[Douse, Christopher H.; Tate, Edward W.; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England; [Douse, Christopher H.; Salgado, Paula S.; Simpson, Peter J.; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Douse, Christopher H.; Thomas, Jemima C.; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Green, Judith L.; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Langsley, Gordon] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France	Imperial College London; Imperial College London; Imperial College London; MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tate, EW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London SW7 2AZ, England.	e.tate@imperial.ac.uk; e.cota@imperial.ac.uk	Salgado, Paula/AAR-5782-2021; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Tate, Edward/0000-0003-2213-5814; Simpson, Pete/0000-0002-2679-9303; Salgado, Paula S./0000-0002-2820-3024; Douse, Christopher/0000-0002-1604-8944; Green, Judith/0000-0001-6825-9404	Royal Society [2008/R1]; UK Medical Research Council [U117532067]; Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish; Medical Research Council [MC_U117532067] Funding Source: researchfish; BBSRC [BB/D02014X/1] Funding Source: UKRI; MRC [MC_U117532067] Funding Source: UKRI	Royal Society(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Royal Society Grant 2008/R1 (to E. W. T. and E. C.) and UK Medical Research Council Grant U117532067 (to A. A. H.).; Recipient of an Institute of Chemical Biology Engineering and Physical Sciences Research Council Doctoral Training Centre MRes/Ph.D. studentship (to C. H. D.).; Recipient of an Engineering and Physical Sciences Research Council Collaborative Awards in Science and Engineering studentship award (to J. C. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmotte A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2004, J BIOMOL NMR, V30, P25, DOI 10.1023/B:JNMR.0000042955.14647.77; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kortagere S, 2010, J CHEM INF MODEL, V50, P840, DOI 10.1021/ci100039k; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Thomas JC, 2010, MOL BIOSYST, V6, P494, DOI 10.1039/b922093c; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WISHART DS, 1994, J BIOMOL NMR, V4, P171	45	20	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36968	36977		10.1074/jbc.M112.379842	http://dx.doi.org/10.1074/jbc.M112.379842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932904	Green Published, hybrid			2022-12-28	WOS:000310588500032
J	Kotani, N; Ishiura, Y; Yamashita, R; Ohnishi, T; Honke, K				Kotani, Norihiro; Ishiura, Yoshihito; Yamashita, Ryusuke; Ohnishi, Tomoko; Honke, Koichi			Fibroblast Growth Factor Receptor 3 (FGFR3) Associated with the CD20 Antigen Regulates the Rituximab-induced Proliferation Inhibition in B-cell Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTI-CD20 MONOCLONAL-ANTIBODY; MULTIPLE-MYELOMA; BLADDER-CANCER; EXPRESSION; APOPTOSIS; MUTATION; THERAPY; KINASE; CHEMOIMMUNOTHERAPY	Rituximab is reported to inhibit the proliferation of lymphoma cells through an unknown CD20-mediated signal transduction pathway. Herein, we investigated cell surface molecules involved in the CD20-mediated signal transduction pathway by using a recently developed technique named enzyme-mediated activation of radical sources. Using this method, we found that under stimulation with rituximab and another anti-CD20 antibody B-Ly1, CD20 was physically associated with fibroblast growth factor receptor 3 (FGFR3) as well as some other receptor tyrosine kinases in Raji cells. However, under stimulation with a noncytotoxic anti-CD20 antibody 2H7, CD20 was not associated with FGFR3 but with the PDGF receptor beta. When the tyrosine kinase activity of FGFR3 was inhibited by the chemical inhibitor PD173074 or an siRNA knockdown strategy, the proliferation inhibition by rituximab was attenuated, indicating that FGFR3 participates in the rituximab-dependent signal transduction pathway leading to proliferation inhibition. These observations raise the possibility that concomitant targeted therapy toward FGFR3 might improve the efficacy and safety of the rituximab therapy.	[Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Ishiura, Yoshihito; Yamashita, Ryusuke; Ohnishi, Tomoko; Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi 7838505, Japan; [Yamashita, Ryusuke] Kochi Univ, Sch Med, Ctr Promote Creat Med Educ, Nankoku, Kochi 7838505, Japan; [Ishiura, Yoshihito] Osaka Kouseinenkin Hosp, Dept Pediat, Osaka 5530003, Japan	Kochi University; Saitama Medical University; Kochi University; Kochi University; Kochi University	Honke, K (corresponding author), Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi 7838505, Japan.	khonke@kochi-u.ac.jp		Kotani, Norihiro/0000-0003-3739-6478				Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chang H, 2005, BLOOD, V106, P353, DOI 10.1182/blood-2005-01-0033; Chen J, 2005, ONCOGENE, V24, P8259, DOI 10.1038/sj.onc.1208989; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Cragg MS, 1999, CURR OPIN IMMUNOL, V11, P541, DOI 10.1016/S0952-7915(99)00010-2; Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268; Deans JP, 1998, J BIOL CHEM, V273, P344, DOI 10.1074/jbc.273.1.344; Deans JP, 2002, IMMUNOLOGY, V107, P176, DOI 10.1046/j.1365-2567.2002.01495.x; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Jang JH, 2001, CANCER RES, V61, P3541; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Li ZH, 2001, BLOOD, V97, P2413, DOI 10.1182/blood.V97.8.2413; MALONEY DG, 1994, BLOOD, V84, P2457; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; PRESS OW, 1987, BLOOD, V69, P584; REFF ME, 1994, BLOOD, V83, P435; Sharkey RM, 2011, MOL CANCER THER, V10, P1072, DOI 10.1158/1535-7163.MCT-11-0115; Stebbings R, 2009, CURR OPIN BIOTECH, V20, P673, DOI 10.1016/j.copbio.2009.10.002; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125; Yamashita R, 2011, J BIOCHEM, V149, P347, DOI 10.1093/jb/mvq148; Zhang Y, 2005, INT J CANCER, V117, P166, DOI 10.1002/ijc.21145	30	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37109	37118		10.1074/jbc.M112.404178	http://dx.doi.org/10.1074/jbc.M112.404178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932894	Green Published, hybrid			2022-12-28	WOS:000310588500045
J	Newington, JT; Rappon, T; Albers, S; Wong, DY; Rylett, RJ; Cumming, RC				Newington, Jordan T.; Rappon, Tim; Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane; Cumming, Robert C.			Overexpression of Pyruvate Dehydrogenase Kinase 1 and Lactate Dehydrogenase A in Nerve Cells Confers Resistance to Amyloid beta and Other Toxins by Decreasing Mitochondrial Respiration and Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; A-BETA; AEROBIC GLYCOLYSIS; SUPEROXIDE-DISMUTASE; BINDING-SITES; PROTEIN; CANCER; STAUROSPORINE; METABOLISM	We previously demonstrated that nerve cell lines selected for resistance to amyloid beta (A beta) peptide exhibit elevated aerobic glycolysis in part due to increased expression of pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA). Here, we show that overexpression of either PDK1 or LDHA in a rat CNS cell line (B12) confers resistance to A beta and other neurotoxins. Treatment of A beta-sensitive cells with various toxins resulted in mitochondrial hyperpolarization, immediately followed by rapid depolarization and cell death, events accompanied by increased production of cellular reactive oxygen species (ROS). In contrast, cells expressing either PDK1 or LDHA maintained a lower mitochondrial membrane potential and decreased ROS production with or without exposure to toxins. Additionally, PDK1- and LDHA-overexpressing cells exhibited decreased oxygen consumption but maintained levels of ATP under both normal culture conditions and following A beta treatment. Interestingly, immunoblot analysis of wild type mouse primary cortical neurons treated with A beta or cortical tissue extracts from 12-month-old APPswe/PS1dE9 transgenic mice showed decreased expression of LDHA and PDK1 when compared with controls. Additionally, post-mortem brain extracts from patients with Alzheimer disease exhibited a decrease in PDK1 expression compared with nondemented patients. Collectively, these findings indicate that key Warburg effect enzymes play a central role in mediating neuronal resistance to A beta or other neurotoxins by decreasing mitochondrial activity and subsequent ROS production. Maintenance of PDK1 or LDHA expression in certain regions of the brain may explain why some individuals tolerate high levels of A beta deposition without developing Alzheimer disease.	[Newington, Jordan T.; Rappon, Tim; Cumming, Robert C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane] Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Albers, Shawn; Wong, Daisy Y.; Rylett, R. Jane] Robarts Res Inst, Mol Brain Res Grp, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Cumming, RC (corresponding author), Univ Western Ontario, Dept Biol, 1151 Richmond St N, London, ON N6A 5B7, Canada.	rcummin5@uwo.ca	Cumming, Robert/G-2185-2010; Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599	Natural Sciences and Engineering Research Council of Canada Grant [355803-2008]; Scottish Rite Charitable Foundation Grant [11103]; Canada Foundation for Innovation Grant [22167]; Canadian Institutes of Health Research Grant [115135]; Alzheimer Society of London; Alzheimer Society of Middlesex; Ontario Graduate Scholarships in Science and Technology	Natural Sciences and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Scottish Rite Charitable Foundation Grant; Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of London; Alzheimer Society of Middlesex; Ontario Graduate Scholarships in Science and Technology	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant 355803-2008 (to R. C. C.), Scottish Rite Charitable Foundation Grant 11103 (to R. C. C.), Canada Foundation for Innovation Grant 22167 (to R. C. C.), and Canadian Institutes of Health Research Grant 115135 (to R. J. R.).; Supported by the Alzheimer Society of London and Middlesex and Ontario Graduate Scholarships in Science and Technology.	Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V171, P189, DOI 10.1016/0006-291X(90)91375-3; Hynes J, 2012, METHODS MOL BIOL, V810, P59, DOI 10.1007/978-1-61779-382-0_4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Newington JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019191; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poisnel G, 2012, NEUROBIOL AGING, V33, P1995, DOI 10.1016/j.neurobiolaging.2011.09.026; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Powers WJ, 1998, J CEREBR BLOOD F MET, V18, P632, DOI 10.1097/00004647-199806000-00005; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sagara Y, 1996, J NEUROSCI, V16, P497; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	58	69	76	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37245	37258		10.1074/jbc.M112.366195	http://dx.doi.org/10.1074/jbc.M112.366195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948140	hybrid, Green Published			2022-12-28	WOS:000310588500057
J	Hasan, NM; Gupta, A; Polishchuk, E; Yu, CH; Polishchuk, R; Dmitriev, OY; Lutsenko, S				Hasan, Nesrin M.; Gupta, Arnab; Polishchuk, Elena; Yu, Corey H.; Polishchuk, Roman; Dmitriev, Oleg Y.; Lutsenko, Svetlana			Molecular Events Initiating Exit of a Copper-transporting ATPase ATP7B from the Trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; N-TERMINAL DOMAIN; MENKES DISEASE; FUNCTIONAL EXPRESSION; DEPENDENT INTERACTION; TRAFFICKING; BINDING; GENE; SIGNALS; PHOSPHORYLATION	The copper-transporting ATPase ATP7B has a dual intracellular localization: the trans-Golgi network (TGN) and cytosolic vesicles. Changes in copper levels, kinase-mediated phosphorylation, and mutations associated with Wilson disease alter the steady-state distribution of ATP7B between these compartments. To identify a primary molecular event that triggers ATP7B exit from the TGN, we characterized the folding, activity, and trafficking of the ATP7B variants with mutations within the regulatory N-terminal domain (N-ATP7B). We found that structural changes disrupting the inter-domain contacts facilitate ATP7B exit from the TGN. Mutating Ser-340/341 in the N-ATP7B individually or together to Ala, Gly, Thr, or Asp produced active protein and shifted the steady-state localization of ATP7B to vesicles, independently of copper levels. The Ser340/341G mutant had a lower kinase-mediated phosphorylation under basal conditions and no copper-dependent phosphorylation. Thus, negative charges introduced by copper-dependent phosphorylation are not obligatory for ATP7B trafficking from the TGN. The Ser340/341A mutation did not alter the overall fold of N-ATP7B, but significantly decreased interactions with the nucleotide-binding domain, mimicking consequences of copper binding to N-ATP7B. We propose that structural changes that specifically alter the inter-domain contacts initiate exit of ATP7B from the TGN, whereas increased phosphorylation may be needed to maintain an open interface between the domains.	[Polishchuk, Elena; Polishchuk, Roman] Telethon Inst Genet & Med, Naples, Italy; [Hasan, Nesrin M.; Gupta, Arnab; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Polishchuk, Elena] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Yu, Corey H.; Dmitriev, Oleg Y.] Univ Saskatchewan, Saskatoon, SK S7N 5E5, Canada	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Johns Hopkins University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Saskatchewan	Lutsenko, S (corresponding author), 725N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Dmitriev, Oleg/AAB-7830-2019		National Institutes of Health [DK071865, P01GM067166]; Telethon [GTF08001, TRPCB4TELD]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071865 and P01GM067166 (to S. L.) and by Telethon Grants GTF08001 and TRPCB4TELD (to R. P.).	Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Materia S, 2012, J BIOL CHEM, V287, P2485, DOI 10.1074/jbc.M111.302216; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	34	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36041	36050		10.1074/jbc.M112.370403	http://dx.doi.org/10.1074/jbc.M112.370403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898812	Green Published, hybrid			2022-12-28	WOS:000310364000026
J	Singh, NK; Kundumani-Sridharan, V; Kumar, S; Verma, SK; Kotla, S; Mukai, H; Heckle, MR; Rao, GN				Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Kumar, Sanjay; Verma, Shailendra K.; Kotla, Sivareddy; Mukai, Hideyuki; Heckle, Mark R.; Rao, Gadiparthi N.			Protein Kinase N1 Is a Novel Substrate of NFATc1-mediated Cyclin D1-CDK6 Activity and Modulates Vascular Smooth Muscle Cell Division and Migration Leading to Inward Blood Vessel Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ACTIVATED T-CELLS; GROWTH-FACTOR RECEPTOR; MONOCYTE CHEMOATTRACTANT; NUCLEAR FACTOR; NEOINTIMA FORMATION; TRANSCRIPTION; INJURY; RHO; PHOSPHORYLATION	Toward understanding the mechanisms of vascular wall remodeling, here we have studied the role of NFATc1 in MCP-1-induced human aortic smooth muscle cell (HASMC) growth and migration and injury-induced rat aortic wall remodeling. We have identified PKN1 as a novel downstream target of NFATc1-cyclin D1/CDK6 activity in mediating vascular wall remodeling following injury. MCP-1, a potent chemoattractant protein, besides enhancing HASMC motility, also induced its growth, and these effects require NFATc1-dependent cyclin D1 expression and CDK4/6 activity. In addition, MCP-1 induced PKN1 activation in a sustained and NFATc1-cyclin D1/CDK6-dependent manner. Furthermore, PKN1 activation is required for MCP-1-induced HASMC growth and migration. Balloon injury induced PKN1 activation in NFAT-dependent manner and pharmacological or dominant negative mutant-mediated blockade of PKN1 function or siRNA-mediated down-regulation of its levels substantially suppressed balloon injury-induced smooth muscle cell migration and proliferation resulting in reduced neointima formation. These novel findings suggest that PKN1 plays a critical role in vascular wall remodeling, and therefore, it could be a promising new target for the next generation of drugs for vascular diseases, particularly restenosis following angioplasty, stent implantation, or vein grafting.	[Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Kumar, Sanjay; Verma, Shailendra K.; Kotla, Sivareddy; Heckle, Mark R.; Rao, Gadiparthi N.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Mukai, Hideyuki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan	University of Tennessee System; University of Tennessee Health Science Center; Kobe University	Rao, GN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Verma, Shailendra Kumar/GYU-7804-2022; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016	Verma, Shailendra Kumar/0000-0001-9142-3022; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; kumar, sanjay/0000-0002-2678-3387; Singh, Nikhlesh/0000-0002-3665-6023; Mukai, Hideyuki/0000-0002-0167-8695; kotla, sivareddy/0000-0001-7516-7647	National Institutes of Health from the NHLBI [HL069908, HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103575, R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069908 and HL103575 from the NHLBI (to G. N. R.).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chow W, 2008, EXP CELL RES, V314, P2919, DOI 10.1016/j.yexcr.2008.07.010; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; IKEDA U, 1995, AM J PHYSIOL-HEART C, V268, pH1021, DOI 10.1152/ajpheart.1995.268.3.H1021; Isagawa T, 2005, MOL CARCINOGEN, V43, P1, DOI 10.1002/mc.20087; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; Standaert M, 1998, J BIOL CHEM, V273, P7470, DOI 10.1074/jbc.273.13.7470; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Turner EC, 2011, J BIOL CHEM, V286, P15440, DOI 10.1074/jbc.M110.181180; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	51	32	34	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36291	36304		10.1074/jbc.M112.361220	http://dx.doi.org/10.1074/jbc.M112.361220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22893700	Green Published, hybrid			2022-12-28	WOS:000310364000050
J	Denisova, OV; Kakkola, L; Feng, L; Stenman, J; Nagaraj, A; Lampe, J; Yadav, B; Aittokallio, T; Kaukinen, P; Ahola, T; Kuivanen, S; Vapalahti, O; Kantele, A; Tynell, J; Julkunen, I; Kallio-Kokko, H; Paavilainen, H; Hukkanen, V; Elliott, RM; De Brabander, JK; Saelens, X; Kainov, DE				Denisova, Oxana V.; Kakkola, Laura; Feng, Lin; Stenman, Jakob; Nagaraj, Ashwini; Lampe, Johanna; Yadav, Bhagwan; Aittokallio, Tero; Kaukinen, Pasi; Ahola, Tero; Kuivanen, Suvi; Vapalahti, Olli; Kantele, Anu; Tynell, Janne; Julkunen, Ilkka; Kallio-Kokko, Hannimari; Paavilainen, Henrik; Hukkanen, Veijo; Elliott, Richard M.; De Brabander, Jef K.; Saelens, Xavier; Kainov, Denis E.			Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; CELLS; NUCLEOSIDE; EXPRESSION; PROTEINS; AGENTS; MCL-1	Influenza A viruses (IAVs) infect humans and cause significant morbidity and mortality. Different treatment options have been developed; however, these were insufficient during recent IAV outbreaks. Here, we conducted a targeted chemical screen in human nonmalignant cells to validate known and search for novel host-directed antivirals. The screen validated saliphenylhalamide (SaliPhe) and identified two novel anti-IAV agents, obatoclax and gemcitabine. Further experiments demonstrated that Mcl-1 (target of obatoclax) provides a novel host target for IAV treatment. Moreover, we showed that obatoclax and SaliPhe inhibited IAV uptake and gemcitabine suppressed viral RNA transcription and replication. These compounds possess broad spectrum antiviral activity, although their antiviral efficacies were virus-, cell type-, and species-specific. Altogether, our results suggest that phase II obatoclax, investigational SaliPhe, and FDA/EMEA-approved gemcitabine represent potent antiviral agents.	[Denisova, Oxana V.; Kakkola, Laura; Stenman, Jakob; Nagaraj, Ashwini; Lampe, Johanna; Yadav, Bhagwan; Aittokallio, Tero; Kainov, Denis E.] FIMM, Inst Mol Med Finland, FI-00290 Helsinki, Finland; [Feng, Lin; Stenman, Jakob] Minerva Fdn, Inst Med Res, FI-00290 Helsinki, Finland; [Kaukinen, Pasi; Ahola, Tero] Inst Biotechnol, FI-00290 Helsinki, Finland; [Kuivanen, Suvi; Vapalahti, Olli] Haartman Inst, FI-00290 Helsinki, Finland; [Vapalahti, Olli; Kantele, Anu] Helsinki Univ Hosp Lab, FI-00290 Helsinki, Finland; [Tynell, Janne; Julkunen, Ilkka] Natl Inst Hlth & Welf, FI-00290 Helsinki, Finland; [Kallio-Kokko, Hannimari] Inst Clin Med, FI-00290 Helsinki, Finland; [Paavilainen, Henrik; Hukkanen, Veijo] Univ Turku, Dept Virol, FI-20520 Turku, Finland; [Elliott, Richard M.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [De Brabander, Jef K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Saelens, Xavier] VIB, Dept Mol Biomed Res, B-9000 Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Finland National Institute for Health & Welfare; University of Turku; University of St Andrews; University of Texas System; University of Texas Southwestern Medical Center Dallas; Flanders Institute for Biotechnology (VIB); Ghent University	Kainov, DE (corresponding author), Inst Mol Med Finland FIMM, Tukholmankatu 8, Helsinki 00290, Finland.	denis.kainov@helsinki.fi	Kantele, Anu/AAS-4131-2021; Denisova, Oxana/AAY-9569-2021; Denisova, Oxana V/I-6471-2012; kainov, denis/I-5526-2019; Denisova, Oxana/M-4328-2019; Yadav, Bhagwan/M-2921-2015; Saelens, Xavier/N-5728-2015; Aittokallio, Tero/B-6583-2009; Denisova, Oxana/X-1906-2019	Kantele, Anu/0000-0002-0004-1000; kainov, denis/0000-0001-7716-6955; Denisova, Oxana/0000-0002-7041-3842; Yadav, Bhagwan/0000-0002-3502-9335; Aittokallio, Tero/0000-0002-0886-9769; Stenman, Jakob/0000-0001-9543-3957; Julkunen, Ilkka/0000-0003-0165-2564; Tynell, Janne/0000-0001-6930-5230; , Xavier/0000-0002-3861-6965; Vapalahti, Olli/0000-0003-2270-6824	National Institutes of Health [CA90349, CA95471]; Jane and Aatos Erkko Foundation; Centre for International Mobility (CIMO); Academy of Finland [138644, 255852]; Robert A. Welch Foundation [I-1422]; NATIONAL CANCER INSTITUTE [R01CA090349, P01CA095471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane and Aatos Erkko Foundation; Centre for International Mobility (CIMO); Academy of Finland(Academy of Finland); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA90349 and CA95471. This work was also supported by the Jane and Aatos Erkko Foundation, Centre for International Mobility (CIMO), the Academy of Finland Grants 138644 and 255852, and Robert A. Welch Foundation Grant I-1422.	Bajwa N, 2012, EXPERT OPIN THER PAT, V22, P37, DOI 10.1517/13543776.2012.644274; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Chen KF, 2012, CANCER LETT, V321, P27, DOI 10.1016/j.canlet.2012.03.023; Dudek SE, 2010, J VIROL, V84, P9439, DOI 10.1128/JVI.00533-10; Feng L, 2012, BIOTECHNIQUES, V52, P263, DOI 10.2144/0000113842; Gesto DS, 2012, CURR MED CHEM, V19, P1076; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Guse K, 2010, J VIROL, V84, P856, DOI 10.1128/JVI.00692-09; Heikkila O, 2009, J GEN VIROL, V90, P197, DOI 10.1099/vir.0.004838-0; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Meneghesso S, 2012, ANTIVIR RES, V94, P35, DOI 10.1016/j.antiviral.2012.01.007; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Muller KH, 2012, TRENDS PHARMACOL SCI, V33, P89, DOI 10.1016/j.tips.2011.10.004; Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Rosebeck S, 2011, VIROLOGY, V417, P293, DOI 10.1016/j.virol.2011.06.010; Sane J, 2012, J INFECT DIS, V206, P407, DOI 10.1093/infdis/jis358; Schneider J, 2009, J VIROL, V83, P701, DOI 10.1128/JVI.01858-08; SCHWARZ AJF, 1962, AM J DIS CHILD, V103, P386, DOI 10.1001/archpedi.1962.02080020398042; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11; Venticinque L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-37; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Weinheimer V.K., 2012, J INFECT DI IN PRESS	29	67	69	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35324	35332		10.1074/jbc.M112.392142	http://dx.doi.org/10.1074/jbc.M112.392142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910914	Green Published, hybrid			2022-12-28	WOS:000309968000041
J	Morimatsu, K; Wu, Y; Kowalczykowski, SC				Morimatsu, Katsumi; Wu, Yun; Kowalczykowski, Stephen C.			RecFOR Proteins Target RecA Protein to a DNA Gap with Either DNA or RNA at the 5 ' Terminus IMPLICATION FOR REPAIR OF STALLED REPLICATION FORKS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECF; BINDING-PROTEIN; GENETIC-RECOMBINATION; HOMOLOGOUS RECOMBINATION; SOS RESPONSE; SSB PROTEIN; MUTANT; INDUCTION; TRIPHOSPHATE	The repair of single-stranded gaps in duplex DNA by homologous recombination requires the proteins of the RecF pathway. The assembly of RecA protein onto gapped DNA (gDNA) that is complexed with the single-stranded DNA-binding protein is accelerated by the RecF, RecO, and RecR (RecFOR) proteins. Here, we show the RecFOR proteins specifically target RecA protein to gDNA even in the presence of a thousand-fold excess of single-stranded DNA (ssDNA). The binding constant of RecF protein, in the presence of the RecOR proteins, to the junction of ssDNA and dsDNA within a gap is 1-2 nM, suggesting that a few RecF molecules in the cell are sufficient to recognize gDNA. We also found that the nucleation of a RecA filament on gDNA in the presence of the RecFOR proteins occurs at a faster rate than filament elongation, resulting in a RecA nucleoprotein filament on ssDNA for 1000-2000 nucleotides downstream (5' -> 3') of the junction with duplex DNA. Thus, RecA loading by RecFOR is localized to a region close to a junction. RecFOR proteins also recognize RNA at the 5'-end of an RNA-DNA junction within an ssDNA gap, which is compatible with their role in the repair of lagging strand gaps at stalled replication forks.	[Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Morimatsu, Katsumi/G-5029-2013		National Institutes of Health [GM62653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62653 (to S. C. K.).	Bianco P R, 1998, Front Biosci, V3, pD570; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; ENNIS DG, 1987, GENETICS, V115, P11; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GOLUB EI, 1983, P NATL ACAD SCI-BIOL, V80, P1401, DOI 10.1073/pnas.80.5.1401; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; Makharashvili N, 2009, J BIOL CHEM, V284, P1425, DOI 10.1074/jbc.M806378200; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; MORIMATSU K, 1995, EUR J BIOCHEM, V228, P779, DOI 10.1111/j.1432-1033.1995.0779m.x; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SILVER MS, 1983, BIOCHEMISTRY-US, V22, P2860, DOI 10.1021/bi00281a014; THOMS B, 1987, J BACTERIOL, V169, P1731, DOI 10.1128/jb.169.4.1731-1736.1987; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; URBANKE C, 1990, BIOCHEMISTRY-US, V29, P1744, DOI 10.1021/bi00459a012; VOLKERT MR, 1987, MUTAT RES, V184, P181, DOI 10.1016/0167-8817(87)90015-0; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; WANG TCV, 1986, J BACTERIOL, V168, P940, DOI 10.1128/jb.168.2.940-946.1986; WANG TCV, 1984, J BACTERIOL, V158, P727, DOI 10.1128/JB.158.2.727-729.1984; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	45	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35621	35630		10.1074/jbc.M112.397034	http://dx.doi.org/10.1074/jbc.M112.397034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902627	hybrid, Green Published			2022-12-28	WOS:000309968000074
J	Mukherjee, S; Sen Santara, S; Das, S; Bose, M; Roy, J; Adak, S				Mukherjee, Supratim; Sen Santara, Sumit; Das, Shantanabha; Bose, Moumita; Roy, Jayasree; Adak, Subrata			NAD(P)H Cytochrome b(5) Oxidoreductase Deficiency in Leishmania major Results in Impaired Linoleate Synthesis Followed by Increased Oxidative Stress and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; RAT-LIVER MICROSOMES; APOPTOSIS-LIKE DEATH; DONOVANI PROMASTIGOTES; ASCORBATE-PEROXIDASE; LONG-CHAIN; AFRICAN TRYPANOSOMES; GENE-TRANSCRIPTION; SULFITE OXIDASE; DEFINED MEDIA	NAD(P)H cytochrome b(5) oxidoreductase (Ncb5or), comprising cytochrome b(5) and cytochrome b(5) reductase domains, is widely distributed in eukaryotic organisms. Although Ncb5or plays a crucial role in lipid metabolism of mice, so far no Ncb5or gene has been reported in the unicellular parasitic protozoa Leishmania species. We have cloned, expressed, and characterized Ncb5or gene from Leishmania major. Steady state catalysis and spectral studies show that NADH can quickly reduce the ferric state of the enzyme to the ferrous state and is able to donate an electron(s) to external acceptors. To elucidate its exact physiological role in Leishmania, we attempted to create NAD(P) H cytochrome b(5) oxidoreductase from L. major (LmNcb5or) knock-out mutants by targeted gene replacement technique. A free fatty acid profile in knock-out (KO) cells reveals marked deficiency in linoleate and linolenate when compared with wild type (WT) or overexpressing cells. KO culture has a higher percentage of dead cells compared with both WT and overexpressing cells. Increased O-2 uptake, uncoupling and ATP synthesis, and loss of mitochondrial membrane potential are evident in KO cells. Flow cytometric analysis reveals the presence of a higher concentration of intracellular H2O2, indicative of increased oxidative stress in parasites lacking LmNcb5or. Cell death is significantly reduced when the KO cells are pretreated with BSA bound linoleate. Real time PCR studies demonstrate a higher Delta 12 desaturase, superoxide dismutase, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA with a concomitant fall in Delta 9 desaturase mRNA expression in LmNcb5or null cell line. Together these findings suggest that decreased linoleate synthesis, and increased oxidative stress and apoptosis are the major consequences of LmNcb5or deficiency in Leishmania.	[Mukherjee, Supratim; Sen Santara, Sumit; Das, Shantanabha; Bose, Moumita; Roy, Jayasree; Adak, Subrata] Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), 4 Raja SC Mullick Rd, Kolkata 700032, India.	adaks@iicb.res.in	sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; sen santara, sumit/0000-0003-2881-0825; MUKHERJEE, SUPRATIM/0000-0002-0356-8879	Council of Scientific and Industrial Research (CSIR) [NWP 0038]; UGC; CSIR-SPM Fellowships	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); CSIR-SPM Fellowships	This work was supported by Council of Scientific and Industrial Research (CSIR) Project NWP 0038, UGC Fellowships (to S. M.), CSIR Fellowships (to S. D., M. B.), and CSIR-SPM Fellowships (to S. S. S.).	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alloatti A, 2011, MOL BIOCHEM PARASIT, V175, P126, DOI 10.1016/j.molbiopara.2010.10.006; Alloatti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014239; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi JY, 1996, J BIOL CHEM, V271, P3581; Clarke SD, 2001, AM J PHYSIOL-GASTR L, V281, pG865, DOI 10.1152/ajpgi.2001.281.4.G865; Das M, 2001, J CELL SCI, V114, P2461; Dolai S, 2007, BBA-GEN SUBJECTS, V1770, P247, DOI 10.1016/j.bbagen.2006.10.001; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUKUSHIMA H, 1981, J BIOL CHEM, V256, P4822; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Hermesh O, 1998, J BIOL CHEM, V273, P3937, DOI 10.1074/jbc.273.7.3937; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HYDE GE, 1991, J BIOL CHEM, V266, P23542; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; KEYES SR, 1980, J BIOL CHEM, V255, P1357; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; Loughran PA, 2001, ARCH BIOCHEM BIOPHYS, V385, P311, DOI 10.1006/abbi.2000.2136; LUVISETTO S, 1987, BIOCHEMISTRY-US, V26, P7332, DOI 10.1021/bi00397a021; LUVISETTO S, 1990, J BIOENERG BIOMEMBR, V22, P635, DOI 10.1007/BF00809068; MCCARTHYBURKE C, 1991, EXP PARASITOL, V73, P385, DOI 10.1016/0014-4894(91)90112-A; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; Oshino N., 1980, HEPATIC CYTOCHROME P, P407; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; PALTAUF F, 1974, J BIOL CHEM, V249, P2661; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; PIETROBON D, 1987, BIOCHEMISTRY-US, V26, P7339, DOI 10.1021/bi00397a022; PUGH EL, 1977, J BIOL CHEM, V252, P68; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; ROTTENBERG H, 1986, BIOCHEMISTRY-US, V25, P1747, DOI 10.1021/bi00355a045; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1018, P1, DOI 10.1016/0005-2728(90)90103-B; Rudolph MJ, 2003, ACTA CRYSTALLOGR D, V59, P1183, DOI 10.1107/S0907444903009934; Santhamma KR, 1995, MOL BIOCHEM PARASIT, V75, P43, DOI 10.1016/0166-6851(95)02510-3; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; STEIGER RF, 1977, J PROTOZOOL, V24, P437, DOI 10.1111/j.1550-7408.1977.tb04771.x; STRITTMATTER P, 1982, J BIOL CHEM, V257, P1883; THIEDE MA, 1986, J BIOL CHEM, V261, P3230; Tripodi K. E., 2011, ENZYME RES; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; WOJTCZAK L, 1976, J BIOENERG BIOMEMBR, V8, P293; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Xu M, 2011, J BIOL CHEM, V286, P11141, DOI 10.1074/jbc.M110.196543; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	72	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34992	35003		10.1074/jbc.M112.389338	http://dx.doi.org/10.1074/jbc.M112.389338			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923617	Green Published, hybrid			2022-12-28	WOS:000309968000012
J	Haferkamp, B; Zhang, HH; Lin, YT; Yeap, XY; Bunce, A; Sharp, J; Xiang, JL				Haferkamp, Bonnie; Zhang, Honghong; Lin, Yuting; Yeap, Xinyi; Bunce, Alex; Sharp, Juanita; Xiang, Jialing			Bax Delta 2 Is a Novel Bax Isoform Unique to Microsatellite Unstable Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET GENE-MUTATIONS; PROGRAMMED CELL-DEATH; BCL-2 FAMILY-MEMBERS; COLON-CANCER; FRAMESHIFT MUTATIONS; MUTATOR PHENOTYPE; POOR-PROGNOSIS; CYTOCHROME-C; PROTEIN BAX; IN-VIVO	The pro-death Bcl-2 family protein and tumor suppressor Bax is frequently mutated in tumors with microsatellite instability (MSI). The mutation often results in a "Bax negative" phenotype and therefore is generally thought to be beneficial to the development of the tumor. Here, we report the identification of a novel Bax isoform, Bax Delta 2, which is unique to microsatellite unstable tumors. Bax Delta 2 is generated by a unique combination of a microsatellite deletion in Bax exon 3 and alternative splicing of Bax exon 2. Consistently, Bax Delta 2 is only detected in MSI cell lines and primary tumors. Bax Delta 2 is a potent cell death inducer but does not directly target mitochondria. In addition, Bax Delta 2 sensitizes certain MSI tumor cells to a subset of chemotherapeutic agents, such as adriamycin. Thus, our data provide evidence that mutation and alternative splicing of tumor suppressors such as Bax are not always beneficial to tumor development but can be detrimental instead.	[Xiang, Jialing] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Sharp, Juanita] Chicago State Univ, Chicago, IL 60628 USA	Illinois Institute of Technology; Chicago State University	Xiang, JL (corresponding author), IIT, Dept Biol & Chem Sci, 3101 S Dearborn St, Chicago, IL 60616 USA.	xiang@iit.edu			National Institutes of Health [CA128114]; NATIONAL CANCER INSTITUTE [R01CA128114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128114 (to J. X.).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; APTE SS, 1995, GENOMICS, V26, P592, DOI 10.1016/0888-7543(95)80180-T; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Chlopkiewicz Bozena, 2002, Acta Pol Pharm, V59, P115; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Falchetti M, 2008, HUM PATHOL, V39, P925, DOI 10.1016/j.humpath.2007.10.024; Fallik D, 2003, CANCER RES, V63, P5738; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goel A, 2003, CANCER RES, V63, P1608; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Hofland KF, 2005, CLIN CANCER RES, V11, P3915, DOI 10.1158/1078-0432.CCR-04-2343; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Jeong SH, 2008, JPN J CLIN ONCOL, V38, P661, DOI 10.1093/jjco/hyn089; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kawaguchi M, 2009, INT J ONCOL, V35, P977, DOI 10.3892/ijo_00000411; Kohler T, 2002, LEUKEMIA, V16, P22, DOI 10.1038/sj.leu.2402340; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Kuismanen SA, 2002, AM J PATHOL, V160, P1953, DOI 10.1016/S0002-9440(10)61144-3; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445; Mrozek A, 2003, CELL DEATH DIFFER, V10, P461, DOI 10.1038/sj.cdd.4401193; Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007; Olejniczak SH, 2008, CLIN CANCER RES, V14, P1550, DOI 10.1158/1078-0432.CCR-07-1255; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Schmitt E, 2000, BIOCHEM BIOPH RES CO, V270, P868, DOI 10.1006/bbrc.2000.2537; Schwartz S, 1999, CANCER RES, V59, P2995; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025062; Sun XD, 2006, PROSTATE, V66, P660, DOI 10.1002/pros.20390; Tamm I, 2002, CANCER GENE THER, V9, P641, DOI 10.1038/sj.cgt.7700480; Thomas AL, 1999, CELL DEATH DIFFER, V6, P97, DOI 10.1038/sj.cdd.4400474; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yin X M, 1995, Curr Top Microbiol Immunol, V194, P331; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou M, 1998, J BIOL CHEM, V273, P11930, DOI 10.1074/jbc.273.19.11930	53	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34722	34729		10.1074/jbc.M112.374785	http://dx.doi.org/10.1074/jbc.M112.374785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910913	Green Published, hybrid			2022-12-28	WOS:000309654200072
J	Herrera-Cruz, M; Cruz, G; Valadez-Graham, V; Fregoso-Lomas, M; Villicana, C; Vazquez, M; Reynaud, E; Zurita, M				Herrera-Cruz, Mariana; Cruz, Grisel; Valadez-Graham, Viviana; Fregoso-Lomas, Mariana; Villicana, Claudia; Vazquez, Martha; Reynaud, Enrique; Zurita, Mario			Physical and Functional Interactions between Drosophila Homologue of Swc6/p18(Hamlet) Subunit of the SWR1/SRCAP Chromatin-remodeling Complex with the DNA Repair/Transcription Factor TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; BICISTRONIC TRANSCRIPT; HISTONE H2A.Z; HUMAN SRCAP; PROTEIN; MUTATIONS; ENCODES; DAMAGE; DISSOCIATION; BIOLOGY	The multisubunit DNA repair and transcription factor TFIIH maintains an intricate cross-talk with different factors to achieve its functions. The p8 subunit of TFIIH maintains the basal levels of the complex by interacting with the p52 subunit. Here, we report that in Drosophila, the homolog of the p8 subunit (Dmp8) is encoded in a bicistronic transcript with the homolog of the Swc6/p18(Hamlet) subunit (Dmp18) of the SWR1/SRCAP chromatin remodeling complex. The SWR1 and SRCAP complexes catalyze the exchange of the canonical histone H2A with the H2AZ histone variant. In eukaryotic cells, bicistronic transcripts are not common, and in some cases, the two encoded proteins are functionally related. We found that Dmp18 physically interacts with the Dmp52 subunit of TFIIH and co-localizes with TFIIH in the chromatin. We also demonstrated that Dmp18 genetically interacts with Dmp8, suggesting that a crosstalk might exist between TFIIH and a component of a chromatin remodeler complex involved in histone exchange. Interestingly, our results also show that when the level of one of the two proteins is decreased and the other maintained, a specific defect in the fly is observed, suggesting that the organization of these two genes in a bicistronic locus has been selected during evolution to allow co-regulation of both genes.	[Herrera-Cruz, Mariana; Cruz, Grisel; Valadez-Graham, Viviana; Fregoso-Lomas, Mariana; Villicana, Claudia; Vazquez, Martha; Reynaud, Enrique; Zurita, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet, Av Univ 2001, Cuernavaca 62250, Morelos, Mexico.	marioz@ibt.unam.mx	Villicaña, Claudia/AAB-8767-2022; Herrera-Cruz, Mariana/F-6971-2018	Villicaña, Claudia/0000-0002-3737-8416; Herrera-Cruz, Mariana/0000-0001-7821-9924; Valadez, Viviana/0000-0002-2556-7375; Cruz Becerra, Grisel/0000-0001-6297-4132; Vazquez, Martha/0000-0003-0329-8802	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico [IN 20109-3]; Consejo Nacional de Ciencia y Tecnologia Grant [127440]; IXTLI/Universidad Nacional Autonoma de Mexico; Fundacion Miguel Aleman; Howard Hughes Medical Institute	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Grant; IXTLI/Universidad Nacional Autonoma de Mexico; Fundacion Miguel Aleman; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by funds from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica/Universidad Nacional Autonoma de Mexico IN 20109-3, Consejo Nacional de Ciencia y Tecnologia Grant 127440, IXTLI/Universidad Nacional Autonoma de Mexico, Fundacion Miguel Aleman, and the Howard Hughes Medical Institute (to M. Z.).	Aguilar-Fuentes J, 2006, J CELL SCI, V119, P3866, DOI 10.1242/jcs.03150; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; Bao YH, 2011, CELL, V144, P158, DOI 10.1016/j.cell.2010.12.024; Betran E, 2000, MOL BIOL EVOL, V17, P1344, DOI 10.1093/oxfordjournals.molbev.a026418; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Jawhari A, 2002, J BIOL CHEM, V277, P31761, DOI 10.1074/jbc.M203792200; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafarga V, 2007, CELL CYCLE, V6, P2319, DOI 10.4161/cc.6.19.4741; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Merino C, 2002, MOL BIOL CELL, V13, P3246, DOI 10.1091/mbc.E02-02-0087; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Reynaud E, 1999, MOL BIOL CELL, V10, P1191, DOI 10.1091/mbc.10.4.1191; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; Sloan J, 1999, NUCLEIC ACIDS RES, V27, P854, DOI 10.1093/nar/27.3.854; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Valadez-Graham V, 2012, NUCLEIC ACIDS RES, V40, P1460, DOI 10.1093/nar/gkr865; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, P861, DOI 10.1093/nar/gkl1085; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	54	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33567	33580		10.1074/jbc.M112.383505	http://dx.doi.org/10.1074/jbc.M112.383505			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865882	Green Published, hybrid			2022-12-28	WOS:000309602100042
J	Nieznanski, K; Choi, JK; Chen, SG; Surewicz, K; Surewicz, WK				Nieznanski, Krzysztof; Choi, Jin-Kyu; Chen, Shugui; Surewicz, Krystyna; Surewicz, Witold K.			Soluble Prion Protein Inhibits Amyloid-beta (A beta) Fibrillization and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; OLIGOMERS; IMPAIRMENT; PEPTIDE; PATHOGENESIS; AGGREGATION; ASSEMBLIES; MECHANISMS	The pathogenesis of Alzheimer disease appears to be strongly linked to the aggregation of amyloid-beta (A beta) peptide and, especially, formation of soluble A beta 1-42 oligomers. It was recently demonstrated that the cellular prion protein, PrPC, binds with high affinity to these oligomers, acting as a putative receptor that mediates at least some of their neurotoxic effects. Here we show that the soluble (i.e. glycophosphatidylinositol anchorfree) prion protein and its N-terminal fragment have a strong effect on the aggregation pathway of A beta 1-42, inhibiting its assembly into amyloid fibrils. Furthermore, the prion protein prevents formation of spherical oligomers that normally occur during A beta fibrillogenesis, acting as a potent inhibitor of A beta 1-42 toxicity as assessed in experiments with neuronal cell culture. These findings may provide a molecular level foundation to explain the reported protective action of the physiologically released N-terminal N1 fragment of PrPC against A beta neurotoxicity. They also suggest a novel approach to pharmacological intervention in Alzheimer disease.	[Nieznanski, Krzysztof; Choi, Jin-Kyu; Chen, Shugui; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Nieznanski, Krzysztof/R-4220-2016	Nieznanski, Krzysztof/0000-0003-0440-2632	National Institutes of Health [NS44158, AG14359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44158 and AG14359 (to W. K. S.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hetenyi C, 2002, BIOCHEM BIOPH RES CO, V292, P931, DOI 10.1006/bbrc.2002.6745; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Rangachari V, 2009, BIOPOLYMERS, V91, P456, DOI 10.1002/bip.21151; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	34	68	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33104	33108		10.1074/jbc.C112.400614	http://dx.doi.org/10.1074/jbc.C112.400614			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22915585	Green Published, hybrid			2022-12-28	WOS:000309602100001
J	Schmidt, E; Nilsson, O; Koskela, A; Tuukkanen, J; Ohlsson, C; Rozell, B; Eriksson, M				Schmidt, Eva; Nilsson, Ola; Koskela, Antti; Tuukkanen, Juha; Ohlsson, Claes; Rozell, Bjorn; Eriksson, Maria			Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMIN-A; PRELAMIN-A; NUCLEAR-ENVELOPE; BONE-FORMATION; FEMORAL-NECK; MICE; DISEASE; DIFFERENTIATION; PHENOTYPE; DYSPLASIA	Hutchinson-Gilford progeria syndrome (HGPS) is a very rare genetic disorder that is characterized by multiple features of premature aging and largely affects tissues of mesenchymal origin. In this study, we describe the development of a tissue-specific mouse model that overexpresses the most common HGPS mutation (LMNA, c.1824C > T, p.G608G) in osteoblasts. Already at the age of 5 weeks, HGPS mutant mice show growth retardation, imbalanced gait and spontaneous fractures. Histopathological examination revealed an irregular bone structure, characterized by widespread loss of osteocytes, defects in mineralization, and a hypocellular red bone marrow. Computerized tomography analysis demonstrated impaired skeletal geometry and altered bone structure. The skeletal defects, which resemble the clinical features reported for bone disease in HGPS patients, was associated with an abnormal osteoblast differentiation. The osteoblast-specific expression of the HGPS mutation increased DNA damage and affected Wnt signaling. In the teeth, irregular dentin formation, as was previously demonstrated in human progeria cases, caused severe dental abnormalities affecting the incisors. The observed phenotype also shows similarities to reported bone abnormalities in aging mice and may therefore help to uncover general principles of the aging process.	[Schmidt, Eva; Eriksson, Maria] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Nilsson, Ola] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden; [Nilsson, Ola] Univ Hosp, SE-17177 Stockholm, Sweden; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, FI-90014 Oulu, Finland; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, SE-40530 Gothenburg, Sweden; [Rozell, Bjorn] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1165 Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Oulu; University of Gothenburg; University of Copenhagen	Eriksson, M (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	Maria.Eriksson.2@ki.se	Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022; Tuukkanen, Juha/R-3728-2018	Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Tuukkanen, Juha/0000-0002-1723-6461; Koskela, Antti/0000-0001-7371-2488; Nilsson, Ola/0000-0002-9986-8138	Karolinska Institutet; Swedish Research Council; Swedish Foundation for Strategic Research; Torsten and Ragnar Soderberg Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation; Hagelen Foundation; Loo and Hans Osterman Foundation	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderberg Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation; Hagelen Foundation; Loo and Hans Osterman Foundation(Instituto de Salud Carlos III)	This work was supported by grants from the Karolinska Institutet, the Swedish Research Council, the Swedish Foundation for Strategic Research, the Torsten and Ragnar Soderberg Foundation, the Tore Nilsson Foundation, the Ake Wiberg Foundation, the Hagelen Foundation, and the Loo and Hans Osterman Foundation.	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boskey AL, 2006, PRIMER METABOLIC BON, V6th, P12; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cunningham VJ, 2010, BONE, V47, P591, DOI 10.1016/j.bone.2010.06.004; de Carlos F, 2008, J ANAT, V213, P509, DOI 10.1111/j.1469-7580.2008.00970.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Domingo DL, 2009, ORAL DIS, V15, P187, DOI 10.1111/j.1601-0825.2009.01521.x; Duarte WR, 2003, J BONE MINER RES, V18, P493, DOI 10.1359/jbmr.2003.18.3.493; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; GARDNER DG, 1969, ORAL SURG ORAL MED O, V28, P877, DOI 10.1016/0030-4220(69)90343-0; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon CM, 2011, J BONE MINER RES, V26, P1670, DOI 10.1002/jbmr.392; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; HEINRICHS C, 1994, ENDOCRINOLOGY, V135, P1113, DOI 10.1210/en.135.3.1113; Jamsa T, 1998, J BIOMECH, V31, P723, DOI 10.1016/S0021-9290(98)00087-6; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Kamoun-Goldrat AS, 2007, J BONE MINER METAB, V25, P211, DOI 10.1007/s00774-007-0750-3; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019313; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nagy A., 2003, MANIPULATING MOUSE E; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Rivas D, 2009, J GERONTOL A-BIOL, V64, P1015, DOI 10.1093/gerona/glp089; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt Eva, 2011, BMC Res Notes, V4, P282, DOI 10.1186/1756-0500-4-282; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHOZAWA T, 1984, ACTA PATHOL JAPON, V34, P797; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; SINENSKY M, 1994, J CELL SCI, V107, P61; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Zreiqat H, 2007, J MOL HISTOL, V38, P381, DOI 10.1007/s10735-007-9117-2	50	31	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33512	33522		10.1074/jbc.M112.366450	http://dx.doi.org/10.1074/jbc.M112.366450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22893709	Green Published, hybrid			2022-12-28	WOS:000309602100037
J	Wojtaszek, J; Lee, CJ; D'Souza, S; Minesinger, B; Kim, H; D'Andrea, AD; Walker, GC; Zhou, P				Wojtaszek, Jessica; Lee, Chul-Jin; D'Souza, Sanjay; Minesinger, Brenda; Kim, Hyungjin; D'Andrea, Alan D.; Walker, Graham C.; Zhou, Pei			Structural Basis of Rev1-mediated Assembly of a Quaternary Vertebrate Translesion Polymerase Complex Consisting of Rev1, Heterodimeric Polymerase (Pol) zeta, and Pol kappa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY DNA-POLYMERASES; OVARIAN-CARCINOMA CELLS; DAMAGE TOLERANCE; C-TERMINUS; 2-POLYMERASE MECHANISMS; UBIQUITIN RECOGNITION; YEAST REV1; PROTEIN; REPAIR; DOMAIN	DNA synthesis across lesions during genomic replication requires concerted actions of specialized DNA polymerases in a potentially mutagenic process known as translesion synthesis. Current models suggest that translesion synthesis in mammalian cells is achieved in two sequential steps, with a Y-family DNA polymerase (kappa, eta, iota, or Rev1) inserting a nucleotide opposite the lesion and with the heterodimeric B-family polymerase zeta, consisting of the catalytic Rev3 subunit and the accessory Rev7 subunit, replacing the insertion polymerase to carry out primer extension past the lesion. Effective translesion synthesis in vertebrates requires the scaffolding function of the C-terminal domain (CTD) of Rev1 that interacts with the Rev1-interacting region of polymerases kappa, eta, and iota and with the Rev7 subunit of polymerase zeta. We report the purification and structure determination of a quaternary translesion polymerase complex consisting of the Rev1 CTD, the heterodimeric Pol zeta complex, and the Pol kappa Rev1-interacting region. Yeast two-hybrid assays were employed to identify important interface residues of the translesion polymerase complex. The structural elucidation of such a quaternary translesion polymerase complex encompassing both insertion and extension polymerases bridged by the Rev1 CTD provides the first molecular explanation of the essential scaffolding function of Rev1 and highlights the Rev1 CTD as a promising target for developing novel cancer therapeutics to suppress translesion synthesis. Our studies support the notion that vertebrate insertion and extension polymerases could structurally cooperate within a megatranslesion polymerase complex (translesionsome) nucleated by Rev1 to achieve efficient lesion bypass without incurring an additional switching mechanism.	[Wojtaszek, Jessica; Lee, Chul-Jin; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [D'Souza, Sanjay; Minesinger, Brenda; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kim, Hyungjin; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA	Duke University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; /0000-0001-7243-8261; Wojtaszek, Jessica/0000-0002-9108-2886	NIGMS; National Institutes of Health (NIH) [GM-079376, ES-015818, R01DK43889, R37HL52725, RC4DK090913]; NIEHS; Stewart Trust Foundation; American Cancer Society; Leukemia and Lymphoma Society Career Development Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090913, R01DK043889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015818, R56ES015818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079376] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Stewart Trust Foundation; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society Career Development Fellowship(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health (NIH), Grant GM-079376 (to P. Z.); NIEHS, NIH, Grant ES-015818 (to G. C. W.); and NIH Grants R01DK43889, R37HL52725, and RC4DK090913 (to A. D. D.). This work was also supported by the Stewart Trust Foundation (to P. Z.) and an American Cancer Society research professorship (to G. C. W.).; Recipient of the Leukemia and Lymphoma Society Career Development Fellowship.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bomar MG, 2010, MOL CELL, V37, P408, DOI 10.1016/j.molcel.2009.12.038; Burschowsky D, 2011, J BIOL CHEM, V286, P1364, DOI 10.1074/jbc.M110.135038; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cui GF, 2010, BIOCHEMISTRY-US, V49, P10198, DOI 10.1021/bi101303t; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; D'Souza S, 2006, MOL CELL BIOL, V26, P8173, DOI 10.1128/MCB.00202-06; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; James P, 1996, GENETICS, V144, P1425; Kosarek JN, 2008, DNA REPAIR, V7, P439, DOI 10.1016/j.dnarep.2007.11.016; LAWRENCE CW, 1979, GENETICS, V92, P397; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; LAWRENCE CW, 1982, MOL GEN GENET, V186, P1, DOI 10.1007/BF00422904; LEMONTT JF, 1971, GENETICS, V68, P21; Lin XJ, 2006, MOL PHARMACOL, V69, P1748, DOI 10.1124/mol.105.020446; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Okuda T, 2005, MOL PHARMACOL, V67, P1852, DOI 10.1124/mol.104.010579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107	47	89	89	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33836	33846		10.1074/jbc.M112.394841	http://dx.doi.org/10.1074/jbc.M112.394841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859295	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000309602100064
J	Kim, YS; Ahn, YH; Song, KJ; Kang, JG; Lee, JH; Jeon, SK; Kim, HC; Yoo, JS; Ko, JH				Kim, Yong-Sam; Ahn, Yeong Hee; Song, Kyoung Jin; Kang, Jeong Gu; Lee, Ju Hee; Jeon, Seong Kook; Kim, Hyoung-Chin; Yoo, Jong Shin; Ko, Jeong-Heon			Overexpression and beta-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1 A "DOUBLE WHAMMY" STRATEGY IN COLON CANCER PROGRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-NECROSIS-FACTOR; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; CELL-PROLIFERATION; TGF-BETA; PROTEIN; GROWTH; MICROENVIRONMENT; INTERLEUKIN-2	There has been ongoing debate over whether tissue inhibitor of metalloproteinase-1 (TIMP-1) is pro- or anti-oncogenic. We confirmed that TIMP-1 reinforced cell proliferation in an alpha v beta 3 integrin-dependent manner and conferred resistance against cytotoxicity triggered by TNF-alpha and IL-2 in WiDr colon cancer cells. The cell-proliferative effects of TIMP-1 contributed to clonogenicity and tumor growth during the onset and early phase of tumor formation in vivo and in vitro. However, mass-produced TIMP-1 impeded further tumor growth by tightly inhibiting the activities of collagenases, which are critical for tumor growth and malignant transformation. Tumor cells could overcome this impasse by overexpression of N-acetylglucosaminyltransferase V, which deteriorates TIMP-1 into an aberrant glycoform. The aberrant glycoform of TIMP-1 was responsible for the mitigated inhibition of collagenases. The outbalanced activities of collagenases can degrade the basement membrane and the interstitial matrix, which act as a physical barrier for tumor growth and progression more efficiently. The concomitant overexpression of TIMP-1 and N-acetylglucosaminyltransferase V enabled WiDr cells to show a higher tumor growth rate as well as more malignant behaviors in a three-dimensional culture system.	[Ko, Jeong-Heon] Korea Res Inst Biosci & Biotechnol, Canc Biomarkers Dev Res Ctr, Taejon, South Korea; [Kim, Hyoung-Chin] Korea Res Inst Biosci & Biotechnol, Biomed Mouse Resource Ctr, Taejon, South Korea; [Ahn, Yeong Hee; Yoo, Jong Shin] Korea Basic Sci Inst, Div Mass Spectrometry, Ochang Myun 363883, Cheongwon Gun, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Basic Science Institute (KBSI)	Ko, JH (corresponding author), Korea Res Inst Biosci & Biotechnol, Canc Biomarkers Dev Res Ctr, 125 Gwahak Ro, Taejon, South Korea.	jhko@kribb.re.kr			"Convergence Research Center Program" of the Ministry of Education, Science, and Technology [2010K001302]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program [KGM3231211]	"Convergence Research Center Program" of the Ministry of Education, Science, and Technology; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by the "Convergence Research Center Program" (2010K001302) of the Ministry of Education, Science, and Technology and grants from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (KGM3231211).	Aljada IS, 2004, J CLIN ONCOL, V22, P3218, DOI 10.1200/JCO.2004.02.110; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bloomston M, 2005, AM J SURG, V189, P675, DOI 10.1016/j.amjsurg.2005.03.008; Caterina NCM, 1998, BBA-PROTEIN STRUCT M, V1388, P21, DOI 10.1016/S0167-4838(98)00158-7; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen GP, 2011, FASEB J, V25, P4531, DOI 10.1096/fj.11-185991; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cullinan AE, 2004, MOL VIS, V10, P315; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Davidsen ML, 2006, BRIT J CANCER, V95, P1114, DOI 10.1038/sj.bjc.6603378; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fowell AJ, 2011, BIOCHEM BIOPH RES CO, V407, P277, DOI 10.1016/j.bbrc.2011.02.009; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; Inagaki D, 2010, ANTICANCER RES, V30, P4127; Itoh T, 1999, CLIN EXP METASTAS, V17, P177, DOI 10.1023/A:1006603723759; Itoh T, 1998, CANCER RES, V58, P1048; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; KHOKHA R, 1994, J NATL CANCER I, V86, P299, DOI 10.1093/jnci/86.4.299; Kim YS, 2008, MOL CELL PROTEOMICS, V7, P1, DOI 10.1074/mcp.M700084-MCP200; Korpi JT, 2011, SURG ONCOL, V20, pE18, DOI 10.1016/j.suronc.2010.08.004; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Martin DC, 1996, ONCOGENE, V13, P569; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Song WM, 2000, DEV BIOL, V227, P606, DOI 10.1006/dbio.2000.9919; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Taube ME, 2006, ONCOGENE, V25, P3041, DOI 10.1038/sj.onc.1209336; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; WINKELHAKE JL, 1987, CANCER RES, V47, P3948; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; YANG SC, 1991, CANCER RES, V51, P3669; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x	52	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32467	32478		10.1074/jbc.M112.370064	http://dx.doi.org/10.1074/jbc.M112.370064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859303	hybrid, Green Published			2022-12-28	WOS:000309168300017
J	Soundararajan, R; Ziera, T; Koo, E; Ling, KR; Wang, J; Borden, SA; Pearce, D				Soundararajan, Rama; Ziera, Tim; Koo, Eric; Ling, Karen; Wang, Jian; Borden, Steffen A.; Pearce, David			Scaffold Protein Connector Enhancer of Kinase Suppressor of Ras Isoform 3 (CNK3) Coordinates Assembly of a Multiprotein Epithelial Sodium Channel (ENaC)-regulatory Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDOSTERONE-INDUCED PROTEINS; LEUCINE-ZIPPER PROTEIN; NA+ CHANNEL; PDZ PROTEINS; NAPI-IIA; CL-COTRANSPORTER; SERUM; ENAC; TRAFFICKING; EXPRESSION	Hormone regulation of ion transport in the kidney tubules is essential for fluid and electrolyte homeostasis in vertebrates. A large body of evidence has suggested that transporters and channels exist in multiprotein regulatory complexes; however, relatively little is known about the composition of these complexes or their assembly. The epithelial sodium channel (ENaC) in particular is tightly regulated by the salt-regulatory hormone aldosterone, which acts at least in part by increasing expression of the serine-threonine kinase SGK1. Here we show that aldosterone induces the formation of a 1.0-1.2-MDa plasma membrane complex, which includes ENaC, SGK1, and the ENaC inhibitor Nedd4-2, a key target of SGK1. We further show that this complex contains the PDZ domain-containing protein connector enhancer of kinase suppressor of Ras isoform 3 (CNK3). CNK3 physically interacts with ENaC, Nedd4-2, and SGK1; enhances the interactions among them; and stimulates ENaC function in a PDZ domain-dependent, aldosterone-induced manner. These results strongly suggest that CNK3 is a molecular scaffold, which coordinates the assembly of a multiprotein ENaC-regulatory complex and hence plays a central role in Na+ homeostasis.	[Soundararajan, Rama; Ziera, Tim; Koo, Eric; Ling, Karen; Wang, Jian; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Borden, Steffen A.] Bayer Healthcare Pharmaceut, Strateg Planning, D-13353 Berlin, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Bayer AG; Bayer Healthcare Pharmaceuticals	Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, 600 16th St,N272C,Box 2140,Genentech Hall, San Francisco, CA 94143 USA.	dpearce@medsfgh.ucsf.edu			National Institutes of Health [K01-DK078679, R01-DK56695, R01-DK85101]; Manning Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085101, K01DK078679, R01DK056695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manning Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01-DK078679 (to R. S.), R01-DK56695 (to D. P.), and R01-DK85101 (to D. P.). This work was also supported by a Manning Foundation award (to D. P.).	Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; AUSIELLO DA, 1992, J BIOL CHEM, V267, P4759; Bacic D, 2004, KIDNEY INT, V66, pS5, DOI 10.1111/j.1523-1755.2004.09102.x; BENOS DJ, 1987, J BIOL CHEM, V262, P10613; BENOS DJ, 1986, P NATL ACAD SCI USA, V83, P8525, DOI 10.1073/pnas.83.22.8525; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Biber J, 2004, AM J PHYSIOL-RENAL, V287, pF871, DOI 10.1152/ajprenal.00244.2004; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; BLAZERYOST B, 1982, BIOCHIM BIOPHYS ACTA, V719, P158, DOI 10.1016/0304-4165(82)90320-8; BLAZERYOST B, 1985, AM J PHYSIOL, V249, pC215, DOI 10.1152/ajpcell.1985.249.3.C215; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Christensen BM, 2010, J AM SOC NEPHROL, V21, P1942, DOI 10.1681/ASN.2009101077; Cunningham R, 2010, UROL RES, V38, P257, DOI 10.1007/s00240-010-0294-1; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Dimke H, 2011, PFLUG ARCH EUR J PHY, V462, P767, DOI 10.1007/s00424-011-1027-1; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Fritz RD, 2005, BIOCHEM BIOPH RES CO, V338, P1906, DOI 10.1016/j.bbrc.2005.10.168; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hernando N, 2004, CURR OPIN NEPHROL HY, V13, P569, DOI 10.1097/00041552-200409000-00014; Hernando N, 2010, UROL RES, V38, P271, DOI 10.1007/s00240-010-0304-3; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Invitrogen, 2006, VIRAPOWER LENT EXPR; Ismailov II, 1996, J MEMBRANE BIOL, V149, P123, DOI 10.1007/s002329900013; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MCDONALD FJ, 1995, BIOCHEM J, V312, P491, DOI 10.1042/bj3120491; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Soundararajan R, 2010, J BIOL CHEM, V285, P39905, DOI 10.1074/jbc.M110.161133; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Spindler B, 1997, PFLUG ARCH EUR J PHY, V434, P323, DOI 10.1007/s004240050403; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stockand JD, 1999, J BIOL CHEM, V274, P35449, DOI 10.1074/jbc.274.50.35449; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Tanimura A, 2011, J MED INVESTIG, V58, P140, DOI 10.2152/jmi.58.140; Thomas SV, 2011, J BIOL CHEM, V286, P32074, DOI 10.1074/jbc.M111.278283; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Xia HH, 2002, J BIOL CHEM, V277, P47765, DOI 10.1074/jbc.M207122200; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	79	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33014	33025		10.1074/jbc.M112.389148	http://dx.doi.org/10.1074/jbc.M112.389148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851176	Green Published, hybrid			2022-12-28	WOS:000309168300064
J	He, J; Shi, LDZ; Truong, LN; Lu, CS; Razavian, N; Li, YJ; Negrete, A; Shiloach, J; Berns, MW; Wu, XH				He, Jing; Shi, Linda Z.; Truong, Lan N.; Lu, Chi-Sheng; Razavian, Niema; Li, Yongjiang; Negrete, Alejandro; Shiloach, Joseph; Berns, Michael W.; Wu, Xiaohua			Rad50 Zinc Hook Is Important for the Mre11 Complex to Bind Chromosomal DNA Double-stranded Breaks and Initiate Various DNA Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; MRE11-RAD50-NBS1 COMPLEX; CHROMATIN RETENTION; MAMMALIAN-CELLS; REPAIR COMPLEX; MRN COMPLEX; NBS1; ATM; PHOSPHORYLATION; PROTEIN	The Mre11-Rad50-Nbs1 (MRN) complex plays critical roles in checkpoint activation and double-stranded break (DSB) repair. The Rad50 zinc hook domain mediates zinc-dependent intercomplex associations of MRN, which is important for DNA tethering. Studies in yeast suggest that the Rad50 zinc hook domain is essential for MRN functions, but its role in mammalian cells is not clear. We demonstrated that the human Rad50 hook mutants are severely defective in various DNA damage responses including ATM (Ataxia telangiectasia mutated) activation, homologous recombination, sensitivity to IR, and activation of the ATR pathway. By using live cell imaging, we observed that the Rad50 hook mutants fail to be recruited to chromosomal DSBs, suggesting a novel mechanism underlying the severe defects observed for the Rad50 hook mutants. In vitro analysis showed that Zn2+ promotes wild type but not the hook mutant of MR to bind double-stranded DNA. In vivo, the Rad50 hook mutants are defective in being recruited to chromosomal DSBs in both H2AX-proficient and -deficient cells, suggesting that the Rad50 hook mutants are impaired in direct binding to chromosomal DSB ends. We propose that the Rad50 zinc hook domain is important for the initial binding of MRN to DSBs, leading to ATM activation to phosphorylate H2AX, which recruits more MRN to the DSB-flanking chromosomal regions. Our studies reveal a critical role for the Rad50 zinc hook domain in establishing and maintaining MRN recruitment to chromosomal DSBs and suggest an important mechanism of how the Rad50 zinc hook domain contributes to DNA repair and checkpoint activation.	[He, Jing; Truong, Lan N.; Lu, Chi-Sheng; Razavian, Niema; Li, Yongjiang; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Negrete, Alejandro; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	HE, JING/J-3099-2014	Razavian, Niema/0000-0001-5746-9860; Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1]; Beckman Laser Institute Inc., Foundation; NATIONAL CANCER INSTITUTE [R01CA140972, R01CA102361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute Inc., Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W). This work was also supported by funds from the Beckman Laser Institute Inc., Foundation (to M. W. B.).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089	38	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31747	31756		10.1074/jbc.M112.384750	http://dx.doi.org/10.1074/jbc.M112.384750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833675	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000309059400016
J	Schwenk, RW; Angin, Y; Steinbusch, LKM; Dirkx, E; Hoebers, N; Coumans, WA; Bonen, A; Broers, JLV; van Eys, GJJM; Glatz, JFC; Luiken, JJFP				Schwenk, Robert W.; Angin, Yeliz; Steinbusch, Laura K. M.; Dirkx, Ellen; Hoebers, Nicole; Coumans, Will A.; Bonen, Arend; Broers, Jos L. V.; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.			Overexpression of Vesicle-associated Membrane Protein (VAMP) 3, but Not VAMP2, Protects Glucose Transporter (GLUT) 4 Protein Translocation in an in Vitro Model of Cardiac Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; HUMAN SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; PLASMA-MEMBRANE; KINASE-C; EXERCISE; TRIACYLGLYCEROL; CONTRACTION; CARDIOMYOCYTES; METABOLISM	Cardiac glucose utilization is regulated by reversible translocation of the glucose transporter GLUT4 from intracellular stores to the plasma membrane. During the onset of diet-induced insulin resistance, elevated lipid levels in the circulation interfere with insulin-stimulated GLUT4 translocation, leading to impaired glucose utilization. Recently, we identified vesicle-associated membrane protein (VAMP) 2 and 3 to be required for insulin- and contraction-stimulated GLUT4 translocation, respectively, in cardiomyocytes. Here, we investigated whether overexpression of VAMP2 and/or VAMP3 could protect insulin- stimulated GLUT4 translocation under conditions of insulin resistance. HL-1 atrial cardiomyocytes transiently overexpressing either VAMP2 or VAMP3 were cultured for 16 h with elevated concentrations of palmitate and insulin. Upon subsequent acute stimulation with insulin, we measured GLUT4 translocation, plasmalemmal presence of the fatty acid transporter CD36, and myocellular lipid accumulation. Overexpression of VAMP3, but not VAMP2, completely prevented lipid-induced inhibition of insulin- stimulated GLUT4 translocation. Furthermore, the plasmalemmal presence of CD36 and intracellular lipid levels remained normal in cells overexpressing VAMP3. However, insulin signaling was not retained, indicating an effect of VAMP3 overexpression downstream of PKB/Akt. Furthermore, we revealed that endogenous VAMP3 is bound by the contraction-activated protein kinase D (PKD), and contraction and VAMP3 overexpression protect insulin-stimulated GLUT4 translocation via a common mechanism. These observations indicate that PKD activates GLUT4 translocation via a VAMP3-dependent trafficking step, which pathway might be valuable to rescue constrained glucose utilization in the insulin-resistant heart.	[Schwenk, Robert W.; Angin, Yeliz; Steinbusch, Laura K. M.; Dirkx, Ellen; Hoebers, Nicole; Coumans, Will A.; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, Cardiovasc Res Inst Maastricht CARIM, NL-6200 MD Maastricht, Netherlands; [Broers, Jos L. V.] Maastricht Univ, Dept Mol Cell Biol, Cardiovasc Res Inst Maastricht CARIM, NL-6200 MD Maastricht, Netherlands; [Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	Maastricht University; Maastricht University; University of Guelph	Schwenk, RW (corresponding author), German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Expt Diabetol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	robert.schwenk@dife.de			Transnational University Limburg; Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Netherlands Heart Foundation, Dutch Diabetes Research Foundation [2006.00.044]; Dutch Kidney Foundation	Transnational University Limburg; Center for Translational Molecular Medicine, project PREDICCt; Netherlands Heart Foundation, Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This work was supported by the Transnational University Limburg. Part of this research was performed within the framework of CTMM, the Center for Translational Molecular Medicine, project PREDICCt, Grant 01C-104, and supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation Grant 2006.00.044, and the Dutch Kidney Foundation.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Bergman BC, 2009, AM J PHYSIOL-ENDOC M, V296, pE358, DOI 10.1152/ajpendo.90747.2008; Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; Coort SLM, 2004, BIOCHEM SOC T, V32, P83, DOI 10.1042/BST0320083; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; DELA F, 1995, DIABETES, V44, P1010, DOI 10.2337/diabetes.44.9.1010; Dirkx E, 2012, J BIOL CHEM, V287, P5871, DOI 10.1074/jbc.M111.281881; Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x; Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Kolter T, 1997, AM J PHYSIOL-ENDOC M, V273, pE59, DOI 10.1152/ajpendo.1997.273.1.E59; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Luiken JJFP, 2009, BIOCHEM J, V419, P447, DOI 10.1042/BJ20082159; Maier VH, 2000, DIABETES, V49, P618, DOI 10.2337/diabetes.49.4.618; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rose AJ, 2009, AM J PHYSIOL-REG I, V297, pR1228, DOI 10.1152/ajpregu.00258.2009; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; TREADWAY JL, 1989, AM J PHYSIOL, V256, pE138, DOI 10.1152/ajpendo.1989.256.1.E138; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; UPHUES I, 1995, BIOCHEM J, V311, P161, DOI 10.1042/bj3110161; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Wojtaszewski JFP, 2000, DIABETES, V49, P325, DOI 10.2337/diabetes.49.3.325	48	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37530	37539		10.1074/jbc.M112.363630	http://dx.doi.org/10.1074/jbc.M112.363630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936810	hybrid, Green Published			2022-12-28	WOS:000310588500081
J	Rao, V; Guan, B; Mutton, LN; Bieberich, CJ				Rao, Varsha; Guan, Bin; Mutton, Laura N.; Bieberich, Charles J.			Proline-mediated Proteasomal Degradation of the Prostate-specific Tumor Suppressor NKX3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; INTRAEPITHELIAL NEOPLASIA; TAT PROTEIN; EXPRESSION; INHIBITORS; INTERACTS; BINDING; DOMAIN; RICH; ATP	Reduced expression of the homeodomain transcription factor NKX3.1 is associated with prostate cancer initiation and progression. NKX3.1 turnover requires post-translational modifications including phosphorylation and ubiquitination. Here, we demonstrate the existence of a non-canonical mechanism for NKX3.1 turnover that does not require ubiquitination. Using a structure-function approach, we have determined that the conserved, C-terminal 21-amino acid domain of NKX3.1 (C21) is required for this novel ubiquitin-independent degradation mechanism. Addition of C21 decreased half-life of enhanced green fluorescence protein (EGFP) by 5-fold, demonstrating that C21 constitutes a portable degron. Point mutational analyses of C21 revealed that a conserved proline residue (Pro-221) is central to degron activity, and mutation to alanine (P221A) increased NKX3.1 half-life >2-fold. Proteasome inhibition and in vivo ubiquitination analyses indicated that degron activity is ubiquitin-independent. Evaluating degron activity in the context of a ubiquitination-resistant, lysine-null NKX3.1 mutant (NKX3.1(KO)) confirmed that P221A mutation conferred additional stability to NKX3.1. Treatment of prostate cancer cell lines with a C21-based peptide specifically increased the level of NKX3.1, suggesting that treatment with degron mimetics may be a viable approach for NKX3.1 restoration.	[Rao, Varsha; Guan, Bin; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Bieberich, CJ (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Guan, Bin/0000-0001-5986-5189; Bieberich, Charles/0000-0002-9208-5077	Congressionally Directed Medical Research Prostate Cancer Program [W81XWH-07-1-0232]	Congressionally Directed Medical Research Prostate Cancer Program	This work was supported by Grant W81XWH-07-1-0232 from the Congressionally Directed Medical Research Prostate Cancer Program (to C. J. B.).	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; Bethel CR, 2007, PROSTATE, V67, P1740, DOI 10.1002/pros.20579; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bowen C, 2000, CANCER RES, V60, P6111; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; Corallini F, 2008, J LEUKOCYTE BIOL, V84, P651, DOI 10.1189/jlb.0408222; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gaczynska M, 2003, BIOCHEMISTRY-US, V42, P8663, DOI 10.1021/bi034784f; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hori T, 2010, CANCER LETT, V287, P98, DOI 10.1016/j.canlet.2009.06.002; Hwang J, 2011, BBA-REV CANCER, V1816, P147, DOI 10.1016/j.bbcan.2011.05.005; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim MJ, 2002, CANCER RES, V62, P2999; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lewis MD, 2004, ONCOGENE, V23, P2315, DOI 10.1038/sj.onc.1207384; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Mack PC, 2003, LUNG CANCER, V41, pS89, DOI 10.1016/S0169-5002(03)00149-1; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Moehler T, 2011, RECENT RESULTS CANC, V183, P239, DOI 10.1007/978-3-540-85772-3_11; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; Prescott JL, 1998, PROSTATE, V35, P71, DOI 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sen N, 2007, J VIROL, V81, P4323, DOI 10.1128/JVI.02279-06; Tahmatzopoulos A, 2004, AKTUEL UROL, V35, P491, DOI 10.1055/s-2004-830048; Tovar C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-49; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Wu G, 2006, J BIOTECHNOL, V124, P496, DOI 10.1016/j.jbiotec.2006.01.015; Yan YT, 2000, MOL CELL BIOL, V20, P661, DOI 10.1128/MCB.20.2.661-671.2000; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Zhang HY, 2008, CANCER RES, V68, P8770, DOI 10.1158/0008-5472.CAN-08-1912	61	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36331	36340		10.1074/jbc.M112.352823	http://dx.doi.org/10.1074/jbc.M112.352823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910912	Green Published, hybrid			2022-12-28	WOS:000310364000054
J	Christ, NA; Bochmann, S; Gottstein, D; Duchardt-Ferner, E; Hellmich, UA; Duterhus, S; Kotter, P; Guntert, P; Entian, KD; Wohnert, J				Christ, Nina A.; Bochmann, Sophie; Gottstein, Daniel; Duchardt-Ferner, Elke; Hellmich, Ute A.; Duesterhus, Stefanie; Koetter, Peter; Guentert, Peter; Entian, Karl-Dieter; Woehnert, Jens			The First Structure of a Lantibiotic Immunity Protein, SpaI from Bacillus subtilis, Reveals a Novel Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; LACTOCOCCUS-LACTIS 6F3; NISIN GENE-CLUSTER; LIPID-II; FUNCTIONAL-ANALYSIS; SYNTHETASE COMPLEX; BIOSYNTHESIS; EXPRESSION; PEPTIDES	Lantibiotics are peptide-derived antibiotics that inhibit the growth of Gram-positive bacteria via interactions with lipid II and lipid II-dependent pore formation in the bacterial membrane. Due to their general mode of action the Gram-positive producer strains need to express immunity proteins (LanI proteins) for protection against their own lantibiotics. Little is known about the immunity mechanism protecting the producer strain against its own lantibiotic on the molecular level. So far, no structures have been reported for any LanI protein. We solved the structure of SpaI, a LanI protein from the subtilin producing strain Bacillus subtilis ATCC 6633. SpaI is a 16.8-kDa lipoprotein that is attached to the outside of the cytoplasmic membrane via a covalent diacylglycerol anchor. SpaI together with the ABC transporter SpaFEG protects the B. subtilis membrane from subtilin insertion. The solution-NMR structure of a 15-kDa biologically active C-terminal fragment reveals a novel fold. We also demonstrate that the first 20 N-terminal amino acids not present in this C-terminal fragment are unstructured in solution and are required for interactions with lipid membranes. Additionally, growth tests reveal that these 20 N-terminal residues are important for the immunity mediated by SpaI but most likely are not part of a possible subtilin binding site. Our findings are the first step on the way of understanding the immunity mechanism of B. subtilis in particular and of other lantibiotic producing strains in general.	[Christ, Nina A.; Bochmann, Sophie; Duchardt-Ferner, Elke; Hellmich, Ute A.; Duesterhus, Stefanie; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Gottstein, Daniel; Hellmich, Ute A.; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Christ, Nina A.; Gottstein, Daniel; Duchardt-Ferner, Elke; Hellmich, Ute A.; Guentert, Peter; Woehnert, Jens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Entian, KD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	entian@bio.uni-frankfurt.de; woehnert@bio.uni-frankfurt.de	Güntert, Peter/L-5577-2013	Güntert, Peter/0000-0002-2911-7574; Hellmich, Ute/0000-0001-7162-285X	Aventis Foundation professorship; Lichtenberg professorship of the Volkswagen Foundation; Deutsche Forschungsgemeinschaft; Center of Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence "Macromolecular Complexes"; Forderfonds of the Goethe University Frankfurt am Main	Aventis Foundation professorship; Lichtenberg professorship of the Volkswagen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center of Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence "Macromolecular Complexes"; Forderfonds of the Goethe University Frankfurt am Main	This work was supported by an Aventis Foundation professorship (to J.W.), a Lichtenberg professorship of the Volkswagen Foundation (to P. G.), the Deutsche Forschungsgemeinschaft (to P. G.), the Center of Biomolecular Magnetic Resonance (BMRZ), the Cluster of Excellence "Macromolecular Complexes" (to K.-D.E. and J.W.), and the Forderfonds of the Goethe University Frankfurt am Main.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANERJEE S, 1988, J BIOL CHEM, V263, P9508; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; Burkard M, 2008, J MICROBIOL METH, V75, P70, DOI 10.1016/j.mimet.2008.05.002; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ NA, 2012, BIOMOL NMR ASSIGN, V6, P9, DOI 10.1007/s12104-011-9314-5; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Draper LA, 2008, CURR PROTEIN PEPT SC, V9, P39; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Entian KD, 1996, ANTON LEEUW INT J G, V69, P109, DOI 10.1007/BF00399416; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fuchs SW, 2011, APPL ENVIRON MICROB, V77, P1698, DOI 10.1128/AEM.01962-10; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; GROSS E, 1971, J AM CHEM SOC, V93, P4634, DOI 10.1021/ja00747a073; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halami PM, 2010, MICROBIOL RES, V165, P183, DOI 10.1016/j.micres.2009.02.001; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hoffmann A, 2004, APPL ENVIRON MICROB, V70, P3263, DOI 10.1128/AEM.70.6.3263-3271.2004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiesau P, 1997, J BACTERIOL, V179, P1475, DOI 10.1128/jb.179.5.1475-1481.1997; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; KLEIN C, 1992, APPL ENVIRON MICROB, V58, P132, DOI 10.1128/AEM.58.1.132-142.1992; KLEIN C, 1994, APPL ENVIRON MICROB, V60, P2793, DOI 10.1128/AEM.60.8.2793-2801.1994; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Oleary W.M., 1988, MICROBIAL LIPIDS, P117; Parisot JL, 2008, ANTIMICROB AGENTS CH, V52, P612, DOI 10.1128/AAC.00836-07; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SCHULLER F, 1989, EUR J BIOCHEM, V182, P181, DOI 10.1111/j.1432-1033.1989.tb14815.x; Seydlova G, 2008, FOLIA MICROBIOL, V53, P303, DOI 10.1007/s12223-008-0047-5; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stein T, 2005, J BACTERIOL, V187, P822, DOI 10.1128/JB.187.3.822-828.2005; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; Takala TM, 2004, FEMS MICROBIOL LETT, V237, P171, DOI 10.1111/j.1574-6968.2004.tb09693.x; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	73	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35286	35298		10.1074/jbc.M112.401620	http://dx.doi.org/10.1074/jbc.M112.401620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904324	Green Published, hybrid			2022-12-28	WOS:000309968000038
J	Hurd, TR; Collins, Y; Abakumova, I; Chouchani, ET; Baranowski, B; Fearnley, IM; Prime, TA; Murphy, MP; James, AM				Hurd, Thomas R.; Collins, Yvonne; Abakumova, Irina; Chouchani, Edward T.; Baranowski, Bartlomiej; Fearnley, Ian M.; Prime, Tracy A.; Murphy, Michael P.; James, Andrew M.			Inactivation of Pyruvate Dehydrogenase Kinase 2 by Mitochondrial Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; COMPLEX; SUPEROXIDE; PYRUVATE-DEHYDROGENASE-KINASE-2; PHOSPHORYLATION; PHOSPHATASE; ACTIVATION; MECHANISMS; H2O2	Reactive oxygen species are byproducts of mitochondrial respiration and thus potential regulators of mitochondrial function. Pyruvate dehydrogenase kinase 2 (PDHK2) inhibits the pyruvate dehydrogenase complex, thereby regulating entry of carbohydrates into the tricarboxylic acid (TCA) cycle. Here we show that PDHK2 activity is inhibited by low levels of hydrogen peroxide (H2O2) generated by the respiratory chain. This occurs via reversible oxidation of cysteine residues 45 and 392 on PDHK2 and results in increased pyruvate dehydrogenase complex activity. H2O2 derives from superoxide (O-2((center dot) over bar)), and we show that conditions that inhibit PDHK2 also inactivate the TCA cycle enzyme, aconitase. These findings suggest that under conditions of high mitochondrial O-2((center dot) over bar) production, such as may occur under nutrient excess and low ATP demand, the increase in O-2(<(center dot)over bar)> and H2O2 may provide feedback signals to modulate mitochondrial metabolism.	[Hurd, Thomas R.; Collins, Yvonne; Abakumova, Irina; Chouchani, Edward T.; Baranowski, Bartlomiej; Fearnley, Ian M.; Prime, Tracy A.; Murphy, Michael P.; James, Andrew M.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Murphy, MP (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-mbu.cam.ac.uk	Abakumova, Irina V/A-9712-2016; James, Andrew M/A-2639-2015; Murphy, Michael P/C-2120-2009; Chouchani, Edward/A-1733-2014	James, Andrew M/0000-0002-0515-9649; Murphy, Michael P/0000-0003-1115-9618; Chouchani, Edward/0000-0002-9203-8094	Medical Research Council (United Kingdom); MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Li J, 2009, J BIOL CHEM, V284, P34458, DOI 10.1074/jbc.M109.065557; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; POPOV KM, 1994, J BIOL CHEM, V269, P29720; POPP DA, 1980, J BIOL CHEM, V255, P7540; RANDLE PJ, 1995, P NUTR SOC, V54, P317, DOI 10.1079/PNS19950057; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; THOR H, 1982, J BIOL CHEM, V257, P2419; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	31	37	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35153	35160		10.1074/jbc.M112.400002	http://dx.doi.org/10.1074/jbc.M112.400002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910903	Green Published, hybrid			2022-12-28	WOS:000309968000025
J	Vindry, C; Lauwers, A; Hutin, D; Soin, R; Wauquier, C; Kruys, V; Gueydan, C				Vindry, Caroline; Lauwers, Aurelien; Hutin, David; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril			dTIS11 Protein-dependent Polysomal Deadenylation Is the Key Step in AU-rich Element-mediated mRNA Decay in Drosophila Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCR4-NOT COMPLEX; BINDING-PROTEINS; GENE-EXPRESSION; BODY FORMATION; TRISTETRAPROLIN; DEGRADATION; TTP; RECRUITMENT; EXOSOME; TURNOVER	The destabilization of AU-rich element (ARE)-containing mRNAs mediated by proteins of the TIS11 family is conserved among eukaryotes including Drosophila. Previous studies have demonstrated that Tristetraprolin, a human protein of the TIS11 family, induces the degradation of ARE-containing mRNAs through a large variety of mechanisms including deadenylation, decapping, and P-body targeting. We have previously shown that the degradation of the mRNA encoding the antimicrobial peptide Cecropin A1 (CecA1) is controlled by the TIS11 protein (dTIS11) in Drosophila cells. In this study, we used CecA1 mRNA as a model to investigate the molecular mechanism of dTIS11-mediated mRNA decay. We observed that during the biphasic deadenylation and decay process of this mRNA, dTIS11 enhances deadenylation performed by the CCR4-CAF-NOT complex while the mRNA is still associated with ribosomes. Sequencing of mRNA degradation intermediates revealed that the complete deadenylation of the mRNA triggers its decapping and decay in both the 5'-3' and the 3'-5' directions. Contrary to the observations made for its mammalian homologs, overexpression of dTIS11 does not promote the localization of ARE-containing mRNAs in P-bodies but rather decreases the accumulation of CecA1 mRNA in these structures by enhancing the degradation process. Therefore, our results suggest that proteins of the TIS11 family may have acquired additional functions in the course of evolution from invertebrates to mammals.	[Vindry, Caroline; Lauwers, Aurelien; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril] Univ Libre Brussels, Fac Sci, Lab Biol Mol Gene, B-6041 Gosselies, Belgium; [Hutin, David] Univ Libre Brussels, Fac Sci, Immunobiol Lab, B-6041 Gosselies, Belgium; [Kruys, Veronique] Univ Libre Brussels, Fac Sci, Ctr Microscopy & Mol Imaging, B-6041 Gosselies, Belgium		Gueydan, C (corresponding author), Univ Libre Brussels, Fac Sci, Lab Biol Mol Gene, 12 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	cgueydan@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403; Vindry, Caroline/0000-0002-2038-0288	Fund for Medical Scientific Research (Belgium) [2.4.511.00.F]; Fonds Brachet; Fonds Van Buuren; "Actions de Recherches Concertees" [AV.06/11-345]; Fonds pour la Recherche en Industrie et Agriculture; Fond Van Buuren	Fund for Medical Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet; Fonds Van Buuren; "Actions de Recherches Concertees"; Fonds pour la Recherche en Industrie et Agriculture(Fonds de la Recherche Scientifique - FNRS); Fond Van Buuren	This work was supported by the Fund for Medical Scientific Research (Belgium, Grant 2.4.511.00.F), the Fonds Brachet, the Fonds Van Buuren, and the "Actions de Recherches Concertees" (Grant AV.06/11-345).; Supported by a doctoral grant of the Fonds pour la Recherche en Industrie et Agriculture and by the Fond Van Buuren.	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Li Y, 2011, RNA, V17, P419, DOI 10.1261/rna.2439811; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Vergara SV, 2008, BIOCHEM SOC T, V36, P1088, DOI 10.1042/BST0361088; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	39	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35527	35538		10.1074/jbc.M112.356188	http://dx.doi.org/10.1074/jbc.M112.356188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932903	hybrid, Green Published			2022-12-28	WOS:000309968000061
J	Roberts, PG; Hirst, J				Roberts, Philippa G.; Hirst, Judy			The Deactive Form of Respiratory Complex I from Mammalian Mitochondria Is a Na+/H+ Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ISCHEMIA-REPERFUSION INJURY; ACTIVE/DE-ACTIVE TRANSITION; BOVINE HEART-MITOCHONDRIA; SUBMITOCHONDRIAL PARTICLES; ESCHERICHIA-COLI; ACTIVE/INACTIVE TRANSITION; PERMEABILITY TRANSITION; QUINONE OXIDOREDUCTASE; ENZYME TRANSITION	In mitochondria, complex I (NADH: ubiquinone oxidoreductase) uses the redox potential energy from NADH oxidation by ubiquinone to transport protons across the inner membrane, contributing to the proton-motive force. However, in some prokaryotes, complex I may transport sodium ions instead, and three subunits in the membrane domain of complex I are closely related to subunits from the Mrp family of Na+/H+ antiporters. Here, we define the relationship between complex I from Bos taurus heart mitochondria, a close model for the human enzyme, and sodium ion transport across the mitochondrial inner membrane. In accord with current consensus, we exclude the possibility of redox-coupled Na+ transport by B. taurus complex I. Instead, we show that the "deactive" form of complex I, which is formed spontaneously when enzyme turnover is precluded by lack of substrates, is a Na+/H+ antiporter. The antiporter activity is abolished upon reactivation by the addition of substrates and by the complex I inhibitor rotenone. It is specific for Na+ over K+, and it is not exhibited by complex I from the yeast Yarrowia lipolytica, which thus has a less extensive deactive transition. We propose that the functional connection between the redox and transporter modules of complex I is broken in the deactive state, allowing the transport module to assert its independent properties. The deactive state of complex I is formed during hypoxia, when respiratory chain turnover is slowed, and may contribute to determining the outcome of ischemia-reperfusion injury.	[Roberts, Philippa G.; Hirst, Judy] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Hirst, J (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council; MRC [MC_U105663141] Funding Source: UKRI; Medical Research Council [MC_U105663141] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aldakkak M, 2011, PHARMACOL RES, V64, P381, DOI 10.1016/j.phrs.2011.06.018; BASHFORD CL, 1977, J BIOL CHEM, V252, P8459; Batista AP, 2011, ACS CHEM BIOL, V6, P477, DOI 10.1021/cb100380y; Batista AP, 2011, BBA-BIOENERGETICS, V1807, P286, DOI 10.1016/j.bbabio.2010.12.008; Batista AP, 2010, BBA-BIOENERGETICS, V1797, P509, DOI 10.1016/j.bbabio.2010.01.020; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; BLONDIN GA, 1969, ARCH BIOCHEM BIOPHYS, V129, P158, DOI 10.1016/0003-9861(69)90162-3; Bridges HR, 2009, BIOCHEM J, V422, P151, DOI 10.1042/BJ20090492; BRIERLEY GP, 1978, ARCH BIOCHEM BIOPHYS, V190, P181, DOI 10.1016/0003-9861(78)90266-7; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAVIES K, 1992, BIOCHEMISTRY-US, V31, P8055, DOI 10.1021/bi00149a040; DOUGLAS MG, 1974, J BIOL CHEM, V249, P5464; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Gemperli AC, 2003, P NATL ACAD SCI USA, V100, P839, DOI 10.1073/pnas.0237328100; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Grivennikova VG, 1997, BBA-BIOENERGETICS, V1319, P223, DOI 10.1016/S0005-2728(96)00163-6; GRZESIEK S, 1989, BIOPHYS J, V55, P1101, DOI 10.1016/S0006-3495(89)82907-8; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Ichimaru N, 2005, BIOCHEMISTRY-US, V44, P816, DOI 10.1021/bi0479003; Kashani-Poor N, 2001, BBA-BIOENERGETICS, V1504, P363, DOI 10.1016/S0005-2728(00)00266-8; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; LI W, 1986, BIOCHEMISTRY-US, V25, P8220, DOI 10.1021/bi00373a015; Loskovich MV, 2005, BIOCHEM J, V387, P677, DOI 10.1042/BJ20041703; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Miyoshi H, 1998, BBA-BIOENERGETICS, V1364, P236, DOI 10.1016/S0005-2728(98)00030-9; Moparthi VK, 2011, BBA-BIOENERGETICS, V1807, P427, DOI 10.1016/j.bbabio.2011.01.005; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; ROTTENBERG H, 1975, BIOCHEMISTRY-US, V14, P2675, DOI 10.1021/bi00683a017; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Sherwood S, 2006, BIOCHEM J, V400, P541, DOI 10.1042/BJ20060766; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; SORGATO MC, 1978, BIOCHEM J, V174, P237, DOI 10.1042/bj1740237; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Steuber J, 2000, MOL MICROBIOL, V35, P428, DOI 10.1046/j.1365-2958.2000.01712.x; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; VIGNE P, 1983, BIOCHEM BIOPH RES CO, V116, P86, DOI 10.1016/0006-291X(83)90384-4; Vinogradov AD, 2001, IUBMB LIFE, V52, P129, DOI 10.1080/15216540152845920	60	59	63	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34743	34751		10.1074/jbc.M112.384560	http://dx.doi.org/10.1074/jbc.M112.384560			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22854968	hybrid, Green Published			2022-12-28	WOS:000309654200074
J	Sekine, S; Kanamaru, Y; Koike, M; Nishihara, A; Okada, M; Kinoshita, H; Kamiyama, M; Maruyama, J; Uchiyama, Y; Ishihara, N; Takeda, K; Ichijo, H				Sekine, Shiori; Kanamaru, Yusuke; Koike, Masato; Nishihara, Ayako; Okada, Masahiro; Kinoshita, Hideyuki; Kamiyama, Miki; Maruyama, Junichi; Uchiyama, Yasuo; Ishihara, Naotada; Takeda, Kohsuke; Ichijo, Hidenori			Rhomboid Protease PARL Mediates the Mitochondrial Membrane Potential Loss-induced Cleavage of PGAM5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; OPA1; FUSION; MORPHOLOGY; PINK1; PHOSPHATASE; IMPORT; IDENTIFICATION; LYMPHOCYTES; APOPTOSIS	Regulated intramembrane proteolysis is a widely conserved mechanism for controlling diverse biological processes. Considering that proteolysis is irreversible, it must be precisely regulated in a context-dependent manner. Here, we show that phosphoglycerate mutase 5 (PGAM5), a mitochondrial Ser/Thr protein phosphatase, is cleaved in its N-terminal transmembrane domain in response to mitochondrial membrane potential (Delta Psi(m)) loss. This Delta Psi(m) loss-dependent cleavage of PGAM5 was mediated by presenilin-associated rhomboid-like (PARL). PARL is a mitochondrial resident rhomboid serine protease and has recently been reported to mediate the cleavage of PINK1, a mitochondrial Ser/Thr protein kinase, in healthy mitochondria with intact Delta Psi(m). Intriguingly, we found that PARL dissociated from PINK1 and reciprocally associated with PGAM5 in response to Delta Psi(m) loss. These results suggest that PARL mediates differential cleavage of PINK1 and PGAM5 depending on the health status of mitochondria. Our data provide a prototypical example of stress-dependent regulation of PARL-mediated regulated intramembrane proteolysis.	[Takeda, Kohsuke] Nagasaki Univ, Div Cell Regulat, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Takeda, Kohsuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ishihara, Naotada] Kurume Univ, Inst Life Sci, Dept Prot Biochem, Kurume, Fukuoka 8390864, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Dept Cell Biol & Neurosci, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Sekine, Shiori; Kanamaru, Yusuke; Nishihara, Ayako; Okada, Masahiro; Kinoshita, Hideyuki; Kamiyama, Miki; Maruyama, Junichi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Kurume University; Juntendo University; University of Tokyo	Takeda, K (corresponding author), Nagasaki Univ, Div Cell Regulat, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	takeda-k@nagasaki-u.ac.jp	Kamiyama, Miki/K-4044-2019; Koike, Masato/F-9584-2010	Kamiyama, Miki/0000-0002-9817-6703; Koike, Masato/0000-0002-3174-5684; Takeda, Kohsuke/0000-0002-8359-8399; Ishihara, Naotada/0000-0002-6305-7149; MARUYAMA, Junichi/0000-0002-3665-2700; Ichijo, Hidenori/0000-0002-5005-6438	Japan Science and Technology Agency PRESTO program; KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global Center of Education and Research for Chemical Biology of the Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [24659027] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Education and Research for Chemical Biology of the Diseases; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation Natural Science Scholarship; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency PRESTO program, KAKENHI from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology of Japan, Global Center of Education and Research for Chemical Biology of the Diseases, the "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation.; Supported by a grant-in-aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan. To whom correspondence should be addressed: Division of Cell Regulation, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan. Tel: 81-95-819-2417; Fax: 81-95-819-2472; E-mail: takeda-k@nagasaki-u.ac.jp.	Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Ishida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030265; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Sado Y, 2006, ACTA HISTOCHEM CYTOC, V39, P89, DOI 10.1267/ahc.06001; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Suzuki H, 2002, J CELL SCI, V115, P1895; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109	42	105	109	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34635	34645		10.1074/jbc.M112.357509	http://dx.doi.org/10.1074/jbc.M112.357509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22915595	hybrid, Green Published			2022-12-28	WOS:000309654200066
J	Chollangi, S; Mather, T; Rodgers, KK; Ash, JD				Chollangi, Srinivas; Mather, Timothy; Rodgers, Karla K.; Ash, John D.			A Unique Loop Structure in Oncostatin M Determines Binding Affinity toward Oncostatin M Receptor and Leukemia Inhibitory Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; ACUTE-PHASE PROTEINS; SIGNAL TRANSDUCER; M OSM; CELL-GROWTH; FACTOR LIF; GP130; ACTIVATION; EXPRESSION; CARDIOTROPHIN-1	Oncostatin M (OSM) and leukemia inhibitory factor are pleiotropic cytokines that belong to the interleukin-6 (IL-6) family. These cytokines play a crucial role in diverse biological events like inflammation, neuroprotection, hematopoiesis, metabolism, and development. The family is grouped together based on structural similarities and their ability to activate the transmembrane receptor glycoprotein 130 (gp130). The common structure among these cytokines defines the spacing and the orientation of binding sites for cell surface receptors. OSM is unique in this family as it can signal using heterodimers of gp130 with either leukemia inhibitory factor receptor (LIFR) (type I) or oncostatin M receptor (OSMR) (type II). We have identified a unique helical loop on OSM between its B and C helices that is not found on other IL-6 family cytokines. This loop is located near the "FXXK" motif in active site III, which is essential for OSM's binding to both LIFR and OSMR. In this study, we show that the BC loop does not play a role in OSM's unique ability to bind OSMR. Shortening of the loop enhanced OSM's interaction with OSMR and LIFR as shown by kinetic and equilibrium binding analysis, suggesting the loop may hinder receptor interactions. As a consequence of improved binding, these structurally modified OSMs exhibited enhanced biological activity, including suppressed proliferation of A375 melanoma cells.	[Ash, John D.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chollangi, Srinivas] Univ Oklahoma, Dept Bioengn, Norman, OK 73019 USA; [Mather, Timothy] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Rodgers, Karla K.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ash, JD (corresponding author), Univ Florida, Dept Ophthalmol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	jash@ufl.edu		Rodgers, Karla/0000-0002-7338-0281; Ash, John/0000-0002-8330-7301	National Institutes of Health [R01 EY016459]; Research to Prevent Blindness;  [P20 RR017703];  [P30 EY021721]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021721, R01EY016459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY016459 and Core Grants P20 RR017703 and P30 EY021721. This work was also supported by the Research to Prevent Blindness.	Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V62, P32, DOI 10.1159/000133439; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; Grant SL, 2001, GROWTH FACTORS, V19, P153, DOI 10.3109/08977190109001083; Heinrich PC, 1995, ANN NY ACAD SCI, V762, P222; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; Horn D, 1990, GROWTH FACTORS, V2, P157, DOI 10.3109/08977199009071502; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Ichihara M, 1997, BLOOD, V90, P165; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Liu HY, 2009, INT J MOL MED, V23, P161, DOI 10.3892/ijmm_00000113; Liu JW, 1997, CELL GROWTH DIFFER, V8, P667; Liu JW, 1998, CYTOKINE, V10, P295, DOI 10.1006/cyto.1997.0283; LIU JW, 1992, J BIOL CHEM, V267, P16763; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NISHIMOTO N, 1994, J EXP MED, V179, P1343, DOI 10.1084/jem.179.4.1343; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; Richards CD, 1997, J IMMUNOL, V159, P2431; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; SPORENO E, 1994, J BIOL CHEM, V269, P10991; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; TAGA T, 1992, CHEM IMMUNOL, V51, P181; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	44	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32848	32859		10.1074/jbc.M112.387324	http://dx.doi.org/10.1074/jbc.M112.387324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22829597	Green Published, hybrid			2022-12-28	WOS:000309168300050
J	Hatano, N; Itoh, Y; Suzuki, H; Muraki, Y; Hayashi, H; Onozaki, K; Wood, IC; Beech, DJ; Muraki, K				Hatano, Noriyuki; Itoh, Yuka; Suzuki, Hiroka; Muraki, Yukiko; Hayashi, Hidetoshi; Onozaki, Kikuo; Wood, Ian C.; Beech, David J.; Muraki, Katsuhiko			Hypoxia-inducible Factor-1 alpha (HIF1 alpha) Switches on Transient Receptor Potential Ankyrin Repeat 1 (TRPA1) Gene Expression via a Hypoxia Response Element-like Motif to Modulate Cytokine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF-ALPHA; FACTOR-I; TRANSCRIPTIONAL REGULATION; INTRACELLULAR CA2+; HUMAN SYNOVIOCYTES; TRPC1 EXPRESSION; SENSORY NEURONS; CATION CHANNELS; HUMAN MONOCYTES	Transient receptor potential ankyrin repeat 1 (TRPA1) forms calcium (Ca2+)- and zinc (Zn2+)-permeable ion channels that sense noxious substances. Despite the biological and clinical importance of TRPA1, there is little knowledge of the mechanisms that lead to transcriptional regulation of TRPA1 and of the functional role of transcriptionally induced TRPA1. Here we show induction of TRPA1 by inflammatory mediators and delineate the underlying molecular mechanisms and functional relevance. In human fibroblast-like synoviocytes, key inflammatory mediators (tumor necrosis factor-alpha and interleukin-1 alpha) induced TRPA1 gene expression via nuclear factor-kappa B signaling and downstream activation of the transcription factor hypoxia-inducible factor-1 alpha (HIF1 alpha). HIF1 alpha unexpectedly acted by binding to a specific hypoxia response element-like motif and its flanking regions in the TRPA1 gene. The induced TRPA1 channels, which were intrinsically activated by endogenous hydrogen peroxide and Zn2+, suppressed secretion of interleukin-6 and interleukin-8. The data suggest a previously unrecognized HIF1 alpha mechanism that links inflammatory mediators to ion channel expression.	[Hatano, Noriyuki; Itoh, Yuka; Suzuki, Hiroka; Muraki, Yukiko; Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Itoh, Yuka; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Onozaki, Kikuo] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Wood, Ian C.; Beech, David J.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	Aichi Gakuin University; Nagoya City University; Nagoya City University; University of Leeds	Muraki, K (corresponding author), Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	kmuraki@dpc.agu.ac.jp	Wood, Ian/AAK-9423-2021	Wood, Ian/0000-0003-1886-2533; Beech, David/0000-0002-7683-9422	Japanese Society of Promotion and Science (JSPS); Cosmetology Research Foundation; Japan Research Foundation for Clinical Pharmacology; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [24590085, 23790966] Funding Source: KAKEN	Japanese Society of Promotion and Science (JSPS); Cosmetology Research Foundation; Japan Research Foundation for Clinical Pharmacology; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (to K. M.) from the Japanese Society of Promotion and Science (JSPS), The Cosmetology Research Foundation, the Japan Research Foundation for Clinical Pharmacology, and the Suzuken Memorial Foundation. Part of this work was supported by the JSPS International Collaboration Program (to K. M. and D. B.).	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Choi JH, 2005, FEBS LETT, V579, P2795, DOI 10.1016/j.febslet.2005.03.097; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; Itoh Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1082, DOI 10.1152/ajpcell.00204.2009; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Smedlund K, 2010, CIRC RES, V106, P1479, DOI 10.1161/CIRCRESAHA.109.213314; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Ueda T, 2011, AM J PHYSIOL-GASTR L, V301, pG138, DOI 10.1152/ajpgi.00511.2010; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	46	72	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31962	31972		10.1074/jbc.M112.361139	http://dx.doi.org/10.1074/jbc.M112.361139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843691	Green Published, hybrid			2022-12-28	WOS:000309059400035
J	Benned-Jensen, T; Norn, C; Laurent, S; Madsen, CM; Larsen, HM; Arfelt, KN; Wolf, RM; Frimurer, T; Sailer, AW; Rosenkilde, MM				Benned-Jensen, Tau; Norn, Christoffer; Laurent, Stephane; Madsen, Christian M.; Larsen, Hjalte M.; Arfelt, Kristine N.; Wolf, Romain M.; Frimurer, Thomas; Sailer, Andreas W.; Rosenkilde, Mette M.			Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CONSTITUTIVE ACTIVITY; 7-TRANSMEMBRANE RECEPTOR; CRYSTAL-STRUCTURE; SIGNALING PATHWAY; STRUCTURAL BASIS; ROR-GAMMA; ACTIVATION; LIGAND; EBI2	Oxysterols are oxygenated cholesterol derivates that are emerging as a physiologically important group of molecules. Although they regulate a range of cellular processes, only few oxysterol-binding effector proteins have been identified, and the knowledge of their binding mode is limited. Recently, the family of G protein-coupled seven transmembrane-spanning receptors (7TM receptors) was added to this group. Specifically, the Epstein-Barr virus-induced gene 2 (EBI2 or GPR183) was shown to be activated by several oxysterols, most potently by 7 alpha,25-dihydroxycholesterol (7 alpha,25-OHC). Nothing is known about the binding mode, however. Using mutational analysis, we identify here four key residues for 7 alpha,25-OHC binding: Arg-87 in TM-II (position II: 20/2.60), Tyr-112 and Tyr-116 (positions III: 09/3.33 and III: 13/3.37) in TM-III, and Tyr-260 in TM-VI (position VI: 16/6.51). Substituting these residues with Ala and/or Phe results in a severe decrease in agonist binding and receptor activation. Docking simulations suggest that Tyr-116 interacts with the 3 beta-OH group in the agonist, Tyr-260 with the 7 alpha-OH group, and Arg-87, either directly or indirectly, with the 25-OH group, although nearby residues likely also contribute. In addition, Tyr-112 is involved in 7 alpha,25-OHC binding but via hydrophobic interactions. Finally, we show that II: 20/2.60 constitutes an important residue for ligand binding in receptors carrying a positively charged residue at this position. This group is dominated by lipid-and nucleotide-activated receptors, here exemplified by the CysLTs, P2Y12, and P2Y14. In conclusion, we present the first molecular characterization of oxysterol binding to a 7TM receptor and identify position II: 20/2.60 as a generally important residue for ligand binding in certain 7TM receptors.	[Benned-Jensen, Tau; Madsen, Christian M.; Arfelt, Kristine N.; Rosenkilde, Mette M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen N, Denmark; [Norn, Christoffer; Larsen, Hjalte M.; Frimurer, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark; [Laurent, Stephane; Wolf, Romain M.; Sailer, Andreas W.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Frimurer, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Laurent, Stephane; Wolf, Romain M.; Sailer, Andreas W.] Novartis Pharma AG, Basel, Switzerland	University of Copenhagen; University of Copenhagen; Novartis; Novo Nordisk Foundation; University of Copenhagen; Novartis	Rosenkilde, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	rosenkilde@sund.ku.dk	; Sailer, Andreas/M-9913-2016	Rosenkilde, Mette Marie/0000-0001-9600-3254; Norn, Christoffer/0000-0002-1450-4651; Sailer, Andreas/0000-0002-9015-7946; Frimruer, Thomas/0000-0002-9682-8245				Alexander Nathan, 2011, IEEE Int Conf Comput Adv Bio Med Sci, V2011, P13, DOI 10.1109/ICCABS.2011.5729867; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Benned-Jensen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024644; Benned-Jensen T, 2011, J BIOL CHEM, V286, P29292, DOI 10.1074/jbc.M110.196345; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lu DS, 1998, MOL ENDOCRINOL, V12, P592, DOI 10.1210/me.12.4.592; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Panini SR, 2001, J LIPID RES, V42, P1678; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu LY, 2010, LIPIDS, V45, P821, DOI 10.1007/s11745-010-3451-y	45	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35470	35483		10.1074/jbc.M112.387894	http://dx.doi.org/10.1074/jbc.M112.387894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22875855	Green Published, hybrid			2022-12-28	WOS:000309968000056
J	Janda, A; Eryilmaz, E; Nakouzi, A; Cowburn, D; Casadevall, A				Janda, Alena; Eryilmaz, Ertan; Nakouzi, Antonio; Cowburn, David; Casadevall, Arturo			Variable Region Identical Immunoglobulins Differing in Isotype Express Different Paratopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTOCOCCUS-NEOFORMANS; NMR-SPECTROSCOPY; CONSTANT-REGION; ANTIGEN-BINDING; FINE SPECIFICITY; ANTIBODY; AFFINITY; PEPTIDE; PROTEIN; POLYSACCHARIDE	The finding that the antibody (Ab) constant (C) region can influence fine specificity suggests that isotype switching contributes to the generation of Ab diversity and idiotype restriction. Despite the centrality of this observation for diverse immunological effects such as vaccine responses, isotype-restricted antibody responses, and the origin of primary and secondary responses, the molecular mechanism(s) responsible for this phenomenon are not understood. In this study, we have taken a novel approach to the problem by probing the paratope with N-15 label peptide mimetics followed by NMR spectroscopy and fluorescence emission spectroscopy. Specifically, we have explored the hypothesis that the C region imposes conformational constraints on the variable (V) region to affect paratope structure in a V region identical IgG(1), IgG(2a), IgG(2b), and IgG(3) mAbs. The results reveal isotype-related differences in fluorescence emission spectroscopy and temperature-related differences in binding and cleavage of a peptide mimetic. We conclude that the C region can modify the V region structure to alter the Ab paratope, thus providing an explanation for how isotype can affect Ab specificity.	[Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, Bronx, NY 10461 USA; [Eryilmaz, Ertan; Cowburn, David] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	arturo.casadevall@einstein.yu.edu	Cowburn, David/A-8448-2008; Markmann, Alena Janda/AAD-7310-2019	Markmann, Alena Janda/0000-0003-3656-9322; Cowburn, David/0000-0001-6770-7172	National Institutes of Health [2P41RR001081, HL059842, AI033774, AI052733, AI033142]; National Institute of General Medical Sciences Grant [9P41GM103311]; Institutional AIDS Training Grant [T32-AI007501]; NIH MSTP Training Grant [T32-GM007288]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, R01AI033774, T32AI007501, R01AI052733, R01AI033142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional AIDS Training Grant; NIH MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P41RR001081. This work was also supported by National Institute of General Medical Sciences Grant 9P41GM103311.; Supported by Institutional AIDS Training Grant T32-AI007501 and NIH MSTP Training Grant T32-GM007288.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bianchi E, 2009, ADV EXP MED BIOL, V611, P121, DOI 10.1007/978-0-387-73657-0_54; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109; Case DA, 2010, AMBER11; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Dadachova E, 2006, J INFECT DIS, V193, P1427, DOI 10.1086/503369; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; ERHAN S, 1974, NATURE, V251, P353, DOI 10.1038/251353a0; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gilliland GL, 2012, METHODS MOL BIOL, V841, P321, DOI 10.1007/978-1-61779-520-6_14; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KATO K, 1991, BIOCHEMISTRY-US, V30, P6604, DOI 10.1021/bi00240a033; Lange H, 1996, EUR J IMMUNOL, V26, P2234, DOI 10.1002/eji.1830260940; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; Messina TC, 2007, BIOPHYS J, V93, P579, DOI 10.1529/biophysj.107.103911; MORAHAN G, 1983, NATURE, V301, P720, DOI 10.1038/301720a0; Nicholas MP, 2010, PROG NUCL MAG RES SP, V57, P111, DOI 10.1016/j.pnmrs.2010.04.003; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritsch O, 2000, EUR J IMMUNOL, V30, P3387, DOI 10.1002/1521-4141(2000012)30:12<3387::AID-IMMU3387>3.0.CO;2-K; REITAN SK, 1995, EUR J IMMUNOL, V25, P1601, DOI 10.1002/eji.1830250620; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; SPIRA G, 1992, J IMMUNOL METHODS, V148, P121, DOI 10.1016/0022-1759(92)90165-P; Tanford C, 1997, PROTEIN SCI, V6, P1358, DOI 10.1002/pro.5560060627; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; TSANG P, 1992, BIOCHEMISTRY-US, V31, P3862, DOI 10.1021/bi00130a018; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407; ZILBER B, 1990, BIOCHEMISTRY-US, V29, P10032, DOI 10.1021/bi00495a004	51	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35409	35417		10.1074/jbc.M112.404483	http://dx.doi.org/10.1074/jbc.M112.404483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22930758	Green Published, hybrid			2022-12-28	WOS:000309968000048
J	Normoyle, KPM; Brieher, WM				Normoyle, Kieran P. M.; Brieher, William M.			Cyclase-associated Protein (CAP) Acts Directly on F-actin to Accelerate Cofilin-mediated Actin Severing across the Range of Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT TURNOVER; INTERACTING PROTEIN-1; IN-VIVO; LISTERIA-MONOCYTOGENES; DEPOLYMERIZING FACTOR; ADP-ACTIN; MOLECULAR-MECHANISMS; NONMUSCLE CELLS; COMET TAILS; BOUND ACTIN	Fast actin depolymerization is necessary for cells to rapidly reorganize actin filament networks. Utilizing a Listeria fluorescent actin comet tail assay to monitor actin disassembly rates, we observed that although a mixture of actin disassembly factors (cofilin, coronin, and actin-interacting protein 1 is sufficient to disassemble actin comet tails in the presence of physiological G-actin concentrations this mixture was insufficient to disassemble actin comet tails in the presence of physiological F-actin concentrations. Using biochemical complementation, we purified cyclase-associated protein (CAP) from thymus extracts as a factor that protects against the inhibition of excess F-actin. CAP has been shown to participate in actin dynamics but has been thought to act by liberating cofilin from ADP center dot G-actin monomers to restore cofilin activity. However, we found that CAP augments cofilin-mediated disassembly by accelerating the rate of cofilin-mediated severing. We also demonstrated that CAP acts directly on F-actin and severs actin filaments at acidic, but not neutral, pH. At the neutral pH characteristic of cytosol in most mammalian cells, we demonstrated that neither CAP nor cofilin are capable of severing actin filaments. However, the combination of CAP and cofilin rapidly severed actin at all pH values across the physiological range. Therefore, our results reveal a new function for CAP in accelerating cofilin-mediated actin filament severing and provide a mechanism through which cells can maintain high actin turnover rates without having to alkalinize cytosol, which would affect many biochemical reactions beyond actin depolymerization.	[Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Normoyle, Kieran P. M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Brieher, WM (corresponding author), Univ Illinois, Dept Cell & Dev Biol, 601 Goodwin Ave, Urbana, IL 61801 USA.	wbrieher@illinois.edu		Normoyle, Kieran/0000-0003-1375-5958; Brieher, William/0000-0002-3168-6688	National Institutes of Health, NIDDK [DK 091169]; Ruth L. Kirschstein National Research Service Award predoctoral fellowship; March of Dimes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091169] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Research Service Award predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 091169 from the NIDDK (to K.P.M.N.) and a Ruth L. Kirschstein National Research Service Award predoctoral fellowship (to K.P.M.N.). This work was also supported by a grant from the March of Dimes.	Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Blondin L, 2002, EUR J BIOCHEM, V269, P4194, DOI 10.1046/j.1432-1033.2002.03101.x; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kueh HY, 2010, BIOPHYS J, V99, P2153, DOI 10.1016/j.bpj.2010.07.038; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Moriyama K, 2002, J CELL SCI, V115, P1591; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Muhlrad A, 2006, FEBS J, V273, P1488, DOI 10.1111/j.1742-4658.2006.05169.x; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; ROTTENBERG DA, 1985, ANN NEUROL, V17, P70, DOI 10.1002/ana.410170116; Sultana H, 2005, TRAFFIC, V6, P930, DOI 10.1111/j.1600-0854.2005.00330.x; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; SWISTON J, 1995, GENE, V165, P273, DOI 10.1016/0378-1119(95)00522-8; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VAUPEL P, 1989, CANCER RES, V49, P6449; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410	56	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35722	35732		10.1074/jbc.M112.396051	http://dx.doi.org/10.1074/jbc.M112.396051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904322	Green Published, hybrid			2022-12-28	WOS:000309968000083
J	Shi, M; Pedchenko, V; Greer, BH; Van Horn, WD; Santoro, SA; Sanders, CR; Hudson, BG; Eichman, BF; Zent, R; Pozzi, A				Shi, Mingjian; Pedchenko, Vadim; Greer, Briana H.; Van Horn, Wade D.; Santoro, Samuel A.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.; Zent, Roy; Pozzi, Ambra			Enhancing Integrin alpha 1 Inserted (I) Domain Affinity to Ligand Potentiates Integrin alpha 1 beta 1-mediated Down-regulation of Collagen Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; BINDING-SITE; A-DOMAIN; FEEDBACK-REGULATION; CRYSTAL-STRUCTURE; ALPHA-2-BETA-1; RECOGNITION; ACTIVATION; SUBUNIT; GENE	Integrin alpha 1 beta 1 binding to collagen IV, which is mediated by the alpha 1-inserted (I) domain, down-regulates collagen synthesis. When unligated, a salt bridge between Arg(287) and Glu(317) is thought to keep this domain in a low affinity conformation. Ligand binding opens the salt bridge leading to a high-affinity conformation. How modulating integrin alpha 1 beta 1 affinity alters collagen homeostasis is unknown. To address this question, we utilized a thermolysin-derived product of the alpha 1 alpha 2 alpha 1 network of collagen IV (alpha 1 alpha 2 alpha 1(IV) truncated protomer) that selectively binds integrin alpha 1 beta 1. We show that an E317A substitution enhanced binding to the truncated protomer, consistent with a previous finding that this substitution eliminates the salt bridge. Surprisingly, we show that an R287A substitution did not alter binding, whereas R287E/E317R substitutions enhanced binding to the truncated protomer. NMR spectroscopy and molecular modeling suggested that eliminating the Glu(317) negative charge is sufficient to induce a conformational change toward the open state. Thus, the role played by Glu(317) is largely independent of the salt bridge. We further show that cells expressing E317A or R287E/E317R substitutions have enhanced down-regulation of collagen IV synthesis, which is mediated by the ERK/MAPK pathway. In conclusion, we have demonstrated that modulating the affinity of the extracellular alpha 1 I domain to collagen IV enhances outside-in signaling by potentiating ERK activation and enhancing the down-regulation of collagen synthesis.	[Shi, Mingjian; Pedchenko, Vadim; Hudson, Billy G.; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Med Nephrol, Nashville, TN 37232 USA; [Pedchenko, Vadim; Santoro, Samuel A.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Van Horn, Wade D.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Greer, Briana H.; Sanders, Charles R.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Greer, Briana H.; Van Horn, Wade D.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Santoro, Samuel A.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Zent, Roy; Pozzi, Ambra] Vet Affairs Med Ctr, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Pozzi, A (corresponding author), Vanderbilt Univ, Med Ctr N, Div Nephrol & Hypertens, Dept Med, B3115, Nashville, TN 37232 USA.	ambra.pozzi@vanderbilt.edu	Van Horn, Wade/GSN-2667-2022	Van Horn, Wade/0000-0002-2493-5578; Shi, Mingjian/0000-0003-1569-9822; Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [2P01DK065123, DK069221, DK075594, DK083187, P30DK79341]; Department of Veterans Affairs; American Heart Association (AHA) [10POST4210008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R01DK075594, R01DK083187, P30DK079341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported, in whole or in part, by National Institutes of Health Grants 2P01DK065123 (to A. P., B. F. E., R. Z., and B. G. H.), DK069221 and DK075594 (to R. Z.), DK083187 (to R. Z. and C. R. S.), and P30DK79341 (the O'Brien) (to A. P. and R. Z.). This work was also supported by a Department of Veterans Affairs Merit Review (to A. P. and R. Z.) and by an American Heart Association (AHA) Established Investigator Award (to R. Z.) and AHA Grant 10POST4210008 (to W. D. V.-H.).	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAHOU WF, 1994, BLOOD, V84, P3734, DOI 10.1182/blood.V84.11.3734.bloodjournal84113734; Borza CM, 2012, J AM SOC NEPHROL, V23, P1027, DOI 10.1681/ASN.2011040367; Borza CM, 2010, J BIOL CHEM, V285, P40114, DOI 10.1074/jbc.M110.156729; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; Dzobo K, 2012, IUBMB LIFE, V64, P87, DOI 10.1002/iub.568; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fleming FE, 2011, J BIOL CHEM, V286, P6165, DOI 10.1074/jbc.M110.142992; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; Gardner H, 1999, J CELL SCI, V112, P263; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; KERN A, 1994, J BIOL CHEM, V269, P22811; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Pozzi A, 2009, CURR PHARM DESIGN, V15, P1318, DOI 10.2174/138161209787846748; Pozzi M, 1998, J CELL BIOL, V142, P587; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	40	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35139	35152		10.1074/jbc.M112.358648	http://dx.doi.org/10.1074/jbc.M112.358648			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22888006	hybrid, Green Published			2022-12-28	WOS:000309968000024
J	Chen, XL; Zhang, J; Zhang, M; Liu, S; Yan, WS; Jung, JH; Chen, XB				Chen, Xiangling; Zhang, Jin; Zhang, Min; Liu, Shou; Yan, Wensheng; Jung, JinHyuk; Chen, Xinbin			Serine 123 Phosphorylation Modulates p21 Protein Stability and Activity by Suppressing Ubiquitin-independent Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; P53; P21(CIP1); P21(WAF1/CIP1); INHIBITION; EXPRESSION; BINDING; PROLIFERATION	The cyclin-dependent kinase inhibitor p21(Waf1/Cip1) is a major regulator of the cell cycle and plays an important role in many cellular processes, including differentiation, stress response, apoptosis, and tumorigenesis. We previously cloned the gene encoding dog p21 and found that unlike its human ortholog, dog p21 is expressed as two isoforms, one high molecular mass band of 23 kDa and one low molecular mass band of 19 kDa. In the current study, we found that the high molecular mass band is phosphorylated, whereas the low molecular mass band is hypophosphorylated. Moreover, by generating multiple mutants of dog p21, we found that serine 123 and proline 124, which form a consensus site for proline-directed phosphorylation, are required for expression of the high molecular mass p21 isoform through phosphorylation at serine 123. Most importantly, we showed that serine 123 phosphorylation inhibits ubiquitin-independent proteasomal degradation of p21 protein and subsequently, prolongs p21 protein half-life and enhances the ability of p21 to suppress cell proliferation. Taken together, these data reveal that serine 123 phosphorylation modulates p21 protein stability and activity by suppressing ubiquitin-independent proteasomal degradation.	[Chen, Xiangling; Zhang, Jin; Zhang, Min; Liu, Shou; Yan, Wensheng; Jung, JinHyuk; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Zhang, J (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu	liu, shou/C-5406-2015		National Institutes of Health [R01 CA076069, R01 CA102188]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA102188, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA076069 and R01 CA102188.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Ji C, 1997, ONCOGENE, V15, P2749, DOI 10.1038/sj.onc.1201441; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Oku T, 1998, GENES CELLS, V3, P357, DOI 10.1046/j.1365-2443.1998.00199.x; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shivji MKK, 1998, ONCOGENE, V17, P2827, DOI 10.1038/sj.onc.1202352; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	42	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34410	34418		10.1074/jbc.M112.384990	http://dx.doi.org/10.1074/jbc.M112.384990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908227	Green Published, hybrid			2022-12-28	WOS:000309654200043
J	Gundimeda, U; McNeill, TH; Elhiani, AA; Schiffman, JE; Hinton, DR; Gopalakrishna, R				Gundimeda, Usha; McNeill, Thomas H.; Elhiani, Albert A.; Schiffman, Jason E.; Hinton, David R.; Gopalakrishna, Rayudu			Green Tea Polyphenols Precondition against Cell Death Induced by Oxygen-Glucose Deprivation via Stimulation of Laminin Receptor, Generation of Reactive Oxygen Species, and Activation of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; RAT PHEOCHROMOCYTOMA CELLS; (-)-EPIGALLOCATECHIN GALLATE; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; CEREBRAL-ISCHEMIA; IN-VITRO; TYROSINE PHOSPHORYLATION; HYDROGEN-PEROXIDE; REGULATED KINASE	As the development of synthetic drugs for the prevention of stroke has proven challenging, utilization of natural products capable of preconditioning neuronal cells against ischemia-induced cell death would be a highly useful complementary approach. In this study using an oxygen-glucose deprivation and reoxygenation (OGD/R) model in PC12 cells, we show that 2-day pretreatment with green tea polyphenols (GTPP) and their active ingredient, epigallocatechin-3-gallate (EGCG), protects cells from subsequent OGD/R-induced cell death. A synergistic interaction was observed between GTPP constituents, with unfractionated GTPP more potently preconditioning cells than EGCG. GTPP-induced preconditioning required the 67-kDa laminin receptor (67LR), to which EGCG binds with high affinity. 67LR also mediated the generation of reactive oxygen species (ROS) via activation of NADPH oxidase. An exogenous ROS-generating system bypassed 67LR to induce preconditioning, suggesting that sublethal levels of ROS are indeed an important mediator in GTPP-induced preconditioning. This role for ROS was further supported by the fact that antioxidants blocked GTPP-induced preconditioning. Additionally, ROS induced an activation and translocation of protein kinase C (PKC), particularly PKC epsilon from the cytosol to the membrane/mitochondria, which was also blocked by antioxidants. The crucial role of PKC in GTPP-induced preconditioning was supported by use of its specific inhibitors. Preconditioning was increased by conditional overexpression of PKC epsilon and decreased by its knock-out with siRNA. Collectively, these results suggest that GTPP stimulates 67LR and thereby induces NADPH oxidase-dependent generation of ROS, which in turn induces activation of PKC, particularly prosurvival isoenzyme PKC epsilon, resulting in preconditioning against cell death induced by OGD/R.	[Gundimeda, Usha; McNeill, Thomas H.; Elhiani, Albert A.; Schiffman, Jason E.; Gopalakrishna, Rayudu] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [McNeill, Thomas H.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90089 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Gopalakrishna, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA.	rgopalak@usc.edu						Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470; Ardehali H, 2006, CIRC RES, V99, P798, DOI 10.1161/01.RES.0000247029.31997.a4; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Barth BM, 2009, MOL CELL NEUROSCI, V41, P274, DOI 10.1016/j.mcn.2009.03.007; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BLUMBERG PM, 1994, PROG CLIN BIOL RES, V387, P3; Bode AM, 2009, CANCER PREV RES, V2, P514, DOI 10.1158/1940-6207.CAPR-09-0083; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Bright R, 2008, NEUROSCI LETT, V441, P120, DOI 10.1016/j.neulet.2008.05.080; Choi YB, 2004, BRAIN RES, V1019, P47, DOI 10.1016/j.brainres.2004.05.079; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; GONZALEZ A, 1993, ANAL BIOCHEM, V215, P184, DOI 10.1006/abio.1993.1574; GOPALAKRISHNA R, 1992, FEBS LETT, V314, P149, DOI 10.1016/0014-5793(92)80962-G; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gundimeda U, 2010, J NEUROSCI RES, V88, P3644, DOI 10.1002/jnr.22519; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Hong J, 2002, CANCER RES, V62, P7241; Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Kanthasamy AG, 2003, ANN NY ACAD SCI, V1010, P683, DOI 10.1196/annals.1299.125; Keller JN, 1998, J NEUROSCI, V18, P687; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Lange-Asschenfeldt C, 2004, J CEREBR BLOOD F MET, V24, P636, DOI 10.1097/01.WCB.0000121235.42748.BF; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Lee SY, 2003, BRAIN RES BULL, V61, P399, DOI 10.1016/S0361-9230(03)00139-4; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Lu QY, 2005, CLIN CANCER RES, V11, P1675, DOI 10.1158/1078-0432.CCR-04-1608; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morre DJ, 2003, PHARMACOL TOXICOL, V92, P234, DOI 10.1034/j.1600-0773.2003.920506.x; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Murakami K, 1998, J NEUROSCI, V18, P205; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Natarajan V, 1996, AM J PHYSIOL-LUNG C, V271, pL400, DOI 10.1152/ajplung.1996.271.3.L400; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Park JW, 2009, J NEUROSCI RES, V87, P567, DOI 10.1002/jnr.21847; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Rahman RMA, 2005, NEUROSCI LETT, V382, P227, DOI 10.1016/j.neulet.2005.03.018; Raval AP, 2007, BRAIN RES, V1184, P345, DOI 10.1016/j.brainres.2007.09.073; Raval AP, 2005, J CEREBR BLOOD F MET, V25, P730, DOI 10.1038/sj.jcbfm.9600071; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Salmeen A, 2010, ONCOGENE, V29, P4473, DOI 10.1038/onc.2010.200; Sang SM, 2007, FREE RADICAL BIO MED, V43, P362, DOI 10.1016/j.freeradbiomed.2007.04.008; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Suganuma M, 1999, CANCER RES, V59, P44; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Tabakman R, 2004, J MOL NEUROSCI, V22, P237, DOI 10.1385/JMN:22:3:237; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang J, 2004, NEUROPHARMACOLOGY, V47, P136, DOI 10.1016/j.neuropharm.2004.03.009; Wang ZF, 2002, ACTA PHARMACOL SIN, V23, P1193; Wang Z, 2008, NEUROL RES, V30, P106, DOI 10.1179/016164107X229894; Xu W, 2007, ACTA PHARMACOL SIN, V28, P1573, DOI 10.1111/j.1745-7254.2007.00502.x; Wise-Faberowski L, 2001, ANESTH ANALG, V93, P1281, DOI 10.1097/00000539-200111000-00051; Xie J, 2000, MOL BRAIN RES, V82, P107, DOI 10.1016/S0169-328X(00)00187-X; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yang CS, 2004, J NUTR, V134, p3181S, DOI 10.1093/jn/134.11.3181S; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608; Zabouri N, 2002, NEUROSCI LETT, V329, P257, DOI 10.1016/S0304-3940(02)00686-9; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	101	47	48	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34694	34708		10.1074/jbc.M112.356899	http://dx.doi.org/10.1074/jbc.M112.356899			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879598	hybrid, Green Published			2022-12-28	WOS:000309654200070
J	Miki, T; Holst, O; Hardt, WD				Miki, Tsuyoshi; Holst, Otto; Hardt, Wolf-Dietrich			The Bactericidal Activity of the C-type Lectin RegIII beta against Gram-negative Bacteria involves Binding to Lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION; VIRULENCE FACTORS; INNATE IMMUNITY; PANETH CELLS; EXPRESSION; MICROBIOTA; PROTEIN; GAMMA; SALMONELLA; HOST	RegIII beta is a member of the C-type lectin family called RegIII. It is known to bind peptidoglycan, and its bactericidal activity shapes the interactions with commensal and pathogenic gut bacteria. However, little is known about its carbohydrate recognition specificity and the bactericidal mechanism, particularly against Gram-negative bacteria. Here, we show that RegIII beta can bind directly to LPS by recognizing the carbohydrate moiety of lipid A via a novel motif that is indispensable for its bactericidal activity. This bactericidal activity of RegIII beta could be inhibited by preincubation with LPS, lipid A, or gentiobiose. The latter is a disaccharide composed of two units of beta-(1 -> 6)-linked D-glucose and resembles the carbohydrate moiety of lipid A. Therefore, this structural element may form a key target site recognized by RegIII beta. Using point-mutated RegIII beta proteins, we found that amino acid residues in two structural motifs termed "loop 1" and "loop 2," are important for peptidoglycan and lipid A binding (Arg-135, Asp-142) and for the bactericidal activity (Glu-134, Asn-136, Asp-142). Thus, the ERN motif and residue Asp-142 in the loop 2 are of critical importance for RegIII beta function. This provides novel insights into the carbohydrate recognition specificity of RegIII beta and explains its bactericidal activity against Gram-negative bacteria.	[Miki, Tsuyoshi; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Forschungszentrum Borstel	Hardt, WD (corresponding author), ETH, Inst Microbiol, Dept Biol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hardt@micro.biol.ethz.ch		Hardt, Wolf-Dietrich/0000-0002-9892-6420	ETH Zurich Research Foundation [ETH-08-08-3]; Naito Foundation	ETH Zurich Research Foundation(ETH Zurich); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant ETH-08-08-3 from the ETH Zurich Research Foundation (to W.-D. H.).; Supported by the Naito Foundation.	Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Keilbaugh SA, 2005, GUT, V54, P623, DOI 10.1136/gut.2004.056028; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Narushima Y, 1997, GENE, V185, P159, DOI 10.1016/S0378-1119(96)00589-6; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	33	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34844	34855		10.1074/jbc.M112.399998	http://dx.doi.org/10.1074/jbc.M112.399998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896700	hybrid, Green Published			2022-12-28	WOS:000309654200083
J	Liu, GQ; Myers, S; Chen, XM; Bissler, JJ; Sinden, RR; Leffak, M				Liu, Guoqi; Myers, Shere; Chen, Xiaomi; Bissler, John J.; Sinden, Richard R.; Leffak, Michael			Replication Fork Stalling and Checkpoint Activation by a PKD1 Locus Mirror Repeat Polypurine-Polypyrimidine (Pu-Py) Tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE CHECKPOINT; C-MYC REPLICATOR; GROSS CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; INTRAMOLECULAR TRIPLEX DNA; SYNTHESIS IN-VITRO; PROTEIN DUE-B; HUMAN-CELLS; MAMMALIAN-CELLS	DNA sequences prone to forming noncanonical structures ( hairpins, triplexes, G-quadruplexes) cause DNA replication fork stalling, activate DNA damage responses, and represent hotspots of genomic instability associated with human disease. The 88-bp asymmetric polypurine-polypyrimidine (Pu-Py) mirror repeat tract from the human polycystic kidney disease (PKD1) intron 21 forms non-B DNA secondary structures in vitro. We show that the PKD1 mirror repeat also causes orientation-dependent fork stalling during replication in vitro and in vivo. When integrated alongside the c-myc replicator at an ectopic chromosomal site in the HeLa genome, the Pu-Py mirror repeat tract elicits a polar replication fork barrier. Increased replication protein A (RPA), Rad9, and ataxia telangiectasia- and Rad3-related (ATR) checkpoint protein binding near the mirror repeat sequence suggests that the DNA damage response is activated upon replication fork stalling. Moreover, the proximal c-myc origin of replication was not required to cause orientation-dependent checkpoint activation. Cells expressing the replication fork barrier display constitutive Chk1 phosphorylation and continued growth, i.e. checkpoint adaptation. Excision of the Pu-Py mirror repeat tract abrogates the DNA damage response. Adaptation to Chk1 phosphorylation in cells expressing the replication fork barrier may allow the accumulation of mutations that would otherwise be remediated by the DNA damage response.	[Liu, Guoqi; Myers, Shere; Chen, Xiaomi; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Bissler, John J.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Sinden, Richard R.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	University System of Ohio; Wright State University Dayton; Cincinnati Children's Hospital Medical Center; Florida Institute of Technology	Liu, GQ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Guoqi.Liu@yahoo.com; Michael.Leffak@wright.edu	Sinden, Richard/AAE-3086-2019	Bissler, John/0000-0001-9685-9183	National Institutes of Health [DK016458, GM53819]; WSU Boonshoft School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819, R01GM099874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WSU Boonshoft School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK016458 (to J. J. B.) and GM53819 (to M. L.). This work was also supported by a grant from the WSU Boonshoft School of Medicine (to G. L.).	Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; BERBERICH S, 1995, J MOL BIOL, V245, P92, DOI 10.1006/jmbi.1994.0010; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Blaszak RT, 1999, NUCLEIC ACIDS RES, V27, P2610, DOI 10.1093/nar/27.13.2610; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Bucek P, 2009, CHEM-EUR J, V15, P12663, DOI 10.1002/chem.200901631; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; CARTY MP, 1993, MOL CELL BIOL, V13, P533, DOI 10.1128/MCB.13.1.533; Carty MP, 1996, J BIOL CHEM, V271, P9637, DOI 10.1074/jbc.271.16.9637; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Chowdhury A, 2010, MOL CELL BIOL, V30, P1495, DOI 10.1128/MCB.00710-09; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Entezam A, 2008, NUCLEIC ACIDS RES, V36, P1050, DOI 10.1093/nar/gkm1136; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Ghosh M, 2004, MOL CELL BIOL, V24, P10193, DOI 10.1128/MCB.24.23.10193-10207.2004; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Inoue Mamiko, 2005, Nucleic Acids Symp Ser (Oxf), P243, DOI 10.1093/nass/49.1.243; Jackson JR, 2000, CANCER RES, V60, P566; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Kendrick S, 2009, J AM CHEM SOC, V131, P17667, DOI 10.1021/ja9076292; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; Krasilnikova Maria M., 2004, V277, P19; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Lahiri M, 2004, MOL CELL, V15, P287, DOI 10.1016/j.molcel.2004.06.034; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2012, MOL CELL BIOL, V32, P1618, DOI 10.1128/MCB.06727-11; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lobachev KS, 2007, FRONT BIOSCI-LANDMRK, V12, P4208, DOI 10.2741/2381; Malott M, 1999, MOL CELL BIOL, V19, P5685; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; O'Callaghan FJK, 2000, J MED GENET, V37, P156, DOI 10.1136/jmg.37.2.156; Patel HP, 2004, NUCLEIC ACIDS RES, V32, P1460, DOI 10.1093/nar/gkh312; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Prindle MJ, 2010, CURR DRUG TARGETS, V11, P1296; Rao BS, 1996, MOL CELL BIOCHEM, V156, P163; Razidlo DF, 2008, DNA REPAIR, V7, P633, DOI 10.1016/j.dnarep.2008.01.009; Rodriguez-Bravo V, 2006, CANCER RES, V66, P8672, DOI 10.1158/0008-5472.CAN-05-4443; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Tiner WJ, 2001, J MOL BIOL, V314, P353, DOI 10.1006/jmbi.2001.5174; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; USSERY DW, 1993, BIOCHEMISTRY-US, V32, P6206, DOI 10.1021/bi00075a013; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Voineagu I, 2009, MOL CARCINOGEN, V48, P309, DOI 10.1002/mc.20512; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Xu YJ, 2010, P NATL ACAD SCI USA, V107, P13561, DOI 10.1073/pnas.1008909107; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	93	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33412	33423		10.1074/jbc.M112.402503	http://dx.doi.org/10.1074/jbc.M112.402503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872635	Green Published, hybrid			2022-12-28	WOS:000309602100028
J	Bourguignon, LYW; Wong, G; Earle, C; Chen, LQ				Bourguignon, Lilly Y. W.; Wong, Gabriel; Earle, Christine; Chen, Liqun			Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MARKER NANOG; IN-VITRO; CD44; MICRORNA; ISOFORMS; BREAST; SOX2	Human head and neck squamous cell carcinoma (HNSCC) is a highly malignant cancer associated with major morbidity and mortality. In this study, we determined that human HNSCC-derived HSC-3 cells contain a subpopulation of cancer stem cells (CSCs) characterized by high levels of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression. These tumor cells also express several stem cell markers (the transcription factors Oct4, Sox2, and Nanog) and display the hallmark CSC properties of self-renewal/clonal formation and the ability to generate heterogeneous cell populations. Importantly, hyaluronan (HA) stimulates the CD44v3 (an HA receptor) interaction with Oct4-Sox2-Nanog leading to both a complex formation and the nuclear translocation of three CSC transcription factors. Further analysis reveals that microRNA-302 (miR-302) is controlled by an upstream promoter containing Oct4-Sox2-Nanog-binding sites, whereas chromatin immunoprecipitation (ChIP) assays demonstrate that stimulation of miR-302 expression by HA-CD44 is Oct4-Sox2-Nanog-dependent in HNSCC-specific CSCs. This process results in suppression of several epigenetic regulators (AOF1/AOF2 and DNMT1) and the up-regulation of several survival proteins (cIAP-1, cIAP-2, and XIAP) leading to self-renewal, clonal formation, and cisplatin resistance. These CSCs were transfected with a specific anti-miR-302 inhibitor to silence miR-302 expression and block its target functions. Our results demonstrate that the anti-miR-302 inhibitor not only enhances the expression of AOF1/AOF2 and DNMT1 but also abrogates the production of cIAP-1, cIAP-2, and XIAP and HA-CD44v3-mediated cancer stem cell functions. Taken together, these findings strongly support the contention that the HA-induced CD44v3 interaction with Oct4-Sox2-Nanog signaling plays a pivotal role in miR-302 production leading to AOF1/AOF2/DNMT1 down-regulation and survival of protein activation. All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, clonal formation, and chemotherapy resistance in HA-CD44v3-activated head and neck cancer.	Univ Calif San Francisco, Dept Med, Endocrine Unit 111N2, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			National Institutes of Health from USPHS [R01 CA66163]; Veterans Affairs Merit Review grants; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA66163 from USPHS. This work was also supported by Veterans Affairs Merit Review grants and a Department of Defense grant.	Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Do JT, 2006, E SCHERING RES FDN W, V60, P35; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Franzmann EJ, 2001, OTOLARYNG HEAD NECK, V124, P426, DOI 10.1067/mhn.2001.114674; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura M, 2005, ONCOL REP, V14, P1281; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schulenburg A, 2006, CANCER-AM CANCER SOC, V107, P2512, DOI 10.1002/cncr.22277; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL C, 1992, J CELL SCI, V103, P293; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Q, 2009, ANTICANCER RES, V29, P1233; Wang SJ, 2007, HEAD NECK-J SCI SPEC, V29, P550, DOI 10.1002/hed.20544; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x	70	205	218	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32800	32824		10.1074/jbc.M111.308528	http://dx.doi.org/10.1074/jbc.M111.308528			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847005	hybrid, Green Published			2022-12-28	WOS:000309168300047
J	Palakodeti, A; Sandstrom, A; Sundaresan, L; Harly, C; Nedellec, S; Olive, D; Scotet, E; Bonneville, M; Adams, EJ				Palakodeti, Aparna; Sandstrom, Andrew; Sundaresan, Lakshmi; Harly, Christelle; Nedellec, Steven; Olive, Daniel; Scotet, Emmanuel; Bonneville, Marc; Adams, Erin J.			The Molecular Basis for Modulation of Human V gamma 9V delta 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTIGENS; CRYSTAL-STRUCTURE; BUTYROPHILIN; RECOGNITION; FAMILY; PYROPHOSPHATE; DOMAIN	Human V gamma 9V delta 2 T cells are well known for their rapid and potent response to infection and tumorigenesis when in the presence of endogenous or exogenous phosphoisoprenoids. However, the molecular mechanisms behind the activation of this gamma delta T cell population remains unclear. Evidence pointing to a role for the CD277/butyrophilin-3 (BTN3A) molecules in this response led us to investigate the structures of these molecules and their modifications upon binding to an agonist antibody (20.1) that mimics phosphoisoprenoid-mediated V gamma 9V delta 2 activation and an antagonist antibody (103.2) that inhibits this reactivity. We find that the three BTN3A isoforms: BTN3A1, BTN3A2, and BTN3A3, have high structural homology to the B7 superfamily of proteins and exist as V-shaped homodimers in solution, associating through the membrane proximal C-type Ig domain. The 20.1 and 103.2 antibodies bind to separate epitopes on the BTN3A Ig-V domain with high affinity but likely with different valencies based on their binding orientation. These structures directly complement functional studies of this system that demonstrate that BTN3A1 is necessary for V gamma 9V delta 2 activation and begin to unravel the extracellular events that occur during stimulation through the V gamma 9V delta 2 T cell receptor.	[Palakodeti, Aparna; Sandstrom, Andrew; Sundaresan, Lakshmi; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Palakodeti, Aparna; Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Harly, Christelle; Nedellec, Steven; Scotet, Emmanuel; Bonneville, Marc] Univ Nantes, INSERM, Inst Rech Therapeut, Ctr Rech Cancerol Nantes Angers,UMR892, F-44007 Nantes, France; [Olive, Daniel] Inst J Paoli I Calmettes, INSERM, Ctr Rech Cancerol Marseille, UMR891, F-13009 Marseille, France	University of Chicago; University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W236, Chicago, IL 60637 USA.	ejadams@uchicago.edu	SCOTET, Emmanuel/AAC-9971-2019; SCOTET, Emmanuel/L-2576-2015	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Sandstrom, Andrew/0000-0002-8629-9087; Harly, Christelle/0000-0002-8045-9166	National Institutes of Health [R01AI073922]; Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073922. This work was also supported by and the Kinship Foundation Searle Scholars Award (to E. J. A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Harly C., 2012, BLOOD IN PRESS; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Kabelitz D., 2010, F1000 MED REP, V2, P45; LANG F, 1995, J IMMUNOL, V154, P5986; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Sugita M, 1998, CLIN IMMUNOL IMMUNOP, V87, P8, DOI 10.1006/clin.1997.4500; TaziAhnini R, 1997, IMMUNOGENETICS, V47, P55, DOI 10.1007/s002510050326; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Yamashiro H, 2010, J LEUKOCYTE BIOL, V88, P757, DOI 10.1189/jlb.0309156; Yamazaki T, 2010, J IMMUNOL, V185, P5907, DOI 10.4049/jimmunol.1000835; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499	39	115	124	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32780	32790		10.1074/jbc.M112.384354	http://dx.doi.org/10.1074/jbc.M112.384354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846996	Green Published, hybrid			2022-12-28	WOS:000309168300045
J	Soares, DC; Bradshaw, NJ; Zou, J; Kennaway, CK; Hamilton, RS; Chen, ZA; Wear, MA; Blackburn, EA; Bramham, J; Bottcher, B; Millar, JK; Barlow, PN; Walkinshaw, MD; Rappsilber, J; Porteous, DJ				Soares, Dinesh C.; Bradshaw, Nicholas J.; Zou, Juan; Kennaway, Christopher K.; Hamilton, Russell S.; Chen, Zhuo A.; Wear, Martin A.; Blackburn, Elizabeth A.; Bramham, Janice; Boettcher, Bettina; Millar, J. Kirsty; Barlow, Paul N.; Walkinshaw, Malcolm D.; Rappsilber, Juri; Porteous, David J.			The Mitosis and Neurodevelopment Proteins NDE1 and NDEL1 Form Dimers, Tetramers, and Polymers with a Folded Back Structure in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; CROSS-LINKING; MASS-SPECTROMETRY; NUDEL; LIS1; SCHIZOPHRENIA; COMPLEX; PROTEOMICS; BINDING	Paralogs NDE1 (nuclear distribution element 1) and NDEL1 (NDE-like 1) are essential for mitosis and neurodevelopment. Both proteins are predicted to have similar structures, based upon high sequence similarity, and they co-complex inmammalian cells. X-ray diffraction studies and homology modeling suggest that their N-terminal regions (residues 8-167) adopt continuous, extended alpha-helical coiled-coil structures, but no experimentally derived information on the structure of their C-terminal regions or the architecture of the full-length proteins is available. In the case of NDE1, no biophysical data exists. Here we characterize the structural architecture of both full-length proteins utilizing negative stain electron microscopy along with our established paradigm of chemical cross-linking followed by tryptic digestion, mass spectrometry, and database searching, which we enhance using isotope labeling for mixed NDE1-NDEL1. We determined that full-length NDE1 forms needle-like dimers and tetramers in solution, similar to crystal structures of NDEL1, as well as chain-like end-to-end polymers. The C-terminal domain of each protein, required for interaction with key protein partners dynein and DISC1 (disrupted-inschizophrenia 1), includes a predicted disordered region that allows a bent back structure. This facilitates interaction of the C-terminal region with the N-terminal coiled-coil domain and is in agreement with previous results showing N- and C-terminal regions of NDEL1 and NDE1 cooperating in dynein interaction. It sheds light on recently identified mutations in the NDE1 gene that cause truncation of the encoded protein. Additionally, analysis of mixed NDE1-NDEL1 complexes demonstrates that NDE1 and NDEL1 can interact directly.	[Soares, Dinesh C.; Bradshaw, Nicholas J.; Millar, J. Kirsty; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Bradshaw, Nicholas J.] Univ Dusseldorf, Inst Neuropathol, D-40225 Dusseldorf, Germany; [Zou, Juan; Chen, Zhuo A.; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Kennaway, Christopher K.; Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Hamilton, Russell S.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Wear, Martin A.; Blackburn, Elizabeth A.; Bramham, Janice; Barlow, Paul N.; Walkinshaw, Malcolm D.] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Dept Biotechnol, D-13353 Berlin, Germany	University of Edinburgh; Heinrich Heine University Dusseldorf; University of Edinburgh; University of Edinburgh; University of Oxford; University of Edinburgh; Technical University of Berlin	Soares, DC (corresponding author), Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Inst Genet & Mol Med, Crewe Rd S, Edinburgh EH4 2XU, Midlothian, Scotland.	Dinesh.Soares@ed.ac.uk; Nicholas.Bradshaw@uni-duesseldorf.de	Rappsilber, Juri/B-7265-2015; walkinshaw, malcolm/AAB-7497-2019; Bottcher, Bettina/E-9397-2010; Soares, Dinesh C/A-4425-2012; Rappsilber, Juri/ABF-3328-2020; Hamilton, Russell/T-7240-2019; Porteous, David J/C-7289-2013; Bradshaw, Nicholas J./A-5625-2009; Porteous, David/AAA-3446-2021	Rappsilber, Juri/0000-0001-5999-1310; Bottcher, Bettina/0000-0002-7962-4849; Soares, Dinesh C/0000-0001-7557-0495; Hamilton, Russell/0000-0002-0598-3793; Porteous, David J/0000-0003-1249-6106; Bradshaw, Nicholas J./0000-0001-5581-8828; Porteous, David/0000-0003-1249-6106; walkinshaw, malcolm/0000-0001-5955-9325; Blackburn, Elizabeth A/0000-0003-1325-9575; CHEN, ZHUO/0000-0003-0811-8348; Zou, Juan/0000-0003-2594-6217	Wellcome Trust [088179/A/09/Z, 084229, 091020]; Wellcome Trust; Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council; Alexander von Humboldt Foundation; Darwin-Trust of Edinburgh; Wellcome Trust Centre [077707, 092076]; Medical Research Council [G0902166, G0100266, G0600014] Funding Source: researchfish; MRC [G0600014, G0100266, G0902166] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Darwin-Trust of Edinburgh; Wellcome Trust Centre(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 088179/A/09/Z (to D. C. S., N. J. B., J. K. M., P. N. B., M. D. W., J. R., and D. J. P.) and funds from the Wellcome Trust (to M. A. W., E. A. B., and J. B.), the Scottish University Life Sciences Alliance, and the Biotechnology and Biological Sciences Research Council.; Now supported by a fellowship from the Alexander von Humboldt Foundation. To whom correspondence may be addressed: Inst. fur Neuropathologie, Geb. 14.79, Universitatsklinikum Dusseldorf, Moorenstr. 5, 40225 Dusseldorf, Germany. Tel.: 49-211-811-8652; Fax: 49-211-811-7804; E-mail: Nicholas.Bradshaw@uni-duesseldorf.de.; Supported by the Darwin-Trust of Edinburgh.; Supported by the Wellcome Trust through Senior Research Fellowship 084229, Wellcome Trust Centre Core Grants 077707 and 092076, and a Wellcome Trust Instrument Grant 091020.	Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Bradshaw NJ, 2009, NEUROSCI LETT, V449, P228, DOI 10.1016/j.neulet.2008.10.095; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Chansard M, 2011, CYTOSKELETON, V68, P540, DOI 10.1002/cm.20532; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Collins DM, 2008, CELL SIGNAL, V20, P2356, DOI 10.1016/j.cellsig.2008.09.017; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hayashi MAF, 2005, P NATL ACAD SCI USA, V102, P3828, DOI 10.1073/pnas.0500330102; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Matic I, 2011, J PROTEOME RES, V10, P4869, DOI 10.1021/pr2004715; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Narayanan S, 2011, J BIOL CHEM, V286, P44266, DOI 10.1074/jbc.M111.271593; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Segal M, 2012, BIOL OPEN, V1, P220, DOI 10.1242/bio.2012307; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	54	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32381	32393		10.1074/jbc.M112.393439	http://dx.doi.org/10.1074/jbc.M112.393439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843697	Green Published, hybrid			2022-12-28	WOS:000309168300009
J	Lee, BH; Eskandari, R; Jones, K; Reddy, KR; Quezada-Calvillo, R; Nichols, BL; Rose, DR; Hamaker, BR; Pinto, BM				Lee, Byung-Hoo; Eskandari, Razieh; Jones, Kyra; Reddy, Kongara Ravinder; Quezada-Calvillo, Roberto; Nichols, Buford L.; Rose, David R.; Hamaker, Bruce R.; Pinto, B. Mario			Modulation of Starch Digestion for Slow Glucose Release through "Toggling" of Activities of Mucosal alpha-Glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MALTASE-GLUCOAMYLASE; MEDICINE SALACIA-RETICULATA; SULFONIUM SULFATE STRUCTURE; GLYCOSIDASE INHIBITORS; SUCRASE-ISOMALTASE; DISACCHARIDE DIGESTION; ENZYME SPECIFICITIES; TRADITIONAL MEDICINE; ACARBOSE; PRINCIPLE	Starch digestion involves the breakdown by alpha-amylase to small linear and branched malto-oligosaccharides, which are in turn hydrolyzed to glucose by the mucosal alpha-glucosidases, maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI). MGAM and SI are anchored to the small intestinal brush-border epithelial cells, and each contains a catalytic N- and C-terminal subunit. All four subunits have alpha-1,4-exohydrolytic glucosidase activity, and the SI N-terminal subunit has an additional exo-debranching activity on the alpha-1,6-linkage. Inhibition of alpha-amylase and/or alpha-glucosidases is a strategy for treatment of type 2 diabetes. We illustrate here the concept of "toggling": differential inhibition of subunits to examine more refined control of glucogenesis of the alpha-amylolyzed starch malto-oligosaccharides with the aim of slow glucose delivery. Recombinant MGAM and SI subunits were individually assayed with alpha-amylolyzed waxy corn starch, consisting mainly of maltose, maltotriose, and branched alpha-limit dextrins, as substrate in the presence of four different inhibitors: acarbose and three sulfonium ion compounds. The IC50 values show that the four alpha-glucosidase subunits could be differentially inhibited. The results support the prospect of controlling starch digestion rates to induce slow glucose release through the toggling of activities of the mucosal alpha-glucosidases by selective enzyme inhibition. This approach could also be used to probe associated metabolic diseases.	[Lee, Byung-Hoo; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Eskandari, Razieh; Reddy, Kongara Ravinder; Pinto, B. Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Jones, Kyra; Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Quezada-Calvillo, Roberto] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, CIEP, San Luis Potosi 78360, Mexico; [Nichols, Buford L.] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Nichols, Buford L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Simon Fraser University; University of Waterloo; Universidad Autonoma de San Luis Potosi; United States Department of Agriculture (USDA); Baylor College of Medicine	Hamaker, BR (corresponding author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, Smith Hall, W Lafayette, IN 47907 USA.	hamakerb@purdue.edu; bpinto@sfu.ca	Yoo, Sang-Ho/AAI-4446-2020	Eskandari, Razieh/0000-0003-1292-4094	Canadian Institutes of Health Research [111237]; Heart and Stroke Foundation of Ontario [NA-6305]; Canadian Institutes of Health Research/Canadian Digestive Health Foundation studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research/Canadian Digestive Health Foundation studentship(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 111237 and Heart and Stroke Foundation of Ontario Grant NA-6305.; Supported by a Canadian Institutes of Health Research/Canadian Digestive Health Foundation studentship.	ABDULLAH M, 1977, CARBOHYD RES, V57, P281, DOI 10.1016/S0008-6215(00)81937-0; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; CHANDRASENA JPC, 1935, CHEM PHARM CEYLON IN; Chehade JM, 2000, DRUGS, V60, P95, DOI 10.2165/00003495-200060010-00006; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; EGGERMONT E, 1969, EUR J BIOCHEM, V9, P483, DOI 10.1111/j.1432-1033.1969.tb00634.x; Eskandari R, 2011, CHEM-EUR J, V17, P14817, DOI 10.1002/chem.201102109; Eskandari R, 2011, CHEM COMMUN, V47, P9134, DOI 10.1039/c1cc13052h; Eskandari R, 2010, BIOORGAN MED CHEM, V18, P2829, DOI 10.1016/j.bmc.2010.03.027; Eskandari R, 2010, ORG LETT, V12, P1632, DOI 10.1021/ol1004005; Ghavami A, 2001, J ORG CHEM, V66, P2312, DOI 10.1021/jo001444g; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; Holman RR, 1999, DIABETES CARE, V22, P960, DOI 10.2337/diacare.22.6.960; JACOB GS, 1995, CURR OPIN STRUC BIOL, V5, P605, DOI 10.1016/0959-440X(95)80051-4; Jayakanthan K, 2009, J AM CHEM SOC, V131, P5621, DOI 10.1021/ja900867q; Jayaweera D., 1981, MED PLANTS USED CE 1, P77; Johnston BD, 2006, J ORG CHEM, V71, P1111, DOI 10.1021/jo052252u; JONES BJM, 1983, GUT, V24, P1152, DOI 10.1136/gut.24.12.1152; Jones K, 2011, BIOORGAN MED CHEM, V19, P3929, DOI 10.1016/j.bmc.2011.05.033; Kelley DE, 1998, DIABETES CARE, V21, P2056, DOI 10.2337/diacare.21.12.2056; KRAUSE HP, 1982, DIGESTION, V23, P232, DOI 10.1159/000198755; Le QT, 2009, CARBOHYD POLYM, V75, P9, DOI 10.1016/j.carbpol.2008.06.001; Lee CK, 2008, J AGR FOOD CHEM, V56, P126, DOI 10.1021/jf072508s; Matsuda H, 1998, CHEM PHARM BULL, V46, P1399, DOI 10.1248/cpb.46.1399; Minami Y, 2008, BIOORGAN MED CHEM, V16, P2734, DOI 10.1016/j.bmc.2008.01.032; Mohan S, 2007, CARBOHYD RES, V342, P1551, DOI 10.1016/j.carres.2007.05.014; Mohan S, 2010, NAT PROD REP, V27, P481, DOI 10.1039/b925950c; Mohan S, 2009, COLLECT CZECH CHEM C, V74, P1117, DOI 10.1135/cccc2009024; Moreno FJ, 1999, CHROMATOGRAPHIA, V50, P705, DOI 10.1007/BF02497308; Muraoka O, 2008, TETRAHEDRON LETT, V49, P7315, DOI 10.1016/j.tetlet.2008.10.036; Oe H, 2008, BIOSCI BIOTECH BIOCH, V72, P1962, DOI 10.1271/bbb.80118; Ozaki S, 2008, J NAT PROD, V71, P981, DOI 10.1021/np070604h; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Robayo-Torres CC, 2006, CLIN GASTROENTEROL H, V4, P276, DOI 10.1016/j.cgh.2005.12.023; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Semenza G., 1987, METABOLIC BASIS INHE, VII, P1623; Sherwood L., 1995, FUNDAMENTALS PHYSL, P517; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; Tanabe G, 2009, BIOORG MED CHEM LETT, V19, P2195, DOI 10.1016/j.bmcl.2009.02.103; Vaidyartanam P. S., 1993, INDIAN MED PLANTS CO, P47; Vasanthan T., 2001, CURRENT PROTOCOLS FO, P673; Wardrop DJ, 2010, NAT PROD REP, V27, P1431, DOI 10.1039/b914958a; Xie WJ, 2011, BIOORGAN MED CHEM, V19, P2015, DOI 10.1016/j.bmc.2011.01.052; Yoshikawa M, 1997, TETRAHEDRON LETT, V38, P8367, DOI 10.1016/S0040-4039(97)10270-2; Yoshikawa M, 2008, HETEROCYCLES, V75, P1397, DOI 10.3987/COM-07-11315; Yuasa H, 2000, TETRAHEDRON LETT, V41, P6615, DOI 10.1016/S0040-4039(00)01129-1; Zhang GY, 2009, CRIT REV FOOD SCI, V49, P852, DOI 10.1080/10408390903372466; [No title captured]	56	50	52	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31929	31938		10.1074/jbc.M112.351858	http://dx.doi.org/10.1074/jbc.M112.351858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22851177	hybrid, Green Published			2022-12-28	WOS:000309059400032
J	Richter, K; Burch, L; Chao, F; Henke, D; Jiang, CC; Daly, J; Zhao, ML; Kissling, G; Diaz, M				Richter, Kathleen; Burch, Lauranell; Chao, Frank; Henke, David; Jiang, Chuancang; Daly, Janssen; Zhao, Ming-Lang; Kissling, Grace; Diaz, Marilyn			Altered Pattern of Immunoglobulin Hypermutation in Mice Deficient in Slip-GC Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; ACTIVATION-INDUCED DEAMINASE; SWITCH DNA RECOMBINATION; SOMATIC HYPERMUTATION; B-CELLS; IG HYPERMUTATION; LUPUS NEPHRITIS; MRL/LPR MICE; AID; ANTIBODY	We recently identified a novel germinal center GTPase, SLIP-GC, that localizes to replication factories in B cells and that, when reduced, induces DNA breaks in lymphoma B cell lines in an activation-induced deaminase (AID)-dependent manner. Herein, we generated mice deficient in SLIP-GC and examined the impact of SLIP-GC deficiency in immunoglobulin hypermutation and class switch recombination, both AID-dependent mechanisms. SLIP-GC-deficient mice experienced a substantial increase in mutations at G:C base pairs at the region down-stream of JH4 in the immunoglobulin heavy chain locus. This change was reflected in the overall mutation frequency, and it was associated with an increase in transitions from G:C base pairs, a hallmark of AID-mediated deamination during replication. In addition, G:C transitions at non-immunoglobulin loci also increased in these mice. Given the intracellular localization of SLIP-GC to sites of replicating DNA, these results suggest that SLIP-GC protects replicating DNA from AID-mediated deamination of cytosines in both strands.	[Richter, Kathleen; Jiang, Chuancang; Daly, Janssen; Zhao, Ming-Lang; Diaz, Marilyn] NIEHS, Somat Hypermutat Grp, NIH, Res Triangle Pk, NC 27709 USA; [Burch, Lauranell; Chao, Frank; Henke, David] NIEHS, Mol Genet Core, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kissling, Grace] NIEHS, Biostat Branch, Environm Dis & Med Program, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Diaz, M (corresponding author), NIEHS, Somat Hypermutat Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	diaz@niehs.nih.gov		Diaz, Marilyn/0000-0002-3046-2746	Division of Intramural Research of the National Institutes of Health through the NIEHS [Z01 ES101603]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES101603, ZICES102546, ZIAES103106] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health through the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Project Z01 ES101603 from the Division of Intramural Research of the National Institutes of Health through the NIEHS (to M. D.).	Borchert GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-347; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; Diaz M, 2005, TRENDS IMMUNOL, V26, P215, DOI 10.1016/j.it.2005.02.008; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Jiang CC, 2011, ARTHRITIS RHEUM-US, V63, P1086, DOI 10.1002/art.30230; Jiang CC, 2009, IMMUNOLOGY, V126, P102, DOI 10.1111/j.1365-2567.2008.02882.x; KLINMAN NR, 1972, J EXP MED, V136, P241, DOI 10.1084/jem.136.2.241; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McCall MN, 1999, BBA-GENE STRUCT EXPR, V1447, P43, DOI 10.1016/S0167-4781(99)00131-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Sabouri Z, 2009, INT IMMUNOL, V21, P947, DOI 10.1093/intimm/dxp061; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; White CA, 2011, AUTOIMMUNITY, V44, P585, DOI 10.3109/08916934.2011.577128; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020	39	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31856	31865		10.1074/jbc.M112.340661	http://dx.doi.org/10.1074/jbc.M112.340661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833677	Green Published, hybrid			2022-12-28	WOS:000309059400026
J	Abderemane-Ali, F; Es-Salah-Lamoureux, Z; Delemotte, L; Kasimova, MA; Labro, AJ; Snyders, DJ; Fedida, D; Tarek, M; Baro, I; Loussouarn, G				Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Delemotte, Lucie; Kasimova, Marina A.; Labro, Alain J.; Snyders, Dirk J.; Fedida, David; Tarek, Mounir; Baro, Isabelle; Loussouarn, Gildas			Dual Effect of Phosphatidyl (4,5)-Bisphosphate PIP2 on Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; G-PROTEINS; ACTIVATION; PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE; KV1.2; HERG; INACTIVATION	Phosphatidylinositol (4,5)-bisphosphate (PIP2) is a phospholipid of the plasma membrane that has been shown to be a key regulator of several ion channels. Functional studies and more recently structural studies of Kir channels have revealed the major impact of PIP2 on the open state stabilization. A similar effect of PIP2 on the delayed rectifiers Kv7.1 and Kv11.1, two voltage-gated K+ channels, has been suggested, but the molecular mechanism remains elusive and nothing is known on PIP2 effect on other Kv such as those of the Shaker family. By combining giant-patch ionic and gating current recordings in COS-7 cells, and voltage-clamp fluorimetry in Xenopus oocytes, both heterologously expressing the voltage-dependent Shaker channel, we show that PIP2 exerts 1) a gain-of-function effect on the maximal current amplitude, consistent with a stabilization of the open state and 2) a loss-of-function effect by positive-shifting the activation voltage dependence, most likely through a direct effect on the voltage sensor movement, as illustrated by molecular dynamics simulations.	[Loussouarn, Gildas] CNRS, Inst Thorax, Unite Inserm, UMR 1087,IRT UN,UMR 6291, F-44007 Nantes 1, France; [Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Loussouarn, Gildas] INSERM, UMR 1087, F-44007 Nantes, France; [Abderemane-Ali, Fayal; Es-Salah-Lamoureux, Zeineb; Loussouarn, Gildas] Univ Nantes, Inst Thorax, F-44007 Nantes, France; [Es-Salah-Lamoureux, Zeineb; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Delemotte, Lucie; Kasimova, Marina A.; Tarek, Mounir] Nancy Univ, CNRS, UMR Struct & Reactivite Syst Mol Complexes 7565, Nancy, France; [Delemotte, Lucie] Temple Univ, Inst Computat & Mol Sci, Philadelphia, PA 19122 USA; [Kasimova, Marina A.] Moscow MV Lomonosov State Univ, Dept Biophys, Fac Biol, Moscow 119991, Russia; [Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2610 Antwerp, Belgium	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Lomonosov Moscow State University; University of Antwerp	Baro, I (corresponding author), CNRS, Inst Thorax, Unite Inserm, UMR 1087,IRT UN,UMR 6291, 8 Quai Moncousu,BP 70721, F-44007 Nantes 1, France.	gildas.loussouarn@inserm.fr	TAREK, Mounir/B-8443-2012; Baró, Isabelle/D-3604-2015; Loussouarn, Gildas/ABH-6043-2020; Baró, Isabelle/ABH-5667-2020; Snyders, Dirk/A-2713-2013; Es-Salah-Lamoureux, Zeineb/D-3908-2015	Baró, Isabelle/0000-0003-4850-4171; Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Snyders, Dirk/0000-0001-7142-6672; Es-Salah-Lamoureux, Zeineb/0000-0003-4530-6655; Labro, Alain J/0000-0002-0871-7511; Delemotte, Lucie/0000-0002-0828-3899	Hubert Curien Program (Tournesol Program) [22628VD]; French Ministere de la Recherche; Lefoulon Delalande Foundation; Fondation de la Recherche Medicale; GENCI-CINES [2011-76742, 2011-75137]	Hubert Curien Program (Tournesol Program); French Ministere de la Recherche(Ministry of Research, France); Lefoulon Delalande Foundation; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); GENCI-CINES	This work was supported by the Hubert Curien Program (Tournesol Program, Project Number 22628VD).; Recipient of a grant from the French Ministere de la Recherche.; Supported by fellowships from the Lefoulon Delalande Foundation and the Fondation de la Recherche Medicale.; Simulations were performed using HPC resources from GENCI-CINES Grant 2011-76742 and 2011-75137.	Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Horne AJ, 2009, CAN J PHYSIOL PHARM, V87, P411, DOI [10.1139/y09-024, 10.1139/Y09-024]; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Loussouarn Gildas, 2006, V337, P167; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mandal M, 2009, MOL PHARMACOL, V76, P1349, DOI 10.1124/mol.109.058701; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Rodriguez-Menchaca A. A., 2012, P NATL ACAD SCI US; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	49	38	38	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36158	36167		10.1074/jbc.M112.382085	http://dx.doi.org/10.1074/jbc.M112.382085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932893	Green Published, hybrid			2022-12-28	WOS:000310364000037
J	Alijevic, O; Kellenberger, S				Alijevic, Omar; Kellenberger, Stephan			Subtype-specific Modulation of Acid-sensing Ion Channel (ASIC) Function by 2-Guanidine-4-methylquinazoline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARADOXICAL STIMULATION; DOMAIN; DESENSITIZATION; ION-CHANNEL-1; CONTRIBUTES; CURRENTS; FAMILY; SENSOR; RANGE; ALTER	Acid-sensing ion channels (ASICs) are neuronal Na+-selective channels that are transiently activated by extracellular acidification. ASICs are involved in fear and anxiety, learning, neurodegeneration after ischemic stroke, and pain sensation. The small molecule 2-guanidine-4-methylquinazoline (GMQ) was recently shown to open ASIC3 at physiological pH. We have investigated the mechanisms underlying this effect and the possibility that GMQ may alter the function of other ASICs besides ASIC3. GMQ shifts the pH dependence of activation to more acidic pH in ASIC1a and ASIC1b, whereas in ASIC3 this shift goes in the opposite direction and is accompanied by a decrease in its steepness. GMQ also induces an acidic shift of the pH dependence of inactivation of ASIC1a, -1b, -2a, and -3. As a consequence, the activation and inactivation curves of ASIC3 but not other ASICs overlap in the presence of GMQ at pH 7.4, thereby creating a window current. At concentrations >1 mM, GMQ decreases maximal peak currents by reducing the unitary current amplitude. Mutation of residue Glu-79 in the palm domain of ASIC3, previously shown to be critical for channel opening by GMQ, disrupted the GMQ effects on inactivation but not activation. This suggests that this residue is involved in the consequences of GMQ binding rather than in the binding interaction itself. This study describes the mechanisms underlying the effects of a novel class of ligands that modulate the function of all ASICs as well as activate ASIC3 at physiological pH.	[Alijevic, Omar; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch		Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [310030-135542]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310030-135542 (to S. K.).	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Blanchard MG, 2011, PFLUG ARCH EUR J PHY, V461, P123, DOI 10.1007/s00424-010-0884-3; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Poirot O, 2006, J PHYSIOL-LONDON, V576, P215, DOI 10.1113/jphysiol.2006.113035; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	40	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36059	36070		10.1074/jbc.M112.360487	http://dx.doi.org/10.1074/jbc.M112.360487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948146	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000310364000028
J	Lehmann, L; Ferrari, R; Vashisht, AA; Wohlschlegel, JA; Kurdistani, SK; Carey, M				Lehmann, Lynn; Ferrari, Roberto; Vashisht, Ajay A.; Wohlschlegel, James A.; Kurdistani, Siavash K.; Carey, Michael			Polycomb Repressive Complex 1 (PRC1) Disassembles RNA Polymerase II Preinitiation Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-27 METHYLATION; VP16 ACTIVATION DOMAIN; METHYLTRANSFERASE ACTIVITY; CHROMATIN-STRUCTURE; GENE-EXPRESSION; HISTONE; MEDIATOR; CORE; DISTINCT; UBIQUITINATION	Despite the important role of Polycomb in genome-wide silencing, little is known of the specific biochemical mechanism by which it inactivates transcription. Here we address how recombinant Polycomb repressive complex 1 (PRC1) inhibits activated RNA polymerase II preinitiation complex (PIC) assembly using immobilized H3K27-methylated chromatin templates in vitro. Recombinant PRC1 inhibited transcription, but had little effect on binding of the activator as reported previously. In contrast, Mediator and the general transcription factors were blocked during assembly or dissociated from preassembled PICs. Importantly, among the PIC components, Tata Binding Protein (TBP) was the most resistant to eviction by PRC1. Immobilized template experiments using purified PRC1, transcription factor II D (TFIID), and Mediator indicate that PRC1 blocks the recruitment of Mediator, but not TFIID. We conclude that PRC1 functions to block or dissociate PICs by interfering with Mediator, but leaves TBP and perhaps TFIID intact, highlighting a specific mechanism for PRC1 transcriptional silencing. Analysis of published genome-wide datasets from mouse embryonic stem cells revealed that the Ring1b subunit of PRC1 and TBP co-enrich at developmental genes. Further, genes enriched for Ring1b and TBP are expressed at significantly lower levels than those enriched for Mediator, TBP, and Ring1b. Collectively, the data are consistent with a model in which PRC1 and TFIID could co-occupy genes poised for activation during development.	[Lehmann, Lynn; Ferrari, Roberto; Vashisht, Ajay A.; Wohlschlegel, James A.; Kurdistani, Siavash K.; Carey, Michael] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Lehmann, Lynn; Carey, Michael] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Carey, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mcarey@mednet.ucla.edu	Ferrari, Roberto/O-8143-2015	Ferrari, Roberto/0000-0002-0453-0899; Kurdistani, Siavash/0000-0003-3295-3511	National Institutes of Health Grant [R01-GM074701]; California Institute for Regenerative Medicine Grant [RN1-00550-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074701, R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Grant(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM074701 (to M. C.).; Supported by California Institute for Regenerative Medicine Grant RN1-00550-1.	Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eadie W. T., 1971, STAT METHODS EXPT PH, P313; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ferrari R, 2012, GENOME RES, V22, P1212, DOI 10.1101/gr.132308.111; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin J. J., 2012, CURR PROTOC MOL BIOL; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tantin D, 1996, METHOD ENZYMOL, V274, P133; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Uhlmann T, 2007, J BIOL CHEM, V282, P2163, DOI 10.1074/jbc.M608451200; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	51	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35784	35794		10.1074/jbc.M112.397430	http://dx.doi.org/10.1074/jbc.M112.397430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910904	Green Published, hybrid			2022-12-28	WOS:000310364000002
J	Wang, RX; Yu, CR; Mahdi, RM; Egwuagu, CE				Wang, Ren-Xi; Yu, Cheng-Rong; Mahdi, Rashid M.; Egwuagu, Charles E.			Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-12 P40 HOMODIMER; INTERLEUKIN-27; IL-27; DIFFERENTIATION; INFLAMMATION; DISEASE; STAT3; PROLIFERATION; UVEORETINITIS; ACTIVATION	IL-12 family cytokines are important in host immunity. Whereas some members (IL-12, IL-23) play crucial roles in pathogenesis of organ-specific autoimmune diseases by inducing the differentiation of Th1 and Th17 lymphocytes, others (IL-27 and IL-35) suppress inflammatory responses and limit tissue injury induced by these T cell subsets. In this study, we have genetically engineered a novel IL27p28/IL12p40 heterodimeric cytokine (p28/p40) that antagonizes signaling downstream of the gp130 receptor. We investigated whether p28/p40 can be used to ameliorate uveitis, a CNS inflammatory disease. Experimental autoimmune uveitis (EAU) is the mouse model of human uveitis and is mediated by Th1 and Th17 cells. We show here that p28/p40 suppressed EAU by inhibiting the differentiation and inflammatory responses of Th1 and Th17 cells while promoting expansion of IL-10(+)- and Foxp3(+)-expressing regulatory T cells. Lymph node cells from mice treated with p28/p40 blocked adoptive transfer of EAU to naive syngeneic mice by immunopathogenic T cells and suppressive effects of p28/p40 derived in part from antagonizing STAT1 and STAT3 pathways induced by IL-27 and IL-6. Interestingly, IL27p28 also suppressed EAU, but to a lesser extent than p28/p40. The inhibition of uveitogenic lymphocyte proliferation and suppression of EAU by p28/p40 and IL27p28 establish efficacy of single chain and heterodimeric IL-12 family cytokines in treatment of a CNS autoimmune disease. Creation of the biologically active p28/p40 heterodimeric cytokine represents an important proof-of-concept experiment, suggesting that cytokines comprising unique IL-12 alpha- and beta-subunit pairing may exist in nature and may constitute a new class of therapeutic cytokines.	[Wang, Ren-Xi; Yu, Cheng-Rong; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, Bldg 10,Rm 10N109A,10 Ctr Dr, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Wang, Renxi/AAM-1326-2020	Wang, Renxi/0000-0003-4130-3334; Yu, Cheng-Rong/0000-0001-7246-0362	National Institutes of Health through the Intramural Research Programs of the NEI; NATIONAL EYE INSTITUTE [ZIAEY000350, ZIAEY000262] Funding Source: NIH RePORTER	National Institutes of Health through the Intramural Research Programs of the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Research Programs of the NEI.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Caspi R. R., 2003, CURR PROTOC IMMUNOL, V15; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; CASPI RR, 1988, J IMMUNOL, V140, P1490; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Egwuagu CE, 2000, BRIT J OPHTHALMOL, V84, P1084; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; Gery Igal, 2002, Int Rev Immunol, V21, P89, DOI 10.1080/08830180212061; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; LING P, 1995, J IMMUNOL, V154, P116; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Matsumoto A, 2003, J EXP MED, V197, P425, DOI 10.1084/jem.20020939; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Nussenblatt RB, 2003, J AUTOIMMUN, V21, P283, DOI 10.1016/S0896-8411(03)00113-6; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Takeda K, 1998, J IMMUNOL, V161, P4652; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Yu CR, 2011, EUR J IMMUNOL, V41, P3495, DOI 10.1002/eji.201141654; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	67	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36012	36021		10.1074/jbc.M112.390625	http://dx.doi.org/10.1074/jbc.M112.390625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936807	Green Published, hybrid			2022-12-28	WOS:000310364000023
J	Li, LT; Miao, R; Bertram, S; Jia, X; Ward, DM; Kaplan, J				Li, Liangtao; Miao, Ren; Bertram, Sophie; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry			A Role for Iron-Sulfur Clusters in the Regulation of Transcription Factor Yap5-dependent High Iron Transcriptional Responses in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDAMINOBACTER-SALICYLATOXIDANS; SCHIZOSACCHAROMYCES-POMBE; MONOTHIOL GLUTAREDOXIN; PROTEIN BIOGENESIS; FISSION YEAST; RING FISSION; MITOCHONDRIAL; EXPRESSION; FEP1	Yeast respond to increased cytosolic iron by activating the transcription factor Yap5 increasing transcription of CCC1, which encodes a vacuolar iron importer. Using a genetic screen to identify genes involved in Yap5 iron sensing, we discovered that a mutation in SSQ1, which encodes a mitochondrial chaperone involved in iron-sulfur cluster synthesis, prevented expression of Yap5 target genes. We demonstrated that mutation or reduced expression of other genes involved in mitochondrial iron-sulfur cluster synthesis (YFH1, ISU1) prevented induction of the Yap5 response. We took advantage of the iron-dependent catalytic activity of Pseudaminobacter salicylatoxidans gentisate 1,2-dioxygenase expressed in yeast to measure changes in cytosolic iron. We determined that reductions in iron-sulfur cluster synthesis did not affect the activity of cytosolic gentisate 1,2-dioxygenase. We show that loss of activity of the cytosolic iron-sulfur cluster assembly complex proteins or deletion of cytosolic glutaredoxins did not reduce expression of Yap5 target genes. These results suggest that the high iron transcriptional response, as well as the low iron transcriptional response, senses iron-sulfur clusters.	[Li, Liangtao; Miao, Ren; Bertram, Sophie; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Miao, Ren/B-9151-2012		National Institutes of Health, NIDDK [DK30534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30534 from the NIDDK (to J.K.).	Askwith C, 1997, J BIOL CHEM, V272, P401; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; HARPEL MR, 1990, J BIOL CHEM, V265, P6301; Hintner JP, 2004, J BIOL CHEM, V279, P37250, DOI 10.1074/jbc.M313500200; Hintner JP, 2001, J BACTERIOL, V183, P6936, DOI 10.1128/JB.183.23.6936-6942.2001; Irazusta V, 2010, FREE RADICAL BIO MED, V48, P411, DOI 10.1016/j.freeradbiomed.2009.11.010; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kim KD, 2011, BIOCHEM BIOPH RES CO, V408, P609, DOI 10.1016/j.bbrc.2011.04.069; LAH MS, 1995, BIOCHEMISTRY-US, V34, P1646, DOI 10.1021/bi00005a021; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Matera I, 2008, J MOL BIOL, V380, P856, DOI 10.1016/j.jmb.2008.05.041; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Stearman R, 1998, GENE, V212, P197, DOI 10.1016/S0378-1119(98)00179-6; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	38	42	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35709	35721		10.1074/jbc.M112.395533	http://dx.doi.org/10.1074/jbc.M112.395533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915593	Green Published, hybrid			2022-12-28	WOS:000309968000082
J	Xu, CX; Xu, M; Tan, L; Yang, H; Permuth-Wey, J; Kruk, PA; Wenham, RM; Nicosia, SV; Lancaster, JM; Sellers, TA; Cheng, JQ				Xu, Cheng-Xiong; Xu, Meng; Tan, Lei; Yang, Hua; Permuth-Wey, Jennifer; Kruk, Patricia A.; Wenham, Robert M.; Nicosia, Santo V.; Lancaster, Johnathan M.; Sellers, Thomas A.; Cheng, Jin Q.			MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; EXPRESSION SIGNATURE; DOWN-REGULATION; HUMAN TUMORS; P53; NANOG; RESISTANCE; DIFFERENTIATION; CHEMOTHERAPY; RECOGNITION	Previous studies have shown aberrant expression of miR-214 in human malignancy. Elevated miR-214 is associated with chemoresistance and metastasis. In this study, we identified miR-214 regulation of ovarian cancer stem cell (OCSC) properties by targeting p53/Nanog axis. Enforcing expression of miR-214 increases, whereas knockdown of miR-214 decreases, OCSC population and self-renewal as well as the Nanog level preferentially in wild-type p53 cell lines. Furthermore, we found that p53 is directly repressed by miR-214 and that miR-214 regulates Nanog through p53. Expression of p53 abrogated miR-214-induced OCSC properties. These data suggest the critical role of miR-214 in OCSC via regulation of the p53-Nanog axis and miR-214 as a therapeutic target for ovarian cancer.	[Xu, Cheng-Xiong; Xu, Meng; Tan, Lei; Yang, Hua; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Permuth-Wey, Jennifer; Sellers, Thomas A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Wenham, Robert M.; Nicosia, Santo V.; Lancaster, Johnathan M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL 33612 USA; [Kruk, Patricia A.; Nicosia, Santo V.; Cheng, Jin Q.] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	Xu, Chengdong/N-5285-2014		China Fellowship Council;  [CA137041];  [W81XWH-11-1-0223];  [CA114343]; NATIONAL CANCER INSTITUTE [R01CA160455, R01CA114343, R01CA137041, P30CA076292] Funding Source: NIH RePORTER	China Fellowship Council; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA137041, W81XWH-11-1-0223 (to J. Q. C.), and CA114343 (to T. A. S.). This work was also supported by the China Fellowship Council (to M. X.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Hagopian GS, 1999, CLIN CANCER RES, V5, P655; Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li N, 2008, NUCLEIC ACIDS RES, V36, P4277, DOI 10.1093/nar/gkn388; Li QY, 2004, J BIOL CHEM, V279, P52175, DOI 10.1074/jbc.M406802200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Liu Y, 2009, CELL CYCLE, V8, P3120, DOI 10.4161/cc.8.19.9627; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Naidu KA, 2007, ANTICANCER RES, V27, P3927; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Tan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023383; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111	45	100	103	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34970	34978		10.1074/jbc.M112.374611	http://dx.doi.org/10.1074/jbc.M112.374611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927443	Green Published, hybrid			2022-12-28	WOS:000309968000010
J	Yuan, ZY; Friedmann, DR; VanderWielen, BD; Collins, KJ; Kovall, RA				Yuan, Zhenyu; Friedmann, David R.; VanderWielen, Bradley D.; Collins, Kelly J.; Kovall, Rhett A.			Characterization of CSL (CBF-1, Su(H), Lag-1) Mutants Reveals Differences in Signaling Mediated by Notch1 and Notch2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE TRANSCRIPTION COMPLEX; PROTEIN SECONDARY STRUCTURE; RBP-J-KAPPA; CRYSTAL-STRUCTURE; BINDING; DNA; MASTERMIND; INSIGHTS; SYSTEM; DIFFERENTIATION	Notch is a conserved signaling pathway that plays essential roles during embryonic development and postnatally in adult tissues; misregulated signaling results in human disease. Notch receptor-ligand interactions trigger cleavage of the Notch receptor and release of its intracellular domain (NICD) from the membrane. NICD localizes to the nucleus where it forms a transcriptionally active complex with the DNA-binding protein CSL and the coactivator Mastermind (MAM) to up-regulate transcription from Notch target genes. Previous studies have determined the structure of the CSL-NICD-MAM ternary complex and characterized mutations that affect complex assembly in functional assays. However, as CSL is expressed in all cell types, these studies have been limited to analyzing mutations in NICD and MAM. Here, we describe a novel set of cellular reagents to characterize how mutations in CSL affect its function as a transcriptional activator. Using retrovirally transduced embryonic fibroblasts from a CSL-null mouse, we generated cell lines that express either wild-type or mutant CSL molecules. We then analyzed these mutants for defects in Notch1- (NICD1) or Notch2 (NICD2)-mediated activation from two different transcriptional reporters (HES-1 or 4xCBS). Our results show that mutations targeted to the different domains of CSL display significant differences in their ability to adversely affect transcription from the two reporters. Additionally, a subset of CSL mutants is sensitive to whether NICD1 or NICD2 was used to activate the reporter. Taken together, these studies provide important molecular insights into how Notch transcription complexes assemble at different target genes and promoter arrangements in vivo.	[Yuan, Zhenyu; VanderWielen, Bradley D.; Collins, Kelly J.; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Friedmann, David R.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University System of Ohio; University of Cincinnati; The Wistar Institute	Kovall, RA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu			National Institutes of Health [CA120199]; Muscular Dystrophy Association; Leukemia and Lymphoma Society; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA120199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120199. This work was also supported by Muscular Dystrophy Association and Leukemia and Lymphoma Society (to R. A. K.) and predoctoral fellowships from the American Heart Association (to K. J. R. and D. R. F.).	Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314, DOI 10.1093/oxfordjournals.jbchem.a123898; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kato H, 1997, DEVELOPMENT, V124, P4133; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	37	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34904	34916		10.1074/jbc.M112.403287	http://dx.doi.org/10.1074/jbc.M112.403287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915591	hybrid, Green Published			2022-12-28	WOS:000309968000004
J	Zhou, YZ; Smith, D; Leong, BJ; Brannstrom, K; Almqvist, F; Chapman, MR				Zhou, Yizhou; Smith, Daniel; Leong, Bryan J.; Brannstrom, Kristoffer; Almqvist, Fredrik; Chapman, Matthew R.			Promiscuous Cross-seeding between Bacterial Amyloids Promotes Interspecies Biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN AGGREGATIVE FIMBRIAE; PRION SPECIES BARRIER; ESCHERICHIA-COLI K-12; X-RAY-DIFFRACTION; YEAST PRION; ALZHEIMERS-DISEASE; MOLECULAR-BASIS; SALMONELLA-TYPHIMURIUM; MULTICELLULAR BEHAVIOR; BETA-PROTEIN	Amyloids are highly aggregated proteinaceous fibers historically associated with neurodegenerative conditions including Alzheimers, Parkinsons, and prion-based encephalopathies. Polymerization of amyloidogenic proteins into ordered fibers can be accelerated by preformed amyloid aggregates derived from the same protein in a process called seeding. Seeding of disease-associated amyloids and prions is highly specific and cross-seeding is usually limited or prevented. Here we describe the first study on the cross-seeding potential of bacterial functional amyloids. Curli are produced on the surface of many Gram-negative bacteria where they facilitate surface attachment and biofilm development. Curli fibers are composed of the major subunit CsgA and the nucleator CsgB, which templates CsgA into fibers. Our results showed that curli subunit homologs from Escherichia coli, Salmonella typhimurium LT2, and Citrobacter koseri were able to cross-seed in vitro. The polymerization of Escherichia coli CsgA was also accelerated by fibers derived from a distant homolog in Shewanella oneidensis that shares less than 30% identity in primary sequence. Cross-seeding of curli proteins was also observed in mixed colony biofilms with E. coli and S. typhimurium. CsgA was secreted from E. coli csgB- mutants assembled into fibers on adjacent S. typhimurium that presented CsgB on its surfaces. Similarly, CsgA was secreted by S. typhimurium csgB- mutants formed curli on CsgB-presenting E. coli. This interspecies curli assembly enhanced bacterial attachment to agar surfaces and supported pellicle biofilm formation. Collectively, this work suggests that the seeding specificity among curli homologs is relaxed and that heterogeneous curli fibers can facilitate multispecies biofilm development.	[Zhou, Yizhou; Smith, Daniel; Leong, Bryan J.; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Almqvist, Fredrik] Umea Univ, Dept Chem, Chem Biol Ctr, S-90187 Umea, Sweden; [Almqvist, Fredrik; Chapman, Matthew R.] Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden	University of Michigan System; University of Michigan; Umea University; Umea University	Chapman, MR (corresponding author), Univ Michigan LSA, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	chapmanm@umich.edu	Brännström, Kristoffer/D-3648-2009; Zhou, Yizhou/G-3680-2014; Brännström, Kristoffer/AAC-1204-2020; Leong, Bryan J/F-2817-2015	Leong, Bryan J/0000-0003-4042-1160; Chapman, Matthew/0000-0002-2645-1294; Almqvist, Fredrik/0000-0002-0504-4446	National Institutes of Health [AI073847]; Umea University Linnaeus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847, R56AI073847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Umea University Linnaeus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073847 and the Umea University Linnaeus Foundation.	Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kim SM, 2012, J MICROBIOL, V50, P175, DOI 10.1007/s12275-012-2044-2; Kobayashi H, 1996, BRIT J RHEUMATOL, V35, P44; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morten S., 2012, FUNCTIONAL IN PRESS; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2008, J MOL BIOL, V380, P570, DOI 10.1016/j.jmb.2008.05.019; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Weiss-Muszkat M, 2010, APPL ENVIRON MICROB, V76, P1545, DOI 10.1128/AEM.01395-09; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	84	84	85	4	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35092	35103		10.1074/jbc.M112.383737	http://dx.doi.org/10.1074/jbc.M112.383737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22891247	Green Published, hybrid			2022-12-28	WOS:000309968000020
J	Enesa, K; Ordureau, A; Smith, H; Barford, D; Cheung, PCF; Patterson-Kane, J; Arthur, JSC; Cohen, P				Enesa, Karine; Ordureau, Alban; Smith, Hilary; Barford, David; Cheung, Peter C. F.; Patterson-Kane, Janet; Arthur, J. Simon C.; Cohen, Philip			Pellino1 Is Required for Interferon Production by Viral Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-KINASE; UBIQUITIN LIGASE PELLINO; TOLL-LIKE RECEPTOR-4; SIGNALING PATHWAY; GENE-EXPRESSION; IKK-EPSILON; TRANSCRIPTION FACTORS; REGULATORY FACTOR-3; PROTEIN-KINASES; DENDRITIC CELLS	Viral double-stranded RNA, a ligand for Toll-like Receptor 3 (TLR3) and the cytoplasmic RNA receptors RIG1 and MDA5, activate a signaling network in which the IKK-related protein kinase TBK1 phosphorylates the transcription factor Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquitin ligase Pellino1. IRF3 then translocates to the nucleus where it stimulates transcription of the interferon beta (IFN beta) gene, but the function of Pellino1 in this pathway is unknown. Here, we report that myeloid cells and embryonic fibroblasts from knock-in mice expressing an E3 ligase-deficient mutant of Pellino1 produce reduced levels of IFN beta mRNA and secrete much less IFN beta in response to viral double-stranded RNA because the interaction of IRF3 with the IFN beta promoter is impaired. These results identify Pellino1 as a novel component of the signal transduction network by which viral double-stranded RNA stimulates IFN beta gene transcription.	[Enesa, Karine; Ordureau, Alban; Smith, Hilary; Arthur, J. Simon C.; Cohen, Philip] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Cohen, Philip] Univ Dundee, Scottish Inst Cell Signaling, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Cheung, Peter C. F.] Nanyang Technol Univ, Singapore 637551, Singapore; [Barford, David] Inst Canc Res, London SW3 6JB, England; [Patterson-Kane, Janet] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G61 1QH, Lanark, Scotland	University of Dundee; University of Dundee; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Glasgow	Cohen, P (corresponding author), Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; Ordureau, Alban/C-7558-2012; Cheung, Peter/A-2213-2011	Arthur, J. Simon/0000-0002-8135-1958; Ordureau, Alban/0000-0002-4924-8520; Barford, David/0000-0001-8810-950X; Patterson-Kane, Janet/0000-0002-9094-1263	Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck KGaA; Janssen Pharmaceutica; Pfizer; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_U127084348, MC_U127081014] Funding Source: researchfish; MRC [MC_U127084348, MC_U127081014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck KGaA; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and the pharmaceutical companies supporting the Division of Signal Transduction Therapy (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KGaA, Janssen Pharmaceutica, and Pfizer).	Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Griffin BD, 2011, EUR J IMMUNOL, V41, P798, DOI 10.1002/eji.201040774; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	44	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34825	34835		10.1074/jbc.M112.367557	http://dx.doi.org/10.1074/jbc.M112.367557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902624	Green Published, hybrid			2022-12-28	WOS:000309654200081
J	Stehle, T; Sreeramulu, S; Lohr, F; Richter, C; Saxena, K; Jonker, HRA; Schwalbe, H				Stehle, Tanja; Sreeramulu, Sridhar; Loehr, Frank; Richter, Christian; Saxena, Krishna; Jonker, Hendrik R. A.; Schwalbe, Harald			The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; SEQUENCE-SPECIFIC ASSIGNMENT; CRYSTAL-STRUCTURE; PHOSPHOTYROSYL PHOSPHATASE; NMR-SPECTRA; BACKBONE DYNAMICS; PULSE SEQUENCES; CHEMICAL-SHIFT; KINASE; RELAXATION	Protein-tyrosine phosphatases (PTPs) and protein-tyrosine kinases co-regulate cellular processes. In pathogenic bacteria, they are frequently exploited to act as key virulence factors for human diseases. Mycobacterium tuberculosis, the causative organism of tuberculosis, secretes a low molecular weight PTP (LMW-PTP), MptpA, which is required for its survival upon infection of host macrophages. Although there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding loop (P-loop) CX5R and the loop containing a critical aspartic acid residue (D-loop), required for the catalytic activity, are well conserved. In most high molecular weight PTPs, ligand binding to the P-loop triggers a large conformational reorientation of the D-loop, in which it moves similar to 10 angstrom, from an "open" to a "closed" conformation. Until now, there have been no ligand-free structures of LMW-PTPs described, and hence the dynamics of the D-loop have remained largely unknown for these PTPs. Here, we present a high resolution solution NMR structure of the free form of the MptpA LMW-PTP. In the absence of ligand and phosphate ions, the D-loop adopts an open conformation. Furthermore, we characterized the binding site of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of both the P- and D-loop in phosphate binding. Notably, in LMW-PTPs, the phosphorylation status of two well conserved tyrosine residues, typically located in the D-loop, regulates the enzyme activity. PtkA, the kinase complementary to MptpA, phosphorylates these two tyrosine residues in MptpA. We characterized the MptpA-PtkA interaction by NMR spectroscopy to show that both the P-and D-loop form part of the binding interface.	[Stehle, Tanja; Sreeramulu, Sridhar; Richter, Christian; Saxena, Krishna; Jonker, Hendrik R. A.; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Biophys Chem, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Jonker, HRA (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	h.jonker@nmr.uni-frankfurt.de	Schwalbe, Harald J/F-9023-2010; Schwalbe, Harald/AAB-3143-2020	Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909	European Union Commission; state of Hesse	European Union Commission(European Commission); state of Hesse	This work was supported by the European Union Commission in the program WeNMR (to H. J. and T. S.). The Center for Biomolecular Magnetic Resonance (BMRZ) is supported by the state of Hesse.	Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; [Anonymous], 2012, 2011 2012 TUB GLOB F; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cowley SC, 2002, RES MICROBIOL, V153, P233, DOI 10.1016/S0923-2508(02)01309-8; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Doreleijers JF, 2012, NUCLEIC ACIDS RES, V40, pD519, DOI 10.1093/nar/gkr1134; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GODDARD TD, 2002, SPARKY; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustafson CLT, 2005, PROTEIN SCI, V14, P2515, DOI 10.1110/ps.051618805; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Lohr F, 2005, J BIOMOL NMR, V32, P309, DOI 10.1007/s10858-005-1195-4; Lohr F, 2002, J BIOMOL NMR, V22, P153, DOI 10.1023/A:1014271204953; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Pervushin KV, 1999, P NATL ACAD SCI USA, V96, P9607, DOI 10.1073/pnas.96.17.9607; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sambrook J., 2006, MOL CLONING LAB MANU, P718; Saxena K, 2005, J BIOMOL NMR, V33, P136, DOI 10.1007/s10858-005-2718-8; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; Schwarzer D, 2006, J AM CHEM SOC, V128, P4192, DOI 10.1021/ja0585174; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva APG, 2010, FUTURE MED CHEM, V2, P1325, DOI 10.4155/fmc.10.214; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Tolkatchev D, 2006, PROTEIN SCI, V15, P2381, DOI 10.1110/ps.062279806; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu HM, 2006, J BACTERIOL, V188, P1509, DOI 10.1128/JB.188.4.1509-1517.2006; Zabell APR, 2006, J BIOL CHEM, V281, P6520, DOI 10.1074/jbc.M506285200; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang ZY, 1997, CURR TOP CELL REGUL, V35, P21, DOI 10.1016/S0070-2137(97)80002-7; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161	77	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34569	34582		10.1074/jbc.M112.399261	http://dx.doi.org/10.1074/jbc.M112.399261			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888002	Green Published, hybrid			2022-12-28	WOS:000309654200060
J	Greibe, E; Fedosov, S; Sorensen, BS; Hojrup, P; Poulsen, SS; Nexo, E				Greibe, Eva; Fedosov, Sergey; Sorensen, Boe S.; Hojrup, Peter; Poulsen, Steen S.; Nexo, Ebba			A Single Rainbow Trout Cobalamin-binding Protein Stands in for Three Human Binders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTRINSIC-FACTOR; TRANSCOBALAMIN; VITAMIN-B12; HAPTOCORRIN; CHROMATOGRAPHY; AQUOCOBALAMIN; SERUM; B-12	Cobalamin uptake and transport in mammals are mediated by three cobalamin-binding proteins: haptocorrin, intrinsic factor, and transcobalamin. The nature of cobalamin-binding proteins in lower vertebrates remains to be elucidated. The aim of this study was to characterize the cobalamin-binding proteins of the rainbow trout (Oncorhynchus mykiss) and to compare their properties with those of the three human cobalamin-binding proteins. High cobalamin-binding capacity was found in trout stomach (210 pmol/g), roe (400 pmol/g), roe fluid (390 nmol/liter), and plasma (2500 nmol/liter). In all cases, it appeared to be the same protein based on analysis of partial sequences and immunological responses. The trout cobalamin-binding protein was purified from roe fluid, sequenced, and further characterized. Like haptocorrin, the trout cobalamin-binding protein was stable at low pH and had a high binding affinity for the cobalamin analog cobinamide. Like haptocorrin and transcobalamin, the trout cobalamin-binding protein was present in plasma and recognized ligands with altered nucleotide moiety. Like intrinsic factors, the trout cobalamin-binding protein was present in the stomach and resisted degradation by trypsin and chymotrypsin. It also resembled intrinsic factor in the composition of conserved residues in the primary cobalamin-binding site in the C terminus. The trout cobalamin-binding protein was glycosylated and displayed spectral properties comparable with those of haptocorrin and intrinsic factor. In conclusion, only one soluble cobalamin-binding protein was identified in the rainbow trout, a protein that structurally behaves like an intermediate between the three human cobalamin-binding proteins.	[Greibe, Eva; Sorensen, Boe S.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; [Fedosov, Sergey] Aarhus Univ, Dept Engn Sci, DK-8000 Aarhus, Denmark; [Hojrup, Peter] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Poulsen, Steen S.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; University of Copenhagen	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Norrebrogade 44,Bldg 9, DK-8000 Aarhus C, Denmark.	evagreibe@gmail.com	Fedosov, Sergey N./J-2340-2019; Greibe, Eva/E-3375-2018; Højrup, Peter/ABG-8477-2020	Fedosov, Sergey N./0000-0002-7016-2959; Greibe, Eva/0000-0002-0417-1195; Nexo, Ebba/0000-0001-9406-9081; Hojrup, Peter/0000-0002-7838-6180; Poulsen, Steen Seier/0000-0003-4419-4911; Sorensen, Boe/0000-0002-9472-8099				ACKERS GK, 1964, BIOCHEMISTRY-US, V3, P723, DOI 10.1021/bi00893a021; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Bledsoe GE, 2003, CRIT REV FOOD SCI, V43, P317, DOI 10.1080/10408690390826545; DOSCHERHOLMEN A, 1981, P SOC EXP BIOL MED, V167, P480, DOI 10.3181/00379727-167-41201; Fedosov SN, 2000, J BIOL CHEM, V275, P11791, DOI 10.1074/jbc.275.16.11791; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; Fieber W, 2002, HELV CHIM ACTA, V85, P927, DOI 10.1002/1522-2675(200203)85:3<927::AID-HLCA927>3.0.CO;2-A; Furger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037421; Galfre G, 1981, Methods Enzymol, V73, P3; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Greibe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035660; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; HEWITT JE, 1991, GENOMICS, V10, P432, DOI 10.1016/0888-7543(91)90329-D; HIPPE E, 1970, BIOCHIM BIOPHYS ACTA, V208, P337, DOI 10.1016/0304-4165(70)90255-2; HIPPE E, 1977, COMP BIOCHEM PHYS B, V56, P305, DOI 10.1016/0305-0491(77)90021-9; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Kalra S, 2004, ARCH BIOCHEM BIOPHYS, V431, P189, DOI 10.1016/j.abb.2004.08.011; LINNELL JC, 1975, COBALAMIN BIOCH PATH, P287; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO BA, 1982, BIOCHIM BIOPHYS ACTA, V708, P178, DOI 10.1016/0167-4838(82)90218-7; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1976, BIOCHIM BIOPHYS ACTA, V446, P143, DOI 10.1016/0005-2795(76)90106-9; Nielsen R, 2001, J AM SOC NEPHROL, V12, P1099, DOI 10.1681/ASN.V1261099; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; TAN CH, 1975, COMP BIOCHEM PHYS B, V50, P541, DOI 10.1016/0305-0491(75)90086-3; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	32	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33917	33925		10.1074/jbc.M112.398016	http://dx.doi.org/10.1074/jbc.M112.398016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872637	Green Published, hybrid			2022-12-28	WOS:000309602100072
J	Jarmalavicius, S; Welte, Y; Walden, P				Jarmalavicius, Saulius; Welte, Yvonne; Walden, Peter			High Immunogenicity of the Human Leukocyte Antigen Peptidomes of Melanoma Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYTIC T-LYMPHOCYTES; LUNG-CARCINOMA; POINT MUTATION; IDENTIFICATION; EPITOPES; MOTIFS; GENE; STIMULATION; DEFINITION; TURNOVER	Human leukocyte antigens (HLA) bind peptides generated by limited proteolysis in cells and present them at the cell surfaces for recognition by T cells. Through this antigen presentation function they control the specificity of T cell responses and thereby adaptive immune responses. Knowledge of HLA-bound peptides is thus key to understanding adaptive immunity and to the development of vaccines and other specific immune intervention strategies. To gain insight into the antigenicity of melanomas, peptides were extracted from HLA isolated from the tumor cells, separated by two-dimensional HPLC, and sequenced by mass spectrometry. The spectra were analyzed by database-dependent MASCOT searches and database-independent de novo sequencing and, where required, confirmed with synthetic peptides, which were also used to determine their immunogenicity. Comparing four different melanoma cell lines, little overlap of the HLA-bound peptides was found, suggesting a high degree of individualization of the HLA peptidomes. This notwithstanding, the peptidomes were highly immunogenic in the patients from whom the tumor cells had been established and in unrelated patients. This broad cross-patient immunogenicity was only exceptionally related to individual peptides. The majority of the identified epitopes were derived from low to medium abundance proteins, mostly involved in sensitive cellular processes such as cell cycle control, DNA replication, control of gene expression, tumor suppressor function, and protein metabolism. The peptidomes thus provide insights into processes potentially related to tumorigenesis. Furthermore, analyses of the peptide sequences yield information on the specificity of peptide selection by HLA applicable to the developing prediction algorithms for T cell epitopes.	[Jarmalavicius, Saulius; Welte, Yvonne; Walden, Peter] Charite Univ Med Berlin, Dept Dermatol Venerol & Allergol, Clin Res Grp Tumor Immunol, D-10098 Berlin, Germany; [Jarmalavicius, Saulius] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Walden, P (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, Charitepl 1, D-10117 Berlin, Germany.	peter.walden@charite.de			German Research Council (Deutsche Forschungsgemeinschaft) [KFO50]; German Ministry for Research and Education [13N9197]; Berlin Cancer Society [WAFF200824]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry for Research and Education(Federal Ministry of Education & Research (BMBF)); Berlin Cancer Society	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft Grant KFO50), German Ministry for Research and Education (Grant 13N9197), and Berlin Cancer Society (Grant WAFF200824).	Arnett KL, 1998, IMMUNOGENETICS, V48, P56, DOI 10.1007/s002510050400; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bredenbeck A, 2005, J IMMUNOL, V174, P6716, DOI 10.4049/jimmunol.174.11.6716; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chaux P, 1999, J IMMUNOL, V163, P2928; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Demine R, 2005, J BIOL CHEM, V280, P17573, DOI 10.1074/jbc.M501233200; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Demine R, 2003, MOL BIOTECHNOL, V25, P71, DOI 10.1385/MB:25:1:71; Echchakir H, 2001, CANCER RES, V61, P4078; FALK K, 1994, IMMUNOGENETICS, V40, P238, DOI 10.1007/BF00167086; Gaudin C, 1999, J IMMUNOL, V162, P1730; Harada M, 2001, CANCER RES, V61, P1089; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hogan KT, 1998, CANCER RES, V58, P5144; Jarmalavicius S, 2010, FASEB J, V24, P937, DOI 10.1096/fj.09-136283; KUBO RT, 1994, J IMMUNOL, V152, P3913; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Liu YF, 2011, CLIN EXP METASTAS, V28, P413, DOI 10.1007/s10585-011-9380-1; Matsumoto T, 2009, INT J BIOL MARKER, V24, P282, DOI 10.1177/172460080902400411; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reynolds SR, 2000, J IMMUNOL METHODS, V244, P59, DOI 10.1016/S0022-1759(00)00254-4; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522	30	23	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33401	33411		10.1074/jbc.M112.358903	http://dx.doi.org/10.1074/jbc.M112.358903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869377	Green Published, hybrid			2022-12-28	WOS:000309602100027
J	Walker, LC; LeVine, H				Walker, Lary C.; LeVine, Harry, III			Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CEREBRAL BETA-AMYLOIDOSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; TO-NEURON TRANSMISSION; A-BETA; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; EXOGENOUS INDUCTION; PRION STRAINS; LEWY BODIES; PATHOLOGY	With advancing age, the brain becomes increasingly susceptible to neurodegenerative diseases, most of which are characterized by the misfolding and errant aggregation of certain proteins. The induction of aggregation involves a crystallization-like seeding mechanism by which a specific protein is structurally corrupted by its misfolded conformer. The latest research indicates that, once formed, proteopathic seeds can spread from one locale to another via cellular uptake, transport, and release. Impeding this process could represent a unified therapeutic strategy for slowing the progression of a wide range of currently intractable disorders.	[Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA; [LeVine, Harry, III] Univ Kentucky, Ctr Aging, Struct Biol Ctr, Lexington, KY 40536 USA; [LeVine, Harry, III] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	Emory University; Emory University; University of Kentucky; University of Kentucky	Walker, LC (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	lary.walker@emory.edu; hlevine@email.uky.edu	Walker, L C/J-6541-2015	Walker, L C/0000-0001-9166-3261	National Institutes of Health [R21AG040589, P01AG005119]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/Office of the Director Grant [P51OD11132]; Coins for Alzheimer's Research Trust (CART) Foundation; Bayer HealthCare Grants4Targets; NATIONAL INSTITUTE ON AGING [P01AG005119, R21AG040589] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/Office of the Director Grant; Coins for Alzheimer's Research Trust (CART) Foundation; Bayer HealthCare Grants4Targets(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R21AG040589 and P01AG005119, National Center for Research Resources Grant P51RR165, and Office of Research Infrastructure Programs/Office of the Director Grant P51OD11132. This work was also supported by the Coins for Alzheimer's Research Trust (CART) Foundation and Bayer HealthCare Grants4Targets.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Arrasate M., 2011, EXP NEUROL IN PRESS; Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BUYUKMIHCI N, 1983, EXP NEUROL, V81, P396, DOI 10.1016/0014-4886(83)90271-6; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Eidelberg D, 2011, J CLIN INVEST, V121, P484, DOI 10.1172/JCI45646; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Frost B, 2009, PRION, V3, P74, DOI 10.4161/pri.3.2.8754; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Head MW, 2012, NEUROPATH APPL NEURO, V38, P296, DOI 10.1111/j.1365-2990.2012.01265.x; Heuer E, 2012, CURR PHARM DESIGN, V18, P1159, DOI 10.2174/138161212799315885; Hofmann J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13505; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kanouchi T, 2012, J NEUROL NEUROSUR PS, V83, P739, DOI 10.1136/jnnp-2011-301826; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Lee He-Jin, 2011, Exp Neurobiol, V20, P181, DOI 10.5607/en.2011.20.4.181; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; LIBERSKI PP, 1990, ARCH VIROL, V111, P141, DOI 10.1007/BF01310512; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2011, MOL PSYCHIATR, DOI [10.1038/mp.2011.120, DOI 10.1038/MP.2011.120]; Morawe T, 2012, MOL NEUROBIOL, V46, P41, DOI 10.1007/s12035-012-8246-0; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ronnback A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.012; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Walker LC, 2002, PEPTIDES, V23, P1241, DOI 10.1016/S0196-9781(02)00059-1; Walker LC, 2000, MOL NEUROBIOL, V21, P83, DOI 10.1385/MN:21:1-2:083; Walker LC, 2000, NEUROBIOL AGING, V21, P559, DOI 10.1016/S0197-4580(00)00160-3; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	99	52	53	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33109	33115		10.1074/jbc.R112.399378	http://dx.doi.org/10.1074/jbc.R112.399378			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879600	hybrid, Green Published			2022-12-28	WOS:000309602100002
J	Wiedner, SD; Burnum, KE; Pederson, LM; Anderson, LN; Fortuin, S; Chauvigne-Hines, LM; Shukla, AK; Ansong, C; Panisko, EA; Smith, RD; Wright, AT				Wiedner, Susan D.; Burnum, Kristin E.; Pederson, LeeAnna M.; Anderson, Lindsey N.; Fortuin, Suereta; Chauvigne-Hines, Lacie M.; Shukla, Anil K.; Ansong, Charles; Panisko, Ellen A.; Smith, Richard D.; Wright, Aaron T.			Multiplexed Activity-based Protein Profiling of the Human Pathogen Aspergillus fumigatus Reveals Large Functional Changes upon Exposure to Human Serum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; OXIDATIVE STRESS-RESPONSE; TANDEM MASS-SPECTRA; KINASE MPKA; BIOSYNTHESIS; GROWTH; GENE; METABOLISM; PROTEOMICS; PATHWAY	Environmental adaptability is critical for survival of the fungal human pathogen Aspergillus fumigatus in the immunocompromised host lung. We hypothesized that exposure of the fungal pathogen to human serum would lead to significant alterations to the organism's physiology, including metabolic activity and stress response. Shifts in functional pathway and corresponding enzyme reactivity of A. fumigatus upon exposure to the human host may represent much needed prognostic indicators of fungal infection. To address this, we employed a multiplexed activity-based protein profiling (ABPP) approach coupled to quantitative mass spectrometry-based proteomics to measure broad enzyme reactivity of the fungus cultured with and without human serum. ABPP showed a shift from aerobic respiration to ethanol fermentation and utilization over time in the presence of human serum, which was not observed in serum-free culture. Our approach provides direct insight into this pathogen's ability to survive, adapt, and proliferate. Additionally, our multiplexed ABPP approach captured a broad swath of enzyme reactivity and functional pathways and provides a method for rapid assessment of the A. fumigatus response to external stimuli.	[Wiedner, Susan D.; Burnum, Kristin E.; Pederson, LeeAnna M.; Anderson, Lindsey N.; Fortuin, Suereta; Chauvigne-Hines, Lacie M.; Shukla, Anil K.; Ansong, Charles; Smith, Richard D.; Wright, Aaron T.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Panisko, Ellen A.] Pacific NW Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wright, AT (corresponding author), Pacific NW Natl Lab, Div Biol Sci, 902 Battelle Blvd, Richland, WA 99352 USA.	aaron.wright@pnnl.gov	Smith, Richard D/J-3664-2012; Fortuin, Suereta/AAV-5804-2021; Burnum, Kristin E/B-1308-2011; Fortuin, Suereta/AAX-8725-2020; Anderson, Lindsey N/S-6375-2016	Smith, Richard D/0000-0002-2381-2349; Fortuin, Suereta/0000-0001-8148-7807; Burnum, Kristin E/0000-0002-2722-4149; Anderson, Lindsey N/0000-0002-8741-7823; Wright, Aaron/0000-0002-3172-5253	National Institutes of Health Grant (NIH), NCRR [5P41RR018522-10]; NIH, NIGMS [8 P41 GM103493-10]; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL); Battelle for the United States Department of Energy [DE-AC05-76RL01830]; National Institutes of Health [P41 GM103493-10]; United States Department of Energy Office of Biological and Environmental Research (DOE/BER); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH), NCRR; NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL); Battelle for the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Office of Biological and Environmental Research (DOE/BER)(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (NIH), NCRR, Grant 5P41RR018522-10 and NIH, NIGMS, Grant 8 P41 GM103493-10. This work was also supported in part by the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), a multiprogram national laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830. This work used instrumentation and capabilities developed under support from the National Institutes of Health (Grant P41 GM103493-10) and the United States Department of Energy Office of Biological and Environmental Research (DOE/BER). Work was performed in the Environmental Molecular Sciences Laboratory, a DOE/BER national scientific user facility at PNNL.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Barglow KT, 2004, CHEM BIOL, V11, P1523, DOI 10.1016/j.chembiol.2004.08.023; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Cagas SE, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010108, 10.1074/mcp.M110.004606]; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Dorr P. K., 2003, U.S. Patent, Patent No. 6514726B; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Gifford AHT, 2002, INFECT IMMUN, V70, P19, DOI 10.1128/IAI.70.1.19-26.2002; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hummel M, 2007, MYCOSES, V50, P18, DOI 10.1111/j.1439-0507.2007.01376.x; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; KAGI JHR, 1960, J BIOL CHEM, V235, P3188; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Kniemeyer O, 2011, PROTEOMICS, V11, P3232, DOI 10.1002/pmic.201100087; Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039; Krappmann S., 2003, ASPERGILLUS FUMIGATU, P63; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lenz T, 2011, J PROTEOMICS, V75, P100, DOI 10.1016/j.jprot.2011.07.017; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Lodeiro S, 2009, ORG LETT, V11, P1241, DOI 10.1021/ol802696a; Luo JJ, 2010, MOL CELL BIOL, V30, P537, DOI 10.1128/MCB.00980-09; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Morrice J, 1998, CURR GENET, V34, P379, DOI 10.1007/s002940050410; Mousavi SAA, 2003, FUNGAL GENET BIOL, V39, P221, DOI 10.1016/S1087-1845(03)00047-1; Oliver BG, 2002, MICROBIOL-SGM, V148, P2627, DOI 10.1099/00221287-148-8-2627; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Palmer GE, 2008, AUTOPHAGY, V4, P982, DOI 10.4161/auto.7075; Papagianni M, 2004, BIOTECHNOL ADV, V22, P189, DOI 10.1016/j.biotechadv.2003.09.005; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; Rhodes JC, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P697; Rodrigues AG, 2005, MED MYCOL, V43, P711, DOI 10.1080/13693780500129814; Roush WR, 1998, J AM CHEM SOC, V120, P10994, DOI 10.1021/ja981792o; Sami L, 2001, MYCOL RES, V105, P1246, DOI 10.1016/S0953-7562(08)61996-6; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Schoberle T, 2007, ADV GENET, V57, P263, DOI 10.1016/S0065-2660(06)57007-5; Shimizu K, 2001, GENETICS, V157, P591; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Taubitz A, 2007, CURR MICROBIOL, V54, P354, DOI 10.1007/s00284-006-0413-y; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Toyotome T, 2012, INT J MED MICROBIOL, V302, P108, DOI 10.1016/j.ijmm.2011.12.001; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Wallwey C, 2010, ORG BIOMOL CHEM, V8, P3500, DOI 10.1039/c003823g; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	75	18	18	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33447	33459		10.1074/jbc.M112.394106	http://dx.doi.org/10.1074/jbc.M112.394106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865858	hybrid, Green Published			2022-12-28	WOS:000309602100031
J	Clokie, SJH; Lau, P; Kim, HH; Coon, SL; Klein, DC				Clokie, Samuel J. H.; Lau, Pierre; Kim, Hyun Hee; Coon, Steven L.; Klein, David C.			MicroRNAs in the Pineal Gland miR-483 REGULATES MELATONIN SYNTHESIS BY TARGETING ARYLALKYLAMINE N-ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN N-ACETYLTRANSFERASE; MESSENGER-RNAS; MOUSE RETINA; EXPRESSION; RAT; GENES; IDENTIFICATION; RHYTHM; AANAT; DIFFERENTIATION	MicroRNAs (miRNAs) play a broad range of roles in biological regulation. In this study, rat pineal miRNAs were profiled for the first time, and their importance was evaluated by focusing on the main function of the pineal gland, melatonin synthesis. Massively parallel sequencing and related methods revealed the miRNA population is dominated by a small group of miRNAs as follows: similar to 75% is accounted for by 15 miRNAs; miR-182 represents 28%. In addition to miR-182, miR-183 and miR-96 are also highly enriched in the pineal gland, a distinctive pattern also found in the retina. This effort also identified previously unrecognized miRNAs and other small noncoding RNAs. Pineal miRNAs do not exhibit a marked night/day difference in abundance with few exceptions (e. g. 2-fold night/day differences in the abundance of miR-96 and miR-182); this contrasts sharply with the dynamic 24-h pattern that characterizes the pineal transcriptome. During development, the abundance of most pineal gland-enriched miRNAs increases; however, there is a marked decrease in at least one, miR-483. miR-483 is a likely regulator of melatonin synthesis, based on the following. It inhibits melatonin synthesis by pinealocytes in culture; it acts via predicted binding sites in the 3'-UTR of arylalkylamine N-acetyltransferase (Aanat) mRNA, the penultimate enzyme in melatonin synthesis, and it exhibits a developmental profile opposite to that of Aanat transcripts. Additionally, a miR-483 targeted antagonist increased melatonin synthesis in neonatal pinealocytes. These observations support the hypothesis that miR-483 suppresses Aanat mRNA levels during development and that the developmental decrease in miR-483 abundance promotes melatonin synthesis.	[Klein, David C.] Eunice Kennedy Shriver NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Lau, Pierre] Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Lau, Pierre] Univ Louvain, LIND, B-3000 Louvain, Belgium	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Klein, DC (corresponding author), Eunice Kennedy Shriver NICHD, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Osada, Hiroyuki/N-4305-2014	Clokie, Samuel/0000-0002-0025-3652; Klein, David/0000-0002-1792-5806	National Institutes of Health Intramural Research Program, NICHD; Grants-in-Aid for Scientific Research [23790115] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NICHD; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NICHD.	Araki M, 2007, DEV NEUROBIOL, V67, P1641, DOI 10.1002/dneu.20534; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Candiani S, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-15; Coon SL, 1996, GENOMICS, V34, P76, DOI 10.1006/geno.1996.0243; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELLISON N, 1972, J NEUROCHEM, V19, P1335, DOI 10.1111/j.1471-4159.1972.tb01458.x; Eriksson T, 2001, EXP CELL RES, V270, P88, DOI 10.1006/excr.2001.5336; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Ho AK, 1996, MOL PHARMACOL, V49, P1104; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moller M, 2007, PROTEOMICS, V7, P2009, DOI 10.1002/pmic.200600963; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PARFITT A, 1975, MOL PHARMACOL, V11, P241; Patterson EE, 2011, CANCER-AM CANCER SOC, V117, P1630, DOI 10.1002/cncr.25724; Peliciari-Garcia RA, 2010, LIFE SCI, V87, P169, DOI 10.1016/j.lfs.2010.06.005; Pfeffer M, 1998, NEUROSCI LETT, V248, P163, DOI 10.1016/S0304-3940(98)00356-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rath MF, 2007, EXP EYE RES, V85, P65, DOI 10.1016/j.exer.2007.02.016; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reiter Russel J., 2007, Critical Reviews in Oncogenesis, V13, P303; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen JY, 2012, P NATL ACAD SCI USA, V109, P3540, DOI 10.1073/pnas.1119201109; SUGDEN D, 1983, J NEUROCHEM, V40, P1647, DOI 10.1111/j.1471-4159.1983.tb08138.x; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wongchitrat P, 2011, NEUROENDOCRINOLOGY, V94, P75, DOI 10.1159/000327430; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	55	86	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25312	25324		10.1074/jbc.M112.356733	http://dx.doi.org/10.1074/jbc.M112.356733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22908386	Green Published, hybrid			2022-12-28	WOS:000306651700039
J	Landau, G; Ran, A; Bercovich, Z; Feldmesser, E; Horn-Saban, S; Korkotian, E; Jacob-Hirsh, J; Rechavi, G; Ron, D; Kahana, C				Landau, Guy; Ran, Avichai; Bercovich, Zippi; Feldmesser, Ester; Horn-Saban, Shirley; Korkotian, Eduard; Jacob-Hirsh, Jasmine; Rechavi, Gideon; Ron, David; Kahana, Chaim			Expression Profiling and Biochemical Analysis Suggest Stress Response as a Potential Mechanism Inhibiting Proliferation of Polyamine-depleted Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; ORNITHINE-DECARBOXYLASE; GENE-EXPRESSION; OXIDATIVE STRESS; TRANSLATION INITIATION; MESSENGER-RNA; CYCLE; APOPTOSIS	Polyamines are small organic polycations that are absolutely required for cell growth and proliferation; yet the basis for this requirement is mostly unknown. Here, we combined a genome-wide expression profiling with biochemical analysis to reveal the molecular basis for inhibited proliferation of polyamine-depleted cells. Transcriptional responses accompanying growth arrest establishment in polyamine-depleted cells or growth resumption following polyamine replenishment were monitored and compared. Changes in the expression of genes related to various fundamental cellular processes were established. Analysis of mirror-symmetric expression patterns around the G(1)-arrest point identified a set of genes representing a stress-response signature. Indeed, complementary biochemical analysis demonstrated activation of the PKR-like endoplasmic reticulum kinase arm of the unfolded protein response and of the stress-induced p38 MAPK. These changes were accompanied by induction of key growth-inhibitory factors such as p21 and Gadd45a and reduced expression of various cyclins, most profoundly cyclin D1, setting the basis for the halted proliferation. However, although the induced stress response could arrest growth, polyamine depletion also inhibited proliferation of PKR-like endoplasmic reticulum kinase and p38 alpha-deficient cells and of cells harboring a nonphosphorylatable mutant eIF2 alpha (S51A), suggesting that additional yet unidentified mechanisms might inhibit proliferation of polyamine-depleted cells. Despite lengthy persistence of the stress and activation of apoptotic signaling, polyamine-depleted cells remained viable, apparently due to induced expression of protective genes and development of autophagy.	[Landau, Guy; Ran, Avichai; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Feldmesser, Ester; Horn-Saban, Shirley] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Jacob-Hirsh, Jasmine; Rechavi, Gideon] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ron, David] Univ Cambridge, Addenbrookes Hosp, Metab Res Lab, Cambridge CB2 0QQ, England; [Ron, David] Univ Cambridge, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	chaim.kahana@weizmann.ac.il	Korkotian, Eduard/K-1744-2012; Korkotian, Eduard/P-4559-2019	Korkotian, Eduard/0000-0001-5515-3387; Ron, David/0000-0002-3014-5636	Israel Academy of Science and Humanities; M. D. Moross Institute for Cancer Research; Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute	Israel Academy of Science and Humanities; M. D. Moross Institute for Cancer Research; Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute	This work was supported by grants from the Israel Academy of Science and Humanities, the M. D. Moross Institute for Cancer Research, and the Kahn Family Research Center for Systems Biology of the Human Cell at the Weizmann Institute.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bhattacharya A, 2003, CANCER RES, V63, P8167; Biswas M, 2011, J BIOL CHEM, V286, P39282, DOI 10.1074/jbc.M111.253807; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Clement A, 2001, AM J RESP CRIT CARE, V164, pS81, DOI 10.1164/ajrccm.164.supplement_2.2106069; CLIFFORD A, 1995, CANCER RES, V55, P1680; d'Azzo A, 2006, CELL DEATH DIFFER, V13, P404, DOI 10.1038/sj.cdd.4401834; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hsieh WC, 2010, MOL CELLS, V30, P311, DOI 10.1007/s10059-010-0120-1; Hu X, 2005, CANCER RES, V65, P11026, DOI 10.1158/0008-5472.CAN-05-1339; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee GH, 2011, J BIOL CHEM, V286, P24743, DOI 10.1074/jbc.M110.167734; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Li L, 1999, AM J PHYSIOL-CELL PH, V276, pC946, DOI 10.1152/ajpcell.1999.276.4.C946; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu Y, 2010, NEOPLASIA, V12, P61, DOI 10.1593/neo.91354; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; Manni A, 2004, CLIN EXP METASTAS, V21, P461, DOI 10.1007/s10585-004-2724-3; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; NISHIKAWA Y, 1980, BIOCHEM BIOPH RES CO, V97, P1296, DOI 10.1016/S0006-291X(80)80007-6; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oku M, 2011, CELL STRUCT FUNCT, V36, P1, DOI 10.1247/csf.10014; Parkkinen JJ, 1997, J CELL BIOCHEM, V66, P165, DOI 10.1002/(SICI)1097-4644(19970801)66:2<165::AID-JCB4>3.3.CO;2-D; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Qin XQ, 1997, ONCOGENE, V14, P53, DOI 10.1038/sj.onc.1200809; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Ray RM, 1999, AM J PHYSIOL-CELL PH, V276, pC684, DOI 10.1152/ajpcell.1999.276.3.C684; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang X, 2009, NUCLEIC ACIDS RES, V37, P7623, DOI 10.1093/nar/gkp755; Zou TT, 2004, AM J PHYSIOL-CELL PH, V286, pC1009, DOI 10.1152/ajpcell.00480.2003	70	30	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35825	35837		10.1074/jbc.M112.381335	http://dx.doi.org/10.1074/jbc.M112.381335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942278	hybrid, Green Published			2022-12-28	WOS:000310364000006
J	Shaltiel, L; Paparizos, C; Fenske, S; Hassan, S; Gruner, C; Rotzer, K; Biel, M; Wahl-Schott, CA				Shaltiel, Lior; Paparizos, Christos; Fenske, Stefanie; Hassan, Sami; Gruner, Christian; Roetzer, Katrin; Biel, Martin; Wahl-Schott, Christian A.			Complex Regulation of Voltage-dependent Activation and Inactivation Properties of Retinal Voltage-gated Cav1.4 L-type Ca2+ Channels by Ca2+-binding Protein 4 (CaBP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; POTASSIUM CURRENT; BETA(2) SUBUNIT; CALMODULIN; MUTATION; FRET; ROD; CA(V)1.4-ALPHA-1; CA(V)1.3; CURRENTS	Cav1.4 L-type Ca2+ channels are crucial for synaptic transmission in retinal photoreceptors and bipolar neurons. Recent studies suggest that the activity of this channel is regulated by the Ca2+-binding protein 4 (CaBP4). In the present study, we explored this issue by examining functional effects of CaBP4 on heterologously expressed Cav1.4. We show that CaBP4 dramatically increases Cav1.4 channel availability. This effect crucially depends on the presence of the C-terminal ICDI (inhibitor of Ca2+-dependent inactivation) domain of Cav1.4 and is absent in a Cav1.4 mutant lacking the ICDI. Using FRET experiments, we demonstrate that CaBP4 interacts with the IQ motif of Cav1.4 and that it interferes with the binding of the ICDI domain. Based on these findings, we suggest that CaBP4 increases Cav1.4 channel availability by relieving the inhibitory effects of the ICDI domain on voltage-dependent Cav1.4 channel gating. We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases. Although both mutants interact with Cav1.4 channels, the functional effects of CaBP4 mutants are only partially preserved, leading to a reduction of Cav1.4 channel availability and loss of function. In conclusion, our study sheds new light on the functional interaction between CaBP4 and Cav1.4. Moreover, it provides insights into the mechanism by which CaBP4 mutants lead to loss of Cav1.4 function and to retinal disease.	Univ Munich, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany	University of Munich; University of Munich	Wahl-Schott, CA (corresponding author), Univ Munich, Dept Pharm Pharmakol Nat Wissensch, Butenandtstr 5-13, D-81377 Munich, Germany.	christian.wahl@cup.uni-muenchen.de	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401; Hassan, Sami/0000-0002-8784-143X	Deutsche Forschungsgemeinschaft (DFG); Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerische Forschungsstiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and by the Bayerische Forschungsstiftung.	Aldahmesh MA, 2010, MOL VIS, V16, P207; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dong Y, 2003, J NEUROSCI, V23, P2686; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Moriondo A, 2001, EUR J NEUROSCI, V14, P19, DOI 10.1046/j.0953-816x.2001.01605.x; Nejatbakhsh N, 2011, ACTA PHARMACOL SIN, V32, P741, DOI 10.1038/aps.2011.64; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	40	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36312	36321		10.1074/jbc.M112.392811	http://dx.doi.org/10.1074/jbc.M112.392811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936811	hybrid, Green Published			2022-12-28	WOS:000310364000052
J	Velazquez-Delgado, EM; Hardy, JA				Velazquez-Delgado, Elih M.; Hardy, Jeanne A.			Zinc-mediated Allosteric Inhibition of Caspase-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; IN-VITRO; COORDINATION ENVIRONMENTS; ACTIVATION; CLEAVAGE; PROTEIN; APOPTOSIS; DISTINCT; SITE; PROCASPASE-3	Zinc and caspase-6 have independently been implicated in several neurodegenerative disorders. Depletion of zinc intracellularly leads to apoptosis by an unknown mechanism. Zinc inhibits cysteine proteases, including the apoptotic caspases, leading to the hypothesis that zinc-mediated inhibition of caspase-6 might contribute to its regulation in a neurodegenerative context. Using inductively coupled plasma optical emission spectroscopy, we observed that caspase-6 binds one zinc per monomer, under the same conditions where the zinc leads to complete loss of enzymatic activity. To understand the molecular details of zinc binding and inhibition, we performed an anomalous diffraction experiment above the zinc edge. The anomalous difference maps showed strong 5 sigma peaks, indicating the presence of one zinc/monomer bound at an exosite distal from the active site. Zinc was not observed bound to the active site. The zinc in the exosite was liganded by Lys-36, Glu-244, and His-287 with a water molecule serving as the fourth ligand, forming a distorted tetrahedral ligation sphere. This exosite appears to be unique to caspase-6, as the residues involved in zinc binding were not conserved across the caspase family. Our data suggest that binding of zinc at the exosite is the primary route of inhibition, potentially locking caspase-6 into the inactive helical conformation.	[Velazquez-Delgado, Elih M.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 Lederle Grad Res Tower,710 N Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM80532, GM-0080]; National Science Foundation [S21000025700000, DGE-0504485]; National Synchrotron Light Source at Brookhaven National Laboratory; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Synchrotron Light Source at Brookhaven National Laboratory; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80532.; Supported by the National Science Foundation Grants S21000025700000 and DGE-0504485.; We thank Kristen Huber for many helpful discussions; Michael Maroney, Nitai Giri, and Julius Campecino for assistance with ICP-OES analysis and insights on zinc coordination geometry; and Scott Garman for exceptional help in calculating the anomalous difference map. We thank Vivian Stojanoff for assistance with data collection and acknowledge NSLS X6A, which is funded by the National Institutes of Health Grant GM-0080, and the National Synchrotron Light Source at Brookhaven National Laboratory, which is supported by the United States Department of Energy Grant DE-AC02-98CH10886.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chimienti F, 2001, BIOCHEM PHARMACOL, V62, P51, DOI 10.1016/S0006-2952(01)00624-4; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Del Rio MJ, 2004, ARCH MED RES, V35, P185, DOI 10.1016/j.arcmed.2004.01.001; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hardy JA, 2009, J BIOL CHEM, V284, P26063, DOI 10.1074/jbc.M109.001826; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Huber KL, 2012, PROTEIN SCI, V21, P1056, DOI 10.1002/pro.2090; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kondoh M, 2005, BIOL PHARM BULL, V28, P757, DOI 10.1248/bpb.28.757; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lucas PW, 2011, INVEST NEW DRUG, V29, P901, DOI 10.1007/s10637-010-9445-z; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Peterson QP, 2009, J MED CHEM, V52, P5721, DOI 10.1021/jm900722z; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; ROGERS JM, 1995, TERATOLOGY, V52, P149, DOI 10.1002/tera.1420520307; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Rudolf E, 2010, BIOMETALS, V23, P339, DOI 10.1007/s10534-010-9302-8; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schrantz N, 2001, CELL DEATH DIFFER, V8, P152, DOI 10.1038/sj.cdd.4400772; Shu N., 2010, PROTEIN STRUCTURE PR, P47; Singh AB, 2002, KIDNEY INT, V62, P106, DOI 10.1046/j.1523-1755.2002.00427.x; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Sukumar N, 2011, J INORG BIOCHEM, V105, P1638, DOI 10.1016/j.jinorgbio.2011.08.002; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Truong-Tran AQ, 2003, BIOCHEM PHARMACOL, V66, P1459, DOI 10.1016/S0006-2952(03)00498-2; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; VALLEE BL, 1993, ACCOUNTS CHEM RES, V26, P543, DOI 10.1021/ar00034a005; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; Velazquez-Delgado EM, 2012, STRUCTURE, V20, P742, DOI 10.1016/j.str.2012.02.003; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Yoo NJ, 2010, TUMORI J, V96, P138, DOI 10.1177/030089161009600122	71	63	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36000	36011		10.1074/jbc.M112.397752	http://dx.doi.org/10.1074/jbc.M112.397752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22891250	Green Published, hybrid			2022-12-28	WOS:000310364000022
J	Kang, JW; Park, YS; Lee, DH; Kim, JH; Kim, MS; Bak, Y; Hong, J; Yoon, DY				Kang, Jeong-Woo; Park, Yun Sun; Lee, Dong Hun; Kim, Jung-Hee; Kim, Man Sub; Bak, Yesol; Hong, Jintae; Yoon, Do-Young			Intracellular Interaction of Interleukin (IL)-32 alpha with Protein Kinase C epsilon (PKC epsilon) and STAT3 Protein Augments IL-6 Production in THP-1 Promonocytic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANXIETY-LIKE BEHAVIOR; PROINFLAMMATORY CYTOKINE; MACROPHAGE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; SIGNALING PATHWAY; CANCER-CELLS; ACTIVATION; EXPRESSION	IL-32 alpha is known as a proinflammatory cytokine. However, several evidences implying its action in cells have been recently reported. In this study, we present for the first time that IL-32 alpha plays an intracellular mediatory role in IL-6 production using constitutive expression systems for IL-32 alpha in THP-1 cells. We show that phorbol 12-myristate 13-acetate (PMA)-induced increase in IL-6 production by IL-32 alpha -expressing cells was higher than that by empty vector-expressing cells and that this increase occurred in a time-and dose-dependent manner. Treatment with MAPK inhibitors did not diminish this effect of IL-32 alpha, and NF-kappa B signaling activity was similar in the two cell lines. Because the augmenting effect of IL-32 alpha was dependent on the PKC activator PMA, we tested various PKC inhibitors. The pan-PKC inhibitor Go6850 and the PKC epsilon inhibitor Ro-31-8220 abrogated the augmenting effect of IL-32 alpha on IL-6 production, whereas the classical PKC inhibitor Go6976 and the PKC delta inhibitor rottlerin did not. In addition, IL-32 alpha was co-immuno-precipitated with PMA-activated PKC epsilon, and this interaction was totally inhibited by the PKC epsilon inhibitor Ro-31-8220. PMA-induced enhancement of STAT3 phosphorylation was observed only in IL-32 alpha-expressing cells, and this enhancement was inhibited by Ro-31-8220, but not by Go6976. We demonstrate that IL-32 alpha mediated STAT3 phosphorylation by forming a trimeric complex with PKC epsilon and enhanced STAT3 localization onto the IL-6 promoter and thereby increased IL-6 expression. Thus, our data indicate that the intracellular interaction of IL-32 alpha with PKC epsilon and STAT3 promotes STAT3 binding to the IL-6 promoter by enforcing STAT3 phosphorylation, which results in increased production of IL-6.	[Kang, Jeong-Woo; Park, Yun Sun; Lee, Dong Hun; Kim, Jung-Hee; Kim, Man Sub; Bak, Yesol; Yoon, Do-Young] Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Hong, Jintae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361463, Chungbuk, South Korea; [Hong, Jintae] Chungbuk Natl Univ, Med Res Ctr, Cheongju 361463, Chungbuk, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University	Yoon, DY (corresponding author), Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	ydy4218@konkuk.ac.kr			National Research Foundation of Korea (NRF) [2010-0019306, 2012R1A2A2A 02008751]; NRF Grant [2009-R1AAA002-351-2009-1-E00007]; Priority Research Centres Program Grant [2012-0006686]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF Grant(National Research Foundation of Korea); Priority Research Centres Program Grant	This work was supported by Basic Program Grants 2010-0019306 and 2012R1A2A2A 02008751 from the National Research Foundation of Korea (NRF), NRF Grant 2009-R1AAA002-351-2009-1-E00007 (to J.-W. K.), and Priority Research Centres Program Grant 2012-0006686 (to D.-Y. Y.).	Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Budas GR, 2007, BIOCHEM SOC T, V35, P1052, DOI 10.1042/BST0351052; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; Cheon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.159756; Choi J, 2010, P NATL ACAD SCI USA, V107, P21082, DOI 10.1073/pnas.1015418107; Churchill EN, 2007, BIOCHEM SOC T, V35, P1040, DOI 10.1042/BST0351040; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fima E, 1999, EUR CYTOKINE NETW, V10, P491; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Hasegawa H, 2011, CYTOKINE, V53, P74, DOI 10.1016/j.cyto.2010.09.002; Heinhuis B, 2012, J BIOL CHEM, V287, P5733, DOI 10.1074/jbc.M111.288290; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang JW, 2009, IMMUNOLOGY, V128, pe532, DOI 10.1111/j.1365-2567.2008.03025.x; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kiriyama Y, 2001, ENDOCRINOLOGY, V142, P3563, DOI 10.1210/en.142.8.3563; Kobayashi H, 2009, CYTOKINE, V46, P351, DOI 10.1016/j.cyto.2009.03.007; Kovanen PE, 2000, BLOOD, V95, P1626, DOI 10.1182/blood.V95.5.1626.005k21_1626_1632; Lesscher HMB, 2008, GENES BRAIN BEHAV, V7, P323, DOI 10.1111/j.1601-183X.2007.00356.x; Lumelsky NL, 1997, BBA-MOL CELL RES, V1358, P79, DOI 10.1016/S0167-4889(97)00051-7; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Mun SH, 2009, ARTHRITIS RHEUM-US, V60, P678, DOI 10.1002/art.24299; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton PM, 2006, PHARMACOL THERAPEUT, V109, P227, DOI 10.1016/j.pharmthera.2005.07.004; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Smyth DC, 2006, J IMMUNOL, V177, P8740, DOI 10.4049/jimmunol.177.12.8740; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; van Kolen K, 2008, J NEUROCHEM, V104, P1, DOI 10.1111/j.1471-4159.2007.04986.x; Yoon S, 2012, ONCOGENE, V31, P3467, DOI 10.1038/onc.2011.517; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	52	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35556	35564		10.1074/jbc.M112.400911	http://dx.doi.org/10.1074/jbc.M112.400911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927445	Green Published, hybrid			2022-12-28	WOS:000309968000068
J	Pfister, AS; Hadjihannas, MV; Rohrig, W; Schambony, A; Behrens, J				Pfister, Astrid S.; Hadjihannas, Michel V.; Roehrig, Waldemar; Schambony, Alexandra; Behrens, Juergen			Amer2 Protein Interacts with EB1 Protein and Adenomatous Polyposis Coli (APC) and Controls Microtubule Stability and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BETA-CATENIN; WILMS-TUMOR; PLUS ENDS; BINDING; PHOSPHORYLATION; GSK3-BETA; DYNAMICS; POLARITY; GROWTH	EB1 is key factor in the organization of the microtubule cytoskeleton by binding to the plus-ends of microtubules and serving as a platform for a number of interacting proteins (termed +TIPs) that control microtubule dynamics. Together with its direct binding partner adenomatous polyposis coli (APC), EB1 can stabilize microtubules. Here, we show that Amer2 (APC membrane recruitment 2), a previously identified membrane-associated APC-binding protein, is a direct interaction partner of EB1 and acts as regulator of microtubule stability together with EB1. Amer2 binds to EB1 via specific (S/T)xIP motifs and recruits it to the plasma membrane. Coexpression of Amer2 and EB1 generates stabilized microtubules at the plasma membrane, whereas knockdown of Amer2 leads to destabilization of microtubules. Knockdown of Amer2, APC, or EB1 reduces cell migration, and morpholino-mediated down-regulation of Xenopus Amer2 blocks convergent extension cell movements, suggesting that the Amer2-EB1-APC complex regulates cell migration by altering microtubule stability.	[Pfister, Astrid S.; Hadjihannas, Michel V.; Roehrig, Waldemar; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Schambony, Alexandra/0000-0001-8771-5487	Deutsche Forschungsgemeinschaft [Be 1550/6-1, SCHA965/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Be 1550/6-1 (to J.B.) and SCHA965/6-1 (to A.S.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Barth AIM, 2002, J CELL SCI, V115, P1583; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Polakis P, 2000, GENE DEV, V14, P1837; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SU LK, 1995, CANCER RES, V55, P2972; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wen YD, 2004, KENYON REV, V26, P1; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	30	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35333	35340		10.1074/jbc.M112.385393	http://dx.doi.org/10.1074/jbc.M112.385393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22898821	hybrid, Green Published			2022-12-28	WOS:000309968000042
J	Wilson, SM; Schmutzler, BS; Brittain, JM; Dustrude, ET; Ripsch, MS; Pellman, JJ; Yeum, TS; Hurley, JH; Hingtgen, CM; White, FA; Khanna, R				Wilson, Sarah M.; Schmutzler, Brian S.; Brittain, Joel M.; Dustrude, Erik T.; Ripsch, Matthew S.; Pellman, Jessica J.; Yeum, Tae-Sung; Hurley, Joyce H.; Hingtgen, Cynthia M.; White, Fletcher A.; Khanna, Rajesh			Inhibition of Transmitter Release and Attenuation of Anti-retroviral-associated and Tibial Nerve Injury-related Painful Peripheral Neuropathy by Novel Synthetic Ca2+ Channel Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; GENE-RELATED PEPTIDE; N-TYPE; SYNAPTIC-TRANSMISSION; BETA-SUBUNIT; PROTEIN; BINDING; BLOCKADE; NEURONS; MICE	N-type Ca2+ channels (CaV2.2) are a nidus for neurotransmitter release and nociceptive transmission. However, the use of CaV2.2 blockers in pain therapeutics is limited by side effects resulting from inhibition of the physiological functions of CaV2.2 within the CNS. We identified an anti-nociceptive peptide (Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., Liu, N., Xiong, W., Ripsch, M. S., Wang, Y., Fehrenbacher, J. C., Fitz, S. D., Khanna, M., Park, C. K., Schmutzler, B. S., Cheon, B. M., Due, M. R., Brustovetsky, T., Ashpole, N. M., Hudmon, A., Meroueh, S. O., Hingtgen, C. M., Brustovetsky, N., Ji, R. R., Hurley, J. H., Jin, X., Shekhar, A., Xu, X. M., Oxford, G. S., Vasko, M. R., White, F. A., and Khanna, R. (2011) Suppression of inflammatory and neuropathic pain by uncoupling CRMP2 from the presynaptic Ca2+ channel complex. Nat. Med. 17, 822-829) derived from the axonal collapsin response mediator protein 2 (CRMP2), a protein known to bind and enhance CaV2.2 activity. Using a peptide tiling array, we identified novel peptides within the first intracellular loop (CaV2.2(388-402), "L1") and the distal C terminus (CaV1.2(2014-2028) "Ct-dis") that bound CRMP2. Microscale thermophoresis demonstrated micromolar and nanomolar binding affinities between recombinant CRMP2 and synthetic L1 and Ct-dis peptides, respectively. Co-immunoprecipitation experiments showed that CRMP2 association with CaV2.2 was inhibited by L1 and Ct-dis peptides. L1 and Ct-dis, rendered cell-penetrant by fusion with the protein transduction domain of the human immunodeficiency virus TAT protein, were tested in in vitro and in vivo experiments. Depolarization-induced calcium influx in dorsal root ganglion (DRG) neurons was inhibited by both peptides. Ct-dis, but not L1, peptide inhibited depolarization-stimulated release of the neuropeptide transmitter calcitonin gene-related peptide in mouse DRG neurons. Similar results were obtained in DRGs from mice with a heterozygous mutation of Nf1 linked to neurofibromatosis type 1. Ct-dis peptide, administered intraperitoneally, exhibited antinociception in a zalcitabine (2'-3'-dideoxycytidine) model of AIDS therapy-induced and tibial nerve injury-related peripheral neuropathy. This study suggests that CaV peptides, by perturbing interactions with the neuromodulator CRMP2, contribute to suppression of neuronal hypersensitivity and nociception.	[Schmutzler, Brian S.; Pellman, Jessica J.; Hingtgen, Cynthia M.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wilson, Sarah M.; Brittain, Joel M.; Dustrude, Erik T.; Hurley, Joyce H.; Hingtgen, Cynthia M.; White, Fletcher A.; Khanna, Rajesh] Indiana Univ Sch Med, Program Med Neurosci, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ripsch, Matthew S.; Yeum, Tae-Sung; White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Hurley, Joyce H.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hingtgen, Cynthia M.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Khanna, Rajesh] Sophia Therapeut LLC, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iu.edu	White, Fletcher/F-3203-2015	White, Fletcher/0000-0002-8408-9262; Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health (NIH), NCRR of the Indiana Clinical and Translational Sciences Institute [RR025761]; NIH, NINDS [NS049136-06]; NIH, NIDA [DA026040-04]; Indiana State Department of Health [A70-9-079138]; American Heart Association [SDG5280023]; Department of Defense [NF1000099]; Ralph W. and Grace M. Showalter Foundation; Indiana University Biomedical Committee [2286501]; Indiana Clinical and Translational Sciences Institute; Elwert Award in Medicine; Paul and Carole Stark Fellowship; Children's Tumor Foundation; Larry Kays Medical Neuroscience Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCRR of the Indiana Clinical and Translational Sciences Institute; NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Indiana State Department of Health; American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Ralph W. and Grace M. Showalter Foundation; Indiana University Biomedical Committee; Indiana Clinical and Translational Sciences Institute; Elwert Award in Medicine; Paul and Carole Stark Fellowship; Children's Tumor Foundation; Larry Kays Medical Neuroscience Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCRR, Project Development Team Grant RR025761 in support of the Indiana Clinical and Translational Sciences Institute (to R. K); NIH, NINDS, Grant NS049136-06 (to F. A. W.); and NIH, NIDA, Grant DA026040-04 (to F. A. W.). This work was also supported by a Clinical and Translational Sciences Award from the Indiana State Department of Health Spinal Cord and Brain Injury Fund (A70-9-079138 to R. K.), American Heart Association National Scientist Development Grant SDG5280023 (to R. K.), Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award NF1000099 (to R. K.), a Ralph W. and Grace M. Showalter Foundation grant (to R. K.), Indiana University Biomedical Committee Research Support Funds Grant 2286501 (to R. K), a Research Inventions and Scientific Commercialization grant (to R. K.) from the Indiana Clinical and Translational Sciences Institute, and the Elwert Award in Medicine (to R. K.).; Supported in part by a Paul and Carole Stark Fellowship.; Supported by a Young Investigator's Award from the Children's Tumor Foundation.; Supported by a Larry Kays Medical Neuroscience Fellowship.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; BOWERSOX SS, 1992, J CARDIOVASC PHARM, V20, P756, DOI 10.1097/00005344-199220050-00011; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brittain JM, 2012, CHANNELS, V6, P94, DOI 10.4161/chan.19415; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Bucci G, 2011, J PHYSIOL-LONDON, V589, P3085, DOI 10.1113/jphysiol.2010.204735; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen JJ, 1996, PEPTIDES, V17, P31, DOI 10.1016/0196-9781(95)02091-8; Chen L, 2007, BIOCHEM SOC T, V35, P821, DOI 10.1042/BST0350821; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DODGE FA, 1967, J PHYSIOL-LONDON, V189, pP90; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hingtgen CM, 2006, NEUROSCIENCE, V137, P637, DOI 10.1016/j.neuroscience.2005.09.030; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Joseph EK, 2004, PAIN, V107, P147, DOI 10.1016/j.pain.2003.10.010; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Li B, 2004, MOL PHARMACOL, V66, P761; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; Manceur AP, 2009, MOL THER, V17, P500, DOI 10.1038/mt.2008.271; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McGivern Joseph G, 2007, Neuropsychiatr Dis Treat, V3, P69, DOI 10.2147/nedt.2007.3.1.69; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Neugebauer V, 1996, NEUROSCIENCE, V71, P1095, DOI 10.1016/0306-4522(95)00473-4; Neugebauer V, 1996, J NEUROPHYSIOL, V76, P3740, DOI 10.1152/jn.1996.76.6.3740; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Piekarz AD, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-54; Polyakov V, 2000, BIOCONJUGATE CHEM, V11, P762, DOI 10.1021/bc000008y; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ripsch MS, 2012, TRANSL NEUROSCI, V3, P1, DOI 10.2478/s13380-012-0002-4; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sluka KA, 1997, PAIN, V71, P157, DOI 10.1016/S0304-3959(97)03354-X; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Tedford HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-6; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Wang YY, 2010, TRANSL NEUROSCI, V1, P106, DOI 10.2478/v10134-010-0025-8; Wang YY, 2011, TRANSL NEUROSCI, V2, P13, DOI 10.2478/s13380-011-0002-9; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; White DM, 1998, BRAIN RES, V801, P50, DOI 10.1016/S0006-8993(98)00539-3; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wilson SM, 2011, CHANNELS, V5, P447, DOI 10.4161/chan.5.5.17363; Winquist RJ, 2005, BIOCHEM PHARMACOL, V70, P489, DOI 10.1016/j.bcp.2005.04.035; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	61	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35065	35077		10.1074/jbc.M112.378695	http://dx.doi.org/10.1074/jbc.M112.378695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22891239	Green Published, hybrid			2022-12-28	WOS:000309968000018
J	Andreasen, M; Nielsen, SB; Runager, K; Christianse, G; Nielse, NC; Enghild, JJ; Otzen, DE				Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Christianse, Gunna; Nielse, Niels Chr.; Enghild, Jan J.; Otzen, Daniel E.			Polymorphic Fibrillation of the Destabilized Fourth Fasciclin-1 Domain Mutant A546T of the Transforming Growth Factor-beta-induced Protein (TGFBIp) Occurs through Multiple Pathways with Different Oligomeric Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-FLOW FRACTIONATION; KERATO-EPITHELIN MUTATIONS; HEAT-INDUCED AGGREGATION; CORNEAL DYSTROPHIES; VESICLE PERMEABILIZATION; SEQUENCE-ANALYSIS; LACTOGLOBULIN AB; GENE-MUTATIONS; BETA-IG-H3; PH	Mutations in the transforming growth factor beta-induced protein (TGFBIp) are linked to the development of corneal dystrophies in which abnormal protein deposition in the cornea leads to a loss of corneal transparency and ultimately blindness. Different mutations give rise to phenotypically distinct corneal dystrophies. Most mutations are located in the fourth fasciclin-1 domain (FAS1-4). The amino acid substitution A546T in the FAS1-4 domain is linked to the development of lattice corneal dystrophy with amyloid deposits in the superficial and deep stroma, classifying it as an amyloid disease. Here we provide a detailed description of the fibrillation of the isolated FAS1-4 domain carrying the A546T substitution. The A546T substitution leads to a significant destabilization of FAS1-4 and induces a partially folded structure with increased surface exposure of hydrophobic patches. The mutation also leads to two distinct fibril morphologies. Long straight fibrils composed of pure beta-sheet structure are formed at lower concentrations, whereas short and curly fibrils containing a mixture of alpha-helical and beta-sheet structures are formed at higher concentrations. The formation of short and curly fibrils is preceded by the formation of a small number of oligomeric species with high membrane permeabilization potential and rapid fibril formation. The long straight fibrils are formed more slowly and through progressively bigger oligomers that lose their membrane permeabilization potential as fibrillation proceeds beyond the lag phase. These different fibril classes and associated biochemical differences may lead to different clinical symptoms associated with the mutation.	[Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Christianse, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Nielse, Niels Chr.] Aarhus Univ, inSPIN, iNANO, DK-8000 Aarhus, Denmark; [Nielse, Niels Chr.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.	dao@inano.au.dk	Nielsen, Søren B/D-5936-2011	Enghild, Jan Johannes/0000-0001-9292-9172; Andreasen, Maria/0000-0002-6096-2995; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish National Research Foundation.	Alizadeh-Pasdar N, 2000, J AGR FOOD CHEM, V48, P328, DOI 10.1021/jf990393p; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Andersen CB, 2007, BIOCHEMISTRY-US, V46, P7314, DOI 10.1021/bi6025374; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreasen M, 2012, BBA-PROTEINS PROTEOM, V1824, P274, DOI 10.1016/j.bbapap.2011.10.014; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chakravarthi SVVK, 2005, INVEST OPHTH VIS SCI, V46, P121, DOI 10.1167/iovs.04-0440; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; CONRAD TJ, 1994, LAB INVEST, V70, P426; Dighiero P, 2000, AM J OPHTHALMOL, V129, P248, DOI 10.1016/S0002-9394(99)00324-4; ESCRIBANO J, 1994, J CELL PHYSIOL, V160, P511, DOI 10.1002/jcp.1041600314; Fraunhofer W, 2004, EUR J PHARM BIOPHARM, V58, P369, DOI 10.1016/j.ejpb.2004.03.034; Fujiki K, 2001, J HUM GENET, V46, P431, DOI 10.1007/s100380170041; Ghodke S, 2012, FEBS J, V279, P752, DOI 10.1111/j.1742-4658.2011.08465.x; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haris PI, 2010, BIOCHEM SOC T, V38, P940, DOI 10.1042/BST0380940; HARIS PI, 1992, BIOCHEMISTRY-US, V31, P6279, DOI 10.1021/bi00142a016; Hoppe C.C., 2008, J BIOL ENG, V2, P1; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Klintworth GK, 1998, AM J PATHOL, V152, P743; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lorenzen N, 2012, BIOPHYS J, V102, P2167, DOI 10.1016/j.bpj.2012.03.047; Macchi F, 2011, LANGMUIR, V27, P12539, DOI 10.1021/la202125c; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Mashima Y, 1997, AM J HUM GENET, V61, P1448, DOI 10.1086/301649; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; Nesgaard L, 2009, BBA-PROTEINS PROTEOM, V1794, P84, DOI 10.1016/j.bbapap.2008.09.021; Nielsen SB, 2012, J MOL BIOL, V421, P601, DOI 10.1016/j.jmb.2012.01.050; Okada M, 1998, AM J OPHTHALMOL, V126, P169, DOI 10.1016/S0002-9394(98)00075-0; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rambaldi DC, 2009, ANAL BIOANAL CHEM, V394, P2145, DOI 10.1007/s00216-009-2899-1; Rosenberg ME, 2000, OPHTHALMOLOGY, V107, P565, DOI 10.1016/S0161-6420(99)00086-X; Runager K, 2011, J BIOL CHEM, V286, P4951, DOI 10.1074/jbc.M110.181099; Schokker EP, 1999, INT DAIRY J, V9, P791, DOI 10.1016/S0958-6946(99)00148-X; Schokker EP, 2000, INT DAIRY J, V10, P233, DOI 10.1016/S0958-6946(00)00047-9; Silveira JR, 2006, METHOD ENZYMOL, V412, P21, DOI 10.1016/S0076-6879(06)12002-9; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Streeten BW, 1999, ARCH OPHTHALMOL-CHIC, V117, P67; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; WAHLUND KG, 1987, ANAL CHEM, V59, P1332, DOI 10.1021/ac00136a016; Weiss JS, 2008, CORNEA, V27, pS1, DOI 10.1097/ICO.0b013e31817780fb; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	68	18	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34730	34742		10.1074/jbc.M112.379552	http://dx.doi.org/10.1074/jbc.M112.379552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893702	Green Published, hybrid			2022-12-28	WOS:000309654200073
J	De Houwer, S; Demeulemeester, J; Thys, W; Taltynov, O; Zmajkovicova, K; Christ, F; Debyser, Z				De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Taltynov, Oliver; Zmajkovicova, Katarina; Christ, Frauke; Debyser, Zeger			Identification of Residues in the C-terminal Domain of HIV-1 Integrase That Mediate Binding to the Transportin-SR2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 REPLICATION; NUCLEAR IMPORT RECEPTOR; SR PROTEINS; PREINTEGRATION COMPLEXES; NONDIVIDING CELLS; LENTIVIRAL VECTOR; DNA INTEGRATION; CATALYTIC CORE; IN-VIVO; INFECTION	Transportin-SR2 (TRN-SR2 and TNPO3) is a cellular cofactor of HIV replication that has been implicated in the nuclear import of HIV. TRN-SR2 was originally identified in a yeast two-hybrid screen as an interaction partner of HIV integrase (IN) and in two independent siRNA screens as a cofactor of viral replication. We have now studied the interaction of TRN-SR2 and HIV IN in molecular detail and identified the TRN-SR2 interacting regions of IN. A weak interaction with the catalytic core domain (CCD) and a strong interaction with the C-terminal domain (CTD) of IN were detected. By dissecting the catalytic core domain (CCD) of IN into short structural fragments, we identified a peptide (INIP1, amino acids (170)EHLKTAVQMAVFIHNFKRKGGI(191)) retaining the ability to interact with TRN-SR2. By dissecting the C-terminal domain (CTD) of IN, we could identify two interacting peptides (amino acids (214)QKQITKIQNFRVYYR(228) and (262)RRKVKIIRDYGK(273)) that come together in the CTD tertiary structure to form an exposed antiparallel beta-sheet. Through site-specific mutagenesis, we defined the following sets of amino acids in IN as important for the interaction with TRN-SR2: Phe-185/Lys-186/Arg-187/Lys-188 in the CCD and Arg-262/Arg-263/Lys-264 and Lys-266/Arg-269 in the CTD. An HIV-1 strain carrying K266A/R269A in IN was replication-defective due to a block in reverse transcription, confounding the study of nuclear import. Insight into the IN/TRN-SR2 interaction interface is necessary to guide drug discovery efforts targeting the nuclear entry step of replication.	[De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Taltynov, Oliver; Zmajkovicova, Katarina; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Belgium.	zeger.debyser@med.kuleuven.be	Christ, Frauke/H-7513-2018; Demeulemeester, Jonas/J-6130-2014; debyser, zeger/H-1310-2013	Demeulemeester, Jonas/0000-0002-2660-2478; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	Fonds Wetenschappelijk Onderzoek [G.0487.10N]; European Union; CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie	Fonds Wetenschappelijk Onderzoek(FWO); European Union(European Commission); CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie	This work was supported in part by Fonds Wetenschappelijk Onderzoek Grant G.0487.10N, European Union FP7 Program Grants THINC and CHAARM, and the CellCoVir SBO Project of the Agenstchap voor Innovatie door Wetenschap en Technologie.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cribier A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-104; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Piller SC, 2003, CURR DRUG TARGETS, V4, P409, DOI 10.2174/1389450033490984; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Van Maele B, 2003, J VIROL, V77, P4685, DOI 10.1128/JVI.77.8.4685-4694.2003; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	54	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34059	34068		10.1074/jbc.M112.387944	http://dx.doi.org/10.1074/jbc.M112.387944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872638	hybrid, Green Published			2022-12-28	WOS:000309654200012
J	Ligons, DL; Tuncer, C; Linowes, BA; Akcay, IM; Kurtulus, S; Deniz, E; Arslan, BA; Cevik, SI; Keller, HR; Luckey, MA; Feigenbaum, L; Moroy, T; Ersahin, T; Atalay, R; Erman, B; Park, JH				Ligons, Davinna L.; Tuncer, Ceren; Linowes, Brett A.; Akcay, Izzet Mehmet; Kurtulus, Sema; Deniz, Emre; Arslan, Belkis Atasever; Cevik, Safak Isil; Keller, Hilary R.; Luckey, Megan A.; Feigenbaum, Lionel; Moeroey, Tarik; Ersahin, Tulin; Atalay, Rengul; Erman, Batu; Park, Jung-Hyun			CD8 Lineage-specific Regulation of Interleukin-7 Receptor Expression by the Transcriptional Repressor Gfi1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL DEVELOPMENT; ZINC-FINGER PROTEIN; GA-BINDING-PROTEIN; IL-7 RECEPTOR; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; IL-7R-ALPHA EXPRESSION; THYMOCYTE DEVELOPMENT; ALPHA EXPRESSION; UP-REGULATION	Interleukin-7 receptor alpha (IL-7R alpha) is essential for T cell survival and differentiation. Glucocorticoids are potent enhancers of IL-7R alpha expression with diverse roles in T cell biology. Here we identify the transcriptional repressor, growth factor independent-1 (Gfi1), as a novel intermediary in glucocorticoid-induced IL-7R alpha up-regulation. We found Gfi1 to be a major inhibitory target of dexamethasone by microarray expression profiling of 3B4.15 T-hybridoma cells. Concordantly, retroviral transduction of Gfi1 significantly blunted IL-7R alpha up-regulation by dexamethasone. To further assess the role of Gfi1 in vivo, we generated bacterial artificial chromosome (BAC) transgenic mice, in which a modified Il7r locus expresses GFP to report Il7r gene transcription. By introducing this BAC reporter transgene into either Gfi1-deficient or Gfi1-transgenic mice, we document in vivo that IL-7R alpha transcription is up-regulated in the absence of Gfi1 and down-regulated when Gfi1 is overexpressed. Strikingly, the in vivo regulatory role of Gfi1 was specific for CD8(+), and not CD4(+) T cells or immature thymocytes. These results identify Gfi1 as a specific transcriptional repressor of the Il7r gene in CD8 T lymphocytes in vivo.	[Tuncer, Ceren; Akcay, Izzet Mehmet; Kurtulus, Sema; Deniz, Emre; Arslan, Belkis Atasever; Cevik, Safak Isil; Erman, Batu] Sabanci Univ, FENS, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Ligons, Davinna L.; Linowes, Brett A.; Keller, Hilary R.; Luckey, Megan A.; Park, Jung-Hyun] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Sci Applicat Int Corp Frederick, Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Moeroey, Tarik] Univ Montreal, Dept Microbiol & Immunol, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Ersahin, Tulin; Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Erman, Batu] Sabanci Univ, Nanotechnol Res & Applicat Ctr, SUNUM, TR-34956 Istanbul, Turkey	Sabanci University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Ihsan Dogramaci Bilkent University; Sabanci University	Erman, B (corresponding author), Sabanci Univ, FENS, Biol Sci & Bioengn Program, Univ Caddesi 27, TR-34956 Istanbul, Turkey.	batu@sabanciuniv.edu; parkhy@mail.nih.gov	Davis, Megan/F-5339-2015; CEVIK, ISIL/K-1320-2012; TUNCER, CEREN/AAM-2353-2021; Ersahin, Tulin/M-5721-2013; Cetin-Atalay, Rengul/O-9826-2014; erman, batu/AAE-1963-2020; Cetin-Atalay, Rengul/F-5780-2013; Park, Jung Hyun/B-5712-2015	Ersahin, Tulin/0000-0002-7474-7890; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Park, Jung Hyun/0000-0002-9547-9055; DENIZ, EMRE/0000-0002-9635-983X; , Hilary/0000-0002-6510-5685; Atasever Arslan, Belkis/0000-0001-5827-8484; Davis, Megan/0000-0002-9674-0753; Akcay, Izzet Mehmet/0000-0001-6364-0062	National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research; Scientific and Technological Research Council of Turkey; Turkish National Academy of Science; TUBITAK 1001 [109T315]; National Institutes of Health-FIRCA [1R03TW008208]; National Institutes of Health-GRIP [1R01TW007270]; FOGARTY INTERNATIONAL CENTER [R03TW008208, R01TW007270] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011214] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish National Academy of Science(Turkish Academy of Sciences); TUBITAK 1001(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); National Institutes of Health-FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health-GRIP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health (NIH) grant from the Intramural Research Program, NCI, Center for Cancer Research.; Supported by the Scientific and Technological Research Council of Turkey scholarships.; Supported by the Turkish National Academy of Science post-doctoral fellowship.; Supported by TUBITAK 1001 Grant 109T315, National Institutes of Health-FIRCA Grant 1R03TW008208, and National Institutes of Health-GRIP Grant 1R01TW007270.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Brewer JA, 2002, J IMMUNOL, V169, P1309, DOI 10.4049/jimmunol.169.3.1309; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Kim HR, 2007, J IMMUNOL, V178, P5473, DOI 10.4049/jimmunol.178.9.5473; Kim HR, 2006, BLOOD, V107, P2855, DOI 10.1182/blood-2005-09-3560; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pargmann D, 2007, EUR J IMMUNOL, V37, P3551, DOI 10.1002/eji.200737130; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purton JF, 2000, IMMUNITY, V13, P179, DOI 10.1016/S1074-7613(00)00018-2; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Shibata H, 2007, IMMUNOL LETT, V111, P45, DOI 10.1016/j.imlet.2007.04.012; Simon A, 2010, BIOINFORMATICS, V26, P2468, DOI 10.1093/bioinformatics/btq410; Sinclair C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002246; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Vacchio MS, 1999, J IMMUNOL, V163, P1327; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang ZF, 2011, BLOOD, V118, P2243, DOI 10.1182/blood-2010-07-298802; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu SY, 2012, TRANSGENIC RES, V21, P201, DOI 10.1007/s11248-011-9508-8; Zhan YF, 2004, INT IMMUNOL, V16, P1315, DOI 10.1093/intimm/dxh134; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	60	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34386	34399		10.1074/jbc.M112.378687	http://dx.doi.org/10.1074/jbc.M112.378687			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865857	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000309654200041
J	Mouilleron, S; Badet-Denisot, MA; Pecqueur, L; Madiona, K; Assrir, N; Badet, B; Golinelli-Pimpaneau, B				Mouilleron, Stephane; Badet-Denisot, Marie-Ange; Pecqueur, Ludovic; Madiona, Karine; Assrir, Nadine; Badet, Bernard; Golinelli-Pimpaneau, Beatrice			Structural Basis for Morpheein-type Allosteric Regulation of Escherichia coli Glucosamine-6-phosphate Synthase EQUILIBRIUM BETWEEN INACTIVE HEXAMER AND ACTIVE DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSAMINE 6-PHOSPHATE SYNTHASE; ANGSTROM CRYSTAL-STRUCTURE; GLUTAMINE; AMMONIA; AMIDOTRANSFERASE; SITE; PURIFICATION; EXPRESSION; BINDING; DOMAIN	The amino-terminal cysteine of glucosamine-6-phosphate synthase (GlmS) acts as a nucleophile to release and transfer ammonia from glutamine to fructose 6-phosphate through a channel. The crystal structure of the C1A mutant of Escherichia coli GlmS, solved at 2.5 angstrom resolution, is organized as a hexamer, where the glutaminase domains adopt an inactive conformation. Although the wild-type enzyme is active as a dimer, size exclusion chromatography, dynamic and quasi-elastic light scattering, native polyacrylamide gel electrophoresis, and ultracentrifugation data show that the dimer is in equilibrium with a hexameric state, in vitro and in cellulo. The previously determined structures of the wild-type enzyme, alone or in complex with glucosamine 6-phosphate, are also consistent with a hexameric assembly that is catalytically inactive because the ammonia channel is not formed. The shift of the equilibrium toward the hexameric form in the presence of cyclic glucosamine 6-phosphate, together with the decrease of the specific activity with increasing enzyme concentration, strongly supports product inhibition through hexamer stabilization. Altogether, our data allow us to propose a morpheein model, in which the active dimer can rearrange into a transiently stable form, which has the propensity to form an inactive hexamer. This would account for a physiologically relevant allosteric regulation of E. coli GlmS. Finally, in addition to cyclic glucose 6-phosphate bound at the active site, the hexameric organization of E. coli GlmS enables the binding of another linear sugar molecule. Targeting this sugar-binding site to stabilize the inactive hexameric state is there-fore suggested for the development of specific antibacterial inhibitors.	[Golinelli-Pimpaneau, Beatrice] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Mouilleron, Stephane; Badet-Denisot, Marie-Ange; Assrir, Nadine; Badet, Bernard] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Golinelli-Pimpaneau, B (corresponding author), CNRS, Coll France, Lab Chim Proc Biol, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	beatrice.golinelli@college-de-france.fr	Golinelli, Beatrice/ABB-8347-2021	Golinelli, Beatrice/0000-0001-8248-4704; mouilleron, stephane/0000-0001-7977-6298; ASSRIR, Nadine/0000-0003-1693-7263; Pecqueur, Ludovic/0000-0002-0396-699X	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by CNRS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; BADET B, 1988, BIOCHEMISTRY-US, V27, P2282, DOI 10.1021/bi00407a006; BADETDENISOT MA, 1993, B SOC CHIM FR, V130, P249; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Buts L, 2001, J MOL BIOL, V309, P193, DOI 10.1006/jmbi.2001.4639; COCHET O, 1992, HYBRIDOMA, V11, P225, DOI 10.1089/hyb.1992.11.225; Durand P, 2008, ARCH BIOCHEM BIOPHYS, V474, P302, DOI 10.1016/j.abb.2008.01.026; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Floquet N, 2007, FEBS LETT, V581, P2981, DOI 10.1016/j.febslet.2007.05.068; Floquet N, 2009, J MOL BIOL, V385, P653, DOI 10.1016/j.jmb.2008.10.032; Gabriel I, 2004, FEMS MICROBIOL LETT, V235, P73, DOI [10.1016/j.femsle.2004.04.013, 10.1111/j.1574-6968.2004.tb09569.x]; Gautam A, 2011, CRIT REV BIOTECHNOL, V31, P295, DOI 10.3109/07388551.2010.525498; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Graack HR, 2001, BIOCHEM J, V360, P401, DOI 10.1042/0264-6021:3600401; Huynh QK, 2000, ARCH BIOCHEM BIOPHYS, V379, P307, DOI 10.1006/abbi.2000.1895; Isupov MN, 1996, STRUCTURE, V4, P801, DOI 10.1016/S0969-2126(96)00087-1; Jaffe EK, 2012, ARCH BIOCHEM BIOPHYS, V519, P144, DOI 10.1016/j.abb.2011.10.010; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2011, CHEMMEDCHEM, V6, P1067, DOI 10.1002/cmdc.201100009; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Milewski S, 1999, J BIOL CHEM, V274, P4000, DOI 10.1074/jbc.274.7.4000; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; Mouilleron S, 2008, J MOL BIOL, V377, P1174, DOI 10.1016/j.jmb.2008.01.077; Mouilleron S, 2007, CURR OPIN STRUC BIOL, V17, P653, DOI 10.1016/j.sbi.2007.09.003; Mouilleron S, 2007, PROTEIN SCI, V16, P485, DOI 10.1110/ps.062598107; Mouilleron S, 2011, ARCH BIOCHEM BIOPHYS, V505, P1, DOI 10.1016/j.abb.2010.08.008; Nakaishi Y, 2009, FEBS LETT, V583, P163, DOI 10.1016/j.febslet.2008.11.041; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Raczynska J, 2007, J MOL BIOL, V372, P672, DOI 10.1016/j.jmb.2007.07.002; Richez C, 2007, PROTEIN EXPRES PURIF, V54, P45, DOI 10.1016/j.pep.2007.01.015; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094; Teplyakov A, 1998, STRUCTURE, V6, P1047, DOI 10.1016/S0969-2126(98)00105-1; Teplyakov A, 1999, PROTEIN SCI, V8, P596; Urban JH, 2007, J MOL BIOL, V373, P521, DOI 10.1016/j.jmb.2007.07.035; Valerio-Lepiniec M, 2010, ARCH BIOCHEM BIOPHYS, V498, P95, DOI 10.1016/j.abb.2010.04.010; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yamamoto H, 2008, J MOL BIOL, V382, P747, DOI 10.1016/j.jmb.2008.07.041; Yuan P, 2008, STRUCTURE, V16, P1275, DOI 10.1016/j.str.2008.04.018	54	15	16	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34533	34546		10.1074/jbc.M112.380378	http://dx.doi.org/10.1074/jbc.M112.380378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22851174	Green Published, hybrid			2022-12-28	WOS:000309654200057
J	Xiong, YN; Khanna, S; Grzenda, AL; Sarmento, OF; Svingen, PA; Lomberk, GA; Urrutia, RA; Faubion, WA				Xiong, Yuning; Khanna, Sahil; Grzenda, Adrienne L.; Sarmento, Olga F.; Svingen, Phyllis A.; Lomberk, Gwen A.; Urrutia, Raul A.; Faubion, William A., Jr.			Polycomb Antagonizes p300/CREB-binding Protein-associated Factor to Silence FOXP3 in a Kruppel-like Factor-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; RESPONSE ELEMENT; TRANSFORMING GROWTH-FACTOR-BETA-1; HISTONE ACETYLTRANSFERASE; INTESTINAL INFLAMMATION; BINDING PROTEIN; IN-VIVO; EXPRESSION; GENE	Inducible gene expression underlies the epigenetically inherited differentiation program of most immune cells. We report that the promoter of the FOXP3 gene possesses two distinct functional states: an "off state" mediated by the polycomb histone methyltransferase complex and a histone acetyltransferase-dependent "on state." Regulating these states is the presence of a Kruppel-like factor (KLF)-containing Polycomb response element. In the KLF10(-/-) mouse, the FOXP3 promoter is epigenetically silenced by EZH2 (Enhancer of Zeste 2)-mediated trimethylation of Histone 3 K27; thus, impaired FOXP3 induction and inappropriate adaptive T regulatory cell differentiation results in vitro and in vivo. The epigenetic transmittance of adaptive T regulatory cell deficiency is demonstrated throughout more than 40 generations of mice. These results provide insight into chromatin remodeling events key to phenotypic features of distinct T cell populations.	[Faubion, William A., Jr.] Mayo Clin, Dept Gastroenterol & Hepatol, Chromatin Dynam & Epigenet Lab, Rochester, MN 55905 USA; [Grzenda, Adrienne L.; Urrutia, Raul A.] Mayo Clin, Dept Mol Biol, Rochester, MN 55905 USA; [Faubion, William A., Jr.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Xiong, Yuning; Khanna, Sahil; Grzenda, Adrienne L.; Sarmento, Olga F.; Svingen, Phyllis A.; Lomberk, Gwen A.; Urrutia, Raul A.; Faubion, William A., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Faubion, WA (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Chromatin Dynam & Epigenet Lab, 200 1st St SW, Rochester, MN 55905 USA.	faubion.william@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Grzenda, Adrienne L/K-4421-2019	Lomberk, Gwen/0000-0001-5463-789X; Grzenda, Adrienne L/0000-0001-5952-6953	National Institutes of Health [AI89714-R01, NCI T32 CA148073]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089714, R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI89714-R01.; Supported by National Institutes of Health Grant NCI T32 CA148073.	Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; CASARES F, 1995, DEVELOPMENT, V121, P1855; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Drummond AJ, 2011, GENEIOUS V5 5; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faubion WA, 2004, GASTROENTEROLOGY, V126, P1759, DOI 10.1053/j.gastro.2004.03.015; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin WC, 2008, DEV GROWTH DIFFER, V50, P321, DOI [10.1111/j.1440-169x.2008.01041.x, 10.1111/j.1440-169X.2008.01041.x]; Liu ZJ, 2010, BIOCHEM BIOPH RES CO, V400, P409, DOI 10.1016/j.bbrc.2010.08.090; Mahmoudi T, 2003, NUCLEIC ACIDS RES, V31, P4147, DOI 10.1093/nar/gkg479; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; RILEY PD, 1987, GENE DEV, V1, P716, DOI 10.1101/gad.1.7.716; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Song A, 2002, J BIOL CHEM, V277, P30055, DOI 10.1074/jbc.M204278200; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496	54	44	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34372	34385		10.1074/jbc.M111.325332	http://dx.doi.org/10.1074/jbc.M111.325332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896699	Green Published, hybrid			2022-12-28	WOS:000309654200040
J	Bidinosti, M; Shimshek, DR; Mollenhauer, B; Marcellin, D; Schweizer, T; Lotz, GP; Schlossmacher, MG; Weiss, A				Bidinosti, Michael; Shimshek, Derya R.; Mollenhauer, Brit; Marcellin, David; Schweizer, Tatjana; Lotz, Gregor P.; Schlossmacher, Michael G.; Weiss, Andreas			Novel One-step Immunoassays to Quantify alpha-Synuclein APPLICATIONS FOR BIOMARKER DEVELOPMENT AND HIGH-THROUGHPUT SCREENING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; ELEVATED LEVELS; LEWY BODIES; DEMENTIA; OLIGOMERS; MUTATION; PROTEIN; LOCUS; CSF	Familial Parkinson disease (PD) can result from alpha-synuclein gene multiplication, implicating the reduction of neuronal alpha-synuclein as a therapeutic target. Moreover, alpha-synuclein content in human cerebrospinal fluid (CSF) represents a PD biomarker candidate. However, capture-based assays for alpha-synuclein quantification in CSF (such as by ELISA) have shown discrepancies and have limited suitability for high-throughput screening. Here, we describe two sensitive, in-solution, time-resolved Forster's resonance energy transfer (TR-FRET)-based immuno-assays for total and oligomeric alpha-synuclein quantification. CSF analysis showed strong concordance for total alpha-synuclein content between two TR-FRET assays and, in agreement with a previously characterized 36 h protocol-based ELISA, demonstrated lower alpha-synuclein levels in PD donors. Critically, the assay suitability for high-throughput screening of siRNA constructs and small molecules aimed at reducing endogenous alpha-synuclein levels was established and validated. In a small-scale proof of concept compound screen using 384 well plates, signals ranged from < 30 to > 120% of the mean of vehicle-treated cells for molecules known to lower and increase cellular alpha-synuclein, respectively. Furthermore, a reverse genetic screen of a kinase-directed siRNA library identified seven genes that modulated alpha-synuclein protein levels (five whose knockdown increased and two that decreased cellular alpha-synuclein protein). This provides critical new biological insight into cellular pathways regulating alpha-synuclein steady-state expression that may help guide further drug discovery efforts. Moreover, we describe an inherent limitation in current alpha-synuclein oligomer detection methodology, a finding that will direct improvement of future assay design. Our one-step TR-FRET-based platform for alpha-synuclein quantification provides a novel platform with superior performance parameters for the rapid screening of large biomarker cohorts and of compound and genetic libraries, both of which are essential to the development of PD therapies.	[Bidinosti, Michael; Shimshek, Derya R.; Marcellin, David; Schweizer, Tatjana; Lotz, Gregor P.; Weiss, Andreas] Novartis Pharma AG, Novartis Inst Biomed Res, Neurosci Discovery Grp, CH-4002 Basel, Switzerland; [Mollenhauer, Brit] Paracelsus Elena Klin, D-34128 Kassel, Germany; [Mollenhauer, Brit] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Mollenhauer, Brit] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Schlossmacher, Michael G.] Univ Ottawa, Div Neurosci, Ottawa Hosp Res Inst, Ottawa, ON, Canada	Novartis; University of Gottingen; University of Gottingen; University of Ottawa; Ottawa Hospital Research Institute	Weiss, A (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, Neurosci Discovery Grp, WSJ 355-2-051-11, CH-4002 Basel, Switzerland.	andreas-1.weiss@novartis.com	Mollenhauer, Brit/F-8863-2010	Shimshek, Derya/0000-0001-8602-7850; Schlossmacher, Michael/0000-0002-0394-0300; Lotz, Gregor/0000-0002-0231-5503	Michael J. Fox Foundation; Parkinson Research Consortium of Ottawa; Government of Canada	Michael J. Fox Foundation; Parkinson Research Consortium of Ottawa; Government of Canada(CGIAR)	This work was supported by funds from the Michael J. Fox Foundation (to B. M. and M. G. S.), the Parkinson Research Consortium of Ottawa, and the Government of Canada (to M. G. S.).	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Montine TJ, 2011, NAT REV NEUROL, V7, P308, DOI 10.1038/nrneurol.2011.66; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Noguchi-Shinohara M, 2009, BRAIN RES, V1251, P1, DOI 10.1016/j.brainres.2008.11.055; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tomlinson J. J., 2010, PROTEIN MISFOLDING D, P817; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou ZG, 2011, MOL CELL NEUROSCI, V48, P29, DOI 10.1016/j.mcn.2011.06.002	48	38	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33691	33705		10.1074/jbc.M112.379792	http://dx.doi.org/10.1074/jbc.M112.379792			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22843695	Green Published, hybrid			2022-12-28	WOS:000309602100052
J	Patel, ES; Chang, LJ				Patel, Ekta S.; Chang, Lung-Ji			Synergistic Effects of Interleukin-7 and Pre-T Cell Receptor Signaling in Human T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DOUBLE-POSITIVE THYMOCYTE; SURFACE EXPRESSION; DEFICIENT MICE; ALPHA-CHAIN; KINASE PATHWAY; IN-VIVO; IL-7; TCR; BETA	The role of IL-7 in pre-T cell receptor (TCR) signaling during human T cell development is poorly understood. To study this, we engineered Molt3, a T cell progenitor T-acute lymphoblastic leukemia cell line, using lentiviral IL-7 receptor alpha (IL-7R alpha) to serve as a model system. IL-7 promoted pre-TCR activation in IL-7R alpha(hi) Molt3 as illustrated by CD25 up-regulation after anti-CD3 stimulation. Anti-CD3 treatment activated Akt and Erk1/2 signaling pathways as proven using specific inhibitors, and IL-7 further enhanced both signaling pathways. The close association of IL-7R alpha with CD3 zeta in the pre-TCR complex was illustrated through live imaging confocal fluorescence microscopy. These results demonstrate a direct and cooperative role of IL-7 in pre-TCR signaling.	[Chang, Lung-Ji] Univ Florida, Dept Mol Genet, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Dept Microbiol, Coll Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chang, LJ (corresponding author), Univ Florida, Dept Mol Genet, Coll Med, 1600 SW Archer Rd,POB 100266, Gainesville, FL 32610 USA.	lchang@mgm.ufl.edu			amfAR [107768-47-RGNT]; Yongling Foundation	amfAR; Yongling Foundation	This work was supported by amfAR Grant 107768-47-RGNT and the Yongling Foundation.	Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Akashi K, 1998, IMMUNOL REV, V165, P13, DOI 10.1111/j.1600-065X.1998.tb01226.x; Andrew D, 2001, J IMMUNOL, V166, P1524, DOI 10.4049/jimmunol.166.3.1524; Arnaud J, 1997, INT IMMUNOL, V9, P615, DOI 10.1093/intimm/9.4.615; Awong Geneve, 2008, V430, P135, DOI 10.1007/978-1-59745-182-6_9; Baird AM, 1998, J LEUKOCYTE BIOL, V63, P669, DOI 10.1002/jlb.63.6.669; Barata JT, 2005, LEUKEMIA LYMPHOMA, V46, P483, DOI 10.1080/10428190400027852; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barata JT, 2004, BLOOD, V103, P1891, DOI 10.1182/blood-2002-12-3861; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; BISELLI R, 1992, SCAND J IMMUNOL, V35, P439, DOI 10.1111/j.1365-3083.1992.tb02879.x; Bolotin E, 1996, BLOOD, V88, P1887; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Carrasco YR, 2002, SEMIN IMMUNOL, V14, P325, DOI 10.1016/S1044-5323(02)00065-9; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; delPorto P, 1995, P NATL ACAD SCI USA, V92, P12105, DOI 10.1073/pnas.92.26.12105; Dervovic D, 2010, SEMIN IMMUNOL, V22, P276, DOI 10.1016/j.smim.2010.04.014; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; HU HZ, 1992, CLIN EXP IMMUNOL, V88, P335; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Johnson SE, 2008, J IMMUNOL, V180, P8109, DOI 10.4049/jimmunol.180.12.8109; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Marino JH, 2010, HUM IMMUNOL, V71, P329, DOI 10.1016/j.humimm.2010.01.009; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Navarro MN, 2007, BLOOD, V110, P4331, DOI 10.1182/blood-2007-06-094938; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Patel ES, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-46; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLUM J, 1993, J IMMUNOL, V150, P2706; Plum J, 1996, BLOOD, V88, P4239; Plum J, 2008, SEMIN IMMUNOPATHOL, V30, P411, DOI 10.1007/s00281-008-0135-2; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; Ramiro AR, 1996, J EXP MED, V184, P519, DOI 10.1084/jem.184.2.519; Ramiro AR, 2001, J IMMUNOL, V167, P5106, DOI 10.4049/jimmunol.167.9.5106; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; SALMERON A, 1991, J IMMUNOL, V147, P3047; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wang B, 2006, VACCINE, V24, P3477, DOI 10.1016/j.vaccine.2006.02.025; Xue L, 2008, EUR J IMMUNOL, V38, P3200, DOI 10.1002/eji.200838614; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yang LF, 2010, BIOCHEM BIOPH RES CO, V400, P16, DOI 10.1016/j.bbrc.2010.07.126; Yasuda Y, 2002, IMMUNOLOGY, V106, P212, DOI 10.1046/j.1365-2567.2002.01402.x; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	72	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33826	33835		10.1074/jbc.M112.380113	http://dx.doi.org/10.1074/jbc.M112.380113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859301	Green Published, hybrid			2022-12-28	WOS:000309602100063
J	Begum, NA; Stanlie, A; Nakata, M; Akiyama, H; Honjo, T				Begum, Nasim A.; Stanlie, Andre; Nakata, Mikiyo; Akiyama, Hideo; Honjo, Tasuku			The Histone Chaperone Spt6 Is Required for Activation-induced Cytidine Deaminase Target Determination through H3K4me3 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CLASS-SWITCH RECOMBINATION; URACIL DNA GLYCOSYLASE; HEAVY-CHAIN GENES; TRANSCRIPTION ELONGATION; SOMATIC HYPERMUTATION; REPETITIVE SEQUENCES; H3K36 METHYLATION; QUALITY-CONTROL; NONCODING RNAS	H3K4me3 plays a critical role in the activation-induced cytidine deaminase (AID)-induced DNA cleavage of switch (S) regions in the immunoglobulin heavy chain (IgH) locus during class-switch recombination (CSR). The histone chaperone complex facilitates chromatin transcription (FACT) is responsible for forming H3K4me3 at AID target loci. Here we show that the histone chaperone suppressor of Ty6 (Spt6) also participates in regulating H3K4me3 for CSR and for somatic hypermutation in AID target loci. We found that H3K4me3 loss was correlated with defects in AID-induced DNA breakage and reduced mutation frequencies in IgH loci in both S and variable regions and in non-IgH loci such as metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and small nucleolar RNA host gene 3 (SNHG3). Global gene expression analysis revealed that Spt6 can act as both a positive and negative transcriptional regulator in B cells, affecting similar to 5% of the genes that includes suppressor of Ty4 (Spt4) and AID. Interestingly, Spt6 regulates CSR and AID expression through two distinct histone modification pathways, H3K4me3 and H3K36me3, respectively. Tandem SH2 domain of Spt6 plays a critical role in CSR and H3K4me3 regulation involving Set1 histone methyltransferase. We conclude that Spt6 is a unique histone chaperone capable of regulating the histone epigenetic state of both AID targets and the AID locus.	[Begum, Nasim A.; Stanlie, Andre; Nakata, Mikiyo; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan; [Akiyama, Hideo] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa 2488555, Japan	Kyoto University; Toray Industries, Inc.	Begum, NA (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan.	nasim@mfour.med.kyoto-u.ac.jp; honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016	Begum, Nasim/0000-0001-7177-188X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17002015, 24590352]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grant-in-aid for Specially Promoted Research 17002015 and Grant-in-Aid for Scientific Research 24590352 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hubert L, 2011, MOL CELL BIOL, V31, P3105, DOI 10.1128/MCB.05158-11; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liu JP, 2011, J BIOL CHEM, V286, P29218, DOI 10.1074/jbc.M111.252130; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NIKAIDO T, 1981, NATURE, V292, P845, DOI 10.1038/292845a0; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Okazaki I, 2011, P NATL ACAD SCI USA, V108, P7920, DOI 10.1073/pnas.1104423108; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peckl-Schmid D, 2010, EUR J IMMUNOL, V40, P3161, DOI 10.1002/eji.200940221; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Stanlie A, 2010, P NATL ACAD SCI USA, V107, P22190, DOI 10.1073/pnas.1016923108; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Yu KF, 2005, MOL CELL BIOL, V25, P1730, DOI 10.1128/MCB.25.5.1730-1736.2005; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	57	48	50	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32415	32429		10.1074/jbc.M112.351569	http://dx.doi.org/10.1074/jbc.M112.351569			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843687	Green Published, hybrid			2022-12-28	WOS:000309168300012
J	Boscher, C; Zheng, YZ; Lakshminarayan, R; Johannes, L; Dennis, JW; Foster, LJ; Nabi, IR				Boscher, Cecile; Zheng, Yu Zi; Lakshminarayan, Ramya; Johannes, Ludger; Dennis, James W.; Foster, Leonard J.; Nabi, Ivan R.			Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; GLYCOSYLATION AFFECTS; ADHERENS JUNCTIONS; PLASMA-MEMBRANE; P120 CATENIN; ASSOCIATION; BINDING; ORGANIZATION; ACTIVATION; RECEPTOR	Galectin-3 binding to cell surface glycoproteins, including branched N-glycans generated by N-acetylglucosaminyltransferase V (Mgat5) activity, forms a multivalent, heterogeneous, and dynamic lattice. This lattice has been shown to regulate integrin and receptor tyrosine kinase signaling promoting tumor cell migration. N-cadherin is a homotypic cell-cell adhesion receptor commonly overexpressed in tumor cells that contributes to cell motility. Here we show that galectin-3 and N-cadherin interact and colocalize with the lipid raft marker GM1 ganglioside in cell-cell junctions of mammary epithelial cancer cells. Disruption of the lattice by deletion of Mgat5, siRNA depletion of galectin-3, or competitive inhibition with lactose stabilizes cell-cell junctions. It also reduces, in a p120-catenin-dependent manner, the dynamic pool of junctional N-cadherin. Proteomic analysis of detergent-resistant membranes (DRMs) revealed that the galectin lattice opposes entry of many proteins into DRM rafts. N-cadherin and catenins are present in DRMs; however, their DRM distribution is not significantly affected by lattice disruption. Galectin lattice integrity increases the mobile fraction of the raft marker, GM1 ganglioside binding cholera toxin B subunit Ctb, at cell-cell contacts in a p120-catenin-independent manner, but does not affect the mobility of either Ctb-labeled GM1 or GFP-coupled N-cadherin in nonjunctional regions. Our results suggest that the galectin lattice independently enhances lateral molecular diffusion by direct interaction with specific glycoconjugates within the adherens junction. By promoting exchange between raft and non-raft microdomains as well as molecular dynamics within junction-specific raft microdomains, the lattice may enhance turnover of N-cadherin and other glycoconjugates that determine junctional stability and rates of cell migration.	[Boscher, Cecile; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Zheng, Yu Zi; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z, Canada; [Zheng, Yu Zi; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z, Canada; [Lakshminarayan, Ramya; Johannes, Ludger] Inst Curie, Traff Signaling & Delivery Lab, Ctr Rech, CNRS,UMR144, F-75248 Paris 05, France; [Dennis, James W.] Univ Toronto, Dept Med Genet & Lab Med & Pathol, Toronto, ON M5G 1L5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Toronto	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@mail.ubc.ca	Dennis, James/E-7268-2013; Lakshminarayan, Ramya/AAT-9527-2021; Johannes, Ludger/M-9778-2017; Nabi, Ivan/GWZ-5144-2022; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Nabi, Ivan/0000-0002-0670-0513; Johannes, Ludger/0000-0002-2168-0004	Canadian Institutes of Health Research (CIHR) [MOP-43938, MOP-77688]; University of British Columbia Four-year Fellowship; Agence Nationale de la Recherche (ProLipCys); Human Science Frontier Program [RGP26/2007]; Canada Foundation for Innovation; British Columbia (BC) Knowledge Development Fund; BC Proteomics Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of British Columbia Four-year Fellowship; Agence Nationale de la Recherche (ProLipCys)(French National Research Agency (ANR)); Human Science Frontier Program(Human Frontier Science Program); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia (BC) Knowledge Development Fund; BC Proteomics Network	This work was supported by Canadian Institutes of Health Research (CIHR) operating Grants MOP-43938 (to I. R. N. and J. W. D.) and MOP-77688 (to L. J. F.).; Supported by a University of British Columbia Four-year Fellowship.; Supported by the Agence Nationale de la Recherche (ProLipCys) and Human Science Frontier Program (Grant RGP26/2007).; The mass spectrometry infrastructure used in this study was supported, in part, by the Canada Foundation for Innovation, the British Columbia (BC) Knowledge Development Fund, and the BC Proteomics Network. These studies were enabled by the imaging platform of LSI Imaging.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; MEHUL B, 1995, FEBS LETT, V360, P160, DOI 10.1016/0014-5793(95)00100-N; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; RAZ A, 1981, CANCER RES, V41, P3642; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146; Zheng YZ, 2009, J PROTEOMICS, V72, P12, DOI 10.1016/j.jprot.2008.09.003	55	72	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32940	32952		10.1074/jbc.M112.353334	http://dx.doi.org/10.1074/jbc.M112.353334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846995	Green Published, hybrid			2022-12-28	WOS:000309168300058
J	Lewis, D; Pilankatta, R; Inesi, G; Bartolommei, G; Moncelli, MR; Tadini-Buoninsegni, F				Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe; Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco			Distinctive Features of Catalytic and Transport Mechanisms in Mammalian Sarco-endoplasmic Reticulum Ca2+ ATPase (SERCA) and Cu+ (ATP7A/B) ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; SARCOPLASMIC-RETICULUM; CALCIUM-BINDING; CA2+-DEPENDENT ATPASE; CHARGE TRANSLOCATION; CRYSTAL-STRUCTURE; CA2+-ATPASE; COUNTERTRANSPORT; RESIDUES; PUMP	Ca2+ (sarco-endoplasmic reticulum Ca2+ ATPase (SERCA)) and Cu+ (ATP7A/B) ATPases utilize ATP through formation of a phosphoenzyme intermediate (E-P) whereby phosphorylation potential affects affinity and orientation of bound cation. SERCA E-P formation is rate-limited by enzyme activation by Ca2+, demonstrated by the addition of ATP and Ca2+ to SERCA deprived of Ca2+ (E2) as compared with ATP to Ca2+-activated enzyme (E1 center dot 2Ca(2+)). Activation by Ca2+ is slower at low pH (2H(+)center dot E2 to E1 center dot 2Ca(2+)) and little sensitive to temperature-dependent activation energy. On the other hand, subsequent (forward or reverse) phosphoenzyme processing is sensitive to activation energy, which relieves conformational constraints limiting Ca2+ translocation. A "H+-gated pathway," demonstrated by experiments on pH variations, charge transfer, and Glu-309 mutation allows luminal Ca2+ release by H+/Ca2+ exchange. As compared with SERCA, initial utilization of ATP by ATP7A/B is much slower and highly sensitive to temperature-dependent activation energy, suggesting conformational constraints of the headpiece domains. Contrary to SERCA, ATP7B phosphoenzyme cleavage shows much lower temperature dependence than EP formation. ATP-dependent charge transfer in ATP7A and -B is observed, with no variation of net charge upon pH changes and no evidence of Cu+/H+ exchange. As opposed to SERCA after Ca2+ chelation, ATP7A/B does not undergo reverse phosphorylation with Pi after copper chelation unless a large N-metal binding extension segment is deleted. This is attributed to the inactivating interaction of the copper-deprived N-metal binding extension with the headpiece domains. We conclude that in addition to common (P-type) phosphoenzyme intermediate formation, SERCA and ATP7A/B possess distinctive features of catalytic and transport mechanisms.	[Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco] Univ Florence, Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Italy	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Florence	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA.	ginesi@cpmcri.com; francesco.tadini@unifi.it	Tadini-Buoninsegni, Francesco/CAJ-5745-2022; Pilankatta, Rajendra/ABC-8821-2021	Pilankatta, Rajendra/0000-0002-8587-8212; TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554	National Institutes of Health [RO1 HL69830]; Ente Cassa di Risparmio di Firenze [2009.0749]; Italian Ministry of Education, University and Research [20083YM37E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL69830. This work was also supported by Ente Cassa di Risparmio di Firenze (2009.0749) and the Italian Ministry of Education, University and Research (PRIN Project 20083YM37E).	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Andersen JP, 1998, ACTA PHYSIOL SCAND, V163, P45; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; Andersson J, 2008, BIOPHYS J, V94, P600, DOI 10.1529/biophysj.107.114033; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Buoninsegni FT, 2004, BIOPHYS J, V86, P3671, DOI 10.1529/biophysj.103.036608; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Fibich A, 2011, BIOPHYS J, V101, P1896, DOI 10.1016/j.bpj.2011.09.014; FORGE V, 1993, J BIOL CHEM, V268, P10953; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; INESI G, 1967, ARCH BIOCHEM BIOPHYS, V121, P665, DOI 10.1016/0003-9861(67)90051-3; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVY D, 1990, J BIOL CHEM, V265, P19524; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P186, DOI 10.1016/0968-0004(87)90090-9; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Pintschovius J, 1999, BIOPHYS J, V76, P814, DOI 10.1016/S0006-3495(99)77245-0; POST RL, 1972, J BIOL CHEM, V247, P6530; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Tadini-Buoninsegni F, 2008, ARCH BIOCHEM BIOPHYS, V476, P75, DOI 10.1016/j.abb.2008.02.031; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Tadini-Buoninsegni F, 2010, FEBS LETT, V584, P4619, DOI 10.1016/j.febslet.2010.10.029; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TSIVKOVSKII R, 2004, HDB ATPASES, P99; TUMER Z, 1995, GENOMICS, V26, P437, DOI 10.1016/0888-7543(95)80160-N; Voskoboinik I, 2001, BIOCHEM BIOPH RES CO, V281, P966, DOI 10.1006/bbrc.2001.4445; WATANABE T, 1981, BIOCHEMISTRY-US, V20, P6617, DOI 10.1021/bi00526a015; WEBER K, 1969, J BIOL CHEM, V244, P4406; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656	59	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32717	32727		10.1074/jbc.M112.373472	http://dx.doi.org/10.1074/jbc.M112.373472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854969	hybrid, Green Published			2022-12-28	WOS:000309168300039
J	Munoz, IM; MacArtney, T; Sanchez-Pulido, L; Ponting, CP; Rocha, S; Rouse, J				Munoz, Ivan M.; MacArtney, Thomas; Sanchez-Pulido, Luis; Ponting, Chris P.; Rocha, Sonia; Rouse, John			Family with Sequence Similarity 60A (FAM60A) Protein Is a Cell Cycle-fluctuating Regulator of the SIN3-HDAC1 Histone Deacetylase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; D1; EXPRESSION; REPRESSION; CHROMATIN; GROWTH; MICE; SIN3	The SIN3A-HDAC complex deacetylates histones thereby repressing gene transcription. Here we describe family with sequence similarity 60A (FAM60A), a cell cycle-regulated protein that binds to the SIN3-HDAC complex. FAM60A expression peaks during G(1) and S phases of the cell cycle in U2OS cells, in a manner similar to the G(1) regulator cyclin D1, which is a known target of SIN3-HDAC. In this light we found that FAM60A binds to SIN3-HDAC-regulated promoters such as cyclin D1 in G(1) and S phases. Cells depleted of FAM60A show increased histone acetylation at the cyclin D1 promoter and elevated levels of cyclin D1 mRNA and protein. Furthermore, depletion of FAM60A altered the periodic association of HDAC1 with the cyclin D1 promoter, increased cyclin D1 expression at all cell cycle phases, and caused premature S phase entry. The data in this study introduce FAM60A as a novel regulator of SIN3-HDAC function and gene expression.	[Rocha, Sonia] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Munoz, Ivan M.; MacArtney, Thomas; Rouse, John] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England	University of Dundee; University of Dundee; University of Oxford	Rocha, S (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	s.rocha@dundee.ac.uk; j.rouse@dundee.ac.uk	Ponting, Chris/AAV-2621-2021	Rocha, Sonia/0000-0002-2413-4981; Sanchez Pulido, Luis/0000-0002-2300-8502; Munoz Munoz, Ivan/0000-0002-1606-5445; Ponting, Chris/0000-0003-0202-7816	Medical Research Council; Division of Signal Transduction Therapy, University of Dundee; Cancer Research UK; Wellcome Trust; Cancer Research UK [12918] Funding Source: researchfish; Medical Research Council [MC_U137761446, MC_U127070192] Funding Source: researchfish; MRC [MC_U137761446, MC_U127070192] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Signal Transduction Therapy, University of Dundee; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to C.C.P. and J.R.), the Division of Signal Transduction Therapy, University of Dundee (to I.M.M., T.M., and J.R.), Cancer Research UK, and the Wellcome Trust (to S.R.).	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BARTKOVA J, 1995, ONCOGENE, V10, P775; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Han EKH, 1998, PROSTATE, V35, P95, DOI 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Resnitzky D, 1997, MOL CELL BIOL, V17, P5640, DOI 10.1128/MCB.17.9.5640; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	21	26	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32346	32353		10.1074/jbc.M112.382499	http://dx.doi.org/10.1074/jbc.M112.382499			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865885	Green Published, hybrid			2022-12-28	WOS:000309168300006
J	Sakurai, A; Matsuda, M; Kiyokawa, E				Sakurai, Atsuro; Matsuda, Michiyuki; Kiyokawa, Etsuko			Activated Ras Protein Accelerates Cell Cycle Progression to Perturb Madin-Darby Canine Kidney Cystogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL ACINI; LUMEN FORMATION; CANCER; MORPHOGENESIS; MEMBRANE; KINASES; TRANSFORMATION; PROLIFERATION; ARCHITECTURE; MECHANISMS	In a number of human cancer cells, K-RAS is frequently mutated and activated constitutively, culminating in the induction of continuous cell growth, a hallmark of cancer cells. It is still unclear, however, how the mutated K-RAS induces morphological abnormalities in cancerous tissues. To investigate the mechanism underlying the K-RAS-induced morphological changes, we utilized an auxin-dependent protein expression system, which enabled us to rapidly induce and evaluate constitutively active K-Ras in MDCK (Madin-Darby canine kidney) cysts, a model for polarized epithelial structure. Cells carrying the constitutively active KRasV12 gene were morphologically indistinguishable from normal cells in two-dimensional culture. However, in a gel of extracellular matrix, KRasV12-expressing cells failed to form a spherical cyst. When KRasV12 induction was delayed until after cyst formation, some cells in the cyst wall lost polarity and were extruded into and accumulated in the luminal space. With effector-specific mutants of KRasV12 and inhibitors for MEK and PI3-kinase, we found that both the Raf-MEK-ERK and PI3-kinase axes are necessary and sufficient for this phenotype. Live cell imaging with cell cycle indicators showed that KRasV12 expression promoted cell cycle progression, which was prevented by either MEK or PI3-kinase inhibitors. From these results, we provide a model wherein active-Ras induces cell cycle progression leading to apical cell extrusion through Raf and PI3-kinase in a cooperative manner. The system developed here can be applied to drug screening for various cancers originating from epithelial cells.	[Sakurai, Atsuro; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Kiyokawa, Etsuko] Kanazawa Med Univ, Dept Oncol Pathol, Uchinada, Ishikawa 9200293, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Kiyokawa, E (corresponding author), 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	kiyokawa@kanazawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [22113001, 22590358] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Blum R, 2005, DRUG RESIST UPDATE, V8, P369, DOI 10.1016/j.drup.2005.11.002; BOS JL, 1989, CANCER RES, V49, P4682; BRINKMANN V, 1995, J CELL BIOL, V131, P1573, DOI 10.1083/jcb.131.6.1573; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gutierrez-Barrera AM, 2007, BIOCHEM BIOPH RES CO, V358, P698, DOI 10.1016/j.bbrc.2007.04.166; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lehnert L, 2001, J CELL BIOL, V152, P911, DOI 10.1083/jcb.152.5.911; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Pearson GW, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2259; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tarutani M, 2003, CANCER RES, V63, P319; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	43	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31703	31711		10.1074/jbc.M112.377804	http://dx.doi.org/10.1074/jbc.M112.377804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829590	hybrid, Green Published			2022-12-28	WOS:000309059400012
J	Vogelauer, M; Krall, AS; Mcbrian, MA; Li, JY; Kurdistani, SK				Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.			Stimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DEACETYLASES; COMPLEX; FAMILY; SIR2; HDAC1; ACETYLATION; INHIBITION; EVOLUTION; SIRTUINS; BINDING	Histone deacetylases (HDACs) function in a wide range of molecular processes, including gene expression, and are of significant interest as therapeutic targets. Although their native complexes, subcellular localization, and recruitment mechanisms to chromatin have been extensively studied, much less is known about whether the enzymatic activity of non-sirtuin HDACs can be regulated by natural metabolites. Here, we show that several coenzyme A (CoA) derivatives, such as acetyl-CoA, butyryl-CoA, HMG-CoA, and malonyl-CoA, as well as NADPH but not NADP(+), NADH, or NAD(+), act as allosteric activators of recombinant HDAC1 and HDAC2 in vitro following a mixed activation kinetic. In contrast, free CoA, like unconjugated butyrate, inhibits HDAC activity in vitro. Analysis of a large number of engineered HDAC1 mutants suggests that the HDAC activity can potentially be decoupled from "activatability" by the CoA derivatives. In vivo, pharmacological inhibition of glucose-6-phosphate dehydrogenase (G6PD) to decrease NADPH levels led to significant increases in global levels of histone H3 and H4 acetylation. The similarity in structures of the identified metabolites and the exquisite selectivity of NADPH over NADP(+), NADH, and NAD(+) as an HDAC activator reveal a previously unrecognized biochemical feature of the HDAC proteins with important consequences for regulation of histone acetylation as well as the development of more specific and potent HDAC inhibitors.	[Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Vogelauer, Maria; Krall, Abigail S.; Mcbrian, Matthew A.; Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Li, Jing-Yu; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mcbrian, Matthew A.; Kurdistani, Siavash K.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu	Li, Jingyu/GSD-1924-2022	Kurdistani, Siavash/0000-0003-3295-3511	California Institute for Regenerative Medicine award; Beckman Young Investigator award; Howard Hughes Medical Institute Early Career award; UCLA Genetics Training Grant fellowship	California Institute for Regenerative Medicine award; Beckman Young Investigator award; Howard Hughes Medical Institute Early Career award(Howard Hughes Medical Institute); UCLA Genetics Training Grant fellowship	This work was supported in part by a California Institute for Regenerative Medicine award and Beckman Young Investigator and Howard Hughes Medical Institute Early Career awards (to S. K. K.).; Supported in part by a UCLA Genetics Training Grant fellowship.	Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Cairns SP, 2008, EXP PHYSIOL, V93, P851, DOI 10.1113/expphysiol.2007.041285; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; CORNISHBOWDEN A, 1986, FEBS LETT, V203, P3, DOI 10.1016/0014-5793(86)81424-7; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dowling DP, 2008, CELL MOL LIFE SCI, V65, P2039, DOI 10.1007/s00018-008-7554-z; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hill AV, 1909, J PHYSIOL-LONDON, V39, P361; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Leunissen CLF, 2011, RES DEV DISABIL, V32, P2660, DOI 10.1016/j.ridd.2011.06.007; Levy H R, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P97; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Reinhart GD, 2004, METHOD ENZYMOL, V380, P187; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; ZIBOH VA, 1970, J LIPID RES, V11, P346	37	58	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32006	32016		10.1074/jbc.M112.362467	http://dx.doi.org/10.1074/jbc.M112.362467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822071	Green Published, hybrid			2022-12-28	WOS:000309059400039
J	Zhou, XB; Wulfsen, I; Korth, M; McClafferty, H; Lukowski, R; Shipston, MJ; Ruth, P; Dobrev, D; Wieland, T				Zhou, Xiaobo; Wulfsen, Iris; Korth, Michael; McClafferty, Heather; Lukowski, Robert; Shipston, Michael J.; Ruth, Peter; Dobrev, Dobromir; Wieland, Thomas			Palmitoylation and Membrane Association of the Stress Axis Regulated Insert (STREX) Controls BK Channel Regulation by Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; SMOOTH-MUSCLE; NEURONAL DEVELOPMENT; ADRENAL CHROMAFFIN; CELLS; PHOSPHORYLATION; PITUITARY; EXPRESSION; CGMP	Large-conductance, calcium- and voltage-gated potassium (BK) channels play an important role in cellular excitability by controlling membrane potential and calcium influx. The stress axis regulated exon (STREX) at splice site 2 inverts BK channel regulation by protein kinase A(PKA) from stimulatory to inhibitory. Here we show that palmitoylation of STREX controls BK channel regulation also by protein kinase C(PKC). In contrast to the 50% decrease of maximal channel activity by PKC in the insertless (ZERO) splice variant, STREX channels were completely resistant to PKC. STREX channel mutants in which Ser(700), located between the two regulatory domains of K+ conductance (RCK) immediately downstream of the STREX insert, was replaced by the phosphomimetic amino acid glutamate (S700E) showed a similar to 50% decrease in maximal channel activity, whereas the S700A mutant retained its normal activity. BK channel inhibition by PKC, however, was effectively established when the palmitoylation-mediated membrane-anchor of the STREX insert was removed by either pharmacological inhibition of palmitoyl transferases or site-directed mutagenesis. These findings suggest that STREX confers a conformation on BK channels where PKC fails to phosphorylate and to inhibit channel activity. Importantly, PKA which inhibits channel activity by disassembling the STREX insert from the plasma membrane, allows PKC to further suppress the channel gating independent from voltage and calcium. Our results present an important example for the cross-talk between ion channel palmitoylation and phosphorylation in regulation of cellular excitability.	[Zhou, Xiaobo; Dobrev, Dobromir] Univ Heidelberg, Mannheim Med Fac, Div Expt Cardiol, D-68167 Mannheim, Germany; [Wulfsen, Iris] Univ Med Ctr Hamburg Eppendorf, Sch Life Sci Hamburg gGmbH, D-20246 Hamburg, Germany; [Korth, Michael] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, D-20246 Hamburg, Germany; [McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Lukowski, Robert; Ruth, Peter] Univ Tubingen, Inst Pharm, Div Pharmacol Toxicol & Clin Pharm, D-72076 Tubingen, Germany; [Wieland, Thomas] Univ Heidelberg, Mannheim Med Fac, Inst Expt & Clin Pharmacol & Toxicol, D-68169 Mannheim, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Edinburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Zhou, XB (corresponding author), Univ Heidelberg, Mannheim Med Fac, Div Expt Cardiol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	xiaobo.zhou@medma.uni-heidelberg.de; thomas.wieland@medma.uni-heidelberg.de	Dobrev, Dobromir/C-7388-2014; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/AAS-1666-2020; Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012; Shipston, Mike/C-7309-2013; Zhou, Xiaobo/AAH-4320-2019	Dobrev, Dobromir/0000-0002-4612-117X; Dobrev, Prof. Dr. med. Dr. h.c. Dobromir/0000-0002-4612-117X; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Shipston, Mike/0000-0001-7544-582X; 	German Center for Cardiovascular Research; Deutsche Forschungsgemeinschaft [SFB 773]	German Center for Cardiovascular Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported the German Center for Cardiovascular Research (grants to D. D. and T. W.) and the Deutsche Forschungsgemeinschaft (SFB 773, Project A2 to P. R.)	Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL1275, DOI 10.1152/ajplung.00259.2003; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Ferrer J, 1996, DIABETOLOGIA, V39, P891, DOI 10.1007/BF00403907; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Hall SK, 2000, J BIOL CHEM, V275, P3749, DOI 10.1074/jbc.275.6.3749; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holdiman AJ, 2002, MOL CELL ENDOCRINOL, V192, P1, DOI 10.1016/S0303-7207(02)00136-3; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lovell PV, 2001, J NEUROSCI, V21, P3429, DOI 10.1523/JNEUROSCI.21-10-03429.2001; Mahmoud SF, 2004, J NEUROENDOCRINOL, V16, P237, DOI 10.1111/j.0953-8194.2004.01154.x; Mahmoud SF, 2002, J NEUROSCI METH, V115, P189, DOI 10.1016/S0165-0270(02)00015-8; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Ruth P, 1997, J BIOL CHEM, V272, P10522; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhu N, 2005, FEBS LETT, V579, P4856, DOI 10.1016/j.febslet.2005.07.069	45	42	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32161	32171		10.1074/jbc.M112.386359	http://dx.doi.org/10.1074/jbc.M112.386359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843729	hybrid, Green Published			2022-12-28	WOS:000309059400053
J	Janzer, A; Stamm, K; Becker, A; Zimmer, A; Buettner, R; Kirfel, J				Janzer, Andreas; Stamm, Katrin; Becker, Astrid; Zimmer, Andreas; Buettner, Reinhard; Kirfel, Jutta			The H3K4me3 Histone Demethylase Fbxl10 Is a Regulator of Chemokine Expression, Cellular Morphology, and the Metabolome of Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; DEPENDENT MANNER; BINDING PROTEIN; 1 LSD1; CELLS; PHD; TRANSCRIPTION; APOPTOSIS; DOMAIN; PROLIFERATION	Fbxl10 (Jhdm1b/Kdm2b) is a conserved and ubiquitously expressed member of the JHDM (JmjC domain-containing histone demethylase) family. Fbxl10 was implicated in the demethylation of H3K4me3 or H3K36me2 thereby removing active chromatin marks and inhibiting gene transcription. Apart from the JmjC domain, Fbxl10 consists of a CxxC domain, a PHD domain, and an Fbox domain. By purifying the JmjC and the PHD domain of Fbxl10 and using different approaches we were able to characterize the properties of these domains in vitro. Our results suggest that Fbxl10 is rather a H3K4me3 than a H3K36me2 histone demethylase. The PHD domain exerts a dual function in binding H3K4me3 and H3K36me2 and exhibiting E3 ubiquitin ligase activity. We generated mouse embryonic fibroblasts stably overexpressing Fbxl10. These cells reveal an increase in cell size but no changes in proliferation, mitosis, or apoptosis. Using a microarray approach we were able to identify potentially new target genes for Fbxl10 including chemokines, the noncoding RNA Xist, and proteins involved in metabolic processes. Additionally, we found that Fbxl10 is recruited to the promoters of Ccl7, Xist, Crabp2, and RipK3. Promoter occupancy by Fbxl10 was accompanied by reduced levels of H3K4me3 but unchanged levels of H3K36me2. Furthermore, knockdown of Fbxl10 using small interfering RNA approaches showed inverse regulation of Fbxl10 target genes. In summary, our data reveal a regulatory role of Fbxl10 in cell morphology, chemokine expression, and the metabolic control of fibroblasts.	[Janzer, Andreas; Kirfel, Jutta] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany; [Stamm, Katrin; Buettner, Reinhard] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany	University of Bonn; University of Cologne; University of Bonn	Kirfel, J (corresponding author), Univ Bonn, Inst Pathol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jutta.kirfel@ukb.uni-bonn.de	Zimmer, Andreas/B-8357-2009		Deutsche Forschungsgemeinschaft Grants [GRK 804, FOR 926]	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grants GRK 804 and FOR 926.	Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chasapis CT, 2009, CURR PHARM DESIGN, V15, P3716, DOI 10.2174/138161209789271825; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Eyman D, 2009, J CELL PHYSIOL, V220, P376, DOI 10.1002/jcp.21776; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Ge R, 2011, CELL DEATH DIFFER, V18, P1184, DOI 10.1038/cdd.2010.185; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hembruff SL, 2010, NEOPLASIA, V12, P425, DOI 10.1593/neo.10200; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Janzer A, 2012, BIOCHEM BIOPH RES CO, V421, P665, DOI 10.1016/j.bbrc.2012.04.057; Kavi Harsh H, 2009, BMC Res Notes, V2, P217, DOI 10.1186/1756-0500-2-217; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Upadhyay AK, 2011, PROG DRUG RES, V67, P107, DOI 10.1007/978-3-7643-8989-5_6; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	38	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30984	30992		10.1074/jbc.M112.341040	http://dx.doi.org/10.1074/jbc.M112.341040			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22825849	Green Published, hybrid			2022-12-28	WOS:000308791300012
J	Hull, RL; Peters, MJ; Perigo, SP; Chan, CK; Wight, TN; Kinsella, MG				Hull, Rebecca L.; Peters, Michael J.; Perigo, Susan Potter; Chan, Christina K.; Wight, Thomas N.; Kinsella, Michael G.			Overall Sulfation of Heparan Sulfate from Pancreatic Islet beta-TC3 Cells Increases Maximal Fibril Formation but Does Not Determine Binding to the Amyloidogenic Peptide Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; FORMATION IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; FORMATION RATHER; MOUSE MODEL; PROTEOGLYCAN; PROTEINS	Islet amyloid, a pathologic feature of type 2 diabetes, contains the islet beta-cell peptide islet amyloid polypeptide (IAPP) as its unique amyloidogenic component. Islet amyloid also contains heparan sulfate proteoglycans (HSPGs) that may contribute to amyloid formation by binding IAPP via their heparan sulfate (HS) chains. We hypothesized that beta-cells produce HS that bind IAPP via regions of highly sulfated disaccharides. Unexpectedly, HS from the beta-cell line beta-TC3 contained fewer regions of highly sulfated disaccharides compared with control normal murine mammary gland (NMuMG) cells. The proportion of HS that bound IAPP was similar in both cell lines ( 65%). The sulfation pattern of IAPP-bound versus non-bound HS from beta-TC3 cells was similar. In contrast, IAPP-bound HS from NMuMG cells contained frequent highly sulfated regions, whereas the nonbound material demonstrated fewer sulfated regions. Fibril formation from IAPP was stimulated equally by IAPP-bound beta-TC3 HS, non-bound beta-TC3 HS, and non-bound NMuMG HS but was stimulated to a greater extent by the highly sulfated IAPP-bound NMuMG HS. Desulfation of HS decreased the ability of both beta-TC3 and NMuMG HS to stimulate IAPP maximal fibril formation, but desulfated HS from both cell types still accelerated fibril formation relative to IAPP alone. In summary, neither binding to nor acceleration of fibril formation from the amyloidogenic peptide IAPP is dependent on overall sulfation in HS synthesized by beta-TC3 cells. This information will be important in determining approaches to reduce HS-IAPP interactions and ultimately prevent islet amyloid formation and its toxic effects in type 2 diabetes.	[Hull, Rebecca L.; Peters, Michael J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Hull, Rebecca L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wight, Thomas N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Perigo, Susan Potter; Chan, Christina K.; Wight, Thomas N.; Kinsella, Michael G.] Benaroya Res Inst Virginia Mason, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute; Virginia Mason Medical Center	Hull, RL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way, Seattle, WA 98108 USA.	rhull@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022	Hull, Rebecca/0000-0001-9690-4087	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA); National Institutes of Health [DK74404, HL18645, HL92969, DK17047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088082, K01DK074404, P30DK017047] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Department of Veterans Affairs, Veterans Affairs Puget Sound Health Care System (Seattle, WA) and National Institutes of Health Grants DK74404 (to R. L. H.), HL18645 and HL92969 (to T. N. W.), and DK17047 (to the University of Washington Diabetes Research Center).	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Aston-Mourney K, 2011, DIABETOLOGIA, V54, P1756, DOI 10.1007/s00125-011-2143-3; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Charge SBP, 1996, J PATHOL, V179, P443; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; KATO M, 1994, J BIOL CHEM, V269, P18881; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINDAHL U, 1973, J BIOL CHEM, V248, P7234; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; OHSAWA H, 1991, ACTA ENDOCRINOL-COP, V124, P45, DOI 10.1530/acta.0.1240045; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	38	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37154	37164		10.1074/jbc.M112.409847	http://dx.doi.org/10.1074/jbc.M112.409847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22936797	hybrid, Green Published			2022-12-28	WOS:000310588500049
J	Nakaya, N; Sultana, A; Lee, HS; Tomarev, SI				Nakaya, Naoki; Sultana, Afia; Lee, Hee-Sheung; Tomarev, Stanislav I.			Olfactomedin 1 Interacts with the Nogo A Receptor Complex to Regulate Axon Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; REGENERATION; EXPRESSION; GENE; INHIBITION; PANCORTINS; MUTATIONS; A2-PANCORTINS; PROTEINS; EPILEPSY	Olfm1, a secreted highly conserved glycoprotein, is detected in peripheral and central nervous tissues and participates in neural progenitor maintenance, cell death in brain, and optic nerve arborization. In this study, we identified Olfm1 as a molecule promoting axon growth through interaction with the Nogo A receptor (NgR1) complex. Olfm1 is coexpressed with NgR1 in dorsal root ganglia and retinal ganglion cells in embryonic and postnatal mice. Olfm1 specifically binds to NgR1, as judged by alkaline phosphatase assay and coimmunoprecipitation. The addition of Olfm1 inhibited the growth cone collapse of dorsal root ganglia neurons induced by myelin-associated inhibitors, indicating that Olfm1 attenuates the NgR1 receptor functions. Olfm1 caused the inhibition of NgR1 signaling by interfering with interaction between NgR1 and its coreceptors p75NTR or LINGO-1. In zebrafish, inhibition of optic nerve extension by olfm1 morpholino oligonucleotides was partially rescued by dominant negative ngr1 or lingo-1. These data introduce Olfm1 as a novel NgR1 ligand that may modulate the functions of the NgR1 complex in axonal growth.	[Nakaya, Naoki; Sultana, Afia; Lee, Hee-Sheung; Tomarev, Stanislav I.] NEI, Sect Mol Mech Glaucoma, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, Sect Mol Mech Glaucoma, Retinal Cell & Mol Biol Lab, NIH, Bldg 6,Room 212,6 Ctr Dr,MSC 0606, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov			National Eye Institute, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000311] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Eye Institute, National Institutes of Health.	Ando K, 2005, NEUROSCIENCE, V133, P947, DOI 10.1016/j.neuroscience.2005.03.009; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Brosamle C, 2009, MOL CELL NEUROSCI, V40, P401, DOI 10.1016/j.mcn.2008.10.009; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cheng AW, 2007, J NEUROSCI, V27, P1519, DOI 10.1523/JNEUROSCI.5154-06.2007; DANIELSON PE, 1994, J NEUROSCI RES, V38, P468, DOI 10.1002/jnr.490380413; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Nagano T, 1998, MOL BRAIN RES, V53, P13, DOI 10.1016/S0169-328X(97)00271-4; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Nakaya N, 2007, GENE EXPR PATTERNS, V7, P723, DOI 10.1016/j.modgep.2007.06.005; O'Brien GS, 2009, CURR BIOL, V19, P2086, DOI 10.1016/j.cub.2009.10.051; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yoda H, 2004, MECH DEVELOP, V121, P715, DOI 10.1016/j.mod.2004.03.021	36	51	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37171	37184		10.1074/jbc.M112.389916	http://dx.doi.org/10.1074/jbc.M112.389916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923615	Green Published, hybrid			2022-12-28	WOS:000310588500051
J	Izumi, S; Saito, A; Kanemoto, S; Kawasaki, N; Asada, R; Iwamoto, H; Oki, M; Miyagi, H; Ochi, M; Imaizumi, K				Izumi, Soutarou; Saito, Atsushi; Kanemoto, Soshi; Kawasaki, Noritaka; Asada, Rie; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Ochi, Mitsuo; Imaizumi, Kazunori			The Endoplasmic Reticulum Stress Transducer BBF2H7 Suppresses Apoptosis by Activating the ATF5-MCL1 Pathway in Growth Plate Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; ATF/CREB FAMILY; ER; INTERFERENCE; EXPRESSION; SURVIVAL; OASIS; ATF5; DIFFERENTIATION	BBF2H7 (box B-binding factor 2 human homolog on chromosome 7) is a basic leucine zipper transmembrane transcription factor that belongs to the cyclic AMP-responsive element-binding protein (CREB)/activating transcription factor (ATF) family. This novel endoplasmic reticulum (ER) stress transducer is localized in the ER and is cleaved in its transmembrane region in response to ER stress. BBF2H7 has been shown to be expressed in proliferating chondrocytes in cartilage during the development of long bones. The target of BBF2H7 is Sec23a, one of the coat protein complex II components. Bbf2h7-deficient (Bbf2h7(-/-)) mice exhibit severe chondrodysplasia, with expansion of the rough ER in proliferating chondrocytes caused by impaired secretion of extracellular matrix (ECM) proteins. We observed a decrease in the number of proliferating chondrocytes in the cartilage of Bbf2h7(-/-) mice. TUNEL staining of the cartilage showed that apoptosis was promoted in Bbf2h7(-/-) chondrocytes. Atf5 (activating transcription factor 5), another member of the CREB/ATF family and an antiapoptotic factor, was also found to be a target of BBF2H7 in chondrocytes. ATF5 activated the transcription of Mcl1 (myeloid cell leukemia sequence 1), which belongs to the antiapoptotic B-cell leukemia/lymphoma 2 family, to suppress apoptosis. Finally, we found that the BBF2H7-ATF5-MCL1 pathway specifically suppressed ER stress-induced apoptosis in chondrocytes. Taken together, our findings indicate that BBF2H7 is activated in response to ER stress caused by synthesis of abundant ECM proteins and plays crucial roles as a bifunctional regulator to accelerate ECM protein secretion and suppress ER stress-induced apoptosis by activating the ATF5-MCL1 pathway during chondrogenesis.	[Izumi, Soutarou; Saito, Atsushi; Kanemoto, Soshi; Kawasaki, Noritaka; Asada, Rie; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Imaizumi, Kazunori] Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan; [Izumi, Soutarou; Ochi, Mitsuo] Hiroshima Univ, Dept Orthoped Surg, Fac Med, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Saito, A (corresponding author), Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asaito@hiroshima-u.ac.jp; imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science KAKENHI [22020030, 24689058, 24659678]; Sumitomo Foundation; Suzuken Memorial Foundation; Kanae Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Kowa Life Science Foundation; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Senri Life Science Foundation; Hokuto Foundation for Bioscience; Japan Prize Foundation; Nakatomi Foundation; Takeda Science Foundation; Pharmacological Research Foundation Tokyo; Daiichi-Sankyo Foundation of Life Science; Inamori Foundation; Naito Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Suzuken Memorial Foundation; Kanae Foundation; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Kowa Life Science Foundation; Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Senri Life Science Foundation; Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Japan Prize Foundation(Japan Prize Foundation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Pharmacological Research Foundation Tokyo(Pharmacological Research Foundation, Tokyo); Daiichi-Sankyo Foundation of Life Science; Inamori Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 22020030, 24689058, and 24659678, the Sumitomo Foundation, the Suzuken Memorial Foundation, the Kanae Foundation, the Mitsui Sumitomo Insurance Welfare Foundation, the Kowa Life Science Foundation, the Ichiro Kanehara Foundation, the Uehara Memorial Foundation, the Senri Life Science Foundation, the Hokuto Foundation for Bioscience, the Japan Prize Foundation, the Nakatomi Foundation, the Takeda Science Foundation, the Pharmacological Research Foundation Tokyo, the Daiichi-Sankyo Foundation of Life Science, the Inamori Foundation, and the Naito Foundation.	Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Delezoide AL, 1997, HUM MOL GENET, V6, P1899, DOI 10.1093/hmg/6.11.1899; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hail N, 2006, APOPTOSIS, V11, P889, DOI 10.1007/s10495-006-6712-8; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Katiyar P., 2011, INT J BIOMED RES, V2, P422; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Pakula TM, 2003, J BIOL CHEM, V278, P45011, DOI 10.1074/jbc.M302372200; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang H, 2007, CELL BIOL INT, V31, P1309, DOI 10.1016/j.cellbi.2007.05.002; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	44	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36190	36200		10.1074/jbc.M112.373746	http://dx.doi.org/10.1074/jbc.M112.373746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936798	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000310364000040
J	Rahman, SM; Janssen, RC; Choudhury, M; Baquero, KC; Aikens, RM; de la Houssaye, BA; Friedman, JE				Rahman, Shaikh M.; Janssen, Rachel C.; Choudhury, Mahua; Baquero, Karalee C.; Aikens, Rebecca M.; de la Houssaye, Becky A.; Friedman, Jacob E.			CCAAT/Enhancer-binding Protein beta (C/EBP beta) Expression Regulates Dietary-induced Inflammation in Macrophages and Adipose Tissue in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTORS; FATTY-ACIDS; ADIPOCYTE DIFFERENTIATION; NLRP3 INFLAMMASOME; NEGATIVE REGULATOR; IMMUNE-RESPONSE; DENDRITIC CELLS; INNATE IMMUNITY	Strong evidence exists for a link between chronic low level inflammation and dietary-induced insulin resistance; however, little is known about the transcriptional networks involved. Here we show that high fat diet (HFD) or saturated fatty acid exposure directly activates CCAAT/enhancer-binding protein beta(C/EBP beta) protein expression in liver, adipocytes, and macrophages. Global C/EBP beta deletion prevented HFD-induced inflammation and surprisingly increased mitochondrial gene expression in white adipose tissue along with brown adipose tissue markers PRDM16, CIDEa, and UCP1, consistent with a resistance to HFD-induced obesity. In isolated peritoneal macrophages from C/EBP beta(-/-) mice, the anti-inflammatory gene LXR alpha and its targets SCD1 and DGAT2 were strikingly up-regulated along with IL-10, while NLRP3, a gene important for activating the inflammasome, was suppressed in response to palmitate. Using RAW 264.7 macrophage cells or 3T3-L1 adipocytes, C/EBP beta knockdown prevented palmitate-induced inflammation and p65-NF kappa B DNA binding activity, while C/EBP beta overexpression induced NF kappa B binding, JNK activation, and pro-inflammatory cytokine gene expression directly. Finally, chimeric bone marrow mice transplanted with bone marrow lacking C/EBP beta(-/-) demonstrated reduced systemic and adipose tissue inflammatory markers, macrophage content, and maintained insulin sensitivity on HFD. Taken together, these results demonstrate that HFD or palmitate exposure triggers C/EBP beta expression that controls expression of distinct aspects of alternative macrophage activation. Reducing C/EBP beta in macrophages confers protection from HFD-induced systemic inflammation and insulin resistance, suggesting it may be an attractive therapeutic target for ameliorating obesity-induced inflammatory responses.	[Rahman, Shaikh M.; Janssen, Rachel C.; Choudhury, Mahua; Baquero, Karalee C.; Aikens, Rebecca M.; de la Houssaye, Becky A.; Friedman, Jacob E.] Univ Colorado Denver Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Friedman, Jacob E.] Univ Colorado Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Friedman, JE (corresponding author), 12801 E 17th Ave,Mail Stop 8106, Aurora, CO 80045 USA.	jed.friedman@ucdenver.edu	Rahman, Shaikh Mizanoor/GLN-7518-2022	Rahman, Shaikh Mizanoor/0000-0002-4879-2663	National Institutes of Health [R01-DK059767]; Colorado Nutrition and Obesity Research Center (NORC) [NIH-P30DK048520]; UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant [P30DK57516]; American Heart Association [09BGIA2060705]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, P30DK057516, R01DK059767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition and Obesity Research Center (NORC); UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK059767 (to J. E. F.) and the Colorado Nutrition and Obesity Research Center (NORC) NIH-P30DK048520.; Supported by a UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant P30DK57516 and a Beginning Grant in Aid from the American Heart Association (09BGIA2060705; Southwest Affiliate).; Supported by an American Diabetes Association Mentored Post-Doctoral Fellowship.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Bennett CE, 2010, DIABETES VASC DIS RE, V7, P195, DOI 10.1177/1479164110366274; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hui TY, 1998, J BIOL CHEM, V273, P27420, DOI 10.1074/jbc.273.42.27420; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rahman SM, 2009, J LIPID RES, V50, P2193, DOI 10.1194/jlr.M800633-JLR200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tsai VWW, 2011, J NEUROSCI, V31, P17612, DOI 10.1523/JNEUROSCI.3449-11.2011; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Wang LQ, 2000, J BIOL CHEM, V275, P14173, DOI 10.1074/jbc.M000764200; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	61	77	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34349	34360		10.1074/jbc.M112.410613	http://dx.doi.org/10.1074/jbc.M112.410613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902781	Green Published, hybrid			2022-12-28	WOS:000309654200038
J	Zhang, WW; Huang, YL; Gunst, SJ				Zhang, Wenwu; Huang, Youliang; Gunst, Susan J.			The Small GTPase RhoA Regulates the Contraction of Smooth Muscle Tissues by Catalyzing the Assembly of Cytoskeletal Signaling Complexes at Membrane Adhesion Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; NONMUSCLE MYOSIN-II; ACTIN POLYMERIZATION; TYROSINE PHOSPHORYLATION; TENSION DEVELOPMENT; ARP2/3 COMPLEX; FOCAL ADHESIONS; CELL-ADHESION; N-WASP; PAXILLIN PHOSPHORYLATION	The activation of the small GTPase RhoA is necessary for ACh-induced actin polymerization and airway smooth muscle (ASM) contraction, but the mechanism by which it regulates these events is unknown. Actin polymerization in ASM is catalyzed by the actin filament nucleation activator, N-WASp and the polymerization catalyst, Arp2/3 complex. Activation of the small GTPase cdc42, a specific N-WASp activator, is also required for actin polymerization and tension generation. We assessed the mechanism by which RhoA regulates actin dynamics and smooth muscle contraction by expressing the dominant negative mutants RhoA T19N and cdc42 T17N, and non-phosphorylatable paxillin Y118/31F and paxillin Delta LD4 deletion mutants in SM tissues. Their effects were evaluated in muscle tissue extracts and freshly dissociated SM cells. Protein interactions and cellular localization were analyzed using proximity ligation assays (PLA), immunofluorescence, and GTPase and kinase assays. RhoA inhibition prevented ACh-induced cdc42 activation, N-WASp activation and the interaction of N-WASp with the Arp2/3 complex at the cell membrane. ACh induced paxillin phosphorylation and its association with the cdc42 GEFS, DOCK180 and alpha/beta PIX. Paxillin tyrosine phosphorylation and its association with beta PIX were RhoA-dependent, and were required for cdc42 activation. The ACh-induced recruitment of paxillin and FAK to the cell membrane was dependent on RhoA. We conclude that RhoA regulates the contraction of ASM by catalyzing the assembly and activation of cytoskeletal signaling modules at membrane adhesomes that initiate signaling cascades that regulate actin polymerization and tension development in response to contractile agonist stimulation. Our results suggest that the RhoA-mediated assembly of adhesome complexes is a fundamental step in the signal transduction process in response to agonist-induced smooth muscle contraction.	[Zhang, Wenwu; Huang, Youliang; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	NHLBI, National Institutes of Health (NIH) [HL-29289, HL074099]; American Lung Association; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029289, R01HL074099, R23HL029289, R01HL109629] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health (NIH) Grants HL-29289 and HL074099; and an American Lung Association and an NIH T32 postdoctoral fellowship (to W. Z.).	Allen WE, 1997, J CELL SCI, V110, P707; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Corteling RL, 2007, AM J PHYSIOL-HEART C, V293, pH440, DOI 10.1152/ajpheart.01374.2006; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Suzuki T, 2000, J EXP MED, V191, P1905, DOI 10.1084/jem.191.11.1905; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	68	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33996	34008		10.1074/jbc.M112.369603	http://dx.doi.org/10.1074/jbc.M112.369603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893699	Green Published, hybrid			2022-12-28	WOS:000309654200007
J	Bien, J; Jefferson, T; Causevic, M; Jumpertz, T; Munter, L; Multhaup, G; Weggen, S; Becker-Pauly, C; Pietrzik, CU				Bien, Jessica; Jefferson, Tamara; Causevic, Mirsada; Jumpertz, Thorsten; Munter, Lisa; Multhaup, Gerd; Weggen, Sascha; Becker-Pauly, Christoph; Pietrzik, Claus U.			The Metalloprotease Meprin beta Generates Amino Terminal-truncated Amyloid beta Peptide Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; SECRETASE; CLEAVAGE; BACE; MODULATION; DEMENTIA; ALPHA	The amyloid beta (A beta) peptide, which is abundantly found in the brains of patients suffering from Alzheimer disease, is central in the pathogenesis of this disease. Therefore, to understand the processing of the amyloid precursor protein (APP) is of critical importance. Recently, we demonstrated that the metalloprotease meprin beta cleaves APP and liberates soluble N-terminal APP (N-APP) fragments. In this work, we present evidence that meprin beta can also process APP in a manner reminiscent of beta-secretase. We identified cleavage sites of meprin beta in the amyloid beta sequence of the wild type and Swedish mutant of APP at positions p1 and p2, thereby generating A beta variants starting at the first or second amino acid residue. We observed even higher kinetic values for meprin beta than BACE1 for both the wild type and the Swedish mutant APP form. This enzymatic activity of meprin beta on APP and A beta generation was also observed in the absence of BACE1/2 activity using a beta-secretase inhibitor and BACE knock-out cells, indicating that meprin beta acts independently of beta-secretase.	[Jefferson, Tamara; Becker-Pauly, Christoph] Univ Kiel, Unit Degrad Protease Web, Inst Biochem, D-24118 Kiel, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Dept Mol Neurodegenerat, D-55128 Mainz, Germany; [Jumpertz, Thorsten; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Munter, Lisa; Multhaup, Gerd] Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	University of Kiel; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Free University of Berlin	Becker-Pauly, C (corresponding author), Univ Kiel, Unit Degrad Protease Web, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de; pietrzik@uni-mainz.de	Causevic, Mirsada/AAM-7423-2020; Becker-Pauly, Christoph/B-7569-2011	Causevic, Mirsada/0000-0002-6099-6415; Munter, Lisa/0000-0001-5736-1462	Deutsche Forschungsgemeinschaft [DFG PI 379/5-1, DFG BE 4086/1-2, SFB877 (project A9)]; Cluster of Excellence "Inflammation at Interfaces"; Federal Ministry of Education and Research [01EW1009, 01GI1004D]; European Community's Seventh Framework Program (FP7) [200931]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Program (FP7)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG PI 379/5-1 (to C. U. P.), DFG BE 4086/1-2, and SFB877 (project A9), by the Cluster of Excellence "Inflammation at Interfaces" (to C. B.-P.), and Federal Ministry of Education and Research Grants 01EW1009 and 01GI1004D (to C. U. P.). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7) under Grant Agreement 200931 (project IBDase).	Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lewczuk P, 2004, ELECTROPHORESIS, V25, P3336, DOI 10.1002/elps.200406068; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Schechter I, 2008, BIOL CHEM, V389, P313, DOI 10.1515/BC.2008.025; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Wiltfang J, 2001, J BIOL CHEM, V276, P42645, DOI 10.1074/jbc.M102790200	38	91	94	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33304	33313		10.1074/jbc.M112.395608	http://dx.doi.org/10.1074/jbc.M112.395608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879596	Green Published, hybrid			2022-12-28	WOS:000309602100019
J	Bouayad, D; Pederzoli-Ribeil, M; Mocek, J; Candalh, C; Arlet, JB; Hermine, O; Reuter, N; Davezac, N; Witko-Sarsat, V				Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Arlet, Jean-Benoit; Hermine, Olivier; Reuter, Nathalie; Davezac, Noelie; Witko-Sarsat, Veronique			Nuclear-to-cytoplasmic Relocalization of the Proliferating Cell Nuclear Antigen (PCNA) during Differentiation Involves a Chromosome Region Maintenance 1 (CRM1)-dependent Export and Is a Prerequisite for PCNA Antiapoptotic Activity in Mature Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; SIGNAL; APOPTOSIS; PROTEIN; DNA; TRANSLOCATION; INFLAMMATION; REPLICATION; ACTIVATION; INHIBITORS	Neutrophils are deprived of proliferative capacity and have a tightly controlled lifespan to avoid their persistence at the site of injury. We have recently described that the proliferating cell nuclear antigen (PCNA), a nuclear factor involved in DNA replication and repair of proliferating cells, is a key regulator of neutrophil survival. In neutrophils, PCNA was localized exclusively in the cytoplasm due to its nuclear-to-cytoplasmic relocalization during granulocytic differentiation. We showed here that leptomycin B, an inhibitor of the chromosome region maintenance 1 (CRM1) exportin, inhibited PCNA relocalization during granulocytic differentiation of HL-60 and NB4 promyelocytic cell lines and of human CD34(+) primary cells. Using enhanced green fluorescent protein fusion constructs, we have demonstrated that PCNA relocalization involved a nuclear export signal (NES) located from Ile-11 to Ile-23 in the PCNA sequence. However, this NES, located at the inner face of the PCNA trimer, was not functional in wild-type PCNA, but instead, was fully active and leptomycin B-sensitive in the monomeric PCNAY114A mutant. To test whether a defect in PCNA cytoplasmic relocalization would affect its antiapoptotic activity in mature neutrophils, a chimeric PCNA fused with the SV40 nuclear localization sequence (NLS) was generated to preclude its cytoplasmic localization. As expected, neutrophil-differentiated PLB985 cells expressing ectopic SV40NLS-PCNA had an increased nuclear PCNA as compared with cells expressing wild-type PCNA. Accordingly, the nuclear PCNA mutant did not show any antiapoptotic activity as compared with wild-type PCNA. Nuclear-to-cytoplasmic relocalization that occurred during myeloid differentiation is essential for PCNA antiapoptotic activity in mature neutrophils and is dependent on the newly identified monomerization-dependent PCNA NES.	[Witko-Sarsat, Veronique] INSERM, U1016, Cochin Inst, F-75014 Paris, France; [Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Witko-Sarsat, Veronique] Univ Paris 05, Cochin Hosp, Inst Cochin, F-75015 Paris, France; [Bouayad, Dikra; Pederzoli-Ribeil, Magali; Mocek, Julie; Candalh, Celine; Witko-Sarsat, Veronique] CNRS, UMR8104, F-75014 Paris, France; [Hermine, Olivier] Univ Paris 05, Dept Hematol, Necker Hosp, F-75015 Paris, France; [Arlet, Jean-Benoit; Hermine, Olivier] Univ Paris 05, CNRS, Necker Hosp, UMR8147, F-75015 Paris, France; [Reuter, Nathalie] Univ Bergen, Computat Biol Unit, N-5008 Bergen, Norway; [Davezac, Noelie] Univ Toulouse 3, CNRS, UMR5547, F-31400 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Witko-Sarsat, V (corresponding author), INSERM, U1016, Cochin Inst, 27Bis Rue Faubourg St Jacques, F-75014 Paris, France.	veronique.witko@inserm.fr	Hermine, Olivier/Q-7072-2018; Witko-Sarsat, Veronique/L-9714-2017; Arlet, Jean Benoit/D-3124-2016; Reuter, Nathalie/G-2037-2012	Witko-Sarsat, Veronique/0000-0002-5296-9601; Reuter, Nathalie/0000-0002-3649-7675; Hermine, Olivier/0000-0003-2574-3874	Institut National de la Sante et de la Recherche Medicale (Inserm); association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship); National Program for Research in Functional Genomics (FUGE) in Norway	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship); National Program for Research in Functional Genomics (FUGE) in Norway	This work was supported by Institut National de la Sante et de la Recherche Medicale (Inserm), the association ABCF Mucoviscidose, Societe Francaise d'Hematologie (SFH, fellowship to D.B.), and National Program for Research in Functional Genomics (FUGE) in Norway (to N. R.).	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; Hino M, 2000, BRIT J HAEMATOL, V109, P314, DOI 10.1046/j.1365-2141.2000.02054.x; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; JONSSON ZO, 1995, EMBO J, V14, P5745, DOI 10.1002/j.1460-2075.1995.tb00261.x; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kim BJ, 2008, BIOL CELL, V100, P675, DOI 10.1042/BC20070158; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANOTTE M, 1991, BLOOD, V77, P1080; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Piard K, 1998, NUCLEIC ACIDS RES, V26, P2598, DOI 10.1093/nar/26.11.2598; Prosperi E, 2006, FASEB J, V20, P833, DOI 10.1096/fj.05-5469hyp; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Scovassi A Ivana, 2006, Methods Mol Biol, V314, P457; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Theilgaard-Monch K, 2006, CURR OPIN IMMUNOL, V18, P54, DOI 10.1016/j.coi.2005.11.010; Uchida S, 2004, BIOCHEM BIOPH RES CO, V316, P226, DOI 10.1016/j.bbrc.2004.02.039; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	42	28	29	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33812	33825		10.1074/jbc.M112.367839	http://dx.doi.org/10.1074/jbc.M112.367839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846997	hybrid, Green Published			2022-12-28	WOS:000309602100062
J	Kikuchi, S; Hara, K; Shimizu, T; Sato, M; Hashimoto, H				Kikuchi, Sotaro; Hara, Kodai; Shimizu, Toshiyuki; Sato, Mamoru; Hashimoto, Hiroshi			Structural Basis of Recruitment of DNA Polymerase zeta by Interaction between REV1 and REV7 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; C-TERMINAL DOMAIN; CATALYTIC SUBUNIT; COMPLEX-FORMATION; Y-FAMILY; REPAIR; MAD2; RECOMBINATION; FRAGMENT; HREV3	REV1, REV3, and REV7 are pivotal proteins in translesion DNA synthesis, which allows DNA synthesis even in the presence of DNA damage. REV1 and REV3 are error-prone DNA polymerases and function as inserter and extender polymerases in this process, respectively. REV7 interacts with both REV1 and REV3, acting as an adaptor that functionally links the two, although the structural basis of this collaboration remains unclear. Here, we show the crystal structure of the ternary complex, composed of the C-terminal domain of human REV1, REV7, and a REV3 fragment. The REV1 C-terminal domain adopts a four-helix bundle that interacts with REV7. A linker region between helices 2 and 3, which is conserved among mammals, interacts with the beta-sheet of REV7. Remarkably, the REV7-binding interface is distinct from the binding site of DNA polymerase eta or kappa. Thus, the REV1 C-terminal domain might facilitate polymerase switching by providing a scaffold for both inserter and extender polymerases to bind. Our structure reveals the basis of DNA polymerase zeta (a complex of REV3 and REV7) recruitment to the stalled replication fork and provides insight into the mechanism of polymerase switching.	[Kikuchi, Sotaro; Sato, Mamoru; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hara, Kodai] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yokohama City University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo	Hashimoto, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp		hara, kodai/0000-0002-1586-6312; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society for the Promotion of Science (JSPS) [18770091, 20770089, 22770109]; National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (KAKENHI) 18770091, 20770089, and 22770109 from the Japan Society for the Promotion of Science (JSPS); the National Project on Protein Structural and Functional Analyses (Protein 3000 Project); and the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; to T. S., M. S, and H. H.).	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hara K, 2009, ACTA CRYSTALLOGR F, V65, P1302, DOI 10.1107/S1744309109046181; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kikuchi S, 2012, ACTA CRYSTALLOGR F, V68, P962, DOI 10.1107/S1744309112032435; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	28	74	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33847	33852		10.1074/jbc.M112.396838	http://dx.doi.org/10.1074/jbc.M112.396838			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859296	Green Published, hybrid			2022-12-28	WOS:000309602100065
J	El Maarouf, A; Yaw, DML; Lindhout, T; Pearse, DD; Wakarchuk, W; Rutishauser, U				El Maarouf, Abderrahman; Yaw, Damali Moyo-Lee; Lindhout, Theresa; Pearse, Damien D.; Wakarchuk, Warren; Rutishauser, Urs			Enzymatic Engineering of Polysialic Acid on Cells in Vitro and in Vivo Using a Purified Bacterial Polysialyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; SPINAL-CORD-INJURY; ADHESION MOLECULE; SCHWANN-CELLS; MOTOR-NEURONS; DIRECTED DIFFERENTIATION; ESCHERICHIA-COLI; SIALIC ACID; PSA-NCAM	In vertebrates, polysialic acid (PSA) is typically added to the neural cell adhesion molecule (NCAM) in the Golgi by PST or STX polysialyltransferase. PSA promotes plasticity, and its enhanced expression by viral delivery of the PST or STX gene has been shown to promote cellular processes that are useful for repair of the injured adult nervous system. Here we demonstrate a new strategy for PSA induction on cells involving addition of a purified polysialyltransferase from Neisseria meningitidis (PSTNm) to the extracellular environment. In the presence of its donor substrate (CMP-Neu5Ac), PSTNm synthesized PSA directly on surfaces of various cell types in culture, including Chinese hamster ovary cells, chicken DF1 fibroblasts, primary rat Schwann cells, and mouse embryonic stem cells. Similarly, injection of PSTNm and donor in vivo was able to produce PSA in different adult brain regions, including the cerebral cortex, striatum, and spinal cord. PSA synthesis by PSTNm requires the presence of the donor CMP-Neu5Ac, and the product could be degraded by the PSA-specific endoneuraminidase-N. Although PSTNm was able to add PSA to NCAM, most of its product was attached to other cell surface proteins. Nevertheless, the PSTNm-induced PSA displayed the ability to attenuate cell adhesion, promote neurite outgrowth, and enhance cell migration as has been reported for endogenous PSA-NCAM. Polysialylation by PSTNm occurred in vivo in less than 2.5 h, persisted in tissues, and then decreased within a few weeks. Together these characteristics suggest that a PSTNm-based approach may provide a valuable alternative to PST gene therapy.	[El Maarouf, Abderrahman; Yaw, Damali Moyo-Lee; Rutishauser, Urs] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, New York, NY 10021 USA; [Lindhout, Theresa; Wakarchuk, Warren] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Pearse, Damien D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Wakarchuk, Warren] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Memorial Sloan Kettering Cancer Center; University of Guelph; University of Miami; National Research Council Canada	El Maarouf, A (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	a-el-maarouf@ski.mskcc.org; u-rutishauser@mskcc.org	Pearse, Damien D/D-3176-2011; Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Pearse, Damien D/0000-0003-1783-221X; Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Lindhout Djukic, Theresa/0000-0003-4745-6913	Canadian Institutes of Health Research [MOP-84272]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by Canadian Institutes of Health Research Operating Grant MOP-84272.	Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; CHO JW, 1994, P NATL ACAD SCI USA, V91, P11427, DOI 10.1073/pnas.91.24.11427; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Daston MM, 1996, J NEUROSCI, V16, P5488; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; El Maarouf A, 2003, J COMP NEUROL, V460, P203, DOI 10.1002/cne.10635; El Maarouf A., 2005, NEUROGLYCOBIOLOGY, P39; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Gravvanis AI, 2007, ACTA NEUROCHIR SUPPL, V100, P51; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Karwaski MF, 2002, PROTEIN EXPRES PURIF, V25, P237, DOI 10.1016/S1046-5928(02)00004-9; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Morley TJ, 2010, J AM CHEM SOC, V132, P9430, DOI 10.1021/ja102644a; Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Seki T, 1998, J NEUROSCI, V18, P3757; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h01s5; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; YIN XH, 1995, DEVELOPMENT, V121, P3439; Zhang Y, 2007, MOL CELL NEUROSCI, V35, P109, DOI 10.1016/j.mcn.2007.02.011; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x	36	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32770	32779		10.1074/jbc.M112.377614	http://dx.doi.org/10.1074/jbc.M112.377614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851175	hybrid, Green Published			2022-12-28	WOS:000309168300044
J	Lee, MB; Kooistra, M; Zhang, BH; Slow, S; Fortier, AL; Garrow, TA; Lever, M; Trasler, JM; Baltz, JM				Lee, Martin B.; Kooistra, Megan; Zhang, Baohua; Slow, Sandy; Fortier, Amanda L.; Garrow, Timothy A.; Lever, Michael; Trasler, Jacquetta M.; Baltz, Jay M.			Betaine Homocysteine Methyltransferase Is Active in the Mouse Blastocyst and Promotes Inner Cell Mass Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREIMPLANTATION EMBRYOS; S-METHYLTRANSFERASE; MAMMALIAN DEVELOPMENT; DNA METHYLATION; METABOLISM; EXPRESSION; MICE; REPRODUCTION; TRANSPORT; LINEAGES	Methyltransferases are an important group of enzymes with diverse roles that include epigenetic gene regulation. The universal donor of methyl groups for methyltransferases is S-adenosylmethionine (AdoMet), which in most cells is synthesized using methyl groups carried by a derivative of folic acid. Another mechanism for AdoMet synthesis uses betaine as the methyl donor via the enzyme betaine-homocysteine methyltransferase (BHMT, EC 2.1.1.5), but it has been considered to be significant only in liver. Here, we show that mouse preimplantation embryos contain endogenous betaine; Bhmt mRNA is first expressed at the morula stage; BHMT is abundant at the blastocyst stage but not other preimplantation stages, and BHMT activity is similarly detectable in blastocyst homogenates but not those of two-cell or morula stage embryos. Knockdown of BHMT protein levels and reduction of enzyme activity using Bhmt-specific antisense morpholinos or a selective BHMT inhibitor resulted in decreased development of embryos to the blastocyst stage in vitro and a reduction in inner cell mass cell number in blastocysts. The detrimental effects of BHMT knockdown were fully rescued by the immediate methyl-carrying product of BHMT, methionine. A physiological role for betaine and BHMT in blastocyst viability was further indicated by increased fetal resorption following embryo transfer of BHMT knockdown blastocysts versus control. Thus, mouse blastocysts are unusual in being able to generate AdoMet not only by the ubiquitous folate-dependent mechanism but also from betaine metabolized by BHMT, likely a significant pool of methyl groups in blastocysts.	[Lee, Martin B.; Kooistra, Megan; Zhang, Baohua; Baltz, Jay M.] Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Div Reprod Med, Ottawa, ON K1H 8L6, Canada; [Lee, Martin B.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Slow, Sandy; Lever, Michael] Canterbury Hlth Labs, Biochem Unit, Christchurch 8140, New Zealand; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Fortier, Amanda L.; Trasler, Jacquetta M.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3H 1P3, Canada; [Fortier, Amanda L.; Trasler, Jacquetta M.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Canterbury Health Laboratories; University of Illinois System; University of Illinois Urbana-Champaign; McGill University; McGill University; McGill University; McGill University	Baltz, JM (corresponding author), Ottawa Hosp Res Inst, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	jmbaltz@ohri.ca		Baltz, Jay/0000-0002-9749-2480	Canadian Institutes of Health Research [MOP97972]; Program on Oocyte Health; Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant [HGG62293]; Lalor Foundation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Program on Oocyte Health; Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant(Canadian Institutes of Health Research (CIHR)); Lalor Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Operating Grant MOP97972 (to J. M. B. and J. T.).; Supported in part by the Program on Oocyte Health funded by Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant HGG62293.; Supported by a Lalor Foundation postdoctoral fellowship.; Member of the Research Institute of the McGill University Health Centre, which is supported in part by the Fonds de la Recherche en Sante du Quebec.	Anas MKI, 2007, J CELL PHYSIOL, V210, P266, DOI 10.1002/jcp.20872; Anas MKI, 2008, DEVELOPMENT, V135, P4123, DOI 10.1242/dev.026575; ANBARI K, 1993, MOL REPROD DEV, V35, P24, DOI 10.1002/mrd.1080350105; BIGGERS JD, 1993, MOL REPROD DEV, V34, P380, DOI 10.1002/mrd.1080340406; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Clark DA, 2008, AM J REPROD IMMUNOL, V60, P192, DOI 10.1111/j.1600-0897.2008.00612.x; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; FitzHarris G, 2006, DEVELOPMENT, V133, P591, DOI 10.1242/dev.02246; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gasperowicz M, 2011, BIOL REPROD, V84, P621, DOI 10.1095/biolreprod.110.085209; Hammer MA, 2002, MOL REPROD DEV, V62, P195, DOI 10.1002/mrd.10088; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hogan B., 1994, MANIPULATING MOUSE E, P178; Ikeda S, 2010, J EXP ZOOL PART A, V313A, P129, DOI 10.1002/jez.581; Jiracek J, 2006, J MED CHEM, V49, P3982, DOI 10.1021/jm050885v; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kwong WY, 2010, REPRODUCTION, V139, P705, DOI 10.1530/REP-09-0517; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lucifero D, 2004, HUM REPROD UPDATE, V10, P3, DOI 10.1093/humupd/dmh002; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; MENEZO Y, 1989, LIFE SCI, V44, P1601, DOI 10.1016/0024-3205(89)90455-4; MILLER JGO, 1985, J EMBRYOL EXP MORPH, V89, P149; MONK M, 1987, DEVELOPMENT, V99, P371; O'Neill C, 1998, HUM REPROD, V13, P1312, DOI 10.1093/humrep/13.5.1312; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Siddall LS, 2002, MOL REPROD DEV, V63, P413, DOI 10.1002/mrd.10202; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Steele W, 2005, REPROD BIOMED ONLINE, V10, P755, DOI 10.1016/S1472-6483(10)61120-0; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tgarashi H, 2007, DEV BIOL, V312, P321, DOI 10.1016/j.ydbio.2007.09.028; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	45	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33094	33103		10.1074/jbc.M112.365478	http://dx.doi.org/10.1074/jbc.M112.365478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847001	hybrid, Green Published			2022-12-28	WOS:000309168300071
J	Wanngren, J; Ottervald, J; Parpal, S; Portelius, E; Stromberg, K; Borgegard, T; Klintenberg, R; Jureus, A; Blomqvist, J; Blennow, K; Zetterberg, H; Lundkvist, J; Rosqvist, S; Karlstrom, H				Wanngren, Johanna; Ottervald, Jan; Parpal, Santiago; Portelius, Erik; Stromberg, Kia; Borgegard, Tomas; Klintenberg, Rebecka; Jureus, Anders; Blomqvist, Jenny; Blennow, Kaj; Zetterberg, Henrik; Lundkvist, Johan; Rosqvist, Susanne; Karlstrom, Helena			Second Generation gamma-Secretase Modulators Exhibit Different Modulation of Notch beta and A beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN APP; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; PRESENILIN PROTEIN; IN-VIVO; PEPTIDE; A-BETA-42; TARGET; PROTEOLYSIS	The gamma-secretase complex is an appealing drug target when the therapeutic strategy is to alter amyloid-beta peptide (A beta) aggregation in Alzheimer disease. gamma-Secretase is directly involved in A beta formation and determines the pathogenic potential of A beta by generating the aggregation-prone A beta 42 peptide. Because gamma-secretase mediates cleavage of many substrates involved in cell signaling, such as the Notch receptor, it is crucial to sustain these pathways while altering the A beta secretion. A way of avoiding interference with the physiological function of gamma-secretase is to use gamma-secretase modulators (GSMs) instead of inhibitors of the enzyme. GSMs modify the A beta formation from producing the amyloid-prone A beta 42 variant to shorter and less amyloidogenic A beta species. The modes of action of GSMs are not fully understood, and even though the pharmacology of GSMs has been thoroughly studied regarding A beta generation, knowledge is lacking about their effects on other substrates, such as Notch. Here, using immunoprecipitation followed by MALDI-TOF MS analysis, we found that two novel, second generation GSMs modulate both Notch beta and A beta production. Moreover, by correlating S3-specific Val-1744 cleavage of Notch intracellular domain (Notch intracellular domain) to total Notch intracellular domain levels using immunocytochemistry, we also demonstrated that Notch intracellular domain is not modulated by the compounds. Interestingly, two well characterized, nonsteroidal anti-inflammatory drugs (nonsteroidal anti-inflammatory drug), R-flurbiprofen and sulindac sulfide, affect only A beta and not Notch beta formation, indicating that second generation GSMs and nonsteroidal anti-inflammatory drug-based GSMs have different modes of action regarding Notch processing.	[Ottervald, Jan; Parpal, Santiago; Stromberg, Kia; Borgegard, Tomas; Klintenberg, Rebecka; Jureus, Anders; Blomqvist, Jenny; Lundkvist, Johan; Rosqvist, Susanne] AstraZeneca, CNS & Pain Innovat Med, SE-15185 Sodertalje, Sweden; [Wanngren, Johanna; Karlstrom, Helena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI Alzheimers Dis Res Ctr, S-14157 Huddinge, Sweden; [Portelius, Erik; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, S-43180 Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London WC1NB6, England	AstraZeneca; Karolinska Institutet; University of Gothenburg; University of London; University College London	Rosqvist, S (corresponding author), AstraZeneca, CNS & Pain Innovat Med, SE-15185 Sodertalje, Sweden.	Susanne.Rosqvist@astrazeneca.com; Helena.Karlstrom@ki.se		Jureus, Anders/0000-0002-8922-6377; Karlstrom, Helena/0000-0002-0498-2473; Parpal, Santiago/0000-0003-2861-0516	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; Karolinska Institutet Stiftelsen for Aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; Karolinska Institutet Stiftelsen for Aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse	This work was supported by grants from Swedish Brain Power, Wallenberg's Foundation, Loo och Hans Ostermans Stiftelse, Stiftelsen Gamla Tjanarinnor, Karolinska Institutet Stiftelsen for Aldersforskning, Swedish Medical Society, Gun och Bertil Stohnes Stiftelse, and Strategic Research Area: Neuroscience under Regulation 2009-1077.	Barrett PJ, 2011, BIOCHEMISTRY-US, V50, P10328, DOI 10.1021/bi201371j; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Jureus A, 2010, J NEUROCHEM, V114, P784, DOI 10.1111/j.1471-4159.2010.06812.x; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lundkvist J, 2007, CURR OPIN PHARMACOL, V7, P112, DOI 10.1016/j.coph.2006.10.002; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tomita T, 2006, CURR PHARM DESIGN, V12, P661, DOI 10.2174/138161206775474206; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe MS, 2010, BIOL CHEM, V391, P839, DOI 10.1515/BC.2010.086; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	46	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32640	32650		10.1074/jbc.M112.376541	http://dx.doi.org/10.1074/jbc.M112.376541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851182	Green Published, hybrid			2022-12-28	WOS:000309168300032
J	van Oosterwijk, N; Knol, J; Dijkhuizen, L; van der Geize, R; Dijkstra, BW				van Oosterwijk, Niels; Knol, Jan; Dijkhuizen, Lubbert; van der Geize, Robert; Dijkstra, Bauke W.			Structure and Catalytic Mechanism of 3-Ketosteroid-Delta 4-(5 alpha)-dehydrogenase from Rhodococcus jostii RHA1 Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUMARATE REDUCTASE; GENE-CLUSTER; PROTEIN; BINDING; DEHYDROGENASE; CRYSTALLOGRAPHY; SUBSTRATE; SURVIVAL; STEROIDS	3-Ketosteroid Delta 4-(5 alpha)-dehydrogenases ( Delta 4-(5 alpha)-KSTDs) are enzymes that introduce a double bond between the C4 and C5 atoms of 3-keto-(5 alpha)-steroids. Here we show that the ro05698 gene from Rhodococcus jostii RHA1 codes for a flavoprotein with Delta 4-(5 alpha)-KSTD activity. The 1.6 angstrom resolution crystal structure of the enzyme revealed three conserved residues ( Tyr-319, Tyr-466, and Ser-468) in a pocket near the isoalloxazine ring system of the FAD co-factor. Site-directed mutagenesis of these residues confirmed that they are absolutely essential for catalytic activity. A crystal structure with bound product 4-androstene-3,17-dione showed that Ser-468 is in a position in which it can serve as the base abstracting the 4 beta-proton from the C4 atom of the substrate. Ser-468 is assisted by Tyr-319, which possibly is involved in shuttling the proton to the solvent. Tyr-466 is at hydrogen bonding distance to the C3 oxygen atom of the substrate and can stabilize the keto-enol intermediate occurring during the reaction. Finally, the FAD N5 atom is in a position to be able to abstract the 5 alpha-hydrogen of the substrate as a hydride ion. These features fully explain the reaction catalyzed by Delta 4-(5 alpha)-KSTDs.	[van Oosterwijk, Niels; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Knol, Jan; Dijkhuizen, Lubbert; van der Geize, Robert] Univ Groningen, Biophys Chem Lab, Dept Microbiol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014; Dijkstra, Bauke W./H-4308-2019	Dijkhuizen, Lubbert/0000-0003-2312-7162; Dijkstra, Bauke W./0000-0001-9731-6586	Netherlands Ministry of Economic Affairs; B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program; Schering-Plough	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program; Schering-Plough(Merck & CompanySchering Plough Corporation)	This was project was supported in part by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private Advanced Chemical Technologies for Sustainability program. This work was also supported by Schering-Plough.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Fujii C, 1999, J BIOCHEM-TOKYO, V126, P662, DOI 10.1093/oxfordjournals.jbchem.a022500; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; ITAGAKI E, 1990, J BIOCHEM-TOKYO, V108, P122, DOI 10.1093/oxfordjournals.jbchem.a123150; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEVY HR, 1959, J BIOL CHEM, V234, P2014; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lyubimov AY, 2007, PROTEIN SCI, V16, P2647, DOI 10.1110/ps.073168207; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; MATSUSHITA H, 1992, J BIOCHEM-TOKYO, V111, P594, DOI 10.1093/oxfordjournals.jbchem.a123803; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; MEDENTSEV AG, 1985, J STEROID BIOCHEM, V23, P365, DOI 10.1016/0022-4731(85)90418-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; RINGOLD HJ, 1963, J BIOL CHEM, V238, P1960; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Oosterwijk N, 2011, ACTA CRYSTALLOGR F, V67, P1269, DOI 10.1107/S1744309111028727; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WIERENGA RK, 1979, J MOL BIOL, V131, P55, DOI 10.1016/0022-2836(79)90301-2; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	52	19	19	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30975	30983		10.1074/jbc.M112.374306	http://dx.doi.org/10.1074/jbc.M112.374306			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22833669	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000308791300011
J	Meyer, BS; Rademann, J				Meyer, B. Sina; Rademann, Joerg			Extra- and Intracellular Imaging of Human Matrix Metalloprotease 11 (hMMP-11) with a Cell-penetrating FRET Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PROGNOSTIC RELEVANCE; HUMAN STROMELYSIN-3; PEPTIDE-SYNTHESIS; INHIBITORS; CANCER; IDENTIFICATION; MOUSE; MMP; ACTIVATION	Matrix metalloprotease 11 (MMP-11), a protease associated with invasion and aggressiveness of cancerous tissue, was postulated as a prognostic marker for pancreatic, breast, and colon cancer patients. Expression analysis, however, did not reveal localization and regulation of this protease. Thus, cellular tools for the visualization of MMP-11 are highly desirable to monitor presence and activity and to elucidate the functional role of MMP-11. Therefore, fluorescein-Dabcyl-labeled Foerster resonance energy transfer (FRET) substrates were developed. The design focused on enhanced peptide binding to human MMP-11, employing an unusual amino acid for the specificity pocket P1'. The addition of several arginines resulted in a cell-permeable FRET substrate SM-P124 (Ac-GRRRK(Dabcyl)-GGAANC-(MeOBn)RMGG-fluorescein). In vitro evaluation of SM-P124 with human MMP-11 showed a 25-fold increase of affinity (k(cat)/K-m = 9.16 x 10(3) M-1 s(-1), K-m = 8 mu M) compared with previously published substrates. Incubation of pancreatic adenocarcinoma cell line MIA PaCa-2 and mamma adenocarcinoma cell line MCF-7 with the substrate SM-P124 (5 mu M) indicated intra-and extracellular MMP-11 activity. A negative control cell line (Jurkat) showed no fluorescent signal either intra-or extra-cellularly. Negative control FRET substrate SM-P123 produced only insignificant extracellular fluorescence without any intracellular fluorescence. SM-P124 therefore enabled intra-and extracellular tracking of MMP-11-overexpressing cancers such as pancreatic and breast adenocarcinoma and might contribute to the understanding of the activation pathways leading to MMP-11-mediated invasive processes.	[Rademann, Joerg] Univ Leipzig, Dept Pharmaceut Chem, D-04103 Leipzig, Germany; [Meyer, B. Sina] Free Univ Berlin, Dept Organ Chem, D-14195 Berlin, Germany; [Meyer, B. Sina; Rademann, Joerg] Leibniz Inst Mol Pharmacol, Dept Med Chem, D-13125 Berlin, Germany	Leipzig University; Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Rademann, J (corresponding author), Univ Leipzig, Dept Pharmaceut Chem, Bruderstr 34, D-04103 Leipzig, Germany.	rademann@uni-leipzig.de	Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165	MolDiag-PaCa [LSH.2004-1.2.2.1]	MolDiag-PaCa	This work was supported by MolDiag-PaCa, Sixth Framework Programme Priority Grant LSH.2004-1.2.2.1.	Ahmad A, 1998, AM J PATHOL, V152, P721; Andreini C, 2004, J PROTEOME RES, V3, P21, DOI 10.1021/pr0340476; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Baldini E, 2004, THYROID, V14, P881, DOI 10.1089/thy.2004.14.881; Barbacid MD, 1998, PROTEIN EXPRES PURIF, V13, P243, DOI 10.1006/prep.1998.0899; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; DELAIN E, 1992, ELECTRON MICROSC REV, V5, P231, DOI 10.1016/0892-0354(92)90012-F; Denys H, 2004, BRIT J CANCER, V90, P1443, DOI 10.1038/sj.bjc.6601661; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fromigue O, 2003, INT J CANCER, V106, P355, DOI 10.1002/ijc.11232; Fuchs SM, 2007, PROTEIN ENG DES SEL, V20, P505, DOI 10.1093/protein/gzm051; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Holtz B, 1999, BIOCHEMISTRY-US, V38, P12174, DOI 10.1021/bi990876m; Isidro-Llobet A, 2009, CHEM REV, V109, P2455, DOI 10.1021/cr800323s; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Kannan R, 1999, PROTEIN EXPRES PURIF, V16, P76, DOI 10.1006/prep.1999.1068; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Laurell H, 2006, WORLD J GASTROENTERO, V12, P3344, DOI 10.3748/wjg.v12.i21.3344; LeDour G, 2008, BIOORGAN MED CHEM, V16, P8745, DOI 10.1016/j.bmc.2008.07.041; Lee S, 2010, CHEM REV, V110, P3087, DOI 10.1021/cr900361p; Leivo I, 2005, CANCER GENET CYTOGEN, V156, P104, DOI 10.1016/j.cancergencyto.2004.04.016; Luo DC, 2002, J BIOL CHEM, V277, P25527, DOI 10.1074/jbc.M202494200; Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Mucha A, 1998, J BIOL CHEM, V273, P2763, DOI 10.1074/jbc.273.5.2763; Nazarenko IA, 1997, NUCLEIC ACIDS RES, V25, P2516, DOI 10.1093/nar/25.12.2516; NOEL A, 1995, J BIOL CHEM, V270, P22866, DOI 10.1074/jbc.270.39.22866; Nuti E, 2009, J MED CHEM, V52, P6347, DOI 10.1021/jm900335a; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; RAMAGE R, 1991, TETRAHEDRON, V47, P6353, DOI 10.1016/S0040-4020(01)86564-9; ROUYER N, 1994, INVAS METAST, V14, P269; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Thewes M, 1996, DIAGN MOL PATHOL, V5, P284, DOI 10.1097/00019606-199612000-00010; Uryga-Polowy V, 2008, CHEMBIOCHEM, V9, P2452, DOI 10.1002/cbic.200800329; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Yamashita K, 2004, INT J CANCER, V110, P201, DOI 10.1002/ijc.20067; Yang J, 2007, BBA-MOL CELL RES, V1773, P400, DOI 10.1016/j.bbamcr.2006.11.002	52	18	18	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371500	http://dx.doi.org/10.1074/jbc.M112.371500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22927434	Green Published, hybrid			2022-12-28	WOS:000310642200022
J	Ramirez-Tapia, LE; Martin, CT				Ramirez-Tapia, Luis E.; Martin, Craig T.			New Insights into the Mechanism of Initial Transcription THE T7 RNA POLYMERASE MUTANT P266L TRANSITIONS TO ELONGATION AT LONGER RNA LENGTHS THAN WILD TYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; ESCHERICHIA-COLI SIGMA(70); LAC UV5 PROMOTER; STRUCTURAL BASIS; ELONGATION COMPLEX; ABORTIVE TRANSCRIPTION; ANGSTROM RESOLUTION; T7-RNA POLYMERASE; TRANSITION; DNA	RNA polymerases undergo substantial structural and functional changes in transitioning from sequence-specific initial transcription to stable and relatively sequence-independent elongation. Initially, transcribing complexes are characteristically unstable, yielding short abortive products on the path to elongation. However, protein mutations have been isolated in RNA polymerases that dramatically reduce abortive instability. Understanding these mutations is essential to understanding the energetics of initial transcription and promoter clearance. We demonstrate here that the P266L point mutation in T7 RNA polymerase, which shows dramatically reduced abortive cycling, also transitions to elongation later, i.e. at longer lengths of RNA. These two properties of the mutant are not necessarily coupled, but rather we propose that they both derive from a weakening of the barrier to RNA-DNA hybrid-driven rotation of the promoter binding N-terminal platform, a motion necessary to achieve programmatically timed release of promoter contacts in the transition to elongation. Parallels in the multisubunit RNA polymerases are discussed.	[Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ramirez-Tapia, Luis E.; Martin, Craig T.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,LGRT 104, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health Grant [1RO1 GM55002]; National Research Service Award from the National Institutes of Health [T32 GM08515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM55002 (to C. T. M.).; Supported by National Research Service Award T32 GM08515 from the National Institutes of Health (to L. E. R.-T.).	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; IKEDA RA, 1987, J BIOL CHEM, V262, P3800; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Vahia AV, 2011, BIOCHEMISTRY-US, V50, P7015, DOI 10.1021/bi200620q; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	36	13	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37352	37361		10.1074/jbc.M112.370643	http://dx.doi.org/10.1074/jbc.M112.370643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923611	hybrid, Green Published			2022-12-28	WOS:000310588500066
J	Coster, G; Gold, A; Chen, D; Schatz, DG; Goldberg, M				Coster, Gideon; Gold, Ayala; Chen, Darlene; Schatz, David G.; Goldberg, Michal			A Dual Interaction between the DNA Damage Response Protein MDC1 and the RAG1 Subunit of the V(D)J Recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; B-CELL; GENOMIC INSTABILITY; ACTIVATING GENE; BRCT REPEATS; HISTONE H2AX; MRN COMPLEX; N-TERMINUS; REPAIR; NBS1	The first step in V(D)J recombination is the formation of specific DNA double-strand breaks (DSBs) by the RAG1 and RAG2 proteins, which form the RAG recombinase. DSBs activate a complex network of proteins termed the DNA damage response (DDR). A key early event in the DDR is the phosphorylation of histone H2AX around DSBs, which forms a binding site for the tandem BRCA1 C-terminal (tBRCT) domain of MDC1. This event is required for subsequent signal amplification and recruitment of additional DDR proteins to the break site. RAG1 bears a histone H2AX-like motif at its C terminus (R1Ct), making it a putative MDC1-binding protein. In this work we show that the tBRCT domain of MDC1 binds the R1Ct motif of RAG1. Surprisingly, we also observed a second binding interface between the two proteins that involves the Proline-Serine-Threonine rich (PST) repeats of MDC1 and the N-terminal non-core region of RAG1 (R1Nt). The repeats-R1Nt interaction is constitutive, whereas the tBRCT-R1Ct interaction likely requires phosphorylation of the R1Ct motif of RAG1. As the C terminus of RAG1 has been implicated in inhibition of RAG activity, we propose a model in which phosphorylation of the R1Ct motif of RAG1 functions as a self-initiated regulatory signal.	[Coster, Gideon; Gold, Ayala; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Chen, Darlene; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA	Hebrew University of Jerusalem; Yale University; Howard Hughes Medical Institute; Yale University	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il	Coster, Gideon/L-6319-2019; Schatz, David/A-6748-2013; Coster, Gideon/B-2781-2009	Coster, Gideon/0000-0002-1449-6655; Schatz, David/0000-0002-5669-1176; Goldberg, Michal/0000-0001-9397-2383	United States-Israel Bi-National Science Foundation [2009286]; Abisch-Frenkel Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER	United States-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Abisch-Frenkel Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Grant 2009286 from the United States-Israel Bi-National Science Foundation (to D. G. S. and M. G.) and by the Abisch-Frenkel Foundation (to M. G.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; CORTES P, 1994, P NATL ACAD SCI USA, V91, P7633, DOI 10.1073/pnas.91.16.7633; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Cui XP, 2007, P NATL ACAD SCI USA, V104, P17046, DOI 10.1073/pnas.0610928104; CUOMO CA, 1994, P NATL ACAD SCI USA, V91, P6156, DOI 10.1073/pnas.91.13.6156; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Noordzij JG, 2000, BLOOD, V96, P203, DOI 10.1182/blood.V96.1.203.013k33_203_209; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santagata S, 2000, IMMUNOL REV, V178, P64, DOI 10.1034/j.1600-065X.2000.17818.x; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Sobacchi C, 2006, HUM MUTAT, V27, P1174, DOI 10.1002/humu.20408; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604	64	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36488	36498		10.1074/jbc.M112.402487	http://dx.doi.org/10.1074/jbc.M112.402487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942284	Green Published, hybrid			2022-12-28	WOS:000310364000068
J	Kryczka, J; Stasiak, M; Dziki, L; Mik, M; Dziki, A; Cierniewski, CS				Kryczka, Jakub; Stasiak, Marta; Dziki, Lukasz; Mik, Michal; Dziki, Adam; Cierniewski, Czeslaw S.			Matrix Metalloproteinase-2 Cleavage of the beta 1 Integrin Ectodomain Facilitates Colon Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; SURFACE ASSOCIATION; INTEGRIN EXPRESSION; TUMOR INVASION; GROWTH-FACTOR; ALPHA-V-BETA-3; MIGRATION; MATRIX-METALLOPROTEINASE-9; LOCALIZATION; INDUCTION	Cancer cell invasion is a key element in metastasis that requires integrins for adhesion/de-adhesion, as well as matrix metalloproteinases (MMPs) for focalized proteolysis. Herein we show that MMP-2 is up-regulated in resected colorectal tumors and degrades beta 1 integrins with the release of fragments containing the beta 1 I-domain. The beta 1 cleavage pattern is similar to that produced by digestion of alpha 5 beta 1 and alpha 2 beta 1 with MMP-2. Two such fragments, at 25 and 75 kDa, were identified after immunoprecipitation, with monoclonal antibody BD610468 reacting with the NH2-terminal I-like ectodomain followed by SDS-PAGE and microsequencing using electrospray (ISI-Q-TOF-Micromass) spectrometry. Cleavage of the beta 1 integrin can be abolished by inhibition of MMP-2 activity; it can be induced by up-regulation of MMP-2 expression, as exemplified by HT29 colon cancer cells transfected with pCMV6-XL5-MMP-2. Co-immunoprecipitation studies of colon cancer cells showed that the beta 1 integrin subunit is associated with MMP-2. The MMP-2-mediated shedding of the I-like domain from beta 1 integrins resulted in decreased adhesion of colon cancer cells to collagen and fibronectin, thus abolishing their receptivity. Furthermore, such cells showed enhanced motility as evaluated by a "wound healing-like" assay and time-lapse microscopy, indicating their increased invasiveness. Altogether, our data demonstrate that MMP-2 amplifies the motility of colon cancer cells, not only by digesting the extracellular matrix components in the vicinity of cancer cells but also by inactivating their major beta 1 integrin receptors.	[Kryczka, Jakub; Stasiak, Marta; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Dziki, Lukasz; Mik, Michal; Dziki, Adam] Med Univ Lodz, Dept Gen & Colorectal Surg, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-92215 Lodz, Poland	Medical University Lodz; Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl		Mik, Michal/0000-0001-6290-1806; Dziki, Adam/0000-0002-5439-6237; Kryczka, Jakub/0000-0002-5719-4139; Dziki, Lukasz/0000-0002-0390-0827	National Science Center, Krakow, Poland [2011/02/A/NZ3/00068]	National Science Center, Krakow, Poland	This work was supported by Project 2011/02/A/NZ3/00068 from the National Science Center, Krakow, Poland.	Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Choi WS, 2010, J THROMB HAEMOST, V8, P1364, DOI 10.1111/j.1538-7836.2010.03837.x; Cierniewski CS, 2010, ANN NY ACAD SCI, V1194, P60, DOI 10.1111/j.1749-6632.2010.05480.x; Cieslak M, 2002, J BIOL CHEM, V277, P6779, DOI 10.1074/jbc.M102325200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Hodgkinson CP, 2000, MOL PHARMACOL, V58, P976, DOI 10.1124/mol.58.5.976; Ise H, 2001, BIOCHEM BIOPH RES CO, V285, P172, DOI 10.1006/bbrc.2001.5139; Kanda S, 2000, ARTERIOSCL THROM VAS, V20, P998, DOI 10.1161/01.ATV.20.4.998; KawakamiKimura N, 1997, BRIT J CANCER, V75, P47, DOI 10.1038/bjc.1997.8; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Menon B, 2006, AM J PHYSIOL-CELL PH, V290, pC254, DOI 10.1152/ajpcell.00235.2005; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morozevich G, 2009, CELL CYCLE, V8, P2219, DOI 10.4161/cc.8.14.8980; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Niewiarowska J, 2009, CANCER GENE THER, V16, P713, DOI 10.1038/cgt.2009.13; Pawlowska Z, 2005, PROTEOMICS, V5, P1217, DOI 10.1002/pmic.200400983; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schaffert CS, 2001, ALCOHOL CLIN EXP RES, V25, P1749, DOI 10.1097/00000374-200112000-00010; SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389, DOI 10.1091/mbc.5.4.389; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Torimura T, 2001, J HEPATOL, V35, P245, DOI 10.1016/S0168-8278(01)00127-1; Toth M, 1997, CANCER RES, V57, P3159; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yu Q, 2000, GENE DEV, V14, P163; Yuan ST, 2000, WORLD J GASTROENTERO, V6, P231; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I	40	57	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36556	36566		10.1074/jbc.M112.384909	http://dx.doi.org/10.1074/jbc.M112.384909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898815	Green Published, hybrid			2022-12-28	WOS:000310364000076
J	Pang, XY; Cao, J; Addington, L; Lovell, S; Battaile, KP; Zhang, N; Rao, JLUM; Dennis, EA; Moise, AR				Pang, Xiao-Yan; Cao, Jian; Addington, Linsee; Lovell, Scott; Battaile, Kevin P.; Zhang, Na; Rao, J. L. Uma Maheswar; Dennis, Edward A.; Moise, Alexander R.			Structure/Function Relationships of Adipose Phospholipase A(2) Containing a Cys-His-His Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TUMOR-SUPPRESSOR; HORMONE-SENSITIVE LIPASE; DIET-INDUCED OBESITY; ESCHERICHIA-COLI; DOWN-REGULATION; GENE; PROTEIN; IDENTIFICATION; EXPRESSION; LIPOLYSIS	Adipose phospholipase A(2) (AdPLA or Group XVI PLA(2)) plays an important role in the onset of obesity by suppressing adipose tissue lipolysis. As a consequence, AdPLA-deficient mice are resistant to obesity induced by a high fat diet or leptin deficiency. It has been proposed that AdPLA mediates its antilipo-lytic effects by catalyzing the release of arachidonic acid. Based on sequence homology, AdPLA is part of a small family of acyltransferases and phospholipases related to lecithin: retinol acyltransferase (LRAT). To better understand the enzymatic mechanism of AdPLA and LRAT-related proteins, we solved the crystal structure of AdPLA. Our model indicates that AdPLA bears structural similarity to proteins from the NlpC/P60 family of cysteine proteases, having its secondary structure elements configured in a circular permutation of the classic papain fold. Using both structural and biochemical evidence, we demonstrate that the enzymatic activity of AdPLA is mediated by a distinctive Cys-His-His catalytic triad and that the C-terminal transmembrane domain of AdPLA is required for the interfacial catalysis. Analysis of the enzymatic activity of AdPLA toward synthetic and natural substrates indicates that AdPLA displays PLA(1) in addition to PLA(2) activity. Thus, our results provide insight into the enzymatic mechanism and biochemical properties of AdPLA and LRAT-related proteins and lead us to propose an alternate mechanism for AdPLA in promoting adipose tissue lipolysis that is not contingent on the release of arachidonic acid and that is compatible with its combined PLA(1)/A(2) activity.	[Pang, Xiao-Yan; Addington, Linsee; Rao, J. L. Uma Maheswar; Moise, Alexander R.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Cao, Jian; Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Lovell, Scott; Zhang, Na] Univ Kansas, Del Shankel Struct Biol Ctr, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, IMCA CAT, Argonne, IL 60439 USA	University of Kansas; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kansas; Hauptman Woodward Medical Research Institute	Moise, AR (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, 5060 Malott Hall,1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	alexmoise@ku.edu	Dennis, Edward A./M-5554-2019; AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009	Dennis, Edward A./0000-0003-3738-3140; AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [5P20RR017708-10, 3P20RR017708-07S1]; National Center for Research Resources; NIGMS [8 P20 GM103420-10, R01 GM20501]; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR017708-10 and 3P20RR017708-07S1, subawards of grants from the National Center for Research Resources (to A. R. M.), Grant 8 P20 GM103420-10) from the NIGMS (to A. R. M.), and Grant R01 GM20501 (to E. A. D.).; We thank Drs. Rick Dobrowsky, Hei Sook Sul, Robert Hanzlik, Jeff Staudinger, and Ross Stein for valuable discussions. Wethank Sara Billings for advice and help in the preparation of the manuscript. We thank Dan Brown and Amanda Wise for help in cloning and initial assay development and Dr. Fei Philip Gao for help in designing the protein purification strategy. We thank Drs. Marcin Golczak and Krzysztof Palczewski for the gift of the pET30b-HRASLS3 bacterial expression construct. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was also supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COPPACK SW, 1994, J LIPID RES, V35, P177; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fain JN, 2000, J LIPID RES, V41, P1689; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAJNAL A, 1994, ONCOGENE, V9, P479; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Lord CC, 2012, DIABETES, V61, P355, DOI 10.2337/db11-0994; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moise AR, 2004, J VIROL, V78, P454, DOI 10.1128/JVI.78.1.454-463.2004; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Plante M, 2009, METHODS MOL BIOL, V579, P469, DOI 10.1007/978-1-60761-322-0_23; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Ren XB, 2010, BIOMOL NMR ASSIGN, V4, P175, DOI 10.1007/s12104-010-9238-5; Roder K, 2002, J BIOL CHEM, V277, P30543, DOI 10.1074/jbc.M111891200; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Sers C, 2002, ONCOGENE, V21, P2829, DOI 10.1038/sj.onc.1205377; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Siegrist S, 2001, ONCOGENE, V20, P5155, DOI 10.1038/sj.onc.1204658; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; Xu QP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022013; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	88	34	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35260	35274		10.1074/jbc.M112.398859	http://dx.doi.org/10.1074/jbc.M112.398859			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923616	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000309968000036
J	Gaucher, JF; Mauge, C; Didry, D; Guichard, B; Renault, L; Carlier, MF				Gaucher, Jean-Francois; Mauge, Chloe; Didry, Dominique; Guichard, Berengere; Renault, Louis; Carlier, Marie-France			Interactions of Isolated C-terminal Fragments of Neural Wiskott-Aldrich Syndrome Protein (N-WASP) with Actin and Arp2/3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FILAMENT NUCLEATION; STRUCTURAL BASIS; FAMILY PROTEINS; MONOMERIC ACTIN; WH2 DOMAINS; ACTIVATION; MECHANISM; NETWORK; SPIRE	Wiskott-Aldrich syndrome proteins (WASP) are a family of proteins that all catalyze actin filament branching with the Arp2/3 complex in a variety of actin-based motile processes. The constitutively active C-terminal domain, called VCA, harbors one or more WASP homology 2 (WH2) domains that bind G-actin, whereas the CA extension binds the Arp2/3 complex. The VCA.actin.Arp2/3 entity associates with a mother filament to form a branched junction from which a daughter filament is initiated. The number and function of WH2-bound actin(s) in the branching process are not known, and the stoichiometry of the VCA.actin.Arp2/3 complex is debated. We have expressed the tandem WH2 repeats of N-WASP, either alone (V) or associated with the C (VC) and CA (VCA) extensions. We analyzed the structure of actin in complex with V, VC, and VCA using protein crystallography and hydrodynamic and spectrofluorimetric methods. The partial crystal structure of the VC.actin 1:1 complex shows two actins in the asymmetric unit with extensive actin-actin contacts. In solution, each of the two WH2 domains in V, VC, and VCA binds G-actin in 1: 2 complexes that participate in barbed end assembly. V, VC, and VCA enhance barbed end depolymerization like profilin but neither nucleate nor sever filaments, in contrast with other WH2 repeats. VCA binds the Arp2/3 complex in a 1: 1 complex even in the presence of a large excess of VCA. VCA.Arp2/3binds one actin in a latrunculin A-sensitive fashion, in a 1: 1: 1 complex, indicating that binding of the second actin to VCA is weakened in the ternary complex.	[Mauge, Chloe; Didry, Dominique; Guichard, Berengere; Renault, Louis; Carlier, Marie-France] CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3082, F-91198 Gif Sur Yvette, France; [Gaucher, Jean-Francois] Univ Paris 05, Fac Pharm, CNRS, Lab Cristallog & RMN Biol,UMR 801, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Carlier, MF (corresponding author), CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3082, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr		RENAULT, Louis/0000-0003-1722-074X	European Research Council ["Forcefulactin" 249982]; European Community [241548]; Agence Nationale pour la Recherche	European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	Recipient of Ligue Nationale Contre le Cancer Equipe Labellisee 2010-2013, European Research Council Advanced Grant "Forcefulactin" 249982, funding from the European Community Seventh Framework Programme FP7/2007-2013 under Grant Agreement 241548, and an Agence Nationale pour la Recherche, Programme Physique et Chimie du Vivant 2006-2009 "Motilactin." To whom correspondence should be addressed. Tel.: 33-01-69-82-34-65; E-mail: carlier@lebs.cnrs-gif.fr.	Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Carlier MF, 2011, NAT STRUCT MOL BIOL, V18, P967, DOI 10.1038/nsmb.2130; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; CASELLA JF, 1995, CELL MOTIL CYTOSKEL, V30, P164, DOI 10.1002/cm.970300208; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kollmar Martin, 2012, BMC Res Notes, V5, P88, DOI 10.1186/1756-0500-5-88; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rebowski G, 2008, P NATL ACAD SCI USA, V105, P10785, DOI 10.1073/pnas.0801650105; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	71	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34646	34659		10.1074/jbc.M112.394361	http://dx.doi.org/10.1074/jbc.M112.394361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22847007	Green Published, hybrid			2022-12-28	WOS:000309654200067
J	Meriin, AB; Mense, M; Colbert, JD; Liang, F; Bihler, H; Zaarur, N; Rock, KL; Sherman, MY				Meriin, Anatoli B.; Mense, Martin; Colbert, Jeff D.; Liang, Feng; Bihler, Hermann; Zaarur, Nava; Rock, Kenneth L.; Sherman, Michael Y.			A Novel Approach to Recovery of Function of Mutant Proteins by Slowing Down Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURODEGENERATIVE DISEASES; AGGRESOME FORMATION; HEAT-SHOCK; AUTOPHAGY; DEGRADATION; F508DEL-CFTR; ASSOCIATION; CHAPERONES; HUNTINGTIN; TOXICITY	Protein homeostasis depends on a balance of translation, folding, and degradation. Here, we demonstrate that mild inhibition of translation results in a dramatic and disproportional reduction in production of misfolded polypeptides in mammalian cells, suggesting an improved folding of newly synthesized proteins. Indeed, inhibition of translation elongation, which slightly attenuated levels of a copepod GFP mutant protein, significantly enhanced its function. In contrast, inhibition of translation initiation had minimal effects on copepod GFP folding. On the other hand, mild suppression of either translation elongation or initiation corrected folding defects of the disease-associated cystic fibrosis transmembrane conductance regulator mutant F508del. We propose that modulation of translation can be used as a novel approach to improve overall proteostasis in mammalian cells, as well as functions of disease-associated mutant proteins with folding deficiencies.	[Meriin, Anatoli B.; Zaarur, Nava; Sherman, Michael Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Mense, Martin] Cyst Fibrosis Fdn Therapeut, Bethesda, MD 20814 USA; [Colbert, Jeff D.; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Liang, Feng; Bihler, Hermann] Flatley Discovery Lab, Charlestown, MA 02129 USA	Boston University; Cystic Fibrosis Foundation; University of Massachusetts System; University of Massachusetts Worcester	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, K-323, Boston, MA 02118 USA.	sherma1@bu.edu		Bihler, Hermann/0000-0002-8167-1548; Meriin, Anatoli/0000-0003-0087-814X; Sherman, Michael/0000-0003-3345-073X	National Institutes of Health [R01 GM086890, R01 AI20248, DK32520, AI007272-25]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007272, R01AI020248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM086890 (to M. Y. S.), R01 AI20248 (to K. L. R.), and DK32520 (to the Diabetes Endocrinology Research Center) and Training Grant AI007272-25 (to J. D. C.).	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Meriin AB, 2012, J CELL SCI, V125, P2665, DOI 10.1242/jcs.098954; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Syntichaki P, 2007, ANN NY ACAD SCI, V1119, P289, DOI 10.1196/annals.1404.001; Thakerar A., 2009, PEDIAT PULMONOL, V44, P305; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Wigley WC, 1999, J CELL BIOL, V145, P481; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	29	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34264	34272		10.1074/jbc.M112.397307	http://dx.doi.org/10.1074/jbc.M112.397307			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902621	hybrid, Green Published			2022-12-28	WOS:000309654200031
J	Saraon, P; Musrap, N; Cretu, D; Karagiannis, GS; Batruch, I; Smith, C; Drabovich, AP; Trudel, D; van der Kwast, T; Morrissey, C; Jarvi, KA; Diamandis, EP				Saraon, Punit; Musrap, Natasha; Cretu, Daniela; Karagiannis, George S.; Batruch, Ihor; Smith, Chris; Drabovich, Andrei P.; Trudel, Dominique; van der Kwast, Theodorus; Morrissey, Colm; Jarvi, Keith A.; Diamandis, Eleftherios P.			Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; GROWTH-FACTOR-BETA; RECEPTOR; EXPRESSION; PROGRESSION; METASTASIS; GAS6; PROLIFERATION; HYPERPLASIA; ACTIVATION	Androgen deprivation constitutes the principal therapy for advanced and metastatic prostate cancers. However, this therapeutic intervention usually results in the transition to a more aggressive androgen-independent prostate cancer. The elucidation of molecular alterations during the progression to androgen independence is an integral step toward discovering more effective targeted therapies. With respect to identifying crucial mediators of this transition, we compared the proteomes of androgen-independent (PC3, DU145, PPC1, LNCaP-SF, and 22Rv1) and androgen-dependent (LNCaP and VCaP) and/or normal prostate epithelial (RWPE) cell lines using mass spectrometry. We identified more than 100 proteins that were differentially secreted in the androgen-independent cell lines. Of these, Protein S (PROS1) was elevated in the secretomes of all of the androgen-independent prostate cancer cell lines, with no detectable secretion in normal and androgen-dependent cell lines. Using quantitative PCR, we observed significantly higher (p < 0.05) tissue expression levels of PROS1 in prostate cancer samples, further indicating its importance in prostate cancer progression. Similarly, immunohistochemistry analysis revealed elevation of PROS1 in high grade prostate cancer (Gleason grade >= 8), and further elevation in castration-resistant metastatic prostate cancer lesions. We also observed its significant (p < 0.05) elevation in high grade prostate cancer seminal plasma samples. Taken together, these results show that PROS1 is elevated in high grade and castration-resistant prostate cancer and could serve as a potential biomarker of aggressive disease.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Joseph & Wolf Lebovic Ctr, Dept Pathol & Lab Med, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Saraon, Punit; Musrap, Natasha; Cretu, Daniela; Karagiannis, George S.; van der Kwast, Theodorus; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Trudel, Dominique; van der Kwast, Theodorus] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Morrissey, Colm] Univ Washington, Dept Urol, Seattle, WA 98467 USA; [Jarvi, Keith A.] Mt Sinai Hosp, Dept Surg, Div Urol, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebovic Ctr, Dept Pathol & Lab Med, Samuel Lunenfeld Res Inst, 60 Murray St,Box 32,Flr 6,Rm L6-201, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca	Trudel, Dominique/AAS-4455-2020; Drabovich, Andrei/E-9347-2012; Saraon, Punit/K-2639-2019	Drabovich, Andrei/0000-0003-3049-7145; Diamandis, Eleftherios/0000-0002-1589-820X; Trudel, Dominique/0000-0001-9820-1772; Van der Kwast, Theodorus/0000-0001-8640-5786	Ontario Graduate Scholarship; Scace Graduate Prostate Cancer Fellowship; Pacific Northwest Prostate Cancer SPORE [P50CA97186]; National Institutes of Health [PO1CA085859]; Richard M. Lucas Foundation; PO1 NIH; NATIONAL CANCER INSTITUTE [P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Scace Graduate Prostate Cancer Fellowship; Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Lucas Foundation; PO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Ontario Graduate Scholarship and the Scace Graduate Prostate Cancer Fellowship.; We acknowledge the support of the University Health Network Pathology Research Program for performing the immunohistochemistry experiments. We thank Apostolos Dimitromanolakis for assistance in analyzing the proteomics data and with statistical analysis. We also thank the patients and their families who were willing to participate in the Prostate Cancer Donor Program, for without them research of this nature would not be possible. We also acknowledge Lawrence True, Eva Corey, Celestia Higano, and Robert Vessella and the rapid autopsy teams in the Urology Department at the University of Washington. The donated material is the result of work supported by resources from the Pacific Northwest Prostate Cancer SPORE (P50CA97186), PO1 NIH, National Institutes of Health, Grant PO1CA085859, and the Richard M. Lucas Foundation.	Alaiya AA, 2011, INT J ONCOL, V38, P1047, DOI 10.3892/ijo.2011.937; Blanchere M, 2001, PROSTATE, V46, P311, DOI 10.1002/1097-0045(20010301)46:4<311::AID-PROS1038>3.0.CO;2-2; Blando JM, 2011, NEOPLASIA, V13, P254, DOI 10.1593/neo.101388; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; CHODAK GW, 1992, J UROLOGY, V147, P798, DOI 10.1016/S0022-5347(17)37389-5; Crawford ED, 2010, J CLIN ONCOL, V28, pE408, DOI 10.1200/JCO.2010.28.7664; Damon SE, 1998, ENDOCRINOLOGY, V139, P3456, DOI 10.1210/en.139.8.3456; Davis JS, 2011, MOL ENDOCRINOL, V25, P611, DOI 10.1210/me.2010-0312; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Deng YX, 2003, CANCER-AM CANCER SOC, V98, P2576, DOI 10.1002/cncr.11849; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Diamandis EP, 1998, TRENDS ENDOCRIN MET, V9, P310, DOI 10.1016/S1043-2760(98)00082-4; Drake RR, 2010, J PROTEOME RES, V9, P2109, DOI 10.1021/pr1001498; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Guo HA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-13; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Miyake H, 2000, CANCER RES, V60, P3058; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; SADI MV, 1991, CANCER, V67, P3057, DOI 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Sierko E, 2010, THROMB RES, V125, pE71, DOI 10.1016/j.thromres.2009.09.011; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Trendel JA, 2008, J BIOMOL SCREEN, V13, P804, DOI 10.1177/1087057108321976; Tsui KH, 2008, ANTICANCER RES, V28, P1993; Tyson DR, 2008, ADV EXP MED BIOL, V630, P133; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; WOLFF JM, 1995, EUR J CANCER, V31A, P339, DOI 10.1016/0959-8049(94)00446-C; Zhang FH, 2005, CLIN CANCER RES, V11, P4512, DOI 10.1158/1078-0432.CCR-04-2571; Zhang Y, 2012, INT J CANCER, V130, P200, DOI 10.1002/ijc.25993; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010	48	49	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34019	34031		10.1074/jbc.M112.384438	http://dx.doi.org/10.1074/jbc.M112.384438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908226	Green Published, hybrid			2022-12-28	WOS:000309654200009
J	Eisenhut, M; Georg, J; Klahn, S; Sakurai, I; Mustila, H; Zhang, PP; Hess, WR; Aro, EM				Eisenhut, Marion; Georg, Jens; Klaehn, Stephan; Sakurai, Isamu; Mustila, Henna; Zhang, Pengpeng; Hess, Wolfgang R.; Aro, Eva-Mari			The Antisense RNA As1_flv4 in the Cyanobacterium Synechocystis sp PCC 6803 Prevents Premature Expression of the flv4-2 Operon upon Shift in Inorganic Carbon Supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO2 CONCENTRATING MECHANISMS; CO2-CONCENTRATING MECHANISM; PHOTOSYSTEM-II; LYSR FAMILY; TRANSCRIPTIONAL REGULATION; FLAVODIIRON PROTEINS; GENE-EXPRESSION; SP PCC-6803; WILD-TYPE; LIMITATION	The functional relevance of natural cis-antisense transcripts is mostly unknown. Here we have characterized the association of three antisense RNAs and one intergenically encoded noncoding RNA with an operon that plays a crucial role in photoprotection of photosystem II under low carbon conditions in the cyanobacterium Synechocystis sp. PCC 6803. Cyanobacteria show strong gene expression dynamics in response to a shift of cells from high carbon to low levels of inorganic carbon (C-i), but the regulatory mechanisms are poorly understood. Among the most up-regulated genes in Synechocystis are flv4, sll0218, and flv2, which are organized in the flv4-2 operon. The flavodiiron proteins encoded by this operon open up an alternative electron transfer route, likely starting from the Q(B) site in photosystem II, under photooxidative stress conditions. Our expression analysis of cells shifted from high carbon to low carbon demonstrated an inversely correlated transcript accumulation of the flv4-2 operon mRNA and one antisense RNA to flv4, designated as As1_flv4. Overexpression of As1_flv4 led to a decrease in flv4-2 mRNA. The promoter activity of as1_flv4 was transiently stimulated by C-i limitation and negatively regulated by the AbrB-like transcription regulator Sll0822, whereas the flv4-2 operon was positively regulated by the transcription factor NdhR. The results indicate that the tightly regulated antisense RNA As1_flv4 establishes a transient threshold for flv4-2 expression in the early phase after a change in C-i conditions. Thus, it prevents unfavorable synthesis of the proteins from the flv4-2 operon.	[Eisenhut, Marion; Sakurai, Isamu; Mustila, Henna; Zhang, Pengpeng; Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Sci, FI-20014 Turku, Finland; [Georg, Jens; Klaehn, Stephan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Turku; University of Freiburg	Aro, EM (corresponding author), Univ Turku, Dept Biochem & Food Sci, FI-20014 Turku, Finland.	evaaro@utu.fi	Georg, Jens/AAD-8057-2019; Mustila, Henna/ABA-2990-2020; Aro, Eva-Mari/Q-8664-2017	Georg, Jens/0000-0002-7746-5522; Mustila, Henna/0000-0002-1939-7197; Aro, Eva-Mari/0000-0002-2922-1435; Hess, Wolfgang/0000-0002-5340-3423; Klahn, Stephan/0000-0002-2933-486X	Academy of Finland Projects [118637, 133299]; European Union Project Solar-H2 (FP7) [212508]; Deutsche Forschungsgemeinschaft (DFG) Focus Program "Sensory and Regulatory RNAs in Prokaryotes" [SPP1258]; Bundesministerium fur Bildung und Forschung Grant [0313921]; DFG-sponsored graduate school "Signal Systems in Plant Model Organisms" [GRK1305]	Academy of Finland Projects(Academy of Finland); European Union Project Solar-H2 (FP7); Deutsche Forschungsgemeinschaft (DFG) Focus Program "Sensory and Regulatory RNAs in Prokaryotes"(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung Grant(Federal Ministry of Education & Research (BMBF)); DFG-sponsored graduate school "Signal Systems in Plant Model Organisms"	This work was supported by Academy of Finland Projects 118637 and 133299 (to E.-M. A. and M. E.), European Union Project Solar-H2 (FP7 Contract 212508) (to E.-M. A.), the Deutsche Forschungsgemeinschaft (DFG) Focus Program "Sensory and Regulatory RNAs in Prokaryotes" SPP1258 and Bundesministerium fur Bildung und Forschung Grant 0313921 (to W. R. H.), and the DFG-sponsored graduate school GRK1305 "Signal Systems in Plant Model Organisms" (to J. G.).	Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Benschop JJ, 2003, PHOTOSYNTH RES, V77, P117, DOI 10.1023/A:1025850230977; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; De Lucia F, 2011, CURR OPIN PLANT BIOL, V14, P168, DOI 10.1016/j.pbi.2010.11.006; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hernandez JA, 2010, J PLANT PHYSIOL, V167, P430, DOI 10.1016/j.jplph.2009.10.009; Ishii A, 2008, PLANT PHYSIOL, V148, P660, DOI 10.1104/pp.108.123505; Jansen T, 2003, FEMS MICROBIOL LETT, V228, P121, DOI 10.1016/S0378-1097(03)00744-4; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Komenda J, 2007, BBA-BIOENERGETICS, V1767, P829, DOI 10.1016/j.bbabio.2007.01.005; Kunert A, 2000, J MICROBIOL METH, V41, P185, DOI 10.1016/S0167-7012(00)00162-7; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Lieman-Hurwitz J, 2009, ENVIRON MICROBIOL, V11, P927, DOI 10.1111/j.1462-2920.2008.01818.x; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Nishimura T, 2008, MOL MICROBIOL, V68, P98, DOI 10.1111/j.1365-2958.2008.06137.x; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Summerfield TC, 2008, APPL ENVIRON MICROB, V74, P5276, DOI 10.1128/AEM.00883-08; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Woodger FJ, 2007, J BACTERIOL, V189, P3335, DOI 10.1128/JB.01745-06; Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Yamauchi Y, 2011, J BACTERIOL, V193, P3702, DOI 10.1128/JB.00284-11; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhang XM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r20; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108	60	61	63	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33153	33162		10.1074/jbc.M112.391755	http://dx.doi.org/10.1074/jbc.M112.391755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22854963	Green Published, hybrid			2022-12-28	WOS:000309602100007
J	Kruger, V; Deckers, M; Hildenbeutel, M; van der Laan, M; Hellmers, M; Dreker, C; Preuss, M; Herrmann, JM; Rehling, P; Wagner, R; Meinecke, M				Krueger, Vivien; Deckers, Markus; Hildenbeutel, Markus; van der Laan, Martin; Hellmers, Maike; Dreker, Christina; Preuss, Marc; Herrmann, Johannes M.; Rehling, Peter; Wagner, Richard; Meinecke, Michael			The Mitochondrial Oxidase Assembly Protein1 (Oxa1) Insertase Forms a Membrane Pore in Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; INNER MEMBRANE; YIDC; EXPORT; TRANSLOCATION; COMPONENT; CHANNEL; COMPLEX; IMPORT; MACHINERY	The inner membrane of mitochondria is especially protein-rich. To direct proteins into the inner membrane, translocases mediate transport and membrane insertion of precursor proteins. Although the majority of mitochondrial proteins are imported from the cytoplasm, core subunits of respiratory chain complexes are inserted into the inner membrane from the matrix. Oxa1, a conserved membrane protein, mediates the insertion of mitochondrion-encoded precursors into the inner mitochondrial membrane. The molecular mechanism by which Oxa1 mediates insertion of membrane spans, entailing the translocation of hydrophilic domains across the inner membrane, is still unknown. We investigated if Oxa1 could act as a protein-conducting channel for precursor transport. Using a biophysical approach, we show that Oxa1 can form a pore capable of accommodating a translocating protein segment. After purification and reconstitution, Oxa1 acts as a cation-selective channel that specifically responds to mitochondrial export signals. The aqueous pore formed by Oxa1 displays highly dynamic characteristics with a restriction zone diameter between 0.6 and 2 nm, which would suffice for polypeptide translocation across the membrane. Single channel analyses revealed four discrete channels per active unit, suggesting that the Oxa1 complex forms several cooperative hydrophilic pores in the inner membrane. Hence, Oxa1 behaves as a pore-forming translocase that is regulated in a membrane potential and substrate-dependent manner.	[Deckers, Markus; Rehling, Peter; Meinecke, Michael] Univ Gottingen, Abt Biochem 2, D-37073 Gottingen, Germany; [Krueger, Vivien; Hellmers, Maike; Dreker, Christina; Wagner, Richard; Meinecke, Michael] Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany; [Hildenbeutel, Markus; Preuss, Marc; Herrmann, Johannes M.] Tech Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [van der Laan, Martin] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Meinecke, Michael] European Neurosci Inst Gottingen, D-37077 Gottingen, Germany	University of Gottingen; University Osnabruck; University of Kaiserslautern; University of Freiburg; Max Planck Society	Rehling, P (corresponding author), Univ Gottingen, Abt Biochem 2, Humboldtallee 23, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de; wagner@uos.de	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; van der Laan, Martin/0000-0003-0789-9912	Human Frontiers in Science Program; Deutsche Forschungsgemeinschaft Grant [FOR967]; Max Planck Society	Human Frontiers in Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by Human Frontiers in Science Program (to M. M.), Deutsche Forschungsgemeinschaft Grant FOR967 (to P. R. and R. W.), the Max Planck Society (to P. R.).	BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; COHEN FS, 1980, J GEN PHYSIOL, V75, P251, DOI 10.1085/jgp.75.3.251; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; Harsman A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454102; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; HILLE B, 2001, ION CHANNELS EXCITAB, P347; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Schwartz MP, 1999, J BIOL CHEM, V274, P12759, DOI 10.1074/jbc.274.18.12759; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Smallridge R, 2003, NAT REV MOL CELL BIO, V4, P343, DOI 10.1038/nrm1107; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200	41	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33314	33326		10.1074/jbc.M112.387563	http://dx.doi.org/10.1074/jbc.M112.387563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22829595	Green Published, hybrid			2022-12-28	WOS:000309602100020
J	Wang, P; Zhu, F; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos			The Antagonistic Actions of Endogenous Interleukin-1 beta and 15-Deoxy-Delta(12,14)-prostaglandin J(2) Regulate the Temporal Synthesis of Matrix Metalloproteinase-9 in Sheared Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES 1; GENE-EXPRESSION; ARTICULAR-CARTILAGE; MMP-9 EXPRESSION; P38 MAPK; INHIBITION; OSTEOARTHRITIS; ACTIVATION; CELLS	Mechanical overloading of articular cartilage producing hydrostatic stress, tensile strain, and fluid flow results in irreversible cartilage erosion and osteoarthritis (OA). Application of high fluid shear to chondrocytes recapitulates the earmarks of OA as evidenced by the induction of proinflammatory cytokines and prostaglandins, which are capable of inducing the expression of matrix-degrading enzymes. Matrix metalloproteinase-9 (MMP-9) synthesis is detected at early but not late stages of OA. However, the underlying mechanism(s) of the MMP-9 temporal regulation remains unknown. Using the T/C-28a2 chondrocyte cell line as a model system, we demonstrated that high fluid shear induces a marked increase in MMP-9 expression at short shear exposure times (3-6 h), which falls below basal levels after prolonged shear exposure (12-48 h). High fluid shear stress induced the rapid and sustained synthesis of IL-1 beta, activating PI3K, ERK1/2, and JNK, which are in turn responsible for MMP-9 expression. Prolonged shear exposure (> 12 h) induced 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) synthesis, which exerted an antagonistic effect on IL-1 beta-mediated PI3K-, ERK1/2-, and JNK-dependent NF-kappa B activation, thereby suppressing MMP-9 expression in human chondrocytes. Reconstructing the signaling network that regulates shear-mediated MMP-9 expression in human chondrocytes may provide insights for developing strategies to treat arthritic disorders.	[Wang, Pu; Zhu, Fei; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Wang, Pu] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110004, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Northeastern University - China	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health from NIAMS [RO1 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR053358 from NIAMS.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Ahmed S, 2005, J NUTR, V135, P2096, DOI 10.1093/jn/135.9.2096; Akhtar N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-66; Boyault S, 2004, FEBS LETT, V572, P33, DOI 10.1016/j.febslet.2004.06.090; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Freemont AJ, 1997, ANN RHEUM DIS, V56, P542, DOI 10.1136/ard.56.9.542; Funovics P, 2006, PROSTAG OTH LIPID M, V79, P230, DOI 10.1016/j.prostaglandins.2006.02.002; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grau R, 2004, CANCER RES, V64, P5162, DOI 10.1158/0008-5472.CAN-04-0849; Hashimoto K, 2002, J GASTROINTEST CANC, V32, P7, DOI 10.1385/IJGC:32:1:7; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hu D, 2007, CONNECT TISSUE RES, V48, P198, DOI 10.1080/03008200701458731; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; Lin YC, 2008, RHEUMATOL INT, V28, P1009, DOI 10.1007/s00296-008-0561-4; Lu YC, 2011, J AGR FOOD CHEM, V59, P4969, DOI 10.1021/jf1046738; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Naito K, 1999, RHEUMATOLOGY, V38, P510, DOI 10.1093/rheumatology/38.6.510; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Pustovrh MC, 2009, EUR J CLIN INVEST, V39, P1082, DOI 10.1111/j.1365-2362.2009.02200.x; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Soeder S, 2006, CLIN EXP RHEUMATOL, V24, P302; Tacon CE, 2010, AM J RESP CELL MOL, V43, P201, DOI 10.1165/rcmb.2009-0216OC; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tsuchiya K, 1997, J ORTHOP RES, V15, P94, DOI 10.1002/jor.1100150114; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027630; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13; Zhu F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015174	46	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31877	31893		10.1074/jbc.M112.362731	http://dx.doi.org/10.1074/jbc.M112.362731			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829602	Green Published, hybrid			2022-12-28	WOS:000309059400028
J	Xie, HR; Sun, XF; Piao, YL; Jegga, AG; Handwerger, S; Ko, MSH; Dey, SK				Xie, Huirong; Sun, Xiaofei; Piao, Yulan; Jegga, Anil G.; Handwerger, Stuart; Ko, Minoru S. H.; Dey, Sudhansu K.			Silencing or Amplification of Endocannabinoid Signaling in Blastocysts via CB1 Compromises Trophoblast Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREIMPLANTATION MOUSE EMBRYO; HYDROLYZING ACID AMIDASE; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; ANANDAMIDE; BRAIN; PALMITOYLETHANOLAMIDE; ACTIVATION; MOTILITY	Endocannabinoid signaling plays key roles in multiple female reproductive events. Previous studies have shown an interesting phenomenon, that mice with either silenced or elevated endocannabinoid signaling via Cnr1 encoding CB1 show similar defects in several pregnancy events, including preimplantation embryo development. To unravel the downstream signaling of this phenomenon, microarray studies were performed using RNAs collected from WT, Cnr1(-/-), and Faah(-/-) mouse blastocysts on day 4 of pregnancy. The results indicate that about 100 genes show unidirectional changes under either silenced or elevated anandamide signaling via CB1. Functional enrichment analysis of the microarray data predicted that multiple biological functions and pathways are affected under aberrant endocannabinoid signaling. Among them, genes enriched in cell migration are suppressed in Cnr1(-/-) or Faah(-/-) blastocysts. Cell migration assays validated the prediction of functional enrichment analysis that cell mobility and spreading of either Cnr1(-/-) or Faah(-/-) trophoblast stem cells are compromised. Either silenced or elevated endocannabinoid signaling via CB1 causes similar changes in downstream targets in preimplantation embryos and trophoblast stem cells. This study provides evidence that a tightly regulated endocannabinoid signaling is critical to normal preimplantation embryo development and migration of trophoblast stem cells.	[Xie, Huirong; Sun, Xiaofei; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Handwerger, Stuart] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; [Piao, Yulan; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Ko, Minoru S. H.] Keio Univ, Sch Med, Dept Syst Med, Sakaguchi Lab, Tokyo 160, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University	Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org	Ko, Minoru S. H./B-7969-2009; Jegga, Anil/H-6140-2011	Ko, Minoru S. H./0000-0002-3530-3015; Jegga, Anil/0000-0002-4881-7752	National Institutes of Health [DA006668]; National Institutes of Health, NIA; March of Dimes; Lalor Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); March of Dimes(March of Dimes); Lalor Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant DA006668 and the Intramural Research Program of the National Institutes of Health, NIA. This work was also supported by the March of Dimes.; Supported by a Lalor Foundation postdoctoral fellowship.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Alvarez-Jaimes LJ, 2011, CURR PHARM BIOTECHNO, V12, P1644; Ambrosini A, 2006, BIOL REPROD, V74, P659, DOI 10.1095/biolreprod.105.046060; Ambrosini A, 2005, J ANDROL, V26, P429, DOI 10.2164/jandrol.04141; ANDREWS GK, 1991, DEV BIOL, V145, P13, DOI 10.1016/0012-1606(91)90209-L; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2002, CHEM PHYS LIPIDS, V121, P135, DOI 10.1016/S0009-3084(02)00147-0; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; Franklin A, 2003, J NEUROSCI, V23, P7767; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Ito A, 2004, CARCINOGENESIS, V25, P2015, DOI 10.1093/carcin/bgh208; Lee KF, 2006, ENDOCRINOLOGY, V147, P79, DOI 10.1210/en.2005-0596; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; NATARAJAN V, 1982, BIOCHIM BIOPHYS ACTA, V712, P342, DOI 10.1016/0005-2760(82)90352-6; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Owen JD, 1999, MOL CELL BIOL, V19, P4806; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Paria BC, 1998, BIOL REPROD, V58, P1490, DOI 10.1095/biolreprod58.6.1490; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Robins JC, 2007, PLACENTA, V28, P1141, DOI 10.1016/j.placenta.2007.05.006; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Sharov AA, 2010, METHOD ENZYMOL, V477, P511, DOI 10.1016/S0076-6879(10)77025-7; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Sidhpura N, 2011, NEUROPHARMACOLOGY, V61, P1070, DOI 10.1016/j.neuropharm.2011.05.034; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Song ZH, 2000, J PHARMACOL EXP THER, V294, P204; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Sun YX, 2005, BBA-MOL CELL BIOL L, V1736, P211, DOI 10.1016/j.bbalip.2005.08.010; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang H, 2006, J CLIN INVEST, V116, P2122, DOI 10.1172/JCI28621; Wang HB, 2007, J BIOL CHEM, V282, P37770, DOI 10.1074/jbc.M706577200; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Zhong P, 2011, J PHYSIOL-LONDON, V589, P4847, DOI 10.1113/jphysiol.2011.215509; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	69	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32288	32297		10.1074/jbc.M112.381145	http://dx.doi.org/10.1074/jbc.M112.381145			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833670	Green Published, hybrid			2022-12-28	WOS:000309059400065
J	Wheeler, LJ; Mathews, CK				Wheeler, Linda J.; Mathews, Christopher K.			Effects of a Mitochondrial Mutator Mutation in Yeast POS5 NADH Kinase on Mitochondrial Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR POOLS; DNA; MUTAGENESIS; IDENTIFICATION; EXTENSION; FIDELITY	Saccharomyces cerevisiae contains three NADH/NAD(+) kinases, one of which is localized in mitochondria and phosphorylates NADH in preference to NAD(+). Strand et al. reported that a yeast mutation in POS5, which encodes the mitochondrial NADH kinase, is a mutator, specific for mitochondrial genes (Strand, M. K., Stuart, G. R., Longley, M. J., Graziewicz, M. A., Dominick, O. C., and Copeland, W. C. (2003) Eukaryot. Cell 2, 809-820). Because of the involvement of NADPH in deoxyribonucleotide biosynthesis, we asked whether mitochondria in a pos5 deletion mutant contain abnormal deoxyribonucleoside triphosphate (dNTP) pools. We found the pools of the four dNTPs to be more than doubled in mutant mitochondrial extracts relative to wild-type mitochondrial extracts. This might partly explain the mitochondrial mutator phenotype. However, the loss of antioxidant protection is also likely to be significant. To this end, we measured pyridine nucleotide pools in mutant and wild-type mitochondrial extracts and found NADPH levels to be diminished by similar to 4-fold in Delta pos5 mitochondrial extracts, with NADP(+) diminished to a lesser degree. Our data suggest that both dNTP abnormalities and lack of antioxidant protection contribute to elevated mitochondrial gene mutagenesis in cells lacking the mitochondrial NADH kinase. The data also confirm previous reports of the specific function of Pos5p in mitochondrial NADP(+) and NADPH biosynthesis.	[Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health [R01 GM073744]; Army Research Office [55953-LS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS.	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2; Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; PASSONEAU JV, 1993, ENZYMATIC ANAL PRACT; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003	21	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31218	31222		10.1074/jbc.M112.394031	http://dx.doi.org/10.1074/jbc.M112.394031			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22843688	Green Published, hybrid			2022-12-28	WOS:000308791300034
J	Chung, KY; Kim, TH; Manglik, A; Alvares, R; Kobilka, BK; Prosser, RS				Chung, Ka Young; Kim, Tae Hun; Manglik, Aashish; Alvares, Rohan; Kobilka, Brian K.; Prosser, R. Scott			Role of Detergents in Conformational Exchange of a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; KCSA POTASSIUM CHANNEL; MODEL-FREE APPROACH; MEMBRANE-PROTEINS; NMR; DYNAMICS; INSIGHTS; LIGAND; STATE; MACROMOLECULES	The G protein-coupled beta(2)-adrenoreceptor (beta(2)AR) signals through the heterotrimeric G proteins G(s) and G(i) and beta-arrestin. As such, the energy landscape of beta(2)AR-excited state conformers is expected to be complex. Upon tagging Cys-265 of beta(2)AR with a trifluoromethyl probe, F-19 NMR was used to assess conformations and possible equilibria between states. Here, we report key differences in beta(2)AR conformational dynamics associated with the detergents used to stabilize the receptor. In dodecyl maltoside (DDM) micelles, the spectra are well represented by a single Lorentzian line that shifts progressively downfield with activation by appropriate ligand. The results are consistent with interconversion between two or more states on a time scale faster than the greatest difference in ligand-dependent chemical shift (i.e. >100 Hz). Given that high detergent off-rates of DDM monomers may facilitate conformational exchange between functional states of beta(2)AR, we utilized the recently developed maltose-neopentyl glycol (MNG-3) diacyl detergent. In MNG-3 micelles, spectra indicated at least three distinct states, the relative populations of which depended on ligand, whereas no ligand-dependent shifts were observed, consistent with the slow exchange limit. Thus, detergent has a profound effect on the equilibrium kinetics between functional states. MNG-3, which has a critical micelle concentration in the nanomolar regime, exhibits an off-rate that is 4 orders of magnitude lower than that of DDM. High detergent off-rates are more likely to facilitate conformational exchange between distinct functional states associated with the G protein-coupled receptor.	[Prosser, R. Scott] Univ Toronto, Dept Chem, UTM, Mississauga, ON L5L 1C6, Canada; [Chung, Ka Young; Manglik, Aashish; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea	University of Toronto; University Toronto Mississauga; Stanford University; Sungkyunkwan University (SKKU)	Prosser, RS (corresponding author), Univ Toronto, Dept Chem, UTM, 3359 Mississauga Rd N, Mississauga, ON L5L 1C6, Canada.	scott.prosser@utoronto.ca	Chung, Ka Young/AAO-7984-2020	Kobilka, Brian/0000-0001-5958-3990; Chung, Ka Young/0000-0001-9038-9571	National Institutes of Health [NH028471]; Natural Sciences and Engineering Research Council of Canada (NSERC) [261980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NH028471 (to B. K. K.). This work was also supported by Research Discovery Award 261980 from the Natural Sciences and Engineering Research Council of Canada (NSERC; to R. S. P.).	Acosta EJ, 2004, J COLLOID INTERF SCI, V274, P652, DOI 10.1016/j.jcis.2004.03.037; ANIANSSON EA, 1974, J PHYS CHEM-US, V78, P1024, DOI 10.1021/j100603a016; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Catoire LJ, 2010, J AM CHEM SOC, V132, P9049, DOI 10.1021/ja101868c; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kang CB, 2011, CURR OPIN CHEM BIOL, V15, P560, DOI 10.1016/j.cbpa.2011.05.025; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Tamm LK, 2006, PROG NUCL MAG RES SP, V48, P201, DOI 10.1016/j.pnmrs.2006.05.005; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Thomas MJ, 1999, BBA-BIOMEMBRANES, V1417, P144, DOI 10.1016/S0005-2736(98)00254-5; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Tsamaloukas AD, 2009, LANGMUIR, V25, P4393, DOI 10.1021/la8033935; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	37	71	71	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36305	36311		10.1074/jbc.M112.406371	http://dx.doi.org/10.1074/jbc.M112.406371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22893704	hybrid, Green Published			2022-12-28	WOS:000310364000051
J	Enns, CA; Ahmed, R; Zhang, AS				Enns, Caroline A.; Ahmed, Riffat; Zhang, An-Sheng			Neogenin Interacts with Matriptase-2 to Facilitate Hemojuvelin Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1Q-LINKED JUVENILE HEMOCHROMATOSIS; REGULATES HEPCIDIN EXPRESSION; REPULSIVE GUIDANCE MOLECULE; SYSTEMIC IRON HOMEOSTASIS; SERINE-PROTEASE TMPRSS6; SOLUBLE HEMOJUVELIN; RECEPTOR NEOGENIN; DOWN-REGULATION; MEMBRANE; METABOLISM	Hemojuvelin (HJV) and matriptase-2 (MT2) are co-expressed in hepatocytes, and both are essential for systemic iron homeostasis. HJV is a glycosylphosphatidylinositol-linked membrane protein that acts as a co-receptor for bone morphogenetic proteins to induce hepcidin expression. MT2 regulates the levels of membrane-bound HJV in hepatocytes by binding to and cleaving HJV into an inactive soluble form that is released from cells. HJV also interacts with neogenin, a ubiquitously expressed transmembrane protein with multiple functions. In this study, we showed that neogenin interacted with MT2 as well as with HJV and facilitated the cleavage of HJV by MT2. In contrast, neogenin was not cleaved by MT2, indicating some degree of specificity by MT2. Down-regulation of neogenin with siRNA increased the amount of MT2 and HJV on the plasma membrane, suggesting a lack of neogenin involvement in their trafficking to the cell surface. The increase in MT2 and HJV upon neogenin knockdown was likely due to the inhibition of cell surface MT2 and HJV internalization. Analysis of the Asn-linked oligosaccharides showed that MT2 cleavage of cell surface HJV was coupled to a transition from high mannose oligosaccharides to complex oligosaccharides on HJV. These results suggest that neogenin forms a ternary complex with both MT2 and HJV at the plasma membrane. The complex facilitates HJV cleavage by MT2, and release of the cleaved HJV from the cell occurs after a retrograde trafficking through the TGN/Golgi compartments.	[Enns, Caroline A.; Ahmed, Riffat; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765, DK72166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054488, R01DK080765, R01DK072166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A. S. Z.) and DK72166 (to C. A. E.).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bae GU, 2009, MOL BIOL CELL, V20, P4920, DOI 10.1091/mbc.E09-06-0491; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	53	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35104	35117		10.1074/jbc.M112.363937	http://dx.doi.org/10.1074/jbc.M112.363937			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893705	Green Published, hybrid			2022-12-28	WOS:000309968000021
J	Epis, MR; Giles, KM; Kalinowski, FC; Barker, A; Cohen, RJ; Leedman, PJ				Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Cohen, Ronald J.; Leedman, Peter J.			Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN EXPRESSION; GENE-EXPRESSION; HYPUSINE FORMATION; PROTEIN-SYNTHESIS; GROWTH ARREST; UP-REGULATION; INITIATION; MICRORNAS; CYCLE; PROLIFERATION	The enzyme deoxyhypusine hydroxylase (DOHH) catalyzes the activation of eukaryotic translation initiation factor (eIF5A), a protein essential for cell growth. Using bioinformatic predictions and reporter gene assays, we have identified a 182-nt element within the DOHH 3'-untranslated region (3'-UTR) that contains a number of target sites for miR-331-3p and miR-642-5p. Quantitative RT-PCR studies demonstrated overexpression of DOHH mRNA and underexpression of miR-331-3p and miR-642-5p in several prostate cancer cell lines compared with normal prostate epithelial cells. Transient overexpression of miR-331-3p and/or miR-642-5p in DU145 prostate cancer cells reduced DOHH mRNA and protein expression and inhibited cell proliferation. We observed synergistic growth inhibition with the combination of miR-331-3p and miR-642-5p and mimosine, a pharmacological DOHH inhibitor. Finally, we identified a significant inverse relationship between the expression of miR-331-3p or miR-642-5p and DOHH in a cohort of human prostate cancer tissues. Our results suggest a novel role for miR-331-3p and miR-642-5p in the control of prostate cancer cell growth via the regulation of DOHH expression and eIF5A activity.	[Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Royal Perth Hosp, Perth, WA 6000, Australia; [Epis, Michael R.; Giles, Keith M.; Kalinowski, Felicity C.; Barker, Andrew; Leedman, Peter J.] Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Cohen, Ronald J.] Uropath Pty Ltd, W Leederville, WA 6007, Australia; [Cohen, Ronald J.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peter.leedman@uwa.edu.au	Leedman, Peter J/O-4044-2014; Barker, Andrew/A-4289-2013	Kalinowski, Felicity/0000-0002-3923-8898	National Health and Medical Research Council of Australia; Prostate Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia	This work was supported by the National Health and Medical Research Council of Australia and the Prostate Cancer Foundation of Australia.	Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENNE R, 1978, J BIOL CHEM, V253, P3078; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Caraglia M., 2011, AMINO ACIDS; Chang HC, 2000, INT J ONCOL, V17, P659; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen KY, 1997, BIOL SIGNAL, V6, P105; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Cracchiolo BM, 2004, GYNECOL ONCOL, V94, P217, DOI 10.1016/j.ygyno.2004.03.018; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; KANG HA, 1994, J BIOL CHEM, V269, P3934; KEMPER WM, 1976, ARCH BIOCHEM BIOPHYS, V174, P603, DOI 10.1016/0003-9861(76)90389-1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulp KS, 1996, TOXICOL APPL PHARM, V139, P356, DOI 10.1006/taap.1996.0176; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; PARK MH, 1993, BIOFACTORS, V4, P95; Park MH, 1997, BIOL SIGNAL, V6, P115; Preukschas M. H., 2011, 2011 EUR MULT CAN S1, V47, P157; Samuni Y, 2001, RADIAT RES, V155, P304, DOI 10.1667/0033-7587(2001)155[0304:RSOMCB]2.0.CO;2; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wartenberg M, 2002, BBA-MOL CELL RES, V1589, P49, DOI 10.1016/S0167-4889(01)00185-9; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; White NMA, 2012, BIOL CHEM, V393, P379, DOI 10.1515/hsz-2011-0246; Witkos TM, 2011, CURR MOL MED, V11, P93; Xie D, 2008, HUM PATHOL, V39, P80, DOI 10.1016/j.humpath.2007.05.011; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Zalatnai A, 2005, PATHOL ONCOL RES, V11, P164, DOI 10.1007/BF02893393; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	57	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35251	35259		10.1074/jbc.M112.374686	http://dx.doi.org/10.1074/jbc.M112.374686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908221	Green Published, hybrid			2022-12-28	WOS:000309968000035
J	Guo, PC; Ma, JD; Jiang, YL; Wang, SJ; Bao, ZZ; Yu, XJ; Chen, YX; Zhou, CZ				Guo, Peng-Chao; Ma, Jin-Di; Jiang, Yong-Liang; Wang, Shu-Jie; Bao, Zhang-Zhi; Yu, Xiao-Jie; Chen, Yuxing; Zhou, Cong-Zhao			Structure of Yeast Sulfhydryl Oxidase Erv1 Reveals Electron Transfer of the Disulfide Relay System in the Mitochondrial Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL TIM PROTEINS; LIVER-REGENERATION; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; BOND FORMATION; CYTOCHROME-C; IN-VIVO; MIA40; IMPORT; AUGMENTOR	The disulfide relay system in the mitochondrial intermembrane space drives the import of proteins with twin CX9C or twin CX3C motifs by an oxidative folding mechanism. This process requires disulfide bond transfer from oxidized Mia40 to a substrate protein. Reduced Mia40 is reoxidized/regenerated by the FAD-linked sulfhydryl oxidase Erv1 (EC 1.8.3.2). Full-length Erv1 consists of a flexible N-terminal shuttle domain (NTD) and a conserved C-terminal core domain (CTD). Here, we present crystal structures at 2.0 angstrom resolution of the CTD and at 3.0 angstrom resolution of a C30S/C133S double mutant of full-length Erv1 (Erv1FL). Similar to previous homologous structures, the CTD exists as a homodimer, with each subunit consisting of a conserved four-helix bundle that accommodates the isoalloxazine ring of FAD and an additional single-turn helix. The structure of Erv1FL enabled us to identify, for the first time, the three-dimensional structure of the Erv1NTD, which is an amphipathic helix flanked by two flexible loops. This structure also represents an intermediate state of electron transfer from the NTD to the CTD of another subunit. Comparative structural analysis revealed that the four-helix bundle of the CTD forms a wide platform for the electron donor NTD. Moreover, computational simulation combined with multiple-sequence alignment suggested that the amphipathic helix close to the shuttle redox enter is critical for the recognition of Mia40, the upstream electron donor. These findings provide structural insights into electron transfer from Mia40 via the shuttle domain of one subunit of Erv1 to the CTD of another Erv1 subunit.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	yu, xiaojie/GSI-9676-2022; guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2012CB911000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Project 2012CB911000.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Lionaki E, 2010, ANTIOXID REDOX SIGN, V13, P1327, DOI 10.1089/ars.2010.3200; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	47	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34961	34969		10.1074/jbc.M112.394759	http://dx.doi.org/10.1074/jbc.M112.394759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910915	hybrid, Green Published			2022-12-28	WOS:000309968000009
J	Lorente, E; Infantes, S; Abia, D; Barnea, E; Beer, I; Garcia, R; Lasala, F; Jimenez, M; Mir, C; Morreale, A; Admon, A; Lopez, D				Lorente, Elena; Infantes, Susana; Abia, David; Barnea, Eilon; Beer, Ilan; Garcia, Ruth; Lasala, Fatima; Jimenez, Mercedes; Mir, Carmen; Morreale, Antonio; Admon, Arie; Lopez, Daniel			A Viral, Transporter Associated with Antigen Processing (TAP)-independent, High Affinity Ligand with Alternative Interactions Endogenously Presented by the Nonclassical Human Leukocyte Antigen E Class I Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; NATURAL-KILLER-CELLS; PEPTIDE-BINDING SPECIFICITY; HLA-E EXPRESSION; VACCINIA VIRUS; INHIBITORY RECEPTOR; RECOGNITION; COMPLEX; EPITOPE; IDENTIFICATION	The transporter associated with antigen processing (TAP) enables the flow of viral peptides generated in the cytosol by the proteasome and other proteases to the endoplasmic reticulum, where they complex with nascent human leukocyte antigen (HLA) class I. Later, these peptide-HLA class I complexes can be recognized by CD8(+) lymphocytes. Cancerous cells and infected cells in which TAP is blocked, as well as individuals with unusable TAP complexes, are able to present peptides on HLA class I by generating them through TAP-independent processing pathways. Here, we identify a physiologically processed HLA-E ligand derived from the D8L protein in TAP-deficient vaccinia virus-infected cells. This natural high affinity HLA-E class I ligand uses alternative interactions to the anchor motifs previously described to be presented on nonclassical HLA class I molecules. This octameric peptide was also presented on HLA-Cw1 with similar binding affinity on both classical and nonclassical class I molecules. In addition, this viral peptide inhibits HLA-E-mediated cytolysis by natural killer cells. Comparison between the amino acid sequences of the presenting HLA-E and HLA-Cw1 alleles revealed a shared structural motif in both HLA class molecules, which could be related to their observed similar cross-reactivity affinities. This motif consists of several residues located on the floor of the peptide-binding site. These data expand the role of HLA-E as an antigen-presenting molecule.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen, Majadahonda 28220, Madrid, Spain; [Abia, David; Morreale, Antonio] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Beer, Ilan] IBM Haifa Res Lab, IL-31905 Haifa, Israel	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Technion Israel Institute of Technology; International Business Machines (IBM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Proc Antigen, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; López, Daniel/0000-0003-0268-5878; LASALA, FATIMA/0000-0001-8183-1866; Admon, Arie/0000-0003-0504-3950; Abia, David/0000-0003-0401-7590	Ministerio de Ciencia e Innovacion; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation; Israel Science Foundation [916/05]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Ministerio de Ciencia e Innovacion and the Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Foundation (to D. L.) and Israel Science Foundation Grant 916/05 (to A. A.).	Alzhanova D, 2009, CELL HOST MICROBE, V6, P433, DOI 10.1016/j.chom.2009.09.013; Anandakrishnan R, 2008, J COMPUT BIOL, V15, P165, DOI 10.1089/cmb.2007.0144; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bertoni R, 1997, J CLIN INVEST, V100, P503, DOI 10.1172/JCI119559; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Cooper S, 1996, J EXP MED, V183, P663, DOI 10.1084/jem.183.2.663; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; FREED ER, 1972, AM J MED, V52, P411, DOI 10.1016/0002-9343(72)90031-9; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Hickman-Miller HD, 2005, J IMMUNOL, V175, P367, DOI 10.4049/jimmunol.175.1.367; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Infantes S, 2011, IMMUNOL CELL BIOL, V89, P558, DOI 10.1038/icb.2010.125; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Jezek Z, 1988, HUMAN MONKEYPOX; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kennedy R, 2007, REV MED VIROL, V17, P93, DOI 10.1002/rmv.527; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LOPEZ D, 1994, J IMMUNOL, V152, P5557; LOPEZ D, 1993, J IMMUNOL, V150, P2675; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lorente E, 2012, J BIOL CHEM, V287, P9990, DOI 10.1074/jbc.M111.314856; Lorente E, 2012, J VIROL, V86, P527, DOI 10.1128/JVI.05737-11; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Nattermann J, 2005, ANTIVIR THER, V10, P95; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Pietra G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907092; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ravindranath MH, 2011, MOL IMMUNOL, V48, P423, DOI 10.1016/j.molimm.2010.09.011; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Sette A, 2005, IMMUNOGENETICS, V57, P53, DOI 10.1007/s00251-004-0749-z; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 1998, J IMMUNOL, V160, P4375; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A	54	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34895	34903		10.1074/jbc.M112.362293	http://dx.doi.org/10.1074/jbc.M112.362293			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927436	hybrid, Green Published			2022-12-28	WOS:000309968000003
J	Schindl, R; Fritsch, R; Jardin, I; Frischauf, I; Kahr, H; Muik, M; Riedl, MC; Groschner, K; Romanin, C				Schindl, Rainer; Fritsch, Reinhard; Jardin, Isaac; Frischauf, Irene; Kahr, Heike; Muik, Martin; Riedl, Maria Christine; Groschner, Klaus; Romanin, Christoph			Canonical Transient Receptor Potential (TRPC) 1 Acts as a Negative Regulator for Vanilloid TRPV6-mediated Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; OPERATED CHANNEL; HUMAN PLATELETS; FUNCTIONAL-ROLE; CATION CHANNEL; ANKYRIN REPEAT; MAST-CELLS; KNOCK-DOWN; SUBUNIT; STIM1	TRP proteins mostly assemble to homomeric channels but can also heteromerize, preferentially within their subfamilies. The TRPC1 protein is the most versatile member and forms various TRPC channel combinations but also unique channels with the distantly related TRPP2 and TRPV4. We show here a novel cross-family interaction between TRPC1 and TRPV6, a Ca2+ selective member of the vanilloid TRP subfamily. TRPV6 exhibited substantial co-localization and in vivo interaction with TRPC1 in HEK293 cells, however, no interaction was observed with TRPC3, TRPC4, or TRPC5. Ca2+ and Na+ currents of TRPV6-overexpressing HEK293 cells are significantly reduced by co-expression of TRPC1, correlating with a dramatically suppressed plasma membrane targeting of TRPV6. In line with their intracellular retention, remaining currents of TRPC1 and TRPV6 co-expression resemble in current-voltage relationship that of TRPV6. Studying the N-terminal ankyrin like repeat domain, structurally similar in the two proteins, we have found that these cytosolic segments were sufficient to mediate a direct heteromeric interaction. Moreover, the inhibitory role of TRPC1 on TRPV6 influx was also maintained by expression of only its N-terminal ankyrin-like repeat domain. Our experiments provide evidence for a functional interaction of TRPC1 with TRPV6 that negatively regulates Ca2+ influx in HEK293 cells.	[Groschner, Klaus] Graz Univ, Inst Pharmacol & Toxicol, A-8010 Graz, Austria; [Jardin, Isaac] Univ Extremadura, Dept Physiol, Caceres 10003, Spain; [Kahr, Heike] Univ Appl Sci Upper Austria, Sch Engn Enviromental Sci, A-4600 Wels, Austria; [Schindl, Rainer; Fritsch, Reinhard; Frischauf, Irene; Muik, Martin; Riedl, Maria Christine; Romanin, Christoph] Univ Linz, Inst Biophys, A-4020 Linz, Austria	University of Graz; Universidad de Extremadura; Johannes Kepler University Linz	Schindl, R (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Linz Gruberstr 40, A-4020 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Schindl, Rainer/V-4205-2019; Frischauf, Irene/AAG-2007-2019; Schindl, Rainer/E-3959-2013; Groschner, Klaus/A-2550-2010; Romanin, Christoph/D-5399-2009; Jardin, Isaac/E-8310-2016	Frischauf, Irene/0000-0003-0661-2932; Schindl, Rainer/0000-0003-0896-8887; Groschner, Klaus/0000-0002-8659-377X; Romanin, Christoph/0000-0003-3756-4136; Jardin, Isaac/0000-0003-4575-8264	Austrian Science Foundation [P22747, P21925, P18169, P22565]; MCI fellowship [BES-2008-002875]; Hertha-Firnberg scholarship [T442]; Austrian Science Fund (FWF) [P 22747, P 21925] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); MCI fellowship; Hertha-Firnberg scholarship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (to F. W. F.): Project P22747 (to R. S.), Project P21925 (to K. G.), and Project P18169 as well as P22565 (to C. R.).; Supported by MCI fellowship (Ref. BES-2008-002875).; Recipient of a Hertha-Firnberg scholarship (T442).	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Beech DJ, 2003, CELL CALCIUM, V33, P433, DOI 10.1016/S0143-4160(03)00054-X; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, BBA-MOL CELL RES, V1783, P84, DOI 10.1016/j.bbamcr.2007.07.007; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kahr H, 2004, J PHYSIOL-LONDON, V557, P121, DOI 10.1113/jphysiol.2004.062653; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Lepage PK, 2007, BIOCHEM SOC T, V35, P81, DOI 10.1042/BST0350081; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P851, DOI 10.1161/ATVBAHA.109.196584; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2009, J MEMBRANE BIOL, V230, P93, DOI 10.1007/s00232-009-9190-4; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Schindl R, 2002, J BIOL CHEM, V277, P26950, DOI 10.1074/jbc.M203700200; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106	52	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35612	35620		10.1074/jbc.M112.400952	http://dx.doi.org/10.1074/jbc.M112.400952			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22932896	Green Published, hybrid			2022-12-28	WOS:000309968000073
J	Yang, C; Wu, J; Sinha, SH; Neveu, JM; Zheng, YG				Yang, Chao; Wu, Jiang; Sinha, Sarmistha H.; Neveu, John M.; Zheng, Yujun George			Autoacetylation of the MYST Lysine Acetyltransferase MOF Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; NONHISTONE PROTEINS; ACETYLATION; COMPLEXES; TIP60; HMOF; ATM; RECRUITMENT; ACTIVATION; MECHANISMS	The MYST family of histone acetyltransferases (HATs) plays critical roles in diverse cellular processes, such as the epigenetic regulation of gene expression. Lysine autoacetylation of the MYST HATs has recently received considerable attention. Nonetheless, the mechanism and function of the autoacetylation process are not well defined. To better understand the biochemical mechanism of MYST autoacetylation and the impact of autoacetylation on the cognate histone acetylation, we carried out detailed analyses of males-absent-on-the-first (MOF), a key member of the MYST family. A number of mutant MOF proteins were produced with point mutations at several key residues near the active site of the enzyme. Autoradiography and immunoblotting data showed that mutation of these residues affects the autoacetylation activity and HAT activity of MOF by various degrees demonstrating that MOF activity is highly sensitive to the chemical changes in those residues. We produced MOF protein in the deacetylated form by using a nonspecific lysine deacetylase. Interestingly, both the autoacetylation activity and the histone acetylation activity of the deacetylated MOF were found to be very close to that of wild-type MOF, suggesting that autoacetylation of MOF only marginally modulates the enzymatic activity. Also, we found that the autoacetylation rates of MOF and deacetylated MOF were much slower than the cognate substrate acetylation. Thus, autoacetylation does not seem to contribute to the intrinsic enzymatic activity in a significant manner. These data provide new insights into the mechanism and function of MYST HAT autoacetylation.	[Yang, Chao; Wu, Jiang; Sinha, Sarmistha H.; Zheng, Yujun George] Georgia State Univ, Ctr Biotechnol & Drug Design, Dept Chem, Atlanta, GA 30302 USA; [Neveu, John M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	University System of Georgia; Georgia State University; Harvard University	Zheng, YG (corresponding author), Georgia State Univ, Ctr Biotechnol & Drug Design, Dept Chem, Atlanta, GA 30302 USA.	yzheng@gsu.edu	Wu, Jiang/J-7731-2013; Zheng, Yujun/P-8975-2014	Wu, Jiang/0000-0002-4124-5413; Zheng, Yujun/0000-0001-7116-3067	National Institutes of Health [R01GM086717]; American Heart Association [12GRNT12070056]; Georgia State University Molecular Basis of Disease Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Georgia State University Molecular Basis of Disease Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086717 (to Y. G. Z.). This work was also supported by American Heart Association Grant 12GRNT12070056 and a Georgia State University Molecular Basis of Disease Fellowship (to C. Y.).	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kundu T. K., 2007, CHROMATIN DIS, P233; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun BF, 2011, CELL RES, V21, P1262, DOI 10.1038/cr.2011.105; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	37	25	25	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34917	34926		10.1074/jbc.M112.359356	http://dx.doi.org/10.1074/jbc.M112.359356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918831	hybrid, Green Published			2022-12-28	WOS:000309968000005
J	Su, SF; Blackwelder, AJ; Grossman, G; Minges, JT; Yuan, LW; Young, SL; Wilson, EM				Su, Shifeng; Blackwelder, Amanda J.; Grossman, Gail; Minges, John T.; Yuan, Lingwen; Young, Steven L.; Wilson, Elizabeth M.			Primate-specific Melanoma Antigen-A11 Regulates Isoform-specific Human Progesterone Receptor-B Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ANDROGEN RECEPTOR; HUMAN ENDOMETRIUM; GENE-EXPRESSION; REPRODUCTIVE PROTEINS; COREGULATOR MAGE-11; COACTIVATOR BINDING; EMBRYO IMPLANTATION; IMMUNOPHILIN FKBP51; EPITHELIAL-CELLS	Progesterone acting through the progesterone receptor(PR) and its coregulators prepares the human endometrium for receptivity to embryo implantation and maintains pregnancy. The menstrual cycle-dependent expression of melanoma antigen-A11 (MAGE-11) in the mid-secretory human endometrium suggested a novel function in human PR signaling. Here we show that MAGE-11 is an isoform-specific coregulator responsible for the greater transcriptional activity of human PR-B relative to PR-A. PR was recruited to progesterone response regions of progesterone-regulated FK506-binding protein 5 (FKBP5) immunophilin and small Ras family G protein cell growth inhibitor RASD1 genes. Expression of MAGE-11 lentivirus shRNA in human endometrial Ishikawa cells expressing PR-B showed that MAGE-11 is required for isoform-specific PR-B up-regulation of FKBP5. In contrast, MAGE-11 was not required for progesterone up-regulation of RASD1 in endometrial cells expressing the PR-A/B heterodimer. Target gene specificity of PR-B depended on the synergistic actions of MAGE-11 and p300 mediated by the unique PR-B NH2-terminal (LLXXVLXXLL119)-L-110 motif that interacts with the MAGE-11 F-box region in a phosphorylation-and ubiquitinylation-dependent manner. A progesterone-dependent mechanism is proposed in which MAGE-11 and p300 increase PR-B up-regulation of the FKBP5 gene. MAGE-11 down-regulates PR-B, similar to the effects of progesterone, and interacts with FKBP5 to stabilize a complex with PR-B. We conclude that the coregulator function of MAGE-11 extends to isoform-specific regulation of PR-B during the cyclic development of the human endometrium.	[Su, Shifeng; Blackwelder, Amanda J.; Grossman, Gail; Minges, John T.; Young, Steven L.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yuan, Lingwen; Young, Steven L.] Univ N Carolina, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Young, Steven L/G-2304-2014	Young, Steven L/0000-0002-5205-4495	National Institutes of Health (NIH) (a United States Public Health Service from NICHD) [HD16910]; NIH Eunice Kennedy Shriver NICHD [HD067721]; Eunice Kennedy Shriver NICHD, Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54-HD35041]; NCI, NIH, Center [P01-CA77739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910, U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (a United States Public Health Service from NICHD); NIH Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver NICHD, Specialized Cooperative Centers Program in Reproduction and Infertility Research; NCI, NIH, Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in whole or part by National Institutes of Health (NIH) Grant HD16910 (a United States Public Health Service grant from NICHD); NIH Eunice Kennedy Shriver NICHD Grant HD067721; Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; and NCI, NIH, Center Grant P01-CA77739.	Amler LC, 2000, CANCER RES, V60, P6134; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; BALATON AJ, 1993, ANN PATHOL, V13, P188; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Brosens JJ, 2010, ULTRASOUND OBST GYN, V36, P1, DOI 10.1002/uog.7714; Buser AC, 2007, MOL ENDOCRINOL, V21, P106, DOI 10.1210/me.2006-0297; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chomez P, 2001, CANCER RES, V61, P5544; Chwalisz K, 2005, ENDOCR REV, V26, P423, DOI 10.1210/er.2005-0001; Cloke B, 2012, MOL CELL ENDOCRINOL, V358, P166, DOI 10.1016/j.mce.2011.06.031; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Conneely OM, 2001, ENDOCRINOLOGY, V142, P2194, DOI 10.1210/en.142.6.2194; Davis CJ, 2000, HUM REPROD, V15, P2418, DOI 10.1093/humrep/15.11.2418; Delbridge Margaret L, 2007, Soc Reprod Fertil Suppl, V65, P1; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Dong X, 2004, J MOL ENDOCRINOL, V32, P843, DOI 10.1677/jme.0.0320843; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Far HRM, 2007, EUR J OBSTET GYN R B, V131, P189, DOI 10.1016/j.ejogrb.2006.07.037; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Gao JG, 2000, MOL ENDOCRINOL, V14, P1954, DOI 10.1210/me.14.12.1954; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Igarashi TM, 2005, FERTIL STERIL, V84, P67, DOI 10.1016/j.fertnstert.2005.01.113; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kolb-Kokocinski A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-29; Lagarde WH, 2012, J BIOL CHEM, V287, P10905, DOI 10.1074/jbc.M111.336081; Le Bihan S, 1998, MOL ENDOCRINOL, V12, P986, DOI 10.1210/mend.12.7.0128; Li L, 2011, BRIT J CANCER, V104, P19, DOI 10.1038/sj.bjc.6606014; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Mote PA, 1999, J CLIN ENDOCR METAB, V84, P2963, DOI 10.1210/jc.84.8.2963; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Nishida M, 1996, Hum Cell, V9, P109; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pieber D, 2001, MOL HUM REPROD, V7, P875, DOI 10.1093/molehr/7.9.875; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reynolds PD, 1998, LAB ANIM SCI, V48, P364; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Samalecos A, 2008, ENDOCRINOLOGY, V149, P5872, DOI 10.1210/en.2008-0602; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smid-Koopman E, 2003, J SOC GYNECOL INVEST, V10, P49, DOI 10.1016/S1071-5576(02)00217-4; Stavreus-Evers A, 2001, FERTIL STERIL, V76, P782, DOI 10.1016/S0015-0282(01)01993-8; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Takimoto GS, 1996, J BIOL CHEM, V271, P13308, DOI 10.1074/jbc.271.23.13308; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang LW, 2011, CURR OPIN PHARMACOL, V11, P360, DOI 10.1016/j.coph.2011.03.008; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034010; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; WILSON EM, 1988, MOL ENDOCRINOL, V2, P1018, DOI 10.1210/mend-2-11-1018; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005; Yin P, 2010, CANCER RES, V70, P1722, DOI 10.1158/0008-5472.CAN-09-2612; Zheng K, 2010, J ANDROL, V31, P79, DOI 10.2164/jandrol.109.008193	84	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34809	34824		10.1074/jbc.M112.372797	http://dx.doi.org/10.1074/jbc.M112.372797			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891251	Green Published, hybrid			2022-12-28	WOS:000309654200080
J	Liang, YJ; Wu, H; Lei, R; Chong, RA; Wei, Y; Lu, X; Tagkopoulos, I; Kung, SY; Yang, QF; Hu, GH; Kang, YB				Liang, Yajun; Wu, Heng; Lei, Rong; Chong, Robert A.; Wei, Yong; Lu, Xin; Tagkopoulos, Ilias; Kung, Sun-Yuan; Yang, Qifeng; Hu, Guohong; Kang, Yibin			Transcriptional Network Analysis Identifies BACH1 as a Master Regulator of Breast Cancer Bone Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; HYPOXIA; GENES; SIGNATURE; DYNAMICS; GROWTH; CELLS; BTB	The application of functional genomic analysis of breast cancer metastasis has led to the identification of a growing number of organ-specific metastasis genes, which often function in concert to facilitate different steps of the metastatic cascade. However, the gene regulatory network that controls the expression of these metastasis genes remains largely unknown. Here, we demonstrate a computational approach for the deconvolution of transcriptional networks to discover master regulators of breast cancer bone metastasis. Several known regulators of breast cancer bone metastasis such as Smad4 and HIF1 were identified in our analysis. Experimental validation of the networks revealed BACH1, a basic leucine zipper transcription factor, as the common regulator of several functional metastasis genes, including MMP1 and CXCR4. Ectopic expression of BACH1 enhanced the malignance of breast cancer cells, and conversely, BACH1 knockdown significantly reduced bone metastasis. The expression of BACH1 and its target genes was linked to the higher risk of breast cancer recurrence in patients. This study established BACH1 as the master regulator of breast cancer bone metastasis and provided a paradigm to identify molecular determinants in complex pathological processes.	[Liang, Yajun; Lei, Rong; Hu, Guohong] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, Shanghai 200025, Peoples R China; [Wu, Heng; Chong, Robert A.; Wei, Yong; Lu, Xin; Hu, Guohong; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Tagkopoulos, Ilias; Kung, Sun-Yuan] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Princeton University; Princeton University; Shandong University	Hu, GH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci,Sch Med, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	ghhu@sibs.ac.cn; ykang@princeton.edu	yang, qiang/GYJ-0971-2022	Kang, Yibin/0000-0002-1626-6730; Hu, Guohong/0000-0002-2980-5166; Yang, Qifeng/0000-0003-0576-8513	New Jersey commission on Cancer Research; Ministry of Science and Technology of China [2011CB510105]; Chinese Academy of Sciences [2009OHTP08, KSCX2-YW-R-192]; National Natural Science Foundation [81071754]; Shanghai Pujiang Plan Grant [10PJ1411600]; National Institutes of Health [R01CA134519, R01CA141062]; Department of Defense; Komen for the Cure; Brewster Foundation; Champalimaud Foundation; NATIONAL CANCER INSTITUTE [R01CA134519, R01CA141062] Funding Source: NIH RePORTER	New Jersey commission on Cancer Research; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Plan Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Brewster Foundation; Champalimaud Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by postdoctoral fellowships from the New Jersey commission on Cancer Research and grants from the Ministry of Science and Technology of China (2011CB510105), the Chinese Academy of Sciences (2009OHTP08, KSCX2-YW-R-192), the National Natural Science Foundation (81071754), and the Shanghai Pujiang Plan Grant (10PJ1411600). To whom correspondence may be addressed. Tel.: 86-21-63846825; E-mail: ghhu@sibs.ac.cn.; Supported by National Institutes of Health Grants R01CA134519 and R01CA141062, the Department of Defense, Komen for the Cure, the Brewster Foundation, and the Champalimaud Foundation. To whom correspondence may be addressed. Tel.: 01-609-258-8834; E-mail: ykang@princeton.edu.	Alvarez A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-243; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Butte A. J., 2000, PAC S BIOC PSB HAW J, P5418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartemink A. J., 2001, PAC S BIOC PSB HAW J, P6422; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lim W. K., 2009, PAC S BIOC PSB HAW J, P14504; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Tagkopoulos I., 2005, 5 IEEE S BIOINF BIOE; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Toki T, 2005, BLOOD, V105, P3100, DOI 10.1182/blood-2004-07-2826; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhong H, 1999, CANCER RES, V59, P5830	45	81	84	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33533	33544		10.1074/jbc.M112.392332	http://dx.doi.org/10.1074/jbc.M112.392332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875853	hybrid, Green Published			2022-12-28	WOS:000309602100039
J	Mathes, T; van Stokkum, IHM; Stierl, M; Kennis, JTM				Mathes, Tilo; van Stokkum, Ivo H. M.; Stierl, Manuela; Kennis, John T. M.			Redox Modulation of Flavin and Tyrosine Determines Photoinduced Proton-coupled Electron Transfer and Photoactivation of BLUF Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED STRUCTURAL-CHANGES; MARCUS INVERTED REGION; HYDROGEN-BOND; ADENYLYL-CYCLASE; LIGHT RECEPTOR; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURES; CELLULAR CAMP; SIDE-CHAINS; APPA	Photoinduced electron transfer in biological systems, especially in proteins, is a highly intriguing matter. Its mechanistic details cannot be addressed by structural data obtained by crystallography alone because this provides only static information on a given redox system. In combination with transient spectroscopy and site-directed manipulation of the protein, however, a dynamic molecular picture of the ET process may be obtained. In BLUF (blue light sensors using FAD) photoreceptors, proton-coupled electron transfer between a tyrosine and the flavin cofactor is the key reaction to switch from a dark-adapted to a light-adapted state, which corresponds to the biological signaling state. Particularly puzzling is the fact that, although the various naturally occurring BLUF domains show little difference in the amino acid composition of the flavin binding pocket, the reaction rates of the forward reaction differ quite largely from a few ps up to several hundred ps. In this study, we modified the redox potential of the flavin/tyrosine redox pair by site-directed mutagenesis close to the flavin C2 carbonyl and fluorination of the tyrosine, respectively. We provide information on how changes in the redox potential of either reaction partner significantly influence photoinduced proton-coupled electron transfer. The altered redox potentials allowed us furthermore to experimentally describe an excited state charge transfer intermediately prior to electron transfer in the BLUF photocycle. Additionally, we show that the electron transfer rate directly correlates with the quantum yield of signaling state formation.	[Mathes, Tilo; van Stokkum, Ivo H. M.; Kennis, John T. M.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, NL-1081 HV Amsterdam, Netherlands; [Stierl, Manuela] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Vrije Universiteit Amsterdam; Humboldt University of Berlin	Mathes, T (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands.	t.mathes@vu.nl	van Stokkum, Ivo HM/E-7175-2015; Mathes, Tilo/C-5715-2011	van Stokkum, Ivo HM/0000-0002-6143-2021; Mathes, Tilo/0000-0002-9694-748X	Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant; LaserLab Europe access program [LCVU-1618]; Deutsche Forschungsgemeinschaft; Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant	Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant; LaserLab Europe access program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant	Supported by the Chemical Sciences Council of the Netherlands Organization for Scientific Research through an ECHO grant to (J. T. M. K.), the LaserLab Europe access program (LCVU-1618), and the Deutsche Forschungsgemeinschaft.; Supported by the Chemical Sciences Council of the Netherlands Foundation for Scientific Research through a Vici grant.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Arents JC, 2011, FEBS LETT, V585, P167, DOI 10.1016/j.febslet.2010.11.035; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y; Bonetti C, 2008, BIOPHYS J, V95, P4790, DOI 10.1529/biophysj.108.139246; Bonetti C, 2009, BIOCHEMISTRY-US, V48, P11458, DOI 10.1021/bi901196x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Braatsch S, 2004, J BACTERIOL, V186, P7726, DOI 10.1128/JB.186.22.7726-7735.2004; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Bucher D, 2009, J NEUROGENET, V23, P220, DOI 10.1080/01677060802441356; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Dragnea V, 2005, BIOCHEMISTRY-US, V44, P15978, DOI 10.1021/bi050839x; Dunitz JD, 2004, CHEMBIOCHEM, V5, P614, DOI 10.1002/cbic.200300801; Fiedler B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1481, DOI 10.1562/2005-06-28-RA-592; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gauden M, 2005, BIOCHEMISTRY-US, V44, P3653, DOI 10.1021/bi047359a; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; GRAMPP G, 1993, ANGEW CHEM INT EDIT, V32, P691, DOI 10.1002/anie.199306911; Grinstead JS, 2006, J AM CHEM SOC, V128, P15066, DOI 10.1021/ja0660103; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Hasegawa K, 2004, BIOCHEMISTRY-US, V43, P14979, DOI 10.1021/bi048671n; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2008, J BIOL CHEM, V283, P30618, DOI 10.1074/jbc.M803864200; Iwata T, 2011, J PHYS CHEM LETT, V2, P1015, DOI 10.1021/jz2003974; Jager A, 2007, J BACTERIOL, V189, P2274, DOI 10.1128/JB.01699-06; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Kennis JTM, 2007, CURR OPIN STRUC BIOL, V17, P623, DOI 10.1016/j.sbi.2007.09.006; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Laan W, 2004, PHOTOCH PHOTOBIO SCI, V3, P1011, DOI 10.1039/b410923f; Larsen DS, 2004, BIOPHYS J, V87, P1858, DOI 10.1529/biophysj.104.043794; Liu ZY, 2012, J AM CHEM SOC, V134, P8104, DOI 10.1021/ja2105009; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; Mathes T., 2007, PHOTOCHEMIE SIGNALTR, P62; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Mathes T, 2011, J PHYS CHEM B, V115, P7963, DOI 10.1021/jp201296m; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moore GF, 2010, J PHYS CHEM B, V114, P14450, DOI 10.1021/jp101592m; MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096; Mullen K.M., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I03; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nagahama T, 2007, NEUROSCI RES, V59, P81, DOI 10.1016/j.neures.2007.05.015; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Nunthaboot N, 2009, J PHOTOCH PHOTOBIO A, V207, P274, DOI 10.1016/j.jphotochem.2009.07.020; Pal PP, 2005, BIOCHEMISTRY-US, V44, P3663, DOI 10.1021/bi0484825; Pandey R, 2011, BIOPHYS J, V100, P2347, DOI 10.1016/j.bpj.2011.04.017; Porcal G, 2003, PHYS CHEM CHEM PHYS, V5, P4123, DOI 10.1039/b306945a; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1569, DOI 10.1021/ja055926r; Shibata Y, 2009, J PHYS CHEM B, V113, P8192, DOI 10.1021/jp901631b; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Stelling AL, 2007, J AM CHEM SOC, V129, P15556, DOI 10.1021/ja074074n; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Thanasekaran P, 1997, J PHYS CHEM A, V101, P8195, DOI 10.1021/jp971746v; Toh KC, 2008, BIOPHYS J, V95, P312, DOI 10.1529/biophysj.107.117788; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Udvarhelyi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P554, DOI 10.1111/j.1751-1097.2010.00884.x; Unno M, 2005, J PHYS CHEM B, V109, P12620, DOI 10.1021/jp0522664; van den Berg PAW, 2004, BIOPHYS J, V87, P2577, DOI 10.1529/biophysj.104.040030; van der Horst MA, 2005, PHOTOCH PHOTOBIO SCI, V4, P688, DOI 10.1039/b418442b; Weber S, 2011, PHOTOCHEM PHOTOBIOL, V87, P574, DOI 10.1111/j.1751-1097.2010.00885.x; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Zirak P, 2007, CHEM PHYS, V335, P15, DOI 10.1016/j.chemphys.2007.03.013; Zirak P, 2006, J PHOTOCH PHOTOBIO B, V83, P180, DOI 10.1016/j.jphotobiol.2005.12.015; Zirak P, 2005, CHEM PHYS, V315, P142, DOI 10.1016/j.chemphys.2005.04.008	82	50	50	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31725	31738		10.1074/jbc.M112.391896	http://dx.doi.org/10.1074/jbc.M112.391896			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833672	Green Published, hybrid			2022-12-28	WOS:000309059400014
J	Durand, E; Derrez, E; Audoly, G; Spinelli, S; Ortiz-Lombardia, M; Raoult, D; Cascales, E; Cambillau, C				Durand, Eric; Derrez, Estelle; Audoly, Gilles; Spinelli, Silvia; Ortiz-Lombardia, Miguel; Raoult, Didier; Cascales, Eric; Cambillau, Christian			Crystal Structure of the VgrG1 Actin Cross-linking Domain of the Vibrio cholerae Type VI Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RTX TOXIN; PROTEIN; HOST; IDENTIFICATION; MECHANISM; REQUIRES	Vibrio cholerae is the cause of the diarrheal disease cholera. V. cholerae produces RtxA, a large toxin of the MARTX family, which is targeted to the host cell cytosol, where its actin cross-linking domain (ACD) cross-links G-actin, leading to F-actin depolymerization, cytoskeleton rearrangements, and cell rounding. These effects on the cytoskeleton prevent phagocytosis and bacterial engulfment by macrophages, thus preventing V. cholerae clearance from the gut. The V. cholerae Type VI secretion-associated VgrG1 protein also contains a C-terminal ACD, which shares 61% identity with MARTX ACD and has been shown to covalently cross-link G-actin. Here, we purified the VgrG1 C-terminal domain and determined its crystal structure. The VgrG1 ACD exhibits a V-shaped three-dimensional structure, formed of 12 beta-strands and nine alpha-helices. Its active site comprises five residues that are conserved in MARTX ACD toxin, within a conserved area of similar to 10 angstrom radius. We showed that less than 100 ACD molecules are sufficient to depolymerize the actin filaments of a fibroblast cell in vivo. Mutagenesis studies confirmed that Glu-16 is critical for the F-actin depolymerization function. Co-crystals with divalent cations and ATP reveal the molecular mechanism of the MARTX/VgrG toxins and offer perspectives for their possible inhibition.	[Audoly, Gilles; Raoult, Didier] CNRS, Fac Med Timone, UMR 6236, IRD 198,Unite Rickettsies URMITE, F-13385 Marseille 05, France; [Cascales, Eric] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, UMR7255,Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Cambillau, Christian] Aix Marseille Univ, CNRS, UMR7257, AFMB, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cambillau, C (corresponding author), Aix Marseille Univ, CNRS, UMR7257, AFMB, 163 Ave Luminy,Case 932,Campus Luminy, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	RAOULT, Didier/A-8434-2008; Durand, Eric/E-6739-2017; CASCALES, ERIC/G-7420-2011	RAOULT, Didier/0000-0002-0633-5974; Durand, Eric/0000-0002-0577-8220; CASCALES, ERIC/0000-0003-0611-9179; Audoly, Gilles/0000-0001-8242-471X	Fondation pour la Recherche Medicale Postdoctoral Fellowship [SPF20101221116]; CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Universite de la Mediterranee; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]	Fondation pour la Recherche Medicale Postdoctoral Fellowship; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite de la Mediterranee; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	Supported by Fondation pour la Recherche Medicale Postdoctoral Fellowship SPF20101221116.; Work in the laboratory of this author was supported by CNRS and funded by Agence Nationale de la Recherche Grant ANR-10-JCJC-1303-03.; Work in the laboratory of this author was supported by CNRS, Universite de la Mediterranee, and grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (FRM DEQ2011-0421282). To whom correspondence should be addressed: AFMB, CNRS UMR7257, Aix-Marseille Universite, 163 Ave. de Luminy, Case 932, 13288 Marseille Cedex 09, France. Tel.: 33-491825590; Fax: 33-491266720; E-mail: cambillau@afmb.univ-mrs.fr.	Audoly G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026528; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Charles RC, 2011, CURR OPIN INFECT DIS, V24, P472, DOI 10.1097/QCO.0b013e32834a88af; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Satchell KJF, 2009, CELL HOST MICROBE, V5, P213, DOI 10.1016/j.chom.2009.03.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Weil AA, 2012, CURR INFECT DIS REP, V14, P1, DOI 10.1007/s11908-011-0221-9	43	47	49	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.390153	http://dx.doi.org/10.1074/jbc.M112.390153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22898822	hybrid, Green Published			2022-12-28	WOS:000310642200052
J	Greaves, J; Lemonidis, K; Gorleku, OA; Cruchaga, C; Grefen, C; Chamberlain, LH				Greaves, Jennifer; Lemonidis, Kimon; Gorleku, Oforiwa A.; Cruchaga, Carlos; Grefen, Christopher; Chamberlain, Luke H.			Palmitoylation-induced Aggregation of Cysteine-string Protein Mutants That Cause Neuronal Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA; CSP; THIOESTERASE; EXOCYTOSIS; HUNTINGTIN; NEURODEGENERATION; IDENTIFICATION; MUTATIONS; CHAPERONE; DISEASE	Recently, mutations in the DNAJC5 gene encoding cysteine-string protein alpha (CSP alpha) were identified to cause the neurodegenerative disorder adult-onset neuronal ceroid lipofuscinosis. The disease-causing mutations (L115R or Delta L116) occur within the cysteine-string domain, a region of the protein that is post-translationally modified by extensive palmitoylation. Here we demonstrate that L115R and Delta L116 mutant proteins are mistargeted in neuroendocrine cells and form SDS-resistant aggregates, concordant with the properties of other mutant proteins linked to neurodegenerative disorders. The mutant aggregates are membrane-associated and incorporate palmitate. Indeed, co-expression of palmitoyltransferase enzymes promoted the aggregation of the CSP alpha mutants, and chemical depalmitoylation solubilized the aggregates, demonstrating that aggregation is induced and maintained by palmitoylation. In agreement with these observations, SDS-resistant CSP alpha aggregates were present in brain samples from patients carrying the L115R mutation and were depleted by chemical depalmitoylation. In summary, this study identifies a novel interplay between genetic mutations and palmitoylation in driving aggregation of CSP alpha mutant proteins. We propose that this palmitoylation-induced aggregation of mutant CSP alpha proteins may underlie the development of adult-onset neuronal ceroid lipofuscinosis in affected families.	[Greaves, Jennifer; Lemonidis, Kimon; Gorleku, Oforiwa A.; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Cruchaga, Carlos] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO 63130 USA; [Grefen, Christopher] Univ Glasgow, Inst Mol Cell & Syst Biol, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland	University of Strathclyde; Washington University (WUSTL); Washington University (WUSTL); University of Glasgow	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	luke.chamberlain@strath.ac.uk	Grefen, Christopher/AAH-4512-2020; Cruchaga, Carlos/ABF-4065-2020	Grefen, Christopher/0000-0002-5820-4466; Cruchaga, Carlos/0000-0002-0276-2899; Greaves, Jennifer/0000-0001-8445-789X; Lemonidis, Kimon/0000-0003-1332-6002	Medical Research Council Senior Fellowship Award [G0601597]; National Institutes of Health [P50 AG05681]; Medical Research Council [G0601597] Funding Source: researchfish; MRC [G0601597] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Medical Research Council Senior Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Medical Research Council Senior Fellowship Award Grant G0601597 and Wellcome Trust Grant 094184 (to L. H. C.). This work was also supported by National Institutes of Health Grant P50 AG05681.	Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	30	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37330	37339		10.1074/jbc.M112.389098	http://dx.doi.org/10.1074/jbc.M112.389098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22902780	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000310588500064
J	McGuire, H; Aurousseau, MRP; Bowie, D; Blunck, R				McGuire, Hugo; Aurousseau, Mark R. P.; Bowie, Derek; Blunck, Rikard			Automating Single Subunit Counting of Membrane Proteins in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTES; ACETYLCHOLINE-RECEPTORS; FLUORESCENCE; STOICHIOMETRY; REVEALS; CHANNEL; SPECTROSCOPY; MICROSCOPY; TRANSIENT; BINDING	Elucidating subunit stoichiometry of neurotransmitter receptors is preferably carried out in a mammalian expression system where the rules of native protein assembly are strictly obeyed. Although successful in Xenopus oocytes, single subunit counting, manually counting photobleaching steps of GFP-tagged subunits, has been hindered in mammalian cells by high background fluorescence, poor control of expression, and low GFP maturation efficiency. Here, we present a fully automated single-molecule fluorescence counting method that separates tagged proteins on the plasma membrane from background fluorescence and contaminant proteins in the cytosol or the endoplasmic reticulum and determines the protein stoichiometry. Lower GFP maturation rates observed in cells cultured at 37 degrees C were partly offset using a monomeric version of superfolder GFP. We were able to correctly identify the stoichiometry of GluK2 and alpha 1 glycine receptors. Our approach permits the elucidation of stoichiometry for a wide variety of plasma membrane proteins in mammalian cells with any commercially available TIRF microscope.	[McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [McGuire, Hugo; Aurousseau, Mark R. P.; Bowie, Derek; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires, Montreal, PQ H3C 3J7, Canada; [Aurousseau, Mark R. P.; Bowie, Derek] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907; Bowie, Derek/0000-0001-9491-8768	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Nature et Technologies fellowship; Canadian Institutes of Health Research fellowship; Canada Research Chair award in Receptor Pharmacology; Canada Research Chair award on Molecular Mechanisms of Membrane Proteins; Fonds de la Recherche en Sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Nature et Technologies fellowship; Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award in Receptor Pharmacology; Canada Research Chair award on Molecular Mechanisms of Membrane Proteins; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by operating grants from Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research (to R. B. and D. B.).; Recipient of a Fonds de Recherche du Quebec-Nature et Technologies fellowship.; Recipient of a Canadian Institutes of Health Research fellowship.; Recipient of Canada Research Chair award in Receptor Pharmacology.; Recipient of Canada Research Chair award on Molecular Mechanisms of Membrane Proteins.; We thank Elise Faure for stimulating discussions and comments on the manuscript. GEPROM is a research group funded by the Fonds de la Recherche en Sante du Quebec.	AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; BULLER AL, 1990, MOL PHARMACOL, V37, P423; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Craggs TD, 2009, CHEM SOC REV, V38, P2865, DOI 10.1039/b903641p; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; HAGIWARA S, 1979, ANNU REV BIOPHYS BIO, V8, P385, DOI 10.1146/annurev.bb.08.060179.002125; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Park M, 2005, B CHEM SOC JPN, V78, P1612, DOI 10.1246/bcsj.78.1612; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pierce DW, 1997, NATURE, V388, P338, DOI 10.1038/41009; Qin F, 2000, BIOPHYS J, V79, P1928, DOI 10.1016/S0006-3495(00)76442-3; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schmidt C, 2008, J MOL BIOL, V376, P658, DOI 10.1016/j.jmb.2007.11.105; Schmidt C, 2009, J MOL BIOL, V390, P182, DOI 10.1016/j.jmb.2009.05.008; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shu D, 2007, EMBO J, V26, P527, DOI 10.1038/sj.emboj.7601506; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Xiao J, 2009, HANDBOOK OF SINGLE-MOLECULE BIOPHYSICS, P43, DOI 10.1007/978-0-387-76497-9_3; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	52	59	61	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35912	35921		10.1074/jbc.M112.402057	http://dx.doi.org/10.1074/jbc.M112.402057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930752	hybrid, Green Published			2022-12-28	WOS:000310364000013
J	Minond, D; Cudic, M; Bionda, N; Giulianotti, M; Maida, L; Houghten, RA; Fields, GB				Minond, Dmitriy; Cudic, Mare; Bionda, Nina; Giulianotti, Marc; Maida, Laura; Houghten, Richard A.; Fields, Gregg B.			Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE EXOSITE INHIBITORS; ALPHA CONVERTING-ENZYME; BIOLOGICAL-ACTIVITY; ACTIVE-SITE; FACTOR VIIA; TNF-ALPHA; IN-VIVO; SPECIFICITY; CONFORMATION; TARGET	A disintegrin and metalloprotease (ADAM) proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off-target toxicity. We hypothesized that secondary binding site (exosite) inhibitors should provide a viable alternative to active site inhibitors. Potential exosites in ADAM structures have been reported, but no studies describing substrate features necessary for exosite interactions exist. Analysis of ADAM cognate substrates revealed that glycosylation is often present in the vicinity of the scissile bond. To study whether glycosylation plays a role in modulating ADAM activity, a tumor necrosis factor alpha (TNF alpha) substrate with and without a glycan moiety attached was synthesized and characterized. Glycosylation enhanced ADAM8 and -17 activities and decreased ADAM10 activity. Metalloprotease (MMP) activity was unaffected by TNF alpha substrate glycosylation. High throughput screening assays were developed using glycosylated and non-glycosylated substrate, and positional scanning was conducted. A novel chemotype of ADAM17-selective probes was discovered from the TPIMS library (Houghten, R. A., Pinilla, C., Giulianotti, M. A., Appel, J. R., Dooley, C. T., Nefzi, A., Ostresh, J. M., Yu, Y., Maggiora, G. M., Medina-Franco, J. L., Brunner, D., and Schneider, J. (2008) Strategies for the use of mixture-based synthetic combinatorial libraries. Scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J. Comb. Chem. 10, 3-19; Pinilla, C., Appel, J. R., Borras, E., and Houghten, R. A. (2003) Advances in the use of synthetic combinatorial chemistry. Mixture-based libraries. Nat. Med. 9, 118-122) that preferentially inhibited glycosylated substrate hydrolysis and spared ADAM10, MMP-8, and MMP-14. Kinetic studies revealed that ADAM17 inhibition occurred via a non-zinc-binding mechanism. Thus, modulation of proteolysis via glycosylation may be used for identifying novel, potentially exosite binding compounds. The newly described ADAM17 inhibitors represent research tools to investigate the role of ADAM17 in the progression of various diseases.	[Minond, Dmitriy; Cudic, Mare; Bionda, Nina; Giulianotti, Marc; Maida, Laura; Houghten, Richard A.; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Torrey Pines Institute for Molecular Studies, Florida	Minond, D (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	dminond@tpims.org		Minond, Dmitriy/0000-0003-2473-5944; Giulianotti, Marc/0000-0002-2232-3789	National Institutes of Health [1R03DA033985-01, CA098799, 1R01DA031370]; James and Esther King Biomedical Research Program [2KN05]; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033985, R01DA031370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03DA033985-01 (to D. M.), CA098799 (to G. B. F.), and 1R01DA031370 (to R. A. H.). This work was also supported by James and Esther King Biomedical Research Program Grant 2KN05 (to D. M.), by the Multiple Sclerosis National Research Institute (to G. B. F.), and by the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bahia MS, 2010, CHEM BIOL DRUG DES, V75, P415, DOI 10.1111/j.1747-0285.2010.00950.x; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Cole AR, 1999, J BIOL CHEM, V274, P7207, DOI 10.1074/jbc.274.11.7207; Copeland R, 2000, ENZYMES, P289; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Falenski JA, 2010, BIOORGAN MED CHEM, V18, P3703, DOI 10.1016/j.bmc.2010.03.061; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Georgiadis D, 2008, BIOORGAN MED CHEM, V16, P8781, DOI 10.1016/j.bmc.2008.08.058; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Hall T, 2009, ARCH BIOCHEM BIOPHYS, V491, P106, DOI 10.1016/j.abb.2009.09.005; Healy EF, 2010, J MOL GRAPH MODEL, V29, P436, DOI 10.1016/j.jmgm.2010.08.006; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Huang A, 2007, BIOORGAN MED CHEM, V15, P6170, DOI 10.1016/j.bmc.2007.06.031; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Letavic MA, 2003, BIOORG MED CHEM LETT, V13, P3243, DOI 10.1016/S0960-894X(03)00666-8; Martinez-Irujo JJ, 1998, BIOCHEM J, V329, P689, DOI 10.1042/bj3290689; McManus AM, 1999, BIOCHEMISTRY-US, V38, P705, DOI 10.1021/bi981956d; MELDAL M, 1994, GLYCOCONJUGATE J, V11, P59, DOI 10.1007/BF00731144; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Murumkar PR, 2010, EXPERT OPIN THER PAT, V20, P31, DOI 10.1517/13543770903465157; Njoroge FG, 2006, BIOORG MED CHEM LETT, V16, P984, DOI 10.1016/j.bmcl.2005.10.090; Otvos L, 2003, MINI-REV MED CHEM, V3, P703, DOI 10.2174/1389557033487809; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pantke MM, 2001, BIOCHEM J, V356, P43, DOI 10.1042/0264-6021:3560043; Patel IR, 1998, J IMMUNOL, V160, P4570; Pinilla C, 2003, NAT MED, V9, P118, DOI 10.1038/nm0103-118; Prudent R, 2010, BBA-PROTEINS PROTEOM, V1804, P493, DOI 10.1016/j.bbapap.2009.09.003; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Santos RG, 2011, ACS COMB SCI, V13, P337, DOI 10.1021/co100065a; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Tagashira M, 2001, BIOCHEMISTRY-US, V40, P11090, DOI 10.1021/bi010306y; TakakuraYamamoto R, 1996, EUR J BIOCHEM, V235, P431, DOI 10.1111/j.1432-1033.1996.00431.x; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Wang Z, 2011, SHOCK, V35, P141, DOI 10.1097/SHK.0b013e3181ec39cc; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Yegneswaran S, 2007, J THROMB HAEMOST, V5, P2062, DOI 10.1111/j.1538-7836.2007.02712.x; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	73	44	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36473	36487		10.1074/jbc.M112.389114	http://dx.doi.org/10.1074/jbc.M112.389114			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927435	Green Published, hybrid			2022-12-28	WOS:000310364000067
J	Altemeier, WA; Schlesinger, SY; Buell, CA; Brauer, R; Rapraeger, AC; Parks, WC; Chen, P				Altemeier, William A.; Schlesinger, Saundra Y.; Buell, Catherine A.; Brauer, Rena; Rapraeger, Alan C.; Parks, William C.; Chen, Peter			Transmembrane and Extracellular Domains of Syndecan-1 Have Distinct Functions in Regulating Lung Epithelial Migration and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CARCINOMA CELLS; INTEGRIN ACTIVATION; CORE PROTEIN; MATRIX; MOUSE; ALPHA(V)BETA(3); ASSOCIATION; SURFACE; REEPITHILIALIZATION	Syndecan-1 is a cell surface proteoglycan that can organize co-receptors into a multimeric complex to transduce intracellular signals. The syndecan-1 core protein has multiple domains that confer distinct cell-and tissue-specific functions. Indeed, the extracellular, transmembrane, and cytoplasmic domains have all been found to regulate specific cellular processes. Our previous work demonstrated that syndecan-1 controls lung epithelial migration and adhesion. Here, we identified the necessary domains of the syndecan-1 core protein that modulate its function in lung epithelial repair. We found that the syndecan-1 transmembrane domain has a regulatory function in controlling focal adhesion disassembly, which in turn controls cell migration speed. In contrast, the extracellular domain facilitates cell adhesion through affinity modulation of alpha(2)beta(1) integrin. These findings highlight the fact that syndecan-1 is a multidimensional cell surface receptor that has several regulatory domains to control various biological processes. In particular, the lung epithelium requires the syndecan-1 transmembrane domain to govern cell migration and is independent from its ability to control cell adhesion via the extracellular domain.	[Altemeier, William A.; Schlesinger, Saundra Y.; Buell, Catherine A.; Brauer, Rena; Parks, William C.; Chen, Peter] Univ Washington, Ctr Lung Biol, Div Pulm & Crit Care Med, Seattle, WA 98109 USA; [Rapraeger, Alan C.] Univ Wisconsin, Dept Human Oncol, Madison, WI 53792 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Chen, P (corresponding author), UW Med S Lake Union, Ctr Lung Biol, 850 Republican St, Seattle, WA 98109 USA.	petechen@uw.edu	Parks, William C./AAH-6786-2021	Altemeier, William/0000-0001-8860-405X; Chen, Peter/0000-0002-5330-1718; Brauer, Rena/0000-0002-5900-4853	National Institutes of Health [HL084396, HL103868, HL086883, HL029594]; American Heart Association; American Lung Association; Cystic Fibrosis Foundation Research Development Program; Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086883, P01HL029594, R01HL103868, K08HL084396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; Cystic Fibrosis Foundation Research Development Program; Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084396 and HL103868 (to P. C.), HL086883 (to W. A. A.), and HL029594 (to W. C. P.). This work was also supported by an American Heart Association beginning grant-in-aid and the American Lung Association (to P. C.) and by the Cystic Fibrosis Foundation Research Development Program (to W. C. P.).; We thank Dr. Ron Seifert for technical assistance. The imaging studies were supported in part by the Mike and Lynn Garvey Cell Imaging Lab at the University of Washington Institute for Stem Cell and Regenerative Medicine.	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Altemeier W. A., 2012, J CELL SCI IN PRESS; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KODA JE, 1985, J BIOL CHEM, V260, P8157; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Ojeh N, 2008, J INVEST DERMATOL, V128, P26, DOI 10.1038/sj.jid.5700967; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2003, J BIOL CHEM, V278, P12888, DOI 10.1074/jbc.M209440200; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816	55	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34927	34935		10.1074/jbc.M112.376814	http://dx.doi.org/10.1074/jbc.M112.376814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22936802	Green Published, hybrid			2022-12-28	WOS:000309968000006
J	Aye, Y; Long, MJC; Stubbe, J				Aye, Yimon; Long, Marcus J. C.; Stubbe, JoAnne			Mechanistic Studies of Semicarbazone Triapine Targeting Human Ribonucleotide Reductase in Vitro and in Mammalian Cells TYROSYL RADICAL QUENCHING NOT INVOLVING REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT IRON CHELATORS; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; DNA-DAMAGE; BIOLOGICAL SAMPLES; ANTITUMOR-ACTIVITY; ESCHERICHIA-COLI; LARGE SUBUNIT; PROTEIN; INHIBITION; HYDROXYUREA	Triapine (R) (3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP)) is a drug in Phase II trials. One of its established cellular targets is the beta(2) subunit of ribonucleotide reductase that requires a diferric-tyrosyl-radical [(Fe-2(III)-Y center dot)(Fe-2(III))] cofactor for de novo DNA biosynthesis. Several mechanisms for 3-AP inhibition of beta(2) have been proposed; one involves direct iron chelation from beta(2), where as a second involves Y center dot destruction by reactive oxygen species formed in situ in the presence of O-2 and reductant by Fe(II)-(3-AP). Inactivation of beta(2) can thus arise from cofactor destruction by loss of iron or Y center dot. In vitro kinetic data on the rates of Fe-55 and Y center dot loss from [(Fe-55(2)III-Y center dot)(Fe-55(2)III)]-beta(2) under aerobic and anaerobic conditions reveal that Y center dot loss alone is sufficient for rapid beta(2) inactivation. Oxyblot (TM) and mass spectrometric analyses of trypsin-digested inhibited beta(2), and lack of Y center dot loss from H2O2 and O-2((center dot) over bar). treatment together preclude reactive oxygen species involvement in Y center dot loss. Three mammalian cell lines treated with 5 mu M 3-AP reveal Y center dot loss and beta(2) inactivation within 30-min of 3-AP-exposure, analyzed by whole-cell EPR and lysate assays, respectively. Selective degradation of apo-over [(Fe-2(III)-Y center dot)(Fe-2(III))]-beta(2) in lysates, similar iron-content in beta(2) immunoprecipitated from 3-AP-treated and untreated [Fe-55]-prelabeled cells, and prolonged (12 h) stability of the inhibited beta(2) are most consistent with Y center dot loss being the predominant mode of inhibition, with beta(2) remaining iron-loaded and stable. A model consistent with in vitro and cell-based biochemical studies is presented in which Fe(II)-(3-AP), which can be cycled with reductant, directly reduces Y center dot of the [(Fe-2(III)-Y center dot)(Fe-2(III))] cofactor of beta(2).	[Aye, Yimon; Stubbe, JoAnne] MIT, Dept Biol, Dept Chem, Cambridge, MA 02139 USA; [Long, Marcus J. C.] Brandeis Univ, Grad Program Biochem & Biophys, Waltham, MA 02454 USA	Massachusetts Institute of Technology (MIT); Brandeis University	Stubbe, J (corresponding author), MIT, Dept Biol, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu		Long, marcus/0000-0002-0343-9671	National Institutes of Health Grant [GM29595]; Damon Runyon Cancer Research Fellowship [DRG2015-09]; Howard Hughes Medical Institute international student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029595, R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Fellowship; Howard Hughes Medical Institute international student fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29595 (to J.S.). This work was also supported by Damon Runyon Cancer Research Fellowship DRG2015-09 (to Y.A.) and a Howard Hughes Medical Institute international student fellowship (to M.J.C.L.).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Alvero AB, 2006, J SOC GYNECOL INVEST, V13, P145, DOI 10.1016/j.jsgi.2005.11.004; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Barycki J.J., 2008, REDOX BIOCH, P11; Berg RW, 2002, CURR DRUG TARGETS, V3, P297, DOI 10.2174/1389450023347605; Bou-Abdallah F, 2008, J BIOL INORG CHEM, V13, P15, DOI 10.1007/s00775-007-0304-0; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Christner C, 1999, J MED CHEM, V42, P3615, DOI 10.1021/jm991038t; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; CORY JG, 1994, BIOCHEM PHARMACOL, V48, P335, DOI 10.1016/0006-2952(94)90105-8; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; DELMAESTRO RF, 1981, MICROVASC RES, V22, P239, DOI 10.1016/0026-2862(81)90095-9; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Enyedy EA, 2011, DALTON T, V40, P5895, DOI 10.1039/c0dt01835j; Enyedy EA, 2010, EUR J INORG CHEM, P1717, DOI 10.1002/ejic.200901174; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Finch RA, 1999, ADV ENZYME REGUL, V39, P3, DOI 10.1016/S0065-2571(98)00017-X; Finch RA, 2000, BIOCHEM PHARMACOL, V59, P983, DOI 10.1016/S0006-2952(99)00419-0; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; Gandhi V., 2006, CANC DRUG DISCOVERY, P153; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gaudu P, 1996, FEBS LETT, V387, P137, DOI 10.1016/0014-5793(96)00480-2; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hsieh YC, 2009, MOL PHARMACOL, V76, P723, DOI 10.1124/mol.109.055772; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kolesar JM, 2008, J INORG BIOCHEM, V102, P693, DOI 10.1016/j.jinorgbio.2007.10.013; Kowol CR, 2009, J MED CHEM, V52, P5032, DOI 10.1021/jm900528d; Krakoff I. H., 1975, ANTINEOPLASTIC IMM 2, P789; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; MCCLARTY GA, 1990, J BIOL CHEM, V265, P7539; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Merlot A. M., 2012, ANTIOXID REDOX SIGNA; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Nutting CM, 2009, ANN ONCOL, V20, P1275, DOI 10.1093/annonc/mdn775; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Popovic-Bijelic A, 2011, J INORG BIOCHEM, V105, P1422, DOI 10.1016/j.jinorgbio.2011.07.003; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; ROSE IA, 1967, J BIOL CHEM, V242, P1870; SAHLIN M, 1990, BIOCHEM BIOPH RES CO, V167, P813, DOI 10.1016/0006-291X(90)92098-K; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2006, MOL CANCER THER, V5, P586, DOI 10.1158/1535-7163.MCT-05-0384; STARGELL LA, 1992, MOL CELL BIOL, V12, P1443, DOI 10.1128/MCB.12.4.1443; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; THELANDER L, 1983, J BIOL CHEM, V258, P4063; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Traynor AM, 2010, INVEST NEW DRUG, V28, P91, DOI 10.1007/s10637-009-9230-z; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu LJ, 2009, BIOCHEM PHARMACOL, V78, P1178, DOI 10.1016/j.bcp.2009.06.103	66	52	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35768	35778		10.1074/jbc.M112.396911	http://dx.doi.org/10.1074/jbc.M112.396911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915594	Green Published, hybrid			2022-12-28	WOS:000309968000087
J	Guan, M; Wang, WB; Liu, XQ; Tong, YM; Liu, Y; Ren, H; Zhu, SY; Dubuisson, J; Baumert, TF; Zhu, YZ; Peng, HR; Aurelian, L; Zhao, P; Qi, ZT				Guan, Mo; Wang, Wenbo; Liu, Xiaoqing; Tong, Yimin; Liu, Yuan; Ren, Hao; Zhu, Shiying; Dubuisson, Jean; Baumert, Thomas F.; Zhu, Yongzhe; Peng, Haoran; Aurelian, Laure; Zhao, Ping; Qi, Zhongtian			Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN GP70; B TYPE-I; NEUTRALIZING ANTIBODIES; CELL ENTRY; SEQUENCE EVOLUTION; E2 GLYCOPROTEIN; LOW-DENSITY; INFECTION; RECEPTOR; RESPONSES	High genetic heterogeneity is an important characteristic of hepatitis C virus (HCV) that contributes to its ability to establish persistent infection. The hypervariable region 1 (HVR1) that includes the first 27 amino acid residues of the E2 envelope glycoprotein is the most variable region within the HCV polyprotein. HVR1 plays a major role in both HCV cell entry and immune evasion, but the respective contribution of specific amino acid residues is still unclear. Our mutagenesis analyses of HCV pseudoparticles and cell culture-derived HCV using the H77 isolate indicate that five residues at positions 14, 15, and 25-27 mediate binding of the E2 protein to the scavenger receptor class B, type I receptor, and any residue herein is indispensable for HCV cell entry. The region spanning positions 16-24 contains the sole neutralizing epitope and is dispensable for HCV entry, but it is involved in heparan binding. More importantly, this region is necessary for the enhancement of HCV entry by high density lipoprotein and interferes with virus neutralization by E2-neutralizing antibodies. Residues at positions 1-13 are also dispensable for HCV entry, but they can affect HCV infectivity by modulating binding of the envelope protein to scavenger receptor class B, type I. Mutations occurring at this site may confer resistance to HVR1 antibodies. These findings further our understanding about the mechanisms of HCV cell entry and the significance of HVR1 variation in HCV immune evasion. They have major implications for the development of HCV entry inhibitors and prophylactic vaccines.	[Guan, Mo; Wang, Wenbo; Liu, Xiaoqing; Tong, Yimin; Liu, Yuan; Ren, Hao; Zhu, Shiying; Zhu, Yongzhe; Peng, Haoran; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Dept Microbiol, Shanghai 200433, Peoples R China; [Dubuisson, Jean] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, CNRS,UMR8204,INSERM,U1019, F-59021 Lille, France; [Baumert, Thomas F.] Univ Strasbourg, Nouvel Hop Civil, Unite Inserm U748, F-67000 Strasbourg, France; [Aurelian, Laure] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Naval Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University System of Maryland; University of Maryland Baltimore	Zhao, P (corresponding author), Second Mil Med Univ, Dept Microbiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	pnzhao@163.com; qizt@smmu.edu.cn	Baumert, Thomas/ABF-4718-2020; Dubuisson, Jean/E-6813-2016	Baumert, Thomas/0000-0002-8864-2168; Dubuisson, Jean/0000-0003-1626-7693	973 Programme of China Research Grants [2009CB522501, 2009CB522503]; Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases [2012ZX10002003-004-010]; Natural Science Foundation of China [81071364, 31170150]; Science Fund for Creative Research Groups; Shanghai Leading Academic Discipline Project [B901]; French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales"; NSFC [30921006]	973 Programme of China Research Grants(National Basic Research Program of China); Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales"(French National Research Agency (ANR)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Programme of China Research Grants 2009CB522501 and 2009CB522503, Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases Grant 2012ZX10002003-004-010, Natural Science Foundation of China Grants 81071364 and 31170150, Science Fund for Creative Research Groups, NSFC Grant 30921006, and Shanghai Leading Academic Discipline Project B901.; International scholar of the Howard Hughes Medical Institute and supported by the French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales."	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Cao J, 2011, VACCINE, V29, P3714, DOI 10.1016/j.vaccine.2011.02.083; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Gomez J, 1999, J VIRAL HEPATITIS, V6, P3, DOI 10.1046/j.1365-2893.1999.t01-1-6120131.x; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Kawaguchi K, 2011, J VIROL, V85, P3408, DOI 10.1128/JVI.02554-10; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Lucas M, 2003, J GEN VIROL, V84, P545, DOI 10.1099/vir.0.18775-0; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Mondelli MU, 1999, HEPATOLOGY, V30, P537, DOI 10.1002/hep.510300233; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; SCARSELLI E, 1995, J VIROL, V69, P4407, DOI 10.1128/JVI.69.7.4407-4412.1995; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10; Uebelhoer L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000143; VANDOORN LJ, 1995, J VIROL, V69, P773, DOI 10.1128/JVI.69.2.773-778.1995; Vieyres G, 2011, J GEN VIROL, V92, P494, DOI 10.1099/vir.0.028092-0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zibert A, 1997, J VIROL, V71, P4123, DOI 10.1128/JVI.71.5.4123-4127.1997	69	38	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35631	35645		10.1074/jbc.M112.382341	http://dx.doi.org/10.1074/jbc.M112.382341			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927442	Green Published, hybrid			2022-12-28	WOS:000309968000075
J	Le Goff, A; Ji, ZL; Leclercq, B; Bourette, RP; Mougel, A; Guerardel, C; de Launoit, Y; Vicogne, J; Goormachtigh, G; Fafeur, V				Le Goff, Arnaud; Ji, Zongling; Leclercq, Berenice; Bourette, Roland P.; Mougel, Alexandra; Guerardel, Cateline; de launoit, Yvan; Vicogne, Jerome; Goormachtigh, Gautier; Fafeur, Veronique			Anti-apoptotic Role of Caspase-cleaved GAB1 Adaptor Protein in Hepatocyte Growth Factor/Scatter Factor-MET Receptor Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; EPITHELIAL MORPHOGENESIS; C-MET; DEPENDENT CLEAVAGE; DOCKING PROTEIN; MEDIATED CLEAVAGE; CELL-SURVIVAL; DOMAIN; TRANSDUCTION; RECRUITMENT	The GRB2-associated binder 1 (GAB1) docking/scaffold protein is a key mediator of the MET-tyrosine kinase receptor activated by hepatocyte growth factor/scatter factor (HGF/SF). Activated MET promotes recruitment and tyrosine phosphorylation of GAB1, which in turn recruits multiple proteins and mediates MET signaling leading to cell survival, motility, and morphogenesis. We previously reported that, without its ligand, MET is a functional caspase target during apoptosis, allowing the generation of a p40-MET fragment that amplifies apoptosis. In this study we established that GAB1 is also a functional caspase target by evidencing a caspase-cleaved p35-GAB1 fragment that contains the MET binding domain. GAB1 is cleaved by caspases before MET, and the resulting p35-GAB1 fragment is phosphorylated by MET upon HGF/SF binding and can interact with a subset of GAB1 partners, PI3K, and GRB2 but not with SHP2. This p35-GAB1 fragment favors cell survival by maintaining HGF/SF-induced MET activation of AKT and by hindering p40-MET pro-apoptotic function. These data demonstrate an anti-apoptotic role of caspase-cleaved GAB1 in HGF/SF-MET signaling.	[Le Goff, Arnaud; Ji, Zongling; Leclercq, Berenice; Bourette, Roland P.; Mougel, Alexandra; Guerardel, Cateline; de launoit, Yvan; Vicogne, Jerome; Goormachtigh, Gautier; Fafeur, Veronique] Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR1 42, Lille, France; [Ji, Zongling] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Manchester	Fafeur, V (corresponding author), Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR1 42, Lille, France.	veronique.fafeur@ibl.fr	Fafeur, Veronique/L-9072-2018; Bourette, Roland/ABB-3343-2020	Vicogne, Jerome/0000-0001-8360-7497; de Launoit, Yvan/0000-0003-1837-9808; Berenice, Leclercq/0000-0002-0045-4825; Goormachtigh, Gautier/0000-0003-1736-8269	CNRS; Pasteur Institute of Lille; Universite Lille-Nord de France; INSERM; Fondation de France; FEDER-Region Nord Pas de Calais; Ligue Regionale Contre le Cancer-Comite de l'Aisne; French Ministere de la Recherche; Association pour la Recherche contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; Universite Lille-Nord de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); FEDER-Region Nord Pas de Calais(Region Hauts-de-France); Ligue Regionale Contre le Cancer-Comite de l'Aisne; French Ministere de la Recherche(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by CNRS, Pasteur Institute of Lille, Universite Lille-Nord de France and INSERM and by grants from Fondation de France, FEDER-Region Nord Pas de Calais, and the Ligue Regionale Contre le Cancer-Comite de l'Aisne.; Supported by research fellowships from French Ministere de la Recherche and Association pour la Recherche contre le Cancer.	Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bachelder RE, 2001, J BIOL CHEM, V276, P34702, DOI 10.1074/jbc.M102806200; Berry DM, 2001, ONCOGENE, V20, P1203, DOI 10.1038/sj.onc.1204218; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Deheuninck J, 2008, BIOCHEM BIOPH RES CO, V367, P573, DOI 10.1016/j.bbrc.2007.12.177; Deheuninck J, 2009, CELL SIGNAL, V21, P1455, DOI 10.1016/j.cellsig.2009.05.005; Enomoto A, 2003, BIOCHEM BIOPH RES CO, V306, P837, DOI 10.1016/S0006-291X(03)01050-7; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Foveau B, 2007, CELL DEATH DIFFER, V14, P752, DOI 10.1038/sj.cdd.4402080; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Goormachtigh G, 2011, BIOCHEM BIOPH RES CO, V411, P780, DOI 10.1016/j.bbrc.2011.07.024; Grasset MF, 2010, J LEUKOCYTE BIOL, V87, P127, DOI 10.1189/jlb.0309151; Green KA, 2004, J BIOL CHEM, V279, P25149, DOI 10.1074/jbc.M402395200; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Leroy C, 2006, ANN NY ACAD SCI, V1090, P188, DOI 10.1196/annals.1378.021; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Sun YQ, 2004, MOL CELL BIOL, V24, P1531, DOI 10.1128/MCB.24.4.1531-1539.2004; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200	49	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35382	35396		10.1074/jbc.M112.409797	http://dx.doi.org/10.1074/jbc.M112.409797			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915589	Green Published, hybrid			2022-12-28	WOS:000309968000046
J	Li, J; Mo, HY; Xiong, G; Zhang, L; He, J; Huang, ZF; Liu, ZW; Chen, QY; Du, ZM; Zheng, LM; Qian, CN; Zeng, YX				Li, Jiang; Mo, Hao-Yuan; Xiong, Geng; Zhang, Lin; He, Jia; Huang, Zhou-Feng; Liu, Zhi-Wei; Chen, Qiu-Yan; Du, Zi-Ming; Zheng, Li-Min; Qian, Chao-Nan; Zeng, Yi-Xin			Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TH17 CELLS; POOR-PROGNOSIS; FACTOR MIF; GENERATION; CANCER; INFLAMMATION; STAT3; DIFFERENTIATION; ANGIOGENESIS	The accumulation of an intratumoral CD4(+) interleukin-17-producing subset (Th17) of tumor-infiltrating lymphocytes (TILs) is a general characteristic in many cancers. The relationship between the percentage of Th17 cells and clinical prognosis differs among cancers. The mechanism responsible for the increasing percentage of such cells in NPC is still unknown, as is their biological function. Here, our data showed an increase of Th17 cells in tumor tissues relative to their numbers in normal nasopharynx tissues or in the matched peripheral blood of NPC patients. Th17 cells in tumor tissue produced more IFN gamma than did those in the peripheral blood of matched NPC patients and healthy controls. We observed high levels of CD154, G-CSF, CXCL1, IL-6, IL-8, and macrophage inhibitory factor (MIF) out of 36 cytokines examined in tumor tissue cultures. MIF promoted the generation and recruitment of Th17 cells mediated by NPC tumor cells in vitro; this promoting effect was mainly dependent on the mammalian target of rapamycin pathway and was mediated by the MIF-CXCR4 axis. Finally, the expression level of MIF in tumor cells and in TILs was positively correlated in NPC tumor tissues, and the frequency of MIF-positive TILs was positively correlated with NPC patient clinical outcomes. Taken together, our findings illustrate that tumor-derived MIF can affect patient prognosis, which might be related to the increase of Th17 cells in the NPC tumor microenvironment.	[Li, Jiang; Zhang, Lin; He, Jia; Zheng, Li-Min] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou 510060, Guangdong, Peoples R China; [Qian, Chao-Nan] Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI 49503 USA; [Li, Jiang; Xiong, Geng; Liu, Zhi-Wei; Du, Zi-Ming; Zheng, Li-Min; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Mo, Hao-Yuan; Huang, Zhou-Feng; Chen, Qiu-Yan; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Van Andel Institute; Sun Yat Sen University; Sun Yat Sen University	Li, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, 651 Dongfeng E Rd, Guangzhou 510060, Guangdong, Peoples R China.	lijiang2@mail.sysu.edu.cn; qianchn@sysucc.org.cn	zheng, limin/HGB-2510-2022; Liu, Zhiwei/AAM-5300-2020; zhan, lin/AAP-5149-2020; ZHANG, LIN/GYD-9123-2022	Liu, Zhiwei/0000-0002-0136-651X; Zheng, Limin/0000-0002-8281-1450; li, jiang/0000-0001-5596-9159	National Natural Science Foundation of China [30872981, 81172164, 81030043]; Guangdong Province Natural Science Foundation [0151008901000156]; National High Technology Research and Development Program of China (863 Program) [20060102A4002]; Major State Basic Research Program (973 Project) of China [2006CB910104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Major State Basic Research Program (973 Project) of China(National Basic Research Program of China)	This work was supported by General Program Grants 30872981 and 81172164 (to J. L.), State Key Program Grant 81030043 (to C.-N. Q.) from the National Natural Science Foundation of China, Guangdong Province Natural Science Foundation Grant 0151008901000156 (to J. L.), National High Technology Research and Development Program of China (863 Program) Grant 20060102A4002 (to C.-N. Q.), and Major State Basic Research Program (973 Project) of China Grant 2006CB910104 (to Y. X. Z.).	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Bachand AM, 2010, CRIT REV TOXICOL, V40, P85, DOI 10.3109/10408440903341696; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; BRANN E, 1990, ARCH INTERN MED, V150, P2495; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Chuang CC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-50; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Durr C, 2010, CANCER RES, V70, P10170, DOI 10.1158/0008-5472.CAN-10-1943; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Gaber T, 2011, J IMMUNOL, V186, P764, DOI 10.4049/jimmunol.0903421; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Krockenberger M, 2010, J CANCER RES CLIN, V136, P651, DOI 10.1007/s00432-009-0702-5; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Liao B, 2010, J SURG ONCOL, V102, P844, DOI 10.1002/jso.21728; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Niedobitek G, 1996, SEMIN CANCER BIOL, V7, P165, DOI 10.1006/scbi.1996.0023; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Radojcic V, 2010, J IMMUNOL, V184, P764, DOI 10.4049/jimmunol.0903006; Ratajczak P, 2010, BLOOD, V116, P1165, DOI 10.1182/blood-2009-12-255810; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shen XH, 2010, J CANCER RES CLIN, V136, P1745, DOI 10.1007/s00432-010-0833-8; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vasef MA, 1997, ANN OTO RHINOL LARYN, V106, P348, DOI 10.1177/000348949710600416; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; WEE A, 1994, J CLIN PATHOL, V47, P453, DOI 10.1136/jcp.47.5.453; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	53	58	61	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35484	35495		10.1074/jbc.M112.367532	http://dx.doi.org/10.1074/jbc.M112.367532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893706	Green Published, hybrid			2022-12-28	WOS:000309968000057
J	Gurung, P; Malireddi, RKS; Anand, PK; Demon, D; Vande Walle, L; Liu, ZP; Vogel, P; Lamkanfi, M; Kanneganti, TD				Gurung, Prajwal; Malireddi, R. K. Subbarao; Anand, Paras K.; Demon, Dieter; Vande Walle, Lieselotte; Liu, Zhiping; Vogel, Peter; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Toll or Interleukin-1 Receptor (TIR) Domain-containing Adaptor Inducing Interferon-beta (TRIF)-mediated Caspase-11 Protease Production Integrates Toll-like Receptor 4 (TLR4) Protein- and Nlrp3 Inflammasome-mediated Host Defense against Enteropathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; CITROBACTER-RODENTIUM; CRYOPYRIN INFLAMMASOME; PATTERN-RECOGNITION; SIGNALING PATHWAY; ACTIVATION; MICE; INNATE; INFECTION; IMMUNITY	Enteric pathogens represent a major cause of morbidity and mortality worldwide. Toll-like receptor (TLR) and inflammasome signaling are critical for host responses against these pathogens, but how these pathways are integrated remains unclear. Here, we show that TLR4 and the TLR adaptor TRIF are required for inflammasome activation in macrophages infected with the enteric pathogens Escherichia coli and Citrobacter rodentium. In contrast, TLR4 and TRIF were dispensable for Salmonella typhimurium-induced caspase-1 activation. TRIF regulated expression of caspase-11, a caspase-1-related protease that is critical for E. coli-and C. rodentium-induced inflammasome activation, but dispensable for inflammasome activation by S. typhimurium. Thus, TLR4- and TRIF-induced caspase-11 synthesis is critical for noncanonical Nlrp3 inflammasome activation in macrophages infected with enteric pathogens.	[Gurung, Prajwal; Malireddi, R. K. Subbarao; Anand, Paras K.; Liu, Zhiping; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Biochem, B-9000 Ghent, Belgium; [Demon, Dieter; Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Suite E7004, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Vogel, Peter/N-2490-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Liu, Zhiping/O-3510-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013	Vogel, Peter/0000-0002-7535-0545; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Liu, Zhiping/0000-0002-5109-4153; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Anand, Paras/0000-0003-2503-3653; Gurung, Prajwal/0000-0002-7451-9433	National Institutes of Health [AR056296, AI101935, CA163507]; European Union [256432]; European Research Council [281600]; Fund for Scientific Research-Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056296, AI101935, and CA163507 (to T.-D. K.). This work was also supported by Marie-Curie Grant 256432 from the European Union, European Research Council Grant 281600, and the Fund for Scientific Research-Flanders Grants G030212N, 1.2.201.10.N.00, and 1.5.122.11.N.00 (to M. L.), and by the American Lebanese Syrian Associated Charities (ALSAC) (to T.-D. K.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Malireddi RKS, 2010, J IMMUNOL, V185, P3127, DOI 10.4049/jimmunol.1001512; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	39	190	196	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34474	34483		10.1074/jbc.M112.401406	http://dx.doi.org/10.1074/jbc.M112.401406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22898816	Green Published, hybrid			2022-12-28	WOS:000309654200049
J	Keil, M; Bareth, B; Woellhaf, MW; Peleh, V; Prestele, M; Rehling, P; Herrmann, JM				Keil, Melanie; Bareth, Bettina; Woellhaf, Michael W.; Peleh, Valentina; Prestele, Martin; Rehling, Peter; Herrmann, Johannes M.			Oxa1-Ribosome Complexes Coordinate the Assembly of Cytochrome c Oxidase in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-BINDING; TERMINAL TAIL; TUNNEL EXIT; PROTEIN; YEAST; INSERTION; INTERACTS; EXPORT; SUBUNITS; OXA1	The terminal enzyme of the respiratory chain, cytochrome c oxidase, consists of a hydrophobic reaction center formed by three mitochondrially encoded subunits with which 9-10 nuclear encoded subunits are associated. The three core subunits are synthesized on mitochondrial ribosomes and inserted into the inner membrane in a co-translational reaction facilitated by the Oxa1 insertase. Oxa1 consists of an N-terminal insertase domain and a C-terminal ribosome-binding region. Mutants lacking the C-terminal region show specific defects in co-translational insertion, suggesting that the close contact of the ribosome with the insertase promotes co-translational insertion of nascent chains. In this study, we inserted flexible linkers of 100 or 200 amino acid residues between the insertase domain and ribosome-binding region of Oxa1 of Saccharomyces cerevisiae. In the absence of the ribosome receptor Mba1, these linkers caused a length-dependent decrease in mitochondrial respiratory activity caused by diminished levels of cytochrome c oxidase. Interestingly, considerable amounts of mitochondrial translation products were still integrated into the inner membrane in these linker mutants. However, they showed severe defects in later stages of the biogenesis process, presumably during assembly into functional complexes. Our observations suggest that the close proximity of Oxa1 to ribosomes is not only used to improve membrane insertion but is also critical for the productive assembly of the subunits of the cytochrome c oxidase. This points to a role for Oxa1 in the spatial coordination of the ribosome with assembly factors that are critical for enzyme biogenesis.	[Keil, Melanie; Woellhaf, Michael W.; Peleh, Valentina; Prestele, Martin; Herrmann, Johannes M.] Univ Kaiserslautern, Dept Cell Biol, D-67663 Kaiserslautern, Germany; [Bareth, Bettina; Rehling, Peter] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Kaiserslautern; University of Gottingen; Max Planck Society	Herrmann, JM (corresponding author), Univ Kaiserslautern, Dept Cell Biol, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	hannes.herrmann@biologie.uni-kl.de			Deutsche Forschungsgemeinschaft [FOR 967]; Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Max-Planck-Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR 967 (to J. M. H. and P. R.), the Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz (to J. M. H.), the Gottingen Graduate School for Neurosciences and Molecular Biosciences (to B. B.), and the Max-Planck-Gesellschaft (to P. R.).	Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; ALTMANN K, 2007, MITOCHONDRIA PRACTIC, P81; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Brandner K, 2005, J BIOL CHEM, V280, P6215, DOI 10.1074/jbc.M412269200; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Elliott LE, 2012, GENETICS, V190, P559, DOI 10.1534/genetics.111.135665; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fujihira E, 2002, J BIOCHEM, V131, P145, DOI 10.1093/oxfordjournals.jbchem.a003069; Funes Soledad, 2007, Methods Mol Biol, V372, P255, DOI 10.1007/978-1-59745-365-3_18; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Giglione C, 2009, TRENDS BIOCHEM SCI, V34, P417, DOI 10.1016/j.tibs.2009.04.003; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Herrmann JM, 2012, BIOCH BIOPH IN PRESS; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Khalimonchuk O, 2005, CURR GENET, V47, P223, DOI 10.1007/s00294-005-0569-1; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Wagner K, 2010, MOL BIOL CELL, V21, P1494, DOI 10.1091/mbc.E09-12-1023; WATSON K, 1972, J CELL BIOL, V55, P721, DOI 10.1083/jcb.55.3.721; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	55	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34484	34493		10.1074/jbc.M112.382630	http://dx.doi.org/10.1074/jbc.M112.382630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904327	Green Published, hybrid			2022-12-28	WOS:000309654200050
J	Wang, CY; Jenkitkasemwong, S; Duarte, S; Sparkman, BK; Shawki, A; Mackenzie, B; Knutson, MD				Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Sparkman, Brian K.; Shawki, Ali; Mackenzie, Bryan; Knutson, Mitchell D.			ZIP8 Is an Iron and Zinc Transporter Whose Cell-surface Expression Is Up-regulated by Cellular Iron Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN-BOUND IRON; METAL-ION TRANSPORTER; FUNCTIONAL-PROPERTIES; RECEPTOR EXPRESSION; GENE ENCODES; RAT-LIVER; OVERLOAD; MOUSE; HEMOCHROMATOSIS; PROTEIN	ZIP8 (SLC39A8) belongs to the ZIP family of metal-ion transporters. Among the ZIP proteins, ZIP8 is most closely related to ZIP14, which can transport iron, zinc, manganese, and cadmium. Here we investigated the iron transport ability of ZIP8, its subcellular localization, pH dependence, and regulation by iron. Transfection of HEK 293T cells with ZIP8 cDNA enhanced the uptake of Fe-59 and Zn-65 by 200 and 40%, respectively, compared with controls. Excess iron inhibited the uptake of zinc and vice versa. In RNA-injected Xenopus oocytes, ZIP8-mediated Fe-55(2+) transport was saturable (K-0.5 of similar to 0.7 mu M) and inhibited by zinc. ZIP8 also mediated the uptake of Cd-109(2+), Co-57(2+), Zn-65(2+) > Mn-54(2+), but not Cu-64 (I or II). By using immunofluorescence analysis, we found that ZIP8 expressed in HEK 293T cells localized to the plasma membrane and partially in early endosomes. Iron loading increased total and cell-surface levels of ZIP8 in H4IIE rat hepatoma cells. We also determined by using site-directed mutagenesis that asparagine residues 40, 88, and 96 of rat ZIP8 are glycosylated and that N-glycosylation is not required for iron or zinc transport. Analysis of 20 different human tissues revealed abundant ZIP8 expression in lung and placenta and showed that its expression profile differs markedly from ZIP14, suggesting nonredundant functions. Suppression of endogenous ZIP8 expression in Be Wo cells, a placental cell line, reduced iron uptake by similar to 40%, suggesting that ZIP8 participates in placental iron transport. Collectively, these data identify ZIP8 as an iron transport protein that may function in iron metabolism.	[Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Sparkman, Brian K.; Shawki, Ali; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Shawki, Ali] Univ Cincinnati, Coll Med, Syst Biol & Physiol Program, Cincinnati, OH 45267 USA	State University System of Florida; University of Florida; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Knutson, MD (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, POB 110370, Gainesville, FL 32611 USA.	mknutson@ufl.edu	Wang, Chia-Yu/ABF-1758-2020	Wang, Chia-Yu/0000-0003-3679-6453; Shawki, Ali/0000-0002-6413-5313; Mackenzie, Bryan/0000-0002-9661-8838	National Institutes of Health from NIDDK [R01 DK080706, R01 DK080047]; National Cancer Institute [R24 CA086307]; University of Cincinnati; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080706, R01DK080047] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080706 (to M. D. K.) and R01 DK080047 (to B. M.) from NIDDK and Grant R24 CA086307 from the National Cancer Institute. This work was also supported by funds from the University of Cincinnati (to B. M.).	ADAMS PC, 1991, CLIN INVEST MED, V14, P16; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Begum NA, 2002, GENOMICS, V80, P630, DOI 10.1006/geno.2002.7000; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; BIERINGS MB, 1991, MOL CELL BIOCHEM, V100, P31, DOI 10.1007/BF00230807; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brissot P, 2002, ADV EXP MED BIOL, V509, P45; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Heaton SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1445, DOI 10.1152/ajpcell.00286.2008; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jarup L, 2002, NEPHROL DIAL TRANSPL, V17, P35, DOI 10.1093/ndt/17.suppl_2.35; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; LAUWERYS R, 1994, SCI TOTAL ENVIRON, V150, P1, DOI 10.1016/0048-9697(94)90125-2; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LU JP, 1989, ACTA PATHOL JAPON, V39, P759; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B., 1999, BIOMEMBRANE TRANSPOR, P327; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; McArdle HJ, 2011, NUTR REV, V69, pS17, DOI 10.1111/j.1753-4887.2011.00428.x; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; Nam H, 2012, BIOMETALS, V25, P115, DOI 10.1007/s10534-011-9487-5; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; PARKES JG, 1993, J LAB CLIN MED, V122, P36; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; Richardson DR, 1999, J LAB CLIN MED, V133, P144, DOI 10.1016/S0022-2143(99)90007-0; SCHADE SG, 1970, J LAB CLIN MED, V75, P435; Scheiber-Mojdehkar B, 2003, BIOCHEM PHARMACOL, V65, P1973, DOI 10.1016/S0006-2952(03)00181-3; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; VALBERG LS, 1969, GASTROENTEROLOGY, V56, P241; Vayenas DV, 1998, INT J CLIN LAB RES, V28, P183, DOI 10.1007/s005990050041; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Zhang Y, 2009, BIOMETALS, V22, P251, DOI 10.1007/s10534-008-9161-8; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	63	236	238	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34032	34043		10.1074/jbc.M112.367284	http://dx.doi.org/10.1074/jbc.M112.367284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22898811	Green Published, hybrid			2022-12-28	WOS:000309654200010
J	Wang, XH; Li, JP; Chiu, LL; Lan, JL; Chen, DY; Boomer, J; Tan, TH				Wang, Xiaohong; Li, Ju-Pi; Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan; Boomer, Jonathan; Tan, Tse-Hua			Attenuation of T Cell Receptor Signaling by Serine Phosphorylation-mediated Lysine 30 Ubiquitination of SLP-76 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR KINASE; N-TERMINAL KINASE; GERMINAL CENTER KINASE; ADAPTER PROTEINS; LINKER PROTEIN; KAPPA-B; PATHWAY; ACTIVATION; HPK1; LYMPHOCYTES	SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa) is an adaptor protein that is essential for T cell development and Tcell receptor (TCR) signaling activation. Previous studies have identified an important negative feedback regulation of SLP-76 by HPK1 (hematopoietic progenitor kinase 1; MAP4K1)-induced Ser-376 phosphorylation. Ser-376 phosphorylation of SLP-76 mediates 14-3-3 binding, resulting in the attenuation of SLP-76 activation and downstream signaling; however, the underlying mechanism of this action remains unknown. Here, we report that phosphorylated SLP-76 is ubiquitinated and targeted for proteasomal degradation during TCR signaling. SLP-76 ubiquitination is mediated by Ser-376 phosphorylation. Furthermore, Lys-30 is identified as a ubiquitination site of SLP-76. Loss of Lys-30 ubiquitination of SLP-76 results in enhanced anti-CD3 antibody-induced ERK and JNK activation. These results reveal a novel regulation mechanism of SLP-76 by ubiquitination and proteasomal degradation of activated SLP-76, which is mediated by Ser-376 phosphorylation, leading to down-regulation of TCR signaling.	[Li, Ju-Pi; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Wang, Xiaohong; Boomer, Jonathan; Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung 40705, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 11221, Taiwan	National Health Research Institutes - Taiwan; Baylor College of Medicine; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	ttan@bcm.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Li, Ju-Pi/AAS-8866-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Li, Ju-Pi/0000-0003-3406-4865	National Institutes of Health [R01 AI066895]; National Health Research Institute (Taiwan) [98A1-IMPP01-014]; Taichung Veterans General Hospital (Taiwan) [TCVGH-NHRI01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institute (Taiwan)(National Health Research Institutes - Taiwan); Taichung Veterans General Hospital (Taiwan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066895 (to T.-H. T.). This work was also supported by National Health Research Institute (Taiwan) Grant 98A1-IMPP01-014 (to T.-H. T.) and Taichung Veterans General Hospital (Taiwan) Grant TCVGH-NHRI01 (to J.-L. L.).	Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Fang N, 1996, J IMMUNOL, V157, P3769; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	30	24	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34091	34100		10.1074/jbc.M112.371062	http://dx.doi.org/10.1074/jbc.M112.371062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902619	hybrid, Green Published			2022-12-28	WOS:000309654200015
J	Mitani, T; Harada, N; Nakano, Y; Inui, H; Yamaji, R				Mitani, Takakazu; Harada, Naoki; Nakano, Yoshihisa; Inui, Hiroshi; Yamaji, Ryoichi			Coordinated Action of Hypoxia-inducible Factor-1 alpha and beta-Catenin in Androgen Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH; WNT; TRANSCRIPTION; ACTIVATION; ENVIRONMENT; INHIBITION; MUTATIONS; PATHWAYS; THERAPY	The androgen receptor (AR) acts as a ligand-dependent transcriptional factor and plays a critical role in the development and progression of androgen-dependent and castration-resistant prostate cancer. Castration results in hypoxia in prostate cancer cells, and hypoxia enhances transcriptional activity of AR through hypoxia-inducible factor (HIF)-1 alpha at low serum androgen levels mimicking the castration-resistant stage. However, HIF-1 alpha is necessary but not sufficient for hypoxia-activated AR transactivation, and the molecular mechanism that regulates AR function in castration-resistant prostate cancer remains unclear. Here, we report that beta-catenin is required for HIF-1 alpha mediated AR transactivation in hypoxic LNCaP prostate cancer cells under low androgen conditions. HIF-1 alpha and beta-catenin coordinately enhanced AR N-terminal and C-terminal interaction. beta-Catenin accumulated in the nucleus in the HIF-1 alpha protein-positive cells of LNCaP xenografts in castrated mice. In LNCaP cells, when HIF-1 alpha was knocked down or was exogenously expressed in the cytoplasm, hypoxia-induced nuclear localization of beta-catenin was inhibited. beta-Catenin formed a complex with HIF-1 alpha both in the nucleus and in the cytoplasm. Hypoxia increased the amount of a complex composed of AR and beta-catenin, and knockdown of HIF-1 alpha attenuated the recruitment of AR and beta-catenin to the androgen response elements (AREs) of androgen-responsive genes. Furthermore, together with beta-catenin, HIF-1 alpha bound to the AREs in the presence of androgen. These results demonstrate that (i) HIF-1 alpha and beta-catenin coordinately enhance AR transactivation by accelerating N-terminal and C-terminal interaction; (ii) HIF-1 alpha promotes nuclear translocation of beta-catenin in hypoxia; and (iii) AR, HIF-1 alpha, and beta-catenin form a ternary complex on AREs.	[Mitani, Takakazu; Harada, Naoki; Inui, Hiroshi; Yamaji, Ryoichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Nakano, Yoshihisa] Osaka Womens Jr Coll, Osaka 5838558, Japan	Osaka Metropolitan University	Yamaji, R (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	yamaji@biochem.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020; Mitani, Takakazu/AAL-8251-2020	Harada, Naoki/0000-0003-3846-388X; Mitani, Takakazu/0000-0002-2272-9228	Japan Society for the Promotion of Science [20580141, 6913]; Grants-in-Aid for Scientific Research [22580152, 11J06913] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research 20580141 (to R. Y.) and Research Fellowship 6913 (to T. M.) from the Japan Society for the Promotion of Science.	Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gobinet J, 2002, MOL CELL ENDOCRINOL, V198, P15, DOI 10.1016/S0303-7207(02)00364-7; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Horii K, 2007, MOL CANCER RES, V5, P383, DOI 10.1158/1541-7786.MCR-06-0226; Hsu CL, 2005, MOL ENDOCRINOL, V19, P350, DOI 10.1210/me.2004-0190; Jang KL, 2005, P NATL ACAD SCI USA, V102, P18431, DOI 10.1073/pnas.0504054102; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Ki H, 2006, CELL BIOL INT, V30, P253, DOI 10.1016/j.cellbi.2005.11.005; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Mostaghel EA, 2009, UROL ONCOL-SEMIN ORI, V27, P251, DOI 10.1016/j.urolonc.2009.03.016; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nishiyama T, 2007, J UROLOGY, V178, P1282, DOI 10.1016/j.juro.2007.05.138; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Parker C, 2004, INT J RADIAT ONCOL, V58, P750, DOI 10.1016/S0360-3016(03)01621-3; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shabsigh A, 2001, J CELL BIOCHEM, V81, P437, DOI 10.1002/1097-4644(20010601)81:3<437::AID-JCB1057>3.3.CO;2-Y; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	42	43	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33594	33606		10.1074/jbc.M112.388298	http://dx.doi.org/10.1074/jbc.M112.388298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865883	Green Published, hybrid			2022-12-28	WOS:000309602100044
J	Butterworth, MB; Zhang, L; Heidrich, EM; Myerburg, MM; Thibodeau, PH				Butterworth, Michael B.; Zhang, Liang; Heidrich, Elisa M.; Myerburg, Michael M.; Thibodeau, Patrick H.			Activation of the Epithelial Sodium Channel (ENaC) by the Alkaline Protease from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; HUMAN GAMMA-INTERFERON; CYSTIC-FIBROSIS; AIRWAY EPITHELIA; NA+ TRANSPORT; RESPIRATORY EPITHELIA; POTENTIAL DIFFERENCE; VIRULENCE FACTORS; SERINE PROTEASES; EXOTOXIN-A	Pseudomonas aeruginosa is an opportunistic pathogen that significantly contributes to the mortality of patients with cystic fibrosis. Chronic infection by Pseudomonas induces sustained immune and inflammatory responses and damage to the airway. The ability of Pseudomonas to resist host defenses is aided, in part, by secreted proteases, which act as virulence factors in multiple modes of infection. Recent studies suggest that misregulation of protease activity in the cystic fibrosis lung may alter fluid secretion and pathogen clearance by proteolytic activation of the epithelial sodium channel (ENaC). To evaluate the possibility that proteolytic activation of ENaC may contribute to the virulence of Pseudomonas, primary human bronchial epithelial cells were exposed to P. aeruginosa and ENaC function was assessed by short circuit current measurements. Apical treatment with a strain known to express high levels of alkaline protease (AP) resulted in an increase in basal ENaC current and a loss of trypsin-inducible ENaC current, consistent with sustained activation of ENaC. To further characterize this AP-induced ENaC activation, AP was purified, and its folding, activity, and ability to activate ENaC were assessed. AP folding was efficient under pH and calcium conditions thought to exist in the airway surface liquid of normal and cystic fibrosis (CF) lungs. Short circuit measurements of ENaC in polarized monolayers indicated that AP activated ENaC in immortalized cell lines as well as post-transplant, primary human bronchial epithelial cells from both CF and non-CF patients. This activation was mapped to the gamma-subunit of ENaC. Based on these data, patho-mechanisms associated with AP in the CF lung are proposed wherein secretion of AP leads to decreased airway surface liquid volume and a corresponding decrease in mucocilliary clearance of pulmonary pathogens.	[Butterworth, Michael B.; Zhang, Liang; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Heidrich, Elisa M.; Myerburg, Michael M.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3500 Terrace St,S327 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	thibodea@pitt.edu	; Zhang, Liang/D-9446-2015	Butterworth, Michael/0000-0002-2173-8333; Zhang, Liang/0000-0003-4268-6939; Thibodeau, Patrick/0000-0002-6790-144X	National Institutes of Health [DK072506, DK083284, DK078917, HL087932]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK078917, R01DK083284, R56DK083284, R00DK078917, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Pittsburgh Cystic Fibrosis Center Cell Core facility (supported, in part, by National Institutes of Health Grant DK072506) for primary human bronchial cells.; This work was supported, in whole or in part, by National Institutes of Health Grants DK083284 (to P. H. T.), DK078917 (to M. B. B.), and HL087932 (to M. M. M.).	Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BURKE V, 1991, PATHOLOGY, V23, P145, DOI 10.3109/00313029109060814; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Catalan MA, 2010, J PHYSIOL-LONDON, V588, P713, DOI 10.1113/jphysiol.2009.183541; Edman K, 2011, CHEMMEDCHEM, V6, P769, DOI 10.1002/cmdc.201000550; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; GOWEN CW, 1986, J PEDIATR-US, V108, P517, DOI 10.1016/S0022-3476(86)80825-3; GRANSTROM M, 1984, ACTA PAEDIATR SCAND, V73, P772, DOI 10.1111/j.1651-2227.1984.tb17774.x; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; HORVAT RT, 1988, INFECT IMMUN, V56, P2925, DOI 10.1128/IAI.56.11.2925-2932.1988; HORVAT RT, 1989, INFECT IMMUN, V57, P1668, DOI 10.1128/IAI.57.6.1668-1674.1989; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; JAGGER KN, 1983, J CLIN MICROBIOL, V17, P55, DOI 10.1128/JCM.17.1.55-59.1983; JAGGER KS, 1982, J CLIN MICROBIOL, V15, P1054, DOI 10.1128/JCM.15.6.1054-1058.1982; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KHARAZMI A, 1984, INFECT IMMUN, V44, P587, DOI 10.1128/IAI.44.3.587-591.1984; KHARAZMI A, 1984, INFECT IMMUN, V43, P161, DOI 10.1128/IAI.43.1.161-165.1984; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; LAZDUNSKI A, 1990, BIOCHIMIE, V72, P147, DOI 10.1016/0300-9084(90)90140-C; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; SUTER S, 1994, AM J RESP CRIT CARE, V150, pS118, DOI 10.1164/ajrccm/150.6_Pt_2.S118; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Xiong L, 2010, ARCH NEUROL-CHICAGO, V67, P617, DOI 10.1001/archneurol.2010.67; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0	54	47	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32556	32565		10.1074/jbc.M112.369520	http://dx.doi.org/10.1074/jbc.M112.369520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859302	Green Published, hybrid			2022-12-28	WOS:000309168300025
J	Uyama, T; Ikematsu, N; Inoue, M; Shinohara, N; Jin, XH; Tsuboi, K; Tonai, T; Tokumura, A; Ueda, N				Uyama, Toru; Ikematsu, Natsuki; Inoue, Manami; Shinohara, Naoki; Jin, Xing-Hua; Tsuboi, Kazuhito; Tonai, Takeharu; Tokumura, Akira; Ueda, Natsuo			Generation of N-Acylphosphatidylethanolamine by Members of the Phospholipase A/Acyltransferase (PLA/AT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS CANNABINOID PRECURSOR; HYDROLYZING ACID AMIDASE; MOLECULAR CHARACTERIZATION; ACYL ETHANOLAMINE; BIOSYNTHESIS; ACYLETHANOLAMINE; ANANDAMIDE; RECEPTOR; CLONING; BRAIN	Bioactive N-acylethanolamines (NAEs), including N-palmitoylethanolamine, N-oleoylethanolamine, and N-arachidonoylethanolamine (anandamide), are formed from membrane glycerophospholipids in animal tissues. The pathway is initiated by N-acylation of phosphatidylethanolamine to form N-acylphosphatidylethanolamine (NAPE). Despite the physiological importance of this reaction, the enzyme responsible, N-acyltransferase, remains molecularly uncharacterized. We recently demonstrated that all five members of the HRAS-like suppressor tumor family are phospholipid-metabolizing enzymes with N-acyltransferase activity and are renamed HRASLS1-5 as phospholipase A/acyltransferase (PLA/AT)-1-5. However, it was poorly understood whether these proteins were involved in the formation of NAPE in living cells. In the present studies, we first show that COS-7 cells transiently expressing recombinant PLA/AT-1, -2, -4, or -5, and HEK293 cells stably expressing PLA/AT-2 generated significant amounts of [C-14]NAPE and [C-14]NAE when cells were metabolically labeled with [C-14]ethanolamine. Second, as analyzed by liquid chromatography-tandem mass spectrometry, the stable expression of PLA/AT-2 in cells remarkably increased endogenous levels of NAPEs and NAEs with various N-acyl species. Third, when NAPE-hydrolyzing phospholipase D was additionally expressed in PLA/AT-2-expressing cells, accumulating NAPE was efficiently converted to NAE. We also found that PLA/AT-2 was partly responsible for NAPE formation in HeLa cells that endogenously express PLA/AT-2. These results suggest that PLA/AT family proteins may produce NAPEs serving as precursors of bioactive NAEs in vivo.	[Uyama, Toru; Shinohara, Naoki; Jin, Xing-Hua; Tsuboi, Kazuhito; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Ikematsu, Natsuki; Inoue, Manami; Tokumura, Akira] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708505, Japan; [Jin, Xing-Hua] Qiqihar Med Univ, Dept Chem, Qiqihar 161006, Peoples R China; [Tonai, Takeharu] Natl Zentsuji Hosp, Clin Res Inst, Zentsuji, Kagawa 7650001, Japan; [Tonai, Takeharu] Natl Zentsuji Hosp, Dept Orthoped Surg, Zentsuji, Kagawa 7650001, Japan	Kagawa University; Tokushima University; Qiqihar Medical University	Ueda, N (corresponding author), Kagawa Univ, Sch Med, Dept Biochem, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	Jin, Xinghua/K-1142-2015	Jin, Xinghua/0000-0002-8883-5234	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation	This study was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. U. and K. T.), the Japan Society for the Promotion of Science (to N. U.), Kagawa University Faculty of Medicine Specially Promoted Research Fund 2010 (to T. U.), Fund for Kagawa University Young Scientists 2011 (to T. U. and K. T.), grants from the Ichiro Kanehara Foundation (to T. U.), the Sumitomo Foundation (to T. U.), the Uehara Memorial Foundation (to T. U.), and the Suzuken Memorial Foundation (to K. T.).	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Akiyama H, 1999, J BIOL CHEM, V274, P32192, DOI 10.1074/jbc.274.45.32192; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; HAJNAL A, 1994, ONCOGENE, V9, P479; HANSEN HS, 1995, BBA-LIPID LIPID MET, V1258, P303, DOI 10.1016/0005-2760(95)00134-X; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Okamoto Y, 2005, BIOCHEM J, V389, P241, DOI 10.1042/BJ20041790; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; SCHMID HHO, 1990, PROG LIPID RES, V29, P1, DOI 10.1016/0163-7827(90)90004-5; SCHMID PC, 1983, J BIOL CHEM, V258, P9302; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Tokumura A, 2009, INT J MED SCI, V6, P168; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	43	43	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31905	31919		10.1074/jbc.M112.368712	http://dx.doi.org/10.1074/jbc.M112.368712			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22825852	Green Published, hybrid			2022-12-28	WOS:000309059400030
J	Yang, ZL; Martens, CA; Bruno, DP; Porcella, SF; Moss, B				Yang, Zhilong; Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.; Moss, Bernard			Pervasive Initiation and 3 '-End Formation of Poxvirus Postreplicative RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS INTERMEDIATE; NUCLEOSIDE TRIPHOSPHATE PHOSPHOHYDROLASES; EARLY MESSENGER-RNAS; TRANSCRIPTION TERMINATION; POLY(A) POLYMERASE; DNA-REPLICATION; NONCODING RNAS; LATE GENES; NPH-II; GENOME	Poxviruses are large DNA viruses that replicate within the cytoplasm and encode a complete transcription system, including a multisubunit RNA polymerase, stage-specific transcription factors, capping and methylating enzymes, and a poly(A) polymerase. Expression of the more than 200 open reading frames by vaccinia virus, the prototype poxvirus, is temporally regulated: early mRNAs are synthesized immediately after infection, whereas intermediate and late mRNAs are synthesized following genome replication. The postreplicative transcripts are heterogeneous in length and overlap the entire genome, which pose obstacles for high resolution mapping. We used tag-based methods in conjunction with high throughput cDNA sequencing to determine the precise 5'-capped and 3'-polyadenylated ends of postreplicative RNAs. Polymerase slippage during initiation of intermediate and late RNA synthesis results in a 5'-poly(A) leader that allowed the unambiguous identification of true transcription start sites. Ninety RNA start sites were located just upstream of intermediate and late open reading frames, but many more appeared anomalous, occurring within coding and non-coding regions, indicating pervasive transcription initiation. We confirmed the presence of functional promoter sequences upstream of representative anomalous start sites and demonstrated that alternative start sites within open reading frames could generate truncated isoforms of proteins. In an analogous manner, poly(A) sequences allowed accurate mapping of the numerous 3'-ends of postreplicative RNAs, which were preceded by a pyrimidine-rich sequence in the DNA coding strand. The distribution of postreplicative promoter sequences throughout the genome provides enormous transcriptional complexity, and the large number of previously unmapped RNAs may have novel functions.	[Yang, Zhilong; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Martens, Craig A.; Bruno, Daniel P.; Porcella, Stephen F.] NIAID, Res Technol Sect, Genom Unit, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moss, B (corresponding author), NIAID, Viral Dis Lab, NIH, 33 North Dr,MSC 3210, Bethesda, MD 20892 USA.	bmoss@nih.gov		Moss, Bernard/0000-0002-2154-8564; Yang, Zhilong/0000-0001-8995-2654	National Institutes of Health Grant from the Division of Intramural Research, NIAID [A1000307-31]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000307] Funding Source: NIH RePORTER	National Institutes of Health Grant from the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant ZIA A1000307-31 from the Division of Intramural Research, NIAID.	AHN BY, 1989, J VIROL, V63, P226, DOI 10.1128/JVI.63.1.226-232.1989; AHN BY, 1992, J VIROL, V66, P971, DOI 10.1128/JVI.66.2.971-982.1992; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BALDICK CJ, 1993, J VIROL, V67, P3515, DOI 10.1128/JVI.67.6.3515-3527.1993; BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992; BERTHOLET C, 1987, CELL, V50, P153, DOI 10.1016/0092-8674(87)90211-X; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; Carninci P, 2008, CURR OPIN CELL BIOL, V20, P274, DOI 10.1016/j.ceb.2008.03.008; COLBY C, 1971, J VIROL, V7, P71, DOI 10.1128/JVI.7.1.71-76.1971; COOPER JA, 1981, J VIROL, V39, P733, DOI 10.1128/JVI.39.3.733-745.1981; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; D'Costa SM, 2008, J BIOL CHEM, V283, P5267, DOI 10.1074/jbc.M709258200; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Earl P L, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1617s43; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; GERSHON PD, 1993, EMBO J, V12, P4705, DOI 10.1002/j.1460-2075.1993.tb06159.x; GERSHON PD, 1991, CELL, V66, P1269, DOI 10.1016/0092-8674(91)90048-4; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gross CH, 1996, J VIROL, V70, P8549, DOI 10.1128/JVI.70.12.8549-8557.1996; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Howard ST, 1999, VIROLOGY, V255, P190, DOI 10.1006/viro.1998.9547; INK BS, 1990, P NATL ACAD SCI USA, V87, P1536, DOI 10.1073/pnas.87.4.1536; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; LEECHEN GJ, 1988, VIROLOGY, V163, P80, DOI 10.1016/0042-6822(88)90235-8; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; MOSS B, 1973, NATURE-NEW BIOL, V245, P59, DOI 10.1038/newbio245059a0; Moss B, 2007, FIELDS VIROLOGY; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; ODA KI, 1967, J MOL BIOL, V27, P395, DOI 10.1016/0022-2836(67)90047-2; PAOLETTI E, 1974, J BIOL CHEM, V249, P3273; PAOLETTI E, 1974, J BIOL CHEM, V249, P3281; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1987, EMBO J, V6, P3787, DOI 10.1002/j.1460-2075.1987.tb02714.x; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; SCHWER B, 1987, CELL, V50, P163, DOI 10.1016/0092-8674(87)90212-1; SEBRING E. D., 1967, J VIROL, V1, P550; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Taylor SD, 2010, J BIOL CHEM, V285, P11692, DOI 10.1074/jbc.M109.088559; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006	65	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31050	31060		10.1074/jbc.M112.390054	http://dx.doi.org/10.1074/jbc.M112.390054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829601	Green Published, hybrid			2022-12-28	WOS:000308791300018
J	Jayasundar, JJ; Ju, JH; He, LL; Liu, DZ; Meilleur, F; Zhao, JK; Callaway, DJE; Bu, ZM				Jayasundar, Jayant James; Ju, Jeong Ho; He, Lilin; Liu, Dazhi; Meilleur, Flora; Zhao, Jinkui; Callaway, David J. E.; Bu, Zimei			Open Conformation of Ezrin Bound to Phosphatidylinositol 4,5-Bisphosphate and to F-actin Revealed by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EZRIN/RADIXIN/MOESIN ERM PROTEINS; SPIN-ECHO SPECTROSCOPY; SMALL-ANGLE SCATTERING; N-TERMINAL DOMAIN; X-RAY-SCATTERING; NA+/H+ EXCHANGER; BINDING-SITE; PLASMA-MEMBRANE; FERM DOMAIN	Ezrin is a member of the ezrin-radixin-moesin family (ERM) of adapter proteins that are localized at the interface between the cell membrane and the cortical actin cytoskeleton, and they regulate a variety of cellular functions. The structure representing a dormant and closed conformation of an ERM protein has previously been determined by x-ray crystallography. Here, using contrast variation small angle neutron scattering, we reveal the structural changes of the full-length ezrin upon binding to the signaling lipid phosphatidylinositol 4,5-bisphosphate (PIP2) and to F-actin. Ezrin binding to F-actin requires the simultaneous binding of ezrin to PIP2. Once bound to F-actin, the opened ezrin forms more extensive contacts with F-actin than generally depicted, suggesting a possible role of ezrin in regulating the interfacial structure and dynamics between the cell membrane and the underlying actin cytoskeleton. In addition, using gel filtration, we find that the conformational opening of ezrin in response to PIP2 binding is cooperative, but the cooperativity is disrupted by a phospho-mimic mutation S249D in the 4.1-ezrin/radixin/moesin (FERM) domain of ezrin. Using surface plasmon resonance, we show that the S249D mutation weakens the binding affinity and changes the kinetics of 4.1-ERM to PIP2 binding. The study provides the first structural view of the activated ezrin bound to PIP2 and to F-actin.	[Jayasundar, Jayant James; Ju, Jeong Ho; Callaway, David J. E.; Bu, Zimei] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [He, Lilin] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA; [He, Lilin] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [He, Lilin; Liu, Dazhi; Meilleur, Flora; Zhao, Jinkui] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN 37831 USA; [Meilleur, Flora] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Callaway, David J. E.] NYU, Sch Med, New York, NY 10016 USA	City University of New York (CUNY) System; City College of New York (CUNY); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; North Carolina State University; New York University	Bu, ZM (corresponding author), CUNY City Coll, Dept Chem, Marshak Sci Bldg,Rm 1336,160 Convent Ave, New York, NY 10031 USA.	zbu@ccny.cuny.edu	Zhao, Jinkui/B-7872-2013; Liu, Dazhi/G-2675-2013; He, Lilin/O-4994-2016	Zhao, Jinkui/0000-0002-7756-1952; Liu, Dazhi/0000-0002-7604-6940; He, Lilin/0000-0002-9560-8101; Meilleur, Flora/0000-0001-9313-8989; Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [5R01HL086496]; National Institutes of Health Grant, NCRR [2G12 RR003060]; Division of Scientific User Facilities, Department of Energy Basic Energy Sciences; Oak Ridge National Laboratory Directed Research and Development Program; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant, NCRR; Division of Scientific User Facilities, Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); Oak Ridge National Laboratory Directed Research and Development Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL086496 (to Z. B.).; City College of New York was recipient of National Institutes of Health Grant 2G12 RR003060 from the NCRR. The work performed at Oak Ridge National Laboratory was supported by the Division of Scientific User Facilities, Department of Energy Basic Energy Sciences, and the Oak Ridge National Laboratory Directed Research and Development Program. We thank D. M. Engelman for comments on the manuscript.	Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Bu ZM, 1998, J APPL CRYSTALLOGR, V31, P533, DOI 10.1107/S0021889897015422; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ENGELMAN DM, 1975, ANNU REV BIOPHYS BIO, V4, P219, DOI 10.1146/annurev.bb.04.060175.001251; Farago B, 2010, BIOPHYS J, V99, P3473, DOI 10.1016/j.bpj.2010.09.058; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Glatter O., 1982, SMALL ANGLE XRAY SCA, P33; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; Hoeflich KP, 2003, BIOCHEMISTRY-US, V42, P11634, DOI 10.1021/bi0350497; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Scott JD, 2009, SCI SIGNAL, V2, DOI [10.1126/scisignal.253pc1, 10.1126/scisignal.296eg14, 10.1126/scisignal.266eg4]; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X; Zhu L., 2008, COMP STUDY EZRIN PHO; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	92	33	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37119	37133		10.1074/jbc.M112.380972	http://dx.doi.org/10.1074/jbc.M112.380972			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22927432	hybrid, Green Published			2022-12-28	WOS:000310588500046
J	Kloft, N; Neukirch, C; von Hoven, G; Bobkiewicz, W; Weis, S; Boller, K; Husmann, M				Kloft, Nicole; Neukirch, Claudia; von Hoven, Gisela; Bobkiewicz, Wiesia; Weis, Silvia; Boller, Klaus; Husmann, Matthias			A Subunit of Eukaryotic Translation Initiation Factor 2 alpha-Phosphatase (CreP/PPP1R15B) Regulates Membrane Traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING TOXINS; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; ACTIVATED PROTEIN-KINASE; CAVEOLIN-1 BINDING MOTIF; PLASMA-MEMBRANE; EIF2-ALPHA DEPHOSPHORYLATION; MULTIVESICULAR BODIES; CELLULAR-RESPONSES; GENE-EXPRESSION; VIBRIO-CHOLERAE	The constitutive reverter of eIF2 alpha phosphorylation (CReP)/PPP1r15B targets the catalytic subunit of protein phosphatase 1 (PP1c) to phosphorylated eIF2 alpha (p-eIF2 alpha) to promote its dephosphorylation and translation initiation. Here, we report a novel role and mode of action of CReP. We found that CReP regulates uptake of the pore-forming Staphylococcus aureus alpha-toxin by epithelial cells. This function was independent of PP1c and translation, although p-eIF2 alpha was involved. The latter accumulated at sites of toxin attack and appeared conjointly with alpha-toxin in early endosomes. CReP localized to membranes, interacted with phosphomimetic eIF2 alpha, and, upon overexpression, induced and decorated a population of intracellular vesicles, characterized by accumulation of N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (N-Rh-PE), a lipid marker of exosomes and intralumenal vesicles of multivesicular bodies. By truncation analysis, we delineated the CReP vesicle induction/association region, which comprises an amphipathic alpha-helix and is distinct from the PP1c interaction domain. CReP was also required for exocytosis from erythroleukemia cells and thus appears to play a broader role in membrane traffic. In summary, the mammalian traffic machinery co-opts p-eIF2 alpha and CReP, regulators of translation initiation.	[Kloft, Nicole; Neukirch, Claudia; von Hoven, Gisela; Bobkiewicz, Wiesia; Weis, Silvia; Husmann, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Boller, Klaus] Paul Ehrlich Inst, Dept Immunol, Morphol Sect, D-63225 Langen, Germany	Johannes Gutenberg University of Mainz; Paul Ehrlich Institute	Husmann, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	husmann@uni-mainz.de	von Hoven, Gisa/AAP-4044-2021		Deutsche Forschungsgemeinschaft [CRC 490]; Project D3	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Project D3	This work was supported by Deutsche Forschungsgemeinschaft, CRC 490, Project D3 (to M. H.). The contributions of G. v. H. were in partial fulfillment of her thesis requirements.	ANTEUNIS A, 1974, CELL TISSUE RES, V149, P497; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bethani I, 2010, EMBO J, V29, P2677, DOI 10.1038/emboj.2010.175; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Chen CH, 2010, J LASER MICRO NANOEN, V5, P1, DOI 10.2961/jlmn.2010.01.0001; De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0; Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kloft N, 2010, MED MICROBIOL IMMUN, V199, P299, DOI 10.1007/s00430-010-0163-0; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; Munter Sylvia, 2006, Sci STKE, V2006, pre5, DOI 10.1126/stke.3352006re5; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Pany S, 2007, BIOCHEM BIOPH RES CO, V363, P197, DOI 10.1016/j.bbrc.2007.08.132; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; Savina A, 2002, J CELL SCI, V115, P2505; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Valeva A, 2000, MOL MICROBIOL, V36, P467, DOI 10.1046/j.1365-2958.2000.01865.x; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Vidal M, 1997, J CELL SCI, V110, P1867; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	85	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35299	35317		10.1074/jbc.M112.379883	http://dx.doi.org/10.1074/jbc.M112.379883			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915583	hybrid, Green Published			2022-12-28	WOS:000309968000039
J	Rollenhagen, M; Kuckuck, S; Ulm, C; Hartmann, M; Galuska, SP; Geyer, R; Geyer, H; Muhlenhoff, M				Rollenhagen, Manuela; Kuckuck, Sarah; Ulm, Christina; Hartmann, Maike; Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard; Muehlenhoff, Martina			Polysialylation of the Synaptic Cell Adhesion Molecule 1 (SynCAM 1) Depends Exclusively on the Polysialyltransferase ST8SiaII in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHESIS; POSTNATAL MOUSE-BRAIN; MONOCLONAL-ANTIBODIES; SOLUBLE ISOFORM; N-GLYCOSYLATION; OLFACTORY-BULB; III REPEAT; RAT-BRAIN; NCAM; STX	Polysialic acid is a unique carbohydrate polymer specifically attached to a limited number of glycoproteins. Among them is synaptic cell adhesion molecule 1 (SynCAM 1), a member of the immunoglobulin (Ig) superfamily composed of three extracellular Ig-like domains. Polysialylation of SynCAM 1 is cell type-specific and was exclusively found in NG2 cells, a class of multifunctional progenitor cells that form specialized synapses with neurons. Here, we studied the molecular requirements for SynCAM 1 polysialylation. Analysis of mice lacking one of the two polysialyltransferases, ST8SiaII or ST8SiaIV, revealed that polysialylation of SynCAM 1 is exclusively mediated by ST8SiaII throughout postnatal brain development. Alternative splicing of the three variable exons 8a, 8b, and 8c can theoretically give rise to eight transmembrane isoforms of SynCAM 1. We detected seven transcript variants in the developing mouse brain, including three variants containing exon 8c, which was so far regarded as a cryptic exon in mice. Polysialylation of SynCAM 1 was restricted to four isoforms in perinatal brain. However, cell culture experiments demonstrated that all transmembrane isoforms of SynCAM 1 can be polysialylated by ST8SiaII. Moreover, analysis of domain deletion constructs revealed that Ig1, which harbors the polysialylation site, is not sufficient as an acceptor for ST8SiaII. The minimal polypeptide required for polysialylation contained Ig1 and Ig2, suggesting an important role for Ig2 as a docking site for ST8SiaII.	[Rollenhagen, Manuela; Kuckuck, Sarah; Hartmann, Maike; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Ulm, Christina; Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Inst Biochem, Fac Med, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Muhlenhoff, M (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [GE 527/5, MU 1774/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GE 527/5 (to H. G.) and MU 1774/3 (to M. M.).	Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Busam RD, 2011, J BIOL CHEM, V286, P4511, DOI 10.1074/jbc.M110.174011; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Hagiyama M, 2011, J IMMUNOL, V186, P5983, DOI 10.4049/jimmunol.1002244; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Koma Y, 2004, ONCOGENE, V23, P5687, DOI 10.1038/sj.onc.1207761; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; Muhlenhoff M, 2001, J BIOL CHEM, V276, P34066, DOI 10.1074/jbc.M101022200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Paukert M, 2006, CURR OPIN NEUROBIOL, V16, P515, DOI 10.1016/j.conb.2006.08.009; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; ROSE MC, 1984, J BIOL CHEM, V259, P3167; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Windfuhr M, 2000, J BIOL CHEM, V275, P32861, DOI 10.1074/jbc.M003507200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	60	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35170	35180		10.1074/jbc.M112.375642	http://dx.doi.org/10.1074/jbc.M112.375642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908220	hybrid, Green Published			2022-12-28	WOS:000309968000027
J	Yu, C; Lou, JZ; Wu, JJ; Pan, LF; Feng, W; Zhang, MJ				Yu, Cong; Lou, Jizhong; Wu, Jingjing; Pan, Lifeng; Feng, Wei; Zhang, Mingjie			Membrane-induced Lever Arm Expansion Allows Myosin VI to Walk with Large and Variable Step Sizes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; MOLECULAR-DYNAMICS; CELLULAR FUNCTIONS; PROTEIN FUNCTION; ACTIN-FILAMENTS; 3-HELIX BUNDLE; CARGO-BINDING; DOMAIN; MOTOR; DIMERIZATION	Myosin VI, the only known minus-ended actin filament-dependent motor, plays diverse cellular roles both as a processive motor and as a mechanical anchor. Although myosin VI has a short lever arm containing only one "IQ-motif" and a unique insertion for CaM binding, the motor walks with large and variable step sizes of similar to 30-36 nm. Here, we show that the previously predicted coiled-coil domain immediately following the IQ-motifs (referred to as the lever arm extension (LAE)) adopts a stable monomeric, three-helix bundle fold in solution. Importantly, the LAE can undergo reversible, lipid membrane-dependent conformational changes. Upon exposure to lipid membranes, the LAE adopts a partially extended rod shape, and the removal of lipids from the LAE converts it back into the compact helix bundle structure. Molecular dynamics simulations indicate that lipid membrane binding may initiate unfolding and thereby trigger the LAE expansion. This reversible, lipid membrane-dependent expansion of the LAE provides a mechanistic base for myosin VI to walk with large and variable step sizes.	[Lou, Jizhong; Feng, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Yu, Cong; Wu, Jingjing; Pan, Lifeng; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn; mzhang@ust.hk	yu, cong/V-5140-2018; , 余聪/AAK-9457-2020	yu, cong/0000-0003-2912-6347; Zhang, Mingjie/0000-0001-9404-0190	National Major Basic Research Program of China [2011CB910503]; National Natural Science Foundation of China [31070657, 31190062, 31070827]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-154, KSCX2-EW-J-3]; Research Grants Council of Hong Kong [664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/M-04/04]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Major Basic Research Program of China Grant 2011CB910503; National Natural Science Foundation of China Grants 31070657, 31190062, and 31070827; Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-154 and KSCX2-EW-J-3; and Research Grants Council of Hong Kong Grants 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, and AoE/M-04/04 (to M. Z.).	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Buss F, 2011, P NATL ACAD SCI USA, V108, P5927, DOI 10.1073/pnas.1103086108; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Kim H, 2010, STRUCTURE, V18, P1443, DOI 10.1016/j.str.2010.09.011; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu YX, 2011, BIOPHYS J, V100, P2964, DOI 10.1016/j.bpj.2011.05.010; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Ovchinnikov V, 2011, BIOPHYS J, V101, P2436, DOI 10.1016/j.bpj.2011.09.044; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Sweeney HL, 2010, CELL, V141, P573, DOI 10.1016/j.cell.2010.04.028; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao T, 2002, P NATL ACAD SCI USA, V99, P11151, DOI 10.1073/pnas.172188399; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	61	7	7	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35021	35035		10.1074/jbc.M111.328781	http://dx.doi.org/10.1074/jbc.M111.328781			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22936804	hybrid, Green Published			2022-12-28	WOS:000309968000014
J	Ma, J; Becker, C; Lowell, CA; Underhill, DM				Ma, Jun; Becker, Courtney; Lowell, Clifford A.; Underhill, David M.			Dectin-1-triggered Recruitment of Light Chain 3 Protein to Phagosomes Facilitates Major Histocompatibility Complex Class II Presentation of Fungal-derived Antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECOGNITION; DECTIN-1; MACROPHAGES; AUTOPHAGY; PHAGOCYTOSIS; RECEPTOR; CELLS; ACTIVATION; RESPONSES; YEAST	Dectin-1 is a pattern recognition receptor that is important for innate immune responses against fungi in humans and mice. Dectin-1 binds to beta-glucans in fungal cell walls and triggers phagocytosis, production of reactive oxygen by the NADPH oxidase, and inflammatory cytokine production which all contribute to host immune responses against fungi. Although the autophagy pathway was originally characterized for its role in the formation of double-membrane compartments engulfing cytosolic organelles and debris, recent studies have suggested that components of the autophagy pathway may also participate in traditional phagocytosis. In this study, we show that Dectin-1 signaling in macrophages and bone marrow-derived dendritic cells triggers formation of LC3II, a major component of the autophagy machinery. Further, Dectin-1 directs the recruitment of LC3II to phagosomes, and this requires Syk, activation of reactive oxygen production by the NADPH oxidase, and ATG5. Using LC3-deficient dendritic cells we show that whereas LC3 recruitment to phagosomes is not important for triggering phagocytosis, killing or Dectin-1-mediated inflammatory cytokine production, it facilitates recruitment of MHC class II molecules to phagosomes and promotes presentation of fungal-derived antigens to CD4 T cells.	[Underhill, David M.] Cedars Sinai Med Ctr, IBIRI, Los Angeles, CA 90048 USA; [Ma, Jun; Becker, Courtney; Underhill, David M.] Cedars Sinai Med Ctr, Div Immunol, Los Angeles, CA 90048 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California San Francisco	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, IBIRI, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X	National Institutes of Health [AI071116, GM085796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071116, R01AI068150, R01AI065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071116 and GM085796 (to D. M. U.).	Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	26	150	155	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34149	34156		10.1074/jbc.M112.382812	http://dx.doi.org/10.1074/jbc.M112.382812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902620	Green Published, hybrid			2022-12-28	WOS:000309654200020
J	Ren, T; Dong, W; Takahashi, Y; Xiang, D; Yuan, YS; Liu, X; Loughran, TP; Sun, SC; Wang, HG; Cheng, H				Ren, Tong; Dong, Wen; Takahashi, Yoshinori; Xiang, Di; Yuan, Yunsheng; Liu, Xin; Loughran, Thomas P., Jr.; Sun, Shao-Cong; Wang, Hong-Gang; Cheng, Hua			HTLV-2 Tax Immortalizes Human CD4(+) Memory T Lymphocytes by Oncogenic Activation and Dysregulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VIRUS TYPE-1 HTLV-1; CELL LEUKEMIA; MEDIATED ACTIVATION; IKK-ALPHA; KINASE; ONCOPROTEIN; INDUCTION; GENE; NF-KAPPA-B2/P100	Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are two closely related retroviruses with the former causing adult T cell leukemia. HTLV-2 infection is prevalent among intravenous drug users, and the viral genome encodes the viral transactivator Tax, which is highly homologous to the transforming protein Tax from HTLV-1. However, the link between HTLV-2 infection and leukemia has not been established. In the present study, we evaluated the activity of HTLV-2 Tax in promoting aberrant proliferation of human CD4 T lymphocytes. Tax2 efficiently immortalized CD4(+) memory T lymphocytes with a CD3/TCR alpha beta/CD4/CD25/CD45RO/CD69 immunophenotype, promoted constitutive activation of PI3K/Akt, I kappa B kinase/NF-kappa B, mitogen-activated protein kinase, and STAT3, and it also increased the level of Mcl-1. Disruption of these oncogenic pathways led to growth retardation and apoptotic cell death of the Tax2-established T cell lines. We further found that Tax2 induced autophagy by interacting with the autophagy molecule complex containing Beclin1 and PI3K class III to form the LC3(+) autophagosome. Tax2-mediated autophagy promoted survival and proliferation of the immortalized T cells. The present study demonstrated the oncogenic properties of Tax2 in human T cells and also implicated Tax2 in serving as a molecular tool to generate distinct T cell subtype lines.	[Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Yuan, Yunsheng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Ren, Tong; Dong, Wen; Takahashi, Yoshinori; Xiang, Di; Yuan, Yunsheng; Liu, Xin; Loughran, Thomas P., Jr.; Wang, Hong-Gang; Cheng, Hua] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Ren, Tong; Cheng, Hua] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St,S219, Baltimore, MD 21201 USA.	hcheng@ihv.umaryland.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA129682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health (to H. C.).	Arsov I, 2011, J IMMUNOL, V186, P2201, DOI 10.4049/jimmunol.1002223; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Chung HK, 2003, BLOOD, V102, P4130, DOI 10.1182/blood-2003-04-1043; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Huang JN, 2009, J BIOL CHEM, V284, P6208, DOI 10.1074/jbc.M806390200; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; LANOIX J, 1994, ONCOGENE, V9, P841; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; MALEFYT RD, 1990, J IMMUNOL, V145, P2297; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Richard V, 2001, AM J PATHOL, V158, P2219, DOI 10.1016/S0002-9440(10)64694-9; Sugahara K, 1997, INT J CANCER, V72, P128, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;128::AID-IJC18&gt;3.0.CO;2-F; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Waldele K, 2004, J VIROL, V78, P6081, DOI 10.1128/JVI.78.12.6081-6090.2004; Wang TG, 2000, AIDS RES HUM RETROV, V16, P1661, DOI 10.1089/08892220050193119; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805	47	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34683	34693		10.1074/jbc.M112.377143	http://dx.doi.org/10.1074/jbc.M112.377143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891252	Green Published, hybrid			2022-12-28	WOS:000309654200069
J	Shi, CS; Huang, NN; Kehrl, JH				Shi, Chong-Shan; Huang, Ning-Na; Kehrl, John H.			Regulator of G-Protein Signaling 3 Isoform 1 (PDZ-RGS3) Enhances Canonical Wnt Signaling and Promotes Epithelial Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; NEGATIVE REGULATOR; WNT/BETA-CATENIN; IMMUNE FUNCTION; AXIN; CANCER; PHOSPHORYLATION; TRANSCRIPTION; INHIBITION; EXPRESSION	The Wnt beta-catenin pathway controls numerous cellular processes including cell differentiation and cell-fate decisions. Wnt ligands engage Frizzled receptors and the low-density-lipoprotein-related protein 5/6 (LRP5/6) receptor complex leading to the recruitment of Dishevelled (Dvl) and Axin1 to the plasma membrane. Axin1 has a regulator of G-protein signaling (RGS) domain that binds adenomatous polyposis coli and G alpha subunits, thereby providing a mechanism by which G alpha subunits can affect beta-catenin levels. Here we show that Wnt signaling enhances the expression of another RGS domain-containing protein, PDZRGS3. Reducing PDZ-RGS3 levels impaired Wnt3a-induced activation of the canonical pathway. PDZ-RGS3 bound GSK3 beta and decreased its catalytic activity toward beta-catenin. PDZRGS3 overexpression enhanced Snail1 and led to morphological and biochemical changes reminiscent of epithelial mesenchymal transition (EMT). These results indicate that PDZ-RGS3 can enhance signals generated by the Wnt canonical pathway and that plays a pivotal role in EMT.	[Shi, Chong-Shan; Huang, Ning-Na; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, 10 Ctr Dr,MSC 1876, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	intramural research program of the NIAID; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000738] Funding Source: NIH RePORTER	intramural research program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the intramural research program of the NIAID, National Institutes of Health.	Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cho H, 2009, PROG MOL BIOL TRANSL, V86, P249, DOI 10.1016/S1877-1173(09)86009-2; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Freisinger CM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001020; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kehrl JH, 2002, GENOMICS, V79, P860, DOI 10.1006/geno.2002.6773; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Louwette S, 2012, FASEB J, V26, P2125, DOI 10.1096/fj.11-198739; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Qiu RX, 2010, STEM CELLS, V28, P1602, DOI 10.1002/stem.478; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Stemmle LN, 2006, MOL PHARMACOL, V70, P1461, DOI 10.1124/mol.106.023705; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	31	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33480	33487		10.1074/jbc.M112.361873	http://dx.doi.org/10.1074/jbc.M112.361873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859293	Green Published, hybrid			2022-12-28	WOS:000309602100034
J	Winkler, CW; Foster, SC; Matsumoto, SG; Preston, MA; Xing, RB; Bebo, BF; Banine, F; Berny-Lang, MA; Itakura, A; McCarty, OJT; Sherman, LS				Winkler, Clayton W.; Foster, Scott C.; Matsumoto, Steven G.; Preston, Marnie A.; Xing, Rubing; Bebo, Bruce F.; Banine, Fatima; Berny-Lang, Michelle A.; Itakura, Asako; McCarty, Owen J. T.; Sherman, Larry S.			Hyaluronan Anchored to Activated CD44 on Central Nervous System Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; P-SELECTIN; MEDIATED MOTILITY; PRIMARY ADHESION; RECEPTOR; INFLAMMATION; INTEGRIN; PROTEIN	The extravasation of lymphocytes across central nervous system (CNS) vascular endothelium is a key step in inflammatory demyelinating diseases including multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The glycosaminoglycan hyaluronan (HA) and its receptor, CD44, have been implicated in this process but their precise roles are unclear. We find that CD44(-/-) mice have a delayed onset of EAE compared with wild type animals. Using an in vitro lymphocyte rolling assay, we find that fewer slow rolling (<1 mu m/s) wild type (WT) activated lymphocytes interact with CD44(-/-) brain vascular endothelial cells (ECs) than with WTECs. We also find that CD44(-/-) ECs fail to anchor HA to their surfaces, and that slow rolling lymphocyte interactions with WTECs are inhibited when the ECs are treated with a pegylated form of the PH20 hyaluronidase (PEG-PH20). Subcutaneous injection of PEG-PH20 delays the onset of EAE symptoms by similar to 1 day and transiently ameliorates symptoms for 2 days following disease onset. These improved symptoms correspond histologically to degradation of HA in the lumen of CNS blood vessels, decreased demyelination, and impaired CD4(+) T-cell extravasation. Collectively these data suggest that HA tethered to CD44 on CNS ECs is critical for the extravasation of activated T cells into the CNS providing new insight into the mechanisms promoting inflammatory demyelinating disease.	[Winkler, Clayton W.; Foster, Scott C.; Matsumoto, Steven G.; Preston, Marnie A.; Xing, Rubing; Bebo, Bruce F.; Banine, Fatima; Sherman, Larry S.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Berny-Lang, Michelle A.; Itakura, Asako; McCarty, Owen J. T.] Oregon Hlth & Sci Univ, Integrat Biosci Dept, Sch Dent, Portland, OR 97239 USA; [Matsumoto, Steven G.] Oregon Hlth & Sci Univ, Sch Med, Dept Biomed Engn, Portland, OR 97239 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University	Sherman, LS (corresponding author), 505 NW 185th Ave, Beaverton, OR 97006 USA.	shermanl@ohsu.edu	Winkler, Clayton/F-8031-2018	Winkler, Clayton/0000-0002-4460-3378; Berny-Lang, Michelle/0000-0001-5889-4295	National Institutes of Health [P51 RR000163, P30 NS061800]; Halozyme Therapeutics Inc.; Laura Fund for Multiple Sclerosis Research; National Multiple Sclerosis Society [CA1055-A-3]; Vertex Pharmaceuticals scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Halozyme Therapeutics Inc.; Laura Fund for Multiple Sclerosis Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Vertex Pharmaceuticals scholar award(Vertex Pharmaceuticals); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P51 RR000163 and P30 NS061800, Halozyme Therapeutics Inc., the Laura Fund for Multiple Sclerosis Research, National Multiple Sclerosis Society Grant CA1055-A-3, and a Vertex Pharmaceuticals scholar award.	ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Brennan FR, 1999, IMMUNOLOGY, V98, P427, DOI 10.1046/j.1365-2567.1999.00894.x; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Campo GM, 2012, J CELL BIOCHEM, V113, P1852, DOI 10.1002/jcb.24054; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Deng X, 2002, J REPROD IMMUNOL, V54, P93, DOI 10.1016/S0165-0378(01)00124-3; Doring A, 2007, J IMMUNOL, V179, P8470, DOI 10.4049/jimmunol.179.12.8470; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; Gares S L, 2000, Dev Immunol, V7, P209, DOI 10.1155/2000/94616; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Hardy CM, 2004, REPRODUCTION, V127, P325, DOI 10.1530/rep.1.00016; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Holmoy T, 2007, ACTA NEUROL SCAND, V115, P39, DOI 10.1111/j.1600-0404.2007.00845.x; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Laman JD, 1998, MULT SCLER, V4, P147, DOI 10.1177/135245859800400312; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; PILARSKI LM, 1993, J IMMUNOL, V150, P4292; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Simpson MA, 2012, INT J CANCER, V131, pE836, DOI 10.1002/ijc.27427; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Sugie K, 2004, P NATL ACAD SCI USA, V101, P14859, DOI 10.1073/pnas.0406168101; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tuohy TMF, 2004, GLIA, V47, P335, DOI 10.1002/glia.20042; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	55	33	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33237	33251		10.1074/jbc.M112.356287	http://dx.doi.org/10.1074/jbc.M112.356287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865853	Green Published, hybrid			2022-12-28	WOS:000309602100014
J	Clark, NJ; Kramer, M; Muthurajan, UM; Luger, K				Clark, Nicholas J.; Kramer, Michael; Muthurajan, Uma M.; Luger, Karolin			Alternative Modes of Binding of Poly(ADP-ribose) Polymerase 1 to Free DNA and Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; STRAND BREAKS; HUMAN PARP-1; ZINC-FINGER; DOMAIN; TRANSCRIPTION; FLUORESCENCE; MODULATION; ACTIVATION; COOPERATE	Poly(ADP-ribose) polymerase 1 (PARP-1) is an abundant nuclear protein that binds chromatin and catalyzes the transfer of ADP-ribose groups to itself and to numerous target proteins upon interacting with damaged DNA. The molecular basis for the dual role of PARP-1 as a chromatin architectural protein and a first responder in DNA repair pathways remains unclear. Here, we quantified the interactions of full-length PARP-1 and its N-terminal half with different types of DNA damage and with defined nucleosome substrates. We found that full-length PARP-1 prefers nucleosomes with two linker DNA extensions over any other substrate (including several free DNA models) and that the C-terminal half of PARP-1 is necessary for this selectivity. We also measured the ability of various substrates to activate PARP-1 activity and found that the most important feature for activation is one free DNA end rather than tight interaction with the activating nucleic acid. Our data provide insight into the different modes of interaction of this multidomain protein with nucleosomes and free DNA.	[Clark, Nicholas J.; Kramer, Michael; Muthurajan, Uma M.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Howard Hughes Med Inst, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute	Luger, K (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	kluger@lamar.colostate.edu		SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [GM088409]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088409. This work was also supported by the Howard Hughes Medical Institute.	Ali AAE, 2012, NAT STRUCT MOL BIOL, V19, P685, DOI 10.1038/nsmb.2335; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Beneke S, 2010, MECH AGEING DEV, V131, P366, DOI 10.1016/j.mad.2010.04.003; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Gagne JP, 2012, SCIENCE, V336, P678, DOI 10.1126/science.1221870; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gurunathan K, 2009, CURR PHARM BIOTECHNO, V10, P559; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; LECAM E, 1994, J MOL BIOL, V235, P1062, DOI 10.1006/jmbi.1994.1057; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mangerich A, 2011, INT J CANCER, V128, P251, DOI 10.1002/ijc.25683; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Winkler D. D., 2012, METHOD ENZYMOL, V512, P1; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Yang CH, 2011, NUCLEIC ACIDS RES, V39, P4122, DOI 10.1093/nar/gkr005; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	35	61	68	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32430	32439		10.1074/jbc.M112.397067	http://dx.doi.org/10.1074/jbc.M112.397067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854955	hybrid, Green Published			2022-12-28	WOS:000309168300013
J	Tran, TH; Shi, XF; Zaia, J; Ai, XB				Tran, Thanh H.; Shi, Xiaofeng; Zaia, Joseph; Ai, Xingbin			Heparan Sulfate 6-O-endosulfatases (Sulfs) Coordinate the Wnt Signaling Pathways to Regulate Myoblast Fusion during Skeletal Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATELLITE STEM-CELLS; BETA-CATENIN; GROWTH; ACTIVATION; EXPRESSION; DIFFERENTIATION; INTERNALIZATION; MYOGENESIS; CAVEOLIN; CANCER	Skeletal muscle regeneration is mediated by satellite cells (SCs). Upon injury, SCs undergo self-renewal, proliferation, and differentiation into myoblasts followed by myoblast fusion to form new myofibers. We previously showed that the heparan sulfate (HS) 6-O-endosulfatases (Sulf1 and -2) repress FGF signaling to induce SC differentiation during muscle regeneration. Here, we identify a novel role of Sulfs in myoblast fusion using a skeletal muscle-specific Sulf double null (Sulf(SK)-DN) mouse. Regenerating Sulf(SK)-DN muscles exhibit reduced canonical Wnt signaling and elevated non-canonical Wnt signaling. In addition, we show that Sulfs are required to repress non-canonical Wnt signaling to promote myoblast fusion. Notably, skeletal muscle-relevant non-canonical Wnt ligands lack HS binding capacity, suggesting that Sulfs indirectly repress this pathway. Mechanistically, we show that Sulfs reduce the canonical Wnt-HS binding and regulate colocalization of the co-receptor LRP5 with caveolin3. Therefore, Sulfs may increase the bioavailability of canonical Wnts for Frizzled receptor and LRP5/6 interaction in lipid raft, which may in turn antagonize non-canonical Wnt signaling. Furthermore, changes in subcellular distribution of active focal adhesion kinase (FAK) are associated with the fusion defect of Sulf-deficient myoblasts and upon noncanonical Wnt treatment. Together, our findings uncover a critical role of Sulfs in myoblast fusion by promoting antagonizing canonical Wnt signaling activities against the noncanonical Wnt pathway during skeletal muscle regeneration.	[Tran, Thanh H.; Ai, Xingbin] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Ai, XB (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 72 E Concord St, Boston, MA 02118 USA.	aix@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Ai, Xingbin/0000-0002-2178-0080	National Institutes of Health [5T32AG000115-24, R01AG034939, R01HL098950, P41RR10888]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000115, R01AG034939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 5T32AG000115-24 (to T. T.) and Grants R01AG034939 (to X. A.) and R01HL098950 and P41RR10888 (to J. Z.).	Ai X., 2005, CHEM BIOL HEPARIN HE, P245; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	39	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32651	32664		10.1074/jbc.M112.353243	http://dx.doi.org/10.1074/jbc.M112.353243			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865881	Green Published, hybrid			2022-12-28	WOS:000309168300033
J	Su, PC; Berger, BW				Su, Pin-Chuan; Berger, Bryan W.			Identifying Key Juxtamembrane Interactions in Cell Membranes Using AraC-based Transcriptional Reporter Assay (AraTM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN INTERACTIONS; PROTEIN-PROTEIN INTERACTIONS; SIGNAL-TRANSDUCTION; RECEPTOR; RAGE; DIMERIZATION; ASSOCIATION; EXPRESSION; BINDING; OLIGOMERIZATION	Dimerization is a key regulatory mechanism in activation of transmembrane (TM) receptors during signal transduction. This process involves a coordinated interplay between extracellular (EX), TM, and cytoplasmic (CYTO) regions to form a specific interface required for both ligand binding and intracellular signaling to occur. While several transcriptional activator-based methods exist for investigating TM interactions in bacterial membranes, expression of TM chimera in these methods occurs in a reverse orientation, and are limited to only TM domains for proper membrane trafficking and integration. We therefore developed a new, AraC-based transcriptional reporter assay (AraTM) that expresses EX-TM-CYTO chimera in their native orientation, thereby enabling membrane trafficking to occur independent of the TM chimera used as well as permitting analysis of EX-TM-CYTO interactions in biological membranes. Using integrin alpha(IIb) TM-CYTO as a model, we observe a large increase in homodimerization for the constitutively active TM mutant L980A relative to wild-type in the TM-CYTO construct (A963-E1008). We also characterized the receptor for advanced glycation endproducts (RAGE), whose homooligomeric state is critical in ligand recognition, and find the specific juxtamembrane region within the CYTO (A375-P394) mediates homodimerization, and is dominant over effects observed when the extracellular C2 domain is included. Furthermore, we find good agreement between our AraTM measurements in bacterial membranes and BRET measurements made on corresponding RAGE constructs expressed in transfected HEK293 cells. Overall, the AraTM assay provides a new approach to identify specific interactions between receptor EX-TM-CYTO domains in biological membranes that are important in regulation of signal transduction.	[Su, Pin-Chuan; Berger, Bryan W.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA; [Berger, Bryan W.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Berger, BW (corresponding author), Lehigh Univ, Dept Chem Engn, B320 Iacocca Hall,111 Res Dr, Bethlehem, PA 18015 USA.	bwb209@lehigh.edu	Berger, Bryan/D-7985-2014	Berger, Bryan/0000-0002-6135-8677	Lehigh University	Lehigh University	This work was supported by Lehigh University, including funds provided through a Faculty Research Grant (FRG).	Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; Eustance RJ, 1996, PROTEINS, V25, P501, DOI 10.1002/(SICI)1097-0134(199608)25:4<501::AID-PROT9>3.3.CO;2-1; Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Ladant D, 2000, RES MICROBIOL, V151, P711, DOI 10.1016/S0923-2508(00)01136-0; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Metcalf DG, 2009, J MOL BIOL, V392, P1087, DOI 10.1016/j.jmb.2009.06.032; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; Oates J, 2010, BBA-BIOMEMBRANES, V1798, P605, DOI 10.1016/j.bbamem.2009.12.016; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ott CM, 2002, J CELL SCI, V115, P2003; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Scartezzini P, 1997, HUM GENET, V99, P387, DOI 10.1007/s004390050377; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Weldon JE, 2006, PROTEIN SCI, V15, P2828, DOI 10.1110/ps.062327506; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	40	19	19	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31515	31526		10.1074/jbc.M112.396895	http://dx.doi.org/10.1074/jbc.M112.396895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822084	Green Published, hybrid			2022-12-28	WOS:000308791300064
J	Busch, F; Mobasheri, A; Shayan, P; Lueders, C; Stahlmann, R; Shakibaei, M				Busch, Franziska; Mobasheri, Ali; Shayan, Parviz; Lueders, Cora; Stahlmann, Ralf; Shakibaei, Mehdi			Resveratrol Modulates Interleukin-1 beta-induced Phosphatidylinositol 3-Kinase and Nuclear Factor kappa B Signaling Pathways in Human Tenocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; HIGH-DENSITY COCULTURE; S-PHASE ARREST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSCRIPTION; LIFE-SPAN; ACTIVATION; APOPTOSIS; EXPRESSION	Resveratrol, an activator of histone deacetylase Sirt-1, has been proposed to have beneficial health effects due to its antioxidant and anti-inflammatory properties. However, the mechanisms underlying the anti-inflammatory effects of resveratrol and the intracellular signaling pathways involved are poorly understood. An in vitro model of human tenocytes was used to examine the mechanism of resveratrol action on IL-1 beta-mediated inflammatory signaling. Resveratrol suppressed IL-1 beta-induced activation of NF-kappa B and PI3K in a dose- and time-dependent manner. Treatment with resveratrol enhanced the production of matrix components collagen types I and III, tenomodulin, and tenogenic transcription factor scleraxis, whereas it inhibited gene products involved in inflammation and apoptosis. IL-1 beta-induced NF-kappa B and PI3K activation was inhibited by resveratrol or the inhibitors of PI3K ( wortmannin), c-Src ( PP1), and Akt ( SH-5) through inhibition of I kappa B kinase, I kappa B alpha phosphorylation, and inhibition of nuclear translocation of NF-kappa B, suggesting that PI3K signaling pathway may be one of the signaling pathways inhibited by resveratrol to abrogate NF-kappa B activation. Inhibition of PI3K by wortmannin attenuated IL-1 beta-induced Akt and p65 acetylation, suggesting that p65 is a downstream component of PI3K/Akt in these responses. The modulatory effects of resveratrol on IL-1 beta-induced activation of NF-kappa B and PI3K were found to be mediated at least in part by the association between Sirt-1 and scleraxis and deacetylation of NF-kappa B and PI3K. Overall, these results demonstrate that activated Sirt-1 plays an essential role in the anti-inflammatory effects of resveratrol and this may be mediated at least in part through inhibition/deacetylation of PI3K and NF-kappa B.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Loughborough LE12 5RD, England; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Lueders, Cora] Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, D-13353 Berlin, Germany; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; ALVARES O, 1995, J PERIODONTOL, V66, P552, DOI 10.1902/jop.1995.66.7.552; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; Ozes ON, 1999, NATURE, V401, P82; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Riley GP, 2001, J HAND SURG-BRIT EUR, V26, P224, DOI 10.1054/jhsb.2001.0560; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P715; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Sun LP, 2011, EXP CELL RES, V317, P932, DOI 10.1016/j.yexcr.2011.01.025; TEWARI DS, 1994, ARCH ORAL BIOL, V39, P657, DOI 10.1016/0003-9969(94)90091-4; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	51	79	82	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377028	http://dx.doi.org/10.1074/jbc.M112.377028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22936809	Green Published, hybrid			2022-12-28	WOS:000310642200039
J	Kang, HE; Weng, CC; Saijo, E; Saylor, V; Bian, JF; Kim, S; Ramos, L; Angers, R; Langenfeld, K; Khaychuk, V; Calvi, C; Bartz, J; Hunter, N; Telling, GC				Kang, Hae-Eun; Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Bian, Jifeng; Kim, Sehun; Ramos, Laylaa; Angers, Rachel; Langenfeld, Katie; Khaychuk, Vadim; Calvi, Carla; Bartz, Jason; Hunter, Nora; Telling, Glenn C.			Characterization of Conformation-dependent Prion Protein Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODY; TRUNCATED FORMS; SHEEP SCRAPIE; PRP; BINDING; BRAIN; MICE	Whereas prion replication involves structural rearrangement of cellular prion protein (PrPC), the existence of conformational epitopes remains speculative and controversial, and PrP transformation is monitored by immunoblot detection of PrP(2730), a protease-resistant counterpart of the pathogenic scrapie form (PrPSc) of PrP. We now describe the involvement of specific amino acids in conformational determinants of novel monoclonal antibodies (mAbs) raised against randomly chimeric PrP. Epitope recognition of two mAbs depended on polymorphisms controlling disease susceptibility. Detection by one, referred to as PRC5, required alanine and asparagine at discontinuous mouse PrP residues 132 and 158, which acquire proximity when residues 126-218 form a structured globular domain. The discontinuous epitope of glycosylation-dependent mAb PRC7 also mapped within this domain at residues 154 and 185. In accordance with their conformational dependence, tertiary structure perturbations compromised recognition by PRC5, PRC7, as well as previously characterized mAbs whose epitopes also reside in the globular domain, whereas conformation-independent epitopes proximal or distal to this region were refractory to such destabilizing treatments. Our studies also address the paradox of how conformational epitopes remain functional following denaturing treatments and indicate that cellular PrP and PrP(27-30) both renature to a common structure that reconstitutes the globular domain.	[Kang, Hae-Eun; Saijo, Eri; Bian, Jifeng; Kim, Sehun; Ramos, Laylaa; Khaychuk, Vadim; Calvi, Carla; Telling, Glenn C.] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Angers, Rachel; Telling, Glenn C.] Univ Kentucky, Integrated Biomed Sci Program, Dept Microbiol Immunol & Mol Genet, Dept Neurol,Med Ctr, Lexington, KY 40536 USA; [Weng, Chu Chun; Saijo, Eri; Saylor, Vicki; Angers, Rachel; Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Langenfeld, Katie; Bartz, Jason] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Hunter, Nora] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland	Colorado State University; University of Kentucky; University of Kentucky; Creighton University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Telling, GC (corresponding author), Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	glenn.telling@colostate.edu	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805; Bartz, Jason/0000-0003-4081-7886	National Institutes of Health [RO1 NS040334, PO1 AI077774-015261, T32 DA022738]; BBSRC [BBS/E/D/05241340, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241340, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS040334 and PO1 AI077774-015261 (to G. C. T.) and T32 DA022738 (to V. K., R. A., and G. C. T.).	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; BARRY RA, 1986, J INFECT DIS, V153, P848, DOI 10.1093/infdis/153.5.848; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; Bilheude JM, 2007, J VIROL METHODS, V145, P169, DOI 10.1016/j.jviromet.2007.05.026; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Dupuy LC, 2009, VACCINE, V27, P4152, DOI 10.1016/j.vaccine.2009.04.049; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Johnson C, 2003, J WILDLIFE DIS, V39, P576, DOI 10.7589/0090-3558-39.3.576; Jones M, 2009, HYBRIDOMA, V28, P13, DOI 10.1089/hyb.2008.0067; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Petsch B, 2011, J VIROL, V85, P4538, DOI 10.1128/JVI.02467-10; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Sasamori E, 2010, ARCH BIOCHEM BIOPHYS, V501, P232, DOI 10.1016/j.abb.2010.06.025; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yuan J, 2005, BIOCHEM BIOPH RES CO, V326, P652, DOI 10.1016/j.bbrc.2004.11.088; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	58	25	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37219	37232		10.1074/jbc.M112.395921	http://dx.doi.org/10.1074/jbc.M112.395921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948149	hybrid, Green Published			2022-12-28	WOS:000310588500055
J	Vartanian, AS; Paz, A; Fortgang, EA; Abramson, J; Dahlquist, FW				Vartanian, Armand S.; Paz, Aviv; Fortgang, Emily A.; Abramson, Jeff; Dahlquist, Frederick W.			Structure of Flagellar Motor Proteins in Complex Allows for Insights into Motor Structure and Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; CHARGED RESIDUES; TORQUE RING; FLIG; ROTOR; ROTATION; DRIVEN	The flagellar motor is one type of propulsion device of motile bacteria. The cytoplasmic ring (C-ring) of the motor interacts with the stator to generate torque in clockwise and counter-clockwise directions. The C-ring is composed of three proteins, FliM, FliN, and FliG. Together they form the "switch complex" and regulate switching and torque generation. Here we report the crystal structure of the middle domain of FliM in complex with the middle and C-terminal domains of FliG that shows the interaction surface and orientations of the proteins. In the complex, FliG assumes a compact conformation in which the middle and C-terminal domains (FliG(MC)) collapse and stack together similarly to the recently published structure of a mutant of FliGMC with a clockwise rotational bias. This intramolecular stacking of the domains is distinct from the intermolecular stacking seen in other structures of FliG. We fit the complex structure into the three-dimensional reconstructions of the motor and propose that the cytoplasmic ring is assembled from 34 FliG and FliM molecules in a 1:1 fashion.	[Vartanian, Armand S.; Fortgang, Emily A.; Dahlquist, Frederick W.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Paz, Aviv; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dahlquist, FW (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	Dahlquist@chem.ucsb.edu	Paz, Aviv/AAN-3966-2021					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Blair DF, 2003, FEBS LETT, V545, P86, DOI 10.1016/S0014-5793(03)00397-1; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Marykwas DL, 1996, J BACTERIOL, V178, P1289, DOI 10.1128/jb.178.5.1289-1294.1996; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Passmore SE, 2008, MICROBIOL-SGM, V154, P714, DOI 10.1099/mic.0.2007/014597-0; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Stock D, 2012, CURR OPIN BIOTECH, V23, P545, DOI 10.1016/j.copbio.2012.01.008; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Yakushi T, 2006, J BACTERIOL, V188, P1466, DOI 10.1128/JB.188.4.1466-1472.2006	30	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35779	35783		10.1074/jbc.C112.378380	http://dx.doi.org/10.1074/jbc.C112.378380			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896702	Green Published, hybrid			2022-12-28	WOS:000310364000001
J	Kobayashi, Y; Tateno, H; Dohra, H; Moriwaki, K; Miyoshi, E; Hirabayashi, J; Kawagishi, H				Kobayashi, Yuka; Tateno, Hiroaki; Dohra, Hideo; Moriwaki, Kenta; Miyoshi, Eiji; Hirabayashi, Jun; Kawagishi, Hirokazu			A Novel Core Fucose-specific Lectin from the Mushroom Pholiota squarrosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; VICIA-FABA AGGLUTININ; COLON-CANCER CELLS; ALPHA-FETOPROTEIN; HEPATOCELLULAR-CARCINOMA; LENS-CULINARIS; OLIGOSACCHARIDE INTERACTIONS; BINDING-SPECIFICITY; ASPERGILLUS-ORYZAE; PURIFICATION	Fuc alpha 1-6 oligosaccharide has a variety of biological functions and serves as a biomarker for hepatocellular carcinoma because of the elevated presence of fucosylated alpha-fetoprotein ( AFP) in this type of cancer. In this study we purified a novel Fuc alpha 1-6-specific lectin from the mushroom Pholiota squarrosa by ion-exchange chromatography and affinity chromatography on thyroglobulin-agarose. The purified lectin was designated as PhoSL ( P. squarrosa lectin). SDS-PAGE, MALDI-TOF mass spectrometry, and N-terminal amino acid sequencing indicate that PhoSL has a molecular mass of 4.5 kDa and consists of 40 amino acids (NH2-APVPVTKLVCDGDTYKCTAYLDFGDGRWVAQWDTNVFHTG-OH). Isoelectric focusing of the lectin showed bands near pI 4.0. The lectin activity was stable between pH 2.0 and 11.0 and at temperatures ranging from 0 to 100 degrees C for incubation times of 30 min. When PhoSL was investigated with frontal affinity chromatography using 132 pyridylaminated oligosaccharides, it was found that the lectin binds only to core alpha 1-6-fucosylated N-glycans and not to other types of fucosylated oligosaccharides, such as alpha 1-2-, alpha 1-3-, and alpha 1-4-fucosylated glycans. Furthermore, PhoSL bound to alpha 1-6-fucosylated AFP but not to non-fucosylated AFP. In addition, PhoSL was able to demonstrate the differential expression of alpha 1-6fucosylation between primary and metastatic colon cancer tissues. Thus, PhoSL will be a promising tool for analyzing the biological functions of alpha 1-6 fucosylation and evaluating Fuc alpha 1-6 oligosaccharides as cancer biomarkers.	[Kobayashi, Yuka] J Oil Mills Inc, Totsuka Ku, Yokohama, Kanagawa 2450064, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba 3058568, Japan; [Dohra, Hideo] Shizuoka Univ, Fac Agr, Inst Genet Res & Biotechnol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Fac Agr, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Suruga Ku, Shizuoka 4228529, Japan; [Moriwaki, Kenta; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Investigat, Suita, Osaka 5650871, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Shizuoka University; Shizuoka University; Shizuoka University; Osaka University	Kobayashi, Y (corresponding author), J Oil Mills Inc, Totsuka Ku, 11 Kagetoricho, Yokohama, Kanagawa 2450064, Japan.	yuka.kobayashi@j-oil.com; achkawa@ipc.shizuoka.ac.jp	Tateno, Hiroaki/M-2706-2018; Hirabayashi, Jun/M-3998-2018	Tateno, Hiroaki/0000-0003-3006-1659; Hirabayashi, Jun/0000-0002-8571-359X; Moriwaki, Kenta/0000-0002-8724-4715; Dohra, Hideo/0000-0002-3919-3538				ABELEV GI, 1963, TRANSPLANTATION, V1, P174, DOI 10.1097/00007890-196301020-00004; ALLEN AK, 1976, BIOCHEM J, V155, P127, DOI 10.1042/bj1550127; Amano J, 2009, GLYCOBIOLOGY, V19, P601, DOI 10.1093/glycob/cwp026; [Anonymous], INT J MED MUSH; AOYAGI Y, 1995, GLYCOCONJUGATE J, V12, P194, DOI 10.1007/BF00731319; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; FORIERS A, 1981, J BIOL CHEM, V256, P5550; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; HARADA H, 1987, ANAL BIOCHEM, V164, P374, DOI 10.1016/0003-2697(87)90507-0; Hirabayashi J, 2000, J CHROMATOGR A, V890, P261, DOI 10.1016/S0021-9673(00)00545-8; Horibe M, 2010, PHYTOCHEMISTRY, V71, P648, DOI 10.1016/j.phytochem.2009.12.003; HOWARD IK, 1971, J BIOL CHEM, V246, P1590; Ichikawa E, 2006, ELECTROPHORESIS, V27, P3480, DOI 10.1002/elps.200600040; Jordinson M, 1999, GUT, V44, P709, DOI 10.1136/gut.44.5.709; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; KAWAGISHI H, 1994, J BIOL CHEM, V269, P1375; KAWAGISHI H, 1995, FOOD REV INT, V11, P63, DOI 10.1080/87559129509541019; KAWAGISHI H, 1988, FEBS LETT, V227, P99, DOI 10.1016/0014-5793(88)80876-7; Kobayashi Y, 2004, J BIOL CHEM, V279, P53048, DOI 10.1074/jbc.M407997200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1; Lundy FT, 1999, MOL BIOTECHNOL, V12, P203, DOI 10.1385/MB:12:2:203; Matsumoto H, 2010, CLIN CHEM LAB MED, V48, P505, DOI 10.1515/CCLM.2010.095; MATSUMOTO I, 1983, J BIOCHEM-TOKYO, V93, P763, DOI 10.1093/jb/93.3.763; Matsumura K, 2009, ANAL BIOCHEM, V386, P217, DOI 10.1016/j.ab.2008.11.044; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; MORINAGA T, 1983, P NATL ACAD SCI-BIOL, V80, P4604, DOI 10.1073/pnas.80.15.4604; Moriwaki K, 2011, J BIOL CHEM, V286, P43123, DOI 10.1074/jbc.M111.262741; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097; Mun JY, 2012, APPL MICROBIOL BIOT, V93, P251, DOI 10.1007/s00253-011-3549-z; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Nakamura-Tsuruta S, 2006, METHOD ENZYMOL, V415, P311, DOI 10.1016/S0076-6879(06)15019-3; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Norton PA, 2008, J CELL BIOCHEM, V104, P136, DOI 10.1002/jcb.21610; Oda Y, 2003, J BIOL CHEM, V278, P32439, DOI 10.1074/jbc.M305181200; Sterling RK, 2007, AM J GASTROENTEROL, V102, P2196, DOI 10.1111/j.1572-0241.2007.01405.x; TAKETA K, 1989, ELECTROPHORESIS, V10, P562, DOI 10.1002/elps.1150100805; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tamura Y, 2010, DIGEST DIS SCI, V55, P3576, DOI 10.1007/s10620-010-1222-5; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Yamagata Y, 2003, CLIN CHIM ACTA, V327, P59, DOI 10.1016/S0009-8981(02)00305-4; Yamamoto K, 2010, J GASTROENTEROL, V45, P1272, DOI 10.1007/s00535-010-0278-5; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688	51	78	82	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33973	33982		10.1074/jbc.M111.327692	http://dx.doi.org/10.1074/jbc.M111.327692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872641	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000309654200005
J	Yoshioka, Y; Kosaka, N; Ochiya, T; Kato, T				Yoshioka, Yusuke; Kosaka, Nobuyoshi; Ochiya, Takahiro; Kato, Takashi			Micromanaging Iron Homeostasis HYPOXIA-INDUCIBLE MICRO-RNA-210 SUPPRESSES IRON HOMEOSTASIS-RELATED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR EXPRESSION; HYPOXIA; ACTIVATION; GENE; IDENTIFICATION; MICRORNAS; MECHANISM; TARGETS; CELLS; DIFFERENTIATION	Iron is fundamental for sustaining life for living organisms, and the iron metabolism is finely regulated at different levels. In cancer cells, deregulation of the iron metabolism induces oxidative stress and drives tumor progression and metastasis; however, the molecular mechanisms of iron homeostasis are not fully understood. Here we found that iron deficiency as well as hypoxia promoted microRNA-210 (miR-210) expression. A central mediator of miR-210 transcriptional activation is the hypoxia-inducible factor (HIF)-1 alpha, and the hypoxia-response element in the miR-210 promoter is confirmed experimentally. This is in agreement with the data from in vivo studies that have demonstrated the presence of miR-210-expressing cells at the chronic hypoxic regions of xeno-grafted tumors. Furthermore we found two essential molecules for iron homeostasis, iron-sulfur cluster scaffold protein (ISCU) and transferrin receptor 1 (TfR), are a direct target of miR-210. Transfection of miR-210 decreases the uptake of transferrin by inhibiting the expression of TfR. In addition, inhibition of miR-210 by anti-miR-210 up-regulates ISCU expression. These findings suggest that miR-210 works as an iron sensor and is involved in the maintenance of iron homeostasis by sustaining the TfR expression level to stimulate cell proliferation and promote cell survival in the hypoxic region within tumors.	[Yoshioka, Yusuke; Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Translat Res Grp, Chuo Ku, Tokyo 1040045, Japan; [Kato, Takashi] Waseda Univ, Dept Biol, Sch Educ, Shinjuku Ku, Tokyo 1628480, Japan; [Yoshioka, Yusuke; Kato, Takashi] Waseda Univ, Grad Sch Sci & Engn, Mol Physiol Unit Major Integrat Biosci & Biomed E, Shinjuku Ku, Tokyo 1628480, Japan	National Cancer Center - Japan; Waseda University; Waseda University	Kato, T (corresponding author), Waseda Univ, Dept Biol, Sch Educ, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan.	tkato@waseda.jp	Kato, Takashi/AFO-2557-2022; Ochiya, Takahiro/AAH-7585-2019	Kato, Takashi/0000-0003-0384-7971; 	Ministry of Education, Culture, Sports, Science, and Technology; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science; Council for Science and Technology Policy (CSTP)	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This work was supported in part by a grant-in-aid for the third-term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science, and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). This work was supported in part by a grant from the Japan Society for the Promotion of Science (to Y. Y.).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campbell J A, 1940, Br Med J, V2, P275; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; CHITAMBAR CR, 1983, J CLIN INVEST, V72, P1314, DOI 10.1172/JCI111087; Clark SF, 2009, CURR OPIN GASTROEN, V25, P122, DOI 10.1097/MOG.0b013e32831ef1cd; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Laftah AH, 2005, ANN HEMATOL, V84, P177, DOI 10.1007/s00277-004-0945-9; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pau MYM, 2007, P NATL ACAD SCI USA, V104, P18355, DOI 10.1073/pnas.0704191104; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; RAJA KB, 1990, INT J EXP PATHOL, V71, P785; Raleigh JA, 1999, RADIAT RES, V151, P580, DOI 10.2307/3580034; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; VAUPEL P, 1989, CANCER RES, V49, P6449; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Ye Hong, 2010, Adv Hematol, V2010, DOI 10.1155/2010/329394	38	59	63	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34110	34119		10.1074/jbc.M112.356717	http://dx.doi.org/10.1074/jbc.M112.356717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896707	Green Published, hybrid			2022-12-28	WOS:000309654200017
J	Fay, JF; Farrens, DL				Fay, Jonathan F.; Farrens, David L.			A Key Agonist-induced Conformational Change in the Cannabinoid Receptor CB1 Is Blocked by the Allosteric Ligand Org 27569	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; ADENOSINE A(2A) RECEPTOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING-SITE; ACTIVATION; RHODOPSIN; EXPRESSION; COMPLEX	Allosteric ligands that modulate how G protein-coupled receptors respond to traditional orthosteric drugs are an exciting and rapidly expanding field of pharmacology. An allosteric ligand for the cannabinoid receptor CB1, Org 27569, exhibits an intriguing effect; it increases agonist binding, yet blocks agonist-induced CB1 signaling. Here we explored the mechanism behind this behavior, using a site-directed fluorescence labeling approach. Our results show that Org 27569 blocks conformational changes in CB1 that accompany G protein binding and/or activation, and thus inhibit formation of a fully active CB1 structure. The underlying mechanism behind this behavior is that simultaneous binding of Org 27569 produces a unique agonist-bound conformation, one that may resemble an intermediate structure formed on the pathway to full receptor activation.	[Fay, Jonathan F.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Mail Code L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu			National Institutes of Health from the National Institute on Drug Abuse (NIDA), NIDA [5R01DA018169, T32 DA007262]; NEI Grant [2R01EY015436-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025684] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA018169] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse (NIDA), NIDA; NEI Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DA018169 (to D. L. F.) from the National Institute on Drug Abuse (NIDA), NIDA Training Grant T32 DA007262 (to J. F. F.), and NEI Grant 2R01EY015436-05 (to D. L. F.).	Calandra B, 1997, BIOTECHNOL LETT, V19, P425, DOI 10.1023/A:1018383808401; Chillakuri CR, 2007, FEBS J, V274, P6106, DOI 10.1111/j.1742-4658.2007.06132.x; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Farrens DL, 2002, J PEPT RES, V60, P336, DOI 10.1034/j.1399-3011.2002.21066.x; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; GETHER U, 1995, J BIOL CHEM, V270, P28268; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Katoch-Rouse R, 2003, J MED CHEM, V46, P642, DOI 10.1021/jm020157x; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kim TK, 2005, PROTEIN EXPRES PURIF, V40, P60, DOI 10.1016/j.pep.2004.10.026; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lakowicz J. R, 2006, PRINCIPLES FLUORESCE, V3rd; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Makriyannis A., 1995, CANNABINOID RECEPTOR, P105; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; Matsuda T, 2000, METHOD ENZYMOL, V316, P465; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shire D, 1996, J BIOL CHEM, V271, P6941, DOI 10.1074/jbc.271.12.6941; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J BIOL CHEM, V285, P7351, DOI 10.1074/jbc.M109.078709; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Xu W, 2005, J PEPT RES, V66, P138, DOI 10.1111/j.1399-3011.2005.00283.x; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	61	35	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33873	33882		10.1074/jbc.M112.352328	http://dx.doi.org/10.1074/jbc.M112.352328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846992	hybrid, Green Published			2022-12-28	WOS:000309602100068
J	Kristiana, I; Luu, W; Stevenson, J; Cartland, S; Jessup, W; Belani, JD; Rychnovsky, SD; Brown, AJ				Kristiana, Ika; Luu, Winnie; Stevenson, Julian; Cartland, Sian; Jessup, Wendy; Belani, Jitendra D.; Rychnovsky, Scott D.; Brown, Andrew J.			Cholesterol through the Looking Glass ABILITY OF ITS ENANTIOMER ALSO TO ELICIT HOMEOSTATIC RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHOLESTEROL; STEROL-REGULATED TRANSPORT; SCAP PROTEIN; BINDING; SREBPS; GOLGI; 25-HYDROXYCHOLESTEROL; IDENTIFICATION; DEGRADATION; LIPOPROTEIN	How cholesterol is sensed to maintain homeostasis has been explained by direct binding to a specific protein, Scap, or through altering the physical properties of the membrane. The enantiomer of cholesterol (ent-cholesterol) is a valuable tool in distinguishing between these two models because it shares non-specific membrane effects with native cholesterol (nat-cholesterol), but not specific binding interactions. This is the first study to compare ent- and nat-cholesterol directly on major molecular parameters of cholesterol homeostasis. We found that ent- cholesterol suppressed activation of the master transcriptional regulator of cholesterol metabolism, SREBP-2, almost as effectively as nat-cholesterol. Importantly, ent-cholesterol induced a conformational change in the cholesterol-sensing protein Scap in isolated membranes in vitro, even when steps were taken to eliminate potential confounding effects from endogenous cholesterol. Ent-cholesterol also accelerated proteasomal degradation of the key cholesterol biosynthetic enzyme, squalene monooxygenase. Together, these findings provide compelling evidence that cholesterol maintains its own homeostasis not only via direct protein interactions, but also by altering membrane properties.	[Kristiana, Ika; Luu, Winnie; Stevenson, Julian; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Cartland, Sian; Jessup, Wendy] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Belani, Jitendra D.; Rychnovsky, Scott D.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of California System; University of California Irvine	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Belani, Jitendra/W-5561-2019	Cartland, Sian/0000-0003-1723-2679; Rychnovsky, Scott/0000-0002-7223-4389	National Health and Medical Research Council Grant [1008081]; Prostate Cancer Foundation Grant [PG2710]; National Heart Foundation of Australia Grant [G11S 5757]	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation Grant; National Heart Foundation of Australia Grant(National Heart Foundation of Australia)	This work was supported by the National Health and Medical Research Council Grant 1008081, the Prostate Cancer Foundation Grant PG2710, and the National Heart Foundation of Australia Grant G11S 5757 (to the Brown Research Laboratory).	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Belani JD, 2008, J ORG CHEM, V73, P2768, DOI 10.1021/jo702694g; Bielska AA, 2012, TRENDS ENDOCRIN MET, V23, P99, DOI 10.1016/j.tem.2011.12.002; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chaudhuri A, 2011, BBA-BIOMEMBRANES, V1808, P19, DOI 10.1016/j.bbamem.2010.10.013; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Kristiana I, 2010, PHARMACOGENOMICS J, V10, P396, DOI 10.1038/tpj.2009.62; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Luker GD, 2000, BIOCHEMISTRY-US, V39, P7651, DOI 10.1021/bi9928593; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MICKUS DE, 1992, J AM CHEM SOC, V114, P359, DOI 10.1021/ja00027a055; Mitchell CR, 2003, METH MOL B, V243, P61; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	44	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33897	33904		10.1074/jbc.M112.360537	http://dx.doi.org/10.1074/jbc.M112.360537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869373	Green Published, hybrid			2022-12-28	WOS:000309602100070
J	Mokrosinski, J; Frimurer, TM; Sivertsen, B; Schwartz, TW; Holst, B				Mokrosinski, Jacek; Frimurer, Thomas M.; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte			Modulation of Constitutive Activity and Signaling Bias of the Ghrelin Receptor by Conformational Constraint in the Second Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; 7-TRANSMEMBRANE RECEPTOR; STRUCTURAL BASIS; OPIOID RECEPTOR; LIGAND-BINDING; HELIX MOVEMENT; AGONIST; IDENTIFICATION; RHODOPSIN	Based on a rare, natural Glu for Ala-204(C+6) variant located six residues after the conserved Cys residue in extracellular loop 2b (ECL2b) associated with selective elimination of the high constitutive signaling of the ghrelin receptor, this loop was subjected to a detailed structure functional analysis. Introduction of Glu in different positions demonstrated that although the constitutive signaling was partly reduced when introduced in position 205(C+7) it was only totally eliminated in position 204(C+6). No charge-charge interaction partner could be identified for the Glu(C+6) variant despite mutational analysis of a number of potential partners in the extracellular loops and outer parts of the transmembrane segments. Systematic probing of position 204(C+6) with amino acid residues of different physicochemical properties indicated that a positively charged Lys surprisingly provided phenotypes similar to those of the negatively charged Glu residue. Computational chemistry analysis indicated that the propensity for the C-terminal segment of extracellular loop 2b to form an extended alpha-helix was increased from 15% in the wild type to 89 and 82% by introduction in position 204(C+6) of a Glu or a Lys residue, respectively. Moreover, the constitutive activity of the receptor was inhibited by Zn2+ binding in an engineered metal ion site, stabilizing an alpha-helical conformation of this loop segment. It is concluded that the high constitutive activity of the ghrelin receptor is dependent upon flexibility in the C-terminal segment of extracellular loop 2 and that mutations or ligand binding that constrains this segment and therebyc onceivably the movements of transmembrane domain V relative to transmembrane domain III inhibits the high constitutive signaling.	[Mokrosinski, Jacek; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Mokrosinski, Jacek; Sivertsen, Bjorn; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Holst, B (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	holst@sund.ku.dk	Mokrosinski, Jacek/M-1963-2019; Mokrosinski, Jacek/J-9506-2012	Mokrosinski, Jacek/0000-0001-5008-0457; Mokrosinski, Jacek/0000-0003-1710-1679; Holst, Birgitte/0000-0001-7432-097X; Frimruer, Thomas/0000-0002-9682-8245; Schwartz, Thue W./0000-0002-0261-6904	Danish Medical Research Council; The NovoNordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; German Science Foundation [KFO 152]; Danish Ministry of Science, Technology, and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; German Science Foundation(German Research Foundation (DFG)); Danish Ministry of Science, Technology, and Innovation	This work was supported by grants from the Danish Medical Research Council, The NovoNordisk Foundation, the Lundbeck Foundation, the Alfred Benzon Foundation, and the German Science Foundation for Financial Support (Grant KFO 152). This work was carried out as part of the "Food, Fitness and Pharma for Health and Disease" research program of the UNIK project, supported by the Danish Ministry of Science, Technology, and Innovation.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Couture L, 1996, EUR J BIOCHEM, V241, P627, DOI 10.1111/j.1432-1033.1996.00627.x; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; Elling CE, 2000, BIOCHEMISTRY-US, V39, P667, DOI 10.1021/bi991777b; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lu ZL, 2000, J BIOL CHEM, V275, P5682, DOI 10.1074/jbc.275.8.5682; Macdonald D, 2001, BIOCHEMISTRY-US, V40, P2530, DOI 10.1021/bi001880x; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosenkilde MM, 2006, MOL PHARMACOL, V70, P1892, DOI 10.1124/mol.106.027425; Ryu KS, 1998, J BIOL CHEM, V273, P6285, DOI 10.1074/jbc.273.11.6285; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; SCHWARTZ TW, 2003, TXB RECEPTOR PHARM, P81; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Wheatley M, 2007, BIOCHEM SOC T, V35, P717, DOI 10.1042/BST0350717; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zoffmann S, 2002, MOL PHARMACOL, V62, P729, DOI 10.1124/mol.62.3.729	72	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33488	33502		10.1074/jbc.M112.383240	http://dx.doi.org/10.1074/jbc.M112.383240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22846991	Green Published, hybrid			2022-12-28	WOS:000309602100035
J	Sugiki, T; Takeuchi, K; Yamaji, T; Takano, T; Tokunaga, Y; Kumagai, K; Hanada, K; Takahashi, H; Shimada, I				Sugiki, Toshihiko; Takeuchi, Koh; Yamaji, Toshiyuki; Takano, Toshiaki; Tokunaga, Yuji; Kumagai, Keigo; Hanada, Kentaro; Takahashi, Hideo; Shimada, Ichio			Structural Basis for the Golgi Association by the Pleckstrin Homology Domain of the Ceramide Trafficking Protein (CERT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13,N-15-LABELED LARGE PROTEINS; CROSS-SATURATION EXPERIMENTS; OXYSTEROL-BINDING-PROTEIN; LIPID-TRANSFER PROTEINS; PH-DOMAIN; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; NONVESICULAR TRAFFICKING; MEMBRANE TRAFFICKING; MOLECULAR-BASIS; CELL-SURFACE	Ceramide transport from the endoplasmic reticulum to the Golgi apparatus is crucial in sphingolipid biosynthesis, and the process relies on the ceramide trafficking protein (CERT), which contains pleckstrin homology (PH) and StAR-related lipid transfer domains. The CERT PH domain specifically recognizes phosphatidylinositol 4-monophosphate (PtdIns(4)P), a characteristic phosphoinositide in the Golgi membrane, and is indispensable for the endoplasmic reticulum-to-Golgi transport of ceramide by CERT. In this study, we determined the three-dimensional structure of the CERT PH domain by using solution NMR techniques. The structure revealed the presence of a characteristic basic groove near the canonical PtdIns(4) P recognition site. An extensive interaction study using NMRand other biophysical techniques revealed that the basic groove coordinates the CERT PH domain for efficient PtdIns(4)P recognition and localization in the Golgi apparatus. The notion was also supported by Golgi mislocalization of the CERT mutants in living cells. The distinctive binding modes reflect the functions of PH domains, as the basic groove is conserved only in thePHdomains involved with the PtdIns(4)P-dependent lipid transport activity but not in those with the signal transduction activity.	[Takahashi, Hideo] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sugiki, Toshihiko; Tokunaga, Yuji; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiki, Toshihiko; Takano, Toshiaki; Tokunaga, Yuji] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan; [Sugiki, Toshihiko; Takeuchi, Koh; Tokunaga, Yuji; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Yamaji, Toshiyuki; Kumagai, Keigo; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Yokohama City University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Infectious Diseases (NIID)	Takahashi, H (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hid@tsurumi.yokohama-cu.ac.jp; shimada@iw-nmr.f.u-tokyo.ac.jp	Kumagai, Keigo/AAG-1385-2021; Takeuchi, Koh/B-4971-2010; Tokunaga, Yuji/L-6339-2018	Takeuchi, Koh/0000-0002-6227-4627; Tokunaga, Yuji/0000-0002-8774-9780; Hanada, Kentaro/0000-0003-1383-2781; Kumagai, Keigo/0000-0002-1663-2905	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Economy, Trade, and Industry; Japan New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [23790064, 24102524, 24890263] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Economy, Trade, and Industry; Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Ministry of Economy, Trade, and Industry, and the Japan New Energy and Industrial Technology Development Organization.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; CERDAN S, 1986, J BIOL CHEM, V261, P4676; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Matsumoto M, 2010, J MAGN RESON, V205, P114, DOI 10.1016/j.jmr.2010.04.011; Meinecke R, 2001, J MED CHEM, V44, P3059, DOI 10.1021/jm0109154; Nakamura T, 2010, J MED CHEM, V53, P1917, DOI 10.1021/jm901099v; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roth M, 2004, NAT CELL BIOL, V6, P384, DOI 10.1038/ncb0504-384; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Sugiki T, 2010, ANAL BIOCHEM, V399, P162, DOI 10.1016/j.ab.2009.12.031; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Xu YQ, 2005, J AM CHEM SOC, V127, P11920, DOI 10.1021/ja053539b; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Zhang L, 2006, BIOINFORMATICS, V22, P2833, DOI 10.1093/bioinformatics/btl477	55	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33706	33718		10.1074/jbc.M112.367730	http://dx.doi.org/10.1074/jbc.M112.367730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869376	Green Published, hybrid			2022-12-28	WOS:000309602100053
J	Aitken, RJ; Whiting, S; De Iuliis, GN; McClymont, S; Mitchell, LA; Baker, MA				Aitken, R. John; Whiting, Sara; De Iuliis, Geoffry N.; McClymont, Samantha; Mitchell, Lisa A.; Baker, Mark A.			Electrophilic Aldehydes Generated by Sperm Metabolism Activate Mitochondrial Reactive Oxygen Species Generation and Apoptosis by Targeting Succinate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SPERMATOZOA; DNA-DAMAGE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GERM-LINE; CAPACITATION; INFERTILITY; SUPEROXIDE; REDUCTASE; PYRUVATE	Oxidative stress is a major cause of defective sperm function in cases of male infertility. Such stress is known to be associated with high levels of superoxide production by the sperm mitochondria; however, the causes of this aberrant activity are unknown. Here we show that electrophilic aldehydes such as 4-hydroxynonenal (4HNE) and acrolein, generated as a result of lipid peroxidation, target the mitochondria of human spermatozoa and stimulate mitochondrial superoxide generation in a dose-and time-dependent manner. The activation of mitochondrial electron leakage by 4HNE is shown to involve the disruption of succinate dehydrogenase activity and subsequent activation of an intrinsic apoptotic cascade beginning with a loss of mitochondrial membrane potential and terminating in oxidative DNA adduct formation, DNA strand breakage, and cell death. A tight correlation between spontaneous mitochondrial superoxide generation and 4HNE content (R-2 = 0.89) in untreated populations of human spermatozoa emphasized the pathophysiological significance of these findings. The latter also provide a biochemical explanation for the self-perpetuating nature of oxidative stress in the male germ line, with the products of lipid peroxidation stimulating free radical generation by the sperm mitochondria in a positive feedback loop.	[Aitken, R. John; Whiting, Sara; De Iuliis, Geoffry N.; McClymont, Samantha; Mitchell, Lisa A.; Baker, Mark A.] Univ Newcastle, Discipline Biol Sci, Fac Sci & IT, Prior Res Ctr Reprod Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Aitken, RJ (corresponding author), Univ Newcastle, Discipline Biol Sci, Fac Sci & IT, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia.	john.aitken@newcastle.edu.au	De Iuliis, Geoffry N./G-7042-2013; Aitken, Robert John/AAY-8238-2020; Mitchell, Lisa/K-5719-2013	De Iuliis, Geoffry N./0000-0002-6978-6123; Aitken, Robert John/0000-0002-9152-156X; 	National Health and Medical Research Council [494802]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Program Grant 494802 (to R.J.A.).	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Aitken RJ, 2010, MOL HUM REPROD, V16, P3, DOI 10.1093/molehr/gap059; Aitken RJ, 2011, REPRODUCTION, V141, P139, DOI 10.1530/REP-10-0232; Aitken RJ, 1998, J CELL SCI, V111, P645; Aitken RJ, 2003, MOL HUM REPROD, V9, P645, DOI 10.1093/molehr/gag086; AITKEN RJ, 1991, AM J OBSTET GYNECOL, V164, P542, DOI 10.1016/S0002-9378(11)80017-7; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Aitken RJ, 2011, ANTIOXID REDOX SIGN, V14, P367, DOI 10.1089/ars.2010.3186; ALVAREZ JG, 1987, J ANDROL, V8, P338; Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Biggers J. D., 1997, METHODS MAMMALIAN EM, P86; BIZE I, 1991, BIOL REPROD, V44, P398, DOI 10.1095/biolreprod44.3.398; Bohme A, 2009, CHEM RES TOXICOL, V22, P742, DOI 10.1021/tx800492x; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chen ZH, 2006, IUBMB LIFE, V58, P372, DOI 10.1080/15216540600686896; De Iuliis GN, 2009, BIOL REPROD, V81, P517, DOI 10.1095/biolreprod.109.076836; DELAMIRANDE E, 1993, FREE RADICAL BIO MED, V14, P157, DOI 10.1016/0891-5849(93)90006-G; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; Espinoza JA, 2009, ANDROLOGIA, V41, P51, DOI 10.1111/j.1439-0272.2008.00878.x; Ford WCL, 2004, HUM REPROD UPDATE, V10, P387, DOI 10.1093/humupd/dmh034; Hughes LM, 2009, MOL PHARMACOL, V76, P113, DOI 10.1124/mol.108.053645; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; HUTSON SM, 1977, J BIOL CHEM, V252, P1309; JONES R, 1979, FERTIL STERIL, V31, P531; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Koppers AJ, 2011, BIOCHEM J, V436, P687, DOI 10.1042/BJ20110114; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Kumar V, 2008, BIOL REPROD, V79, P190, DOI 10.1095/biolreprod.107.066704; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; Lashin OM, 2006, FREE RADICAL BIO MED, V40, P886, DOI 10.1016/j.freeradbiomed.2005.10.040; MALDONADO ME, 1972, J BIOL CHEM, V247, P2711; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mitchell LA, 2011, INT J ANDROL, V34, P2, DOI 10.1111/j.1365-2605.2009.01042.x; Parr RG, 1999, J AM CHEM SOC, V121, P1922, DOI 10.1021/ja983494x; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; SANBORN BM, 1971, BIOCHIM BIOPHYS ACTA, V227, P219, DOI 10.1016/0005-2744(71)90055-6; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; TOSIC J, 1946, NATURE, V158, P485, DOI 10.1038/158485a0; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zini A, 2009, J ANDROL, V30, P219, DOI 10.2164/jandrol.108.006908; Zoccarato F, 2009, J BIOENERG BIOMEMBR, V41, P387, DOI 10.1007/s10863-009-9238-2	44	154	160	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33048	33060		10.1074/jbc.M112.366690	http://dx.doi.org/10.1074/jbc.M112.366690			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851170	Green Published, hybrid			2022-12-28	WOS:000309168300067
J	Miranda-Laferte, E; Schmidt, S; Jara, AC; Neely, A; Hidalgo, P				Miranda-Laferte, Erick; Schmidt, Silke; Jara, Antonella C.; Neely, Alan; Hidalgo, Patricia			A Short Polybasic Segment between the Two Conserved Domains of the beta(2a)-Subunit Modulates the Rate of Inactivation of R-type Calcium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; MOLECULAR DETERMINANTS; DEPENDENT INACTIVATION; CHARGE MOVEMENT; VOLTAGE; PALMITOYLATION; IDENTIFICATION; COMPLEX; BINDING; LINKER	Besides opening and closing, high voltage-activated calcium channels transit to a nonconducting inactivated state from which they do not re-open unless the plasma membrane is repolarized. Inactivation is critical for temporal regulation of intracellular calcium signaling and prevention of a deleterious rise in calcium concentration. R-type high voltage-activated channels inactivate fully in a few hundred milliseconds when expressed alone. However, when co-expressed with a particular beta-subunit isoform, beta(2a), inactivation is partial and develops in several seconds. Palmitoylation of a unique di-cysteine motif at the N terminus anchors beta(2a) to the plasma membrane. The current view is that membrane-anchored beta(2a) immobilizes the channel inactivation machinery and confers slow inactivation phenotype. beta-Subunits contain one Src homology 3 and one guanylate kinase domain, flanked by variable regions with unknown structures. Here, we identified a short polybasic segment at the boundary of the guanylate kinase domain that slows down channel inactivation without relocating a palmitoylation-deficient beta(2a) to the plasma membrane. Substitution of the positively charged residues within this segment by alanine abolishes its slow inactivation-conferring phenotype. The linker upstream from the polybasic segment, but not the N- and C-terminal variable regions, masks the effect of this determinant. These results reveal a novel mechanism for inhibiting voltage-dependent inactivation of R-type calcium channels by the beta(2a)-subunit that might involve electrostatic interactions with an unknown target on the channel's inactivation machinery or its modulatory components. They also suggest that intralinker interactions occlude the action of the polybasic segment and that its functional availability is regulated by the palmitoylated state of the beta(2a)-subunit.	[Jara, Antonella C.; Neely, Alan] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2349400, Chile; [Miranda-Laferte, Erick; Schmidt, Silke; Hidalgo, Patricia] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Universidad de Valparaiso; Hannover Medical School	Neely, A (corresponding author), Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2349400, Chile.	alan.neely@cinv.cl; hidalgo.patricia@mh-hannover.de	Hidalgo, Patricia/I-7506-2013	Hidalgo, Patricia/0000-0002-4162-6590; Neely, Alan/0000-0002-6007-2159	Deutsche Forschung Gemeinschaft [DFG Hi 800/3-1, 4-1]; Fondo Nacional de Ciencia y Tecnologia [FONDECYT 1090635]; German-Chilean Scientific Cooperation Program	Deutsche Forschung Gemeinschaft(German Research Foundation (DFG)); Fondo Nacional de Ciencia y Tecnologia; German-Chilean Scientific Cooperation Program	This work was supported by Deutsche Forschung Gemeinschaft Grants DFG Hi 800/3-1 and 4-1 (to P. H.), Fondo Nacional de Ciencia y Tecnologia Grant FONDECYT 1090635 (to A. N.), and the German-Chilean Scientific Cooperation Program Grant DFG-CONICYT 2010 (to P. H. and A. N.).	BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 2005, MOL B INT U, P95; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Gonzalez-Gutierrez G, 2008, J GEN PHYSIOL, V132, P383, DOI 10.1085/jgp.200709901; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539, DOI 10.1152/ajpcell.1996.271.5.C1539; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Restituito S, 2000, J NEUROSCI, V20, P9046; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Stotz SC, 2004, J BIOL CHEM, V279, P3793, DOI 10.1074/jbc.M308991200; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347	38	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32588	32597		10.1074/jbc.M112.362509	http://dx.doi.org/10.1074/jbc.M112.362509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851179	Green Published, hybrid			2022-12-28	WOS:000309168300028
J	Yamamoto, M; Miyai, M; Matsumoto, Y; Tsuboi, R; Hibino, T				Yamamoto, Mami; Miyai, Masashi; Matsumoto, Yuuko; Tsuboi, Ryoji; Hibino, Toshihiko			Kallikrein-related Peptidase-7 Regulates Caspase-14 Maturation during Keratinocyte Terminal Differentiation by Generating an Intermediate Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRATUM-CORNEUM; ATOPIC-DERMATITIS; HUMAN EPIDERMIS; PROTEOLYTIC CASCADE; SERINE-PROTEASE; SKIN; ACTIVATION; EXPRESSION; FILAGGRIN; DESQUAMATION	The maturation and activation mechanisms of caspases are generally well understood, except for those of caspase-14, which is activated at the onset of keratinocyte terminal differentiation. We investigated the possible involvement of epidermal proteases expressed in the late stage of differentiation, and found that the chymotrypsin-like serine protease kallikrein-related peptidase-7 (KLK7) cleaved procaspase-14 at Tyr(178), generating an intermediate form that consists of a large (20 kDa) and a small subunit (8 kDa). We prepared an antibody directed to this cleavage site (h14Y178 Ab), and confirmed that it recognized a 20-kDa band formed when procaspase-14 was incubated with chymotrypsin or KLK7. We then constructed a constitutively active form of the intermediate, revC14-Y178. The substrate specificity of revC14-Y178 was completely different from that of caspase-14, showing broad specificity for various caspase substrates except WEHD-7-amino-4-trifluoromethylcoumarin (AFC), the preferred substrate of active, mature caspase-14. K-m values for VEID-AFC, DEVD-AFC, LEVD-AFC, and LEHD-AFC were 0.172, 0.261, 0.504, and 0.847 mu M, respectively. We confirmed that the mature form of caspase-14 was generated when procaspase-14 was incubated with KLK7 or revC14-Y178. Expression of constitutively active KLK7 in cultured keratinocytes resulted in generation of both the intermediate form and the mature form of caspase-14. Immunohistochemical analysis demonstrated that the intermediate form was localized at the granular layer. Our results indicate that regulation of procaspase-14 maturation during terminal differentiation is a unique two-step process involving KLK7 and an activation intermediate of caspase-14.	[Yamamoto, Mami; Miyai, Masashi; Matsumoto, Yuuko; Hibino, Toshihiko] Shiseido Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2368643, Japan; [Yamamoto, Mami; Tsuboi, Ryoji] Tokyo Med & Dent Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan	Shiseido Company, Limited; Tokyo Medical & Dental University (TMDU)	Hibino, T (corresponding author), Shiseido Res Ctr, Kanazawa Ku, 2-12-1 Fukuura, Yokohama, Kanagawa 2368643, Japan.	toshihiko.hibino1@to.shiseido.co.jp						Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V277, P655, DOI 10.1006/bbrc.2000.3698; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; Eissa A, 2011, J BIOL CHEM, V286, P687, DOI 10.1074/jbc.M110.125310; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hibino T, 2010, J CELL BIOCHEM, V109, P487, DOI 10.1002/jcb.22425; HORII I, 1989, BRIT J DERMATOL, V121, P587, DOI 10.1111/j.1365-2133.1989.tb08190.x; Hoste E, 2011, J INVEST DERMATOL, V131, P2233, DOI 10.1038/jid.2011.153; Ishida-Yamamoto A, 2011, MED MOL MORPHOL, V44, P1, DOI 10.1007/s00795-010-0513-4; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V247, P780, DOI 10.1006/bbrc.1998.8815; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Mikolajczyk J, 2004, BIOCHEMISTRY-US, V43, P10560, DOI 10.1021/bi0498048; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nicotera P, 2007, NAT CELL BIOL, V9, P621, DOI 10.1038/ncb0607-621; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Scott FL, 2007, J BIOCHEM, V142, P435, DOI 10.1093/jb/mvm156; Simon M, 2008, BRIT J DERMATOL, V159, P77, DOI 10.1111/j.1365-2133.2008.08578.x; Sotiropoulou G, 2010, BIOL CHEM, V391, P321, DOI 10.1515/BC.2010.036; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Van de Craen M, 1998, CELL DEATH DIFFER, V5, P838, DOI 10.1038/sj.cdd.4400444; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Yamamoto M, 2011, J DERMATOL SCI, V61, P110, DOI 10.1016/j.jdermsci.2010.11.018	36	24	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32825	32834		10.1074/jbc.M112.357467	http://dx.doi.org/10.1074/jbc.M112.357467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22825846	Green Published, hybrid			2022-12-28	WOS:000309168300048
J	Zhang, Y; Toh, L; Lau, P; Wang, XY				Zhang, Yong; Toh, LingLing; Lau, Peishan; Wang, Xueying			Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/beta-Catenin Pathway in Human Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; CATALYTIC SUBUNIT; CERVICAL-CANCER; IMMORTAL CELLS; ALPHA-ENHANCER; TUMOR-CELLS; C-MYC; EXPRESSION; GENE	Telomerase activation plays a critical role in human carcinogenesis through the maintenance of telomeres, but the activation mechanism during carcinogenesis remains unclear. The human telomerase reverse transcriptase (hTERT) promoter has been shown to promote hTERT gene expression selectively in tumor cells but not in normal cells. Deregulation of the Wnt/beta catenin signaling pathway is reported to be associated with human carcinogenesis. However, little is known about whether the Wnt/beta-catenin pathway is involved in activating hTERT transcription and inducing telomerase activity (TA). In this study, we report that hTERT is a novel target of the Wnt/beta-catenin pathway. Transient activation of the Wnt/beta-catenin pathway either by transfection of a constitutively active form of beta-catenin or by LiCl or Wnt-3a conditioned medium treatment induced hTERT mRNA expression and elevated TA in different cell lines. Furthermore, we found that silencing endogenous beta-catenin expression by beta-catenin gene-specific shRNA effectively decreased hTERT expression, suppressed TA, and accelerated telomere shortening. Of the four members of the lymphoid-enhancing factor (LEF)/T-cell factor (TCF) family, only TCF4 showed more effective stimulation on the hTERT promoter. Ectopic expression of a dominant negative form of TCF4 inhibited hTERT expression in cancer cells. Through promoter mapping, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we found that hTERT is a direct target of beta-catenin.TCF4-mediated transcription and that the TCF4 binding site at the hTERT promoter is critical for beta-catenin.TCF4-dependent expression regulation. Given the pivotal role of telomerase in carcinogenesis, these results may offer insight into the regulation of telomerase in human cancer.	[Zhang, Yong; Toh, LingLing; Lau, Peishan; Wang, Xueying] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Toh, LingLing] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wang, XY (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, 10 Kent Ridge Crescent,Blk MD4A 02-04, Singapore 119260, Singapore.	bchwxy@nus.edu.sg			MOE-Academic Research Fund (AcRF) Tier 1 Faculty Research Committee (FRC) grant	MOE-Academic Research Fund (AcRF) Tier 1 Faculty Research Committee (FRC) grant	This work is supported by funding from the MOE-Academic Research Fund (AcRF) Tier 1 Faculty Research Committee (FRC) grant.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; ALEXANDERBRIDGES M, 1992, J CELL BIOCHEM, V48, P129, DOI 10.1002/jcb.240480204; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Barker N, 2000, ADV CANCER RES, V77, P1; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Betts DH, 2006, METH MOL B, V325, P149; Bilsland AE, 2006, CANCER RES, V66, P1363, DOI 10.1158/0008-5472.CAN-05-1941; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Blasco MA, 2003, TRENDS CELL BIOL, V13, P289, DOI 10.1016/S0962-8924(03)00085-0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chai JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-512; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P149, DOI 10.1002/ajhb.21127; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirkpatrick KL, 2003, BREAST CANCER RES TR, V77, P277, DOI 10.1023/A:1021849217054; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meyerson M, 2000, J CLIN ONCOL, V18, P2626, DOI 10.1200/JCO.2000.18.13.2626; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; OOSTERWEGEL MA, 1991, INT IMMUNOL, V3, P1189, DOI 10.1093/intimm/3.11.1189; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takakura M, 1998, CANCER RES, V58, P1558; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Walne AJ, 2008, MECH AGEING DEV, V129, P48, DOI 10.1016/j.mad.2007.10.006; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Yatabe N, 2004, ONCOGENE, V23, P3708, DOI 10.1038/sj.onc.1207460; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452	63	139	143	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32494	32511		10.1074/jbc.M112.368282	http://dx.doi.org/10.1074/jbc.M112.368282			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854964	Green Published, hybrid			2022-12-28	WOS:000309168300020
J	Wang, WY; Linsdell, P				Wang, Wuyang; Linsdell, Paul			Relative Movements of Transmembrane Regions at the Outer Mouth of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Pore during Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; POSITIVE CHARGES; CONFORMATIONAL-CHANGES; ANION CONDUCTION; SEGMENT; DOMAIN; STATE; IDENTIFICATION; TRANSPORTERS; PERMEATION	Multiple transmembrane (TM) segments line the pore of the cystic fibrosis transmembrane conductance regulator Cl- channel; however, the relative alignment of these TMs and their relative movements during channel gating are unknown. To gain three-dimensional structural information on the outer pore, we have used patch clamp recording to study the proximity of pairs of cysteine side chains introduced into TMs 6 and 11, using both disulfide cross-linking and Cd2+ coordination. Following channel activation, disulfide bonds could apparently be formed between three cysteine pairs (of 15 studied): R334C/T1122C, R334C/G1127C, and T338C/S1118C. To examine the state dependence of cross-linking, we combined these cysteine mutations with a nucleotide-binding domain mutation (E1371Q) that stabilizes the channel open state. Investigation of the effects of the E1371Q mutation on disulfide bond formation and Cd2+ coordination suggests that although R334C/T1122C and T338C/S1118C are closer together in the channel open state, R334C/G1127C are close together and can form disulfide bonds only when the channel is closed. These results provide important new information on the three-dimensional structure of the outer mouth of the cystic fibrosis transmembrane conductance regulator channel pore: TMs 6 and 11 are close enough together to form disulfide bonds in both open and closed channels. Moreover, the altered relative locations of residues in open and in closed channels that we infer allow us to propose that channel opening and closing may be associated with a relative translational movement of TMs 6 and 11, with TM6 moving "down" (toward the cytoplasm) during channel opening.	[Wang, Wuyang; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; Wang, Wuyang/0000-0003-1875-5463	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Bell DC, 2009, PFLUG ARCH EUR J PHY, V458, P259, DOI 10.1007/s00424-008-0613-3; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gupta J, 2001, BIOCHEMISTRY-US, V40, P6620, DOI 10.1021/bi002819v; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Li MS, 2011, AM J PHYSIOL-CELL PH, V300, pC65, DOI 10.1152/ajpcell.00290.2010; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	40	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32136	32146		10.1074/jbc.M112.385096	http://dx.doi.org/10.1074/jbc.M112.385096			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843683	Green Published, hybrid			2022-12-28	WOS:000309059400051
J	Panter, MS; Jain, A; Leonhardt, RM; Ha, T; Cresswell, P				Panter, Michaela S.; Jain, Ankur; Leonhardt, Ralf M.; Ha, Taekjip; Cresswell, Peter			Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; HLA CLASS-I; CYTOMEGALOVIRUS US6 GLYCOPROTEIN; CELL-SURFACE EXPRESSION; ANTIGEN PRESENTATION; REDOX REGULATION; TRANSPORTER TAP; HEAVY-CHAINS; TAPASIN; MOLECULES	Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is responsible for MHCI recruitment and peptide binding optimization, is particularly critical for modeling of the PLC. Here, we characterized the stoichiometry of the human PLC using both biophysical and biochemical approaches. By means of single-molecule pulldown (SiMPull), we determined a TAP/tapasin ratio of 1: 2, consistent with previous studies of insect-cell microsomes, rat-human chimeric cells, and HeLa cells expressing truncated TAP subunits. We also report that the tapasin/MHC I ratio varies, with the PLC population comprising both 2: 1 and 2: 2 complexes, based on mutational and co-precipitation studies. The MHC I-saturated PLC may be particularly prevalent among peptide-selective alleles, such as HLA-C4. Additionally, MHC I association with the PLC increases when its peptide supply is reduced by inhibiting the proteasome or by blocking TAP-mediated peptide transport using viral inhibitors. Taken together, our results indicate that the composition of the human PLC varies under normal conditions and dynamically adapts to alterations in peptide supply that may arise during viral infection. These findings improve our understanding of the quality control of MHC I peptide loading and may aid the structural and functional modeling of the human PLC.	[Panter, Michaela S.; Leonhardt, Ralf M.; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Panter, Michaela S.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Jain, Ankur; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jain, Ankur; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S670, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [AI083025, GM065367, T32AI07019]; Howard Hughes Medical Institute; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025, R01AI097206, T32AI007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083025 and GM065367 (to T. H.) and Training Grant T32AI07019 (to the Yale Department of Immunobiology). This work was also supported by the Howard Hughes Medical Institute and a Cancer Research Institute Fellowship (to R. M. L.).	Alberts P, 2001, CURR BIOL, V11, P242, DOI 10.1016/S0960-9822(01)00073-2; Antoniou AN, 2002, IMMUNOLOGY, V106, P182, DOI 10.1046/j.1365-2567.2002.01415.x; Arunachalam B, 1998, J IMMUNOL, V160, P5797; Bangia N, 2005, IMMUNOLOGY, V114, P346, DOI 10.1111/j.1365-2567.2005.02103.x; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; BARNSTABLE CJ, 1978, BRIT MED BULL, V34, P241, DOI 10.1093/oxfordjournals.bmb.a071504; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Halenius A, 2006, J BIOL CHEM, V281, P5383, DOI 10.1074/jbc.M510223200; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Hulpke S., 2012, CELL MOL LI IN PRESS; Jain A, 2012, NAT PROTOC, V7, P445, DOI 10.1038/nprot.2011.452; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; KLEIN E, 1968, CANCER RES, V28, P1300; Knittler MR, 1999, CURR BIOL, V9, P999, DOI 10.1016/S0960-9822(99)80448-5; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; KUSARI J, 1986, MOL CELL BIOL, V6, P2062, DOI 10.1128/MCB.6.6.2062; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Neisig A, 1998, J IMMUNOL, V160, P171; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Rufer E, 2007, J IMMUNOL, V179, P5717, DOI 10.4049/jimmunol.179.9.5717; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SEONG RH, 1988, J EXP MED, V167, P288, DOI 10.1084/jem.167.2.288; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stepensky D, 2007, TRAFFIC, V8, P1530, DOI 10.1111/j.1600-0854.2007.00639.x; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; TRAPANI JA, 1989, IMMUNOGENETICS, V29, P25, DOI 10.1007/BF02341610; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	66	42	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31172	31184		10.1074/jbc.M112.387704	http://dx.doi.org/10.1074/jbc.M112.387704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829594	Green Published, hybrid			2022-12-28	WOS:000308791300030
J	Yahiro, K; Satoh, M; Nakano, M; Hisatsune, J; Isomoto, H; Sap, J; Suzuki, H; Nomura, F; Noda, M; Moss, J; Hirayama, T				Yahiro, Kinnosuke; Satoh, Mamoru; Nakano, Masayuki; Hisatsune, Junzo; Isomoto, Hajime; Sap, Jan; Suzuki, Hidekazu; Nomura, Fumio; Noda, Masatoshi; Moss, Joel; Hirayama, Toshiya			Low-density Lipoprotein Receptor-related Protein-1 (LRP1) Mediates Autophagy and Apoptosis Caused by Helicobacter pylori VacA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE-BETA; GASTRIC EPITHELIAL-CELLS; ANION-SELECTIVE CHANNELS; VACUOLATING-CYTOTOXIN; MITOCHONDRIAL APOPTOSIS; TUMOR-GROWTH; LIPID RAFTS; T-CELL; TOXIN; DEATH	In Helicobacter pylori infection, vacuolating cytotoxin (VacA)-induced mitochondrial damage leading to apoptosis is believed to be a major cause of cell death. It has also been proposed that VacA-induced autophagy serves as a host mechanism to limit toxin-induced cellular damage. Apoptosis and autophagy are two dynamic and opposing processes that must be balanced to regulate cell death and survival. Here we identify the low-density lipoprotein receptor-related protein-1 (LRP1) as the VacA receptor for toxin-induced autophagy in the gastric epithelial cell line AZ-521, and show that VacA internalization through binding to LRP1 regulates the autophagic process including generation of LC3-II from LC3-I, which is involved in formation of autophagosomes and autolysosomes. Knockdown of LRP1 and Atg5 inhibited generation of LC3-II as well as cleavage of PARP, a marker of apoptosis, in response to VacA, whereas caspase inhibitor, benzyloxycarbonyl-VAD-fluoromethylketone (Z-VAD-fmk), and necroptosis inhibitor, Necrostatin-1, did not inhibit VacA-induced autophagy, suggesting that VacA-induced autophagy via LRP1 binding precedes apoptosis. Other VacA receptors such as RPTP alpha, RPTP beta, and fibronectin did not affect VacA-induced autophagy or apoptosis. Therefore, we propose that the cell surface receptor, LRP1, mediates VacA-induced autophagy and apoptosis.	[Nakano, Masayuki; Hisatsune, Junzo; Hirayama, Toshiya] Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan; [Yahiro, Kinnosuke; Noda, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba 2608670, Japan; [Satoh, Mamoru; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba 2608670, Japan; [Hisatsune, Junzo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Bacteriol, Hiroshima 7348551, Japan; [Isomoto, Hajime] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki 8528523, Japan; [Sap, Jan] Univ Paris Diderot, CNRS, UMR 7216, Sorbonne Paris Cite, Paris, France; [Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Chiba University; Chiba University; Hiroshima University; Nagasaki University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Keio University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp	SUZUKI, HIDEKAZU/S-9376-2019; Suzuki, Hidekazu/J-4396-2013	Yahiro, Kinnosuke/0000-0002-9813-0780	Ministry of Education, Culture, Sports, Science and Technology of Japan; Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency; National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency; National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Improvement of Research Environment for Young Researchers from the Japan Science and Technology Agency.; Supported by the Intramural Research Program, National Institutes of Health, NHLBI.	Akada JK, 2010, DIS MODEL MECH, V3, P605, DOI 10.1242/dmm.004879; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 2003, CANCER RES, V63, P951; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Foo JH, 2010, J MOL BIOL, V401, P792, DOI 10.1016/j.jmb.2010.06.065; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Genisset C, 2007, CELL MICROBIOL, V9, P1481, DOI 10.1111/j.1462-5822.2006.00886.x; GHIRA P, 1995, INFECT IMMUN, V63, P4154, DOI 10.1128/IAI.63.10.4154-4160.1995; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hennig EE, 2005, FEMS IMMUNOL MED MIC, V44, P143, DOI 10.1016/j.femsim.2004.10.020; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Isomoto H, 2010, TOHOKU J EXP MED, V220, P3, DOI 10.1620/tjem.220.3; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kuck D, 2001, INFECT IMMUN, V69, P5080, DOI 10.1128/IAI.69.8.5080-5087.2001; Kuo CH, 2003, BIOCHEM BIOPH RES CO, V303, P640, DOI 10.1016/S0006-291X(03)00380-2; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Nakayama M, 2006, INFECT IMMUN, V74, P6571, DOI 10.1128/IAI.00356-06; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Sewald X, 2011, CELL MICROBIOL, V13, P482, DOI 10.1111/j.1462-5822.2010.01551.x; Singh M, 2006, CURR MICROBIOL, V52, P254, DOI 10.1007/s00284-005-0103-1; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Tombola F, 1999, BIOPHYS J, V76, P1401, DOI 10.1016/S0006-3495(99)77301-7; Torres VJ, 2005, J BIOL CHEM, V280, P21107, DOI 10.1074/jbc.M501042200; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Yahiro K, 2003, J BIOL CHEM, V278, P19183, DOI 10.1074/jbc.M300117200; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yoshimori T, 2007, CELL, V128, P833, DOI 10.1016/j.cell.2007.02.023; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V	54	91	97	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31104	31115		10.1074/jbc.M112.387498	http://dx.doi.org/10.1074/jbc.M112.387498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822085	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000308791300023
J	Musee, J; Marnett, LJ				Musee, Joel; Marnett, Lawrence J.			Prostaglandin H Synthase-2-catalyzed Oxygenation of 2-Arachidonoylglycerol Is More Sensitive to Peroxide Tone than Oxygenation of Arachidonic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX; OXIDATIVE STRESS; MECHANISM; SYNTHASE; 2-ARACHIDONYLGLYCEROL; CYCLOOXYGENASE-2; HYDROPEROXIDES; BIOSYNTHESIS; PURIFICATION; RECEPTOR	The endocannabinoid, 2-arachidonoylglycerol (2-AG), is a selective substrate for the inducible isoform of prostaglandin H synthase (PGHS), PGHS-2. Its turnover leads to the formation of glyceryl esters of prostaglandins (PG-Gs), a subset of which elicits agonism at unique, as yet unidentified, receptors. The k(cat)/K-m values for oxygenation of arachidonic acid (AA) and 2-AG by PGHS-2 are very similar, but the sensitivities of the two substrates to peroxide-dependent activation have not been compared. 15-Hydroperoxy derivatives of AA and 2-AG were found to be comparable in their ability to serve as substrates for the peroxidase activities of PGHS-2, PGHS-1, and glutathione peroxidase (GPx). They also were comparable in the activation of AA oxygenation by cyanide-inhibited PGHS-2. However, oxygenation of 2-AG was significantly suppressed relative to AA by the presence of GPx and GSH. Furthermore, 2-AG oxygenation by peroxidase-deficient H388YmPGHS-2 was much less efficient than AA oxygenation. Wild-type rates of 2-AG oxygenation were restored by treatment of H388YmPGHS-2 with hydroperoxide derivatives of AA or 2-AG. RNAi silencing of phospholipid hydroperoxide-specific GPx (GPx4) in NIH/3T3 cells led to increases in cellular peroxidation and in the levels of the isoprostane product, 8-epi-PGF(2 alpha). GPx4 silencing led to 2-4-fold increases in PG-G formation but no change in PG formation. Thus, cellular peroxide tone may be an important determinant of the extent of endocannabinoid oxygenation by PGHS-2.	[Marnett, Lawrence J.] Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, Dept Biochem,AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol,Dept Chem & Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med,Ctr Mol Toxicol, Dept Biochem,AB Hancock Jr Mem Lab Canc Res, Vanderbilt Inst Chem Biol, 2200 Pierce Ave, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health Research Grant [GM15431]; Vanderbilt Medical-Scientist Training Program Grant [GM07347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, P01GM015431, P50GM015431] Funding Source: NIH RePORTER	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Medical-Scientist Training Program Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM15431. This work was also supported by Vanderbilt Medical-Scientist Training Program Grant GM07347.	DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; FUNK MO, 1976, LIPIDS, V11, P113, DOI 10.1007/BF02532660; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; KULMACZ RJ, 1990, METHOD ENZYMOL, V186, P431; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sakamoto H, 2000, J BIOL CHEM, V275, P40028, DOI 10.1074/jbc.M003191200; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Tsai AL, 1997, J BIOL CHEM, V272, P8885; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200	29	13	16	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37383	37394		10.1074/jbc.M112.381202	http://dx.doi.org/10.1074/jbc.M112.381202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942274	Green Published, hybrid			2022-12-28	WOS:000310588500069
J	Bhukhai, K; Suksen, K; Bhummaphan, N; Janjorn, K; Thongon, N; Tantikanlayaporn, D; Piyachaturawat, P; Suksamrarn, A; Chairoungdua, A				Bhukhai, Kanit; Suksen, Kanoknetr; Bhummaphan, Narumol; Janjorn, Keatdamrong; Thongon, Natthakan; Tantikanlayaporn, Duangrat; Piyachaturawat, Pawinee; Suksamrarn, Apichart; Chairoungdua, Arthit			A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3 beta Protein-dependent Activation of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; BETA-CATENIN; RECEPTOR ACTIVATOR; BONE LOSS; WNT; TRANSCRIPTION; EXPRESSION; PHOSPHORYLATION; OSTEOBLASTS; SURVIVAL	Estrogen promotes growth in many tissues by activating Wnt/beta-catenin signaling. Recently, ASPP 049, a diarylheptanoid isolated from Curcuma comosa Roxb., has been identified as a phytoestrogen. This investigation determined the involvement of Wnt/beta-catenin signaling in the estrogenic activity of this diarylheptanoid in transfected HEK 293T and in mouse preosteoblastic (MC3T3-E1) cells using a TOPflash luciferase assay and immunofluorescence. ASPP 049 rapidly activated T-cell-specific transcription factor/lymphoid enhancer binding factor-mediated transcription activity and induced beta-catenin accumulation in the nucleus. Interestingly, the effects of ASPP 049 on the transcriptional activity and induction and accumulation of beta-catenin protein in the nucleus of MC3T3-E1 cells were greater compared with estradiol. Activation of beta-catenin in MC3T3-E1cells was inhibited by ICI 182,780, suggesting that an estrogen receptor is required. In addition, ASPP 049 induced phosphorylations at serine 473 of Akt and serine 9 of GSK-3 beta. Moreover, ASPP 049 also induced proliferation and expressions of Wnt target genes Axin2 and Runx2 in MC3T3-E1 cells. In addition, ASPP 049 increased alkaline phosphatase expression, and activity that was abolished by DKK-1, a blocker of the Wnt/beta-catenin receptor. Taken together, these results suggest that ASPP 049 from C. comosa induced osteoblastic cell proliferation and differentiation through ER alpha-, Akt-, and GSK-3 beta-dependent activation of beta-catenin signaling. Our findings provide a scientific rationale for using C. comosa as a dietary supplement to prevent bone loss in postmenopausal women.	[Bhukhai, Kanit; Suksen, Kanoknetr; Janjorn, Keatdamrong; Thongon, Natthakan; Tantikanlayaporn, Duangrat; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok 10400, Thailand; [Bhummaphan, Narumol; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Toxicol Grad Program, Fac Sci, Bangkok 10400, Thailand; [Bhukhai, Kanit; Bhummaphan, Narumol; Janjorn, Keatdamrong; Thongon, Natthakan; Piyachaturawat, Pawinee; Chairoungdua, Arthit] Mahidol Univ, Res Ctr Transport Prot Med Innovat, Fac Sci, Bangkok 10400, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Dept Chem, Fac Sci, Bangkok 10240, Thailand	Mahidol University; Mahidol University; Mahidol University; Ramkhamhaeng University	Chairoungdua, A (corresponding author), Mahidol Univ, Dept Physiol, Fac Sci, Rama 4 Rd, Bangkok 10400, Thailand.	arthit.chi@mahidol.ac.th	Tantikanlayaporn, Duangrat/AAB-3358-2021; Piyachaturawat, Pawinee/R-5817-2019; Suksamrarn, Apichart/R-8782-2019	Tantikanlayaporn, Duangrat/0000-0002-1197-4957; Thongon, Natthakan/0000-0002-6169-403X	Faculty of Science, Mahidol University; office of the Higher Education Commission; National Research Council of Thailand; Mahidol University under the National Research Universities Initiative (NRU)	Faculty of Science, Mahidol University; office of the Higher Education Commission; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Mahidol University under the National Research Universities Initiative (NRU)	This project was supported by Faculty of Science, Mahidol University, the office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (NRU), and the National Research Council of Thailand.	Armstrong JL, 2001, J BIOL CHEM, V276, P952, DOI 10.1074/jbc.M004812200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2863(03)00056-1; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Intapad S, 2009, VASC PHARMACOL, V51, P284, DOI 10.1016/j.vph.2009.07.005; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McDougall KE, 2003, ENDOCRINOLOGY, V144, P1994, DOI 10.1210/en.2002-0074; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Piyachaturawat P, 1995, ASIA PAC J PHARMACOL, V10, P121; Rubin J, 2002, J CLIN ENDOCR METAB, V87, P4273, DOI 10.1210/jc.2002-020656; SEEMAN E, 1992, J BONE MINER RES, V7, P1467; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Suksamrarn A, 2008, BIOORGAN MED CHEM, V16, P6891, DOI 10.1016/j.bmc.2008.05.051; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Wandosell F, 2012, J NEUROENDOCRINOL, V24, P191, DOI 10.1111/j.1365-2826.2011.02186.x; Weerachayaphorn J, 2011, J ETHNOPHARMACOL, V137, P956, DOI 10.1016/j.jep.2011.06.040; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Winuthayanon W, 2009, J AGR FOOD CHEM, V57, P840, DOI 10.1021/jf802702c; Wood CE, 2010, CLIN CANCER RES, V16, P946, DOI 10.1158/1078-0432.CCR-09-1541; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	38	54	64	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36168	36178		10.1074/jbc.M112.344747	http://dx.doi.org/10.1074/jbc.M112.344747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936801	Green Published, hybrid			2022-12-28	WOS:000310364000038
J	Coneyworth, LJ; Jackson, KA; Tyson, J; Bosomworth, HJ; van der Hagen, E; Hann, GM; Ogo, OA; Swann, DC; Mathers, JC; Valentine, RA; Ford, D				Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Swann, Daniel C.; Mathers, John C.; Valentine, Ruth A.; Ford, Dianne			Identification of the Human Zinc Transcriptional Regulatory Element (ZTRE) A PALINDROMIC PROTEIN-BINDING DNA SEQUENCE RESPONSIBLE FOR ZINC-INDUCED TRANSCRIPTIONAL REPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY ZINC; FACTOR MTF-1; NUCLEOTIDE-SEQUENCE; TRANSPORTERS; METAL; HOMEOSTASIS; DEFICIENCY; EXPRESSION; ZNT5; ACTIVATION	Many genes with crucial roles in zinc homeostasis in mammals respond to fluctuating zinc supply through unknown mechanisms, and uncovering these mechanisms is essential to understanding the process at cellular and systemic levels. We detected zinc-dependent binding of a zinc-induced protein to a specific sequence, the zinc transcriptional regulatory element (ZTRE), in the SLC30A5 (zinc transporter ZnT5) promoter and showed that substitution of the ZTRE abrogated the repression of a reporter gene in response to zinc. We identified the ZTRE in other genes, including (through an unbiased search) the CBWD genes and (through targeted analysis) in multiple members of the SLC30 family, including SLC30A10, which is repressed by zinc. The function of the CBWD genes is currently unknown, but roles for homologs in metal homeostasis are being uncovered in bacteria. We demonstrated that CBWD genes are repressed by zinc and that substitution of the ZTRE in SLC30A10 and CBWD promoter-reporter constructs abrogates this response. Other metals did not affect expression of the transcriptional regulator, binding to the ZTRE or promoter-driven reporter gene expression. These findings provide the basis for elucidating how regulation of a network of genes through this novel mechanism contributes to zinc homeostasis and how the cell orchestrates this response.	[Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Swann, Daniel C.; Valentine, Ruth A.; Ford, Dianne] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4NN, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Mathers, John C.; Valentine, Ruth A.; Ford, Dianne] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Bosomworth, Helen J.; Valentine, Ruth A.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Ford, D (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4NN, Tyne & Wear, England.	dianne.ford@ncl.ac.uk		Swan, Daniel/0000-0001-8978-8129; Mathers, John/0000-0003-3406-3002; tyson, John/0000-0002-1108-7602; Jackson, Kelly/0000-0001-9116-3769	Biotechnology and Biological Sciences Research Council [BB/F019637/1, BB/D01669X/2]; Medical Research Council; Tertiary Education Trust through Benue State University, Makurdi, Nigeria; Human Nutrition Research Centre, Newcastle University; BBSRC [BB/D01669X/2, BB/F019637/1, BB/D01669X/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01669X/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tertiary Education Trust through Benue State University, Makurdi, Nigeria; Human Nutrition Research Centre, Newcastle University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council Research Grants BB/F019637/1 (to D. F.) and BB/D01669X/2 (to R. A. V.) plus a Ph.D. studentship supporting L. J. C. (awarded to D. F.); Medical Research Council Ph.D. studentships supporting K. A. J. (awarded to D. F.) and supporting H. J. B. (awarded to R. A. V.); the Tertiary Education Trust Fund through Benue State University, Makurdi, Nigeria (Ph.D. studentship supporting O. A. O.); and the Human Nutrition Research Centre, Newcastle University (vacation studentship supporting G. M. H.).	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Chowanadisai W, 2005, J NEUROCHEM, V94, P510, DOI 10.1111/j.1471-4159.2005.03246.x; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; CROUZET J, 1991, J BACTERIOL, V173, P6074, DOI 10.1128/jb.173.19.6074-6087.1991; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Ford D, 2011, P NUTR SOC, V70, P374, DOI 10.1017/S0029665111000851; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Helston RM, 2007, PLACENTA, V28, P437, DOI 10.1016/j.placenta.2006.07.002; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mendel RR, 2007, NAT PROD REP, V24, P963, DOI 10.1039/b703112m; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Radtke F, 1996, BIOL CHEM H-S, V377, P47, DOI 10.1515/bchm3.1996.377.1.47; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Thornton JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023878; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wong A, 2004, GENOMICS, V84, P239, DOI 10.1016/j.ygeno.2004.03.001; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	44	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36567	36581		10.1074/jbc.M112.397000	http://dx.doi.org/10.1074/jbc.M112.397000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22902622	Green Published, hybrid			2022-12-28	WOS:000310364000077
J	Gohlke, H; Schlieper, D; Groth, G				Gohlke, Holger; Schlieper, Daniel; Groth, Georg			Resolving the Negative Potential Side (n-side) Water-accessible Proton Pathway of F-type ATP Synthase by Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL ARGININE RESIDUE; C-RING ROTATION; SUBUNIT-C; AQUEOUS ACCESS; ROTOR RING; ROTARY MOTOR; ALPHA; TRANSLOCATION; MEMBRANE; ARCHITECTURE	The rotation of F1Fo-ATP synthase is powered by the proton motive force across the energy-transducing membrane. The protein complex functions like a turbine; the proton flow drives the rotation of the c-ring of the transmembrane F-o domain, which is coupled to the ATP-producing F-1 domain. The hairpin-structured c-protomers transport the protons by reversible protonation/deprotonation of a conserved Asp/Glu at the outer transmembrane helix (TMH). An open question is the proton transfer pathway through the membrane at atomic resolution. The protons are thought to be transferred via two half-channels to and from the conserved cAsp/Glu in the middle of the membrane. By molecular dynamics simulations of c-ring structures in a lipid bilayer, we mapped a water channel as one of the half-channels. We also analyzed the suppressor mutant cP24D/E61G in which the functional carboxylate is shifted to the inner TMH of the c-protomers. Current models concentrating on the "locked" and "open" conformations of the conserved carboxylate side chain are unable to explain the molecular function of this mutant. Our molecular dynamics simulations revealed an extended water channel with additional water molecules bridging the distance of the outer to the inner TMH. We suggest that the geometry of the water channel is an important feature for the molecular function of the membrane part of F1Fo-ATP synthase. The inclination of the proton pathway isolates the two half-channels and may contribute to a favorable clockwise rotation in ATP synthesis mode.	[Schlieper, Daniel; Groth, Georg] Univ Dusseldorf, Inst Biochem Plant Physiol, D-40204 Dusseldorf, Germany; [Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40204 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Groth, G (corresponding author), Univ Dusseldorf, Inst Biochem Plant Physiol, D-40204 Dusseldorf, Germany.	georg.groth@hhu.de			Deutsche Forschungsgemeinschaft [GR 1616/5-3]; funds of the initiative "Fit for Excellence" at the Heinrich Heine University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); funds of the initiative "Fit for Excellence" at the Heinrich Heine University	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (GR 1616/5-3) (to G. G.) and by funds of the initiative "Fit for Excellence" at the Heinrich Heine University (to H. G.).	Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Hakulinen JK, 2012, P NATL ACAD SCI USA, V109, pE2050, DOI 10.1073/pnas.1203971109; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Pierson HE, 2011, J BIOL CHEM, V286, P38583, DOI 10.1074/jbc.M111.294868; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vik SB, 1998, J BIOL CHEM, V273, P16229, DOI 10.1074/jbc.273.26.16229; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200	67	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36536	36543		10.1074/jbc.M112.398396	http://dx.doi.org/10.1074/jbc.M112.398396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942277	Green Published, hybrid			2022-12-28	WOS:000310364000074
J	Redanz, S; Standar, K; Podbielski, A; Kreikemeyer, B				Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd			Heterologous Expression of sahH Reveals That Biofilm Formation Is Autoinducer-2-independent in Streptococcus sanguinis but Is Associated with an Intact Activated Methionine Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING SIGNAL; GROUP-A STREPTOCOCCI; ESCHERICHIA-COLI; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; S-ADENOSYLHOMOCYSTEINE; INFECTIVE ENDOCARDITIS; FUNCTIONAL-ANALYSIS; LUXS; VIRULENCE	Numerous studies have claimed deleterious effects of LuxS mutation on many bacterial phenotypes, including bacterial biofilm formation. Genetic complementation mostly restored the observed mutant phenotypes to WT levels, leading to the postulation that quorum sensing via a family of molecules generically termed autoinducer-2 (AI-2) is essential for many phenotypes. Because LuxS mutation has dual effects, this hypothesis needs to be investigated into the details for each bacterial species. In this study we used S. sanguinis SK36 as a model biofilm bacterium and employed physiological characterization and transcriptome approaches on WT and luxS-deficient strains, in combination with chemical, luxS, and sahH complementation experiments. SahH enables a direct conversion of SAH to homocysteine and thereby restores the activated methionine cycle in a luxS-negative background without formation of the AI-2 precursor 4,5-dihydroxy-2,3-pentanedione. With this strategy we were able to dissect the individual contribution of LuxS and AI-2 activity in detail. Our data revealed that S. sanguinis biofilm formation is independent from AI-2 substance pools and is rather supported by an intact activated methyl cycle. Of 216 differentially transcribed genes in the luxS mutant, 209 were restored by complementation with a gene encoding the S-adenosylhomocysteine hydrolase. Only nine genes, mainly involved in natural competence, were directly affected by the AI-2 quorum-sensing substance pool. Cumulatively, this suggested that biofilm formation in S. sanguinis is not under control of AI-2. Our study suggests that previously evaluated LuxS mutants in other species need to be revisited to resolve the precise contribution of AI-2 substance pools and the methionine pathways.	[Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Schillingallee 70, D-18057 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Redanz, Sylvio/0000-0003-1541-2545; Kreikemeyer, Bernd/0000-0001-9527-5098	PathoGenoMic Plus Program Grant [FKZ 0313801M]; ERANet PathoGenoMics I Program Grant [FKZ 0313936B]; German Federal Ministry of Education and Research	PathoGenoMic Plus Program Grant; ERANet PathoGenoMics I Program Grant; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by PathoGenoMic Plus Program Grant FKZ 0313801M and ERANet PathoGenoMics I Program Grant FKZ 0313936B from the German Federal Ministry of Education and Research.	Ahmed NAAM, 2008, ORAL MICROBIOL IMMUN, V23, P492, DOI 10.1111/j.1399-302X.2008.00460.x; Ahmed NAAM, 2007, J ANTIMICROB CHEMOTH, V60, P49, DOI 10.1093/jac/dkm124; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blehert DS, 2003, J BACTERIOL, V185, P4851, DOI 10.1128/JB.185.16.4851-4860.2003; Callahan JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026403; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; De Keersmaecker SCJ, 2005, J BIOL CHEM, V280, P19563, DOI 10.1074/jbc.M412660200; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Grinwis ME, 2010, J CLIN MICROBIOL, V48, P395, DOI 10.1128/JCM.01807-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joyce EA, 2004, INFECT IMMUN, V72, P2964, DOI 10.1128/IAI.72.5.2964-2975.2004; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kushner SR, 1978, GENET ENG N Y, P17; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; McNab R, 2003, J MED MICROBIOL, V52, P541, DOI 10.1099/jmm.0.05128-0; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Merritt J, 2005, MICROBIOL-SGM, V151, P157, DOI 10.1099/mic.0.27554-0; Merritt J, 2003, INFECT IMMUN, V71, P1972, DOI 10.1128/IAI.71.4.1972-1979.2003; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Moslehi-Jenabian S, 2009, INT J FOOD MICROBIOL, V135, P295, DOI 10.1016/j.ijfoodmicro.2009.08.011; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Pecharki D, 2008, ORAL MICROBIOL IMMUN, V23, P79, DOI 10.1111/j.1399-302X.2007.00395.x; Petersen FC, 2006, ANTON LEEUW INT J G, V90, P109, DOI 10.1007/s10482-006-9065-y; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Redanz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027827; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Romao S, 2006, MICROBIOL-SGM, V152, P333, DOI 10.1099/mic.0.28406-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Shao H, 2007, INFECT IMMUN, V75, P4211, DOI 10.1128/IAI.00402-07; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Sztajer H, 2008, J BACTERIOL, V190, P401, DOI 10.1128/JB.01086-07; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; UELAND PM, 1982, PHARMACOL REV, V34, P223; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Walters M, 2006, J BACTERIOL, V188, P5668, DOI 10.1128/JB.00648-06; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Zhu L, 2011, MOL ORAL MICROBIOL, V26, P117, DOI 10.1111/j.2041-1014.2010.00602.x	71	20	30	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36111	36122		10.1074/jbc.M112.379230	http://dx.doi.org/10.1074/jbc.M112.379230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942290	hybrid, Green Published			2022-12-28	WOS:000310364000033
J	Bardai, FH; Price, V; Zaayman, M; Wang, LL; D'Mello, SR				Bardai, Farah H.; Price, Valerie; Zaayman, Marcus; Wang, Lulu; D'Mello, Santosh R.			Histone Deacetylase-1 (HDAC1) Is a Molecular Switch between Neuronal Survival and Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEURODEGENERATIVE DISEASES; GLYCOGEN-SYNTHASE KINASE-3; PROTECTS NEURONS; NERVOUS-SYSTEM; GROWTH-FACTOR; INHIBITION; TOXICITY; MODELS; NEUROPROTECTION; ACTIVATION	Both neuroprotective and neurotoxic roles have previously been described for histone deacetylase-1 (HDAC1). Here we report that HDAC1 expression is elevated in vulnerable brain regions of two mouse models of neurodegeneration, the R6/2 model of Huntington disease and the Ca2+/calmodulin-dependent protein kinase (CaMK)/p25 double-transgenic model of tauopathic degeneration, suggesting a role in promoting neuronal death. Indeed, elevating HDAC1 expression by ectopic expression promotes the death of otherwise healthy cerebellar granule neurons and cortical neurons in culture. The neurotoxic effect of HDAC1 requires interaction and cooperation with HDAC3, which has previously been shown to selectively induce the death of neurons. HDAC1-HDAC3interaction is greatly elevated under conditions of neurodegeneration both in vitro and in vivo. Furthermore, the knockdown of HDAC3 suppresses HDAC1-induced neurotoxicity, and the knockdown of HDAC1 suppresses HDAC3 neurotoxicity. As described previously for HDAC3, the neurotoxic effect of HDAC1 is inhibited by treatment with IGF-1, the expression of Akt, or the inhibition of glycogen synthase kinase 3 beta (GSK3 beta). In addition to HDAC3, HDAC1 has been shown to interact with histone deacetylase-related protein (HDRP), a truncated form of HDAC9, whose expression is down-regulated during neuronal death. In contrast to HDAC3, the interaction between HDRP and HDAC1 protects neurons from death, an effect involving acquisition of the deacetylase activity of HDAC1 by HDRP. We find that elevated HDRP inhibits HDAC1-HDAC3 interaction and prevents the neurotoxic effect of either of these two proteins. Together, our results suggest that HDAC1 is a molecular switch between neuronal survival and death. Its interaction with HDRP promotes neuronal survival, whereas interaction with HDAC3 results in neuronal death.	[Bardai, Farah H.; Price, Valerie; Zaayman, Marcus; Wang, Lulu; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020; Zaayman, Marcus/AAM-6528-2021	D'Mello, Santosh/0000-0002-7652-1334; Zaayman, Marcus/0000-0003-1531-8313	National Institutes of Health [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058462, R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40408 and NS058462 (to S. R. D.).	Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hernandez F, 2009, MINI-REV MED CHEM, V9, P1024, DOI 10.2174/138955709788922647; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Ma C, 2011, J BIOL CHEM, V286, P4819, DOI 10.1074/jbc.M110.146860; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Wang LL, 2010, J NEUROSCI RES, V88, P1970, DOI 10.1002/jnr.22352; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	37	101	107	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35444	35453		10.1074/jbc.M112.394544	http://dx.doi.org/10.1074/jbc.M112.394544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918830	hybrid, Green Published			2022-12-28	WOS:000309968000054
J	Benabid, R; Wartelle, J; Malleret, L; Guyot, N; Gangloff, S; Lebargy, F; Belaaouaj, A				Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Gangloff, Sophie; Lebargy, Francois; Belaaouaj, Azzaq			Neutrophil Elastase Modulates Cytokine Expression CONTRIBUTION TO HOST DEFENSE AGAINST PSEUDOMONAS AERUGINOSA-INDUCED PNEUMONIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SURFACTANT PROTEIN-D; CYSTIC-FIBROSIS; INNATE IMMUNITY; FACTOR-ALPHA; INFLAMMATORY PROTEIN-2; ALVEOLAR MACROPHAGES; PANCREATIC ELASTASE; LEUKOCYTE ELASTASE	There is accumulating evidence that following bacterial infection, the massive recruitment and activation of the phagocytes, neutrophils, is accompanied with the extracellular release of active neutrophil elastase (NE), a potent serine protease. Using NE-deficient mice in a clinically relevant model of Pseudomonas aeruginosa-induced pneumonia, we provide compelling in vivo evidence that the absence of NE was associated with decreased protein and transcript levels of the proinflammatory cytokines TNF-alpha, MIP-2, and IL-6 in the lungs, coinciding with increased mortality of mutant mice to infection. The implication of NE in the induction of cytokine expression involved at least in part Toll-like receptor 4 (TLR-4). These findings were further confirmed following exposure of cultured macrophages to purified NE. Together, our data suggest strongly for the first time that NE not only plays a direct antibacterial role as it has been previously reported, but released active enzyme can also modulate cytokine expression, which contributes to host protection against P. aeruginosa. In light of our findings, the long held view that considers NE as a prime suspect in P. aeruginosa-associated diseases will need to be carefully reassessed. Also, therapeutic strategies aiming at NE inhibition should take into account the physiologic roles of the enzyme.	[Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Lebargy, Francois; Belaaouaj, Azzaq] Inserm Avenir Program, F-51092 Reims, France; [Benabid, Rym; Wartelle, Julien; Malleret, Laurette; Guyot, Nicolas; Gangloff, Sophie; Lebargy, Francois; Belaaouaj, Azzaq] CHU Reims, EA 4303, F-51092 Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims	Belaaouaj, A (corresponding author), 45 Rue Cognacq Jay, F-51092 Reims, France.	azzaq.belaaouaj@univ-reims.fr	Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456; gangloff, sophie/0000-0003-2651-9372	Inserm Avenir Program; Fondation pour la Recherche Medicale; Agence Nationale Recherche; Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne; Contrat de Projets Etat-Region	Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale Recherche(French National Research Agency (ANR)); Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne; Contrat de Projets Etat-Region	This work was supported by the Inserm Avenir Program, Fondation pour la Recherche Medicale, Agence Nationale Recherche, Association Regionale Pour I'Aide aux Insuffisants Respiratoires de Champagne Ardenne, and Contrat de Projets Etat-Region.	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; BIRRER P, 1995, RESPIRATION, V62, P25; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BURET A, 1994, INFECT IMMUN, V62, P5335, DOI 10.1128/IAI.62.12.5335-5343.1994; Calkins CM, 2002, J SURG RES, V104, P124, DOI 10.1006/jsre.2002.6422; CAMPBELL EJ, 1979, J CLIN INVEST, V64, P824, DOI 10.1172/JCI109530; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Dichtl Wolfgang, 2000, Molecular Cell Biology Research Communications, V4, P50, DOI 10.1006/mcbr.2000.0256; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; GOSSELIN D, 1995, INFECT IMMUN, V63, P3272, DOI 10.1128/IAI.63.9.3272-3278.1995; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Hirche TO, 2005, J IMMUNOL, V174, P1557, DOI 10.4049/jimmunol.174.3.1557; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lee JH, 2003, AM J RESP CRIT CARE, V168, P1462, DOI 10.1164/rccm.200302-303OC; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liou TG, 1995, BIOCHEMISTRY-US, V34, P16171, DOI 10.1021/bi00049a032; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Matalon S, 2009, FASEB J, V23, P1415, DOI 10.1096/fj.08-120568; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; RAO NV, 1993, AM J RESP CELL MOL, V8, P612, DOI 10.1165/ajrcmb/8.6.612; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Roghanian A, 2006, AM J RESP CRIT CARE, V174, P1189, DOI 10.1164/rccm.200605-632OC; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; Sharma AK, 2007, AM J PHYSIOL-LUNG C, V293, pL105, DOI 10.1152/ajplung.00470.2006; Shibata S, 2010, J ANESTH, V24, P901, DOI 10.1007/s00540-010-1030-2; Standiford TJ, 1996, BIOL SIGNAL, V5, P203; TAMURA Y, 1992, MICROB PATHOGENESIS, V12, P237, DOI 10.1016/0882-4010(92)90058-V; Tsujimoto H, 2005, SHOCK, V23, P39, DOI 10.1097/01.shk.0000145936.31967.d7; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Velard F, 2009, ACTA BIOMATER, V5, P1708, DOI 10.1016/j.actbio.2009.01.008; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; ZUCKERFRANKLIN D, 1981, J HISTOCHEM CYTOCHEM, V29, P451, DOI 10.1177/29.3.451	63	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34883	34894		10.1074/jbc.M112.361352	http://dx.doi.org/10.1074/jbc.M112.361352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927440	Green Published, hybrid			2022-12-28	WOS:000309968000002
J	Fei, J; Chen, JJ				Fei, Jia; Chen, Junjie			KIAA1530 Protein Is Recruited by Cockayne Syndrome Complementation Group Protein A (CSA) to Participate in Transcription-coupled Repair (TCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UV-SENSITIVE SYNDROME; NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; NUCLEAR-MATRIX; IN-VIVO; DAMAGE; CHROMATIN; IRRADIATION; MUTATIONS	Transcription-coupled repair (TCR) is the major pathway involved in the removal of UV-induced photolesions from the transcribed strand of active genes. Two Cockayne syndrome (CS) complementation group proteins, CSA and CSB, are important for TCR repair. The molecular mechanisms by which CS proteins regulate TCR remain elusive. Here, we report the characterization of KIAA1530, an evolutionarily conserved protein that participates in this pathway through its interaction with CSA and the TFIIH complex. We found that UV irradiation led to the recruitment of KIAA1530 onto chromatin in a CSA-dependent manner. Cells lacking KIAA1530 were highly sensitive to UV irradiation and displayed deficiency in TCR. In addition, KIAA1530 depletion abrogated stability of the CSB protein following UV irradiation. More excitingly, we found that a unique CSA mutant (W361C), which was previously identified in a patient with (UVS)-S-s syndrome, showed defective KIAA1530 binding and resulted in a failure of recruiting KIAA1530 and stabilizing CSB after UV treatment. Together, our data not only reveal that KIAA1530 is an important player in TCR but also lead to a better understanding of the molecular mechanism underlying (UVS)-S-s syndrome.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Fei, Jia/K-3287-2016; Fei, Jia/G-6866-2011	Fei, Jia/0000-0003-0612-6176	Swiss National Science Foundation [PBZHP3-135924]; Department of Defense [W81XWH-05-1-0470]; MD Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Department of Defense(United States Department of Defense); MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Postdoctoral Fellowship PBZHP3-135924 from the Swiss National Science Foundation.; Recipient of Era of Hope Scholar Award W81XWH-05-1-0470 from the Department of Defense and MD Anderson Cancer Center Support Grant CA016672. To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, Unit 66, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Rm. Y3.6006, Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5396; E-mail: jchen8@mdanderson.org.	Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Bhatia PK, 1996, J BACTERIOL, V178, P5977, DOI 10.1128/jb.178.20.5977-5988.1996; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; ITOH T, 1995, AM J HUM GENET, V56, P1267; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Koehler DR, 1996, NUCLEIC ACIDS RES, V24, P2877, DOI 10.1093/nar/24.15.2877; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; MITCHELL DL, 1990, J BIOL CHEM, V265, P5353; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	31	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35118	35126		10.1074/jbc.M112.398131	http://dx.doi.org/10.1074/jbc.M112.398131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902626	Green Published, hybrid			2022-12-28	WOS:000309968000022
J	Koharudin, LMI; Kollipara, S; Aiken, C; Gronenborn, AM				Koharudin, Leonardus M. I.; Kollipara, Sireesha; Aiken, Christopher; Gronenborn, Angela M.			Structural Insights into the Anti-HIV Activity of the Oscillatoria agardhii Agglutinin Homolog Lectin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CYANOVIRIN-N; IMMUNODEFICIENCY-VIRUS TYPE-1; INACTIVATING PROTEIN; DC-SIGN; CULTURED CYANOBACTERIUM; CRYSTAL-STRUCTURES; BINDING-SITES; CONTAINS 2; POTENT; SPECIFICITY	Oscillatoria agardhii agglutinin homolog (OAAH) proteins belong to a recently discovered lectin family. All members contain a sequence repeat of similar to 66 amino acids, with the number of repeats varying among different family members. Apart from data for the founding member OAA, neither three-dimensional structures, information about carbohydrate binding specificities, nor antiviral activity data have been available up to now for any other members of the OAAH family. To elucidate the structural basis for the antiviral mechanism of OAAHs, we determined the crystal structures of Pseudomonas fluorescens and Myxococcus xanthus lectins. Both proteins exhibit the same fold, resembling the founding family member, OAA, with minor differences in loop conformations. Carbohydrate binding studies by NMR and x-ray structures of glycan-lectin complexes reveal that the number of sugar binding sites corresponds to the number of sequence repeats in each protein. As for OAA, tight and specific binding to alpha 3, alpha 6-mannopentaose was observed. All the OAAH proteins described here exhibit potent anti-HIV activity at comparable levels. Altogether, our results provide structural details of the protein-carbohydrate interaction for this novel lectin family and insights into the molecular basis of their HIV inactivation properties.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kollipara, Sireesha; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3,Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Aiken, Christopher/Y-9252-2019	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080642 (to A. M. G.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koharudin LMI, 2011, STRUCTURE, V19, P1170, DOI 10.1016/j.str.2011.05.010; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Keefe BR, 2000, MOL PHARMACOL, V58, P982, DOI 10.1124/mol.58.5.982; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	40	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33796	33811		10.1074/jbc.M112.388579	http://dx.doi.org/10.1074/jbc.M112.388579			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865886	Green Published, hybrid			2022-12-28	WOS:000309602100061
J	Stura, EA; Le Roux, L; Guitot, K; Garcia, S; Bregant, S; Beau, F; Vera, L; Collet, G; Ptchelkine, D; Bakirci, H; Dive, V				Stura, Enrico A.; Le Roux, Laura; Guitot, Karine; Garcia, Sandra; Bregant, Sarah; Beau, Fabrice; Vera, Laura; Collet, Guillaume; Ptchelkine, Denis; Bakirci, Huseyin; Dive, Vincent			Structural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys(165)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; IRREVERSIBLE INHIBITORS; SUBSTRATE RECOGNITION; ACTIVE-SITE; LIGHT-CHAIN; SEROTYPE; BINDING; IDENTIFICATION; PROTEASE; PROGRAM	Clostridium botulinum neurotoxin type A (BoNT/A) is one of the most potent toxins for humans and a major biothreat agent. Despite intense chemical efforts over the past 10 years to develop inhibitors of its catalytic domain (catBoNT/A), highly potent and selective inhibitors are still lacking. Recently, small inhibitors were reported to covalently modify catBoNT/A by targeting Cys(165), a residue located in the enzyme active site just above the catalytic zinc ion. However, no direct proof of Cys(165) modification was reported, and the poor accessibility of this residue in the x-ray structure of catBoNT/A raises concerns about this proposal. To clarify this issue, the functional role of Cys(165) was first assessed through a combination of site-directed mutagenesis and structural studies. These data suggested that Cys(165) is more involved in enzyme catalysis rather than in structural property. Then by peptide mass fingerprinting and x-ray crystallography, we demonstrated that a small compound containing a sulfonyl group acts as inhibitor of catBoNT/A through covalent modification of Cys(165). The crystal structure of this covalent complex offers a structural framework for developing more potent covalent inhibitors catBoNT/A. Other zinc metalloproteases can be founded in the protein database with a cysteine at a similar location, some expressed by major human pathogens; thus this work should find broader applications for developing covalent inhibitors.	[Stura, Enrico A.; Le Roux, Laura; Guitot, Karine; Garcia, Sandra; Bregant, Sarah; Beau, Fabrice; Vera, Laura; Collet, Guillaume; Ptchelkine, Denis; Bakirci, Huseyin; Dive, Vincent] CE Saclay, Commissariat Energie Atom, IBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Dive, V (corresponding author), CE Saclay, Commissariat Energie Atom, IBiTec S, Serv Ingn Mol Prot, Bat 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Stura, Enrico A./A-2793-2010	Stura, Enrico A./0000-0001-6718-2118	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hale M, 2011, J BIOL CHEM, V286, P1802, DOI 10.1074/jbc.M110.146464; KITZ R, 1962, J BIOL CHEM, V237, P3245; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li B., BIOORG MED CHEM, V19, P7338; Li B, 2011, MOLECULES, V16, P202, DOI 10.3390/molecules16010202; Li B, 2010, J MED CHEM, V53, P2264, DOI 10.1021/jm901852f; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemirowicz G, 2008, MOL MICROBIOL, V70, P853, DOI 10.1111/j.1365-2958.2008.06444.x; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Stura EA., 1999, CRYSTALLIZATION PROT, P113; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Willis B, 2008, ANGEW CHEM INT EDIT, V47, P8360, DOI 10.1002/anie.200705531; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	37	15	15	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33607	33614		10.1074/jbc.M112.396697	http://dx.doi.org/10.1074/jbc.M112.396697			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869371	Green Published, hybrid			2022-12-28	WOS:000309602100045
J	Filippova, N; Yang, XH; King, P; Nabors, LBZ				Filippova, Natalia; Yang, Xiuhua; King, Peter; Nabors, L. Burt			Phosphoregulation of the RNA-binding Protein Hu Antigen R (HuR) by Cdk5 Affects Centrosome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; MESSENGER-RNA; CELL-CYCLE; BETA-CATENIN; STABILITY; NUCLEAR; PHOSPHORYLATION; PROLIFERATION; LOCALIZATION; NEUROGENESIS	Hu antigen R(HuR) is an mRNA-binding protein belonging to the ELAV family. It is highly expressed in cancer and involved in cell survival and proliferation. The impact of post-translational regulation of HuR and resulting cellular effects are poorly understood. In the current report, we describe a direct interaction between HuR and Cdk5 in glioma. We determined that Cdk5 specifically phosphorylates HuR at the serine 202 residue in the unique hinge region. The molecular consequences of this interaction are an altered HuR ability to bind, stabilize, and promote translation of mRNAs. At the cellular level, the anomalous HuR phosphorylation at this site evokes robust defects in centrosome duplication and cohesion as well as arrest of cell cycle progression. Subcellular fractionation and immunofluorescence technique confirm a direct integration of HuR and Cdk5 with centrosomes. We propose that HuR stores mRNA in the centrosome and that HuR phosphorylation by Cdk5 controls de novo protein synthesis in near proximity to centrosomes and, thus, impacts centrosome function.	[Filippova, Natalia; Yang, Xiuhua; King, Peter; Nabors, L. Burt] Univ Alabama Birmingham, Dept Neurol, Sch Med, Birmingham, AL 35294 USA; [King, Peter] Vet Affairs Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nabors, LBZ (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sch Med, 510 20th St S,FOT 1020, Birmingham, AL 35294 USA.	bnabors@uab.edu	Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511	National Institutes of Health [R01 CA112397]; Southern Research Institute; NATIONAL CANCER INSTITUTE [R01CA112397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112397 (to L. B. N.).; We greatly appreciate the space and support provided by the Southern Research Institute. We thank Dr. Lynn Rasmussen for great advice and Robert E McHugh for technical assistance.	Ale-Agha N, 2009, HEPATOLOGY, V50, P1567, DOI 10.1002/hep.23146; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bahmanyar S, 2010, J CELL SCI, V123, P3125, DOI 10.1242/jcs.064782; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Chi MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004900; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; John PCL, 2001, PROTOPLASMA, V216, P119, DOI 10.1007/BF02673865; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Lai PY, 2011, CELL DEATH DIFFER, V18, P1836, DOI 10.1038/cdd.2011.54; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meigs T. E., 2008, CSH PROTOC, V2008; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nabors LB, 2001, CANCER RES, V61, P2154; Nabors LLB, 2003, CANCER RES, V63, P4181; Nebreda AR, 2006, CURR OPIN CELL BIOL, V18, P192, DOI 10.1016/j.ceb.2006.01.001; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Rosales JL, 2010, CELL CYCLE, V9, P618, DOI 10.4161/cc.9.3.10597; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vijayakumar S., 2011, LOW DOS RAD RES INV; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010	58	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32277	32287		10.1074/jbc.M112.353912	http://dx.doi.org/10.1074/jbc.M112.353912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829587	Green Published, hybrid			2022-12-28	WOS:000309059400064
J	Lima, BP; Huyen, TTT; Basell, K; Becher, D; Antelmann, H; Wolfe, AJ				Lima, Bruno P.; Huyen, Tran Thi Thanh; Baesell, Katrin; Becher, Doerte; Antelmann, Haike; Wolfe, Alan J.			Inhibition of Acetyl Phosphate-dependent Transcription by an Acetylatable Lysine on RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR CPXR; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; ENVELOPE STRESS; ALPHA-SUBUNIT; GLOBAL SIGNAL; COENZYME-A; PROTEIN; PHOSPHORYLATION; TRANSDUCTION	The ability of bacteria to adapt to environmental changes has allowed these organisms to thrive in all parts of the globe. By monitoring their extracellular and intracellular environments, bacteria assure their most appropriate response for each environment. Post-translational modification of proteins is one mechanism by which cells respond to their changing environments. Here, we report that two post-translational modifications regulate transcription of the extracytoplasmic stress-responsive promoter cpxP: (i) acetyl phosphate-dependent phosphorylation of the response regulator CpxR and (ii) acetyl coenzyme A-dependent acetylation of the alpha subunit of RNA polymerase. Together, these two post-translational modifications fine-tune cpxP transcription in response to changes in the intracellular environment.	[Lima, Bruno P.; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Huyen, Tran Thi Thanh; Baesell, Katrin; Becher, Doerte; Antelmann, Haike] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany	Loyola University Chicago; Ernst Moritz Arndt Universitat Greifswald	Wolfe, AJ (corresponding author), 2160 S 1st Ave,Bldg 105, Maywood, IL 60153 USA.	awolfe@lumc.edu	Lima, Bruno/K-3228-2019; Becher, Doerte/B-4454-2015; Antelmann, Haike/I-3129-2019	Lima, Bruno/0000-0003-4619-4712; Becher, Doerte/0000-0002-9630-5735; Antelmann, Haike/0000-0002-1766-4386	National Institutes of Health [GM066130]; Loyola University Chicago Potts Foundation [LU11200]; Deutsche Forschungsgemeinschaft [AN746/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loyola University Chicago Potts Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066130 and Loyola University Chicago Potts Foundation Award LU11200 (to A. J. W.) and Deutsche Forschungsgemeinschaft Project AN746/2-1 (to H. A.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; Boll JM, 2011, P NATL ACAD SCI USA, V108, P20160, DOI 10.1073/pnas.1113013108; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Chi BK, 2010, PROTEOMICS, V10, P3155, DOI 10.1002/pmic.201000230; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; JACKOWSKI S, 1986, J BACTERIOL, V166, P866, DOI 10.1128/jb.166.3.866-871.1986; Keating DH, 2008, BIOL PROCED ONLINE, V10, P36, DOI 10.1251/bpo141; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Liu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023314; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Miot M, 2011, NEW BIOTECHNOL, V28, P277, DOI 10.1016/j.nbt.2010.06.012; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Silhavy T. J., 1984, EXPT GENE FUSIONS; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Spinola SM, 2010, INFECT IMMUN, V78, P3898, DOI 10.1128/IAI.00432-10; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	53	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32147	32160		10.1074/jbc.M112.365502	http://dx.doi.org/10.1074/jbc.M112.365502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829598	hybrid, Green Published			2022-12-28	WOS:000309059400052
J	Prigge, M; Schneider, F; Tsunoda, SP; Shilyansky, C; Wietek, J; Deisseroth, K; Hegemann, P				Prigge, Matthias; Schneider, Franziska; Tsunoda, Satoshi P.; Shilyansky, Carrie; Wietek, Jonas; Deisseroth, Karl; Hegemann, Peter			Color-tuned Channelrhodopsins for Multiwavelength Optogenetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL CONTROL; VOLVOX-CARTERI; IN-VIVO; LIGHT; ACTIVATION; CHANNEL; CELLS; PHOTOCYCLE; CIRCUITRY	Channelrhodopsin-2 is a light-gated ion channel and a major tool of optogenetics. It is used to control neuronal activity via blue light. Here we describe the construction of color-tuned high efficiency channelrhodopsins (ChRs), based on chimeras of Chlamydomonas channelrhodopsin-1 and Volvox channelrhodopsin-1. These variants show superb expression and plasma membrane integration, resulting in 3-fold larger photocurrents in HEK cells compared with channelrhodopsin-2. Further molecular engineering gave rise to chimeric variants with absorption maxima ranging from 526 to 545 nm, dovetailing well with maxima of channelrhodopsin-2 derivatives ranging from 461 to 492 nm. Additional kinetic fine-tuning led to derivatives in which the lifetimes of the open state range from 19 ms to 5 s. Finally, combining green-with blue-absorbing variants allowed independent activation of two distinct neural cell populations at 560 and 405 nm. This novel panel of channelrhodopsin variants may serve as an important toolkit element for dual-color cell stimulation in neural circuits.	[Prigge, Matthias; Schneider, Franziska; Tsunoda, Satoshi P.; Wietek, Jonas; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Shilyansky, Carrie; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Comp Numer Control Program, Dept Bioengn, Stanford, CA 94305 USA; [Shilyansky, Carrie; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Comp Numer Control Program, Dept Psychiat, Stanford, CA 94305 USA	Humboldt University of Berlin; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol, D-10115 Berlin, Germany.	hegemape@rz.hu-berlin.de	Wietek, Jonas/AFQ-6404-2022; Tsunoda, Satoshi/AAN-7023-2021; Wietek, Jonas/I-5911-2015	Wietek, Jonas/0000-0002-8079-7042; Wietek, Jonas/0000-0002-8079-7042; Tsunoda, Satoshi/0000-0003-3636-1521	National Institutes of Health; Howard Hughes Medical Institute; Gatsby Foundation; DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery); German Research Foundation; Deutsche Forschungsgemeinschaft [HE3824/9-3, HE3824/9-4]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gatsby Foundation; DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported, in whole or in part, by the National Institutes of Health. Also supported by the Howard Hughes Medical Institute, the Gatsby Foundation, and the DARPA REPAIR program (reorganization and plasticity to accelerate injury recovery).; Supported by the German Research Foundation and Deutsche Forschungsgemeinschaft Grants HE3824/9-3 and 9-4. To whom correspondence should be addressed. Tel.: 0049-30-2093-8681; E-mail: hegemape@rz.huberlin.de.	Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Prigge M, 2010, CHANNELS, V4, P241, DOI 10.4161/chan.4.3.11888; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	25	114	137	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31804	31812		10.1074/jbc.M112.391185	http://dx.doi.org/10.1074/jbc.M112.391185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843694	hybrid, Green Published			2022-12-28	WOS:000309059400021
J	McAllister, CS; Taghavi, N; Samuel, CE				McAllister, Christopher S.; Taghavi, Nora; Samuel, Charles E.			Protein Kinase PKR Amplification of Interferon beta Induction Occurs through Initiation Factor eIF-2 alpha-mediated Translational Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTORS; TRANSCRIPTION FACTORS; DEPENDENT ACTIVATION; REGULATORY FACTOR-3; TEMPORAL CONTROL; MESSENGER-RNA; RECOGNITION; MECHANISM	The protein kinase PKR is activated by RNA with double-stranded (ds) structure and subsequently impairs translation through phosphorylation of protein synthesis initiation factor eIF-2 alpha. PKR also mediates activation of signal transduction pathways leading to interferon beta (IFN-beta) gene induction following virus-infection or RNA transfection. We previously demonstrated in measles virus-infected cells that PKR is required for the maximal induction of IFN-beta gene expression by the interferon promoter stimulator gene 1(IPS-1) adaptor-dependent cytosolic RNA sensor pathway. While both IPS-1 and PKR are important mediators of IFN-beta induction, with PKR contributing to an enhanced NF-kappa B activation, the mechanism by which PKR enhances NF-kappa B activity and amplifies IFN-beta induction is unresolved. Herein we tested the possibility that PKR could activate signal transduction pathways indirectly through translational control responses. Following transfection with synthetic or natural dsRNAs or infection with measles virus, we observed increased mRNA but decreased protein levels for the inhibitor of NF-kappa B signaling, I kappa B-alpha, that correlated with PKR activation and eIF-2 alpha phosphorylation. Importantly, knockdown of PKR increased I kappa B-alpha protein levels and impaired IFN-beta induction. Additionally, inhibition of translation by cycloheximide treatment rescued IFN-beta induction following PKR knockdown but not IPS-1 knockdown. Mutation of eIF-2 alpha to prevent phosphorylation also impaired IFN-beta induction in PKR-sufficient virus-infected cells. These results suggest that an eIF-2 alpha-dependent translation inhibition mechanism is sufficient to explain the PKR-mediated amplification of IPS-1-dependent IFN-beta induction by foreign RNA.	[McAllister, Christopher S.; Taghavi, Nora; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			NIAID, National Institutes of Health, U.S. Public Health Service [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012520, R01AI020611, R01AI012520] Funding Source: NIH RePORTER	NIAID, National Institutes of Health, U.S. Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Research Grants AI-12520 and AI-20611 from the NIAID, National Institutes of Health, U.S. Public Health Service.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; CASHDOLLAR LW, 1984, VIROLOGY, V133, P191, DOI 10.1016/0042-6822(84)90438-0; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Taghavi N, 2012, VIROLOGY, V427, P208, DOI 10.1016/j.virol.2012.01.029; THOMIS DC, 1992, VIROLOGY, V188, P33, DOI 10.1016/0042-6822(92)90732-5; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Toth A. M., 2006, PROG NUCL ACIDS RES, V81, P369; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	61	62	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36384	36392		10.1074/jbc.M112.390039	http://dx.doi.org/10.1074/jbc.M112.390039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948139	Green Published, hybrid			2022-12-28	WOS:000310364000058
J	Sobhany, M; Kakuta, Y; Sugiura, N; Kimata, K; Negishi, M				Sobhany, Mack; Kakuta, Yoshimitsu; Sugiura, Nobuo; Kimata, Koji; Negishi, Masahiko			The Structural Basis for a Coordinated Reaction Catalyzed by a Bifunctional Glycosyltransferase in Chondroitin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; POLYMERASE; PROTEOGLYCANS; MECHANISM	Bifunctional chondroitin synthase K4CP catalyzes glucuronic acid and N-acetylgalactosamine transfer activities and polymerizes a chondroitin chain. Here we have determined that an N-terminal region (residues 58-134) coordinates two transfer reactions and enables K4CP to catalyze polymerization. When residues 58-107 are deleted, K4CP loses polymerase activity while retaining both transfer activities. Peptide (DWPSDL118)-D-113 within this N-terminal region interacts with C-terminal peptide (YTWEKI682)-Y-677. The deletion of either sequence abolishes glucuronic acid but not N-acetylgalactosamine transfer activity in K4CP. Both donor bindings and transfer activities are lost by mutating (YTWEKI682)-Y-677 to (677)DAWEDI(682). On the other hand, acceptor substrates retain their binding to K4CP mutants. The characteristics of these K4CP mutants highlight different states of the enzyme reaction, providing an underlying structural basis for how these peptides play essential roles in coordinating the two glycosyltransferase activities for K4CP to elongate the chondroitin chain.	[Sobhany, Mack; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biochem, Fukuoka 8128581, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyushu University; Aichi Medical University	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health (Intramural Research Program of NIEHS) [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZICES102545] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	National Institutes of Health (Intramural Research Program of NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES1005-01 (Intramural Research Program of NIEHS).	Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Jorpes E, 1935, Biochem J, V29, P1817; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PRESS WH, 1989, NUMERICAL RECIPES FO; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617	13	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36022	36028		10.1074/jbc.M112.375873	http://dx.doi.org/10.1074/jbc.M112.375873			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936799	Green Published, hybrid			2022-12-28	WOS:000310364000024
J	Cameron, EA; Maynard, MA; Smith, CJ; Smith, TJ; Koropatkin, NM; Martens, EC				Cameron, Elizabeth A.; Maynard, Mallory A.; Smith, Christopher J.; Smith, Thomas J.; Koropatkin, Nicole M.; Martens, Eric C.			Multidomain Carbohydrate-binding Proteins Involved in Bacteroides thetaiotaomicron Starch Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; HUMAN GUT SYMBIONT; ALPHA-AMYLASE; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; I-TASSER; GLYCOGEN; DOMAIN; RECOGNITION; COMPLEX	Human colonic bacteria are necessary for the digestion of many dietary polysaccharides. The intestinal symbiont Bacteroides thetaiotaomicron uses five outer membrane proteins to bind and degrade starch. Here, we report the x-ray crystallographic structures of SusE and SusF, two outer membrane proteins composed of tandem starch specific carbohydrate-binding modules (CBMs) with no enzymatic activity. Examination of the two CBMs in SusE and three CBMs in SusF reveals subtle differences in the way each binds starch and is reflected in their K-d values for both high molecular weight starch and small maltooligosaccharides. Thus, each site seems to have a unique starch preference that may enable these proteins to interact with different regions of starch or its breakdown products. Proteins similar to SusE and SusF are encoded in many other polysaccharide utilization loci that are possessed by human gut bacteria in the phylum Bacteroidetes. Thus, these proteins are likely to play an important role in carbohydrate metabolism in these abundant symbiotic species. Understanding structural changes that diversify and adapt related proteins in the human gut microbial community will be critical to understanding the detailed mechanistic roles that they perform in the complex digestive ecosystem.	[Cameron, Elizabeth A.; Maynard, Mallory A.; Smith, Christopher J.; Koropatkin, Nicole M.; Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Thomas J.; Koropatkin, Nicole M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Michigan System; University of Michigan; Donald Danforth Plant Science Center	Koropatkin, NM (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	nkoropat@umich.edu; emartens@umich.edu	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793	National Institutes of Health [K01DK084214]; University of Michigan [GM07544]; University of Michigan Gastrointestinal Peptides Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor program [085P1000817]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); University of Michigan Gastrointestinal Peptides Research Center; United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K01DK084214 (to E. C. M), the University of Michigan Biological Sciences Scholars Program, and pilot/feasibility grants from the University of Michigan Gastrointestinal Peptides Research Center (to E. C. M. and N. M. K.).; Supported by University of Michigan Genetics Training Grant GM07544.; We thank the United States Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor program Grant 085P1000817.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON KL, 1989, J BACTERIOL, V171, P3199, DOI 10.1128/jb.171.6.3199-3204.1989; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Holdeman L. V, 1977, ANAEROBE LAB MANUAL, V4th; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Juge N, 2006, BBA-PROTEINS PROTEOM, V1764, P275, DOI 10.1016/j.bbapap.2005.11.008; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2007, J BIOL CHEM, V282, P2606, DOI 10.1074/jbc.M610222200; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Latorre-Garcia L, 2005, J BIOTECHNOL, V118, P167, DOI 10.1016/j.jbiotec.2005.03.019; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sumitani J, 2000, BIOCHEM J, V350, P477, DOI 10.1042/0264-6021:3500477; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	74	78	2	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34614	34625		10.1074/jbc.M112.397380	http://dx.doi.org/10.1074/jbc.M112.397380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910908	Green Published, hybrid			2022-12-28	WOS:000309654200064
J	Dogan, J; Schmidt, T; Mu, X; Engstrom, A; Jemth, P				Dogan, Jakob; Schmidt, Tanja; Mu, Xin; Engstrom, Ake; Jemth, Per			Fast Association and Slow Transitions in the Interaction between Two Intrinsically Disordered Protein Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COACTIVATOR BINDING DOMAIN; CONFORMATIONAL SELECTION; UNSTRUCTURED PROTEINS; COMPLEX; CBP; RECRUITMENT; RECOGNITION; MECHANISM; STATE	Proteins that contain long disordered regions are prevalent in the proteome and frequently associated with diseases. However, the mechanisms by which such intrinsically disordered proteins (IDPs) recognize their targets are not well understood. Here, we report the first experimental investigation of the interaction kinetics of the nuclear co-activator binding domain of CREB-binding protein and the activation domain from the p160 transcriptional co-activator for thyroid hormone and retinoid receptors. Both protein domains are intrinsically disordered in the free state and synergistically fold upon binding each other. Using the stopped-flow technique, we found that the binding reaction is fast, with an association rate constant of 3 x 10(7) M-1 s(-1) at 277 K. Mutation of a conserved buried intermolecular salt bridge showed that electrostatics govern the rapid association. Furthermore, upon mutation of the salt bridge or at high salt concentration, an additional kinetic phase was detected (similar to 20 and similar to 40 s(-1), respectively, at 277 K), suggesting that the salt bridge may steer formation of the productive bimolecular complex in an intramolecular step. Finally, we directly measured slow kinetics for the IDP domains (similar to 1 s(-1) at 277 K) related to conformational transitions upon binding. Together, the experiments demonstrate that the interaction involves several steps and accumulation of intermediate states. Our data are consistent with an induced fit mechanism, in agreement with previous simulations. We propose that the slow transitions may be a consequence of the multipartner interactions of IDPs.	[Dogan, Jakob; Schmidt, Tanja; Mu, Xin; Engstrom, Ake; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Dogan, J (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	Jakob.Dogan@imbim.uu.se; Per.Jemth@imbim.uu.se			Swedish Research Council (Natural and Engineering Sciences); Human Frontiers Young Investigator Science Program; Lars Hierta Memorial Foundation	Swedish Research Council (Natural and Engineering Sciences)(Swedish Research Council); Human Frontiers Young Investigator Science Program; Lars Hierta Memorial Foundation	This work was supported by the Swedish Research Council (Natural and Engineering Sciences) and the Human Frontiers Young Investigator Science Program and the Lars Hierta Memorial Foundation.	Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Karlsson OA, 2012, J MOL BIOL, V417, P253, DOI 10.1016/j.jmb.2012.01.042; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353	28	66	66	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34316	34324		10.1074/jbc.M112.399436	http://dx.doi.org/10.1074/jbc.M112.399436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22915588	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309654200035
J	Ghosal, G; Leung, JWC; Nair, BC; Fong, KW; Chen, JJ				Ghosal, Gargi; Leung, Justin Wai-Chung; Nair, Binoj C.; Fong, Ka-Wing; Chen, Junjie			Proliferating Cell Nuclear Antigen (PCNA)-binding Protein C1orf124 Is a Regulator of Translesion Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE TOLERANCE; POSTREPLICATION REPAIR; GENOMIC INSTABILITY; STALLED REPLICATION; POLYMERASE SWITCH; REV1 PROTEIN; PCNA; UBIQUITIN; RAD18; STABILITY	DNA damage-induced proliferating cell nuclear antigen (PCNA) ubiquitination serves as the key event mediating post-replication repair. Post-replication repair involves either translesion synthesis (TLS) or damage avoidance via template switching. In this study, we have identified and characterized C1orf124 as a regulator of TLS. C1orf124 co-localizes and interacts with unmodified and mono-ubiquitinated PCNA at UV light-induced damage sites, which require the PIP box and UBZ domain of C1orf124. C1orf124 also binds to the AAA-ATPase valosin-containing protein via its SHP domain, and cellular resistance to UV radiation mediated by C1orf124 requires its interactions with valosin-containing protein and PCNA. Interestingly, C1orf124 binds to replicative DNA polymerase POLD3 and PDIP1 under normal conditions but preferentially associates with TLS polymerase eta (POLH) upon UV damage. Depletion of C1orf124 compromises PCNA monoubiquitination, RAD18 chromatin association, and RAD18 localization to UV damage sites. Thus, C1orf124 acts at multiple steps in TLS, stabilizes RAD18 and ubiquitinated PCNA at damage sites, and facilitates the switch from replicative to TLS polymerase to bypass DNA lesion.	[Ghosal, Gargi; Leung, Justin Wai-Chung; Nair, Binoj C.; Fong, Ka-Wing; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org		Ghosal, Gargi/0000-0001-8399-5354; Fong, Ka-wing/0000-0001-6995-0264; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA100109, P30CA016672, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of Era of Hope Scholar Award W81XWH-05-1-0470 from the United States Department of Defense and member of the MD Anderson Cancer Center (supported by National Institutes of Health Grant CA016672).	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gari K, 2009, CRIT REV BIOCHEM MOL, V44, P292, DOI 10.1080/10409230903154150; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lee KY, 2008, MOL CELLS, V26, P5; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409	39	79	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34225	34233		10.1074/jbc.M112.400135	http://dx.doi.org/10.1074/jbc.M112.400135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902628	Green Published, hybrid			2022-12-28	WOS:000309654200027
J	Hegde, ML; Banerjee, S; Hegde, PM; Bellot, LJ; Hazra, TK; Boldogh, I; Mitra, S				Hegde, Muralidhar L.; Banerjee, Srijita; Hegde, Pavana M.; Bellot, Larry J.; Hazra, Tapas K.; Boldogh, Istvan; Mitra, Sankar			Enhancement of NEIL1 Protein-initiated Oxidized DNA Base Excision Repair by Heterogeneous Nuclear Ribonucleoprotein U (hnRNP-U) via Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AP-ENDONUCLEASE APE1/REF-1; RESISTANCE GENE MDR1; DOUBLE-STRAND BREAKS; GLYCOSYLASE NEIL1; OXIDATIVE STRESS; BINDING-PROTEIN; HUMAN-CELLS; SAF-A; DAMAGE; IDENTIFICATION	Repair of oxidized base lesions in the human genome, initiated by DNA glycosylases, occurs via the base excision repair pathway using conserved repair and some non-repair proteins. However, the functions of the latter noncanonical proteins in base excision repair are unclear. Here we elucidated the role of heterogeneous nuclear ribonucleoprotein-U (hnRNP-U), identified in the immunoprecipitate of human NEIL1, a major DNA glycosylase responsible for oxidized base repair. hnRNP-U directly interacts with NEIL1 in vitro via the NEIL1 common interacting C-terminal domain, which is dispensable for its enzymatic activity. Their in-cell association increases after oxidative stress. hnRNP-U stimulates the NEIL1 in vitro base excision activity for 5-hydroxyuracil in duplex, bubble, forked, or single-stranded DNA substrate, primarily by enhancing product release. Using eluates from FLAG-NEIL1 immunoprecipitates from human cells, we observed 3-fold enhancement in complete repair activity after oxidant treatment. The lack of such enhancement in hnRNP-U-depleted cells suggests its involvement in repairing enhanced base damage after oxidative stress. The NEIL1 disordered C-terminal region binds to hnRNP-U at equimolar ratio with high affinity (K-d = similar to 54 nM). The interacting regions in hnRNP-U, mapped to both termini, suggest their proximity in the native protein; these are also disordered, based on PONDR (Predictor of Naturally Disordered Regions) prediction and circular dichroism spectra. Finally, depletion of hnRNP-U and NEIL1 epistatically sensitized human cells at low oxidative genome damage, suggesting that the hnRNP-U protection of cells after oxidative stress is largely due to enhancement of NEIL1-mediated repair.	[Hegde, Muralidhar L.; Banerjee, Srijita; Hegde, Pavana M.; Bellot, Larry J.; Hazra, Tapas K.; Mitra, Sankar] UTMB, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hegde, Muralidhar L.] UTMB, Dept Neurol, Galveston, TX 77555 USA; [Hazra, Tapas K.] UTMB, Dept Internal Med, Galveston, TX 77555 USA; [Boldogh, Istvan] UTMB, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hazra, Tapas K.; Boldogh, Istvan; Mitra, Sankar] UTMB, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Mitra, S (corresponding author), MRB 6-136,301 Univ Blvd, Galveston, TX 77555 USA.	samitra@utmb.edu	Classen, Scott/AAY-8176-2020	Hegde, Muralidhar/0000-0001-7333-8123; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health through USPHS [R01 CA81063, P01 CA092584, R01 NS073976, ES018948]; NIEHS Center (National Institutes of Health) [P30 ES06676]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976] Funding Source: NIH RePORTER	National Institutes of Health through USPHS; NIEHS Center (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA81063 and P01 CA092584 (to S. M.), R01 NS073976 (to T. K. H.), and ES018948 (to I. B.) through the USPHS.; We thank Drs. D. W. Bolen and L. Holthauzen (Department of Biochemistry and Molecular Biology) for the use of the Biophysical Core Facility and Drs. M. Banadakoppa and C. Yallampalli (Department of Obstetrics and Gynecology) for fluorescence microscopy. We acknowledge the help of Dr. T. Wood of the NIEHS Center (National Institutes of Health), supported by Grant P30 ES06676 for large scale purification of pUC19CPD plasmid. We thank former Mitra laboratory members Drs. C. Theriot and A. Das for various help and Dr. D. Konkel for critically editing this manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; Bozner P, 1997, J NEUROPATH EXP NEUR, V56, P1356, DOI 10.1097/00005072-199712000-00010; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chatterjee M, 2012, J BIOL CHEM, V287, DOI [10.1074/jbc.M112.415067, 10.1074/jbc.M111.272179]; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Douki T, 2003, NUCLEIC ACIDS RES, V31, P3134, DOI 10.1093/nar/gkg408; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Meyer TE, 1998, INT J CANCER, V77, P55, DOI 10.1002/(SICI)1097-0215(19980703)77:1<55::AID-IJC10>3.0.CO;2-8; Mukherjee SK, 1997, MOL CHEM NEUROPATHOL, V32, P59, DOI 10.1007/BF02815167; Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Theriot CA, 2010, DNA REPAIR, V9, P643, DOI 10.1016/j.dnarep.2010.02.014; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; YANG JT, 1986, METHOD ENZYMOL, V130, P208	50	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34202	34211		10.1074/jbc.M112.384032	http://dx.doi.org/10.1074/jbc.M112.384032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902625	Green Published, hybrid			2022-12-28	WOS:000309654200025
J	Kumar, NV; Rangarajan, PN				Kumar, Nallani Vijay; Rangarajan, Pundi N.			The Zinc Finger Proteins Mxr1p and Repressor of Phosphoenolpyruvate Carboxykinase (ROP) Have the Same DNA Binding Specificity but Regulate Methanol Metabolism Antagonistically in Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UTILIZATION PATHWAY; EXPRESSION; PROMOTER; IDENTIFICATION; GENES	The methanol-inducible alcohol oxidase I (AOXI) promoter of the methylotrophic yeast, Pichia pastoris, is used widely for the production of recombinant proteins. AOXI transcription is regulated by the zinc finger protein Mxr1p (methanol expression regulator 1). ROP (repressor of phosphoenolpyruvate carboxykinase, PEPCK) is a methanol- and biotin starvation-inducible zinc finger protein that acts as a negative regulator of PEPCK in P. pastoris cultured in biotin-deficient, glucose-ammonium medium. The function of ROP during methanol metabolism is not known. In this study, we demonstrate that ROP represses methanol-inducible expression of AOXI when P. pastoris is cultured in a nutrient-rich medium containing yeast extract, peptone, and methanol (YPM). Deletion of the gene encoding ROP results in enhanced expression of AOXI and growth promotion whereas overexpression of ROP results in repression of AOXI and growth retardation of P. pastoris cultured in YPM medium. Surprisingly, deletion or overexpression of ROP has no effect on AOXI gene expression and growth of P. pastoris cultured in a minimal medium containing yeast nitrogen base and methanol (YNBM). Subcellular localization studies indicate that ROP translocates from cytosol to nucleus of cells cultured in YPM but not YNBM. In vitro DNA binding studies indicate that AOXI promoter sequences containing 5' CYCCNY 3' motifs serve as binding sites for Mxr1p as well as ROP. Thus, Mxr1p and ROP exhibit the same DNA binding specificity but regulate methanol metabolism antagonistically in P. pastoris. This is the first report on the identification of a transcriptional repressor of methanol metabolism in any yeast species.	[Kumar, Nallani Vijay; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Department of Biotechnology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, New Delhi, India.	Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Koller A, 2000, YEAST, V16, P651, DOI 10.1002/(SICI)1097-0061(200005)16:7<651::AID-YEA580>3.3.CO;2-6; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Maniatis T., 1982, MOL CLONING LAB MANU; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	12	16	18	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34465	34473		10.1074/jbc.M112.365304	http://dx.doi.org/10.1074/jbc.M112.365304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888024	hybrid, Green Published			2022-12-28	WOS:000309654200048
J	Mitchell, DA; Hamel, LD; Ishizuka, K; Mitchell, G; Schaefer, LM; Deschenes, RJ				Mitchell, David A.; Hamel, Laura D.; Ishizuka, Kayoko; Mitchell, Gayatri; Schaefer, Logan M.; Deschenes, Robert J.			The Erf4 Subunit of the Yeast Ras Palmitoyl Acyltransferase Is Required for Stability of the Acyl-Erf2 Intermediate and Palmitoyl Transfer to a Ras2 Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; SACCHAROMYCES-CEREVISIAE; PROTEIN PALMITOYLATION; MENTAL-RETARDATION; UBIQUITIN LIGASE; GENE; DEGRADATION; EXPRESSION; FAMILY; PALMITOYLTRANSFERASE	Protein S-palmitoylation is a posttranslational modification in which a palmitoyl group is added to a protein via a thioester linkage on cysteine. Palmitoylation is a reversible modification involved in protein membrane targeting, receptor trafficking and signaling, vesicular biogenesis and trafficking, protein aggregation, and protein degradation. An example of the dynamic nature of this modification is the palmitoylation-depalmitoylation cycle that regulates the subcellular trafficking of Ras family GTPases. The Ras protein acyltransferase (PAT) consists of a complex of Erf2-Erf4 and DHHC9-GCP16 in yeast and mammalian cells, respectively. Both subunits are required for PAT activity, but the function of the Erf4 and Gcp16 subunits has not been established. This study elucidates the function of Erf4 and shows that one role of Erf4 is to regulate Erf2 stability through an ubiquitin-mediated pathway. In addition, Erf4 is required for the stable formation of the palmitoyl-Erf2 intermediate, the first step of palmitoyl transfer to protein substrates. In the absence of Erf4, the rate of hydrolysis of the active site palmitoyl thioester intermediate is increased, resulting in reduced palmitoyl transfer to a Ras2 substrate. This is the first demonstration of regulation of a DHHC PAT enzyme by an associated protein.	[Deschenes, Robert J.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Deschenes, RJ (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	rdeschen@health.usf.edu			National Institutes of Health [CA50211, GM73976]; NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50211 and GM73976 (to R. J. D.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JUNG V, 1995, MOL CELL BIOL, V15, P1333; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	43	34	34	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34337	34348		10.1074/jbc.M112.379297	http://dx.doi.org/10.1074/jbc.M112.379297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904317	Green Published, hybrid			2022-12-28	WOS:000309654200037
J	Ramabhadran, V; Gurel, PS; Higgs, HN				Ramabhadran, Vinay; Gurel, Pinar S.; Higgs, Henry N.			Mutations to the Formin Homology 2 Domain of INF2 Protein Have Unexpected Effects on Actin Polymerization and Severing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR FUNCTION; CAPPING PROTEIN; FISSION YEAST; FH2 DOMAIN; ATP-ACTIN; ADP-ACTIN; FILAMENTS; MECHANISM; ELONGATION; NUCLEATION	INF2 (inverted formin 2) is a formin protein with unusual biochemical characteristics. As with other formins, the formin homology 2 (FH2) domain of INF2 accelerates actin filament assembly and remains at the barbed end, modulating elongation. The unique feature of INF2 is its ability to sever filaments and enhance depolymerization, which requires the C-terminal region. Physiologically, INF2 acts in the secretory pathway and is mutated in two human diseases, focal and segmental glomerulosclerosis and Charcot-Marie-Tooth disease. In this study, we investigate the effects of mutating two FH2 residues found to be key in other formins: Ile-643 and Lys-792. Surprisingly, neither mutation abolishes barbed end binding, as judged by pyrene-actin and total internal reflection (TIRF) microscopy elongation assays. The I643A mutation causes tight capping of a subset of filaments, whereas K792A causes slow elongation of all filaments. The I643A mutation has a minor inhibitory effect on polymerization activity but causes almost complete abolition of severing and depolymerization activity. The K792A mutation has relatively small effects on polymerization, severing, and depolymerization. In cells, the K792A mutant causes actin accumulation around the endoplasmic reticulum to a similar extent as wild type, whereas the I643A mutant causes no measurable polymerization. The inability of I643A to induce actin polymerization in cells is explained by its inability to promote robust actin polymerization in the presence of capping protein. These results highlight an important point: it is dangerous to assume that mutation of conserved FH2 residues will have equivalent effects in all formins. The work also suggests that both mutations have effects on the mechanism of processive elongation.	[Ramabhadran, Vinay; Gurel, Pinar S.; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818, R01 DK088826]; Hitchcock Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM069818 and R01 DK088826. This work was also supported by the Hitchcock Foundation.	Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Boyer O, 2011, J AM SOC NEPHROL, V22, P239, DOI 10.1681/ASN.2010050518; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gbadegesin RA, 2012, KIDNEY INT, V81, P94, DOI 10.1038/ki.2011.297; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lee HK, 2011, PEDIATR NEPHROL, V26, P73, DOI 10.1007/s00467-010-1644-5; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	45	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34234	34245		10.1074/jbc.M112.365122	http://dx.doi.org/10.1074/jbc.M112.365122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879592	Green Published, hybrid			2022-12-28	WOS:000309654200028
J	Muylaert, I; Zhao, ZY; Andersson, T; Elias, P				Muylaert, Isabella; Zhao, Zhiyuan; Andersson, Torbjorn; Elias, Per			Simplex Virus Type 1 UL8 Protein Required for DNA Synthesis and UL52 Primase Interaction in the Virus Replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN-BINDING PROTEIN; HERPESVIRUS MACROMOLECULAR-SYNTHESIS; HELICASE-PRIMASE; HOMOLOGOUS RECOMBINATION; GENE-PRODUCTS; C-TERMINUS; REPLICATION; POLYMERASE; SEQUENCE; SUBUNIT	We have used oriS-dependent transient replication assays to search for species-specific interactions within the herpes simplex virus replisome. Hybrid replisomes derived from herpes simplex virus type 1 (HSV-1) and equine herpesvirus type 1 (EHV-1) failed to support DNA replication in cells. Moreover, the replisomes showed a preference for their cognate origin of replication. The results demonstrate that the herpesvirus replisome behaves as a molecular machine relying on functionally important interactions. We then searched for functional interactions in the replisome context by subjecting HSV-1 UL8 protein to extensive mutagenesis. 52 mutants were made by replacing single or clustered charged amino acids with alanines. Four mutants showed severe replication defects. Mutant A23 exhibited a lethal phenotype, and mutants A49, A52 and A53 had temperature-sensitive phenotypes. Mutants A49 and A53 did not interact with UL52 primase as determined by co-immunoprecipitation experiments. Using GFP-tagged UL8, we demonstrate that all mutants were unable to support formation of ICP8-containing nuclear replication foci. Extended mutagenesis suggested that a highly conserved motif corresponding to mutant A49 serves an important role for establishing a physical contact between UL8 and UL52. The replication-defective mutations affected conserved amino acids, and similar phenotypes were observed when the corresponding mutations were introduced into EHV-1 UL8.	[Muylaert, Isabella; Zhao, Zhiyuan; Andersson, Torbjorn; Elias, Per] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden	University of Gothenburg	Muylaert, I (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Sahlgrenska Acad, Box 440, SE-40530 Gothenburg, Sweden.	isabella.muylaert@medkem.gu.se; per.elias@medkem.gu.se	Zhao, Zhiyuan/Q-9330-2018	Zhao, Zhiyuan/0000-0002-6962-1791	Swedish Cancer Foundation; Swedish Research Council	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Cancer Foundation and the Swedish Research Council (to P. E.).	Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Barnard EC, 1997, VIROLOGY, V237, P97, DOI 10.1006/viro.1997.8763; Barrera I, 1998, J VIROL, V72, P1203, DOI 10.1128/JVI.72.2.1203-1209.1998; BLOOM DC, 1994, J VIROL, V68, P3761, DOI 10.1128/JVI.68.6.3761-3772.1994; Bridges KG, 2000, J BIOL CHEM, V275, P472, DOI 10.1074/jbc.275.1.472; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; Falkenberg M, 1998, J BIOL CHEM, V273, P32154, DOI 10.1074/jbc.273.48.32154; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Livingston CM, 2008, J VIROL, V82, P6324, DOI 10.1128/JVI.00455-08; LOCKSHON D, 1988, MOL CELL BIOL, V8, P4018, DOI 10.1128/MCB.8.10.4018; Loregian A, 2006, J VIROL, V80, P6247, DOI 10.1128/JVI.02551-05; Marsden HS, 1997, J VIROL, V71, P6390, DOI 10.1128/JVI.71.9.6390-6397.1997; MAVROMARANAZOS P, 1987, VIROLOGY, V161, P593, DOI 10.1016/0042-6822(87)90156-5; MCLEAN GW, 1994, J GEN VIROL, V75, P2699, DOI 10.1099/0022-1317-75-10-2699; Mohni KN, 2010, J VIROL, V84, P12152, DOI 10.1128/JVI.01643-10; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; Olsson M, 2009, J BIOL CHEM, V284, P16246, DOI 10.1074/jbc.M807551200; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHERMAN G, 1992, J VIROL, V66, P4884, DOI 10.1128/JVI.66.8.4884-4892.1992; Stengel G, 2011, J VIROL, V85, P957, DOI 10.1128/JVI.01688-10; STOW ND, 1993, VIROLOGY, V196, P413, DOI 10.1006/viro.1993.1496; Weller SK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001105; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Yao XD, 1997, J VIROL, V71, P6842, DOI 10.1128/JVI.71.9.6842-6849.1997; Yao XD, 2001, J BIOL CHEM, V276, P2905, DOI 10.1074/jbc.M005627200; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	38	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33142	33152		10.1074/jbc.M112.356782	http://dx.doi.org/10.1074/jbc.M112.356782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22851167	Green Published, hybrid			2022-12-28	WOS:000309602100006
J	Singh, V; Aballay, A				Singh, Varsha; Aballay, Alejandro			Endoplasmic Reticulum Stress Pathway Required for Immune Homeostasis Is Neurally Controlled by Arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; NEURONS; EXPRESSION; ACTIVATION; INFECTION	In response to pathogen infection, the host innate immune system activates microbial killing pathways and cellular stress pathways that need to be balanced because insufficient or excessive immune responses have deleterious consequences. Recent studies demonstrate that two G protein-coupled receptors (GPCRs) in the nervous system of Caenorhabditis elegans control immune homeostasis. To investigate further how GPCR signaling controls immune homeostasis at the organismal level, we studied arrestin-1 (ARR-1), which is the only GPCR adaptor protein in C. elegans. The results indicate that ARR-1 is required for GPCR signaling in ASH, ASI, AQR, PQR, and URX neurons, which control the unfolded protein response and a p38 mitogen-activated protein kinase signaling pathway required for innate immunity. ARR-1 activity also controlled immunity through ADF chemosensory and AFD thermosensory neurons that regulate longevity. Furthermore, we found that although ARR-1 played a key role in the control of immunity by AFD thermosensory neurons, it did not control longevity through these cells. However, ARR-1 partially controlled longevity through ADF neurons.	[Singh, Varsha; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054, Durham, NC 27710 USA.	a.aballay@duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM070977] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Andersson J, 2005, J INTERN MED, V257, P122, DOI 10.1111/j.1365-2796.2004.01440.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Tracey KJ, 2011, SCIENCE, V332, P673, DOI 10.1126/science.1206353; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	33	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33191	33197		10.1074/jbc.M112.398362	http://dx.doi.org/10.1074/jbc.M112.398362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875856	Green Published, hybrid			2022-12-28	WOS:000309602100010
J	Rong, ZL; Fu, XM; Wang, MY; Xu, Y				Rong, Zhili; Fu, Xuemei; Wang, Meiyan; Xu, Yang			A Scalable Approach to Prevent Teratoma Formation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUICIDE GENE; SELECTIVE ABLATION; CYTOTOXIC ANTIBODY; MOLECULAR-CLONING; NANOG; PLURIPOTENCY; EXPRESSION; DISEASE; THERAPEUTICS; PODOCALYXIN	As the renewable source of all cell types in the body, human embryonic stem cells (hESCs) hold great promise for human cell therapy. However, one major bottleneck that hinders the clinic application of hESCs is that hESCs remaining with their differentiated derivatives pose cancer risk by forming teratomas after transplantation. NANOGis a critical pluripotency factor specifically expressed in hESCs but rarely in their differentiated derivatives. By introducing a hyperactive variant of herpes simplex virus thymidine kinase gene into the 3'-untranslated region of the endogenous NANOG gene of hESCs through homologous recombination, we developed a safe and highly scalable approach to efficiently eliminate the teratoma risk associated with hESCs without apparent negative impact on their differentiated cell types. As thymidine kinase is widely used in human gene therapy trials and is the therapeutic target of U. S. Food and Drug Administration-approved drugs, our strategy could be effectively applied to the clinic development of hESC-based human cell therapy.	[Rong, Zhili; Fu, Xuemei; Wang, Meiyan; Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fu, Xuemei] Chengdu Womens & Childrens Cent Hosp, Chengdu, Sichuan, Peoples R China	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Rong, Zhili/H-7561-2014	Rong, Zhili/0000-0002-1699-7074; Wang, Meiyan/0000-0002-4838-7182; Xu, Yang/0000-0001-5574-921X	National Natural Science Foundation of China [81172828]; California Institute for Regenerative Medicine [ET-01277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by Grant 81172828 from National Natural Science Foundation of China (to X. F.) and Early Translational Grant ET-01277 from California Institute for Regenerative Medicine (to Y. X.).	Arumugam SB, 2011, INDIAN J PATHOL MICR, V54, P501, DOI 10.4103/0377-4929.85082; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Black ME, 2001, CANCER RES, V61, P3022; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/RME.11.18, 10.2217/rme.11.18]; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Hara A, 2008, STEM CELLS DEV, V17, P619, DOI 10.1089/scd.2007.0235; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; McGavin JK, 2001, DRUGS, V61, P1153, DOI 10.2165/00003495-200161080-00016; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Potdar PD, 2011, HUM CELL, V24, P51, DOI 10.1007/s13577-011-0011-6; RUBINSTEIN E, 1993, THROMB RES, V71, P377, DOI 10.1016/0049-3848(93)90162-H; Scadden David, 2012, Cell Stem Cell, V10, P149, DOI 10.1016/j.stem.2012.01.010; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shen Y, 2006, CANCER GENE THER, V13, P975, DOI 10.1038/sj.cgt.7700946; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x	36	43	48	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32338	32345		10.1074/jbc.M112.383810	http://dx.doi.org/10.1074/jbc.M112.383810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865887	hybrid, Green Published			2022-12-28	WOS:000309168300005
J	Garner, K; Hunt, AN; Koster, G; Somerharju, P; Groves, E; Li, M; Raghu, P; Holic, R; Cockcroft, S				Garner, Kathryn; Hunt, Alan N.; Koster, Grielof; Somerharju, Pentti; Groves, Emily; Li, Michelle; Raghu, Padinjat; Holic, Roman; Cockcroft, Shamshad			Phosphatidylinositol Transfer Protein, Cytoplasmic 1 (PITPNC1) Binds and Transfers Phosphatidic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; PHOSPHOLIPASE-D ACTIVATION; RETINAL-DEGENERATION-B; II TYPE-1 RECEPTOR; DROSOPHILA PHOTORECEPTORS; DIACYLGLYCEROL KINASE; ENDOPLASMIC-RETICULUM; STREPTOLYSIN-O; LIPID TRANSFER; HL-60 CELLS	Phosphatidylinositol transfer proteins (PITPs) are versatile proteins required for signal transduction and membrane traffic. The best characterized mammalian PITPs are the Class I PITPs, PITP alpha (PITPNA) and PITP beta (PITPNB), which are single domain proteins with a hydrophobic cavity that binds a phosphatidylinositol (PI) or phosphatidylcholine molecule. In this study, we report the lipid binding properties of an uncharacterized soluble PITP, phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) (alternative name, RdgB beta), of the Class II family. We show that the lipid binding properties of this protein are distinct to Class I PITPs because, besides PI, RdgB beta binds and transfers phosphatidic acid (PA) but hardly binds phosphatidylcholine. RdgB beta when purified from Escherichia coli is preloaded with PA and phosphatidylglycerol. When RdgB beta was incubated with permeabilized HL60 cells, phosphatidylglycerol was released, and PA and PI were now incorporated into RdgB beta. After an increase in PA levels following activation of endogenous phospholipase D or after addition of bacterial phospholipase D, binding of PA to RdgB beta was greater at the expense of PI binding. We propose that RdgB beta, when containing PA, regulates an effector protein or can facilitate lipid transfer between membrane compartments.	[Garner, Kathryn; Groves, Emily; Li, Michelle; Holic, Roman; Cockcroft, Shamshad] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England; [Hunt, Alan N.; Koster, Grielof] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [Somerharju, Pentti] Univ Helsinki, Dept Biochem & Dev Biol, Inst Biomed, FIN-00014 Helsinki, Finland; [Raghu, Padinjat] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	University of London; University College London; University of Southampton; University of Helsinki; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Cockcroft, S (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England.	s.cockcroft@ucl.ac.uk	Holic, Roman/AAC-8402-2019; Padinjat, Raghu/Z-5578-2019; Hunt, Alan N/A-7432-2008; Cockcroft, Shamshad/F-9480-2011; Garner, Kathryn/AAQ-2052-2020; Roman, Holic/X-7500-2018	Holic, Roman/0000-0003-1347-4785; Hunt, Alan N/0000-0001-5938-2152; Garner, Kathryn/0000-0001-8539-8959; Roman, Holic/0000-0003-1347-4785; Cockcroft, Shamshad/0000-0002-5731-476X	British Heart Foundation [FS/08/044/25498]; Lister Institute	British Heart Foundation(British Heart Foundation); Lister Institute	This work was supported in part by British Heart Foundation Grant FS/08/044/25498.; Supported by a studentship from the Lister Institute.	Alb JG, 2007, J LIPID RES, V48, P1857, DOI 10.1194/jlr.M700145-JLR200; Alb JG, 2002, MOL BIOL CELL, V13, P739, DOI 10.1091/mbc.01-09-0457; Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Cockcroft S, 2011, CRIT REV BIOCHEM MOL, V46, P89, DOI 10.3109/10409238.2010.538664; Cockcroft Shamshad, 2009, V462, P363, DOI 10.1007/978-1-60327-115-8_23; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Garner K, 2011, BIOCHEM J, V439, P97, DOI 10.1042/BJ20110649; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOLBROOK PG, 1992, J BIOL CHEM, V267, P16834; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Hunt AN, 2004, BBA-MOL CELL BIOL L, V1686, P50, DOI 10.1016/j.bbalip.2004.08.003; Iwata R, 2011, P NATL ACAD SCI USA, V108, P7589, DOI 10.1073/pnas.1016232108; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Nakada T, 2011, CRIT CARE MED, V39, P1641, DOI 10.1097/CCM.0b013e318218665a; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; Shadan S, 2008, TRAFFIC, V9, P1743, DOI 10.1111/j.1600-0854.2008.00794.x; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; STUTCHFIELD J, 1993, BIOCHEM J, V293, P649, DOI 10.1042/bj2930649; STUTCHFIELD J, 1988, BIOCHEM J, V250, P375, DOI 10.1042/bj2500375; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; VANPARIDON PA, 1988, BIOCHEMISTRY-US, V27, P6208, DOI 10.1021/bi00417a003; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; Vordtriede PB, 2005, BIOCHEMISTRY-US, V44, P14760, DOI 10.1021/bi051191r; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	44	54	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32263	32276		10.1074/jbc.M112.375840	http://dx.doi.org/10.1074/jbc.M112.375840			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822086	hybrid, Green Published			2022-12-28	WOS:000309059400063
J	Valentin-Hansen, L; Groenen, M; Nygaard, R; Frimurer, TM; Holliday, ND; Schwartz, TW				Valentin-Hansen, Louise; Groenen, Marleen; Nygaard, Rie; Frimurer, Thomas M.; Holliday, Nicholas D.; Schwartz, Thue W.			The Arginine of the DRY Motif in Transmembrane Segment III Functions as a Balancing Micro-switch in the Activation of the beta 2-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; HYDROGEN-BOND NETWORK; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; IONIC LOCK; CONSTITUTIVE ACTIVITY; SCREENING ASSAY; ACTIVE STATE; RHODOPSIN	Recent high resolution x-ray structures of the beta 2-adrenergic receptor confirmed a close salt-bridge interaction between the suspected micro-switch residue ArgIII:26 (Arg3.50) and the neighboring AspIII:25 (Asp3.49). However, neither the expected "ionic lock" interactions between ArgIII:26 and GluVI:-06 (Glu6.30) in the inactive conformation nor the interaction with TyrV:24 (Tyr5.58) in the active conformation were observed in the x-ray structures. Here we find through molecular dynamics simulations, after removal of the stabilizing T4 lysozyme, that the expected salt bridge between ArgIII:26 and GluVI:-06 does form relatively easily in the inactive receptor conformation. Moreover, mutational analysis of GluVI:-06 in TM-VI and the neighboring AspIII:25 in TM-III demonstrated that these two residues do function as locks for the inactive receptor conformation as we observed increased G(s) signaling, arrestin mobilization, and internalization upon alanine substitutions. Conversely, TyrV:24 appears to play a role in stabilizing the active receptor conformation as loss of function of G(s) signaling, arrestin mobilization, and receptor internalization was observed upon alanine substitution of TyrV:24. The loss of function of the TyrV:24 mutant could partly be rescued by alanine substitution of either AspIII:25 or GluVI:-06 in the double mutants. Surprisingly, removal of the side chain of the ArgIII:26 micro-switch itself had no effect on G(s) signaling and internalization and only reduced arrestin mobilization slightly. It is suggested that ArgIII:26 is equally important for stabilizing the inactive and the active conformation through interaction with key residues in TM-III, -V, and -VI, but that the ArgIII:26 micro-switch residue itself apparently is not essential for the actual G protein activation.	[Valentin-Hansen, Louise; Nygaard, Rie; Schwartz, Thue W.] Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Ctr Prot Res, Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Groenen, Marleen; Holliday, Nicholas D.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Cell Signalling Res Grp, Nottingham NG7 2UH, England	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Nottingham	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk	Nygaard, Rie/B-7351-2013	Holliday, Nicholas/0000-0002-2900-828X; Schwartz, Thue W./0000-0002-0261-6904; Frimruer, Thomas/0000-0002-9682-8245	Novo Nordisk Foundation; Health and Medical Sciences faculty at University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Health and Medical Sciences faculty at University of Copenhagen	The recipient of a Ph.D. stipend from the Health and Medical Sciences faculty at University of Copenhagen.; We thank a persistent referee for forcing us to make the crucial double mutants. The Novo Nordisk Foundation Center for Basic Metabolic Research is based on an unconditional grant from the Novo Nordisk Foundation.	Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elster L, 2007, J BIOMOL SCREEN, V12, P41, DOI 10.1177/1087057106295895; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Huang RRC, 1995, BIOCHEMISTRY-US, V34, P16467, DOI 10.1021/bi00050a030; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2005, MOL PHARMACOL, V68, P11, DOI 10.1124/mol.105.011239; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibold A, 1998, RECEPTOR CHANNEL, V5, P375; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vrecl M, 2004, J BIOMOL SCREEN, V9, P322, DOI 10.1177/1087057104263212; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	36	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31973	31982		10.1074/jbc.M112.348565	http://dx.doi.org/10.1074/jbc.M112.348565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843684	Green Published, hybrid			2022-12-28	WOS:000309059400036
J	Popp, D; Narita, A; Lee, LJ; Larsson, M; Robinson, RC				Popp, David; Narita, Akihiro; Lee, Lin Jie; Larsson, Marten; Robinson, Robert C.			Microtubule-like Properties of the Bacterial Actin Homolog ParM-R1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC INSTABILITY; DNA SEGREGATION; ELECTRON-MICROSCOPY; MITOTIC SPINDLE; OSCILLATIONS; MECHANISM; PROTEIN; NUCLEATION; CYTOSKELETON; FILAMENTS	In preparation for mammalian cell division, microtubules repeatedly probe the cytoplasm to capture chromosomes and assemble the mitotic spindle. Critical features of this microtubule system are the formation of radial arrays centered at the centrosomes and dynamic instability, leading to persistent cycles of polymerization and depolymerization. Here, we show that actin homolog, ParM-R1 that drives segregation of the R1 multidrug resistance plasmid from Escherichia coli, can also self-organize in vitro into asters, which resemble astral microtubules. ParM-R1 asters grow from centrosome-like structures consisting of interconnected nodes related by a pseudo 8-fold symmetry. In addition, we show that ParM-R1 is able to perform persistent microtubule-like oscillations of assembly and disassembly. In vitro, a whole population of ParM-R1 filaments is synchronized between phases of growth and shrinkage, leading to prolonged synchronous oscillations even at physiological ParM-R1 concentrations. These results imply that the selection pressure to reliably segregate DNA during cell division has led to common mechanisms within diverse segregation machineries.	[Popp, David; Lee, Lin Jie; Larsson, Marten; Robinson, Robert C.] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Robinson, Robert C.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Robinson, Robert C.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nagoya University; Nagoya University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Popp, D (corresponding author), Proteos, David Popp Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Larsson, Marten/0000-0002-7855-9539	Biomedical Research Council, A*STAR; Joint Council Office (JCO) [10/03/FG/06/04]; ERATO, JST; Grants-in-Aid for Scientific Research [20227008] Funding Source: KAKEN	Biomedical Research Council, A*STAR(Agency for Science Technology & Research (A*STAR)); Joint Council Office (JCO); ERATO, JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	D. P., L.J.L., M. L., and R. C. R. thank the Biomedical Research Council, A*STAR for support. This work was funded in part by Joint Council Office (JCO) Grant Project (10/03/FG/06/04 (D. P., R. C. R.)).; We thank ERATO, JST for support in the initial stage of this work and Y. Maeda for helpful discussions.	Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; BAYLEY PM, 1989, J CELL SCI, V93, P241; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; HESS B, 1987, TRENDS BIOCHEM SCI, V12, P45, DOI 10.1016/0968-0004(87)90024-7; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Lange BMH, 2005, HISTOCHEM CELL BIOL, V124, P325, DOI 10.1007/s00418-005-0032-x; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lin YC, 2007, MACROMOLECULES, V40, P7714, DOI 10.1021/ma070862l; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MANDELKOW EM, 1992, CELL MOTIL CYTOSKEL, V22, P235, DOI 10.1002/cm.970220403; MARKUS M, 1984, P NATL ACAD SCI-BIOL, V81, P4394, DOI 10.1073/pnas.81.14.4394; Markus M., 1988, CHEM BIOL ORG; MARX A, 1994, EUR BIOPHYS J BIOPHY, V22, P405, DOI 10.1007/BF00180162; MELKI R, 1988, EMBO J, V7, P2653, DOI 10.1002/j.1460-2075.1988.tb03118.x; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; OBERMANN H, 1990, J BIOL CHEM, V265, P4382; Oosawa F., 1975, THERMODYNAMICS POLYM; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pogliano J, 2008, CURR OPIN CELL BIOL, V20, P19, DOI 10.1016/j.ceb.2007.12.006; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Popp D, 2010, BIOCHEM BIOPH RES CO, V391, P1598, DOI 10.1016/j.bbrc.2009.12.078; Popp D, 2009, J MOL BIOL, V388, P209, DOI 10.1016/j.jmb.2009.02.057; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Sasaki D, 2005, J MUSCLE RES CELL M, V26, P93, DOI 10.1007/s10974-005-0249-2; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	42	2	2	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37078	37088		10.1074/jbc.M111.319491	http://dx.doi.org/10.1074/jbc.M111.319491			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22908230	Green Published, hybrid			2022-12-28	WOS:000310588500042
J	Iverson, TM; Maklashina, E; Cecchini, G				Iverson, Tina M.; Maklashina, Elena; Cecchini, Gary			Structural Basis for Malfunction in Complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COLI FUMARATE REDUCTASE; SUCCINATE-UBIQUINONE OXIDOREDUCTASE; SITE-DIRECTED MUTAGENESIS; QUINONE-BINDING-SITE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; NECK PARAGANGLIOMAS; CRYSTAL-STRUCTURE; FAMILIAL PARAGANGLIOMA	Complex II couples oxidoreduction of succinate and fumarate at one active site with that of quinol/quinone at a second distinct active site over 40 angstrom away. This process links the Krebs cycle to oxidative phosphorylation and ATP synthesis. The pathogenic mutation or inhibition of human complex II or its assembly factors is often associated with neurodegeneration or tumor formation in tissues derived from the neural crest. This brief overview of complex II correlates the clinical presentations of a large number of symptom-associated alterations in human complex II activity and assembly with the biochemical manifestations of similar alterations in the complex II homologs from Escherichia coli. These analyses provide clues to the molecular basis for diseases associated with aberrant complex II function.	[Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Iverson, TM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	tina.iverson@vanderbilt.edu; gary.cecchini@ucsf.edu			National Institutes of Health [GM61606, GM79419]; Department of Veterans Affairs Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079419, R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants GM61606 and GM79419. This work was also supported by Department of Veterans Affairs Biomedical Laboratory Research and Development.	ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Antonello M, 2008, EUR J VASC ENDOVASC, V36, P517, DOI 10.1016/j.ejvs.2008.06.021; Bacca A, 2013, HEAD NECK-J SCI SPEC, V35, P23, DOI 10.1002/hed.22910; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bayley JP, 2010, CURR OPIN GENET DEV, V20, P324, DOI 10.1016/j.gde.2010.02.008; Bayley JP, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-39; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Beinert H, 2002, BBA-BIOENERGETICS, V1553, P7, DOI 10.1016/S0005-2728(01)00235-3; Benn DE, 2006, J CLIN ENDOCR METAB, V91, P827, DOI 10.1210/jc.2005-1862; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BLAUT M, 1989, J BIOL CHEM, V264, P13599; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; CECCHINI G, 1995, J BACTERIOL, V177, P4587, DOI 10.1128/jb.177.16.4587-4592.1995; Cervera AM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-89; De Preter K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-55; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; Fish JH, 2007, HEAD NECK-J SCI SPEC, V29, P864, DOI 10.1002/hed.20638; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Giancaspero TA, 2008, FEBS J, V275, P1103, DOI 10.1111/j.1742-4658.2008.06270.x; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Horvath R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041; Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Korpershoek E, 2007, ENDOCR-RELAT CANCER, V14, P453, DOI 10.1677/ERC-06-0044; Korpershoek E, 2011, J CLIN ENDOCR METAB, V96, pE1472, DOI 10.1210/jc.2011-1043; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Levitas A, 2010, EUR J HUM GENET, V18, P1160, DOI 10.1038/ejhg.2010.83; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Lima J, 2007, J CLIN ENDOCR METAB, V92, P4853, DOI 10.1210/jc.2007-0640; Liu GH, 2004, PROTEINS, V55, P756, DOI 10.1002/prot.20009; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MANODORI A, 1992, BIOCHEMISTRY-US, V31, P2703, DOI 10.1021/bi00125a010; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; Pagnamenta AT, 2006, MOL GENET METAB, V89, P214, DOI 10.1016/j.ymgme.2006.05.003; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Piccini V, 2012, ENDOCR-RELAT CANCER, V19, P149, DOI 10.1530/ERC-11-0369; Poeppel TD, 2011, J CLIN ONCOL, V29, pE812, DOI 10.1200/JCO.2011.36.2269; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; Schiavi F, 2006, ANN NY ACAD SCI, V1073, P190, DOI 10.1196/annals.1353.020; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sevilla MA, 2009, OTOLARYNG HEAD NECK, V140, P724, DOI 10.1016/j.otohns.2009.01.004; Shimizu H, 2012, J BIOCHEM, V151, P589, DOI 10.1093/jb/mvs051; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Srirangalingam U, 2008, CLIN ENDOCRINOL, V69, P587, DOI 10.1111/j.1365-2265.2008.03274.x; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Tomasiak TM, 2011, J BIOL CHEM, V286, P3047, DOI 10.1074/jbc.M110.192849; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Tunez I, 2010, MOLECULES, V15, P878, DOI 10.3390/molecules15020878; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202; Warburg O, 1924, BIOCHEM Z, V152, P319; WERTH MT, 1990, P NATL ACAD SCI USA, V87, P8965, DOI 10.1073/pnas.87.22.8965; Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	82	30	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35430	35438		10.1074/jbc.R112.408419	http://dx.doi.org/10.1074/jbc.R112.408419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904323	hybrid, Green Published			2022-12-28	WOS:000309968000050
J	Wang, YT; Tong, XM; Omoregie, ES; Liu, WJ; Meng, SD; Ye, X				Wang, Yetao; Tong, Xiaomei; Omoregie, Ehimwenma Sheena; Liu, Wenjun; Meng, Songdong; Ye, Xin			Tetraspanin 6 (TSPAN6) Negatively Regulates Retinoic Acid-inducible Gene I-like Receptor-mediated Immune Signaling in a Ubiquitination-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; VIRUS; RNA; IDENTIFICATION; INDUCTION; LIGASE; CARDIF	The recognition between retinoic acid-inducible gene I-like receptors (RLRs) and viral RNA triggers an intracellular cascade of signaling to induce the expression of type I IFNs. Both positive and negative regulation of the RLR signaling pathway are important for the host antiviral immune response. Here, we demonstrate that the tetraspanin protein TSPAN6 inhibits RLR signaling by affecting the formation of the adaptor MAVS (mitochondrial antiviral signaling)-centered signalosome. We found that overexpression of TSPAN6 impaired RLR-mediated activation of IFN-stimulated response element, NF-kappa B, and IFN-beta promoters, whereas knockdown of TSPAN6 enhanced the RLR-mediated signaling pathway. Interestingly, as the RLR pathway was activated, TSPAN6 underwent Lys-63-linked ubiquitination, which promoted its association with MAVS. The interaction of TSPAN6 and MAVS interfered with the recruitment of RLR downstream molecules TRAF3, MITA, and IRF3 to MAVS. Further study revealed that the first transmembrane domain of TSPAN6 is critical for its ubiquitination and association with MAVS as well as its inhibitory effect on RLR signaling. We concluded that TSPAN6 functions as a negative regulator of the RLR pathway by interacting with MAVS in a ubiquitination-dependent manner.	[Wang, Yetao; Tong, Xiaomei; Liu, Wenjun; Meng, Songdong; Ye, Xin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Wang, Yetao] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China; [Omoregie, Ehimwenma Sheena] Univ Benin, Fac Life Sci, Dept Biochem, Benin, Nigeria	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Benin	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn	omoregie, Ehimwenma Sheena/AAE-1379-2022	Wang, Yetao/0000-0001-8101-5455	Ministry of Science and Technology of China [2012CB519003, 2011CB504802, 2011CB504705]; Chinese Academy of Sciences (CAS) [KSCX2-YW-R-198, KSCX2-EW-J-6]; Academy of Sciences for the Developing World (TWAS; Trieste, Italy); Innovative Research Group of the National Natural Science Foundation of China [81021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Academy of Sciences for the Developing World (TWAS; Trieste, Italy); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Ministry of Science and Technology of China Grants 2012CB519003, 2011CB504802, and 2011CB504705; Chinese Academy of Sciences (CAS) Innovation Projects KSCX2-YW-R-198 and KSCX2-EW-J-6; and the Academy of Sciences for the Developing World (TWAS; Trieste, Italy).; Principal Investigator of the Innovative Research Group of the National Natural Science Foundation of China (supported by Grant 81021003). To whom correspondence should be addressed: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-10-6480-7508; Fax: 86-10-6480-7513; E-mail: yex@im.ac.cn.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Veenbergen S, 2011, IMMUNOL LETT, V138, P129, DOI 10.1016/j.imlet.2011.03.010; Wang YT, 2012, EUR J IMMUNOL, V42, P1304, DOI 10.1002/eji.201142125; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	20	24	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34626	34634		10.1074/jbc.M112.390401	http://dx.doi.org/10.1074/jbc.M112.390401			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908223	Green Published, hybrid			2022-12-28	WOS:000309654200065
J	Andres-Bergos, J; Tardio, L; Larranaga-Vera, A; Gomez, R; Herrero-Beaumont, G; Largo, R				Andres-Bergos, Jessica; Tardio, Lidia; Larranaga-Vera, Ane; Gomez, Rodolfo; Herrero-Beaumont, Gabriel; Largo, Raquel			The Increase in O-Linked N-Acetylglucosamine Protein Modification Stimulates Chondrogenic Differentiation Both in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; INSULIN-RESISTANCE; NUCLEOCYTOPLASMIC PROTEINS; GLCNAC MODIFICATION; HYPERTROPHIC DIFFERENTIATION; MURINE CHONDROCYTES; 3T3-L1 ADIPOCYTES; BONE-GROWTH; PLATE; GLYCOSYLATION	Insulin is an inducer of chondrocyte hypertrophy and growth plate chondrogenesis, although the specific molecular mechanisms behind these effects are mostly unknown. Our aim was to investigate whether insulin-induced chondrocyte hypertrophy occurs through a modification in the amount of O-linked N-acetylglucosamine (O-GlcNAc)-modified proteins and in the expression of the key enzymes of this pathway, O-GlcNAc transferase and O-GlcNAcase (OGA). We also studied if O-GlcNAc accumulation per se, induced by an OGA inhibitor, was able to induce pre-hypertrophic chondrocyte differentiation both in vitro and in vivo. Insulin-induced differentiation of ATDC5 pre-chondrocytes occurred alongside a gradual increase in the accumulation of O-GlcNac-modified proteins (O-GlcNAcylated proteins), as well as an increase in the expression of O-GlcNAc transferase and OGA. In the absence of insulin, O-GlcNAc accumulation induced by thiamet-G, a specific OGA inhibitor, was able to increase the gene expression of differentiation markers, as well as the activity of MMP-2 and -9. Thiamet-G also activated pERK, p-JNK, and p-p38 and the O-GlcNAcylation of Akt. Thiamet-G administration to C57/bl mice induced a significant expansion in the growth plate height and in the hypertrophic zone height. Therefore, our results show that O-GlcNAc glycosylation has chondromodulating activity.	[Largo, Raquel] Univ Autonoma Madrid, Inst Invest Sanitaria Fdn Jimenez Diaz, Joint & Bone Res Unit, Dept Rheumatol, Madrid 28040, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz	Largo, R (corresponding author), Univ Autonoma Madrid, Inst Invest Sanitaria Fdn Jimenez Diaz, Joint & Bone Res Unit, Dept Rheumatol, Reyes Catolicos 2, Madrid 28040, Spain.	rlargo@fjd.es	Gomez, Rodolfo/B-4642-2012; Largo, R/B-2949-2009; Larranaga-Vera, Ane/AAH-1779-2019	Gomez, Rodolfo/0000-0002-1309-1023; Largo, R/0000-0001-6525-2944; Herrero-Beaumont, Gabriel/0000-0002-3241-991X; Larranaga-Vera, Ane/0000-0002-3905-9363	Instituto de Salud Carlos III [PS09/0034, PS09/01625]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Instituto de Salud Carlos III Grants PS09/0034 (to R. L.) and PS09/01625 (to G. H.-B.).	Alvarez-Soria MA, 2008, OSTEOARTHR CARTILAGE, V16, P1484, DOI 10.1016/j.joca.2008.04.022; Bailon-Plaza A, 1999, BONE, V24, P211, DOI 10.1016/S8756-3282(98)00171-9; Beam HA, 2002, J ORTHOPAED RES, V20, P1210, DOI 10.1016/S0736-0266(02)00066-9; Belke DD, 2011, J APPL PHYSIOL, V111, P157, DOI 10.1152/japplphysiol.00147.2011; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Brochhausen C, 2009, J TISSUE ENG REGEN M, V3, P416, DOI 10.1002/term.192; Challa TD, 2010, MOL CELL ENDOCRINOL, V323, P282, DOI 10.1016/j.mce.2010.03.025; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; De Luca F, 2006, PEDIATR RES, V59, P625, DOI 10.1203/01.pdr.0000214966.60416.1b; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Goldberg H, 2011, AM J PHYSIOL-ENDOC M, V301, pE713, DOI 10.1152/ajpendo.00108.2011; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Hsieh TJ, 2012, J CELL PHYSIOL, V227, P108, DOI 10.1002/jcp.22707; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hutchison MR, 2007, ENDOCRINOLOGY, V148, P3122, DOI 10.1210/en.2006-1264; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Ishihara K, 2010, BIOCHEM BIOPH RES CO, V398, P489, DOI 10.1016/j.bbrc.2010.06.105; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kayal R, 2009, BONE, V44, P357, DOI 10.1016/j.bone.2008.10.042; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krzeslak A, 2011, ONCOL REP, V26, P743, DOI 10.3892/or.2011.1333; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; LuValle P, 2000, FRONT BIOSCI-LANDMRK, V5, pD493, DOI 10.2741/LuValle; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Mikic B, 2004, J ORTHOPAED RES, V22, P552, DOI 10.1016/j.orthres.2003.09.002; Park S, 2011, CELL MOL LIFE SCI, V68, P3377, DOI 10.1007/s00018-011-0640-7; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Phornphutkul C, 2006, MOL CELL ENDOCRINOL, V249, P107, DOI 10.1016/j.mce.2006.02.002; PRITCHARD JJ, 1952, J ANAT, V86, P259; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tardio L, 2010, OSTEOARTHR CARTILAGE, V18, pS111, DOI 10.1016/S1063-4584(10)60271-3; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tchetina EV, 2011, ARTHRITIS, DOI 10.1155/2011/683970; Temu TM, 2010, AM J PHYSIOL-ENDOC M, V299, pE325, DOI 10.1152/ajpendo.00145.2010; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-91; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	67	67	69	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33615	33628		10.1074/jbc.M112.354241	http://dx.doi.org/10.1074/jbc.M112.354241			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859309	Green Published, hybrid			2022-12-28	WOS:000309602100046
J	Chen, CC; Wang, KY; Shen, CKJ				Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James			The Mammalian de Novo DNA Methyltransferases DNMT3A and DNMT3B Are Also DNA 5-Hydroxymethylcytosine Dehydroxymethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TET PROTEINS; 5-METHYLCYTOSINE; DEMETHYLATION; METHYLATION; EXPRESSION; REPLICATION; MECHANISMS; CONVERSION; OXIDATION; GENOME	For cytosine (C) demethylation of vertebrate DNA, it is known that the TET proteins could convert 5-methyl C (5-mC) to 5-hydroxymethyl C (5-hmC). However, DNA dehydroxymethylase(s), or enzymes able to directly convert 5-hmC to C, have been elusive. We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases. Significantly, intactness of the C methylation catalytic sites of these de novo enzymes is also required for their 5-hmC dehydroxymethylation activity. That DNMT3A and DNMT3B function bidirectionally both as DNA methyltransferases and as dehydroxymethylases raises intriguing and new questions regarding the structural and functional aspects of these enzymes and their regulatory roles in the dynamic modifications of the vertebrate genomes during development, carcinogenesis, and gene regulation.	[Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Frontier of Science Award from the National Science Council (NSC); Academia Sinica (AS), Taipei, Taiwan	Frontier of Science Award from the National Science Council (NSC); Academia Sinica (AS), Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by the Frontier of Science Award from the National Science Council (NSC) and the Academia Sinica (AS), Taipei, Taiwan.	Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Castro GD, 1996, CHEM-BIOL INTERACT, V99, P289, DOI 10.1016/0009-2797(95)03680-6; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Haffner MC, 2011, ONCOTARGET, V2, P627; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Park SK, 2009, PLANT PHYSIOL, V150, P552, DOI 10.1104/pp.109.135426; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J., 2001, MOL CLONING LAB MANU; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	43	130	139	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33116	33121		10.1074/jbc.C112.406975	http://dx.doi.org/10.1074/jbc.C112.406975			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22898819	Green Published, hybrid			2022-12-28	WOS:000309602100003
J	Kashyap, T; Rabinovitz, I				Kashyap, Trinayan; Rabinovitz, Isaac			The Calcium/Calcineurin Pathway Promotes Hemidesmosome Stability through Inhibition of beta 4 Integrin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-6-BETA-4 INTEGRIN; CELL-MIGRATION; ALPHA(6)BETA(4) INTEGRIN; CARCINOMA-CELLS; CALCINEURIN; PROTEIN; KINASE; GROWTH; COMPONENTS; RECEPTORS	Cell migration depends on cells being able to create and disassemble adhesive contacts. Hemidesmosomes are multiprotein structures that attach epithelia to basal lamina and disassemble during migration and carcinoma invasion. Phosphorylation of the beta 4 integrin, a hemidesmosome component, induces disassembly. Although kinases involved in beta 4 phosphorylation have been identified, little is known about phosphatases countering kinase action. Here we report that calcineurin, a serine-threonine protein phosphatase, regulates beta 4 phosphorylation. Calcineurin inhibitor cyclosporin A (CsA) and calcineurin-siRNA increase beta 4 phosphorylation, induce hemidesmosome disassembly, and increase migration in HaCat keratinocytes, suggesting that calcineurin negatively regulates beta 4 phosphorylation. We found no direct dephosphorylation of beta 4 by calcineurin or association between beta 4 and calcineurin, suggesting indirect regulation of beta 4 phosphorylation. We therefore assessed calcineurin influence on MAPK and PKC, known to phosphorylate beta 4. CsA increased MAPK activity, whereas MAPK inhibitors reduced CsA-induced beta 4 phosphorylation, suggesting that calcineurin restricts beta 4 phosphorylation by MAPK. Calcineurin is activated by calcium. Increased [Ca2+](i) reduces beta 4 phosphorylation and stabilizes hemidesmosomes, effects that are reversed by CsA, indicating that calcineurin mediates calcium effects on beta 4. However, MAPK activation is increased when [Ca2+](i) is increased, suggesting that calcineurin activates an additional mechanism that counteracts MAPK-induced beta 4 phosphorylation. Interestingly, in some squamous cell carcinoma cells, which have reduced hemidesmosomes and increased beta 4 phosphorylation, an increase in [Ca2+](i) using thapsigargin, bradykinin, or acetylcholine can increase hemidesmosomes and reduce beta 4 phosphorylation in a calcineurin-dependent manner. These findings have implications in calcineurin-inhibitor induced carcinoma, a complication of immunosuppressive therapy.	Beth Israel Deaconess Med Ctr, Dept Pathol, Vasc Biol Res Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rabinovitz, I (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol RN 227D, 330 Brookline Ave, Boston, MA 02215 USA.	irabinov@bidmc.harvard.edu			National Institutes of Health [CA120202]; NATIONAL CANCER INSTITUTE [R01CA120202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120202 (to I. R.).	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Bachelder RE, 1999, J BIOL CHEM, V274, P20733, DOI 10.1074/jbc.274.29.20733; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; HEPLER JR, 1987, J BIOL CHEM, V262, P2951; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; PRICE JE, 1988, J INVEST DERMATOL, V91, P258, DOI 10.1111/1523-1747.ep12470396; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SCHREMMERDANNINGER E, 1995, EUR J PHARMACOL, V283, P207, DOI 10.1016/0014-2999(95)00347-N; TALWAR HS, 1990, J INVEST DERMATOL, V95, P705, DOI 10.1111/1523-1747.ep12514507; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996	40	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32440	32449		10.1074/jbc.M112.385245	http://dx.doi.org/10.1074/jbc.M112.385245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865863	hybrid, Green Published			2022-12-28	WOS:000309168300014
J	Miyamoto, H; Katsuyama, E; Miyauchi, Y; Hoshi, H; Miyamoto, K; Sato, Y; Kobayashi, T; Iwasaki, R; Yoshida, S; Mori, T; Kanagawa, H; Fujie, A; Hao, W; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Miyamoto, Kana; Sato, Yuiko; Kobayashi, Tami; Iwasaki, Ryotaro; Yoshida, Shigeyuki; Mori, Tomoaki; Kanagawa, Hiroya; Fujie, Atsuhiro; Hao, Wu; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			An Essential Role for STAT6-STAT1 Protein Signaling in Promoting Macrophage Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY GIANT-CELLS; DC-STAMP; OSTEOCLASTS; RECEPTOR; INTERLEUKIN-4; STAT6; DIFFERENTIATION; ACTIVATION; LIGAND; PHOSPHORYLATION	Macrophage lineage cells such as osteoclasts and foreign body giant cells (FBGCs) form multinuclear cells by cell-cell fusion of mononuclear cells. Recently, we reported that two seven-transmembrane molecules, osteoclast stimulatory transmembrane protein (OC-STAMP) and dendritic cell-specific transmembrane protein (DC-STAMP), were essential for osteoclast and FBGC cell-cell fusion in vivo and in vitro. However, signaling required to regulate FBGC fusion remained largely unknown. Here, we show that signal transducer and activator of transcription 1 (STAT1) deficiency in macrophages enhanced cell-cell fusion and elevated DC-STAMP expression in FBGCs. By contrast, lack of STAT6 increased STAT1 activation, significantly inhibiting cell-cell fusion and decreasing OC-STAMP and DC-STAMP expression in IL-4-induced FBGCs. Furthermore, either STAT1 loss or co-expression of OC-STAMP/DC-STAMP was sufficient to induce cell-cell fusion of FBGCs without IL-4. We conclude that the STAT6-STAT1 axis regulates OC-STAMP and DC-STAMP expression and governs fusogenic mechanisms in FBGCs.	[Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Miyamoto, Kana; Sato, Yuiko; Kobayashi, Tami; Mori, Tomoaki; Kanagawa, Hiroya; Fujie, Atsuhiro; Hao, Wu; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Hiroya; Katsuyama, Eri; Miyauchi, Yoshiteru; Hoshi, Hiroko; Yoshida, Shigeyuki; Mori, Tomoaki; Fujie, Atsuhiro; Miyamoto, Takeshi] Keio Univ, Sch Med, Ctr Human Metabol Syst Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Iwasaki, Ryotaro; Yoshida, Shigeyuki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Kana; Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Keio Kanrinmaru Project, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Toyama, Yoshiaki/K-5743-2013; Matsumoto, Morio M/L-6227-2013; hao, wu/HDM-1705-2022					Abe E, 1999, CALCIFIED TISSUE INT, V64, P508, DOI 10.1007/s002239900641; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; ARONSON M, 1962, NATURE, V193, P399, DOI 10.1038/193399a0; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; DeFife KM, 1997, J IMMUNOL, V158, P3385; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; MBALAVIELE G, 1995, J CLIN INVEST, V95, P2757, DOI 10.1172/JCI117979; MCNALLY AK, 1995, AM J PATHOL, V147, P1487; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Pesu M, 2000, BLOOD, V95, P494, DOI 10.1182/blood.V95.2.494; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sawatani Y, 2008, INT IMMUNOL, V20, P1259, DOI 10.1093/intimm/dxn082; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205; ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4	31	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32479	32484		10.1074/jbc.M112.358226	http://dx.doi.org/10.1074/jbc.M112.358226			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865856	Green Published, hybrid			2022-12-28	WOS:000309168300018
J	Burns, V; Kerppola, TK				Burns, Veronica; Kerppola, Tom Klaus			Opposite Orientations of a Transcription Factor Heterodimer Bind DNA Cooperatively with Interaction Partners but Have Different Effects on Interferon-beta Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOS-JUN; FOS-JUN-NFAT1 COMPLEXES; CRYSTAL-STRUCTURE; IN-VITRO; ENHANCEOSOME; RECRUITMENT; PROMOTERS; DOMAINS; SITES	ATF2-Jun, IRF3, and HMGI recognize a composite regulatory element within the interferon-beta enhancer (IFNb). Cooperative ATF2-Jun-IRF3 complex formation at IFNb has been proposed to require a fixed orientation of ATF2-Jun binding. Our results show that ATF2-Jun heterodimers bound IFNb in both orientations alone and in association with IRF3 and HMGI. Two sets of symmetrically located amino acid residues in ATF2 and Jun facilitated the interactions between heterodimers bound in opposite orientations and IRF3 at IFNb. IRF3 and HMGI bound IFNb in association with both orientations of ATF2-Jun heterodimers with the same cooperativity. ATF2-Jun heterodimers that bound IFNb in opposite orientations in vitro had different effects on interferon-beta gene transcription when they were co-expressed with IRF3 in cultured cells. These heterodimers had different transcriptional activities at different endogenous genes. Different regions of ATF2 and Jun mediated their orientation-dependent transcriptional activities at different genes. These studies revealed that cooperative DNA binding does not require a unique nucleoprotein complex configuration, and that transcription factor complexes that bind the same enhancer in different configurations can have different transcriptional activities.	[Burns, Veronica; Kerppola, Tom Klaus] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kerppola, TK (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	kerppola@umich.edu	Kerppola, Tom/AFK-6155-2022; Kerppola, Tom/AAG-4457-2022	Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446; Burns, Veronica/0000-0002-7491-8338	National Institutes of Health [R01-DA030339]; University of Michigan Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DA030339 (to T. K. K.) and by the University of Michigan Molecular Biophysics Training Grant (to V. E. B.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; CHEN L, 1995, CURR BIOL, V5, P882, DOI 10.1016/S0960-9822(95)00178-3; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Diebold RJ, 1998, P NATL ACAD SCI USA, V95, P7915, DOI 10.1073/pnas.95.14.7915; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Leonard DA, 1998, NAT STRUCT BIOL, V5, P877, DOI 10.1038/2316; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Ramirez-Carrozzi V, 2003, MOL CELL BIOL, V23, P1737, DOI 10.1128/MCB.23.5.1737-1749.2003; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Ramirez-Carrozzi VR, 2001, P NATL ACAD SCI USA, V98, P4893, DOI 10.1073/pnas.091095998; Ramirez-Carrozzi VR, 2001, J BIOL CHEM, V276, P21797, DOI 10.1074/jbc.M101494200; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6	24	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31833	31844		10.1074/jbc.M112.374462	http://dx.doi.org/10.1074/jbc.M112.374462			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843696	Green Published, hybrid			2022-12-28	WOS:000309059400024
J	Zhong, SP; Xu, J; Li, P; Tsukamoto, H				Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu			Caveosomal Oxidative Stress Causes Src-p21(ras) Activation and Lysine 63 TRAF6 Protein Polyubiquitination in Iron-induced M1 Hepatic Macrophage Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTRACELLULAR IRON; KINASE; INTERLEUKIN-1; INDUCTION; FERRITIN; PATHWAY; P21RAS; CELLS; LIVER	Proinflammatory M1 activation of hepatic macrophages (HM) is critical in pathogenesis of hepatitis, but its mechanisms are still elusive. Our earlier work demonstrates the role of ferrous iron (Fe2+) as a pathogen-associated molecular pattern-independent agonist for activation of I kappa B kinase (IKK) and NF-kappa B in HM via activation and interaction of p21(ras), transforming growth factor beta-activated kinase-1 (TAK1), and phosphatidylinositol 3-kinase (PI3K) in caveosomes. However, iron-induced signaling upstream of these kinases is not known. Here we show that Fe2+ induces generation of superoxide anion (O-2(radical anion)) in endosomes, reduces protein-tyrosine phosphatase (PTP) activity, and activates Src at 2 similar to 10 min of Fe2+ addition to rat primary HM culture. Superoxide dismutase (SOD) blocks O-2(radical anion) generation, PTP inhibition, and Src activation. Fe2+-induced p21(ras) activity is abrogated with the Src inhibitor PP2 and SOD. Fe2+ stimulates Lys(63)-linked polyubiquitination (polyUb) of TRAF6 in caveosomes, and a dominant negative K63R mutant of ubiquitin or SOD prevents iron-induced TRAF6 polyUb and TAK1 activation. These results demonstrate that Fe2+-generated O-2(radical anion) mediates p21(ras) and TAK1 activation via PTP inhibition and Lys(63)-polyUb of TRAF6 in caveosomes for proinflammatory M1 activation in HM.	[Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90033 USA; [Zhong, Shuping; Xu, Jun; Li, Peggy; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California; University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 1333 San Pablo St,MMR 402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu			National Institutes of Health [P50AA011999, R24AA012885, RC2AA019392, R21AA017288, K01AA020524]; Medical Research Service of the Department of Veterans Affairs; Suntory Business Expert Ltd.; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, RC2AA019392, P50AA011999, R21AA017288, K01AA020524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Suntory Business Expert Ltd.; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999 (to H. T.), R24AA012885 (to H. T.), RC2AA019392 (to H. T.), R21AA017288 (to S. Z.), and K01AA020524 (to J. X.), and by the Medical Research Service of the Department of Veterans Affairs (to H. T.) and Suntory Business Expert Ltd.	Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; David MD, 2005, J IMMUNOL, V175, P8236, DOI 10.4049/jimmunol.175.12.8236; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; KENNEDY JI, 1986, CHEST, V89, pS123, DOI 10.1378/chest.89.3_Supplement.123S; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Satchell L, 2012, BIOCHEMISTRY-US, V51, P3767, DOI 10.1021/bi2017975; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tacchini L, 1997, GASTROENTEROLOGY, V113, P946, DOI 10.1016/S0016-5085(97)70191-4; Tsukamoto H, 1999, AM J PHYSIOL-GASTR L, V277, pG1240, DOI 10.1152/ajpgi.1999.277.6.G1240; Williams R, 2012, J NEUROCHEM, V120, P7, DOI 10.1111/j.1471-4159.2011.07536.x; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Yuan XM, 1999, FREE RADICAL RES, V30, P221, DOI 10.1080/10715769900300241; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	22	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32078	32084		10.1074/jbc.M112.377358	http://dx.doi.org/10.1074/jbc.M112.377358			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829592	Green Published, hybrid			2022-12-28	WOS:000309059400045
J	Hey, F; Czyzewicz, N; Jones, P; Sablitzky, F				Hey, Fiona; Czyzewicz, Nathan; Jones, Peter; Sablitzky, Fred			DEF6, a Novel Substrate for the Tec Kinase ITK, Contains a Glutamine-rich Aggregation-prone Region and Forms Cytoplasmic Granules that Co-localize with P-bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STRESS GRANULES; GUANINE-NUCLEOTIDE EXCHANGE; T-CELL-ACTIVATION; IMMUNOLOGICAL SYNAPSE; TRANSCRIPTION FACTOR; PROCESSING BODIES; FAMILY KINASES; MESSENGER-RNA; COILED COILS; PROTEIN	Localization of DEF6 (SLAT/IBP), a Rho-family guanine nucleotide exchange factor, to the center of the immune synapse is dependent upon ITK, a Tec-family kinase that regulates the spatiotemporal organization of components of T cell signaling pathways and Cdc42-dependent actin polymerization. Here we demonstrate that ITK both interacts with DEF6 and phosphorylates DEF6 at tyrosine residues Tyr(210) and Tyr(222). Expression of a GFP-tagged Y210E-Y222E phosphomimic resulted in the formation of DEF6 cytoplasmic granules that co-localized with decapping enzyme 1 (DCP1), a marker of P-bodies; sites of mRNA degradation. Similarly treatment of cells with puromycin or sodium arsenite, reagents that arrest translation, also resulted in the accumulation of DEF6 in cytoplasmic granules. Bioinformatics analysis identified a glutamine-rich, heptad-repeat region; a feature of aggregating proteins, within the C-terminal region of DEF6 with the potential to promote granule formation through a phosphorylation-dependent unmasking of this region. These data suggest that in addition to its role as a GEF, DEF6 may also function in regulating mRNA translation.	[Sablitzky, Fred] Univ Nottingham, Queens Med Ctr, Sch Biol Mol Cell & Dev Biol, Nottingham NG7 2UH, England; [Jones, Peter] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Sablitzky, F (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biol Mol Cell & Dev Biol, Nottingham NG7 2UH, England.	fred.sablitzky@nottingham.ac.uk	Sablitzky, Fred/A-2276-2011	Sablitzky, Fred/0000-0001-9718-1546	University of Nottingham; MRC studentship	University of Nottingham; MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported through the University of Nottingham and a MRC studentship (to F. H.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altman A, 2009, IMMUNITY, V31, P1, DOI 10.1016/j.immuni.2009.06.013; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Blomberg KEM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-233; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Canonigo-Balancio AJ, 2009, J IMMUNOL, V183, P7259, DOI 10.4049/jimmunol.0902573; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5595, DOI 10.1021/bi700127c; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Joseph RE, 2009, J MOL BIOL, V391, P164, DOI 10.1016/j.jmb.2009.06.023; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	53	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31073	31084		10.1074/jbc.M112.346767	http://dx.doi.org/10.1074/jbc.M112.346767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829599	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308791300020
J	Millonig, G; Ganzleben, I; Peccerella, T; Casanovas, G; Brodziak-Jarosz, L; Breitkopf-Heinlein, K; Dick, TP; Seitz, HK; Muckenthaler, MU; Mueller, S				Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Casanovas, Guillem; Brodziak-Jarosz, Lidia; Breitkopf-Heinlein, Katja; Dick, Tobias P.; Seitz, Helmut-Karl; Muckenthaler, Martina U.; Mueller, Sebastian			Sustained Submicromolar H2O2 Levels Induce Hepcidin via Signal Transducer and Activator of Transcription 3 (STAT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; TRANSGENIC MICE; IRON OVERLOAD; INFLAMMATION; EXPRESSION; PATHWAY; ANEMIA; IL-6; CATALASE	The peptide hormone hepcidin regulates mammalian iron homeostasis by blocking ferroportin-mediated iron export from macrophages and the duodenum. During inflammation, hepcidin is strongly induced by interleukin 6, eventually leading to the anemia of chronic disease. Here we show that hepatoma cells and primary hepatocytes strongly up-regulate hepcidin when exposed to low concentrations of H2O2 (0.3-6 mu M), concentrations that are comparable with levels of H2O2 released by inflammatory cells. In contrast, bolus treatment of H2O2 has no effect at low concentrations and even suppresses hepcidin at concentrations of > 50 mu M. H2O2 treatment synergistically stimulates hepcidin promoter activity in combination with recombinant interleukin-6 or bone morphogenetic protein-6 and in a manner that requires a functional STAT3-responsive element. The H2O2-mediated hepcidin induction requires STAT3 phosphorylation and is effectively blocked by siRNA-mediated STAT3 silencing, overexpression of SOCS3 (suppressor of cytokine signaling 3), and antioxidants such as N-acetylcysteine. Glycoprotein 130 (gp130) is required for H2O2 responsiveness, and Janus kinase 1 (JAK1) is required for adequate basal signaling, whereas Janus kinase 2 (JAK2) is dispensable upstream of STAT3. Importantly, hepcidin levels are also increased by intracellular H2O2 released from the respiratory chain in the presence of rotenone or antimycin A. Our results suggest a novel mechanism of hepcidin regulation by nanomolar levels of sustained H2O2. Thus, similar to cytokines, H2O2 provides an important regulatory link between inflammation and iron metabolism.	[Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Seitz, Helmut-Karl; Mueller, Sebastian] Heidelberg Univ, Alcohol Res Ctr, D-69120 Heidelberg, Germany; [Millonig, Gunda; Ganzleben, Ingo; Peccerella, Teresa; Seitz, Helmut-Karl; Mueller, Sebastian] Salem Med Ctr, D-69120 Heidelberg, Germany; [Casanovas, Guillem; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Oncol Hematol Immunol & Pulmonol, D-69120 Heidelberg, Germany; [Casanovas, Guillem; Muckenthaler, Martina U.] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Brodziak-Jarosz, Lidia; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, D-69120 Heidelberg, Germany; [Breitkopf-Heinlein, Katja] Heidelberg Univ, Fac Med Mannheim, Med Clin, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Millonig, G (corresponding author), Heidelberg Univ, Alcohol Res Ctr, D-69120 Heidelberg, Germany.	gunda.millonig@uni-heidelberg.de; sebastian.mueller@urz.uni-heidelberg.de		Muckenthaler, Martina/0000-0002-3778-510X; Casanovas, Guillem/0000-0002-1791-041X	Dietmar Hopp-Stiftung; Manfred Lautenschlager-Stiftung; Olympia-Morata-Fellowship from the University of Heidelberg; YAEL Foundation; European Community's Seventh Framework Programme (FP7) [215009]; Dietmar Hopp Stiftung; eRARE-BMBF (HMA-IRON); Network HepatoSys/Virtual Liver grant	Dietmar Hopp-Stiftung; Manfred Lautenschlager-Stiftung; Olympia-Morata-Fellowship from the University of Heidelberg; YAEL Foundation; European Community's Seventh Framework Programme (FP7); Dietmar Hopp Stiftung; eRARE-BMBF (HMA-IRON); Network HepatoSys/Virtual Liver grant	This work was supported in part by the Dietmar Hopp-Stiftung and the Manfred Lautenschlager-Stiftung.; Supported by an Olympia-Morata-Fellowship from the University of Heidelberg and a research grant from the YAEL Foundation. To whom correspondence may be addressed. Tel.: 49-6221-483-201; Fax: 49-6221-483494; E-mail: gunda.millonig@uni-heidelberg.de.; Supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 215009.; Supported by the Dietmar Hopp Stiftung, eRARE-BMBF (HMA-IRON), and the Network HepatoSys/Virtual Liver grant.	Andriopoulos B, 2007, J BIOL CHEM, V282, P20301, DOI 10.1074/jbc.M702463200; Bagu ET, 2011, J MOL ENDOCRINOL, V47, P299, DOI 10.1530/JME-11-0060; BelAiba RS, 2004, BIOL CHEM, V385, P249, DOI 10.1515/BC.2004.019; BOVERIS A, 1971, BIOCHIM BIOPHYS ACTA, V245, P1, DOI 10.1016/0005-2728(71)90002-8; CARTWRIGHT GE, 1946, SCIENCE, V103, P72, DOI 10.1126/science.103.2664.72; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Franke K, 2004, ANTIOXID REDOX SIGN, V6, P721, DOI 10.1089/1523086041361613; Ganz T, 2002, ISRAEL MED ASSOC J, V4, P1043; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ikemura M, 2010, MOL PHARMACEUT, V7, P2069, DOI 10.1021/mp100110c; Island M. L., 2004, BIOCHEM J, V437, P477; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; LITWIN JA, 1987, AM J PATHOL, V128, P141; LIVINGSTON JN, 1977, J BIOL CHEM, V252, P560; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; Millonig G, 2009, FREE RADICAL BIO MED, V46, P182, DOI 10.1016/j.freeradbiomed.2008.09.043; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; MUELLER S, 1995, J BIOLUM CHEMILUM, V10, P229, DOI 10.1002/bio.1170100406; Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Mutze S, 2003, J BIOL CHEM, V278, P40542, DOI 10.1074/jbc.M307159200; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; TEST ST, 1984, J BIOL CHEM, V259, P399; Truksa J, 2007, BLOOD CELL MOL DIS, V39, P255, DOI 10.1016/j.bcmd.2007.06.014	47	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37472	37482		10.1074/jbc.M112.358911	http://dx.doi.org/10.1074/jbc.M112.358911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932892	Green Published, hybrid			2022-12-28	WOS:000310588500076
J	Ferreras, C; Rushton, G; Cole, CL; Babur, M; Telfer, BA; van Kuppevelt, TH; Gardiner, JM; Williams, KJ; Jayson, GC; Avizienyte, E				Ferreras, Cristina; Rushton, Graham; Cole, Claire L.; Babur, Muhammad; Telfer, Brian A.; van Kuppevelt, Toin H.; Gardiner, John M.; Williams, Kaye J.; Jayson, Gordon C.; Avizienyte, Egle			Endothelial Heparan Sulfate 6-O-Sulfation Levels Regulate Angiogenic Responses of Endothelial Cells to Fibroblast Growth Factor 2 and Vascular Endothelial Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR ANGIOGENESIS; METASTASIS; SEQUENCE; BINDING; VEGF; FGF; PROTEOGLYCANS; SPECIFICITY; EXPRESSION	Fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor 165 (VEGF(165)) are potent pro-angiogenic growth factors that play a pivotal role in tumor angiogenesis. The activity of these growth factors is regulated by heparan sulfate (HS), which is essential for the formation of FGF2/FGF receptor (FGFR) and VEGF(165)/VEGF receptor signaling complexes. However, the structural characteristics of HS that determine activation or inhibition of such complexes are only partially defined. Here we show that ovarian tumor endothelium displays high levels of HS sequences that harbor glucosamine 6-O-sulfates when compared with normal ovarian vasculature where these sequences are also detected in perivascular area. Reduced HS 6-O-sulfotransferase 1 (HS6ST-1) or 6-O-sulfotransferase 2 (HS6ST-2) expression in endothelial cells impacts upon the prevalence of HS 6-O-sulfate moieties in HS sequences, which consist of repeating short, highly sulfated S domains interspersed by transitional N-acetylated/N-sulfated domains. 1-40% reduction in 6-O-sulfates significantly compromises FGF2- and VEGF(165)-induced endothelial cell sprouting and tube formation in vitro and FGF2-dependent angiogenesis in vivo. Moreover, HS on wild-type neighboring endothelial or smooth muscle cells fails to restore endothelial cell sprouting and tube formation. The affinity of FGF2 for HS with reduced 6-O-sulfation is preserved, although FGFR1 activation is inhibited correlating with reduced receptor internalization. These data show that 6-O-sulfate moieties in endothelial HS are of major importance in regulating FGF2- and VEGF(165)-dependent endothelial cell functions in vitro and in vivo and highlight HS6ST-1 and HS6ST-2 as potential targets of novel antiangiogenic agents.	[Ferreras, Cristina; Rushton, Graham; Cole, Claire L.; Jayson, Gordon C.; Avizienyte, Egle] Univ Manchester, Sch Canc & Enabling Sci, Translat Angiogenesis Grp, Manchester M20 4BX, Lancs, England; [Babur, Muhammad; Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Hypoxia & Therapeut Grp, Manchester M13 9PT, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Fac Sci, NL-6500 HB Nijmegen, Netherlands; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands; [Gardiner, John M.] Univ Manchester, Sch Chem, Manchester Interdisciplinary Bioctr, Manchester M17DN, Lancs, England	University of Manchester; University of Manchester; Radboud University Nijmegen; Radboud University Nijmegen; University of Manchester	Avizienyte, E (corresponding author), Univ Manchester, Sch Canc & Enabling Sci, Translat Angiogenesis Grp, Manchester M20 4BX, Lancs, England.	eavizienyte@picr.man.ac.uk	van Kuppevelt, A.H.M.S.M./L-4463-2015; williams, kaye/HHN-5342-2022; Gardiner, John M/Q-7268-2017; Jayson, Gordon C/O-8224-2015	Gardiner, John M/0000-0003-1827-6817; Jayson, Gordon C/0000-0002-8515-8944; Telfer, Brian/0000-0003-1857-5120	Cancer Research United Kingdom Project Grant [C2075/A11994]; Medical Research Council Developmental Pathway Funding Scheme [G0902173/1]; Cancer Research UK [11994] Funding Source: researchfish	Cancer Research United Kingdom Project Grant; Medical Research Council Developmental Pathway Funding Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research United Kingdom Project Grant C2075/A11994 and Medical Research Council Developmental Pathway Funding Scheme G0902173/1.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Backen AC, 2007, BRIT J CANCER, V96, P1544, DOI 10.1038/sj.bjc.6603747; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HISCOCK DRR, 1995, BBA-GEN SUBJECTS, V1244, P104, DOI 10.1016/0304-4165(94)00206-D; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; LYON M, 1994, J BIOL CHEM, V269, P11216; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; PYE DA, 1995, BBA-MOL CELL RES, V1266, P235, DOI 10.1016/0167-4889(95)00012-H; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Whitworth MK, 2005, CLIN CANCER RES, V11, P4282, DOI 10.1158/1078-0432.CCR-04-1386	39	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36132	36146		10.1074/jbc.M112.384875	http://dx.doi.org/10.1074/jbc.M112.384875			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927437	hybrid, Green Published			2022-12-28	WOS:000310364000035
J	Stoneham, CA; Hollinshead, M; Hajitou, A				Stoneham, Charlotte A.; Hollinshead, Michael; Hajitou, Amin			Clathrin-mediated Endocytosis and Subsequent Endo-Lysosomal Trafficking of Adeno-associated Virus/Phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRAL PENTON BASE; VIRUS ENTRY; IN-VIVO; INTERNALIZATION; VECTORS; ALPHA; RGD; INHIBITOR; RECEPTORS; INTEGRINS	Adeno-associated virus/phage (AAVP) is a gene delivery vector constructed as a hybrid between adeno-associated virus and filamentous phage. Tumor targeting following systemic administration has previously been demonstrated in several in vivo cancer models, with tumor specificity achieved through display of an alpha(v) integrin-targeting ligand on the capsid. However, high titers of AAVP are required for transduction of large numbers of mammalian cells. This study is the first to investigate the mechanisms involved in entry and intracellular trafficking of AAVP. Using a combination of flow cytometry, confocal, and electron microscopy techniques, together with pharmacological agents, RNAi and dominant negative mutants, we have demonstrated that targeted AAVP endocytosis is both dynamin and clathrin-dependent. Following entry, the majority of AAVP particles are sequestered by the endosomal-lysosomal degradative pathway. Finally, we have demonstrated that disruption of this pathway leads to improved transgene expression by AAVP, thus demonstrating that escape from the late endosomes/lysosomes is a critical step for improving gene delivery by AAVP. These findings have important implications for the rational design of improved AAVP and RGD-targeted vectors.	[Stoneham, Charlotte A.; Hajitou, Amin] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, London W12 0NN, England; [Hollinshead, Michael] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Virol Sect, London W2 1PG, England	Imperial College London; Imperial College London	Hajitou, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, Hammersmith Hosp Campus,160 Cane Rd, London W12 0NN, England.	a.hajitou@imperial.ac.uk		Stoneham, Charlotte/0000-0003-3729-6936; Hajitou, Amin/0000-0003-1119-5686	UK Medical Research Council (MRC) [G0701159]; Leverhulme Trust [RF/2/RFG/2009/0114]; Medical Research Council; Medical Research Council [G0701159] Funding Source: researchfish; MRC [G0701159] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Grant G0701159 from the UK Medical Research Council (MRC), and Research Fellowship RF/2/RFG/2009/0114 from The Leverhulme Trust.; Supported by a Medical Research Council Doctoral Training Grant.	Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Di Giovine M, 2001, VIROLOGY, V282, P102, DOI 10.1006/viro.2000.0809; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2007, NAT PROTOC, V2, P523, DOI 10.1038/nprot.2007.51; HART SL, 1994, J BIOL CHEM, V269, P12468; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P450, DOI 10.1016/S0167-4889(98)00162-1; Larocca D, 1998, HUM GENE THER, V9, P2393, DOI 10.1089/hum.1998.9.16-2393; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; NGAHA EO, 1982, COMP BIOCHEM PHYS C, V73, P109, DOI 10.1016/0306-4492(82)90176-9; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Piersanti S, 2004, J MOL MED, V82, P467, DOI 10.1007/s00109-004-0543-2; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROIVAINEN M, 1991, J VIROL, V65, P4735, DOI 10.1128/JVI.65.9.4735-4740.1991; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Trepel M, 2009, MOL CANCER THER, V8, P2383, DOI 10.1158/1535-7163.MCT-09-0110; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	38	45	49	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35849	35859		10.1074/jbc.M112.369389	http://dx.doi.org/10.1074/jbc.M112.369389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22915587	Green Published, hybrid			2022-12-28	WOS:000310364000008
J	Vasanthavada, K; Hu, XY; Tuton-Blasingame, T; Hsia, Y; Sampath, S; Pacheco, R; Freeark, J; Falick, AM; Tang, S; Fong, J; Kohler, K; La Mattina-Hawkins, C; Vierra, C				Vasanthavada, Keshav; Hu, Xiaoyi; Tuton-Blasingame, Tiffany; Hsia, Yang; Sampath, Sujatha; Pacheco, Ryan; Freeark, Jordan; Falick, Arnold M.; Tang, Simon; Fong, Justine; Kohler, Kristin; La Mattina-Hawkins, Coby; Vierra, Craig			Spider Glue Proteins Have Distinct Architectures Compared with Traditional Spidroin Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK-WIDOW SPIDER; ENTROPIC ELASTIC PROCESSES; SILK FIBROIN; AMPULLATE SILK; DRAGLINE SILK; FIBERS; SEQUENCE; IDENTIFICATION; MECHANISMS; MORPHOLOGY	Adhesive spider glues are required to perform a variety of tasks, including web construction, prey capture, and locomotion. To date, little is known regarding the molecular and structural features of spider glue proteins, in particular bioadhesives that interconnect dragline or scaffolding silks during three-dimensional web construction. Here we use biochemical and structural approaches to identify and characterize two aggregate gland specific gene products, AgSF1 and AgSF2, and demonstrate that these proteins co-localize to the connection joints of both webs and wrapping silks spun from the black widow spider, Latrodectus hesperus. Protein architectures are markedly divergent between AgSF1 and AgSF2, as well as traditional spider silk fibroin family members, suggesting connection joints consist of a complex proteinaceous network. AgSF2 represents a nonglycosylated 40-kDa protein that has novel internal amino acid block repeats with the consensus sequence NVNVN embedded in a glycine-rich matrix. Analysis of the amino acid sequence of AgSF1 reveals pentameric QPGSG iterations that are similar to conserved modular elements within mammalian elastin, a rubber-like elastomeric protein that interfaces with collagen. Wet-spinning methodology using purified recombinant proteins show AgSF1 has the potential to self-assemble into fibers. X-ray fiber diffraction studies performed on these synthetic fibers reveal the presence of noncrystalline domains that resemble classical rubber networks. Collectively, these data support that the aggregate gland serves to extrude a protein mixture that contains substances that allow for the self-assembly of fiber-like structures that interface with dragline silks to mediate prey capture.	[Vasanthavada, Keshav; Hu, Xiaoyi; Tuton-Blasingame, Tiffany; Hsia, Yang; Pacheco, Ryan; Freeark, Jordan; Fong, Justine; Kohler, Kristin; La Mattina-Hawkins, Coby; Vierra, Craig] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Tang, Simon] Univ Pacific, Sch Engn & Comp Sci, Stockton, CA 95211 USA; [Sampath, Sujatha] Arizona State Univ, Magnet Resonance Res Ctr, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of the Pacific; University of the Pacific; Arizona State University; Arizona State University-Tempe	Vierra, C (corresponding author), Univ Pacific, Dept Biol Sci, 3601 Pacific Ave, Stockton, CA 95211 USA.	cvierra@pacific.edu	Tang, Simon/AAZ-1179-2021	Tang, Simon/0000-0002-5570-3921; Kohler, Kristin/0000-0001-7753-843X	National Science Foundation RUI [MCB-0950372, DMR-1105310]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Center for Research Resources [5P41RR007707]; NIGMS from the National Institutes of Health [8P41GM103543]; Division Of Materials Research [1105310] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0950372] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103543] Funding Source: NIH RePORTER	National Science Foundation RUI(National Science Foundation (NSF)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation RUI Grants MCB-0950372 and DMR-1105310.; We thank Dr. Jason Li, Asylum Research, for technical assistance on the AFM imaging and Jeff Yarger, Arizona State University, Department of Chemistry & Biochemistry, for help with the x-ray diffraction data collection. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. DE-AC02-06CH11357. Use of the BioCARS Sector 14 was also supported by grants from the National Center for Research Resources Grant 5P41RR007707 and NIGMS Grant 8P41GM103543 from the National Institutes of Health.	Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Foelix R., 2011, BIOL SPIDERS; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GEIGER T, 1987, J BIOL CHEM, V262, P785; George RA, 2000, TRENDS BIOCHEM SCI, V25, P515, DOI 10.1016/S0968-0004(00)01643-1; Geurts P, 2010, BIOMACROMOLECULES, V11, P3495, DOI 10.1021/bm101002w; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hsia Y., 2012, JOVE-J VIS EXP, V65, P4191; Hu XY, 2006, BIOCHEMISTRY-US, V45, P3506, DOI 10.1021/bi052105q; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; Jeffery F., 2011, JOVE, V47, P2382; Keum JK, 2005, POLYMER, V46, P939, DOI 10.1016/j.polymer.2004.12.004; Kovoor J., 1987, P160; Kushner AM, 2011, ANGEW CHEM INT EDIT, V50, P9026, DOI 10.1002/anie.201006496; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Murthy N.S., 2004, RIGAKU J, V21, P15; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Pouchkina NN, 2003, INSECT BIOCHEM MOLEC, V33, P229, DOI 10.1016/S0965-1748(02)00207-2; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1; SANDBERG LB, 1985, PATHOL BIOL, V33, P266; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; URRY DW, 1988, J PROTEIN CHEM, V7, P81, DOI 10.1007/BF01025240; URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447; Zussman E, 2006, J POLYM SCI POL PHYS, V44, P1482, DOI 10.1002/polb.20803	41	28	29	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35986	35999		10.1074/jbc.M112.399816	http://dx.doi.org/10.1074/jbc.M112.399816			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927444	Green Published, hybrid			2022-12-28	WOS:000310364000021
J	Dutta, T; Malhotra, A; Deutscher, MP				Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.			Exoribonuclease and Endoribonuclease Activities of RNase BN/RNase Z both Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRNASE-Z-FAMILY; ESCHERICHIA-COLI; ZINC PHOSPHODIESTERASE; PROCESSING ENZYME; PRECURSORS; BN; PROTEINS; MATURATION; MOLECULES; GROWTH	Escherichia coli RNase BN, a member of the RNase Z family of endoribonucleases, differs from other family members in that it also can act as an exoribonuclease in vitro. Here, we examine whether this activity of RNase BN also functions in vivo. Comparison of the x-ray structure of RNase BN with that of Bacillus subtilis RNase Z, which lacks exoribonuclease activity, revealed that RNase BN has a narrower and more rigid channel downstream of the catalytic site. We hypothesized that this difference in the putative RNA exit channel might be responsible for the acquisition of exoribonuclease activity by RNase BN. Accordingly, we generated several mutant RNase BN proteins in which residues within a loop in this channel were converted to the corresponding residues present in B. subtilis RNase Z, thus widening the channel and increasing its flexibility. The resulting mutant RNase BN proteins had reduced or were essentially devoid of exoribonuclease activity in vitro. Substitution of one mutant rbn gene (P142G) for wild type rbn in the E. coli chromosome revealed that the exoribonuclease activity of RNase BN is not required for maturation of phage T4 tRNA precursors, a known specific function of this RNase. On the other hand, removal of the exoribonuclease activity of RNase BN in a cell lacking other processing RNases leads to slower growth and affects maturation of multiple tRNA precursors. These findings help explain how RNase BN can act as both an exo- and an endoribonuclease and also demonstrate that its exoribonuclease activity is capable of functioning in vivo, thus widening the potential role of this enzyme in E. coli.	[Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021; Malhotra, Arun/A-3916-2008; Malhotra, Arun/Z-5140-2019	Malhotra, Arun/0000-0001-6656-7841; Malhotra, Arun/0000-0001-6656-7841	National Institutes of Health Grant [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M.P.D.).	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; DEUTSCHER MP, 1974, J BIOL CHEM, V249, P6696; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dutta T, 2010, J BIOL CHEM, V285, P22872, DOI 10.1074/jbc.M110.141101; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; MAISURIAN AN, 1973, MOL GEN GENET, V120, P227, DOI 10.1007/BF00267154; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, P NATL ACAD SCI USA, V72, P1491, DOI 10.1073/pnas.72.4.1491; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08	30	15	15	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35747	35755		10.1074/jbc.M112.407403	http://dx.doi.org/10.1074/jbc.M112.407403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893707	Green Published, hybrid			2022-12-28	WOS:000309968000085
J	Giral, H; Cranston, D; Lanzano, L; Caldas, Y; Sutherland, E; Rachelson, J; Dobrinskikh, E; Weinman, EJ; Doctor, RB; Gratton, E; Levi, M				Giral, Hector; Cranston, DeeAnn; Lanzano, Luca; Caldas, Yupanqui; Sutherland, Eileen; Rachelson, Joanna; Dobrinskikh, Evgenia; Weinman, Edward J.; Doctor, R. Brian; Gratton, Enrico; Levi, Moshe			NHE3 Regulatory Factor 1 (NHERF1) Modulates Intestinal Sodium-dependent Phosphate Transporter (NaPi-2b) Expression in Apical Microvilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; NA+-H+ EXCHANGER; IN-VITRO MODEL; PDZ PROTEINS; DIETARY PHOSPHATE; PROXIMAL TUBULES; RENAL ADAPTATION; CACO-2BBE CELLS; VITAMIN-D; COTRANSPORTER	P-i uptake in the small intestine occurs predominantly through the NaPi-2b (SLC34a2) co-transporter. NaPi-2b is regulated by changes in dietary P-i but the mechanisms underlying this regulation are largely undetermined. Sequence analyses show NaPi-2b has a PDZ binding motif at its C terminus. Immunofluorescence imaging shows NaPi-2b and two PDZ domain containing proteins, NHERF1 and PDZK1, are expressed in the apical microvillar domain of rat small intestine enterocytes. Co-immunoprecipitation studies in rat enterocytes show that NHERF1 associates with NaPi-2b but not PDZK1. In HEK co-expression studies, GFP-NaPi-2b co-precipitates with FLAG-NHERF1. This interaction is markedly diminished when the C-terminal four amino acids are truncated from NaPi-2b. FLIM-FRET analyses using tagged proteins in CACO-2(BBE) cells show a distinct phasor shift between NaPi-2b and NHERF1 but not between NaPi-2b and the PDZK1 pair. This shift demonstrates that NaPi-2b and NHERF1 reside within 10 nm of each other. NHERF1(-/-) mice, but not PDZK1(-/-) mice, had a diminished adaptation of NaPi-2b expression in response to a low Pi diet. Together these studies demonstrate that NHERF1 associates with NaPi-2b in enterocytes and regulates NaPi-2b adaptation.	[Levi, Moshe] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Giral, Hector; Cranston, DeeAnn; Caldas, Yupanqui; Sutherland, Eileen; Rachelson, Joanna; Dobrinskikh, Evgenia; Doctor, R. Brian; Levi, Moshe] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80045 USA; [Lanzano, Luca; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Levi, M (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, 12700 E 19th Ave,Res 2,Rm 7002,Box C281, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu		Lanzano', Luca/0000-0001-6539-394X; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [R01 DK066029-6, R01 DK-080769, 8P41GM103540, P50-GM076516]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080769, R01DK066029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103540, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK066029-6 (to M. L., E. G., H. G., Y. C., and L. L.), R01 DK-080769 (to B. D., D. C., J. R., and E. D.), 8P41GM103540 (to E. G. and L. L.), and P50-GM076516 (to E. G. and L. L.).	Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Biber J, 2005, J MEMBRANE BIOL, V203, P111, DOI 10.1007/s00232-005-0738-7; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Caldas YA, 2011, KIDNEY INT, V80, P535, DOI 10.1038/ki.2011.159; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Capuano P, 2005, AM J PHYSIOL-CELL PH, V288, pC429, DOI 10.1152/ajpcell.00331.2004; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dobrinskikh E, 2010, AM J PHYSIOL-CELL PH, V299, pC1324, DOI 10.1152/ajpcell.00183.2010; Donowitz M, 2010, PHYSIOL GENOMICS, V42A, P200, DOI 10.1152/physiolgenomics.00001.2010; Farrow EG, 2010, NAT REV NEPHROL, V6, P207, DOI 10.1038/nrneph.2010.17; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Fujiya M, 2011, INFLAMM BOWEL DIS, V17, P907, DOI 10.1002/ibd.21444; Giral H, 2011, J BIOL CHEM, V286, P15032, DOI 10.1074/jbc.M110.199752; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hattenhauer O, 1999, AM J PHYSIOL-GASTR L, V277, pG756, DOI 10.1152/ajpgi.1999.277.4.G756; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hoag HM, 1999, J CLIN INVEST, V104, P679, DOI 10.1172/JCI7103; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; KEMPSON SA, 1995, AM J PHYSIOL-RENAL, V268, pF784, DOI 10.1152/ajprenal.1995.268.4.F784; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Lanzano L, 2011, J BIOPHOTONICS, V4, P415, DOI 10.1002/jbio.201100002; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Marks J, 2006, EXP PHYSIOL, V91, P531, DOI 10.1113/expphysiol.2005.032516; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Musch MW, 2008, AM J PHYSIOL-GASTR L, V295, pG909, DOI 10.1152/ajpgi.90312.2008; Naderi ASA, 2010, NAT REV NEPHROL, V6, P657, DOI 10.1038/nrneph.2010.121; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ohkido I, 2003, PFLUG ARCH EUR J PHY, V446, P106, DOI 10.1007/s00424-003-1010-6; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; PETERSON MD, 1993, J CELL SCI, V105, P445; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Sugiura T, 2008, DRUG METAB DISPOS, V36, P1181, DOI 10.1124/dmd.107.020321; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641	57	32	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35047	35056		10.1074/jbc.M112.392415	http://dx.doi.org/10.1074/jbc.M112.392415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904329	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000309968000016
J	Litvinov, RI; Mekler, A; Shuman, H; Bennett, JS; Barsegov, V; Weisel, JW				Litvinov, Rustem I.; Mekler, Andrey; Shuman, Henry; Bennett, Joel S.; Barsegov, Valeri; Weisel, John W.			Resolving Two-dimensional Kinetics of the Integrin alpha IIb beta 3-Fibrinogen Interactions Using Binding-Unbinding Correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIGAND INTERACTIONS; HIGH-STRENGTH STATES; BETA(2) INTEGRIN; ICAM-1 BONDS; CATCH BONDS; ADHESION; FORCE; ACTIVATION; FIBRINOGEN; DISSOCIATION	Using a combined experimental and theoretical approach named binding-unbinding correlation spectroscopy (BUCS), we describe the two-dimensional kinetics of interactions between fibrinogen and the integrin alpha IIb beta 3, the ligand-receptor pair essential for platelet function during hemostasis and thrombosis. The methodology uses the optical trap to probe force-free association of individual surface-attached fibrinogen and alpha IIb beta 3 molecules and forced dissociation of an IIb beta 3-fibrinogen complex. This novel approach combines force clamp measurements of bond lifetimes with the binding mode to quantify the dependence of the binding probability on the interaction time. We found that fibrinogen-reactive alpha IIb beta 3 pre-exists in at least two states that differ in their zero force on-rates (k(on1) = 1.4 x 10(-4) and k(on2) x 2.3 x 10(-4) mu m(2)/s), off-rates (k(off1) = 2.42 and k(off2) = 0.60 s(-1)), and dissociation constants (K-d1 = 1.7 x 10(4) and K-d2 = 2.6 x 10(3) mu m(-2)). The integrin activator Mn2+ changed the on-rates and affinities (K-d1 = 5 x 10(4) and K-d2 = 0.3 x 10(3) mu m(-2)) but did not affect the off-rates. The strength of alpha IIb beta 3-fibrinogen interactions was time-dependent due to a progressive increase in the fraction of the high affinity state of the alpha IIb beta 3-fibrinogen complex characterized by a faster on-rate. Upon Mn2+-induced integrin activation, the force-dependent off-rates decrease while the complex undergoes a conformational transition from a lower to higher affinity state. The results obtained provide quantitative estimates of the two-dimensional kinetic rates for the low and high affinity alpha IIb beta 3 and fibrinogen interactions at the single molecule level and offer direct evidence for the time-and force-dependent changes in alpha IIb beta 3 conformation and ligand binding activity, underlying the dynamics of fibrinogen-mediated platelet adhesion and aggregation.	[Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA; [Litvinov, Rustem I.; Mekler, Andrey; Weisel, John W.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Shuman, Henry] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Bennett, Joel S.] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Lowell; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Barsegov, V (corresponding author), Univ Massachusetts, Dept Chem, 401B Olney Hall, Lowell, MA 01854 USA.	Valeri_Barsegov@uml.edu; weisel@mail.med.upenn.edu	Barsegov, Valeri/A-6203-2014; Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917	National Institutes of Health [HL030954/HL090774, HL40387/HL81012]; American Heart Association [09SDG2460023]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030954, R01HL090774, R56HL090774, P01HL040387, P50HL081012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL030954/HL090774 (to J.W.W.) and HL40387/HL81012 (to J.S.B.). This work was also supported by American Heart Association Grant 09SDG2460023 (to V.B.).	Agnihotri A, 2009, COLLOID SURFACE B, V71, P138, DOI 10.1016/j.colsurfb.2009.01.019; Barsegov V, 2006, J PHYS CHEM B, V110, P26403, DOI 10.1021/jp0653306; Barsegov V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168302; Barsegov V, 2006, BIOPHYS J, V90, P3827, DOI 10.1529/biophysj.105.075937; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bergmeier W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005132; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; Chen W., 2011, PLOS COMPUT BIOL, V7; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Danilowicz C, 2005, ANAL CHEM, V77, P3023, DOI 10.1021/ac050057+; DICERA E, 1990, BIOPHYS CHEM, V37, P147, DOI 10.1016/0301-4622(90)88015-K; DICERA E, 1988, P NATL ACAD SCI USA, V85, P5077; Edwards LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00086; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9; Hantgan RR, 2006, PROTEIN SCI, V15, P1893, DOI 10.1110/ps.052049506; Huang J, 2012, MOL IMMUNOL, V52, P155, DOI 10.1016/j.molimm.2012.05.004; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kuroki K, 2011, METHODS MOL BIOL, V748, P83, DOI 10.1007/978-1-61779-139-0_6; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; Long M, 2006, CELL MOL IMMUNOL, V3, P79; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Rico F, 2011, METHODS MOL BIOL, V736, P331, DOI 10.1007/978-1-61779-105-5_20; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xiang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027946; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	46	28	28	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35275	35285		10.1074/jbc.M112.404848	http://dx.doi.org/10.1074/jbc.M112.404848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893701	Green Published, hybrid			2022-12-28	WOS:000309968000037
J	Minder, P; Bayha, E; Becker-Pauly, C; Sterchi, EE				Minder, Petra; Bayha, Elke; Becker-Pauly, Christoph; Sterchi, Erwin E.			Meprin alpha Transactivates the Epidermal Growth Factor Receptor (EGFR) via Ligand Shedding, thereby Enhancing Colorectal Cancer Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBENZOIC ACID HYDROLASE; HUMAN SMALL-INTESTINE; METALLOPROTEASE MEPRIN; PABA-PEPTIDE; BETA-SUBUNIT; DIFFERENTIAL EXPRESSION; CONVERTING-ENZYME; TGF-ALPHA; ACTIVATION; MEMBRANE	Meprin alpha, an astacin-type metalloprotease is overexpressed in colorectal cancer cells and is secreted in a non-polarized fashion, leading to the accumulation of meprin alpha in the tumor stroma. The transition from normal colonocytes to colorectal cancer correlates with increased meprin alpha activity at primary tumor sites. A role for meprin alpha in invasion and metastatic dissemination is supported by its pro-angiogenic and pro-migratory activity. In the present study, we provide evidence for a meprin alpha-mediated transactivation of the EGFR signaling pathway and suggest that this mechanism is involved in colorectal cancer progression. Using alkaline phosphatase-tagged EGFR ligands and an ELISA assay, we demonstrate that meprin alpha is capable of shedding epidermal growth factor (EGF) and transforming growth factor-alpha (TGF alpha) from the plasma membrane. Shedding was abrogated using actinonin, an inhibitor for meprin alpha. The physiological effects of meprin alpha-mediated shedding of EGF and TGF alpha were investigated with human colorectal adenocarcinoma cells (Caco-2). Proteolytically active meprin alpha leads to an increase in EGFR and ERK1/2 phosphorylation and subsequently enhances cell proliferation and migration. In conclusion, the implication of meprin alpha in the EGFR/MAPK signaling pathway indicates a role of meprin alpha in colorectal cancer progression.	[Minder, Petra; Bayha, Elke; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Bern; University of Kiel	Sterchi, EE (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buehlstr 28, CH-3012 Bern, Switzerland.	erwin.sterchi@ibmm.unibe.ch	Becker-Pauly, Christoph/B-7569-2011		Swiss National Science Foundation [31003A 125212/1]; Deutsche Forschungsgemeinschaft (DFG) [BE 4086/1-2, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by Swiss National Science Foundation Grant 31003A 125212/1 and by the Deutsche Forschungsgemeinschaft (DFG) Grant BE 4086/1-2 and SFB877 (project A9), and the Cluster of Excellence "Inflammation at Interfaces" (to C. B. P.).	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Anoopkumar-Dukie S, 2005, BRIT J RADIOL, V78, P945, DOI 10.1259/bjr/54004230; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COHEN STANLEY, 1965, DEVELOP BIOL, V12, P394, DOI 10.1016/0012-1606(65)90005-9; Crouch SP, 1993, J IMMUNOL METHODS, V1, P81; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Half E, 2004, INT J CANCER, V108, P540, DOI 10.1002/ijc.11599; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Ishmael FT, 2001, J BIOL CHEM, V276, P23207, DOI 10.1074/jbc.M102654200; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jefferson T., 2012, CELL MOL LI IN PRESS; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; Strachan L, 2001, J BIOL CHEM, V276, P18265, DOI 10.1074/jbc.M006935200; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tampellini M, 2007, VIRCHOWS ARCH, V450, P321, DOI 10.1007/s00428-007-0370-2; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarom N, 2011, DISCOV MED, V11, P95; YASUI W, 1988, CANCER RES, V48, P137	62	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35201	35211		10.1074/jbc.M112.368910	http://dx.doi.org/10.1074/jbc.M112.368910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923609	Green Published, hybrid			2022-12-28	WOS:000309968000030
J	Nakaya, M; Chikura, S; Watari, K; Mizuno, N; Mochinaga, K; Mangmool, S; Koyanagi, S; Ohdo, S; Sato, Y; Ide, T; Nishida, M; Kurose, H				Nakaya, Michio; Chikura, Satsuki; Watari, Kenji; Mizuno, Natsumi; Mochinaga, Koji; Mangmool, Supachoke; Koyanagi, Satoru; Ohdo, Shigehiro; Sato, Yoji; Ide, Tomomi; Nishida, Motohiro; Kurose, Hitoshi			Induction of Cardiac Fibrosis by beta-Blocker in G Proteinin-dependent and G Protein-coupled Receptor Kinase 5/beta-Arrestin2-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; BIASED AGONISM; HEART-FAILURE; ARRESTIN; GRKS; PHOSPHORYLATION; TRAFFICKING; ACTIVATION	G-protein coupled receptors (GPCRs) have long been known as receptors that activate G protein-dependent cellular signaling pathways. In addition to the G protein-dependent pathways, recent reports have revealed that several ligands called "biased ligands" elicit G protein-independent and beta-arrestin-dependent signaling through GPCRs (biased agonism). Several beta-blockers are known as biased ligands. All beta-blockers inhibit the binding of agonists to the beta-adrenergic receptors. In addition to beta-blocking action, some beta-blockers are reported to induce cellular responses through G protein-independent and beta-arrestin-dependent signaling pathways. However, the physiological significance induced by the beta-arrestin-dependent pathway remains much to be clarified in vivo. Here, we demonstrate that metoprolol, a beta(1)-adrenergic receptor-selective blocker, could induce cardiac fibrosis through a G protein-independent and beta-arrestin2-dependent pathway. Metoprolol, a beta-blocker, increased the expression of fibrotic genes responsible for cardiac fibrosis in cardiomyocytes. Furthermore, metoprolol induced the interaction between beta(1)-adrenergic receptor and beta-arrestin2, but not beta-arrestin1. The interaction between beta(1)-adrenergic receptor and beta-arrestin2 by metoprolol was impaired in the G protein-coupled receptor kinase 5 (GRK5)knockdown cells. Metoprolol-induced cardiac fibrosis led to cardiac dysfunction. However, the metoprolol-induced fibrosis and cardiac dysfunction were not evoked in beta-arrestin2- or GRK5-knock-out mice. Thus, metoprolol is a biased ligand that selectively activates a G protein-independent and GRK5/beta-arrestin2-dependent pathway, and induces cardiac fibrosis. This study demonstrates the physiological importance of biased agonism, and suggests that G protein-independent and beta-arrestin-dependent signaling is a reason for the diversity of the effectiveness of beta-blockers.	[Nakaya, Michio; Chikura, Satsuki; Watari, Kenji; Mizuno, Natsumi; Mochinaga, Koji; Mangmool, Supachoke; Nishida, Motohiro; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan; [Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut Sci, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan	Kyushu University; Kyushu University; Kyushu University; National Institute of Health Sciences - Japan	Kurose, H (corresponding author), Kyushu Univ, Dept Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp		Koyanagi, Satoru/0000-0003-4849-2377; Mizuno, Natsumi/0000-0001-7161-266X; Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Scientific Research on Priority Areas; Grants-in-Aid for Scientific Research [22136008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Na, M. Ni, and H.K.), a Grant-in-aid for Scientific Research on Innovative Areas (to M. Ni), a Grant-in-aid for Scientific Research on Priority Areas (to H.K.), the Takeda Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. Na).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRODDE OE, 1993, PHARMACOL THERAPEUT, V60, P405, DOI 10.1016/0163-7258(93)90030-H; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Cruickshank JM, 2007, INT J CARDIOL, V120, P10, DOI 10.1016/j.ijcard.2007.01.069; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gustafsson AB, 2000, MOL PHARMACOL, V58, P1470, DOI 10.1124/mol.58.6.1470; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hjalmarson A, 1999, LANCET, V353, P2001; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Metra M, 2004, HEART FAIL REV, V9, P123, DOI 10.1023/B:HREV.0000046367.99002.a4; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reiter MJ, 2004, PROG CARDIOVASC DIS, V47, P11, DOI 10.1016/j.pcad.2004.04.004; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P21028, DOI 10.1073/pnas.1004169107; Varma DR, 1999, BRIT J PHARMACOL, V127, P895, DOI 10.1038/sj.bjp.0702616; WAAGSTEIN F, 1989, CIRCULATION, V80, P551, DOI 10.1161/01.CIR.80.3.551; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yamamoto K, 2002, CARDIOVASC RES, V55, P76, DOI 10.1016/S0008-6363(02)00341-3; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	50	38	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35669	35677		10.1074/jbc.M112.357871	http://dx.doi.org/10.1074/jbc.M112.357871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22888001	hybrid, Green Published			2022-12-28	WOS:000309968000078
J	Sikorski, TW; Joo, YJ; Ficarro, SB; Askenazi, M; Buratowski, S; Marto, JA				Sikorski, Timothy W.; Joo, Yoo Jin; Ficarro, Scott B.; Askenazi, Manor; Buratowski, Stephen; Marto, Jarrod A.			Proteomic Analysis Demonstrates Activator- and Chromatin-specific Recruitment to Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; QUANTITATIVE PROTEOMICS; PREINITIATION COMPLEX; TRANSCRIPTION REINITIATION; IN-VIVO; MEDIATOR; QUANTIFICATION; IDENTIFICATION; MECHANISM; ENHANCER	In-depth characterization of RNA polymerase II preinitiation complexes remains an important and challenging goal. We used quantitative mass spectrometry to explore context-dependent Saccharomyces cerevisiae preinitiation complex formation at the HIS4 promoter reconstituted on naked and chromatinized DNA templates. The transcription activators Gal4-VP16 and Gal4-Gcn4 recruited a limited set of chromatin-related coactivator complexes, namely the chromatin remodeler Swi/Snf and histone acetyltransferases SAGA and NuA4, suggesting that transcription stimulation is mediated through these factors. Moreover, the two activators differentially recruited the coactivator complexes, consistent with specific activator-coactivator interactions. Chromatinized templates suppressed recruitment of basal transcription factors, thereby amplifying the effect of activators, compared with naked DNA templates. This system is sensitive, highly reproducible, and easily applicable to mapping the repertoire of proteins found at any promoter.	[Sikorski, Timothy W.; Joo, Yoo Jin; Ficarro, Scott B.; Askenazi, Manor; Buratowski, Stephen; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sikorski, Timothy W.; Ficarro, Scott B.; Askenazi, Manor; Marto, Jarrod A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Askenazi, Manor; Marto, Jarrod A.] Harvard Univ, Sch Med, Blais Prote Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu; jarrod_marto@dfci.harvard.edu	Joo, Yoo Jin/AAK-6614-2020	Askenazi, Manor/0000-0003-1646-833X	National Institutes of Health [GM46498]; Dana-Farber Strategic Research Initiative; National Defense Science and Engineering Graduate predoctoral fellowship; National Research Foundation of Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Strategic Research Initiative; National Defense Science and Engineering Graduate predoctoral fellowship; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46498 (to S. B.). This work was also supported by the Dana-Farber Strategic Research Initiative (to J.A.M.).; Supported by a National Defense Science and Engineering Graduate predoctoral fellowship.; Supported by a National Research Foundation of Korea postdoctoral fellowship.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Benaglia T, 2009, J STAT SOFTW, V32, P1; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Ficarro SB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011064; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wenger CD, 2011, NAT METHODS, V8, P933, DOI [10.1038/NMETH.1716, 10.1038/nmeth.1716]; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhou F, 2011, ANAL CHEM, V83, P6996, DOI 10.1021/ac200639v; Zhou F, 2010, J PROTEOME RES, V9, P6242, DOI 10.1021/pr1004696	40	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35397	35408		10.1074/jbc.M112.391581	http://dx.doi.org/10.1074/jbc.M112.391581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902623	Green Published, hybrid			2022-12-28	WOS:000309968000047
J	Stengel, R; Rivera-Milla, E; Sahoo, N; Ebert, C; Bollig, F; Heinemann, SH; Schonherr, R; Englert, C				Stengel, Rayk; Rivera-Milla, Eric; Sahoo, Nirakar; Ebert, Christina; Bollig, Frank; Heinemann, Stefan H.; Schoenherr, Roland; Englert, Christoph			Kcnh1 Voltage-gated Potassium Channels Are Essential for Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-QT SYNDROME; HUMAN ETHER; FUNCTIONAL EXPRESSION; K+ CHANNELS; GENE; INHIBITION; PROLIFERATION; VERTEBRATE; CLONING; HERG	The Kcnh1 gene encodes a voltage-gated potassium channel highly expressed in neurons and involved in tumor cell proliferation, yet its physiological roles remain unclear. We have used the zebrafish as a model to analyze Kcnh1 function in vitro and in vivo. We found that the kcnh1 gene is duplicated in teleost fish (i.e. kcnh1a and kcnh1b) and that both genes are maternally expressed during early development. In adult zebrafish, kcnh1a and kcnh1b have distinct expression patterns but share expression in brain and testis. Heterologous expression of both genes in Xenopus oocytes revealed a strong conservation of characteristic functional properties between human and fish channels, including a unique sensitivity to intracellular Ca2+/calmodulin and modulation of voltage-dependent gating by extracellular Mg2+. Using a morpholino antisense approach, we demonstrate a strong kcnh1 loss-of-function phenotype in developing zebrafish, characterized by growth retardation, delayed hind-brain formation, and embryonic lethality. This late phenotype was preceded by transcriptional up-regulation of known cell-cycle inhibitors (p21, p27, cdh2) and down-regulation of pro-proliferative factors, including cyclin D1, at 70% epiboly. These results reveal an unanticipated basic activity of kcnh1 that is crucial for early embryonic development and patterning.	[Stengel, Rayk; Sahoo, Nirakar; Heinemann, Stefan H.; Schoenherr, Roland] Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, D-07745 Jena, Germany; [Stengel, Rayk; Sahoo, Nirakar; Heinemann, Stefan H.; Schoenherr, Roland] Univ Jena, D-07745 Jena, Germany; [Rivera-Milla, Eric; Ebert, Christina; Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schonherr, R (corresponding author), Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, Hans Knoll Str 2, D-07745 Jena, Germany.	Roland.Schoenherr@uni-jena.de	Schönherr, Roland/K-8713-2013	Schönherr, Roland/0000-0003-0633-0775; Heinemann, Stefan H./0000-0002-4144-0251; Englert, Christoph/0000-0002-5931-3189; Sahoo, Nirakar/0000-0003-0669-3840	Deutsche Forschungsgemeinschaft [SFB 604]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB 604) (to C. E. and to S. H. H.).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chalasani K, 2011, MOL BIOL CELL, V22, P1505, DOI 10.1091/mbc.E10-08-0675; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Force A, 1999, GENETICS, V151, P1531; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KAPLAN WD, 1969, GENETICS, V61, P399; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Mittelstadt S. W., 2008, Journal of Pharmacological and Toxicological Methods, V57, P100, DOI 10.1016/j.vascn.2007.10.004; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ohno S., 1970, P1; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Scholz EP, 2009, BIOCHEM BIOPH RES CO, V381, P159, DOI 10.1016/j.bbrc.2009.02.042; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Starkus JG, 2003, PFLUG ARCH EUR J PHY, V447, P44, DOI 10.1007/s00424-003-1121-0; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B, 2001, ZFIN DIRECT DATA SUB; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Wang MH, 2004, BIOCHEM BIOPH RES CO, V324, P971, DOI 10.1016/j.bbrc.2004.09.162; Webb SE, 2007, CLIN EXP PHARMACOL P, V34, P897, DOI 10.1111/j.1440-1681.2007.04709.x; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	56	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35565	35575		10.1074/jbc.M112.363978	http://dx.doi.org/10.1074/jbc.M112.363978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927438	Green Published, hybrid			2022-12-28	WOS:000309968000069
J	Takeuchi, H; Kantharia, J; Sethi, MK; Bakker, H; Haltiwanger, RS				Takeuchi, Hideyuki; Kantharia, Joshua; Sethi, Maya K.; Bakker, Hans; Haltiwanger, Robert S.			Site-specific O-Glucosylation of the Epidermal Growth Factor-like (EGF) Repeats of Notch EFFICIENCY OF GLYCOSYLATION IS AFFECTED BY PROPER FOLDING AND AMINO ACID SEQUENCE OF INDIVIDUAL EGF REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED-N-ACETYLGLUCOSAMINE; FACTOR-LIKE MODULES; FACTOR-LIKE DOMAIN; MAMMALIAN NOTCH; FUCOSYL-TRANSFERASE; FACTOR-IX; PROTEIN O-FUCOSYL-TRANSFERASE-1; EXTRACELLULAR DOMAIN; MOLECULAR-CLONING; MODIFIES NOTCH	O-Glucosylation of epidermal growth factor-like (EGF) repeats in the extracellular domain of Notch is essential for Notch function. O-Glucose can be elongated by xylose to the trisaccharide, Xyl alpha 1-3Xyl alpha 1-3Glc beta 1-O-Ser, whose synthesis is catalyzed by the consecutive action of three glycosyltransferases. A UDP-glucose: protein O-glucosyltransferase (Poglut/Rumi) transfers O-glucose to serine within the O-glucose consensus. Subsequently, either of two UDP-xylose: glucoside xylosyltransferases (Gxylt1 or Gxylt2) transfers xylose to O-glucose. Finally, a UDP-xylose: xyloside xylosyltransferase (Xxylt1) transfers xylose to Xyl alpha 1-3Glc beta 1-O-EGF. Our prior site-mapping studies demonstrated that O-glucose consensus sites are modified at high but variable stoichiometries in mouse Notch1 and identified a novel glycosylation site with alanine in place of proline, suggesting a revised, broader consensus sequence (CXSX(P/A)C). Here we examined the molecular basis for this site specificity. A panel of EGF repeats from human coagulation factor 9 (FA9), mouse Notch1, and Notch2 were bacterially expressed and purified by reverse phase HPLC for use in in vitro enzyme assays. We demonstrate that proper folding of EGF repeats is essential for glycosylation by Poglut/Rumi, that alanine can substitute for proline in the context of coagulation factor 9 EGF repeat for O-glucose transfer, confirming the new consensus sequence, and that positively charged residues within the O-glucose consensus sequence reduce efficiency of glycosylation by Poglut/Rumi. Moreover, proper folding of EGF repeats is also important for the activities of Gxylt1, Gxylt2, and Xxylt1. These results indicate that protein folding and amino acid sequences of individual EGF repeats fundamentally affect both attachment and elongation of O-glucose glycans.	[Takeuchi, Hideyuki; Kantharia, Joshua; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; [Sethi, Maya K.; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hannover Medical School	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	Robert.Haltiwanger@StonyBrook.edu	Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017; Takeuchi, Hideyuki/AAZ-9210-2020	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; 	National Institutes of Health [GM61126]; Mizutani Foundation for Glycoscience; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61126 (to R. S. H.). This work was also supported by a research grant from Mizutani Foundation for Glycoscience (to H. T.) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (from Regenerative Biology to Reconstructive Therapy) for the work in Hannover.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; GIANNELLI F, 1993, NUCLEIC ACIDS RES, V21, P3075, DOI 10.1093/nar/21.13.3075; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HASE S, 1990, J BIOL CHEM, V265, P1858; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luther KB, 2009, INT J BIOCHEM CELL B, V41, P1011, DOI 10.1016/j.biocel.2008.10.001; Luther KB, 2009, J BIOL CHEM, V284, P3294, DOI 10.1074/jbc.M805502200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Montejo JM, 1999, HUM MUTAT, V13, P160, DOI 10.1002/(SICI)1098-1004(1999)13:2<160::AID-HUMU9>3.3.CO;2-3; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Zhong DG, 2002, J BIOL CHEM, V277, P3622, DOI 10.1074/jbc.M111202200	41	61	62	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33934	33944		10.1074/jbc.M112.401315	http://dx.doi.org/10.1074/jbc.M112.401315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872643	Green Published, hybrid			2022-12-28	WOS:000309654200002
J	Yao, L; Li, WM; She, H; Dou, J; Jia, LL; He, YL; Yang, Q; Zhu, JQ; Capiro, NL; Walker, DI; Pennell, KD; Pang, YP; Liu, Y; Han, YF; Mao, ZX				Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Capiro, Natalie L.; Walker, Douglas I.; Pennell, Kurt D.; Pang, Yuanping; Liu, Yong; Han, Yifan; Mao, Zixu			Activation of Transcription Factor MEF2D by Bis(3)-cognitin Protects Dopaminergic Neurons and Ameliorates Parkinsonian Motor Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-ENHANCER FACTOR-2; CEREBELLAR GRANULE NEURONS; D-ASPARTATE RECEPTORS; OXIDATIVE STRESS; DISEASE; SURVIVAL; APOPTOSIS; GROWTH; TARGETS; MPTP	Parkinson disease (PD) is characterized by the selective demise of dopaminergic (DA) neurons in the substantial nigra pars compacta. Dysregulation of transcriptional factor myocyte enhancer factor 2D (MEF2D) has been implicated in the pathogenic process in in vivo and in vitro models of PD. Here, we identified a small molecule bis(3)-cognitin (B3C) as a potent activator of MEF2D. We showed that B3C attenuated the toxic effects of neurotoxin 1-methyl-4-phenylpyridinium (MPP+) by activating MEF2D via multiple mechanisms. B3C significantly reduced MPP+-induced oxidative stress and potentiated Akt to down-regulate the activity of MEF2 inhibitor glycogen synthase kinase 3 beta (GSK3 beta) in a DA neuronal cell line SN4741. Furthermore, B3C effectively rescued MEF2D from MPP+-induced decline in both nucleic and mitochondrial compartments. B3C offered SN4741 cells potent protection against MPP+-induced apoptosis via MEF2D. Interestingly, B3C also protected SN4741 cells from wild type or mutant A53T alpha-synuclein-induced cytotoxicity. Using the in vivo PD model of C57BL/6 mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP), we showed that B3C maintained redox homeostasis, promoted Akt function activity, and restored MEF2D level in midbrain neurons. Moreover, B3C greatly prevented the loss of tyrosine hydroxylase signal in substantial nigra pars compacta DA neurons and ameliorated behavioral impairments in mice treated with MPTP. Collectedly, our studies identified B3C as a potent neuroprotective agent whose effectiveness relies on its ability to effectively up-regulate MEF2D in DA neurons against toxic stress in models of PD in vitro and in vivo.	[Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Yao, Lu; Liu, Yong] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol Environm & Genes Related Dis, Key Lab Educ Minist, Xian 710061, Shaanxi, Peoples R China; [Li, Wenming; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Chinese Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Capiro, Natalie L.; Walker, Douglas I.; Pennell, Kurt D.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Pang, Yuanping] Mayo Fdn Med Educ & Res, Rochester, MN 55905 USA	Emory University; Emory University; Xi'an Jiaotong University; Hong Kong Polytechnic University; Tufts University; Mayo Clinic	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Whitehead Bldg,Rm 505L,615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Pennell, Kurt D/F-6862-2010; Capiro, Natalie/G-5955-2010; zhu, jinqiu/F-5039-2015; Pennell, Kurt/ABD-8337-2020	Pennell, Kurt D/0000-0002-5788-6397; Capiro, Natalie/0000-0002-8125-1658; zhu, jinqiu/0000-0003-1090-2609; Han, Yifan/0000-0002-5833-069X; Pang, Yuan-Ping/0000-0003-0838-2560	National Institutes of Health [AG023695, NS048254, 1P50NS071669, ES015317, ES015317-002]; Michael J. Fox Foundation; Research Grants Council of Hong Kong [5609/09M, 5610/11M]; Hong Kong Polytechnic University [G-U952]; National Science Foundation [CHE-03200783]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254, P50NS071669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG023695 and NS048254 (to Z. M.), 1P50NS071669 (to W. L.), and ES015317 and ES015317-002 (to Z. M.). This work was also supported in part by a grant from the Michael J. Fox Foundation (to Z. M.), in part by grants from the Research Grants Council of Hong Kong (5609/09M; 5610/11M) and the Hong Kong Polytechnic University (G-U952) (to Y. H.), and in part by National Science Foundation Grant CHE-03200783 (to K. D. P.).	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; Chu YP, 2011, NEUROBIOL DIS, V41, P71, DOI 10.1016/j.nbd.2010.08.022; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Luo JL, 2010, J BIOL CHEM, V285, P19947, DOI 10.1074/jbc.M110.111286; Mandel SA, 2008, CNS NEUROSCI THER, V14, P352, DOI 10.1111/j.1755-5949.2008.00060.x; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Pang YP, 1996, J BIOL CHEM, V271, P23646, DOI 10.1074/jbc.271.39.23646; Prasad KN, 1999, J AM COLL NUTR, V18, P413, DOI 10.1080/07315724.1999.10718878; Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714; Richter F, 2007, J NEUROSCI RES, V85, P681, DOI 10.1002/jnr.21159; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Schapira A, 2004, LANCET NEUROL, V3, P362, DOI 10.1016/S1474-4422(04)00769-0; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Sherer TB, 2002, J NEUROSCI, V22, P7006; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sun X, 2010, TOXICOLOGY, V271, P5, DOI 10.1016/j.tox.2010.01.001; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007	46	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34246	34255		10.1074/jbc.M112.367540	http://dx.doi.org/10.1074/jbc.M112.367540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891246	Green Published, hybrid			2022-12-28	WOS:000309654200029
J	Zhang, L; Iyer, J; Chowdhury, A; Ji, M; Xiao, L; Yang, SP; Chen, YH; Tsai, MY; Dong, JX				Zhang, Lin; Iyer, Jyoti; Chowdhury, Aparajita; Ji, Ming; Xiao, Ling; Yang, Shuping; Chen, Yuanhong; Tsai, Ming-Ying; Dong, Jixin			KIBRA Regulates Aurora Kinase Activity and Is Required for Precise Chromosome Alignment During Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN PHOSPHATASE 1; LYMPHOCYTIC-LEUKEMIA; EPISODIC MEMORY; DROSOPHILA; HIPPO; PHOSPHORYLATION; HOMOLOG; PATHWAY; TARGET	The Hippo pathway controls organ size and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. KIBRA was recently identified as a novel regulator of the Hippo pathway. Several of the components of the Hippo pathway are important regulators of mitosis-related cell cycle events. We recently reported that KIBRA is phosphorylated by the mitotic kinases Aurora-A and -B. However, the role KIBRA plays in mitosis has not been established. Here, we show that KIBRA activates the Aurora kinases and is required for full activation of Aurora kinases during mitosis. KIBRA also promotes the phosphorylation of large tumor suppressor 2 (Lats2) on Ser(83) by activating Aurora-A, which controls Lats2 centrosome localization. However, Aurora-A is not required for KIBRA to associate with Lats2. We also found that Lats2 inhibits the Aurora-mediated phosphorylation of KIBRA on Ser(539), probably via regulating protein phosphatase 1. Consistent with playing a role in mitosis, siRNA-mediated knockdown of KIBRA causes mitotic abnormalities, including defects of spindle and centrosome formation and chromosome misalignment. We propose that the KIBRA-Aurora-Lats2 protein complexes form a novel axis that regulates precise mitosis.	[Zhang, Lin; Iyer, Jyoti; Chowdhury, Aparajita; Ji, Ming; Xiao, Ling; Yang, Shuping; Chen, Yuanhong; Tsai, Ming-Ying; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Tsai, MY (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	mtsai@unmc.edu; dongj@unmc.edu	Iyer, Jyoti/AAM-5009-2020	Iyer, Jyoti/0000-0002-0942-6919	National Center for Research Resources, National Institutes of Health [5P20GM103489]; Nebraska Cancer and Smoking Disease Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Cancer and Smoking Disease Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 5P20GM103489 from the National Center for Research Resources, National Institutes of Health and a grant from the Nebraska Cancer and Smoking Disease Research Program (to J. D.).	Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hill VK, 2011, EPIGENETICS-US, V6, P326, DOI 10.4161/epi.6.3.14404; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Shimizu T, 2008, GENETICS, V178, P957, DOI 10.1534/genetics.107.081570; Shinawi T, 2012, EPIGENETICS-US, V7, P211, DOI 10.4161/epi.7.3.19222; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	47	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34069	34077		10.1074/jbc.M112.385518	http://dx.doi.org/10.1074/jbc.M112.385518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904328	Green Published, hybrid			2022-12-28	WOS:000309654200013
J	Bernal-Bayard, P; Hervas, M; Cejudo, FJ; Navarro, JA				Bernal-Bayard, Pilar; Hervas, Manuel; Cejudo, Francisco J.; Navarro, Jose A.			Electron Transfer Pathways and Dynamics of Chloroplast NADPH-dependent Thioredoxin Reductase C (NTRC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; PLANT PEROXIREDOXINS; 2-CYS PEROXIREDOXINS; HALF-REACTION; MECHANISM; ENZYME; GLUTAREDOXINS; PROTECTION; KINETICS	NADPH-dependent thioredoxin reductases (NTRs) contain a flavin cofactor and a disulfide as redox-active groups. The catalytic mechanism of standard NTR involves a large conformational change between two configurations. Oxygenic photosynthetic organisms possess a plastid-localized NTR, called NTRC, with a thioredoxin module fused at the C terminus. NTRC is an efficient reductant of 2-Cys peroxiredoxins (2-Cys Prxs) and thus is involved in the protection against oxidative stress, among other functions. Although the mechanism of electron transfer of canonical NTRs is well established, it is not yet known in NTRC. By employing stopped-flow spectroscopy, we have carried out a comparative kinetic study of the electron transfer reactions involving NTRC, the truncated NTR module of NTRC, and NTRB, a canonical plant NTR. Whereas the three NTRs maintain the conformational change associated with the reductive cycle of catalysis, NTRC intramolecular electron transfer to the thioredoxin module presents two kinetic components (k(ET) of similar to 2 and 0.1 s(-1)), indicating the occurrence of additional dynamic motions. Moreover, the dynamic features associated with the electron transfer to the thioredoxin module are altered in the presence of 2-Cys Prx. NTRC shows structural constraints that may locate the thioredoxin module in positions with different efficiencies for electron transfer, the presence of 2-Cys Prx shifting the conformational equilibrium of the thioredoxin module to a specific position, which is not the most efficient.	[Navarro, Jose A.] CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; Univ Seville, CicCartuja, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla	Navarro, JA (corresponding author), CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, Seville 41092, Spain.	jnavarro@ibvf.csic.es	navarro, jose a/B-6354-2015; Cejudo, Francisco Javier/M-2749-2014; Hervas, Manuel/K-9279-2014	navarro, jose a/0000-0002-0536-6074; Cejudo, Francisco Javier/0000-0002-3936-5491; Hervas, Manuel/0000-0003-4523-8891; BERNAL-BAYARD, PILAR/0000-0003-0243-1827	Andalusian Government European Regional Development Fund from Ministry of Science and Innovation [BIO-022, CVI-4528]; European Regional Development Fund from Ministry of Science and Innovation [BIO2010-15430]; Andalusian Government Grant [BIO-182, CVI-5919]	Andalusian Government European Regional Development Fund from Ministry of Science and Innovation; European Regional Development Fund from Ministry of Science and Innovation; Andalusian Government Grant	This work was supported by Andalusian Government European Regional Development Fund-cofinanced Grants BIO-022 and CVI-4528 (to J.A.N.) and European Regional Development Fund-cofinanced Grant BIO2010-15430 from Ministry of Science and Innovation and Andalusian Government Grant BIO-182 and CVI-5919 (to F.J.C.).	Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Hervas M, 2012, BIOCHEMISTRY-US, V51, P1178, DOI 10.1021/bi201904p; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; LENNON BW, 1995, BIOCHEMISTRY-US, V34, P3670, DOI 10.1021/bi00011a023; Lennon BW, 1997, BIOCHEMISTRY-US, V36, P9464, DOI 10.1021/bi970307j; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Perez-Ruiz JM, 2009, MOL PLANT, V2, P457, DOI 10.1093/mp/ssp011; Perez-Ruiz JM, 2009, FEBS LETT, V583, P1399, DOI 10.1016/j.febslet.2009.03.067; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Massey V., 1970, PYRIDINE NUCLEOTIDE, P393; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; NAVARRO JA, 1991, BIOCHEMISTRY-US, V30, P2192, DOI 10.1021/bi00222a024; Negri A, 2010, PROTEINS, V78, P36, DOI 10.1002/prot.22490; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Reichheld JP, 2005, FEBS LETT, V579, P337, DOI 10.1016/j.febslet.2004.11.094; Reynolds CM, 2001, BIOCHEMISTRY-US, V40, P3912, DOI 10.1021/bi002766h; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; TOLLIN G, 1995, J BIOENERG BIOMEMBR, V27, P303, DOI 10.1007/BF02110100; van Berkel W. J. H., 2008, WILEY ENCY CHEM BIOL, P1; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Veine DM, 1998, PROTEIN SCI, V7, P369; Wang PF, 1998, BIOCHEMISTRY-US, V37, P16378, DOI 10.1021/bi980754e; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wulff RP, 2011, BIOCHEMISTRY-US, V50, P3713, DOI 10.1021/bi200058a	42	28	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33865	33872		10.1074/jbc.M112.388991	http://dx.doi.org/10.1074/jbc.M112.388991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22833674	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000309602100067
J	Martin, M; Leffler, J; Blom, AM				Martin, Myriam; Leffler, Jonatan; Blom, Anna M.			Annexin A2 and A5 Serve as New Ligands for C1q on Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MANNOSE-BINDING LECTIN; DEPENDENT PROTEIN-S; SERUM AMYLOID-P; C4B-BINDING PROTEIN; FACTOR-H; COMPLEMENT ACTIVATION; NECROTIC CELLS; IN-VITRO; SURFACE	C1q is the initiator of the classical complement pathway and opsonizes apoptotic cells to facilitate phagocytosis. Deficiency of C1q is the strongest known risk factor for development of systemic lupus erythematosus (SLE), which appears to be related to ensuing impaired clearance of apoptotic material. The objective of the current study was to investigate new ligands for C1q on the surface of apoptotic cells. We revealed that the two phospholipid-binding proteins annexin A2 and A5 are, beside DNA, significant C1q ligands. We furthermore, demonstrated that C1q binds directly to histones exposed on the surface of dying cells but we did not detect significant interaction with phosphatidylserine. The complement inhibitors C4b-binding protein and factor H also interact with dying cells, most likely to decrease complement activation beyond the level of C3 to allow noninflammatory clearance. Despite the fact that C4b-binding protein, factor H, and C1q share some ligands on dying cells, we showed that these three proteins did not compete with one another for binding to apoptotic cells. We additionally demonstrated that the way in which apoptosis is induced influenced both the degree of apoptosis and the binding of C1q. The knowledge, that annexin A2 and A5 act as ligands for C1q on apoptotic cells, sheds new light on the pathophysiology of autoimmune diseases.	[Martin, Myriam; Leffler, Jonatan; Blom, Anna M.] Lund Univ, Dept Lab Med Malmo, S-20502 Malmo, Sweden	Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Inga Marie Nilssons Gata 53, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/AFS-7369-2022; Leffler, Jonatan/D-4630-2011; Blom, Anna/B-9607-2009; Leffler, Jonatan/A-8748-2018	Leffler, Jonatan/0000-0001-5674-8462; Blom, Anna/0000-0002-1348-1734; Leffler, Jonatan/0000-0001-5674-8462; Martin, Myriam/0000-0003-1526-8678	Soderberg Foundation; Swedish Research Council Grant [K2009-68X-14928-06-3]; Swedish Foundation for Strategic Research; Swedish Rheumatism Association; National Board of Health and Welfare and Skane University Hospital; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustaf V's 80th Birthday Foundation; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation	Soderberg Foundation; Swedish Research Council Grant(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Rheumatism Association; National Board of Health and Welfare and Skane University Hospital; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustaf V's 80th Birthday Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation	This work was supported in part by the Soderberg Foundation, Swedish Research Council Grant K2009-68X-14928-06-3, the Swedish Foundation for Strategic Research, the Swedish Rheumatism Association, the National Board of Health and Welfare and Skane University Hospital, and the Osterlund, Greta and Johan Kock, King Gustaf V's 80th Birthday, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg Foundations.	Ao W, 2011, RHEUMATOL INT, V31, P865, DOI 10.1007/s00296-010-1379-4; Baroni M, 2010, THROMB RES, V125, pE33, DOI 10.1016/j.thromres.2009.09.015; Baruah P, 2010, EUR J IMMUNOL, V40, P1758, DOI 10.1002/eji.200940158; Bengtsson A, 1999, J AUTOIMMUN, V13, P111, DOI 10.1006/jaut.1999.0300; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chabaud S, 2011, J CELL PHYSIOL, V226, P1907, DOI 10.1002/jcp.22520; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; HICKS PS, 1992, J IMMUNOL, V149, P3689; Hrycek A, 2012, RHEUMATOL INT, V32, P1335, DOI 10.1007/s00296-011-1793-2; Iaccarino L, 2011, AUTOIMMUN REV, V10, P553, DOI 10.1016/j.autrev.2011.04.007; Ji NY, 2009, INT J MOL MED, V24, P765, DOI 10.3892/ijmm_00000290; JIANG HX, 1992, J BIOL CHEM, V267, P25597; Kang YH, 2012, IMMUNOBIOLOGY, V217, P455, DOI 10.1016/j.imbio.2011.10.008; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Korb LC, 1997, J IMMUNOL, V158, P4525; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsuda R, 2003, RESUSCITATION, V57, P171, DOI 10.1016/S0300-9572(03)00034-0; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; PAQUES EP, 1979, H-S Z PHYSIOL CHEM, V360, P177, DOI 10.1515/bchm2.1979.360.1.177; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; STURFELT G, 1985, SCAND J RHEUMATOL, V14, P184, DOI 10.3109/03009748509165503; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tissot B, 2003, EUR J BIOCHEM, V270, P4714, DOI 10.1046/j.1432-1033.2003.03870.x; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2005, EXPERT OPIN BIOL TH, V5, P243, DOI 10.1517/14712598.5.2.243; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580	53	78	82	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33733	33744		10.1074/jbc.M112.341339	http://dx.doi.org/10.1074/jbc.M112.341339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879587	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309602100056
J	Vakili, H; Jin, Y; Cattini, PA				Vakili, Hana; Jin, Yan; Cattini, Peter A.			Negative Regulation of Human Growth Hormone Gene Expression by Insulin Is Dependent on Hypoxia-inducible Factor Binding in Primary Non-tumor Pituitary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; GH-RELEASING HORMONE; FACTOR 1-ALPHA; FACTOR-I; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; TARGET GENES; CANCER CELLS; OBESITY; MICE	Insulin controls growth hormone (GH) production at multiple levels, including via a direct effect on pituitary somatotrophs. There are no data, however, on the regulation of the intact human (h) GHgene (hGH1) by insulin in non-tumor pituitary cells, but the proximal promoter region (nucleotides -496/+1) responds negatively to insulin in transfected pituitary tumor cells. A DNA-protein interaction was also induced by insulin at nucleotides -308/-235. Here, we confirmed the presence of a hypoxia-inducible factor 1 (HIF-1) binding site within these sequences (-264/-259) and investigated whether HIF-1 is associated with insulin regulation of "endogenous" hGH1. In the absence of primary human pituitary cells, transgenic mice expressing the intact hGH locus in a somatotroph-specific manner were generated. A significant and dose-dependent decrease in hGH and mouse GH RNA levels was detected in primary pituitary cell cultures from these mice with insulin treatment. Increasing HIF-1 alpha availability with a hypoxia mimetic significantly decreased hGH RNA levels and was accompanied by recruitment of HIF-1 alpha to the hGH1 promoter in situ as seen with insulin. Both inhibition of HIF-1 DNA binding by echinomycin and RNA interference of HIF-1 alpha synthesis blunted the negative effect of insulin on hGH1 but not mGH. The insulin response is also sensitive to histone deacetylase inhibition/trichostatin A and associated with a decrease in H3/H4 hyperacetylation in the proximal hGH1 promoter region. These data are consistent with HIF-1-dependent down-regulation of hGH1 by insulin via chromatin remodeling specifically in the proximal promoter region.	[Vakili, Hana; Jin, Yan; Cattini, Peter A.] Univ Manitoba, Dept Physiol, Div Endocrine & Metab Dis, Winnipeg, MB R3E 3J9, Canada	University of Manitoba	Cattini, PA (corresponding author), Univ Manitoba, Dept Physiol, Div Endocrine & Metab Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 3J9, Canada.	peter_cattini@umanitoba.ca			Canadian Institutes of Health Research Grant [MT-10853]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MT-10853.	Adams JM, 2009, ACTA PHYSIOL HUNG, V96, P19, DOI 10.1556/APhysiol.96.2009.1.2; Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Buettner R, 2000, AM J PHYSIOL-ENDOC M, V278, pE563, DOI 10.1152/ajpendo.2000.278.3.E563; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Christoforidis Athanasios, 2005, Pediatr Endocrinol Rev, V3, P5; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; De Marinis L, 2004, J CLIN ENDOCR METAB, V89, P174, DOI 10.1210/jc.2002-021308; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Erman A, 2011, INT J OBESITY, V35, P1520, DOI 10.1038/ijo.2011.10; FORMICA JV, 1983, ANTIMICROB AGENTS CH, V24, P735, DOI 10.1128/AAC.24.5.735; Fukuda R, 2003, CANCER RES, V63, P2330; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2008, EMBO REP, V9, P891, DOI 10.1038/embor.2008.126; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jin Y, 2009, PLACENTA, V30, P226, DOI 10.1016/j.placenta.2008.12.011; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Krawczak M, 1999, GENE, V237, P143, DOI 10.1016/S0378-1119(99)00313-3; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Lanzi R, 1997, J CLIN ENDOCR METAB, V82, P2239, DOI 10.1210/jc.82.7.2239; Lee KJ, 2010, BBA-MOL CELL RES, V1803, P608, DOI 10.1016/j.bbamcr.2010.01.004; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; LIRA SA, 1993, MOL ENDOCRINOL, V7, P694, DOI 10.1210/me.7.5.694; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lombardero Matilde, 2006, Pituitary, V9, P137, DOI 10.1007/s11102-006-9989-2; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Luque RM, 2006, J MOL ENDOCRINOL, V37, P25, DOI 10.1677/jme.1.02042; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; LYTRAS A, 1994, MOL ENDOCRINOL, V8, P478, DOI 10.1210/me.8.4.478; MACCARIO M, 1995, J CLIN ENDOCR METAB, V80, P3774, DOI 10.1210/jc.80.12.3774; Moller N, 2003, GROWTH HORM IGF RES, V13, pS18, DOI 10.1016/S1096-6374(03)00048-0; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; NICKEL BE, 1990, ENDOCRINOLOGY, V126, P971, DOI 10.1210/endo-126-2-971; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; Pataky Z, 2010, EXP CLIN ENDOCR DIAB, V118, P427, DOI 10.1055/s-0029-1233448; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; PRAGER D, 1988, J BIOL CHEM, V263, P16580; PRAGER D, 1990, J CLIN INVEST, V85, P1680, DOI 10.1172/JCI114620; Procopio M, 1995, CLIN ENDOCRINOL, V43, P665, DOI 10.1111/j.1365-2265.1995.tb00532.x; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Ronsch K, 2011, EPIGENETICS-US, V6, P610, DOI 10.4161/epi.6.5.15300; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Scacchi M, 2010, EUR J ENDOCRINOL, V163, P201, DOI 10.1530/EJE-10-0160; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; STRASBURGER CJ, 1990, ACTA PAEDIATR SCAND, P82; Takahashi S, 2002, HORM RES, V58, P157, DOI 10.1159/000065488; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; VANDYKE MM, 1984, SCIENCE, V225, P1122, DOI 10.1126/science.6089341; Vidal S, 2002, J HISTOCHEM CYTOCHEM, V50, P533, DOI 10.1177/002215540205000410; Wang L, 2010, J HUAZHONG U SCI-MED, V30, P349, DOI 10.1007/s11596-010-0355-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553; Weng Q., 2010, INVESTIG NEW DRUGS, V9, P1177; Xi L, 2004, AM J PHYSIOL-HEART C, V287, pH2369, DOI 10.1152/ajpheart.00422.2004; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yang SM, 2004, OBES RES, V12, P330, DOI 10.1038/oby.2004.41; Yang XY, 2010, J MOL ENDOCRINOL, V45, P19, DOI 10.1677/JME-10-0017; Yi SJ, 2002, MOL BIOL EVOL, V19, P1083, DOI 10.1093/oxfordjournals.molbev.a004166; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yoshida D, 2006, J NEURO-ONCOL, V78, P217, DOI 10.1007/s11060-005-9017-9; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33282	33292		10.1074/jbc.M112.380949	http://dx.doi.org/10.1074/jbc.M112.380949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22833680	Green Published, hybrid			2022-12-28	WOS:000309602100017
J	Apte-Sengupta, S; Negi, S; Leonard, VHJ; Oezguen, N; Navaratnarajah, CK; Braun, W; Cattaneo, R				Apte-Sengupta, Swapna; Negi, Surendra; Leonard, Vincent H. J.; Oezguen, Numan; Navaratnarajah, Chanakha K.; Braun, Werner; Cattaneo, Roberto			Base of the Measles Virus Fusion Trimer Head Receives the Signal That Triggers Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSICAL-CHEMICAL PROPERTIES; ATTACHMENT PROTEIN; PARAMYXOVIRUS FUSION; CELLULAR RECEPTOR; MONOCLONAL-ANTIBODIES; SEQUENCE MOTIFS; 4-HELIX BUNDLE; F-PROTEIN; HEMAGGLUTININ; REVEALS	The measles virus (MV) fusion (F) protein trimer executes membrane fusion after receiving a signal elicited by receptor binding to the hemagglutinin (H) tetramer. Where and how this signal is received is understood neither for MV nor for other paramyxoviruses. Because only the prefusion structure of the parainfluenza virus 5 (PIV5) F-trimer is available, to study signal receipt by the MV F-trimer, we generated and energy-refined a homology model. We used two approaches to predict surface residues of the model interacting with other proteins. Both approaches measured interface propensity values for patches of residues. The second approach identified, in addition, individual residues based on the conservation of physical chemical properties among F-proteins. Altogether, about 50 candidate interactive residues were identified. Through iterative cycles of mutagenesis and functional analysis, we characterized six residues that are required specifically for signal transmission; their mutation interferes with fusion, although still allowing efficient F-protein processing and cell surface transport. One residue is located adjacent to the fusion peptide, four line a cavity in the base of the F-trimer head, while the sixth residue is located near this cavity. Hydrophobic interactions in the cavity sustain the fusion process and contacts with H. The cavity is flanked by two different subunits of the F-trimer. Tetrameric H-stalks may be lodged in apposed cavities of two F-trimers. Because these insights are based on a PIV5 homology model, the signal receipt mechanism may be conserved among paramyxoviruses.	[Apte-Sengupta, Swapna; Leonard, Vincent H. J.; Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Apte-Sengupta, Swapna; Leonard, Vincent H. J.; Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Grad Sch, Rochester, MN 55905 USA; [Negi, Surendra; Oezguen, Numan; Braun, Werner] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Negi, Surendra; Oezguen, Numan; Braun, Werner] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cattaneo, R (corresponding author), Mayo Clin, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	Cattaneo.Roberto@mayo.edu	Braun, Werner/A-6642-2012; Oezguen, Numan/C-9267-2009; Navaratnarajah, Chanakha/AAB-6171-2019	Oezguen, Numan/0000-0002-3175-2382; Navaratnarajah, Chanakha/0000-0002-4513-8412	National Institutes of Health [R01-CA090636]; NATIONAL CANCER INSTITUTE [R01CA090636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA090636 (to R. C.).	Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; [Anonymous], 2011, NATURE, V473, P434; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Ivanciuc O, 2004, CURR MED CHEM, V11, P583, DOI 10.2174/0929867043455819; Kupferschmidt K, 2012, SCIENCE, V336, P406, DOI 10.1126/science.336.6080.406; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lamb R.A., 2007, FIELDS VIROLOGY, VFifth, P1305; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108; Ludwig K, 2008, J VIROL, V82, P3775, DOI 10.1128/JVI.02154-07; MALVOISIN E, 1990, J VIROL, V64, P5160, DOI 10.1128/JVI.64.10.5160-5162.1990; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mathura VS, 2003, BIOINFORMATICS, V19, P1381, DOI 10.1093/bioinformatics/btg164; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Moss WJ, 2009, CURR TOP MICROBIOL, V330, P173; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakayama T, 2001, J GEN VIROL, V82, P2143, DOI 10.1099/0022-1317-82-9-2143; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Negi SS, 2008, J STRUCT BIOL, V161, P18, DOI 10.1016/j.jsb.2007.08.016; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porotto M, 2012, J BIOL CHEM, V287, P778, DOI 10.1074/jbc.M111.298059; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; SANNER M, 1989, J COMPUT AID MOL DES, V3, P195, DOI 10.1007/BF01533068; SCHAUMANN T, 1990, BIOPOLYMERS, V29, P679, DOI 10.1002/bip.360290403; Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40; SHESHBERADARAN H, 1986, J GEN VIROL, V67, P1381, DOI 10.1099/0022-1317-67-7-1381; Soman Kizhake V., 2001, NUCLEASE METHODS PRO, P263; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tsurudome M, 2011, J VIROL, V85, P3153, DOI 10.1128/JVI.01666-10; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zokarkar A, 2012, J VIROL, V86, P2600, DOI 10.1128/JVI.06546-11	52	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33026	33035		10.1074/jbc.M112.373308	http://dx.doi.org/10.1074/jbc.M112.373308			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859308	hybrid, Green Published			2022-12-28	WOS:000309168300065
J	Curtis, JM; Hahn, WS; Stone, MD; Inda, JJ; Droullard, DJ; Kuzmicic, JP; Donoghue, MA; Long, EK; Armien, AG; Lavandero, S; Arriaga, E; Griffin, TJ; Bernlohr, DA				Curtis, Jessica M.; Hahn, Wendy S.; Stone, Matthew D.; Inda, Jacob J.; Droullard, David J.; Kuzmicic, Jovan P.; Donoghue, Margaret A.; Long, Eric K.; Armien, Anibal G.; Lavandero, Sergio; Arriaga, Edgar; Griffin, Timothy J.; Bernlohr, David A.			Protein Carbonylation and Adipocyte Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; BEEF-HEART MITOCHONDRIA; CYTOCHROME-C RELEASE; COMPLEX-I; OXIDATIVE STRESS; PHOSPHATE CARRIER; PERMEABILITY TRANSITION; SUPEROXIDE-PRODUCTION; LIPID-PEROXIDATION; ATP SYNTHASOME	Carbonylation is the covalent, non-reversible modification of the side chains of cysteine, histidine, and lysine residues by lipid peroxidation end products such as 4-hydroxy- and 4-oxononenal. In adipose tissue the effects of such modifications are associated with increased oxidative stress and metabolic dysregulation centered on mitochondrial energy metabolism. To address the role of protein carbonylation in the pathogenesis of mitochondrial dysfunction, quantitative proteomics was employed to identify specific targets of carbonylation in GSTA4-silenced or overexpressing 3T3-L1 adipocytes. GSTA4-silenced adipocytes displayed elevated carbonylation of several key mitochondrial proteins including the phosphate carrier protein, NADH dehydrogenase 1 alpha subcomplexes 2 and 3, translocase of inner mitochondrial membrane 50, and valyl-tRNA synthetase. Elevated protein carbonylation is accompanied by diminished complex I activity, impaired respiration, increased superoxide production, and a reduction in membrane potential without changes in mitochondrial number, area, or density. Silencing of the phosphate carrier or NADH dehydrogenase 1 alpha subcomplexes 2 or 3 in 3T3-L1 cells results in decreased basal and maximal respiration. These results suggest that protein carbonylation plays a major instigating role in cytokine-dependent mitochondrial dysfunction and may be linked to the development of insulin resistance in the adipocyte.	[Curtis, Jessica M.; Hahn, Wendy S.; Stone, Matthew D.; Inda, Jacob J.; Droullard, David J.; Long, Eric K.; Griffin, Timothy J.; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Donoghue, Margaret A.; Arriaga, Edgar] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Armien, Anibal G.] Univ Minnesota, Coll Vet Med, Minneapolis, MN 55455 USA; [Kuzmicic, Jovan P.; Lavandero, Sergio] Univ Chile, Ctr Estudios Mol Celula, Santiago 8380492, Chile; [Lavandero, Sergio] UT SW Med Ctr, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidad de Chile; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bernlohr, DA (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	bernl001@umn.edu	Lavandero, Sergio/B-6001-2013	Lavandero, Sergio/0000-0003-4258-1483; Griffin, Timothy/0000-0001-6801-2559; Hahn, Wendy/0000-0002-4374-5876	National Institutes of Health [DE017734, 5T32DK007203, NIH DK084669, MN-70-043, DK050456]; Comision Nacional de Investigacion Cientifica y Tecnologia (Chile); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669, R56DK084669, P30DK050456, T32DK007203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Nacional de Investigacion Cientifica y Tecnologia (Chile); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE017734 (to T.J.G.), 5T32DK007203 (to M. A. D.), NIH DK084669 and MN-70-043 (to D. A. B.), and DK050456 (to The Minnesota Obesity Center).; Holds a Ph.D. scholarship from Comision Nacional de Investigacion Cientifica y Tecnologia (Chile).	Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheng JZ, 2001, ARCH BIOCHEM BIOPHYS, V392, P197, DOI 10.1006/abbi.2001.2452; Curtis JM, 2012, TRENDS ENDOCRIN MET, V23, P399, DOI 10.1016/j.tem.2012.05.008; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kramer R, 1998, EXP PHYSIOL, V83, P259, DOI 10.1113/expphysiol.1998.sp004111; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lautt WW, 2010, CAN J PHYSIOL PHARM, V88, P313, DOI 10.1139/Y09-130; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Long EK, 2010, FREE RADICAL BIO MED, V48, P384, DOI 10.1016/j.freeradbiomed.2009.10.048; Mark RJ, 1997, J NEUROSCI, V17, P1046; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagai K, 2008, FREE RADICAL RES, V42, P921, DOI 10.1080/10715760802555585; Nishi Y, 2011, BIOCHEM J, V435, P421, DOI 10.1042/BJ20101708; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Onsongo G, 2010, PROTEOMICS, V10, P3533, DOI 10.1002/pmic.201000189; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Raza H, 2002, BIOCHEM J, V366, P45, DOI 10.1042/BJ20020533; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Sharma R, 2008, BIOCHEMISTRY-US, V47, P143, DOI 10.1021/bi701559f; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TYLER DD, 1969, BIOCHEM J, V111, P665, DOI 10.1042/bj1110665; Xu X, 2010, ANAL CHEM, V82, P4570, DOI 10.1021/ac100577q; Xu X, 2009, FREE RADICAL BIO MED, V46, P905, DOI 10.1016/j.freeradbiomed.2008.12.019; Yang YZ, 2008, TOXICOL APPL PHARM, V230, P187, DOI 10.1016/j.taap.2008.03.018; Yuan Q, 2007, CHEM RES TOXICOL, V20, P129, DOI 10.1021/tx600270f	65	47	47	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32967	32980		10.1074/jbc.M112.400663	http://dx.doi.org/10.1074/jbc.M112.400663			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22822087	hybrid, Green Published			2022-12-28	WOS:000309168300060
J	Winiarska, M; Nowis, D; Bil, J; Glodkowska-Mrowka, E; Muchowicz, A; Wanczyk, M; Bojarczuk, K; Dwojak, M; Firczuk, M; Wilczek, E; Wachowska, M; Roszczenko, K; Miaczynska, M; Chlebowska, J; Basak, GW; Golab, J				Winiarska, Magdalena; Nowis, Dominika; Bil, Jacek; Glodkowska-Mrowka, Eliza; Muchowicz, Angelika; Wanczyk, Malgorzata; Bojarczuk, Kamil; Dwojak, Michal; Firczuk, Malgorzata; Wilczek, Ewa; Wachowska, Malgorzata; Roszczenko, Katarzyna; Miaczynska, Marta; Chlebowska, Justyna; Basak, Grzegorz Wladyslaw; Golab, Jakub			Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; FARNESYLTRANSFERASE INHIBITOR TIPIFARNIB; ANTIGEN-EXPRESSION; DOWN-REGULATION; IMMUNOPHENOTYPIC CHANGES; RITUXIMAB THERAPY; PHASE-II; IN-VITRO	Anti-CD20 monoclonal antibodies (mAbs) are successfully used in the management of non-Hodgkin lymphomas and chronic lymphocytic leukemia. We have reported previously that statins induce conformational changes in CD20 molecules and impair rituximab-mediated complement-dependent cytotoxicity. Here we investigated in more detail the influence of farnesyltransferase inhibitors (FTIs) on CD20 expression and antitumor activity of anti-CD20 mAbs. Among all FTIs studied, L-744,832 had the most significant influence on CD20 levels. It significantly increased rituximab-mediated complement-dependent cytotoxicity against primary tumor cells isolated from patients with non-Hodgkin lymphomas or chronic lymphocytic leukemia and increased CD20 expression in the majority of primary lymphoma/leukemia cells. Incubation of Raji cells with L-744,832 led to up-regulation of CD20 at mRNA and protein levels. Chromatin immunoprecipitation assay revealed that inhibition of farnesyltransferase activity was associated with increased binding of PU.1 and Oct-2 to the CD20 promoter sequences. These studies indicate that CD20 expression can be modulated by FTIs. The combination of FTIs with anti-CD20 mAbs is a promising therapeutic approach, and its efficacy should be examined in patients with B-cell tumors.	[Winiarska, Magdalena; Nowis, Dominika; Bil, Jacek; Glodkowska-Mrowka, Eliza; Muchowicz, Angelika; Wanczyk, Malgorzata; Bojarczuk, Kamil; Dwojak, Michal; Firczuk, Malgorzata; Wachowska, Malgorzata; Roszczenko, Katarzyna; Chlebowska, Justyna; Golab, Jakub] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, PL-02097 Warsaw, Poland; [Bil, Jacek] Minist Interior & Adm, Cent Clin Hosp, Dept Invas Cardiol, PL-02507 Warsaw, Poland; [Wilczek, Ewa] Med Univ Warsaw, Dept Pathol, Ctr Biostruct Res, PL-02004 Warsaw, Poland; [Miaczynska, Marta] Int Inst Mol & Cell Biol, Cell Biol Lab, PL-02109 Warsaw, Poland; [Basak, Grzegorz Wladyslaw] Med Univ Warsaw, Dept Hematol Oncol & Internal Dis, PL-02097 Warsaw, Poland; [Golab, Jakub] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Medical University of Warsaw; Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Golab, J (corresponding author), Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, 1A Banacha Str,F Bldg, PL-02097 Warsaw, Poland.	jakub.golab@wum.edu.pl	Firczuk, Małgorzata/G-3414-2013; Nowis, Dominika/P-6866-2019; Nowis, Dominika/P-1213-2017; Bojarczuk, Kamil/AAC-4824-2020; Golab, Jakub/K-6974-2013; Bil, Jacek/D-4850-2015; Muchowicz, Angelika/J-7494-2012; Glodkowska-Mrowka, Eliza/AAC-7294-2020; Wolinska, Ewa/AAE-4628-2021; Wachowska, Malgorzata/X-1707-2018; Glodkowska-Mrowka, Eliza/AAR-8503-2021	Firczuk, Małgorzata/0000-0002-1719-5233; Nowis, Dominika/0000-0003-2748-9523; Nowis, Dominika/0000-0003-2748-9523; Bojarczuk, Kamil/0000-0002-6110-4060; Golab, Jakub/0000-0002-2830-5100; Bil, Jacek/0000-0002-8724-5611; Muchowicz, Angelika/0000-0003-4707-1722; Glodkowska-Mrowka, Eliza/0000-0002-5865-8425; Wachowska, Malgorzata/0000-0001-7199-9649; Glodkowska-Mrowka, Eliza/0000-0002-5865-8425; Chlebowska-Tuz, Justyna/0000-0002-3997-3948; Wolinska, Ewa/0000-0001-9592-1301; Bobrowicz, Malgorzata/0000-0002-9078-5168; Basak, Grzegorz/0000-0003-3858-8180; Miaczynska, Marta/0000-0003-0031-5267; Winiarska, Magdalena/0000-0001-5605-3329	Medical University of Warsaw [1M19/NM4/11, 1M19/PM13]; Polish Ministry of Science [3JP3, 3JP4, N N402 352938]; European Union within the European Regional Development Fund through Innovative Economy Grant [POIG.01.01.02-00-008/08]; Genmab A/S; Foundation for Polish Science; European Union European Regional Development Fund	Medical University of Warsaw; Polish Ministry of Science(Ministry of Science and Higher Education, Poland); European Union within the European Regional Development Fund through Innovative Economy Grant; Genmab A/S(Genmab); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union European Regional Development Fund(European Commission)	This work was supported in part by Medical University of Warsaw Grants 1M19/NM4/11 (to M. Wanczyk) and 1M19/PM13 (to M. Winiarska), Grants 3JP3 (to D. N.) and 3JP4 and N N402 352938 (to M. Winiarska) from the Polish Ministry of Science and the European Union within the European Regional Development Fund through Innovative Economy Grant POIG.01.01.02-00-008/08, and by Genmab A/S.; Members of TEAM Programme co-financed by the Foundation for Polish Science and the European Union European Regional Development Fund.	Adjei AA, 2003, J CLIN ONCOL, V21, P1760, DOI 10.1200/JCO.2003.09.075; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Bezombes C, 2011, MOL CANCER RES, V9, P1435, DOI 10.1158/1541-7786.MCR-11-0154; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; Davis TA, 1999, CLIN CANCER RES, V5, P611; Efuet ET, 2006, CANCER RES, V66, P1040, DOI 10.1158/0008-5472.CAN-05-3416; Foran JM, 2001, BRIT J HAEMATOL, V114, P881, DOI 10.1046/j.1365-2141.2001.03019.x; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Haidar JH, 2003, EUR J HAEMATOL, V70, P330, DOI 10.1034/j.1600-0609.2003.00007.x; Hainsworth JD, 2005, J CLIN ONCOL, V23, P1088, DOI 10.1200/JCO.2005.12.191; Henry C, 2010, BLOOD, V115, P2420, DOI 10.1182/blood-2009-06-229112; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Jilani I, 2003, BLOOD, V102, P3514, DOI 10.1182/blood-2003-01-0055; Kinoshita T, 1998, J CLIN ONCOL, V16, P3916; Lapalombella R, 2008, BLOOD, V112, P5180, DOI 10.1182/blood-2008-01-133108; Maeshima AM, 2009, CANCER SCI, V100, P54, DOI 10.1111/j.1349-7006.2008.01005.x; Mankai A, 2008, CANCER RES, V68, P7512, DOI 10.1158/0008-5472.CAN-07-6446; Mankai A, 2009, ANN NY ACAD SCI, V1173, P721, DOI 10.1111/j.1749-6632.2009.04614.x; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Michel RB, 2002, CLIN CANCER RES, V8, P2632; Michel RB, 2002, CLIN CANCER RES, V8, P2701; Pickartz T, 2001, EXP HEMATOL, V29, P1410, DOI 10.1016/S0301-472X(01)00753-6; Schmitz K, 1999, BRIT J HAEMATOL, V106, P571, DOI 10.1046/j.1365-2141.1999.01608.x; Seliem RM, 2006, APPL IMMUNOHISTO M M, V14, P18, DOI 10.1097/01.pai.0000145130.02931.74; Sivaraman S, 2000, CYTOKINES CELL MOL T, V6, P81, DOI 10.1080/13684730050515804; Tomita A, 2007, INT J HEMATOL, V86, P49, DOI 10.1532/IJH97.07028; Tsai PC, 2012, CLIN CANCER RES, V18, P1039, DOI 10.1158/1078-0432.CCR-11-1429; Turzanski J, 2008, LEUKEMIA LYMPHOMA, V49, P1578, DOI 10.1080/10428190802163313; Ushmorov A, 2006, BLOOD, V107, P2493, DOI 10.1182/blood-2005-09-3765; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Venugopal P, 2000, LEUKEMIA RES, V24, P411, DOI 10.1016/S0145-2126(99)00206-4; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Winiarska M, 2011, FRONT BIOSCI-LANDMRK, V16, P277, DOI 10.2741/3688; Witzig TE, 2011, BLOOD, V118, P4882, DOI 10.1182/blood-2011-02-334904; Wojciechowski W, 2005, J IMMUNOL, V174, P7859, DOI 10.4049/jimmunol.174.12.7859	41	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31983	31993		10.1074/jbc.M112.374751	http://dx.doi.org/10.1074/jbc.M112.374751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843692	Green Published, hybrid			2022-12-28	WOS:000309059400037
J	Visweswaraiah, J; Lee, SJ; Hinnebusch, AG; Sattlegger, E				Visweswaraiah, Jyothsna; Lee, Su Jung; Hinnebusch, Alan G.; Sattlegger, Evelyn			Overexpression of Eukaryotic Translation Elongation Factor 3 Impairs Gcn2 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EIF-2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; YEAST; INITIATION; RIBOSOMES; GENE; PHOSPHORYLATION; PURIFICATION	In eukaryotes, phosphorylation of translation initiation factor 2 alpha (eIF2 alpha) by the kinase Gcn2 (general control nonderepressible 2) is a key response to amino acid starvation. Sensing starvation requires that Gcn2 directly contacts its effector protein Gcn1, and both must contact the ribosome. We have proposed that Gcn2 is activated by uncharged tRNA bound to the ribosomal decoding (A) site, in a manner facilitated by ribosome-bound Gcn1. Protein synthesis requires cyclical association of eukaryotic elongation factors (eEFs) with the ribosome. Gcn1 and Gcn2 are large proteins, raising the question of whether translation and monitoring amino acid availability can occur on the same ribosome. Part of the ribosome-binding domain in Gcn1 has homology to one of the ribosome-binding domains in eEF3, suggesting that these proteins utilize overlapping binding sites on the ribosome and consequently cannot function simultaneously on the same ribosome. Supporting this idea, we found that eEF3 overexpression in Saccharomyces cerevisiae diminished growth on amino acid starvation medium (Gcn(-) phenotype) and decreased eIF2 alpha phosphorylation, and that the growth defect associated with constitutively active Gcn2 was diminished by eEF3 overexpression. Overexpression of the eEF3 HEAT domain, or C terminus, was sufficient to confer a Gcn(-) phenotype, and both fragments have ribosome affinity. eEF3 overexpression did not significantly affect Gcn1-ribosome association, but it exacerbated the Gcn(-) phenotype of Gcn1-M7A that has reduced ribosome affinity. Together, this suggests that eEF3 blocks Gcn1 regulatory function on the ribosome. We propose that the Gcn1-Gcn2 complex only functions on ribosomes with A-site-bound uncharged tRNA, because eEF3 does not occupy these stalled complexes.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Auckland 0745, Albany, New Zealand; [Hinnebusch, Alan G.; Sattlegger, Evelyn] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Massey University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, POB 102 904, Auckland 0745, Albany, New Zealand.	e.sattlegger@massey.ac.nz			National Institutes of Health; Marsden Fund Council Grant [MAU0607]; Massey University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsden Fund Council Grant(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Intramural Research Program (to A. G. H.). This work was also supported by Marsden Fund Council Grant MAU0607 administered by the Royal Society of New Zealand, a Massey University Technicians Award (to E. S. for supporting S. J. L.), the Massey University Research Fund (to E. S.), and a Massey University Ph.D. Scholarship (to J. V.).	Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Cashel M, 1987, ESCHERICHIA COLI SAL, P1410; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; DASMAHAPATRA B, 1981, J BIOL CHEM, V256, P9999; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elskaya AV, 1997, BIOCHEMISTRY-US, V36, P10492, DOI 10.1021/bi970631e; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDMAN E, 1990, MOL MICROBIOL, V4, P2035, DOI 10.1111/j.1365-2958.1990.tb00563.x; Gontarek RR, 1998, J BIOL CHEM, V273, P10249, DOI 10.1074/jbc.273.17.10249; HANNIG EM, 1990, GENETICS, V126, P549; HILTON JL, 1965, ARCH BIOCHEM BIOPHYS, V112, P544, DOI 10.1016/0003-9861(65)90093-7; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kambampati R, 1997, J BIOL CHEM, V272, P6377, DOI 10.1074/jbc.272.10.6377; Kambampati R, 1997, PROTEIN EXPRES PURIF, V10, P209, DOI 10.1006/prep.1997.0728; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kiel MC, 2001, EUR J BIOCHEM, V268, P278, DOI 10.1046/j.1432-1327.2001.01873.x; Kiel MC, 1999, BIOCHIMIE, V81, P1097, DOI 10.1016/S0300-9084(99)00352-1; LAROSSA RA, 1984, J BIOL CHEM, V259, P8753; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; MURCHIE MJ, 1978, BIOCHIM BIOPHYS ACTA, V520, P233, DOI 10.1016/0005-2787(78)90024-2; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.212, DOI 10.1038/PROTEX.2011.212]; SIKORSKI RS, 1989, GENETICS, V122, P19; SKOGERSON L, 1976, P NATL ACAD SCI USA, V73, P73, DOI 10.1073/pnas.73.1.73; Taylor DR, 2006, STRUCTURE FUNCTION E; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Visweswaraiah J, 2011, J BIOL CHEM, V286, P36568, DOI 10.1074/jbc.M111.248898; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Zaborske JM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-29; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	40	16	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.368266	http://dx.doi.org/10.1074/jbc.M112.368266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22888004	hybrid, Green Published			2022-12-28	WOS:000310642200015
J	Aro, E; Khatri, R; Gerard-O'Riley, R; Mangiavini, L; Myllyharju, J; Schipani, E				Aro, Ellinoora; Khatri, Richa; Gerard-O'Riley, Rita; Mangiavini, Laura; Myllyharju, Johanna; Schipani, Ernestina			Hypoxia-inducible Factor-1 (HIF-1) but Not HIF-2 Is Essential for Hypoxic Induction of Collagen Prolyl 4-Hydroxylases in Primary Newborn Mouse Epiphyseal Growth Plate Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT ISOFORM; LIMB BUD MESENCHYME; BACULOVIRUS EXPRESSION; MATRIX SYNTHESIS; GENE-EXPRESSION; HIF-2-ALPHA; HIF-1-ALPHA; CARTILAGE; ERYTHROPOIETIN; PHENOTYPE	Hypoxia-inducible factors (HIFs) are the master regulators of hypoxia-responsive genes. They play a critical role in the survival, development, and differentiation of chondrocytes in the avascular hypoxic fetal growth plate, which is rich in extracellular matrix (ECM) and in its main component, collagens. Several genes involved in the synthesis, maintenance, and degradation of ECM are regulated by HIFs. Collagen prolyl 4-hydroxylases (C-P4Hs) are key enzymes in collagen synthesis because the resulting 4-hydroxyprolines are necessary for the stability of all collagen molecules. The vertebrate C-P4Hs are alpha(2)beta(2) tetramers with three isoforms of the catalytic alpha subunit, yielding C-P4Hs of types I-III. C-P4H-I is the main form in most cells, but C-P4H-II is the major form in chondrocytes. We postulated here that post-translational modification of collagens, particularly 4-hydroxylation of proline residues, could be one of the modalities by which HIF regulates the adaptive responses of chondrocytes in fetal growth plates. To address this hypothesis, we used primary epiphyseal growth plate chondrocytes isolated from newborn mice with conditionally inactivated genes for HIF-1 alpha, HIF-2 alpha, or the von Hippel-Lindau protein. The data obtained showed that C-P4H alpha(I) and alpha(II) mRNA levels were increased in hypoxic chondrocytes in a manner dependent on HIF-1 but not on HIF-2. Furthermore, the increases in the C-P4H mRNA levels were associated with both increased amounts of the C-P4H tetramers and augmented C-P4H activity in hypoxia. The hypoxia inducibility of the C-P4H isoenzymes is thus likely to ensure sufficient C-P4H activity for collagen synthesis occurring in chondrocytes in a hypoxic environment.	[Aro, Ellinoora; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Khatri, Richa; Gerard-O'Riley, Rita; Mangiavini, Laura; Schipani, Ernestina] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Oulu; University of Oulu; Indiana University System; Indiana University Bloomington	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi; eschipan@iupui.edu	Mangiavini, Laura/K-6340-2016	Mangiavini, Laura/0000-0003-1892-1249	National Institutes of Health [R01 AR04819]; Health Science Council [200471, 202469]; Center of Excellence programme, Academy of Finland; S. Juselius Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Science Council; Center of Excellence programme, Academy of Finland; S. Juselius Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR04819 (to E. S.). This work was also supported by Health Science Council Grants 200471 and 202469 and the Center of Excellence 2012-2017 programme from the Academy of Finland, and the S. Juselius Foundation (to J. M.).	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Egerbacher Monika, 2003, Pediatr Endocrinol Rev, V1, P2; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Grimmer C, 2006, AM J PATHOL, V169, P491, DOI 10.2353/ajpath.2006.050738; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2010, CELL TISSUE RES, V339, P19, DOI 10.1007/s00441-009-0841-7; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schipani E, 2001, GENE DEV, V15, P2865; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Svoboda KKH, 1998, MICROSC RES TECHNIQ, V43, P111, DOI 10.1002/(SICI)1097-0029(19981015)43:2<111::AID-JEMT4>3.0.CO;2-O; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	44	56	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37134	37144		10.1074/jbc.M112.352872	http://dx.doi.org/10.1074/jbc.M112.352872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930750	hybrid, Green Published			2022-12-28	WOS:000310588500047
J	Balasubramanian, S; Kanade, S; Han, BS; Eckert, RL				Balasubramanian, Sivaprakasam; Kanade, Santosh; Han, Bingshe; Eckert, Richard L.			A Proteasome Inhibitor-stimulated Nrf1 Protein-dependent Compensatory Increase in Proteasome Subunit Gene Expression Reduces Polycomb Group Protein Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EZH2 HISTONE METHYLTRANSFERASE; SKIN-CANCER CELLS; BMI-1 ONCOPROTEIN; COLORECTAL-CANCER; MULTIPLE-MYELOMA; INK4A-ARF LOCUS; BREAST-CANCER; SULFORAPHANE; PROLIFERATION; MECHANISM	The polycomb group (PcG) proteins, Bmi-1 and Ezh2, are important epigenetic regulators that enhance skin cancer cell survival. We recently showed that Bmi-1 and Ezh2 protein level is reduced by treatment with the dietary chemopreventive agents, sulforaphane and green tea polyphenol, and that this reduction involves ubiquitination of Bmi-1 and Ezh2, suggesting a key role of the proteasome. In the present study, we observe a surprising outcome that Bmi-1 and Ezh2 levels are reduced by treatment with the proteasome inhibitor, MG132. We show that this is associated with a compensatory increase in the level of mRNA encoding proteasome protein subunits in response to MG132 treatment and an increase in proteasome activity. The increase in proteasome subunit level is associated with increased Nrf1 and Nrf2 level. Moreover, knockdown of Nrf1 attenuates the MG132-dependent increase in proteasome subunit expression and restores Bmi-1 and Ezh2 expression. The MG132-dependent loss of Bmi-1 and Ezh2 is associated with reduced cell proliferation, accumulation of cells in G(2), and increased apoptosis. These effects are attenuated by forced expression of Bmi-1, suggesting that PcG proteins, consistent with a prosurvival action, may antagonize the action of MG132. These studies describe a compensatory Nrf1-dependent, and to a lesser extent Nrf2-dependent, increase in proteasome subunit level in proteasome inhibitor-treated cells and confirm that PcG protein levels are regulated by proteasome activity.	[Balasubramanian, Sivaprakasam; Kanade, Santosh; Han, Bingshe; Eckert, Richard L.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Obstet & Gynecol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR053851, R01 CA131074]; NATIONAL CANCER INSTITUTE [R01CA131074, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR053851 and R01 CA131074 (to R. L. E.).	Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Balasubramanian S, 2008, NUTR REV, V66, pS65, DOI 10.1111/j.1753-4887.2008.00071.x; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Balasubramanian S, 2010, CARCINOGENESIS, V31, P496, DOI 10.1093/carcin/bgp314; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Eckert RL, 2011, J INVEST DERMATOL, V131, P295, DOI 10.1038/jid.2010.318; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hatano A, 2010, BIOCHEM BIOPH RES CO, V397, P93, DOI 10.1016/j.bbrc.2010.05.074; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Kidani K, 2009, ORAL ONCOL, V45, P39, DOI 10.1016/j.oraloncology.2008.03.016; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lancet JE, 2011, CLIN CANCER RES, V17, P1140, DOI 10.1158/1078-0432.CCR-10-1878; Laubach J, 2011, ANNU REV MED, V62, P249, DOI 10.1146/annurev-med-070209-175325; Lee K, 2008, J INVEST DERMATOL, V128, P9, DOI 10.1038/sj.jid.5700949; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2007, EXP BIOL MED, V232, P227; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weikert S, 2005, INT J MOL MED, V16, P349; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300	48	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36179	36189		10.1074/jbc.M112.359281	http://dx.doi.org/10.1074/jbc.M112.359281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932898	hybrid, Green Published			2022-12-28	WOS:000310364000039
J	Bayer, H; Essig, K; Stanzel, S; Frank, M; Gildersleeve, JC; Berger, MR; Voss, C				Bayer, Helene; Essig, Katharina; Stanzel, Sven; Frank, Martin; Gildersleeve, Jeffrey C.; Berger, Martin R.; Voss, Cristina			Evaluation of Riproximin Binding Properties Reveals a Novel Mechanism for Cellular Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; PROSTATE-SPECIFIC ANTIGEN; BREAST-CANCER PATIENTS; HUMAN COLON; SUBMAXILLARY MUCIN; GLYCAN STRUCTURES; GLYCOSYLATION; CARCINOMA; SERUM; BOVINE	Riproximin is a cytotoxic type II ribosome-inactivating protein showing high selectivity for tumor cell lines. Its binding to cell surface glycans is crucial for subsequent internalization and cytotoxicity. In this paper, we describe a unique mechanism of interaction and discuss its implications for the cellular targeting and cytotoxicity of riproximin. On a carbohydrate microarray, riproximin specifically bound to two types of asialo-glycans, namely to bi- and triantennary complex N-glycan structures (NA2/NA3) and to repetitive N-acetyl-D-galactosamine (GalNAc), the so-called clustered Tn antigen, a cancer-specific O-glycan on mucins. Two glycoproteins showing high riproximin binding, the NA3-presenting asialofetuin and the clustered Tn-rich asialo-bovine submaxillary mucin, were subsequently chosen as model glycoproteins to mimic the binding interactions of riproximin with the two types of glycans. ELISA analyses were used to relate the two binding specificities of riproximin to its two sugar binding sites. The ability of riproximin to cross-link the two model proteins revealed that binding of the two types of glycoconjugates occurs within different binding sites. The biological implications of these binding properties were analyzed in cellular assays. The cytotoxicity of riproximin was found to depend on its specific and concomitant interaction with the two glycoconjugates as well as on dynamic avidity effects typical for lectins binding to multivalent glycoproteins. The presence of definite, cancer-related structures on the cells to be targeted determines the therapeutic potency of riproximin. Due to its cross-linking ability, riproximin is expected to show a high degree of specificity for cells exposing both NA2/NA3 and clustered Tn structures.	[Voss, Cristina] Heidelberg Pharma GmbH, Dept Biochem, D-68526 Ladenburg, Germany; [Bayer, Helene; Essig, Katharina; Berger, Martin R.] German Canc Res Ctr, Toxicol & Chemotherapy Unit, D-69120 Heidelberg, Germany; [Stanzel, Sven] German Canc Res Ctr, Dept Biostat, D-69120 Heidelberg, Germany; [Frank, Martin] BIOGNOS AB, S-41705 Gothenburg, Sweden; [Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, Frederick, MD 21702 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Voss, C (corresponding author), Heidelberg Pharma GmbH, Dept Biochem, Schriesheimer Str 101, D-68526 Ladenburg, Germany.	c.voss@hdpharma.com	Gildersleeve, Jeffrey/N-3392-2014	Essig, Katharina/0000-0001-5928-6013; Frank, Martin/0000-0002-1006-6746; Gildersleeve, Jeffrey/0000-0002-3744-6423	National Institutes of Health, NCI, Intramural Research Program; German Federal Ministry of Economics and Technology [Pro Inno II KF0425101UL6, ZIM KF2301002AJ0]; NATIONAL CANCER INSTITUTE [ZIABC010740] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Intramural Research Program.; Supported by German Federal Ministry of Economics and Technology Grants Pro Inno II KF0425101UL6 and ZIM KF2301002AJ0.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Bayer H, 2012, PROTEIN EXPRES PURIF, V82, P97, DOI 10.1016/j.pep.2011.11.018; BHATTACHARYYA L, 1988, ARCH BIOCHEM BIOPHYS, V262, P605, DOI 10.1016/0003-9861(88)90412-2; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; CHANDRASEKARAN EV, 1983, J BIOL CHEM, V258, P7213; Dam TK, 2007, J BIOL CHEM, V282, P28256, DOI 10.1074/jbc.M704677200; Dam TK, 2010, ADV CARBOHYD CHEM BI, V63, P139, DOI 10.1016/S0065-2318(10)63005-3; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DOWNS F, 1969, BIOCHEMISTRY-US, V8, P1760, DOI 10.1021/bi00832a060; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; FODSTAD O, 1984, CANCER RES, V44, P862; Freire T, 2005, CANCER RES, V65, P7880, DOI 10.1158/0008-5472.CAN-04-3746; Girbes T, 2003, CELL MOL BIOL, V49, P537; GREEN ED, 1988, J BIOL CHEM, V263, P18253; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Horrix C, 2011, CELL MOL LIFE SCI, V68, P1269, DOI 10.1007/s00018-010-0524-2; Inoue M, 2001, CANCER RES, V61, P950; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Karg SR, 2009, PLANT PHYSIOL BIOCH, V47, P160, DOI 10.1016/j.plaphy.2008.10.005; Kumar SR, 2005, CLIN CANCER RES, V11, P6868, DOI 10.1158/1078-0432.CCR-05-0146; Lattova E, 2010, J PROTEOME RES, V9, P1533, DOI 10.1021/pr9010266; Lee JJ, 2009, STAT BIOPHARM RES, V1, P4, DOI 10.1198/sbr.2009.0001; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; LIN JY, 1970, NATURE, V227, P292, DOI 10.1038/227292a0; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Nan BC, 1998, GLYCOCONJUGATE J, V15, P1033, DOI 10.1023/A:1006950311937; NILSSON B, 1979, J BIOL CHEM, V254, P4545; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Peracaula R, 2003, GLYCOBIOLOGY, V13, P457, DOI 10.1093/glycob/cwg041; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Saldova R, 2011, ANN ONCOL, V22, P1113, DOI 10.1093/annonc/mdq570; Sarrats A, 2010, OMICS, V14, P465, DOI 10.1089/omi.2010.0050; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Strafors P., 2012, ADV EXP MED BIOL, V729, P111; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Tabares G, 2006, GLYCOBIOLOGY, V16, P132, DOI 10.1093/glycob/cwj042; Telford JE, 2011, BIOCHEM SOC T, V39, P327, DOI 10.1042/BST0390327; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Vercoutter-Edouart AS, 2008, PROTEOMICS, V8, P3236, DOI 10.1002/pmic.200800151; Voss C, 2006, TOXICOL APPL PHARM, V211, P177, DOI 10.1016/j.taap.2005.05.016; Voss C, 2006, FASEB J, V20, P1194, DOI 10.1096/fj.05-5231fje; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007	61	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35873	35886		10.1074/jbc.M112.368548	http://dx.doi.org/10.1074/jbc.M112.368548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22872642	Green Published, hybrid			2022-12-28	WOS:000310364000010
J	Kim, JC; Crary, B; Chang, YC; Kwon-Chung, KJ; Kim, KJ				Kim, Jong-Chul; Crary, Benjamin; Chang, Yun C.; Kwon-Chung, Kyung J.; Kim, Kee J.			Cryptococcus neoformans Activates RhoGTPase Proteins Followed by Protein Kinase C, Focal Adhesion Kinase, and Ezrin to Promote Traversal across the Blood-Brain Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ESCHERICHIA-COLI K1; CENTRAL-NERVOUS-SYSTEM; RHO GTPASES; INVASION; MENINGITIS; INTERNALIZATION; TRANSLOCATION; CYTOSKELETON; STRATEGIES	Cryptococcus neoformans is an opportunistic fungal pathogen that causes meningoencephalitis. Previous studies have demonstrated that Cryptococcus binding and invasion of human brain microvascular endothelial cells (HBMEC) is a prerequisite for transmigration across the blood-brain barrier. However, the molecular mechanism involved in the cryptococcal blood-brain barrier traversal is poorly understood. In this study we examined the signaling events in HBMEC during interaction with C. neoformans. Analysis with inhibitors revealed that cryptococcal association, invasion, and transmigration require host actin cytoskeleton rearrangement. Rho pulldown assays revealed that Cryptococcus induces activation of three members of RhoGTPases, e.g. RhoA, Rac1, and Cdc42, and their activations are required for cryptococcal transmigration across the HBMEC monolayer. Western blot analysis showed that Cryptococcus also induces phosphorylation of focal adhesion kinase (FAK), ezrin, and protein kinase C alpha (PKC alpha), all of which are involved in the rearrangement of host actin cytoskeleton. Down-regulation of FAK, ezrin, or PKC alpha by shRNA knockdown, dominant-negative transfection, or inhibitors significantly reduces cryptococcal ability to traverse the HBMEC monolayer, indicating their positive role in cryptococcal transmigration. In addition, activation of RhoGTPases is the upstream event for phosphorylation of FAK, ezrin, and PKC alpha during C. neoformans-HBMEC interaction. Taken together, our findings demonstrate that C. neoformans activates RhoGTPases and subsequently FAK, ezrin, and PKC alpha to promote their traversal across the HBMEC monolayer, which is the critical step for cryptococcal brain infection and development of meningitis.	[Kim, Jong-Chul; Crary, Benjamin; Kim, Kee J.] Univ Kansas, Dept Microbiol Mol Genet & Immunol, Med Ctr, Kansas City, KS 66160 USA; [Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Lab Clin Infect Dis, Mol Microbiol Sect, NIH, Bethesda, MD 20892 USA	University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kim, KJ (corresponding author), Univ Kansas, Dept Microbiol Mol Genet & Immunol, Med Ctr, Kansas City, KS 66160 USA.	kkim@kumc.edu			National Institutes of Health [P20RR016443, R01DA027729]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR016443 and R01DA027729 (to K.J.K.) and NIAID intramural grants (to Y.C.C. and K.J.K.-C.).	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Badger JL, 1999, INFECT IMMUN, V67, P4208, DOI 10.1128/IAI.67.8.4208-4215.1999; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Casadevall A, 2010, J CLIN INVEST, V120, P1389, DOI 10.1172/JCI42949; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chung JW, 2003, J BIOL CHEM, V278, P16857, DOI 10.1074/jbc.M301028200; Eugene E, 2002, J CELL SCI, V115, P1231; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Jain SK, 2006, J INFECT DIS, V193, P1287, DOI 10.1086/502631; Jarvis WD, 1999, INVEST NEW DRUG, V17, P227, DOI 10.1023/A:1006328303451; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Khan NA, 2002, J BIOL CHEM, V277, P15607, DOI 10.1074/jbc.M112224200; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kwon-Chung KJ, 2000, MED MYCOL, V38, P205, DOI 10.1080/mmy.38.s1.205.213; Maruvada R., 2012, CELL MICROB IN PRESS; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sheen TR, 2010, J MOL MED, V88, P633, DOI 10.1007/s00109-010-0630-5; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Voelz K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015968; Wilson SL, 1998, J INFECT DIS, V178, P1658, DOI 10.1086/314490; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	50	32	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36147	36157		10.1074/jbc.M112.389676	http://dx.doi.org/10.1074/jbc.M112.389676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898813	hybrid, Green Published			2022-12-28	WOS:000310364000036
J	Ramani, K; Tomasi, ML; Yang, HP; Ko, K; Lu, SC				Ramani, Komal; Tomasi, Maria Lauda; Yang, Heping; Ko, Kwangsuk; Lu, Shelly C.			Mechanism and Significance of Changes in Glutamate-Cysteine Ligase Expression during Hepatic Fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTIONAL REGULATION; COORDINATED ACTIVATION; SYNTHETIC ENZYMES; GLUTATHIONE; NRF2; PROTEINS; SUMOYLATION; INDUCTION	GSH is synthesized sequentially by glutamate-cysteine ligase (GCL) and GSH synthase and defends against oxidative stress, which promotes hepatic stellate cell (HSC) activation. Changes in GSH synthesis during HSC activation are poorly characterized. Here, we examined the expression of GSH synthetic enzymes in rat HSC activation and reversion to quiescence. Expression of the GCL catalytic subunit (GCLC) fell during HSC activation and increased when activated HSCs revert back to quiescence. Blocking the increase in GCLC expression kept HSCs in an activated state. Activated HSCs have higher nuclear levels and binding activity of MafG to the antioxidant response element (ARE) of GCLC but lower Nrf2/MafG heterodimer binding to the ARE. Quiescent HSCs have a lower nuclear MafG level but higher Nrf2/MafG heterodimer binding to ARE. This occurred because of enhanced sumoylation of Nrf2 and MafG by SUMO-1, which promoted Nrf2 binding to ARE and heterodimerization with MafG. In vivo, knockdown of GCLC exacerbated bile duct ligation-induced liver injury and fibrosis. Ursodeoxycholic acid and S-adenosylmethionine are anti-fibrotic in bile duct ligation, but this effect was nearly lost if GCLC induction was blocked. In conclusion, sumoylation of Nrf2 and MafG enhances heterodimerization and increases GCLC expression, which keeps HSCs in a quiescent state. Antifibrotic agents require activation of GCLC to fully exert their protective effect.	[Ramani, Komal; Tomasi, Maria Lauda; Yang, Heping; Ko, Kwangsuk; Lu, Shelly C.] Univ So Calif, Div Gastroenterol & Liver Dis, USC Res Ctr Liver Dis,Kech Sch Med, So Calif Res Ctr Alcohol & Pancreat Dis & Cirrhos, Los Angeles, CA 90033 USA	University of Southern California	Lu, SC (corresponding author), Univ So Calif, Div Gastroenterol & Liver Dis, USC Res Ctr Liver Dis,Kech Sch Med, So Calif Res Ctr Alcohol & Pancreat Dis & Cirrhos, HMR415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Lu, Shelly/AAH-5937-2021; Ramani, Komal/AAH-5913-2021; tomasi, maria lauda/AAI-1819-2021	Lu, Shelly/0000-0003-2128-5407; 	National Institutes of Health [K99AA017774, R01DK092407, R01AT1576, F32AA020150, P30DK48522, R24 AA12885-07]; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092407, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA017774, R24AA012885, R00AA017774, F32AA020150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99AA017774 (to K. R.), R01DK092407 and R01AT1576 (to S. C. L. and H. Y.), and F32AA020150 (to M. L. T.).; 293T cells and isolated mouse hepatocytes were provided by the Cell Culture Core, and pathological sections and staining were done by the Imaging Core of the University of Southern California Research Center for Liver Diseases (supported by National Institutes of Health Grant P30DK48522). Hepatic stellate cells from sham and BDL rats were provided by the Non-Parenchymal Cell Core of the University of Southern California-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis (supported by National Institutes of Health Grant R24 AA12885-07).	Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BURT AD, 1993, J PATHOL, V170, P105, DOI 10.1002/path.1711700203; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Fu YM, 2008, MOL PHARMACOL, V73, P1465, DOI 10.1124/mol.107.040634; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314; Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Maubach G, 2011, WORLD J GASTROENTERO, V17, P2748, DOI [10.3748/wjg.v17.i22., 10.3748/wjg.v17.i22.2748]; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Tsukamoto H, 1996, AM J PHYSIOL-GASTR L, V270, pG581, DOI 10.1152/ajpgi.1996.270.4.G581; Xia M, 2010, J BIOL CHEM, V285, P20015, DOI 10.1074/jbc.M109.094821; Yang HP, 2010, HEPATOLOGY, V51, P1291, DOI 10.1002/hep.23471; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795; Zheng SZ, 2007, FREE RADICAL BIO MED, V43, P444, DOI 10.1016/j.freeradbiomed.2007.04.016	30	40	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36341	36355		10.1074/jbc.M112.370775	http://dx.doi.org/10.1074/jbc.M112.370775			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942279	Green Published, hybrid			2022-12-28	WOS:000310364000055
J	Han, YJ; Agarwal, V; Dodd, D; Kim, J; Bae, B; Mackie, RI; Nair, SK; Cann, IKO				Han, Yejun; Agarwal, Vinayak; Dodd, Dylan; Kim, Jason; Bae, Brian; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.			Biochemical and Structural Insights into Xylan Utilization by the Thermophilic Bacterium Caldanaerobius polysaccharolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; ALPHA-GLUCURONIDASE; BETA-XYLOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS; THERMOTOGA-MARITIMA; GENE-CLUSTER; CLOSTRIDIUM-THERMOCELLUM; THERMOSTABLE ENZYMES; CRYSTAL-STRUCTURES	Hemicellulose is the next most abundant plant cell wall component after cellulose. The abundance of hemicellulose such as xylan suggests that their hydrolysis and conversion to biofuels can improve the economics of bioenergy production. In an effort to understand xylan hydrolysis at high temperatures, we sequenced the genome of the thermophilic bacterium Caldanaerobius polysaccharolyticus. Analysis of the partial genome sequence revealed a gene cluster that contained both hydrolytic enzymes and also enzymes key to the pentose-phosphate pathway. The hydrolytic enzymes in the gene cluster were demonstrated to convert products from a large endoxylanase (Xyn10A) predicted to anchor to the surface of the bacterium. We further use structural and calorimetric studies to demonstrate that the end products of Xyn10A hydrolysis of xylan are recognized and bound by XBP1, a putative solute-binding protein, likely for transport into the cell. The XBP1 protein showed preference for xylo-oligosaccharides as follows: xylotriose > xylobiose > xylotetraose. To elucidate the structural basis for the oligosaccharide preference, we solved the co-crystal structure of XBP1 complexed with xylotriose to a 1.8-angstrom resolution. Analysis of the biochemical data in the context of the co-crystal structure reveals the molecular underpinnings of oligosaccharide length specificity.	[Agarwal, Vinayak; Bae, Brian; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Han, Yejun; Dodd, Dylan; Kim, Jason; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Han, Yejun; Dodd, Dylan; Kim, Jason; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Kim, Jason] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA.	snair@illinois.edu; icann@illinois.edu	Agarwal, Vinayak/L-5688-2017; Nair, Satish/AAY-2510-2021; Han, Yejun/AAC-7411-2019	Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Energy Biosciences Institute.	Abboft DW, 2007, J MOL BIOL, V369, P759, DOI 10.1016/j.jmb.2007.03.045; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BABA T, 1994, APPL ENVIRON MICROB, V60, P2252, DOI 10.1128/AEM.60.7.2252-2258.1994; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; de Wet BJM, 2006, ENZYME MICROB TECH, V38, P649, DOI 10.1016/j.enzmictec.2005.07.018; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Eneyskaya EV, 2007, ARCH BIOCHEM BIOPHYS, V457, P225, DOI 10.1016/j.abb.2006.10.024; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; HURTUBISE Y, 1995, MOL MICROBIOL, V17, P367, DOI 10.1111/j.1365-2958.1995.mmi_17020367.x; Jun HS, 2003, CAN J MICROBIOL, V49, P171, DOI 10.1139/W03-024; King MR, 2002, J AGR FOOD CHEM, V50, P5676, DOI 10.1021/jf0202281; Kurokawa J, 2002, APPL MICROBIOL BIOT, V59, P455, DOI 10.1007/s00253-002-1048-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE YE, 1993, J BACTERIOL, V175, P5890, DOI 10.1128/JB.175.18.5890-5898.1993; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Licht A, 2011, J MOL BIOL, V406, P92, DOI 10.1016/j.jmb.2010.11.048; Liebl WG, 2008, J BACTERIOL, V190, P1350, DOI 10.1128/JB.01149-07; LITTLE E, 1994, J MOL EVOL, V39, P631, DOI 10.1007/BF00160409; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meissner K, 2000, MOL MICROBIOL, V36, P898, DOI 10.1046/j.1365-2958.2000.01909.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mierzwa M, 2005, PREP BIOCHEM BIOTECH, V35, P243, DOI 10.1081/PB-200065648; Milner Y., 1967, CARBOHYD RES, V4, P359, DOI DOI 10.1016/S0008-6215(00)80191-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2003, J BIOL CHEM, V278, P20286, DOI 10.1074/jbc.M302205200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Rohman A, 2007, ACTA CRYSTALLOGR F, V63, P932, DOI 10.1107/S1744309107046015; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Selvaraj T, 2010, J MICROBIOL, V48, P856, DOI 10.1007/s12275-010-0285-5; Shallom D, 2004, J BACTERIOL, V186, P6928, DOI 10.1128/JB.186.20.6928-6937.2004; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vahedi-Faridi A, 2010, J MOL BIOL, V397, P709, DOI 10.1016/j.jmb.2010.01.054; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; WINTERHALTER C, 1995, MOL MICROBIOL, V15, P431, DOI 10.1111/j.1365-2958.1995.tb02257.x; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28; [No title captured]	61	40	42	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34946	34960		10.1074/jbc.M112.391532	http://dx.doi.org/10.1074/jbc.M112.391532			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918832	Green Published, hybrid			2022-12-28	WOS:000309968000008
J	Korde, AS; Maragos, WF				Korde, Amit S.; Maragos, William F.			Identification of an N-Methyl-D-aspartate Receptor in Isolated Nervous System Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; GLUTAMATE RECEPTORS; SIGNALING PATHWAY; GNRH NEURONS; CALCIUM; EXPRESSION; MEMBRANE; SUBUNIT; APOPTOSIS; MESSENGER	NMDA ionotropic glutamate receptors gate the cytoplasmic influx of calcium, which may, depending on the intensity of the stimulus, subserve either normal synaptic communication or cell death. We demonstrate that when isolated mitochondria are exposed to calcium and NMDA agonists, there is a significant increase in mitochondrial calcium levels. The agonist/antagonist response studies on purified mitochondria suggest the presence of a receptor on mitochondria with features similar to plasma membrane NMDA receptors. Immunogold electron microscopy of hippocampal tissue sections revealed extensive localization of NR2a subunit immunoreactivity on mitochondria. Transient transfection of neuronal GT1-7 cells with an NR1-NR2a NMDA receptor subunit cassette specifically targeting mitochondria resulted in a significant increase in mitochondrial calcium and neuroprotection against glutamate-induced cell death. Mitochondria prepared from GT1-7 cells in which the NR1 subunit of NMDA receptors was silenced demonstrated a decrease in calcium uptake. Our findings are the first to demonstrate that mitochondria express a calcium transport protein that shares characteristics with the NMDA receptor and may play a neuroprotective role.	[Korde, Amit S.; Maragos, William F.] Hunter Holmes McGuire Vet Hosp, Neurol Serv, Richmond, VA 23294 USA; [Maragos, William F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Maragos, WF (corresponding author), Hunter Holmes McGuire Vet Hosp, Neurol Serv, Rm 2B-175,1201 Broad Rock Blvd, Richmond, VA 23294 USA.	william.maragos@va.gov		Korde, Amit/0000-0003-0702-290X	National Institutes of Health [NS01941, NS42111]; McGuire Veterans Administration Medical Center; McGuire Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGuire Veterans Administration Medical Center; McGuire Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS01941 and NS42111 (to W. F. M.) and McGuire Veterans Administration Medical Center and McGuire Research Institute.	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Budd SL, 1996, J NEUROCHEM, V67, P2282; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1988, J CARDIOVASC PHARM, V12, pS69; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Franconi F, 1998, BRIT J PHARMACOL, V124, P35, DOI 10.1038/sj.bjp.0701790; Genever PG, 1999, J INVEST DERMATOL, V112, P337, DOI 10.1046/j.1523-1747.1999.00509.x; Genever PG, 1999, BLOOD, V93, P2876; GREENAMYRE JT, 1985, J PHARMACOL EXP THER, V233, P254; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUNTLEY GW, 1994, J NEUROSCI, V14, P3603; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Khodorov B, 1996, FEBS LETT, V393, P135, DOI 10.1016/0014-5793(96)00873-3; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Kraemer R., 1992, MOL MECH BIOENERGETI, P359; Lancelot E, 1998, PROG BRAIN RES, V116, P331, DOI 10.1016/S0079-6123(08)60446-X; LEBOURDELLES B, 1994, J NEUROCHEM, V62, P2091; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mahesh VB, 1999, NEUROENDOCRINOLOGY, V69, P397, DOI 10.1159/000054442; MARAGOS WF, 1988, J NEUROSCI, V8, P493; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MORHENN VB, 1994, EUR J PHARM-MOLEC PH, V268, P409, DOI 10.1016/0922-4106(94)90066-3; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Patton AJ, 1998, BONE, V22, P645, DOI 10.1016/S8756-3282(98)00061-1; Peng TI, 1998, MOL PHARMACOL, V53, P974; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Purcell WM, 1996, J NEUROIMMUNOL, V65, P49, DOI 10.1016/0165-5728(95)00182-4; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; White RJ, 1996, J NEUROSCI, V16, P5688; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	46	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35192	35200		10.1074/jbc.M111.322032	http://dx.doi.org/10.1074/jbc.M111.322032			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22918829	hybrid, Green Published			2022-12-28	WOS:000309968000029
J	Larue, R; Gupta, K; Wuensch, C; Shkriabai, N; Kessl, JJ; Danhart, E; Feng, L; Taltynov, O; Christ, F; Van Duyne, GD; Debyser, Z; Foster, MP; Kvaratskhelia, M				Larue, Ross; Gupta, Kushol; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Danhart, Eric; Feng, Lei; Taltynov, Oliver; Christ, Frauke; Van Duyne, Gregory D.; Debyser, Zeger; Foster, Mark P.; Kvaratskhelia, Mamuka			Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE TRANSCRIPTION COMPLEXES; NUCLEAR-LOCALIZATION SIGNAL; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; DNA-BINDING DOMAIN; IMPORTIN-BETA; MOLECULAR-DYNAMICS; NONDIVIDING CELLS; CATALYTIC DOMAIN	Transportin 3 (TNPO3 or TRN-SR2) has been shown to be an important cellular factor for early steps of lentiviral replication. However, separate studies have implicated distinct mechanisms for TNPO3 either through its interaction with HIV-1 integrase or capsid. Here we have carried out a detailed biophysical characterization of TNPO3 and investigated its interactions with viral proteins. Biophysical analyses including circular dichroism, analytical ultracentrifugation, small-angle x-ray scattering, and homology modeling provide insight into TNPO3 architecture and indicate that it is highly structured and exists in a mon-omer-dimer equilibrium in solution. In vitro biochemical binding assays argued against meaningful direct interaction between TNPO3 and the capsid cores. Instead, TNPO3 effectively bound to the functional intasome but not to naked viral DNA, suggesting that TNPO3 can directly engage the HIV-1 IN tetramer pre-bound to the cognate DNA. Mass spectrometry-based protein footprinting and site-directed mutagenesis studies have enabled us to map several interacting amino acids in the HIV-1 IN C-terminal domain and the cargo binding domain of TNPO3. Our findings provide important information for future genetic analysis to better understand the role of TNPO3 and its interacting partners for HIV-1 replication.	[Larue, Ross; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA; [Larue, Ross; Wuensch, Christiane; Shkriabai, Nikolozi; Kessl, Jacques J.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Comprehens Canc, Coll Pharm, Columbus, OH 43210 USA; [Danhart, Eric; Foster, Mark P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Taltynov, Oliver; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Flanders, Belgium	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; KU Leuven	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Foster, Mark P/F-6332-2012; Kessl, Jacques/J-6073-2015; Kessl, Jacques/AAV-2526-2021; Gupta, Kushol/GOE-5620-2022; Christ, Frauke/H-7513-2018; debyser, zeger/H-1310-2013	Foster, Mark P/0000-0001-9645-7491; Gupta, Kushol/0000-0002-7006-2667; Larue, Ross/0000-0002-0170-7345; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	National Institutes of Health [AI062520, AI097044, GM077234]; EU; FWO; IWT SBO CellCoVir; BOF of the KULeuven; Department of Energy (DOE) program Integrated Diffraction Analysis Technologies; DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097044, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077234, R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); FWO(FWO); IWT SBO CellCoVir; BOF of the KULeuven; Department of Energy (DOE) program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI062520 (to M. K.), AI097044 (to J. J. K.), and GM077234 (to M. P. F). This work was also supported by the FP7 EU project THINC, the FWO, the IWT SBO CellCoVir, and the BOF of the KULeuven.; We thank Gregory Hura, Jane Tanamachi, Kevin Dyer, and Michal Hammel (Advanced Light Source) for assistance with data collection. X-ray scattering and diffraction technologies and their applications to the determination of macromolecular shapes and conformations at the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, were supported in part by the Department of Energy (DOE) program Integrated Diffraction Analysis Technologies and the DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under contract DE-AC02-05CH11231 with the United States Department of Energy. HIV-1 IN monoclonal antibody (8G4) was obtained from National Institutes of Health AIDS Research and Reference Reagent Program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bhardwaj A, 2010, BIOCHEMISTRY-US, V49, P5042, DOI 10.1021/bi100292y; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown P. O., 1997, P161; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L, PYMOL MOL GRAPHICS S; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Grunwald M, 2011, EMBO J, V30, P427, DOI 10.1038/emboj.2010.320; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Jayappa KD, 2011, J MOL BIOL, V410, P847, DOI 10.1016/j.jmb.2011.04.011; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kobbi L, 2011, J MOL BIOL, V410, P875, DOI 10.1016/j.jmb.2011.03.005; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mckee CJ, 2009, METHODS, V47, P304, DOI 10.1016/j.ymeth.2008.10.023; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V77, P2896; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	83	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34044	34058		10.1074/jbc.M112.384669	http://dx.doi.org/10.1074/jbc.M112.384669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22872640	hybrid, Green Published			2022-12-28	WOS:000309654200011
J	Mitomi, Y; Nomura, T; Kurosawa, M; Nukina, N; Furukawa, Y				Mitomi, Yasushi; Nomura, Takao; Kurosawa, Masaru; Nukina, Nobuyuki; Furukawa, Yoshiaki			Post-aggregation Oxidation of Mutant Huntingtin Controls the Interactions between Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; METHIONINE OXIDATION; IN-VITRO; PRION PROTEIN; DISEASE; MICE; MUTATION; BETA; VIVO; DYSFUNCTION	Aggregation of protein molecules is a pathological hallmark of many neurodegenerative diseases. Abnormal modifications have often been observed in the aggregated proteins, supporting the aggregation mechanism regulated by post-translational modifications on proteins. Modifications are in general assumed to occur in soluble proteins before aggregation, but actually it remains quite obscure when proteins are modified in the course of the aggregation. Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo. Copper ions as well as added hydrogen peroxide are found to oxidize the methionine residue, but notably, this oxidative modification occurs only in the aggregated HTT but not in the soluble state. Furthermore, the methionine oxidation creates additional interactions among HTT aggregates and alters overall morphologies of the aggregates. We thus reveal that protein aggregates can be a target of oxidative modifications and propose that such a "post-aggregation" modification is a relevant factor to regulate properties of protein aggregates.	[Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111542, 22110004, 22770162]; CREST from Japan Science and Technology Agency; Research Committee for Ataxic Diseases from MHLW; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Research Committee for Ataxic Diseases from MHLW; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid 24111542 (to Y. F.) and 22110004 (to N. N.) for Scientific Research on Innovative Areas and Grant-in-Aid 22770162 for Young Scientists (B) (to Y. F.) and Strategic Research Program for Brain Sciences (to N. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, funds from CREST from Japan Science and Technology Agency (to N. N.), a grant-in-aid from the Research Committee for Ataxic Diseases from MHLW (to N. N.), and a grant from the Naito Foundation (to Y. F.).	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ding F, 2012, J MOL BIOL, V421, P548, DOI 10.1016/j.jmb.2011.12.029; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Fox JH, 2011, J BIOL CHEM, V286, P18320, DOI 10.1074/jbc.M110.199448; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MEYER RA, 1975, BIOPHYS J, V15, P191, DOI 10.1016/S0006-3495(75)85811-5; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	51	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34764	34775		10.1074/jbc.M112.387035	http://dx.doi.org/10.1074/jbc.M112.387035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891249	Green Published, hybrid			2022-12-28	WOS:000309654200076
J	Huang, LP; Kirschke, CP; Lay, YAE; Levy, LB; Lamirande, DE; Zhang, PH				Huang, Liping; Kirschke, Catherine P.; Lay, Yu-An E.; Levy, Lauren B.; Lamirande, Danielle E.; Zhang, Patrick H.			Znt7-null Mice Are More Susceptible to Diet-induced Glucose Intolerance and Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; MAMMALIAN ZINC TRANSPORTER; RECEPTOR SUBSTRATE FAMILY; PANCREATIC BETA-CELLS; PHOSPHOTYROSINE PROTEIN; SLC30 FAMILY; RISK LOCI; EXPRESSION; ZNT8; SECRETION	The Znt7 gene encodes a ubiquitously expressed zinc transporter that is involved in transporting cytoplasmic zinc into the Golgi apparatus and a ZnT7-containing vesicular compartment. Overexpression of ZnT7 in the pancreatic beta-cell stimulates insulin synthesis and secretion through regulation of insulin gene transcription. In this study, we demonstrate that ZnT7 is expressed in the mouse skeletal muscle. The activity of the insulin signaling pathway was down-regulated in myocytes isolated from the femoral muscle of Znt7 knock-out (KO) mice. High fat diet consumption (45% kcal) induced weight gain in male Znt7 KO mice but not female Znt7 KO mice. Male Znt7 KO mice fed the high fat diet at 5 weeks of age for 10 weeks exhibited hyperglycemia in the non-fasting state. Oral glucose tolerance tests revealed that male Znt7 KO mice fed the high fat diet had severe glucose intolerance. Insulin tolerance tests showed that male Znt7 KO mice were insulin-resistant. Diet-induced insulin resistance in male Znt7 KO mice was paralleled by a reduction in mRNA expression of Insr, Irs2, and Akt1 in the primary skeletal myotubes isolated from the KO mice. Overexpression of ZnT7 in a rat skeletal muscle cell line (L6) increased Irs2 mRNA expression, Irs2 and Akt phosphorylation, and glucose uptake. We conclude that a combination of decreased insulin secretion and increased insulin resistance accounts for the glucose intolerance observed in Znt7 KO mice.	[Huang, Liping; Kirschke, Catherine P.; Lamirande, Danielle E.; Zhang, Patrick H.] Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr,Obes & Metab Res Unit, Davis, CA 95616 USA; [Huang, Liping; Lay, Yu-An E.; Levy, Lauren B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis	Huang, LP (corresponding author), Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr,Obes & Metab Res Unit, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	liping.huang@ars.usda.gov		Zhang, Patrick/0000-0003-3796-6880	United States Department of Agriculture, Agricultural Research Service [5306-515-30-014-00D, 5306-515-20-007-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture, Agricultural Research Service, Projects 5306-515-30-014-00D and 5306-515-20-007-00D.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; DAWSON NJ, 1970, COMP BIOCHEM PHYSIOL, V37, P589, DOI 10.1016/0010-406X(70)90104-0; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gajda A. M., 2007, ANIMAL LAB NEWS; Gohlke Henning, 2008, Rev Diabet Stud, V5, P25, DOI 10.1900/RDS.2008.5.25; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2010, EXP CELL RES, V316, P2630, DOI 10.1016/j.yexcr.2010.06.017; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; Kirschke CP, 2008, J MOL HISTOL, V39, P359, DOI 10.1007/s10735-008-9174-1; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Mantzoros CS, 1998, J AM COLL NUTR, V17, P270, DOI 10.1080/07315724.1998.10718758; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prasad AS, 2001, NUTRITION, V17, P67, DOI 10.1016/S0899-9007(00)00469-X; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Suzuki R, 2004, J BIOL CHEM, V279, P25039, DOI 10.1074/jbc.M311956200; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33883	33896		10.1074/jbc.M111.309666	http://dx.doi.org/10.1074/jbc.M111.309666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22854958	hybrid, Green Published			2022-12-28	WOS:000309602100069
J	Dubinnyi, MA; Osmakov, DI; Koshelev, SG; Kozlov, SA; Andreev, YA; Zakaryan, NA; Dyachenko, IA; Bondarenko, DA; Arseniev, AS; Grishin, EV				Dubinnyi, Maxim A.; Osmakov, Dmitry I.; Koshelev, Sergey G.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Zakaryan, Naira A.; Dyachenko, Igor A.; Bondarenko, Dmitry A.; Arseniev, Alexander S.; Grishin, Eugene V.			Lignan from Thyme Possesses Inhibitory Effect on ASIC3 Channel Current	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; INFLAMMATORY PAIN; ESSENTIAL OILS; ACID; PEPTIDE; ANTIOXIDANT; COMPOUND; EXTRACT; APETX2; VENOM	A novel compound was identified in the acidic extract of Thymus armeniacus collected in the Lake Sevan region of Armenia. This compound, named "sevanol," to our knowledge is the first low molecular weight natural molecule that has a reversible inhibition effect on both the transient and the sustained current of human ASIC3 channels expressed in Xenopus laevis oocytes. Sevanol completely blocked the transient component (IC50 353 +/- 23 mu M) and partially (similar to 45%) inhibited the amplitude of the sustained component (IC50 of 234 +/- 53 mu M). Other types of acid-sensing ion channel (ASIC) channels were intact to sevanol application, except ASIC1a, which showed more than six times less affinity to it as compared with the inhibitory action on the ASIC3 channel. To elucidate the structure of sevanol, the set of NMR spectra in two solvents (d(6)-DMSO and D2O) was collected, and the complete chemical structure was confirmed by liquid chromatography-mass spectrometry with electrospray ionization (LC-ESI+-MS) fragmentation. This compound is a new lignan built up of epiphyllic acid and two isocitryl esters in positions 9 and 10. In vivo administration of sevanol (1-10 mg/kg) significantly reversed thermal hyperalgesia induced by complete Freund's adjuvant injection and reduced response to acid in a writhing test. Thus, we assume the probable considerable role of sevanol in known analgesic and anti-inflammatory properties of thyme.	[Dubinnyi, Maxim A.; Osmakov, Dmitry I.; Koshelev, Sergey G.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Arseniev, Alexander S.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Zakaryan, Naira A.] Natl Acad Sci Republ Armenia NAS RA, H Buniatian Inst Biochem, Yerevan 375014, Armenia; [Dyachenko, Igor A.; Bondarenko, Dmitry A.] Russian Acad Sci, Branch Shemyakin Ovchinnikov Inst Bioorgan Chem, Pushchino 142290, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Institute of Biochemistry after H. Buniatyan - NAS RA; National Academy of Sciences of Armenia; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Dubinnyi, MA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya St, Moscow 117997, Russia.	maxim@nmr.ru; osmadim@gmail.com	Kozlov, Sergey A/D-1548-2012; Dubinnyi, Maxim/I-4722-2012; Osmakov, Dmitry/H-5560-2019; Bondarenko, Dmitry A/T-9356-2017; Andreev, Yaroslav A/C-6627-2012; DI Igor, Dyachenko/K-9060-2017	Kozlov, Sergey A/0000-0002-0242-4240; Dubinnyi, Maxim/0000-0002-5463-0169; Bondarenko, Dmitry A/0000-0002-8055-0066; Osmakov, Dmitry/0000-0001-6588-5012; Andreev, Yaroslav/0000-0002-7628-0980	Russian Academy of Sciences; Ministry of Education and Science of the Russian Federation [16.512.11.2195]; Russian Foundation for Basic Research	Russian Academy of Sciences(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the "Molecular and Cell Biology" and "Fundamental Sciences for Medicine" Programs of the Russian Academy of Sciences, by the Ministry of Education and Science of the Russian Federation, Contract 16.512.11.2195 from 14.03.2011, and by the Russian Foundation for Basic Research.	Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Apers S., 2003, Phytochemistry Reviews, V2, P201, DOI 10.1023/B:PHYT.0000045497.90158.d2; Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Cullmann F, 1999, PHYTOCHEMISTRY, V52, P1651, DOI 10.1016/S0031-9422(99)00372-6; CULLMANN F, 1993, PHYTOCHEMISTRY, V34, P831, DOI 10.1016/0031-9422(93)85367-Z; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; ElHabazi K, 2006, J ETHNOPHARMACOL, V107, P406, DOI 10.1016/j.jep.2006.03.029; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Figueiredo AC, 2008, CURR PHARM DESIGN, V14, P3120, DOI 10.2174/138161208786404218; Garateix A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-10; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Hazzit M, 2006, J AGR FOOD CHEM, V54, P6314, DOI 10.1021/jf0606104; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kaloustian J, 2005, J SCI FOOD AGR, V85, P2437, DOI 10.1002/jsfa.2274; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Kuduk SD, 2011, BIOORG MED CHEM LETT, V21, P4255, DOI 10.1016/j.bmcl.2011.05.064; Mahmoudi M, 2008, FITOTERAPIA, V79, P361, DOI 10.1016/j.fitote.2008.04.004; Marino M, 1999, J FOOD PROTECT, V62, P1017, DOI 10.4315/0362-028X-62.9.1017; Miura K, 2002, J AGR FOOD CHEM, V50, P1845, DOI 10.1021/jf011314o; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Ramezani M, 2001, FITOTERAPIA, V72, P255, DOI 10.1016/S0367-326X(00)00290-2; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Stahl-Biscup E., 2002, THYME GENUS THYMUS, P263; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Weissberg A, 2011, INT J MASS SPECTROM, V299, P158, DOI 10.1016/j.ijms.2010.10.024	34	28	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32993	33000		10.1074/jbc.M112.366427	http://dx.doi.org/10.1074/jbc.M112.366427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854960	hybrid, Green Published			2022-12-28	WOS:000309168300062
J	Peng, C; Ye, J; Yan, SF; Kong, SS; Shen, Y; Li, CY; Li, QY; Zheng, YF; Deng, KJ; Xu, T; Tao, WF				Peng, Chao; Ye, Jian; Yan, Shunfei; Kong, Shanshan; Shen, Ye; Li, Chenyu; Li, Qinyu; Zheng, Yufang; Deng, Kejing; Xu, Tian; Tao, Wufan			Ablation of Vacuole Protein Sorting 18 (Vps18) Gene Leads to Neurodegeneration and Impaired Neuronal Migration by Disrupting Multiple Vesicle Transport Pathways to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBRAL CORTICAL DEVELOPMENT; ALZHEIMERS-DISEASE; PURKINJE-CELLS; MICE LACKING; DEEP-ORANGE; AUTOPHAGY; MOUSE; INTEGRIN; CORTEX	Intracellular vesicle transport pathways are critical for neuronal survival and central nervous system development. The Vps-C complex regulates multiple vesicle transport pathways to the lysosome in lower organisms. However, little is known regarding its physiological function in mammals. We deleted Vps18, a central member of Vps-C core complex, in neural cells by generating Vps18(F/F); Nestin-Cre mice (Vps18 conditional knock-out mice). These mice displayed severe neurodegeneration and neuronal migration defects. Mechanistic studies revealed that Vps18 deficiency caused neurodegeneration by blocking multiple vesicle transport pathways to the lysosome, including autophagy, endocytosis, and biosynthetic pathways. Our study also showed that ablation of Vps18 resulted in up-regulation of beta 1 integrin in mouse brain probably due to lysosome dysfunction but had no effects on the reelin pathway, expression of N-cadherin, or activation of JNK, which are implicated in the regulation of neuronal migration. Finally, we demonstrated that knocking down beta 1 integrin partially rescued the migration defects, suggesting that Vps18 deficiency-mediated up-regulation of beta 1 integrin may contribute to the defect of neuronal migration in the Vps18-deficient brain. Our results demonstrate important roles of Vps18 in neuron survival and migration, which are disrupted in multiple neural disorders.	[Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06536 USA; [Peng, Chao; Ye, Jian; Yan, Shunfei; Kong, Shanshan; Shen, Ye; Li, Chenyu; Deng, Kejing; Xu, Tian; Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Peng, Chao; Ye, Jian; Yan, Shunfei; Kong, Shanshan; Tao, Wufan] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Qinyu; Zheng, Yufang] Fudan Univ, Dept Physiol & Biophys, Sch Life Sci, Shanghai 200433, Peoples R China	Howard Hughes Medical Institute; Yale University; Fudan University; Fudan University; Fudan University	Xu, T (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06536 USA.	tian.xu@yale.edu; wufan_tao@fudan.edu.cn	Peng, Chao/P-4818-2018; Ye, Jian/ABG-4873-2020; Zheng, Yufang/F-1091-2011; Peng, Chao/AAG-9187-2019	Ye, Jian/0000-0002-7168-0117; Zheng, Yufang/0000-0002-0488-2624; 	National Basic Research Program of China [2011CB510102, 2006CB806700]; National Natural Science Foundation of China [31171406, 30971666, 30630043]; Hi-tech Research and Development Program of China [2007AA022101]; Science and Technology Committee of Shanghai Municipality [08JC1400800]; Project 211 of the Chinese Ministry of Education; Project 985 of the Chinese Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Project 211 of the Chinese Ministry of Education(Ministry of Education, China); Project 985 of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Basic Research Program of China (Grants 2011CB510102 and 2006CB806700); National Natural Science Foundation of China (Grants 31171406, 30971666, and 30630043); Hi-tech Research and Development Program of China (Grant 2007AA022101); and Key Projects Grant for Basic Research (Grant 08JC1400800) from the Science and Technology Committee of Shanghai Municipality and Projects 211 and 985 of the Chinese Ministry of Education.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Cheung ZH, 2011, J NEUROCHEM, V118, P317, DOI 10.1111/j.1471-4159.2011.07314.x; Chi CW, 2010, J BIOL CHEM, V285, P21817, DOI 10.1074/jbc.M110.131714; Chintala S, 2009, BRAIN RES, V1266, P18, DOI 10.1016/j.brainres.2009.02.035; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harlow E., 1999, USING ANTIBODIES LAB; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schmid RS, 2005, CEREB CORTEX, V15, P1632, DOI 10.1093/cercor/bhi041; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; YUASA S, 1993, ANAT EMBRYOL, V188, P317; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256; Zhang M, 2008, FRONT BIOSCI-LANDMRK, V13, P6086, DOI 10.2741/3140; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	49	27	28	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32861	32873		10.1074/jbc.M112.384305	http://dx.doi.org/10.1074/jbc.M112.384305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854957	Green Published, hybrid			2022-12-28	WOS:000309168300052
J	Zhang, Y; Wei, XB; Liu, LX; Liu, SX; Wang, ZY; Zhang, B; Fan, BX; Yang, F; Huang, SY; Jiang, F; Chen, YHH; Yi, F				Zhang, Yan; Wei, Xinbing; Liu, Lixia; Liu, Suxia; Wang, Ziying; Zhang, Bin; Fan, Baoxia; Yang, Fan; Huang, Shanying; Jiang, Fan; Chen, Youhai H.; Yi, Fan			TIPE2, a Novel Regulator of Immunity, Protects against Experimental Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; NADPH OXIDASE; CEREBRAL-ISCHEMIA; NEGATIVE REGULATOR; INFLAMMATORY CELLS; RAT-BRAIN; EXPRESSION; HOMEOSTASIS; REPERFUSION	The inflammatory responses accompanying stroke are recognized to contribute to secondary ischemic injury. TIPE2 is a very recently identified negative regulator of inflammation that maintains immune homeostasis. However, it is unknown whether TIPE2 is expressed in the brain and contributes to the regulation of cerebral diseases. In this study, we explored the potential roles of TIPE2 in cerebral ischemia/reperfusion injury. TIPE-/- mice were used to assess whether TIPE2 provides neuroprotection following cerebral ischemia/reperfusion induced by middle cerebral artery occlusion (MCAO), and in vitro primary cerebral cell cultures were used to investigate the expression and regulation of TIPE2. Our results show that genetic ablation of the Tipe2 gene significantly increased the cerebral volume of infarction and neurological dysfunction in mice subjected to MCAO. Flow cytometric analysis revealed more infiltrating macrophages, neutrophils, and lymphocytes in the ischemic hemisphere of TIPE2(-/-) mice. The responses to inflammatory cytokines and chemokines were significantly increased in TIPE2(-/-) mouse brain after MCAO. We further observed that TIPE2 was highly induced in WT mice after cerebral ischemia and was expressed mainly in microglia/macrophages, but not in neurons and astrocytes. Finally, we found that regulation of TIPE2 expression was associated with NADPH oxidase activity. These findings demonstrate, for the first time, that TIPE2 is involved in the pathogenesis of stroke and suggest that TIPE2 plays an essential role in a signal transduction pathway that links the inflammatory immune response to specific conditions after cerebral ischemia. Targeting TIPE2 may be a new therapeutic strategy for stroke treatment.	[Zhang, Yan; Wei, Xinbing; Liu, Lixia; Wang, Ziying; Zhang, Bin; Fan, Baoxia; Yang, Fan; Yi, Fan] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China; [Liu, Suxia] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Peoples R China; [Huang, Shanying; Jiang, Fan] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China; [Huang, Shanying; Jiang, Fan] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Peoples R China; [Chen, Youhai H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Shandong University; Shandong University; Shandong University; Shandong University; University of Pennsylvania	Yi, F (corresponding author), Shandong Univ, Sch Med, Dept Pharmacol, 44 W Wenhua Rd, Jinan 250012, Shandong, Peoples R China.	fanyi@sdu.edu.cn	Jiang, Fan/B-7753-2013; Chen, Youhai/AAJ-4031-2021	Jiang, Fan/0000-0001-9466-2192; 	Scientific Research Foundation for the National Nature Science Foundation of China [30901551, 81070918, 81070572, 81170772]; National 973 Basic Research Program of China [2010CB732605]; Research Fund for the Doctoral Program of Higher Education, State Education Ministry, China [20090131120081]; Shandong Natural Science Fund for Distinguished Young Scholars [JQ201121]; Foundation for Excellent Young and Middle-Aged Scientists of Shandong Province, China [BS2009SW005, BS2009YY017]; Independent Innovation Foundation of Shandong University [IIFSDU, 2010JC17, 2012TS116]; China Postdoctoral Science Foundation [2012M511041]; Foundation of Program for New Century Excellent Talents in University [NCET-11-0311]	Scientific Research Foundation for the National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education, State Education Ministry, China; Shandong Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation for Excellent Young and Middle-Aged Scientists of Shandong Province, China; Independent Innovation Foundation of Shandong University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Scientific Research Foundation for the National Nature Science Foundation of China (Grants 30901551, 81070918, 81070572, and 81170772), the National 973 Basic Research Program of China (Grant 2010CB732605), the Research Fund for the Doctoral Program of Higher Education, State Education Ministry, China (Grant 20090131120081), the Shandong Natural Science Fund for Distinguished Young Scholars (Grant JQ201121), the Foundation for Excellent Young and Middle-Aged Scientists of Shandong Province, China (Grants BS2009SW005 and BS2009YY017), the Independent Innovation Foundation of Shandong University (Grants IIFSDU, 2010JC17, and 2012TS116), the China Postdoctoral Science Foundation (Grant 2012M511041), and the Foundation of Program for New Century Excellent Talents in University (Grant NCET-11-0311).	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Becker KJ, 2010, STROKE, V41, pS75, DOI 10.1161/STROKEAHA.110.592881; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kim GS, 2009, J NEUROSCI, V29, P14779, DOI 10.1523/JNEUROSCI.4161-09.2009; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Manhas N, 2010, J NEUROCHEM, V114, P1476, DOI 10.1111/j.1471-4159.2010.06868.x; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Yang QW, 2008, J CEREBR BLOOD F MET, V28, P1588, DOI 10.1038/jcbfm.2008.50; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhao J, 2007, CELL SIGNAL, V19, P831, DOI 10.1016/j.cellsig.2006.10.006	36	64	69	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32546	32555		10.1074/jbc.M112.348755	http://dx.doi.org/10.1074/jbc.M112.348755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859306	Green Published, hybrid			2022-12-28	WOS:000309168300024
J	Hong, IK; Jeoung, DI; Ha, KS; Kim, YM; Lee, H				Hong, In-Kee; Jeoung, Doo-Il; Ha, Kwon-Soo; Kim, Young-Myeong; Lee, Hansoo			Tetraspanin CD151 Stimulates Adhesion-dependent Activation of Ras, Rac, and Cdc42 by Facilitating Molecular Association between beta(1) Integrins and Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; ACTIN STRESS FIBERS; CELL-ADHESION; TRANSMEMBRANE-4 SUPERFAMILY; CLINICAL-SIGNIFICANCE; ALPHA-3-BETA-1; EXPRESSION; KINASE; PKC; ALPHA-6-BETA-4	Tetraspanin CD151 associates with laminin-binding alpha(3)beta(1)/alpha(6)beta(1) integrins in epithelial cells and regulates adhesion-dependent signaling events. We found here that CD151 plays a role in recruiting Ras, Rac1, and Cdc42, but not Rho, to the cell membrane region, leading to the formation of alpha(3)beta(1)/alpha(6)beta(1) integrin-CD151-GTPases complexes. Furthermore, cell adhesion to laminin enhanced CD151 association with beta(1) integrin and, thereby, increased complex formation between the beta(1) family of integrins and small GTPases, Ras, Rac1, and Cdc42. Adhesion receptor complex-associated small GTPases were activated by CD151-beta(1) integrin complex-stimulating adhesion events, such as alpha(3)beta(1)/alpha(6)beta(1) integrin-activating cell-to-laminin adhesion and homophilic CD151 interaction-generating cell-to-cell adhesion. Additionally, FAK and Src appeared to participate in this adhesion-dependent activation of small GTPases. However, engagement of laminin-binding integrins in CD151-deficient cells or CD151-specific siRNA-transfected cells did not activate these GTPases to the level of cells expressing CD151. Small GTPases activated by engagement of CD151-beta(1) integrin complexes contributed to CD151-induced cell motility and MMP-9 expression in human melanoma cells. Importantly, among the four tetraspanin proteins that associate with beta(1) integrin, only CD151 exhibited the ability to facilitate complex formation between the beta(1) family of integrins and small GTPases and stimulate beta(1) integrin-dependent activation of small GTPases. These results suggest that CD151 links alpha(3)beta(1)/alpha(6)beta(1) integrins to Ras, Rac1, and Cdc42 by promoting the formation of multimolecular complexes in the membrane, which leads to the up-regulation of adhesion-dependent small GTPase activation.	[Hong, In-Kee; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea; [Hong, In-Kee; Jeoung, Doo-Il; Ha, Kwon-Soo; Lee, Hansoo] Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University; Kangwon National University	Lee, H (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Dept Biol Sci, Chunchon 200701, Kangwon Do, South Korea.	hslee@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0024380, 2009-0054632]; NRF	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (Grant 2011-0024380). This work was also supported by the Mid-career Researcher Program through an NRF grant funded by the MEST (Grant 2009-0054632).	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Chen G., 2008, OPEN BIOTECHNOL J, V2, P133, DOI [10.2174/1874070700802010133, DOI 10.2174/1874070700802010133]; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kohno M, 2002, INT J CANCER, V97, P336, DOI 10.1002/ijc.1605; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LEE HS, 1993, J BIOL CHEM, V268, P5255; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shigeta M, 2003, J CELL BIOL, V163, P165, DOI 10.1083/jcb.200301075; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Soldaini E, 2003, EUR J IMMUNOL, V33, P455, DOI 10.1002/immu.200310021; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Testa JE, 1999, CANCER RES, V59, P3812; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yanez-Mo M, 2001, MICROCIRCULATION, V8, P153; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	65	43	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32027	32039		10.1074/jbc.M111.314443	http://dx.doi.org/10.1074/jbc.M111.314443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843693	Green Published, hybrid			2022-12-28	WOS:000309059400041
J	Pelisch, F; Pozzi, B; Risso, G; Munoz, MJ; Srebrow, A				Pelisch, Federico; Pozzi, Berta; Risso, Guillermo; Javier Munoz, Manuel; Srebrow, Anabella			DNA Damage-induced Heterogeneous Nuclear Ribonucleoprotein K SUMOylation Regulates p53 Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; PROTEIN SUMOYLATION; HNRNP-K; UBIQUITIN LIGASES; IN-VIVO; HIPK2; COMPLEX; GENE; REPRESSION; PC2	Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a nucleocytoplasmic shuttling protein that is a key player in the p53-triggered DNA damage response, acting as a cofactor for p53 in response to DNA damage. hnRNP K is a substrate of the ubiquitin E3 ligase MDM2 and, upon DNA damage, is de-ubiquitylated. In sharp contrast with the role and consequences of the other post-translational modifications, nothing is known about the role of SUMO conjugation to hnRNP K in p53 transcriptional co-activation. In the present work, we show that hnRNP K is modified by SUMO in lysine 422 within its KH3 domain, and sumoylation is regulated by the E3 ligase Pc2/CBX4. Most interestingly, DNA damage stimulates hnRNP K sumoylation through Pc2 E3 activity, and this modification is required for p53 transcriptional activation. Abrogation of hnRNP K sumoylation leads to an aberrant regulation of the p53 target gene p21. Our findings link the DNA damage-induced Pc2 activation to the p53 transcriptional co-activation through hnRNP K sumoylation.	[Pelisch, Federico; Pozzi, Berta; Risso, Guillermo; Javier Munoz, Manuel; Srebrow, Anabella] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn,Dept Fisiol Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pelisch, F (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn,Dept Fisiol Biol, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	fpelisch@fbmc.fcen.uba.ar; asrebrow@fbmc.fcen.uba.ar	Pelisch, Federico/C-3815-2011; Pelisch, Federico/H-9219-2013	Munoz, Manuel J./0000-0002-1152-5449; Pozzi, Berta/0000-0002-4744-9337; Pelisch, Federico/0000-0003-4575-1492	EURSNET; ANPCyT; University of Buenos Aires	EURSNET; ANPCyT(ANPCyT); University of Buenos Aires(University of Buenos Aires)	This work was supported by EURSNET (to A. S.) and ANPCyT and University of Buenos Aires (to F. P. and A. S.).	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Pelisch F, 2010, P NATL ACAD SCI USA, V107, P16119, DOI 10.1073/pnas.1004653107; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	54	61	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30789	30799		10.1074/jbc.M112.390120	http://dx.doi.org/10.1074/jbc.M112.390120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22825850	Green Published, hybrid			2022-12-28	WOS:000308579800067
J	Zhao, XB; Khajo, A; Jarrett, S; Suarez, J; Levitsky, Y; Burger, RM; Jarzecki, AA; Magliozzo, RS				Zhao, Xiangbo; Khajo, Abdelahad; Jarrett, Sanchez; Suarez, Javier; Levitsky, Yan; Burger, Richard M.; Jarzecki, Andrzej A.; Magliozzo, Richard S.			Specific Function of the Met-Tyr-Trp Adduct Radical and Residues Arg-418 and Asp-137 in the Atypical Catalase Reaction of Catalase-Peroxidase KatG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MYCOBACTERIUM-TUBERCULOSIS; HYDROGEN-PEROXIDE; BURKHOLDERIA-PSEUDOMALLEI; COMPOUND-II; HORSERADISH-PEROXIDASE; ISONIAZID ACTIVATION; CRYSTAL-STRUCTURE; CROSS-LINK; KINETICS	Catalase activity of the dual-function heme enzyme catalase-peroxidase (KatG) depends on several structural elements, including a unique adduct formed from covalently linked side chains of three conserved amino acids (Met-255, Tyr-229, and Trp-107, Mycobacterium tuberculosis KatG numbering) (MYW). Mutagenesis, electron paramagnetic resonance, and optical stopped-flow experiments, along with calculations using density functional theory (DFT) methods revealed the basis of the requirement for a radical on the MYW-adduct, for oxyferrous heme, and for conserved residues Arg-418 and Asp-137 in the rapid catalase reaction. The participation of an oxyferrous heme intermediate (dioxyheme) throughout the pH range of catalase activity is suggested from our finding that carbon monoxide inhibits the activity at both acidic and alkaline pH. In the presence of H2O2, the MYW-adduct radical is formed normally in KatG[D137S] but this mutant is defective in forming dioxyheme and lacks catalase activity. KatG[R418L] is also catalase deficient but exhibits normal formation of the adduct radical and dioxyheme. Both mutants exhibit a coincidence between MYW-adduct radical persistence and H2O2 consumption as a function of time, and enhanced subunit oligomerization during turnover, suggesting that the two mutations disrupting catalase turnover allow increased migration of the MYW-adduct radical to protein surface residues. DFT calculations showed that an interaction between the side chain of residue Arg-418 and Tyr-229 in the MYW-adduct radical favors reaction of the radical with the adjacent dioxyheme intermediate present throughout turnover in WT KatG. Release of molecular oxygen and regeneration of resting enzyme are thereby catalyzed in the last step of a proposed catalase reaction.	[Zhao, Xiangbo; Khajo, Abdelahad; Jarrett, Sanchez; Suarez, Javier; Levitsky, Yan; Burger, Richard M.; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Khajo, Abdelahad; Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Chem, New York, NY 10016 USA; [Khajo, Abdelahad; Suarez, Javier; Jarzecki, Andrzej A.; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cuny.edu			National Institutes of Health [R01-AI060014, 2R56AI060014-06A1]; NSF [CHE-1058116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060014, R56AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER; Division Of Chemistry [1058116] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI060014 and 2R56AI060014-06A1 (NIAID) and NSF Grant CHE-1058116 (to R. S. M.).	ADEDIRAN SA, 1989, EUR J BIOCHEM, V186, P571, DOI 10.1111/j.1432-1033.1989.tb15246.x; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; COTTON ML, 1973, CAN J BIOCHEM CELL B, V51, P627, DOI 10.1139/o73-078; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; Glendening E. D., 2001, NBO 5 0; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Jakopitsch C, 2005, J BIOL CHEM, V280, P9037, DOI 10.1074/jbc.M413317200; Jakopitsch C, 2003, BIOCHEMISTRY-US, V42, P5292, DOI 10.1021/bi026944d; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; KEILIN D, 1951, BIOCHEM J, V49, P88, DOI 10.1042/bj0490088; NAKAJIMA R, 1987, J BIOL CHEM, V262, P2576; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; WILSON TM, 1995, MOL MICROBIOL, V15, P1009, DOI 10.1111/j.1365-2958.1995.tb02276.x; WITTENBERG JB, 1967, J BIOL CHEM, V242, P626; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yordanov ND, 2000, SPECTROCHIM ACTA A, V56, P373, DOI 10.1016/S1386-1425(99)00248-6; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	36	20	20	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37057	37065		10.1074/jbc.M112.401208	http://dx.doi.org/10.1074/jbc.M112.401208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22918833	Green Published, hybrid			2022-12-28	WOS:000310588500040
J	Ishii, K; Adachi, T; Imamura, K; Takano, S; Usui, K; Suzuki, K; Hamamoto, H; Watanabe, T; Sekimizu, K				Ishii, Kenichi; Adachi, Tatsuo; Imamura, Katsutoshi; Takano, Shinya; Usui, Kimihito; Suzuki, Kazushi; Hamamoto, Hiroshi; Watanabe, Takeshi; Sekimizu, Kazuhisa			Serratia marcescens Induces Apoptotic Cell Death in Host Immune Cells via a Lipopolysaccharide- and Flagella-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOFILM DEVELOPMENT; PARALYTIC PEPTIDE; ESCHERICHIA-COLI; SILKWORM; DROSOPHILA; INFECTION; VIRULENCE; BACTERIAL; PROTEIN; MODEL	Injection of Serratia marcescens into the blood (hemolymph) of the silkworm, Bombyx mori, induced the activation of c-Jun NH2-terminal kinase (JNK), followed by caspase activation and apoptosis of blood cells (hemocytes). This process impaired the innate immune response in which pathogen cell wall components, such as glucan, stimulate hemocytes, leading to the activation of insect cytokine paralytic peptide. S. marcescens induced apoptotic cell death of silkworm hemocytes and mouse peritoneal macrophages in vitro. We searched for S. marcescens transposon mutants with attenuated ability to induce apoptosis of silkworm hemocytes. Among the genes identified, disruption mutants of wecA (a gene involved in lipopolysaccharide O-antigen synthesis), and flhD and fliR (essential genes in flagella synthesis) showed reduced motility and impaired induction of mouse macrophage cell death. These findings suggest that S. marcescens induces apoptosis of host immune cells via lipopolysaccharide- and flagella-dependent motility, leading to the suppression of host innate immunity.	[Ishii, Kenichi; Adachi, Tatsuo; Imamura, Katsutoshi; Usui, Kimihito; Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Takano, Shinya; Suzuki, Kazushi; Watanabe, Takeshi] Niigata Univ, Dept Appl Biol Chem, Fac Agr, Niigata 9502181, Japan	University of Tokyo; Niigata University	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019; Suzuki, Kazushi/I-4509-2016	Hamamoto, Hiroshi/0000-0001-9315-7442; 	JSPS [21790063, 21-10519]; Genome Pharmaceuticals Co. Ltd. [20390021, 21022015]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Genome Pharmaceuticals Co. Ltd.	This work was supported by a Grant-in-Aid for Young Scientists (B) (21790063) and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (21-10519) from JSPS. This study was supported in part by a Grant-in-Aid for Scientific Research (B) (20390021), a Grant-in-Aid for Scientific Research on Priority Areas (21022015), and grants from Genome Pharmaceuticals Co. Ltd.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; BOTT M, 1994, MOL MICROBIOL, V14, P347, DOI 10.1111/j.1365-2958.1994.tb01295.x; Carbonell GV, 2004, RES MICROBIOL, V155, P25, DOI 10.1016/j.resmic.2003.09.009; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; DeFlaun MF, 1999, APPL ENVIRON MICROB, V65, P759; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2005, RES ADV ANTIMICROB A, V5, P1; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Jia J, 2003, INFECT IMMUN, V71, P3361, DOI 10.1128/IAI.71.6.3361-3370.2003; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2011, DRUG DISCOV THER, V5, P66, DOI 10.5582/ddt.2011.v5.2.66; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kanuka H, 1999, P NATL ACAD SCI USA, V96, P145, DOI 10.1073/pnas.96.1.145; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Labbate M, 2004, J BACTERIOL, V186, P692, DOI 10.1128/JB.186.3.692-698.2004; Labbate M, 2007, J BACTERIOL, V189, P2702, DOI 10.1128/JB.01582-06; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lee JH, 2007, INSECT BIOCHEM MOLEC, V37, P1338, DOI 10.1016/j.ibmb.2007.08.007; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Majumdar T, 2009, MICROB PATHOGENESIS, V46, P98, DOI 10.1016/j.micpath.2008.11.002; Maragakis LL, 2008, INFECT CONT HOSP EP, V29, P418, DOI 10.1086/587969; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nishida S, 1997, FEMS MICROBIOL LETT, V150, P297, DOI 10.1016/S0378-1097(97)00134-1; Pei ZF, 2002, J BIOL CHEM, V277, P48677, DOI 10.1074/jbc.M208810200; Scully LR, 2006, FEMS MICROBIOL LETT, V263, P1, DOI 10.1111/j.1574-6968.2006.00388.x; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Taniai K, 1997, BIOCHEM BIOPH RES CO, V231, P623, DOI 10.1006/bbrc.1997.6151; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Toratani T, 2008, MICROBIOL-SGM, V154, P1326, DOI 10.1099/mic.0.2007/016246-0; Usui K, 2009, MICROB PATHOGENESIS, V46, P59, DOI 10.1016/j.micpath.2008.10.010; Villari P, 2001, INFECT CONT HOSP EP, V22, P630, DOI 10.1086/501834; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Wickstrum JR, 2009, INFECT IMMUN, V77, P4827, DOI 10.1128/IAI.00246-09	57	31	34	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36582	36592		10.1074/jbc.M112.399667	http://dx.doi.org/10.1074/jbc.M112.399667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22859304	hybrid, Green Published			2022-12-28	WOS:000310364000078
J	Liu, YY; Kogai, T; Schultz, JJ; Mody, K; Brent, GA				Liu, Yan-Yun; Kogai, Takahiko; Schultz, James J.; Mody, Kaizeen; Brent, Gregory A.			Thyroid Hormone Receptor Isoform-specific Modification by Small Ubiquitin-like Modifier (SUMO) Modulates Thyroid Hormone-dependent Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; SUMOYLATION; BINDING; REPRESSOR; PROTEIN; ALPHA	Thyroid hormone receptor (TR) alpha and beta mediate thyroid hormone action at target tissues. TR isoforms have specific roles in development and in adult tissues. The mechanisms underlying TR isoform-specific action, however, are not well understood. We demonstrate that posttranslational modification of TR by conjugation of smallSUMOtoTR alpha and TR beta plays an important role in triiodothyronine (T3) action and TR isoform specificity. TR alpha was sumoylated at lysines 283 and 389, and TR beta at lysines 50, 146, and 443. Sumoylation of TR beta was ligand-dependent, and sumoylation of TR alpha was ligand-independent. TR alpha-SUMO conjugation utilized the E3 ligase PIASx beta and TR beta-SUMO conjugation utilized predominantly PIAS1. SUMO1 and SUMO3 conjugation to TR was important for T3-dependent gene regulation, as demonstrated in transient transfection assay and studies of endogenous gene regulation. The functional role of SUMO1 and SUMO3 in T3 induction in transient expression assays was closely matched to the pattern of TR and cofactor recruitment to thyroid hormone response elements (TREs) as determined by ChIP assays. SUMO1 was required for the T3-induced recruitment of the co-activator CREB-binding protein (CBP) and release of nuclear receptor co-repressor (NCoR) on a TRE but had no significant effect on TR DNA binding. SUMO1 was required for T3-mediated recruitment of NCoR and release of CBP from the TSH beta-negative TRE. SUMO3 was required for T3-stimulated TR binding to the TSH beta-negative TRE and recruitment of NCoR. These findings demonstrate that conjugation of SUMO to TR has a TR-isoform preference and is important for T3-dependent gene induction and repression.	[Liu, Yan-Yun] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Med, Los Angeles, CA 90073 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Physiol, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, YY (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Dept Med, Bldg 114,Rm 229,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	yyl@ucla.edu; gbrent@ucla.edu		Liu, Yan-Yun/0000-0003-1946-2275	Veterans Affairs Merit Review Funds	Veterans Affairs Merit Review Funds(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Funds.	Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; BRENT GA, 1989, J BIOL CHEM, V264, P178; CARR FE, 1987, J BIOL CHEM, V262, P981; CARR FE, 1994, J BIOL CHEM, V269, P4175; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Liu G, 2006, BIOCHEM BIOPH RES CO, V349, P360, DOI 10.1016/j.bbrc.2006.08.049; Liu YY, 2011, ENDOCRINOLOGY, V152, P1143, DOI 10.1210/en.2010-0580; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	35	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36499	36508		10.1074/jbc.M112.344317	http://dx.doi.org/10.1074/jbc.M112.344317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930759	hybrid, Green Published			2022-12-28	WOS:000310364000069
J	Runyan, CE; Liu, ZY; Schnaper, HW				Runyan, Constance E.; Liu, Zongyi; Schnaper, H. William			Phosphatidylinositol 3-Kinase and Rab5 GTPase Inversely Regulate the Smad Anchor for Receptor Activation (SARA) Protein Independently of Transforming Growth Factor-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FYVE DOMAIN PROTEIN; PHOSPHOINOSITIDE 3-KINASE; INTRACELLULAR TRAFFICKING; P85-ALPHA SUBUNIT; KINASE B; WORTMANNIN; INHIBITION; BINDS; ENDOCYTOSIS	SARA has been shown to be a regulator of epithelial cell phenotype, with reduced expression during TGF-beta 1-mediated epithelial-to-mesenchymal transition. Examination of the pathways that might play a role in regulating SARA expression identified phosphatidylinositol 3-kinase (PI3K) pathway inhibition as sufficient to reduce SARA expression. The mechanism of PI3K inhibition-mediated SARA down-regulation differs from that induced by TGF-beta 1 in that, unlike TGF-beta 1, PI3K-dependent depletion of SARA was apparent within 6 h and did not occur at the mRNA or promoter level but was blocked by inhibition of proteasome-mediated degradation. This effect was independent of Akt activity because neither reducing nor enhancing Akt activity modulated the expression of SARA. Therefore, this is likely a direct effect of p85 alpha action, and co-immunoprecipitation of SARA and p85 alpha confirmed that these proteins interact. Both SARA and PI3K have been shown to be associated with endosomes, and either LY294002 or p85 alpha knockdown enlarged SARA-containing endocytic vesicles. Inhibition of clathrin-mediated endocytosis blocked SARA down-regulation, and a localization-deficient mutant SARA was protected against down-regulation. As inhibiting PI3K can activate the endosomal fusion-regulatory small GTPase Rab5, we expressed GTPase-deficient Rab5 and observed endosomal enlargement and reduced SARA protein expression, similar to that seen with PI3K inhibition. Importantly, either interference with PI3K via LY294002 or p85 alpha knockdown, or constitutive activity of the Rab5 pathway, enhanced the expression of smooth muscle alpha-actin. Together, these data suggest that although TGF-beta 1 can induce epithelial-to-mesenchymal transition through reduction in SARA expression, SARA is also basally regulated by its interaction with PI3K.	[Runyan, Constance E.; Liu, Zongyi; Schnaper, H. William] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University	Runyan, CE (corresponding author), Northwestern Univ, Dept Pediat, 310 W Super St,Searle 4-490, Chicago, IL 60611 USA.	c-runyan@northwestern.edu		Liu, Cheri/0000-0002-2394-750X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK049362, R01DK049362, R01DK075663] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK049362, R01 DK075663, R01 DK049362] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson DH, 2005, METHOD ENZYMOL, V403, P552, DOI 10.1016/S0076-6879(05)03048-X; Awwad HO, 2007, EXP CELL RES, V313, P2586, DOI 10.1016/j.yexcr.2007.04.034; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen XM, 2001, EMBO REP, V2, P842, DOI 10.1093/embo-reports/kve179; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Fruman DA, 2010, CURR TOP MICROBIOL, V346, P225, DOI 10.1007/82_2010_39; Gillooly DJ, 1999, BIOCHEM J, V344, P605, DOI 10.1042/0264-6021:3440605; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Grille SJ, 2003, CANCER RES, V63, P2172; Houle S, 2003, BIOCHEM J, V375, P151, DOI 10.1042/BJ20030872; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Jones AT, 1998, MOL BIOL CELL, V9, P323, DOI 10.1091/mbc.9.2.323; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; MIN BH, 1990, J BIOL CHEM, V265, P16667; Mousavi SA, 2003, BIOCHEM J, V372, P861, DOI 10.1042/BJ20021136; Nakajima Y, 1997, MOL BIOL CELL, V8, P577, DOI 10.1091/mbc.8.4.577; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2009, J BIOL CHEM, V284, P25181, DOI 10.1074/jbc.M109.032847; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004; Worou ME, 2011, CARDIOVASC RES, V91, P320, DOI 10.1093/cvr/cvr072; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao YQ, 2008, TRAFFIC, V9, P2253, DOI 10.1111/j.1600-0854.2008.00819.x	43	16	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35815	35824		10.1074/jbc.M112.380493	http://dx.doi.org/10.1074/jbc.M112.380493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942286	Green Published, hybrid			2022-12-28	WOS:000310364000005
J	Shulga, YV; Anderson, RA; Topham, MK; Epand, RM				Shulga, Yulia V.; Anderson, Richard A.; Topham, Matthew K.; Epand, Richard M.			Phosphatidylinositol-4-phosphate 5-Kinase Isoforms Exhibit Acyl Chain Selectivity for Both Substrate and Lipid Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL KINASE-ZETA; MOLECULAR-SPECIES ANALYSIS; PHOSPHATE KINASE; 4-PHOSPHATE 5-KINASE; I-ALPHA; ARACHIDONOYL SPECIFICITY; ACID; GAMMA; MEMBRANE; BETA	Phosphatidylinositol 4,5-bisphosphate is mostly produced in the cell by phosphatidylinositol-4-phosphate 5-kinases (PIP5K) and has a crucial role in numerous signaling events. Here we demonstrate that in vitro all three isoforms of PIP5K, alpha, beta, and gamma, discriminate among substrates with different acyl chains for both the substrates phosphatidylinositol 4-phosphate (PtdIns4P) and phosphatidylinositol (PtdIns) although to different extents, with isoform gamma being the most selective. Fully saturated dipalmitoyl-PtdIns4P was a poor substrate for all three isoforms, but both the 1-stearoyl-2-arachidonoyl and the 1-stearoyl-2-oleoyl forms of PtdIns4P were good substrates. V-max was greater for the 1-stearoyl-2-arachidonoyl form compared with the 1-stearoyl-2-oleoyl form, although for PIP5K beta the difference was small. For the alpha and gamma isoforms, K-m was much lower for 1-stearoyl-2-oleoyl PtdIns4P, making this lipid the better substrate of the two under most conditions. Activation of PIP5K by phosphatidic acid is also acyl chain-dependent. Species of phosphatidic acid with two unsaturated acyl chains are much better activators of PIP5K than those containing one saturated and one unsaturated acyl chain. PtdIns is a poor substrate for PIP5K, but it also shows acyl chain selectivity. Curiously, there is no acyl chain discrimination among species of phosphatidic acid in the activation of the phosphorylation of PtdIns. Together, our findings indicate that PIP5K isoforms alpha, beta, and gamma act selectively on substrates and activators with different acyl chains. This could be a tightly regulated mechanism of producing physiologically active unsaturated phosphatidylinositol 4,5-bisphosphate species in the cell.	[Shulga, Yulia V.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Anderson, Richard A.] Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	McMaster University; University of Wisconsin System; University of Wisconsin Madison; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health, NCI [CA095463, R01CA104708]; Natural Sciences and Engineering Research Council of Canada [9848]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA095463, R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA095463 (to M. K. T.) and R01CA104708 (to R. A. A.). This study was also supported by Natural Sciences and Engineering Research Council of Canada Grant 9848 (to R. M. E.).	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Balgoma D, 2008, FEBS J, V275, P6180, DOI 10.1111/j.1742-4658.2008.06742.x; Cazzolli R, 2007, DIABETOLOGIA, V50, P1732, DOI 10.1007/s00125-007-0709-x; Chen MZ, 2009, J BIOL CHEM, V284, P23743, DOI 10.1074/jbc.M109.036509; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Epand RM, 2012, BBA-BIOMEMBRANES, V1818, P957, DOI 10.1016/j.bbamem.2011.07.018; Epand RM, 2004, BIOCHEMISTRY-US, V43, P14778, DOI 10.1021/bi0484724; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Galiano FJ, 2002, J CELL BIOCHEM, V85, P131, DOI 10.1002/jcb.10100; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; Hicks AM, 2006, BBA-MOL CELL BIOL L, V1761, P1022, DOI 10.1016/j.bbalip.2006.05.010; HILL TL, 1978, P NATL ACAD SCI USA, V75, P1101, DOI 10.1073/pnas.75.3.1101; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; HOLBROOK PG, 1992, J BIOL CHEM, V267, P16834; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; KLOTZ IM, 1977, P NATL ACAD SCI USA, V74, P4959, DOI 10.1073/pnas.74.11.4959; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; LEE C, 1991, J BIOL CHEM, V266, P22837; Li F, 2001, J MOL NEUROSCI, V16, P205, DOI 10.1385/JMN:16:2-3:205; Li W, 2012, MOL CELL, V45, P25, DOI 10.1016/j.molcel.2011.11.017; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; LOUIE K, 1988, BIOCHEMISTRY-US, V27, P9014, DOI 10.1021/bi00425a020; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Manes S, 2010, FASEB J, V24, P3381, DOI 10.1096/fj.09-153106; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Noda Y, 2012, P NATL ACAD SCI USA, V109, P1725, DOI 10.1073/pnas.1107808109; Parker G J, 1998, Methods Mol Biol, V105, P127; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; PETTITT TR, 1993, BIOCHEM J, V289, P487, DOI 10.1042/bj2890487; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shulga YV, 2011, FEBS LETT, V585, P4025, DOI 10.1016/j.febslet.2011.11.016; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sugimoto H, 1999, BBA-MOL CELL BIOL L, V1438, P264, DOI 10.1016/S1388-1981(99)00059-1; Sugiura T, 1996, J LIPID MEDIAT CELL, V14, P51, DOI 10.1016/0929-7855(96)00508-1; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wieffer M, 2012, METHOD CELL BIOL, V108, P209, DOI 10.1016/B978-0-12-386487-1.00011-0; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	70	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35953	35963		10.1074/jbc.M112.370155	http://dx.doi.org/10.1074/jbc.M112.370155			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942276	Green Published, hybrid			2022-12-28	WOS:000310364000017
J	Wei, ZK; Lei, X; Seldin, MM; Wong, GW				Wei, Zhikui; Lei, Xia; Seldin, Marcus M.; Wong, G. William			Endopeptidase Cleavage Generates a Functionally Distinct Isoform of C1q/Tumor Necrosis Factor-related Protein-12 (CTRP12) with an Altered Oligomeric State and Signaling Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GENE; ACRP30/ADIPONECTIN; ADIPOKINE; GLUCOSE; FAMILY; DEGENERATION; ACTIVATION; MUTATION; MODEL	Adipose tissue-derived adipokines are an important class of secreted metabolic regulators that mediate tissue cross-talk to control systemic energy balance. We recently described C1q/TNF-related protein-12 (CTRP12), a novel insulin-sensitizing adipokine that regulates glucose metabolism in liver and adipose tissue. However, the biochemical properties of CTRP12 and its naturally occurring cleaved isoform have not been characterized. Here, we show that CTRP12 is a secreted hormone subjected to multiple functionally relevant posttranslational modifications at highly conserved residues. For example, Asn(39) is glycosylated, whereas Cys(85) mediates the assembly of higher order oligomeric structure. Endopeptidase cleavage at Lys(91) generates a cleaved globular gCTRP12 isoform, the expression of which is increased by insulin. PCSK3/furin was identified as the major proprotein convertase expressed by adipocytes that mediates the endogenous cleavage of CTRP12. Cleavage at Lys(91) is context-dependent: mutation of the charged Arg(93) to Ala on the P2' position enhanced cleavage, and triple mutations (K90A/K91A/R93A) abolished cleavage. Importantly, the two isoforms of CTRP12 differ in oligomeric structures and are functionally distinct. The full-length protein forms trimers and larger complexes, and the cleaved isoform consisted of predominantly dimers. Whereas full-length fCTRP12 strongly activated Akt signaling in H4IIE hepatocytes and 3T3-L1 adipocytes, gCTRP12 preferentially activated MAP kinase (ERK1/2 and p38 MAPK) signaling. Further, only fCTRP12 improved insulin-stimulated glucose uptake in adipocytes. These results reveal a novel mechanism controlling signaling specificity and function of a hormone via cleavage-dependent alteration in oligomeric state.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health Grant [DK084171]; American Heart Association Grant [SDG2260721]; American Heart Association Fellowship [PRE3790034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported by American Heart Association Grant SDG2260721.; Supported by American Heart Association Fellowship PRE3790034.	Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Briggs DB, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-24; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	28	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35804	35814		10.1074/jbc.M112.365965	http://dx.doi.org/10.1074/jbc.M112.365965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942287	Green Published, hybrid			2022-12-28	WOS:000310364000004
J	Aldridge, C; Storm, A; Cline, K; Dabney-Smith, C				Aldridge, Cassie; Storm, Amanda; Cline, Kenneth; Dabney-Smith, Carole			The Chloroplast Twin Arginine Transport (Tat) Component, Tha4, Undergoes Conformational Changes Leading to Tat Protein Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI TATA; TRANSLOCATION SYSTEM; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; MONOVALENT STREPTAVIDIN; PRECURSOR PROTEINS; BACILLUS-SUBTILIS; SIGNAL PEPTIDE; BINDING-SITE; IN TOPOLOGY	Twin arginine transport (Tat) systems transport folded proteins using proton-motive force as sole energy source. The thylakoid Tat system comprises three membrane components. A complex composed of cpTatC and Hcf106 is the twin arginine signal peptide receptor. Signal peptide binding triggers assembly of Tha4 for the translocation step. Tha4 is thought to serve as the protein-conducting element, and the topology it adopts during transport produces the transmembrane passageway. We analyzed Tha4 topology and conformation in actively transporting translocases and compared that with Tha4 in nontransporting membranes. Using cysteine accessibility labeling techniques and diagnostic protease protection assays, we confirm an overall N-OUT-C-IN topology for Tha4 that is maintained under transport conditions. Significantly, the amphipathic helix (APH) and C-tail exhibited substantial changes in accessibility when actively engaged in protein transport. Compared with resting state, cysteines within the APH became less accessible to stromally applied modifying reagent. The APH proximal C-tail, although still accessible to Cys-directed reagents, was much less accessible to protease. We attribute these changes in accessibility to indicate the Tha4 conformation that is adopted in the translocase primed for translocation. We propose that in the primed translocase, the APH partitions more extensively and uniformly into the membrane interface and the C-tails pack closer together in a mesh-like network. Implications for the mode by which the substrate protein crosses the bilayer are discussed.	[Aldridge, Cassie; Cline, Kenneth] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Storm, Amanda; Dabney-Smith, Carole] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	State University System of Florida; University of Florida; University System of Ohio; Miami University	Dabney-Smith, C (corresponding author), 651 E High St, Oxford, OH USA.	adabney@MiamiOH.edu	Storm, Amanda R/AAF-2600-2021; Dabney-Smith, Carole/C-2432-2008	Storm, Amanda R/0000-0002-3736-2043; Dabney-Smith, Carole/0000-0003-1347-3870; Aldridge, Cassie/0000-0002-9162-3478	National Institutes of Health [R01 GM46951]; Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences [DE-FG02-10ER16138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM46951 (to K. C.) and Department of Energy Office of Science Early Career Research Program Grant DE-FG02-10ER16138 (to C. D. S.) through the Office of Basic Energy Sciences.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Chan CS, 2011, BBA-BIOMEMBRANES, V1808, P2289, DOI 10.1016/j.bbamem.2011.05.024; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Grage SL, 2010, METHODS MOL BIOL, V618, P183, DOI 10.1007/978-1-60761-594-1_13; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jackson SA, 2010, BIOCHEMISTRY-US, V49, P2765, DOI 10.1021/bi100217h; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Martin JR, 2009, PLANT J, V58, P831, DOI 10.1111/j.1365-313X.2009.03816.x; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Vilen H, 2009, J BACTERIOL, V191, P3339, DOI 10.1128/JB.01782-08; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s	38	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34752	34763		10.1074/jbc.M112.385666	http://dx.doi.org/10.1074/jbc.M112.385666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896708	Green Published, hybrid			2022-12-28	WOS:000309654200075
J	Chong, HH; Yao, X; Sun, JP; Qiu, ZL; Zhang, M; Waltersperger, S; Wang, MT; Cui, S; He, YX				Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Waltersperger, Sandro; Wang, Meitian; Cui, Sheng; He, Yuxian			The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSMEMBRANE PROTEIN GP41; VIRAL MEMBRANE-FUSION; COILED-COIL DOMAIN; ENVELOPE GLYCOPROTEIN; CORE STRUCTURE; ATOMIC-STRUCTURE; RESISTANT HIV-1; PEPTIDE; ENFUVIRTIDE	CP621-652 is a potent HIV-1 fusion inhibitor peptide derived from the C-terminal heptad repeat of gp41. We recently identified that its N-terminal residues Met-626 and Thr-627 adopt a unique hook-like structure (termed M-T hook) thus stabilizing the interaction of the inhibitor with the deep pocket on the N-terminal heptad repeat. In this study, we further demonstrated that the M-T hook structure is a key determinant of CP621-652 in terms of its thermostability and anti-HIV activity. To directly define the structure and function of the M-T hook, we generated the peptide MT-C34 by incorporating Met-626 and Thr-627 into the N terminus of the C-terminal heptad repeat-derived peptide C34. The high resolution crystal structure (1.9 angstrom) of MT-C34 complexed by an N-terminal heptad repeat-derived peptide reveals that the M-T hook conformation is well preserved at the N-terminal extreme of the inhibitor. Strikingly, addition of two hook residues could dramatically enhance the binding affinity and thermostability of 6-helix bundle core. Compared with C34, MT-C34 exhibited significantly increased activity to inhibit HIV-1 envelope-mediated cell fusion (6.6-fold), virus entry (4.5-fold), and replication (6-fold). Mechanistically, MT-C34 had a 10.5-fold higher increase than C34 in blocking 6-helix bundle formation. We further showed that MT-C34 possessed higher potency against T20 (Enfuvirtide, Fuzeon)-resistant HIV-1 variants. Therefore, this study provides convincing data for our proposed concept that the M-T hook structure is critical for designing HIV-1 fusion inhibitors.	[Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Chong, Huihui; Yao, Xue; Sun, Jianping; Qiu, Zonglin; Zhang, Meng; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Cui, S (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cui.sheng@ipb.pumc.edu.cn; yhe@ipb.pumc.edu.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	Natural Science Foundation of China [81025009, 81271830]; National 973 Program of China [2010CB530100]; Beijing Natural Science Foundation [7122116]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Outstanding Youth Award of Natural Science Foundation of China Grant 81025009, National 973 Program of China Grant 2010CB530100, Natural Science Foundation of China Grant 81271830, and Beijing Natural Science Foundation Grant 7122116.	Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Li J, 2009, IMMUNOBIOLOGY, V214, P51, DOI 10.1016/j.imbio.2008.04.005; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000; Wexler-Cohen Y, 2006, J BIOL CHEM, V281, P9005, DOI 10.1074/jbc.M512475200; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao X, 2012, J BIOL CHEM, V287, P26618, DOI 10.1074/jbc.M112.381079; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	44	49	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34558	34568		10.1074/jbc.M112.390393	http://dx.doi.org/10.1074/jbc.M112.390393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879603	Green Published, hybrid			2022-12-28	WOS:000309654200059
J	Woloszynek, JC; Hu, Y; Pham, CTN				Woloszynek, Josh C.; Hu, Ying; Pham, Christine T. N.			Cathepsin G-regulated Release of Formyl Peptide Receptor Agonists Modulate Neutrophil Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; N-TERMINAL PEPTIDE; ANNEXIN-I; CATHELICIDIN PEPTIDE; HOST-DEFENSE; ANTIMICROBIAL PEPTIDES; INSULIN-SECRETION; SERINE PROTEASES; LAVAGE FLUID; LIPOCORTIN 1	Neutrophil serine proteases play an important role in inflammation by modulating neutrophil effector functions. We have previously shown that neutrophils deficient in the serine proteases cathepsin G and neutrophil elastase (CG/NE neutrophils) exhibit severe defects in chemokine CXCL2 release and reactive oxygen species (ROS) production when activated on immobilized immune complex. Exogenously added active CG rescues these defects, but the mechanism remains undefined. Using a protease-based proteomic approach, we found that, in vitro, the addition of exogenous CG to immune complex-stimulated CG/NE neutrophils led to a decrease in the level of cell-associated annexin A1 (AnxA1) and cathelin-related antimicrobial peptide (CRAMP), both known inflammatory mediators. We further confirmed that, in vivo, CG was required for the extracellular release of AnxA1 and CRAMP in a subcutaneous air pouch model. In vitro, CG efficiently cleaved AnxA1, releasing the active N-terminal peptide Ac2-26, and processed CRAMP in limited fashion. Ac2-26 and CRAMP peptides enhanced the release of CXCL2 by CG/NE neutrophils in a dose-dependent manner via formyl peptide receptor (FPR) stimulation. Blockade of FPRs by an antagonist, Boc2 (t-Boc-Phe-D-Leu-Phe-D-Leu-Phe), abrogates CXCL2 release, whereas addition of FPR agonists, fMLF and F2L, relieves Boc2 inhibition. Furthermore, the addition of active CG, but not inactive CG, also relieves Boc2 inhibition. These findings suggest that CG modulates neutrophil effector functions partly by controlling the release (and proteolysis) of FPR agonists. Unexpectedly, we found that mature CRAMP, but not Ac2-26, induced ROS production through an FPR-independent pathway.	[Woloszynek, Josh C.; Hu, Ying; Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pham, CTN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, 660 S Euclid Ave,Bx 8045, St Louis, MO 63110 USA.	cpham@dom.wustl.edu			Arthritis Foundation; National Institutes of Health [AR007279, AI049261, AI049261-08S2, P30AR048335]; National Institutes of Health, NCI Cancer Center [P30 CA91842]; National Center for Research Resources, a component of the National Institutes of Health [UL1 RR024992]; National Institutes of Health Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049261, R01AI049261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335, T32AR007279] Funding Source: NIH RePORTER	Arthritis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a postdoctoral fellowship from the Arthritis Foundation (to J. C. W.), National Institutes of Health T32 Training Grant AR007279 (to J. C. W.), and the National Institutes of Health Grants AI049261 and supplemental AI049261-08S2 (to C. T. N. P.). The Siteman Cancer Center is supported in part by National Institutes of Health, NCI Cancer Center Support Grant P30 CA91842. The Speed Congenics Facility of the Rheumatic Diseases Core Center is supported by National Institutes of Health Grant P30AR048335. This work was also supported by Grant UL1 RR024992 from the National Center for Research Resources, a component of the National Institutes of Health and the National Institutes of Health Roadmap for Medical Research.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bjerknes R, 1997, EUR J ENDOCRINOL, V136, P92, DOI 10.1530/eje.0.1360092; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Bylund J, 2001, ANTIMICROB AGENTS CH, V45, P1700, DOI 10.1128/AAC.45.6.1700-1704.2001; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CIRINO G, 1993, BRIT J PHARMACOL, V108, P573, DOI 10.1111/j.1476-5381.1993.tb12843.x; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Hong SH, 2002, FEBS LETT, V532, P17, DOI 10.1016/S0014-5793(02)03613-X; HUANG KS, 1987, J BIOL CHEM, V262, P7639; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PEPINSKY RB, 1986, J BIOL CHEM, V261, P4239; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rafiq K, 2008, CIRC RES, V102, P32, DOI 10.1161/CIRCRESAHA.107.150573; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rescher U, 2006, BBA-MOL CELL RES, V1763, P1320, DOI 10.1016/j.bbamcr.2006.08.041; SMITH SF, 1990, ENVIRON HEALTH PERSP, V85, P135, DOI 10.2307/3430676; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stie J, 2007, J LEUKOCYTE BIOL, V82, P161, DOI 10.1189/jlb.0906586; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tsao FHC, 1998, AM J RESP CELL MOL, V18, P120, DOI 10.1165/ajrcmb.18.1.2808; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; VERBANAC D, 1993, FEBS LETT, V317, P255, DOI 10.1016/0014-5793(93)81287-A; Vishwanatha JK, 1998, CLIN CANCER RES, V4, P2559; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Won JH, 2003, BIOCHEM BIOPH RES CO, V307, P389, DOI 10.1016/S0006-291X(03)01197-5; Xu LM, 2009, INFLAMM RES, V58, P921, DOI 10.1007/s00011-009-0066-y; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang YH, 1997, INFLAMMATION, V21, P583, DOI 10.1023/A:1027330021479; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; Zarember KA, 2002, INFECT IMMUN, V70, P569, DOI 10.1128/IAI.70.2.569-576.2002; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zheng Y, 2007, BRIT J DERMATOL, V157, P1124, DOI 10.1111/j.1365-2133.2007.08196.x; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zuyderduyn S, 2006, J ALLERGY CLIN IMMUN, V117, P1328, DOI 10.1016/j.jaci.2006.03.022	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34101	34109		10.1074/jbc.M112.394452	http://dx.doi.org/10.1074/jbc.M112.394452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879591	Green Published, hybrid			2022-12-28	WOS:000309654200016
J	Guo, J; Wang, TZ; Li, X; Shallow, H; Yang, TH; Li, WT; Xu, JM; Fridman, MD; Yang, XL; Zhang, ST				Guo, Jun; Wang, Tingzhong; Li, Xian; Shallow, Heidi; Yang, Tonghua; Li, Wentao; Xu, Jianmin; Fridman, Michael D.; Yang, Xiaolong; Zhang, Shetuan			Cell Surface Expression of Human Ether-a-go-go-related Gene (hERG) Channels Is Regulated by Caveolin-3 Protein via the Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; SHORT-QT SYNDROME; I-KR; POTASSIUM CHANNEL; MEMBRANE-PROTEINS; EXTRACELLULAR K+; FAMILY; IDENTIFICATION; DEGRADATION; ENDOCYTOSIS	The human ether-a-go-go-related gene (hERG) encodes the rapidly activating delayed rectifier potassium channel (I-Kr) which plays an important role in cardiac repolarization. A reduction or increase in hERG current can cause long or short QT syndrome, respectively, leading to fatal cardiac arrhythmias. The channel density in the plasma membrane is a key determinant of the whole cell current amplitude. To gain insight into the molecular mechanisms for the regulation of hERG density at the plasma membrane, we used whole cell voltage clamp, Western blotting, and immunocytochemical methods to investigate the effects of an integral membrane protein, caveolin-3 (Cav3) on hERG expression levels. Our data demonstrate that Cav3, hERG, and ubiquitin-ligase Nedd4-2 interact with each other and form a complex. Expression of Cav3 thus enhances the hERG-Nedd4-2 interaction, leading to an increased ubiquitination and degradation of mature, plasma-membrane localized hERG channels. Disrupting Nedd4-2 interaction with hERG by mutations eliminates the effects of Cav3 on hERG channels. Knockdown of endogenous Cav3 or Nedd4-2 in cultured neonatal rat ventricular myocytes using siRNA led to an increase in native I-Kr. Our data demonstrate that hERG expression in the plasma membrane is regulated by Cav3 via Nedd4-2. These findings extend our understanding of the regulation of hERG channels and cardiac electrophysiology.	[Guo, Jun; Wang, Tingzhong; Li, Xian; Shallow, Heidi; Yang, Tonghua; Li, Wentao; Xu, Jianmin; Fridman, Michael D.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall,Rm 429, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Wang, Tingzhong/0000-0002-6390-7967; Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research Grant [MOP 72911]; Heart and Stroke Foundation of Ontario Grant [T 6612]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Grant	This work was supported by the Canadian Institutes of Health Research Grant MOP 72911 and the Heart and Stroke Foundation of Ontario Grant T 6612 (to S. Z.).	Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2011, J BIOL CHEM, V286, P34664, DOI 10.1074/jbc.M111.253351; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shallow H, 2011, BIOPHYS J, V100, P102; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	46	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33132	33141		10.1074/jbc.M112.389643	http://dx.doi.org/10.1074/jbc.M112.389643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879586	Green Published, hybrid			2022-12-28	WOS:000309602100005
J	Jung, HI; Gayomba, SR; Rutzke, MA; Craft, E; Kochian, LV; Vatamaniuk, OK				Jung, Ha-il; Gayomba, Sheena R.; Rutzke, Michael A.; Craft, Eric; Kochian, Leon V.; Vatamaniuk, Olena K.			COPT6 Is a Plasma Membrane Transporter That Functions in Copper Homeostasis in Arabidopsis and Is a Novel Target of SQUAMOSA Promoter-binding Protein-like 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; MOLECULAR CHARACTERIZATION; OXIDATIVE STRESS; DOWN-REGULATION; GENE; YEAST; EXPRESSION; DEGRADATION; ELEMENTS	Among the mechanisms controlling copper homeostasis in plants is the regulation of its uptake and tissue partitioning. Here we characterized a newly identified member of the conserved CTR/COPT family of copper transporters in Arabidopsis thaliana, COPT6. We showed that COPT6 resides at the plasma membrane and mediates copper accumulation when expressed in the Saccharomyces cerevisiae copper uptake mutant. Although the primary sequence of COPT6 contains the family conserved domains, including methionine-rich motifs in the extracellular N-terminal domain and a second transmembrane helix (TM2), it is different from the founding family member, S. cerevisiae Ctr1p. This conclusion was based on the finding that although the positionally conserved Met(106) residue in the TM2 of COPT6 is functionally essential, the conserved Met(27) in the N-terminal domain is not. Structure-function studies revealed that the N-terminal domain is dispensable for COPT6 function in copper-replete conditions but is important under copper-limiting conditions. In addition, COPT6 interacts with itself and with its homolog, COPT1, unlike Ctr1p, which interacts only with itself. Analyses of the expression pattern showed that although COPT6 is expressed in different cell types of different plant organs, the bulk of its expression is located in the vasculature. We also show that COPT6 expression is regulated by copper availability that, in part, is controlled by a master regulator of copper homeostasis, SPL7. Finally, studies using the A. thaliana copt6-1 mutant and plants overexpressing COPT6 revealed its essential role during copper limitation and excess.	[Jung, Ha-il; Gayomba, Sheena R.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Rutzke, Michael A.; Craft, Eric; Kochian, Leon V.] Cornell Univ, Robert W Holley Ctr Agr & Hlth, USDA ARS, Ithaca, NY 14853 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA)	Vatamaniuk, OK (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Kochian, Leon/ABH-6148-2020	Kochian, Leon/0000-0003-3416-089X	Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch [125433]; USDA-CSREES NYC-MRF [S1041 125853]; Cornell start-up grant	Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch; USDA-CSREES NYC-MRF(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Cornell start-up grant	This work was supported by the Cornell University Agricultural Experiment Station USDA-CSREES NYC-FFF-Hatch 125433, USDA-CSREES NYC-MRF S1041 125853, and a Cornell start-up grant (to O. K. V).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andres-Colas N, 2010, PLANT PHYSIOL, V153, P170, DOI 10.1104/pp.110.153676; Arteca RN, 2000, PHYSIOL PLANTARUM, V108, P188, DOI 10.1034/j.1399-3054.2000.108002188.x; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohu CM, 2007, PHYSIOL PLANTARUM, V129, P747, DOI 10.1111/j.1399-3054.2007.00879.x; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2007, BIOMETALS, V20, P705, DOI 10.1007/s10534-006-9054-7; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Garcia-Molina A, 2011, PLANT J, V65, P848, DOI 10.1111/j.1365-313X.2010.04472.x; Gavnholt B, 2002, PHYSIOL PLANTARUM, V116, P273, DOI 10.1034/j.1399-3054.2002.1160301.x; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jung HI, 2011, METHODS MOL BIOL, V744, P109, DOI 10.1007/978-1-61779-123-9_8; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Kim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012938; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Klaumann S, 2011, NEW PHYTOL, V192, P393, DOI 10.1111/j.1469-8137.2011.03798.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lequeux H, 2010, PLANT PHYSIOL BIOCH, V48, P673, DOI 10.1016/j.plaphy.2010.05.005; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; MURPHY A, 1995, PLANT PHYSIOL, V108, P29, DOI 10.1104/pp.108.1.29; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sancenon V, 2004, J BIOL CHEM, V279, P15348, DOI 10.1074/jbc.M313321200; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Xiao ZG, 2002, CHEM COMMUN, P588, DOI 10.1039/b111180a; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yonkovich J, 2002, J BIOL CHEM, V277, P23981, DOI 10.1074/jbc.C200203200; Yuan M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-69; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhai Zhiyang, 2009, J Vis Exp, DOI 10.3791/1149; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	73	60	68	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33252	33267		10.1074/jbc.M112.397810	http://dx.doi.org/10.1074/jbc.M112.397810			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865877	hybrid, Green Published			2022-12-28	WOS:000309602100015
J	Nishimura, R; Wakabayashi, M; Hata, K; Matsubara, T; Honma, S; Wakisaka, S; Kiyonari, H; Shioi, G; Yamaguchi, A; Tsumaki, N; Akiyama, H; Yoneda, T				Nishimura, Riko; Wakabayashi, Makoto; Hata, Kenji; Matsubara, Takuma; Honma, Shiho; Wakisaka, Satoshi; Kiyonari, Hiroshi; Shioi, Go; Yamaguchi, Akira; Tsumaki, Noriyuki; Akiyama, Haruhiko; Yoneda, Toshiyuki			Osterix Regulates Calcification and Degradation of Chondrogenic Matrices through Matrix Metalloproteinase 13 (MMP13) Expression in Association with Transcription Factor Runx2 during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CHONDROCYTE DIFFERENTIATION; COLLAGEN GENE; OSTEOBLAST DIFFERENTIATION; CAMPOMELIC DYSPLASIA; BONE-DEVELOPMENT; GROWTH-PLATE; II COLLAGEN; CARTILAGE	Endochondral ossification is temporally and spatially regulated by several critical transcription factors, including Sox9, Runx2, and Runx3. Although the molecular mechanisms that control the late stages of endochondral ossification (e.g. calcification) are physiologically and pathologically important, these precise regulatory mechanisms remain unclear. Here, we demonstrate that Osterix is an essential transcription factor for endochondral ossification that functions downstream of Runx2. The global and conditional Osterix-deficient mice studied here exhibited a defect of cartilage-matrix ossification and matrix vesicle formation. Importantly, Osterix deficiencies caused the arrest of endochondral ossification at the hypertrophic stage. Microarray analysis revealed that matrix metallopeptidase 13 (MMP13) is an important target of Osterix. We also showed that there exists a physical interaction between Osterix and Runx2 and that these proteins function cooperatively to induce MMP13 during chondrocyte differentiation. Most interestingly, the introduction of MMP13 stimulated the calcification of matrices in Osterix-deficient mouse limb bud cells. Our results demonstrated that Osterix was essential to endochondral ossification and revealed that the physical and functional interaction between Osterix and Runx2 were necessary for the induction of MMP13 during endochondral ossification.	[Nishimura, Riko; Wakabayashi, Makoto; Hata, Kenji; Matsubara, Takuma; Yoneda, Toshiyuki] Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Honma, Shiho; Wakisaka, Satoshi] Osaka Univ, Dept Oral Anat, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kiyonari, Hiroshi; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Yamaguchi, Akira] Tokyo Med Dent Sch, Dept Oral Pathol, Bunkyo Ku, Tokyo 1138549, Japan; [Tsumaki, Noriyuki] Osaka Univ, Dept Orthoped, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthoped, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Kyoto University	Nishimura, R (corresponding author), Osaka Univ, Dept Mol & Cellular Biochem, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Matsubara, Takuma/B-5031-2019; Yamaguchi, Akira/AAX-9286-2020; Kiyonari, Hiroshi/N-7936-2015	Matsubara, Takuma/0000-0002-8505-0431; Tsumaki, Noriyuki/0000-0002-0520-3654; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research; 21st Century COE Program; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research; 21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology grants-in-aid for Scientific Research (to T. Y. and R. N.); the 21st Century COE Program (to T. Y. and R. N.); the Uehara Memorial Foundation (to R. N.); and the Astellas Foundation for Research on Metabolic Disorders (to R. N.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kawaguchi H, 2008, MOL CELLS, V25, P1; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu Y, 2000, J BIOL CHEM, V275, P12712, DOI 10.1074/jbc.275.17.12712; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Takahashi I, 1998, J CELL SCI, V111, P2067; Takigawa Y, 2010, J CELL SCI, V123, P3780, DOI 10.1242/jcs.071373; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	38	114	122	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33179	33190		10.1074/jbc.M111.337063	http://dx.doi.org/10.1074/jbc.M111.337063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869368	Green Published, hybrid			2022-12-28	WOS:000309602100009
J	Su, WM; Han, GS; Casciano, J; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Casciano, Jessica; Carman, George M.			Protein Kinase A-mediated Phosphorylation of Pah1p Phosphatidate Phosphatase Functions in Conjunction with the Pho85p-Pho80p and Cdc28p-Cyclin B Kinases to Regulate Lipid Synthesis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CTP SYNTHETASE; PHOSPHOLIPID-SYNTHESIS; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; MEMBRANE-PROTEINS; ORTHOLOGUE PAH1P; CHOLINE KINASE; METABOLISM; IDENTIFICATION	Pah1p, which functions as phosphatidate phosphatase (PAP) in the yeast Saccharomyces cerevisiae, plays a crucial role in lipid homeostasis by controlling the relative proportions of its substrate phosphatidate and its product diacylglycerol. The diacylglycerol produced by PAP is used for the synthesis of triacylglycerol as well as for the synthesis of phospholipids via the Kennedy pathway. Pah1p is a highly phosphorylated protein in vivo and has been previously shown to be phosphorylated by the protein kinases Pho85p-Pho80p and Cdc28p-cyclin B. In this work, we showed that Pah1p was a bona fide substrate for protein kinase A, and we identified by mass spectrometry and mutagenesis that Ser-10, Ser-677, Ser-773, Ser-774, and Ser-788 were the target sites of phosphorylation. Protein kinase A-mediated phosphorylation of Pah1p inhibited its PAP activity by decreasing catalytic efficiency, and the inhibitory effect was primarily conferred by phosphorylation at Ser-10. Analysis of the S10A and S10D mutations (mimicking dephosphorylation and phosphorylation, respectively), alone or in combination with the seven alanine (7A) mutations of the sites phosphorylated by Pho85p-Pho80p and Cdc28p-cyclin B, indicated that phosphorylation at Ser-10 stabilized Pah1p abundance and inhibited its association with membranes, PAP activity, and triacylglycerol synthesis. The S10A mutation enhanced the physiological effects imparted by the 7A mutations, whereas the S10D mutations attenuated the effects of the 7A mutations. These data indicated that the protein kinase A-mediated phosphorylation of Ser-10 functions in conjunction with the phosphorylations mediated by Pho85p-Pho80p and Cdc28p-cyclin B and that phospho-Ser-10 should be dephosphorylated for proper PAP function.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from the USPHS [GM-50679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 from the USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; CULBERTSON MR, 1975, GENETICS, V80, P23; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	85	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33364	33376		10.1074/jbc.M112.402339	http://dx.doi.org/10.1074/jbc.M112.402339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865862	Green Published, hybrid			2022-12-28	WOS:000309602100024
J	Erion, R; DiAngelo, JR; Crocker, A; Sehgal, A				Erion, Renske; DiAngelo, Justin R.; Crocker, Amanda; Sehgal, Amita			Interaction between Sleep and Metabolism in Drosophila with Altered Octopamine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-LIKE PEPTIDES; GENETIC-ANALYSIS; LIFE-SPAN; PROTEIN; GROWTH; STARVATION; RECEPTOR; OBESITY; CELLS; FLIES	Sleep length and metabolic dysfunction are correlated, but the causal relationship between these processes is unclear. Octopamine promotes wakefulness in the fly by acting through the insulin-producing cells (IPCs) in the fly brain. To determine if insulin signaling mediates the effects of octopamine on sleep: wake behavior, we assayed flies in which insulin signaling activity was genetically altered. We found that increasing insulin signaling does not promote wake, nor does insulin appear to mediate the wake-promoting effects of octopamine. Octopamine also affects metabolism in invertebrate species, including, as we show here, Drosophila melanogaster. Triglycerides are decreased in mutants with compromised octopamine signaling and elevated in flies with increased activity of octopaminergic neurons. Interestingly, this effect is mediated at least partially by insulin, suggesting that effects of octopamine on metabolism are independent of its effects on sleep. We further investigated the relative contribution of metabolic and sleep phenotypes to the starvation response of flies with altered octopamine signaling. Hyperactivity (indicative of foraging) induced by starvation was elevated in octopamine receptor mutants, despite their high propensity for sleep, indicating that their metabolic state dictates their behavioral response under these conditions. Moreover, flies with increased octopamine signaling do not suppress sleep in response to starvation, even though they are normally hyper-aroused, most likely because of their high triglyceride levels. Together, these data suggest that observed correlations between sleep and metabolic phenotypes can result from shared molecular pathways rather than causality, and environmental conditions can lead to the dominance of one phenotype over the other.	[Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Neurosci, Translat Res Ctr 10 135, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [DiAngelo, Justin R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Hofstra University	Sehgal, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Translat Res Ctr 10 135, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			National Institutes of Health [P01 AG17628]; Predoctoral Training Grant in Genetics [T32 GM008216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Grant in Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part by National Institutes of Health Grant P01 AG17628 and a Predoctoral Training Grant in Genetics (T32 GM008216, to R. E.).	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hildebrandt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023796; Horne J, 2009, NEUROSCI BIOBEHAV R, V33, P466, DOI 10.1016/j.neubiorev.2008.12.002; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; MACFADYEN UM, 1973, J APPL PHYSIOL, V35, P391, DOI 10.1152/jappl.1973.35.3.391; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thimgan MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000466; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	47	47	47	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32406	32414		10.1074/jbc.M112.360875	http://dx.doi.org/10.1074/jbc.M112.360875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22829591	Green Published, hybrid			2022-12-28	WOS:000309168300011
J	Gabriel, L; Lvov, A; Orthodoxou, D; Rittenhouse, AR; Kobertz, WR; Melikian, HE				Gabriel, Luke; Lvov, Anatoli; Orthodoxou, Demetra; Rittenhouse, Ann R.; Kobertz, William R.; Melikian, Haley E.			The Acid-sensitive, Anesthetic-activated Potassium Leak Channel, KCNK3, Is Regulated by 14-3-3 beta-dependent, Protein Kinase C (PKC)-mediated Endocytic Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; DOMAIN K+ CHANNEL; EPITHELIAL NA+ CHANNELS; DOPAMINE TRANSPORTER; TASK-1 KCNK3; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; MECHANISMS; AMPA	The acid-sensitive neuronal potassium leak channel, KCNK3, is vital for setting the resting membrane potential and is the primary target for volatile anesthetics. Recent reports demonstrate that KCNK3 activity is down-regulated by PKC; however, the mechanisms responsible for PKC-induced KCNK3 down-regulation are undefined. Here, we report that endocytic trafficking dynamically regulates KCNK3 activity. Phorbol esters and Group I metabotropic glutamate receptor (mGluR) activation acutely decreased both native and recombinant KCNK3 currents with concomitant KCNK3 surface losses in cerebellar granule neurons and cell lines. PKC-mediated KCNK3 internalization required the presence of both 14-3-3 beta and a novel potassium channel endocytic motif, because depleting either 14-3-3 beta protein levels or ablating the endocytic motif completely abrogated PKC-regulated KCNK3 trafficking. These results demonstrate that neuronal potassium leak channels are not static membrane residents but are subject to 14-3-3 beta-dependent regulated trafficking, providing a straightforward mechanism to modulate neuronal excitability and synaptic plasticity by Group I mGluRs.	[Gabriel, Luke; Orthodoxou, Demetra; Melikian, Haley E.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA; [Gabriel, Luke; Rittenhouse, Ann R.; Kobertz, William R.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Grad Program Neurosci, Worcester, MA 01604 USA; [Lvov, Anatoli; Kobertz, William R.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01604 USA; [Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Lvov, Anatoli/E-6747-2012; Melikian, Haley/S-8301-2016	Orthodoxou, Demetra/0000-0002-9279-5300; Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169, GM070650]; University of Massachusetts Center for AIDS Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Center for AIDS Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA15169 (to H. E. M.) and GM070650 (to W. R. K.). This work was also supported by the University of Massachusetts Center for AIDS Research (to H. E. M. and W. R. K.).	Ahern CA, 2009, BIOCHEMISTRY-US, V48, P517, DOI 10.1021/bi8018515; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bayliss DA, 2001, RESP PHYSIOL, V129, P159, DOI 10.1016/S0034-5687(01)00288-2; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Buckingham SD, 2005, TRENDS PHARMACOL SCI, V26, P361, DOI 10.1016/j.tips.2005.05.003; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2009, J CELL SCI, V122, P4186, DOI 10.1242/jcs.058420; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kim DY, 2011, J BIOL CHEM, V286, P8106, DOI 10.1074/jbc.M110.134692; Kindler CH, 2005, REGION ANESTH PAIN M, V30, P260, DOI 10.1016/j.rapm.2004.12.001; Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meuth SG, 2003, J NEUROSCI, V23, P6460; Meuth SG, 2009, NEUROBIOL DIS, V33, P1, DOI 10.1016/j.nbd.2008.09.006; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; PREZEAU L, 1994, MOL PHARMACOL, V45, P570; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Ritzen A, 2005, BASIC CLIN PHARMACOL, V97, P202, DOI 10.1111/j.1742-7843.2005.pto_156.x; Sekiyama N, 1996, BRIT J PHARMACOL, V117, P1493, DOI 10.1111/j.1476-5381.1996.tb15312.x; Smith J, 2001, MOL ENDOCRINOL, V15, P1539, DOI 10.1210/me.15.9.1539; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tang B, 2009, AM J RESP CELL MOL, V41, P476, DOI 10.1165/rcmb.2008-0412OC; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; von Zastrow M, 2010, DRUG ALCOHOL DEPEN, V108, P166, DOI 10.1016/j.drugalcdep.2010.02.014; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	80	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32354	32366		10.1074/jbc.M112.391458	http://dx.doi.org/10.1074/jbc.M112.391458			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846993	Green Published, hybrid			2022-12-28	WOS:000309168300007
J	Huang, CD; Bhaskaran, R; Mohanty, S				Huang, Chengdong; Bhaskaran, Rajagopalan; Mohanty, Smita			Eukaryotic N-Glycosylation Occurs via the Membrane-anchored C-terminal Domain of the Stt3p Subunit of Oligosaccharyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OLIGOSACCHARYLTRANSFERASE; YEAST OLIGOSACCHARYLTRANSFERASE; TRANSFERASE COMPLEX; NMR-SPECTROSCOPY; LEISHMANIA-MAJOR; PROTEIN; RECOGNITION; SEQUENCE; SYNTHASE; BIOLOGY	N-Glycosylation is an essential and highly conserved protein modification. In eukaryotes, it is catalyzed by a multisubunit membrane-associated enzyme, oligosaccharyltransferase (OT). We report the high resolution structure of the C-terminal domain of eukaryotic Stt3p. Unlike its soluble beta-sheet-rich prokaryotic counterparts, our model reveals that the C-terminal domain of yeast Stt3p is highly helical and has an overall oblate spheroid-shaped structure containing a membrane-embedded region. Anchoring of this protein segment to the endoplasmic reticulum membrane is likely to bring the membrane-embedded donor substrate closer, thus facilitating glycosylation efficiency. Structural comparison of the region near the WWDYG signature motif revealed that the acceptor substrate-binding site of yeast OT strikingly resembles its prokaryotic counterparts, suggesting a conserved mechanism of N-glycosylation from prokaryotes to eukaryotes. Furthermore, comparison of the NMR and cryo-EM structures of yeast OT revealed that the molecular architecture of this acceptor substrate-recognizing domain has interesting spatial specificity for interactions with other essential OT subunits.	[Huang, Chengdong; Bhaskaran, Rajagopalan; Mohanty, Smita] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Auburn University System; Auburn University	Mohanty, S (corresponding author), Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg,Mell St, Auburn, AL 36849 USA.	mohansm@auburn.edu	Mohanty, Smita/AAP-2969-2021; Huang, Chengdong/G-8454-2018	Huang, Chengdong/0000-0002-8997-9459; Bhaskaran, Raj/0000-0001-8008-9962	National Institutes of Health [GM66340, DK082397]; United States Department of Agriculture PECASE [2003-35302-12930, 2011-65503-20030]; National Science Foundation [IBN-0628064]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture PECASE; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The 900-MHz NMR data were collected at the NMR Facility of the University of Georgia, funded by National Institutes of Health Grant GM66340. We thank Dr. Uma V. Katre for critical reading of the manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grant DK082397 (to S. M.). This work was also supported by United States Department of Agriculture PECASE Award 2003-35302-12930 and Grant 2011-65503-20030 and by National Science Foundation Grant IBN-0628064 (to S. M.).	Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Gayen S, 2011, BIOCHEM BIOPH RES CO, V409, P572, DOI 10.1016/j.bbrc.2011.05.050; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Huang CD, 2010, J AM CHEM SOC, V132, P3662, DOI 10.1021/ja100078z; Huang CD, 2010, BIOCHEMISTRY-US, V49, P1115, DOI 10.1021/bi902181v; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lennarz WJ, 2007, ACTA BIOCHIM POL, V54, P673, DOI 10.18388/abp.2007_3131; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Yan Q, 1999, J BIOL CHEM, V274, P5021, DOI 10.1074/jbc.274.8.5021; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Zubkov S, 2004, P NATL ACAD SCI USA, V101, P3821, DOI 10.1073/pnas.0400512101	43	7	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32450	32458		10.1074/jbc.M112.342253	http://dx.doi.org/10.1074/jbc.M112.342253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865878	hybrid, Green Published			2022-12-28	WOS:000309168300015
J	Qi, RS; Singh, D; Kao, CC				Qi, Rongsu; Singh, Divyendu; Kao, C. Cheng			Proteolytic Processing Regulates Toll-like Receptor 3 Stability and Endosomal Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; NUCLEIC-ACID; BINDING-SITE; TLR3; RECOGNITION; ACTIVATION; UNC93B1; DNA	Toll-like receptors (TLRs) 3, 7, and 9 are innate immune receptors that recognize nucleic acids from pathogens in endosomes and initiate signaling transductions that lead to cytokine production. Activation of TLR9 for signaling requires proteolytic processing within the ectodomain by endosome-associated proteases. Whether TLR3 requires similar proteolytic processing to become competent for signaling remains unclear. Herein we report that human TLR3 is proteolytically processed to form two fragments in endosomes. Unc93b1 is required for processing by transporting TLR3 through the Golgi complex and to the endosomes. Proteolytic cleavage requires the eight-amino acid Loop1 within leucine-rich repeat 12 of the TLR3 ectodomain. Proteolytic cleavage is not required for TLR3 signaling in response to poly(I:C), although processing could modulate the degree of response toward viral double-stranded RNAs, especially in mouse cells. Both the full-length and cleaved fragments of TLR3 can bind poly(I:C) and are present in endosomes. However, although the full-length TLR3 has a half-life in HEK293T cells of 3 h, the cleaved fragments have half-lives in excess of 7 h. Inhibition of TLR3 cleavage by either treatment with cathepsin inhibitor or by a mutation in Loop1 decreased the abundance of TLR3 in endosomes targeted for lysosomal degradation.	[Qi, Rongsu; Singh, Divyendu; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA	Indiana University System; Indiana University Bloomington	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA.	ckao@indiana.edu			Indiana Economic Development Corp.	Indiana Economic Development Corp.	This work was supported in part by a grant from the Indiana Economic Development Corp. (to C. C. K.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Avalos AM, 2011, EUR J IMMUNOL, V41, P2820, DOI 10.1002/eji.201141563; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2006, J ENDOTOXIN RES, V12, P375, DOI 10.1179/096805106X118780; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; CHEN JW, 1986, BIOCHEM SOC SYMP, P97; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fukuda K, 2008, J BIOL CHEM, V283, P22787, DOI 10.1074/jbc.M802284200; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Stenmark H, 2001, GENOME BIOL, V2; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tokisue Takashi, 2008, Nucleic Acids Symp Ser (Oxf), P203, DOI 10.1093/nass/nrn103; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Weber C, 2012, IMMUNOLOGY, V136, P64, DOI 10.1111/j.1365-2567.2012.03559.x; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186	50	69	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32617	32629		10.1074/jbc.M112.387803	http://dx.doi.org/10.1074/jbc.M112.387803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865861	Green Published, hybrid			2022-12-28	WOS:000309168300030
J	Wang, CY; Chen, CL; Tseng, YL; Fang, YT; Lin, YS; Su, WC; Chen, CC; Chang, KC; Wang, YC; Lin, CF				Wang, Chi-Yun; Chen, Chia-Ling; Tseng, Yau-Lin; Fang, Yi-Ting; Lin, Yee-Shin; Su, Wu-Chou; Chen, Chien-Chin; Chang, Kung-Chao; Wang, Yi-Ching; Lin, Chiou-Feng			Annexin A2 Silencing Induces G(2) Arrest of Non-small Cell Lung Cancer Cells through p53-dependent and -independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMER RECOGNITION PROTEINS; N-TERMINAL KINASE; C-JUN; DOWN-REGULATION; DNA-REPLICATION; TYROSINE KINASE; PLASMINOGEN-ACTIVATOR; II OVEREXPRESSION; BINDING PROTEINS; EPITHELIAL-CELLS	Annexin A2 (ANXA2) overexpression is required for cancer cell proliferation; however, the molecular mechanisms underlying ANXA2-mediated regulation of the cell cycle are still unknown. ANXA2 is highly expressed in non-small cell lung cancer (NSCLC) and is positively correlated with a poor prognosis. NSCLC A549 cells lacking ANXA2 exhibited defects in tumor growth in vivo and in cell proliferation in vitro without cytotoxicity. ANXA2 knockdown induced cell cycle arrest at G(2) phase. Unexpectedly, ANXA2 silencing increased the expression of p53 and its downstream genes, which resulted in p53-dependent and -independent G(2) arrest. Aberrant JNK inactivation, which was observed in ANXA2-deficient cells, inhibited cell proliferation following G(2) arrest. A lack of ANXA2 caused a loss of JNK-regulated c-Jun expression, resulting in an increase in p53 transcription. These results demonstrate a novel role for ANXA2 in NSCLC cell proliferation by facilitating the cell cycle partly through the regulation of p53 via JNK/c-Jun.	[Wang, Chi-Yun; Su, Wu-Chou; Chen, Chien-Chin; Chang, Kung-Chao; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan; [Wang, Chi-Yun; Lin, Yee-Shin; Su, Wu-Chou; Wang, Yi-Ching; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Chen, Chia-Ling; Fang, Yi-Ting; Lin, Yee-Shin; Lin, Chiou-Feng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Coll Med, Tainan 701, Taiwan; [Tseng, Yau-Lin] Natl Cheng Kung Univ, Dept Surg, Coll Med, Tainan 701, Taiwan; [Lin, Yee-Shin; Lin, Chiou-Feng] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Su, Wu-Chou] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan 701, Taiwan; [Chen, Chien-Chin; Chang, Kung-Chao] Natl Cheng Kung Univ, Dept Pathol, Coll Med, Tainan 701, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Lin, CF (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.	cflin@mail.ncku.edu.tw	Chen, Chien-Chin/A-9977-2016; Wang, Yi-Ching/J-8702-2019	Chen, Chien-Chin/0000-0001-9599-0884; Wang, Yi-Ching/0000-0002-7694-2067; Su, Wu-Chou/0000-0003-2953-4105; Wang, Chi-Yun/0000-0003-0317-5378	National Science Council, Taiwan [100-2320-B-006-009-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Grant 100-2320-B-006-009-MY3.	Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Bao HY, 2009, INT J HEMATOL, V90, P177, DOI 10.1007/s12185-009-0356-8; Braden AR, 2009, J NANOSCI NANOTECHNO, V9, P2856, DOI 10.1166/jnn.2009.028; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; COLE SPC, 1992, BRIT J CANCER, V65, P498, DOI 10.1038/bjc.1992.103; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Emoto K, 2001, ANTICANCER RES, V21, P1339; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Feigenberg SJ, 2007, J THORAC ONCOL, V2, P287, DOI 10.1097/01.JTO.0000263710.54073.b3; Frank GD, 2000, BIOCHEM BIOPH RES CO, V270, P761, DOI 10.1006/bbrc.2000.2505; FRITSCHE M, 1993, ONCOGENE, V8, P307; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Gillette JM, 2004, J CELL BIOCHEM, V92, P820, DOI 10.1002/jcb.20117; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; Hansen MDH, 2002, J BIOL CHEM, V277, P45371, DOI 10.1074/jbc.M207747200; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang PY, 2010, PROTEIN CELL, V1, P218, DOI 10.1007/s13238-010-0019-9; Huang Y, 2008, MOL CELL BIOCHEM, V309, P117, DOI 10.1007/s11010-007-9649-5; Inanami O, 1999, ANTIOXID REDOX SIGN, V1, P501, DOI 10.1089/ars.1999.1.4-501; Ishida T, 2006, BIOORG MED CHEM LETT, V16, P1859, DOI 10.1016/j.bmcl.2006.01.032; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Kassam G, 1997, J BIOL CHEM, V272, P15093, DOI 10.1074/jbc.272.24.15093; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; KUMBLE KD, 1992, J CELL SCI, V101, P35; Langfort Renata, 2010, Pneumonol Alergol Pol, V78, P379; Liu Jie, 2003, BMC Biochem, V4, P10, DOI 10.1186/1471-2091-4-10; Liu SL, 2002, ARCH BIOCHEM BIOPHYS, V406, P173, DOI 10.1016/S0003-9861(02)00430-7; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Nygaard SJT, 1998, J NEURO-ONCOL, V38, P11, DOI 10.1023/A:1005953000523; Ohtani-Fujita N, 1998, BIOCHEM BIOPH RES CO, V251, P648, DOI 10.1006/bbrc.1998.9511; Paciucci R, 1998, ONCOGENE, V16, P625, DOI 10.1038/sj.onc.1201564; Pedeux R, 2002, INT J CANCER, V98, P811, DOI 10.1002/ijc.10275; Petersson S, 2009, MELANOMA RES, V19, P215, DOI 10.1097/CMR.0b013e32832c6358; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rodrigo JP, 2011, HEAD NECK-J SCI SPEC, V33, P1708, DOI 10.1002/hed.21661; ROSEMAN BJ, 1994, ONCOL RES, V6, P561; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shang LS, 2009, J CELL MOL MED, V13, P4176, DOI 10.1111/j.1582-4934.2008.00468.x; Sharma MR, 2006, EXP MOL PATHOL, V81, P136, DOI 10.1016/j.yexmp.2006.03.002; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; VISHWANATHA JK, 1993, CARCINOGENESIS, V14, P2575, DOI 10.1093/carcin/14.12.2575; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; VISHWANATHA JK, 1993, J CELL SCI, V105, P533; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Wang CY, 2009, MOL BIOL CELL, V20, P4153, DOI 10.1091/mbc.E09-02-0174; Wang TN, 2010, CANCER-AM CANCER SOC, V116, P1518, DOI 10.1002/cncr.24871; Wang YX, 2012, PATHOL ONCOL RES, V18, P183, DOI 10.1007/s12253-011-9427-2; Warnes GR, 2009, GPLOTS VARIOUS R PRO, V2, P4; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Win T, 2008, LUNG, V186, P97, DOI 10.1007/s00408-007-9067-1; Xiao L, 2000, CANCER RES, V60, P400; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Zhang J, 2010, SAUDI MED J, V31, P374; Zhang SY, 2008, LUNG CANCER, V62, P295, DOI 10.1016/j.lungcan.2008.05.008; Zhang Xun, 2003, Zhonghua Zhongliu Zazhi, V25, P353	89	58	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32512	32524		10.1074/jbc.M112.351957	http://dx.doi.org/10.1074/jbc.M112.351957			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859294	Green Published, hybrid			2022-12-28	WOS:000309168300021
J	Arulanandam, BP; Chetty, SL; Yu, JJ; Leonard, S; Klose, K; Seshu, J; Cap, A; Valdes, JJ; Chambers, JP				Arulanandam, Bernard P.; Chetty, Senthilnath Lakshmana; Yu, Jieh-Juen; Leonard, Sean; Klose, Karl; Seshu, Janakiram; Cap, Andrew; Valdes, James J.; Chambers, James P.			Francisella DnaK Inhibits Tissue-nonspecific Alkaline Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; TULARENSIS SUBSP NOVICIDA; PROTECTIVE IMMUNITY; ESCHERICHIA-COLI; SERUM COMPONENTS; WHOLE-BLOOD; IN-VIVO; SCHU S4; MICE; CHALLENGE	Following pulmonary infection with Francisella tularensis, we observed an unexpected but significant reduction of alkaline phosphatase, an enzyme normally up-regulated following inflammation. However, no reduction was observed in mice infected with a closely related Gram-negative pneumonic organism (Klebsiella pneumoniae) suggesting the inhibition may be Francisella-specific. In similar fashion to in vivo observations, addition of Francisella lysate to exogenous alkaline phosphatase (tissue-nonspecific isozyme) was inhibitory. Partial purification and subsequent proteomic analysis indicated the inhibitory factor to be the heat shock protein DnaK. Incubation with increasing amounts of anti-DnaK antibody reduced the inhibitory effect in a dose-dependent manner. Furthermore, DnaK contains an adenosine triphosphate binding domain at its N terminus, and addition of adenosine triphosphate enhances dissociation of DnaK with its target protein, e. g. alkaline phosphatase. Addition of adenosine triphosphate resulted in decreased DnaK co-immunoprecipitated with alkaline phosphatase as well as reduction of Francisella-mediated alkaline phosphatase inhibition further supporting the binding of Francisella DnaK to alkaline phosphatase. Release of DnaK via secretion and/or bacterial cell lysis into the extracellular milieu and inhibition of plasma alkaline phosphatase could promote an orchestrated, inflammatory response advantageous to Francisella.	[Arulanandam, Bernard P.; Chetty, Senthilnath Lakshmana; Yu, Jieh-Juen; Leonard, Sean; Klose, Karl; Seshu, Janakiram; Chambers, James P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Cap, Andrew] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Valdes, James J.] USA, Edgewood Chem Biol Command, Aberdeen Proving Ground, MD 21010 USA	University of Texas System; University of Texas at San Antonio (UTSA); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Chambers, JP (corresponding author), Univ Texas San Antonio, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	james.chambers@UTSA.edu	Arulanandam, Bernard P/O-9501-2014	Lakshmanachetty, Senthilnath/0000-0002-3760-2772	National Institutes of Health [AI057986]; Center of Excellence in Infection Genomics Contract [W911NF-11-1-0136]; San Antonio Life Sciences Institute [14-3300-24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Infection Genomics Contract; San Antonio Life Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI057986, Center of Excellence in Infection Genomics Contract W911NF-11-1-0136, and San Antonio Life Sciences Institute Grant 14-3300-24.	Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Coburn SP, 1998, J CLIN ENDOCR METAB, V83, P3951, DOI 10.1210/jc.83.11.3951; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; EDELSON JD, 1988, AM REV RESPIR DIS, V138, P1268, DOI 10.1164/ajrccm/138.5.1268; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FERNLEY HN, 1969, BIOCHEM J, V111, P187, DOI 10.1042/bj1110187; Fossati G, 2003, J BACTERIOL, V185, P4256, DOI 10.1128/JB.185.14.4256-4267.2003; Fraley CD, 2007, P NATL ACAD SCI USA, V104, P3526, DOI 10.1073/pnas.0609733104; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAMBLETON P, 1977, BRIT J EXP PATHOL, V58, P644; HAMBLETON P, 1978, BRIT J EXP PATHOL, V59, P630; Havlasova J, 2002, PROTEOMICS, V2, P857, DOI 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; KELLER JA, 1988, MOL MICROBIOL, V2, P31, DOI 10.1111/j.1365-2958.1988.tb00004.x; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; OHKUBO A, 1974, J BIOL CHEM, V249, P7174; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Poelstra K, 1997, LAB INVEST, V76, P319; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Richards MI, 2008, J MED MICROBIOL, V57, P1183, DOI 10.1099/jmm.0.2008/001826-0; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vanet A, 1998, INFECT IMMUN, V66, P1023, DOI 10.1128/IAI.66.3.1023-1027.1998; Verweij WR, 2004, SHOCK, V22, P174, DOI 10.1097/01.shk.0000132485.05049.8a; VOLLER A, 1976, BRIT J EXP PATHOL, V57, P243; Xu Q, 2002, LIVER, V22, P8, DOI 10.1034/j.1600-0676.2002.220102.x; Yu JJ, 2008, EUR J CLIN MICROBIOL, V27, P323, DOI 10.1007/s10096-007-0434-x	44	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37185	37194		10.1074/jbc.M112.404400	http://dx.doi.org/10.1074/jbc.M112.404400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22923614	Green Published, hybrid			2022-12-28	WOS:000310588500052
J	Epstein, LF; Chen, H; Emkey, R; Whittington, DA				Epstein, Linda F.; Chen, Hao; Emkey, Renee; Whittington, Douglas A.			The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NON-HODGKINS-LYMPHOMA; FACTOR-I RECEPTOR; CRYSTAL-STRUCTURE; EXPERIMENTAL-MODELS; ANTITUMOR-ACTIVITY; ALK KINASE; CHROMOSOMAL TRANSLOCATION; PROTEIN-KINASES; LUNG-CANCER	Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that, when genetically altered by mutation, amplification, chromosomal translocation or inversion, has been shown to play an oncogenic role in certain cancers. Small molecule inhibitors targeting the kinase activity of ALK have proven to be effective therapies in certain ALK-driven malignancies and one such inhibitor, crizotinib, is now approved for the treatment of EML4-ALK-driven, non-small cell lung cancer. In neuroblastoma, activating point mutations in the ALK kinase domain can drive disease progression, with the two most common mutations being F1174L and R1275Q. We report here crystal structures of the ALK kinase domain containing the F1174L and R1275Q mutations. Also included are crystal structures of ALK in complex with novel small molecule ALK inhibitors, including a classic type II inhibitor, that stabilize previously unobserved conformations of the ALK activation loop. Collectively, these structures illustrate a different series of activation loop conformations than has been observed in previous ALK crystal structures and provide insight into the activating nature of the R1275Q mutation. The novel active site topologies presented here may also aid the structure-based drug design of a new generation of ALK inhibitors.	[Epstein, Linda F.; Chen, Hao; Emkey, Renee; Whittington, Douglas A.] Amgen Inc, Dept Mol Struct & Characterizat, Cambridge, MA 02142 USA	Amgen	Whittington, DA (corresponding author), 360 Binney St, Cambridge, MA 02142 USA.	dwhittin@amgen.com			Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC0206CH11357]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	We thank John Robinson for N-terminal sequencing and Michele Potashman and Marian C. Bryan for the synthesis of compounds 1 and 2, respectively. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC0206CH11357. Research performed at the Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Arber DA, 1996, HUM PATHOL, V27, P590, DOI 10.1016/S0046-8177(96)90167-7; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bossi RT, 2010, BIOCHEMISTRY-US, V49, P6813, DOI 10.1021/bi1005514; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Bryan MC, 2012, J MED CHEM, V55, P1698, DOI 10.1021/jm201565s; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Drew AE, 2011, J BIOMOL SCREEN, V16, P164, DOI 10.1177/1087057110394657; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grande E, 2011, MOL CANCER THER, V10, P569, DOI 10.1158/1535-7163.MCT-10-0615; Griffin CA, 1999, CANCER RES, V59, P2776; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kinoshita K, 2011, J MED CHEM, V54, P6286, DOI 10.1021/jm200652u; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lee CC, 2010, BIOCHEM J, V430, P425, DOI 10.1042/BJ20100609; Lewis RT, 2012, J MED CHEM, V55, P6523, DOI 10.1021/jm3005866; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; McTigue MA, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2327; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ott GR, 2011, J MED CHEM, V54, P6328, DOI 10.1021/jm200758k; Ott GR, 2010, ACS MED CHEM LETT, V1, P493, DOI 10.1021/ml100158s; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Potashman MH, 2007, J MED CHEM, V50, P4351, DOI 10.1021/jm070034i; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Wood AC, 2009, J CLIN ONCOL, V27	63	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37447	37457		10.1074/jbc.M112.391425	http://dx.doi.org/10.1074/jbc.M112.391425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22932897	hybrid, Green Published			2022-12-28	WOS:000310588500074
J	Jaspers, MHJ; Nolde, K; Behr, M; Joo, SH; Plessmann, U; Nikolov, M; Urlaub, H; Schuh, R				Jaspers, Martin H. J.; Nolde, Kai; Behr, Matthias; Joo, Seol-hee; Plessmann, Uwe; Nikolov, Miroslav; Urlaub, Henning; Schuh, Reinhard			The Claudin Megatrachea Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTION ORGANIZATION; TUBE-SIZE; TIGHT JUNCTIONS; NA+/K+ ATPASE; DROSOPHILA; ENDOCYTOSIS; BINDING; MATRIX; MORPHOGENESIS; LOCALIZATION	Claudins are integral transmembrane components of the tight junctions forming trans-epithelial barriers in many organs, such as the nervous system, lung, and epidermis. In Drosophila three claudins have been identified that are required for forming the tight junctions analogous structure, the septate junctions (SJs). The lack of claudins results in a disruption of SJ integrity leading to a breakdown of the trans-epithelial barrier and to disturbed epithelial morphogenesis. However, little is known about claudin partners for transport mechanisms and membrane organization. Here we present a comprehensive analysis of the claudin proteome in Drosophila by combining biochemical and physiological approaches. Using specific antibodies against the claudin Megatrachea for immunoprecipitation and mass spectrometry, we identified 142 proteins associated with Megatrachea in embryos. The Megatrachea interacting proteins were analyzed in vivo by tissue-specific knockdown of the corresponding genes using RNA interference. We identified known and novel putative SJ components, such as the gene product of CG3921. Furthermore, our data suggest that the control of secretion processes specific to SJs and dependent on Sec61p may involve Megatrachea interaction with Sec61 subunits. Also, our findings suggest that clathrin-coated vesicles may regulate Megatrachea turnover at the plasma membrane similar to human claudins. As claudins are conserved both in structure and function, our findings offer novel candidate proteins involved in the claudin interactome of vertebrates and invertebrates.	[Schuh, Reinhard] Max Planck Inst Biophys Chem, Res Grp Mol Organogenesis, D-37077 Gottingen, Germany; [Plessmann, Uwe; Nikolov, Miroslav; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Behr, Matthias] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Bonn	Schuh, R (corresponding author), Max Planck Inst Biophys Chem, Res Grp Mol Organogenesis, D-37077 Gottingen, Germany.	rschuh@gwdg.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257	Max-Planck-Society [MPIbpc Abt.11020]; Deutsche Forschungsgemeinschaft [SFB645]; Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen	This work was supported by the Max-Planck-Society (MPIbpc Abt.11020).; Supported by the Deutsche Forschungsgemeinschaft (SFB645).; Supported by a fellowship from the Ph.D. program "Molecular Biology," International Max Planck Research School at the Georg August University Gottingen.	Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; BAZINET C, 1993, GENETICS, V134, P1119; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Ivanov AI, 2004, NOVART FDN SYMP, V263, P124; IVANOV AI, 2004, NOVART FDN SYMP, V263, P211; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wingen C, 2009, GENE EXPR PATTERNS, V9, P549, DOI 10.1016/j.gep.2009.06.007; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Zhang C. X., 2000, DROSOPHILA PROTOCOLS, P563	53	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36756	36765		10.1074/jbc.M112.399410	http://dx.doi.org/10.1074/jbc.M112.399410			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930751	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310588500013
J	Mockel, A; Obringer, C; Hakvoort, TBM; Seeliger, M; Lamers, WH; Stoetzel, C; Dollfus, H; Marion, V				Mockel, Anais; Obringer, Cathy; Hakvoort, Theodorus B. M.; Seeliger, Mathias; Lamers, Wouter H.; Stoetzel, Corinne; Dollfus, Helene; Marion, Vincent			Pharmacological Modulation of the Retinal Unfolded Protein Response in Bardet-Biedl Syndrome Reduces Apoptosis and Preserves Light Detection Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INITIATION-FACTOR 2-ALPHA; RETINITIS-PIGMENTOSA; VALPROIC ACID; MOUSE MODEL; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; CILIA DEFECTS; CELL FATE	Ciliopathies, a class of rare genetic disorders, present often with retinal degeneration caused by protein transport defects between the inner segment and the outer segment of the photoreceptors. Bardet-Biedl syndrome is one such ciliopathy, genetically heterogeneous with 17 BBS genes identified to date, presenting early onset retinitis pigmentosa. By investigating BBS12-deprived retinal explants and the Bbs12(-/-) murine model, we show that the impaired intraciliary transport results in protein retention in the endoplasmic reticulum. The protein overload activates a proapoptotic unfolded protein response leading to a specific Caspase12-mediated death of the photoreceptors. Having identified a therapeutic window in the early postnatal retinal development and through optimized pharmacological modulation of the unfolded protein response, combining three specific compounds, namely valproic acid, guanabenz, and a specific Caspase12 inhibitor, achieved efficient photoreceptor protection, thereby maintaining light detection ability in vivo.	[Marion, Vincent] Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res INSERM,EA 3949, Lab Physiopathol Syndromes Rares Hereditaires,AVE, F-67085 Strasbourg, France; [Hakvoort, Theodorus B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1100 DD Amsterdam, Netherlands; [Seeliger, Mathias; Stoetzel, Corinne] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, D-72076 Tubingen, Germany; [Dollfus, Helene] Hop Univ Strasbourg, Serv Genet Med, F-67200 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Marion, V (corresponding author), Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res INSERM,EA 3949, Lab Physiopathol Syndromes Rares Hereditaires,AVE, 9th Floor,Bldg 3,11 Rue Humann, F-67085 Strasbourg, France.	vincent.marion@unistra.fr	Lamers, Wouter H./D-2965-2012; Marion, Vincent/H-9730-2016	Marion, Vincent/0000-0002-8271-7376; Dollfus, Helene/0000-0002-2249-895X; obringer, cathy/0000-0002-7349-8749	Agence Nationale pour la Recherche (ANR Call for Rare Diseases); INSERM Avenir Program; RETINA France; UNADEV; Fondation de France	Agence Nationale pour la Recherche (ANR Call for Rare Diseases)(French National Research Agency (ANR)); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); RETINA France; UNADEV; Fondation de France(Fondation de France)	This work was supported by the Agence Nationale pour la Recherche (ANR Call for Rare Diseases 2009) and the INSERM Avenir Program.; We thank RETINA France, UNADEV, Fondation de France, and the patient associations for support. We thank the Institut Clinique de la Souris for the generation of the Bbs12 mouse model, Michel Roux for the lending of the ERG device, and UMR748 employees for the mice breeding.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balan AG, 2010, ALCOHOL, V44, P553, DOI 10.1016/j.alcohol.2010.07.003; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Clemson CM, 2011, BRIT J OPHTHALMOL, V95, P89, DOI 10.1136/bjo.2009.175356; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sandberg MA, 2011, BRIT J OPHTHALMOL, V95, P744, DOI 10.1136/bjo.2010.198176; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Schooneveld MJ, 2011, BRIT J OPHTHALMOL, V95, P153, DOI 10.1136/bjo.2010.194373; Wang JF, 1999, MOL PHARMACOL, V55, P521; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhang ZZ, 2011, NEUROSCI LETT, V504, P88, DOI 10.1016/j.neulet.2011.09.003	59	35	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37483	37494		10.1074/jbc.M112.386821	http://dx.doi.org/10.1074/jbc.M112.386821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22869374	hybrid, Green Published			2022-12-28	WOS:000310588500077
J	Fang, Y; Yu, YH; Hou, Q; Zheng, X; Zhang, M; Zhang, DY; Li, JX; Wu, XR; Huang, CS				Fang, Yong; Yu, Yonghui; Hou, Qi; Zheng, Xiao; Zhang, Min; Zhang, Dongyun; Li, Jingxia; Wu, Xue-Ru; Huang, Chuanshu			The Chinese Herb Isolate Isorhapontigenin Induces Apoptosis in Human Cancer Cells by Down-regulating Overexpression of Antiapoptotic Protein XIAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED INHIBITOR; TRAIL-MEDIATED APOPTOSIS; NUCLEAR-FACTOR; GENE PROMOTER; IN-VITRO; EXPRESSION; INDUCTION; ARSENITE; SP1; PROLIFERATION	Although the Chinese herb Gnetum cleistostachyum has been used as a remedy for cancers for hundred years, the active compounds and molecular mechanisms underlying its anti-cancer activity have not been explored. Recently a new derivative of stilbene compound, isorhapontigenin (ISO), was isolated from this Chinese herb. In the present study, we examined the potential of ISO in anti-cancer activity and the mechanisms involved in human cancer cell lines. We found that ISO exhibited significant inhibitory effects on human bladder cancer cell growth that was accompanied by marked apoptotic induction as well as down-regulation of the X-linked inhibitor of apoptosis protein (XIAP). Further studies have shown that ISO down-regulation of XIAP protein expression was only observed in endogenous XIAP, but not in constitutionally exogenously expressed XIAP in the same cells, excluding the possibility of ISO regulating XIAP expression at the level of protein degradation. We also identified that ISO down-regulated XIAP gene transcription via inhibition of Sp1 transactivation. There was no significant effect of ISO on apoptosis and colony formation of cells transfected with exogenous HA-tagged XIAP. Collectively, current studies, for the first time to the best of our knowledge, identify ISO as a major active compound for the anti-cancer activity of G. cleistostachyum by down-regulation of XIAP expression and induction of apoptosis through specific targeting of a SP1 pathway, and cast new light on the treatment of the cancer patients with XIAP overexpression.	[Fang, Yong; Yu, Yonghui; Zheng, Xiao; Zhang, Min; Zhang, Dongyun; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Fang, Yong] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310016, Zhejiang, Peoples R China; [Hou, Qi] Mat Med Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Hou, Qi] Peking Union Med Coll, Beijing 100050, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York University; New York University	Huang, CS (corresponding author), 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health from NCI [CA112557]; NIEHS [ES000260, ES010344]; National Science Foundation [NSFC81229002, NSFC30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from the NCI, ES000260 and ES010344 from the NIEHS, and National Science Foundation Grants NSFC81229002 and NSFC30971516.	Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cai T, 2011, CURR CANCER DRUG TAR, V11, P548, DOI 10.2174/156800911795656001; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, MOL CANCER THER, V8, P2762, DOI 10.1158/1535-7163.MCT-09-0509; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Holt SV, 2011, ONCOL REP, V25, P1177, DOI 10.3892/or.2011.1167; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Huang KS, 2002, PLANTA MED, V68, P916, DOI 10.1055/s-2002-34951; Huang KS, 2000, PHYTOCHEMISTRY, V54, P875, DOI 10.1016/S0031-9422(00)00151-5; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; Jiang C, 2011, MOL MED REP, V4, P667, DOI 10.3892/mmr.2011.472; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li HL, 2005, FREE RADICAL BIO MED, V38, P243, DOI 10.1016/j.freeradbiomed.2004.10.020; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Liu Y, 2011, J INT MED RES, V39, P1682, DOI 10.1177/147323001103900510; Liu YL, 2004, BIOCHEM PHARMACOL, V67, P777, DOI 10.1016/j.bcp.2003.09.025; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Rajput Sandeep, 2010, Front Biosci (Schol Ed), V2, P176; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; Shibata T, 2008, ANN SURG ONCOL, V15, P3579, DOI 10.1245/s10434-008-0062-4; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Song L, 2011, ONCOGENE, V30, P1360, DOI 10.1038/onc.2010.506; Wai PY, 2012, WORLD J CLIN ONCOL, V3, P15, DOI 10.5306/wjco.v3.i2.15; Wang SM, 2011, CURR TOP MICROBIOL, V348, P89, DOI 10.1007/82_2010_111; Wang ZH, 2011, INT J ONCOL, V39, P1123, DOI 10.3892/ijo.2011.1115; Yano K, 2011, INT J ONCOL, V38, P365, DOI 10.3892/ijo.2010.874; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002; Zhang LA, 2010, CLIN CANCER RES, V16, P4478, DOI 10.1158/1078-0432.CCR-10-0859	40	50	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35234	35243		10.1074/jbc.M112.389494	http://dx.doi.org/10.1074/jbc.M112.389494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896709	Green Published, hybrid			2022-12-28	WOS:000309968000033
J	Hanna, J; Waterman, D; Boselli, M; Finley, D				Hanna, John; Waterman, David; Boselli, Monica; Finley, Daniel			Spg5 Protein Regulates the Proteasome in Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; BUDDING YEAST; DEGRADATION; PARTICLE; GENE; IDENTIFICATION; STARVATION; COMPLEXES; AUTOPHAGY	The ubiquitin-proteasome system is the major pathway for selective protein degradation in eukaryotes. Despite extensive study of this system, the mechanisms by which proteasome function and cell growth are coordinated remain unclear. Here, we identify Spg5 as a novel component of the ubiquitin-proteasome system. Spg5 binds the regulatory particle of the proteasome and the base subassembly in particular, but it is excluded from mature proteasomes. The SPG5 gene is strongly induced in the stationary phase of budding yeast, and spg5 Delta mutants show a progressive loss of viability under these conditions. Accordingly, during logarithmic growth, Spg5 appears largely dispensable for proteasome function, but during stationary phase the proteasomes of spg5 Delta mutants show both structural and functional defects. This loss of proteasome function is reflected in the accumulation of oxidized proteins preferentially in stationary phase in spg5 Delta mutants. Thus, Spg5 is a positive regulator of the proteasome that is critical for survival of cells that have ceased to proliferate due to nutrient limitation.	[Hanna, John; Waterman, David; Boselli, Monica; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hanna, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jwhanna@partners.org; Daniel_Finley@hms.harvard.edu			National Institutes of Health [R37GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM043601 (to D. F.).	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2005, METHODS YEAST GENETI; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Devenish Rodney J, 2012, Front Biosci (Schol Ed), V4, P1354; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	34	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34400	34409		10.1074/jbc.M112.390294	http://dx.doi.org/10.1074/jbc.M112.390294			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904326	Green Published, hybrid			2022-12-28	WOS:000309654200042
J	Saito, K; Kandori, H; Ishikita, H				Saito, Keisuke; Kandori, Hideki; Ishikita, Hiroshi			Factors That Differentiate the H-bond Strengths of Water Near the Schiff Bases in Bacteriorhodopsin and Anabaena Sensory Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER HYDROGEN-BOND; PROTON-TRANSFER; ELECTROSTATIC CALCULATIONS; DISSOCIATION-CONSTANTS; HISTIDINE-RESIDUES; IONIZABLE GROUPS; IMIDAZOLE RING; PK(A); RELEASE; ASPARTATE-85	Bacteriorhodopsin (BR) functions as a light-driven proton pump, whereas Anabaena sensory rhodopsin (ASR) is believed to function as a photosensor despite the high similarity in their protein sequences. In Fourier transform infrared (FTIR) spectroscopic studies, the lowest O-D stretch for D2O was observed at similar to 2200 cm(-1) in BR but was significantly higher in ASR (>2500 cm(-1)), which was previously attributed to a water molecule near the Schiff base (W402) that is H-bonded to Asp-85 in BR and Asp-75 in ASR. We investigated the factors that differentiate the lowest O-D stretches of W402 in BR and ASR. Quantum mechanical/molecular mechanical calculations reproduced the H-bond geometries of the crystal structures, and the calculated O-D stretching frequencies were corroborated by the FTIR band assignments. The potential energy profiles indicate that the smaller O-D stretching frequency in BR originates from the significantly higher pK(a)(Asp-85) in BR relative to the pK(a)(Asp-75) in ASR, which were calculated to be 1.5 and -5.1, respectively. The difference is mostly due to the influences of Ala-53, Arg-82, Glu-194-Glu-204, and Asp-212 on pK(a)(Asp-85) in BR and the corresponding residues Ser-47, Arg-72, Ser-188-Asp-198, and Pro-206 on pK(a)(Asp-75) in ASR. Because these residues participate in proton transfer pathways in BR but not in ASR, the presence of a strongly H-bonded water molecule near the Schiff base ultimately results from the proton-pumping activity in BR.	[Saito, Keisuke; Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Nagoya Institute of Technology; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Sakyo Ku, 202 Bldg E,Yoshida Konoe Cho, Kyoto 6068501, Japan.	hiro@cp.kyoto-u.ac.jp	Saito, Keisuke/D-2528-2009; Ishikita, Hiroshi/G-9864-2018	Saito, Keisuke/0000-0002-2293-9743; Ishikita, Hiroshi/0000-0002-5849-8150	JST PRESTO program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22740276, 20108014]; MEXT; Takeda Science Foundation; Kyoto University; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22740276] Funding Source: KAKEN	JST PRESTO program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kyoto University; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JST PRESTO program (to H. I.), Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan 22740276 (to K. S.) and 20108014 (to H. K.), Special Coordination Fund for Promoting Science and Technology of MEXT (to H. I.), Takeda Science Foundation (to H. I.), Kyoto University Step-up Grant-in-aid for Young Scientists (to H. I.), and Grant for Basic Science Research Projects from the Sumitomo Foundation (to H. I.).	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; BAASOV T, 1986, BIOCHEMISTRY-US, V25, P5249, DOI 10.1021/bi00366a040; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; BALASHOV SP, 1995, BIOCHEMISTRY-US, V34, P8820, DOI 10.1021/bi00027a034; Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; Bombarda E, 2006, J AM CHEM SOC, V128, P12129, DOI 10.1021/ja0619657; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN LS, 1993, BIOPHYS J, V65, P124, DOI 10.1016/S0006-3495(93)81064-6; Calimet N, 2004, J MOL BIOL, V339, P571, DOI 10.1016/j.jmb.2004.03.075; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Frey PA, 2006, ISOTOPE EFFECTS CHEM, P975; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Gerencser L, 2001, BIOCHEMISTRY-US, V40, P1850, DOI 10.1021/bi0021636; Goyal P, 2011, J AM CHEM SOC, V133, P14981, DOI 10.1021/ja201568s; Han K-L, 2010, HYDROGEN BONDING TRA, P377; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Hayashi S, 2004, J AM CHEM SOC, V126, P10516, DOI 10.1021/ja047506s; Ishikita H, 2003, BIOCHEMISTRY-US, V42, P3882, DOI 10.1021/bi026781t; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; KANDORI H, 1995, J AM CHEM SOC, V117, P2118, DOI 10.1021/ja00112a036; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Lanyi JK, 2007, J MOL BIOL, V365, P1379, DOI 10.1016/j.jmb.2006.11.016; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; METZ G, 1992, FEBS LETT, V303, P237, DOI 10.1016/0014-5793(92)80528-O; MIKENDA W, 1986, J MOL STRUCT, V147, P1, DOI 10.1016/0022-2860(86)87054-5; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; ROUSSO I, 1995, BIOCHEMISTRY-US, V34, P12059, DOI 10.1021/bi00037a049; Saito K, 2012, P NATL ACAD SCI USA, V109, P167, DOI 10.1073/pnas.1113599108; Saito K, 2011, J AM CHEM SOC, V133, P14379, DOI 10.1021/ja203947k; SAMPOGNA RV, 1994, BIOPHYS J, V66, P1341, DOI 10.1016/S0006-3495(94)80925-7; Schutz CN, 2004, PROTEINS, V55, P711, DOI 10.1002/prot.20096; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Shibata N, 2005, BIOCHEMISTRY-US, V44, P7406, DOI 10.1021/bi050122+; Song YF, 2003, BIOCHEMISTRY-US, V42, P9875, DOI 10.1021/bi034482d; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943	51	18	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34009	34018		10.1074/jbc.M112.388348	http://dx.doi.org/10.1074/jbc.M112.388348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865888	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309654200008
J	Benjannet, S; Hamelin, J; Chretien, M; Seidah, NG				Benjannet, Suzanne; Hamelin, Josee; Chretien, Michel; Seidah, Nabil G.			Loss- and Gain-of-function PCSK9 Variants CLEAVAGE SPECIFICITY, DOMINANT NEGATIVE EFFECTS, AND LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PCSK9; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; HEPG2 CELLS; CHOLESTEROL; MUTATIONS; PROTEIN; FURIN; PH; PROSEGMENT	The proprotein convertase PCSK9 is a major target in the treatment of hypercholesterolemia because of its ability bind the LDL receptor (LDLR) and enhance its degradation in endosomes/lysosomes. In the endoplasmic reticulum, the zymogen pro-PCSK9 is first autocatalytically cleaved at its internal Gln(152)down arrow, resulting in a secreted enzymatically inactive complex of PCSK9 with its inhibitory prosegment (prosegment.PCSK9), which is the active form of PCSK9 on the LDLR. We mutagenized the P1 cleavage site Gln(152) into all other residues except Cys and analyzed the expression and secretion of the resulting mutants. The data demonstrated the following. 1) The only P1 residues recognized by PCSK9 are Gln > Met > Ala > Ser > Thr approximate to Asn, revealing an unsuspected specificity. 2) All other mutations led to the formation of an unprocessed zymogen that acted as a dominant negative retaining the native protein in the endoplasmic reticulum. Analysis of a large panoply of known natural and artificial point mutants revealed that this general dominant negative observation applies to all PCSK9 mutations that result in the inability of the protein to exit the endoplasmic reticulum. Such a tight quality control property of the endoplasmic reticulum may lead to the development of specific PCSK9 small molecule inhibitors that block its autocatalytic processing. Finally, inspired by the most active gain-of-function mutant, D374Y, we evaluated the LDLR degradation activity of 18 Asp(374) variants of PCSK9. All Asp374 mutations resulted in similar gain-of-function activity on the LDLR except that D374E was as active as native PCSK9, D374G was relatively less active, and D374N and D374P were completely inactive.	[Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Chretien, Michel] Ottawa Hosp, Res Inst, Ottawa, ON K1Y 4E9, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Seidah, NG (corresponding author), Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; CHRETIEN, Michel/0000-0002-8588-4460	Canadian Institutes of Health Research (CIHR) Grant [MOP-102741]; CIHR [MOP-102618, 211351]; Strauss Foundation	Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-102741, Team Grant MOP-44363, and Canada Chair Grant 216684 (to N. G. S.), CIHR Grants MOP-102618 and 211351 (to M. C.), and Strauss Foundation grants (to N. G. S. and M. C.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Akram ON, 2010, ARTERIOSCL THROM VAS, V30, P1279, DOI 10.1161/ATVBAHA.110.209007; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Cariou B, 2009, ARTERIOSCL THROM VAS, V29, P2191, DOI 10.1161/ATVBAHA.109.194191; Chretien M., 2012, BIOCH CELL IN PRESS; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Geoghegan KF, 2009, BIOCHEMISTRY-US, V48, P2941, DOI 10.1021/bi802232m; Gutierrez-Cirlos C, 2011, ANN HEPATOL, V10, P155, DOI 10.1016/S1665-2681(19)31564-9; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Y., 2012, J MOL BIOL IN PRESS; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	53	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33745	33755		10.1074/jbc.M112.399725	http://dx.doi.org/10.1074/jbc.M112.399725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22875854	Green Published, hybrid			2022-12-28	WOS:000309602100057
J	Alibhoy, AA; Giardina, BJ; Dunton, DD; Chiang, HL				Alibhoy, Abbas A.; Giardina, Bennett J.; Dunton, Danielle D.; Chiang, Hui-Ling			Vps34p Is Required for the Decline of Extracellular Fructose-1,6-bisphosphatase in the Vacuole Import and Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; VPS15 PROTEIN-KINASE; CATABOLITE INACTIVATION; PLASMA-MEMBRANE; VID VESICLES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PTDINS 3-KINASE; ACTIN PATCHES; LIPID KINASE; AUTOPHAGY	When Saccharomyces cerevisiae are starved of glucose for a prolonged period of time, gluconeogenic enzymes such as fructose-1,6-bisphosphatase (FBPase), malate dehydrogenase, isocitrate lyase, and phosphoenolpyruvate carboxykinase are induced. However, when glucose is added to prolonged-starved cells, these enzymes are degraded in the vacuole via the vacuole import and degradation (Vid) pathway. The Vid pathway merges with the endocytic pathway to remove intracellular and extracellular proteins simultaneously. Ultrastructural and cell extraction studies indicate that substantial amounts of FBPase were in the extracellular fraction (periplasm) during glucose starvation. FBPase levels in the extracellular fraction decreased after glucose re-feeding in wild-type cells. The decline of FBPase in the extracellular fraction was dependent on the SLA1 and ARC18 genes involved in actin polymerization and endocytosis. Moreover, the reduction of extracellular FBPase was also dependent on the VPS34 gene. VPS34 encodes the PI3 kinase and is also required for the Vid pathway. Vps34p co-localized with actin patches in prolonged-starved cells. In the absence of this gene, FBPase and the Vid vesicle protein Vid24p associated with actin patches before and after the addition of glucose. Furthermore, high levels of FBPase remained in the extracellular fraction in the Delta vps34 mutant during glucose re-feeding. When the Asn-736 residue of Vps34p was mutated and when the C-terminal 11 amino acids were deleted, mutant proteins failed to co-localize with actin patches, and FBPase in the extracellular fraction did not decrease as rapidly. We suggest that VPS34 plays a critical role in the decline of extracellular FBPase in response to glucose.	[Alibhoy, Abbas A.; Giardina, Bennett J.; Dunton, Danielle D.; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01 GM59480]; Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM59480. This work was also supported by a Tobacco Settlement Fund (to H.-L.C.).	Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; BANTA LM, 1990, MOL CELL BIOL, V10, P4638, DOI 10.1128/MCB.10.9.4638; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P23357, DOI 10.1074/jbc.M109.075143; Brown C Randell, 2009, Commun Integr Biol, V2, P177; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Budovskaya YV, 2002, J BIOL CHEM, V277, P287, DOI 10.1074/jbc.M109263200; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hoffman M, 1996, GENETICS, V143, P1555; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; RIBALLO E, 1995, J BACTERIOL, V177, P5622, DOI 10.1128/jb.177.19.5622-5627.1995; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	59	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33080	33093		10.1074/jbc.M112.360412	http://dx.doi.org/10.1074/jbc.M112.360412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833678	Green Published, hybrid			2022-12-28	WOS:000309168300070
J	Liu, L; Arun, A; Ellis, L; Peritore, C; Donmez, G				Liu, Lei; Arun, Anirudh; Ellis, Lakia; Peritore, Carina; Donmez, Gizem			Sirtuin 2 (SIRT2) Enhances 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Nigrostriatal Damage via Deacetylating Forkhead Box O3a (Foxo3a) and Activating Bim Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; AGGREGATION; APOPTOSIS; MODELS	Sirtuins are NAD-dependent protein deacetylases that were shown to have beneficial effects against age-related diseases. SIRT2 is a strong deacetylase that is highly expressed in brain. It has been associated with neurodegenerative diseases. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a dopaminergic neurotoxin that replicates most of the clinical features of Parkinson disease (PD) and produces a reliable and reproducible lesion of the nigrostriatal dopaminergic pathway and neurodegeneration after its systemic administration. Chronic administration of MPTP induces lesion via apoptosis. We show here that SIRT2 deacetylates Foxo3a, increases RNA and protein levels of Bim, and as a result, enhances apoptosis in the MPTP model of PD. We also show that neurodegeneration induced by chronic MPTP regimen is prevented by genetic deletion of SIRT2 in mouse. Deletion of SIRT2 leads to the reduction of apoptosis due to an increase in acetylation of Foxo3a and a decrease in Bim levels. We demonstrate that SIRT2 deacetylates Foxo3a, activates Bim, and induces apoptosis only in 1-methyl-4-phenylpyridinium- treated cells. Therefore, designing SIRT2 inhibitors might be helpful to develop effective treatments for PD.	[Liu, Lei; Arun, Anirudh; Ellis, Lakia; Peritore, Carina; Donmez, Gizem] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Donmez, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Gizem.Donmez@tufts.edu			Department of Neuroscience; Tufts Center for Neuroscience Research; Charlton Research Award; Ellison Medical Foundation	Department of Neuroscience; Tufts Center for Neuroscience Research; Charlton Research Award; Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by a start-up fund from the Department of Neuroscience, Tufts Center for Neuroscience Research Pilot Award, Charlton Research Award, and Ellison Medical Foundation New Scholar in Aging Award (to G.D.).	Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x	14	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32307	32311		10.1074/jbc.C112.403048	http://dx.doi.org/10.1074/jbc.C112.403048			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22898818	Green Published, hybrid			2022-12-28	WOS:000309168300002
J	Mechaly, A; Levy, H; Epstein, E; Rosenfeld, R; Marcus, H; Ben-Arie, E; Shafferman, A; Ordentlich, A; Mazor, O				Mechaly, Adva; Levy, Haim; Epstein, Eyal; Rosenfeld, Ronit; Marcus, Hadar; Ben-Arie, Einat; Shafferman, Avigdor; Ordentlich, Arie; Mazor, Ohad			A Novel Mechanism for Antibody-based Anthrax Toxin Neutralization INHIBITION OF PREPORE-TO-PORE CONVERSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; LETHAL FACTOR; RECEPTOR; INFECTION; BINDING; CLOSTRIDIUM; VACCINES; IMMUNITY	Protective antigen (PA), a key component of anthrax toxin, mediates the entry of lethal factor (LF) or edema factor (EF) through a membranal pore into target cells. We have previously reported the isolation and chimerization of cAb29, an anti-PA monoclonal antibody that effectively neutralizes anthrax toxin in an unknown mechanism. The aim of this study was to elucidate the neutralizing mechanism of this antibody in vitro and to test its ability to confer post-exposure protection against anthrax in vivo. By systematic evaluation of the steps taking place during the PA-based intoxication process, we found that cAb29 did not interfere with the initial steps of intoxication, namely its ability to bind to the anthrax receptor, the consecutive proteolytic cleavage to PA(63), oligomerization, prepore formation, or LF binding. However, the binding of cAb29 to the prepore prevented its pH-triggered transition to the transmembranal pore, thus preventing the last step of intoxication, i.e. the translocation of LF/EF into the cell. Epitope mapping, using a phage display peptide library, revealed that cAb29 binds the 2 alpha(1) loop in domain 2 of PA, a loop that undergoes major conformational changes during pore formation. In vivo, we found that 100% of anthrax-infected rabbits survived when treated with cAb29 12 h after exposure. In conclusion, these experiments demonstrate that cAb29 exerts its potent neutralizing activity in a unique manner by blocking the prepore-to-pore conversion process.	[Rosenfeld, Ronit; Ben-Arie, Einat; Shafferman, Avigdor; Ordentlich, Arie; Mazor, Ohad] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel; Israel Inst Biol Res, Dept Infect Dis, IL-74100 Ness Ziona, Israel; [Epstein, Eyal; Marcus, Hadar] Israel Inst Biol Res, Dept Biotechnol, IL-74100 Ness Ziona, Israel		Ordentlich, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel.	arieo@iibr.gov.il						Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Bann JG, 2012, PROTEIN SCI, V21, P1, DOI 10.1002/pro.752; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Crowe SR, 2010, J INFECT DIS, V202, P251, DOI 10.1086/653495; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; Grabenstein JD, 2008, CLIN INFECT DIS, V46, P129, DOI 10.1086/523578; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Mazor O, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P275, DOI 10.1007/978-90-481-9054-6_30; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Rosenfeld R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006351; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Williams AS, 2009, PROTEIN SCI, V18, P2277, DOI 10.1002/pro.238; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zarebski LM, 2008, EXPERT REV VACCINES, V7, P55, DOI 10.1586/14760584.7.1.55	26	20	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32665	32673		10.1074/jbc.M112.400473	http://dx.doi.org/10.1074/jbc.M112.400473			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22869370	Green Published, hybrid			2022-12-28	WOS:000309168300034
J	Shakeri, B; Bourdin, B; Demers-Giroux, PO; Sauve, R; Parent, L				Shakeri, Behzad; Bourdin, Benoite; Demers-Giroux, Pierre-Olivier; Sauve, Remy; Parent, Lucie			A Quartet of Leucine Residues in the Guanylate Kinase Domain of Ca-V beta Determines the Plasma Membrane Density of the Ca(V)2.3 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; I-II-LINKER; SUBUNIT INTERACTION; INACTIVATION; MODULATION; TERMINUS; IDENTIFICATION; TRYPTOPHAN; EXPRESSION; CONTAINS	Ca-V beta subunits are formed by a Src homology 3 domain and a guanylate kinase-like (GK) domain connected through a variable HOOK domain. Complete deletion of the Src homology 3 domain (75 residues) as well as deletion of the HOOK domain (47 residues) did not alter plasma membrane density of Ca(V)2.3 nor its typical activation gating. In contrast, six-residue deletions in the GK domain disrupted cell surface trafficking and functional expression of Ca(V)2.3. Mutations of residues known to carry nanomolar affinity binding in the GK domain of Ca-V beta (P175A, P179A, M195A, M196A, K198A, S295A, R302G, R307A, E339G, N340G, and A345G) did not significantly alter cell surface targeting or gating modulation of Ca(V)2.3. Nonetheless, mutations of a quartet of leucine residues (either single or multiple mutants) in the alpha 3, alpha 6, beta 10, and alpha 9 regions of the GK domain were found to significantly impair cell surface density of Ca(V)2.3 channels. Furthermore, the normalized protein density of Ca(V)2.3 was nearly abolished with the quadruple Ca-V beta 3 Leu mutant L200G/L303G/L337G/L342G. Altogether, our observations suggest that the four leucine residues in Ca-V beta 3 form a hydrophobic pocket surrounding key residues in the alpha-interacting domain of Ca(V)2.3. This interaction appears to play an essential role in conferring Ca-V beta-induced modulation of the protein density of Ca-V alpha 1 subunits in Ca(V)2 channels.	[Parent, Lucie] Univ Montreal, Dept Physiol, Downtown Stn, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca			Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was completed with Grant MOP13390 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chen YH, 2009, FEBS LETT, V583, P1969, DOI 10.1016/j.febslet.2009.05.001; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dresviannikov A, 2009, PFLUG ARCH EUR J PHY, V457, P743, DOI 10.1007/s00424-008-0549-7; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kamp MA, 2012, BBA-PROTEINS PROTEOM, V1824, P1045, DOI 10.1016/j.bbapap.2012.05.008; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Pereverzev A, 2002, MOL CELL NEUROSCI, V21, P352, DOI 10.1006/mcne.2002.1179; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Restituito S, 2000, J NEUROSCI, V20, P9046; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	57	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32835	32847		10.1074/jbc.M112.387233	http://dx.doi.org/10.1074/jbc.M112.387233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846999	Green Published, hybrid			2022-12-28	WOS:000309168300049
J	Ha, CM; Park, D; Han, JK; Jang, JI; Park, JY; Hwang, EM; Seok, H; Chang, S				Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Jang, June-Ill; Park, Jae-Yong; Hwang, Eun Mi; Seok, Heon; Chang, Sunghoe			Calcyon Forms a Novel Ternary Complex with Dopamine D-1 Receptor through PSD-95 Protein and Plays a Role in Dopamine Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; UP-REGULATION; INTERACTING PROTEIN; D1 RECEPTORS; DOMAIN; INHIBITION; SCHIZOPHRENIA; BINDING	Calcyon, once known for interacting directly with the dopamine D-1 receptor (D1DR), is implicated in various neuropsychiatric disorders including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. Although its direct interaction with D1DR has been shown to be misinterpreted, it still plays important roles in D1DR signaling. Here, we found that calcyon interacts with the PSD-95 and subsequently forms a ternary complex with D1DR through PSD-95. Calcyon is phosphorylated on Ser-169 by the PKC activator phorbol 12-myristate 13-acetate or by the D1DR agonist SKF-81297, and its phosphorylation increases its association with PSD-95 and recruitment to the cell surface. Interestingly, the internalization of D1DR at the cell surface was enhanced by phorbol 12-myristate 13-acetate and SKF-81297 in the presence of calcyon, but not in the presence of its S169A phospho-deficient mutant, suggesting that the phosphorylation of calcyon and the internalization of the surface D1DR are tightly correlated. Our results suggest that calcyon regulates D1DR trafficking by forming a ternary complex with D1DR through PSD-95 and thus possibly linking glutamatergic and dopamine receptor signalings. This also raises the possibility that a novel ternary complex could represent a potential therapeutic target for the modulation of related neuropsychiatric disorders.	[Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Ha, Chang Man; Park, Daehun; Han, Jeong-Kyu; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Med Res Ctr, Neurosci Res Inst, Seoul 110799, South Korea; [Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul 110799, South Korea; [Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomax Inst, Seoul 110799, South Korea; [Jang, June-Ill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Inst Hlth Sci, Dept Physiol, Sch Med,Biomed Ctr BK21, Jinju 660751, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Med Res Ctr Neural Dysfunct, Jinju 660751, South Korea; [Park, Jae-Yong; Hwang, Eun Mi] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan Gun 367805, Chungcheongbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ulsan National Institute of Science & Technology (UNIST); Gyeongsang National University; Gyeongsang National University; Korea Institute of Science & Technology (KIST); Jungwon University	Ha, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 314 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	gkckdaks@snu.ac.kr; sunghoe@snu.ac.kr	Chang, Sunghoe/J-2784-2012; Hwang, Eun Mi/HHN-3030-2022	Park, Daehun/0000-0002-2829-1319; chang, sunghoe/0000-0002-3446-7288; Park, Jae-Yong/0000-0001-7698-7890	National Research Foundation (NRF) of Korea [20100022375, SRC 20100029395]; Ministry of Education, Science and Technology (MEST), Republic of Korea	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grant 20100022375 from the National Research Foundation (NRF) of Korea (to C. M. H.) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea. Research was also supported by grants from the NRF of Korea (SRC 20100029395) (to S. C.) funded by the MEST, Republic of Korea.	Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Clinton SM, 2005, AM J PSYCHIAT, V162, P1859, DOI 10.1176/appi.ajp.162.10.1859; Davidson HT, 2009, EUR J NEUROSCI, V29, P42, DOI 10.1111/j.1460-9568.2008.06563.x; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heijtz RD, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-33; Heijtz RD, 2007, PHYSIOL BEHAV, V92, P155, DOI 10.1016/j.physbeh.2007.05.024; Hu SQ, 2009, J NEUROSCI RES, V87, P3626, DOI 10.1002/jnr.22163; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koh PO, 2003, ARCH GEN PSYCHIAT, V60, P311, DOI 10.1001/archpsyc.60.3.311; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Lezcano N, 2006, SCIENCE, V314, P1681; Lidow MS, 2001, EUR J PHARMACOL, V427, P187, DOI 10.1016/S0014-2999(01)01265-1; Luo XG, 2004, AM J MED GENET B, V125B, P25, DOI 10.1002/ajmg.b.20092; Morell M, 2008, NAT PROTOC, V3, P22, DOI 10.1038/nprot.2007.496; Pegan S, 2007, BIOCHEMISTRY-US, V46, P5315, DOI 10.1021/bi062228q; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sornarajah L, 2008, J NEUROPHYSIOL, V99, P3052, DOI 10.1152/jn.90301.2008; Sun PH, 2009, CELL RES, V19, P612, DOI 10.1038/cr.2009.30; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Vazdarjanova A, 2011, MOL PSYCHIATR, V16, P672, DOI 10.1038/mp.2011.14; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200; Zhang JP, 2009, J NEUROSCI, V29, P2948, DOI 10.1523/JNEUROSCI.4424-08.2009	33	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31813	31822		10.1074/jbc.M112.370601	http://dx.doi.org/10.1074/jbc.M112.370601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843680	Green Published, hybrid			2022-12-28	WOS:000309059400022
J	Mukherjee, S; Cruz-Rodriguez, O; Bolton, E; Iniguez-Lluhi, JA				Mukherjee, Sarmistha; Cruz-Rodriguez, Osvaldo; Bolton, Eric; Iniguez-Lluhi, Jorge A.			The in Vivo Role of Androgen Receptor SUMOylation as Revealed by Androgen Insensitivity Syndrome and Prostate Cancer Mutations Targeting the Proline/Glycine Residues of Synergy Control Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; GENE-MUTATIONS; PRENATAL TESTOSTERONE; BINDING; IDENTIFICATION; PIASY; DESUMOYLATION; TRANSCRIPTION; MECHANISMS; SENESCENCE	The androgen receptor (AR) mediates the effects of male sexual hormones on development and physiology. Alterations in AR function are central to reproductive disorders, prostate cancer, and Kennedy disease. AR activity is influenced by post-translational modifications, but their role in AR-based diseases is poorly understood. Conjugation by small ubiquitin-like modifier (SUMO) proteins at two synergy control (SC) motifs in AR exerts a promoter context-dependent inhibitory role. SC motifs are composed of a four-amino acid core that is often preceded and/or followed by nearby proline or glycine residues. The function of these flanking residues, however, has not been examined directly. Remarkably, several AR mutations associated with oligospermia and androgen insensitivity syndrome map to Pro-390, the conserved proline downstream of the first SC motif in AR. Similarly, mutations at Gly-524, downstream of the second SC motif, were recovered in recurrent prostate cancer samples. We now provide evidence that these clinically isolated substitutions lead to a partial loss of SC motif function and AR SUMOylation that affects multiple endogenous genes. Consistent with a structural role as terminators of secondary structure elements, substitution of Pro-390 by Gly fully supports both SC motif function and SUMOylation. As predicted from the functional properties of SC motifs, the clinically isolated mutations preferentially enhance transcription driven by genomic regions harboring multiple AR binding sites. The data support the view that alterations in AR SUMOylation play significant roles in AR-based diseases and offer novel SUMO-based therapeutic opportunities.	[Mukherjee, Sarmistha; Cruz-Rodriguez, Osvaldo; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bolton, Eric] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	Sarmistha.Mukherjee@jefferson.edu; iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health from USPHS [DK61656-01, P60 DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061656, R56DK061656, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK61656-01 from USPHS (to J. A. I.) and Grant P60 DK20572.	Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhangoo A, 2010, ASIAN J ANDROL, V12, P561, DOI 10.1038/aja.2010.6; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Bormann CL, 2011, REPRODUCTION, V142, P167, DOI 10.1530/REP-10-0210; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Ferlin A, 2006, CLIN ENDOCRINOL, V65, P606, DOI 10.1111/j.1365-2265.2006.02635.x; Garolla A, 2005, ENDOCR-RELAT CANCER, V12, P645, DOI 10.1677/erc.1.00954; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Gottlieb B, 1999, HUM MUTAT, V14, P527, DOI 10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO;2-X; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; Hiort O, 1996, AM J MED GENET, V63, P218, DOI 10.1002/(SICI)1096-8628(19960503)63:1<218::AID-AJMG38>3.0.CO;2-P; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hyytinen ER, 2002, LAB INVEST, V82, P1591, DOI 10.1097/01.LAB.0000038924.67707.75; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; MULLER J, 1987, INT J ANDROL, V10, P543, DOI 10.1111/j.1365-2605.1987.tb00354.x; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pinsky L., 1994, P 76 ANN M END SOC A; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; RAJPERTDEMEYTS E, 1993, EUR UROL, V23, P54; Recabarren SE, 2008, ENDOCRINOLOGY, V149, P6444, DOI 10.1210/en.2008-0785; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; SAVAGE MO, 1990, CLIN ENDOCRINOL, V32, P519, DOI 10.1111/j.1365-2265.1990.tb00893.x; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Yang HJ, 2009, EXPERT OPIN INV DRUG, V18, P957, DOI 10.1517/13543780903002074; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	57	23	23	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31195	31206		10.1074/jbc.M112.395210	http://dx.doi.org/10.1074/jbc.M112.395210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829593	hybrid, Green Published			2022-12-28	WOS:000308791300032
J	Endo-Streeter, S; Tsui, MKM; Odom, AR; Block, J; York, JD				Endo-Streeter, Stuart; Tsui, Man-Kin Marco; Odom, Audrey R.; Block, Jeremy; York, John D.			Structural Studies and Protein Engineering of Inositol Phosphate Multikinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE 3-KINASE; STRUCTURE VALIDATION; ARGININE METABOLISM; CRYSTAL-STRUCTURE; C-BETA; BINDING; KINASE; SYMMETRY	Inositol phosphates (IPs) regulate vital processes in eukaryotes, and their production downstream of phospholipase C activation is controlled through a network of evolutionarily conserved kinases and phosphatases. Inositol phosphate multikinase (IPMK, also called Ipk2 and Arg82) accounts for phosphorylation of IP3 to IP5, as well as production of several other IP molecules. Here, we report the structure of Arabidopsis thaliana IPMK alpha at 2.9 angstrom and find it is similar to the yeast homolog Ipk2, despite 17% sequence identity, as well as the active site architecture of human IP3 3-kinase. Structural comparison and substrate modeling were used to identify a putative basis for IPMK selectivity. To test this model, we re-engineered binding site residues predicted to have restricted substrate specificity. Using steady-state kinetics and in vivo metabolic labeling studies in modified yeast strains, we observed that K117W and K117W:K121W mutants exhibited nearly normal 6-kinase function but harbored significantly reduced 3-kinase activity. These mutants complemented conditional nutritional growth defects observed in ipmk null yeast and, remarkably, suppressed lethality observed in ipmk null flies. Our data are consistent with the hypothesis that IPMK 6-kinase activity and production of Ins(1,4,5,6)P-4 are critical for cellular signaling. Overall, our studies provide new insights into the structure and function of IPMK and utilize a synthetic biological approach to redesign inositol phosphate signaling pathways.	[York, John D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, DUMC Box 3813, Durham, NC 27710 USA.	john.york@vanderbilt.edu	Tsui, Man-kin/E-9612-2010; John, Audrey Odom/AAF-1300-2019	John, Audrey Odom/0000-0001-8395-8537	Howard Hughes Medical Institute; National Institutes of Health [RO1 HL-55672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078031] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health Grant RO1 HL-55672 (both to J.D.Y.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chamberlain PP, 2005, BIOCHEMISTRY-US, V44, P14486, DOI 10.1021/bi051256q; Chang SC, 2006, BIOCHEM BIOPH RES CO, V339, P209, DOI 10.1016/j.bbrc.2005.10.201; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; DUBOIS E, 1994, MOL GEN GENET, V243, P315, DOI 10.1007/BF00301067; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; DUBOIS E, 1985, MOL GEN GENET, V198, P283, DOI 10.1007/BF00383008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ives EB, 2000, J BIOL CHEM, V275, P36575, DOI 10.1074/jbc.M007586200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MESSENGUY F, 1991, MOL CELL BIOL, V11, P2852, DOI 10.1128/MCB.11.5.2852; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Seeds AM, 2004, J BIOL CHEM, V279, P47222, DOI 10.1074/jbc.M408295200; Sheldrick G. M., 1997, SHELX97 MANUAL; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Stolz LE, 1998, GENETICS, V148, P1715; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014	42	23	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35360	35369		10.1074/jbc.M112.365031	http://dx.doi.org/10.1074/jbc.M112.365031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896696	hybrid, Green Published			2022-12-28	WOS:000309968000045
J	Tokutake, T; Kasuga, K; Yajima, R; Sekine, Y; Tezuka, T; Nishizawa, M; Ikeuchi, T				Tokutake, Takayoshi; Kasuga, Kensaku; Yajima, Ryuji; Sekine, Yumi; Tezuka, Toshiyuki; Nishizawa, Masatoyo; Ikeuchi, Takeshi			Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-beta at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3 beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD COGNITIVE IMPAIRMENT; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; GAMMA-SECRETASE; MOUSE MODEL; PHOSPHORYLATION; OLIGOMERS; BRAIN; PROTEIN	Alzheimer disease (AD) is neuropathologically characterized by the formation of senile plaques from amyloid-beta (A beta) and neurofibrillary tangles composed of phosphorylated Tau. Although there is growing evidence for the pathogenic role of soluble A beta species in AD, the major question of how A beta induces hyperphosphorylation of Tau remains unanswered. To address this question, we here developed a novel cell coculture system to assess the effect of extracellular A beta at physiologically relevant levels naturally secreted from donor cells on the phosphorylation of Tau in recipient cells. Using this assay, we demonstrated that physiologically relevant levels of secreted A beta are sufficient to cause hyperphosphorylation of Tau in recipient N2a cells expressing human Tau and in primary culture neurons. This hyperphosphorylation of Tau is inhibited by blocking A beta production in donor cells. The expression of familial AD-linked PSEN1 mutants and APP Delta E693 mutant that induce the production of oligomeric A beta in donor cells results in a similar hyperphosphorylation of Tau in recipient cells. The mechanism underlying the A beta-induced Tau hyperphosphorylation is mediated by the impaired insulin signal transduction because we demonstrated that the phosphorylation of Akt and GSK3 beta upon insulin stimulation is less activated under this condition. Treating cells with the insulin-sensitizing drug rosiglitazone, a peroxisome proliferator-activated receptor gamma agonist, attenuates the A beta-dependent hyperphosphorylation of Tau. These findings suggest that the disturbed insulin signaling cascade may be implicated in the pathways through which soluble A beta induces Tau phosphorylation and further support the notion that correcting insulin signal dysregulation in AD may offer a potential therapeutic approach.	[Tokutake, Takayoshi; Kasuga, Kensaku; Yajima, Ryuji; Sekine, Yumi; Tezuka, Toshiyuki; Nishizawa, Masatoyo; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan; [Ikeuchi, Takeshi] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9518585, Japan	Niigata University; Niigata University	Ikeuchi, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1-757 Asahimachi, Niigata 9518585, Japan.	ikeuchi@bri.niigata-u.ac.jp	Tokutake, Takayoshi/AAY-3873-2020; Kasuga, Kensaku/AAQ-6627-2020	Tokutake, Takayoshi/0000-0002-4808-0471; Kasuga, Kensaku/0000-0002-2178-0769	Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS) [20590990, 23591234]; Suzuken Memorial Foundation; JSPS [21890078]; Tsubaki Memorial Foundation	Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS); Suzuken Memorial Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tsubaki Memorial Foundation	This work was supported in part by Grants-in-aid for Scientific Research (C) 20590990 and 23591234 from the Ministry of Education and Science/Japan Society for the Promotion of Science (JSPS) (to T. I.), a grant from the Suzuken Memorial Foundation (to T. I.), Grant-in-Aid for Young Scientists 21890078 from JSPS (to K. K.), and a grant from the Tsubaki Memorial Foundation (to T. T.).	Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HILL JM, 1986, NEUROSCIENCE, V17, P1127, DOI 10.1016/0306-4522(86)90082-5; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; Kasuga K, 2009, J NEUROL, V256, P1351, DOI 10.1007/s00415-009-5096-4; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sato Naoyuki, 2011, Curr Aging Sci, V4, P118; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sheu WHH, 2011, J PHARMACEUT BIOMED, V54, P759, DOI 10.1016/j.jpba.2010.10.008; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	45	81	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35222	35233		10.1074/jbc.M112.348300	http://dx.doi.org/10.1074/jbc.M112.348300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910909	Green Published, hybrid			2022-12-28	WOS:000309968000032
J	Xi, CX; Hu, YZ; Buckhaults, P; Moskophidis, D; Mivechi, NF				Xi, Caixia; Hu, Yanzhong; Buckhaults, Phillip; Moskophidis, Demetrius; Mivechi, Nahid F.			Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR HSF1; BREAST-CANCER; MOLECULAR CHAPERONES; TUMOR PROGRESSION; GROWTH; DISEASE; STRESS; LEADS; BETA	ErbB2/Neu oncogene is overexpressed in 25% of invasive/metastatic breast cancers. We have found that deletion of heat shock factor Hsf1 in mice overexpressing ErbB2/Neu significantly reduces mammary tumorigenesis and metastasis. Hsf1(+/-)ErbB2/Neu(+) tumors exhibit reduced cellular proliferative and invasive properties associated with reduced activated ERK1/2 and reduced epithelial-mesenchymal transition (EMT). Hsf1(+/+)Neu(+) mammary epithelial cells exposed to TGF beta show high levels of ERK1/2 activity and EMT; this is associated with reduced expression of E-cadherin and increased expression of Slug and vimentin, a mesenchymal marker. In contrast, Hsf1(-/-)Neu(+) or Hsf1(+/+)Neu(+) cells do not exhibit activated ERK1/2 and show reduced EMT in the presence of TGF beta. The ineffective activation of the RAS/RAF/MEK/ERK1/2 signaling pathway in cells with reduced levels of HSF1 is due to the low levels of HSP90 in complex with RAF1 that are required for RAF1 stability and maturation. These results indicate a powerful inhibitory effect conferred by HSF1 downstream target genes in the inhibition of ErbB2-induced breast cancers in the absence of the Hsf1 gene.	[Xi, Caixia; Hu, Yanzhong; Moskophidis, Demetrius; Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Buckhaults, Phillip] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Mivechi, NF (corresponding author), 1120 15th St,CN3141, Augusta, GA 30912 USA.	nmivechi@georgiahealth.edu			National Institutes of Health [CA062130, CA132640, CA121951]; NATIONAL CANCER INSTITUTE [R01CA132640, R01CA121951, R01CA062130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA062130 and CA132640 (to N.F.M.) and CA121951 (to D.M.). Georgia Health Sciences University was formerly known as the Medical College of Georgia.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Calderwood SK, 2010, INT J HYPERTHER, V26, P681, DOI 10.3109/02656736.2010.490254; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Ciocca DR, 2006, J STEROID BIOCHEM, V102, P32, DOI 10.1016/j.jsbmb.2006.09.008; Citri A, 2004, CELL CYCLE, V3, P51; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; Hu YZ, 2006, MOL CELL BIOL, V26, P3282, DOI 10.1128/MCB.26.8.3282-3294.2006; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jego G., 2010, CANC LETT IN PRESS; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Jin XJ, 2009, J CELL BIOCHEM, V107, P504, DOI 10.1002/jcb.22151; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li YH, 2011, J GENET GENOMICS, V38, P111, DOI 10.1016/j.jgg.2011.02.001; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Meng L, 2011, ONCOGENE, V30, P2836, DOI 10.1038/onc.2011.5; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yun CH, 2010, ARCH BIOCHEM BIOPHYS, V495, P8, DOI 10.1016/j.abb.2009.12.003; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	50	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35646	35657		10.1074/jbc.M112.377481	http://dx.doi.org/10.1074/jbc.M112.377481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22847003	Green Published, hybrid			2022-12-28	WOS:000309968000076
J	Yokogawa, M; Kobashigawa, Y; Yoshida, N; Ogura, K; Harada, K; Inagaki, F				Yokogawa, Mariko; Kobashigawa, Yoshihiro; Yoshida, Naoki; Ogura, Kenji; Harada, Kohsuke; Inagaki, Fuyuhiko			NMR Analyses of the Interaction between the FYVE Domain of Early Endosome Antigen 1 (EEA1) and Phosphoinositide Embedded in a Lipid Bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PX DOMAIN; DODECYLPHOSPHOCHOLINE MICELLES; MEMBRANE INSERTION; CRYSTAL-STRUCTURE; CROSS-SATURATION; PROTEIN; NANODISCS; MECHANISM; RESIDUES	Phosphoinositides (PIs) are crucial lipid components of membranes and are involved in a number of cellular processes through interactions with their effector proteins. Recently, we have established a lipid-protein nanoscale bilayer (nanodisc) containing PIs, hereafter referred to as PI-nanodisc and demonstrated that it could be used for both qualitative and quantitative evaluations of protein-membrane interactions. Here, we report further NMR analyses for obtaining structural insights at the residue-specific level between PI-binding effector protein and PI-nanodisc, using the FYVE domain of early endosome antigen 1 (EEA1), denoted as EEA1 FYVE, and PI(3)P-nanodisc as a model system. We performed a combination of the NMR analyses including chemical shift perturbation, transferred cross-saturation, and paramagnetic relaxation enhancement experiments. These enabled an identification of the interaction surface, structural change, and relative orientation of EEA1 FYVE to the PI(3) P-incorporated lipid bilayer, substantiating that NMR analyses of protein-membrane interactions using nanodisc makes it possible to show the residue-specific interactions in the lipid bilayer environment.	[Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Yoshida, Naoki; Harada, Kohsuke] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Inagaki, F (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Kita21 Nishi11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp			Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology; Japan Society for the Promotion of Science through the Targeted Proteins Research Program; Grants-in-Aid for Scientific Research [24121701, 22570109] Funding Source: KAKEN	Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology; Japan Society for the Promotion of Science through the Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science through its Funding Program for World Leading Innovative R&D on Science and Technology and the Targeted Proteins Research Program.	Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; Kami Keiichiro, 2009, V462, P291, DOI 10.1007/978-1-60327-115-8_20; Kobashigawa Y, 2011, ANAL BIOCHEM, V410, P77, DOI 10.1016/j.ab.2010.11.021; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P677, DOI 10.1021/bi00118a007; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Matsuda T, 2004, J MOL RECOGNIT, V17, P41, DOI 10.1002/jmr.656; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nakamura T, 2005, BIOPHYS J, V89, P4051, DOI 10.1529/biophysj.105.066910; Nishida N, 2011, METHODS MOL BIOL, V757, P129, DOI 10.1007/978-1-61779-166-6_10; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sankaran VG, 2001, BIOCHEMISTRY-US, V40, P8581, DOI 10.1021/bi010425d; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stampoulis P., 2012, J BIOL CHEM; Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	35	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34936	34945		10.1074/jbc.M112.398255	http://dx.doi.org/10.1074/jbc.M112.398255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915584	Green Published, hybrid			2022-12-28	WOS:000309968000007
J	Zhao, LL; Pence, MG; Christov, PP; Wawrzak, Z; Choi, JY; Rizzo, CJ; Egli, M; Guengerich, FP				Zhao, Linlin; Pence, Matthew G.; Christov, Plamen P.; Wawrzak, Zdzislaw; Choi, Jeong-Yun; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Basis of Miscoding of the DNA Adduct N-2,3-Ethenoguanine by Human Y-family DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; N2,3-ETHENOGUANINE; BYPASS; DAMAGE; REPLICATION; EFFICIENT; PROGRAM; LESIONS	N-2,3-Ethenoguanine (N-2,3-epsilon G)is one of the exocyclic DNA adducts produced by endogenous processes (e. g. lipid peroxidation) and exposure to bioactivated vinyl monomers such as vinyl chloride, which is a known human carcinogen. Existing studies exploring the miscoding potential of this lesion are quite indirect because of the lability of the glycosidic bond. We utilized a 2'-fluoro isostere approach to stabilize this lesion and synthesized oligonucleotides containing 2'-fluoro-N-2,3-epsilon-2'-deoxyarabinoguanosine to investigate the miscoding potential of N-2,3-epsilon G by Y-family human DNA polymerases (pols). In primer extension assays, pol eta and pol kappa replicated through N-2,3-epsilon G, whereas pol iota and REV1 yielded only 1-base incorporation. Steady-state kinetics revealed that dCTP incorporation is preferred opposite N-2,3-epsilon G with relative efficiencies in the order of pol kappa > REV1> pol eta approximate to pol iota, and dTTP misincorporation is the major miscoding event by all four Y-family human DNA pols. Pol iota had the highest dTTP misincorporation frequency (0.71) followed by pol eta (0.63). REV1 misincorporated dTTP and dGTP with much lower frequencies. Crystal structures of pol iota with N-2,3-epsilon G paired to dCTP and dTTP revealed Hoogsteen-like base pairing mechanisms. Two hydrogen bonds were observed in the N-2,3-epsilon G: dCTP base pair, whereas only one appears to be present in the case of the N-2,3-epsilon G: dTTP pair. Base pairing mechanisms derived from the crystal structures explain the slightly favored dCTP insertion for pol iota in steady-state kinetic analysis. Taken together, these results provide a basis for the mutagenic potential of N-2,3-epsilon G.	[Zhao, Linlin; Pence, Matthew G.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Christov, Plamen P.; Rizzo, Carmelo J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Zhao, Linlin; Pence, Matthew G.; Christov, Plamen P.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Choi, Jeong-Yun] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Div Pharmacol,Dept Mol Cell Biol, Gyeonggi Do 440746, South Korea	Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Sungkyunkwan University (SKKU)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Zhao, Linlin/H-1652-2013; Pence, Matthew/J-1379-2012	Zhao, Linlin/0000-0002-8821-4198; Pence, Matthew/0000-0003-2271-789X	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institutes of Health from the United States Public Health Service [R01 ES010546, R01 ES010375, P01 ES05355, T32 ES007028, P30 ES000267]; National Research Foundation from the Ministry of Education, Science and Technology Korea [2010-0006538]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, T32ES007028, P01ES005355, P30ES000267, R01ES010546] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; National Institutes of Health from the United States Public Health Service; National Research Foundation from the Ministry of Education, Science and Technology Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The use of the Advanced Photon Source and Life Sciences Collaborative Access Team Sector 21 was supported by United States Department of Energy Grant DE-AC02-06CH11357 and Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010546 (to F. P. G.), R01 ES010375 (to F. P. G. and M. E.), P01 ES05355 (to M. E. and C. J. R.), T32 ES007028 (to F. P. G. and M. G. P.), and P30 ES000267 (to M. E., F. P. G., and C. J. R.) from the United States Public Health Service. This work was also supported by National Research Foundation Grant 2010-0006538 from the Ministry of Education, Science and Technology Korea (to J.-Y. C.).	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; Anzahaee MY, 2011, J AM CHEM SOC, V133, P728, DOI 10.1021/ja109817p; Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; CHENG KC, 1991, P NATL ACAD SCI USA, V88, P9974, DOI 10.1073/pnas.88.22.9974; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; DeLano W.L, PYMOL MOL GRAPHICS S; DOSANJH MK, 1994, P NATL ACAD SCI USA, V91, P1024, DOI 10.1073/pnas.91.3.1024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Gonzalez-Reche LM, 2002, TOXICOL LETT, V134, P71, DOI 10.1016/S0378-4274(02)00165-0; Hang B, 2003, MUTAT RES-FUND MOL M, V531, P191, DOI 10.1016/j.mrfmmm.2003.07.006; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; KOCHETKOV NK, 1971, TETRAHEDRON LETT, P1993; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; LEONARD NJ, 1993, CHEMTRACTS BIOCH MOL, V4, P251; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Li F, 2006, BIOCHEMISTRY-US, V45, P4141, DOI 10.1021/bi052322r; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Marion MJ, 1996, INT ARCH OCC ENV HEA, V68, P394; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; PLUM GE, 1995, J MOL BIOL, V248, P679; Rozenski J, 2002, J AM SOC MASS SPECTR, V13, P200, DOI 10.1016/S1044-0305(01)00354-3; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Shibutani S, 1996, BIOCHEMISTRY-US, V35, P14992, DOI 10.1021/bi961446o; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Singer B, 2002, BIOCHEMISTRY-US, V41, P1778, DOI 10.1021/bi0119114; SINGER B, 1991, CARCINOGENESIS, V12, P745, DOI 10.1093/carcin/12.4.745; SINGER B, 1987, CARCINOGENESIS, V8, P745, DOI 10.1093/carcin/8.5.745; Srinivasadesikan V, 2011, J PHYS CHEM B, V115, P10537, DOI 10.1021/jp202738v; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2011, PROTEIN SCI, V20, P1781, DOI 10.1002/pro.723; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	59	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35516	35526		10.1074/jbc.M112.403253	http://dx.doi.org/10.1074/jbc.M112.403253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22910910	Green Published, hybrid			2022-12-28	WOS:000309968000060
J	Zhou, Y; Holmseth, S; Guo, CY; Hassel, B; Hofner, G; Huitfeldt, HS; Wanner, KT; Danbolt, NC				Zhou, Yun; Holmseth, Silvia; Guo, Caiying; Hassel, Bjornar; Hoefner, Georg; Huitfeldt, Henrik S.; Wanner, Klaus T.; Danbolt, Niels C.			Deletion of the gamma-Aminobutyric Acid Transporter 2 (GAT2 and SLC6A13) Gene in Mice Leads to Changes in Liver and Brain Taurine Contents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; PERFUSED-RAT-LIVER; GABA TRANSPORTERS; MOUSE-BRAIN; GLUTAMATE TRANSPORTERS; CEREBRAL-CORTEX; MOLECULAR CHARACTERIZATION; BETAINE/GABA TRANSPORTER	The GABA transporters (GAT1, GAT2, GAT3, and BGT1) have mostly been discussed in relation to their potential roles in controlling the action of transmitter GABA in the nervous system. We have generated the first mice lacking the GAT2 (slc6a13) gene. Deletion of GAT2(both mRNA and protein) neither affected growth, fertility, nor life span under nonchallenging rearing conditions. Immunocytochemistry showed that the GAT2 protein was predominantly expressed in the plasma membranes of periportal hepatocytes and in the basolateral membranes of proximal tubules in the renal cortex. This was validated by processing tissue from wild-type and knockout mice in parallel. Deletion of GAT2 reduced liver taurine levels by 50%, without affecting the expression of the taurine transporter TAUT. These results suggest an important role for GAT2 in taurine uptake from portal blood into liver. In support of this notion, GAT2-transfected HEK293 cells transported [H-3] taurine. Furthermore, most of the uptake of [H-3] GABA by cultured rat hepatocytes was due to GAT2, and this uptake was inhibited by taurine. GAT2 was not detected in brain parenchyma proper, excluding a role in GABA inactivation. It was, however, expressed in the leptomeninges and in a subpopulation of brain blood vessels. Deletion of GAT2 increased brain taurine levels by 20%, suggesting a taurine-exporting role for GAT2 in the brain.	[Zhou, Yun; Holmseth, Silvia; Danbolt, Niels C.] Univ Oslo, Inst Basic Med Sci, Dept Anat, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; [Guo, Caiying] HHMI, Ashburn, VA 20147 USA; [Hassel, Bjornar] Oslo Univ Hosp, Dept Neurohabilitat, N-0372 Oslo, Norway; [Hassel, Bjornar] Norwegian Def Res Estab, N-2027 Kjeller, Norway; [Hoefner, Georg; Wanner, Klaus T.] Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany; [Huitfeldt, Henrik S.] Univ Oslo, Oslo Univ Hosp, Dept Pathol, N-0372 Oslo, Norway	University of Oslo; Howard Hughes Medical Institute; University of Oslo; Norwegian Defence Research Establishment; University of Munich; University of Oslo	Danbolt, NC (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Ctr Mol Biol & Neurosci, POB 1105 Blindern, N-0317 Oslo, Norway.	n.c.danbolt@medisin.uio.no	Zhou, Yun/I-1840-2017; Danbolt, Niels Christian/A-1907-2014	Zhou, Yun/0000-0002-5682-0169; Danbolt, Niels Christian/0000-0003-4227-4520	Norwegian Research Council Grant [183727/S10]	Norwegian Research Council Grant(Research Council of Norway)	This work was supported by Norwegian Research Council Grant 183727/S10.	Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO;2-C; Beckstrom H, 2001, J NEUROCHEM, V78, P37; Bella DL, 2002, AMINO ACIDS, V23, P453, DOI 10.1007/s00726-002-0213-z; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BORDEN LA, 1995, J NEUROCHEM, V64, P977; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Burnham CE, 1996, BBA-BIOMEMBRANES, V1284, P4, DOI 10.1016/0005-2736(96)00118-6; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1999, J COMP NEUROL, V409, P482; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dominy J, 2004, J NEUROCHEM, V89, P1195, DOI 10.1111/j.1471-4159.2004.02410.x; Dominy J, 2004, NEUROCHEM RES, V29, P97, DOI 10.1023/B:NERE.0000010437.81860.d5; DURKIN MM, 1995, MOL BRAIN RES, V33, P7, DOI 10.1016/0169-328X(95)00101-W; Eulenburg V, 2010, BRAIN RES REV, V63, P103, DOI 10.1016/j.brainresrev.2010.01.003; Evans JE, 1996, J COMP NEUROL, V376, P431, DOI 10.1002/(SICI)1096-9861(19961216)376:3<431::AID-CNE6>3.0.CO;2-3; FERENCI P, 1988, GASTROENTEROLOGY, V95, P402, DOI 10.1016/0016-5085(88)90497-0; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; Gavish M, 1999, PHARMACOL REV, V51, P629; GOODYER PR, 1985, BIOCHIM BIOPHYS ACTA, V818, P45, DOI 10.1016/0005-2736(85)90136-1; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HARDISON WGM, 1980, BIOCHIM BIOPHYS ACTA, V598, P145, DOI 10.1016/0005-2736(80)90272-2; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Henjum S, 2007, NEUROCHEM INT, V50, P365, DOI 10.1016/j.neuint.2006.09.004; HESPE W, 1969, BRAIN RES, V14, P663, DOI 10.1016/0006-8993(69)90206-6; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; INOUE M, 1988, J BIOCHEM-TOKYO, V104, P155, DOI 10.1093/oxfordjournals.jbchem.a122413; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Janzen JWG, 1987, J HISTOCHEM CYTOCHEM, V35, P49, DOI 10.1177/35.1.2878950; Jursky F, 1999, J NEUROSCI RES, V55, P394, DOI 10.1002/(SICI)1097-4547(19990201)55:3<394::AID-JNR14>3.0.CO;2-E; Kang YS, 2002, J NEUROCHEM, V83, P1188, DOI 10.1046/j.1471-4159.2002.01223.x; Kragler A, 2005, EUR J PHARMACOL, V519, P43, DOI 10.1016/j.ejphar.2005.06.053; Kragler A, 2008, EUR J MED CHEM, V43, P2404, DOI 10.1016/j.ejmech.2008.01.005; Kuroda E, 2000, MICROSC RES TECHNIQ, V48, P116, DOI 10.1002/(SICI)1097-0029(20000115)48:2<116::AID-JEMT7>3.3.CO;2-G; Lee NY, 2004, BRAIN RES, V1023, P141, DOI 10.1016/j.brainres.2004.07.033; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lehre AC, 2011, EPILEPSY RES, V95, P70, DOI 10.1016/j.eplepsyres.2011.02.014; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LEVY LM, 1993, FEBS LETT, V317, P79, DOI 10.1016/0014-5793(93)81495-L; Li Y., 2012, J HISTOCHEM IN PRESS, V60; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; Minelli A, 2003, DEV BRAIN RES, V142, P7, DOI 10.1016/S0165-3806(03)00007-5; MINUK GY, 1984, HEPATOLOGY, V4, P180, DOI 10.1002/hep.1840040203; Motulsky H., 2004, FITTING MODELS BIOL, P222; NIELSEN EB, 1991, EUR J PHARMACOL, V196, P257, DOI 10.1016/0014-2999(91)90438-V; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; Pabel J, 2012, CHEMMEDCHEM, V7, P1245, DOI 10.1002/cmdc.201200126; Parsons RB, 1998, J HEPATOL, V29, P595, DOI 10.1016/S0168-8278(98)80155-4; Phillips CL, 2004, J AM SOC NEPHROL, V15, P1744, DOI 10.1097/01.ASN.0000131520.07008.B3; Qume M, 1996, BIOCHEM PHARMACOL, V52, P1355, DOI 10.1016/S0006-2952(96)00454-6; Rasgado-Flores H, 2012, EXP NEUROL, V233, P457, DOI 10.1016/j.expneurol.2011.11.019; ROBERTS E, 1953, J BIOL CHEM, V201, P393; SAIKI H, 1992, J BIOL CHEM, V267, P192; SCHAFER DF, 1981, P SOC EXP BIOL MED, V167, P301; Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432; Sergeeva OA, 2003, J PHYSIOL-LONDON, V550, P911, DOI 10.1113/jphysiol.2003.045864; Skarpen E, 2000, MOL CARCINOGEN, V28, P84, DOI 10.1002/1098-2744(200006)28:2<84::AID-MC4>3.0.CO;2-X; SMITH KE, 1992, MOL PHARMACOL, V42, P563; Soudijn W, 2000, CURR MED CHEM, V7, P1063, DOI 10.2174/0929867003374363; STURMAN JA, 1978, J NUTR, V108, P1462, DOI 10.1093/jn/108.9.1462; Takanaga T, 2001, J CEREBR BLOOD F MET, V21, P1232, DOI 10.1097/00004647-200110000-00012; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; Vinnakota S, 1997, J NEUROCHEM, V69, P2238; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WHITE HL, 1981, MOL CELL BIOCHEM, V39, P253, DOI 10.1007/BF00232578; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhang Y, 1998, BRAIN RES, V808, P1, DOI 10.1016/S0006-8993(98)00767-7; Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011	89	73	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35733	35746		10.1074/jbc.M112.368175	http://dx.doi.org/10.1074/jbc.M112.368175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896705	hybrid, Green Published			2022-12-28	WOS:000309968000084
J	Song, JH; Lafont, A; Chen, JR; Wu, FM; Shirahige, K; Rankin, S				Song, Jianhua; Lafont, Andrea; Chen, Jingrong; Wu, Frank M.; Shirahige, Katsuhiko; Rankin, Susannah			Cohesin Acetylation Promotes Sister Chromatid Cohesion Only in Association with the Replication Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DNA-POLYMERASE-ALPHA; S-PHASE; SACCHAROMYCES-CEREVISIAE; ESTABLISHMENT; ACETYLTRANSFERASE; SORORIN; COMPLEX; ECO1; YEAST	Acetylation of the Smc3 subunit of cohesin is essential to establish functional cohesion between sister chromatids. Smc3 acetylation is catalyzed by members of the Eco family of acetyl-transferases, although the mechanism by which acetylation is regulated and how it promotes cohesion are largely unknown. In vertebrates, the cohesin complex binds to chromatin during mitotic exit and is converted to a functional form during or shortly after DNA replication. The conserved proliferating cell nuclear antigen-interacting protein box motif in yeast Eco1 is required for function, and cohesin is acetylated during the S phase. This has led to the notion that acetylation of cohesin is stimulated by interaction of Eco1 with the replication machinery. Here we show that in vertebrates Smc3 acetylation occurs independently of DNA replication. Smc3 is readily acetylated before replication is initiated and after DNA replication is complete. However, we also show that functional acetylation occurs only in association with the replication machinery: disruption of the interaction between XEco2 and proliferating cell nuclear antigen prevents cohesion establishment while having little impact on the overall levels of Smc3 acetylation. These results demonstrate that Smc3 acetylation can occur throughout interphase but that only acetylation in association with the replication fork promotes sister chromatid cohesion. These data reveal how the generation of cohesion is limited to the appropriate time and place during the cell cycle and provide insight into the mechanism by which acetylation ensures cohesion.	[Song, Jianhua; Lafont, Andrea; Chen, Jingrong; Rankin, Susannah] Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Wu, Frank M.; Rankin, Susannah] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Tokyo	Rankin, S (corresponding author), Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	susannah-rankin@omrf.org		Rankin, Susannah/0000-0002-4056-6610	National Institutes of Health from the National Center for Research Resources [RR016478]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016478 from the National Center for Research Resources.	Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Heidinger-Pauli JM, 2010, GENETICS, V185, P1249, DOI 10.1534/genetics.110.116871; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Higashi TL, 2012, CURR BIOL, V22, P977, DOI 10.1016/j.cub.2012.04.013; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; LUKE M, 1989, DEV BIOL, V136, P459, DOI 10.1016/0012-1606(89)90271-6; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Rankin S, 1997, CURR BIOL, V7, P451, DOI 10.1016/S0960-9822(06)00192-8; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sarkaria JN, 1999, CANCER RES, V59, P4375; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takagi M, 2008, FEBS J, V275, P6109, DOI 10.1111/j.1742-4658.2008.06736.x; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tutter Antonin V., 2006, V322, P121; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whelan G, 2012, EMBO J, V31, P71, DOI 10.1038/emboj.2011.381; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	41	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34325	34336		10.1074/jbc.M112.400192	http://dx.doi.org/10.1074/jbc.M112.400192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896698	Green Published, hybrid			2022-12-28	WOS:000309654200036
J	Vermeer, LS; Lan, Y; Abbate, V; Ruh, E; Bui, TT; Wilkinson, LJ; Kanno, T; Jumagulova, E; Kozlowska, J; Patel, J; McIntyre, CA; Yam, WC; Siu, G; Atkinson, RA; Lam, JKW; Bansal, SS; Drake, AF; Mitchell, GH; Mason, AJ				Vermeer, Louic S.; Lan, Yun; Abbate, Vincenzo; Ruh, Emrah; Bui, Tam T.; Wilkinson, Louise J.; Kanno, Tokuwa; Jumagulova, Elmira; Kozlowska, Justyna; Patel, Jayneil; McIntyre, Caitlin A.; Yam, W. C.; Siu, Gilman; Atkinson, R. Andrew; Lam, Jenny K. W.; Bansal, Sukhvinder S.; Drake, Alex F.; Mitchell, Graham H.; Mason, A. James			Conformational Flexibility Determines Selectivity and Antibacterial, Antiplasmodial, and Anticancer Potency of Cationic alpha-Helical Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-VESICLES; SECONDARY STRUCTURE; ESCHERICHIA-COLI; CELL SELECTIVITY; HEPARAN-SULFATE; MODEL MEMBRANES; LYTIC PEPTIDES; LIPID-BILAYERS; BUFORIN II	We used a combination of fluorescence, circular dichroism (CD), and NMR spectroscopies in conjunction with size exclusion chromatography to help rationalize the relative antibacterial, antiplasmodial, and cytotoxic activities of a series of proline-free and proline-containing model antimicrobial peptides (AMPs) in terms of their structural properties. When compared with proline-free analogs, proline-containing peptides had greater activity against Gram-negative bacteria, two mammalian cancer cell lines, and intraerythrocytic Plasmodium falciparum, which they were capable of killing without causing hemolysis. In contrast, incorporation of proline did not have a consistent effect on peptide activity against Mycobacterium tuberculosis. In membrane-mimicking environments, structures with high alpha-helix content were adopted by both proline-free and proline-containing peptides. In solution, AMPs generally adopted disordered structures unless their sequences comprised more hydrophobic amino acids or until coordinating phosphate ions were added. Proline-containing peptides resisted ordering induced by either method. The roles of the angle subtended by positively charged amino acids and the positioning of the proline residues were also investigated. Careful positioning of proline residues in AMP sequences is required to enable the peptide to resist ordering and maintain optimal antibacterial activity, whereas varying the angle subtended by positively charged amino acids can attenuate hemolytic potential albeit with a modest reduction in potency. Maintaining conformational flexibility improves AMP potency and selectivity toward bacterial, plasmodial, and cancerous cells while enabling the targeting of intracellular pathogens.	[Vermeer, Louic S.; Lan, Yun; Abbate, Vincenzo; Bui, Tam T.; Wilkinson, Louise J.; Kanno, Tokuwa; Jumagulova, Elmira; Kozlowska, Justyna; Patel, Jayneil; McIntyre, Caitlin A.; Bansal, Sukhvinder S.; Drake, Alex F.; Mason, A. James] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Lan, Yun; Lam, Jenny K. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Lan, Yun; Ruh, Emrah; Mitchell, Graham H.] Kings Coll London, Dept Immunobiol, Malaria Lab, London SE1 9RT, England; [Lan, Yun; Ruh, Emrah; Mitchell, Graham H.] Guys Hosp, St Thomas Hosp, Sch Med, London SE1 9RT, England; [Yam, W. C.; Siu, Gilman] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Atkinson, R. Andrew] Kings Coll London, Ctr Biomol Spect, London SE1 1UL, England; [Atkinson, R. Andrew] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; University of Hong Kong; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Hong Kong; University of London; King's College London; University of London; King's College London	Mason, AJ (corresponding author), Kings Coll London, Inst Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England.	james.mason@kcl.ac.uk	Lam, Jenny/A-4842-2010; Vermeer, Louic S/I-4883-2012; Mason, James/J-2273-2012; Abbate, Vincenzo/K-6204-2019; SIU, Kit Hang/L-7796-2017; Mitchell, Graham/AAA-5654-2020; Atkinson, Robert Andrew/ABE-8068-2020	Lam, Jenny/0000-0003-2997-010X; Mason, James/0000-0003-0411-602X; SIU, Kit Hang/0000-0002-4354-3393; Atkinson, Robert Andrew/0000-0002-3645-9492; Mitchell, G.H./0000-0002-4922-8044; Abbate, Vincenzo/0000-0002-3300-0520; Vermeer, Louic/0000-0003-1815-7412; Bui, Tam Thu Thi/0000-0002-8074-4928	Medical Research Council [NIRG G0801072/87482]; Wellcome Trust; University of London Central Research Fund Grant AR/CRF/B; Applied Photophysics Ltd.; Research Fund for Control of Infectious Diseases [RFCID 11100682]; Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme; Medical Research Council [G0801072] Funding Source: researchfish; MRC [G0801072] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of London Central Research Fund Grant AR/CRF/B; Applied Photophysics Ltd.; Research Fund for Control of Infectious Diseases; Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant NIRG G0801072/87482 (to A. J. M.), The Wellcome Trust Value in People Award (to A. J. M.) and Capital Award (to the King's College London Centre for Biomolecular Spectroscopy), University of London Central Research Fund Grant AR/CRF/B, Applied Photophysics Ltd., Research Fund for Control of Infectious Diseases Grant RFCID 11100682 (to J. K. W. L. and A. J. M.), and the Hong Kong Special Administrative Region University of Hong Kong Seed Funding Programme (to J. K. W. L.).	ALLEY MC, 1988, CANCER RES, V48, P589; ANDREU D, 1985, BIOCHEMISTRY-US, V24, P1683, DOI 10.1021/bi00328a017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Avrahami D, 2001, BIOCHEMISTRY-US, V40, P12591, DOI 10.1021/bi0105330; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; Chen Y, 1996, J AM CHEM SOC, V118, P9271, DOI 10.1021/ja961307u; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DRAKE AF, 1988, BIOPHYS CHEM, V31, P143, DOI 10.1016/0301-4622(88)80019-X; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Epand RF, 2010, BIOPHYS J, V98, P2564, DOI 10.1016/j.bpj.2010.03.002; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Fadnes B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-116; Fadnes B, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-183; Fossi M, 2005, J MAGN RESON, V175, P92, DOI 10.1016/j.jmr.2005.03.020; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; Goddard D., 2008, SPARKY 3; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hong SY, 1999, BIOCHEM PHARMACOL, V58, P1775, DOI 10.1016/S0006-2952(99)00259-2; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026; Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lan Y, 2010, BBA-BIOMEMBRANES, V1798, P1934, DOI 10.1016/j.bbamem.2010.07.003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; Mason AJ, 2009, J BIOL CHEM, V284, P119, DOI 10.1074/jbc.M806201200; Nishikawa M, 2004, FEMS MICROBIOL LETT, V239, P255, DOI 10.1016/j.femsle.2004.08.043; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Porcelli F, 2004, J BIOL CHEM, V279, P45815, DOI 10.1074/jbc.M405454200; Pukala TL, 2004, BIOCHEMISTRY-US, V43, P937, DOI 10.1021/bi035760b; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Song YM, 2004, BIOCHEM BIOPH RES CO, V314, P615, DOI 10.1016/j.bbrc.2003.12.142; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TATHAM AS, 1983, BIOCHEM J, V211, P683, DOI 10.1042/bj2110683; Unger T, 2001, BIOCHEMISTRY-US, V40, P6388, DOI 10.1021/bi0026066; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Yang ST, 2006, FEBS J, V273, P4040, DOI 10.1111/j.1742-4658.2006.05407.x; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	58	63	67	0	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34120	34133		10.1074/jbc.M112.359067	http://dx.doi.org/10.1074/jbc.M112.359067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22869378	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000309654200018
J	Wadsater, M; Laursen, T; Singha, A; Hatzakis, NS; Stamou, D; Barker, R; Mortensen, K; Feidenhans'l, R; Moller, BL; Cardenas, M				Wadsater, Maria; Laursen, Tomas; Singha, Aparajita; Hatzakis, Nikos S.; Stamou, Dimitrios; Barker, Robert; Mortensen, Kell; Feidenhans'l, Robert; Moller, Birger Lindberg; Cardenas, Marite			Monitoring Shifts in the Conformation Equilibrium of the Membrane Protein Cytochrome P450 Reductase (POR) in Nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; CYANOGENIC GLUCOSIDE DHURRIN; NANOSCALE LIPID-BILAYERS; FMN BINDING-SITE; ELECTRON-TRANSFER; SORGHUM-BICOLOR; NEUTRON REFLECTOMETRY; DIFLAVIN REDUCTASES; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEINS	Nanodiscs are self-assembled similar to 50-nm(2) patches of lipid bilayers stabilized by amphipathic belt proteins. We demonstrate that a well ordered dense film of nanodiscs serves for non-destructive, label-free studies of isolated membrane proteins in a native like environment using neutron reflectometry (NR). This method exceeds studies of membrane proteins in vesicle or supported lipid bilayer because membrane proteins can be selectively adsorbed with controlled orientation. As a proof of concept, the mechanism of action of the membrane-anchored cytochrome P450 reductase (POR) is studied here. This enzyme is responsible for catalyzing the transfer of electrons from NADPH to cytochrome P450s and thus is a key enzyme in the biosynthesis of numerous primary and secondary metabolites in plants. Neutron reflectometry shows a coexistence of two different POR conformations, a compact and an extended form with a thickness of 44 and 79 angstrom, respectively. Upon complete reduction by NADPH, the conformational equilibrium shifts toward the compact form protecting the reduced FMN cofactor from engaging in unspecific electron transfer reaction.	[Wadsater, Maria; Cardenas, Marite] Univ Copenhagen, Inst Chem, Fac Sci, DK-2100 Copenhagen, Denmark; [Wadsater, Maria; Cardenas, Marite] Univ Copenhagen, Nanosci Ctr, Fac Sci, DK-2100 Copenhagen, Denmark; [Laursen, Tomas; Moller, Birger Lindberg] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; [Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Nanosci Ctr,Dept Chem, Dept Neurosci & Pharmacol,Bionanotechnol Lab, DK-2100 Copenhagen, Denmark; [Barker, Robert] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Mortensen, Kell; Feidenhans'l, Robert] Niels Bohr Inst, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; Institut Laue-Langevin (ILL); University of Copenhagen; Niels Bohr Institute	Cardenas, M (corresponding author), Univ Copenhagen, Inst Chem, Fac Sci, Univ Pk 5, DK-2100 Copenhagen, Denmark.	cardenas@nano.ku.dk	Cardenas, Marite/AAG-1793-2019; Hatzakis, Nikos S/C-2715-2015; Møller, Birger Lindberg/GQI-1792-2022; Cárdenas, Marité/O-4669-2014; Stamou, Dimitrios/D-5042-2016; Mortensen, Kell/A-5066-2009; Møller, Birger Lindberg/H-2657-2014; Hatzakis, Nikos/P-3865-2019; Barker, Robert D/E-6386-2012; Singha, Aparajita/AAN-8356-2021	Cardenas, Marite/0000-0003-0392-3540; Hatzakis, Nikos S/0000-0003-4202-0328; Møller, Birger Lindberg/0000-0002-3252-3119; Cárdenas, Marité/0000-0003-0392-3540; Stamou, Dimitrios/0000-0001-8456-8995; Mortensen, Kell/0000-0002-8998-9390; Møller, Birger Lindberg/0000-0002-3252-3119; Hatzakis, Nikos/0000-0003-4202-0328; Barker, Robert D/0000-0002-8645-5385; Singha, Aparajita/0000-0001-6301-0394; Feidenhansl, Robert/0000-0002-7963-3649; Laursen, Tomas/0000-0002-6493-2259	Center for Synthetic Biology at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation; Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center; Danish government; Villum Research Center "Pro-Active Plants."	Center for Synthetic Biology at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation; Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center; Danish government; Villum Research Center "Pro-Active Plants."	This work was supported by the Center for Synthetic Biology at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation, the Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center funded by the Danish government, and the Villum Research Center "Pro-Active Plants."	ABELES F, 1948, ANN PHYS-PARIS, V3, P504; Akesson A, 2012, SOFT MATTER, V8, P5658, DOI 10.1039/c2sm00013j; Aliverti A, 1999, METH MOL B, V131, P9; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bayburt TH, 2000, LANGMUIR, V16, P5993, DOI 10.1021/la991449c; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; Carlson JW, 1997, BIOPHYS J, V73, P1184, DOI 10.1016/S0006-3495(97)78150-5; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hatzakis NS, 2012, J AM CHEM SOC, V134, P9296, DOI 10.1021/ja3011429; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ivanov AS, 2010, ACS CHEM BIOL, V5, P767, DOI 10.1021/cb100055v; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Jensen K, 2011, PHYTOCHEMISTRY, V72, P2113, DOI 10.1016/j.phytochem.2011.05.001; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Kent MS, 2008, BIOPHYS J, V94, P2115, DOI 10.1529/biophysj.107.113498; Kent MS, 2010, BIOPHYS J, V99, P1940, DOI 10.1016/j.bpj.2010.07.016; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Skar-Gislinge N, 2010, J AM CHEM SOC, V132, P13713, DOI 10.1021/ja1030613; Thomas RK, 2004, ANNU REV PHYS CHEM, V55, P391, DOI 10.1146/annurev.physchem.54.011002.103830; Wadsater M, 2011, LANGMUIR, V27, P15065, DOI 10.1021/la203100n; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587	50	52	55	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34596	34603		10.1074/jbc.M112.400085	http://dx.doi.org/10.1074/jbc.M112.400085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891242	Green Published, hybrid			2022-12-28	WOS:000309654200062
J	Zhang, HD; Lee, SJ; Kulczyk, AW; Zhu, B; Richardson, CC				Zhang, Huidong; Lee, Seung-Joo; Kulczyk, Arkadiusz W.; Zhu, Bin; Richardson, Charles C.			Heterohexamer of 56- and 63-kDa Gene 4 Helicase-Primase of Bacteriophage T7 in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; LAGGING-STRAND SYNTHESIS; NUCLEOTIDE-BINDING SITE; POLYMERASE-ACTIVITY; PRIMER SYNTHESIS; SINGLE-MOLECULE; DTTP HYDROLYSIS; LINKER REGION; PROTEIN; TEMPLATE	Bacteriophage T7 expresses two forms of gene 4 protein (gp4). The 63-kDa full-length gp4 contains both the helicase and primase domains. T7 phage also express a 56-kDa truncated gp4 lacking the zinc binding domain of the primase; the protein has helicase activity but no DNA-dependent primase activity. Although T7 phage grow better when both forms are present, the role of the 56-kDa gp4 is unknown. The two molecular weight forms oligomerize by virtue of the helicase domain to form heterohexamers. The 56-kDa gp4 and any mixture of 56- and 63-kDa gp4 show higher helicase activity in DNA unwinding and strand-displacement DNA synthesis than that observed for the 63-kDa gp4. However, single-molecule measurements show that heterohexamers have helicase activity similar to the 63-kDa gp4 hexamers. In oligomerization assays the 56-kDa gp4 and any mixture of the 56- and 63-kDa gp4 oligomerize to form more hexamers than does the 63-kDa gp4. The zinc binding domain of the 63-kDa gp4 interferes with hexamer formation, an inhibition that is relieved by the insertion of the 56-kDa species. Compared with the 63-kDa gp4, heterohexamers synthesize a reduced amount of oligoribonucleotides, mediated predominately by the 63-kDa subunits via a cis mode. During coordinated DNA synthesis 7% of the tetraribonucleotides synthesized are used as primers by both heterohexamers and hexamers of the 63-kDa gp4. Overall, an equimolar mixture of the two forms of gp4 shows the highest rate of DNA synthesis during coordinated DNA synthesis.	[Zhang, Huidong; Lee, Seung-Joo; Kulczyk, Arkadiusz W.; Zhu, Bin; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health Public Health Service [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant GM 54937 (to C.C.R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bianchi M, 2012, P NATL ACAD SCI USA, V109, P1713, DOI 10.1073/pnas.1121485109; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KIM YT, 1992, J BIOL CHEM, V267, P15032; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2009, J VIROL, V83, P8418, DOI 10.1128/JVI.00855-09; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Nakai H., 1988, DNA REPLICATION MUTA, P85; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	49	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34273	34287		10.1074/jbc.M112.401158	http://dx.doi.org/10.1074/jbc.M112.401158			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22887996	hybrid, Green Published			2022-12-28	WOS:000309654200032
J	Arriola, DJ; Mayo, SL; Skarra, DV; Benson, CA; Thackray, VG				Arriola, David J.; Mayo, Susan L.; Skarra, Danalea V.; Benson, Courtney A.; Thackray, Varykina G.			FOXO1 Transcription Factor Inhibits Luteinizing Hormone beta Gene Expression in Pituitary Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; GROWTH-FACTOR-I; GNRH PULSE FREQUENCY; PROTEIN-KINASE-C; OXIDATIVE STRESS; NEGATIVE REGULATION; RESPONSE ELEMENT; GRANULOSA-CELLS; L-BETA-T2 CELLS; DISCRETE STAGES	Synthesis of luteinizing hormone (LH) is tightly controlled by a complex network of hormonal signaling pathways that can be modulated by metabolic cues, such as insulin. One group of candidate genes that may be regulated by insulin signaling in pituitary gonadotrope cells is the FOXO subfamily of forkhead transcription factors. In this study we investigated whether FOXO1 is expressed in gonadotropes and if it can modulate LH beta-subunit (Lhb) gene expression. We demonstrated that FOXO1 is expressed in murine gonadotrope cells and that insulin signaling increased FOXO1 phosphorylation and cytoplasmic localization in a PI3K-dependent manner. We also showed that FOXO1 repressed basal transcription and gonadotropin-releasing hormone ( GnRH) induction of both the murine and human LHB genes in L beta T2 cells, suggesting that FOXO1 regulation of LHB transcription may be conserved between rodents and humans. Although we did not detect FOXO1 binding to the proximal Lhb promoter, the FOXO1 DNA binding domain was necessary for the suppression, suggesting that FOXO1 exerts its effect through protein-protein interactions with transcription factors/cofactors required for Lhb gene expression. FOXO1 repression mapped to the proximal Lhb promoter containing steroidogenic factor 1 (SF1), pituitary homeobox 1 (PTX1), and early growth response protein 1 (EGR1) binding elements. Additionally, FOXO1 blocked induction of the Lhb promoter with overexpressed SF1, PTX1, and EGR1, indicating that FOXO1 repression occurs via these transcription factors but not through regulation of their promoters. In summary, we demonstrate that FOXO1 phosphorylation and cellular localization is regulated by insulin signaling in gonadotropes and that FOXO1 inhibits Lhb transcription. Our study also suggests that FOXO1 may play an important role in controlling LH levels in response to metabolic cues.	[Thackray, Varykina G.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Reprod Med, 9500 Gilman Dr,MC0674, La Jolla, CA 92093 USA.	vthackray@ucsd.edu			National Institutes of Health [K01 DK080467, R01 HD067448, T32 HD007203]; UCSD/UCLA Diabetes and Endocrinology Research Center [P30 DK063491]; NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; UCSD Academic Senate Health Sciences Research Grant; NCI Cancer Support Grant [P30 CA023100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, T32HD007203, R01HD067448, U54HD012303, F32HD074414] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, K01DK080467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD/UCLA Diabetes and Endocrinology Research Center; NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; UCSD Academic Senate Health Sciences Research Grant; NCI Cancer Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK080467 and R01 HD067448 (to V. G. T.) as well as T32 HD007203 (to D. V. S.). This work was also supported by a pilot and feasibility grant from the UCSD/UCLA Diabetes and Endocrinology Research Center (P30 DK063491) by NICHD, National Institutes of Health through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and by a UCSD Academic Senate Health Sciences Research Grant.; We thank Djurdjica Coss, Kellie Breen, and Pamela Mellon for helpful discussions and comments. We also thank Scott Kelley for suggestions and critical reading of the manuscript. We acknowledge using the UCSD Cancer Center DNA Sequencing Shared Resource funded in part by the NCI Cancer Support Grant P30 CA023100 for DNA sequencing.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Alarid ET, 1998, MOL CELL ENDOCRINOL, V140, P25; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Armstrong J, 1997, ENDOCRINOLOGY, V138, P1903, DOI 10.1210/en.138.5.1903; ATTARDI B, 1990, MOL ENDOCRINOL, V4, P721, DOI 10.1210/mend-4-5-721; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brosens JJ, 2009, ADV EXP MED BIOL, V665, P227; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Charles MA, 2008, GENESIS, V46, P507, DOI 10.1002/dvg.20398; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; Cunningham MA, 2003, ENDOCRINOLOGY, V144, P5585, DOI 10.1210/en.2003-0678; Dorn C, 2004, AM J OBSTET GYNECOL, V191, P132, DOI 10.1016/j.ajog.2004.01.054; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Dunaif A, 2001, ANNU REV MED, V52, P401, DOI 10.1146/annurev.med.52.1.401; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; Harris D, 2002, ENDOCRINOLOGY, V143, P1018, DOI 10.1210/en.143.3.1018; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V254, P84, DOI 10.1016/j.mce.2006.04.015; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V252, P126, DOI 10.1016/j.mce.2006.03.026; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jiang QR, 2005, J MOL ENDOCRINOL, V35, P145, DOI 10.1677/jme.1.01754; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2009, DEV BIOL, V331, P292, DOI 10.1016/j.ydbio.2009.05.546; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Leblanc P, 1997, ENDOCRINOLOGY, V138, P574, DOI 10.1210/en.138.2.574; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Mann RJ, 2003, RECENT PROG HORM RES, V58, P343, DOI 10.1210/rp.58.1.343; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Navratil AM, 2009, MOL CELL ENDOCRINOL, V311, P47, DOI 10.1016/j.mce.2009.07.014; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rose A, 2004, J BIOL CHEM, V279, P52500, DOI 10.1074/jbc.M404571200; Rosenberg SB, 2002, MOL ENDOCRINOL, V16, P1280, DOI 10.1210/me.16.6.1280; Salisbury TB, 2007, MOL ENDOCRINOL, V21, P963, DOI 10.1210/me.2006-0383; Schweizer-Groyer G, 2006, ANN NY ACAD SCI, V1091, P296, DOI 10.1196/annals.1378.075; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SOLDANI R, 1994, EUR J ENDOCRINOL, V131, P641, DOI 10.1530/eje.0.1310641; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thackray VG, 2009, ENDOCRINOLOGY, V150, P2395, DOI 10.1210/en.2008-1027; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vasilyev VV, 2002, ENDOCRINOLOGY, V143, P3414, DOI 10.1210/en.2001-211215; Weck J, 2000, MOL ENDOCRINOL, V14, P472, DOI 10.1210/me.14.4.472; Xia YX, 2001, EUR J ENDOCRINOL, V144, P73, DOI 10.1530/eje.0.1440073; Yoo RY, 2006, FERTIL STERIL, V85, P1049, DOI 10.1016/j.fertnstert.2005.09.037; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	83	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33424	33435		10.1074/jbc.M112.362103	http://dx.doi.org/10.1074/jbc.M112.362103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865884	Green Published, hybrid			2022-12-28	WOS:000309602100029
J	Cai, CX; Teng, L; Vu, D; He, JQ; Guo, YR; Li, QH; Tang, XL; Rokosh, G; Bhatnagar, A; Bolli, R				Cai, Chuanxi; Teng, Lei; Duc Vu; He, Jia-Qiang; Guo, Yiru; Li, Qianghong; Tang, Xian-Liang; Rokosh, Gregg; Bhatnagar, Aruni; Bolli, Roberto			The Heme Oxygenase 1 Inducer (CoPP) Protects Human Cardiac Stem Cells against Apoptosis through Activation of the Extracellular Signal-regulated Kinase (ERK)/NRF2 Signaling Pathway and Cytokine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES INSULIN SENSITIVITY; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CARBON-MONOXIDE; PARACRINE MECHANISMS; VENTRICULAR-FUNCTION; TRANSCRIPTION FACTOR; PROGENITOR CELLS; GROWTH-FACTOR; GENE	Intracoronary delivery of c-kit-positive human cardiac stem cells (hCSCs) is a promising approach to repair the infarcted heart, but it is severely limited by the poor survival of donor cells. Cobalt protoporphyrin (CoPP), a well known heme oxygenase 1 inducer, has been used to promote endogenous CO generation and protect against ischemia/reperfusion injury. Therefore, we determined whether preconditioning hCSCs with CoPP promotes CSC survival. c-kit-positive, lineage-negative hCSCs were isolated from human heart biopsies. Lactate dehydrogenase release assays demonstrated that preconditioning CSCs with CoPP markedly enhanced cell survival after oxidative stress induced by H2O2, concomitant with up-regulation of heme oxygenase 1, COX-2, and anti-apoptotic proteins (BCL2, BCL2-A1, and MCL-1) and increased phosphorylation of NRF2. Apoptotic cytometric assays showed that pretreatment of CSCs with CoPP enhanced the cells' resistance to apoptosis induced by oxidative stress. Conversely, knocking down HO-1, COX-2, or NRF2 by shRNA gene silencing abrogated the cytoprotective effects of CoPP. Further, preconditioning CSCs with CoPP led to a global increase in release of cytokines, such as EGF, FGFs, colony-stimulating factors, and chemokine ligand. Conditioned medium from cells pretreated with CoPP conferred naive CSCs remarkable resistance to apoptosis, demonstrating that cytokines released by preconditioned cells play a key role in the anti-apoptotic effects of CoPP. Preconditioning CSCs with CoPP also induced an increase in the phosphorylation of Erk1/2, which are known to modulate multiple pro-survival genes. These results potentially provide a simple and effective strategy to enhance survival of CSCs after transplantation and, therefore, their efficacy in repairing infarcted myocardium.	[Cai, Chuanxi; Teng, Lei; Duc Vu; He, Jia-Qiang; Guo, Yiru; Li, Qianghong; Tang, Xian-Liang; Rokosh, Gregg; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, 550 S Jackson St, Louisville, KY 40292 USA.	rbolli@louisville.edu	Teng, Lei/G-3562-2012; Guo, Yiru/L-2618-2015; Cai, Chuanxi/AAW-1488-2020; Tang, Xian-Liang/L-5703-2015; Rokosh, Gregg/J-2730-2013; Bolli, Roberto/A-6870-2010	Teng, Lei/0000-0001-9213-4054; Guo, Yiru/0000-0002-0614-9899; Rokosh, Gregg/0000-0002-9214-2254	National Institutes of Health [R21 HL104315, R01 HL114951, P20 RR024489, R01 HL55757, HL-70897, HL-76794, P01HL78825]; American Heart Association Grant [12BGIA9090005]; Kentucky Science and Engineering Foundation Grant [2134-RDE-013]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114951, P01HL078825, R01HL076794, R21HL104315, R01HL070897, R01HL055757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); Kentucky Science and Engineering Foundation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL104315 and R01 HL114951 (to C. C.); P20 RR024489 (to A. B.); and R01 HL55757, HL-70897, HL-76794, and P01HL78825 (to R. B.). This work was also supported by American Heart Association Grant 12BGIA9090005 (to C. C.) and Kentucky Science and Engineering Foundation Grant 2134-RDE-013 (to C. C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dawn B, 2005, Minerva Cardioangiol, V53, P549; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dzau VJ, 2005, J AM COLL CARDIOL, V46, P1351, DOI 10.1016/j.jacc.2005.07.023; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2010, J CARDIOVASC TRANSL, V3, P89, DOI 10.1007/s12265-009-9161-2; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Kawamoto S, 2011, TISSUE ENG PT A, V17, P1605, DOI 10.1089/ten.tea.2010.0447; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Liu XL, 2007, AM J PHYSIOL-HEART C, V293, pH48, DOI 10.1152/ajpheart.00741.2006; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mohri T, 2006, J BIOL CHEM, V281, P6442, DOI 10.1074/jbc.M508969200; Morita T, 1995, J CLIN INVEST, V96, P2676, DOI 10.1172/JCI118334; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Orozco-Ibarra M, 2009, INT J BIOCHEM CELL B, V41, P1304, DOI 10.1016/j.biocel.2008.11.003; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Piantadosi CA, 2002, NEW ENGL J MED, V347, P1054, DOI 10.1056/NEJMp020104; Rani KGA, 2010, GROWTH FACTORS, V28, P157, DOI 10.3109/08977190903512628; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Schuh A, 2009, BASIC RES CARDIOL, V104, P403, DOI 10.1007/s00395-008-0763-7; Shintani Satoshi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS123, DOI 10.1038/ncpcardio0430; Shirai T, 1998, J THORAC CARDIOV SUR, V115, P210, DOI 10.1016/S0022-5223(98)70459-3; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Smith H, 2012, STEM CELLS DEV, V21, P476, DOI 10.1089/scd.2011.0025; Stastna M, 2010, PROTEOMICS, V10, P245, DOI 10.1002/pmic.200900515; Stastna M, 2009, FEBS LETT, V583, P1800, DOI 10.1016/j.febslet.2009.03.026; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sun BW, 2008, INT J BIOL SCI, V4, P176; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Yau TM, 2005, ANN THORAC SURG, V80, P1779, DOI 10.1016/j.athoracsur.2005.04.079; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695; Zhou P, 2009, SEMIN IMMUNOPATHOL, V31, P411, DOI 10.1007/s00281-009-0166-3; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	66	80	87	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33720	33732		10.1074/jbc.M112.385542	http://dx.doi.org/10.1074/jbc.M112.385542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879597	Green Published, hybrid			2022-12-28	WOS:000309602100055
J	Padilla-Meier, GP; Gilcrease, EB; Weigele, PR; Cortines, JR; Siegel, M; Leavitt, JC; Teschke, CM; Casjens, SR				Padilla-Meier, G. Pauline; Gilcrease, Eddie B.; Weigele, Peter R.; Cortines, Juliana R.; Siegel, Molly; Leavitt, Justin C.; Teschke, Carolyn M.; Casjens, Sherwood R.			Unraveling the Role of the C-terminal Helix Turn Helix of the Coat-binding Domain of Bacteriophage P22 Scaffolding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PHAGE-P22 PROCAPSIDS; FUNCTIONAL DOMAINS; ELECTRON CRYOMICROSCOPY; MATURATION TRANSITION; SALMONELLA PHAGE-P22; STRUCTURAL PROTEINS; NUCLEOTIDE-SEQUENCE; CIRCULAR-DICHROISM; DNA ENCAPSULATION	Many viruses encode scaffolding and coat proteins that co-assemble to form procapsids, which are transient precursor structures leading to progeny virions. In bacteriophage P22, the association of scaffolding and coat proteins is mediated mainly by ionic interactions. The coat protein-binding domain of scaffolding protein is a helix turn helix structure near the C terminus with a high number of charged surface residues. Residues Arg-293 and Lys-296 are particularly important for coat protein binding. The two helices contact each other through hydrophobic side chains. In this study, substitution of the residues of the interface between the helices, and the residues in the beta-turn, by aspartic acid was used examine the importance of the conformation of the domain in coat binding. These replacements strongly affected the ability of the scaffolding protein to interact with coat protein. The severity of the defect in the association of scaffolding protein to coat protein was dependent on location, with substitutions at residues in the turn and helix 2 causing the most significant effects. Substituting aspartic acid for hydrophobic interface residues dramatically perturbs the stability of the structure, but similar substitutions in the turn had much less effect on the integrity of this domain, as determined by circular dichroism. We propose that the binding of scaffolding protein to coat protein is dependent on angle of the beta-turn and the orientation of the charged surface on helix 2. Surprisingly, formation of the highly complex procapsid structure depends on a relatively simple interaction.	[Padilla-Meier, G. Pauline; Cortines, Juliana R.; Siegel, Molly; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Gilcrease, Eddie B.; Weigele, Peter R.; Leavitt, Justin C.; Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	University of Connecticut; University of Connecticut; Utah System of Higher Education; University of Utah	Teschke, CM (corresponding author), Rm 2200,Emma Eccles Jones Med Res Bldg,15 N Med D, Salt Lake City, UT 84112 USA.	teschke@uconn.edu; sherwood.casjens@path.utah.edu	Weigele, Peter/AIE-8230-2022; Cortines, Juliana/V-3997-2019	Weigele, Peter/0000-0003-3696-4541; Cortines, Juliana/0000-0003-2481-9267; Leavitt, Justin/0000-0003-4544-0483	National Institutes of Health [R01 GM076661, R01 AI074825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076661 (to C. M. T.) and R01 AI074825 ( to S. R. C.).	ADAMS MB, 1985, J VIROL, V53, P180, DOI 10.1128/JVI.53.1.180-184.1985; Aramli LA, 1999, J BIOL CHEM, V274, P22217, DOI 10.1074/jbc.274.32.22217; Baines J., 2003, VIRAL GENOME PACKAGI, P135; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Black Lindsay W., 1994, P218; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; CASJENS S, 1979, J MOL BIOL, V131, P1, DOI 10.1016/0022-2836(79)90298-5; Cerritelli ME, 1996, J MOL BIOL, V258, P299, DOI 10.1006/jmbi.1996.0251; Chang JR, 2009, VIROLOGY, V384, P144, DOI 10.1016/j.virol.2008.11.016; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Cherwa JE, 2008, J VIROL, V82, P5774, DOI 10.1128/JVI.02758-07; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; Dokland T, 1999, CELL MOL LIFE SCI, V56, P580, DOI 10.1007/s000180050455; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; EARNSHAW W, 1978, J MOL BIOL, V126, P721, DOI 10.1016/0022-2836(78)90017-7; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; FULLER MT, 1982, J MOL BIOL, V156, P633, DOI 10.1016/0022-2836(82)90270-4; Gibson W, 2008, CURR TOP MICROBIOL, V325, P187; GOPE R, 1983, J VIROL, V47, P96, DOI 10.1128/JVI.47.1.96-105.1983; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1993, J BIOL CHEM, V268, P9358; Greene B, 1996, VIROLOGY, V225, P82, DOI 10.1006/viro.1996.0577; Greene B, 1999, J BIOL CHEM, V274, P16135, DOI 10.1074/jbc.274.23.16135; Greene B, 1999, J BIOL CHEM, V274, P16141, DOI 10.1074/jbc.274.23.16141; GREENE B, 1994, VIROLOGY, V205, P188, DOI 10.1006/viro.1994.1634; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; Huet A, 2010, J VIROL, V84, P9350, DOI 10.1128/JVI.00942-10; ISRAEL V, 1967, VIROLOGY, V33, P317, DOI 10.1016/0042-6822(67)90150-X; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENK E, 1975, VIROLOGY, V68, P182, DOI 10.1016/0042-6822(75)90160-9; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; Luque I, 1996, BIOCHEMISTRY-US, V35, P13681, DOI 10.1021/bi961319s; Medina E, 2010, J MOL BIOL, V401, P813, DOI 10.1016/j.jmb.2010.06.060; Morais MC, 2004, MOL CELL, V15, P991, DOI 10.1016/j.molcel.2004.08.023; Padilla-Meier GP, 2011, J MOL BIOL, V410, P226, DOI 10.1016/j.jmb.2011.05.006; Parent KN, 2005, VIROLOGY, V340, P33, DOI 10.1016/j.virol.2005.06.018; Parent KN, 2004, MOL MICROBIOL, V54, P1036, DOI 10.1111/j.1365-2958.2004.04326.x; Parent KN, 2007, J MOL BIOL, V365, P513, DOI 10.1016/j.jmb.2006.09.088; Parent KN, 2006, J MOL BIOL, V359, P1097, DOI 10.1016/j.jmb.2006.03.068; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Parker MH, 1997, PROTEIN SCI, V6, P1583, DOI 10.1002/pro.5560060722; Parker MH, 1998, J MOL BIOL, V281, P69, DOI 10.1006/jmbi.1998.1917; Parker MH, 1998, VIROLOGY, V250, P337, DOI 10.1006/viro.1998.9386; Parker MH, 2001, BIOCHEMISTRY-US, V40, P8962, DOI 10.1021/bi0026167; Parker MH, 1997, J MOL BIOL, V268, P655, DOI 10.1006/jmbi.1997.0995; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1990, BIOCHEMISTRY-US, V29, P5626, DOI 10.1021/bi00475a030; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Prevelige PE, 2012, ADV EXP MED BIOL, V726, P325, DOI 10.1007/978-1-4614-0980-9_14; RAY P, 1975, VIROLOGY, V64, P247, DOI 10.1016/0042-6822(75)90096-3; RISHOVD S, 1994, VIROLOGY, V200, P744, DOI 10.1006/viro.1994.1238; SCHWARZ JJ, 1989, GENETICS, V121, P635; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Suhanovsky MM, 2011, VIROLOGY, V417, P418, DOI 10.1016/j.virol.2011.06.025; Sun YH, 2000, J MOL BIOL, V297, P1195, DOI 10.1006/jmbi.2000.3620; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Teschke CM, 1999, BIOCHEMISTRY-US, V38, P2873, DOI 10.1021/bi982739f; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; Thuman-Commike PA, 2000, J VIROL, V74, P3871, DOI 10.1128/JVI.74.8.3871-3873.2000; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Tuma R, 1998, J MOL BIOL, V281, P81, DOI 10.1006/jmbi.1998.1916; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weigele PR, 2005, J MOL BIOL, V348, P831, DOI 10.1016/j.jmb.2005.03.004; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601; Zlotnick A, 2012, VIROLOGY, V428, P64, DOI 10.1016/j.virol.2012.03.017	82	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33766	33780		10.1074/jbc.M112.393132	http://dx.doi.org/10.1074/jbc.M112.393132			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879595	Green Published, hybrid			2022-12-28	WOS:000309602100059
J	Zhang, Y; Xiao, X; Zhang, XM; Zhao, ZQ; Zhang, YQ				Zhang, Yan; Xiao, Xiao; Zhang, Xiao-Meng; Zhao, Zhi-Qi; Zhang, Yu-Qiu			Estrogen Facilitates Spinal Cord Synaptic Transmission via Membrane-bound Estrogen Receptors IMPLICATIONS FOR PAIN HYPERSENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CINGULATE CORTEX CONTRIBUTES; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EVOKED FIELD POTENTIALS; NMDA RECEPTOR; DORSAL-HORN; HYPOTHALAMIC NEURONS; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS	Recent evidence suggests that estrogen is synthesized in the spinal dorsal horn and plays a role in nociceptive processes. However, the cellular and molecular mechanisms underlying these effects remain unclear. Using electrophysiological, biochemical, and morphological techniques, we here demonstrate that 17 beta-estradiol (E2), a major form of estrogen, can directly modulate spinal cord synaptic transmission by 1) enhancing NMDA receptor-mediated synaptic transmission in dorsal horn neurons, 2) increasing glutamate release from primary afferent terminals, 3) increasing dendritic spine density in cultured spinal cord dorsal horn neurons, and 4) potentiating spinal cord long term potentiation (LTP) evoked by high frequency stimulation (HFS) of Lissauer's tract. Notably, E2-BSA, a ligand that acts only on membrane estrogen receptors, can mimic E2-induced facilitation of HFS-LTP, suggesting a nongenomic action of this neurosteroid. Consistently, cell surface biotinylation demonstrated that three types of ERs (ER alpha, ER beta, and GPER1) are localized on the plasma membrane of dorsal horn neurons. Furthermore, the ER alpha and ER beta antagonist ICI 182,780 completely abrogates the E2-induced facilitation of LTP. ER beta (but not ER alpha) activation can recapitulate E2-induced persistent increases in synaptic transmission (NMDA-dependent) and dendritic spine density, indicating a critical role of ER beta in spinal synaptic plasticity. E2 also increases the phosphorylation of ERK, PKA, and NR2B, and spinal HFS-LTP is prevented by blockade of PKA, ERK, or NR2B activation. Finally, HFS increases E2 release in spinal cord slices, which can be prevented by aromatase inhibitor androstatrienedione, suggesting activity-dependent local synthesis and release of endogenous E2.	Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200032, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Zhang, Yan] Wannan Med Coll, Cell Electrophysiol Lab, Wuhu 241002, Peoples R China	Fudan University; Fudan University; Wannan Medical College		yuqiuzhang@fudan.edu.cn	Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020		National Natural Science Foundation of China [31271183, 31121061, 31070973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271183, 31121061, and 31070973.	Adams MM, 2004, J COMP NEUROL, V474, P419, DOI 10.1002/cne.20148; ARAI A, 1992, BRAIN RES, V598, P173, DOI 10.1016/0006-8993(92)90181-8; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Cao H, 2009, NEUROSCI BULL, V25, P301, DOI 10.1007/s12264-009-0904-5; Cao H, 2009, J NEUROSCI, V29, P3307, DOI 10.1523/JNEUROSCI.4300-08.2009; Cheng LZ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-1; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Evrard H, 2000, J COMP NEUROL, V423, P552, DOI 10.1002/1096-9861(20000807)423:4<552::AID-CNE2>3.0.CO;2-S; Evrard HC, 2004, J NEUROSCI, V24, P7225, DOI 10.1523/JNEUROSCI.1638-04.2004; Evrard HC, 2006, AM J PHYSIOL-REG I, V291, pR291, DOI 10.1152/ajpregu.00930.2005; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Fu Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-26; Gu Q, 1996, J NEUROSCI, V16, P3620; Ji R R, 2007, Handb Exp Pharmacol, P359; Ji R. R., 2005, NEUROSCI B, V21, P3; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji YP, 2011, PAIN, V152, P1182, DOI 10.1016/j.pain.2011.01.046; Jiang P, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-2; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lagrange AH, 1997, MOL PHARMACOL, V51, P605, DOI 10.1124/mol.51.4.605; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu NJ, 2011, J NEUROSCI, V31, P11836, DOI 10.1523/JNEUROSCI.1901-11.2011; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Mermelstein PG, 2009, J NEUROENDOCRINOL, V21, P257, DOI 10.1111/j.1365-2826.2009.01838.x; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Murphy DD, 1998, J NEUROSCI, V18, P2550; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Peng GD, 2009, J BIOL CHEM, V284, P30138, DOI 10.1074/jbc.M109.036756; Peng HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE416, DOI 10.1152/ajpendo.00129.2009; PETERSON ER, 1982, SCIENCE, V217, P377, DOI 10.1126/science.6124041; Qiu J, 2003, J NEUROSCI, V23, P9529; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Singh M, 1999, J NEUROSCI, V19, P1179; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2010, J NEUROSCI, V30, P13454, DOI 10.1523/JNEUROSCI.3264-10.2010; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tang B, 2008, PAIN, V137, P540, DOI 10.1016/j.pain.2007.10.017; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Xin WJ, 2006, J NEUROSCI RES, V84, P934, DOI 10.1002/jnr.21013; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Ying B, 2006, BIOCHEM BIOPH RES CO, V340, P1264, DOI 10.1016/j.bbrc.2005.12.139; Zadran S, 2009, P NATL ACAD SCI USA, V106, P21936, DOI 10.1073/pnas.0912558106; Zamani MR, 2004, NEUROSCIENCE, V129, P243, DOI 10.1016/j.neuroscience.2004.06.082; Zhong YQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-92; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	66	39	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33268	33281		10.1074/jbc.M112.368142	http://dx.doi.org/10.1074/jbc.M112.368142			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869379	Green Published, hybrid			2022-12-28	WOS:000309602100016
J	Skjoedt, MO; Roversi, P; Hummelshoj, T; Palarasah, Y; Rosbjerg, A; Johnson, S; Lea, SM; Garred, P				Skjoedt, Mikkel-Ole; Roversi, Pietro; Hummelshoj, Tina; Palarasah, Yaseelan; Rosbjerg, Anne; Johnson, Steven; Lea, Susan M.; Garred, Peter			Crystal Structure and Functional Characterization of the Complement Regulator Mannose-binding Lectin (MBL)/Ficolin-associated Protein-1 (MAP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEASE-1; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; ACTIVATION; PATHWAY; MBL; MASP1; SERUM; IDENTIFICATION; COAGULATION	The human lectin complement pathway activation molecules comprise mannose-binding lectin (MBL) and ficolin-1, -2, and -3 in complex with associated serine proteases MASP-1, -2, and -3 and the non-enzymatic small MBL associated protein or sMAP. Recently, a novel plasma protein named MBL/ficolin-associated protein-1 (MAP-1) was identified in humans. This protein is the result of a differential splicing of the MASP1 gene and includes the major part of the heavy chain but lacks the serine protease domain. We investigated the direct interactions of MAP-1 and MASP-3 with ficolin-3 and MBL using surface plasmon resonance and found affinities around 5 nM and 2.5 nM, respectively. We studied structural aspects of MAP-1 and could show by multi-angle laser light scattering that MAP-1 forms a calcium-dependent homodimer in solution. We were able to determine the crystal structure of MAP-1, which also contains a head-to-tail dimer similar to 146 angstrom long. This structure of MAP-1 also enables modeling and assembly of the MASP-1 molecule in its entirety. Finally we found that MAP-1 competes with all three MASPs for ligand binding and is able to mediate a strong dose-dependent inhibitory effect on the lectin pathway activation, as measured by levels of C3 and C9.	[Skjoedt, Mikkel-Ole] Univ Copenhagen, Rigshosp, Dept Clin Immunol, Mol Med Lab,Fac Hlth Sci,Sect 7631, DK-2100 Copenhagen, Denmark; [Roversi, Pietro; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Palarasah, Yaseelan] Univ So Denmark, Res Unit Canc & Inflammat, DK-5000 Copenhagen, Denmark; [Hummelshoj, Tina] Rigshosp, Inst Inflammat Res, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Oxford; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Skjoedt, MO (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Immunol, Mol Med Lab,Fac Hlth Sci,Sect 7631, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	moskjoedt@gmail.com	Johnson, Steven J/F-9182-2016; Roversi, Pietro/F-8925-2011; Lea, Susan M/B-7678-2009; Roversi, Pietro/AAK-4241-2021	Johnson, Steven J/0000-0002-7877-3543; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Roversi, Pietro/0000-0001-9280-9437; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Garred, Peter/0000-0002-2876-8586; Palarasah, Yaseelan/0000-0002-9337-0232; Rosbjerg, Anne/0000-0001-6736-3138	National Research Council for Health and Disease in Denmark; Capital Region of Denmark; Novo Nordisk Research Foundation; Sven Andersen Research Foundation; John and Birthe Meyer Foundation; Rigshospitalet	National Research Council for Health and Disease in Denmark; Capital Region of Denmark; Novo Nordisk Research Foundation(Novo Nordisk Foundation); Sven Andersen Research Foundation; John and Birthe Meyer Foundation; Rigshospitalet	This work was supported by the National Research Council for Health and Disease in Denmark, the Capital Region of Denmark, The Novo Nordisk Research Foundation, The Sven Andersen Research Foundation, and the John and Birthe Meyer Foundation and Rigshospitalet.	Busche MN, 2008, DIABETOLOGIA, V51, P1544, DOI 10.1007/s00125-008-1044-6; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; Palarasah Y, 2011, CLIN EXP IMMUNOL, V164, P388, DOI 10.1111/j.1365-2249.2011.04322.x; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; RASMUSSEN JM, 1990, J CLIN LAB IMMUNOL, V31, P59; RASMUSSEN M, 1988, CLIN EXP IMMUNOL, V74, P131; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2011, IMMUNOBIOLOGY, V216, P625, DOI 10.1016/j.imbio.2010.09.011; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Vorup-Jensen T, 2001, INT IMMUNOPHARMACOL, V1, P677, DOI 10.1016/S1567-5769(00)00052-7; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	42	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32913	32921		10.1074/jbc.M112.386680	http://dx.doi.org/10.1074/jbc.M112.386680			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854970	Green Published, hybrid			2022-12-28	WOS:000309168300056
J	Taxman, DJ; Swanson, KV; Broglie, PM; Wen, HT; Holley-Guthrie, E; Huang, MTH; Callaway, JB; Eitas, TK; Duncan, JA; Ting, JPY				Taxman, Debra J.; Swanson, Karen V.; Broglie, Peter M.; Wen, Haitao; Holley-Guthrie, Elizabeth; Huang, Max Tze-Han; Callaway, Justin B.; Eitas, Tim K.; Duncan, Joseph A.; Ting, Jenny P. Y.			Porphyromonas gingivalis Mediates Inflammasome Repression in Polymicrobial Cultures through a Novel Mechanism Involving Reduced Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; E-SELECTIN EXPRESSION; FUSOBACTERIUM-NUCLEATUM; ENDOTHELIAL-CELLS; HOST RESPONSE; MOUSE MODEL; PROTEIN; ACTIVATION; INHIBITION; LIPOPOLYSACCHARIDE	The interleukin (IL)-1 beta-processing inflammasome has recently been identified as a target for pathogenic evasion of the inflammatory response by a number of bacteria and viruses. We postulated that the periodontal pathogen, Porphyromonas gingivalis may suppress the inflammasome as a mechanism for its low immunogenicity and pathogenic synergy with other, more highly immunogenic periodontal bacteria. Our results show that P. gingivalis lacks signaling capability for the activation of the inflammasome in mouse macrophages. Furthermore, P. gingivalis can suppress inflammasome activation by another periodontal bacterium, Fusobacterium nucleatum. This repression affects IL-1 beta processing, as well as other inflammasome-mediated processes, including IL-18 processing and cell death, in both human and mouse macrophages. F. nucleatum activates IL-1 beta processing through the Nlrp3 inflammasome; however, P. gingivalis repression is not mediated through reduced levels of inflammasome components. P. gingivalis can repress Nlrp3 inflammasome activation by Escherichia coli, and by danger-associated molecular patterns and pattern-associated molecular patterns that mediate activation through endocytosis. However, P. gingivalis does not suppress Nlrp3 inflammasome activation by ATP or nigericin. This suggests that P. gingivalis may preferentially suppress endocytic pathways toward inflammasome activation. To directly test whether P. gingivalis infection affects endocytosis, we assessed the uptake of fluorescent particles in the presence or absence of P. gingivalis. Our results show that P. gingivalis limits both the number of cells taking up beads and the number of beads taken up for bead-positive cells. These results provide a novel mechanism of pathogen-mediated inflammasome inhibition through the suppression of endocytosis.	[Taxman, Debra J.; Swanson, Karen V.; Wen, Haitao; Holley-Guthrie, Elizabeth; Callaway, Justin B.; Eitas, Tim K.; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA; [Taxman, Debra J.; Swanson, Karen V.; Wen, Haitao; Holley-Guthrie, Elizabeth; Huang, Max Tze-Han; Callaway, Justin B.; Eitas, Tim K.; Duncan, Joseph A.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Broglie, Peter M.; Duncan, Joseph A.] Univ N Carolina, Div Infect Dis, Sch Med, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Taxman, DJ (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA.	debra_taxman@med.unc.edu	Wen, Haitao/AAJ-7621-2020	Swanson, Karen V/0000-0003-3105-0599	National Institutes of Health [DE016326, AI029564, AI057157, AI088255]; UNC STD; HIV Training Program (National Institutes of Health) [T32AI007001]; Burroughs Wellcome Fund through the Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, R56AI029564, R01AI029564, R01AI088255, U54AI057157, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC STD; HIV Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund through the Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported, in whole or in part, by National Institutes of Health Grants DE016326, AI029564, and AI057157 (to J. T.) and AI088255 (to J. A. D).; Awardee of the UNC STD and HIV Training Program (National Institutes of Health Grant T32AI007001).; Supported by the Burroughs Wellcome Fund through the Career Award for Medical Scientists.	Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Belanger M, 2006, AUTOPHAGY, V2, P165, DOI 10.4161/auto.2828; Belibasakis G. N., 2012, INNATE IMMU IN PRESS; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Cutler Christopher W., 1995, Trends in Microbiology, V3, P45, DOI 10.1016/S0966-842X(00)88874-5; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; DARVEAU RP, 1995, INFECT IMMUN, V63, P1311, DOI 10.1128/IAI.63.4.1311-1317.1995; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Ebersole JL, 1997, MICROB PATHOGENESIS, V23, P23, DOI 10.1006/mpat.1996.0129; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; GENCO CA, 1991, INFECT IMMUN, V59, P1255, DOI 10.1128/IAI.59.4.1255-1263.1991; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Jin C., 2003, J CLIN IMMUNOL, V30, P628; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Metzger Z, 2009, J ENDODONT, V35, P86, DOI 10.1016/j.joen.2008.10.015; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Okugawa T, 2010, J DENT RES, V89, P186, DOI 10.1177/0022034509354843; Petit F, 1996, J VIROL, V70, P5860, DOI 10.1128/JVI.70.9.5860-5866.1996; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Reig N, 2008, CELL MICROBIOL, V10, P1190, DOI 10.1111/j.1462-5822.2008.01121.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x	50	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32791	32799		10.1074/jbc.M112.401737	http://dx.doi.org/10.1074/jbc.M112.401737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843689	Green Published, hybrid			2022-12-28	WOS:000309168300046
J	Weinreb, PH; Li, S; Gao, SX; Liu, T; Pepinsky, RB; Caravella, JA; Lee, JH; Woods, VL				Weinreb, Paul H.; Li, Sheng; Gao, Sharon X.; Liu, Tong; Pepinsky, R. Blake; Caravella, Justin A.; Lee, Jun H.; Woods, Virgil L., Jr.			Dynamic Structural Changes Are Observed upon Collagen and Metal Ion Binding to the Integrin alpha 1 I Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; LIGAND-MIMETIC ANTIBODY; DEPENDENT ADHESION SITE; PROTEIN-KINASE-A; CATION-BINDING; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODY; PHOSPHOLIPASE A(2); DIVALENT-CATIONS; H/D EXCHANGE	We have applied hydrogen-deuterium exchange mass spectrometry, in conjunction with differential scanning calorimetry and protein stability analysis, to examine solution dynamics of the integrin alpha 1 I domain induced by the binding of divalent cations, full-length type IV collagen, or a function-blocking monoclonal antibody. These studies revealed features of integrin activation and alpha 1I-ligand complexes that were not detected by static crystallographic data. Mg2+ and Mn2+ stabilized alpha 1I but differed in their effects on exchange rates in the alpha C helix. Ca2+ impacted alpha 1I conformational dynamics without altering its gross thermal stability. Interaction with collagen affected the exchange rates in just one of three metal ion-dependent adhesion site (MIDAS) loops, suggesting that MIDAS loop 2 plays a primary role in mediating ligand binding. Collagen also induced changes consistent with increased unfolding in both the alpha C and allosteric C-terminal helices of alpha 1I. The antibody AQC2, which binds to alpha 1I in a ligand-mimetic manner, also reduced exchange in MIDAS loop 2 and increased exchange in alpha C, but it did not impact the C-terminal region. This is the first study to directly demonstrate the conformational changes induced upon binding of an integrin I domain to a full-length collagen ligand, and it demonstrates the utility of the deuterium exchange mass spectrometry method to study the solution dynamics of integrin/ligand and integrin/metal ion interactions. Based on the ligand and metal ion binding data, we propose a model for collagen-binding integrin activation that explains the differing abilities of Mg2+, Mn2+, and Ca2+ to activate I domain-containing integrins.	[Weinreb, Paul H.] Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA; [Li, Sheng; Liu, Tong; Lee, Jun H.; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA	Biogen; University of California System; University of California San Diego	Weinreb, PH (corresponding author), Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA.	paul.weinreb@biogenidec.com; vwoods@ucsd.edu		Weinreb, Paul/0000-0002-0802-0052	National Institutes of Health [CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, AI2008031, GM037684, GM020501, GM066170, GM093325, NS070899, RR029388]; University of California IUCRP Program, Biogen Idec [UC10591]; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R21AI076961, R01AI081982, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093325, F32GM020501, R01GM066170, R01GM020501, R01GM037684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California IUCRP Program, Biogen Idec; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA099835, CA118595, AI076961, AI072106, AI068730, AI081982, AI2008031, GM037684, GM020501, GM066170, GM093325, NS070899, and RR029388. This work was also supported by Discovery Grant UC10591 from the University of California IUCRP Program, Biogen Idec corporate sponsor (to V. L. W.).	Abraham WM, 2004, AM J RESP CRIT CARE, V169, P97, DOI 10.1164/rccm.200304-543OC; Ajroud K, 2004, J BIOL CHEM, V279, P25483, DOI 10.1074/jbc.M402901200; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen L, 2007, ARCH OPHTHALMOL-CHIC, V125, P783, DOI 10.1001/archopht.125.6.783; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; DUBAND JL, 1992, DEVELOPMENT, V116, P585; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Gotwals PJ, 1999, BIOCHEMISTRY-US, V38, P8280, DOI 10.1021/bi982860m; Griggs DW, 1998, J BIOL CHEM, V273, P22113, DOI 10.1074/jbc.273.34.22113; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y., 2008, MASS SPECTROMETRY AN, P123; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ianaro A, 2000, LAB INVEST, V80, P73, DOI 10.1038/labinvest.3780010; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Karpusas M, 2003, J MOL BIOL, V327, P1031, DOI 10.1016/S0022-2836(03)00203-1; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Liddington R, 1998, STRUCT FOLD DES, V6, P937, DOI 10.1016/S0969-2126(98)00094-X; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; LUQUE A, 1994, FEBS LETT, V346, P278, DOI 10.1016/0014-5793(94)00490-0; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; Meharra EJ, 2000, CELL IMMUNOL, V201, P1, DOI 10.1006/cimm.2000.1630; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Obsil T, 1999, FEBS LETT, V457, P311, DOI 10.1016/S0014-5793(99)01063-7; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103; Tu TT, 2010, J AM SOC MASS SPECTR, V21, P1660, DOI 10.1016/j.jasms.2010.03.030; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinreb PH, 2002, ANAL BIOCHEM, V306, P305, DOI 10.1006/abio.2002.5723; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhang HM, 2009, P NATL ACAD SCI USA, V106, P18345, DOI 10.1073/pnas.0909301106; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	77	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32897	32912		10.1074/jbc.M112.354365	http://dx.doi.org/10.1074/jbc.M112.354365			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847004	Green Published, hybrid			2022-12-28	WOS:000309168300055
J	Heller, NM; Qi, XL; Gesbert, F; Keegan, AD				Heller, Nicola M.; Qi, Xiulan; Gesbert, Franck; Keegan, Achsah D.			The Extracellular and Transmembrane Domains of the gamma C and Interleukin (IL)-13 Receptor alpha 1 Chains, Not Their Cytoplasmic Domains, Dictate the Nature of Signaling Responses to IL-4 and IL-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; EPITHELIAL-CELLS; SPECIES-SPECIFICITY; ASTHMA PATHOGENESIS; STRUCTURAL BASIS; FACTOR-I; T-CELLS; ACTIVATION; EXPRESSION; JAK3	Previously, we demonstrated that the gamma C subunit of type I IL-4 receptor was required for robust tyrosine phosphorylation of the downstream adapter protein, IRS-2, correlating with the expression of genes (ArgI, Retnla, and Chi3l3) characteristic of alternatively activated macrophages. We located an I4R-like motif (IRS-2 docking sequence) in the gamma C cytoplasmic domain but not in the IL-13R alpha 1. Thus, we predicted that the gamma C tail directed enhanced IRS-2 phosphorylation. To test this, IL-4 signaling responses were examined in a mutant of the key I4R motif tyrosine residue (Y325F) and different gamma C truncation mutants (gamma 285, gamma 308, gamma 318, gamma 323, and gamma FULL LENGTH (FL)) co-expressed in L-cells or CHO cells with wild-type (WT) IL-4R alpha. Surprisingly, IRS-1 phosphorylation was not diminished in Y325F L-cell mutants suggesting Tyr-325 was not required for the robust insulin receptor substrate response. IRS-2, STAT6, and JAK3 phosphorylation was observed in CHO cells expressing gamma 323 and gamma FL but not in gamma 318 and gamma 285 mutants. In addition, when CHO cells expressed gamma 318, gamma 323, or gamma FL with IL-2R beta, IL-2 induced phospho-STAT5 only in the gamma 323 and gamma FL clones. Our data suggest that a smaller (5 amino acid) interval than previously determined is necessary for JAK3 activation/gamma C-mediated signaling in response to IL-4 and IL-2. Chimeric receptor chains of the gamma C tail fused to the IL-13R alpha 1 extracellular and transmembrane domain did not elicit robust IRS-2 phosphorylation in response to IL-13 suggesting that the extracellular/transmembrane domains of the IL-4/IL-13 receptor, not the cytoplasmic domains, control signaling efficiency. Understanding this pathway fully will lead to rational drug design for allergic disease.	[Heller, Nicola M.; Qi, Xiulan; Keegan, Achsah D.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gesbert, Franck] Univ Paris 11, INSERM, UMR S1004, F-94807 Villejuif, France	University System of Maryland; University of Maryland Baltimore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Keegan, AD (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu		Gesbert, Franck/0000-0002-5800-8385	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096897, R00HL096897] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL096897, K99 HL096897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Andrews RP, 2001, J IMMUNOL, V166, P1716, DOI 10.4049/jimmunol.166.3.1716; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Coombs JH, 2010, ANN RHEUM DIS, V69, P413, DOI 10.1136/ard.2009.108159; Corrigall VM, 2001, J IMMUNOL, V166, P4141, DOI 10.4049/jimmunol.166.6.4141; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; Heller N., 2012, ALLERGIC DIS HIGHLIG, P43; Heller NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039673; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Kimura S, 2010, CURR OPIN INVEST DR, V11, P1442; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lai SY, 1997, J CLIN INVEST, V99, P169, DOI 10.1172/JCI119144; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; LEE JS, 1993, J BIOL CHEM, V268, P4092; Lesur O, 1997, AM J PHYSIOL-LUNG C, V273, pL495, DOI 10.1152/ajplung.1997.273.3.L495; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Malarde V, 2009, BIOCHEM BIOPH RES CO, V387, P409, DOI 10.1016/j.bbrc.2009.07.041; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MOSMANN TR, 1987, J IMMUNOL, V138, P1813; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Muthukumaran G, 1997, J BIOL CHEM, V272, P4993, DOI 10.1074/jbc.272.8.4993; Nelson BH, 1996, MOL CELL BIOL, V16, P309; Ozawa A, 2003, J LEUKOCYTE BIOL, V74, P352, DOI 10.1189/jlb.0103044; PARK LS, 1987, P NATL ACAD SCI USA, V84, P1669, DOI 10.1073/pnas.84.6.1669; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Quaedackers ME, 2009, TRANSPLANTATION, V88, P1002, DOI 10.1097/TP.0b013e3181b9ced7; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; REINECKER HC, 1995, P NATL ACAD SCI USA, V92, P8353, DOI 10.1073/pnas.92.18.8353; Rothenberg ME, 2011, J IMMUNOL, V187, P4873, DOI 10.4049/jimmunol.1004159; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; van der Velden VHJ, 1998, CYTOKINE, V10, P803, DOI 10.1006/cyto.1998.0365; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; WANG LM, 1995, BLOOD, V86, P4218, DOI 10.1182/blood.V86.11.4218.bloodjournal86114218; Weidemann T, 2007, J MOL BIOL, V366, P1365, DOI 10.1016/j.jmb.2006.11.095; West K, 2009, CURR OPIN INVEST DR, V10, P491; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Zhong J, 2010, MOL IMMUNOL, V47, P1207, DOI 10.1016/j.molimm.2009.12.017	53	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31948	31961		10.1074/jbc.M112.348896	http://dx.doi.org/10.1074/jbc.M112.348896			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22829596	Green Published, hybrid			2022-12-28	WOS:000309059400034
J	Ramakrishnan, NA; Drescher, MJ; Khan, KM; Hatfield, JS; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Khan, Khalid M.; Hatfield, James S.; Drescher, Dennis G.			HCN1 and HCN2 Proteins Are Expressed in Cochlear Hair Cells HCN1 CAN FORM A TERNARY COMPLEX WITH PROTOCADHERIN 15 CD3 AND F-ACTIN-BINDING FILAMIN A OR CAN INTERACT WITH HCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; INWARDLY RECTIFYING CURRENTS; NUCLEOTIDE-GATED CHANNELS; MOUSE INNER-EAR; PACEMAKER CHANNELS; MECHANOELECTRICAL TRANSDUCTION; MOLECULAR CHARACTERIZATION; INSTANTANEOUS CURRENT; MAMMALIAN COCHLEA; CATION CHANNELS	A unique coupling between HCN1 and stereociliary tip-link protein protocadherin 15 has been described for a teleost vestibular hair-cell model and mammalian organ of Corti (OC) (Ramakrishnan, N. A., Drescher, M. J., Barretto, R. L., Beisel, K. W., Hatfield, J. S., and Drescher, D. G. (2009) J. Biol. Chem. 284, 3227-3238). We now show that Ca2+-dependent interaction of the organ of Corti HCN1 and protocadherin 15 CD3 is mediated by amino-terminal sequence specific to HCN1 and is not replicated by analogous specific peptides for HCN2 or HCN4 nor by amino-terminal sequence conserved across HCN isoforms utilized in channel formation. Furthermore, the HCN1-specific peptide binds both phosphatidylinositol (3,4,5)-trisphosphate and phosphatidylinositol (4,5)-bisphosphate but not phosphatidylinositol 4-phosphate. Singly isolated cochlear inner and outer hair cells express HCN1 transcript, and HCN1 and HCN2 protein is immunolocalized to hair-cell stereocilia by both z-stack confocal and pre-embedding EM immunogold microscopy, with stereociliary tip-link and subcuticular plate sites. Quantitative PCR indicates HCN1/HCN2/HCN3/HCN4 = 9:9:1:89 in OC of the wild-type mouse, with HCN4 protein primarily attributable to inner sulcus cells. A mutant form of HCN1 mRNA and protein is expressed in the OC of an HCN1 mutant, corresponding to a full-length sequence with the in-frame deletion of pore-S6 domains, predicted by construct. The mutant transcript of HCN1 is similar to 9-fold elevated relative to wild-type levels, possibly representing molecular compensation, with unsubstantial changes in HCN2, HCN3, and HCN4. Immunoprecipitation protocols indicate alternate interactions of full-length proteins; HCN1 can interact with protocadherin 15 CD3 and F-actin-binding filamin A forming a complex that does not include HCN2, or HCN1 can interact with HCN2 forming a complex without protocadherin 15 CD3 but including F-actin-binding fascin-2.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, Detroit, MI 48201 USA; [Khan, Khalid M.] Kuwait Univ, Fac Med, Dept Anat, Safat 13110, Kuwait; [Hatfield, James S.] Vet Affairs Med Ctr, Electron Microscopy Lab, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Kuwait University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wayne State University	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, 261 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [R01 DC004076, R01 DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC004076 (to M. J. D.) and R01 DC000156 (to D. G. D.).	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Calloe K, 2005, BIOPHYS J, V89, P2159, DOI 10.1529/biophysj.105.063792; Cao XJ, 2011, J NEUROPHYSIOL, V106, P630, DOI 10.1152/jn.00015.2010; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher MJ, 2010, NEUROSCIENCE, V171, P1054, DOI 10.1016/j.neuroscience.2010.09.051; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484, DOI 10.1152/jn.1995.73.4.1484; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Horwitz GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008627; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V438, P8, DOI 10.1007/s004240050873; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; KOLESNIKOV SS, 1991, FEBS LETT, V290, P167, DOI 10.1016/0014-5793(91)81251-3; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Mistrik P, 2006, PFLUG ARCH EUR J PHY, V452, P718, DOI 10.1007/s00424-006-0095-0; MOCKETT BG, 1994, J NEUROSCI, V14, P6992; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Mukherjea D, 2008, J NEUROSCI, V28, P13056, DOI 10.1523/JNEUROSCI.1307-08.2008; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Sugihara I, 1996, J PHYSIOL-LONDON, V495, P665, DOI 10.1113/jphysiol.1996.sp021624; Tran N, 2002, J BIOL CHEM, V277, P43588, DOI 10.1074/jbc.M208477200; Trapani JG, 2011, J NEUROSCI, V31, P1614, DOI 10.1523/JNEUROSCI.3369-10.2011; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; van Netten SM, 2009, PFLUG ARCH EUR J PHY, V458, P273, DOI 10.1007/s00424-008-0617-z; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Ye B, 2009, J BIOL CHEM, V284, P25553, DOI 10.1074/jbc.M109.007583; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009	62	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375832	http://dx.doi.org/10.1074/jbc.M112.375832			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22948144	Green Published, hybrid			2022-12-28	WOS:000310642200005
J	Stadtmueller, BM; Kish-Trier, E; Ferrell, K; Petersen, CN; Robinson, H; Myszka, DG; Eckert, DM; Formosa, T; Hill, CP				Stadtmueller, Beth M.; Kish-Trier, Erik; Ferrell, Katherine; Petersen, Charisse N.; Robinson, Howard; Myszka, David G.; Eckert, Debra M.; Formosa, Tim; Hill, Christopher P.			Structure of a Proteasome Pba1-Pba2 Complex IMPLICATIONS FOR PROTEASOME ASSEMBLY, ACTIVATION, AND BIOLOGICAL FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; YEAST; GATE; MECHANISMS; SUBSTRATE; REVEALS; TERMINI; SYSTEM; UMP1P	The 20S proteasome is an essential, 28-subunit protease that sequesters proteolytic sites within a central chamber, thereby repressing substrate degradation until proteasome activators open the entrance/exit gate. Two established activators, Blm10 and PAN/19S, induce gate opening by binding to the pockets between proteasome alpha-subunits using C-terminal HbYX (hydrophobic-tyrosine-any residue) motifs. Equivalent HbYX motifs have been identified in Pba1 and Pba2, which function in proteasome assembly. Here, we demonstrate that Pba1-Pba2 proteins form a stable heterodimer that utilizes its HbYX motifs to bind mature 20S proteasomes in vitro and that the Pba1-Pba2 HbYX motifs are important for a physiological function of proteasomes, the maintenance of mitochondrial function. Other factors that contribute to proteasome assembly or function also act in the maintenance of mitochondrial function and display complex genetic interactions with one another, possibly revealing an unexpected pathway of mitochondrial regulation involving the Pba1-Pba2 proteasome interaction. Our determination of a proteasome Pba1-Pba2 crystal structure reveals a Pba1 HbYX interaction that is superimposable with those of known activators, a Pba2 HbYX interaction that is different from those reported previously, and a gate structure that is disrupted but not sufficiently open to allow entry of even small peptides. These findings extend understanding of proteasome interactions with HbYX motifs and suggest multiple roles for Pba1-Pba2 interactions throughout proteasome assembly and function.	[Stadtmueller, Beth M.; Kish-Trier, Erik; Ferrell, Katherine; Petersen, Charisse N.; Myszka, David G.; Eckert, Debra M.; Formosa, Tim; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu		Petersen, Charisse/0000-0003-4045-2610; Stadtmueller, Beth/0000-0003-0637-3206; Formosa, Tim/0000-0002-8477-2483	National Institutes of Health Grant [RO1 GM59135]; Postdoctoral Fellowship National Institutes of Health Multidisciplinary Cancer Research Training Program (MCRTP) [T32CA092347]; National Center for Research Resources; United States Department of Energy, Office of Basic Energy Sciences; National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099195, R01GM059135] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Fellowship National Institutes of Health Multidisciplinary Cancer Research Training Program (MCRTP); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM59135 (to C. P. H.).; Supported by Postdoctoral Fellowship National Institutes of Health T32CA092347 Multidisciplinary Cancer Research Training Program (MCRTP).; We thank William Alexander, Zaily Connell, and Ira Baci for technical assistance. We thank Mark Hochstrasser and Andrew Kusmierczyk for insightful discussions and for providing Pba1 and Pba2 template DNA that was used to generate the expression vector used in these studies. Data collection at the National Synchrotron Light Source was funded by the National Center for Research Resources. Operations of the National Synchrotron Light Source are supported by the United States Department of Energy, Office of Basic Energy Sciences, and by the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Braun HA, 2005, J BIOL CHEM, V280, P28394, DOI 10.1074/jbc.M502453200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sasaki K, 2010, MOL CELL BIOL, V30, P3864, DOI 10.1128/MCB.00216-10; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	41	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37371	37382		10.1074/jbc.M112.367003	http://dx.doi.org/10.1074/jbc.M112.367003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22930756	hybrid, Green Published			2022-12-28	WOS:000310588500068
J	Ford, CG; Kolappan, S; Phan, HTH; Waldor, MK; Winther-Larsen, HC; Craig, L				Ford, Christopher G.; Kolappan, Subramaniapillai; Phan, Hanh T. H.; Waldor, Matthew K.; Winther-Larsen, Hanne C.; Craig, Lisa			Crystal Structures of a CTX phi pIII Domain Unbound and in Complex with a Vibrio cholerae TolA Domain Reveal Novel Interaction Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINOR COAT PROTEIN; FILAMENTOUS PHAGE INFECTION; SINGLE-STRANDED-DNA; N-TERMINAL DOMAINS; ESCHERICHIA-COLI; COLONIZATION FACTOR; BACTERIOPHAGE FD; PILUS; PENETRATION; SITE	Vibrio cholerae colonize the small intestine where they secrete cholera toxin, an ADP-ribosylating enzyme that is responsible for the voluminous diarrhea characteristic of cholera disease. The genes encoding cholera toxin are located on the genome of the filamentous bacteriophage, CTX phi, that integrates as a prophage into the V. cholerae chromosome. CTX phi infection of V. cholerae requires the toxin-coregulated pilus and the periplasmic protein TolA. This infection process parallels that of Escherichia coli infection by the Ff family of filamentous coliphage. Here we demonstrate a direct interaction between the N-terminal domain of the CTX phi minor coat protein pIII (pIII-N1) and the C-terminal domain of TolA (TolA-C) and present x-ray crystal structures of pIII-N1 alone and in complex with TolA-C. The structures of CTX phi pIII-N1 and V. cholerae TolA-C are similar to coliphage pIII-N1 and E. coli TolA-C, respectively, yet these proteins bind via a distinct interface that in E. coli TolA corresponds to a colicin binding site. Our data suggest that the TolA binding site on pIII-N1 of CTX phi is accessible in the native pIII protein. This contrasts with the Ff family phage, where the TolA binding site on pIII is blocked and requires a pilus-induced unfolding event to become exposed. We propose that CTX phi pIII accesses the periplasmic TolA through retraction of toxin-coregulated pilus, which brings the phage through the outer membrane pilus secretin channel. These data help to explain the process by which CTX phi converts a harmless marine microbe into a deadly human pathogen.	[Ford, Christopher G.; Kolappan, Subramaniapillai; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Phan, Hanh T. H.; Winther-Larsen, Hanne C.] Univ Oslo, Sch Pharm, N-0316 Oslo, Norway; [Phan, Hanh T. H.; Winther-Larsen, Hanne C.] Univ Oslo, Lab Microbial Dynam, N-0316 Oslo, Norway; [Waldor, Matthew K.] Harvard Univ, Div Infect Dis, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Simon Fraser University; University of Oslo; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca		Craig, Lisa/0000-0001-8515-9915; Waldor, Matthew/0000-0003-1843-7000	Natural Sciences and Engineering Research Council; National Institutes of Health [NIH R37 AI-42347]; Howard Hughes Medical Institute; Kristine Bonnevie fellowship; EMBIO fellowship; University of Oslo; Research Council of Norway; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Kristine Bonnevie fellowship; EMBIO fellowship; University of Oslo; Research Council of Norway(Research Council of Norway); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Natural Sciences and Engineering Research Council, National Institutes of Health Grant NIH R37 AI-42347, and the Howard Hughes Medical Institute.; Supported in part by the Kristine Bonnevie and EMBIO fellowships, University of Oslo, and by the Research Council of Norway.; Supported by a New Investigator Award from the Canadian Institutes of Health Research and a Scholar Award from the Michael Smith Foundation for Health Research. To whom correspondence should be addressed. Tel.: 778-782-7140; Fax: 778-782-5583; E-mail: licraig@sfu.ca.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bennett NJ, 2006, J MOL BIOL, V356, P266, DOI 10.1016/j.jmb.2005.11.069; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Clarke M, 2008, DANCING TIMES, V98, P105; Click EM, 1998, J BACTERIOL, V180, P1723, DOI 10.1128/JB.180.7.1723-1728.1998; CRISSMAN JW, 1984, VIROLOGY, V132, P445, DOI 10.1016/0042-6822(84)90049-7; Davis BM, 2000, J BACTERIOL, V182, P6992, DOI 10.1128/JB.182.24.6992-6998.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Deng LW, 2002, J MOL BIOL, V319, P603, DOI 10.1016/S0022-2836(02)00260-7; DEZWAIG RN, 1967, J BACTERIOL, V94, P1112, DOI 10.1128/JB.94.4.1112-1123.1967; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GOLDBERG I, 1986, J BACTERIOL, V165, P723, DOI 10.1128/jb.165.3.723-731.1986; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; GRANT RA, 1981, J BIOL CHEM, V256, P539; GRAY CW, 1981, J MOL BIOL, V146, P621, DOI 10.1016/0022-2836(81)90050-4; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Heilpern AJ, 2003, J BACTERIOL, V185, P1037, DOI 10.1128/JB.185.3.1037-1044.2003; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; HUFF JP, 1990, BIOTECHNIQUES, V9, P570; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Jakob RP, 2012, MOL MICROBIOL, V84, P1124, DOI 10.1111/j.1365-2958.2012.08079.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZZARONI JC, 1981, J BACTERIOL, V145, P1351, DOI 10.1128/JB.145.3.1351-1358.1981; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; Li C, 2012, J BIOL CHEM, V287, P19048, DOI 10.1074/jbc.M112.342246; LOPEZ J, 1982, J VIROL, V42, P1099, DOI 10.1128/JVI.42.3.1099-1107.1982; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rakonjac J, 1998, J MOL BIOL, V282, P25, DOI 10.1006/jmbi.1998.2006; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Scott Jamie K., 1994, Current Opinion in Biotechnology, V5, P40, DOI 10.1016/S0958-1669(05)80068-0; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; STENGELE I, 1990, J MOL BIOL, V212, P143, DOI 10.1016/0022-2836(90)90311-9; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Wen ZQ, 1997, BIOCHEMISTRY-US, V36, P7810, DOI 10.1021/bi970342q; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	67	13	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36258	36272		10.1074/jbc.M112.403386	http://dx.doi.org/10.1074/jbc.M112.403386			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942280	Green Published, hybrid			2022-12-28	WOS:000310364000047
J	Jin, CS; Ekwall, AKH; Bylund, J; Bjorkman, L; Estrella, RP; Whitelock, JM; Eisler, T; Bokarewa, M; Karlsson, NG				Jin, Chunsheng; Ekwall, Anna-Karin Hultgard; Bylund, Johan; Bjorkman, Lena; Estrella, Ruby P.; Whitelock, John M.; Eisler, Thomas; Bokarewa, Maria; Karlsson, Niclas G.			Human Synovial Lubricin Expresses Sialyl Lewis x Determinant and Has L-selectin Ligand Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERFICIAL ZONE PROTEIN; ARTICULAR-CARTILAGE; GENE-EXPRESSION; RECOMBINANT LUBRICIN; PROTEOGLYCAN-4; FLUID; FRICTION; BOVINE; CELLS; MODEL	Lubricin (or proteoglycan 4 (PRG4)) is an abundant mucin-like glycoprotein in synovial fluid (SF) and a major component responsible for joint lubrication. In this study, it was shown that O-linked core 2 oligosaccharides (Gal beta 1-3(GlcNAc beta 1-6)GalNAc alpha 1-Thr/Ser) on lubricin isolated from rheumatoid arthritis SF contained both sulfate and fucose residues, and SF lubricin was capable of binding to recombinant L-selectin in a glycosylation-dependent manner. Using resting human polymorphonuclear granulocytes (PMN) from peripheral blood, confocal microscopy showed that lubricin coated circulating PMN and that it partly co-localized with L-selectin expressed by these cells. In agreement with this, activation-induced shedding of L-selectin also mediated decreased lubricin binding to PMN. It was also found that PMN recruited to inflamed synovial area and fluid in rheumatoid arthritis patients kept a coat of lubricin. These observations suggest that lubricin is able to bind to PMN via an L-selectin-dependent and -independent manner and may play a role in PMN-mediated inflammation.	[Jin, Chunsheng; Karlsson, Niclas G.] Univ Gothenburg, Dept Med Biochem, Inst Biomed, S-40530 Gothenburg, Sweden; [Ekwall, Anna-Karin Hultgard; Bylund, Johan; Bjorkman, Lena; Bokarewa, Maria] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, S-40530 Gothenburg, Sweden; [Estrella, Ruby P.; Whitelock, John M.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [Eisler, Thomas] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-17177 Stockholm, Sweden	University of Gothenburg; University of Gothenburg; University of New South Wales Sydney; Danderyds Hospital; Karolinska Institutet	Jin, CS (corresponding author), Univ Gothenburg, Dept Med Biochem, Inst Biomed, Box 440,Medicinaregatan 9A, S-40530 Gothenburg, Sweden.	chunsheng.jin@medkem.gu.se	Bokarewa, Maria I/A-8114-2019; Karlsson, Niclas/G-5235-2013	Bokarewa, Maria I/0000-0001-9424-5145; Karlsson, Niclas/0000-0002-3045-2628; Ekwall, Anna-Karin/0000-0001-8236-6089; Whitelock, John/0000-0003-1835-802X	European Union [PIRG-GA-2007-205302]; Swedish Research Council Grant LTQ [342-2004-4434]; Knut och Alice Wallenberg's Stiftelse Grant LTQ XL [KAW2007.0118]; Swedish Research Council [521-2007-4263, 521-2009-3443]; King Gustav V Memorial Foundation; Swedish state (LUA/ALF)	European Union(European Commission); Swedish Research Council Grant LTQ; Knut och Alice Wallenberg's Stiftelse Grant LTQ XL; Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustav V Memorial Foundation; Swedish state (LUA/ALF)	This work was supported by European Union Marie Curie Programme Grant PIRG-GA-2007-205302. The mass spectrometers were purchased with Swedish Research Council Grant LTQ, 342-2004-4434 and Knut och Alice Wallenberg's Stiftelse Grant LTQ XL, KAW2007.0118. The confocal microscope was purchased with Swedish Research Council Grant 521-2007-4263 (to J. B.). Additional support was from Swedish Research Council Grant 521-2009-3443, the King Gustav V Memorial Foundation, and the Swedish state (LUA/ALF).	Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P857, DOI 10.1002/art.1780270804; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DuRaine G, 2009, J ORTHOP RES, V27, P249, DOI 10.1002/jor.20713; Edwards SW, 1997, IMMUNOL TODAY, V18, P320, DOI 10.1016/S0167-5699(97)01087-6; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Elsaid KA, 2007, ARTHRITIS RHEUM, V56, P108, DOI 10.1002/art.22321; Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Grad S, 2006, BIORHEOLOGY, V43, P259; Hayes CA, 2011, BIOINFORMATICS, V27, P1343, DOI 10.1093/bioinformatics/btr137; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Ilgner S., 2002, Cellular and Molecular Biology Online Papers, V48, pOL243; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; Jay GD, 2000, J RHEUMATOL, V27, P594; Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325; Justen H P, 2000, Mol Cell Biol Res Commun, V3, P165, DOI 10.1006/mcbr.2000.0211; Kamphorst JJ, 2007, J PROTEOME RES, V6, P4388, DOI 10.1021/pr0704534; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karlsson NG, 1996, J MASS SPECTROM, V31, P560; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Khan AI, 2003, INFLAMMATION, V27, P265, DOI 10.1023/A:1026056525755; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; Kuroda M, 1999, P NATL ACAD SCI USA, V96, P5025, DOI 10.1073/pnas.96.9.5025; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Leppanen A, 2010, GLYCOBIOLOGY, V20, P1170, DOI 10.1093/glycob/cwq083; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liu YJ, 2004, BLOOD, V103, P4449, DOI 10.1182/blood-2003-06-1825; Lord MS, 2012, CONNECT TISSUE RES, V53, P132, DOI 10.3109/03008207.2011.614364; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; MOHR W, 1981, ANN RHEUM DIS, V40, P396, DOI 10.1136/ard.40.4.396; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pillinger M. H., 2004, RHEUMATOID ARTHRITIS, P161; Poppe L, 1997, J AM CHEM SOC, V119, P1727, DOI 10.1021/ja9610702; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; SCUDDER PR, 1994, GLYCOBIOLOGY, V4, P929, DOI 10.1093/glycob/4.6.929; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Teeple E, 2008, J ORTHOP RES, V26, P231, DOI 10.1002/jor.20492; Thomsson E, 2011, J VIROL METHODS, V175, P53, DOI 10.1016/j.jviromet.2011.04.014; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Vugmeyster Y, 2012, AAPS J, V14, P97, DOI 10.1208/s12248-011-9315-4; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	67	34	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35922	35933		10.1074/jbc.M112.363119	http://dx.doi.org/10.1074/jbc.M112.363119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930755	Green Published, hybrid			2022-12-28	WOS:000310364000014
J	Li, HT; Hemann, C; Abdelghany, TM; El-Mahdy, MA; Zweier, JL				Li, Haitao; Hemann, Craig; Abdelghany, Tamer M.; El-Mahdy, Mohamed A.; Zweier, Jay L.			Characterization of the Mechanism and Magnitude of Cytoglobin-mediated Nitrite Reduction and Nitric Oxide Generation under Anaerobic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE-OXIDASE; BLOOD; NEUROGLOBIN; KINETICS; PROTEIN; OXYGEN; HEME; NO; DEOXYHEMOGLOBIN; HEMOGLOBIN	Cytoglobin (Cygb) is a recently discovered cytoplasmic heme-binding globin. Although multiple hemeproteins have been reported to function as nitrite reductases in mammalian cells, it is unknown whether Cygb can also reduce nitrite to nitric oxide (NO). The mechanism, magnitude, and quantitative importance of Cygb-mediated nitrite reduction in tissues have not been reported. To investigate this pathway and its quantitative importance, EPR spectroscopy, spectrophotometric measurements, and chemiluminescence NO analyzer studies were performed. Under anaerobic conditions, mixing nitrite with ferrous-Cygb triggered NO formation that was trapped and detected using EPR spin trapping. Spectrophotometric studies revealed that nitrite binding to ferrous-Cygb is followed by formation of ferric-Cygb and NO. The kinetics and magnitude of Cygb-mediated NO formation were characterized. It was observed that Cygb-mediated NO generation increased linearly with the increase of nitrite concentration under anaerobic conditions. This Cygb-mediated NO production greatly increased with acidosis and near-anoxia as occur in ischemic conditions. With the addition of nitrite, soluble guanylyl cyclase activation was significantly higher in normal smooth muscle cells compared with Cygb knocked down cells with Cygb accounting for similar to 40% of the activation in control cells and similar to 60% in cells subjected to hypoxia for 48 h. Overall, these studies show that Cygb-mediated nitrite reduction can play an important role in NO generation and soluble guanylyl cyclase activation under hypoxic conditions, with this process regulated by pH, oxygen tension, nitrite concentration, and the redox state of the cells.	Ohio State Univ, Coll Med, Ctr Biomed EPR Spect & Imaging, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zweier, JL (corresponding author), 611 Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	jay.zweier@osumc.edu	ABDELGHANY, Tamer/L-7347-2019; Abdelghany, Tamer/R-7026-2019	Abdelghany, Tamer/0000-0002-2568-9356; Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [HL63744, HL65608, HL38324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038324, P01HL065608, R01HL038324, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J. L. Z.).	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dezfulian C, 2007, CARDIOVASC RES, V75, P327, DOI 10.1016/j.cardiores.2007.05.001; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Joshi MS, 2002, P NATL ACAD SCI USA, V99, P10341, DOI 10.1073/pnas.152149699; KUPPUSAMY P, 1995, J MAGN RESON SER B, V107, P116, DOI 10.1006/jmrb.1995.1067; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2009, J BIOL CHEM, V284, P33850, DOI 10.1074/jbc.M109.019125; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Liu XP, 2007, J BIOL CHEM, V282, P8831, DOI 10.1074/jbc.M611684200; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; Ormerod JOM, 2011, CARDIOVASC RES, V89, P560, DOI 10.1093/cvr/cvq299; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; SERGEEV N S, 1985, Journal of Applied Biochemistry, V7, P86; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tornig J, 1999, J AM SOC NEPHROL, V10, P77; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1994, J MAGN RESON SER B, V105, P52, DOI 10.1006/jmrb.1994.1099; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304	49	101	105	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36623	36633		10.1074/jbc.M112.342378	http://dx.doi.org/10.1074/jbc.M112.342378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896706	Green Published, hybrid			2022-12-28	WOS:000310364000082
J	Randak, CO; Heul, ARV; Welsh, MJ				Randak, Christoph O.; Heul, Amanda R. Ver; Welsh, Michael J.			Demonstration of Phosphoryl Group Transfer Indicates That the ATP-binding Cassette (ABC) Transporter Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Exhibits Adenylate Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MALTOSE TRANSPORTER; MOLECULAR-BASIS; PROTEIN-KINASE; DOMAIN; SITE; AMP; IDENTIFICATION; NUCLEOTIDES; MECHANISM	Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane-spanning adenosine 5'-triphosphate (ATP)-binding cassette (ABC) transporter. ABC transporters and other nuclear and cytoplasmic ABC proteins have ATPase activity that is coupled to their biological function. Recent studies with CFTR and two nonmembrane-bound ABC proteins, the DNA repair enzyme Rad50 and a structural maintenance of chromosome (SMC) protein, challenge the model that the function of all ABC proteins depends solely on their associated ATPase activity. Patch clamp studies indicated that in the presence of physiologically relevant concentrations of adenosine 5'-monophosphate (AMP), CFTR Cl- channel function is coupled to adenylate kinase activity (ATP+AMP reversible arrow 2 ADP). Work with Rad50 and SMC showed that these enzymes catalyze both ATPase and adenylate kinase reactions. However, despite the supportive electrophysiological results with CFTR, there are no biochemical data demonstrating intrinsic adenylate kinase activity of a membrane-bound ABC transporter. We developed a biochemical assay for adenylate kinase activity, in which the radioactive gamma-phosphate of a nucleotide triphosphate could transfer to a photoactivatable AMP analog. UV irradiation could then trap the P-32 on the adenylate kinase. With this assay, we discovered phosphoryl group transfer that labeled CFTR, thereby demonstrating its adenylate kinase activity. Our results also suggested that the interaction of nucleotide triphosphate with CFTR at ATP-binding site 2 is required for adenylate kinase activity. These biochemical data complement earlier biophysical studies of CFTR and indicate that the ABC transporter CFTR can function as an adenylate kinase.	[Randak, Christoph O.; Heul, Amanda R. Ver] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Randak, CO (corresponding author), Univ Iowa, Dept Pediat, 500 EMRB, Iowa City, IA 52242 USA.	christoph-randak@uiowa.edu		Randak, Christoph/0000-0003-3264-4137; Welsh, Michael/0000-0002-1646-6206	National Institutes of Health [K08HL097071, HL51670, HL091842, HL102288]; Cystic Fibrosis Foundation (CFF) [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, U01HL102288, P01HL051670, K08HL097071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (CFF); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C.O.R.) and HL51670, HL091842, and HL102288 (to M.J.W.). This work was also supported by Cystic Fibrosis Foundation (CFF) Grant RANDAK09Q0.; The recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship. To whom correspondence should be addressed: Dept. of Pediatrics, University of Iowa, 500 EMRB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: christoph-randak@uiowa.edu.	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; CZARNECKI JJ, 1984, BIOCHIM BIOPHYS ACTA, V800, P41, DOI 10.1016/0304-4165(84)90092-8; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DONOHUE J, 1960, J MOL BIOL, V2, P363, DOI 10.1016/S0022-2836(60)80047-2; EVANS FE, 1974, FEBS LETT, V41, P253, DOI 10.1016/0014-5793(74)81223-8; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; FRY DC, 1987, BIOCHEMISTRY-US, V26, P1645, DOI 10.1021/bi00380a024; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HOPPE J, 1978, EUR J BIOCHEM, V90, P427, DOI 10.1111/j.1432-1033.1978.tb12621.x; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OGAWA Y, 1981, J IMMUNOL, V127, P1369; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RIORDAN JR, 1989, SCIENCE, V245, P1066; SALVUCCI ME, 1992, BIOCHEMISTRY-US, V31, P4479, DOI 10.1021/bi00133a014; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4	46	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36105	36110		10.1074/jbc.M112.408450	http://dx.doi.org/10.1074/jbc.M112.408450			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948143	Green Published, hybrid			2022-12-28	WOS:000310364000032
J	Srivastava, DP; Copits, BA; Xie, Z; Huda, R; Jones, KA; Mukherji, S; Cahill, ME; VanLeeuwen, JE; Woolfrey, KM; Rafalovich, I; Swanson, GT; Penzes, P				Srivastava, Deepak P.; Copits, Bryan A.; Xie, Zhong; Huda, Rafiq; Jones, Kelly A.; Mukherji, Srishti; Cahill, Michael E.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.; Rafalovich, Igor; Swanson, Geoffrey T.; Penzes, Peter			Afadin Is Required for Maintenance of Dendritic Structure and Excitatory Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC ADHESION; SPINE; MECHANISMS; PLASTICITY; BRAIN; MORPHOGENESIS; TRANSCRIPTION; DENSITY; NECTIN; GROWTH	The dendritic field of a neuron, which is determined by both dendritic architecture and synaptic strength, defines the synaptic input of a cell. Once established, a neuron's dendritic field is thought to remain relatively stable throughout a cell's lifetime. Perturbations in a dendritic structure or excitatory tone of a cell and thus its dendritic field are cellular alterations thought to be correlated with a number of psychiatric disorders. Although several proteins are known to regulate the development of dendritic arborization, much less is known about the mechanisms that maintain dendritic morphology and synaptic strength. In this study, we find that afadin, a component of N-cadherin.beta-catenin.alpha-N-catenin adhesion complexes, is required for the maintenance of established dendritic arborization and synapse number. We further demonstrate that afadin directly interacts with AMPA receptors and that loss of this protein reduces the surface expression of GluA1- and GluA2-AMPA receptor sub-units. Collectively, these data suggest that afadin is required for the maintenance of dendritic structure and excitatory tone.	[Srivastava, Deepak P.; Mukherji, Srishti] Kings Coll London, Inst Psychiat, James Black Ctr, Dept Neurosci, London SE5 9NU, England; [Srivastava, Deepak P.; Mukherji, Srishti] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 9NU, England; [Srivastava, Deepak P.; Xie, Zhong; Huda, Rafiq; Jones, Kelly A.; Cahill, Michael E.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.; Rafalovich, Igor; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Copits, Bryan A.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	University of London; King's College London; University of London; King's College London; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Srivastava, DP (corresponding author), Kings Coll London, Inst Psychiat, James Black Ctr, Dept Neurosci, London SE5 9NU, England.	deepak.srivastava@kcl.ac.uk; p-penzes@northwestern.edu	Xie, Zhong/B-6829-2011; Penzes, Peter/L-3987-2016	Xie, Zhong/0000-0002-8348-4455; Penzes, Peter/0000-0001-5449-1640; Cahill, Michael/0000-0003-0574-2655; Srivastava, Deepak Prakash/0000-0001-6512-9065; Huda, Rafiq/0000-0002-6814-9966	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards [1F31MH087043, 1F31AG031621, 1F31MH085362]; NIH, NIMH [MH071316, MH097216]; NIH, NINDS [NS44322]; Royal Society UK; American Heart Association (AHA); National Alliance for Research on Schizophrenia and Depression (NARSAD); Autism Speaks, NARSAD, Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097216, R01MH071316, F31MH085362, F31MH087043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044322, R01NS071952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG031621] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards; NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Society UK(Royal Society of London); American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Autism Speaks, NARSAD, Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Awards 1F31MH087043 (to J. E. V.), 1F31AG031621 (to M. E. C.), and 1F31MH085362 (to K. A. J.); NIH, NIMH, Grants MH071316 and MH097216 (to P. P.); and NIH, NINDS, Grant NS44322 (to G. T. S.). This work was also supported by grants from the Royal Society UK, American Heart Association (AHA), and National Alliance for Research on Schizophrenia and Depression (NARSAD) (to D. P. S.); an AHA predoctoral fellowship (to K. M. W.); and an Autism Speaks, NARSAD, Brain Research Foundation grant (to P. P.).	Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; El-Hussein AE, 2000, SCIENCE, V290, P1364; GREENOUGH WT, 1984, TRENDS NEUROSCI, V7, P229, DOI 10.1016/S0166-2236(84)80211-8; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Rogers C. A., 2001, SOC NEUR ABSTR, V27, P16; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004474; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35964	35974		10.1074/jbc.M112.363358	http://dx.doi.org/10.1074/jbc.M112.363358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948147	hybrid, Green Published			2022-12-28	WOS:000310364000018
J	Bhowmick, R; Halder, UC; Chattopadhyay, S; Chanda, S; Nandi, S; Bagchi, P; Nayak, MK; Chakrabarti, O; Kobayashi, N; Chawla-Sarkar, M				Bhowmick, Rahul; Halder, Umesh Chandra; Chattopadhyay, Shiladitya; Chanda, Shampa; Nandi, Satabdi; Bagchi, Parikshit; Nayak, Mukti Kant; Chakrabarti, Oishee; Kobayashi, Nobumichi; Chawla-Sarkar, Mamta			Rotaviral Enterotoxin Nonstructural Protein 4 Targets Mitochondria for Activation of Apoptosis during Infection (Publication with Expression of Concern. See vol. 294, pg. 15119, 2019) (Withdrawn Publication. See vol. 295, pg. 13956, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							CELL-DEATH; INNER MITOCHONDRIAL; CYTOCHROME-C; MA104 CELLS; BAX; MEMBRANE; TRANSLOCATION; BCL-2; NSP4; DYSFUNCTION	Viruses have evolved to encode multifunctional proteins to control the intricate cellular signaling pathways by using very few viral proteins. Rotavirus is known to express six nonstructural and six structural proteins. Among them, NSP4 is the enterotoxin, known to disrupt cellular Ca2+ homeostasis by translocating to endoplasmic reticulum. In this study, we have observed translocation of NSP4 to mitochondria resulting in dissipation of mitochondrial membrane potential during virus infection and NSP4 overexpression. Furthermore, transfection of the N- and C-terminal truncated NSP4 mutants followed by analyzing NSP4 localization by immunofluorescence microscopy identified the 61-83-amino acid region as the shortest mitochondrial targeting signal. NSP4 exerts its proapoptotic effect by interacting with mitochondrial proteins adenine nucleotide translocator and voltage-dependent anion channel, resulting in dissipation of mitochondrial potential, release of cytochrome c from mitochondria, and caspase activation. During early infection, apoptosis activation by NSP4 was inhibited by the activation of cellular survival pathways (PI3K/AKT), because PI3K inhibitor results in early induction of apoptosis. However, in the presence of both PI3K inhibitor and NSP4 siRNA, apoptosis was delayed suggesting that the early apoptotic signal is initiated by NSP4 expression. This proapoptotic function of NSP4 is balanced by another virus-encoded protein, NSP1, which is implicated in PI3K/AKT activation because overexpression of both NSP4 and NSP1 in cells resulted in reduced apoptosis compared with only NSP4-expressing cells. Overall, this study reports on the mechanism by which enterotoxin NSP4 exerts cytotoxicity and the mechanism by which virus counteracts it at the early stage for efficient infection.	[Bhowmick, Rahul; Halder, Umesh Chandra; Chattopadhyay, Shiladitya; Chanda, Shampa; Nandi, Satabdi; Bagchi, Parikshit; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata 700010, W Bengal, India; [Nayak, Mukti Kant] Univ Calcutta, Dept Zool, Kolkata 700019, India; [Chakrabarti, Oishee] Saha Inst Nucl Phys, Struct Genom Sect, Kolkata 700064, India; [Kobayashi, Nobumichi] Sapporo Med Univ, Dept Hyg, Sapporo, Hokkaido 0608556, Japan	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Calcutta; Saha Institute of Nuclear Physics; Sapporo Medical University	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, P-33,CIT Rd Scheme XM, Kolkata 700010, W Bengal, India.	chawlam70@gmail.com			Indian Council of Medical Research, New Delhi; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Council of Scientific and Industrial Research, India; University Grants Commission, India	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India)	This work was supported in part by the Indian Council of Medical Research, New Delhi, and the Program for Funding Research Centers for Emerging and Reemerging Infectious Diseases (Okayama University-National Institute of Cholera and Enteric Diseases, India) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.; Supported by junior research fellowships from the Council of Scientific and Industrial Research, India.; Supported by junior research fellowships from the University Grants Commission, India.	Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; BERGMANN CC, 1989, EMBO J, V8, P1695, DOI 10.1002/j.1460-2075.1989.tb03561.x; Bozidis P., 2007, CURR PROTOC CELL BIO, V3, P27; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; Chaibi C, 2005, VIROLOGY, V332, P480, DOI 10.1016/j.virol.2004.11.039; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen J, 2007, J VIROL, V81, P6757, DOI 10.1128/JVI.00172-07; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; D'Agostino DM, 2002, J BIOL CHEM, V277, P34424, DOI 10.1074/jbc.M203023200; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Estes M. K., 2001, FIELDS VIROLOGY; Estes MK, 2001, NOVART FDN SYMP, V238, P82; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694; Gouttenoire J, 2009, J VIROL, V83, P11378, DOI 10.1128/JVI.01122-09; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halder UC, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.75; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jolly CL, 2000, VIROLOGY, V275, P89, DOI 10.1006/viro.2000.0470; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; Martin-Latil S, 2007, J VIROL, V81, P4457, DOI 10.1128/JVI.02344-06; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; O'Brien JA, 2000, J VIROL, V74, P5388, DOI 10.1128/JVI.74.11.5388-5394.2000; ORRENIUS S, 1994, J NEURAL TRANSM-SUPP, P1; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Perez JF, 1998, VIROLOGY, V252, P17, DOI 10.1006/viro.1998.9433; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; SMITH EM, 1979, J GEN VIROL, V43, P513, DOI 10.1099/0022-1317-43-3-513; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Taylor J. A., 2003, VIRAL GASTROENTERITI; TAYLOR JA, 1992, J VIROL, V66, P3566, DOI 10.1128/JVI.66.6.3566-3572.1992; Tian P, 1996, J VIROL, V70, P6973, DOI 10.1128/JVI.70.10.6973-6981.1996; TOLSKAYA EA, 1995, J VIROL, V69, P1181, DOI 10.1128/JVI.69.2.1181-1189.1995; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wood-Allum CA, 2006, BRAIN, V129, P1693, DOI 10.1093/brain/awl118; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	59	40	40	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35004	35020		10.1074/jbc.M112.369595	http://dx.doi.org/10.1074/jbc.M112.369595			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22888003	hybrid, Green Published			2022-12-28	WOS:000309968000013
J	Chen, JX; Winarski, KL; Myerburg, MM; Pitt, BR; Sheng, SH				Chen, Jingxin; Winarski, Katie L.; Myerburg, Mike M.; Pitt, Bruce R.; Sheng, Shaohu			Probing the Structural Basis of Zn2+ Regulation of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELF-INHIBITION; GAMMA-SUBUNIT; HISTIDINE-RESIDUES; ION CHANNELS; EXTRACELLULAR DOMAINS; PULMONARY TOXICITY; ALPHA-SUBUNIT; ENAC; ACTIVATION	Extracellular Zn2+ activates the epithelial Na+ channel (ENaC) by relieving Na+ self-inhibition. However, a biphasic Zn2+ dose response was observed, suggesting that Zn2+ has dual effects on the channel (i.e. activating and inhibitory). To investigate the structural basis for this biphasic effect of Zn2+, we examined the effects of mutating the 10 extracellular His residues of mouse gamma ENaC. Four mutations within the finger subdomain (gamma H193A, gamma H200A, gamma H202A, and gamma H239A) significantly reduced the maximal Zn2+ activation of the channel. Whereas gamma H193A, gamma H200A, and gamma H202A reduced the apparent affinity of the Zn2+ activating site, gamma H239A diminished Na+ self-inhibition and thus concealed the activating effects of Zn2+. Mutation of a His residue within the palm subdomain (gamma H88A) abolished the low-affinity Zn2+ inhibitory effect. Based on structural homology with acid-sensing ion channel 1, gamma Asp(516) was predicted to be in close proximity to gamma His(88). Ala substitution of the residue (gamma 516A) blunted the inhibitory effect of Zn2+. Our results suggest that external Zn2+ regulates ENaC activity by binding to multiple extracellular sites within the gamma-subunit, including (i) a high-affinity stimulatory site within the finger subdomain involving His(193), His(200), and His(202) and (ii) a low-affinity Zn2+ inhibitory site within the palm subdomain that includes His(88) and Asp(516).	[Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, SH (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 ES014701, K08 HL087932, P30 DK079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014701, K08 HL087932, and P30 DK079307.	Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HARRISON NL, 1994, NEUROPHARMACOLOGY, V33, P935, DOI 10.1016/0028-3908(94)90152-X; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Prieditis H, 2002, EXP LUNG RES, V28, P563, DOI 10.1080/01902140290096782; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; St Croix Claudette M, 2005, Proc Am Thorac Soc, V2, P236, DOI 10.1513/pats.200501-007AC; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	50	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35589	35598		10.1074/jbc.M112.394734	http://dx.doi.org/10.1074/jbc.M112.394734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22930753	Green Published, hybrid			2022-12-28	WOS:000309968000071
J	Geng, H; Liu, Q; Xue, CH; David, LL; Beer, TM; Thomas, GV; Dai, MS; Qian, DZ				Geng, Hao; Liu, Qiong; Xue, Changhui; David, Larry L.; Beer, Tomasz M.; Thomas, George V.; Dai, Mu-Shui; Qian, David Z.			HIF1 alpha Protein Stability Is Increased by Acetylation at Lysine 709	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; HISTONE DEACETYLASES; FACTOR 1-ALPHA; TUMOR-GROWTH; HIF-1-ALPHA; DEGRADATION; VHL; PATHWAY	Lysine acetylation regulates protein stability and function. p300 is a component of the HIF-1 transcriptional complex and positively regulates the transactivation of HIF-1. Here, we show a novel molecular mechanism by which p300 facilitates HIF-1 activity. p300 increases HIF-1 alpha (HIF1 alpha) protein acetylation and stability. The regulation can be opposed by HDAC1, but not by HDAC3, and is abrogated by disrupting HIF1 alpha-p300 interaction. Mechanistically, p300 specifically acetylates HIF1 alpha at Lys-709, which increases the protein stability and decreases polyubiquitination in both normoxia and hypoxia. Compared with the wild-type protein, a HIF1 alpha K709A mutant protein is more stable, less polyubiquitinated, and less dependent on p300. Overexpression of the HIF1 alpha wild-type or K709A mutant in cancer cells lacking the endogenous HIF1 alpha shows that the K709A mutant is transcriptionally more active toward the HIF-1 reporter and some endogenous target genes. Cancer cells containing the K709A mutant are less sensitive to hypoxia-induced growth arrest than the cells containing the HIF1 alpha wildtype. Taken together, these data demonstrate a novel biological consequence upon HIF1 alpha-p300 interaction, in which HIF1 alpha can be stabilized by p300 via Lys-709 acetylation.	[Geng, Hao; Liu, Qiong; Xue, Changhui; David, Larry L.; Beer, Tomasz M.; Thomas, George V.; Dai, Mu-Shui; Qian, David Z.] Oregon Hlth & Sci Univ, Oregon Hlth & Sci Univ Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University	Qian, DZ (corresponding author), OHSU, Oregon Hlth & Sci Univ Knight Canc Inst, 3303 SW Bond Ave,CH14R, Portland, OR 97239 USA.	qianzh@ohsu.edu	Liu, Qiong/G-8666-2014; Qian, David Z/AAL-3441-2021	Liu, Qiong/0000-0003-4114-5540; Thomas, George V/0000-0001-7416-8840	U. S. Public Health Service Grant from the National Cancer Institute, National Institutes of Health [R01CA149253]; NATIONAL CANCER INSTITUTE [R01CA149253, R01CA160474] Funding Source: NIH RePORTER	U. S. Public Health Service Grant from the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U. S. Public Health Service Grant R01CA149253 from the National Cancer Institute, National Institutes of Health.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Harten SK, 2009, ADV ENZYME REGUL, V49, P43, DOI 10.1016/j.advenzreg.2008.12.005; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim SH, 2007, ONCOL REP, V17, P647; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	33	95	96	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35496	35505		10.1074/jbc.M112.400697	http://dx.doi.org/10.1074/jbc.M112.400697			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908229	hybrid, Green Published			2022-12-28	WOS:000309968000058
J	Valley, CC; Cembran, A; Perlmutter, JD; Lewis, AK; Labello, NP; Gao, J; Sachs, JN				Valley, Christopher C.; Cembran, Alessandro; Perlmutter, Jason D.; Lewis, Andrew K.; Labello, Nicholas P.; Gao, Jiali; Sachs, Jonathan N.			The Methionine-aromatic Motif Plays a Unique Role in Stabilizing Protein Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN INTERACTIONS; VON-WILLEBRAND-DISEASE; GLYCOPROTEIN-IB-ALPHA; CRYSTAL-STRUCTURE; SALT-BRIDGE; ALZHEIMERS-DISEASE; GLOBULAR-PROTEINS; DIVALENT SULFUR; BONE-RESORPTION; AMINO-ACIDS	Of the 20 amino acids, the precise function of methionine (Met) remains among the least well understood. To establish a determining characteristic of methionine that fundamentally differentiates it from purely hydrophobic residues, we have used in vitro cellular experiments, molecular simulations, quantum calculations, and a bioinformatics screen of the Protein Data Bank. We show that approximately one-third of all known protein structures contain an energetically stabilizing Met-aromatic motif and, remarkably, that greater than 10,000 structures contain this motif more than 10 times. Critically, we show that as compared with a purely hydrophobic interaction, the Metaromatic motif yields an additional stabilization of 1-1.5 kcal/mol. To highlight its importance and to dissect the energetic underpinnings of this motif, we have studied two clinically relevant TNF ligand-receptor complexes, namely TRAIL-DR5 and LT alpha-TNFR1. In both cases, we show that the motif is necessary for high affinity ligand binding as well as function. Additionally, we highlight previously overlooked instances of the motif in several disease-related Met mutations. Our results strongly suggest that the Met-aromatic motif should be exploited in the rational design of therapeutics targeting a range of proteins.	[Valley, Christopher C.; Perlmutter, Jason D.; Lewis, Andrew K.; Sachs, Jonathan N.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Cembran, Alessandro; Gao, Jiali] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Labello, Nicholas P.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sachs, JN (corresponding author), Univ Minnesota, Dept Biomed Engn, Rm 7-105 NHH,312 Church St SE, Minneapolis, MN 55455 USA.	jnsachs@umn.edu	Cembran, Alessandro/B-1561-2016	Cembran, Alessandro/0000-0002-9868-4994; Perlmutter, Jason/0000-0003-2855-2360	National Institutes of Health [R21 CA152668]; American Cancer Society [IRG-58-001-49 IRG49-28]; NATIONAL CANCER INSTITUTE [R21CA152668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 CA152668. This work was also supported by American Cancer Society Grant IRG-58-001-49 IRG49-28.	Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; BODNER BL, 1980, BIOCHEM BIOPH RES CO, V94, P807, DOI 10.1016/0006-291X(80)91306-6; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Cabaleiro-Lago EM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152577; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cregut D, 1999, PROTEIN SCI, V8, P271; Duan GL, 2001, MOL PHYS, V99, P1689, DOI 10.1080/00268970110063917; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Gao J, 1998, BIOPHYS J, V74, P1115, DOI 10.1016/S0006-3495(98)77830-0; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Imai YN, 2007, J MED CHEM, V50, P1189, DOI 10.1021/jm061038a; Iqbalsyah TM, 2005, BIOCHEMISTRY-US, V44, P10449, DOI 10.1021/bi0508690; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; MAIER K, 1991, AM REV RESPIR DIS, V143, P271, DOI 10.1164/ajrccm/143.2.271; Mologni L, 2010, BIOORGAN MED CHEM, V18, P1482, DOI 10.1016/j.bmc.2010.01.011; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; MORGAN RS, 1978, INT J PEPT PROT RES, V11, P209; MORGAN RS, 1980, INT J PEPT PROT RES, V15, P177; Moriki T, 1997, BLOOD, V90, P698, DOI 10.1182/blood.V90.2.698.698_698_705; NEMETHY G, 1981, BIOCHEM BIOPH RES CO, V98, P482, DOI 10.1016/0006-291X(81)90865-2; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Ringer AL, 2007, PROTEIN SCI, V16, P2216, DOI 10.1110/ps.073002307; ROSENFIELD RE, 1977, J AM CHEM SOC, V99, P4860, DOI 10.1021/ja00456a072; RUSSELL SD, 1993, BLOOD, V81, P1787; Saito H, 2007, ARTHRITIS RHEUM-US, V56, P1164, DOI 10.1002/art.22495; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Sherrill CD, 2009, J PHYS CHEM A, V113, P10146, DOI 10.1021/jp9034375; SINGH UC, 1988, P NATL ACAD SCI USA, V85, P4280, DOI 10.1073/pnas.85.12.4280; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Suzuki Y, 2006, J PERIODONTAL RES, V41, P81, DOI 10.1111/j.1600-0765.2005.00812.x; Ta HM, 2010, P NATL ACAD SCI USA, V107, P20281, DOI 10.1073/pnas.1011686107; Tsai J, 2002, BIOPHYS CHEM, V101, P187, DOI 10.1016/S0301-4622(02)00198-9; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993	56	202	204	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					34979	34991		10.1074/jbc.M112.374504	http://dx.doi.org/10.1074/jbc.M112.374504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22859300	hybrid, Green Published			2022-12-28	WOS:000309968000011
J	Vigetti, D; Deleonibus, S; Moretto, P; Karousou, E; Viola, M; Bartolini, B; Hascall, VC; Tammi, M; De Luca, G; Passi, A				Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Karousou, Eugenia; Viola, Manuela; Bartolini, Barbara; Hascall, Vincent C.; Tammi, Markku; De Luca, Giancarlo; Passi, Alberto			Role of UDP-N-Acetylglucosamine (GlcNAc) and O-GlcNAcylation of Hyaluronan Synthase 2 in the Control of Chondroitin Sulfate and Hyaluronan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MOLECULAR-CLONING; DIABETIC COMPLICATIONS; INSULIN-RESISTANCE; HEPARAN-SULFATE; XENOPUS-LAEVIS; UP-REGULATION; TUNICA MEDIA; PROTEIN; GLUCOSE	Hyaluronan (HA) is a glycosaminoglycan present in most tissue microenvironments that can modulate many cell behaviors, including proliferation, migration, and adhesive proprieties. In contrast with other glycosaminoglycans, which are synthesized in the Golgi, HA is synthesized at the plasma membrane by one or more of the three HA synthases (HAS1-3), which use cytoplasmic UDP-glucuronic acid and UDP-N-acetylglucosamine as substrates. Previous studies revealed the importance of UDP-sugars for regulating HA synthesis. Therefore, we analyzed the effect of UDP-GlcNAc availability and protein glycosylation with O-linked N-acetylglucosamine (O-GlcNAcylation) on HA and chondroitin sulfate synthesis in primary human aortic smooth muscle cells. Glucosamine treatment, which increases UDP-GlcNAc availability and protein O-GlcNAcylation, increased synthesis of both HA and chondroitin sulfate. However, increasing O-GlcNAcylation by stimulation with O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate without a concomitant increase of UDP-GlcNAc increased only HA synthesis. We found that HAS2, the main synthase in aortic smooth muscle cells, can be O-GlcNAcylated on serine 221, which strongly increased its activity and its stability (t(1/2) > 5 h versus similar to 17 min without O-GlcNAcylation). S221A mutation prevented HAS2 O-GlcNAcylation, which maintained the rapid turnover rate even in the presence of GlcN and increased UDP-GlcNAc. These findings could explain the elevated matrix HA observed in diabetic vessels that, in turn, could mediate cell dedifferentiation processes critical in vascular pathologies.	[Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Karousou, Eugenia; Viola, Manuela; Bartolini, Barbara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Cleveland, OH 44195 USA; [Tammi, Markku] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Biomed, Kuopio 70211, Finland	University of Insubria; Cleveland Clinic Foundation; University of Eastern Finland	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Chirurg & Morfol, Via J H Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Vigetti, Davide/C-9861-2010; Viola, Manuela/B-7120-2011; Tammi, Markku/AAQ-7878-2021; passi, alberto g/A-1752-2018	Vigetti, Davide/0000-0002-6339-8453; Viola, Manuela/0000-0002-0634-6390; passi, alberto g/0000-0003-3328-3089	Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS); Fondo di Ateneo per la Ricerca (FAR); Centro Insubre di Biotecnologie per la Salute Umana young researcher award; School of Biological and Medical Science, University of Insubria, Varese, Italy; Sigrid Juselius Foundation; Cancer Center of Eastern Finland; Kuopio University Hospital EVO Funds	Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS); Fondo di Ateneo per la Ricerca (FAR); Centro Insubre di Biotecnologie per la Salute Umana young researcher award; School of Biological and Medical Science, University of Insubria, Varese, Italy; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Center of Eastern Finland; Kuopio University Hospital EVO Funds	This work was supported in part by the Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS), the Fondo di Ateneo per la Ricerca (FAR), and a Centro Insubre di Biotecnologie per la Salute Umana young researcher award (to D. V.).; Recipient of a Ph.D. fellowship from the School of Biological and Medical Science, University of Insubria, Varese, Italy.; Recipient of financial support from Sigrid Juselius Foundation, Cancer Center of Eastern Finland, and Kuopio University Hospital EVO Funds.	Badi I, 2009, FEBS LETT, V583, P2486, DOI 10.1016/j.febslet.2009.07.001; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chisalita SI, 2009, J MOL ENDOCRINOL, V43, P231, DOI 10.1677/JME-09-0021; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardiville S, 2010, J BIOL CHEM, V285, P19205, DOI 10.1074/jbc.M109.080572; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HEICKENDORFF L, 1994, DIABETOLOGIA, V37, P286, DOI 10.1007/BF00398056; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Magee C, 2001, BIOCHEM J, V360, P667, DOI 10.1042/0264-6021:3600667; Marsh SA, 2011, CARDIOVASC RES, V89, P487, DOI 10.1093/cvr/cvq405; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xing DQ, 2008, AM J PHYSIOL-HEART C, V295, pH335, DOI 10.1152/ajpheart.01259.2007	61	96	96	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35544	35555		10.1074/jbc.M112.402347	http://dx.doi.org/10.1074/jbc.M112.402347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22887999	Green Published, hybrid			2022-12-28	WOS:000309968000067
J	Ross, CL; Liang, XW; Liu, Q; Murray, BE; Hook, M; Ganesh, VK				Ross, Cana L.; Liang, Xiaowen; Liu, Qing; Murray, Barbara E.; Hoeoek, Magnus; Ganesh, Vannakambadi K.			Targeted Protein Engineering Provides Insights into Binding Mechanism and Affinities of Bacterial Collagen Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; BIOCHEMICAL-CHARACTERIZATION; SURFACE-PROTEINS; VIRULENCE FACTOR; IV COLLAGENS; HUG MODEL; CELL-WALL; MSCRAMM; ACE	The collagen-binding bacterial proteins, Ace and Cna, are well characterized on the biochemical and structural level. Despite overall structural similarity, recombinant forms of the Ace and Cna ligand-binding domains exhibit significantly different affinities and binding kinetics for collagen type I (CI) in vitro. In this study, we sought to understand, in submolecular detail, the bases for these differences. Using a structure-based approach, we engineered Cna and Ace variants by altering specific structural elements within the ligand-binding domains. Surface plasmon resonance-based binding analysis demonstrated that mutations that are predicted to alter the orientation of the Ace and Cna N-1 and N-2 subdomains significantly affect the interaction between the MSCRAMM (microbial surface components recognizing adhesive matrix molecule) and CI in vitro, including affinity, association/dissociation rates and binding ratio. Moreover, we utilized this information to engineer an Ace variant with an 11,000-fold higher CI affinity than the parent protein. Finally, we noted that several engineered proteins that exhibited a weak interaction with CI recognized more sites on CI, suggesting an inverse correlation between affinity and specificity.	[Ross, Cana L.; Liang, Xiaowen; Liu, Qing; Hoeoek, Magnus; Ganesh, Vannakambadi K.] Texas A&M Hlth Sci Ctr, Ctr Inflammatory & Infect Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Murray, Barbara E.] Univ Texas Med Sch, Div Infect Dis, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Ganesh, VK (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Inflammatory & Infect Dis, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	vganesh@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951	National Institutes of Health from the NIAID [R01AI047923]; American Heart Association [10POST4160090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047923] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI047923 from the NIAID (to B. E. M. and M. H.). This work was also supported by American Heart Association Fellowship 10POST4160090 (to C. L. R.). A patent (pending) application has been filed based on some results in the manuscript.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Biacore Life Sciences, 2004, BIAEVALUATION SOFTW; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Mamo W, 2000, MICROBIOL IMMUNOL, V44, P381, DOI 10.1111/j.1348-0421.2000.tb02509.x; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Sato Y, 2004, J DENT RES, V83, P534, DOI 10.1177/154405910408300705; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Xu Y, 2004, J BIOL CHEM, V279, P51760, DOI 10.1074/jbc.M406417200; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	34	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34856	34865		10.1074/jbc.M112.371054	http://dx.doi.org/10.1074/jbc.M112.371054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865854	Green Published, hybrid			2022-12-28	WOS:000309654200084
J	Cao, WJ; Sabatino, DE; Altynova, E; Lange, AM; Casina, VC; Camire, RM; Zheng, XL				Cao, Wenjing; Sabatino, Denise E.; Altynova, Ekaterina; Lange, Amy M.; Casina, Veronica C.; Camire, Rodney M.; Zheng, X. Long			Light Chain of Factor VIII Is Sufficient for Accelerating Cleavage of von Willebrand Factor by ADAMTS13 Metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR MULTIMERS; PHENOTYPE; DELIVERY; REQUIRES; INCREASE; DOMAIN; RISK	We previously demonstrated that coagulation factor VIII (FVIII) accelerates proteolytic cleavage of von Willebrand factor (VWF) by A disintegrin and metalloprotease with thrombospondin type 1 repeats (ADAMTS13) under fluid shear stress. In this study, the structural elements of FVIII required for the rate-enhancing effect and the biological relevance of this cofactor activity are determined using a murine model. An isolated light chain of human FVIII (hFVIII-LC) increases proteolytic cleavage of VWF by ADAMTS13 under shear in a concentration-dependent manner. The maximal rate-enhancing effect of hFVIII-LC is similar to 8-fold, which is comparable with human full-length FVIII and B-domain deleted FVIII (hFVIII-BDD). The heavy chain (hFVIII-HC) and the light chain lacking the acidic (a3) region (hFVIII-LC Delta a3) have no effect in accelerating VWF proteolysis by ADAMTS13 under the same conditions. Although recombinant hFVIII-HC and hFVIII-LC Delta a3 do not detectably bind immobilized VWF, recombinant hFVIII-LC binds VWF with high affinity (K-D, similar to 15 nM). Moreover, ultra-large VWF multimers accumulate in the plasma of fVIII(-/-) mice after hydrodynamic challenge but not in those reconstituted with either hFVIII-BDD or hFVIII-LC. These results suggest that the light chain of FVIII, which is not biologically active for clot formation, is sufficient for accelerating proteolytic cleavage of VWF by ADAMTS13 under fluid shear stress and (patho) physiological conditions. Our findings provide novel insight into the molecular mechanism of how FVIII regulates VWF homeostasis.	[Cao, Wenjing; Casina, Veronica C.; Zheng, X. Long] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Cao, Wenjing; Casina, Veronica C.; Zheng, X. Long] Childrens Hosp Philadelphia, Dept Lab Med, Philadelphia, PA 19104 USA; [Sabatino, Denise E.; Camire, Rodney M.; Zheng, X. Long] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sabatino, Denise E.; Altynova, Ekaterina; Lange, Amy M.; Camire, Rodney M.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Zheng, XL (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zheng@email.chop.edu	Zheng, X. Long/ABD-7362-2021	Zheng, X. Long/0000-0003-1680-5295	National Institutes of Health [HL079027, HL074124]; American Heart Association [09POST2250397, 0940100N]; Bayer Hemophilia awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079027, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Bayer Hemophilia awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079027 and HL074124. This work was also supported by American Heart Association Postdoctoral Fellowship 09POST2250397 (to W. C.), Bayer Hemophilia awards, and American Heart Association Grant 0940100N (to X. L. Z.).	BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Chen LX, 2007, MOL THER, V15, P1856, DOI 10.1038/sj.mt.6300268; Crawley JTB, 2008, J THROMB HAEMOST, V6, P583, DOI 10.1111/j.1538-7836.2008.02902.x; Donadelli R, 2006, BLOOD, V107, P1943, DOI 10.1182/blood-2005-07-2972; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Fuchigami S, 2008, THROMB RES, V122, P618, DOI 10.1016/j.thromres.2007.12.025; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Goodeve AC, 2003, SEMIN THROMB HEMOST, V29, P23, DOI 10.1055/s-2003-37936; Grunewald M, 2002, HAEMOPHILIA, V8, P768, DOI 10.1046/j.1365-2516.2002.00686.x; Kaikita K, 2006, J THROMB HAEMOST, V4, P2490, DOI 10.1111/j.1538-7836.2006.02161.x; Matsukawa M, 2007, AM J CARDIOL, V100, P760, DOI 10.1016/j.amjcard.2007.03.095; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Moake JL, 2002, ANNU REV MED, V53, P75, DOI 10.1146/annurev.med.53.082901.103948; Niiya M, 2009, MOL THER, V17, P34, DOI 10.1038/mt.2008.223; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Sabatino DE, 2011, MOL THER, V19, P442, DOI 10.1038/mt.2010.240; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Skipwith CG, 2010, J BIOL CHEM, V285, P28596, DOI 10.1074/jbc.M110.131227; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Xiao J, 2011, ARTERIOSCL THROM VAS, V31, P2261, DOI 10.1161/ATVBAHA.111.229609; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhao BQ, 2009, BLOOD, V114, P3329, DOI 10.1182/blood-2009-03-213264; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200	32	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32459	32466		10.1074/jbc.M112.390690	http://dx.doi.org/10.1074/jbc.M112.390690			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854959	Green Published, hybrid			2022-12-28	WOS:000309168300016
J	Fekonja, O; Bencina, M; Jerala, R				Fekonja, Ota; Bencina, Mojca; Jerala, Roman			Toll/Interleukin-1 Receptor Domain Dimers as the Platform for Activation and Enhanced Inhibition of Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; TIR-DOMAIN; RHEUMATOID-ARTHRITIS; CELL ACTIVATION; LEUCINE-ZIPPER; COILED-COIL; HUMAN MYD88; FAMILY; RECRUITMENT; COMPLEXES	TIR (Toll/IL-1 receptor) domains mediate interactions between TLR (Toll-like) or IL-1 family receptors and signaling adapters. While homotypic TIR domain interactions mediate receptor activation they are also usurped by microbial TIR domain containing proteins for immunosuppression. Here we show the role of a dimerized TIR domain platform for the suppression as well as for the activation of MyD88 signaling pathway. Coiled-coil dimerization domain, present in many bacterial TCPs, potently augments suppression of TLR/IL-1R signaling. The addition of a strong coiled-coil dimerization domain conferred the superior inhibition against the wide spectrum of TLRs and prevented the constitutive activation by a dimeric TIR platform. We propose a molecular model of MyD88-mediated signaling based on the dimerization of TIR domains as the limiting step.	[Fekonja, Ota; Bencina, Mojca; Jerala, Roman] Natl Inst Chem, Biotechnol Lab, Ljubljana 1000, Slovenia; [Bencina, Mojca; Jerala, Roman] Ctr Excellence EN FIST, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Biotechnol Lab, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si			Slovenian Research Agency; Centre of Excellence EN-FIST, Ljubljana, Slovenia; EU structural funds	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence EN-FIST, Ljubljana, Slovenia; EU structural funds	This work was supported by the Slovenian Research Agency (to R. J. and M. B.) and Centre of Excellence EN-FIST, Ljubljana, Slovenia supported in part by the EU structural funds.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Avbelj M, 2011, J IMMUNOL, V187, P2394, DOI 10.4049/jimmunol.1100515; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hardiman G, 1996, ONCOGENE, V13, P2467; Hua F, 2005, BIOCHEM BIOPH RES CO, V338, P1118, DOI 10.1016/j.bbrc.2005.10.068; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Roszik J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-346; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Spear AM, 2009, TRENDS MICROBIOL, V17, P393, DOI 10.1016/j.tim.2009.06.005; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	41	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30993	31002		10.1074/jbc.M112.376186	http://dx.doi.org/10.1074/jbc.M112.376186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829600	hybrid, Green Published			2022-12-28	WOS:000308791300013
J	Ann, EJ; Kim, HY; Seo, MS; Mo, JS; Kim, MY; Yoon, JH; Ahn, JS; Park, HS				Ann, Eun-Jung; Kim, Hwa-Young; Seo, Mi-Sun; Mo, Jung-Soon; Kim, Mi-Yeon; Yoon, Ji-Hye; Ahn, Ji-Seon; Park, Hee-Sae			Wnt5a Controls Notch1 Signaling through CaMKII-mediated Degradation of the SMRT Corepressor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GAMMA-SECRETASE; KINASE-II; INTRACELLULAR DOMAIN; RETINOIC ACID; BETA-APP; PRESENILIN; RECEPTOR; APH-1; EXPRESSION	Serine-threonine Ca2+/calmodulin-dependent protein kinase II (CaMKII) is the key component in noncanonical Wnt5a signaling and has been shown to regulate its signaling. In this study, we found that CaMKII induced by Wnt5a remarkably reduced the protein stability of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT), a co-repressor of Notch signaling, through proteasomal degradation. Wnt5a was found to enhance Notch1 intracellular domain (Notch1-IC) transcription activity, which could be inhibited by treatment with KN93, a CaMKII inhibitor. The kinase activity of CaMKII was essential for the activation of Notch signaling. We also determined that CaMKII could enhance the association between Notch1-IC and RBP-Jk. Furthermore, the physical association between RBP-Jk and SMRT was substantially suppressed by CaMKII. We demonstrated that CaMKII directly bound and phosphorylated SMRT at Ser-1407, thereby facilitating SMRT translocation from the nucleus to the cytoplasm and proteasome-dependent degradation. These results suggest that CaMKII down-regulated the protein stability of SMRT through proteasomal degradation.	[Ann, Eun-Jung; Kim, Hwa-Young; Seo, Mi-Sun; Mo, Jung-Soon; Kim, Mi-Yeon; Yoon, Ji-Hye; Ahn, Ji-Seon; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Park, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	proteome@jnu.ac.kr	Ahn, Ji-Seon/GRO-6218-2022	Ahn, Ji-Seon/0000-0001-9465-2517	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100455]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by Grant A100455 of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	AbuIssa R, 1996, J NEUROGENET, V10, P239, DOI 10.3109/01677069609083465; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1996, DEVELOPMENT, V122, P2719; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; HING HK, 1994, MECH DEVELOP, V47, P261, DOI 10.1016/0925-4773(94)90044-2; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong SH, 1998, MOL ENDOCRINOL, V12, P1161, DOI 10.1210/me.12.8.1161; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim MY, 2010, CELL DEATH DIFFER, V17, P1728, DOI 10.1038/cdd.2010.50; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leimeister C, 2000, MECH DEVELOP, V98, P175, DOI 10.1016/S0925-4773(00)00459-7; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mamaeva OA, 2009, J CELL BIOCHEM, V106, P25, DOI 10.1002/jcb.21973; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Struewing IT, 2007, EXP CELL RES, V313, P3526, DOI 10.1016/j.yexcr.2007.07.012; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zhou YY, 2001, MOL CELL BIOCHEM, V220, P1, DOI 10.1023/A:1011087910699	78	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36814	36829		10.1074/jbc.M112.356048	http://dx.doi.org/10.1074/jbc.M112.356048			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22888005	Green Published, hybrid			2022-12-28	WOS:000310588500018
J	Liu, YC; Zhu, X; Nakamura, A; Orlando, R; Soll, D; Whitman, WB				Liu, Yuchen; Zhu, Xiang; Nakamura, Akiyoshi; Orlando, Ron; Soell, Dieter; Whitman, William B.			Biosynthesis of 4-Thiouridine in tRNA in the Methanogenic Archaeon Methanococcus maripaludis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI TRANSFER-RNA; NEAR-ULTRAVIOLET LIGHT; IN-VITRO BIOSYNTHESIS; ESCHERICHIA-COLI; GROWTH DELAY; POSTTRANSCRIPTIONAL MODIFICATION; SALMONELLA-TYPHIMURIUM; LIQUID-CHROMATOGRAPHY; CYSTEINE DESULFURASE; THIAZOLE MOIETY	4-Thiouridine (s(4)U) is a conserved modified nucleotide at position 8 of bacterial and archaeal tRNAs and plays a role in protecting cells from near-UV killing. Escherichia coli employs the following two enzymes for its synthesis: the cysteine desulfurase IscS, which forms a Cys persulfide enzyme adduct from free Cys; and ThiI, which adenylates U8 and transfers sulfur from IscS to form s(4)U. The C-terminal rhodanese-like domain (RLD) of ThiI is responsible for the sulfurtransferase activity. The mechanism of s(4)U biosynthesis in archaea is not known as many archaea lack cysteine desulfurase and an RLD of the putative ThiI. Using the methanogenic archaeon Methanococcus maripaludis, we show that deletion of ThiI (MMP1354) abolished the biosynthesis of s(4)U but not of thiamine. MMP1354 complements an Escherichia coli Delta thiI mutant for s(4)U formation, indicating that MMP1354 is sufficient for sulfur incorporation into s(4)U. In the absence of an RLD, MMP1354 uses Cys(265) and Cys(268) located in the PP-loop pyrophosphatase domain to generate persulfide and disulfide intermediates for sulfur transfer. In vitro assays suggest that S2- is a physiologically relevant sulfur donor for s(4)U formation catalyzed by MMP1354 (K-m for Na2S is similar to 1mM). Thus, methanogenic archaea developed a strategy for sulfur incorporation into s(4)U that differs from bacteria; this may be an adaptation to life in sulfide-rich environments.	[Liu, Yuchen; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Liu, Yuchen; Nakamura, Akiyoshi; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Chem, Athens, GA 30602 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	University System of Georgia; University of Georgia; Yale University; University System of Georgia; University of Georgia; Yale University	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	whitman@uga.edu	Nakamura, Akiyoshi/L-4928-2016; Whitman, William/AAC-5896-2020	Nakamura, Akiyoshi/0000-0003-2828-3033; Liu, Yuchen/0000-0003-0842-5882; Whitman, William/0000-0003-1229-0423	National Institutes of Health [GM22854, P41-RR-018502]; Department of Energy Office of Basic Energy Sciences [DE-FG02-05ER15709, DE-FG02-98ER20311]; University of Georgia Graduate School; Japan Society for the Promotion of Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); University of Georgia Graduate School; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM22854 (to D. S.) and P41-RR-018502 (to R. O.). This work was also supported by Department of Energy Office of Basic Energy Sciences Grants DE-FG02-05ER15709 (to W. W.) and DE-FG02-98ER20311.; Recipient of a doctoral dissertation completion award from the University of Georgia Graduate School.; Recipient of a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science.	ABRELL JW, 1971, J BIOL CHEM, V246, P294; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bender RA, 2011, J BACTERIOL, V193, P4574, DOI 10.1128/JB.05666-11; BEST AN, 1978, J BACTERIOL, V133, P240, DOI 10.1128/JB.133.1.240-250.1978; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; CARRE DS, 1974, BIOCHIMIE, V56, P1089, DOI 10.1016/S0300-9084(74)80097-0; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; EMILSSON V, 1992, NUCLEIC ACIDS RES, V20, P4499, DOI 10.1093/nar/20.17.4499; FAVRE A, 1969, BIOCHEM BIOPH RES CO, V37, P266, DOI 10.1016/0006-291X(69)90729-3; FAVRE A, 1971, J MOL BIOL, V58, P367, DOI 10.1016/0022-2836(71)90252-X; FAVRE A, 1985, BIOCHIMIE, V67, P335, DOI 10.1016/S0300-9084(85)80076-6; GERNHARDT P, 1990, MOL GEN GENET, V221, P273, DOI 10.1007/BF00261731; Gupta R., 1995, P119; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kambampati R, 1999, BIOCHEMISTRY-US, V38, P16561, DOI 10.1021/bi991119r; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KRAMER GF, 1988, J BACTERIOL, V170, P2344, DOI 10.1128/jb.170.5.2344-2351.1988; Lauhon CT, 2004, J BIOL CHEM, V279, P23022, DOI 10.1074/jbc.M401757200; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; LEIGH JA, 1983, APPL ENVIRON MICROB, V45, P800, DOI 10.1128/AEM.45.3.800-803.1983; Lin W, 2004, ARCH MICROBIOL, V181, P68, DOI 10.1007/s00203-003-0629-1; LIPSETT MN, 1978, J BACTERIOL, V135, P993, DOI 10.1128/JB.135.3.993-997.1978; Liu Y., 2012, ENVIRON MICROBIOL, V194, P4933; Liu YC, 2012, TRENDS MICROBIOL, V20, P251, DOI 10.1016/j.tim.2012.02.002; Liu YC, 2012, J BIOL CHEM, V287, P5426, DOI 10.1074/jbc.M111.313700; Liu YC, 2010, J BIOL CHEM, V285, P31923, DOI 10.1074/jbc.M110.152447; Martinez-Gomez NC, 2011, J BACTERIOL, V193, P4582, DOI 10.1128/JB.05325-11; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; Mueller EG, 1998, NUCLEIC ACIDS RES, V26, P2606, DOI 10.1093/nar/26.11.2606; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Phillips G, 2011, CURR OPIN MICROBIOL, V14, P335, DOI 10.1016/j.mib.2011.03.001; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Rajakovich L. J., 2012, J BACTERIOL; RAMABHADRAN TV, 1976, P NATL ACAD SCI USA, V73, P59, DOI 10.1073/pnas.73.1.59; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka Y, 2009, RNA, V15, P1498, DOI 10.1261/rna.1614709; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; THOMAS G, 1980, EUR J BIOCHEM, V113, P67; THOMAS G, 1975, BIOCHEM BIOPH RES CO, V66, P1454, DOI 10.1016/0006-291X(75)90522-7; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; Waterman DG, 2006, J MOL BIOL, V356, P97, DOI 10.1016/j.jmb.2005.11.013; Webb E, 1997, J BACTERIOL, V179, P4399, DOI 10.1128/jb.179.13.4399-4402.1997; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Wright CM, 2002, CHEM COMMUN, P2708, DOI 10.1039/b208626c; You DL, 2008, CHEMBIOCHEM, V9, P1879, DOI 10.1002/cbic.200800033; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	65	40	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36683	36692		10.1074/jbc.M112.405688	http://dx.doi.org/10.1074/jbc.M112.405688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22904325	Green Published, hybrid			2022-12-28	WOS:000310588500006
J	Takarada, T; Kodama, A; Hotta, S; Mieda, M; Shimba, S; Hinoi, E; Yoneda, Y				Takarada, Takeshi; Kodama, Ayumi; Hotta, Shogo; Mieda, Michihiro; Shimba, Shigeki; Hinoi, Eiichi; Yoneda, Yukio			Clock Genes Influence Gene Expression in Growth Plate and Endochondral Ossification in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN CLOCK; INDIAN HEDGEHOG; CHONDROGENIC DIFFERENTIATION; PROTEIN; KINASE; BMAL1; PROLIFERATION; TRANSCRIPTION; INTERFERENCE; OSCILLATIONS	We have previously shown transient promotion by parathyroid hormone of Period-1 (Per1) expression in cultured chondrocytes. Here we show the modulation by clock genes of chondrogenic differentiation through gene transactivation of the master regulator of chondrogenesis Indian hedgehog (IHH) in chondrocytes of the growth plate. Several clock genes were expressed with oscillatory rhythmicity in cultured chondrocytes and rib growth plate in mice, whereas chondrogenesis was markedly inhibited in stable transfectants of Per1 in chondrocytic ATDC5 cells and in rib growth plate chondrocytes from mice deficient of brain and muscle aryl hydrocarbon receptor nuclear translocator-like (BMAL1). Ihh promoter activity was regulated by different clock gene products, with clear circadian rhythmicity in expression profiles of Ihh in the growth plate. In BMAL1-null mice, a predominant decrease was seen in Ihh expression in the growth plate with a smaller body size than in wild-type mice. BMAL1 deficit led to disruption of the rhythmic expression profiles of both Per1 and Ihh in the growth plate. A clear rhythmicity was seen with Ihh expression in ATDC5 cells exposed to dexamethasone. In young mice defective of BMAL1 exclusively in chondrocytes, similar abnormalities were found in bone growth and Ihh expression. These results suggest that endochondral ossification is under the regulation of particular clock gene products expressed in chondrocytes during postnatal skeletogenesis through a mechanism relevant to the rhythmic Ihh expression.	[Takarada, Takeshi; Kodama, Ayumi; Hotta, Shogo; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan; [Mieda, Michihiro] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan; [Shimba, Shigeki] Nihon Univ, Coll Pharm, Dept Hlth Sci, Chiba 2748555, Japan	Kanazawa University; Kanazawa University; Nihon University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704; Mieda, Michihiro/0000-0002-2451-7034	Ministry of Education, Culture, Sports, Science and Technology, Japan [20790250]; Foundation of Growth Science, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Growth Science, Japan	This work was supported in part by Grant-in-aid for Scientific Research 20790250 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. T.) and by a Research Grant from Foundation of Growth Science, Japan (to T. T.).	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Deckelbaum RA, 2002, J CELL SCI, V115, P3015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Muhlbauer E, 2004, FEBS LETT, V564, P91, DOI 10.1016/S0014-5793(04)00322-9; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Noonan KJ, 2004, J PEDIATR ORTHOPED, V24, P726, DOI 10.1097/01241398-200411000-00024; Okamura H, 2010, ADV DRUG DELIVER REV, V62, P876, DOI 10.1016/j.addr.2010.06.004; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takarada T, 2008, J CELL PHYSIOL, V215, P320, DOI 10.1002/jcp.21310; Takarada T, 2007, EUR J PHARMACOL, V575, P1, DOI 10.1016/j.ejphar.2007.07.041; Takarada T, 2009, BONE, V45, P568, DOI 10.1016/j.bone.2009.05.004; Takarada T, 2009, J CELL PHYSIOL, V220, P756, DOI 10.1002/jcp.21821; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	36	74	77	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36081	36095		10.1074/jbc.M112.408963	http://dx.doi.org/10.1074/jbc.M112.408963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936800	hybrid, Green Published			2022-12-28	WOS:000310364000030
J	Tan, KW; Ong, TC; Gao, YF; Tiong, YS; Wong, KN; Chew, FT; Mok, YK				Tan, Kang Wei; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Mok, Yu Keung			NMR Structure and IgE Epitopes of Blo t 21, a Major Dust Mite Allergen from Blomia tropicalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTIVITY; CHEMICAL-SHIFT; P 5; IDENTIFICATION; RESONANCE; SYSTEM; C-13; RESTRAINTS; ASSIGNMENT; DATABASE	Blo t 21 is a paralogue of the group 5 allergen, Blo t 5, a major allergen from the dust mite Blomia tropicalis. Blo t 21 has moderate sequence identity (40.7%) to Blo t 5 and low to moderate cross-reactivity to Blo t 5. In B. tropicalis, the most prevalent and allergenic allergens are in the order of Blo t 21, Blo t 5, and Blo t 7. Here, we determined the NMR solution structure of Blo t 21, which represents the first structure of the group 21 dust mite allergen. The structure of Blo t 21 closely resembles the structures of Blo t 5 and Der p 5, comprising three anti-parallel alpha-helices arranged in a helical bundle. Using site-directed mutagenesis and specific IgE binding ELISA, Blo t 21 was found to contain both conserved and unique charged IgE epitope residues at the L2 loop region and on helix alpha 3. Cross-inhibition assays confirmed that Blo t 21 has a low to moderate cross-reactivity with Blo t 5 and Der p 5 and represents a novel group of major allergen in B. tropicalis. In addition to group 5 allergens, Blo t 21 has also a low to moderate cross-reactivity with group 21 allergens from Dermatophagoides mites, confirming that B. tropicalis is a major and distinct source of dust mite allergens.	[Tan, Kang Wei; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore	National University of Singapore	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Chew, Fook Tim/E-7259-2010; Mok, Yu Keung/H-8019-2012	Chew, Fook Tim/0000-0003-1337-5146; Mok, Yu Keung/0000-0002-2829-4878	Biomedical Research Council [04/1/21/19/315]; National Medical Research Council of Singapore [NMRC/1150/2008]; Ministry of Education [MOE 2011-T2-2-002]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Ministry of Education	This work was supported by Biomedical Research Council Grant 04/1/21/19/315, National Medical Research Council of Singapore Grant NMRC/1150/2008, and Ministry of Education Tier 2 Grant MOE 2011-T2-2-002.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caraballo L, 1998, INT ARCH ALLERGY IMM, V117, P38, DOI 10.1159/000023988; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Cheong N, 2003, ALLERGY, V58, P912, DOI 10.1034/j.1398-9995.2003.00215.x; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Chua KY, 2007, PROTEIN PEPTIDE LETT, V14, P325; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W, 2002, PYMOL 0 99; Gao YF, 2007, J ALLERGY CLIN IMMUN, V120, P105, DOI 10.1016/j.jaci.2007.02.032; Goddard D., 2008, SPARKY 3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mueller GA, 2010, J BIOL CHEM, V285, P25394, DOI 10.1074/jbc.M110.128306; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Naik MT, 2007, J BIOMOL NMR, V38, P189, DOI 10.1007/s10858-006-9113-y; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robaina JCG, 2003, INT ARCH ALLERGY IMM, V131, P182, DOI 10.1159/000071484; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Tsai WJ, 2003, J IMMUNOL METHODS, V276, P163, DOI 10.1016/S0022-1759(03)00105-4; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yi Fong Cheng, 2006, Inflammation & Allergy Drug Targets, V5, P261	34	29	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34776	34785		10.1074/jbc.M112.348730	http://dx.doi.org/10.1074/jbc.M112.348730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22887997	Green Published, hybrid			2022-12-28	WOS:000309654200077
J	King, JD; Lee, J; Riemen, CE; Neumann, D; Xiong, S; Foskett, JK; Mehta, A; Muimo, R; Hallows, KR				King, J. Darwin, Jr.; Lee, Jeffrey; Riemen, Claudia E.; Neumann, Dietbert; Xiong, Sheng; Foskett, J. Kevin; Mehta, Anil; Muimo, Richmond; Hallows, Kenneth R.			Role of Binding and Nucleoside Diphosphate Kinase A in the Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; IN-VITRO; HISTIDINE PHOSPHORYLATION; CHLORIDE CHANNEL; FLUID SECRETION; R-DOMAIN; CFTR; INHIBITION; TRANSPORT; ATP	Cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel mutations cause cystic fibrosis lung disease. A better understanding of CFTR regulatory mechanisms could suggest new therapeutic strategies. AMP-activated protein kinase (AMPK) binds to and phosphorylates CFTR, attenuating PKA-activated CFTR gating. However, the requirement for AMPK binding to CFTR and the potential role of other proteins in this regulation are unclear. We report that nucleoside diphosphate kinaseA(NDPK-A) interacts with both AMPK and CFTR in overlay blots of airway epithelial cell lysates. Binding studies in Xenopus oocytes and transfected HEK-293 cells revealed that a CFTR peptide fragment that binds AMPK (CFTR-1420-57) disrupted the AMPK-CFTR interaction. Introduction of CFTR-1420-57 into human bronchial Calu-3 cells enhanced forskolin-stimulated whole cell conductance in patch clamp measurements. Similarly, injection of CFTR-1420-57 into Xenopus oocytes blocked the inhibition of cAMP-stimulated CFTR conductance by AMPK in two-electrode voltage clamp studies. AMPK also inhibited CFTR conductance with co-expression of WT NDPK-A in two-electrode voltage clamp studies, but co-expression of a catalytically inactive H118F mutant or various Ser-120 NDPK-A mutants prevented this inhibition. In vitro phosphorylation of WT NDPK-A was enhanced by purified active AMPK, but phosphorylation was prevented in H118F and phosphomimic Ser-120 NDPK-A mutants. AMPK does not appear to phosphorylate NDPK-A directly but rather promotes an NDPK-A autophosphorylation event that involves His-118 and Ser-120. Taken together, these results suggest that NDPK-A exists in a functional cellular complex with AMPK and CFTR in airway epithelia, and NDPK-A catalytic function is required for the AMPK-dependent regulation of CFTR.	[King, J. Darwin, Jr.; Lee, Jeffrey; Xiong, Sheng; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Riemen, Claudia E.; Mehta, Anil] Univ Dundee, Div Med Sci, Dundee DD1 9SY, Scotland; [Neumann, Dietbert] Cardiovasc Res Inst, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Xiong, Sheng] Jinan Univ, Coll Life Sci & Technol, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China; [Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Muimo, Richmond] Univ Sheffield, Sch Med, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Dundee; Maastricht University; Jinan University; University of Pennsylvania; University of Sheffield	Hallows, KR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu	Foskett, Kevin/R-2549-2019; Hallows, Kenneth/A-8477-2013	Foskett, J. Kevin/0000-0002-8854-0268; Neumann, Dietbert/0000-0002-4316-684X; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [P30 DK079307, R01 DK075048, T32 HL007563]; Cystic Fibrosis Foundation [KING10F0, HALLOW06P0]; Wellcome Trust [086370/Z/08/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK075048 (to K. R. H.), and T32 HL007563 (to J. D. K.). This work was also supported by Cystic Fibrosis Foundation Grants KING10F0 (to J. D. K.) and HALLOW06P0 (to K. R. H.).; Supported by Wellcome Trust Grant 086370/Z/08/Z.	Annesley SJ, 2011, N-S ARCH PHARMACOL, V384, P341, DOI 10.1007/s00210-011-0615-0; BELL CL, 1993, AM J PHYSIOL, V264, pC925, DOI 10.1152/ajpcell.1993.264.4.C925; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; Biondi RM, 1996, ANAL BIOCHEM, V242, P165, DOI 10.1006/abio.1996.0449; Biondi RM, 1996, FEBS LETT, V399, P183, DOI 10.1016/S0014-5793(96)01299-9; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dar HH, 2010, BIOCHEM J, V430, P539, DOI 10.1042/BJ20100026; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Guerrant R. L., 1990, REV INFECT DIS, V12, P41; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kowluru A, 2003, AM J PHYSIOL-ENDOC M, V285, pE498, DOI 10.1152/ajpendo.00121.2003; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Muimo R, 2000, J BIOL CHEM, V275, P36632, DOI 10.1074/jbc.M000829200; Muimo R, 2006, J BIOENERG BIOMEMBR, V38, P181, DOI 10.1007/s10863-006-9033-2; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Onyenwoke RU, 2012, MOL BIOL CELL, V23, P381, DOI 10.1091/mbc.E11-08-0699; Pastor-Soler NM, 2012, CURR OPIN NEPHROL HY, V21, P523, DOI 10.1097/MNH.0b013e3283562390; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Treharne KJ, 2009, MOL CELL BIOCHEM, V329, P107, DOI 10.1007/s11010-009-0118-1; TREHARNE KJ, 1994, AM J PHYSIOL-LUNG C, V267, pL592, DOI 10.1152/ajplung.1994.267.5.L592; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	51	25	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33389	33400		10.1074/jbc.M112.396036	http://dx.doi.org/10.1074/jbc.M112.396036			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869372	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000309602100026
J	Zhou, HY; Chen, SR; Byun, HS; Chen, H; Li, L; Han, HD; Lopez-Berestein, G; Sood, AK; Pan, HL				Zhou, Hong-Yi; Chen, Shao-Rui; Byun, Hee-Sun; Chen, Hong; Li, Li; Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin			N-Methyl-D-aspartate Receptor- and Calpain-mediated Proteolytic Cleavage of K+-Cl- Cotransporter-2 Impairs Spinal Chloride Homeostasis in Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PERIPHERAL-NERVE INJURY; SUPERFICIAL DORSAL-HORN; NMDA RECEPTOR; SUBSTANTIA-GELATINOSA; MYELINATED AFFERENTS; DOWN-REGULATION; SYNAPTIC INPUT; ANION GRADIENT; NEURONS	Loss of synaptic inhibition by gamma-aminobutyric acid and glycine due to potassium chloride cotransporter-2 (KCC2) down-regulation in the spinal cord is a critical mechanism of synaptic plasticity in neuropathic pain. Here we present novel evidence that peripheral nerve injury diminishes glycine-mediated inhibition and induces a depolarizing shift in the reversal potential of glycine-mediated currents (E-glycine) in spinal dorsal horn neurons. Blocking glutamate N-methyl-D-aspartate (NMDA) receptors normalizes synaptic inhibition, E-glycine, and KCC2 by nerve injury. Strikingly, nerve injury increases calcium-dependent calpain activity in the spinal cord that in turn causes KCC2 cleavage at the C terminus. Inhibiting calpain blocks KCC2 cleavage induced by nerve injury and NMDA, thereby normalizing E-glycine. Furthermore, calpain inhibition or silencing of mu-calpain at the spinal level reduces neuropathic pain. Thus, nerve injury promotes proteolytic cleavage of KCC2 through NMDA receptor-calpain activation, resulting in disruption of chloride homeostasis and diminished synaptic inhibition in the spinal cord. Targeting calpain may represent a new strategy for restoring KCC2 levels and tonic synaptic inhibition and for treating chronic neuropathic pain.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Zhou, Hong-Yi; Chen, Shao-Rui; Byun, Hee-Sun; Chen, Hong; Li, Li; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770; Zhou, Hongyi/0000-0001-5074-5180	National Institutes of Health [GM064830, NS045602, NS073935, GM092599, CA151668]; N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE [U54CA151668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092599, R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935, R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830, NS045602, and NS073935 (to H.-L.P.), GM092599 (to A.K.S.), and CA151668 (to G.L.-B.). This work was also supported by the N. G. and Helen T. Hawkins endowment (to H.-L.P).	Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Eaton MJ, 2002, GENE THER, V9, P1387, DOI 10.1038/sj.gt.3301814; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gellerman DM, 1997, J NEUROCHEM, V69, P131; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Isaev D, 2000, NEUROREPORT, V11, P4055, DOI 10.1097/00001756-200012180-00030; Jolivalt CG, 2008, PAIN, V140, P48, DOI 10.1016/j.pain.2008.07.005; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Kiefer RT, 2008, PAIN MED, V9, P1173, DOI 10.1111/j.1526-4637.2007.00402.x; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MAO JR, 1992, BRAIN RES, V588, P144, DOI 10.1016/0006-8993(92)91354-H; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Park JS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-67; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Sigtermans MJ, 2009, PAIN, V145, P304, DOI 10.1016/j.pain.2009.06.023; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang XL, 2007, J PHYSIOL-LONDON, V579, P849, DOI 10.1113/jphysiol.2006.126102; Waxman SG, 1999, PAIN, pS133, DOI 10.1016/S0304-3959(99)00147-5; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu K, 1997, P NATL ACAD SCI USA, V94, P13273, DOI 10.1073/pnas.94.24.13273; Ye ZY, 2012, J NEUROSCI, V32, P8560, DOI 10.1523/JNEUROSCI.1346-12.2012; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang HM, 2009, NEUROSCIENCE, V158, P875, DOI 10.1016/j.neuroscience.2008.10.042; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	60	99	102	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33853	33864		10.1074/jbc.M112.395830	http://dx.doi.org/10.1074/jbc.M112.395830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22854961	Green Published, hybrid			2022-12-28	WOS:000309602100066
J	Ghosh, S; Adhikary, A; Chakraborty, S; Nandi, P; Mohanty, S; Chakraborty, S; Bhattacharjee, P; Mukherjee, S; Putatunda, S; Chakraborty, S; Chakraborty, A; Sa, G; Das, T; Sen, PC				Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Samik; Nandi, Pinki; Mohanty, Suchismita; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mukherjee, Sanhita; Putatunda, Salil; Chakraborty, Srabasti; Chakraborty, Arijit; Sa, Gaurisankar; Das, Tanya; Sen, Parimal C.			Nifetepimine, a Dihydropyrimidone, Ensures CD4(+) T Cell Survival in a Tumor Microenvironment by Maneuvering Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INDUCED APOPTOSIS; IMMUNE EVASION; CALCIUM PUMPS; PKC-THETA; EXPRESSION; ACTIVATION; KINASE; CANCER	Multiple mechanisms have been proposed by which tumors induce T cell apoptosis to circumvent tumor immunesurveillance. Although sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) have long been known to regulate intracellular Ca2+ homeostasis, few studies have examined the role of SERCA in processes of T lymphocyte survival and activation. In this context it remains largely unexplored as to how tumors jeopardize SERCA function to disable T cell-mediated anti-tumor immunity. Here, we show that human CD4(+) T cells in the presence of tumor conditions manifested an up-regulation of SERCA3 expression that resulted in development of endoplasmic reticulum stress leading to CD4(+) T cell apoptosis. Prostaglandin E-2 produced by the tumor cell plays a critical role in up-regulating SERCA3 by enhancing the binding of its transcription factor Sp1. Gene manipulation and pharmacological approaches further established that an increase in SERCA expression also resulted in subsequent inhibition of PKC alpha and -theta and retention of NF kappa B in the cytosol; however, down-modulation of SERCA3 expression by a dihydropyrimidone derivative, ethyl-4-(3-nitro)-phenyl-6- methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5 carboxylate (nifetepimine), protected the CD4(+) T cells from tumor-induced apoptosis. In fact, nifetepimine-mediated restoration of PKC activity resulted in nuclear translocation of p65NF kappa B, thereby ensuring its survival. Studies further undertaken in a tumor-bearing mice model revalidated the immunoprotective role of nifetepimine. Our present study thus strongly suggests that imbalance in cellular calcium homeostasis is an important factor leading to CD4(+) T cell death during cancer and holds promise that nifetepimine may have the potential to be used as an immunorestoring agent in cancer bearers.	[Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Samik; Nandi, Pinki; Mohanty, Suchismita; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mukherjee, Sanhita; Sa, Gaurisankar; Das, Tanya; Sen, Parimal C.] Bose Inst, Div Mol Med, Calcutta Improvement Trust Scheme VIIM P1 12, Kolkata 700054, India; [Putatunda, Salil; Chakraborty, Arijit] Maulana Azad Coll, Dept Chem, Kolkata 700013, India; [Chakraborty, Srabasti] Behala Coll, Dept Chem, Kolkata 700060, India	Department of Science & Technology (India); Bose Institute	Sen, PC (corresponding author), Bose Inst, Div Mol Med, Calcutta Improvement Trust Scheme VIIM P1 12, Kolkata 700054, India.	parimal@bic.boseinst.ernet.in	Putatunda, Salil/O-1172-2017; Chakraborty, Supriya/GNP-4762-2022; Bhattacharjee, Pushpak/AFV-4590-2022; Chakraborty, Samik/Q-1779-2018; Chakraborty, Supriya/U-4306-2018	Putatunda, Salil/0000-0002-0244-3329; Chakraborty, Supriya/0000-0002-6517-0217; Chakraborty, Samik/0000-0002-5232-0474; Chakraborty, Supriya/0000-0002-0800-5792	Department of Science and Technology, Council of Scientific and Industrial Research, Department of Biotechnology, Government of India	Department of Science and Technology, Council of Scientific and Industrial Research, Department of Biotechnology, Government of India	This work was supported by the Department of Science and Technology, Council of Scientific and Industrial Research, Department of Biotechnology, Government of India.	ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Bhattacharyya A, 2004, CANCER LETT, V209, P147, DOI 10.1016/j.canlet.2003.12.025; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chaabane C, 2006, BIOCHEM BIOPH RES CO, V345, P1377, DOI 10.1016/j.bbrc.2006.05.054; Chattopadhyay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007382; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chin GM, 2006, MOL CANCER THER, V5, P2580, DOI 10.1158/1535-7163.MCT-06-0201; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dellis O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-59; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Falsone FS, 2001, ARKIVOC, V2, P1111; Finke J, 1999, IMMUNOL TODAY, V20, P158, DOI 10.1016/S0167-5699(98)01435-2; Gastman BR, 2000, BLOOD, V95, P2015, DOI 10.1182/blood.V95.6.2015; Gelebart P, 2002, J BIOL CHEM, V277, P26310, DOI 10.1074/jbc.M201747200; Gohain M, 2004, SYNLETT, P235, DOI 10.1055/s-2003-43374; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; Hadri L, 2002, J BIOL CHEM, V277, P36471, DOI 10.1074/jbc.M204731200; Higgins ER, 2006, BIOPHYS J, V91, P151, DOI 10.1529/biophysj.105.075747; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kappe CO, 1999, SYNTHESIS-STUTTGART, P1799; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; KLUCK RM, 1994, BBA-MOL CELL RES, V1223, P247, DOI 10.1016/0167-4889(94)90233-X; Launay S, 1997, J BIOL CHEM, V272, P10746; Mandal D, 2006, INT IMMUNOPHARMACOL, V6, P433, DOI 10.1016/j.intimp.2005.09.005; Mason RP, 1999, J AM COLL CARDIOL, V34, P1857, DOI 10.1016/S0735-1097(99)00447-7; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; Nielsen MB, 2000, CANCER CHEMOTH PHARM, V46, pS62, DOI 10.1007/PL00014052; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Real LM, 2001, CANCER IMMUNOL IMMUN, V49, P621, DOI 10.1007/s002620000154; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Salazar-Onfray F, 1999, MED ONCOL, V16, P86, DOI 10.1007/BF02785841; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Silberman DM, 2005, CELL MOL LIFE SCI, V62, P1744, DOI 10.1007/s00018-005-5058-7; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Szamel M, 1998, J IMMUNOL, V160, P2207; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; WUYTACK F, 1994, J BIOL CHEM, V269, P1410	50	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32881	32896		10.1074/jbc.M112.357889	http://dx.doi.org/10.1074/jbc.M112.357889			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851172	hybrid, Green Published			2022-12-28	WOS:000309168300054
J	Oda, M; Kabura, M; Takagishi, T; Suzue, A; Tominaga, K; Urano, S; Nagahama, M; Kobayashi, K; Furukawa, K; Furukawa, K; Sakurai, J				Oda, Masataka; Kabura, Michiko; Takagishi, Teruhisa; Suzue, Ayaka; Tominaga, Kaori; Urano, Shiori; Nagahama, Masahiro; Kobayashi, Keiko; Furukawa, Keiko; Furukawa, Koichi; Sakurai, Jun			Clostridium perfringens Alpha-toxin Recognizes the GM1a-TrkA Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING SITES; PHOSPHOLIPASE-C; BOTULINUM NEUROTOXIN; BIOLOGICAL-ACTIVITIES; GANGLIOSIDE GM1; PC12 CELLS; SHEEP ERYTHROCYTES; NEURITE-OUTGROWTH; ENDOTHELIAL-CELLS; CHOLERA-TOXIN	Clostridium perfringens alpha-toxin is the major virulence factor in the pathogenesis of gas gangrene. Alpha-toxin is a 43-kDa protein with two structural domains; the N-domain contains the catalytic site and coordinates the divalent metal ions, and the C-domain is a membrane-binding site. The role of the exposed loop region (72-93 residues) in the N-domain, however, has been unclear. Here we show that this loop contains a ganglioside binding motif (H center dot center dot center dot SXWY center dot center dot center dot G) that is the same motif seen in botulinum neurotoxin and directly binds to a specific conformation of the ganglioside Neu5Ac alpha 2-3(Gal beta 1-3GalNAc beta 1-4)Gal beta 1-4Glc beta 1Cer (GM1a) through a carbohydrate moiety. Confocal microscopy analysis using fluorescently labeled BODIPY-GM1a revealed that the toxin colocalized with GM1a and induced clustering of GM1a on the cell membranes. Alpha-toxin was only slightly toxic in beta 1,4-N-acetylgalactosaminyltransferase knock-out mice, which lack the a-series gangliosides that contain GM1a, but was highly toxic in alpha 2,8-sialyltransferase knock-out mice, which lack both b-series and c-series gangliosides, similar to the control mice. Moreover, experiments with site-directed mutants indicated that Trp-84 and Tyr-85 in the exposed alpha-toxin loop play an important role in the interaction with GM1a and subsequent activation of TrkA. These results suggest that binding of alphatoxin to GM1a facilitates the activation of the TrkA receptor and induces a signal transduction cascade that promotes the release of chemokines. Therefore, we conclude that GM1a is the primary cellular receptor for alpha-toxin, which can be a potential target for drug developed against this pathogen.	[Oda, Masataka; Kabura, Michiko; Takagishi, Teruhisa; Suzue, Ayaka; Tominaga, Kaori; Urano, Shiori; Nagahama, Masahiro; Kobayashi, Keiko; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan; [Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 466, Japan	Tokushima Bunri University; Nagoya University	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan.	masa@ph.bunri-u.ac.jp	Oda, Masataka/ABG-6047-2020		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government [21790431]; MEXT-supported Program for the Strategic Research Foundation at Private Universities [S0801078]; Grants-in-Aid for Scientific Research [23590526] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 21790431 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government and MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (S0801078).	Alape-Giron A, 2000, EUR J BIOCHEM, V267, P5191, DOI 10.1046/j.1432-1327.2000.01588.x; Arimitsu H, 2009, PROTEIN EXPRES PURIF, V67, P96, DOI 10.1016/j.pep.2009.04.011; Bryant AE, 1996, INFECT IMMUN, V64, P358, DOI 10.1128/IAI.64.1.358-362.1996; Bunting M, 1997, J CLIN INVEST, V100, P565, DOI 10.1172/JCI119566; Clark GC, 2003, J MOL BIOL, V333, P759, DOI 10.1016/j.jmb.2003.07.016; Duchemin AM, 2002, J NEUROCHEM, V81, P696, DOI 10.1046/j.1471-4159.2002.00831.x; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Flores-Diaz M, 2005, J BIOL CHEM, V280, P26680, DOI 10.1074/jbc.M500278200; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Holmgren J, 1980, Adv Exp Med Biol, V125, P453; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Jepson M, 2001, FEBS LETT, V495, P172, DOI 10.1016/S0014-5793(01)02385-7; Jepson M, 1999, INFECT IMMUN, V67, P3297, DOI 10.1128/IAI.67.7.3297-3301.1999; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Kitamura M, 2005, BBA-MOL BASIS DIS, V1741, P1, DOI 10.1016/j.bbadis.2005.04.005; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Mutoh T, 2000, GLYCOCONJUGATE J, V17, P233, DOI 10.1023/A:1026597408790; Mutoh T, 1998, J BIOL CHEM, V273, P26001, DOI 10.1074/jbc.273.40.26001; NAGAHAMA M, 1995, J BACTERIOL, V177, P1179, DOI 10.1128/jb.177.5.1179-1185.1995; Nagahama M, 2002, MICROBIOL IMMUNOL, V46, P647, DOI 10.1111/j.1348-0421.2002.tb02748.x; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Ochi S, 2002, MICROBIOL-SGM, V148, P237, DOI 10.1099/00221287-148-1-237; Oda M, 2006, INFECT IMMUN, V74, P2876, DOI 10.1128/IAI.74.5.2876-2886.2006; Oda M, 2008, J PHARMACOL EXP THER, V327, P934, DOI 10.1124/jpet.108.143677; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2012, BBA-MOL BASIS DIS, V1822, P1581, DOI 10.1016/j.bbadis.2012.06.007; Oda M, 2011, BIOCHEM BIOPH RES CO, V411, P241, DOI 10.1016/j.bbrc.2011.06.103; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Pitto M, 1998, FEBS LETT, V439, P93, DOI 10.1016/S0014-5793(98)01344-1; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P2618, DOI 10.1016/j.bbamem.2011.06.008; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Walker N, 2000, ARCH BIOCHEM BIOPHYS, V384, P24, DOI 10.1006/abbi.2000.2065; Yamazaki Y, 2007, BIOCHEM J, V407, P31, DOI 10.1042/BJ20070090	51	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33070	33079		10.1074/jbc.M112.393801	http://dx.doi.org/10.1074/jbc.M112.393801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22847002	Green Published, hybrid			2022-12-28	WOS:000309168300069
J	Watanabe, S; Morimoto, D; Fukumori, F; Shinomiya, H; Nishiwaki, H; Kawano-Kawada, M; Sasai, Y; Tozawa, Y; Watanabe, Y				Watanabe, Seiya; Morimoto, Daichi; Fukumori, Fumiyasu; Shinomiya, Hiroto; Nishiwaki, Hisashi; Kawano-Kawada, Miyuki; Sasai, Yuuki; Tozawa, Yuzuru; Watanabe, Yasuo			Identification and Characterization of D-Hydroxyproline Dehydrogenase and Delta(1)-Pyrroline-4-hydroxy-2-carboxylate Deaminase Involved in Novel L-Hydroxyproline Metabolism of Bacteria METABOLIC CONVERGENT EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-PROLINE DEHYDROGENASE; AMINO-ACID DEHYDROGENASE; CRYSTAL-STRUCTURE; ALTERNATIVE PATHWAY; D-GLUCARATE; GENE; PROTEINS; INSIGHT; OXIDASE; DEHYDRATASE	L-Hydroxyproline (4-hydroxyproline) mainly exists in collagen, and most bacteria cannot metabolize this hydroxyamino acid. Pseudomonas putida and Pseudomonas aeruginosa convert L-hydroxyproline to alpha-ketoglutarate via four hypothetical enzymatic steps different from known mammalian pathways, but the molecular background is rather unclear. Here, we identified and characterized for the first time two novel enzymes, D-hydroxyproline dehydrogenase and Delta(1)-pyrroline-4-hydroxy-2-carboxylate (Pyr4H2C) deaminase, involved in this hypothetical pathway. These genes were clustered together with genes encoding other catalytic enzymes on the bacterial genomes. D-Hydroxyproline dehydrogenases from P. putida and P. aeruginosa were completely different from known bacterial proline dehydrogenases and showed similar high specificity for substrate (D-hydroxyproline) and some artificial electron acceptor( s). On the other hand, the former is a homomeric enzyme only containing FAD as a prosthetic group, whereas the latter is a novel heterododecameric structure consisting of three different subunits (alpha(4)beta(4)gamma(4)), and two FADs, FMN, and [2Fe-2S] iron-sulfur cluster were contained in alpha beta gamma of the heterotrimeric unit. These results suggested that the L-hydroxyproline pathway clearly evolved convergently in P. putida and P. aeruginosa. Pyr4H2C deaminase is a unique member of the dihydrodipicolinate synthase/N-acetylneuraminate lyase protein family, and its activity was competitively inhibited by pyruvate, a common substrate for other dihydrodipicolinate synthase/N-acetylneuraminate lyase proteins. Furthermore, disruption of Pyr4H2C deaminase genes led to loss of growth on L-hydroxyproline (as well as D-hydroxyproline) but not L-and D-proline, indicating that this pathway is related only to L-hydroxyproline degradation, which is not linked to proline metabolism.	[Watanabe, Seiya; Morimoto, Daichi; Nishiwaki, Hisashi; Kawano-Kawada, Miyuki; Sasai, Yuuki; Watanabe, Yasuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Kawano-Kawada, Miyuki] Ehime Univ, Integrated Ctr Sci INCS, Matsuyama, Ehime 7908566, Japan; [Fukumori, Fumiyasu] Toyo Univ, Fac Life Sci, Itakura, Gunma 3740193, Japan; [Shinomiya, Hiroto] Ehime Prefectural Inst Publ Hlth & Environm Sci, Matsuyama, Ehime 7900003, Japan; [Tozawa, Yuzuru] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Ehime University; Ehime University; Toyo University; Ehime University	Watanabe, S (corresponding author), Ehime Univ, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 7908566, Japan.	irab@agr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020	Tozawa, Yuzuru/0000-0002-3885-1105; KAWANO-KAWADA, Miyuki/0000-0002-1168-9291	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18760592]; JGC-S Scholarship Foundation; Nippon Life Insurance Foundation; Asahi Glass Foundation; Takahashi Industrial and Economic Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JGC-S Scholarship Foundation; Nippon Life Insurance Foundation(Nippon Life Insurance Foundation); Asahi Glass Foundation; Takahashi Industrial and Economic Research Foundation	This work was supported in part by a Grant-in-aid for Young Scientists (B) 18760592 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. W.), a JGC-S Scholarship Foundation (to S. W.), the Nippon Life Insurance Foundation (to S. W.), the Asahi Glass Foundation (to S. W.), and the Takahashi Industrial and Economic Research Foundation (to S. W.).	ADAMS E, 1960, J BIOL CHEM, V235, P3499; Aghaie A, 2008, J BIOL CHEM, V283, P15638, DOI 10.1074/jbc.M800487200; BATER AJ, 1977, ARCH MICROBIOL, V112, P287, DOI 10.1007/BF00413094; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Cooper SK, 2008, J BIOL CHEM, V283, P10485, DOI 10.1074/jbc.M702181200; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GRYDER RM, 1969, J BACTERIOL, V97, P292, DOI 10.1128/JB.97.1.292-306.1969; HEACOCK AM, 1975, J BIOL CHEM, V250, P2599; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; Kobayashi Y, 2011, ENVIRON MICROBIOL, V13, P2007, DOI 10.1111/j.1462-2920.2010.02344.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manoharan H. T., 1980, J BIOSCIENCE, V2, P107; Pollegioni L, 2004, BIOTECHNOL PROGR, V20, P467, DOI 10.1021/bp034206q; Riedel TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026021; Sambrook J., 2001, MOL CLONING LAB MANU; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Satomura T, 2011, APPL MICROBIOL BIOT, V89, P1075, DOI 10.1007/s00253-010-2914-7; Shibasaki T, 1999, APPL ENVIRON MICROB, V65, P4028; SINGH RMM, 1965, J BIOL CHEM, V240, P4344; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; TA DT, 1992, J BIOL CHEM, V267, P11120; Tanigawa M, 2010, AMINO ACIDS, V38, P247, DOI 10.1007/s00726-009-0240-0; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; YONEYA T, 1961, J BIOL CHEM, V236, P3272; ZANKER H, 1994, J BACTERIOL, V176, P4511, DOI 10.1128/JB.176.15.4511-4517.1994	39	31	32	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32674	32688		10.1074/jbc.M112.374272	http://dx.doi.org/10.1074/jbc.M112.374272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833679	Green Published, hybrid			2022-12-28	WOS:000309168300035
J	Zhou, LQ; Wu, J; Wang, WT; Yu, W; Zhao, GN; Zhang, P; Xiong, J; Li, M; Xue, Z; Wang, X; Xie, XM; Guo, ZC; Lv, X; Liu, DP				Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei			The AT-rich DNA-binding Protein SATB2 Promotes Expression and Physical Association of Human (G)gamma- and (A)gamma-Globin Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; ERYTHROID-DIFFERENTIATION; ACTIVE CHROMATIN; NUCLEAR-MATRIX; GAMMA-PE; SITES; ORGANIZATION; INTERACTS; REQUIRES; ELEMENTS	Matrix attachment region (MAR)-binding protein (MARBP) has profound influence on gene transcriptional control by tethering genes to the nuclear scaffold. MARBP SATB2 is recently known as a versatile regulator functioning in the differentiation of multiple cell types including embryonic stem cells, osteoblasts and immunocytes. Roles of SATB2 in erythroid cells and its working mechanism in orchestrating target gene expression are largely unexplored. We show here that SATB2 is expressed in erythroid cells and activates gamma-globin genes by binding to MARs in their promoters and recruiting histone acetylase PCAF. Further analysis in higher-order chromatin structure shows that SATB2 affects physical proximity of human (G)gamma- and (A)gamma-globin promoters via self-association. We also found that SATB2 interacts with SATB1, which specifically activates epsilon-globin gene expression. Our results establish SATB2 as a novel gamma-globin gene regulator and provide a glimpse of the differential and cooperative roles of SATB family proteins in modulating clustered genes transcription and mediating higher-order chromatin structures.	[Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhou, Li-Quan; Wu, Jie; Wang, Wen-Tian; Yu, Wei; Zhao, Guang-Nian; Zhang, Peng; Xiong, Jian; Li, Man; Xue, Zheng; Wang, Xing; Xie, Xue-Min; Guo, Zhi-Chen; Lv, Xiang; Liu, De-Pei] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, X (corresponding author), Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.	lvxiang99@yahoo.com.cn; liudp@pumc.edu.cn		Liu, De-Pei/0000-0002-2636-4297; Zhou, Li-quan/0000-0002-9332-9408	National Natural Science Foundation of China [31030026, 31021091]; National Basic Research Program [2011CB964803, 2011CB965203]; National Laboratory of Medical Molecular Biology [2060204]; Beijing municipal government [YB20081002301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Laboratory of Medical Molecular Biology; Beijing municipal government	This work was supported by the National Natural Science Foundation of China (Grant 31030026), the National Basic Research Program (Grants 2011CB964803 and 2011CB965203), the National Natural Science Foundation of China (Grant 31021091), the National Laboratory of Medical Molecular Biology (Grant 2060204), and Grant YB20081002301 from the Beijing municipal government.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Case SS, 1999, DNA CELL BIOL, V18, P805, DOI 10.1089/104454999314809; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gong H, 2009, BIOCHEM BIOPH RES CO, V383, P11, DOI 10.1016/j.bbrc.2009.03.122; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; JACKSON CE, 1995, J BIOL CHEM, V270, P28448; LLOYD JA, 1994, J BIOL CHEM, V269, P19385; Lopez RA, 2002, P NATL ACAD SCI USA, V99, P602, DOI 10.1073/pnas.022412699; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004629; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Xue Z, 2012, NUCLEIC ACIDS RES, V40, P4804, DOI 10.1093/nar/gks064; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhao Q, 2004, J BIOL CHEM, V279, P41477, DOI 10.1074/jbc.M405129200; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	37	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30641	30652		10.1074/jbc.M112.355271	http://dx.doi.org/10.1074/jbc.M112.355271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22825848	Green Published, hybrid			2022-12-28	WOS:000308579800054
J	Basit, F; Humphreys, R; Fulda, S				Basit, Farhan; Humphreys, Robin; Fulda, Simone			RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; KAPPA-B ACTIVATION; TESTING STAGE 1; CANCER-CELLS; ALPHA; ANTAGONISTS; XIAP; RIPOPTOSOME; CASPASE-8	Searching for new strategies to trigger apoptosis in rhabdomyosarcoma (RMS), we investigated the effect of two novel classes of apoptosis-targeting agents, i.e. monoclonal antibodies against TNF-related apoptosis-inducing ligand (TRAIL) receptor 1 (mapatumumab) and TRAIL receptor 2 (lexatumumab) and small-molecule inhibitors of inhibitor of apoptosis (IAP) proteins. Here, we report that IAP inhibitors synergized with lexatumumab, but not with mapatumumab, to reduce cell viability and to induce apoptosis in several RMS cell lines in a highly synergistic manner (combination index <0.1). Cotreatment-induced apoptosis was accompanied by enhanced activation of caspase-8, -9, and -3; loss of mitochondrial membrane potential; and caspase-dependent apoptosis. In addition, IAP inhibitor and lexatumumab cooperated to stimulate the assembly of a cytosolic complex containing RIP1, FADD, and caspase-8. Importantly, knockdown of RIP1 by RNA interference prevented the formation of the RIP1.FADD.caspase-8 complex and inhibited subsequent activation of caspase-8, -9, and -3; loss of mitochondrial membrane potential; and apoptosis upon treatment with IAP inhibitor and lexatumumab. In addition, RIP1 silencing rescued clonogenic survival of cells treated with the combination of lexatumumab and IAP inhibitor, thus underscoring the critical role of RIP1 in cotreatment-induced apoptosis. By comparison, the TNF alpha-blocking antibody Enbrel had no effect on IAP inhibitor/lexatumumab-induced apoptosis, indicating that an autocrine TNF alpha loop is dispensable. By demonstrating that IAP inhibitors and lexatumumab synergistically trigger apoptosis in a RIP1-dependent but TNF alpha-independent manner in RMS cells, our findings substantially advance our understanding of IAP inhibitor-mediated regulation of TRAIL-induced cell death.	[Basit, Farhan; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Humphreys, Robin] Human Genome Sci Inc, Oncol Res Dept, Rockville, MD 20850 USA	Goethe University Frankfurt; GlaxoSmithKline; Human Genome Sciences Inc	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe; Federal Minisrty of Education and Research [01GM0871, 01GM1104C]	Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Minisrty of Education and Research	This work was supported in part by grants from the Deutsche Krebshilfe and the Federal Minisrty of Education and Research (01GM0871 and 01GM1104C) (to S.F.).	Abhari B. A., 2012, ONCOGENE IN PRESS; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; CHAO B, 2006, Patent No. 2005024700; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Dagher R, 1999, Oncologist, V4, P34; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fox NL, 2010, EXPERT OPIN BIOL TH, V10, P1, DOI 10.1517/14712590903319656; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7; Kang ZG, 2011, CLIN CANCER RES, V17, P3181, DOI 10.1158/1078-0432.CCR-10-2874; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Loeder S, 2009, CANCER RES, V69, P8977, DOI 10.1158/0008-5472.CAN-09-2604; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Smith MA, 2010, PEDIATR BLOOD CANCER, V54, P307, DOI 10.1002/pbc.22188; Stadel D, 2010, CLIN CANCER RES, V16, P5734, DOI 10.1158/1078-0432.CCR-10-0985; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	38	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38767	38777		10.1074/jbc.M112.398966	http://dx.doi.org/10.1074/jbc.M112.398966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22927431	Green Published, hybrid			2022-12-28	WOS:000310982800034
J	Shao, HJ; Lee, S; Gae-Scott, S; Nakata, C; Chen, SJ; Hamad, AR; Chakravarti, S				Shao, HanJuan; Lee, Seakwoo; Gae-Scott, Sherri; Nakata, Chiaki; Chen, Shoujun; Hamad, Abdel R.; Chakravarti, Shukti			Extracellular Matrix Lumican Promotes Bacterial Phagocytosis, and Lum(-/-) Mice Show Increased Pseudomonas aeruginosa Lung Infection Severity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEINS; GRAM-NEGATIVE BACTERIA; COLLAGEN FIBRILLOGENESIS; PHAGOSOME MATURATION; CORNEAL OPACITY; EXPRESSION; PROTEOGLYCAN; FIBROMODULIN; DECORIN; LPS	Phagocytosis is central to bacterial clearance, but the exact mechanism is incompletely understood. Here, we show a novel and critical role for lumican, the connective tissue extracellular matrix small leucine-rich repeat proteoglycan, in CD14-mediated bacterial phagocytosis. In Psuedomonas aeruginosa lung infections, lumican-deficient (Lum(-/-)) mice failed to clear the bacterium from lungs, tissues, and showed a dramatic increase in mortality. In vitro, phagocytosis of nonopsonized Gram-negative Escherichia coli and P. aeruginosa was inhibited in Lum(-/-) peritoneal macrophages (M Phi s). Lumican co-localized with CD14, CD18, and bacteria on Lum(+/+) M Phi surfaces. Using two different P. aeruginosa strains that require host CD14 (808) or CD18/CR3 (P1) for phagocytosis, we showed that lumican has a larger role in CD14-mediated phagocytosis. Recombinant lumican (rLum) restored phagocytosis in Lum(-/-) M Phi s. Surface plasmon resonance showed specific binding of rLum to CD14 (K-A = 2.15 x 10(6) M-1), whereas rLumY20A, and not rLumY21A, where a tyrosine in each was replaced with an alanine, showed 60-fold decreased binding. The rLumY20A variant also failed to restore phagocytosis in Lum(-/-) M Phi s, indicating Tyr-20 to be functionally important. Thus, in addition to a structural role in connective tissues, lumican has a major protective role in Gram-negative bacterial infections, a novel function for small leucine-rich repeat proteoglycans.	[Shao, HanJuan; Lee, Seakwoo; Gae-Scott, Sherri; Chakravarti, Shukti] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Nakata, Chiaki; Hamad, Abdel R.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Dept Ophthalmol, Sch Med, Baltimore, MD 21205 USA; [Chen, Shoujun] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL 33612 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of South Florida	Chakravarti, S (corresponding author), Johns Hopkins Univ, Dept Med, Sch Med, 720 Rutland Ave, Baltimore, MD 21205 USA.	schakra1@jhmi.edu			National Institutes of Health [NEI EY11654]; NATIONAL EYE INSTITUTE [R01EY011654, R56EY011654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant NEI EY11654 (to S. C).	Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; Grunwald U, 1996, J IMMUNOL, V157, P4119; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Heale JP, 2001, J INFECT DIS, V183, P1214, DOI 10.1086/319685; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; Lambiase A, 2009, NEW MICROBIOL, V32, P277; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Leygue E, 2000, J PATHOL, V192, P313; Lu YP, 2002, PATHOL INT, V52, P519, DOI 10.1046/j.1440-1827.2002.01384.x; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Naito Z, 2002, INT J ONCOL, V20, P943; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pagani L, 2005, J CLIN MICROBIOL, V43, P3824, DOI 10.1128/JCM.43.8.3824-3828.2005; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROUGHLEY PJ, 1994, MICROSC RES TECHNIQ, V28, P385, DOI 10.1002/jemt.1070280505; Safdar A, 2009, EXPERT OPIN DRUG SAF, V8, P435, DOI 10.1517/14740330903036083; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Sztrolovics R, 1999, SPINE, V24, P1765, DOI 10.1097/00007632-199909010-00003; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Troup S, 2003, CLIN CANCER RES, V9, P207; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056	50	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35860	35872		10.1074/jbc.M112.380550	http://dx.doi.org/10.1074/jbc.M112.380550			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22865855	Green Published, hybrid			2022-12-28	WOS:000310364000009
J	Wong, A; Zhang, YW; Jeschke, GR; Turk, BE; Rudnick, G				Wong, Albert; Zhang, Yuan-Wei; Jeschke, Grace R.; Turk, Benjamin E.; Rudnick, Gary			Cyclic GMP-dependent Stimulation of Serotonin Transport Does Not Involve Direct Transporter Phosphorylation by cGMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; SUBSTRATE; SPECIFICITY; TRAFFICKING; MODULATION; ACTIVATION	The serotonin transporter (SERT) is responsible for reuptake of serotonin (5-hydroxytryptamine) after its exocytotic release from neurons. It is the primary target for antidepressants and stimulants, including "ecstasy" (3,4-methylenedioxymethamphetamine). SERT is regulated by several processes, including a cyclic GMP signaling pathway involving nitric oxide synthase, guanylyl cyclase, and cGMP-dependent protein kinase (PKG). Here, we show that SERT was phosphorylated in a PKG I alpha-dependent manner in vitro, but that SERT was not a direct substrate of PKG. We generated an analog-sensitive gatekeeper residue mutant of PKG I alpha (M438G) that efficiently used the ATP analog N-6-benzyl-ATP. This mutant, but not the wild type (WT) kinase, used the ATP analog to phosphorylate both a model peptide substrate as well as an established protein substrate of PKG (vasodilator-stimulated phosphoprotein). PKG I alpha M438G effectively substituted for the WT kinase in stimulating SERT-mediated 5-hydroxytryptamine transport in cultured cells. Addition of either WT or mutant PKG I alpha M438G to membranes containing SERT in vitro led to radiolabel incorporation from [gamma-P-33]ATP but not from similarly labeled N-6-benzyl-ATP, indicating that SERT was phosphorylated by another kinase that could not utilize the ATP analog. These results are consistent with the proposed SERT phosphorylation site, Thr-276, being highly divergent from the consensus PKG phosphorylation site sequence, which we verified through peptide library screening. Another proposed SERT kinase, the p38 mitogen-activated protein kinase, could not substitute for PKG in this assay, and p38 inhibitors did not block PKG-dependent phosphorylation of SERT. The results suggest that PKG initiates a kinase cascade that leads to phosphorylation of SERT by an as yet unidentified protein kinase.	[Wong, Albert; Zhang, Yuan-Wei; Jeschke, Grace R.; Turk, Benjamin E.; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251; Jeschke, Grace/0000-0001-6271-7750	National Institutes of Health from the USPHS [R01 DA008213, R01 GM079498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 DA008213 (to G. R.) and R01 GM079498 (to B. E. T.) from the USPHS.	Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bauman AL, 2000, J NEUROSCI, V20, P7571; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Boyle SN, 2007, BIOCHEMISTRY-US, V46, P11614, DOI 10.1021/bi701119s; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Kilic F, 2003, MOL PHARMACOL, V64, P440, DOI 10.1124/mol.64.2.440; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007; Zhang YW, 2011, J BIOL CHEM, V286, P2461, DOI 10.1074/jbc.M110.203935; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	33	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36051	36058		10.1074/jbc.M112.394726	http://dx.doi.org/10.1074/jbc.M112.394726			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942288	Green Published, hybrid			2022-12-28	WOS:000310364000027
J	Wurzburg, BA; Kim, B; Tarchevskaya, SS; Eggel, A; Vogel, M; Jardetzky, TS				Wurzburg, Beth A.; Kim, Beomkyu; Tarchevskaya, Svetlana S.; Eggel, Alexander; Vogel, Monique; Jardetzky, Theodore S.			An Engineered Disulfide Bond Reversibly Traps the IgE-Fc(3-4) in a Closed, Nonreceptor Binding Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-E; HUMAN IGE; ANTIIMMUNOGLOBULIN-E; REVEALS; ASTHMA; FLEXIBILITY; INHIBITION	IgE antibodies interact with the high affinity IgE Fc receptor, Fc epsilon RI, and activate inflammatory pathways associated with the allergic response. The IgE-Fc region, comprising the C-terminal domains of the IgE heavy chain, binds Fc epsilon RI and can adopt different conformations ranging from a closed form incompatible with receptor binding to an open, receptor-bound state. A number of intermediate states are also observed in different IgE-Fc crystal forms. To further explore this apparent IgE-Fc conformational flexibility and to potentially trap a closed, inactive state, we generated a series of disulfide bond mutants. Here we describe the structure and biochemical properties of an IgE-Fc mutant that is trapped in the closed, non-receptor binding state via an engineered disulfide at residue 335 (Cys-335). Reduction of the disulfide at Cys-335 restores the ability of IgE-Fc to bind to its high affinity receptor, Fc epsilon RI alpha. The structure of the Cys-335 mutant shows that its conformation is within the range of previously observed, closed form IgE-Fc structures and that it retains the hydrophobic pocket found in the hinge region of the closed conformation. Locking the IgE-Fc into the closed state with the Cys-335 mutation does not affect binding of two other IgE-Fc ligands, omalizumab and DARP in E2_79, demonstrating selective blocking of the high affinity receptor binding.	[Wurzburg, Beth A.; Kim, Beomkyu; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Eggel, Alexander; Vogel, Monique] Univ Bern, Inst Immunol, Bern, Switzerland	Stanford University; University of Bern	Jardetzky, TS (corresponding author), Gilbert Biol Sci Bldg,371 Serra Mall,Rm 2, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Kim, Beomkyu/AAM-7220-2020; Eggel, Alexander/J-8177-2019	Eggel, Alexander/0000-0001-8746-3339	National Institutes of Health [AI-18939]; American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018939, R01AI018939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-18939 (to T. S. J.). This work was also supported by an American Asthma Foundation Senior Investigator Award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnes PJ, 2006, PHARMACOL THERAPEUT, V109, P238, DOI 10.1016/j.pharmthera.2005.08.001; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; Berger WE, 2006, ALLERGY ASTHMA PROC, V27, pS29; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowak D, 2006, RESP MED, V100, P1907, DOI 10.1016/j.rmed.2005.10.004; Owen CE, 2007, PHARMACOL THERAPEUT, V113, P121, DOI 10.1016/j.pharmthera.2006.07.003; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Vogel M, 2007, ANN NY ACAD SCI, V1109, P9, DOI 10.1196/annals.1398.002; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2002, MOL IMMUNOL, V38, P1063, DOI 10.1016/S0161-5890(02)00035-4; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	32	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36251	36257		10.1074/jbc.M112.407502	http://dx.doi.org/10.1074/jbc.M112.407502			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948141	Green Published, hybrid			2022-12-28	WOS:000310364000046
J	Wei, WJ; Sun, HY; Ting, KY; Zhang, LH; Lee, HC; Li, GR; Yue, JB				Wei, Wen-Jie; Sun, Hai-Ying; Ting, Kai Yiu; Zhang, Li-He; Lee, Hon-Cheung; Li, Gui-Rong; Yue, Jianbo			Inhibition of Cardiomyocytes Differentiation of Mouse Embryonic Stem Cells by CD38/cADPR/Ca2+ Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; RECEPTOR; CARDIOGENESIS; CALRETICULIN; ACTIVATION; TRANSIENT; CHANNELS; MYOCYTES; MICE; BMP	Cyclic adenosine diphosphoribose ( cADPR) is an endogenous Ca2+ mobilizing messenger that is formed by ADP-ribosyl cyclases from nicotinamide adenine dinucleotide (NAD). The main ADP-ribosyl cyclase in mammals is CD38, a multi-functional enzyme and a type II membrane protein. Here we explored the role of CD38-cADPR-Ca2+ in the cardiomyogenesis of mouse embryonic stem (ES) cells. We found that the mouse ES cells are responsive to cADPR and possess the key components of the cADPR signaling pathway. In vitro cardiomyocyte (CM) differentiation of mouse ES cells was initiated by embryoid body (EB) formation. Interestingly, beating cells appeared earlier and were more abundant in CD38 knockdown EBs than in control EBs. Real-time RT-PCR and Western blot analyses further showed that the expression of several cardiac markers, including GATA4, MEF2C, NKX2.5, and alpha-MLC, were increased markedly in CD38 knockdown EBs than those in control EBs. Similarly, FACS analysis showed that more cardiac Troponin T-positive CMs existed in CD38 knockdown or 8-Br-cADPR, a cADPR antagonist, treated EBs compared with that in control EBs. On the other hand, overexpression of CD38 in mouse ES cells significantly inhibited CM differentiation. Moreover, CD38 knockdown ES cell-derived CMs possess the functional properties characteristic of normal ES cell-derived CMs. Last, we showed that the CD38-cADPR pathway negatively modulated the FGF4-Erks1/2 cascade during CM differentiation of ES cells, and transiently inhibition of Erk1/2 blocked the enhanced effects of CD38 knockdown on the differentiation of CM from ES cells. Taken together, our data indicate that the CD38-cADPR-Ca2+ signaling pathway antagonizes the CM differentiation of mouse ES cells.	[Wei, Wen-Jie; Sun, Hai-Ying; Ting, Kai Yiu; Lee, Hon-Cheung; Li, Gui-Rong; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Li-He] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	University of Hong Kong; Peking University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	, 李贵荣（沧海一粟）/AAZ-4335-2020; Li, Gui-Rong/C-4341-2009; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	, 李贵荣（沧海一粟）/0000-0002-9437-2280; Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong [N_HKU 737/09]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) Grants HKU 784710M, HKU 782709M, HKU 785911M, a National Natural Science Foundation of China (NSFC)/RGC Grant from Hong Kong (N_HKU 737/09) and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	Apati A, 2012, MOL CELL ENDOCRINOL, V353, P57, DOI 10.1016/j.mce.2011.08.038; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Creton R, 2000, DEV BIOL, V217, P375, DOI 10.1006/dbio.1999.9542; Farokhpour M, 2009, TOXICOL IN VITRO, V23, P1422, DOI 10.1016/j.tiv.2009.07.008; Galione A, 2000, Sci STKE, V2000, ppe1; Galione Antony, 1998, Cell Biochemistry and Biophysics, V28, P19, DOI 10.1007/BF02738307; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Itzhaki I, 2006, ANN NY ACAD SCI, V1080, P207, DOI 10.1196/annals.1380.017; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; KUEMMERLE JF, 1995, J BIOL CHEM, V270, P25488, DOI 10.1074/jbc.270.43.25488; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Kwong AKY, 2012, BIOCHEMISTRY-US, V51, P555, DOI 10.1021/bi201509f; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li PL, 1997, ADV EXP MED BIOL, V419, P437; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lickteig K, 1996, MOL REPROD DEV, V44, P146, DOI 10.1002/(SICI)1098-2795(199606)44:2<146::AID-MRD2>3.0.CO;2-N; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mikoshiba K, 2011, CELL CALCIUM, V49, P331, DOI 10.1016/j.ceca.2010.12.006; Moorman AFM, 2004, ANN NY ACAD SCI, V1015, P171, DOI 10.1196/annals.1302.014; Munoz-Chapuli R, 2010, J CARDIOVASC TRANSL, V3, P37, DOI 10.1007/s12265-009-9146-1; MURTHY KS, 1995, AM J PHYSIOL-GASTR L, V269, pG93, DOI 10.1152/ajpgi.1995.269.1.G93; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pandur P, 2005, BIOL CELL, V97, P197; Papp S, 2009, STEM CELLS, V27, P1507, DOI 10.1002/stem.85; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Quattrocelli M, 2011, J CELL BIOCHEM, V112, P2006, DOI 10.1002/jcb.23118; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; Sarkar Prasenjit, 2009, Critical Reviews in Biomedical Engineering, V37, P283, DOI 10.1615/CritRevBiomedEng.v37.i4-5.10; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Takahashi J, 2003, BIOCHEM BIOPH RES CO, V312, P434, DOI 10.1016/j.bbrc.2003.10.143; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zeevi-Levin N, 2010, CRIT REV EUKAR GENE, V20, P51, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.40; Zhang F, 2008, CELL SIGNAL, V20, P637, DOI 10.1016/j.cellsig.2007.11.013; Zhang G, 2006, AM J PHYSIOL-HEART C, V290, pH1172, DOI 10.1152/ajpheart.00441.2005; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhu XL, 1996, DEV DYNAM, V207, P429, DOI 10.1002/(SICI)1097-0177(199612)207:4<429::AID-AJA7>3.0.CO;2-J	59	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35599	35611		10.1074/jbc.M112.392530	http://dx.doi.org/10.1074/jbc.M112.392530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908234	hybrid, Green Published			2022-12-28	WOS:000309968000072
J	Carpenter, MA; Li, M; Rathore, A; Lackey, L; Law, EK; Land, AM; Leonard, B; Shandilya, SMD; Bohn, MF; Schiffer, CA; Brown, WL; Harris, RS				Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Shandilya, Shivender M. D.; Bohn, Markus-Frederik; Schiffer, Celia A.; Brown, William L.; Harris, Reuben S.			Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AID/APOBEC FAMILY; TET PROTEINS; AID; EXCISION; HYPERMUTATION; TISSUES; 5-METHYLCYTOSINE; DEMETHYLATION; RECOGNITION; METHYLATION	Multiple studies have indicated that the TET oxidases and, more controversially, the activation-induced cytidine deaminase/APOBEC deaminases have the capacity to convert genomic DNA5-methylcytosine (MeC) into altered nucleobases that provoke excision repair and culminate in the replacement of the original MeC with a normal cytosine (C). We show that human APOBEC3A (A3A) efficiently deaminates both MeC to thymine (T) and normal C to uracil (U) in single-stranded DNA substrates. In comparison, the related enzyme APOBEC3G (A3G) has undetectable MeC to T activity and 10-fold less C to U activity. Upon 100-fold induction of endogenous A3A by interferon, the MeC status of bulk chromosomal DNA is unaltered, whereas both MeC and C nucleobases in transfected plasmid DNA substrates are highly susceptible to editing. Knockdown experiments show that endogenous A3A is the source of both of these cellular DNA deaminase activities. This is the first evidence for nonchromosomal DNA MeC to T editing in human cells. These biochemical and cellular data combine to suggest a model in which the expanded substrate versatility of A3A may be an evolutionary adaptation that occurred to fortify its innate immune function in foreign DNA clearance by myeloid lineage cell types.	[Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Minneapolis, MN 55455 USA; [Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Shandilya, Shivender M. D.; Bohn, Markus-Frederik; Schiffer, Celia A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu	Shandilya, Shivender/D-8451-2013; Brown, William/GXN-2777-2022	Shandilya, Shivender/0000-0002-2479-2087; Bohn, Markus-Frederik/0000-0002-0369-1922; Carpenter, Michael/0000-0001-9524-5323; Lackey, Lela/0000-0003-2163-4005	National Institutes of Health [R01 AI064046, P01 GM091743, T32 AI083196]; University of Minnesota Academic Health Center [11.54]; Institutes of Health [T32 DE07288]; National Science Foundation; Canadian Institute of Health;  [F32 GM095219]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, F32GM095219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Institutes of Health(National Health Research Institutes - Taiwan); National Science Foundation(National Science Foundation (NSF)); Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064046 and P01 GM091743. This work was also supported by Seed Grant 11.54 from the University of Minnesota Academic Health Center.; Supported by Institutes of Health Grant T32 DE07288 and subsequently Grant F32 GM095219.; Supported in part by an National Science Foundation predoctoral fellowship and a position with the Molecular Virology Training Grant T32 AI083196 from the National Institutes of Health.; Supported by a Canadian Institute of Health Research Postdoctoral Fellowship.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Wijesinghe P., 2012, NUCL ACIDS IN PRESS; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	49	101	106	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34801	34808		10.1074/jbc.M112.385161	http://dx.doi.org/10.1074/jbc.M112.385161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896697	Green Published, hybrid			2022-12-28	WOS:000309654200079
J	Ikeda, Y; Aihara, K; Yoshida, S; Iwase, T; Tajima, S; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Tomita, S; Tsuchiya, K; Sata, M; Akaike, M; Kato, S; Matsumoto, T; Tamaki, T				Ikeda, Yasumasa; Aihara, Ken-ichi; Yoshida, Sumiko; Iwase, Takashi; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Tomita, Shuhei; Tsuchiya, Koichiro; Sata, Masataka; Akaike, Masashi; Kato, Shigeaki; Matsumoto, Toshio; Tamaki, Toshiaki			Heparin Cofactor II, a Serine Protease Inhibitor, Promotes Angiogenesis via Activation of the AMP-activated Protein Kinase-Endothelial Nitric-oxide Synthase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-INDUCED ANGIOGENESIS; PERIPHERAL ARTERIAL-DISEASE; PROTECTIVE FACTOR; DERMATAN SULFATE; DEFICIENT MICE; THROMBIN; CELLS; PHOSPHORYLATION; ADIPONECTIN; PLASMA	We previously clarified that heparin cofactor II (HCII), a serine proteinase inhibitor, exerts various protective actions on cardiovascular diseases in both experimental and clinical studies. In the present study, we aimed to clarify whether HCII participates in the regulation of angiogenesis. Male heterozygous HCII-deficient (HCII+/-) mice and male littermate wild-type (HCII+/+) mice at the age of 12-16 weeks were subjected to unilateral hindlimb ligation surgery. Laser speckle blood flow analysis showed that blood flow recovery in response to hindlimb ischemia was delayed in HCII+/- mice compared with that in HCII+/+ mice. Capillary number, arteriole number, and endothelial nitric-oxide synthase (eNOS), AMP-activated protein kinase (AMPK), and liver kinase B1 (LKB1) phosphorylation in ischemic muscles were decreased in HCII+/- mice. Human purified HCII (h-HCII) administration almost restored blood flow recovery, capillary density, and arteriole number as well as phosphorylation levels of eNOS, AMPK, and LKB1 in ischemic muscles of HCII+/- mice. Although treatment with h-HCII increased phosphorylation levels of eNOS, AMPK, and LKB1 in human aortic endothelial cells (HAECs), the h-HCII-induced eNOS phosphorylation was abolished by compound C, an AMPK inhibitor, and by AMPK siRNA. In a similar fashion, tube formation, proliferation, and migration of HAECs were also promoted by h-HCII treatment and were abrogated by pretreatment with compound C. HCII potentiates the activation of vascular endothelial cells and the promotion of angiogenesis in response to hindlimb ischemia via an AMPK-eNOS signaling pathway. These findings suggest that HCII is a novel therapeutic target for treatment of patients with peripheral circulation insufficiency.	[Aihara, Ken-ichi; Yoshida, Sumiko; Matsumoto, Toshio] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan; [Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tomita, Shuhei; Tamaki, Toshiaki] Univ Tokushima, Grad Sch Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan; [Iwase, Takashi; Sata, Masataka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med Pharmacol, Tokushima 7708503, Japan; [Akaike, Masashi] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med Educ, Tokushima 7708503, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; University of Tokyo	Aihara, K (corresponding author), Univ Tokushima, Grad Sch Hlth Biosci, Dept Med & Bioregulatory Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	aihara@tokushima-u.ac.jp	Aihara, Ken-ichi/AEE-8245-2022	Aihara, Ken-ichi/0000-0001-8906-0920; Ikeda, Yasumasa/0000-0003-4318-7349	Grants-in-Aid for Scientific Research [22390159, 23790089, 24590381] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; Aihara K, 2007, J CLIN INVEST, V117, P1514, DOI 10.1172/JCI27095; Aihara K, 2009, J ATHEROSCLER THROMB, V16, P127, DOI 10.5551/jat.E695; Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Derian CK, 2002, BIOCHEMISTRY-MOSCOW+, V67, P56, DOI 10.1023/A:1013900130415; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084; Harris MB, 2004, AM J PHYSIOL-HEART C, V287, pH560, DOI 10.1152/ajpheart.00214.2004; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang PH, 2007, INT J CARDIOL, V114, P152, DOI 10.1016/j.ijcard.2005.12.009; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Ise T, 2011, HYPERTENS RES, V34, P225, DOI 10.1038/hr.2010.211; Izumi Y, 2009, HYPERTENS RES, V32, P675, DOI 10.1038/hr.2009.77; Kanagawa Y, 2001, THROMB HAEMOSTASIS, V85, P101, DOI 10.1055/s-0037-1612911; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li P, 2010, AM J PHYSIOL-ENDOC M, V299, pE560, DOI 10.1152/ajpendo.00284.2010; Mees B, 2007, ARTERIOSCL THROM VAS, V27, P1926, DOI 10.1161/ATVBAHA.107.145375; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Ohkawara H, 2010, CARDIOVASC RES, V88, P492, DOI 10.1093/cvr/cvq221; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; PARKER KA, 1985, J BIOL CHEM, V260, P3501; Schillinger M, 2004, THROMB HAEMOSTASIS, V92, P1108, DOI 10.1160/TH04-05-031; Shirk RA, 2000, J BIOL CHEM, V275, P18085, DOI 10.1074/jbc.M001659200; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sumitomo-Ueda Y, 2010, HYPERTENSION, V56, P430, DOI 10.1161/HYPERTENSIONAHA.110.152207; Takamori N, 2004, CIRCULATION, V109, P481, DOI 10.1161/01.CIR.0000109695.39671.37; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; TOLLEFSEN DM, 1982, J BIOL CHEM, V257, P2162; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Tollefsen DM, 2007, ARTERIOSCL THROM VAS, V27, P454, DOI 10.1161/01.ATV.0000256471.22437.88; Vicente CP, 2007, BLOOD, V110, P4261, DOI 10.1182/blood-2007-04-086611; Watts VL, 2009, EXP BIOL MED, V234, P132, DOI 10.3181/0807-RM-233; Yamanaga K, 2000, THROMB RES, V98, P95, DOI 10.1016/S0049-3848(99)00201-7	43	27	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34256	34263		10.1074/jbc.M112.353532	http://dx.doi.org/10.1074/jbc.M112.353532			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904320	Green Published, hybrid			2022-12-28	WOS:000309654200030
J	Liu, YN; Zhou, JH; Zhao, WJ; Li, XZ; Jiang, R; Liu, CJ; Guo, FJ				Liu, Yanna; Zhou, Jinghua; Zhao, Wenjun; Li, Xiangzhu; Jiang, Rong; Liu, Chuanju; Guo, Feng-Jin			XBP1S Associates with RUNX2 and Regulates Chondrocyte Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR XBP-1; PLASMA-CELL DIFFERENTIATION; HORMONE-RELATED PEPTIDE; MESSENGER-RNA; INDIAN-HEDGEHOG; P204 PROTEIN; ER STRESS; IRE1-ALPHA-XBP1 PATHWAY	BMP2 (bone morphogenetic protein 2) is known to activate unfolded protein response signaling molecules, including XBP1S and ATF6. However, the influence on XBP1S and ATF6 in BMP2-induced chondrocyte differentiation has not yet been elucidated. In this study, we demonstrate that BMP2 mediates mild endoplasmic reticulum stress-activated ATF6 and directly regulates XBP1S splicing in the course of chondrogenesis. XBP1S is differentially expressed during BMP2-stimulated chondrocyte differentiation and exhibits prominent expression in growth plate chondrocytes. This expression is probably due to the activation of the XBP1 gene by ATF6 and splicing by IRE1a. ATF6 directly binds to the 5'-flanking regulatory region of the XBP1 gene at its consensus binding elements. Overexpression of XBP1S accelerates chondrocyte hypertrophy, as revealed by enhanced expression of type II collagen, type X collagen, and RUNX2; however, knockdown of XBP1S via the RNAi approach abolishes hypertrophic chondrocyte differentiation. In addition, XBP1S associates with RUNX2 and enhances RUNX2-induced chondrocyte hypertrophy. Altered expression of XBP1S in chondrocyte hypertrophy was accompanied by altered levels of IHH (Indian hedgehog) and PTHrP (parathyroid hormone-related peptide). Collectively, XBP1S may be a novel regulator of hypertrophic chondrocyte differentiation by 1) acting as a cofactor of RUNX2 and 2) affecting IHH/PTHrP signaling.	[Liu, Yanna; Zhou, Jinghua; Zhao, Wenjun; Li, Xiangzhu; Guo, Feng-Jin] Chongqing Med Univ, Dept Cell Biol & Genet, Core Facil Dev Biol, Chongqing 400016, Peoples R China; [Jiang, Rong] Chongqing Med Univ, Lab Stem Cells & Tissue Engn, Chongqing 400016, Peoples R China; [Liu, Chuanju] NYU, Sch Med, Dept Orthopaed Surg & Cell Biol, New York, NY 10016 USA	Chongqing Medical University; Chongqing Medical University; New York University	Guo, FJ (corresponding author), Chongqing Med Univ, Dept Cell Biol & Genet, Core Facil Dev Biol, Chongqing 400016, Peoples R China.	guo.fengjin@gmail.com		liu, chuanju/0000-0002-7181-8032	National Science Foundation of China [81171697]; Natural Science Foundation Project of CQ CSTC [2011jjA10047]; University Excellent Talent Support Project of Chong-Qing Education Committee [2011-65]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); University Excellent Talent Support Project of Chong-Qing Education Committee	This work was supported by National Science Foundation of China Grant 81171697, Natural Science Foundation Project of CQ CSTC Grant 2011jjA10047, and University Excellent Talent Support Project of Chong-Qing Education Committee Grant 2011-65.	Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chen H, 2012, J GENE MED, V14, P231, DOI 10.1002/jgm.2614; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Hu ZH, 2007, BONE, V40, P1462, DOI 10.1016/j.bone.2007.01.021; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Iwamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P6, DOI 10.1053/joca.2002.0860; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Johnson KA, 2008, AM J PATHOL, V172, P440, DOI 10.2353/ajpath.2008.070753; Karp SJ, 2000, DEVELOPMENT, V127, P543; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Li XZ, 2012, MOL CELL BIOCHEM, V365, P99, DOI 10.1007/s11010-012-1248-4; Luan Y, 2008, MOL BIOL CELL, V19, P2113, DOI 10.1091/mbc.E07-10-1057; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Lui JCK, 2010, BONE, V46, P1380, DOI 10.1016/j.bone.2010.01.373; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Reimold AM, 2000, GENE DEV, V14, P152; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang M, 2009, J CELL SCI, V122, P1382, DOI 10.1242/jcs.040709; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	53	27	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34500	34513		10.1074/jbc.M112.385922	http://dx.doi.org/10.1074/jbc.M112.385922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22865880	hybrid, Green Published			2022-12-28	WOS:000309654200055
J	Mertens, HDT; Kjaergaard, M; Mysling, S; Gardsvoll, H; Jorgensen, TJD; Svergun, DI; Ploug, M				Mertens, Haydyn D. T.; Kjaergaard, Magnus; Mysling, Simon; Gardsvoll, Henrik; Jorgensen, Thomas J. D.; Svergun, Dmitri I.; Ploug, Michael			A Flexible Multidomain Structure Drives the Function of the Urokinase-type Plasminogen Activator Receptor (uPAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPPED-MONOCLONAL-ANTIBODIES; CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; TUMOR-GROWTH; CANCER; VITRONECTIN; SCATTERING; INVASION; BINDING; EPITOPE	The urokinase-type plasminogen activator receptor (uPAR) provides a rendezvous between proteolytic degradation of the extracellular matrix and integrin-mediated adhesion to vitronectin. These processes are, however, tightly linked because the high affinity binding of urokinase regulates the binding of uPAR to matrix-embedded vitronectin. Although crystal structures exist to define the corresponding static bi- and trimolecular receptor complexes, it is evident that the dynamic property of uPAR plays a decisive role in its function. In the present study, we combine small angle x-ray scattering, hydrogen-deuterium exchange, and surface plasmon resonance to develop a structural model describing the allosteric regulation of uPAR. We show that the flexibility of its N-terminal domain provides the key for understanding this allosteric mechanism. Importantly, our model has direct implications for understanding uPAR-assisted cell adhesion and migration as well as for translational research, including targeted intervention therapy and non-invasive tumor imaging in vivo.	[Gardsvoll, Henrik; Ploug, Michael] Rigshosp, Finsen Lab, DK-2200 Copenhagen N, Denmark; [Gardsvoll, Henrik; Ploug, Michael] Copenhagen Bioctr, BRIC, DK-2200 Copenhagen N, Denmark; [Mertens, Haydyn D. T.; Svergun, Dmitri I.] DESY, European Mol Biol Lab EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [Kjaergaard, Magnus] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark; [Mysling, Simon; Jorgensen, Thomas J. D.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Rigshospitalet; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Copenhagen; University of Southern Denmark	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk	Kjaergaard, Magnus/AAD-7717-2019	Kjaergaard, Magnus/0000-0002-7020-9366; Svergun, Dmitri/0000-0003-0830-5696; Jorgensen, Thomas J.D./0000-0002-7149-316X; Ploug, Michael/0000-0003-2215-4265; Mertens, Haydyn/0000-0002-5664-744X; Mysling, Simon/0000-0003-4221-6320	EMBL Interdisciplinary Postdocs program (EIPOD); Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer); National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	EMBL Interdisciplinary Postdocs program (EIPOD); Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer)(Danmarks Grundforskningsfond); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a fellowship from the EMBL Interdisciplinary Postdocs program (EIPOD) (to H. D. T. M.) and a grant from the Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer) (to M. P. and H. G.).; We thank Gitte Juhl-Funch, Haldis Egholm Monsted, and John Post for excellent technical assistance. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081). All plots were created using the software package GRACE.	Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Ellis V, 1996, J BIOL CHEM, V271, P14779, DOI 10.1074/jbc.271.25.14779; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Khanna M, 2011, ACS CHEM BIOL, V6, P1232, DOI 10.1021/cb200180m; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kriegbaum M. C., 2011, CURR DRUG TARGETS, V27, P27; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Li ZB, 2008, CLIN CANCER RES, V14, P4758, DOI 10.1158/1078-0432.CCR-07-4434; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Luther T, 1997, AM J PATHOL, V150, P1231; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Persson M, 2012, J NUCL MED, V53, P138, DOI 10.2967/jnumed.110.083386; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PLOUG M, 1992, BLOOD, V79, P1447; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schmiedeberg N, 2002, J MED CHEM, V45, P4984, DOI 10.1021/jm020254q; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Serrati S, 2011, ARTHRITIS RHEUM-US, V63, P2584, DOI 10.1002/art.30439; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058	56	39	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34304	34315		10.1074/jbc.M112.398404	http://dx.doi.org/10.1074/jbc.M112.398404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896701	hybrid, Green Published			2022-12-28	WOS:000309654200034
J	Tanveer, R; Gowran, A; Noonan, J; Keating, SE; Bowie, AG; Campbell, VA				Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Keating, Sinead E.; Bowie, Andrew G.; Campbell, Veronica A.			The Endocannabinoid, Anandamide, Augments Notch-1 Signaling in Cultured Cortical Neurons Exposed to Amyloid-beta and in the Cortex of Aged Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX FACTORS; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CELL FATE; NICASTRIN; ACTIVATION; PRESENILIN; NUMB; TRANSDUCTION	Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although A beta(1-42) increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of gamma-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of A beta(1-42). AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate A beta(1-40). Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.	[Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Campbell, Veronica A.] Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland; [Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Campbell, Veronica A.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Keating, Sinead E.; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Campbell, VA (corresponding author), Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland.	vacmpbll@tcd.ie	Gowran, Aoife/K-6671-2016	Bowie, Andrew/0000-0001-5316-4373	Health Research Board Ireland	Health Research Board Ireland	This work is supported by Health Research Board Ireland.	Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boland B, 2003, NEUROBIOL AGING, V24, P179, DOI 10.1016/S0197-4580(02)00060-X; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Brijbassi S, 2007, NEUROBIOL DIS, V25, P291, DOI 10.1016/j.nbd.2006.09.013; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Chan SL, 2002, NEUROMOL MED, V1, P55; Checler F, 2010, NEURODEGENER DIS, V7, P50, DOI 10.1159/000283483; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Dale TC, 1998, BIOCHEM J, V329, P209; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frampton G, 2010, EXP CELL RES, V316, P1465, DOI 10.1016/j.yexcr.2010.03.017; Franberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009772; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Harrison H, 2010, CANCER RES, V70, P8973, DOI 10.1158/0008-5472.CAN-10-1559; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Kim SY, 2007, BBA-MOL CELL RES, V1773, P736, DOI 10.1016/j.bbamcr.2007.02.001; Kodam A, 2008, NEUROBIOL AGING, V29, P724, DOI 10.1016/j.neurobiolaging.2006.12.005; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Mackie K, 2006, INT J OBESITY, V30, pS19, DOI 10.1038/sj.ijo.0803273; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murphy Niamh, 2012, J Neuroinflammation, V9, P79, DOI 10.1186/1742-2094-9-79; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Nguyen V, 2006, BRAIN RES, V1086, P76, DOI 10.1016/j.brainres.2006.02.122; Noonan J, 2010, J BIOL CHEM, V285, P38543, DOI 10.1074/jbc.M110.162040; Pamren A, 2011, J BIOL CHEM, V286, P31153, DOI 10.1074/jbc.C111.235267; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	62	41	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34709	34721		10.1074/jbc.M112.350678	http://dx.doi.org/10.1074/jbc.M112.350678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891244	hybrid, Green Published			2022-12-28	WOS:000309654200071
J	Ukpabi, G; Takayama, SJ; Mauk, AG; Murphy, MEP				Ukpabi, Georgia; Takayama, Shin-ichi J.; Mauk, A. Grant; Murphy, Michael E. P.			Inactivation of the Heme Degrading Enzyme IsdI by an Active Site Substitution That Diminishes Heme Ruffling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA HEME; STAPHYLOCOCCUS-AUREUS; CORYNEBACTERIUM-DIPHTHERIAE; STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURES; HYDROXIDE COMPLEX; CATALYTIC SITE; CYTOCHROMES-B; OXYGENASE; PORPHYRINS	IsdG and IsdI are paralogous heme degrading enzymes from the bacterium Staphylococcus aureus. Heme bound by these enzymes is extensively ruffled such that the meso-carbons at the sites of oxidation are distorted toward bound oxygen. In contrast, the canonical heme oxygenase family degrades heme that is bound with minimal distortion. Trp-66 is a conserved heme pocket residue in IsdI implicated in heme ruffling. IsdI variants with Trp-66 replaced with residues having less bulky aromatic and alkyl side chains were characterized with respect to catalytic activity, heme ruffling, and electrochemical properties. The heme degradation activity of the W66Y and W66F variants was approximately half that of the wild-type enzyme, whereas the W66L and W66A variants were inactive. A crystal structure and NMR spectroscopic analysis of the W66Y variant reveals that heme binds to this enzyme with less heme ruffling than observed for wild-type IsdI. The reduction potential of this variant (-96 +/- 7 mV versus standard hydrogen electrode) is similar to that of wild-type IsdI (-89 +/- 7 mV), so we attribute the diminished activity of this variant to the diminished heme ruffling observed for heme bound to this enzyme and conclude that Trp-66 is required for optimal catalytic activity.	[Ukpabi, Georgia; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Takayama, Shin-ichi J.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Takayama, Shin-ichi J.; Mauk, A. Grant] Univ British Columbia, UBC Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Grant.Mauk@ubc.ca; Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014	Uehara Memorial Foundation; Canada Research Chair; Canadian Institutes of Health Research (CIHR) [MOP-49597]; Canadian Blood Services-CIHR; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Uehara Memorial Foundation(Uehara Memorial Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services-CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by a postdoctoral fellowship from the Uehara Memorial Foundation (to S. J. T.), a Canada Research Chair (to A. G. M.), Canadian Institutes of Health Research (CIHR) Operating Grant MOP-49597 (M. E. P. M.), a Canadian Blood Services-CIHR partnership grant (to A. G. M.), and the Canadian Foundation for Innovation (to A. G. M. and M. E. P. M.).; We thank Professor Lawrence McIntosh for use of the NMR spectrometer. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Cai S, 2006, INORG CHEM, V45, P3519, DOI 10.1021/ic0515352; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Caignan GA, 2003, J AM CHEM SOC, V125, P11842, DOI 10.1021/ja036147i; Chu GC, 1999, J BIOL CHEM, V274, P24490, DOI 10.1074/jbc.274.35.24490; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1545, DOI 10.1021/bi00458a028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh A, 1999, J PHYS CHEM B, V103, P1363, DOI 10.1021/jp9830124; Gorst CM, 1998, J AM CHEM SOC, V120, P8875, DOI 10.1021/ja9815475; Haddad RE, 2003, J AM CHEM SOC, V125, P1253, DOI 10.1021/ja0280933; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Ma JG, 1998, BIOCHEMISTRY-US, V37, P12431, DOI 10.1021/bi981189i; Ma LH, 2006, J AM CHEM SOC, V128, P6657, DOI 10.1021/ja0584626; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 2006, COORDIN CHEM REV, V250, P2271, DOI 10.1016/j.ccr.2006.03.001; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; Ryeng H, 2002, J AM CHEM SOC, V124, P8099, DOI 10.1021/ja0202659; SAFO MK, 1992, J AM CHEM SOC, V114, P7066, DOI 10.1021/ja00044a017; Sato H, 2007, J INORG BIOCHEM, V101, P1394, DOI 10.1016/j.jinorgbio.2007.05.016; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walker FA, 1996, J AM CHEM SOC, V118, P12109, DOI 10.1021/ja961971a; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YAMAMOTO Y, 1993, BIOCHIM BIOPHYS ACTA, V1203, P267, DOI 10.1016/0167-4838(93)90093-7; Yang F, 2009, J BIOL INORG CHEM, V14, P1077, DOI 10.1007/s00775-009-0551-3; Yatsunyk LA, 2005, INORG CHEM, V44, P2848, DOI 10.1021/ic049089q; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987; Zhou ZC, 2010, ORG LETT, V12, P1780, DOI 10.1021/ol100434w	46	30	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34179	34188		10.1074/jbc.M112.393249	http://dx.doi.org/10.1074/jbc.M112.393249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891243	Green Published, hybrid			2022-12-28	WOS:000309654200023
J	Bijakowski, C; Vadon-Le Goff, S; Delolme, F; Bourhis, JM; Lecorche, P; Ruggiero, F; Becker-Pauly, C; Yiallouros, I; Stoocker, W; Dive, V; Hulmes, DJS; Moali, C				Bijakowski, Cecile; Vadon-Le Goff, Sandrine; Delolme, Frederic; Bourhis, Jean-Marie; Lecorche, Pascaline; Ruggiero, Florence; Becker-Pauly, Christoph; Yiallouros, Irene; Stoecker, Walter; Dive, Vincent; Hulmes, David J. S.; Moali, Catherine			Sizzled Is Unique among Secreted Frizzled-related Proteins for Its Ability to Specifically Inhibit Bone Morphogenetic Protein-1 (BMP-1)/Tolloid-like Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; NEGATIVE FEEDBACK REGULATOR; MAMMALIAN TOLLOID-LIKE; MYOCARDIAL-INFARCTION; ALPHA-SUBUNIT; LYSYL OXIDASE; BETA-SUBUNIT; CUB DOMAINS; METALLOPROTEINASES; ASTACIN	BMP-1/tolloid-like proteinases (BTPs) are major enzymes involved in extracellular matrix assembly and activation of bioactive molecules, both growth factors and anti-angiogenic molecules. Although the control of BTP activity by several enhancing molecules is well established, the possibility that regulation also occurs through endogenous inhibitors is still debated. Secreted frizzled-related proteins (sFRPs) have been studied as possible candidates, with highly contradictory results, after the demonstration that sizzled, a sFRP found in Xenopus and zebrafish, was a potent inhibitor of Xenopus and zebrafish tolloid-like proteases. In this study, we demonstrate that mammalian sFRP-1, -2, and -4 do not modify human BMP-1 activity on several of its known substrates including procollagen I, procollagen III, pN-collagen V, and prolysyl oxidase. In contrast, Xenopus sizzled appears as a tight binding inhibitor of human BMP-1, with aK(i) of 1.5 +/- 0.5 nM, and is shown to strongly inhibit other human tolloid isoforms mTLD and mTLL-1. Because sizzled is the most potent inhibitor of human tolloid-like proteinases known to date, we have studied its mechanism of action in detail and shown that the frizzled domain of sizzled is both necessary and sufficient for inhibitory activity and that it acts directly on the catalytic domain of BMP-1. Residues in sizzled required for inhibition include Asp-92, which is shared by sFRP-1 and -2, and also Phe-94, Ser-43, and Glu-44, which are specific to sizzled, thereby providing a rational basis for the absence of inhibitory activity of human sFRPs.	[Bijakowski, Cecile; Vadon-Le Goff, Sandrine; Delolme, Frederic; Bourhis, Jean-Marie; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, CNRS, FRE3310, Inst Biol & Chim Prot,FR3302, F-69367 Lyon 7, France; [Lecorche, Pascaline; Dive, Vincent] CEA Saclay, SIMOPRO, F-91191 Gif Sur Yvette, France; [Ruggiero, Florence] Ecole Normale Super Lyon, CNRS, UMR 5242, Inst Genom Fonct Lyon, F-69364 Lyon 7, France; [Becker-Pauly, Christoph] Univ Kiel, Unit Degrad Protease Web, Inst Biochem, D-24118 Kiel, Germany; [Yiallouros, Irene; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Kiel; Johannes Gutenberg University of Mainz	Moali, C (corresponding author), Univ Lyon, CNRS, FRE3310, Inst Biol & Chim Prot,FR3302, 7 Passage Vercors, F-69367 Lyon 7, France.	c.moali@ibcp.fr	le goff, sandrine/AAE-1990-2019; Stöcker, Walter/AAB-9704-2019; Becker-Pauly, Christoph/B-7569-2011	Stöcker, Walter/0000-0002-1515-6994; MOALI, Catherine/0000-0003-2479-4290; vadon-le goff, sandrine/0000-0002-4582-2273; RUGGIERO, Florence/0000-0003-2915-5359; Bourhis, Jean-Marie/0000-0002-3151-1546; Hulmes, David/0000-0002-0651-1317	Agence Nationale de la Recherche (project SCAR FREE); Agence Nationale de la Recherche (project TOLLREG); Fondation de France; CNRS; Universite Claude Bernard Lyon 1; Lyon Biopole; Deutsche Forschungsgemeinschaft [Sto185/3-2, SFB492, BE 4086/1-2, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Agence Nationale de la Recherche (project SCAR FREE)(French National Research Agency (ANR)); Agence Nationale de la Recherche (project TOLLREG)(French National Research Agency (ANR)); Fondation de France(Fondation de France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Lyon Biopole; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by the Agence Nationale de la Recherche (projects SCAR FREE and TOLLREG), the Fondation de France, the CNRS, the Universite Claude Bernard Lyon 1, the Lyon Biopole (to D. J. S. H. and C. M.), Deutsche Forschungsgemeinschaft Grants Sto185/3-2, SFB492 (to W. S. and I. Y.), BE 4086/1-2, SFB877, and the Cluster of Excellence "Inflammation at Interfaces" (to C. B.- P.).	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Berry R, 2010, FEBS LETT, V584, P657, DOI 10.1016/j.febslet.2009.12.050; Bhat RA, 2007, J CELL BIOCHEM, V102, P1519, DOI 10.1002/jcb.21372; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2003, J SURG RES, V113, P208, DOI 10.1016/S0022-4804(03)00188-4; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Ferguson M. W. J., 2008, International Patent, Patent No. 2008125869; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Gopalakrishnan B, 2004, J BIOL CHEM, V279, P30904, DOI 10.1074/jbc.M402252200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Jasuja R, 2007, J BIOL CHEM, V282, P9053, DOI 10.1074/jbc.M610929200; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Martin R, 2000, ANAL BIOCHEM, V277, P276, DOI 10.1006/abio.1999.4395; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moali C, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P539; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muir A, 2011, J BIOL CHEM, V286, P41905, DOI 10.1074/jbc.R111.299768; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Reyda S, 1999, BIOCHEM J, V344, P851, DOI 10.1042/0264-6021:3440851; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salic AN, 1997, DEVELOPMENT, V124, P4739; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sun ZC, 2011, MOL CELL BIOCHEM, V352, P25, DOI 10.1007/s11010-011-0736-2; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; Takahara K, 1996, GENOMICS, V34, P157, DOI 10.1006/geno.1996.0260; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3	71	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33581	33593		10.1074/jbc.M112.380816	http://dx.doi.org/10.1074/jbc.M112.380816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22825851	Green Published, hybrid			2022-12-28	WOS:000309602100043
J	Cohen, L; Asraf, H; Sekler, I; Hershfinkel, M				Cohen, Limor; Asraf, Hila; Sekler, Israel; Hershfinkel, Michal			Extracellular pH Regulates Zinc Signaling via an Asp Residue of the Zinc-sensing Receptor (ZnR/GPR39)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; COORDINATION ENVIRONMENTS; MOLECULAR-MECHANISM; INTRACELLULAR CA2+; NA+/H+ EXCHANGE; COLONIC CRYPTS; ION CHANNELS; MUCOSAL PH; CELLS; CALCIUM	Zinc activates a specific Zn2+ -sensing receptor, ZnR/GPR39, and thereby triggers cellular signaling leading to epithelial cell proliferation and survival. Epithelial cells that express ZnR, particularly colonocytes, face frequent changes in extracellular pH that are of physiological and pathological implication. Here we show that the ZnR/GPR39-dependent Ca2+ responses in HT29 colonocytes were maximal at pH 7.4 but were reduced by about 50% at pH 7.7 and by about 62% at pH 7.1 and were completely abolished at pH 6.5. Intracellular acidification did not attenuate ZnR/GPR39 activity, indicating that the pH sensor of this protein is located on an extracellular domain. ZnR/GPR39-dependent activation of extracellular-regulated kinase (ERK) 1/2 or AKT pathways was abolished at acidic extracellular pH of 6.5. A similar inhibitory effect was monitored for the ZnR/GPR39-dependent up-regulation of Na+/H+ exchange activity at pH 6.5. Focusing on residues putatively facing the extracellular domain, we sought to identify the pH sensor of ZnR/GPR39. Replacing the histidine residues forming the Zn2+ binding site, His(17) or His(19), or other extracellular-facing histidines to alanine residues did not abolish the pH dependence of ZnR/GPR39. In contrast, replacing Asp(313) with alanine resulted in similar Ca2+ responses triggered by ZnR/GPR39 at pH 7.4 or 6.5. This mutant also showed similar activation of ERK1/2 and AKT pathways, and ZnR-dependent up-regulation of Na+/H+ exchange at pH 7.4 and pH 6.5. Substitution of Asp(313) to His or Glu residues restored pH sensitivity of the receptor. This indicates that Asp(313), which was shown to modulate Zn2+ binding, is an essential residue of the pH sensor of GPR39. In conclusion, ZnR/GPR39 is tuned to sense physiologically relevant changes in extracellular pH that thus regulate ZnR-dependent signaling and ion transport activity.	[Cohen, Limor; Asraf, Hila; Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hershfinkel, M (corresponding author), Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, POB 653, IL-84105 Beer Sheva, Israel.	hmichal@bgu.ac.il	Hershfinkel, Michal/F-1548-2012	Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [513/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 513/09 (to M. H.).	Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Arena EA, 2012, AM J PHYSIOL-CELL PH, V302, pC412, DOI 10.1152/ajpcell.00163.2011; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Bachmann O, 2011, BIOL PHARM BULL, V34, P794, DOI 10.1248/bpb.34.794; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; CHU SY, 1995, P NATL ACAD SCI USA, V92, P3303, DOI 10.1073/pnas.92.8.3303; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; Cohen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035482; Dong X, 2011, ACTA PHYSIOL, V201, P97, DOI 10.1111/j.1748-1716.2010.02207.x; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Gent AK, 1999, J PHYSIOL-LONDON, V517, P507, DOI 10.1111/j.1469-7793.1999.0507t.x; Goo Tyralee, 2010, Curr Gastroenterol Rep, V12, P465, DOI 10.1007/s11894-010-0147-7; Gore A, 2004, J BIOL CHEM, V279, P11106, DOI 10.1074/jbc.M400005200; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; Hargitai D, 2010, RESP PHYSIOL NEUROBI, V170, P67, DOI 10.1016/j.resp.2009.12.001; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holzer P, 2011, ACTA PHYSIOL, V201, P63, DOI 10.1111/j.1748-1716.2010.02143.x; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Levinthal C, 2009, PHARMACOLOGY, V83, P88, DOI 10.1159/000180124; Liu JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019638; Luk HH, 2002, EUR J PHARMACOL, V443, P197, DOI 10.1016/S0014-2999(02)01592-3; Lukin JA, 2004, CHEM REV, V104, P1219, DOI 10.1021/cr940325w; Malin SA, 2009, J NEUROSCI, V29, P743, DOI 10.1523/JNEUROSCI.3791-08.2009; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; MCDOUGALL CJ, 1993, DIGEST DIS SCI, V38, P542, DOI 10.1007/BF01316512; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Perdikis DA, 1998, DIGEST DIS SCI, V43, P1537, DOI 10.1023/A:1018871016691; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Quinn SJ, 2004, J BIOL CHEM, V279, P37241, DOI 10.1074/jbc.M404520200; Sandoval M, 2011, BIOL PHARM BULL, V34, P803, DOI 10.1248/bpb.34.803; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; Segal D, 2004, BIOCHEM BIOPH RES CO, V323, P1145, DOI 10.1016/j.bbrc.2004.08.211; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; Sharma M, 2005, J PHOTOCH PHOTOBIO B, V81, P107, DOI 10.1016/j.jphotobiol.2005.07.001; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; THORNTON JR, 1981, LANCET, V1, P1081; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Umemura T, 2002, J BIOL CHEM, V277, P1593, DOI 10.1074/jbc.M109930200; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WALKER ARP, 1992, GUT, V33, P572, DOI 10.1136/gut.33.4.572; Walsh BM, 2007, AM J PHYSIOL-CELL PH, V293, pC1687, DOI 10.1152/ajpcell.00189.2006; Wilson M, 2012, J BIOL CHEM, V287, P9322, DOI 10.1074/jbc.C111.320796	57	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33339	33350		10.1074/jbc.M112.372441	http://dx.doi.org/10.1074/jbc.M112.372441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879599	Green Published, hybrid			2022-12-28	WOS:000309602100022
J	Takahata, Y; Hinoi, E; Takarada, T; Nakamura, Y; Ogawa, S; Yoneda, Y				Takahata, Yoshifumi; Hinoi, Eiichi; Takarada, Takeshi; Nakamura, Yukari; Ogawa, Shinya; Yoneda, Yukio			Positive Regulation by gamma-Aminobutyric Acid B Receptor Subunit-1 of Chondrogenesis through Acceleration of Nuclear Translocation of Activating Transcription Factor-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GABA(B) RECEPTOR; EXPRESSION CLONING; INDIAN-HEDGEHOG; PROTEIN; GROWTH; BRAIN; DIFFERENTIATION; MINERALIZATION; CHONDROCYTES	A view that signaling machineries for the neurotransmitter gamma-aminobutyric acid (GABA) are functionally expressed by cells outside the central nervous system is now prevailing. In this study, we attempted to demonstrate functional expression of GABAergic signaling molecules by chondrocytes. In cultured murine costal chondrocytes, mRNA was constitutively expressed for metabotropic GABA(B) receptor subunit-1 (GABA(B)R1), but not for GABA(B)R2. Immunohistochemical analysis revealed the predominant expression of GABABR1 by prehypertrophic to hypertrophic chondrocytes in tibial sections of newborn mice. The GABA(B)R agonist baclofen failed to significantly affect chondrocytic differentiation determined by Alcian blue staining and alkaline phosphatase activity in cultured chondrocytes, whereas newborn mice knocked out of GABA(B)R1 (KO) showed a decreased body size and delayed calcification in hyoid bone and forelimb and hindlimb digits. Delayed calcification was also seen in cultured metatarsals from KO mice with a marked reduction of Indian hedgehog gene (Ihh) expression. Introduction of GABABR1 led to synergistic promotion of the transcriptional activity of activating transcription factor-4 (ATF4) essential for normal chondrogenesis, in addition to facilitating ATF4-dependent Ihh promoter activation. Although immunoreactive ATF4 was negligibly detected in the nucleus of chondrocytes from KO mice, ATF4 expression was again seen in the nucleus and cytoplasm after the retroviral introduction of GABABR1 into cultured chondrocytes from KO mice. In nuclear extracts of KO chondrocytes, a marked decrease was seen in ATF4 DNA binding. These results suggest that GABABR1 positively regulates chondrogenesis through a mechanism relevant to the acceleration of nuclear translocation of ATF4 for Ihh expression in chondrocytes.	[Takahata, Yoshifumi; Hinoi, Eiichi; Takarada, Takeshi; Nakamura, Yukari; Ogawa, Shinya; Yoneda, Yukio] Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Mol Pharmacol Lab, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021; Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22659065]; Ono Medical Research Foundation; Mishima Kaiun Memorial Foundation, Japan; Grants-in-Aid for Scientific Research [24650196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Mishima Kaiun Memorial Foundation, Japan(Mishima Kaiun Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 22659065 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to E. H.) and in part by research grants from the Ono Medical Research Foundation and the Mishima Kaiun Memorial Foundation, Japan (to E. H.).	Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Long FX, 2006, DEV BIOL, V298, P327, DOI 10.1016/j.ydbio.2006.06.042; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020167; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SCHERFT JP, 1984, METAB BONE DIS RELAT, V5, P195, DOI 10.1016/0221-8747(84)90030-4; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; Takahata Y, 2011, J BIOL CHEM, V286, P32906, DOI 10.1074/jbc.M111.253526; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; Wang LY, 2006, J BIOL CHEM, V281, P24553, DOI 10.1074/jbc.M600939200; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33293	33303		10.1074/jbc.M112.344051	http://dx.doi.org/10.1074/jbc.M112.344051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879594	hybrid, Green Published			2022-12-28	WOS:000309602100018
J	Cenik, B; Sephton, CF; Cenik, BK; Herz, J; Yu, G				Cenik, Basar; Sephton, Chantelle F.; Cenik, Bercin Kutluk; Herz, Joachim; Yu, Gang			Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FRONTOTEMPORAL LOBAR DEGENERATION; GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR PROGRANULIN; BREAST-CANCER CELLS; KNOCKOUT MICE; IN-VIVO; NEURITE OUTGROWTH; GENE-EXPRESSION; DEFICIENT MICE; HOST-DEFENSE	GRN mutations cause frontotemporal lobar degeneration with TDP-43-positive inclusions. The mechanism of pathogenesis is haploinsufficiency. Recently, homozygous GRN mutations were detected in two patients with neuronal ceroid lipofuscinosis, a lysosomal storage disease. It is unknown whether the pathogenesis of these two conditions is related. Progranulin is cleaved into smaller peptides called granulins. Progranulin and granulins are attributed with roles in cancer, inflammation, and neuronal physiology. Cell surface receptors for progranulin, but not granulin peptides, have been reported. Revealing the cell surface receptors and the intracellular functions of granulins and progranulin is crucial for understanding their contributions to neurodegeneration.	[Cenik, Basar; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cenik, Basar; Sephton, Chantelle F.; Herz, Joachim; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Cenik, Bercin Kutluk] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu; gang.yu@utsouthwestern.edu			National Institutes of Health [HL63762, HL20948, R01AG029547]; Consortium for Frontotemporal Dementia Research; Alzheimer's Association; Welch Foundation [I-1776]; American Health Assistance Foundation; American Federation for Aging Research; Murchison Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, P01HL020948, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Alzheimer's Association(Alzheimer's Association); Welch Foundation(The Welch Foundation); American Health Assistance Foundation(BrightFocus Foundation); American Federation for Aging Research; Murchison Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63762 (to J.H.), HL20948 (to J.H.), and R01AG029547 (to G.Y.). This work was also supported by the Consortium for Frontotemporal Dementia Research, the Alzheimer's Association, Welch Foundation Grant I-1776, the American Health Assistance Foundation, the American Federation for Aging Research, and the Murchison Foundation.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Akil H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025097; Almeida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026454; ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BELCOURT DR, 1993, J BIOL CHEM, V268, P9230; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Bossu P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-65; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P10458; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Donald CD, 2001, ANTICANCER RES, V21, P3739; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liau LM, 2000, CANCER RES, V60, P1353; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Matsumura N, 2006, CLIN CANCER RES, V12, P1402, DOI 10.1158/1078-0432.CCR-05-2003; Miyanishi M, 2007, ONCOL REP, V17, P329; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Serrero G, 2003, BIOCHEM BIOPH RES CO, V308, P409, DOI 10.1016/S0006-291X(03)01452-9; Serrero G, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3111; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Songsrirote K, 2010, J PROTEOMICS, V73, P1479, DOI 10.1016/j.jprot.2010.02.013; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Tapia L, 2011, J NEUROSCI, V31, P11126, DOI 10.1523/JNEUROSCI.6244-10.2011; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Verhoef Cornelis, 2007, Curr Treat Options Oncol, V8, P417, DOI 10.1007/s11864-007-0044-y; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Xu J, 2011, IET SIGNAL PROCESS, V5, P16, DOI 10.1049/iet-spr.2009.0284; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	98	146	150	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32298	32306		10.1074/jbc.R112.399170	http://dx.doi.org/10.1074/jbc.R112.399170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22859297	Green Published, hybrid			2022-12-28	WOS:000309168300001
J	Haidari, M; Zhang, W; Caivano, A; Chen, ZP; Ganjehei, L; Mortazavi, A; Stroud, C; Woodside, DG; Willerson, JT; Dixon, RAF				Haidari, Mehran; Zhang, Wei; Caivano, Amy; Chen, Zhenping; Ganjehei, Leila; Mortazavi, Ahmadreza; Stroud, Christopher; Woodside, Darren G.; Willerson, James T.; Dixon, Richard A. F.			Integrin alpha(2)beta(1) Mediates Tyrosine Phosphorylation of Vascular Endothelial Cadherin Induced by Invasive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; TRANSENDOTHELIAL MIGRATION; BARRIER FUNCTION; IN-VITRO; LEUKOCYTE TRANSMIGRATION; PREFERENTIAL ADHESION; SIGNALING PROMOTES; PROTEIN-KINASES; METASTASIS; ACTIVATION	The molecular mechanisms that regulate the endothelial response during transendothelial migration (TEM) of invasive cancer cells remain elusive. Tyrosine phosphorylation of vascular endothelial cadherin (VE-cad) has been implicated in the disruption of endothelial cell adherens junctions and in the diapedesis of metastatic cancer cells. We sought to determine the signaling mechanisms underlying the disruption of endothelial adherens junctions after the attachment of invasive breast cancer cells. Attachment of invasive breast cancer cells (MDA-MB-231) to human umbilical vein endothelial cells induced tyrosine phosphorylation of VE-cad, dissociation of beta-catenin from VE-cad, and retraction of endothelial cells. Breast cancer cell-induced tyrosine phosphorylation of VE-cad was mediated by activation of the H-Ras/Raf/MEK/ERK signaling cascade and depended on the phosphorylation of endothelial myosin light chain (MLC). The inhibition of H-Ras or MLC in endothelial cells inhibited TEM of MDA-MB-231 cells. VE-cad tyrosine phosphorylation in endothelial cells induced by the attachment of MDA-MB-231 cells was mediated by MDA-MB-231 alpha(2)beta(1) integrin. Compared with highly invasive MDA-MB-231 breast cancer cells, weakly invasive MCF-7 breast cancer cells expressed lower levels of alpha(2)beta(1) integrin. TEM of MCF-7 as well as induction of VE-cad tyrosine phosphorylation and dissociation of beta-catenin from the VE-cad complex by MCF-7 cells were lower than in MDA-MB-231 cells. These processes were restored when MCF-7 cells were treated with beta(1)-activating antibody. Moreover, the response of endothelial cells to the attachment of prostatic (PC-3) and ovarian (SKOV3) invasive cancer cells resembled the response to MDA-MB-231 cells. Our study showed that the MDA-MB-231 cell-induced disruption of endothelial adherens junction integrity is triggered by MDA-MB-231 cell alpha(2)beta(1) integrin and is mediated by H-Ras/MLC-induced tyrosine phosphorylation of VE-cad.	[Haidari, Mehran; Zhang, Wei; Caivano, Amy; Chen, Zhenping; Ganjehei, Leila; Mortazavi, Ahmadreza; Woodside, Darren G.; Willerson, James T.; Dixon, Richard A. F.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Stroud, Christopher; Willerson, James T.] Univ Texas Houston, Med Sch Houston, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Haidari, M (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, POB 20345,C1000, Houston, TX 77030 USA.	Mehran.Haidari@uth.tmc.edu			MacDonald General Research Fund [09RDM002]	MacDonald General Research Fund	This work was supported by MacDonald General Research Fund Grant 09RDM002 (to M. H.).	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181; BLISS RD, 1995, CLIN EXP METASTAS, V13, P173, DOI 10.1007/BF00132205; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Cooper CR, 2000, CLIN CANCER RES, V6, P4839; Di Ciano-Oliveira C, 2005, AM J PHYSIOL-CELL PH, V289, pC68, DOI 10.1152/ajpcell.00631.2004; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Haidari M, 2012, EXP CELL RES, V318, P1673, DOI 10.1016/j.yexcr.2012.05.009; Haidari M, 2011, CARDIOVASC RES, V92, P456, DOI 10.1093/cvr/cvr240; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Ho WC, 1997, MOL BIOL CELL, V8, P1863, DOI 10.1091/mbc.8.10.1863; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; KUSAMA T, 1995, INT J CANCER, V63, P112, DOI 10.1002/ijc.2910630120; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Li YH, 1999, CLIN EXP METASTAS, V17, P423, DOI 10.1023/A:1006614232388; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; NICOLSON GL, 1982, J HISTOCHEM CYTOCHEM, V30, P214, DOI 10.1177/30.3.7061823; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Ramirez N. E., J CLIN INVEST, V121, P226; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; van der Pluijm, 1997, LAB INVEST, V77, P665; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wu M., CANCER, V116, P2768; Yang CQ, 2003, CANCER RES, V63, P8312; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; YU DH, 1994, CANCER RES, V54, P3260	41	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32981	32992		10.1074/jbc.M112.395905	http://dx.doi.org/10.1074/jbc.M112.395905			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833667	Green Published, hybrid			2022-12-28	WOS:000309168300061
J	Irieda, H; Morita, T; Maki, K; Homma, M; Aiba, H; Sudo, Y				Irieda, Hiroki; Morita, Teppei; Maki, Kimika; Homma, Michio; Aiba, Hiroji; Sudo, Yuki			Photo-induced Regulation of the Chromatic Adaptive Gene Expression by Anabaena Sensory Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-2 SIGMA-FACTORS; RNA-POLYMERASE; SCHIFF-BASE; HYDROGEN-BOND; FTIR; TRANSCRIPTION; PROTEINS; COMPLEX; ROLES; WATER	Rhodopsin molecules are photochemically reactive membrane-embedded proteins, with seven transmembrane alpha-helices, which bind the chromophore retinal (vitamin A aldehyde). They are roughly divided into two groups according to their basic functions: (i) ion transporters such as proton pumps, chloride pumps, and cation channels; and (ii) photo-sensors such as sensory rhodopsin from microbes and visual pigments from animals. Anabaena sensory rhodopsin (ASR), found in 2003 in the cyanobacterium Anabaena PCC7120, is categorized as a microbial sensory rhodopsin. To investigate the function of ASR in vivo, ASR and the promoter sequence of the pigment protein phycocyanin were co-introduced into Escherichia coli cells with the reporter gene crp. The result clearly showed that ASR functions as a repressor of the CRP protein expression and that this is fully inhibited by the light activation of ASR, suggesting that ASR would directly regulate the transcription of crp. The repression is also clearly inhibited by the truncation of the C-terminal region of ASR, or mutations on the C-terminal Arg residues, indicating the functional importance of the C-terminal region. Thus, our results demonstrate a novel function of rhodopsin molecules and raise the possibility that the membrane-spanning protein ASR could work as a transcriptional factor. In the future, the ASR activity could be utilized as a tool for arbitrary protein expression in vivo regulated by visible light.	[Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Morita, Teppei; Aiba, Hiroji] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Irieda, Hiroki/N-8455-2015; Sudo, Yuki/AGY-0493-2022	Irieda, Hiroki/0000-0002-4545-9187; Sudo, Yuki/0000-0001-8155-9356	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22018010, 23687019]; Grants-in-Aid for Scientific Research [23657100] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 22018010 and 23687019 (to Y. S.).	AIBA H, 1981, J BIOL CHEM, V256, P1905; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; Brown LS, 2006, PHOTOCH PHOTOBIO SCI, V5, P538, DOI 10.1039/b514537f; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Imamura S, 2004, GENES CELLS, V9, P1175, DOI 10.1111/j.1365-2443.2004.00808.x; JOHNSON TR, 1988, J BACTERIOL, V170, P1858, DOI 10.1128/jb.170.4.1858-1865.1988; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kawanabe A, 2006, BIOCHEMISTRY-US, V45, P4362, DOI 10.1021/bi052324b; Kawanabe A, 2008, BIOCHEMISTRY-US, V47, P10033, DOI 10.1021/bi800941a; Kawanabe A, 2007, J AM CHEM SOC, V129, P8644, DOI 10.1021/ja072085a; Kehoe DM, 2010, P NATL ACAD SCI USA, V107, P9029, DOI 10.1073/pnas.1004510107; Klare JP, 2011, EUR J CELL BIOL, V90, P731, DOI 10.1016/j.ejcb.2011.04.013; Koksharova OA, 2002, APPL MICROBIOL BIOT, V58, P123, DOI 10.1007/s00253-001-0864-9; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; SCHNEIDER GJ, 1991, GENE, V105, P51, DOI 10.1016/0378-1119(91)90513-B; SCHNEIDER GJ, 1987, J BIOL CHEM, V262, P14633; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Shi LC, 2006, J MOL BIOL, V358, P686, DOI 10.1016/j.jmb.2006.02.036; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Shibato J, 2002, MOL GENET GENOMICS, V267, P684, DOI 10.1007/s00438-002-0704-3; Sineshchekov OA, 2006, BIOPHYS J, V91, P4519, DOI 10.1529/biophysj.106.093641; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Singh B, 2001, CURR MICROBIOL, V43, P265, DOI 10.1007/s002840010299; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Stowe-Evans EL, 2004, PHOTOCH PHOTOBIO SCI, V3, P495, DOI 10.1039/b316952a; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y., 2012, CRC HDB ORGANIC PHOT, P1173; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Vogeley L, 2007, J MOL BIOL, V367, P741, DOI 10.1016/j.jmb.2006.11.074; Yoshimura T, 2007, FEBS LETT, V581, P1495, DOI 10.1016/j.febslet.2007.03.010	41	35	36	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32485	32493		10.1074/jbc.M112.390864	http://dx.doi.org/10.1074/jbc.M112.390864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22872645	hybrid, Green Published			2022-12-28	WOS:000309168300019
J	Chen, KR; Chang, CH; Huang, CY; Lin, CY; Lin, WY; Lo, YC; Yang, CY; Hsing, EW; Chen, LF; Shih, SR; Shiau, AL; Lei, HY; Tan, TH; Ling, P				Chen, Kuan-Ru; Chang, Chun-Hung; Huang, Ching-Yu; Lin, Chun-Yang; Lin, Wan-Ying; Lo, Yin-Chiu; Yang, Chia-Yu; Hsing, En-Wei; Chen, Lin-Fang; Shih, Shin-Ru; Shiau, Ai-Li; Lei, Huan-Yao; Tan, Tse-Hua; Ling, Pin			TBK1-associated Protein in Endolysosomes (TAPE)/CC2D1A Is a Key Regulator Linking RIG-I-like Receptors to Antiviral Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN PROTEIN; CC2D1A; TRAFFICKING; RECOGNITION; DROSOPHILA; STIMULATOR; RESPONSES; PATHWAY; SENSOR; GENE	Retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) are key RNA viral sensors for triggering antiviral immunity. The underlying mechanisms for RLRs to trigger antiviral immunity have yet to be explored. Here we report the identification of TAPE (TBK1-associated protein in endolysosomes) as a novel regulator of the RLR pathways. TAPE functionally and physically interacts with RIG-I, MDA5, and IPS-1 to activate the IFN-beta promoter. TAPE knockdown impairs IFN-beta activation induced by RLRs but not IPS-1. TAPE-deficient cells are defective in cytokine production upon RLR ligand stimulation. During RNA virus infection, TAPE knockdown or deficiency diminishes cytokine production and antiviral responses. Our data demonstrate a critical role for TAPE in linking RLRs to antiviral immunity.	[Chen, Kuan-Ru; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Chun-Hung; Lin, Chun-Yang; Lin, Wan-Ying; Lo, Yin-Chiu; Chen, Lin-Fang; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Huang, Ching-Yu; Yang, Chia-Yu; Hsing, En-Wei; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan; [Hsing, En-Wei] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Tsing Hua University; Baylor College of Medicine; Chang Gung University	Ling, P (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	lingpin@mail.ncku.edu.tw	Tan, Tse-Hua/ABD-7080-2021; Shih, Shin-Ru/M-9711-2016; Tan, Tse-Hua/E-3983-2010; shiau, A-Li/C-2885-2012; LING, PIN/C-6764-2009; Huang, Ching-Yu/E-3981-2010; Lin, Chun-Yang/AAH-1897-2020	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; shiau, A-Li/0000-0003-2449-8547; Lin, Chun-Yang/0000-0002-3064-0178; Huang, Ching-yu/0000-0002-5758-281X; Shih, Shin-Ru/0000-0003-4874-401X	National Science Council in Taiwan [NSC 97-2320-B-006-014-MY3, NSC 100-2320-B-006-013-MY3, NSC 100-2321-B-002-013]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council in Taiwan (Grants NSC 97-2320-B-006-014-MY3, NSC 100-2320-B-006-013-MY3, and NSC 100-2321-B-002-013).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chang CH, 2011, J BIOL CHEM, V286, P7043, DOI 10.1074/jbc.M110.164632; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Martinelli N, 2012, J MOL BIOL, V419, P75, DOI 10.1016/j.jmb.2012.02.044; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; Ou XM, 2003, J NEUROSCI, V23, P7415; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Usami Y, 2012, J VIROL, V86, P3746, DOI 10.1128/JVI.06539-11; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhao M, 2011, J NEUROPHYSIOL, V105, P1506, DOI 10.1152/jn.00950.2010; Zhao M, 2010, J BIOL CHEM, V285, P24372, DOI 10.1074/jbc.M109.100057; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	22	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32216	32221		10.1074/jbc.C112.394346	http://dx.doi.org/10.1074/jbc.C112.394346			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833682	Green Published, hybrid			2022-12-28	WOS:000309059400058
J	Desplats, P; Spencer, B; Crews, L; Pathel, P; Morvinski-Friedmann, D; Kosberg, K; Roberts, S; Patrick, C; Winner, B; Winkler, J; Masliah, E				Desplats, Paula; Spencer, Brian; Crews, Leslie; Pathel, Pruthul; Morvinski-Friedmann, Dinorah; Kosberg, Kori; Roberts, Scott; Patrick, Christina; Winner, Beate; Winkler, Juergen; Masliah, Eliezer			alpha-Synuclein Induces Alterations in Adult Neurogenesis in Parkinson Disease Models via p53-mediated Repression of Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PROGENITOR CELLS; GENE-EXPRESSION; DENTATE GYRUS; P53; APOPTOSIS; NEURONS; ARREST; GROWTH; MICE	Parkinson disease is characterized by the loss of dopaminergic neurons mainly in the substantia nigra. Accumulation of alpha-synuclein and cell loss has been also reported in many other brain regions including the hippocampus, where it might impair adult neurogenesis, contributing to nonmotor symptoms. However, the molecular mechanisms of these alterations are still unknown. In this report we show that alpha-synuclein-accumulating adult rat hippocampus neural progenitors present aberrant neuronal differentiation, with reduction of Notch1 expression and downstream signaling targets. We characterized a Notch1 proximal promoter that contains p53 canonical response elements. In vivo binding of p53 represses the transcription of Notch1 in neurons. Moreover, we demonstrated that alpha-synuclein directly binds to the DNA at Notch1 promoter vicinity and also interacts with p53 protein, facilitating or increasing Notch1 signaling repression, which interferes with maturation and survival of neural progenitors cells. This study provides a molecular basis for alpha-synuclein-mediated disruption of adult neurogenesis in Parkinson disease.	[Desplats, Paula; Spencer, Brian; Crews, Leslie; Pathel, Pruthul; Kosberg, Kori; Roberts, Scott; Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Morvinski-Friedmann, Dinorah] Salk Inst Biol Studies, La Jolla, CA 92093 USA; [Winner, Beate] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, Jr Res Grp 3, D-91054 Erlangen, Germany; [Winkler, Juergen] Univ Erlangen Nurnberg, Div Mol Neurol, D-91054 Erlangen, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Desplats, P (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr,MTF 344, La Jolla, CA 92093 USA.	pdesplat@ucsd.edu	Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019; Desplats, Paula/AFW-5030-2022; Crews, Leslie/B-7584-2014	Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Crews, Leslie/0000-0003-0704-0067	National Institutes of Health [AG5131, AG18440, AG22074, AG3197, AG10435, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R37AG018440, R01AG018440, P01AG022074, P01AG010435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG18440, AG22074, AG3197, AG10435, and NS057096 (to E.M.).	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Amson R, 2000, P NATL ACAD SCI USA, V97, P5346, DOI 10.1073/pnas.97.10.5346; Boardman PE, 2003, NUCLEIC ACIDS RES, V31, P3572, DOI 10.1093/nar/gkg511; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buchen Elizabeth T., 2008, V52, P267; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elliott RC, 2001, NEUROSCIENCE, V106, P79, DOI 10.1016/S0306-4522(01)00198-1; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Greenberg DA, 2006, NAT MED, V12, P884, DOI 10.1038/nm0806-884; Harding AJ, 2002, ANN NEUROL, V51, P125, DOI 10.1002/ana.10071; Hegde ML, 2003, ARCH BIOCHEM BIOPHYS, V418, P169, DOI 10.1016/j.abb.2003.08.015; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F; Jimenez JS, 2010, J ALZHEIMERS DIS, V22, P375, DOI 10.3233/JAD-2010-100189; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Kawai T, 2005, NEUROSCI LETT, V380, P17, DOI 10.1016/j.neulet.2005.01.005; Kempermann Gerd, 2008, V52, P159; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; Medrano S, 2005, BIOCHEM BIOPH RES CO, V331, P828, DOI 10.1016/j.bbrc.2005.03.194; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Qi RZ, 2003, CANCER RES, V63, P8323; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Winner B, 2004, J NEUROPATH EXP NEUR, V63, P1155, DOI 10.1093/jnen/63.11.1155; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06	57	53	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31691	31702		10.1074/jbc.M112.354522	http://dx.doi.org/10.1074/jbc.M112.354522			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833673	Green Published, hybrid			2022-12-28	WOS:000309059400011
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			A Conformational Switch in a Partially Unwound Helix Selectively Determines the Pathway for Substrate Release from the Carnitine/gamma-Butyrobetaine Antiporter CaiT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/BETAINE SYMPORTER BETP; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; GALACTOSE TRANSPORTER; MOLECULAR-DYNAMICS; STATE; NA+; METABOLISM; MECHANISM	CaiT is a homotrimeric antiporter that exchanges L-carnitine (CRN) with gamma-butyrobetaine(GBB) across the bacterial membrane. Three structures have been resolved to date for CaiT, all in the inward-facing state: CRN-bound (with four CRNs per subunit), GBB-bound (two GBBs per subunit), and apo. One of the reported binding sites is the counterpart of the primary site observed in structurally similar transporters. However, the mechanism and pathway(s) of CRN/GBB unbinding and translocation, or even the ability of the substrates to dislodge from the reported binding sites, are yet to be determined. To shed light on these issues, we performed a total of 1.3 mu s of molecular dynamics simulations and examined the dynamics of substrate-bound CaiT structures under different conditions. We find that both CRN and GBB are able to dissociate completely from their primary site into the cytoplasm. Substrate molecules initially located at the secondary sites dissociate even faster (within tens of nanoseconds) into the extra- or intra-cellular regions. Interestingly, the unbinding pathway from the primary site appears to be dictated by the geometry of the unwound part of the transmembrane (TM) helix 3, mostly around Thr(100) therein. Arg(262) on TM7, which apparently mimics the role of Na+ in CaiT structural homologues, plays a key role in triggering the dissociation of the substrate away from the primary site and guiding its release to the cytoplasm provided that the unwound part of TM3 switches from a shielding to a yielding pose.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3058 Biomed Sci Tower 3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE) [TG-MCB100144, 3P41 RR006009 20S1]; National Institutes of Health from the NIGMS [R01 GM086238]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238] Funding Source: NIH RePORTER	National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Science Foundation through resources provided by the Extreme Science and Engineering Discovery Environment (XSEDE) (Grants TG-MCB100144 and 3P41 RR006009 20S1) and by National Institutes of Health Grant R01 GM086238 from the NIGMS (to I. B.).	Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; FRITZ IB, 1964, AM J PHYSIOL, V206, P531, DOI 10.1152/ajplegacy.1964.206.3.531; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; JUNG K, 1987, J BASIC MICROB, V27, P131, DOI 10.1002/jobm.3620270303; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1; Li J, 2012, BBA-BIOMEMBRANES, V1818, P263, DOI 10.1016/j.bbamem.2011.09.011; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1271, DOI 10.1021/bi00857a007; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; TREEM WR, 1988, NEW ENGL J MED, V319, P1331, DOI 10.1056/NEJM198811173192006; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x; Zomot E, 2011, J BIOL CHEM, V286, P19693, DOI 10.1074/jbc.M110.202085; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	28	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31823	31832		10.1074/jbc.M112.397364	http://dx.doi.org/10.1074/jbc.M112.397364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843728	Green Published, hybrid			2022-12-28	WOS:000309059400023
J	Li, Y; Macdonald-Obermann, J; Westfall, C; Piwnica-Worms, D; Pike, LJ				Li, Yu; Macdonald-Obermann, Jennifer; Westfall, Corey; Piwnica-Worms, David; Pike, Linda J.			Quantitation of the Effect of ErbB2 on Epidermal Growth Factor Receptor Binding and Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; NEGATIVE COOPERATIVITY; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; DIMER FORMATION; LIGAND-BINDING; LIVING CELLS; DOMAIN; MEMBRANE	The epidermal growth factor (EGF) receptor is a member of the ErbB family of receptors that also includes ErbB2, ErbB3, and ErbB4. These receptors form homo- and heterodimers in response to ligand with ErbB2 being the preferred dimerization partner. Here we use I-125-EGF binding to quantitate the interaction of the EGF receptor with ErbB2. We show that the EGFR/ErbB2 heterodimer binds EGF with a 7-fold higher affinity than the EGFR homodimer. Because it cannot bind a second ligand, the EGFR/ErbB2 heterodimer is not subject to ligand-induced dissociation caused by the negatively cooperative binding of EGF to the second site on the EGFR homodimer. This increases the stability of the heterodimer relative to the homodimer and is associated with enhanced and prolonged EGF receptor autophosphorylation. These effects are independent of the kinase activity of ErbB2 but require back-to-back dimerization of the EGF receptor with ErbB2. Back-to-back dimerization is also required for phosphorylation of ErbB2. These findings provide a molecular explanation for the apparent preference of the EGF receptor for dimerizing with ErbB2 and suggest that the phosphorylation of ErbB2 occurs largely in the context of the EGFR/ErbB2 heterodimer, rather than through lateral phosphorylation of isolated ErbB2 subunits.	[Li, Yu; Macdonald-Obermann, Jennifer; Westfall, Corey; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu	Li, Yu/E-8600-2013		National Institutes of Health [R01GM82824, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM82824 (to L. J. P.) and P50 CA94056 (to D. P.-W.).	Adak S, 2011, J BIOL CHEM, V286, P45146, DOI 10.1074/jbc.M111.274175; Adak S, 2011, J BIOL CHEM, V286, P1545, DOI 10.1074/jbc.M110.182899; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; CONTRERAS MA, 1983, METHOD ENZYMOL, V92, P277; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; SARUP JC, 1991, GROWTH REGULAT, V1, P72; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	24	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31116	31125		10.1074/jbc.M112.373647	http://dx.doi.org/10.1074/jbc.M112.373647			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822073	Green Published, hybrid			2022-12-28	WOS:000308791300024
J	Maes, M; Rimon, A; Kozachkov-Magrisso, L; Friedler, A; Padan, E				Maes, Michal; Rimon, Abraham; Kozachkov-Magrisso, Lena; Friedler, Assaf; Padan, Etana			Revealing the Ligand Binding Site of NhaA Na+/H+ Antiporter and Its pH Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL INTERACTIONS; EVOLUTIONARY ORIGINS; TRANSMEMBRANE DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; MODEL-STRUCTURE; ION-TRANSPORT; ALKALINE PH; MEMBRANE	pH and Na+ homeostasis in all cells requires Na+/H+ antiporters. In most cases, their activity is tightly pH-regulated. NhaA, the main antiporter of Escherichia coli, has homologues in all biological kingdoms. The crystal structure of NhaA provided insights into the mechanism of action and pH regulation of an antiporter. However, the active site of NhaA remained elusive because neither Na+ nor Li+, the NhaA ligands, were observed in the structure. Using isothermal titration calorimetry, we show that purified NhaA binds Li+ in detergent micelles. This interaction is driven by an increase in enthalpy (Delta H of -8000 +/- 300 cal/mol and Delta S of -15.2 cal/mol/degree at 283 K), involves a single binding site per NhaA molecule, and is highly specific and drastically dependent on pH; Li+ binding was observed only at pH 8.5. Combining mutational analysis with the isothermal titration calorimetry measurements revealed that Asp-163, Asp-164, Thr-132, and Asp-133 form the Li+ binding site, whereas Lys-300 plays an important role in pH regulation of the antiporter.	[Maes, Michal; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, Alexander Silberman Inst Life Sci, Fac Sci, IL-91904 Jerusalem, Israel; [Rimon, Abraham; Kozachkov-Magrisso, Lena; Padan, Etana] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, Fac Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Alexander Silberman Inst Life Sci, Fac Sci, Safra Campus, IL-91904 Jerusalem, Israel.	assaf.friedler@mail.huji.ac.il; etana@vms.huji.ac.il		Maes, Michal/0000-0002-7406-3982	European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7; United State-Israel Binational Science Foundation (BSF) [501/03-16.2]; Israel Science Foundation [284/12]; European Research Council under the European Community Seventh Framework Programme [203413]	European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7; United State-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); European Research Council under the European Community Seventh Framework Programme	This work was supported in part by European Drug Initiative on Channels and Transporters (EDICT) Grant EU FP 7, United State-Israel Binational Science Foundation (BSF) Grant 501/03-16.2, and Israel Science Foundation Grant 284/12 (to E. P.).; Supported by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 203413. To whom correspondence may be addressed. Tel.: 972-2-6585746; Fax: 972-2-6585345; E-mail: assaf.friedler@mail.huji.ac.il.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Inoue S, 2001, J BIOCHEM, V129, P569, DOI 10.1093/oxfordjournals.jbchem.a002892; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuwabara N, 2006, BIOCHEMISTRY-US, V45, P14834, DOI 10.1021/bi061048d; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; Noumi T, 1997, J BIOCHEM-TOKYO, V121, P661; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1993, J BIOENERG BIOMEMBR, V25, P647; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A., 1997, THESIS HEBREW U JERU; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	45	43	43	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.391128	http://dx.doi.org/10.1074/jbc.M112.391128			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22915592	hybrid, Green Published			2022-12-28	WOS:000310642200048
J	Benedusi, V; Martorana, F; Brambilla, L; Maggi, A; Rossi, D				Benedusi, Valeria; Martorana, Francesca; Brambilla, Liliana; Maggi, Adriana; Rossi, Daniela			The Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; SKELETAL-MUSCLE; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; SPINAL-CORDS; ANIMAL-MODEL; SURVIVAL; DISEASE; CELLS	Recent evidence highlights the peroxisome proliferator-activated receptors (PPARs) as critical neuroprotective factors in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). To gain new mechanistic insights into the role of these receptors in the context of ALS, here we investigated how PPAR transcriptional activity varies in hSOD1(G93A) ALS transgenic mice. We demonstrate that PPAR gamma-driven transcription selectively increases in the spinal cord of symptomatic hSOD1(G93A) mice. This phenomenon correlates with the up-regulation of target genes, such as lipoprotein lipase and glutathione S-transferase alpha-2, which are implicated in scavenging lipid peroxidation by-products. Such events are associated with enhanced PPAR gamma immunoreactivity within motor neuronal nuclei. This observation, and the fact that PPAR gamma displays increased responsiveness in cultured hSOD1(G93A) motor neurons, points to a role for this receptor in neutralizing deleterious lipoperoxidation derivatives within the motor cells. Consistently, in both motor neuron-like cultures and animal models, we report that PPAR gamma is activated by lipid peroxidation end products, such as 4-hydroxynonenal, whose levels are elevated in the cerebrospinal fluid and spinal cord from ALS patients. We propose that the accumulation of critical concentrations of lipid peroxidation adducts during ALS progression leads to the activation of PPAR gamma in motor neurons. This in turn triggers self-protective mechanisms that involve the up-regulation of lipid detoxification enzymes, such as lipoprotein lipase and glutathione S-transferase alpha-2. Our findings indicate that anticipating natural protective reactions by pharmacologically modulating PPAR gamma transcriptional activity may attenuate neurodegeneration by limiting the damage induced by lipid peroxidation derivatives.	[Martorana, Francesca; Brambilla, Liliana; Rossi, Daniela] IRCCS Fdn Salvatore Maugeri, Lab Res Neurodegenerat Disorders, I-27100 Pavia, Italy; [Benedusi, Valeria; Maggi, Adriana] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Benedusi, Valeria; Maggi, Adriana] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; University of Milan	Rossi, D (corresponding author), IRCCS Fdn Salvatore Maugeri, Lab Res Neurodegenerat Disorders, I-27100 Pavia, Italy.	daniela.rossi@fsm.it	Brambilla, Liliana/AAA-3303-2021; Rossi, Daniela Maria/AAA-3401-2021	Brambilla, Liliana/0000-0001-5714-3625; Rossi, Daniela Maria/0000-0002-3346-1327; Maggi, Adriana/0000-0001-5700-5273; MARTORANA, FRANCESCA/0000-0003-4091-8134; Benedusi, Valeria/0000-0003-4791-4806	Telethon Foundation [GGP05244]; Italian Ministry of Health; European Union [NoE DIMI LSHBCT-2005-512146, 278850]	Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	This work was supported by Telethon Foundation Grant GGP05244 (to D. R.), the Italian Ministry of Health, European Union's Sixth Framework Programme under grant agreement NoE DIMI LSHBCT-2005-512146 (Diagnostic Molecular Imaging - DiMI) (to A. M.), and Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278850 (Imaging of Neuroinflammation in Neurodegenerative Diseases - INMiND) (to A. M.).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200; Amin RH, 2010, AM J PHYSIOL-ENDOC M, V298, pE28, DOI 10.1152/ajpendo.00446.2009; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Benedusi V, 2012, ENDOCRINOLOGY, V153, P2777, DOI 10.1210/en.2011-1925; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chen HF, 2010, BRAIN RES, V1340, P52, DOI 10.1016/j.brainres.2010.03.075; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Cullingford TE, 2002, NEUROPHARMACOLOGY, V42, P724, DOI 10.1016/S0028-3908(02)00014-X; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; FRISA PS, 1994, J NEUROSCI RES, V39, P47, DOI 10.1002/jnr.490390107; GUNTINASLICHIUS O, 1993, J MICROSC-OXFORD, V172, P177, DOI 10.1111/j.1365-2818.1993.tb03409.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Miana-Mena FJ, 2011, J NEUROL, V258, P762, DOI 10.1007/s00415-010-5825-8; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017985; Lever TE, 2009, DYSPHAGIA, V24, P180, DOI 10.1007/s00455-008-9190-z; Liang HY, 2011, MUSCLE NERVE, V44, P947, DOI 10.1002/mus.22217; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Paradis E, 2003, J BIOL CHEM, V278, P9698, DOI 10.1074/jbc.M208452200; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pedersen WA, 1999, EXP NEUROL, V155, P1, DOI 10.1006/exnr.1998.6890; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Shibata N, 2004, BRAIN RES, V1019, P170, DOI 10.1016/j.brainres.2004.05.110; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Vigh L, 2005, ACTA NEUROPATHOL, V109, P567, DOI 10.1007/s00401-004-0977-1; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009	69	46	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35899	35911		10.1074/jbc.M112.366419	http://dx.doi.org/10.1074/jbc.M112.366419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22910911	hybrid, Green Published			2022-12-28	WOS:000310364000012
J	Nam, KH; Ding, F; Haitjema, C; Huang, QQ; DeLisa, MP; Ke, AL				Nam, Ki Hyun; Ding, Fran; Haitjema, Charles; Huang, Qingqiu; DeLisa, Matthew P.; Ke, Ailong			Double-stranded Endonuclease Activity in Bacillus halodurans Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated Cas2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; CRISPR/CAS SYSTEM; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; RNA; BACTERIA; DEFENSE; DNA; RECOGNITION; SEQUENCE	The CRISPR (clustered regularly interspaced short palindromic repeats) system is a prokaryotic RNA-based adaptive immune system against extrachromosomal genetic elements. Cas2 is a universally conserved core CRISPR-associated protein required for the acquisition of new spacers for CRISPR adaptation. It was previously characterized as an endoribonuclease with preference for single-stranded (ss) RNA. Here, we show using crystallography, mutagenesis, and isothermal titration calorimetry that the Bacillus halodurans Cas2 (Bha_Cas2) from the subtype I-C/Dvulg CRISPR instead possesses metal-dependent endonuclease activity against double-stranded (ds) DNA. This activity is consistent with its putative function in producing new spacers for insertion into the 5'-end of the CRISPR locus. Mutagenesis and isothermal titration calorimetry studies revealed that a single divalent metal ion (Mg2+ or Mn2+), coordinated by a symmetric Asp pair in the Bha_Cas2 dimer, is involved in the catalysis. We envision that a pH-dependent conformational change switches Cas2 into a metal-binding competent conformation for catalysis. We further propose that the distinct substrate preferences among Cas2 proteins may be determined by the sequence and structure in the beta 1-alpha 1 loop.	[Nam, Ki Hyun; Ding, Fran; Huang, Qingqiu; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Haitjema, Charles; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Huang, Qingqiu] Cornell Univ, Macromol Diffract Facil, CHESS, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ak425@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Nam, Ki Hyun/N-6812-2019	Nam, Ki Hyun/0000-0003-3268-354X; DeLisa, Matthew/0000-0003-3226-1566	Public Health Service [GM-086766, GM-059604]; National Research Foundation of Korea; Korean Ministry of Education, Science, and Technology [NRF-2010-357-C00106]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086766, R01GM059604, R01GM102543] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by the Public Health Service Grants GM-086766 and GM-059604 (to A. K.) and by the National Research Foundation of Korea Grant from the Korean Ministry of Education, Science, and Technology NRF-2010-357-C00106 (to K. H. N.).	Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P1928, DOI 10.1016/j.febslet.2009.04.047; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	48	62	70	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35943	35952		10.1074/jbc.M112.382598	http://dx.doi.org/10.1074/jbc.M112.382598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22942283	hybrid, Green Published			2022-12-28	WOS:000310364000016
J	Delphin, C; Bouvier, D; Seggio, M; Couriol, E; Saoudi, Y; Denarier, E; Bosc, C; Valiron, O; Bisbal, M; Arnal, I; Andrieux, A				Delphin, Christian; Bouvier, Denis; Seggio, Maxime; Couriol, Emilie; Saoudi, Yasmina; Denarier, Eric; Bosc, Christophe; Valiron, Odile; Bisbal, Mariano; Arnal, Isabelle; Andrieux, Annie			MAP6-F Is a Temperature Sensor That Directly Binds to and Protects Microtubules from Cold-induced Depolymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOP PROTEINS; ANTARCTIC FISHES; BETA-STRUCTURE; DAILY TORPOR; ENDS; TUBULINS; STABILIZATION; DOUBLECORTIN; HIBERNATION; STABILITY	Microtubules are dynamic structures that present the peculiar characteristic to be ice-cold labile in vitro. In vivo, microtubules are protected from ice-cold induced depolymerization by the widely expressed MAP6/STOP family of proteins. However, the mechanism by which MAP6 stabilizes microtubules at 4 degrees C has not been identified. Moreover, the microtubule cold sensitivity and therefore the needs for microtubule stabilization in the wide range of temperatures between 4 and 37 degrees C are unknown. This is of importance as body temperatures of animals can drop during hibernation or torpor covering a large range of temperatures. Here, we show that in the absence of MAP6, microtubules in cells below 20 degrees C rapidly depolymerize in a temperature-dependent manner whereas they are stabilized in the presence of MAP6. We further show that in cells, MAP6-F binding to and stabilization of microtubules is temperature-dependent and very dynamic, suggesting a direct effect of the temperature on the formation of microtubule/MAP6 complex. We also demonstrate using purified proteins that MAP6-F binds directly to microtubules through its Mc domain. This binding is temperature-dependent and coincides with progressive conformational changes of the Mc domain as revealed by circular dichroism. Thus, MAP6 might serve as a temperature sensor adapting its conformation according to the temperature to maintain the cellular microtubule network in organisms exposed to temperature decrease.	[Delphin, Christian; Seggio, Maxime; Couriol, Emilie; Saoudi, Yasmina; Denarier, Eric; Bosc, Christophe; Valiron, Odile; Bisbal, Mariano; Andrieux, Annie] Inst Natl Sante & Rech Med, Commissariat Energie Atom, Team Physiopathol Cytoskeleton 1, GIN iRTSV GPC U836, F-38042 Grenoble 9, France; [Bouvier, Denis] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Arnal, Isabelle] Inst Natl Sante & Rech Med, Team Dynam & Struct Regulat Cytoskeleton 13, GIN U836, F-38042 Grenoble 9, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm)	Delphin, C (corresponding author), Univ Grenoble 1, Inserm U836, Equipe 1, Batiment Edmond J Safra,Site Sante La Tronche,BP, F-38042 Grenoble 9, France.	christian.delphin@ujf-grenoble.fr	Denarier, Eric/X-6137-2019; saoudi, yasmina/AAW-7354-2020; Bosc, Christophe/P-3401-2017; Arnal, Isabelle/X-6559-2019; Denarier, Eric/H-3555-2017; Bosc, Christophe/Q-8877-2019; Bisbal, Mariano/AAE-9308-2021; ANDRIEUX, ANNIE/B-2134-2017; Christian, Delphin/P-9284-2017	Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Bisbal, Mariano/0000-0002-3870-6151; ANDRIEUX, ANNIE/0000-0002-4022-6405; Christian, Delphin/0000-0003-3240-8695; Arnal, Isabelle/0000-0001-6149-8189	INSERM; CEA; University Joseph Fourier; French National Research Agency [2010Blan120201 CBioS]; Roche Pharmaceutic RPF program	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); University Joseph Fourier; French National Research Agency(French National Research Agency (ANR)); Roche Pharmaceutic RPF program	This work was supported by INSERM, CEA, University Joseph Fourier, and French National Research Agency Awards 2010Blan120201 CBioS (to A. A.).; Recipient of the Roche Pharmaceutic RPF program (AA team and F Hoffmann-La Roche Ltd, Basel, Switzerland).	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Detrich HW, 1997, COMP BIOCHEM PHYS A, V118, P501, DOI 10.1016/S0300-9629(97)00012-1; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Letournel F, 2003, J NEUROPATH EXP NEUR, V62, P1211, DOI 10.1093/jnen/62.12.1211; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Modig C, 2000, BIOCHEM BIOPH RES CO, V269, P787, DOI 10.1006/bbrc.2000.2362; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; OLMSTED JB, 1975, BIOCHEMISTRY-US, V14, P2996, DOI 10.1021/bi00684a032; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; REGULA CS, 1981, J CELL BIOL, V89, P45, DOI 10.1083/jcb.89.1.45; SCHILSTRA MJ, 1991, BIOCHEM J, V277, P839, DOI 10.1042/bj2770839; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; VERA JC, 1988, FEBS LETT, V232, P159, DOI 10.1016/0014-5793(88)80408-3; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5	36	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35127	35138		10.1074/jbc.M112.398339	http://dx.doi.org/10.1074/jbc.M112.398339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904321	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000309968000023
J	Fujikawa, M; Kobayashi, K; Kozawa, T				Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro			Direct Oxidation of the [2Fe-2S] Cluster in SoxR Protein by Superoxide DISTINCT DIFFERENTIAL SENSITIVITY TO SUPEROXIDE-MEDIATED SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS SENSOR SOXR; ESCHERICHIA-COLI; PULSE-RADIOLYSIS; PSEUDOMONAS-AERUGINOSA; RESPONSE REGULON; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; GENE-EXPRESSION; IN-VIVO; DNA	The [2Fe-2S] transcription factor SoxR is activated by reversible one-electron oxidation of its [2Fe-2S] cluster, leading to enhanced production of various antioxidant proteins through induction of the soxRS regulon in Escherichia coli. Recently, there has been considerable debate about whether superoxide (O (center dot) over bar (2).) activates SoxR directly. To elucidate the underlying activation mechanism, we investigated SoxR interaction with O (center dot) over bar (2). using pulse radiolysis. Radiolytically generated hydrated electrons reduced the oxidized form of the [2Fe-2S] cluster of SoxR within 2 mu s. A subsequent increase in absorption in the visible region corresponding to reoxidation of the [2Fe-2S] cluster was observed on a time scale of milliseconds. Addition of human copper/zinc superoxide dismutase inhibited this delayed oxidation in a concentration-dependent fashion (I-50 = 1.0 mu M), indicating that O (center dot) over bar (2). oxidized the reduced form of SoxR directly. The second-order rate constant of this process was estimated to be 5 x 10(8) M-1 s(-1). A similar result was observed after pulse radiolysis of Pseudomonas aeruginosa SoxR. However, superoxide dismutase inhibited the oxidation of reduced SoxR much more effectively in P. aeruginosa, even at a lower concentration (I-50 = 80 nM), indicating that the soxRS response is much more sensitive to O (center dot) over bar2. in E. coli than in P. aeruginosa. These results suggest that SoxR proteins play a distinct regulatory role in the activation of O (center dot) over bar2.	[Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Osaka University	Kobayashi, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Ibaraki, Osaka 5670047, Japan.	kobayasi@sanken.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research (C) from the Ministry of Education, Science, Sports, and Culture of Japan (to K.K.).	ANSARI AZ, 1995, NATURE, V374, P371; BIELSKI BHJ, 1978, PHOTOCHEM PHOTOBIOL, V28, P645, DOI 10.1111/j.1751-1097.1978.tb06986.x; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Bonnot F, 2012, J AM CHEM SOC, V134, P5120, DOI 10.1021/ja209297n; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Coulter ED, 2000, J AM CHEM SOC, V122, P11555, DOI 10.1021/ja005583r; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; HASE T, 1977, J BIOCHEM-TOKYO, V82, P267, DOI 10.1093/oxfordjournals.jbchem.a131679; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056; Hidalgo Elena, 1996, P435; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; KLUG D, 1972, J BIOL CHEM, V247, P4839; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Kobayashi K, 1999, FEBS LETT, V451, P227, DOI 10.1016/S0014-5793(99)00565-7; KOBAYASHI K, 1989, J BIOL CHEM, V264, P15280; KOBAYASHI K, 1995, J CHEM SOC DALTON, P2885, DOI 10.1039/dt9950002885; Kobayashi K, 2011, BIOCHEMISTRY-US, V50, P9468, DOI 10.1021/bi201526y; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Kovacs JA, 2007, ACCOUNTS CHEM RES, V40, P501, DOI 10.1021/ar600059h; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; KUO CF, 1987, J BIOL CHEM, V262, P4724; LIOCHEV SI, 1991, J BIOL CHEM, V266, P8747; LIOCHEV SI, 1993, ARCH BIOCHEM BIOPHYS, V301, P379, DOI 10.1006/abbi.1993.1159; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Liochev SI, 2011, FREE RADICAL BIO MED, V50, P1813, DOI 10.1016/j.freeradbiomed.2011.03.029; Mathe C, 2005, J AM CHEM SOC, V127, P16436, DOI 10.1021/ja053808y; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; Mustafa G, 2008, J BIOL CHEM, V283, P22215, DOI 10.1074/jbc.M800911200; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; PICK M, 1974, J AM CHEM SOC, V96, P7329, DOI 10.1021/ja00830a026; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; SAWADA Y, 1975, BIOCHEMISTRY-US, V14, P3761, DOI 10.1021/bi00688a007; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Watanabe S, 2006, ACTA CRYSTALLOGR F, V62, P1275, DOI 10.1107/S1744309106048482; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; WU J, 1995, J BIOL CHEM, V270, P10323, DOI 10.1074/jbc.270.17.10323	62	39	40	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35702	35708		10.1074/jbc.M112.395079	http://dx.doi.org/10.1074/jbc.M112.395079			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22908228	hybrid, Green Published			2022-12-28	WOS:000309968000081
J	Gregory, AD; Hale, P; Perlmutter, DH; Houghton, AM				Gregory, Alyssa D.; Hale, Pamela; Perlmutter, David H.; Houghton, A. McGarry			Clathrin Pit-mediated Endocytosis of Neutrophil Elastase and Cathepsin G by Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; COMPLEX SEC RECEPTOR; PHYSIOLOGICAL FUNCTIONS; NONOXIDATIVE MECHANISM; MEASLES-VIRUS; LUNG INJURY; DEGRADATION; MICE; EMPHYSEMA; MUTANTS	Neutrophil elastase (NE) is a neutrophil-derived serine proteinase with broad substrate specificity. We have recently demonstrated that NE is capable of entering tumor cell endosomes and processing novel intracellular substrates. In the current study, we sought to determine the mechanism by which NE enters tumor cells. Our results show that NE enters into early endosomal antigen-1(+) endosomes in a dynamin- and clathrin-dependent but flotillin-1- and caveolin-1-independent fashion. Cathepsin G (but not proteinase-3) also enters tumor endosomes via the same mechanism. We utilized I-125-labeled NE to demonstrate that NE binds to the surface of cancer cells. Incubation of radiolabeled NE with lung cancer cells displays a dissociation constant (K-d) of 284 nM. Because NE is known to bind to heparan sulfate-and chondroitin sulfate-containing proteoglycans, we treated cells with glycanases to remove these confounding factors, which did not significantly diminish cell surface binding or endosomal entry. Thus, NE and CG bind to the surface of cancer cells, presumably to a cell surface receptor, and subsequently undergo clathrin pit-mediated endocytosis.	[Houghton, A. McGarry] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Gregory, Alyssa D.; Houghton, A. McGarry] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Hale, Pamela; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Houghton, A. McGarry] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle	Houghton, AM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,POB 19024,D4-100, Seattle, WA 98109 USA.	houghton@fhcrc.org			National Institutes of Health through NHLBI [R01HL108979]; NHLBI [5T32HL007563]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563, R01HL108979] Funding Source: NIH RePORTER	National Institutes of Health through NHLBI; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL108979 through the NHLBI (to A. M. H.) and 5T32HL007563-24 through the NHLBI (to A. D. G.). This work was also supported by an American Lung Association senior research award (to A. D. G.).	BAUGH RJ, 1976, BIOCHEMISTRY-US, V15, P836, DOI 10.1021/bi00649a017; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Buchholz CJ, 1997, J BIOL CHEM, V272, P22072, DOI 10.1074/jbc.272.35.22072; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; JOSLIN G, 1992, J CLIN INVEST, V90, P1150, DOI 10.1172/JCI115934; Kaynar AM, 2008, AM J RESP CELL MOL, V39, P53, DOI 10.1165/rcmb.2007-0315OC; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Liou TG, 1996, J IMMUNOL, V157, P2624; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; SENIOR RM, 1977, AM REV RESPIR DIS, V116, P469, DOI 10.1164/arrd.1977.116.3.469; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a	30	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35341	35350		10.1074/jbc.M112.385617	http://dx.doi.org/10.1074/jbc.M112.385617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22915586	Green Published, hybrid			2022-12-28	WOS:000309968000043
J	Wang, WF; Guo, J; Yu, DY; Vorster, PJ; Chen, WJ; Wu, YT				Wang, Weifeng; Guo, Jia; Yu, Dongyang; Vorster, Paul J.; Chen, WanJun; Wu, Yuntao			A Dichotomy in Cortical Actin and Chemotactic Actin Activity between Human Memory and Naive T Cells Contributes to Their Differential Susceptibility to HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CCR7 LIGANDS CCL19; PREFERENTIAL REPLICATION; VIRAL REPLICATION; TRANSCRIPTION; LYMPHOCYTES; ENTRY; COSTIMULATION; RESERVOIR; MOVEMENT	Human memory and naive CD4 T cells can mainly be identified by the reciprocal expression of the CD45RO or CD45RA isoforms. In HIV-1 infection, blood CD45RO memory CD4 T cells are preferentially infected and serve as a major viral reservoir. The molecular mechanism dictating this differential susceptibility to HIV-1 remains largely obscure. Here, we report that the different susceptibility of memory and naive T cells to HIV is not determined by restriction factors such as Apobec3G or BST2. However, we observed a phenotypic distinction between human CD45RO and CD45RA resting CD4 T cells in their cortical actin density and actin dynamics. CD45RO CD4 T cells possess a higher cortical actin density and can be distinguished as CD45RO(+)Actin(high). In contrast, CD45RA T cells are phenotypically CD45RA(+)Actin(low). In addition, the cortical actin in CD45RO memory CD4 T cells is more dynamic and can respond to low dosages of chemotactic induction by SDF-1, whereas that of naive cells cannot, despite a similar level of the chemokine receptor CXCR4 present on both cells. We further demonstrate that this difference in the cortical actin contributes to their differential susceptibility to HIV-1; resting memory but not naive T cells are highly responsive to HIV-mediated actin dynamics that promote higher levels of viral entry and early DNA synthesis in resting memory CD4 T cells. Furthermore, transient induction of actin dynamics in resting naive T cells rescues HIV latent infection following CD3/CD28 stimulation. These results suggest a key role of chemotactic actin activity in facilitating HIV-1 latent infection of these T cell subsets.	[Wang, Weifeng; Guo, Jia; Yu, Dongyang; Vorster, Paul J.; Wu, Yuntao] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Chen, WanJun] NIDCR, Mucosal Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Wu, YT (corresponding author), George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, 10900 Univ Blvd, Manassas, VA 20110 USA.	ywu8@gmu.edu	Guo, Jia/C-8678-2014; wang, weifeng/N-4140-2013; Guo, Jia/L-2102-2013	Love, Zelda/0000-0002-2478-7720	National Institutes of Health USPHS Grant from NIAID [1R01AI081568]; National Institutes of Health Intramural Research Program of NIDCR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	National Institutes of Health USPHS Grant from NIAID; National Institutes of Health Intramural Research Program of NIDCR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health USPHS Grant 1R01AI081568; Supported by National Institutes of Health Intramural Research Program of NIDCR.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Ansari AW, 2006, INT IMMUNOL, V18, P1443, DOI 10.1093/intimm/dxl078; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Beverley P C, 1992, Semin Immunol, V4, P35; BEVERLEY PCL, 1991, IMMUNOL RES, V10, P196, DOI 10.1007/BF02919692; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CAYOTA A, 1990, LANCET, V336, P941, DOI 10.1016/0140-6736(90)92311-5; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CROFT M, 1994, J IMMUNOL, V152, P2675; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; Damas JK, 2009, CLIN EXP IMMUNOL, V157, P400, DOI 10.1111/j.1365-2249.2009.03976.x; Damas JK, 2009, AIDS, V23, P135, DOI 10.1097/QAD.0b013e32831cf595; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; FENYO EM, 1988, J VIROL, V62, P4414; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Helbert MR, 1997, CLIN EXP IMMUNOL, V107, P300, DOI 10.1111/j.1365-2249.1997.280-ce1170.x; Jin F, 2008, BONE MARROW TRANSPL, V42, P581, DOI 10.1038/bmt.2008.222; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Korin YD, 1999, J VIROL, V73, P6526, DOI 10.1128/JVI.73.8.6526-6532.1999; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; MEDINA E, 1994, CLIN EXP IMMUNOL, V97, P266, DOI 10.1111/j.1365-2249.1994.tb06079.x; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Ratajczak MZ, 2010, LEUKEMIA, V24, P976, DOI 10.1038/leu.2010.53; Riley JL, 1998, J VIROL, V72, P8273, DOI 10.1128/JVI.72.10.8273-8280.1998; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; STOUT RD, 1992, CELL IMMUNOL, V141, P433, DOI 10.1016/0008-8749(92)90161-H; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Woods TC, 1997, BLOOD, V89, P1635, DOI 10.1182/blood.V89.5.1635.1635_1635_1641; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Wu YT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-86; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	69	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35455	35469		10.1074/jbc.M112.362400	http://dx.doi.org/10.1074/jbc.M112.362400			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22879601	hybrid, Green Published			2022-12-28	WOS:000309968000055
J	Huck, B; Kemkemer, R; Franz-Wachtel, M; Macek, B; Hausser, A; Olayioye, MA				Huck, Bettina; Kemkemer, Ralf; Franz-Wachtel, Mirita; Macek, Boris; Hausser, Angelika; Olayioye, Monilola A.			GIT1 Phosphorylation on Serine 46 by PKD3 Regulates Paxillin Trafficking and Cellular Protrusive Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; P21-ACTIVATED KINASE; MASS-SPECTROMETRY; SIGNALING COMPLEX; FOCAL ADHESIONS; LEADING-EDGE; ACTIN; MIGRATION; ACTIVATION; TRANSPORT	The continuous assembly and disassembly of focal adhesions is required for efficient cell spreading and migration. The G-protein-coupled receptor kinase-interacting protein 1 (GIT1) is a multidomain protein whose dynamic localization to sites of cytoskeletal remodeling is critically involved in the regulation of these processes. Here we provide evidence that the subcellular localization of GIT1 is regulated by protein kinase D3 (PKD3) through direct phosphorylation on serine 46. GIT1 phosphorylation on serine 46 was abrograted by PKD3 depletion, thereby identifying GIT1 as the first specific substrate for this kinase. A GIT1 S46D phosphomimetic mutant localized to motile, paxillin-positive cytoplasmic complexes, whereas the phosphorylation-deficient GIT1 S46A was enriched in focal adhesions. We propose that phosphorylation of GIT1 on serine 46 by PKD3 represents a molecular switch by which GIT1 localization, paxillin trafficking, and cellular protrusive activity are regulated.	[Huck, Bettina; Hausser, Angelika; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr Tuebingen, D-72076 Tubingen, Germany	University of Stuttgart; Max Planck Society; Eberhard Karls University of Tubingen	Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de	Macek, Boris/N-1442-2015; Hausser, Angelika/AAC-4531-2021	Macek, Boris/0000-0002-1206-2458; 	German Cancer Aid [109583]; Landesgraduiertenforderung; DFG	German Cancer Aid(Deutsche Krebshilfe); Landesgraduiertenforderung; DFG(German Research Foundation (DFG))	This work was funded by the German Cancer Aid 109583.; Supported by a fellowship from the Landesgraduiertenforderung.; Supported by the DFG Heisenberg program. To whom correspondence should be addressed: University of Stuttgart, Institute of Cell Biology and Immunology, Allmandring 31, 70569 Stuttgart, Germany. Tel.: 49-711-685-69301; Fax: 49-711-685-66774; E-mail: monilola.olayioye@izi.uni-stuttgart.de.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Manabe R, 2002, J CELL SCI, V115, P1497; Matafora V, 2001, J CELL SCI, V114, P4509; Mayhew MW, 2006, J PROTEOME RES, V5, P2417, DOI 10.1021/pr060140t; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ren YX, 2012, MOL CELL BIOCHEM, V365, P109, DOI 10.1007/s11010-012-1249-3; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34604	34613		10.1074/jbc.M112.374652	http://dx.doi.org/10.1074/jbc.M112.374652			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893698	hybrid, Green Published			2022-12-28	WOS:000309654200063
J	Majumdar, R; Railkar, R; Dighe, RR				Majumdar, Ritankar; Railkar, Reema; Dighe, Rajan R.			The Antibodies against the Computationally Designed Mimic of the Glycoprotein Hormone Receptor Transmembrane Domain Provide Insights into Receptor Activation and Suppress the Constitutively Activated Receptor Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-STIMULATING HORMONE; THYROTROPIN RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; LIGAND-BINDING; HINGE REGION; LUTROPIN RECEPTOR; ALPHA-SUBUNIT; LOOP; ECTODOMAIN	The exoloops of glycoprotein hormone receptors (GpHRs) transduce the signal generated by the ligand-ectodomain interactions to the transmembrane helices either through direct hormonal contact and/or by modulating the interdomain interactions between the hinge region (HinR) and the transmembrane domain (TMD). The ligand-induced conformational alterations in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormone receptor/thyroid stimulating hormone receptor were mapped using exoloop-specific antibodies generated against a mini-TMD protein designed to mimic the native exoloop conformations that were created by joining the thyroid stimulating hormone receptor exoloops constrained through helical tethers and library-derived linkers. The antibody against the mini-TMD specifically recognized all three GpHRs and inhibited the basal and hormone-stimulated cAMP production without affecting hormone binding. Interestingly, binding of the antibody to all three receptors was abolished by prior incubation of the receptors with the respective hormones, suggesting that the exoloops are buried in the hormone-receptor complexes. The antibody also suppressed the high basal activities of gain-of-function mutations in the HinRs, exoloops, and TMDs such as those involved in precocious puberty and thyroid toxic adenomas. Using the antibody and point/deletion/chimeric receptor mutants, we demonstrate that changes in the HinR-exoloop interactions play an important role in receptor activation. Computational analysis suggests that the mini-TMD antibodies act by conformationally locking the transmembrane helices by means of restraining the exoloops and the juxta-membrane regions. Using GpHRs as a model, we describe a novel computational approach of generating soluble TMD mimics that can be used to explain the role of exoloops during receptor activation and their interplay with TMDs.	[Majumdar, Ritankar; Railkar, Reema; Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Dighe, RR (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in	Railkar, Reema/AAE-7258-2022; Majumdar, Ritankar/AAE-7249-2022	Majumdar, Ritankar/0000-0001-6624-0187; Railkar, Reema/0000-0002-6808-7814	Department of Biotechnology, Government of India, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India, New Delhi.; Recipient of a Council of Scientific and Industrial Research, New Delhi, fellowship.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; Dupakuntla M, 2010, MOL CELL ENDOCRINOL, V315, P131, DOI 10.1016/j.mce.2009.10.002; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Gadkari RA, 2007, MOL CELL ENDOCRINOL, V260, P23, DOI 10.1016/j.mce.2006.07.006; GUSTAVSSON B, 1994, BIOCHEM BIOPH RES CO, V199, P612, DOI 10.1006/bbrc.1994.1272; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Heymann B, 2001, BIOPHYS J, V81, P1295, DOI 10.1016/S0006-3495(01)75787-6; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; KANESHIGE M, 1995, HORM METAB RES, V27, P267, DOI 10.1055/s-2007-979956; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kosugi S, 1997, FEBS LETT, V406, P139, DOI 10.1016/S0014-5793(97)00256-1; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Majumdar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040291; Majumdar R, 2012, FEBS LETT, V586, P810, DOI 10.1016/j.febslet.2012.01.052; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; MOYLE WR, 1995, J BIOL CHEM, V270, P20020, DOI 10.1074/jbc.270.34.20020; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Neumann S, 2001, MOL ENDOCRINOL, V15, P1294, DOI 10.1210/me.15.8.1294; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Saha S, 2010, METALLOMICS, V2, P754, DOI 10.1039/c0mt00028k; Shinozaki H, 2001, MOL ENDOCRINOL, V15, P972, DOI 10.1210/me.15.6.972; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wonerow P, 2001, J MOL MED, V79, P707, DOI 10.1007/s001090100279; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Yeagle PL, 1997, BIOCHEMISTRY-US, V36, P9649, DOI 10.1021/bi970908a; YOO JK, 1993, J BIOL CHEM, V268, P13034; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	52	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34514	34532		10.1074/jbc.M112.355032	http://dx.doi.org/10.1074/jbc.M112.355032			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904318	Green Published, hybrid			2022-12-28	WOS:000309654200056
J	Zhang, DY; Li, JX; Zhang, M; Gao, GX; Zuo, ZH; Yu, YH; Zhu, LD; Gao, JM; Huang, CS				Zhang, Dongyun; Li, Jingxia; Zhang, Min; Gao, Guangxun; Zuo, Zhenghong; Yu, Yonghui; Zhu, Linda; Gao, Jimin; Huang, Chuanshu			The Requirement of c-Jun N-terminal Kinase 2 in Regulation of Hypoxia-inducing Factor-1 alpha mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL ANTISENSE TRANSCRIPTS; NICKEL-INDUCED TRANSFORMATION; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEOLIN; PROTEIN; HIF-1-ALPHA; JNK; EXPRESSION; INDUCTION; TRISTETRAPROLIN	The mRNAof hif-1 alpha is considered as being constitutively and ubiquitously expressed, regardless of the level of oxygen tension. However many recent reports have showed that hif-1 alpha mRNA could be regulated by natural antisense transcripts, potential microRNAs, and low O-2. In this study, it was found that a deficiency of JNK2 expression reduced HIF-1 alpha protein induction in response to nickel treatment resulting from the impaired expression of hif-1 alpha mRNA. Both the promoter luciferase assay and mRNA degradation assay clearly showed that depletion of JNK2 affected stability of hif-1 alpha mRNA, rather than regulated its transcription. In addition, nucleolin, a classic histone chaperone, was demonstrated to physically bind to hif-1 alpha mRNA and maintain its stability. Further investigation indicated that JNK2 regulated nucleolin expression and might in turn stabilize hif-1 alpha mRNA. Collectively, we provided one more piece of evidence for the oncogenic role of JNK2 and nucleolin in regulating the cancer microenvironments by controlling HIF-1 alpha expression.	[Zhang, Dongyun; Li, Jingxia; Gao, Guangxun; Zuo, Zhenghong; Yu, Yonghui; Zhu, Linda; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Zhang, Min; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Wenzhou Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu@env.med.nyu.edu	Zuo, Zhenghong/G-4615-2010; Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096	NIH/NCI [CA112557]; NIH/NIEHS [ES000260, ES010344];  [NSFC81229002];  [NSFC 30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from NIH/NCI and ES000260 and ES010344 from NIH/NIEHS as well as NSFC81229002 and NSFC 30971516.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; BEACH LR, 1978, J BIOL CHEM, V253, P2628; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Chen CY, 2000, GENE DEV, V14, P1236; Chen NY, 2001, CANCER RES, V61, P3908; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Ding J, 2006, J BIOL CHEM, V281, P9093, DOI 10.1074/jbc.M510537200; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; FURST A, 1984, IARC SCI PUBL, P245; Ginisty H, 1999, J CELL SCI, V112, P761; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; GRANDJEAN P, 1984, IARC SCI PUBL, P469; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 1996, INT J ONCOL, V8, P389; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lin NY, 2008, BIOCHEM BIOPH RES CO, V365, P69, DOI 10.1016/j.bbrc.2007.10.119; Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2; Maxwell PH, 2001, EXP NEPHROL, V9, P235; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rossignol F, 2004, GENE, V339, P121, DOI 10.1016/j.gene.2004.06.029; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Semenza GL., 2007, SCI STKE, V2007, pCM8, DOI [DOI 10.1126/STKE.4072007CM8, 10.1126/stke.4072007cm8]; She QB, 2002, CANCER RES, V62, P1343; Sirri V, 1997, CYTOMETRY, V28, P147, DOI 10.1002/(SICI)1097-0320(19970601)28:2<147::AID-CYTO8>3.3.CO;2-G; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Zhang DY, 2007, CARCINOGENESIS, V28, P883, DOI 10.1093/carcin/bgl186; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang QW, 2003, TOXICOL APPL PHARM, V192, P201, DOI 10.1016/S0041-008X(03)00280-1; Zou AP, 2001, PHYSIOL GENOMICS, V6, P159, DOI 10.1152/physiolgenomics.2001.6.3.159	59	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34361	34371		10.1074/jbc.M112.365882	http://dx.doi.org/10.1074/jbc.M112.365882			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22910906	Green Published, hybrid			2022-12-28	WOS:000309654200039
J	Zou, LY; Zhu-Mauldin, X; Marchase, RB; Paterson, AJ; Liu, J; Yang, QL; Chatham, JC				Zou, Luyun; Zhu-Mauldin, Xiaoyuan; Marchase, Richard B.; Paterson, Andrew J.; Liu, Jian; Yang, Qinglin; Chatham, John C.			Glucose Deprivation-induced Increase in Protein O-GlcNAcylation in Cardiomyocytes Is Calcium-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; ISCHEMIA-REPERFUSION INJURY; GLCNAC MODIFICATION; NEONATAL CARDIOMYOCYTES; UP-REGULATION; POSTTRANSLATIONAL MODIFICATION; HEXOSAMINE PATHWAY; INSULIN-RESISTANCE; MAMMALIAN-CELLS; KINASE-BETA	The posttranslational modification of nuclear and cytosolic proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc) has been shown to play an important role in cellular response to stress. Although increases in O-GlcNAc levels have typically been thought to be substrate-driven, studies in several transformed cell lines reported that glucose deprivation increased O-GlcNAc levels by a number of different mechanisms. A major goal of this study therefore was to determine whether in primary cells, such as neonatal cardiomyocytes, glucose deprivation increases O-GlcNAc levels and if so by what mechanism. Glucose deprivation significantly increased cardiomyocyte O-GlcNAc levels in a time-dependent manner and was associated with decreased O-GlcNAcase (OGA) but not O-GlcNAc transferase (OGT) protein. This response was unaffected by either the addition of pyruvate as an alternative energy source or by the p38 MAPK inhibitor SB203580. However, the response to glucose deprivation was blocked completely by glucosamine, but not by inhibition of OGA with 2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. Interestingly, the CaMKII inhibitor KN93 also significantly reduced the response to glucose deprivation. Lowering extracellular Ca2+ with EGTA or blocking store operatedCa(2+) entry with SKF96365 also attenuated the glucose deprivation-induced increase in O-GlcNAc. In C2C12 and HEK293 cells both glucose deprivation and heat shock increased O-GlcNAc levels, and CaMKII inhibitor KN93 attenuated the response to both stresses. These results suggest that increased intracellular calcium and subsequent activation of CaMKII play a key role in regulating the stress-induced increase in cellular O-GlcNAc levels.	[Zou, Luyun; Zhu-Mauldin, Xiaoyuan; Chatham, John C.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Marchase, Richard B.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Paterson, Andrew J.] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Dept Med, Birmingham, AL 35294 USA; [Liu, Jian; Yang, Qinglin] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Chatham, JC (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, 1670 Univ Blvd,Volker Hall G001, Birmingham, AL 35294 USA.	jchatham@uab.edu			National Institutes of Health [HL101192, HL079364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079364, R01HL101192, R01HL085499, R01HL084456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported, in whole or in part, by National Institutes of Health Grants HL101192 and HL079364 (to J. C. C.).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Donadio AC, 2008, J CELL BIOCHEM, V103, P800, DOI 10.1002/jcb.21449; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Durgan DJ, 2011, J BIOL CHEM, V286, P44606, DOI 10.1074/jbc.M111.278903; Faust AC, 2011, CRIT CARE NURSE, V31, pE9, DOI 10.4037/ccn2011188; Fulop N, 2008, BIOGERONTOLOGY, V9, P139, DOI 10.1007/s10522-007-9123-5; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Shaw P, 1996, ONCOGENE, V12, P921; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Takeda K, 2004, J MOL CELL CARDIOL, V36, P821, DOI 10.1016/j.yjmcc.2004.03.008; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Toleman C, 2006, BBA-GEN SUBJECTS, V1760, P829, DOI 10.1016/j.bbagen.2006.01.017; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yan H, 2012, J CELL MOL MED, V16, P2049, DOI 10.1111/j.1582-4934.2011.01500.x; Zachara N. E., 2011, CURR PROTOC PROTEIN, V95, P1761; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	59	42	42	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34419	34431		10.1074/jbc.M112.393207	http://dx.doi.org/10.1074/jbc.M112.393207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22908225	Green Published, hybrid			2022-12-28	WOS:000309654200044
J	Bufe, B; Schumann, T; Zufall, F				Bufe, Bernd; Schumann, Timo; Zufall, Frank			Formyl Peptide Receptors from Immune and Vomeronasal System Exhibit Distinct Agonist Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-FORMYLPEPTIDE RECEPTOR; FUNCTIONAL EXPRESSION; CHEMOTACTIC AGONIST; PROTEIN; IDENTIFICATION; NEUTROPHILS; GENES; CHEMOATTRACTANTS; G-ALPHA(16); PHEROMONES	The formyl peptide receptor (Fpr) family is well known for its contribution to immune defense against pathogens in human and rodent leukocytes. Recently, several structurally related members of these receptors were discovered in sensory neurons of the mouse vomeronasal organ (VNO), key detectors of pheromones and related semiochemicals. Although the biological role of vomeronasal Fprs is not yet clear, the known contribution of other Fprs to host immune defense suggested that they could contribute to vomeronasal pathogen sensing. Precise knowledge about the agonist properties of mouse Fprs is required to determine their function. We expressed all seven mouse and three human Fprs using an in vitro system and tested their activation with 32 selected compounds by conducting high throughput calcium measurements. We found an intriguing functional conservation between human and mouse immune Fprs that is most likely a consequence of closely similar biological constraints. By contrast, our data suggest a neofunctionalization of the vomeronasal Fprs. We show that the vomeronasal receptor mFpr-rs1 can be activated robustly by W-peptide and structural derivatives but not by other typical ligands of immune Fprs. mFpr-rs1 exhibits a stereo-selective preference for peptides containing D-amino acids. The same peptide motifs are contained in pathogenic microorganisms. Thus, the ligand profile of mFpr-rs1 is consistent with a role in vomeronasal pathogen sensing.	[Bufe, Bernd; Schumann, Timo; Zufall, Frank] Univ Saarland, Sch Med, Dept Physiol, D-66421 Homburg, Germany	Saarland University	Bufe, B (corresponding author), Univ Saarland, Sch Med, Dept Physiol, Kirrbergerstr Bldg 58, D-66421 Homburg, Germany.	bernd.bufe@uks.eu	Zufall, Frank/AAE-5290-2021; Bufe, Bernd/N-6685-2018	Zufall, Frank/0000-0002-4383-8618; Bufe, Bernd/0000-0003-1610-0658	Deutsche Forschungsgemeinschaft [SFB 894, INST 256/271-1 FUGG]; HOMFORexzellent grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFORexzellent grant	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 894 (to F. Z.) and INST 256/271-1 FUGG (to F. Z. and B. B.) and by a HOMFORexzellent 2011 grant (to B. B.).	Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ferrero DM, 2010, WIRES SYST BIOL MED, V2, P23, DOI 10.1002/wsbm.39; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Hartt JK, 2000, BIOCHEM BIOPH RES CO, V272, P699, DOI 10.1006/bbrc.2000.2846; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mody SM, 2000, MOL PHARMACOL, V57, P13; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Su SB, 1999, J IMMUNOL, V162, P5924; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; TRICE JM, 1985, SEMIN ARTHRITIS RHEU, V15, P45, DOI 10.1016/0049-0172(85)90009-5; Wang ZG, 2002, GENE, V299, P57, DOI 10.1016/S0378-1119(02)01012-0; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zdobnov EM, 2005, FEBS LETT, V579, P3355, DOI 10.1016/j.febslet.2005.04.006	44	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33644	33655		10.1074/jbc.M112.375774	http://dx.doi.org/10.1074/jbc.M112.375774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22859307	hybrid, Green Published			2022-12-28	WOS:000309602100048
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			Transfer-messenger RNA-SmpB Protein Regulates Ribonuclease R Turnover by Promoting Binding of HsIUV and Lon Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TMRNA-MEDIATED SURVEILLANCE; END RULE PATHWAY; ESCHERICHIA-COLI; SUBSTRATE RECOGNITION; RIBOSOME RESCUE; NUCLEASE DOMAIN; HSLUV PROTEASE; STRUCTURED RNA; STABLE RNA; DEGRADATION	RNase R, an important exoribonuclease involved in degradation of structured RNA, is subject to a novel mechanism of regulation. The enzyme is extremely unstable in rapidly growing cells but becomes stabilized under conditions of stress, such as stationary phase or cold shock. RNase R instability results from acetylation which promotes binding of tmRNA-SmpB, two trans-translation factors, to its C-terminal region. Here, we examine how binding of tmRNA-SmpB leads to proteolysis of RNase R. We show that RNase R degradation is due to two proteases, HsIUV and Lon. In their absence, RNase R is stable. We also show, using an in vitro system that accurately replicates the in vivo process, that tmRNA-SmpB is not essential, but it stimulates binding of the protease to the N-terminal region of RNase R and that it does so by a direct interaction between the protease and SmpB which stabilizes protease binding. Thus, a sequence of events, initiated by acetylation of a single Lys residue, results in proteolysis of RNase R in exponential phase cells. RNase R in stationary phase or in cold-shocked cells is not acetylated, and thereby remains stable. Such a regulatory mechanism, dependent on protein acetylation, has not been observed previously in bacterial cells.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Liang, Wenxing/E-7133-2012		National Institutes of Health Grant [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dougan DA, 2010, MOL MICROBIOL, V76, P545, DOI 10.1111/j.1365-2958.2010.07120.x; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	34	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33472	33479		10.1074/jbc.M112.375287	http://dx.doi.org/10.1074/jbc.M112.375287			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879590	Green Published, hybrid			2022-12-28	WOS:000309602100033
J	Nishi, M; Aoyama, F; Kisa, F; Zhu, H; Sun, MZ; Lin, PH; Ohta, H; Van, B; Yamamoto, S; Kakizawa, S; Sakai, H; Ma, JJ; Sawaguchi, A; Takeshima, H				Nishi, Miyuki; Aoyama, Fumiyo; Kisa, Fumihiko; Zhu, Hua; Sun, Mingzhai; Lin, Peihui; Ohta, Hiroya; Van, Bo; Yamamoto, Shinichiro; Kakizawa, Sho; Sakai, Hideki; Ma, Jianjie; Sawaguchi, Akira; Takeshima, Hiroshi			TRIM50 Protein Regulates Vesicular Trafficking for Acid Secretion in Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; PHOSPHOINOSITIDE 3-KINASE; SKELETAL-MUSCLE; OXYNTIC CELLS; IN-VITRO; LOCALIZATION; RECEPTOR; TRANSFORMATION; MAINTENANCE; CHANNELS	Of the TRIM/RBCC family proteins taking part in a variety of cellular processes, TRIM50 is a stomach-specific member with no defined biological function. Our biochemical data demonstrated that TRIM50 is specifically expressed in gastric parietal cells and is predominantly localized in the tubulovesicular and canalicular membranes. In cultured cells ectopically expressing GFP-TRIM50, confocal microscopic imaging revealed dynamic movement of TRIM50-associated vesicles in a phosphoinositide 3-kinase-dependent manner. A protein overlay assay detected preferential binding of the PRY-SPRY domain from the TRIM50 C-terminal region to phosphatidylinositol species, suggesting that TRIM50 is involved in vesicular dynamics by sensing the phosphorylated state of phosphoinositol lipids. Trim50 knockout mice retained normal histology in the gastric mucosa but exhibited impaired secretion of gastric acid. In response to histamine, Trim50 knock-out parietal cells generated deranged canaliculi, swollen microvilli lacking actin filaments, and excess multilamellar membrane complexes. Therefore, TRIM50 seems to play an essential role in tubulovesicular dynamics, promoting the formation of sophisticated canaliculi and microvilli during acid secretion in parietal cells.	[Aoyama, Fumiyo; Sawaguchi, Akira] Miyazaki Univ, Fac Med, Miyazaki 8891692, Japan; [Nishi, Miyuki; Kisa, Fumihiko; Ohta, Hiroya; Van, Bo; Yamamoto, Shinichiro; Kakizawa, Sho; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Zhu, Hua; Sun, Mingzhai; Lin, Peihui; Ma, Jianjie] Univ Med & Dent New Jersey, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Sakai, Hideki] Toyama Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan	University of Miyazaki; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toyama	Sawaguchi, A (corresponding author), Miyazaki Univ, Fac Med, Miyazaki 8891692, Japan.	sawa@fc.miyazaki-u.ac.jp; takeshim@pharm.kyoto-u.ac.jp	Sun, Mingzhai/B-4945-2012; Lin, Pei-Hui/I-3011-2015; Zhu, Hua/G-4409-2010	Lin, Pei-Hui/0000-0002-3894-5099; Takeshima, Hiroshi/0000-0003-4525-3725; Zhu, Hua/0000-0001-7136-7326	National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Ministry of Health and Welfare; Takeda Science Foundation; UBE Foundation; Japan Foundation for Applied Enzymology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24790073, 23240055] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); UBE Foundation(UBE Foundation); Japan Foundation for Applied Enzymology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science, the Ministry of Health and Welfare, the Takeda Science Foundation, the UBE Foundation, and the Japan Foundation for Applied Enzymology.	BLACK JA, 1982, GASTROENTEROLOGY, V83, P595; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CHEW CS, 1990, METHOD ENZYMOL, V191, P640; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; Fujii T, 2009, J BIOL CHEM, V284, P619, DOI 10.1074/jbc.M806562200; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jain RN, 2008, J CLIN INVEST, V118, P2459, DOI 10.1172/JCI33569; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Ko G, 2010, P NATL ACAD SCI USA, V107, P21511, DOI 10.1073/pnas.1016390107; Lang PA, 2007, CELL PHYSIOL BIOCHEM, V20, P527, DOI 10.1159/000107536; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Masumiya H, 2009, CHANNELS, V3, P6, DOI 10.4161/chan.3.1.7571; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sawaguchi A, 2005, ARCH HISTOL CYTOL, V68, P151, DOI 10.1679/aohc.68.151; Sawaguchi A, 2004, J HISTOCHEM CYTOCHEM, V52, P77, DOI 10.1177/002215540405200108; Sawaguchi A, 2006, J ELECTRON MICROSC, V55, P97, DOI 10.1093/jmicro/dfl004; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	40	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33523	33532		10.1074/jbc.M112.370551	http://dx.doi.org/10.1074/jbc.M112.370551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872646	hybrid, Green Published			2022-12-28	WOS:000309602100038
J	Wanka, C; Steinbach, JP; Rieger, J				Wanka, Christina; Steinbach, Joachim P.; Rieger, Johannes			Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE METABOLITES; TUMOR HYPOXIA; CANCER CELLS; TKTL1; P53; EXPRESSION; GROWTH; MUTATIONS; RECEPTOR; KINASE	Altered metabolism in tumor cells is increasingly recognized as a core component of the neoplastic phenotype. Because p53 has emerged as a master metabolic regulator, we hypothesized that the presence of wild-type p53 in glioblastoma cells could confer a selective advantage to these cells under the adverse conditions of the glioma microenvironment. Here, we report on the effects of the p53-dependent effector Tp53-induced glycolysis and apoptosis regulator (TIGAR) on hypoxia-induced cell death. We demonstrate that TIGAR is overexpressed in glioblastomas and that ectopic expression of TIGAR reduces cell death induced by glucose and oxygen restriction. Metabolic analyses revealed that TIGAR inhibits glycolysis and promotes respiration. Further, generation of reactive oxygen species (ROS) levels was reduced whereas levels of reduced glutathione were elevated in TIGAR-expressing cells. Finally, inhibiting the transketolase isoenzyme transketolase-like 1 (TKTL1) by siRNA reversed theses effects of TIGAR. These findings suggest that glioma cells benefit from TIGAR expression by (i) improving energy yield from glucose via increased respiration and (ii) enhancing defense mechanisms against ROS. Targeting metabolic regulators such as TIGAR may therefore be a valuable strategy to enhance glioma cell sensitivity toward spontaneously occurring or therapy-induced starvation conditions or ROS-inducing-therapeutic approaches.	[Wanka, Christina; Steinbach, Joachim P.; Rieger, Johannes] Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60528 Frankfurt, Germany	Goethe University Frankfurt	Steinbach, JP (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	joachim.steinbach@med.uni-frankfurt.de		Rieger, Johannes/0000-0002-7918-1777	Deutsche Forschungsgemeinschaft (DFG) [GRK 1302/1, RI2175/1-1]; Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt"; interdisciplinary center for neuroscience Frankfurt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt"; interdisciplinary center for neuroscience Frankfurt	This work was supported by Grant GRK 1302/1 from the Deutsche Forschungsgemeinschaft (DFG) (to J. P. S.), DFG grant RI2175/1-1 (to J. P. S. and J. R.), and a Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt" and the interdisciplinary center for neuroscience Frankfurt (to J. P. S. and J. R.).	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Campbell JA, 1925, J PHYSIOL-LONDON, V60, P20, DOI 10.1113/jphysiol.1925.sp002217; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Coy JF, 2005, CLIN LAB, V51, P257; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Foldi M, 2007, ONCOL REP, V17, P841; Goldschmidt-Clermont PJ, 1999, GENE EXPRESSION, V7, P255; Griendling KK, 1999, CIRC RES, V85, P562, DOI 10.1161/01.RES.85.6.562; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; JAMIESON D, 1964, NATURE, V201, P1227, DOI 10.1038/2011227a0; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kayser G, 2011, PATHOLOGY, V43, P719, DOI 10.1097/PAT.0b013e32834c352b; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; OLINSKI R, 1992, ARCH BIOCHEM BIOPHYS, V297, P139, DOI 10.1016/0003-9861(92)90651-C; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sattler UGA, 2010, RADIOTHER ONCOL, V94, P102, DOI 10.1016/j.radonc.2009.11.007; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SRIDHAR KS, 1983, CANCER RES, V43, P4629; Steinbach JP, 2004, CANCER RES, V64, P1575, DOI 10.1158/0008-5472.CAN-03-3775; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Steinbach JP, 2002, BRAIN PATHOL, V12, P12; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tabatabaei P, 2008, J NEURO-ONCOL, V90, P35, DOI 10.1007/s11060-008-9625-2; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Volker HU, 2008, AM J CLIN PATHOL, V130, P50, DOI 10.1309/6H9844AMMET82DBJ; Walenta S, 2002, BIOMOL ENG, V18, P249, DOI 10.1016/S1389-0344(01)00107-1; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wibom C, 2010, J PROTEOME RES, V9, P2909, DOI 10.1021/pr901088r; Wischhusen J, 2004, CELL DEATH DIFFER, V11, P1150, DOI 10.1038/sj.cdd.4401477; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Yaromina A, 2009, INT J RADIAT BIOL, V85, P972, DOI 10.3109/09553000903232868; Yuan WJ, 2010, CANCER BIOL THER, V9, P710, DOI 10.4161/cbt.9.9.11431	68	120	127	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33436	33446		10.1074/jbc.M112.384578	http://dx.doi.org/10.1074/jbc.M112.384578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22887998	hybrid, Green Published			2022-12-28	WOS:000309602100030
J	Breshears, LM; Schlievert, PM; Peterson, ML				Breshears, Laura M.; Schlievert, Patrick M.; Peterson, Marnie L.			A Disintegrin and Metalloproteinase 17 (ADAM17) and Epidermal Growth Factor Receptor (EGFR) Signaling Drive the Epithelial Response to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 (TSST-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; NECROSIS-FACTOR-ALPHA; CELLS; ENTEROTOXINS; INFLAMMATION; PENETRATION; ACTIVATION; EXPRESSION; SYNDECANS; CLEAVAGE	Staphylococcal superantigens (SAgs), such as toxic shock syndrome toxin-1 (TSST-1), are the main cause of toxic shock syndrome (TSS). SAgs deregulate the host immune system after penetrating epithelial barriers such as the vaginal mucosa. In response to TSST-1, human vaginal epithelial cells (HVECs) produce cytokines and undergo morphological changes. The epithelial signaling mechanisms employed by SAgs remain largely unknown and are the focus of the work presented here. Analysis of published microarray data identified a network of genes up-regulated by HVECs in response to TSST-1 that includes the sheddase, a disintegrin and metalloproteinase 17 (ADAM17). Investigation revealed that the ADAM17 proteolytic targets, amphiregulin (AREG), transforming growth factor alpha (TGF alpha), syndecan-1 (SDC1), and tumor necrosis factor receptor 1 (TNFR1), are shed from HVECs in response to TSST-1. TAPI-1 (an ADAM inhibitor) completely abrogates all observed shedding and the production of the cytokine interleukin-8 (IL-8). Knock-down studies show that ADAM17, but not the closely related ADAM10, is required for AREG, TGF alpha, and TNFR1 shedding. Both ADAM10 and ADAM17 contribute to SDC1 shedding and IL-8 production by HVECs in response to TSST-1. EGFR signaling is critical for up-regulation of IL-8 at the transcriptional level in response to TSST-1 and is also necessary for AREG, TGF alpha, and TNFR1 shedding. A model is proposed describing the interactions of TSST-1, ADAMs, and the EGFR that lead to establishment of a proinflammatory positive feedback loop in epithelial cells and demonstrate a role for SAgs in the initial stages of disease.	[Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, McGuire Translat Res Facil, Minneapolis, MN 55455 USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Peterson, ML (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, McGuire Translat Res Facil, Rm 4-212, Minneapolis, MN 55455 USA.	peter377@umn.edu		Breshears, Laura/0000-0002-0997-1140; Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health through the NIAID [R01AI073366-03, R01AI074283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073366, R01AI074283] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073366-03 and R01AI074283 through the NIAID.	Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Aubert V, 2000, INFECT IMMUN, V68, P120, DOI 10.1128/IAI.68.1.120-124.2000; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Brosnahan AJ, 2008, BIOCHEMISTRY-US, V47, P12995, DOI 10.1021/bi801468w; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Damm M, 2006, OTOLARYNG HEAD NECK, V134, P245, DOI 10.1016/j.otohns.2005.11.016; Davis CC, 2003, AM J OBSTET GYNECOL, V189, P1785, DOI 10.1016/S0002-9378(03)00873-1; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gotte Martin, 2003, ScientificWorldJournal, V3, P1327; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; KUSHNARYOV VM, 1984, J INFECT DIS, V150, P535, DOI 10.1093/infdis/150.4.535; KUSHNARYOV VM, 1984, INFECT IMMUN, V45, P566, DOI 10.1128/IAI.45.3.566-571.1984; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Schaefers MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032813; Schlievert PM, 2000, INFECT IMMUN, V68, P3630, DOI 10.1128/IAI.68.6.3630-3634.2000; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Shupp JW, 2002, INFECT IMMUN, V70, P2178, DOI 10.1128/IAI.70.4.2178-2186.2002; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	44	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32578	32587		10.1074/jbc.M112.352534	http://dx.doi.org/10.1074/jbc.M112.352534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22833676	Green Published, hybrid			2022-12-28	WOS:000309168300027
J	Ildefonso, CJ; Bond, WS; Al-Tawashi, AR; Hurwitz, MY; Hurwitz, RL				Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.			The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; TUMOR-CELL MIGRATION; GAMMA-SECRETASE; GENE-THERAPY; CONGENITAL AMAUROSIS; HYALURONAN FRAGMENTS; MURINE NEUROBLASTOMA; IMMUNE-RESPONSE; CANCER CELLS; PROMOTES	The success of gene therapy in the ocular environment is partly due to the presence of hyaluronan in vitreous. Here we explore the mechanism of hyaluronan-mediated enhancement of adenoviral vector transgene expression. Introduction of hyaluronan receptor CD44 into CD44-negative cells followed by transduction in the presence of vitreous with an adenoviral vector containing an IL-12-coding transgene increases IL-12 secretion. We demonstrate that sequential CD44 proteolysis is responsible for hyaluronan-mediated enhancement. Metalloproteinase or gamma-secretase inhibitors decrease adenoviral-mediated transgene expression. Deletion of these proteolytic sites in CD44 also inhibits transgene expression. Expression of CD44 with a mutation to prevent phosphorylation of serine 325 inhibits the response to vitreous. Expression of the CD44 intracellular domain enhances transgene expression in the absence of vitreous. CD44-mediated enhancement of gene expression was observed with vectors using different promoters and appears because of an increase in mRNA production, not because of an increase in vector transduction as determined by quantitative RT-PCR and quantitative PCR, respectively. These data fit a model where the interaction of hyaluronan in vitreous and CD44 modulates transgene expression by initiating CD44 proteolysis and release of the cytoplasmic domain, resulting in increased transgene transcription.	[Ildefonso, Cristhian J.; Bond, Wesley S.; Hurwitz, Richard L.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Texas Children Canc Ctr, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Texas Children Hematol Ctr, Houston, TX 77030 USA; [Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Ildefonso, Cristhian J.; Bond, Wesley S.; Al-Tawashi, Azza R.; Hurwitz, Mary Y.; Hurwitz, Richard L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hurwitz, Richard L.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hurwitz, RL (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, 1102 Bates St,Suite 1025, Houston, TX 77030 USA.	rlhurwit@txch.org	Ildefonso, Cristhian/AAC-3576-2021	Ildefonso, Cristhian/0000-0001-6179-720X	National Institutes of Health [GM085793, CA103698, CA97762]; Clayton Foundation for Research; Retina Research Foundation; Golfers Against Cancer; Howard Hughes Medical Institute's Med-Into-Grad Initiative; NATIONAL CANCER INSTITUTE [P20CA103698, R21CA097762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Retina Research Foundation; Golfers Against Cancer; Howard Hughes Medical Institute's Med-Into-Grad Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085793 (to C. J. I.), CA103698 (to R. L. H.), and CA97762 (to R. L. H.). This work was also supported by the Clayton Foundation for Research, the Retina Research Foundation, and Golfers Against Cancer and in part by a grant from the Howard Hughes Medical Institute's Med-Into-Grad Initiative.	Bennett J, 2003, GENE THER, V10, P977, DOI 10.1038/sj.gt.3302030; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brenner M, 2010, MOL THER, V18, P451, DOI 10.1038/mt.2010.12; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chaudhuri SR, 2007, MOL THER, V15, P566, DOI 10.1038/sj.mt.6300044; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cichy J, 2005, BBA-MOL CELL RES, V1745, P59, DOI 10.1016/j.bbamcr.2005.02.006; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Iinuma H, 2006, J IMMUNOL, V176, P3461, DOI 10.4049/jimmunol.176.6.3461; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khan T, 2006, JNCI-J NATL CANCER I, V98, P190, DOI 10.1093/jnci/djj021; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; Lewis CA, 2001, BIOCHEM J, V357, P843, DOI 10.1042/0264-6021:3570843; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Murai S, 2004, VIRCHOWS ARCH, V445, P271, DOI 10.1007/s00428-004-1029-x; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; PURE E, 1995, J EXP MED, V181, P55, DOI 10.1084/jem.181.1.55; Ryu CH, 2011, HUM GENE THER, V22, P733, DOI 10.1089/hum.2010.187; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; TAYLOR KA, 1992, ANAL BIOCHEM, V201, P190, DOI 10.1016/0003-2697(92)90194-C; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32697	32707		10.1074/jbc.M112.347369	http://dx.doi.org/10.1074/jbc.M112.347369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22865879	Green Published, hybrid			2022-12-28	WOS:000309168300037
J	Redeker, V; Pemberton, S; Bienvenut, W; Bousset, L; Melki, R				Redeker, Virginie; Pemberton, Samantha; Bienvenut, Willy; Bousset, Luc; Melki, Ronald			Identification of Protein Interfaces between alpha-Synuclein, the Principal Component of Lewy Bodies in Parkinson Disease, and the Molecular Chaperones Human Hsc70 and the Yeast Ssa1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CROSS-LINKING; LEVODOPA THERAPY; FIBRIL FORMATION; BINDING; DEATH; HSP70; TRANSMISSION; PEPTIDES; TOXICITY	Fibrillar alpha-synuclein (alpha-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD). This neuropathologic form of alpha-Syn plays a central role in PD progression as it has been shown to propagate between neurons. Tools that interfere with alpha-Syn assembly or change the physicochemical properties of the fibrils have potential therapeutic properties as they may be sufficient to interfere with and/or halt cell-to-cell transmission and the systematic spread of alpha-Syn assemblies within the central nervous system. Vertebrate molecular chaperones from the constitutive/heat-inducible heat shock protein 70 (Hsc/p70) family have been shown to hinder the assembly of soluble alpha-Syn into fibrils and to bind to the fibrils and very significantly reduce their toxicity. To understand how Hsc70 family members sequester soluble alpha-Syn, we set up experiments to identify the molecular chaperone-alpha-Syn surface interfaces. We cross-linked human Hsc70 and its yeast homologue Ssa1p and alpha-Syn using a chemical cross-linker and mapped the Hsc70- and Ssa1p-alpha-Syn interface. We show that the client binding domain of Hsc70 and Ssa1p binds two regions within alpha-Syn similar to a tweezer, with the first spanning residues 10-45 and the second spanning residues 97-102. Our findings define what is necessary and sufficient for engineering Hsc70-and Ssa1p-derived polypeptide with minichaperone properties with a potential as therapeutic agents in Parkinson disease through their ability to affect alpha-Syn assembly and/or toxicity.	[Redeker, Virginie; Pemberton, Samantha; Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Bienvenut, Willy] CNRS, Ctr Rech Gif, FRC3115, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018	Redeker, Virginie/0000-0003-2694-8388; bousset, luc/0000-0002-0433-4337; Bienvenut, Willy/0000-0003-4192-3920	French Ministry of Education, Research, and Technology; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale; Era-Net Neuron; Agence Nationale pour la Recherche [ANR-08-NEUR-001-01]; Fondation de France (Parkinson); Human Frontier Science Program	French Ministry of Education, Research, and Technology; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Era-Net Neuron; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France (Parkinson); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the French Ministry of Education, Research, and Technology; the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Sante et de la Recherche Medicale, the Era-Net Neuron, the Agence Nationale pour la Recherche (ANR-08-NEUR-001-01), the Fondation de France (Parkinson), and the Human Frontier Science Program.	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; COTZIAS GC, 1969, J AMER MED ASSOC, V207, P1353, DOI 10.1001/jama.1969.03150200119022; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linstrom F D, 1977, Ann Intern Med, V86, P298; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McClellan AJ, 2000, GENETICS, V156, P501; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; Nasstrom T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027230; Pemberton Samantha, 2012, Commun Integr Biol, V5, P94; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Redeker V, 2010, FEBS J, V277, P5112, DOI 10.1111/j.1742-4658.2010.07915.x; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Seebacher J, 2006, J PROTEOME RES, V5, P2270, DOI 10.1021/pr060154z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TERRITO MC, 1973, JAMA-J AM MED ASSOC, V226, P1347, DOI 10.1001/jama.226.11.1347; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; WANAMAKER WM, 1976, JAMA-J AM MED ASSOC, V235, P2217, DOI 10.1001/jama.235.20.2217; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	40	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32630	32639		10.1074/jbc.M112.387530	http://dx.doi.org/10.1074/jbc.M112.387530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843682	Green Published, hybrid			2022-12-28	WOS:000309168300031
J	Stiegler, AL; Draheim, KM; Li, XF; Chayen, NE; Calderwood, DA; Boggon, TJ				Stiegler, Amy L.; Draheim, Kyle M.; Li, Xiaofeng; Chayen, Naomi E.; Calderwood, David A.; Boggon, Titus J.			Structural Basis for Paxillin Binding and Focal Adhesion Targeting of beta-Parvin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; LD MOTIFS; ALPHA-PARVIN; SECONDARY-STRUCTURE; ANKYRIN REPEAT; CELL-ADHESION; PROTEIN; COMPLEX; LOCALIZATION; RECOGNITION	beta-Parvin is a cytoplasmic adaptor protein that localizes to focal adhesions where it interacts with integrin-linked kinase and is involved in linking integrin receptors to the cytoskeleton. It has been reported that despite high sequence similarity to beta-parvin, beta-parvin does not bind paxillin, suggesting distinct interactions and cellular functions for these two closely related parvins. Here, we reveal that beta-parvin binds directly and specifically to leucine-aspartic acid repeat (LD) motifs in paxillin via its C-terminal calponin homology (CH2) domain. We present the co-crystal structure of beta-parvin CH2 domain in complex with paxillin LD1 motif to 2.9 angstrom resolution and find that the interaction is similar to that previously observed between beta-parvin and paxillin LD1. We also present crystal structures of unbound beta-parvin CH2 domain at 2.1 angstrom and 2.0 angstrom resolution that show significant conformational flexibility in the N-terminal alpha-helix, suggesting an induced fit upon paxillin binding. We find that beta-parvin has specificity for the LD1, LD2, and LD4 motifs of paxillin, with K-D values determined to 27, 42, and 73 mu M, respectively, by surface plasmon resonance. Furthermore, we show that proper localization of beta-parvin to focal adhesions requires both the paxillin and integrin-linked kinase binding sites and that paxillin is important for early targeting of beta-parvin. These studies provide the first molecular details of beta-parvin binding to paxillin and help define the requirements for beta-parvin localization to focal adhesions.	[Stiegler, Amy L.; Draheim, Kyle M.; Li, Xiaofeng; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Chayen, Naomi E.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW7 2AZ, England	Yale University; Yale University; Yale University; Imperial College London	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [R01GM088240, RR026992]; American Cancer Society; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM088240 and RR026992.; Supported by an American Cancer Society postdoctoral fellowship.; Supported by an American Heart Association postdoctoral fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chayen NE, 2005, PROG BIOPHYS MOL BIO, V88, P329, DOI 10.1016/j.pbiomolbio.2004.07.007; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Korenbaum E, 2001, GENE, V279, P69, DOI 10.1016/S0378-1119(01)00743-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev A. A., 2012, CCP4 NEWSLETTER, V48; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li XF, 2011, J BIOL CHEM, V286, P26138, DOI 10.1074/jbc.M110.211250; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Olski TM, 2001, J CELL SCI, V114, P525; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1994, J CELL SCI, V107, P1583; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	54	25	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32566	32577		10.1074/jbc.M112.367342	http://dx.doi.org/10.1074/jbc.M112.367342			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22869380	Green Published, hybrid			2022-12-28	WOS:000309168300026
J	Tan, GY; Niu, JX; Shi, YL; Ouyang, HS; Wu, ZH				Tan, Guangyun; Niu, Jixiao; Shi, Yuling; Ouyang, Hongsheng; Wu, Zhao-Hui			NF-kappa B-dependent MicroRNA-125b Up-regulation Promotes Cell Survival by Targeting p38 alpha upon Ultraviolet Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DNA-DAMAGE RESPONSE; UV-RADIATION; IONIZING-RADIATION; GENOTOXIC STRESS; EXPRESSION; INDUCTION; CANCER; ATM; INHIBITION	UV-induced stress response involves expression change of a myriad of genes, which play critical roles in modulating cell cycle arrest, DNA repair, and cell survival. Alteration of microRNAs has been found in cells exposed to UV, yet their function in UV stress response remains elusive. Here, we show that UV radiation induces up-regulation of miR-125b, which negatively regulates p38 alpha expression through targeting its 3'-UTR. Increase of miR-125b depends on UV-induced NF-kappa B activation, which enhances miR-125b gene transcription upon UV radiation. The DNA damage-responsive kinase ATM (ataxia telangiectasia mutated) is indispensable for UV-induced NF-kappa B activation, which may regulate p38 alpha activation and IKK beta-dependent I kappa B alpha degradation in response to UV. Consequently, repression of p38 alpha by miR-125b prohibits prolonged hyperactivation of p38 alpha by UV radiation, which is required for protecting cells from UV-induced apoptosis. Altogether, our data support a critical role of NF-kappa B-dependent up-regulation of miR-125b, which forms a negative feedback loop to repress p38 alpha activation and promote cell survival upon UV radiation.	[Tan, Guangyun; Niu, Jixiao; Shi, Yuling; Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Tan, Guangyun; Niu, Jixiao; Shi, Yuling; Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Ctr Adult Canc Res, Memphis, TN 38163 USA; [Tan, Guangyun; Ouyang, Hongsheng] Jilin Univ, Coll Anim Sci & Vet Med, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130062, Jilin, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Jilin University	Wu, ZH (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, 19 S Manassas St, Memphis, TN 38163 USA.	zwu6@uthsc.edu			National Institutes of Health [CA149251]; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA149251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA149251 (to Z. W.).; Supported by a scholarship from the Chinese Scholarship Council.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chaudhuri AA, 2012, P NATL ACAD SCI USA, V109, P4233, DOI 10.1073/pnas.1200677109; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Ravi D, 2008, MOL CELL BIOCHEM, V308, P193, DOI 10.1007/s11010-007-9628-x; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shaham L., 2012, LEUKEMIA IN PRESS; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wan GH, 2011, TRENDS BIOCHEM SCI, V36, P478, DOI 10.1016/j.tibs.2011.06.002; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	52	61	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33036	33047		10.1074/jbc.M112.383273	http://dx.doi.org/10.1074/jbc.M112.383273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854965	Green Published, hybrid			2022-12-28	WOS:000309168300066
J	Gault, CR; Eblen, ST; Neumann, CA; Hannun, YA; Obeid, LM				Gault, Christopher R.; Eblen, Scott T.; Neumann, Carola A.; Hannun, Yusuf A.; Obeid, Lina M.			Oncogenic K-Ras Regulates Bioactive Sphingolipids in a Sphingosine Kinase 1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; BREAST-CANCER CELLS; QUANTITATIVE-ANALYSIS; PLASMA-MEMBRANE; POOR SURVIVAL; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; GROWTH; PHOSPHORYLATION; TRANSLOCATION	Sphingosine kinase 1 (SK1) is an important enzyme involved in the production of the bioactive lipid sphingosine 1-phosphate (S1P). SK1 is overexpressed in many forms of cancer, however, the contribution of SK1 to cancer progression is still unclear. One of the best characterized mutations found in several forms of human cancer is an activating point mutation in the Ras oncogene, which disrupts its GTPase activity and leads to stimulation of the MEK/ERK pathway. Because SK1 activity and subcellular localization have been shown to be regulated by ERK, we wished to investigate the effect of oncogenic Ras, a potent activator of the Raf/MEK/ERK pathway, on the activity of SK1 and sphingolipid metabolism. Using HEK293T cells transiently transfected with the K-RasG12V oncogene and both wild type and Sphk1(-/-) mouse embryonic fibroblasts stably infected with retroviral K-RasG12V, we found that K-RasG12V increases the production of S1P and decreases the production of ceramide in a SK1-dependent manner. In addition, we found that expression of the K-RasG12V oncogene leads to plasma membrane localization of SK1 and a reduction in cytosolic levels of SK1. This effect is likely mediated by the Raf/MEK/ERK pathway as constitutively active B-Raf or MEK1 are able to activate SK1, but constitutively active Akt1 is not. We believe this research has important implications for how sphingolipids may be contributing to oncogenic transformation and provide some of the first evidence for oncogenes inducing specific changes in sphingolipid metabolism through SK1 regulation.	[Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gault, Christopher R.; Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Eblen, Scott T.; Neumann, Carola A.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu		Neumann, Carola/0000-0003-2801-9531; obeid, lina/0000-0002-0734-0847	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR018823]; NCI [IPO1CA097132, P30 CA 138313, R01CA131-200, P01 CA0971321]; National Institutes of Health NCRR SC COBRE [P20 RR017677]; National Institutes of Health [NHLBI NRSA 5F30 HL093991, NIGMS R01 GM062887, NCI P01CA097132]; NIEHS [K22 ES012985-01]; MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC [1I0 BX000156 01A1]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA131200, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL093991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health NCRR SC COBRE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Marianne Dubard-Gault for help in generating the SK1 mutants and Kathy Wiita-Fisk for administrative assistance in preparing this manuscript. Measurement of sphingolipids was conducted by the Lipidomics Core of Medical University of South Carolina (MUSC) in a facility constructed with support from National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. LC-MS/MS analysis of sphingolipids was performed by Lipidomics Shared Resource, MUSC(25) supported by NCI Grants IPO1CA097132 and P30 CA 138313 and National Institutes of Health NCRR SC COBRE Grant P20 RR017677. Laboratory space in the CRI building of MUSC was supported by National Institutes of Health Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources.; This work was supported, in whole or in part, by National Institutes of Health Grants NHLBI NRSA 5F30 HL093991 (to C. R. G.), NIGMS R01 GM062887 and NCI P01CA097132 (to Y. A. H.), R01CA131-200 from the NCI (to S. E.), K22 ES012985-01 from the NIEHS (to C. N.), P01 CA0971321 from the NCI (to L. M. O.), and by MERIT Award 1I0 BX000156 01A1) (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Medical Center, Charleston, SC.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; KIM MY, 1991, J BIOL CHEM, V266, P484; Knapp P, 2010, PROSTAG OTH LIPID M, V92, P62, DOI 10.1016/j.prostaglandins.2010.03.002; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Sobue S, 2008, ONCOGENE, V27, P6023, DOI 10.1038/onc.2008.198; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SPIEGEL S, 1994, BREAST CANCER RES TR, V31, P337, DOI 10.1007/BF00666166; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	43	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31794	31803		10.1074/jbc.M112.385765	http://dx.doi.org/10.1074/jbc.M112.385765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22833671	hybrid, Green Published			2022-12-28	WOS:000309059400020
J	Schlessinger, A; Wittwer, MB; Dahlin, A; Khuri, N; Bonomi, M; Fan, H; Giacomini, KM; Sali, A				Schlessinger, Avner; Wittwer, Matthias B.; Dahlin, Amber; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Giacomini, Kathleen M.; Sali, Andrej			High Selectivity of the gamma-Aminobutyric Acid Transporter 2 (GAT-2, SLC6A13) Revealed by Structure-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; 5-AMINOLEVULINIC ACID; ALTERNATING ACCESS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM; SUBSTRATE; MECHANISM; DISCOVERY; DYNAMICS	The solute carrier 6 (SLC6) is a family of ion-dependent transporters that mediate uptake into the cell of osmolytes such as neurotransmitters and amino acids. Four SLC6 members transport GABA, a key neurotransmitter that triggers inhibitory signaling pathways via various receptors (e. g., GABA(A)). The GABA transporters (GATs) regulate the concentration of GABA available for signaling and are thus targeted by a variety of anticonvulsant and relaxant drugs. Here, we characterize GAT-2, a transporter that plays a role in peripheral GABAergic mechanisms, by constructing comparative structural models based on crystallographic structures of the leucine transporter LeuT. Models of GAT-2 in two different conformations were constructed and experimentally validated, using site-directed mutagenesis. Computational screening of 594,166 compounds including drugs, metabolites, and fragment-like molecules from the ZINC database revealed distinct ligands for the two GAT-2 models. 31 small molecules, including high scoring compounds and molecules chemically related to known and predicted GAT-2 ligands, were experimentally tested in inhibition assays. Twelve ligands were found, six of which were chemically novel (e. g., homotaurine). Our results suggest that GAT-2 is a high selectivity/low affinity transporter that is resistant to inhibition by typical GABAergic inhibitors. Finally, we compared the binding site of GAT-2 with those of other SLC6 members, including the norepinephrine transporter and other GATs, to identify ligand specificity determinants for this family. Our combined approach may be useful for characterizing interactions between small molecules and other membrane proteins, as well as for describing substrate specificities in other protein families.	[Schlessinger, Avner; Wittwer, Matthias B.; Dahlin, Amber; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Giacomini, Kathleen M.; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Schlessinger, Avner; Khuri, Natalia; Bonomi, Massimiliano; Fan, Hao; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Giacomini, KM (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, 1550 4th St,Box 2911, San Francisco, CA 94143 USA.	kathy.giacomini@ucsf.edu; sali@salilab.org	Giacomini, Kathleen/AEF-2452-2022; Wittwer, Matthias/AFY-6872-2022; Wittwer, Matthias/F-7679-2011	Bonomi, Massimiliano/0000-0002-7321-0004	National Institutes of Health [R01 GM54762, U54 GM093342, P01 GM71790, U54 GM074929, U01 GM61390, R25 CA112355, F32 GM088991]; Swiss National Science Foundation [PBBSP3-133384]; Hewlett Packard; IBM; NetApps; Intel; Ron Conway; Mike Homer; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM088991, R01GM054762, U01GM061390, U54GM074929, P01GM071790, U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hewlett Packard; IBM(International Business Machines (IBM)); NetApps; Intel(Intel Corporation); Ron Conway; Mike Homer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM54762, U54 GM093342, and P01 GM71790 (to A. S.); U54 GM074929 and U01 GM61390 (to A. S. and K. M. G.); R25 CA112355 (to A. D.); and F32 GM088991 (to A. Sc.). This work was also supported by Swiss National Science Foundation Grant for Prospective Researchers PBBSP3-133384 (to M. B. W.). We also acknowledge funding for computing hardware from Hewlett Packard, IBM, NetApps, Intel, Ron Conway, and Mike Homer.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Albers JW, 2004, MUSCLE NERVE, V30, P410, DOI 10.1002/mus.20137; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bednarczyk D, 2010, ANAL BIOCHEM, V405, P50, DOI 10.1016/j.ab.2010.06.012; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; Carter LP, 2009, PHARMACOL THERAPEUT, V121, P100, DOI 10.1016/j.pharmthera.2008.10.003; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Garbutt JC, 2010, ALCOHOL CLIN EXP RES, V34, P1849, DOI 10.1111/j.1530-0277.2010.01273.x; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; MORETTI MB, 1995, INT J BIOCHEM CELL B, V27, P169, DOI 10.1016/1357-2725(95)00002-7; Musiol R, 2011, CURR PHARM DESIGN, V17, P3548, DOI 10.2174/138161211798194549; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nakashita M, 1997, NEUROSCI RES, V29, P87, DOI 10.1016/S0168-0102(97)00072-2; Nyola A, 2010, CURR OPIN STRUC BIOL, V20, P415, DOI 10.1016/j.sbi.2010.05.007; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	73	40	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388157	http://dx.doi.org/10.1074/jbc.M112.388157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22932902	hybrid, Green Published			2022-12-28	WOS:000310642200014
J	Berntsson, RPA; Schuurman-Wolters, GK; Dunny, G; Slotboom, DJ; Poolman, B				Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Dunny, Gary; Slotboom, Dirk-Jan; Poolman, Bert			Structure and Mode of Peptide Binding of Pheromone Receptor PrgZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAECALIS PLASMID PCF10; ENTEROCOCCUS-FAECALIS; SEX-PHEROMONE; MACROMOLECULAR STRUCTURES; PROTEIN OPPA; CONJUGATION; EXPRESSION; CCF10; CRYSTALLOGRAPHY; VALIDATION	Wepresent the crystal structure of the pheromone receptor protein PrgZ from Enterococcus faecalis in complex with the heptapeptide cCF10 (LVTLVFV), which is used in signaling between conjugative recipient and donor cells. Comparison of PrgZ with homologous oligopeptide-binding proteins (AppA and OppA) explains the high specificity of PrgZ for hydrophobic heptapeptides versus the promiscuity of peptide binding in the homologous proteins.	[Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Berntsson, Ronnie P. -A.; Schuurman-Wolters, Gea K.; Slotboom, Dirk-Jan; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Dunny, Gary] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Groningen; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Berntsson, Ronnie/J-3535-2019	Berntsson, Ronnie/0000-0001-6848-322X	National Institutes of Health [GM49530]; The Netherlands Organisation for Scientific Research (NWO) [700.56.302]; European Union; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49530 (to G. D.). This work was also supported by a Vici grant (to D.-J. S.) and TOP Subsidy Grant 700.56.302 (to B. P.) from The Netherlands Organisation for Scientific Research (NWO) and by the European Union European Drug Initiative on Channels and Transporters (EDICT) Program.	Antiporta MH, 2002, J BACTERIOL, V184, P1155, DOI 10.1128/jb.184.4.1155-1162.2002; Bae T, 2000, J MOL BIOL, V297, P861, DOI 10.1006/jmbi.2000.3628; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berntsson RPA, 2011, J BACTERIOL, V193, P4254, DOI 10.1128/JB.00447-11; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fixen KR, 2007, J BACTERIOL, V189, P1399, DOI 10.1128/JB.01226-06; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Hunt CP, 1998, BRIT J BIOMED SCI, V55, P149; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klepsch MM, 2011, J MOL BIOL, V414, P75, DOI 10.1016/j.jmb.2011.09.043; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kozlowicz BK, 2006, MOL MICROBIOL, V62, P958, DOI 10.1111/j.1365-2958.2006.05434.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maqbool A, 2011, J BIOL CHEM, V286, P31512, DOI 10.1074/jbc.M111.267179; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MORI M, 1984, FEBS LETT, V178, P97, DOI 10.1016/0014-5793(84)81248-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	35	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37165	37170		10.1074/jbc.M112.386334	http://dx.doi.org/10.1074/jbc.M112.386334			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948145	hybrid, Green Published			2022-12-28	WOS:000310588500050
J	Ozaki, S; Noguchi, Y; Hayashi, Y; Miyazaki, E; Katayama, T				Ozaki, Shogo; Noguchi, Yasunori; Hayashi, Yasuhisa; Miyazaki, Erika; Katayama, Tsutomu			Differentiation of the DnaA-oriC Subcomplex for DNA Unwinding in a Replication Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; ORIGIN RECOGNITION; E. COLI; REGULATORY INACTIVATION; NUCLEOPROTEIN COMPLEXES; SEQUENTIAL BINDING; STRUCTURAL BASIS; GENE-EXPRESSION	In Escherichia coli, ATP-DnaA multimers formed on the replication origin oriC promote duplex unwinding, which leads to helicase loading. Based on a detailed functional analysis of the oriC sequence motifs, we previously proposed that the left half of oriC forms an ATP-DnaA subcomplex competent for oriC unwinding, whereas the right half of oriC forms a distinct ATP-DnaA subcomplex that facilitates helicase loading. However, the molecular basis for the functional difference between these ATP-DnaA subcomplexes remains unclear. By analyzing a series of novel DnaA mutants, we found that structurally distinct DnaA multimers form on each half of oriC. DnaA AAA + domain residues Arg-227 and Leu-290 are specifically required for oriC unwinding. Notably, these residues are required for the ATP-DnaA-specific structure of DnaA multimers in complex with the left half of oriC but not for that with the right half. These results support the idea that the ATP-DnaA multimers formed on oriC are not uniform and that they can adopt different conformations. Based on a structural model, we propose that Arg-227 and Leu-290 play a crucial role in inter-ATP-DnaA interaction and are a prerequisite for the formation of unwinding-competent DnaA subcomplexes on the left half of oriC. These residues are not required for the interaction with DnaB, nucleotide binding, or regulatory DnaA-ATP hydrolysis, which further supports their important role in inter-DnaA interaction. The corresponding residues are evolutionarily conserved and are required for unwinding in the initial complexes of Thermotoga maritima, an ancient hyperthermophile. Therefore, our findings suggest a novel and common mechanism for ATP-DnaA-dependent activation of initial complexes.	[Ozaki, Shogo; Noguchi, Yasunori; Hayashi, Yasuhisa; Miyazaki, Erika; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Ozaki, Shogo/0000-0002-4384-1366; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science [19370077, 17080005, 21770187]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for Promotion of Science (Grants 19370077, 17080005, and 21770187).	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CASSLER MR, 1995, EMBO J, V14, P5833, DOI 10.1002/j.1460-2075.1995.tb00271.x; Charbon G, 2011, MOL MICROBIOL, V79, P914, DOI 10.1111/j.1365-2958.2010.07493.x; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HWANG DS, 1992, J BIOL CHEM, V267, P23083; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2011, J BIOL CHEM, V286, P29336, DOI 10.1074/jbc.M111.233403; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leonard AC, 2005, MOL MICROBIOL, V55, P978, DOI 10.1111/j.1365-2958.2004.04467.x; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; SAMITT CE, 1989, EMBO J, V8, P989, DOI 10.1002/j.1460-2075.1989.tb03462.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Saxena R, 2011, J BIOL CHEM, V286, P33770, DOI 10.1074/jbc.M111.223495; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x	67	41	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37458	37471		10.1074/jbc.M112.372052	http://dx.doi.org/10.1074/jbc.M112.372052			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22942281	Green Published, hybrid			2022-12-28	WOS:000310588500075
J	Fang, WB; Jokar, I; Zou, A; Lambert, D; Dendukuri, P; Cheng, N				Fang, Wei Bin; Jokar, Iman; Zou, An; Lambert, Diana; Dendukuri, Prasanthi; Cheng, Nikki			CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SMOOTH MUSCLE ACTIN; TGF-BETA; PROSTATE-CANCER; MAP KINASE; IMMUNOHISTOCHEMICAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MACROPHAGE RECRUITMENT; INDUCED APOPTOSIS; ONCOGENE PRODUCT	Increased cell motility and survival are important hallmarks of metastatic tumor cells. However, the mechanisms that regulate the interplay between these cellular processes remain poorly understood. In these studies, we demonstrate that CCL2, a chemokine well known for regulating immune cell migration, plays an important role in signaling to breast cancer cells. We report that in a panel of mouse and human breast cancer cell lines CCL2 enhanced cell migration and survival associated with increased phosphorylation of Smad3 and p42/44MAPK proteins. The G protein-coupled receptor CCR2 was found to be elevated in breast cancers, correlating with CCL2 expression. RNA interference of CCR2 expression in breast cancer cells significantly inhibited CCL2-induced migration, survival, and phosphorylation of Smad3 and p42/44MAPK proteins. Disruption of Smad3 expression in mammary carcinoma cells blocked CCL2-induced cell survival and migration and partially reduced p42/44MAPK phosphorylation. Ablation of MAPK phosphorylation in Smad3-deficient cells with the MEK inhibitor U0126 further reduced cell survival but not migration. These data indicate that Smad3 signaling through MEK-p42/44MAPK regulates CCL2-induced cell motility and survival, whereas CCL2 induction of MEK-p42/44MAPK signaling independent of Smad3 functions as an alternative mechanism for cell survival. Furthermore, we show that CCL2-induced Smad3 signaling through MEK-p42/44MAPK regulates expression and activity of Rho GTPase to mediate CCL2-induced breast cancer cell motility and survival. With these studies, we characterize an important role for CCL2/CCR2 chemokine signaling in regulating the intrinsic relationships between breast cancer cell motility and survival with implications on the metastatic process.	[Fang, Wei Bin; Jokar, Iman; Zou, An; Lambert, Diana; Dendukuri, Prasanthi; Cheng, Nikki] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Cheng, N (corresponding author), Univ Kansas, Dept Pathol & Lab Med, Med Ctr, 3901 Rainbow Blvd,MS 3003, Kansas City, KS 66160 USA.	ncheng@kumc.edu			National Institutes of Health from the NCI [R00 CA127357-03]; United States Department of Health and Human Services; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE [R00CA127357] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Health and Human Services; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 CA127357-03 from the NCI and United States Department of Health and Human Services (to N. C.). This work was also supported by funds from the Kansas Bioscience Authority (to N. C.).	Amar S, 2009, BREAST CANCER RES TR, V114, P413, DOI 10.1007/s10549-008-0032-3; [Anonymous], 1978, BIOCH VIRUSES, P21; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Arefieva TI, 2005, CYTOKINE, V31, P439, DOI 10.1016/j.cyto.2005.06.016; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Blanc C, 2000, CANCER RES, V60, P4386; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Buxton ILO, 2008, CIRC RES, V102, P151, DOI 10.1161/CIRCRESAHA.107.170217; CAMERON DA, 1994, BRIT J CANCER, V70, P120, DOI 10.1038/bjc.1994.259; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381; Choi Kyu Hun, 2000, Korean Journal of Internal Medicine, V15, P218; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DIXON RA, 1981, ANTIMICROB AGENTS CH, V20, P321, DOI 10.1128/AAC.20.3.321; Duchene J, 2002, J BIOL CHEM, V277, P40375, DOI 10.1074/jbc.M202744200; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; ERNST CA, 1994, J IMMUNOL, V152, P3541; ERSKINE RJ, 1992, AM J VET RES, V53, P375; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Florio T, 2000, J PHYSIOL-PARIS, V94, P239, DOI 10.1016/S0928-4257(00)00214-X; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Gangur V, 2002, VET IMMUNOL IMMUNOP, V86, P127, DOI 10.1016/S0165-2427(02)00018-1; Ghellal A, 2000, ANTICANCER RES, V20, P4413; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guo L, 2007, INT J BIOL MARKER, V22, P1; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hembruff SL, 2010, NEOPLASIA, V12, P425, DOI 10.1593/neo.10200; Herrera A. C., 2012, CANC IMMUNO IN PRESS; HOSHINO Y, 1995, EXP HEMATOL, V23, P1035; Hotta K, 1996, BIOCHEM BIOPH RES CO, V225, P69, DOI 10.1006/bbrc.1996.1132; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Johnson Z, 2004, BIOCHEM SOC T, V32, P366, DOI 10.1042/BST0320366; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Juan SH, 2007, NEPHROL DIAL TRANSPL, V22, P732, DOI 10.1093/ndt/gfl699; KAHN T, 1972, LANCET, V1, P498; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Koumoundourou D, 2007, ANTICANCER RES, V27, P2613; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lang HN, 1997, HEARING RES, V111, P177, DOI 10.1016/S0378-5955(97)00098-1; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Lu Y, 2009, CLIN EXP METASTAS, V26, P161, DOI 10.1007/s10585-008-9226-7; Maglione JE, 2001, CANCER RES, V61, P8298; Mantovani A, 2011, EUR J IMMUNOL, V41, P2522, DOI 10.1002/eji.201141894; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mazzoni E, 2003, MOL CANCER RES, V1, P776; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Mellado M, 1998, J IMMUNOL, V161, P805; MIZUKAMI Y, 1990, ANTICANCER RES, V10, P1115; MIZUKAMI Y, 1991, ANTICANCER RES, V11, P1485; Moon A, 2000, INT J CANCER, V85, P176, DOI 10.1002/(SICI)1097-0215(20000115)85:2<176::AID-IJC5>3.0.CO;2-E; Moore-Smith L, 2011, J MAMMARY GLAND BIOL, V16, P89, DOI 10.1007/s10911-011-9216-2; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Okamoto S, 1996, ANTICANCER RES, V16, P2699; PAAPE MJ, 1990, AM J VET RES, V51, P1055; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pilat MJP, 1998, ANTICANCER RES, V18, P2575; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Qualls JE, 2011, CURR TOP DEV BIOL, V94, P309, DOI 10.1016/B978-0-12-380916-2.00010-3; Richardsen Elin, 2012, BMC Res Notes, V5, P110, DOI 10.1186/1756-0500-5-110; Riggins GJ, 1997, CANCER RES, V57, P2578; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roca H, 2009, NEOPLASIA, V11, P1309, DOI 10.1593/neo.09936; Ross KR, 2007, CELL SIGNAL, V19, P923, DOI 10.1016/j.cellsig.2006.11.008; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Samanta D, 2012, FRONT BIOSCI-LANDMRK, V17, P1281, DOI 10.2741/3986; Schuh JoAnn C L, 2004, Toxicol Pathol, V32 Suppl 1, P53, DOI 10.1080/01926230490424770; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Talmadge JE, 2011, SEMIN CANCER BIOL, V21, P131, DOI 10.1016/j.semcancer.2010.12.002; Tamiolakis D, 2002, EUR J GYNAECOL ONCOL, V23, P469; Tian F, 2003, CANCER RES, V63, P8284; TSUKAMOTO H, 1992, J INVEST DERMATOL, V98, P116, DOI 10.1111/1523-1747.ep12496020; Tylaska LA, 2002, CYTOKINE, V18, P184, DOI 10.1006/cyto.2002.1031; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; YAMASHIRO S, 1994, AM J PATHOL, V145, P856; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhao SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023262; Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274	108	133	137	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36593	36608		10.1074/jbc.M112.365999	http://dx.doi.org/10.1074/jbc.M112.365999			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22927430	Green Published, hybrid			2022-12-28	WOS:000310364000079
J	Klemm, HMJ; Welton, JM; Masters, CL; Klug, GM; Boyd, A; Hill, AF; Collins, SJ; Lawson, VA				Klemm, Helen M. J.; Welton, Jeremy M.; Masters, Colin L.; Klug, Genevieve M.; Boyd, Alison; Hill, Andrew F.; Collins, Steven J.; Lawson, Victoria A.			The Prion Protein Preference of Sporadic Creutzfeldt-Jakob Disease Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-TRANSFUSION; CYCLIC AMPLIFICATION; STRAIN VARIATION; RESISTANT; BRAIN; RISK; CLASSIFICATION; GLYCOSYLATION; TRANSMISSION; CONVERSION	Sporadic Creutzfeldt-Jakob disease (CJD) is the most prevalent manifestation of the transmissible spongiform encephalopathies or prion diseases affecting humans. The disease encompasses a spectrum of clinical phenotypes that have been correlated with molecular subtypes that are characterized by the molecular mass of the protease-resistant fragment of the disease-related conformation of the prion protein and a polymorphism at codon 129 of the gene encoding the prion protein. A cell-free assay of prion protein misfolding was used to investigate the ability of these sporadic CJD molecular subtypes to propagate using brain-derived sources of the cellular prion protein ( PrPC). This study confirmed the presence of three distinct sporadic CJD molecular subtypes with PrPC substrate requirements that reflected their codon 129 associations in vivo. However, the ability of a sporadic CJD molecular subtype to use a specific PrPC substrate was not determined solely by codon 129 as the efficiency of prion propagation was also influenced by the composition of the brain tissue from which the PrPC substrate was sourced, thus indicating that nuances in PrPC or additional factors may determine sporadic CJD subtype. The results of this study will aid in the design of diagnostic assays that can detect prion disease across the diversity of sporadic CJD subtypes.	[Klemm, Helen M. J.; Welton, Jeremy M.; Klug, Genevieve M.; Boyd, Alison; Collins, Steven J.; Lawson, Victoria A.] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Klug, Genevieve M.; Boyd, Alison; Collins, Steven J.] Univ Melbourne, Australian Natl Creutzfeldt Jakob Dis Registry, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Masters, Colin L.; Hill, Andrew F.; Collins, Steven J.; Lawson, Victoria A.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Lawson, VA (corresponding author), Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	vlawson@unimelb.edu.au	Hill, Andrew F./AAH-2854-2020; Welton, Jeremy/AAH-4120-2019; Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F/B-4527-2009	Welton, Jeremy/0000-0002-9446-9162; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Lawson, Victoria/0000-0002-7362-7176	Australia National Health and Medical Research Council Grant NHMRC [454546]; Melbourne University Research Grant Scheme	Australia National Health and Medical Research Council Grant NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Melbourne University Research Grant Scheme	This work was supported by Australia National Health and Medical Research Council Grant NHMRC ID 454546 and by the Melbourne University Research Grant Scheme.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Editorial team, 2007, EUROSURVEILLANCE, V12, P3117; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Jones M, 2008, NEUROREPORT, V19, P1783, DOI 10.1097/WNR.0b013e328318edfa; Jones M, 2009, TRANSFUSION, V49, P376, DOI 10.1111/j.1537-2995.2008.01954.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Lawson VA, 2005, J NEUROCHEM, V93, P793, DOI 10.1111/j.1471-4159.2005.03104.x; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012351; Lewis V, 2005, NEUROLOGY, V65, P113, DOI 10.1212/01.wnl.0000167188.65787.a0; Lewis V, 2009, J NEUROPATH EXP NEUR, V68, P1125, DOI 10.1097/NEN.0b013e3181b96981; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mahillo-Fernandez I, 2008, NEUROEPIDEMIOLOGY, V31, P229, DOI 10.1159/000163097; OBRIEN JS, 1965, J LIPID RES, V6, P537; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Priola SA, 2001, EMBO J, V20, P6692, DOI 10.1093/emboj/20.23.6692; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Ward HJT, 2008, ANN NEUROL, V63, P347, DOI 10.1002/ana.21294; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zimmermann K, 1999, ACTA NEUROPATHOL, V97, P355, DOI 10.1007/s004010050998	55	7	7	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36465	36472		10.1074/jbc.M112.368803	http://dx.doi.org/10.1074/jbc.M112.368803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22930754	Green Published, hybrid			2022-12-28	WOS:000310364000066
J	Varfaj, F; Lampe, JN; de Montellano, PRO				Varfaj, Fatbardha; Lampe, Jed N.; de Montellano, Paul R. Ortiz			Role of Cysteine Residues in Heme Binding to Human Heme Oxygenase-2 Elucidated by Two-dimensional NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-GEL DIGESTION; CARBON-MONOXIDE; PROTEIN; SEQUENCE; GENE; YEAST; PURIFICATION; EXPRESSION; DOMAINS; CLONING	Human heme oxygenases 1 and 2 (HO-1 and HO-2) degrade heme in the presence of oxygen and NADPH-cytochrome P450 reductase, producing ferrous iron, CO, and biliverdin. HO-1 is an inducible enzyme, but HO-2 is constitutively expressed in selected tissues and is involved in signaling and regulatory processes. HO-2 has three cysteine residues that have been proposed to modulate the affinity for heme, whereas HO-1 has none. Here we use site-specific mutagenesis and two-dimensional NMR of L-[3-C-13] cysteine-labeled proteins to determine the redox state of the individual cysteines in HO-2 and assess their roles in binding of heme. The results indicate that in the apoprotein, Cys(282) and Cys(265) are in the oxidized state, probably in an intramolecular disulfide bond. The addition of a reducing agent converts them to the reduced, free thiol state. Two-dimensional NMR of site-specific mutants reveals that the redox state of Cys(265) and Cys(282) varies with the presence or absence of other Cys residues, indicating that the microenvironments of the Cys residues are mutually interdependent. Cys(265) appears to be in a relatively hydrophilic, oxidizable environment compared with Cys(127) and Cys(282). Chemical shift data indicate that none of the cysteines stably coordinates to the heme iron atom. In the oxidized state of the apoprotein, heme is bound 2.5-fold more tightly than in the reduced state. This small difference in heme affinity between the oxidized and reduced states of the protein is much less than previously reported, suggesting that it is not a significant factor in the physiological regulation of cellular heme levels.	[Varfaj, Fatbardha; Lampe, Jed N.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263	National Institutes of Health [DK30297]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30297.	Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; CREUSOT F, 1988, J MOL BIOL, V204, P263, DOI 10.1016/0022-2836(88)90574-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; DRYGAS ME, 1989, J BIOL CHEM, V264, P17897; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Gardner JD, 2010, J BIOL INORG CHEM, V15, P1117, DOI 10.1007/s00775-010-0672-8; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Jiang YY, 2009, J INORG BIOCHEM, V103, P316, DOI 10.1016/j.jinorgbio.2008.11.002; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P178; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Mossner E, 2000, FEBS LETT, V477, P21, DOI 10.1016/S0014-5793(00)01738-5; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Steiner H, 1996, J BIOL CHEM, V271, P32605, DOI 10.1074/jbc.271.51.32605; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; TRIGGSRAINE BL, 1988, J BACTERIOL, V170, P4415, DOI 10.1128/jb.170.9.4415-4419.1988; Wehrli F.W., 1976, INTERPRETATION CARBO; WILKS A, 1993, J BIOL CHEM, V268, P22357; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; YOSHIDA T, 1978, J BIOL CHEM, V253, P4224; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848	31	23	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35181	35191		10.1074/jbc.M112.378042	http://dx.doi.org/10.1074/jbc.M112.378042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22923613	Green Published, hybrid			2022-12-28	WOS:000309968000028
J	Chicca, A; Marazzi, J; Nicolussi, S; Gertsch, J				Chicca, Andrea; Marazzi, Janine; Nicolussi, Simon; Gertsch, Juerg			Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOID ANANDAMIDE; N-ARACHIDONOYLETHANOLAMINE ANANDAMIDE; VANILLOID VR1 RECEPTORS; HUMAN ENDOTHELIAL-CELLS; DOSE-RESPONSE CURVES; INHIBITOR AM404; MONOACYLGLYCEROL LIPASE; QUANTITATIVE ESTIMATION; ENZYMATIC-HYDROLYSIS	Despite extensive research on the trafficking of anandamide (AEA) across cell membranes, little is known about the membrane transport of other endocannabinoids, such as 2-arachidonoylglycerol (2-AG). Previous studies have provided data both in favor and against a cell membrane carrier-mediated transport of endocannabinoids, using different methodological approaches. Because AEA and 2-AG undergo rapid and almost complete intracellular hydrolysis, we employed a combination of radioligand assays and absolute quantification of cellular and extracellular endocannabinoid levels. In human U937 leukemia cells, 100 nM AEA and 1 mu M 2-AG were taken up through a fast and saturable process, reaching a plateau after 5 min. Employing differential pharmacological blockage of endocannabinoid uptake, breakdown, and interaction with intracellular binding proteins, we show that eicosanoid endocannabinoids harboring an arachidonoyl chain compete for a common membrane target that regulates their transport, whereas other N-acylethanolamines did not interfere with AEA and 2-AG uptake. By combining fatty acid amide hydrolase or monoacyl glycerol lipase inhibitors with hydrolase-inactive concentrations of the AEA transport inhibitors UCM707 (1 mu M) and OMDM-2 (5 mu M), a functional synergism on cellular AEA and 2-AG uptake was observed. Intriguingly, structurally unrelated AEA uptake inhibitors also blocked the cellular release of AEA and 2-AG. We show, for the first time, that UCM707 and OMDM-2 inhibit the bidirectional movement of AEA and 2-AG across cell membranes. Our findings suggest that a putative endocannabinoid cell membrane transporter controls the cellular AEA and 2-AG trafficking and metabolism.	[Chicca, Andrea; Marazzi, Janine; Nicolussi, Simon; Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland	University of Bern	Gertsch, J (corresponding author), Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland.	gertsch@ibmm.unibe.ch	Chicca, Andrea/AAP-7156-2020	Chicca, Andrea/0000-0001-9593-636X; Gertsch, Jurg/0000-0003-0978-1555; Nicolussi, Simon/0000-0003-1260-3282	Swiss National Science Foundation National Centre of Competence in Research TransCure; University of Bern Foundation; Novartis Research Foundation [10B48]	Swiss National Science Foundation National Centre of Competence in Research TransCure; University of Bern Foundation; Novartis Research Foundation	This work was supported by the Swiss National Science Foundation National Centre of Competence in Research TransCure, the University of Bern Foundation, and Novartis Research Foundation Grant 10B48.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Alptekin A, 2010, EUR J PHARMACOL, V634, P10, DOI 10.1016/j.ejphar.2010.02.013; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Battista N, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00009; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blom T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004713; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Centonze D, 2004, NEUROPSYCHOPHARMACOL, V29, P1488, DOI 10.1038/sj.npp.1300458; Chicca A, 2009, INT IMMUNOPHARMACOL, V9, P850, DOI 10.1016/j.intimp.2009.03.006; CHU AJ, 1993, CELL BIOCHEM FUNCT, V11, P201, DOI 10.1002/cbf.290110308; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Petrocellis L, 2001, FEBS LETT, V506, P253, DOI 10.1016/S0014-5793(01)02934-9; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 1998, BIOCHEM J, V331, P15; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Fasia L, 2003, EUR J BIOCHEM, V270, P3498, DOI 10.1046/j.1432-1033.2003.03724.x; Felder CC, 2006, MOL INTERV, V6, P149, DOI 10.1124/mi.6.3.6; Fezza F, 2002, FEBS LETT, V513, P294, DOI 10.1016/S0014-5793(02)02341-4; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Fogli S, 2006, FEBS LETT, V580, P1733, DOI 10.1016/j.febslet.2006.02.024; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Hajos N, 2004, EUR J NEUROSCI, V19, P2991, DOI 10.1111/j.0953-816X.2004.03433.x; Hamtiaux L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026823; Hermann A, 2006, AAPS J, V8, pE409, DOI 10.1007/BF02854913; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Hillard CJ, 2000, CHEM PHYS LIPIDS, V108, P123, DOI 10.1016/S0009-3084(00)00191-2; Izeboud CA, 2000, N-S ARCH PHARMACOL, V362, P184, DOI 10.1007/s002100000281; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Jarrahian A, 2000, J NEUROCHEM, V74, P2597, DOI 10.1046/j.1471-4159.2000.0742597.x; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kelley BG, 2004, EUR J PHARMACOL, V496, P33, DOI 10.1016/j.ejphar.2004.06.011; La Rana G, 2008, NEUROPHARMACOLOGY, V54, P521, DOI 10.1016/j.neuropharm.2007.10.021; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Ligresti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010239; Liu YJ, 2009, BIOL CELL, V101, P133, DOI 10.1042/BC20080083; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lopez-Rodriguez ML, 2003, EUR J MED CHEM, V38, P403, DOI 10.1016/S0223-5234(03)00045-X; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; Maccarrone M, 2002, BIOCHEM J, V366, P137, DOI 10.1042/BJ20020438; Maccarrone M, 2002, BLOOD, V100, P4040, DOI 10.1182/blood-2002-05-1444; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Marazzi J, 2011, J IMMUNOL METHODS, V373, P219, DOI 10.1016/j.jim.2011.08.021; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; McFarland MJ, 2008, MOL PHARMACOL, V74, P101, DOI 10.1124/mol.108.044834; McFarland MJ, 2004, J BIOL CHEM, V279, P41991, DOI 10.1074/jbc.M407250200; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; Moore SA, 2005, P NATL ACAD SCI USA, V102, P17852, DOI 10.1073/pnas.0507470102; Muthian S, 2000, J PHARMACOL EXP THER, V293, P289; Nicholson RA, 2003, BRAIN RES, V978, P194, DOI 10.1016/S0006-8993(03)02808-7; Nievergelt A, 2011, J IMMUNOL, V187, P4140, DOI 10.4049/jimmunol.1100880; Obata T, 2003, J CHROMATOGR B, V792, P131, DOI 10.1016/S1570-0232(03)00311-8; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2010, J LIPID RES, V51, P2435, DOI 10.1194/jlr.D004176; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; POCH G, 1990, J PHARMACOL METHOD, V24, P311, DOI 10.1016/0160-5402(90)90015-D; POCH G, 1990, CAN J PHYSIOL PHARM, V68, P1338; POCH G, 1995, J PHARMACOL TOXICOL, V33, P197, DOI 10.1016/1056-8719(95)00016-B; POCH G, 1980, J PHARMACOL METHOD, V4, P179, DOI 10.1016/0160-5402(80)90036-4; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schmid PC, 2000, CHEM PHYS LIPIDS, V104, P185, DOI 10.1016/S0009-3084(99)00124-3; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; Ueda N, 1999, FEBS LETT, V454, P267, DOI 10.1016/S0014-5793(99)00820-0; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P656, DOI 10.1016/j.intimp.2005.10.002; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808; Zoerner AA, 2011, BBA-MOL CELL BIOL L, V1811, P706, DOI 10.1016/j.bbalip.2011.08.004; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	113	92	95	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34660	34682		10.1074/jbc.M112.373241	http://dx.doi.org/10.1074/jbc.M112.373241			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879589	hybrid, Green Published			2022-12-28	WOS:000309654200068
J	Vaara, M; Itkonen, H; Hillukkala, T; Liu, Z; Nasheuer, HP; Schaarschmidt, D; Pospiech, H; Syvaoja, JE				Vaara, Markku; Itkonen, Harri; Hillukkala, Tomi; Liu, Zhe; Nasheuer, Heinz-Peter; Schaarschmidt, Daniel; Pospiech, Helmut; Syvaoja, Juhani E.			Segregation of Replicative DNA Polymerases during S Phase DNA POLYMERASE is an element of, BUT NOT DNA POLYMERASES alpha/delta, ARE ASSOCIATED WITH LAMINS THROUGHOUT S PHASE IN HUMAN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; EUKARYOTIC CELLS; MCM2-7 HELICASE; ALPHA-PRIMASE; GINS COMPLEX; EPSILON; CDC45; FORK; ORIGIN; DELTA	DNA polymerases (Pol) alpha, delta, and is an element of replicate the bulk of chromosomal DNA in eukaryotic cells, Pol is an element of being the main leading strand and Pol delta the lagging strand DNA polymerase. By applying chromatin immunoprecipitation (ChIP) and quantitative PCR we found that at G(1)/S arrest, all three DNA polymerases were enriched with DNA containing the early firing lamin B2 origin of replication and, 2 h after release from the block, with DNA containing the origin at the upstream promoter region of the MCM4 gene. Pol alpha, delta, and is an element of were released from these origins upon firing. All three DNA polymerases, Mcm3 and Cdc45, but not Orc2, still formed complexes in late S phase. Reciprocal ChIP of the three DNA polymerases revealed that at G(1)/S arrest and early in S phase, Pol alpha, delta, and is an element of were associated with the same nucleoprotein complexes, whereas in late S phase Pol is an element of and Pol alpha/delta were largely associated with distinct complexes. At G(1)/S arrest, the replicative DNA polymerases were associated with lamins, but in late S phase only Pol is an element of, not Pol alpha/delta, remained associated with lamins. Consistently, Pol is an element of, but not Pol delta, was found in nuclear matrix fraction throughout the cell cycle. Therefore, Pol is an element of and Pol alpha/delta seem to pursue their functions at least in part independently in late S phase, either by physical uncoupling of lagging strand maturation from the fork progression, or by recruitment of Pol delta, but not Pol is an element of, to post-replicative processes such as translesion synthesis or post-replicative repair.	[Vaara, Markku; Itkonen, Harri; Liu, Zhe] Univ Eastern Finland, Dept Biol, FI-80101 Joensuu, Finland; [Hillukkala, Tomi; Pospiech, Helmut] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Nasheuer, Heinz-Peter] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Schaarschmidt, Daniel] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Pospiech, Helmut] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, FI-70211 Kuopio, Finland	University of Eastern Finland; Finland National Institute for Health & Welfare; University of Oulu; Ollscoil na Gaillimhe-University of Galway; University of Konstanz; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Eastern Finland	Syvaoja, JE (corresponding author), POB 1627, FI-70211 Kuopio, Finland.	juhani.syvaoja@uef.fi	Nasheuer, Heinz P./B-9025-2008; Pospiech, Helmut/J-8598-2015	Nasheuer, Heinz Peter/0000-0002-9218-9079; Itkonen, Harri/0000-0002-5194-7064	Academy of Finland Grants [106986, 123082]	Academy of Finland Grants(Academy of Finland)	This work was supported by Academy of Finland Grants 106986 (to H.P.) and 123082 (to J.E.S.).	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2010, FEBS LETT, V584, P2596, DOI 10.1016/j.febslet.2010.04.003; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson R. T., 1993, CELL CYCLE PRACTICAL, P1; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; NASHEUER HP, 1988, J BIOL CHEM, V263, P8981; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pavlov YI, 2001, GENETICS, V159, P47; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pospiech H, 1999, NUCLEIC ACIDS RES, V27, P3799, DOI 10.1093/nar/27.19.3799; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rytkonen AK, 2006, FEBS J, V273, P5535, DOI 10.1111/j.1742-4658.2006.05544.x; Rytkonen AK, 2006, FEBS J, V273, P2984, DOI 10.1111/j.1742-4658.2006.05310.x; Schaarschmidt D, 2002, NUCLEIC ACIDS RES, V30, P4176, DOI 10.1093/nar/gkf532; Shikata Koh, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-21; STADLBAUER F, 1994, EUR J BIOCHEM, V222, P781, DOI 10.1111/j.1432-1033.1994.tb18925.x; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; TENHAGEN KG, 1993, NUCLEIC ACIDS RES, V21, P2139, DOI 10.1093/nar/21.9.2139; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; UITTO L, 1995, NUCLEIC ACIDS RES, V23, P244, DOI 10.1093/nar/23.2.244; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x	51	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33327	33338		10.1074/jbc.M112.357996	http://dx.doi.org/10.1074/jbc.M112.357996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22887995	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000309602100021
J	Jiang, RS; Krzycki, JA				Jiang, Ruisheng; Krzycki, Joseph A.			PylSn and the Homologous N-terminal Domain of Pyrrolysyl-tRNA Synthetase Bind the tRNA That Is Essential for the Genetic Encoding of Pyrrolysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; AMINO-ACID; METHYLAMINE METHYLTRANSFERASES; METHANOSARCINA-BARKERI; BIOSYNTHESIS; UAG; VIVO; ANALOGS; LYSINE; MONOMETHYLAMINE	Pyrrolysine is represented by an amber codon in genes encoding proteins such as the methylamine methyltransferases present in some Archaea and Bacteria. Pyrrolysyl-tRNA synthetase (PylRS) attaches pyrrolysine to the amber-suppressing tRNA(Pyl). Archaeal PylRS, encoded by pylS, has a catalytic C-terminal domain but an N-terminal region of unknown function and structure. In Bacteria, homologs of the N- and C-terminal regions of archaeal PylRS are respectively encoded by pylSn and pylSc. We show here that wild type PylS from Methanosarcina barkeri and PylSn from Desulfitobacterium hafniense bind tRNA(Pyl) in EMSA with apparent K-d values of 0.12 and 0.13 mu M, respectively. Truncation of the N-terminal region of PylS eliminated detectable tRNA(Pyl) binding as measured by EMSA, but not catalytic activity. Achimeric protein with PylSn fused to the N terminus of truncated PylS regained EMSA-detectable tRNA(Pyl) binding. PylSn did not bind other D. hafniense tRNAs, nor did the competition by the Escherichia coli tRNA pool interfere with tRNA(Pyl) binding. Further indicating the specificity of PylSn interaction with tRNA(Pyl), substitutions of conserved residues in tRNA(Pyl) in the variable loop, D stem, and T stem and loop had significant impact in binding, whereas those having base changes in the acceptor stem or anticodon stem and loop still retained the ability to complex with PylSn. PylSn and the N terminus of PylS comprise the protein superfamily TIGR03129. The members of this family are not similar to any known RNA-binding protein, but our results suggest their common function involves specific binding of tRNA(Pyl).	[Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Jiang, Ruisheng; Krzycki, Joseph A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu			National Institutes of Health [GM070663]; Department of Energy [DE-FG0202-91ER200042]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM070663. This work was also supported by Department of Energy Grant DE-FG0202-91ER200042 (to J. A. K.).	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Bovee ML, 1999, BIOCHEMISTRY-US, V38, P13725, DOI 10.1021/bi991182g; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Cellitti SE, 2011, NAT CHEM BIOL, V7, P528, DOI [10.1038/NCHEMBIO.586, 10.1038/nchembio.586]; Fekner T, 2011, CURR OPIN CHEM BIOL, V15, P387, DOI 10.1016/j.cbpa.2011.03.007; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gaston MA, 2011, CURR OPIN MICROBIOL, V14, P342, DOI 10.1016/j.mib.2011.04.001; Gaston MA, 2011, NATURE, V471, P647, DOI 10.1038/nature09918; Goodchild A, 2004, MOL MICROBIOL, V53, P309, DOI 10.1111/j.1365-2958.2004.04130.x; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Herring S, 2007, FEBS LETT, V581, P3197, DOI 10.1016/j.febslet.2007.06.004; Herring S, 2007, NUCLEIC ACIDS RES, V35, P1270, DOI 10.1093/nar/gkl1151; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; Katayama H, 2012, BIOSCI BIOTECH BIOCH, V76, P205, DOI 10.1271/bbb.110653; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-21; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Lee MM, 2008, BIOCHEM BIOPH RES CO, V374, P470, DOI 10.1016/j.bbrc.2008.07.074; Li WT, 2009, J MOL BIOL, V385, P1156, DOI 10.1016/j.jmb.2008.11.032; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Longstaff DG, 2007, MOL MICROBIOL, V63, P229, DOI 10.1111/j.1365-2958.2006.05500.x; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Quitterer F, 2012, ANGEW CHEM INT EDIT, V51, P1339, DOI 10.1002/anie.201106765; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Theobald-Dietrich A, 2004, NUCLEIC ACIDS RES, V32, P1091, DOI 10.1093/nar/gkh266; WATANABE Y, 1994, NUCLEIC ACIDS RES, V22, P5378, DOI 10.1093/nar/22.24.5378; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yanagisawa T, 2006, ACTA CRYSTALLOGR F, V62, P1031, DOI 10.1107/S1744309106036700; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514	40	40	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32738	32746		10.1074/jbc.M112.396754	http://dx.doi.org/10.1074/jbc.M112.396754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851181	Green Published, hybrid			2022-12-28	WOS:000309168300041
J	Khanna-Gupta, A; Abayasekara, N; Levine, M; Sun, H; Virgilio, M; Nia, N; Halene, S; Sportoletti, P; Jeong, JY; Pandolfi, PP; Berliner, N				Khanna-Gupta, Arati; Abayasekara, Nirmalee; Levine, Michelle; Sun, Hong; Virgilio, Maria; Nia, Navid; Halene, Stephanie; Sportoletti, Paolo; Jeong, Jee-Yeong; Pandolfi, Pier Paolo; Berliner, Nancy			Up-regulation of Translation Eukaryotic Initiation Factor 4E in Nucleophosmin 1 Haploinsufficient Cells Results in Changes in CCAAT Enhancer-binding Protein alpha Activity IMPLICATIONS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-ALPHA; MESSENGER-RNA; C-MYC; MUSCLE-CELLS; TRANSCRIPTION; GENE; EXPRESSION; TARGET; CANCER; C/EBP-ALPHA-P-30	NPM1 is a ubiquitously expressed nucleolar phosphoprotein, the gene for which maps to chromosome 5q35 in close proximity to a commonly deleted region associated with (del)5q, a type of myelodysplastic syndrome (MDS). This region is also a frequent target of deletions in de novo and therapy-related MDS/acute myeloid leukemia. Previous studies have shown that Npm1(+/-) mice develop an MDS-like disease that transforms to acute myeloid leukemia over time. To better understand the mechanism by which NPM1 haploinsufficiency causes an MDS phenotype, we generated factor-dependent myeloid cell lines from the bone marrow of Npm1(+/+) and Npm1(+/-) mice and demonstrated compromised neutrophil-specific gene expression in the MNPM1(+/-) cells. We attribute these observations to increased levels of the shorter, dominant negative leukemogenic isoform (p30) of CCAAT enhancer-binding protein alpha (C/EBP alpha). We show that this increase is caused, in part, by elevated levels of the activated translation initiation factor eIF4E, overexpression of which also increases translation of C/EBP alpha p30 in HEK293 cells. In a positive feedback loop, eIF4E expression is further elevated both at the mRNA and protein levels by C/EBP alpha p30 but not by the full-length C/EBP alpha p42. Re-expression of C/EBP alpha p42 or NPM1 but not C/EBP alpha p30 in MNPM1(+/-) cells partially rescues the myeloid phenotype. Our observations suggest that the aberrant feed-forward pathway that keeps eIF4E and C/EBP alpha p30 elevated in NPM1(+/-) cells contributes to the MDS phenotype associated with NPM1 deficiency.	[Khanna-Gupta, Arati; Abayasekara, Nirmalee; Levine, Michelle; Sun, Hong; Virgilio, Maria; Nia, Navid; Jeong, Jee-Yeong; Berliner, Nancy] Harvard Univ, Sch Med, Div Hematol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Sportoletti, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Dept Med, Boston, MA 02115 USA; [Sportoletti, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Halene, Stephanie] Yale Univ, Sch Med, Sect Hematol, New Haven, CT 06510 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University	Khanna-Gupta, A (corresponding author), Harvard Univ, Sch Med, Div Hematol, Brigham & Womens Hosp, Karp 5-212,1 Blackfan Circle, Boston, MA 02115 USA.	akhanna-gupta@partners.org	Sportoletti, Paolo/AAE-5907-2020; SPORTOLETTI, PAOLO/K-6013-2016	Pandolfi, Pier Paolo/0000-0002-5352-5295; SPORTOLETTI, PAOLO/0000-0002-5630-9862; Virgilio, Maria/0000-0002-4940-188X	National Institutes of Health [CA-71692, CA-74031, P01-HL63357]; NATIONAL CANCER INSTITUTE [R01CA074031, R37CA071692, R01CA071692] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL063357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-71692 and CA-74031 (to P. P. P.) and P01-HL63357 (to N. B.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Borger P, 2009, J ALLERGY CLIN IMMUN, V123, P639, DOI 10.1016/j.jaci.2008.11.006; Calkhoven CF, 2000, GENE DEV, V14, P1920; Calkhoven CF, 2002, TRENDS MOL MED, V8, P577, DOI 10.1016/S1471-4914(02)02424-3; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Falini B, 2008, HAEMATOLOGICA, V93, P775, DOI 10.3324/haematol.12225; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gadad Shrikanth S., 2009, V523, P263, DOI 10.1007/978-1-59745-190-1_18; Geletu M, 2007, BLOOD, V110, P3301, DOI 10.1182/blood-2007-01-071035; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hankey W, 2011, HEMATOL REP, V3, P13, DOI 10.4081/hr.2011.e5; Hou JQ, 2012, ONCOTARGET, V3, P118; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Khanna-Gupta A, 2005, EXP HEMATOL, V33, P42, DOI 10.1016/j.exphem.2004.09.009; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Khanna-Gupta A, 2007, BLOOD, V109, P4181, DOI 10.1182/blood-2005-05-022004; Khanna-Gupta A, 2011, EXP HEMATOL, V39, P133, DOI 10.1016/j.exphem.2010.10.011; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Li SR, 2011, BLOOD, V117, P5157, DOI 10.1182/blood-2010-10-314278; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Mahalingam M, 2001, PROG MOLEC, V27, P131; Makhlouf AA, 2001, GENE, V267, P1, DOI 10.1016/S0378-1119(01)00399-7; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mink S, 1996, P NATL ACAD SCI USA, V93, P6635, DOI 10.1073/pnas.93.13.6635; Mueller BU, 2006, CURR OPIN HEMATOL, V13, P7, DOI 10.1097/01.moh.0000190110.08156.96; Muller C, 2010, EMBO J, V29, P897, DOI 10.1038/emboj.2009.404; Naoe T, 2006, CANCER SCI, V97, P963, DOI 10.1111/j.1349-7006.2006.00270.x; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Olney HJ, 2007, LEUKEMIA RES, V31, P427, DOI 10.1016/j.leukres.2006.10.023; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pulikkan JA, 2010, LEUKEMIA, V24, P914, DOI 10.1038/leu.2010.37; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831	43	12	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32728	32737		10.1074/jbc.M112.373274	http://dx.doi.org/10.1074/jbc.M112.373274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851180	Green Published, hybrid			2022-12-28	WOS:000309168300040
J	Bogel, G; Gujdar, A; Geiszt, M; Lanyi, A; Fekete, A; Sipeki, S; Downward, J; Buday, L				Boegel, Gabor; Gujdar, Annamaria; Geiszt, Miklos; Lanyi, Arpad; Fekete, Anna; Sipeki, Szabolcs; Downward, Julian; Buday, Laszlo			Frank-ter Haar Syndrome Protein Tks4 Regulates Epidermal Growth Factor-dependent Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN; PX-DOMAIN; PODOSOME FORMATION; RAS ACTIVATION; CANCER-CELLS; ACTIN; INVADOPODIA; CORTACTIN; RECEPTOR	Mutations in the SH3PXD2B gene coding for the Tks4 protein are responsible for the autosomal recessive Frank-ter Haar syndrome. Tks4, a substrate of Src tyrosine kinase, is implicated in the regulation of podosome formation. Here, we report a novel role for Tks4 in the EGF signaling pathway. In EGF-treated cells, Tks4 is tyrosine-phosphorylated and associated with the activated EGF receptor. This association is not direct but requires the presence of Src tyrosine kinase. In addition, treatment of cells with LY294002, an inhibitor of PI 3-kinase, or mutations of the PX domain reduces tyrosine phosphorylation and membrane translocation of Tks4. Furthermore, a PX domain mutant (R43W) Tks4 carrying a reported point mutation in a Frank-ter Haar syndrome patient showed aberrant intracellular expression and reduced phosphoinositide binding. Finally, silencing of Tks4 was shown to markedly inhibit HeLa cell migration in a Boyden chamber assay in response to EGF or serum. Our results therefore reveal a new function for Tks4 in the regulation of growth factor-dependent cell migration.	[Fekete, Anna; Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, H-1113 Budapest, Hungary; [Boegel, Gabor; Gujdar, Annamaria; Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Sch Med, Dept Med Chem, H-1094 Budapest, Hungary; [Geiszt, Miklos] Semmelweis Univ, Sch Med, Dept Physiol, H-1094 Budapest, Hungary; [Lanyi, Arpad] Univ Debrecen, Inst Immunol, H-4032 Debrecen, Hungary; [Downward, Julian] London Res Inst, Canc Res United Kingdom, London WC2A 3PX, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Semmelweis University; University of Debrecen; Cancer Research UK; University of London; University College London	Buday, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Karolina St 29, H-1113 Budapest, Hungary.	buday@enzim.hu		Downward, Julian/0000-0002-2331-4729; Sipeki, Szabolcs/0000-0002-9678-6743	Hungarian Research Fund OTKA [K 83867, K 81676]; Hungarian Academy of Sciences; Social Reform Operative Program (TAMOP) [4.2.1/B-09/1/KONV/ 2010-007]; New Hungary Development Plan; European Social Fund; Cancer Research UK [15680] Funding Source: researchfish	Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Social Reform Operative Program (TAMOP); New Hungary Development Plan; European Social Fund(European Social Fund (ESF)); Cancer Research UK(Cancer Research UK)	This work was supported by Hungarian Research Fund OTKA Grants K 83867 and K 81676 and by the "Lendulet" grants from the Hungarian Academy of Sciences (to L. B. and M. G.), by the Social Reform Operative Program (TAMOP) 4.2.1/B-09/1/KONV/ 2010-007 Project (to A. L.), and by the New Hungary Development Plan, co-financed by the European Social Fund.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Belsches A P, 1997, Front Biosci, V2, pd501; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Ellson CD, 2002, J CELL SCI, V115, P1099; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gianni D, 2011, EUR J CELL BIOL, V90, P164, DOI 10.1016/j.ejcb.2010.05.007; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Lanyi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023653; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; Murphy DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022499; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	36	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31321	31329		10.1074/jbc.M111.324897	http://dx.doi.org/10.1074/jbc.M111.324897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829589	Green Published, hybrid			2022-12-28	WOS:000308791300043
J	Zamora, R; Azhar, N; Namas, R; Metukuri, MR; Clermont, T; Gladstone, C; Namas, RA; Hermus, L; Megas, C; Constantine, G; Billiar, TR; Fink, MP; Vodovotz, Y				Zamora, Ruben; Azhar, Nabil; Namas, Rajaie; Metukuri, Mallikarjuna R.; Clermont, Thierry; Gladstone, Chase; Namas, Rami A.; Hermus, Linda; Megas, Cristina; Constantine, Gregory; Billiar, Timothy R.; Fink, Mitchell P.; Vodovotz, Yoram			Identification of a Novel Pathway of Transforming Growth Factor-beta 1 Regulation by Extracellular NAD(+) in Mouse Macrophages IN VITRO AND IN SILICO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; GROWTH-FACTOR-BETA; CYCLIC ADP-RIBOSE; CYTOTOXIC T-CELLS; SPLITTING ENZYME; INTRACELLULAR CALCIUM; NITRIC-OXIDE; TGF-BETA; ACTIVATION; RIBOSYLATION	Extracellular beta-nicotinamide adenine dinucleotide (NAD(+)) is anti-inflammatory. We hypothesized that NAD(+) would modulate the anti-inflammatory cytokine Transforming Growth Factor (TGF)-beta 1. Indeed, NAD(+) led to increases in both active and latent cell-associated TGF-beta 1 in RAW 264.7 mouse macrophages as well as in primary peritoneal macrophages isolated from both C3H/HeJ (TLR4-mutant) and C3H/HeOuJ (wild-type controls for C3H/HeJ) mice. NAD(+) acts partially via cyclicADP-ribose (cADPR) and subsequent release of Ca2+. Treatment of macrophages with the cADPR analog 3-deaza-cADPR or Ca2+ ionophores recapitulated the effects of NAD(+) on TGF-beta 1, whereas the cADPR antagonist 8-Br-cADPR, Ca2+ chelation, and antagonism of L-type Ca2+ channels suppressed these effects. The time and dose effects of NAD(+) on TGF-beta 1 were complex and could be modeled both statistically and mathematically. Model-predicted levels of TGF-beta 1 protein and mRNA were largely confirmed experimentally but also suggested the presence of other mechanisms of regulation of TGF-beta 1 by NAD beta. Thus, in vitro and in silico evidence points to NAD(+) as a novel modulator of TGF-beta 1.	[Zamora, Ruben; Azhar, Nabil; Namas, Rajaie; Metukuri, Mallikarjuna R.; Clermont, Thierry; Gladstone, Chase; Namas, Rami A.; Hermus, Linda; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Azhar, Nabil; Vodovotz, Yoram] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA; [Megas, Cristina; Constantine, Gregory] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15261 USA; [Constantine, Gregory; Billiar, Timothy R.; Fink, Mitchell P.; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15219 USA; [Fink, Mitchell P.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zamora, R (corresponding author), Univ Pittsburgh, Dept Surg, W943 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	zamorar@pitt.edu	Namas, Rami/AAD-5796-2020; Namas, Rami/AAD-5793-2020; Namas, Rajaie/U-2206-2019; Namas, Rami/GZK-4999-2022	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321; Namas, Rajaie/0000-0003-0353-895X	National Institutes of Health Grants [R01-AI080799, P50-GM53789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI080799 and P50-GM53789.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARTMAN M, 1979, ARCH BIOCHEM BIOPHYS, V195, P121, DOI 10.1016/0003-9861(79)90333-3; ARTMAN M, 1978, SCIENCE, V202, P1293, DOI 10.1126/science.214853; ARTMAN M, 1979, J RETICULOENDOTH SOC, V25, P479; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Chong HY, 1999, J CELL PHYSIOL, V178, P275, DOI 10.1002/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.3.CO;2-H; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Fink MP, 2009, J LEUKOCYTE BIOL, V86, P203, DOI 10.1189/jlb.0309137; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Franco L, 1998, FASEB J, V12, P1507; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; Han XN, 2003, J PHARMACOL EXP THER, V307, P443, DOI 10.1124/jpet.103.056556; Hauschildt S, 1998, PROG CLIN BIOL RES, V397, P147; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Khan AU, 2002, AM J PHYSIOL-LUNG C, V282, pL1082, DOI 10.1152/ajplung.00358.2001; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Liu ZX, 2001, J IMMUNOL, V167, P4942, DOI 10.4049/jimmunol.167.9.4942; Looms DK, 2001, BIOCHEM J, V355, P87, DOI 10.1042/bj3550087; Luhrmann A, 1998, ANTIMICROB AGENTS CH, V42, P1911, DOI 10.1128/AAC.42.8.1911; MAEHAMA T, 1995, J BIOL CHEM, V270, P22747, DOI 10.1074/jbc.270.39.22747; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Metukuri MR, 2009, WOUND REPAIR REGEN, V17, P578, DOI 10.1111/j.1524-475X.2009.00509.x; Namazi MR, 2003, FASEB J, V17, P1377, DOI 10.1096/fj.03-0002hyp; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NOWICKI M, 1991, CELL IMMUNOL, V132, P115, DOI 10.1016/0008-8749(91)90011-Y; Okamoto S, 1998, J IMMUNOL, V160, P4190; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Ramakers BP, 2011, SHOCK, V36, P208, DOI 10.1097/SHK.0b013e318225aee4; Rigby MR, 1996, J IMMUNOL, V156, P4259; Romanello M, 2001, BIOCHEM BIOPH RES CO, V285, P1226, DOI 10.1006/bbrc.2001.5325; Sethi JK, 1997, J BIOL CHEM, V272, P16358, DOI 10.1074/jbc.272.26.16358; TWARDZIK DR, 1990, ANN NY ACAD SCI, V593, P276, DOI 10.1111/j.1749-6632.1990.tb16119.x; Vodovotz Y, 1999, CANCER RES, V59, P2142; Vodovotz Y, 2001, PROG INFLAM RES, P41; Wahl SM, 1999, MICROBES INFECT, V1, P1247, DOI 10.1016/S1286-4579(99)00261-0; Wang J, 1997, ADV EXP MED BIOL, V419, P191; Wang J, 1996, J IMMUNOL, V156, P2819; WANG J, 1994, J IMMUNOL, V153, P4048; Wong L, 1999, BBA-GEN SUBJECTS, V1472, P555, DOI 10.1016/S0304-4165(99)00161-0; Zamora R, 2005, CRIT CARE MED, V33, pS478, DOI 10.1097/01.CCM.0000191725.59611.14	45	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31003	31014		10.1074/jbc.M112.344309	http://dx.doi.org/10.1074/jbc.M112.344309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22829588	Green Published, hybrid			2022-12-28	WOS:000308791300014
J	Love, RP; Xu, HX; Chelico, L				Love, Robin P.; Xu, Huixin; Chelico, Linda			Biochemical Analysis of Hypermutation by the Deoxycytidine Deaminase APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED CYTIDINE DEAMINASE; SOMATIC HYPERMUTATION; VIF PROTEIN; HIV-1 VIF; REVERSE-TRANSCRIPTASE; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; HUMAN-CELLS	APOBEC3A belongs to a family of single-stranded DNA (ssDNA) DNA cytosine deaminases that are known for restriction of HIV through deamination-induced mutational inactivation, e. g. APOBEC3G, or initiation of somatic hypermutation and class switch recombination (activation-induced cytidine deaminase). APOBEC3A, which is localized to both the cytoplasm and nucleus, not only restricts HIV but can also initiate catabolism of cellular DNA. Despite being ascribed these roles, there is a paucity of data available on the biochemical mechanism by which APOBEC3A deaminates ssDNA. Here we assessed APOBEC3A deamination activity on ssDNA and in dynamic systems modeling HIV replication (cytoplasmic event) and DNA transcription (nuclear event). We find that APOBEC3A, unlike the highly processive APOBEC3G, exhibits low or no processivity when deaminating synthetic ssDNA substrates with two cytosines located 5-63 nucleotides apart, likely because of an apparent K-d in the micromolar range (9.1 mu M). APOBEC3A was able to deaminate nascently synthesized (-) DNA in an in vitro model HIV replication assay but induced fewer mutations overall in comparison to APOBEC3G. However, the data indicate that the target deamination motif (5'-TC for APOBEC3A and 5'-CC for APOBEC3G) and not the number of mutations best predicted the ability to mutationally inactivate HIV. We further assessed APOBEC3A for the ability to deaminate dsDNA undergoing transcription, which could allow for collateral deaminations to occur in genomic DNA similar to the action of activation-induced cytidine deaminase. That APOBEC3A was able to deaminate dsDNA undergoing transcription suggests a genomic cost of a deamination-based retroviral restriction system.	[Love, Robin P.; Xu, Huixin; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Love, Robin/0000-0002-2509-706X; Chelico, Linda/0000-0003-4673-8978	Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; National Institutes of Health [ISI0RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada, a new investigator establishment grant from the Saskatchewan Health Research Foundation, and The Canadian Foundation for Innovation.; DNA substrates for deamination assays were obtained through the Tri-Link Biotechnologies Research Rewards Program. The SEC-LX/UV/RI instrumentation was supported by National Institutes of Health Award ISI0RR023748-01. We thank Madison Adolph for assistance with preparation of plasmids for DNA sequencing and Yuqing Feng and Anjuman Ara for critical discussion of the manuscript.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Betts MJ, 2003, AMINO ACID PROPERTIE, P289; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Miyagi E, 2010, J VIROL, V84, P11067, DOI 10.1128/JVI.01249-10; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	72	60	61	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30812	30822		10.1074/jbc.M112.393181	http://dx.doi.org/10.1074/jbc.M112.393181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822074	hybrid, Green Published			2022-12-28	WOS:000308579800069
J	Dickson, AM; Anderson, JR; Barnhart, MD; Sokoloski, KJ; Oko, L; Opyrchal, M; Galanis, E; Wilusz, CJ; Morrison, TE; Wilusz, J				Dickson, Alexa M.; Anderson, John R.; Barnhart, Michael D.; Sokoloski, Kevin J.; Oko, Lauren; Opyrchal, Mateusz; Galanis, Evanthia; Wilusz, Carol J.; Morrison, Thomas E.; Wilusz, Jeffrey			Dephosphorylation of HuR Protein during Alphavirus Infection Is Associated with HuR Relocalization to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA-BINDING; HNRNP A1 INTERACTS; SINDBIS-VIRUS; NUCLEAR IMPORT; PHOSPHORYLATION; MOSQUITO; POLYADENYLATION; TRANSCRIPTS; EXPRESSION; LIGANDS	We have demonstrated previously that the cellular HuR protein binds U-rich elements in the 3' untranslated region (UTR) of Sindbis virus RNA and relocalizes from the nucleus to the cytoplasm upon Sindbis virus infection in 293T cells. In this study, we show that two alphaviruses, Ross River virus and Chikungunya virus, lack the conserved high-affinity U-rich HuR binding element in their 3' UTRs but still maintain the ability to interact with HuR with nanomolar affinities through alternative binding elements. The relocalization of HuR protein occurs during Sindbis infection of multiple mammalian cell types as well as during infections with three other alphaviruses. Interestingly, the relocalization of HuR is not a general cellular reaction to viral infection, as HuR protein remained largely nuclear during infections with dengue and measles virus. Relocalization of HuR in a Sindbis infection required viral gene expression, was independent of the presence of a high-affinity U-rich HuR binding site in the 3' UTR of the virus, and was associated with an alteration in the phosphorylation state of HuR. Sindbis virus-induced HuR relocalization was mechanistically distinct from the movement of HuR observed during a cellular stress response, as there was no accumulation of caspase-mediated HuR cleavage products. Collectively, these data indicate that virus-induced HuR relocalization to the cytoplasm is specific to alphavirus infections and is associated with distinct posttranslational modifications of this RNA-binding protein.	[Dickson, Alexa M.; Anderson, John R.; Barnhart, Michael D.; Sokoloski, Kevin J.; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Parasitol, Ft Collins, CO 80523 USA; [Oko, Lauren; Morrison, Thomas E.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA; [Opyrchal, Mateusz; Galanis, Evanthia] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN 55905 USA; [Sokoloski, Kevin J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic; Indiana University System; Indiana University Bloomington	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Parasitol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/F-7241-2017; Wilusz, Carol/AAC-2901-2021		National Institutes of Health [AI063434]; NIAID, National Institutes of Health through the Rocky Mountain Regional Center of Excellence [U54 AI-065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI063434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, National Institutes of Health through the Rocky Mountain Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in whole or in part, by National Institutes of Health Grant AI063434 and NIAID, National Institutes of Health award U54 AI-065357 through the Rocky Mountain Regional Center of Excellence (to J.W.).	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; BARTON DJ, 1988, J VIROL, V62, P3597, DOI 10.1128/JVI.62.10.3597-3602.1988; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008; Doller A, 2011, CARCINOGENESIS, V32, P676, DOI 10.1093/carcin/bgr024; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Gui HX, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-59; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Jupille H. J., 2011, VIROLOGY, V178, P32; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; PARDIGON N, 1993, J VIROL, V67, P5003, DOI 10.1128/JVI.67.8.5003-5011.1993; Pardigon N, 1996, J VIROL, V70, P1173, DOI 10.1128/JVI.70.2.1173-1181.1996; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Yu TX, 2011, NUCLEIC ACIDS RES, V39, P8472, DOI 10.1093/nar/gkr567; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200	41	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36229	36238		10.1074/jbc.M112.371203	http://dx.doi.org/10.1074/jbc.M112.371203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22915590	Green Published, hybrid			2022-12-28	WOS:000310364000044
J	Kondapalli, KC; Kallay, LM; Muszelik, M; Rao, R				Kondapalli, Kalyan C.; Kallay, Laura M.; Muszelik, Melanie; Rao, Rajini			Unconventional Chemiosmotic Coupling of NHA2, a Mammalian Na+/H+ Antiporter, to a Plasma Membrane H+ Gradient	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-LITHIUM COUNTERTRANSPORT; EVOLUTIONARY ORIGINS; CANDIDATE GENE; EXCHANGER; CELLS; NHE3	Human NHA2, a newly discovered cation proton antiporter, is implicated in essential hypertension by gene linkage analysis. We show that NHA2 mediates phloretin-sensitive Na+-Li+ counter-transport (SLC) activity, an established marker for hypertension. In contrast to bacteria and fungi where H+ gradients drive uptake of metabolites, secondary transport at the plasma membrane of mammalian cells is coupled to the Na+ electrochemical gradient. Our findings challenge this paradigm by showing coupling of NHA2 and V-type H+-ATPase at the plasma membrane of kidney-derived MDCK cells, resulting in a virtual Na+ efflux pump. Thus, NHA2 functionally recapitulates an ancient shared evolutionary origin with bacterial NhaA. Although plasma membrane H+ gradients have been observed in some specialized mammalian cells, the ubiquitous tissue distribution of NHA2 suggests that H+-coupled transport is more widespread. The coexistence of Na+ and H+-driven chemiosmotic circuits has implications for salt and pH regulation in the kidney.	[Kondapalli, Kalyan C.; Kallay, Laura M.; Muszelik, Melanie; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Kondapalli, Kalyan C/N-8097-2019		National Institutes of Health [DK054214]; American Heart Association [11POST7380034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 (to R. R.) and American Heart Association Grant 11POST7380034 (to K. C. K.).	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Anderson CMH, 2010, PHYSIOLOGY, V25, P364, DOI 10.1152/physiol.00027.2010; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; CANESSA M, 1980, NEW ENGL J MED, V302, P772, DOI 10.1056/NEJM198004033021403; CANESSA M, 1995, TRENDS CARDIOVAS MED, V5, P102, DOI 10.1016/1050-1738(95)00004-S; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Ecelbarger CA, 2006, CURR HYPERTENS REP, V8, P158, DOI 10.1007/s11906-006-0013-z; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Harvey WR, 2009, J EXP BIOL, V212, P1620, DOI 10.1242/jeb.031534; HelmleKolb C, 1997, PFLUG ARCH EUR J PHY, V434, P123, DOI 10.1007/s004240050372; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Kammerer CM, 2001, HYPERTENSION, V37, P398, DOI 10.1161/01.HYP.37.2.398; Lahr TF, 2000, PFLUG ARCH EUR J PHY, V439, P610, DOI 10.1007/s004240050984; Lee BL, 2011, BIOCHEM CELL BIOL, V89, P189, DOI [10.1139/o10-140, 10.1139/O10-140]; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Morrison AC, 2005, AM J HYPERTENS, V18, P653, DOI 10.1016/j.amjhyper.2004.11.030; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; WEDER AB, 1986, NEW ENGL J MED, V314, P198, DOI 10.1056/NEJM198601233140402; Wegmann M, 2003, PROSTAG LEUKOTR ESS, V69, P315, DOI 10.1016/j.plefa.2003.06.002; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zerbini G, 1997, AM J PHYSIOL-CELL PH, V272, pC1373, DOI 10.1152/ajpcell.1997.272.4.C1373	29	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36239	36250		10.1074/jbc.M112.403550	http://dx.doi.org/10.1074/jbc.M112.403550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948142	Green Published, hybrid			2022-12-28	WOS:000310364000045
J	Vallese, F; Berto, P; Ruzzene, M; Cendron, L; Sarno, S; De Rosa, E; Giacometti, GM; Costantini, P				Vallese, Francesca; Berto, Paola; Ruzzene, Maria; Cendron, Laura; Sarno, Stefania; De Rosa, Edith; Giacometti, Giorgio M.; Costantini, Paola			Biochemical Analysis of the Interactions between the Proteins Involved in the [FeFe]-Hydrogenase Maturation Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-CLUSTER; FEFE HYDROGENASE; SCAFFOLD PROTEIN; HYDF; INSIGHTS; ACTIVATION; ENZYMES	[FeFe]-hydrogenases are iron-sulfur proteins characterized by a complex active site, the H-cluster, whose assembly requires three conserved maturases. HydE and HydG are radical S-adenosylmethionine enzymes that chemically modify a H-cluster precursor on HydF, a GTPase with a dual role of scaffold on which this precursor is synthesized, and carrier to transfer it to the hydrogenase. Coordinate structural and functional relationships between HydF and the two other maturases are crucial for the H-cluster assembly. However, to date only qualitative analysis of this protein network have been provided. In this work we showed that the interactions of HydE and HydG with HydF are distinct events, likely occurring in a precise functional order driven by different kinetic properties, independently of the HydF GTPase activity, which is instead involved in the dissociation of the maturases from the scaffold. We also found that HydF is able to interact with the hydrogenase only when co-expressed with the two other maturases, indicating that under these conditions it harbors per se all the structural elements needed to transfer the H-cluster precursor, thus completing the maturation process. These results open new working perspectives aimed at improving the knowledge of how these complex metalloenzymes are biosynthesized.	[Vallese, Francesca; Cendron, Laura; Giacometti, Giorgio M.; Costantini, Paola] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Berto, Paola; Ruzzene, Maria; Sarno, Stefania; De Rosa, Edith] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Costantini, P (corresponding author), Univ Padua, Dept Biol, Viale G Colombo 3, I-35131 Padua, Italy.	paola.costantini@unipd.it	cendron, Laura/A-5202-2014	Cendron, Laura/0000-0002-0125-0461; Ruzzene, Maria/0000-0001-8712-8151	Ministero delle Politiche Agricole e Forestali; Fondazione Cassa di Risparmio di Padova e Rovigo	Ministero delle Politiche Agricole e Forestali; Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo)	This work was supported by Ministero delle Politiche Agricole e Forestali Grant (to G. M. G.).; Recipient of a Ph.D. fellowship from the Fondazione Cassa di Risparmio di Padova e Rovigo.	Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Cendron L, 2011, J BIOL CHEM, V286, P43944, DOI 10.1074/jbc.M111.281956; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duffus BR, 2012, BBA-PROTEINS PROTEOM, V1824, P1254, DOI 10.1016/j.bbapap.2012.01.002; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ruzzene M, 1999, FEBS LETT, V461, P32, DOI 10.1016/S0014-5793(99)01409-X; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107	25	25	25	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36544	36555		10.1074/jbc.M112.388900	http://dx.doi.org/10.1074/jbc.M112.388900			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932901	hybrid, Green Published			2022-12-28	WOS:000310364000075
J	Koshino, I; Mohandas, N; Takakuwa, Y				Koshino, Ichiro; Mohandas, Narla; Takakuwa, Yuichi			Identification of a Novel Role for Dematin in Regulating Red Cell Membrane Function by Modulating Spectrin-Actin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE; MALARIAL INFECTION; HEMOLYTIC-ANEMIA; BUNDLING PROTEIN; ADDUCIN; STABILITY; PHOSPHORYLATION; BINDING; PURIFICATION; SKELETAL	The membrane skeleton plays a central role in maintaining the elasticity and stability of the erythrocyte membrane, two biophysical features critical for optimal functioning and survival of red cells. Many constituent proteins of the membrane skeleton are phosphorylated by various kinases, and phosphorylation of beta-spectrin by casein kinase and of protein 4.1R by PKC has been documented to modulate erythrocyte membrane mechanical stability. In this study, we show that activation of endogenous PKA by cAMP decreases membrane mechanical stability and that this effect is mediated primarily by phosphorylation of dematin. Co-sedimentation assay showed that dematin facilitated interaction between spectrin and F-actin, and phosphorylation of dematin by PKA markedly diminished this activity. Quartz crystal microbalance measurement revealed that purified dematin specifically bound the tail region of the spectrin dimer in a saturable manner with a submicromolar affinity. Pulldown assay using recombinant spectrin fragments showed that dematin, but not phospho-dematin, bound to the tail region of the spectrin dimer. These findings imply that dematin contributes to the maintenance of erythrocyte membrane mechanical stability by facilitating spectrin-actin interaction and that phosphorylation of dematin by PKA can modulate these effects. In this study, we have uncovered a novel functional role for dematin in regulating erythrocyte membrane function.	[Koshino, Ichiro; Takakuwa, Yuichi] Tokyo Womens Med Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo 1628666, Japan; [Mohandas, Narla] New York Blood Ctr, New York, NY 10065 USA	Tokyo Women's Medical University; New York Blood Center	Takakuwa, Y (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Biochem, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	takakuwa@research.twmu.ac.jp			National Institutes of Health [DK26263, DK32094, HL31579]; Takada Scientific Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18590408]; Grants-in-Aid for Scientific Research [22591112] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263, P01DK032094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takada Scientific Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK26263, DK32094, and HL31579. This work was also supported by the Takada Scientific Foundation and by Grant-in-aid for Scientific Research 18590408 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; CORREAS I, 1986, J BIOL CHEM, V261, P3310; Gallagher P. G., 2010, WILLIAMS HEMATOLOGY; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Kamata K, 2008, AM J HEMATOL, V83, P371, DOI 10.1002/ajh.21126; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Koshino I, 2009, EXP PARASITOL, V123, P381, DOI 10.1016/j.exppara.2009.08.019; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1982, BLOOD, V59, P768; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; SIEGEL DL, 1985, J CELL BIOL, V100, P775, DOI 10.1083/jcb.100.3.775; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; UNGEWICKELL E, 1979, NATURE, V280, P811, DOI 10.1038/280811a0; Vardar D, 2002, CELL MOTIL CYTOSKEL, V52, P9, DOI 10.1002/cm.10027	29	35	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35244	35250		10.1074/jbc.M111.305441	http://dx.doi.org/10.1074/jbc.M111.305441			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927433	Green Published, hybrid			2022-12-28	WOS:000309968000034
J	Jana, M; Mondal, S; Gonzalez, FJ; Pahan, K				Jana, Malabendu; Mondal, Susanta; Gonzalez, Frank J.; Pahan, Kalipada			Gemfibrozil, a Lipid-lowering Drug, Increases Myelin Genes in Human Oligodendrocytes via Peroxisome Proliferator-activated Receptor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; PPAR-DELTA; ADOPTIVE TRANSFER; NITRIC-OXIDE; TRANSCRIPTIONAL REPRESSION; NEUTRAL SPHINGOMYELINASE	An increase in CNS remyelination and a decrease in CNS inflammation are important steps to halt the progression of multiple sclerosis. Earlier studies have shown that gemfibrozil, a lipid-lowering drug, has anti-inflammatory properties. The current study identified another novel property of gemfibrozil in stimulating the expression of myelin-specific genes (myelin basic protein, myelin oligodendrocyte glycoprotein, 2',3'-cyclic-nucleotide 3'-phosphodiesterase, and proteolipid protein (PLP)) in primary human oligodendrocytes, mixed glial cells, and spinal cord organotypic cultures. Although gemfibrozil is a known activator of peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we were unable to detect PPAR-alpha in either gemfibrozil-treated or untreated human oligodendrocytes, and gemfibrozil increased the expression of myelin genes in oligodendrocytes isolated from both wild type and PPAR-alpha(-/-) mice. On the other hand, gemfibrozil markedly increased the expression of PPAR-beta but not PPAR-gamma. Consistently, antisense knockdown of PPAR-beta, but not PPAR-gamma, abrogated the stimulatory effect of gemfibrozil on myelin genes in human oligodendrocytes. Gemfibrozil also did not up-regulate myelin genes in oligodendroglia isolated from PPAR-beta(-/-) mice. Chromatin immunoprecipitation analysis showed that gemfibrozil induced the recruitment of PPAR-beta to the promoter of PLP and myelin oligodendrocyte glycoprotein genes in human oligodendrocytes. Furthermore, gemfibrozil treatment also led to the recruitment of PPAR-beta to the PLP promoter in vivo in the spinal cord of experimental autoimmune encephalomyelitis mice and suppression of experimental autoimmune encephalomyelitis symptoms in PLP-T cell receptor transgenic mice. These results suggest that gemfibrozil stimulates the expression of myelin genes via PPAR-beta and that gemfibrozil, a prescribed drug for humans, may find further therapeutic use in demyelinating diseases.	[Jana, Malabendu; Mondal, Susanta; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			National Institutes of Health [AT6681, NS64564, NS71479]; National Multiple Sclerosis Society [RG4170-A-1]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479 (to K. P.). This work was also supported by National Multiple Sclerosis Society Grant RG4170-A-1 (to M. J.).	Alleva DG, 2002, J LEUKOCYTE BIOL, V71, P677; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Arnold R, 2006, VIROLOGY, V346, P427, DOI 10.1016/j.virol.2005.11.009; Asayama K, 1999, MOL CELL BIOCHEM, V194, P227, DOI 10.1023/A:1006930513476; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Berger T, 2000, ADV RES NEURODEGENER, V8, P351; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Cimini A, 2003, GLIA, V41, P3, DOI 10.1002/glia.10143; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Granneman J, 1998, J NEUROSCI RES, V51, P563, DOI 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Hsu HC, 2001, J LAB CLIN MED, V137, P414, DOI 10.1067/mlc.2001.114991; Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; Powell E, 2007, PPAR RES, V2007; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Wegner M, 2000, GLIA, V31, P1, DOI 10.1002/(SICI)1098-1136(200007)31:1<1::AID-GLIA10>3.0.CO;2-V; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Zhao SP, 2003, CLIN CHIM ACTA, V332, P61, DOI 10.1016/S0009-8981(03)00123-2; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	49	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34134	34148		10.1074/jbc.M112.398552	http://dx.doi.org/10.1074/jbc.M112.398552			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22879602	Green Published, hybrid			2022-12-28	WOS:000309654200019
J	Proffitt, KD; Virshup, DM				Proffitt, Kyle D.; Virshup, David M.			Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL DERMAL HYPOPLASIA; POLARITY GENE PORCUPINE; TRANSMEMBRANE PROTEIN; PORCN MUTATIONS; P24 PROTEINS; SECRETION; PATHWAY; GASTRULATION; CANCER; CELLS	Gradients of diverse Wnt proteins regulate development, renewal, and differentiation. Porcupine (PORCN) is a membrane-bound O-acyltransferase that is required for post-translational modification of all Wnts to enable their transport, secretion, and activity. Mutations in PORCN are associated with focal dermal hypoplasia (FDH), whereas gene deletion causes embryonic lethality in mice. To study the protein in more detail, zinc finger nucleases were used to edit the PORCN genomic locus, establishing two HT1080 fibrosarcoma clones null for PORCN activity that facilitate the study of PORCN structure and function. We establish that PORCN is a key non-redundant node for the regulation of global Wnt signaling because PORCN null cells are completely incapable of autocrine Wnt signaling. The strength of Wnt signaling is exquisitely sensitive to PORCN expression, with a dynamic range of at least 3 orders of magnitude, suggesting that PORCN activity is a key modulator of all Wnt ligand activity. Consistent with this, we find that multiple FDH-associated mutants have only subtle alterations in enzyme activity yet are associated with a severe FDH phenotype. These studies support an essential regulatory role of PORCN in shaping Wnt signaling gradients.	[Proffitt, Kyle D.; Virshup, David M.] Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Virshup, David M.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Virshup, David M.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27705 USA	National University of Singapore; National University of Singapore; Duke University	Virshup, DM (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	Duke-NUS Signature Research Program; Agency for Science, Technology, and Research, Singapore; Ministry of Health, Singapore; Singapore Translational Research Investigator Award; National Research Foundation; National Medical Research Council	Duke-NUS Signature Research Program; Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); Singapore Translational Research Investigator Award; National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Duke-NUS Signature Research Program funded by the Agency for Science, Technology, and Research, Singapore, and the Ministry of Health, Singapore, and a Singapore Translational Research Investigator Award (to D. M. V.) funded by the National Research Foundation and the National Medical Research Council.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Bornholdt D, 2009, HUM MUTAT, V30, pE618, DOI 10.1002/humu.20992; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen QH, 2012, J CELL SCI, V125, P2224, DOI 10.1242/jcs.098368; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chen Z, 2008, ONCOGENE, V27, P3483, DOI 10.1038/sj.onc.1211006; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Fernandes PH, 2010, GENET TEST MOL BIOMA, V14, P709, DOI 10.1089/gtmb.2010.0089; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Harmsen MB, 2009, EUR J HUM GENET, V17, P1207, DOI 10.1038/ejhg.2009.40; Harterink M, 2012, ACTA PHYSIOL, V204, P8, DOI 10.1111/j.1748-1716.2011.02287.x; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032331; Lombardi MP, 2011, HUM MUTAT, V32, P723, DOI 10.1002/humu.21505; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	51	82	87	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34167	34178		10.1074/jbc.M112.381970	http://dx.doi.org/10.1074/jbc.M112.381970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888000	Green Published, hybrid			2022-12-28	WOS:000309654200022
J	Yoon, YD; Zhang, XQ; Cho, WH				Yoon, Youngdae; Zhang, Xiuqi; Cho, Wonhwa			Phosphatidylinositol 4,5-Bisphosphate (PtdIns(4,5)P-2) Specifically Induces Membrane Penetration and Deformation by Bin/Amphiphysin/Rvs (BAR) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DIFFERENTIAL SUBCELLULAR-LOCALIZATION; CYTOSOLIC PHOSPHOLIPASE A(2); MISSING-IN-METASTASIS; KINASE-C-ALPHA; PLASMA-MEMBRANE; STRUCTURAL BASIS; ACTIN CYTOSKELETON; INTERFACIAL CATALYSIS; ACTIVATION MECHANISMS	Cellular proteins containing Bin/amphiphysin/Rvs (BAR) domains play a key role in clathrin-mediated endocytosis. Despite extensive structural and functional studies of BAR domains, it is still unknown how exactly these domains interact with the plasma membrane containing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) and whether they function by a universal mechanism or by different mechanisms. Here we report that PtdIns(4,5)P-2 specifically induces partial membrane penetration of the N-terminal amphiphilic alpha-helix (H-0) of two representative N-BAR domains from Drosophila amphiphysin (dAmp-BAR) and rat endophilin A1 (EndoA1-BAR). Our quantitative fluorescence imaging analysis shows that PtdIns(4,5) P-2-dependent membrane penetration of H-0 is important for self-association of membrane-bound dAmp-BAR and EndoA1-BAR and their membrane deformation activity. EndoA1-BAR behaves differently from dAmp-BAR because the former has an additional amphiphilic alpha-helix that penetrates the membrane in a PtdIns(4,5)P-2-independent manner. Depletion of PtdIns(4,5)P-2 from the plasma membrane of HEK293 cells abrogated the membrane deforming activity of EndoA1-BAR and dAmp-BAR. Collectively, these studies suggest that the local PtdIns(4,5)P-2 concentration in the plasma membrane may regulate the membrane interaction and deformation by N-BAR domain-containing proteins during clathrin-mediated endocytosis.	[Yoon, Youngdae; Zhang, Xiuqi; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, WH (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			National Institutes of Health [GM68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Heath RJW, 2008, J CELL SCI, V121, P1951, DOI 10.1242/jcs.023895; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Lee BI, 1996, BIOCHEMISTRY-US, V35, P4231, DOI 10.1021/bi9524777; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	71	32	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34078	34090		10.1074/jbc.M112.372789	http://dx.doi.org/10.1074/jbc.M112.372789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888025	Green Published, hybrid			2022-12-28	WOS:000309654200014
J	Bergeret, F; Gavalda, S; Chalut, C; Malaga, W; Quemard, A; Pedelacq, JD; Daffe, M; Guilhot, C; Mourey, L; Bon, C				Bergeret, Fabien; Gavalda, Sabine; Chalut, Christian; Malaga, Wladimir; Quemard, Annaik; Pedelacq, Jean-Denis; Daffe, Mamadou; Guilhot, Christophe; Mourey, Lionel; Bon, Cecile			Biochemical and Structural Study of the Atypical Acyltransferase Domain from the Mycobacterial Polyketide Synthase Pks13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; ACYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; MALONYL-COA; TRANSACYLASE; TUBERCULOSIS; IDENTIFICATION; BIOSYNTHESIS; ARCHITECTURE; SITE	Pks13 is a type I polyketide synthase involved in the final biosynthesis step of mycolic acids, virulence factors, and essential components of the Mycobacterium tuberculosis envelope. Here, we report the biochemical and structural characterization of a 52-kDa fragment containing the acyl-transferase domain of Pks13. This fragment retains the ability to load atypical extender units, unusually long chain acyl-CoA with a predilection for carboxylated substrates. High resolution crystal structures were determined for the apo, palmitoylated, and carboxypalmitoylated forms. Structural conservation with type I polyketide synthases and related fatty-acid synthases also extends to the interdomain connections. Subtle changes could be identified both in the active site and in the upstream and downstream linkers in line with the organization displayed by this singular polyketide synthase. More importantly, the crystallographic analysis illustrated for the first time how a long saturated chain can fit in the core structure of an acyltransferase domain through a dedicated channel. The structures also revealed the unexpected binding of a 12-mer peptide that might provide insight into domain-domain interaction.	[Mourey, Lionel; Bon, Cecile] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France; Univ Toulouse, Univ Toulouse 3, IPBS, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mourey, L (corresponding author), Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	lionel.mourey@ipbs.fr; cecile.bon@ipbs.fr	BON, cecile C/F-9231-2018; Pedelacq, Jean-Denis/C-6053-2011; Mourey, Lionel/B-5662-2009	Mourey, Lionel/0000-0002-8259-1259; PEDELACQ, Jean-Denis/0000-0002-3202-2517; Quemard, Annaik/0000-0002-5545-3424; Bon, Cecile/0000-0002-3700-2646; Chalut, Christian/0000-0002-4849-1369	European Commission Grant [LSHP-CT-2006037217]; "Vaincre la Mucoviscidose" (France) [IC0716]; French "Agence Nationale de la Recherche" Grant [09-BLAN-0298-01]; "Region Midi-Pyrenees" Grant [09005193]; European Regional Development Fund Grant [34249]	European Commission Grant(European CommissionEuropean Commission Joint Research Centre); "Vaincre la Mucoviscidose" (France); French "Agence Nationale de la Recherche" Grant(French National Research Agency (ANR)); "Region Midi-Pyrenees" Grant(Region Occitanie); European Regional Development Fund Grant	This work was supported by European Commission Grant LSHP-CT-2006037217, "Vaincre la Mucoviscidose" (France) Grant IC0716, French "Agence Nationale de la Recherche" Grant 09-BLAN-0298-01, "Region Midi-Pyrenees" Grant 09005193, and European Regional Development Fund Grant 34249.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DeLano W.L, PYMOL MOL GRAPHICS S; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Koppisch AT, 2003, BIOCHEMISTRY-US, V42, P11057, DOI 10.1021/bi0349672; Kwan DH, 2011, MOLECULES, V16, P6092, DOI 10.3390/molecules16076092; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liou GF, 2003, CURR OPIN CHEM BIOL, V7, P279, DOI 10.1016/S1367-5931(03)00016-4; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Maier T, 2010, Q REV BIOPHYS, V43, P373, DOI 10.1017/S0033583510000156; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pappenberger G, 2010, J MOL BIOL, V397, P508, DOI 10.1016/j.jmb.2010.01.066; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; RUCH FE, 1973, J BIOL CHEM, V248, P8095; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneider TR, 2004, ACTA CRYSTALLOGR D, V60, P2269, DOI 10.1107/S0907444904023492; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhang L, 2007, PROTEIN SCI, V16, P1184, DOI 10.1110/ps.072757307	59	29	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33675	33690		10.1074/jbc.M111.325639	http://dx.doi.org/10.1074/jbc.M111.325639			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22825853	hybrid, Green Published			2022-12-28	WOS:000309602100051
J	Holmborn, K; Habicher, J; Kasza, Z; Eriksson, AS; Filipek-Gorniok, B; Gopal, S; Couchman, JR; Ahlberg, PE; Wiweger, M; Spillmann, D; Kreuger, J; Ledin, J				Holmborn, Katarina; Habicher, Judith; Kasza, Zsolt; Eriksson, Anna S.; Filipek-Gorniok, Beata; Gopal, Sandeep; Couchman, John R.; Ahlberg, Per E.; Wiweger, Malgorzata; Spillmann, Dorothe; Kreuger, Johan; Ledin, Johan			On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; MOLECULAR-CLONING; HSPG SYNTHESIS; CELL POLARITY; GROWTH-PLATE; EXPRESSION; EXT2; PROTEOGLYCANS; GLYPICAN; XYLOSE	The present study addresses the roles of heparan sulfate (HS) proteoglycans and chondroitin sulfate (CS) proteoglycans in the development of zebrafish pharyngeal cartilage structures. uxs1 and b3gat3 mutants, predicted to have impaired biosynthesis of both HS and CS because of defective formation of the common proteoglycan linkage tetrasaccharide were analyzed along with ext2 and extl3 mutants, predicted to have defective HS polymerization. Notably, the effects on HS and CS biosynthesis in the respective mutant strains were shown to differ from what had been hypothesized. In uxs1 and b3gat3 mutant larvae, biosynthesis of CS was shown to be virtually abolished, whereas these mutants still were capable of synthesizing 50% of the HS produced in control larvae. extl3 and ext2 mutants on the other hand were shown to synthesize reduced amounts of hypersulfated HS. Further, extl3 mutants produced higher levels of CS than control larvae, whereas morpholino-mediated suppression of csgalnact1/csgalnact2 resulted in increased HS biosynthesis. Thus, the balance of the Extl3 and Csgalnact1/Csgalnact2 proteins influences the HS/CS ratio. A characterization of the pharyngeal cartilage element morphologies in the single mutant strains, as well as in ext2;uxs1 double mutants, was conducted. A correlation between HS and CS production and phenotypes was found, such that impaired HS biosynthesis was shown to affect chondrocyte intercalation, whereas impaired CS biosynthesis inhibited formation of the extracellular matrix surrounding chondrocytes.	[Holmborn, Katarina; Kasza, Zsolt; Eriksson, Anna S.; Filipek-Gorniok, Beata; Ahlberg, Per E.; Spillmann, Dorothe; Kreuger, Johan] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Habicher, Judith; Ledin, Johan] Uppsala Univ, Sci Life Lab, Dept Organism Biol, SE-75236 Uppsala, Sweden; [Gopal, Sandeep; Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Wiweger, Malgorzata] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands	Uppsala University; Uppsala University; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kreuger, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se; Johan.Ledin@ebc.uu.se	Kreuger, Johan/HDM-1503-2022; Ahlberg, Per/E-8086-2013; Korzeniowska, Małgorzata Irena/AFS-1696-2022; Wiweger, Małgorzata/AAX-6584-2021	Wiweger, Małgorzata/0000-0002-9537-9257; Ledin, Johan/0000-0002-7319-7735; Gopal, Sandeep/0000-0002-6706-6747; Ahlberg, Per/0000-0001-9054-2900	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Foundation for Strategic Research Project [A3 05:207g]; Foundation for Proteoglycan Research at Uppsala University; Knut and Alice Wallenberg Foundation; Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Foundation for Strategic Research Project; Foundation for Proteoglycan Research at Uppsala University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"	The work was supported by funds from the Swedish Research Council (to J. K., P. A., and J. L.), the Swedish Cancer Society (to J. K., D. S., and A. E.), the Swedish Childhood Cancer Foundation (to J. K.), Swedish Foundation for Strategic Research Project A3 05:207g (to J. K.), the Foundation for Proteoglycan Research at Uppsala University (J. K., D. S., A. E.), the Knut and Alice Wallenberg Foundation (J. L., P. A.), and the Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations" (J. L., P. A.).	Ahrens MJ, 2009, DEVELOPMENT, V136, P3463, DOI 10.1242/dev.040592; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Edgren G, 1997, GLYCOBIOLOGY, V7, P103, DOI 10.1093/glycob/7.1.103; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; Grandel H, 2000, DEVELOPMENT, V127, P4169; Gulberti S, 2005, THESCIENTIFICWORLDJO, V5, P510, DOI 10.1100/tsw.2005.65; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Janvier P, 2007, GEODIVERSITAS, V29, P143; Jennes I, 2009, HUM MUTAT, V30, P1620, DOI 10.1002/humu.21123; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Roehl H. H., 2000, DEV DYNAM, V239, P1901; Schilling TF, 1996, DEVELOPMENT, V123, P329; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yao T, 2008, ZOOL SCI, V25, P976, DOI 10.2108/zsj.25.976; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	47	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33905	33916		10.1074/jbc.M112.401646	http://dx.doi.org/10.1074/jbc.M112.401646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22869369	Green Published, hybrid			2022-12-28	WOS:000309602100071
J	Close, P; Gillard, M; Ladang, A; Jiang, ZS; Papuga, J; Hawkes, N; Nguyen, L; Chapelle, JP; Bouillenne, F; Svejstrup, J; Fillet, M; Chariot, A				Close, Pierre; Gillard, Magali; Ladang, Aurelie; Jiang, Zheshen; Papuga, Jessica; Hawkes, Nicola; Laurent Nguyen; Chapelle, Jean-Paul; Bouillenne, Fabrice; Svejstrup, Jesper; Fillet, Marianne; Chariot, Alain			DERP6 (ELP5) and C3ORF75 (ELP6) Regulate Tumorigenicity and Migration of Melanoma Cells as Subunits of Elongator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II HOLOENZYME; FAMILIAL DYSAUTONOMIA; TRANSCRIPTIONAL ELONGATION; HOLO-ELONGATOR; IN-VIVO; COMPLEX; GENE; EXPRESSION; PROTEIN; ACETYLTRANSFERASE	The Elongator complex is composed of 6 subunits (Elp1-Elp6) and promotes RNAPII transcript elongation through histone acetylation in the nucleus as well as tRNA modification in the cytoplasm. This acetyltransferase complex directly or indirectly regulates numerous biological processes ranging from exocytosis and resistance to heat shock in yeast to cell migration and neuronal differentiation in higher eukaryotes. The identity of human ELP1 through ELP4 has been reported but human ELP5 and ELP6 have remained uncharacterized. Here, we report that DERP6 (ELP5) and C3ORF75 (ELP6) encode these subunits of human Elongator. We further investigated the importance and function of these two subunits by a combination of biochemical analysis and cellular assays. Our results show that DERP6/ELP5 is required for the integrity of Elongator and directly connects ELP3 to ELP4. Importantly, the migration and tumorigenicity of melanoma-derived cells are significantly decreased upon Elongator depletion through ELP1 or ELP3. Strikingly, DERP6/ELP5 and C3ORF75/ELP6-depleted melanoma cells have similar defects, further supporting the idea that DERP6/ELP5 and C3ORF75/ELP6 are essential for Elongator function. Together, our data identify DERP6/ELP5 and C3ORF75/ELP6 as key players for migration, invasion and tumorigenicity of melanoma cells, as integral subunits of Elongator.	[Close, Pierre] Univ Liege, CHU Sart Tilman, Lab Med Chem GIGA R, B-4000 Liege, Belgium; [Close, Pierre; Gillard, Magali; Ladang, Aurelie; Jiang, Zheshen; Papuga, Jessica; Laurent Nguyen; Chapelle, Jean-Paul; Fillet, Marianne; Chariot, Alain] Univ Liege, CHU Sart Tilman, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Liege, Belgium; [Close, Pierre; Gillard, Magali; Ladang, Aurelie; Jiang, Zheshen; Papuga, Jessica; Chapelle, Jean-Paul; Fillet, Marianne; Chariot, Alain] Univ Liege, CHU Sart Tilman, GIGA Signal Transduct & Lab Med Chem, B-4000 Liege, Belgium; [Laurent Nguyen] Univ Liege, CHU Sart Tilman, Dev Neurobiol Unit, B-4000 Liege, Belgium; [Bouillenne, Fabrice] Univ Liege, CHU Sart Tilman, Ctr Prot Engn, B-4000 Liege, Belgium; [Fillet, Marianne] Univ Liege, CHU Sart Tilman, Lab Analyt Pharmaceut Chem, Dept Pharm,CIRM, B-4000 Liege, Belgium; [Chariot, Alain] Univ Liege, CHU Sart Tilman, Walloon Excellence Life Sci & Biotechnol WELBIO, GIGA R, B-4000 Liege, Belgium; [Hawkes, Nicola; Svejstrup, Jesper] Canc Res UK London Res Inst, Mech Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; WELBIO; Cancer Research UK	Close, P (corresponding author), Univ Liege, CHU Sart Tilman, Lab Med Chem GIGA R, Tour GIGA 2 B34, B-4000 Liege, Belgium.	Pierre.Close@ulg.ac.be; Alain.chariot@ulg.ac.be	Nguyen, Laurent/E-9882-2016; Ladang, Aurelie/AAR-5822-2021	Ladang, Aurelie/0000-0002-5316-3108; Fillet, Marianne/0000-0002-1453-6282; Nguyen, Laurent/0000-0002-8560-3008; CLOSE, PIERRE/0000-0002-8844-9616; Chariot, Alain/0000-0002-1691-4347; Jiang, Zheshen/0000-0002-4914-7041; Svejstrup, Jesper/0000-0003-4964-6147	F.N.R.S. the Belgian Federation against Cancer; University of Liege [11/16-01]; Centre Anti-Cancereux; "Leon Fredericq" Foundation (Faculty of Medicine, University of Liege); Federal Ministery of Science [6/12]; King Baudouin Foundation (Brussels, Belgium); Cancer Research UK; TELEVIE; Cancer Research UK [11567] Funding Source: researchfish	F.N.R.S. the Belgian Federation against Cancer(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); Centre Anti-Cancereux; "Leon Fredericq" Foundation (Faculty of Medicine, University of Liege); Federal Ministery of Science; King Baudouin Foundation (Brussels, Belgium); Cancer Research UK(Cancer Research UK); TELEVIE; Cancer Research UK(Cancer Research UK)	This work was supported by grants from the F.N.R.S. the Belgian Federation against Cancer, the Concerted Research Action Program (11/16-01, University of Liege), the "Centre Anti-Cancereux," the "Leon Fredericq" Foundation (Faculty of Medicine, University of Liege), the Inter-University Attraction Pole 6/12 (Federal Ministery of Science), and the King Baudouin Foundation (Brussels, Belgium). This work was also supported by a generous in-house grant from Cancer Research UK (to J. S.) and TELEVIE PhD fellowships (to M. G., A. L., and Z. J.).	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Bauer F, 2012, CELL REPORTS, V1, P424, DOI 10.1016/j.celrep.2012.04.001; Bolukbasi E, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110031; Boone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015590; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Close P, 2012, NATURE, V484, P386, DOI 10.1038/nature10925; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fellows J, 2000, J BIOL CHEM, V275, P12896, DOI 10.1074/jbc.275.17.12896; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Glatt S, 2012, NAT STRUCT MOL BIOL, V19, P314, DOI 10.1038/nsmb.2234; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Gold-von Simson Gabrielle, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P218, DOI 10.1016/j.cppeds.2005.12.001; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Lin ZJ, 2012, J BIOL CHEM, V287, P21501, DOI 10.1074/jbc.M112.341560; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Nelissen H, 2005, P NATL ACAD SCI USA, V102, P7754, DOI 10.1073/pnas.0502600102; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Versees W, 2010, MOL MICROBIOL, V76, P1065, DOI 10.1111/j.1365-2958.2010.07162.x; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yuan J, 2006, MOL BIOL REP, V33, P151, DOI 10.1007/s11033-006-6273-5	53	37	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32535	32545		10.1074/jbc.M112.402727	http://dx.doi.org/10.1074/jbc.M112.402727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22854966	hybrid, Green Published			2022-12-28	WOS:000309168300023
J	Lalo, U; Jones, S; Roberts, JA; Mahaut-Smith, MP; Evans, RJ				Lalo, Ulyana; Jones, Sarah; Roberts, Jonathan A.; Mahaut-Smith, Martyn P.; Evans, Richard J.			Heat Shock Protein 90 Inhibitors Reduce Trafficking of ATP-gated P2X1 Receptors and Human Platelet Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; P2X(1) ION-CHANNEL; INTRACELLULAR CA2+; LIPID RAFTS; IN-VIVO; ACTIVATION; RESPONSES; IDENTIFICATION; CURRENTS; PURINOCEPTORS	We have used selective inhibitors to determine whether the molecular chaperone heat shock protein 90 (HSP90) has an effect on both recombinant and native human P2X1 receptors. P2X1 receptor currents in HEK293 cells were reduced by similar to 70-85% by the selective HSP90 inhibitor geldanamycin (2 mu M, 20 min). This was associated with a speeding in the time course of desensitization as well as a reduction in cell surface expression. Imaging in real time of photoactivatable GFP-tagged P2X receptors showed that they are highly mobile. Geldanamycin almost abolished this movement for P2X1 receptors but had no effect on P2X2 receptor trafficking. P2X1/2 receptor chimeras showed that the intracellular N and C termini were involved in geldanamycin sensitivity. Geldanamycin also inhibited native P2X1 receptor-mediated responses. Platelet P2X1 receptors play an important role in hemostasis, contribute to amplification of signaling to a range of stimuli including collagen, and are novel targets for antithrombotic therapies. Platelet P2X1 receptor-, but not P2Y1 receptor-, mediated increases in intracellular calcium were reduced by 40-45% following HSP90 inhibition with geldanamycin or radicicol. Collagen stimulation leads to ATP release from platelets, and calcium increases to low doses of collagen were also reduced by similar to 40% by the HSP90 inhibitors consistent with an effect on P2X1 receptors. These studies suggest that HSP90 inhibitors may be as effective as selective antagonists in regulating platelet P2X1 receptors, and their potential effects on hemostasis should be considered in clinical studies.	[Lalo, Ulyana; Jones, Sarah; Roberts, Jonathan A.; Mahaut-Smith, Martyn P.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Roberts, Jon/A-6771-2012	Jones, Sarah/0000-0001-8154-3928	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chaumont S, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162329; Dolgin E, 2011, NAT MED, V17, P646, DOI 10.1038/nm0611-646; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Fung CYE, 2012, BLOOD, V119, P3613, DOI 10.1182/blood-2011-10-386052; Fung CYE, 2005, THROMB HAEMOSTASIS, V94, P37, DOI 10.1160/TH04-11-0732; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiao JD, 2008, CARDIOVASC RES, V77, P126, DOI 10.1093/cvr/cvm028; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lecut C, 2012, J THROMB HAEMOST, V10, P453, DOI 10.1111/j.1538-7836.2011.04606.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; McDowell TS, 2002, NEUROREPORT, V13, P437, DOI 10.1097/00001756-200203250-00015; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Oury C, 2001, THROMB HAEMOSTASIS, V86, P1264; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; Suttitanamongkol S, 2000, BIOCHEM J, V345, P307, DOI 10.1042/0264-6021:3450307; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116	39	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32747	32754		10.1074/jbc.M112.376566	http://dx.doi.org/10.1074/jbc.M112.376566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851178	Green Published, hybrid			2022-12-28	WOS:000309168300042
J	Ou, YW; Ma, L; Dong, LJ; Ma, LY; Zhao, ZT; Ma, L; Zhou, W; Fan, J; Wu, CY; Yu, CJ; Zhan, QM; Song, YM				Ou, Yunwei; Ma, Ling; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Wu, Chuanyue; Yu, Chunjiang; Zhan, Qimin; Song, Yongmei			Migfilin Protein Promotes Migration and Invasion in Human Glioma through Epidermal Growth Factor Receptor-mediated Phospholipase C-gamma and STAT3 Protein Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMAS; PROGNOSTIC-SIGNIFICANCE; EGF RECEPTOR; BIOLOGY; CALCIUM; GLIOBLASTOMA; ASSOCIATION; DEGRADATION; PLC-GAMMA-1; METHYLATION	Migfilin is critical for cell shape and motile regulation. However, its pathological role in glioma is unknown. Using an immunohistochemical staining assay, we demonstrate that there is a significant correlation between expression of Migfilin and pathological tumor grade in 217 clinical glioma samples. High Migfilin expression is associated with poor prognosis for patients with glioma. Investigation of the molecular mechanism shows that Migfilin promotes migration and invasion in glioma cells. Moreover, Migfilin positively modulates the expression and activity of epidermal growth factor receptor, and Migfilin-mediated migration and invasion depend on epidermal growth factor receptor-induced PLC-gamma and STAT3-signaling pathways. Our results may provide significant clinical application, including use of Migfilin as a molecular marker in glioma for early diagnosis and as an indicator of prognosis.	[Ou, Yunwei; Yu, Chunjiang] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Ou, Yunwei; Dong, Lijia; Ma, Liying; Zhao, Zitong; Ma, Li; Zhou, Wei; Fan, Jing; Zhan, Qimin; Song, Yongmei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Ling] Capital Med Univ, Fu Xing Hosp, Dept Intens Care Unit, Beijing 100045, Peoples R China; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, CJ (corresponding author), Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China.	cjyu1955@sina.com; zhanqimin@pumc.edu.cn; ymsong.2008@gmail.com		song, yongmei/0000-0002-7789-0158	973 National Key Fundamental Research Program of China [2011CB911004, 2011CB910801]; National Natural Science Foundation of China [81071633]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grants 2011CB911004 and 2011CB910801 and National Natural Science Foundation of China Grant 81071633.	Afra D, 2002, LANCET, V359, P1011; Akazawa H, 2004, J CELL BIOL, V164, P395, DOI 10.1083/jcb.200309159; Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Fine HA, 2007, CANCER J, V13, P349, DOI 10.1097/PPO.0b013e31815b18db; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kim MJ, 2000, EXP MOL MED, V32, P101, DOI 10.1038/emm.2000.18; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Poot DHJ, 2010, LECT NOTES COMPUT SC, V6361, P615; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Zee E, 1998, J PERIODONTAL RES, V33, P65; Wang XJ, 2001, EXP CELL RES, V267, P28, DOI 10.1006/excr.2001.5241; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2009, NEURO-ONCOLOGY, V11, P69, DOI 10.1215/15228517-2008-078; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Yang Liu, 2003, Cancer Control, V10, P138; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147	41	26	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32394	32405		10.1074/jbc.M112.393900	http://dx.doi.org/10.1074/jbc.M112.393900			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22843679	hybrid, Green Published			2022-12-28	WOS:000309168300010
J	Levitt, PS; Papp-Wallace, KM; Taracila, MA; Hujer, AM; Winkler, ML; Smith, KM; Xu, Y; Harris, ME; Bonomo, RA				Levitt, Peter S.; Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Hujer, Andrea M.; Winkler, Marisa L.; Smith, Kerri M.; Xu, Yan; Harris, Michael E.; Bonomo, Robert A.			Exploring the Role of a Conserved Class A Residue in the Omega-Loop of KPC-2 beta-Lactamase A MECHANISM FOR CEFTAZIDIME HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; SUBSTRATE PROFILE; CRYSTAL-STRUCTURE; K. PNEUMONIAE; CARBAPENEMASE; MUTANT; SUBSTITUTIONS; RESOLUTION	Gram-negative bacteria harboring KPC-2, a class A beta-lactamase, are resistant to all beta-lactam antibiotics and pose a major public health threat. Arg-164 is a conserved residue in all class A beta-lactamases and is located in the solvent-exposed Omega-loop of KPC-2. To probe the role of this amino acid in KPC-2, we performed site-saturation mutagenesis. When compared with wild type, 11 of 19 variants at position Arg-164 in KPC-2 conferred increased resistance to the oxyimino-cephalosporin, ceftazidime (minimum inhibitory concentration; 32 -> 128 mg/liter) when expressed in Escherichia coli. Using the R164S variant of KPC-2 as a representative beta-lactamase for more detailed analysis, we observed only a modest 25% increase in k(cat)/K-m for ceftazidime (0.015 -> 0.019 mu M-1 s(-1)). Employing pre-steady-state kinetics and mass spectrometry, we determined that acylation is rate-limiting for ceftazidime hydrolysis by KPC-2, whereas deacylation is rate-limiting in the R164S variant, leading to accumulation of acyl-enzyme at steady-state. CD spectroscopy revealed that a conformational change occurred in the turnover of ceftazidime by KPC-2, but not the R164S variant, providing evidence for a different form of the enzyme at steady state. Molecular models constructed to explain these findings suggest that ceftazidime adopts a unique conformation, despite preservation of Omega-loop structure. We propose that the R164S substitution in KPC-2 enhances ceftazidime resistance by proceeding through "covalent trapping" of the substrate by a deacylation impaired enzyme with a lower K-m. Future antibiotic design must consider the distinctive behavior of the Omega-loop of KPC-2.	[Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Hujer, Andrea M.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Harris, Michael E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Hujer, Andrea M.; Winkler, Marisa L.; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept Vet, Res Serv, Cleveland, OH 44106 USA; [Smith, Kerri M.; Xu, Yan] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; Cleveland State University	Bonomo, RA (corresponding author), 10701 East Blvd, Cleveland, OH 44106 USA.	robert.bonomo@med.va.gov	Smith, Kerri M/D-9878-2011; Smith, Kerri/P-4609-2019; Papp-Wallace, Krisztina/L-2923-2019; Xu, Yan/AAW-4085-2021	Papp-Wallace, Krisztina/0000-0002-9976-7898; Smith, Kerri/0000-0001-5161-3278	National Institutes of Health [1R01-A1063517]; Medical Scientist Training Program Training Grant from Case Western Reserve University [T32 GM07250]; Veterans Affairs Career Development Program; Veterans Affairs Merit Review Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM096000] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program Training Grant from Case Western Reserve University; Veterans Affairs Career Development Program; Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-A1063517 (to R. A. B.).; Supported by Medical Scientist Training Program Training Grant T32 GM07250 from Case Western Reserve University.; Supported by the Veterans Affairs Career Development Program.; Supported by the Veterans Affairs Merit Review Program. To whom correspondence should be addressed: 10701 East Blvd., Cleveland, OH 44106. Tel.: 216-791-3800, Ext. 4399; Fax: 216-231-3482; E-mail: robert.bonomo@med.va.gov.	Alba J, 2005, ANTIMICROB AGENTS CH, V49, P4760, DOI 10.1128/AAC.49.11.4760-4762.2005; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bergamasco MD, 2012, TRANSPL INFECT DIS, V14, P198, DOI 10.1111/j.1399-3062.2011.00688.x; Bos F, 2008, ANTIMICROB AGENTS CH, V52, P1072, DOI 10.1128/AAC.01035-07; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; CLSI (Clinical and Laboratory Standards Institute), 2017, M100 PERF STAND ANT; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; HERZBERG O, 1991, BIOCHEMISTRY-US, V30, P9503, DOI 10.1021/bi00103a017; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Kontopoulou K, 2010, J HOSP INFECT, V76, P70, DOI 10.1016/j.jhin.2010.03.021; KUZIN AP, 1995, BIOCHEMISTRY-US, V34, P9532, DOI 10.1021/bi00029a030; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, PROTEIN SCI, V19, P1714, DOI 10.1002/pro.454; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Sampson JM, 2011, ANTIMICROB AGENTS CH, V55, P2303, DOI 10.1128/AAC.01360-10; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; SOUGAKOFF W, 1989, GENE, V78, P339, DOI 10.1016/0378-1119(89)90236-9; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; TaibiTronche P, 1996, J AM CHEM SOC, V118, P7441, DOI 10.1021/ja9529753; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; WEBER DA, 1990, J INFECT DIS, V162, P460, DOI 10.1093/infdis/162.2.460; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a	41	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31783	31793		10.1074/jbc.M112.348540	http://dx.doi.org/10.1074/jbc.M112.348540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843686	Green Published, hybrid			2022-12-28	WOS:000309059400019
J	Yang, WW; Lu, Y; Xu, YC; Xu, LZ; Zheng, W; Wu, YY; Li, L; Shen, PP				Yang, Weiwei; Lu, Yan; Xu, Yichen; Xu, Lizhi; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping			Estrogen Represses Hepatocellular Carcinoma (HCC) Growth via Inhibiting Alternative Activation of Tumor-associated Macrophages (TAMs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA; LIVER-CANCER; MAMMARY-TUMORS; PROGRESSION; GENE; METASTASIS; MICE; HEPATOCARCINOGENESIS; EXPRESSION; INVASION	Hepatocarcinoma cancer (HCC), one of the most malignant cancers, occurs significantly more often in men than in women; however, little is known about its underlying molecular mechanisms. Here we identified that 17 beta-estradiol (E2) could suppress tumor growth via regulating the polarization of macrophages. We showed that E2 re-administration reduced tumor growth in orthotopic and ectopic mice HCC models. E2 functioned as a suppressor for macrophage alternative activation and tumor progression by keeping estrogen receptor beta (ER beta) away from interacting with ATP5J (also known as ATPase-coupling factor 6), a part of ATPase, thus inhibiting the JAK1-STAT6 signaling pathway. These studies introduce a novel mechanism for suppressing male-predominant HCC.	[Yang, Weiwei; Lu, Yan; Xu, Yichen; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yang, Weiwei; Lu, Yan; Xu, Yichen; Zheng, Wei; Wu, Yuanyuan; Li, Long; Shen, Pingping] Nanjing Univ, Model Anim Res Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Xu, Lizhi] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Shen, PP (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	ppshen@nju.edu.cn			National Natural Science Foundation of China [31070764, 91013015, 81121062]; National Key Basic Research Program of China [2010CB912203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Projects 31070764, 91013015, and 81121062 and National Key Basic Research Program of China Project 2010CB912203.	Albini A, 2010, Q J NUCL MED MOL IM, V54, P244; Bao XF, 2007, J MOL MED, V85, P85, DOI 10.1007/s00109-006-0113-x; Barajas M, 2001, HEPATOLOGY, V33, P52, DOI 10.1053/jhep.2001.20796; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Gallo C, 1998, LANCET, V352, P17; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hoenerhoff MJ, 2011, TOXICOL PATHOL, V39, P678, DOI 10.1177/0192623311407213; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Liu CL, 2000, AM J GASTROENTEROL, V95, P218; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 2006, DRUG DISCOV TODAY TH, V3, P361, DOI DOI 10.1016/J.DDSTR.2006.07.001; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200; Yao XM, 2003, CLIN CANCER RES, V9, P2719; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	45	83	88	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40140	40149		10.1074/jbc.M112.348763	http://dx.doi.org/10.1074/jbc.M112.348763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22908233	Green Published, hybrid			2022-12-28	WOS:000311448800005
J	Chanthaphavong, RS; Loughran, PA; Lee, TYS; Scott, MJ; Billiar, TR				Chanthaphavong, R. Savanh; Loughran, Patricia A.; Lee, Tiffany Y. S.; Scott, Melanie J.; Billiar, Timothy R.			A Role for cGMP in Inducible Nitric-oxide Synthase (iNOS)-induced Tumor Necrosis Factor (TNF) alpha-converting Enzyme (TACE/ADAM17) Activation, Translocation, and TNF Receptor 1 (TNFR1) Shedding in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; HEPATOCELLULAR APOPTOSIS; ORGAN MORPHOGENESIS; SIGNAL-TRANSDUCTION; PROTEIN-KINASES; POTENTIAL ROLE; ADAM PROTEASE; SEPTIC SHOCK; GENE FAMILY; CYCLIC-GMP	We and others have previously shown that the inducible nitric-oxide synthase (iNOS) and nitric oxide (NO) are hepatoprotective in a number of circumstances, including endotoxemia. In vitro, hepatocytes are protected from tumor necrosis factor (TNF) alpha-induced apoptosis via cGMP-dependent and cGMP-independent mechanisms. We have shown that the cGMP-dependent protective mechanisms involve the inhibition of death-inducing signaling complex formation. We show here that LPS-induced iNOS expression leads to rapid TNF receptor shedding from the surface of hepatocytes via NO/cGMP/protein kinase G-dependent activation and surface translocation of TNF alpha-converting enzyme (TACE/ADAM17). The activation of TACE is associated with the up-regulation of iRhom2 as well as the interaction and phosphorylation of TACE and iRhom2, which are also NO/cGMP/protein kinase G-dependent. These findings suggest that one mechanism of iNOS/NO-mediated protection of hepatocytes involves the rapid shedding of TNF receptor 1 to limit TNF alpha signaling.	[Chanthaphavong, R. Savanh; Loughran, Patricia A.; Lee, Tiffany Y. S.; Scott, Melanie J.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu	Loughran, Patricia/AAB-1184-2021		National Institutes of Health [R37-GM-044100, R01-GM-050441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441, R37GM044100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM-044100 and R01-GM-050441.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; BILLIAR TR, 1990, J LEUKOCYTE BIOL, V48, P565, DOI 10.1002/jlb.48.6.565; BILLIAR TR, 1992, AM J PHYSIOL, V262, pC1077, DOI 10.1152/ajpcell.1992.262.4.C1077; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Costelli P, 2003, CELL DEATH DIFFER, V10, P997, DOI 10.1038/sj.cdd.4401281; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Eum HA, 2011, AM J PATHOL, V179, P1221, DOI 10.1016/j.ajpath.2011.05.046; Eum HA, 2011, ADV EXP MED BIOL, V691, P617, DOI 10.1007/978-1-4419-6612-4_65; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iglesias J, 2003, AM J KIDNEY DIS, V41, P62, DOI 10.1053/ajkd.2003.50024; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Kim PKM, 2002, J BIOL CHEM, V277, P38855, DOI 10.1074/jbc.M203484200; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kubota Y, 2006, DEVELOPMENT, V133, P263, DOI 10.1242/dev.02195; LEIST M, 1995, AM J PATHOL, V146, P1220; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Li JR, 2000, J BIOL CHEM, V275, P13026, DOI 10.1074/jbc.275.17.13026; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nishiwaki K, 2004, NAT CELL BIOL, V6, P31, DOI 10.1038/ncb1079; Oberholzer A, 2001, J ENDOTOXIN RES, V7, P375, DOI 10.1177/09680519010070050501; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Podbilewicz B, 2004, NAT CELL BIOL, V6, P9, DOI 10.1038/ncb0104-9; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Refsum SE, 1996, J PEDIATR SURG, V31, P928, DOI 10.1016/S0022-3468(96)90413-3; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Santos D O, 1999, Nihon Hansenbyo Gakkai Zasshi, V68, P185; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; SEGLEN PO, 1977, ACTA BIOL MED GER, V36, P1789; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Takada Y, 2003, J BIOL CHEM, V278, P23390, DOI 10.1074/jbc.M213237200; TRACEY KJ, 1988, ANN INST PASTEUR IMM, V139, P311, DOI 10.1016/0769-2625(88)90148-1; TRACEY KJ, 1991, CIRC SHOCK, V35, P123; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; Wang Y, 2006, APOPTOSIS, V11, P441, DOI 10.1007/s10495-005-4293-6; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Zamora R, 2001, J BIOL CHEM, V276, P46887, DOI 10.1074/jbc.M101865200; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200	73	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35887	35898		10.1074/jbc.M112.365171	http://dx.doi.org/10.1074/jbc.M112.365171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898814	Green Published, hybrid			2022-12-28	WOS:000310364000011
J	Jackson, MI; Cao, J; Zeng, HW; Uthus, E; Combs, GF				Jackson, Matthew I.; Cao, Jay; Zeng, Huawei; Uthus, Eric; Combs, Gerald F., Jr.			S-Adenosylmethionine-dependent Protein Methylation Is Required for Expression of Selenoprotein P and Gluconeogenic Enzymes in HepG2 Human Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; COACTIVATOR PGC-1-ALPHA; INSULIN-RESISTANCE; METABOLIC SYNDROME; METHIONINE; LIVER; INHIBITION; SUPPLEMENTATION; POLYMORPHISMS; ASSOCIATION	Cellular methylation processes enable expression of gluconeogenic enzymes and metabolism of the nutrient selenium. Selenium status has been proposed to relate to type II diabetes risk, and plasma levels of selenoprotein P (SEPP1) have been positively correlated with insulin resistance. Increased expression of gluconeogenic enzymes glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase 1 (PCK1) has negative consequences for blood glucose management in type II diabetics. Transcriptional regulation of SEPP1 is directed by the same transcription factors that control the expression of G6PC and PCK1, and these factors are activated by methylation of arginine residues. We sought to determine whether expression of SEPP1 and the aforementioned glucoconeogenic enzymes are regulated by protein methylation, the levels of which are reliant upon adequate S-adenosylmethionine (SAM) and inhibited by S-adenosylhomocysteine (SAH). We treated a human hepatocyte cell line, HepG2, with inhibitors of adenosylhomocysteine hydrolase (AHCY) known to increase concentration of SAH before analysis of G6PC, PCK1, and SEPP1 expression. Increasing SAH decreased 1) the SAM/SAH ratio, 2) protein-arginine methylation, and 3) expression of SEPP1, G6PC, and PCK1 transcripts. Furthermore, hormone-dependent induction of gluconeogenic enzymes was reduced by inhibition of protein methylation. When protein-arginine methyltransferase 1 expression was reduced by siRNA treatment, G6PC expression was inhibited. These findings demonstrate that hepatocellular SAM-dependent protein methylation is required for both SEPP1 and gluconeogenic enzyme expression and that inhibition of protein arginine methylation might provide a route to therapeutic interventions in type II diabetes.	[Jackson, Matthew I.; Cao, Jay; Zeng, Huawei; Uthus, Eric; Combs, Gerald F., Jr.] ARS, Grand Forks Human Nutr Res Ctr, USDA, Grand Forks, ND 58203 USA	United States Department of Agriculture (USDA)	Jackson, MI (corresponding author), ARS, Grand Forks Human Nutr Res Ctr, USDA, 2420 2nd Ave S, Grand Forks, ND 58203 USA.	matthew.jackson@ars.usda.gov		Jackson, Matthew/0000-0001-7535-1831				Andrade-Cetto A, 2010, J ETHNOPHARMACOL, V130, P93, DOI 10.1016/j.jep.2010.04.016; Arora P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-95; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Barres R, 2011, AM J CLIN NUTR, V93, p897S, DOI 10.3945/ajcn.110.001933; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Chen AR, 2010, CLIN INVEST MED, V33, pE290, DOI 10.25011/cim.v33i5.14354; Choi D., 2012, HEPATOLOGY IN PRESS; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; COWARD JK, 1977, J MED CHEM, V20, P500, DOI 10.1021/jm00214a008; Frelut ML, 2011, INT J PEDIATR OBES, V6, pE312, DOI 10.3109/17477166.2010.486835; INGROSSO D, 1991, ADV EXP MED BIOL, V307, P263; Iwasaki H, 2008, BIOCHEM BIOPH RES CO, V372, P314, DOI 10.1016/j.bbrc.2008.05.051; Iwasaki H, 2007, BIOCHEM BIOPH RES CO, V364, P1015, DOI 10.1016/j.bbrc.2007.10.113; Iwasaki H, 2009, LIFE SCI, V85, P161, DOI 10.1016/j.lfs.2009.05.007; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Krones-Herzig A, 2006, J BIOL CHEM, V281, P3025, DOI 10.1074/jbc.M509770200; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lee JH, 2011, DIABETES RES CLIN PR, V94, P111, DOI 10.1016/j.diabres.2011.07.005; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Ohta Y, 2008, TOXICOL APPL PHARM, V226, P169, DOI 10.1016/j.taap.2007.09.011; Rock C, 2009, BIOMETALS, V22, P995, DOI 10.1007/s10534-009-9251-2; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Song ZY, 2005, BBA-MOL CELL RES, V1743, P205, DOI 10.1016/j.bbamcr.2004.12.001; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Tanaka H, 2010, EUR J PHARMACOL, V645, P185, DOI 10.1016/j.ejphar.2010.07.018; TANDON SK, 1986, BIOCHEM PHARMACOL, V35, P2763, DOI 10.1016/0006-2952(86)90187-5; Tchantchou F, 2008, J ALZHEIMERS DIS, V14, P323; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; van Driel LMJW, 2009, J NUTR, V139, P2315, DOI 10.3945/jn.109.109710; Vasilopoulos Y, 2011, GENET TEST MOL BIOMA, V15, P613, DOI 10.1089/gtmb.2010.0256; WAGNER J, 1984, ANAL BIOCHEM, V140, P108, DOI 10.1016/0003-2697(84)90140-4; Wang X, 2011, MINI-REV MED CHEM, V11, P1082, DOI 10.2174/138955711797247761; Williams KT, 2012, DIABETES-METAB RES, V28, P123, DOI 10.1002/dmrr.1281; Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P2613, DOI 10.2174/138161208786071326; Yasui K, 2011, J MED FOOD, V14, P930, DOI 10.1089/jmf.2010.1396; Yun K. U., 2012, EUR J NUTR IN PRESS	45	19	21	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36455	36464		10.1074/jbc.M112.412932	http://dx.doi.org/10.1074/jbc.M112.412932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22932905	hybrid, Green Published			2022-12-28	WOS:000310364000065
J	Wang, XF; Wang, SZ; Lu, YB; Gibson, MP; Liu, Y; Yuan, BZ; Feng, JQ; Qin, CL				Wang, Xiaofang; Wang, Suzhen; Lu, Yongbo; Gibson, Monica P.; Liu, Ying; Yuan, Baozhi; Feng, Jian Q.; Qin, Chunlin			FAM20C Plays an Essential Role in the Formation of Murine Teeth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; AMELOGENESIS IMPERFECTA; MICE DISPLAY; ENAMEL DEFECTS; SIALOPHOSPHOPROTEIN; MINERALIZATION; EXPRESSION; LEADS; DENTINOGENESIS; MATURATION	FAM20Cis highly expressed in bone and tooth. Previously, we showed that Fam20C conditional knock-out (KO) mice manifest hypophosphatemic rickets, which highlights the crucial roles of this molecule in promoting bone formation and mediating phosphate homeostasis. In this study, we characterized the dentin, enamel, and cementum of Sox2-Cre-mediated Fam20C KO mice. The KO mice exhibited small malformed teeth, severe enamel defects, very thin dentin, less cementum than normal, and overall hypomineralization in the dental mineralized tissues. In situ hybridization and immunohistochemistry analyses revealed remarkable down-regulation of dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein in odontoblasts, along with a sharply reduced expression of ameloblastin and amelotin in ameloblasts. Collectively, these data indicate that FAM20Cis essential to the differentiation and mineralization of dental tissues through the regulation of molecules critical to the differentiation of tooth-formative cells.	[Wang, Xiaofang; Wang, Suzhen; Lu, Yongbo; Gibson, Monica P.; Liu, Ying; Feng, Jian Q.; Qin, Chunlin] Texas A&M Hlth Sci Ctr Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Yuan, Baozhi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Yuan, Baozhi] William S Middleton Mem Vet Adm Med Ctr, Dept Vet Affairs, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Qin, CL (corresponding author), Texas A&M Hlth Sci Ctr Baylor Coll Dent, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Lu, Yongbo/0000-0003-3692-1736	National Institutes of Health [DE005092]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027032, R56AR027032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE005092 (to C. Q.).	An Chunying, 2010, Kobe J Med Sci, V55, pE82; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chen L, 2011, CLIN EXP PHARMACOL P, V38, P395, DOI 10.1111/j.1440-1681.2011.05526.x; Du Y, 2002, EXP HEMATOL, V30, P649, DOI 10.1016/S0301-472X(02)00817-2; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Moses KD, 2006, EUR J ORAL SCI, V114, P216, DOI 10.1111/j.1600-0722.2006.00353.x; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Smith CE, 2011, EUR J ORAL SCI, V119, P125, DOI 10.1111/j.1600-0722.2011.00871.x; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404	37	49	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35934	35942		10.1074/jbc.M112.386862	http://dx.doi.org/10.1074/jbc.M112.386862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22936805	Green Published, hybrid			2022-12-28	WOS:000310364000015
J	Alvarez, Y; Rodriguez, M; Municio, C; Hugo, E; Alonso, S; Ibarrola, N; Fernandez, N; Crespo, MS				Alvarez, Yolanda; Rodriguez, Mario; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Ibarrola, Nieves; Fernandez, Nieves; Sanchez Crespo, Mariano			Sirtuin 1 Is a Key Regulator of the Interleukin-12 p70/Interleukin-23 Balance in Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; HISTONE H3; AUTOIMMUNE INFLAMMATION; DIFFERENTIAL REGULATION; PROTEIN SIR2; IFN-GAMMA; C-REL; IL-12; ACETYLATION	Stimulation of human dendritic cells with the fungal surrogate zymosan produces IL-23 and a low amount of IL-12 p70. Trans-repression of il12a transcription, which encodes IL-12 p35 chain, by proteins of the Notch family and lysine deacetylation reactions have been reported as the underlying mechanisms, but a number of questions remain to be addressed. Zymosan produced the location of sirtuin 1 (SIRT1) to the nucleus, enhanced its association with the il12a promoter, increased the nuclear concentration of the SIRT1 co-substrate NAD(+), and decreased chromatin accessibility in the nucleosome-1 of il12a, which contains a kappa B-site. The involvement of deacetylation reactions in the inhibition of il12a transcription was supported by the absence of Ac-Lys-14-histone H3 in dendritic cells treated with zymosan upon coimmunoprecipitation of transducin-like enhancer of split. In contrast, we did not obtain evidence of a possible effect of SIRT1 through the deacetylation of c-Rel, the central element of the NF-kappa B family involved in il12a regulation. These data indicate that an enhancement of SIRT1 activity in response to phagocytic stimuli may reduce the accessibility of c-Rel to the il12a promoter and its transcriptional activation, thus regulating the IL-12 p70/ IL-23 balance and modulating the ongoing immune response.	[Alvarez, Yolanda; Rodriguez, Mario; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Sanchez Crespo, Mariano] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Ibarrola, Nieves] Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Fernandez, Nieves] Univ Valladolid, Dept Bioquim & Biol Mol, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Universidad de Valladolid	Crespo, MS (corresponding author), CSIC, Inst Biol & Genet Mol, C Sanzy Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Municio, Cristina/D-2916-2019; Alvarez, Yolanda/AAD-4964-2021; Fernández, Nieves/N-5426-2018; Rodríguez, Mario/AAE-9602-2020	Municio, Cristina/0000-0002-8552-8183; Fernández, Nieves/0000-0002-9141-3956; Rodríguez, Mario/0000-0002-4587-3863; Alvarez, Yolanda/0000-0002-4851-8277; Sanchez Crespo, Mariano/0000-0002-6149-154X	Plan Nacional de Salud y Farmacia [SAF2007-60446, SAF2010-15070]; Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon Grant [CSI003A11-2]	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon Grant(Junta de Castilla y Leon)	This work was supported by Plan Nacional de Salud y Farmacia Grants SAF2007-60446 and SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular, and Junta de Castilla y Leon Grant CSI003A11-2.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; FISHER TL, 1973, J BIOL CHEM, V248, P4293; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Goriely S, 2003, BLOOD, V101, P4894, DOI 10.1182/blood-2002-09-2851; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Hassan AH, 2006, J BIOL CHEM, V281, P18126, DOI 10.1074/jbc.M602851200; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kollet JI, 2006, MOL IMMUNOL, V43, P623, DOI 10.1016/j.molimm.2005.04.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Legutko A, 2011, J IMMUNOL, V187, P4517, DOI 10.4049/jimmunol.1101493; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PALMERE RM, 1970, J ORG CHEM, V35, P2703, DOI 10.1021/jo00833a049; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Purushotham A, 2012, FASEB J, V26, P656, DOI 10.1096/fj.11-195172; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	66	23	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35689	35701		10.1074/jbc.M112.391839	http://dx.doi.org/10.1074/jbc.M112.391839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893703	hybrid, Green Published			2022-12-28	WOS:000309968000080
J	Gong, K; Chen, C; Zhan, Y; Chen, Y; Huang, ZB; Li, WH				Gong, Ke; Chen, Chao; Zhan, Yao; Chen, Yan; Huang, Zebo; Li, Wenhua			Autophagy-related Gene 7 (ATG7) and Reactive Oxygen Species/Extracellular Signal-regulated Kinase Regulate Tetrandrine-induced Autophagy in Human Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; CYTOCHROME-C; APOPTOSIS; DEATH; ACTIVATION; PATHWAY; MITOCHONDRIA; THERAPY; GROWTH; PERMEABILIZATION	Tetrandrine, a bisbenzylisoquinoline alkaloid isolated from the broadly used Chinese medicinal herb Stephaniae tetrandrae, exhibits potent antitumor effects and has the potential to be used as a cancer chemotherapeutic agent. We previously reported that high concentrations of tetrandrine induce apoptosis in liver cancer cells. Here, we found that in human hepatocellular carcinoma (HCC) cells, a low dose of tetrandrine (5 mu M) induced the expression of LC3-II, resulted in the formation of acidic autophagolysosome vacuoles (AVOs), and caused a punctate fluorescence pattern with the GFP-LC3 protein, which all are markers for cellular autophagy. Tetrandrine induced the production of intracellular reactive oxygen species (ROS), and treatment with ROS scavengers significantly abrogated the tetrandrine-induced autophagy. These results suggest that the generation of ROS plays an important role in promoting tetrandrine-induced autophagy. Tetrandrine-induced mitochondrial dysfunction resulted in ROS accumulation and autophagy. ROS generation activated the ERK MAP kinase, and the ERK signaling pathway at least partially contributed to tetrandrine-induced autophagy in HCC cells. Moreover, we found that tetrandrine transcriptionally regulated the expression of autophagy related gene 7 (ATG7), which promoted tetrandrine-induced autophagy. In addition to in vitro studies, similar results were also observed in vivo, where tetrandrine caused the accumulation of ROS and induced cell autophagy in a tumor xenograft model. Interestingly, tetrandrine treatment also induced autophagy in a ROS-dependent manner in C. elegans muscle cells. Therefore, these findings suggest that tetrandrine is a potent autophagy agonist and may be a promising clinical chemotherapeutic agent.	[Gong, Ke; Chen, Chao; Zhan, Yao; Li, Wenhua] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Chen, Yan; Huang, Zebo] Wuhan Univ, Coll Pharm, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Li, WH (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	whli@whu.edu.cn	Huang, Zebo/AAF-2382-2019	Huang, Zebo/0000-0003-2431-3741	National Basic Research Program of China [2010CB529800]; National Nature Science Foundation of China [81273540]; Chinese 111 project [B06018]; major scientific and technological special project for "Significant Creation of New Drugs" [2011ZX09102-001-32, 2011ZX09401-302-4]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project(Ministry of Education, China - 111 Project); major scientific and technological special project for "Significant Creation of New Drugs"	This work was supported by National Basic Research Program of China Grant 2010CB529800, National Nature Science Foundation of China Grant 81273540, The Chinese 111 project (B06018), and the major scientific and technological special project for "Significant Creation of New Drugs" Grants 2011ZX09102-001-32 and 2011ZX09401-302-4.	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Balague C, 2000, BLOOD, V95, P820, DOI 10.1182/blood.V95.3.820.003k32_820_828; Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen Y, 2009, INT J CANCER, V124, P2260, DOI 10.1002/ijc.24208; Cheng TH, 2001, J MOL CELL CARDIOL, V33, P1805, DOI 10.1006/jmcc.2001.1444; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Gailhouste L, 2010, INT J CANCER, V126, P1367, DOI 10.1002/ijc.24950; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Ibanez A, 2009, BIOCHEM J, V422, P161, DOI 10.1042/BJ20082118; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Jang BC, 2004, BIOCHEM PHARMACOL, V67, P1819, DOI 10.1016/j.bcp.2004.01.018; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuo CC, 2011, FREE RADICAL BIO MED, V51, P2195, DOI 10.1016/j.freeradbiomed.2011.09.023; Lee JH, 2002, INT J ONCOL, V21, P1239; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Lin ML, 2010, CANCER LETT, V291, P46, DOI 10.1016/j.canlet.2009.09.016; Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Quinsay MN, 2010, J MOL CELL CARDIOL, V48, P1146, DOI 10.1016/j.yjmcc.2009.12.004; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Wu JM, 2010, CANCER LETT, V287, P187, DOI 10.1016/j.canlet.2009.06.009; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Yue ZY, 2008, AUTOPHAGY, V4, P94, DOI 10.4161/auto.5202; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031	57	100	110	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35576	35588		10.1074/jbc.M112.370585	http://dx.doi.org/10.1074/jbc.M112.370585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22927446	Green Published, hybrid			2022-12-28	WOS:000309968000070
J	Muller, MP; Shkumatov, AV; Oesterlin, LK; Schoebel, S; Goody, PR; Goody, RS; Itzen, A				Mueller, Matthias P.; Shkumatov, Alexander V.; Oesterlin, Lena K.; Schoebel, Stefan; Goody, Philip R.; Goody, Roger S.; Itzen, Aymelt			Characterization of Enzymes from Legionella pneumophila Involved in Reversible Adenylylation of Rab1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; SMALL GTPASE RAB1; NUCLEOTIDE-EXCHANGE; BIOLOGICAL MACROMOLECULES; STRUCTURAL INSIGHTS; GDI DISPLACEMENT; KINETIC-DATA; FIC DOMAIN; AMPYLATION	After the pathogenic bacterium Legionella pneumophila is phagocytosed, it injects more than 250 different proteins into the cytoplasm of host cells to evade lysosomal digestion and to replicate inside the host cell. Among these secreted proteins is the protein DrrA/SidM, which has been shown to modify Rab1b, a main regulator of vesicular trafficking in eukaryotic cells, by transfer of adenosine monophosphate(AMP) to Tyr(77). In addition, Legionella provides the protein SidD that hydrolytically reverses the covalent modification, suggesting a tight spatial and temporal control of Rab1 function by Legionella during infection. Small angle x-ray scattering experiments of DrrA allowed us to validate a tentative complex model built by combining available crystallographic data. We have established the effects of adenylylation on Rab1 interactions and properties in a quantitative way. In addition, we have characterized the kinetics of DrrA-catalyzed adenylylation as well as SidD-catalyzed deadenylylation toward Rab1 and have determined the nucleotide specificities of both enzymes. This study enhances our knowledge of proteins subverting Rab1 function at the Legionella-containing vacuole.	[Itzen, Aymelt] Tech Univ Munich, Dept Chem, CIPSM, D-85747 Garching, Germany; [Mueller, Matthias P.; Oesterlin, Lena K.; Schoebel, Stefan; Goody, Philip R.; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Shkumatov, Alexander V.] DESY, European Mol Biol Lab, Hamburg Outstat, D-22603 Hamburg, Germany	Technical University of Munich; Max Planck Society; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Itzen, A (corresponding author), Tech Univ Munich, Dept Chem, CIPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	aymelt.itzen@tum.de	Itzen, Aymelt/F-5157-2014; Goody, Roger S/J-8845-2014	Itzen, Aymelt/0000-0002-4249-5617; Goody, Roger S/0000-0002-0772-0444; Muller, Matthias/0000-0002-1529-8933; Goody, Philip Roger/0000-0002-1485-4221	Max-Planck-Society; Deutsche Forschungsgemeinschaft [SFB642, A4]; International Max Planck Research School in Chemical Biology (Dortmund, Germany)	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology (Dortmund, Germany)	This work was supported by grants from the Max-Planck-Society and the Deutsche Forschungsgemeinschaft (SFB642, Grant A4).; Supported by the International Max Planck Research School in Chemical Biology (Dortmund, Germany).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chavas LMG, 2007, ACTA CRYSTALLOGR D, V63, P769, DOI 10.1107/S0907444907019725; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; Goody Roger S, 2011, Commun Integr Biol, V4, P72, DOI 10.4161/cib.4.1.13857; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Itzen A, 2011, SEMIN CELL DEV BIOL, V22, P48, DOI 10.1016/j.semcdb.2010.10.003; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Oesterlin LK, 2012, P NATL ACAD SCI USA, V109, P5621, DOI 10.1073/pnas.1121161109; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rigden DJ, 2011, FEBS LETT, V585, P2749, DOI 10.1016/j.febslet.2011.08.006; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P1, DOI 10.1016/j.semcdb.2010.12.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Tilney LG, 2001, J CELL SCI, V114, P4637; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wittmann JG, 2004, FEBS LETT, V568, P23, DOI 10.1016/j.febslet.2004.05.004; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu YB, 2004, STRUCTURE, V12, P861, DOI 10.1016/S0969-2126(04)00111-X; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	60	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35036	35046		10.1074/jbc.M112.396861	http://dx.doi.org/10.1074/jbc.M112.396861			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22872634	Green Published, hybrid			2022-12-28	WOS:000309968000015
J	Kim, KW; Moinuddin, SGA; Atwell, KM; Costa, MA; Davin, LB; Lewis, NG				Kim, Kye-Won; Moinuddin, Syed G. A.; Atwell, Kathleen M.; Costa, Michael A.; Davin, Laurence B.; Lewis, Norman G.			Opposite Stereoselectivities of Dirigent Proteins in Arabidopsis and Schizandra Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; DEHYDROGENASE; PATHWAY; LIGNANS; LIGNIN; FAMILY	How stereoselective monolignol-derived phenoxy radical-radical coupling reactions are differentially biochemically orchestrated in planta, whereby for example they afford (+)- and (-)-pinoresinols, respectively, is both a fascinating mechanistic and evolutionary question. In earlier work, biochemical control of (+)-pinoresinol formation had been established to be engendered by a (+)-pinoresinol-forming dirigent protein in Forsythia intermedia, whereas the presence of a (-)-pinoresinol-forming dirigent protein was indirectly deduced based on the enantiospecificity of downstream pinoresinol reductases (AtPrRs) in Arabidopsis thaliana root tissue. In this study of 16 putative dirigent protein homologs in Arabidopsis, AtDIR6, AtDIR10, and AtDIR13 were established to be root-specific using a beta-glucuronidase reporter gene strategy. Of these three, in vitro analyses established that only recombinant AtDIR6 was a (-)-pinoresinol-forming dirigent protein, whose physiological role was further confirmed using overexpression and RNAi strategies in vivo. Interestingly, its closest homolog, AtDIR5, was also established to be a (-)-pinoresinol-forming dirigent protein based on in vitro biochemical analyses. Both of these were compared in terms of properties with a (+)-pinoresinol-forming dirigent protein from Schizandra chinensis. In this context, sequence analyses, site-directed mutagenesis, and region swapping resulted in identification of putative substrate binding sites/regions and candidate residues controlling distinct stereoselectivities of coupling modes.	[Kim, Kye-Won; Moinuddin, Syed G. A.; Atwell, Kathleen M.; Costa, Michael A.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Davin, Laurence/0000-0002-3248-6485; Hwang, Julianne/0000-0002-9222-1729; Lewis, Norman/0000-0001-5742-032X	National Science Foundation [MCB-0417291, MCB-1052557]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; Department of Energy's Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1052557] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0417291 and MCB-1052557 and the G. Thomas and Anita Hargrove Center for Plant Genomic Research.; We thank Greg Pearce (Institute of Biological Chemistry) for the S. peruvianum cell cultures used for heterologous expression of DPs, Julianna Gothard for growing Arabidopsis plants, and Dr. Helen Skaltsa (University of Athens, Greece) for providing authentic samples of the two lariciresinol glucosides. NMR spectra were acquired in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory, Richland, WA. We gratefully acknowledge the assistance of Dr. John R. Cort in collection and processing of NMR spectra.	Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Burlat V, 2001, PHYTOCHEMISTRY, V57, P883, DOI 10.1016/S0031-9422(01)00117-0; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; DUFFIELD AM, 1967, J HETEROCYCLIC CHEM, V4, P16, DOI 10.1002/jhet.5570040104; Ford JD, 2001, J NAT PROD, V64, P1388, DOI 10.1021/np010367x; Gang DR, 1999, CHEM BIOL, V6, P143, DOI 10.1016/S1074-5521(99)89006-1; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Halls SC, 2002, BIOCHEMISTRY-US, V41, P9455, DOI 10.1021/bi0259709; Halls SC, 2004, BIOCHEMISTRY-US, V43, P2587, DOI 10.1021/bi035959o; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KATAYAMA T, 1992, PHYTOCHEMISTRY, V31, P3875, DOI 10.1016/S0031-9422(00)97545-9; Kim K.-W., 2010, JOINT ANN M AM SOC P; Kim Kye-Won, 2006, V323, P263; Kim MK, 2002, PLANT MOL BIOL, V49, P199, DOI 10.1023/A:1014940930703; Kim SJ, 2004, P NATL ACAD SCI USA, V101, P1455, DOI 10.1073/pnas.0307987100; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; Liu JG, 2008, PHYTOCHEMISTRY, V69, P3038, DOI 10.1016/j.phytochem.2008.06.007; Moinuddin SGA, 2006, ORG BIOMOL CHEM, V4, P808, DOI 10.1039/b516563f; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Nakatsubo T, 2008, J BIOL CHEM, V283, P15550, DOI 10.1074/jbc.M801131200; Uzal EN, 2009, J PLANT PHYSIOL, V166, P831, DOI 10.1016/j.jplph.2008.11.009; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Patten AM, 2010, MOL BIOSYST, V6, P499, DOI 10.1039/b819206e; Pickel B, 2012, FEBS J, V279, P1980, DOI 10.1111/j.1742-4658.2012.08580.x; Pickel B, 2010, ANGEW CHEM INT EDIT, V49, P202, DOI 10.1002/anie.200904622; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SUGIYAMA M, 1993, HETEROCYCLES, V36, P117; Suzuki S, 2002, J WOOD SCI, V48, P536, DOI 10.1007/BF00766653; Turlapati PV, 2011, PLANTA, V233, P439, DOI 10.1007/s00425-010-1298-3; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; Yamamoto S, 2004, J MASS SPECTROM, V39, P1337, DOI 10.1002/jms.726; ZHUANG LG, 1982, PLANTA MED, V45, P172, DOI 10.1055/s-2007-971368	39	65	72	1	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33957	33972		10.1074/jbc.M112.387423	http://dx.doi.org/10.1074/jbc.M112.387423			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22854967	hybrid, Green Published			2022-12-28	WOS:000309654200004
J	Priyadarzini, TRK; Selvin, JFA; Gromiha, MM; Fukui, K; Veluraja, K				Priyadarzini, Thanu R. K.; Selvin, Jeyasigamani F. A.; Gromiha, M. Michael; Fukui, Kazuhiko; Veluraja, Kasinadar			Theoretical Investigation on the Binding Specificity of Sialyldisaccharides with Hemagglutinins of Influenza A Virus by Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; SIALIC-ACID; RECEPTOR SPECIFICITY; AMINO-ACID; SUGAR CHAINS; HOST-CELL; C-VIRUS; ORIGIN; EVOLUTION; SUBSTITUTIONS	Recognition of cell-surface sialyldisaccharides by influenza A hemagglutinin (HA) triggers the infection process of influenza. The changes in glycosidic torsional linkage and the receptor conformations may alter the binding specificity of HAs to the sialylglycans. In this study, 10-ns molecular dynamics simulations were carried out to examine the structural and dynamic behavior of the HAs bound with sialyldisaccharides Neu5Ac alpha(2-3) Gal (N23G) and Neu5Ac alpha(2-6) Gal (N26G). The analysis of the glycosidic torsional angles and the pair interaction energy between the receptor and the interacting residues of the binding site reveal that N23G has two binding modes for H1 and H5 and a single binding mode for H3 and H9. For N26G, H1 and H3 has two binding modes, and H5 and H9 has a single binding mode. The direct and water-mediated hydrogen bonding interactions between the receptors and HAs play dominant roles in the structural stabilization of the complexes. It is concluded from pair interaction energy and Molecular Mechanic-Poisson-Boltz-mann Surface Area calculations that N26G is a better receptor for H1 when compared with N23G. N23G is a better receptor for H5 when compared with N26G. However, H3 and H9 can recognize N23G and N26G in equal binding specificity due to the marginal energy difference (approximate to 2.5 kcal/mol). The order of binding specificity of N23G is H3 > H5 > H9 > H1 and N26G is H1 > H3 > H5 > H9, respectively. The proposed conformational models will be helpful in designing inhibitors for influenza virus.	[Priyadarzini, Thanu R. K.; Selvin, Jeyasigamani F. A.; Veluraja, Kasinadar] Manonmaniam Sundaranar Univ, Dept Phys, Tirunelveli 627012, Tamil Nadu, India; [Gromiha, M. Michael] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Fukui, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350064, Japan	Manonmaniam Sundaranar University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; National Institute of Advanced Industrial Science & Technology (AIST)	Veluraja, K (corresponding author), Manonmaniam Sundaranar Univ, Dept Phys, Tirunelveli 627012, Tamil Nadu, India.	veluraja@msuniv.ac.in	veluraja, kasinadar/R-3089-2019; Gromiha, Michael/H-8493-2019	Michael, Gromiha/0000-0002-1776-4096	Department of Biotechnology [BT/PR4251/BID/07/2003, BT/BI/25/001/2006]; Department of Science and Technology [SR/S0/BB-53/2003]; Council of Scientific and Industrial Research; Department of Biotechnology, India; National Institute of Advanced Industrial Science and Technology, Japan [BT/BI/14/028/2007]	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Institute of Advanced Industrial Science and Technology, Japan	Recipient of Department of Biotechnology Grant BT/PR4251/BID/07/2003.; Recipient of Department of Science and Technology Grant SR/S0/BB-53/2003 and a grant from Council of Scientific and Industrial Research.; Supported by the Department of Biotechnology, India, and National Institute of Advanced Industrial Science and Technology, Japan Collaborative Project BT/BI/14/028/2007.; We acknowledge the use of the Bioinformatics Center at the Department of Physics, Manonmaniam Sundaranar University, which is funded by Department of Biotechnology Grant BT/BI/25/001/2006.	ARNOTT S, 1972, J CHEM SOC PERK T 2, P324, DOI 10.1039/p29720000324; BAUM LG, 1990, ACTA HISTOCHEM, P35; BROSSMER R, 1993, FEBS LETT, V323, P96, DOI 10.1016/0014-5793(93)81456-A; Case D.A., 2006, AMBER VERSION 9, V9; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dawson ED, 2007, ANAL CHEM, V79, P378, DOI 10.1021/ac061920o; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; FLIPPEN JL, 1973, ACTA CRYSTALLOGR B, V29, P1881, DOI 10.1107/S0567740873005698; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gottschalk A, 1959, VIRUSES, V3, P51; GUNTHER I, 1993, VIRUS RES, V27, P147, DOI 10.1016/0168-1702(93)90078-2; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo SK, 2007, VIRUS RES, V129, P64, DOI 10.1016/j.virusres.2007.05.005; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lau LT, 2004, BIOCHEM BIOPH RES CO, V313, P336, DOI 10.1016/j.bbrc.2003.11.131; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Lekcharoensuk P, 2010, VET MICROBIOL, V145, P230, DOI 10.1016/j.vetmic.2010.04.008; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nadtanet N., 2010, MONATSH CHEM, V141, P801; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyadarzini TRK, 2012, CARBOHYD RES, V351, P93, DOI 10.1016/j.carres.2012.01.015; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schwahn AB, 2009, ANAL CHEM, V81, P3500, DOI 10.1021/ac900026f; SKEHEL JJ, 1995, AM J RESP CRIT CARE, V152, pS13, DOI 10.1164/ajrccm/152.4_Pt_2.S13; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suzuki Y, 2001, INT CONGR SER, V1219, P521, DOI 10.1016/S0531-5131(01)00630-6; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tobita K, 1997, Nihon Rinsho, V55, P2512; Vasudevan SV, 2002, BIOPOLYMERS, V63, P168, DOI 10.1002/bip.10019; Veluraja K, 2008, J THEOR BIOL, V252, P15, DOI 10.1016/j.jtbi.2007.12.024; VELURAJA K, 1980, BIOCHIM BIOPHYS ACTA, V630, P442, DOI 10.1016/0304-4165(80)90293-7; Veluraja K, 2010, CARBOHYD RES, V345, P2030, DOI 10.1016/j.carres.2010.06.021; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97; ZIMMER G, 1992, EUR J BIOCHEM, V204, P209, DOI 10.1111/j.1432-1033.1992.tb16626.x	58	26	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34547	34557		10.1074/jbc.M112.357061	http://dx.doi.org/10.1074/jbc.M112.357061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22846994	Green Published, hybrid			2022-12-28	WOS:000309654200058
J	Montgomery, C; Pei, ZT; Watkins, PA; Miziorko, HM				Montgomery, Christa; Pei, Zhengtong; Watkins, Paul A.; Miziorko, Henry M.			Identification and Characterization of an Extramitochondrial Human 3-Hydroxy-3-methylglutaryl-CoA Lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-METHYLGLUTARYL COENZYME; HMG-COA LYASE; ENZYME-ACTIVITY; KETONE-BODIES; EXPRESSION; CELLS; LIVER; DEHYDROGENASE; DEFICIENCY; METABOLISM	3-Hydroxy-3-methylglutaryl-CoA lyase-like protein (HMGCLL1) has been annotated in the Mammalian Genome Collection as a previously unidentified human HMG-CoA lyase (HMGCL). To test the validity of this annotation and evaluate the physiological role of the protein, plasmids were constructed for protein expression in Escherichia coli and Pichia pastoris. Protein expression in E. coli produced insoluble material. In contrast, active HMGCLL1 could be recovered upon expression in P. pastoris. Antibodies were prepared against a unique peptide sequence found in the N terminus of the protein. In immunodetection experiments, the antibodies discriminated between HMGCLL1 and mitochondrial HMGCL. Purified enzyme was characterized and demonstrated to cleave HMG-CoA to acetoacetate and acetyl-CoA with catalytic and affinity properties comparable with human mitochondrial HMGCL. The deduced HMGCLL1 sequence contains an N-terminal myristoylation motif; the putative modification site was eliminated by construction of a G2A HMGCLL1. Modification of both proteins was attempted using human N-myristoyltransferase and [H-3] myristoyl-CoA. Wild-type protein was clearly modified, whereas G2A protein was not labeled. Myristoylation of HMGCLL1 affects its cellular localization. Upon transfection of appropriate expression plasmids into COS1 cells, immunofluorescence detection indicates that G2A HMGCLL1 exhibits a diffuse pattern, suggesting a cytosolic location. In contrast, wildtype HMGCLL1 exhibits a punctate as well as a perinuclear immunostaining pattern, indicating myristoylation dependent association with nonmitochondrial membrane compartments. In control experiments with the HMGCL expression plasmid, protein is localized in the mitochondria, as anticipated. The available results for COS1 cell expression, as well as endogenous expression in U87 cells, indicate that HMGCLL1 is an extramitochondrial hydroxymethylglutaryl-CoA lyase.	[Montgomery, Christa; Miziorko, Henry M.] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Pei, Zhengtong; Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Pei, Zhengtong; Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	University of Missouri System; University of Missouri Kansas City; Johns Hopkins University; Johns Hopkins University	Miziorko, HM (corresponding author), Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	miziorkoh@umkc.edu		Watkins, Paul A./0000-0002-3246-1405	National Institutes of Health [DK21491, HD020461]; Marion-Merrell-Dow foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021491, R37DK021491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marion-Merrell-Dow foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK21491 and HD020461 and the Marion-Merrell-Dow foundation.	BACHHAWAT BK, 1955, J BIOL CHEM, V216, P727; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Fu ZJ, 2010, J BIOL CHEM, V285, P26341, DOI 10.1074/jbc.M110.139931; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; GOLDFARB S, 1971, J LIPID RES, V12, P512; Green D, 1996, BIOCHEMISTRY-US, V35, P8158, DOI 10.1021/bi952807n; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; HILDEBRANDT LA, 1995, AM J PHYSIOL-CELL PH, V269, pC22, DOI 10.1152/ajpcell.1995.269.1.C22; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Linder S, 1996, BIOTECHNIQUES, V20, P980; Montgomery C, 2011, FASEB J, V25; Montgomery C, 2011, ARCH BIOCHEM BIOPHYS, V511, P48, DOI 10.1016/j.abb.2011.04.004; PATEL MS, 1981, P NATL ACAD SCI-BIOL, V78, P7214, DOI 10.1073/pnas.78.11.7214; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; Pie J, 2007, MOL GENET METAB, V92, P198, DOI 10.1016/j.ymgme.2007.06.020; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057	25	13	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33227	33236		10.1074/jbc.M112.393231	http://dx.doi.org/10.1074/jbc.M112.393231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22865860	hybrid, Green Published			2022-12-28	WOS:000309602100013
J	Wu, L; Pan, LF; Zhang, CC; Zhang, MJ				Wu, Lin; Pan, Lifeng; Zhang, Chuchu; Zhang, Mingjie			Large Protein Assemblies Formed by Multivalent Interactions between Cadherin23 and Harmonin Suggest a Stable Anchorage Structure at the Tip Link of Stereocilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY HAIR-CELLS; USHER-SYNDROME PROTEINS; DOMAIN-CONTAINING PROTEIN; MYOSIN VIIA; CROSS-LINKS; COMPLEX; TRANSDUCTION; REVEALS; EAR; MECHANOTRANSDUCTION	Stereocilia tip links of inner ear hair cells are subjected to constant stretching during hair-bundle deflection, and accordingly are well designed to prevent from being broken by mechanical tensions. The roots of tip links, which couple tip links with the cytoskeleton, supposedly play important roles in withstanding large forces under stimulated conditions. The upper root of the tip link is mainly formed by the cytoplasmic tail of cadherin23 and its actin-anchoring protein harmonin. However, the detailed organization mode of the two proteins that gives rise to a strong upper root remains unclear. Here we show that the exon68-encoded peptide of cadherin23 can either interact with the N-terminal domain (NTD) of harmonin or form a homodimer. We demonstrate that the three harmonin binding sites of cadherin23, namely the NTD-binding motif, the exon68 peptide, and the C-terminal PDZ binding motif, do not synergize with each other in binding to harmonin, instead they facilitate formation of polymeric cadherin23/harmonin complexes. The exon68 peptide can promote the cadherin23/harmonin polymer formation via either binding to harmonin NTD or self-dimerization. We propose that the polymeric cadherin23/harmonin complex formed beneath the upper tip link membranes may serve as part of the stable rootlet structure for anchoring the tip links of stereocilia.	[Wu, Lin; Pan, Lifeng; Zhang, Chuchu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Inst Adv Study, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk		Zhang, Mingjie/0000-0001-9404-0190; Zhang, Chuchu/0000-0001-9234-6073	Research Grants Council of Hong Kong [664009, 660709, 663610, 663811, HKUST6/CRF/10, SEG_HKUST06]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Grants 664009, 660709, 663610, 663811, HKUST6/CRF/10, and SEG_HKUST06 from the Research Grants Council of Hong Kong (to M. Z.).	Afrin R, 2006, BIOCHEM BIOPH RES CO, V348, P238, DOI 10.1016/j.bbrc.2006.07.050; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; JARAMILLO F, 1992, FASEB J, V6, pA516; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAMOO Y, 1994, BIOCHEMISTRY-US, V33, P8272, DOI 10.1021/bi00193a014; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SIMON JA, 1995, CHEM BIOL, V2, P53, DOI 10.1016/1074-5521(95)90080-2; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010	41	22	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33460	33471		10.1074/jbc.M112.378505	http://dx.doi.org/10.1074/jbc.M112.378505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22879593	Green Published, hybrid			2022-12-28	WOS:000309602100032
J	Zorn, JA; Wolan, DW; Agard, NJ; Wells, JA				Zorn, Julie A.; Wolan, Dennis W.; Agard, Nicholas J.; Wells, James A.			Fibrils Colocalize Caspase-3 with Procaspase-3 to Foster Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; INDUCED-PROXIMITY MODEL; ZYMOGEN ACTIVATION; PROTEOLYTIC-ENZYMES; ALLOSTERIC SITE; CELL-DEATH; IN-VITRO; INTERMEDIATE-FILAMENTS; HUNTINGTONS-DISEASE; DIMER INTERFACE	Most proteases are expressed as inactive precursors, or zymogens, that become activated by limited proteolysis. We previously identified a small molecule, termed 1541, that dramatically promotes the maturation of the zymogen, procaspase-3, to its mature form, caspase-3. Surprisingly, compound 1541 self-assembles into nanofibrils, and localization of procaspase- 3 to the fibrils promotes activation. Here, we interrogate the biochemical mechanism of procaspase- 3 activation on 1541 fibrils in addition to proteogenic amyloid-beta(1-40) fibrils. In contrast to previous reports, we find no evidence that procaspase- 3 alone is capable of self-activation, consistent with its fate-determining role in executing apoptosis. In fact, mature caspase-3 is > 10(7)-fold more active than procaspase-3, making this proenzyme a remarkably inactive zymogen. However, we also show that fibril-induced colocalization of trace amounts of caspase-3 or other initiator proteases with procaspase- 3 dramatically stimulates maturation of the proenzyme in vitro. Thus, similar to known cellular signaling complexes, these synthetic or natural fibrils can serve as platforms to concentrate procaspase- 3 for trans-activation by upstream proteases.	[Zorn, Julie A.; Wolan, Dennis W.; Agard, Nicholas J.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016; Agard, Nicholas/AAU-6495-2020	Agard, Nicholas/0000-0003-4916-2484; Wolan, Dennis/0000-0001-9879-8353	National Institutes of Health Grant [R01 CA136779]; NCI [F32 CA119641-03]; Achievement Rewards for College Scientists (ARCS) Foundation Award; Scleroderma Research Foundation Evnin-Wright Fellowship; Multiple Myeloma Translational Initiative (MMTI) at UCSF;  [F32 AI077177]; NATIONAL CANCER INSTITUTE [F32CA119641, R01CA136779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077177] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Achievement Rewards for College Scientists (ARCS) Foundation Award; Scleroderma Research Foundation Evnin-Wright Fellowship; Multiple Myeloma Translational Initiative (MMTI) at UCSF; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136779, Grant F32 CA119641-03 from NCI (to D. W. W.), and Grant F32 AI077177 (to N. J. A.). This work was also supported by an Achievement Rewards for College Scientists (ARCS) Foundation Award (to J. A. Z.), a Scleroderma Research Foundation Evnin-Wright Fellowship (to J. A. Z.), and the Multiple Myeloma Translational Initiative (MMTI) at UCSF.	Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Ganesan R, 2006, J MOL BIOL, V359, P1378, DOI 10.1016/j.jmb.2006.04.051; GERTLER A, 1974, BIOCHEMISTRY-US, V13, P1302, DOI 10.1021/bi00703a038; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; GRAYBILL TL, 1995, BIOORG MED CHEM LETT, V5, P1197, DOI 10.1016/0960-894X(95)00194-X; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Karki P, 2005, ARCH BIOCHEM BIOPHYS, V442, P125, DOI 10.1016/j.abb.2005.07.023; KASSELL B, 1973, SCIENCE, V180, P1022, DOI 10.1126/science.180.4090.1022; KAY J, 1971, J BIOL CHEM, V246, P6661; Khan AR, 1998, PROTEIN SCI, V7, P815; KINGSTON IB, 1995, NAT MED, V1, P138; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; LONSDALEECCLES JD, 1978, BIOCHEMISTRY-US, V17, P2805, DOI 10.1021/bi00607a016; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; MADISON EL, 1993, METHOD ENZYMOL, V223, P249; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2003, BIOCHEMISTRY-US, V42, P12311, DOI 10.1021/bi034999p; Pop C, 2001, BIOCHEMISTRY-US, V40, P14224, DOI 10.1021/bi011037e; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; ROBINSON NC, 1973, BIOCHEMISTRY-US, V12, P420, DOI 10.1021/bi00727a010; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schipper JL, 2011, BIOPHYS CHEM, V159, P100, DOI 10.1016/j.bpc.2011.05.013; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen A, 2010, MOL BIOSYST, V6, P1431, DOI 10.1039/c003913f; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; SILVERBERG M, 1982, BLOOD, V60, P64; Smith TJ, 2006, J AM CHEM SOC, V128, P14456, DOI 10.1021/ja065557e; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Twiddy D, 2006, J BIOL CHEM, V281, P3876, DOI 10.1074/jbc.M507393200; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Wu JW, 2001, EUR J BIOCHEM, V268, P1547, DOI 10.1046/j.1432-1033.2001.01914.x; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yuan RT, 2012, APOPTOSIS, V17, P229, DOI 10.1007/s10495-011-0677-y; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	86	39	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33781	33795		10.1074/jbc.M112.386128	http://dx.doi.org/10.1074/jbc.M112.386128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22872644	Green Published, hybrid			2022-12-28	WOS:000309602100060
J	Robertson, AB; Matson, SW				Robertson, Adam B.; Matson, Steven W.			Reconstitution of the Very Short Patch Repair Pathway from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH-REPAIR; ENDONUCLEASE VSR PROTEIN; DEOXYRIBONUCLEIC-ACID; FUNCTIONAL INTERACTIONS; CYTOSINE METHYLATION; GENE-PRODUCT; HYDROLYTIC DEAMINATION; REPLICATION FIDELITY; N-GLYCOSIDASE; POLYMERASE-I	The Escherichia coli very short patch (VSP) repair pathway corrects thymidine-guanine mismatches that result from spontaneous hydrolytic deamination damage of 5-methyl cytosine. The VSP repair pathway requires the Vsr endonuclease, DNA polymerase I, a DNA ligase, MutS, and MutL to function at peak efficiency. The biochemical roles of most of these proteins in the VSP repair pathway have been studied extensively. However, these proteins have not been studied together in the context of VSP repair in an in vitro system. Using purified components of the VSP repair system in a reconstitution reaction, we have begun to develop an understanding of the role played by each of these proteins in the VSP repair pathway and have gained insights into their interactions. In this report we demonstrate an in vitro reconstitution of the VSP repair pathway using a plasmid DNA substrate. Surprisingly, the repair track length can be modulated by the concentration of DNA ligase. We propose roles for MutL and MutS in coordination of this repair pathway.	[Robertson, Adam B.; Matson, Steven W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Matson, Steven W.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			National Institutes of Health [GM 33476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 33476 (to S. W. M.).	AU KG, 1992, J BIOL CHEM, V267, P12142; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; BHAGWAT AS, 1988, GENE, V74, P155; Bhagwat AS, 2002, MOL MICROBIOL, V44, P1421, DOI 10.1046/j.1365-2958.2002.02989.x; Drotschmann K, 1998, NUCLEIC ACIDS RES, V26, P948, DOI 10.1093/nar/26.4.948; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; DZIDIC S, 1989, MOL GEN GENET, V217, P254, DOI 10.1007/BF02464889; Elliott SL, 2005, J MOL BIOL, V353, P692, DOI 10.1016/j.jmb.2005.08.048; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; Gonzalez-Nicieza R, 2001, J MOL BIOL, V310, P501, DOI 10.1006/jmbi.2001.4799; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; HENNECKE F, 1991, NATURE, V353, P776, DOI 10.1038/353776a0; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; JONES M, 1987, CELL, V50, P621, DOI 10.1016/0092-8674(87)90035-3; KARRAN P, 1980, BIOCHEMISTRY-US, V19, P6005, DOI 10.1021/bi00567a010; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; LIEB M, 1991, GENETICS, V128, P23; LIEB M, 1987, J BACTERIOL, V169, P5241, DOI 10.1128/jb.169.11.5241-5246.1987; LIEB M, 1995, J BACTERIOL, V177, P660, DOI 10.1128/jb.177.3.660-666.1995; LIEB M, 1986, GENETICS, V114, P1041; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; Macintyre G, 1997, J BACTERIOL, V179, P6048, DOI 10.1128/jb.179.19.6048-6052.1997; Mansour CA, 2001, MUTAT RES-DNA REPAIR, V485, P331, DOI 10.1016/S0921-8777(01)00071-4; MODRICH P, 1973, J BIOL CHEM, V248, P7495; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Monastiriakos SK, 2004, DNA REPAIR, V3, P639, DOI 10.1016/j.dnarep.2004.02.008; Polosina YY, 2010, MUTAT RES-REV MUTAT, V705, P228, DOI 10.1016/j.mrrev.2010.07.002; Polosina YY, 2010, BIOESSAYS, V32, P51, DOI 10.1002/bies.200900089; Polosina YY, 2009, J BACTERIOL, V191, P4041, DOI 10.1128/JB.00066-09; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Robertson AB, 2006, J BIOL CHEM, V281, P19949, DOI 10.1074/jbc.M601604200; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SOHAIL A, 1990, J BACTERIOL, V172, P4214, DOI 10.1128/jb.172.8.4214-4221.1990; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; SU SS, 1988, J BIOL CHEM, V263, P6829; Tsutakawa SE, 1999, MOL CELL, V3, P621, DOI 10.1016/S1097-2765(00)80355-X; Turner DP, 2000, J MOL BIOL, V304, P765, DOI 10.1006/jmbi.2000.4248; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; WELSH KM, 1987, J BIOL CHEM, V262, P15624; YAO M, 1995, J BIOL CHEM, V270, P28609, DOI 10.1074/jbc.270.48.28609; YAO M, 1994, J BIOL CHEM, V269, P16260; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	57	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32953	32966		10.1074/jbc.M112.384321	http://dx.doi.org/10.1074/jbc.M112.384321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22846989	Green Published, hybrid			2022-12-28	WOS:000309168300059
J	Schmid, F; Fliegert, R; Westphal, T; Bauche, A; Guse, AH				Schmid, Frederike; Fliegert, Ralf; Westphal, Tim; Bauche, Andreas; Guse, Andreas H.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Degradation by Alkaline Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; PHOSPHODIESTERASE ACTIVITY; CA2+; CALCIUM; CD38; 2ND-MESSENGER; LOCALIZATION; HYDROLYSIS; ACTIVATION; ISOENZYMES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a ubiquitous second messenger providing a Ca2+ trigger in a wide range of cell types. However, its metabolism is not well understood. Here, we demonstrate the presence of endogenous NAADP in HeLa cells. CD38, a promiscuous enzyme described to be involved in NAADP metabolism, was not detectable in HeLa cells. In cell-free extracts of HeLa cells, NAADP was degraded to nicotinic acid adenine dinucleotide (NAAD). The enzyme was enriched in membranes (10,000 x g pellet) and displayed characteristics typical of alkaline phosphatase (AP), e. g. pH optimum at 8-9 and sensitivity to the inhibitors L-homoarginine and L-leucine. Importantly, NAADP at physiological concentrations (50-100 nM) was degraded to NAAD. Expression of AP isoenzymes was analyzed in HeLa cells. Based on the results together with inhibitor studies, the placental AP isoform emerged as the best candidate for NAADP degradation in HeLa cells. In contrast to HeLa cells, Jurkat T cells or HEK293 cells did not express any AP isoenzymes and did not display any NAADP 2'-phosphatase activity. Finally, the placental AP isoform was expressed heterologously in HEK293 cells, resulting in reconstitution of NAADP 2'-phosphatase activity in cell-free extracts. On the basis of the results, we provide evidence for AP as the metabolizing enzyme of NAADP in cells that do not express CD38.	[Schmid, Frederike; Fliegert, Ralf; Westphal, Tim; Bauche, Andreas; Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Calcium Signalling Grp, Dept Biochem & Signal Transduct, D-20246 Hamburg, Germany; [Bauche, Andreas; Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Guse, AH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Calcium Signalling Grp, Dept Biochem & Signal Transduct, Martinistr 52, D-20246 Hamburg, Germany.	guse@uke.de			Deutsche Forschungsgemeinschaft [GU 360/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GU 360/15-1 (to A. H. G.).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BENHAM F, 1977, J HISTOCHEM CYTOCHEM, V25, P266, DOI 10.1177/25.4.870558; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; BIRGE SJ, 1974, J CLIN INVEST, V54, P710, DOI 10.1172/JCI107809; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bruzzone S, 2001, FASEB J, V15, P10; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Demenis MA, 2000, IUBMB LIFE, V49, P113; ELSON NA, 1969, BIOCHEM GENET, V3, P549, DOI 10.1007/BF00485476; FISHMAN WH, 1970, CLIN CHIM ACTA, V29, P339, DOI 10.1016/0009-8981(70)90057-4; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Guida L, 2004, J BIOL CHEM, V279, P22066, DOI 10.1074/jbc.M314137200; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HARKNESS DR, 1968, ARCH BIOCHEM BIOPHYS, V126, P513, DOI 10.1016/0003-9861(68)90436-0; HERZ F, 1985, EXPERIENTIA, V41, P1357, DOI 10.1007/BF01949989; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P8368, DOI 10.1021/bi012038+; LIN CW, 1976, J HISTOCHEM CYTOCHEM, V24, P659, DOI 10.1177/24.5.58927; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517; SASAKI M, 1973, CANCER RES, V33, P3008; SAY JC, 1991, BIOCHIM BIOPHYS ACTA, V1074, P256, DOI 10.1016/0304-4165(91)90161-9; Schar BK, 1997, CANCER RES, V57, P3841; Schmid F, 2011, FEBS LETT, V585, P3544, DOI 10.1016/j.febslet.2011.10.017; Schweitzer K, 2001, ANAL BIOCHEM, V299, P218, DOI 10.1006/abio.2001.5419; SINGER RM, 1974, J CELL BIOL, V60, P777, DOI 10.1083/jcb.60.3.777; SIVANAESAN L, 1991, BIOCHEM INT, V25, P561; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; SUMIKAWA K, 1990, BIOCHIM BIOPHYS ACTA, V1046, P27, DOI 10.1016/0005-2760(90)90090-K; TOKUMITSU S, 1981, J HISTOCHEM CYTOCHEM, V29, P1080, DOI 10.1177/29.9.7026668; WILSON PD, 1981, HISTOCHEM J, V13, P31, DOI 10.1007/BF01005837; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang L, 2005, J BIOL CHEM, V280, P37289, DOI 10.1074/jbc.M504260200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	45	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32525	32534		10.1074/jbc.M112.362715	http://dx.doi.org/10.1074/jbc.M112.362715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22851169	Green Published, hybrid			2022-12-28	WOS:000309168300022
J	Daleke, MH; van der Woude, AD; Parret, AHA; Ummels, R; de Groot, AM; Watson, D; Piersma, SR; Jimenez, CR; Luirink, J; Bitter, W; Houben, ENG				Daleke, Maria H.; van der Woude, Aniek D.; Parret, Annabel H. A.; Ummels, Roy; de Groot, A. Marit; Watson, David; Piersma, Sander R.; Jimenez, Connie R.; Luirink, Joen; Bitter, Wilbert; Houben, Edith N. G.			Specific Chaperones for the Type VII Protein Secretion Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE; SYSTEM; PPE; MYCOBACTERIA; SURFACE; SIGNAL; RD1; PE	Mycobacteria use the dedicated type VII protein secretion systems ESX-1 and ESX-5 to secrete virulence factors across their highly hydrophobic cell envelope. The substrates of these systems include the large mycobacterial PE and PPE protein families, which are named after their characteristic Pro-Glu and Pro-Pro-Glu motifs. Pathogenic mycobacteria secrete large numbers of PE/PPE proteins via the major export pathway, ESX-5. In addition, a few PE/PPE proteins have been shown to be exported by ESX-1. It is not known how ESX-1 and ESX-5 recognize their cognate PE/PPE substrates. In this work, we investigated the function of the cytosolic protein EspG(5), which is essential for ESX-5-mediated secretion in Mycobacterium marinum, but for which the role in secretion is not known. By performing protein co-purifications, we show that EspG(5) interacts with several PPE proteins and a PE/PPE complex that is secreted by ESX-5, but not with the unrelated ESX-5 substrate EsxN or with PE/PPE proteins secreted by ESX-1. Conversely, the ESX-1 paralogue EspG(1) interacted with a PE/PPE couple secreted by ESX-1, but not with PE/PPE substrates of ESX-5. Furthermore, structural analysis of the complex formed by EspG(5) and PE/PPE indicates that these proteins interact in a 1:1:1 ratio. In conclusion, our study shows that EspG(5) and EspG(1) interact specifically with PE/PPE proteins that are secreted via their own ESX systems and suggests that EspG proteins are specific chaperones for the type VII pathway.	[Daleke, Maria H.; van der Woude, Aniek D.; Ummels, Roy; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands; [Daleke, Maria H.; van der Woude, Aniek D.; de Groot, A. Marit; Watson, David; Luirink, Joen; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Parret, Annabel H. A.] Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Piersma, Sander R.; Jimenez, Connie R.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, OncoProte Lab, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL); Vrije Universiteit Amsterdam	Houben, ENG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	e.houben@vumc.nl	Bitter, Wilbert/ABG-3726-2020; Luirink, Joen/AAB-8658-2021; Bitter, Wilbert/AAA-6872-2019; Jimenez, Connie/AAI-3763-2020; Houben, Edith N.G./B-2110-2015; Bitter, W/CAJ-5778-2022	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; Parret, Annabel/0000-0003-0635-8890; Jimenez, Connie R/0000-0002-3103-4508; van der Woude, Aniek/0000-0002-7786-9893	Netherlands Organization for Scientific Research; European Community [201762]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by funding from an Earth and Life Sciences (ALW) Open Program grant (to M. H. D.) and an Excellent CHemical Research (ECHO) grant (to A. D. v. d. W.), both from The Netherlands Organization for Scientific Research, and by the European Community Seventh Framework Programme (FP7/2007-2013) under Grant 201762 (to W. B.).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Bottai D, 2011, J INFECT DIS, V203, P1155, DOI 10.1093/infdis/jiq089; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Hayward CMM, 1999, VACCINE, V17, P1272, DOI 10.1016/S0264-410X(98)00350-8; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Puttinaowarat S., 2000, Fish Veterinary Journal, P6; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003	30	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31939	31947		10.1074/jbc.M112.397596	http://dx.doi.org/10.1074/jbc.M112.397596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843727	hybrid, Green Published			2022-12-28	WOS:000309059400033
J	Kim, HG; Kim, DJ; Li, SQ; Lee, KY; Li, X; Bode, AM; Dong, ZG				Kim, Hong-Gyum; Kim, Dong Joon; Li, Shengqing; Lee, Kun Yeong; Li, Xiang; Bode, Ann M.; Dong, Zigang			Polycomb (PcG) Proteins, BMI1 and SUZ12, Regulate Arsenic-induced Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MALIGNANT-TRANSFORMATION; HUMAN KERATINOCYTE TRANSFORMATION; TRITHORAX GROUP PROTEINS; TUMOR-SUPPRESSOR LOCUS; EPITHELIAL-CELLS; LUNG-CANCER; MEDIATED REPRESSION; DNA METHYLATION; GENE; P16(INK4A)	Inorganic arsenic is a well-documented human carcinogen associated with cancers of the skin, lung, liver, and bladder. However, the underlying mechanisms explaining the tumorigenic role of arsenic are not well understood. The present study explored a potential mechanism of cell transformation induced by arsenic exposure. Exposure to a low dose (0.5 mu M) of arsenic trioxide (As2O3) caused transformation of BALB/c 3T3 cells. In addition, in a xenograft mouse model, tumor growth of the arsenic-induced transformed cells was dramatically increased. In arsenic-induced transformed cells, polycomb group (PcG) proteins, including BMI1 and SUZ12, were activated resulting in enhanced histone H3K27 tri-methylation levels. On the other hand, tumor suppressor p16(INK4a) and p19(ARF) mRNA and protein expression were dramatically suppressed. Introduction of small hairpin (sh) RNA-BMI1 or -SUZ12 into BALB/c 3T3 cells resulted in suppression of arsenic-induced transformation. Histone H3K27 tri-methylation returned to normal in BMI1- or SUZ12-knockdown BALB/c 3T3 cells compared with BMI1- or SUZ12-wildtype cells after arsenic exposure. As a consequence, the expression of p16(INK4a) and p19(ARF) was recovered in arsenic-treated BMI1- or SUZ12-knockdown cells. Thus, arsenic-induced cell transformation was blocked by inhibition of PcG function. Taken together, these results strongly suggest that the polycomb proteins, BMI1 and SUZ12 are required for cell transformation induced by organic arsenic exposure.	[Kim, Hong-Gyum; Kim, Dong Joon; Li, Shengqing; Lee, Kun Yeong; Li, Xiang; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Kim, Dong Joon/AAL-8967-2020		Hormel Foundation; National Institutes of Health [ES016548, R37 CA081064, CA120388, CA077646]; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and National Institutes of Health Grants ES016548, R37 CA081064, CA120388, and CA077646.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P243, DOI 10.1289/ehp.9630; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Gebel TW, 1999, SCIENCE, V283, P1458; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang YL, 2008, CANCER RES, V68, P9131, DOI 10.1158/0008-5472.CAN-08-3025; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; KAKUNAGA T, 1973, INT J CANCER, V12, P463, DOI 10.1002/ijc.2910120217; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Lee MO, 2011, J THORAC ONCOL, V6, P423, DOI 10.1097/JTO.0b013e3182018ace; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Liu J, 2006, TOXICOL APPL PHARM, V216, P407, DOI 10.1016/j.taap.2006.06.006; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muramatsu D, 2009, MUTAT RES-GEN TOX EN, V675, P66, DOI 10.1016/j.mrgentox.2009.02.008; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Pizzatti L, 2010, GENE CHROMOSOME CANC, V49, P107, DOI 10.1002/gcc.20722; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srivastav RK, 2011, BIOCHEM J, V438, P495, DOI 10.1042/BJ20110035; Tie F, 2001, DEVELOPMENT, V128, P275; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wen GY, 2008, MOL MED, V14, P2, DOI 10.2119/2007-00090.Wen; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063	46	26	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31920	31928		10.1074/jbc.M112.360362	http://dx.doi.org/10.1074/jbc.M112.360362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22843710	Green Published, hybrid			2022-12-28	WOS:000309059400031
J	Maclean, KN; Greiner, LS; Evans, JR; Sood, SK; Lhotak, S; Markham, NE; Stabler, SP; Allen, RH; Austin, RC; Balasubramaniam, V; Jiang, H				Maclean, Kenneth N.; Greiner, Lori S.; Evans, Jeffrey R.; Sood, Sudesh K.; Lhotak, Sarka; Markham, Neil E.; Stabler, Sally P.; Allen, Robert H.; Austin, Richard C.; Balasubramaniam, Vivek; Jiang, Hua			Cystathionine Protects against Endoplasmic Reticulum Stress-induced Lipid Accumulation, Tissue Injury, and Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE DEFICIENT HOMOCYSTINURIA; BETA-SYNTHASE; ALANINE AMINOTRANSFERASE; URINARY CYSTATHIONINE; GAMMA-CYSTATHIONASE; GSH EXTRUSION; MOUSE MODEL; GUINEA-PIGS; IN-VITRO; HOMOCYSTEINE	Cystathionine (R-S-(2-amino-2-carboxyethyl)-L-homocysteine) is a non-proteinogenic thioether containing amino acid. In mammals, cystathionine is formed as an intermediate of the transsulfuration pathway by the condensation of serine and homocysteine (Hcy) in a reaction catalyzed by cystathionine beta-synthase (CBS). Cystathionine is subsequently converted to cysteine plus ammonia and alpha-ketobutyrate by the action of cystathionine gamma-lyase (CGL). Pathogenic mutations in CBS result in CBS-deficient homocystinuria (HCU) which, if untreated, results in mental retardation, thromboembolic complications and connective tissue disorders. Currently there is no known function for cystathionine other than serving as an intermediate in transsulfuration and to date, the possible contribution of the abolition of cystathionine synthesis to pathogenesis in HCU has not been investigated. Using both mouse and cell-culture models, we have found that cystathionine is capable of blocking the induction of hepatic steatosis and kidney injury, acute tubular necrosis, and apoptotic cell death by the endoplasmic reticulum stress inducing agent tunicamycin. Northern and Western blotting analysis indicate that the protective effects of cystathionine occur without any obvious alteration of the induction of the unfolded protein response. Our data constitute the first experimental evidence that the abolition of cystathionine synthesis may contribute to the pathology of HCU and that this compound has therapeutic potential for disease states where ER stress is implicated as a primary initiating pathogenic factor.	[Maclean, Kenneth N.; Greiner, Lori S.; Evans, Jeffrey R.; Markham, Neil E.; Balasubramaniam, Vivek; Jiang, Hua] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Stabler, Sally P.; Allen, Robert H.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Sood, Sudesh K.; Lhotak, Sarka; Austin, Richard C.] St Josephs Hosp, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Sood, Sudesh K.; Lhotak, Sarka; Austin, Richard C.] St Josephs Hosp, Dept Med, Hamilton, ON L8N 4A6, Canada; McMaster Univ, Hamilton, ON L8N 4A6, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; McGill University; McMaster University; McGill University; McMaster University; McMaster University	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313, Aurora, CO 80045 USA.	ken.maclean@UCdenver.edu			Heart and Stroke Foundation of Ontario [T-6146]; Canadian Institutes of Health Research [MOP-74477]; Ontario Research and Development Challenge Fund; William R. Hummel Homocystinuria Research Fund; Jerome LeJeune Foundation; Denver Children's Hospital [6703]; St. Joseph's Healthcare Hamilton; Special Products U.K.	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); William R. Hummel Homocystinuria Research Fund; Jerome LeJeune Foundation; Denver Children's Hospital; St. Joseph's Healthcare Hamilton; Special Products U.K.	This work was supported in part by research grants (to R. C. A.) from the Heart and Stroke Foundation of Ontario (T-6146), the Canadian Institutes of Health Research (MOP-74477), and the Ontario Research and Development Challenge Fund. This work was also supported by the William R. Hummel Homocystinuria Research Fund, the Jerome LeJeune Foundation, Special Products U.K., and research award 6703 from the Denver Children's Hospital (to K. N. M.). Financial support from St. Joseph's Healthcare Hamilton is acknowledged.	ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; AW TY, 1984, J BIOL CHEM, V259, P9355; Barber T, 1999, J NUTR, V129, P928, DOI 10.1093/jn/129.5.928; BERGMEYER HU, 1980, J CLIN CHEM CLIN BIO, V18, P521; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; FINNIE JW, 1988, ACTA NEUROPATHOL, V75, P411, DOI 10.1007/BF00687795; FINNIE JW, 1989, PATHOLOGY, V21, P194, DOI 10.3109/00313028909061058; GAULL G, 1972, PEDIATR RES, V6, P538, DOI 10.1203/00006450-197206000-00002; GEISER CF, 1968, CANCER, V22, P856, DOI 10.1002/1097-0142(196810)22:4<856::AID-CNCR2820220424>3.0.CO;2-1; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; GJESSING LR, 1963, SCAND J CLIN LAB INV, V15, P601, DOI 10.3109/00365516309051341; Gurney JG, 1997, J PEDIAT HEMATOL ONC, V19, P428, DOI 10.1097/00043426-199709000-00004; Gurney JG, 1996, CANCER, V78, P532; HAZELTON GA, 1986, J PHARMACOL EXP THER, V237, P341; HELSON L, 1972, CLIN CHEM, V18, P613; HOUGHTON CB, 1991, J BIOCHEM TOXICOL, V6, P221, DOI 10.1002/jbt.2570060308; Hubmacher D, 2005, J BIOL CHEM, V280, P34946, DOI 10.1074/jbc.M504748200; Hutchinson S, 2005, J MOL BIOL, V346, P833, DOI 10.1016/j.jmb.2004.11.038; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; KLEIN CE, 1988, CANCER, V62, P291, DOI 10.1002/1097-0142(19880715)62:2<291::AID-CNCR2820620211>3.0.CO;2-Q; KOJ A, 1986, FOLIA HISTOCHEM CYTO, V24, P7; Kuznetsov G, 1996, P NATL ACAD SCI USA, V93, P8584, DOI 10.1073/pnas.93.16.8584; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; Machida Y, 1995, PHYSIOL CHEM PHYS M, V27, P203; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2004, J BIOL CHEM, V279, P8558, DOI 10.1074/jbc.M310211200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mudd S., 2001, METABOLIC MOL BASES, P2007; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Quere I, 1999, BIOCHEM BIOPH RES CO, V254, P127, DOI 10.1006/bbrc.1998.9079; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SHINOZUKA S, 1982, EUR J BIOCHEM, V124, P377; STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74; VANCE JE, 1985, CAN J BIOCHEM CELL B, V63, P870, DOI 10.1139/o85-108; VOLPE JJ, 1972, BIOL NEONATE, V20, P385; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhang J, 1995, J INHERIT METAB DIS, V18, P675, DOI 10.1007/BF02436756; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	47	46	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31994	32005		10.1074/jbc.M112.355172	http://dx.doi.org/10.1074/jbc.M112.355172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22854956	hybrid, Green Published			2022-12-28	WOS:000309059400038
J	Weeks, SA; Lee, CA; Zhao, Y; Smidansky, ED; August, A; Arnold, JJ; Cameron, CE				Weeks, Spencer A.; Lee, Cheri A.; Zhao, Yan; Smidansky, Eric D.; August, Avery; Arnold, Jamie J.; Cameron, Craig E.			A Polymerase Mechanism-based Strategy for Viral Attenuation and Vaccine Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; DISEASE VIRUS MUTANT; POLIOVIRUS PATHOGENESIS; NUCLEOTIDYL TRANSFER; FUNCTIONAL DOMAINS; ERROR CATASTROPHE; KINETIC-ANALYSIS; DNA-POLYMERASES; FIDELITY; REPLICATION	Live, attenuated vaccines have prevented morbidity and mortality associated with myriad viral pathogens. Development of live, attenuated vaccines has traditionally relied on empirical methods, such as growth in nonhuman cells. These approaches require substantial time and expense to identify vaccine candidates and to determine their mechanisms of attenuation. With these constraints, at least a decade is required for approval of a live, attenuated vaccine for use in humans. We recently reported the discovery of an active site lysine residue that contributes to the catalytic efficiency of all nucleic acid polymerases (Castro, C., Smidansky, E. D., Arnold, J. J., Maksimchuk, K. R., Moustafa, I., Uchida, A., Gotte, M., Konigsberg, W., and Cameron, C. E. ( 2009) Nat. Struct. Mol. Biol. 16, 212-218). Here we use a model RNA virus and its polymerase to show that mutation of this residue from lysine to arginine produces an attenuated virus that is genetically stable and elicits a protective immune response. Given the conservation of this residue in all viral polymerases, this study suggests that a universal, mechanism-based strategy may exist for viral attenuation and vaccine development.	[Weeks, Spencer A.; Lee, Cheri A.; Zhao, Yan; Smidansky, Eric D.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	cec9@psu.edu			National Institutes of Health Grant [AI053531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053531, R56AI053531] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI053531 (to C. E. C.).	Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; Goetz KB, 2010, NAT BIOTECHNOL, V28, P910, DOI 10.1038/nbt0910-910; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; NOMOTO A, 1982, P NATL ACAD SCI-BIOL, V79, P5793, DOI 10.1073/pnas.79.19.5793; Oh HS, 2009, J VIROL, V83, P9370, DOI 10.1128/JVI.02076-08; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867	30	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31618	31622		10.1074/jbc.C112.401471	http://dx.doi.org/10.1074/jbc.C112.401471			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22854962	Green Published, hybrid			2022-12-28	WOS:000309059400001
